Citrus Sinensis ID: 014347
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 426 | 2.2.26 [Sep-21-2011] | |||||||
| Q8RWC9 | 444 | CBL-interacting serine/th | yes | no | 0.880 | 0.844 | 0.726 | 1e-159 | |
| Q94C40 | 432 | CBL-interacting serine/th | no | no | 0.854 | 0.842 | 0.702 | 1e-154 | |
| Q9LGV5 | 461 | CBL-interacting protein k | yes | no | 0.875 | 0.809 | 0.693 | 1e-152 | |
| Q0D4B2 | 525 | CBL-interacting protein k | no | no | 0.856 | 0.695 | 0.702 | 1e-152 | |
| Q75L42 | 454 | CBL-interacting protein k | no | no | 0.849 | 0.797 | 0.671 | 1e-146 | |
| Q2V452 | 441 | CBL-interacting serine/th | no | no | 0.884 | 0.854 | 0.530 | 1e-121 | |
| Q6ZLP5 | 450 | CBL-interacting protein k | no | no | 0.854 | 0.808 | 0.547 | 1e-120 | |
| Q2QY53 | 438 | CBL-interacting protein k | no | no | 0.873 | 0.849 | 0.525 | 1e-119 | |
| Q2RAX3 | 454 | CBL-interacting protein k | no | no | 0.835 | 0.784 | 0.548 | 1e-118 | |
| Q84VQ3 | 439 | CBL-interacting serine/th | no | no | 0.847 | 0.822 | 0.532 | 1e-118 |
| >sp|Q8RWC9|CIPK1_ARATH CBL-interacting serine/threonine-protein kinase 1 OS=Arabidopsis thaliana GN=CIPK1 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 560 bits (1444), Expect = e-159, Method: Compositional matrix adjust.
Identities = 273/376 (72%), Positives = 328/376 (87%), Gaps = 1/376 (0%)
Query: 5 EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
+K ++GMRLG+YELGRTLGEGNFGKVKFA+D SG FAVKI++K+RI L + QIKRE
Sbjct: 9 KKAEKGMRLGKYELGRTLGEGNFGKVKFAKDTVSGHSFAVKIIDKSRIADLNFSLQIKRE 68
Query: 65 IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
I TLK+LKHP++VRLHEVLASK+KI MV+E VTGGELFD+I S G+L E +GRK+FQQLI
Sbjct: 69 IRTLKMLKHPHIVRLHEVLASKTKINMVMELVTGGELFDRIVSNGKLTETDGRKMFQQLI 128
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
DG+SYCH+KGVFHRDLKLEN+LLD+KG+IKI+DFGLSALPQHFRDDGLLHTTCGSPNYVA
Sbjct: 129 DGISYCHSKGVFHRDLKLENVLLDAKGHIKITDFGLSALPQHFRDDGLLHTTCGSPNYVA 188
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
PEVLANRGYDGA SDIWSCGVILYVILTG LPFDDRNLAVLYQKI +GD +P+WLSPGA
Sbjct: 189 PEVLANRGYDGAASDIWSCGVILYVILTGCLPFDDRNLAVLYQKICKGDPPIPRWLSPGA 248
Query: 245 QNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP-DDDEEDIFVDNEAFSMHEVPSDG 303
+ +++++L+PNPV RIT+ GIKA EWF+ +Y P+ P DDDEE++ D++AFS+ E+ S+
Sbjct: 249 RTMIKRMLDPNPVTRITVVGIKASEWFKLEYIPSIPDDDDEEEVDTDDDAFSIQELGSEE 308
Query: 304 GRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEM 363
G+ SP +INAFQLIGMSS LDLSGFFE+E+VSER+IRFTSN SAKDLLE+IE VTEM
Sbjct: 309 GKGSDSPTIINAFQLIGMSSFLDLSGFFEQENVSERRIRFTSNSSAKDLLEKIETAVTEM 368
Query: 364 GFRVQKKNGKVNISSQ 379
GF VQKK+ K+ + +
Sbjct: 369 GFSVQKKHAKLRVKQE 384
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q94C40|CIPKH_ARATH CBL-interacting serine/threonine-protein kinase 17 OS=Arabidopsis thaliana GN=CIPK17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 545 bits (1404), Expect = e-154, Method: Compositional matrix adjust.
Identities = 257/366 (70%), Positives = 310/366 (84%), Gaps = 2/366 (0%)
Query: 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
+GMR+G+YELGRTLGEGN KVKFA D +G FA+KI+EK+ I L ++ QIKREI TL
Sbjct: 4 KGMRVGKYELGRTLGEGNSAKVKFAIDTLTGESFAIKIIEKSCITRLNVSFQIKREIRTL 63
Query: 69 KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
K+LKHPN+VRLHEVLASK+KIYMVLE VTGG+LFD+I SKG+L E +GRK+FQQLIDGVS
Sbjct: 64 KVLKHPNIVRLHEVLASKTKIYMVLECVTGGDLFDRIVSKGKLSETQGRKMFQQLIDGVS 123
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
YCHNKGVFHRDLKLEN+LLD+KG+IKI+DFGLSAL QH+R+DGLLHTTCGSPNYVAPEVL
Sbjct: 124 YCHNKGVFHRDLKLENVLLDAKGHIKITDFGLSALSQHYREDGLLHTTCGSPNYVAPEVL 183
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 248
AN GYDGA SDIWSCGVILYVILTG LPFDD NLAV+ +KIF+GD +P+W+S GA+ ++
Sbjct: 184 ANEGYDGAASDIWSCGVILYVILTGCLPFDDANLAVICRKIFKGDPPIPRWISLGAKTMI 243
Query: 249 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPG 308
+++L+PNPV R+TIAGIKA +WF+ DYTP+N DDD++ + + F M E + ++P
Sbjct: 244 KRMLDPNPVTRVTIAGIKAHDWFKHDYTPSNYDDDDDVYLIQEDVFMMKEYEEE--KSPD 301
Query: 309 SPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQ 368
SP +INAFQLIGMSS LDLSGFFE E +SER+IRFTSN AKDLLE IE I TEMGF +Q
Sbjct: 302 SPTIINAFQLIGMSSFLDLSGFFETEKLSERQIRFTSNSLAKDLLENIETIFTEMGFCLQ 361
Query: 369 KKNGKV 374
KK+ K+
Sbjct: 362 KKHAKL 367
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LGV5|CIPK1_ORYSJ CBL-interacting protein kinase 1 OS=Oryza sativa subsp. japonica GN=CIPK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 540 bits (1390), Expect = e-152, Method: Compositional matrix adjust.
Identities = 263/379 (69%), Positives = 315/379 (83%), Gaps = 6/379 (1%)
Query: 1 MVIAEKKQEGMR---LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI 57
MV E + E R LGRYE+GRTLGEGNFGKVK+A+ L +G FA+KIL++N+I+ L+
Sbjct: 1 MVNGEAEAECTRASLLGRYEIGRTLGEGNFGKVKYARHLATGAHFAIKILDRNKILSLRF 60
Query: 58 TDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR 117
DQI+REI TLKLLKHPNVVRLHEV ASK+KIYMVLEYV GGELFDKIA KG+L E EGR
Sbjct: 61 DDQIRREIGTLKLLKHPNVVRLHEVAASKTKIYMVLEYVNGGELFDKIAVKGKLSEHEGR 120
Query: 118 KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 177
+LFQQLID VSYCH+KGV+HRDLK EN+L+D +GNIKISDFGLSALPQH +DGLLHTTC
Sbjct: 121 RLFQQLIDAVSYCHDKGVYHRDLKPENVLVDRRGNIKISDFGLSALPQHLGNDGLLHTTC 180
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP 237
GSPNY+APEVL NRGYDG+ SDIWSCGVILYV+L GYLPFDDRNL VLYQKIF+GD ++P
Sbjct: 181 GSPNYIAPEVLQNRGYDGSLSDIWSCGVILYVMLVGYLPFDDRNLVVLYQKIFKGDTQIP 240
Query: 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMH 297
KWLSP A++LLR+ILEPNP+KRI IAGIK EWF++DYTP P DD++D ++D+ +
Sbjct: 241 KWLSPSARDLLRRILEPNPMKRINIAGIKEHEWFQKDYTPVVPYDDDDDNYLDS-VLPIK 299
Query: 298 EVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIE 357
E + + P INAFQLIGM+S LDLSGFFE+ED S+RKIRFTS HS KDL ++IE
Sbjct: 300 EQIDEAKQE--KPTHINAFQLIGMASALDLSGFFEEEDASQRKIRFTSTHSPKDLFDKIE 357
Query: 358 DIVTEMGFRVQKKNGKVNI 376
++VTEMGF+VQ+ N K+ +
Sbjct: 358 NVVTEMGFQVQRGNSKLKV 376
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D4B2|CIPKL_ORYSJ CBL-interacting protein kinase 21 OS=Oryza sativa subsp. japonica GN=CIPK21 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 537 bits (1383), Expect = e-152, Method: Compositional matrix adjust.
Identities = 258/367 (70%), Positives = 304/367 (82%), Gaps = 2/367 (0%)
Query: 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
MR+G+YE+GR LGEG+FGKVK A+ D+G FA+KIL++ RI+ +KI +QIKREIATLK
Sbjct: 81 AMRMGKYEMGRALGEGHFGKVKLARHADTGAAFAIKILDRQRILAMKIDEQIKREIATLK 140
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
LLKHPNVVRLHEV ASK+KIYMVLEYV GGELFDKIA KG+L E EGRKLFQQL+D VSY
Sbjct: 141 LLKHPNVVRLHEVSASKTKIYMVLEYVNGGELFDKIALKGKLSEKEGRKLFQQLMDAVSY 200
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
CH KGV+HRDLK EN+L+D+KGNIK+SDFGLSALPQ+ R DGLLHTTCGSPNY+APEVL
Sbjct: 201 CHEKGVYHRDLKPENVLVDAKGNIKVSDFGLSALPQNQRKDGLLHTTCGSPNYIAPEVLL 260
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 249
NRGYDG+ SDIWSCGVILYV+LTG LPFDD+N VLYQKI +GD ++PKWLSPGAQ++LR
Sbjct: 261 NRGYDGSLSDIWSCGVILYVMLTGNLPFDDQNTVVLYQKILKGDARIPKWLSPGAQDILR 320
Query: 250 KILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGS 309
KIL+PNP+ R+ I GI+A EWF QDYTPA P DD++D + + M E + T +
Sbjct: 321 KILDPNPITRLDITGIRAHEWFRQDYTPAMPFDDDDDNNISDGNLHMTE--NQDIETSPA 378
Query: 310 PPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQK 369
INAFQLIGMSSCLDLSGFFEKEDVSERKIRF SN+S L E+IE VTE GF+VQK
Sbjct: 379 ISQINAFQLIGMSSCLDLSGFFEKEDVSERKIRFVSNYSPTSLFEKIESTVTEKGFQVQK 438
Query: 370 KNGKVNI 376
+GK+ +
Sbjct: 439 NSGKLKV 445
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q75L42|CIPKH_ORYSJ CBL-interacting protein kinase 17 OS=Oryza sativa subsp. japonica GN=CIPK17 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 517 bits (1332), Expect = e-146, Method: Compositional matrix adjust.
Identities = 245/365 (67%), Positives = 302/365 (82%), Gaps = 3/365 (0%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
LG YE+GRTLGEGNFGKVK+A+ L +G FAVKIL++ R++ L+ DQI+REIATLKLL+
Sbjct: 10 LGGYEMGRTLGEGNFGKVKYARHLATGGHFAVKILDRGRVVSLRAGDQIRREIATLKLLR 69
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
HP+VVRLHEV ASK+KIYMVLE+V GGELF++IA KG+L E EGR+LFQQLIDGVSYCH+
Sbjct: 70 HPHVVRLHEVAASKTKIYMVLEFVNGGELFERIAVKGKLSEKEGRRLFQQLIDGVSYCHD 129
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
+GV+HRDLK EN+L+D KGNIKISDFGLSALPQH +DGLLHTTCGSPNY+APEVL N+G
Sbjct: 130 RGVYHRDLKPENVLVDQKGNIKISDFGLSALPQHLGNDGLLHTTCGSPNYIAPEVLQNKG 189
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 252
YDG+ SDIWSCGVILYV+L GYLPFDDRN+ VLYQKIF+GD ++PKWLS AQNLLR+IL
Sbjct: 190 YDGSLSDIWSCGVILYVMLIGYLPFDDRNIVVLYQKIFKGDTQIPKWLSHSAQNLLRRIL 249
Query: 253 EPNPVKRITIAGIKADEWFEQDYTPANP-DDDEEDIFVDNEAFSMHEVPSDGGRTPGSPP 311
EPNP+KRI +AGIK+ EWF++DY P P DDD+ED+ + ++ + G +
Sbjct: 250 EPNPMKRIDMAGIKSHEWFQKDYIPVLPYDDDDEDVQFGARLPAKEQINDEPGDK--NSH 307
Query: 312 LINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKN 371
INAFQLIGM+S LDLSGFFE E+VS+R+IRFTS H KD ++IE TE+GF+VQ+ +
Sbjct: 308 QINAFQLIGMASSLDLSGFFEDEEVSQRRIRFTSTHPPKDAFDKIESSATELGFQVQRGH 367
Query: 372 GKVNI 376
K+ +
Sbjct: 368 SKLKL 372
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2V452|CIPK3_ARATH CBL-interacting serine/threonine-protein kinase 3 OS=Arabidopsis thaliana GN=CIPK3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 434 bits (1117), Expect = e-121, Method: Compositional matrix adjust.
Identities = 210/396 (53%), Positives = 285/396 (71%), Gaps = 19/396 (4%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
++Q R+G+YE+GRT+GEG F KVKFA++ ++G P A+KIL+K +++ K+ +QI+REI
Sbjct: 4 RQQVKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREI 63
Query: 66 ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID 125
AT+KL+KHPNVV+L+EV+ASK+KI+++LEYVTGGELFDKI + GR++E E R+ FQQLI
Sbjct: 64 ATMKLIKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIH 123
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
V YCH++GV+HRDLK EN+LLDS GN+KISDFGLSAL Q RDDGLLHT+CG+PNYVAP
Sbjct: 124 AVDYCHSRGVYHRDLKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAP 183
Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ 245
EVL +RGYDGAT+D+WSCGV+LYV+L GYLPFDD NL LY+KI G+F P WLS GA
Sbjct: 184 EVLNDRGYDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLYKKISSGEFNCPPWLSLGAM 243
Query: 246 NLLRKILEPNPVKRITIAGIKADEWFEQDYTPA-------NPDDDEEDIFVDNEAFSMHE 298
L+ +IL+PNP+ R+T + DEWF++DY P + DD + +F D+E + E
Sbjct: 244 KLITRILDPNPMTRVTPQEVFEDEWFKKDYKPPVFEERDDSNMDDIDAVFKDSEEHLVTE 303
Query: 299 VPSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIED 358
+ P INAF++I MS L+L F+ E +R+ R T A +++E+IE+
Sbjct: 304 ------KREEQPAAINAFEIISMSRGLNLENLFDPEQEFKRETRITLRGGANEIIEKIEE 357
Query: 359 IVTEMGFRVQKKNGKVNISSQLTHFNIKTSVISNIN 394
+GF VQKKN K+ + N+K N+N
Sbjct: 358 AAKPLGFDVQKKNYKMRLE------NVKAGRKGNLN 387
|
Involved in the resistance to some abiotic stresses (e.g. high salt, hyperosmotic stress) in young seedlings, by regulating the expression of several stress-inducible genes (cold-and salt-induced genes but not drought-responsive genes). Required for the ABA response during germination. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6ZLP5|CIPKN_ORYSJ CBL-interacting protein kinase 23 OS=Oryza sativa subsp. japonica GN=CIPK23 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 432 bits (1111), Expect = e-120, Method: Compositional matrix adjust.
Identities = 206/376 (54%), Positives = 278/376 (73%), Gaps = 12/376 (3%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
R+GRYELGRTLGEG F KVKFA++ DSG A+KIL+K++++ K+ QIKREI+T+KL+
Sbjct: 9 RVGRYELGRTLGEGTFAKVKFARNADSGENVAIKILDKDKVLKHKMIAQIKREISTMKLI 68
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
+HPNV+R+HEV+ASK+KIY+V+E VTGGELFDKIAS+GRL+E + RK FQQLI+ V YCH
Sbjct: 69 RHPNVIRMHEVMASKTKIYIVMELVTGGELFDKIASRGRLKEDDARKYFQQLINAVDYCH 128
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
++GV+HRDLK EN+LLD+ G +K+SDFGLSAL Q R+DGLLHTTCG+PNYVAPEV+ N+
Sbjct: 129 SRGVYHRDLKPENLLLDASGTLKVSDFGLSALSQQVREDGLLHTTCGTPNYVAPEVINNK 188
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251
GYDGA +D+WSCGVIL+V++ GYLPF+D NL LY+KIF+ DF P W S A+ L++KI
Sbjct: 189 GYDGAKADLWSCGVILFVLMAGYLPFEDSNLMSLYKKIFKADFSCPSWFSTSAKKLIKKI 248
Query: 252 LEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVD------NEAFSMHEVPSDGGR 305
L+PNP RITIA + +EWF++ Y P P + D+ +D NE+ ++ + R
Sbjct: 249 LDPNPSTRITIAELINNEWFKKGYQP--PRFETADVNLDDINSIFNESGDQTQLVVE--R 304
Query: 306 TPGSPPLINAFQLIGMSSCLDLSGFFEKEDVS--ERKIRFTSNHSAKDLLERIEDIVTEM 363
P ++NAF+LI S L+L FEK+ +R+ RF S A ++L +IE M
Sbjct: 305 REERPSVMNAFELISTSQGLNLGTLFEKQSQGSVKRETRFASRLPANEILSKIEAAAGPM 364
Query: 364 GFRVQKKNGKVNISSQ 379
GF VQK+N K+ + +
Sbjct: 365 GFNVQKRNYKLKLQGE 380
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2QY53|CIPKW_ORYSJ CBL-interacting protein kinase 32 OS=Oryza sativa subsp. japonica GN=CIPK32 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 427 bits (1097), Expect = e-119, Method: Compositional matrix adjust.
Identities = 205/390 (52%), Positives = 280/390 (71%), Gaps = 18/390 (4%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
R+G+YELGRT+GEG F KVKFA+D ++G P A+KIL+K +++ K+ +QIKREI+T+KL+
Sbjct: 9 RVGKYELGRTIGEGTFAKVKFARDTETGDPVAIKILDKEKVLKHKMVEQIKREISTMKLI 68
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
KHPNVVR++EV+ SK+KIY+VLEYVTGGELFD I + GR++E E R+ FQQLI+ V YCH
Sbjct: 69 KHPNVVRIYEVMGSKTKIYIVLEYVTGGELFDTIVNHGRMREDEARRYFQQLINAVDYCH 128
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
++GV+HRDLK EN+LLDS GN+K+SDFGLSAL Q +DDGLLHTTCG+PNYVAPEVL ++
Sbjct: 129 SRGVYHRDLKPENLLLDSYGNLKVSDFGLSALSQQIKDDGLLHTTCGTPNYVAPEVLEDQ 188
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251
GYDGA +D+WSCGVIL+V+L GYLPF+D NL LY+KI +F P W S A+ LL +I
Sbjct: 189 GYDGAMADLWSCGVILFVLLAGYLPFEDSNLMTLYKKISNAEFTFPPWTSFPAKRLLTRI 248
Query: 252 LEPNPVKRITIAGIKADEWFEQDYTPANPD-------DDEEDIFVDNEAFSMHEVPSDGG 304
L+PNP+ R+TI I DEWF++ Y D DD +F D+E + E +
Sbjct: 249 LDPNPMTRVTIPEILEDEWFKKGYKRPEFDEKYDTTLDDVYAVFNDSEEHHVTEKKEE-- 306
Query: 305 RTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMG 364
P +NAF+LI MS+ L+L F+ E +R+ RFTS K+++ +IE+ +G
Sbjct: 307 -----PEALNAFELISMSAGLNLGNLFDSEQEFKRETRFTSKCPPKEIVRKIEEAAKPLG 361
Query: 365 FRVQKKNGKVNI----SSQLTHFNIKTSVI 390
F VQKKN K+ + + + + N+ T ++
Sbjct: 362 FDVQKKNYKLRLEKVKAGRKGNLNVATEIL 391
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2RAX3|CIPKX_ORYSJ CBL-interacting protein kinase 33 OS=Oryza sativa subsp. japonica GN=CIPK33 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 426 bits (1095), Expect = e-118, Method: Compositional matrix adjust.
Identities = 203/370 (54%), Positives = 271/370 (73%), Gaps = 14/370 (3%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
R+G+YELGRT+GEG F KVKFA+D ++G P A+KIL+K +++ K+ +QIKREI+T+KL+
Sbjct: 9 RVGKYELGRTIGEGTFAKVKFARDTETGDPVAIKILDKEKVLKHKMVEQIKREISTMKLI 68
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
KHPNVVR++EV+ SK+ IY+VLEYVTGGELFD I + GR++E E R+ FQQLI+ V YCH
Sbjct: 69 KHPNVVRIYEVMGSKTNIYIVLEYVTGGELFDTIVNHGRMREDEARRYFQQLINAVDYCH 128
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
++GV+HRDLK EN+LLDS GN+K+SDFGLSAL Q +DDGLLHTTCG+PNYVAPEVL ++
Sbjct: 129 SRGVYHRDLKPENLLLDSYGNLKVSDFGLSALSQQIKDDGLLHTTCGTPNYVAPEVLEDQ 188
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251
GYDGA +D+WSCGVIL+V+L GYLPF+D NL LY+KI +F P W S A+ LL +I
Sbjct: 189 GYDGAMADLWSCGVILFVLLAGYLPFEDSNLMTLYKKISNAEFTFPPWTSFPAKRLLTRI 248
Query: 252 LEPNPVKRITIAGIKADEWFEQDYTPANPD-------DDEEDIFVDNEAFSMHEVPSDGG 304
L+PNP+ RITI I DEWF++ Y D DD + +F D+E + E +
Sbjct: 249 LDPNPMTRITIPEILEDEWFKKGYKRPEFDEKYDTTLDDVDAVFNDSEEHHVTEKKEE-- 306
Query: 305 RTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMG 364
P +NAF+LI MS+ L+L F+ E +R+ RFTS K+++ +IE+ +G
Sbjct: 307 -----PEALNAFELISMSAGLNLGNLFDSEQEFKRETRFTSKCPPKEIVRKIEEAAKPLG 361
Query: 365 FRVQKKNGKV 374
F VQKKN K+
Sbjct: 362 FDVQKKNYKI 371
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q84VQ3|CIPKQ_ARATH CBL-interacting serine/threonine-protein kinase 26 OS=Arabidopsis thaliana GN=CIPK26 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 424 bits (1091), Expect = e-118, Method: Compositional matrix adjust.
Identities = 199/374 (53%), Positives = 276/374 (73%), Gaps = 13/374 (3%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
R+G+YE+G+TLG+G F KV+ A + ++G A+KIL+K +++ K+ +QI+REI T+KL+
Sbjct: 9 RVGKYEVGKTLGQGTFAKVRCAVNTETGERVALKILDKEKVLKHKMAEQIRREICTMKLI 68
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
HPNVVRL+EVLASK+KIY+VLE+ TGGELFDKI GRL+E RK FQQLI+ V YCH
Sbjct: 69 NHPNVVRLYEVLASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKYFQQLINAVDYCH 128
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
++GV+HRDLK EN+LLD++GN+K+SDFGLSAL + R DGLLHT CG+PNY APEVL ++
Sbjct: 129 SRGVYHRDLKPENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGTPNYAAPEVLNDQ 188
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251
GYDGAT+D+WSCGVIL+V+L GYLPF+D NL LY+KI G++ P WLSPGA+NL+ +I
Sbjct: 189 GYDGATADLWSCGVILFVLLAGYLPFEDSNLMTLYKKIIAGEYHCPPWLSPGAKNLIVRI 248
Query: 252 LEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE-------DIFVDNEAFSMHEVPSDGG 304
L+PNP+ RITI + D WF+++Y PA ++ EE +F D+E + E +
Sbjct: 249 LDPNPMTRITIPEVLGDAWFKKNYKPAVFEEKEEANLDDVDAVFKDSEEHHVTEKKEE-- 306
Query: 305 RTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMG 364
P +NAF+LI MS LDL FE+E+ +R+ RF + +A DL+++IE+ +G
Sbjct: 307 ----QPTSMNAFELISMSRALDLGNLFEEEEGFKRETRFAAKGAANDLVQKIEEASKPLG 362
Query: 365 FRVQKKNGKVNISS 378
F +QKKN K+ + +
Sbjct: 363 FDIQKKNYKMRLEN 376
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 426 | ||||||
| 255556588 | 436 | CBL-interacting serine/threonine-protein | 0.868 | 0.848 | 0.816 | 0.0 | |
| 224110276 | 474 | predicted protein [Populus trichocarpa] | 0.859 | 0.772 | 0.820 | 0.0 | |
| 356548027 | 446 | PREDICTED: CBL-interacting serine/threon | 0.863 | 0.825 | 0.787 | 1e-173 | |
| 356530499 | 447 | PREDICTED: CBL-interacting serine/threon | 0.887 | 0.845 | 0.746 | 1e-171 | |
| 363807952 | 448 | uncharacterized protein LOC100805710 [Gl | 0.863 | 0.821 | 0.768 | 1e-169 | |
| 357450323 | 465 | CBL-interacting protein kinase [Medicago | 0.859 | 0.787 | 0.782 | 1e-167 | |
| 356558505 | 437 | PREDICTED: CBL-interacting serine/threon | 0.870 | 0.848 | 0.747 | 1e-165 | |
| 359477295 | 392 | PREDICTED: CBL-interacting serine/threon | 0.741 | 0.806 | 0.841 | 1e-161 | |
| 297736814 | 391 | unnamed protein product [Vitis vinifera] | 0.739 | 0.805 | 0.838 | 1e-159 | |
| 357479181 | 446 | CBL-interacting protein kinase [Medicago | 0.863 | 0.825 | 0.734 | 1e-158 |
| >gi|255556588|ref|XP_002519328.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] gi|223541643|gb|EEF43192.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 652 bits (1681), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 306/375 (81%), Positives = 341/375 (90%), Gaps = 5/375 (1%)
Query: 2 VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI 61
++ + GMRLG YELGRTLGEGNFGKVK A+++DSGLPFAVKILEKNRIIHL I+DQI
Sbjct: 1 MVTHQHHNGMRLGNYELGRTLGEGNFGKVKLAKNIDSGLPFAVKILEKNRIIHLNISDQI 60
Query: 62 KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ 121
KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYV GGELFD+IASKG+L EA+GRKLFQ
Sbjct: 61 KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVNGGELFDRIASKGKLPEAQGRKLFQ 120
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
QL+DGVSYCHNKGVFHRDLKLEN+L+D+KGNIKISDFGLSALPQHFRDDGLLHTTCGSPN
Sbjct: 121 QLVDGVSYCHNKGVFHRDLKLENVLVDAKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 180
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLS 241
YVAPE+L+NRGYDGATSD WSCGVILYVILTGYLPFDDRNLAVLYQKIF+GD ++PKWLS
Sbjct: 181 YVAPEILSNRGYDGATSDTWSCGVILYVILTGYLPFDDRNLAVLYQKIFKGDAQIPKWLS 240
Query: 242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPS 301
GAQN++R+IL+PNPV RIT+A IK+DEWF+QDYTPA EEDI +DNE FSMHE+P
Sbjct: 241 SGAQNMIRRILDPNPVTRITMADIKSDEWFKQDYTPA-----EEDIHIDNEGFSMHELPP 295
Query: 302 DGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVT 361
+G SP LINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSN S KDLL++IE+ T
Sbjct: 296 EGESILRSPTLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNRSMKDLLQKIEETAT 355
Query: 362 EMGFRVQKKNGKVNI 376
EMGFR+QKKNGK+ +
Sbjct: 356 EMGFRIQKKNGKLKV 370
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224110276|ref|XP_002315469.1| predicted protein [Populus trichocarpa] gi|116265922|gb|ABJ91209.1| CBL-interacting protein kinase 1 [Populus trichocarpa] gi|222864509|gb|EEF01640.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 646 bits (1667), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 301/367 (82%), Positives = 343/367 (93%), Gaps = 1/367 (0%)
Query: 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
GM+LG+YELGRTLGEGNFGKVK A+++++G PFAVKILEKNRII LKITDQIKREIATLK
Sbjct: 14 GMQLGKYELGRTLGEGNFGKVKLAKNIETGQPFAVKILEKNRIIDLKITDQIKREIATLK 73
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFD+IASKG+L EAEGRK+FQQLIDGVSY
Sbjct: 74 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDRIASKGKLPEAEGRKMFQQLIDGVSY 133
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
CH+KGVFHRDLKLEN+L+D+KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE+L+
Sbjct: 134 CHSKGVFHRDLKLENVLVDAKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEILS 193
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 249
NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF+GD ++PKWLSPGA+N+++
Sbjct: 194 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFKGDAQVPKWLSPGAKNMIK 253
Query: 250 KILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGS 309
+IL+PNPV RIT A IKADEWF+ DYTP + ++++D+++D+ AFS+ E PS+ G +P S
Sbjct: 254 RILDPNPVTRITTADIKADEWFKLDYTPMDSAEEQDDVYIDDAAFSIQEAPSEDG-SPKS 312
Query: 310 PPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQK 369
P LINAFQLIGMSSCLDLSG FEKEDVSERKIRFTSNHS DLLE+IEDIVTEMGFRVQK
Sbjct: 313 PNLINAFQLIGMSSCLDLSGLFEKEDVSERKIRFTSNHSMSDLLEKIEDIVTEMGFRVQK 372
Query: 370 KNGKVNI 376
+NG+ +
Sbjct: 373 RNGRFQV 379
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356548027|ref|XP_003542405.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 613 bits (1581), Expect = e-173, Method: Compositional matrix adjust.
Identities = 292/371 (78%), Positives = 331/371 (89%), Gaps = 3/371 (0%)
Query: 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
++EGMRLG+YELGRTLGEGNFGKVKFA++ DSG FAVKI+EKN+I+ L IT+QIKREIA
Sbjct: 12 EREGMRLGKYELGRTLGEGNFGKVKFARNTDSGQAFAVKIIEKNKIVDLNITNQIKREIA 71
Query: 67 TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
TLKLL+HPNVVRL+EVLASK+KIYMVLEYV GGELFD IASKG+L E E RKLFQQLIDG
Sbjct: 72 TLKLLRHPNVVRLYEVLASKTKIYMVLEYVNGGELFDIIASKGKLTEGECRKLFQQLIDG 131
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
VSYCH KGVFHRDLKLEN+L+D+KGNIK++DFGLSALPQH R+DGLLHTTCGSPNYVAPE
Sbjct: 132 VSYCHTKGVFHRDLKLENVLVDNKGNIKVTDFGLSALPQHLREDGLLHTTCGSPNYVAPE 191
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246
VLAN+GYDGATSD WSCGVILYV LTGYLPFDDRNL VLYQKIF+GD ++PKWLSPGAQN
Sbjct: 192 VLANKGYDGATSDTWSCGVILYVSLTGYLPFDDRNLVVLYQKIFKGDAQIPKWLSPGAQN 251
Query: 247 LLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDG-GR 305
++R+IL+PNP RIT+AGIK D WF++ Y PANP+D ED+ VDNEAFS HE P++ R
Sbjct: 252 MIRRILDPNPETRITMAGIKEDPWFKKGYIPANPED--EDVHVDNEAFSSHEEPNEAEQR 309
Query: 306 TPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGF 365
GSP LINAFQLIGMSSCLDLSGFFEKEDVSERKIRF S S KDL++RIED VTEM F
Sbjct: 310 NSGSPTLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFASILSVKDLIDRIEDTVTEMEF 369
Query: 366 RVQKKNGKVNI 376
RV+KKNGK+ +
Sbjct: 370 RVEKKNGKLKV 380
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356530499|ref|XP_003533818.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 606 bits (1562), Expect = e-171, Method: Compositional matrix adjust.
Identities = 283/379 (74%), Positives = 339/379 (89%), Gaps = 1/379 (0%)
Query: 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
+ K+++G+RLG+YELG+TLGEGNFGKVK A+D SG FAVKIL+K++II L DQIK
Sbjct: 6 LGRKEEQGVRLGKYELGKTLGEGNFGKVKLARDTHSGKLFAVKILDKSKIIDLNNIDQIK 65
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
REI+TLKLLKHPNVVRL+EVLASK+KIYMVLEYV GGELFDKIASKG+L+EAEGRK+FQQ
Sbjct: 66 REISTLKLLKHPNVVRLYEVLASKTKIYMVLEYVNGGELFDKIASKGKLKEAEGRKIFQQ 125
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
LID VS+CHNKGVFHRDLKLEN+L+D+KGNIKI+DF LSALPQHFR+DGLLHTTCGSPNY
Sbjct: 126 LIDCVSFCHNKGVFHRDLKLENVLVDAKGNIKITDFNLSALPQHFREDGLLHTTCGSPNY 185
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 242
VAPE+LAN+GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF+G+ ++P+WLSP
Sbjct: 186 VAPEILANKGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFKGEVQIPRWLSP 245
Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSD 302
G+QN+++++L+ NP RIT+A IK DEWF++ YTPANP+D+EE +++D+E FS+H+V +
Sbjct: 246 GSQNIIKRMLDANPKTRITMAMIKEDEWFKEGYTPANPEDEEESVYIDDEDFSIHDVSHE 305
Query: 303 GGR-TPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVT 361
+ P SP LINAFQLI MSS LDLSG FE+EDVSERKIRFTS HS KDL+ERIEDIVT
Sbjct: 306 ADQGCPRSPTLINAFQLISMSSSLDLSGLFEQEDVSERKIRFTSIHSPKDLVERIEDIVT 365
Query: 362 EMGFRVQKKNGKVNISSQL 380
EMGFRVQKKNG + + ++
Sbjct: 366 EMGFRVQKKNGMLKVIQEI 384
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|363807952|ref|NP_001242199.1| uncharacterized protein LOC100805710 [Glycine max] gi|255644530|gb|ACU22768.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 602 bits (1553), Expect = e-169, Method: Compositional matrix adjust.
Identities = 285/371 (76%), Positives = 329/371 (88%), Gaps = 3/371 (0%)
Query: 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
++EGMRLG+Y+LGRTLGEGNFGKVKFA++ DSG FAVKI++KN I+ + IT+QI REIA
Sbjct: 14 EREGMRLGKYDLGRTLGEGNFGKVKFARNTDSGQAFAVKIIDKNTIVDINITNQIIREIA 73
Query: 67 TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
TLKLL+HPNVVRL+EVLASK+KIYMVLEYV GGELFD IASKG+ E EGRKLFQQLIDG
Sbjct: 74 TLKLLRHPNVVRLYEVLASKTKIYMVLEYVNGGELFDIIASKGKHIEGEGRKLFQQLIDG 133
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
VSYCH KGVFHRDLKLEN+L+D+KGNIKI+DFGLSALPQH R+DGLLHTTCGSPNYVAPE
Sbjct: 134 VSYCHTKGVFHRDLKLENVLVDNKGNIKITDFGLSALPQHLREDGLLHTTCGSPNYVAPE 193
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246
VLAN+GYDGATSD WSCGVILYVIL G+LPFDDRNL VLYQKIF+GD ++PKWL+PGA+N
Sbjct: 194 VLANKGYDGATSDTWSCGVILYVILPGHLPFDDRNLVVLYQKIFKGDVQIPKWLTPGARN 253
Query: 247 LLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDG-GR 305
++R+IL+PNP RIT+AGIK D WF++ Y P NP+D ED++VD EAFS+HE P++ R
Sbjct: 254 MIRRILDPNPETRITMAGIKEDPWFKKGYIPVNPED--EDVYVDQEAFSIHEQPNEAEQR 311
Query: 306 TPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGF 365
GSP LINAFQLIGMSSCLDLSGFFEKEDVSERKIRF SN S KDL+ERIED TEM F
Sbjct: 312 NSGSPSLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFASNLSVKDLIERIEDTATEMEF 371
Query: 366 RVQKKNGKVNI 376
RV+KKNGK+ +
Sbjct: 372 RVEKKNGKLKV 382
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357450323|ref|XP_003595438.1| CBL-interacting protein kinase [Medicago truncatula] gi|355484486|gb|AES65689.1| CBL-interacting protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 593 bits (1529), Expect = e-167, Method: Compositional matrix adjust.
Identities = 288/368 (78%), Positives = 331/368 (89%), Gaps = 2/368 (0%)
Query: 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
+RLG+YELG+TLGEGNFGKVK A+D D G FAVKILEKN+I+ L TDQIKREI+TLKL
Sbjct: 15 VRLGKYELGKTLGEGNFGKVKLARDTDCGQFFAVKILEKNKIVDLNNTDQIKREISTLKL 74
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
LKHPNVVRL+EVLASK+KIYMVLEYV GGELFDKI+SKG+L EA GRK+FQQLIDGVSYC
Sbjct: 75 LKHPNVVRLYEVLASKTKIYMVLEYVNGGELFDKISSKGKLTEAHGRKMFQQLIDGVSYC 134
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
HNKGVFHRDLKLEN+L+D+KGNIKI+DF LSALPQH R DGLLHTTCGSPNYVAPE+LAN
Sbjct: 135 HNKGVFHRDLKLENVLVDAKGNIKITDFNLSALPQHCRADGLLHTTCGSPNYVAPEILAN 194
Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 250
RGYDGA SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF+ D ++P+WLSPGAQN+++K
Sbjct: 195 RGYDGAKSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFKADVQIPRWLSPGAQNIIKK 254
Query: 251 ILEPNPVKRITIAGIKADEWFEQDYTPAN--PDDDEEDIFVDNEAFSMHEVPSDGGRTPG 308
IL+PNP R+T+ IK DEWF++ Y PAN +++EED+F+D+EAFS+HEV DG ++P
Sbjct: 255 ILDPNPKTRVTMDMIKEDEWFKEGYNPANLEDEEEEEDVFIDDEAFSIHEVSLDGDQSPK 314
Query: 309 SPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQ 368
SP LINAFQLIGMSSCLDLSGFFE+EDVSERKIRFTSNHS KDL E+IEDIV EMGF+V
Sbjct: 315 SPALINAFQLIGMSSCLDLSGFFEQEDVSERKIRFTSNHSPKDLTEKIEDIVIEMGFKVH 374
Query: 369 KKNGKVNI 376
KKNGK+ +
Sbjct: 375 KKNGKLKV 382
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356558505|ref|XP_003547546.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 588 bits (1516), Expect = e-165, Method: Compositional matrix adjust.
Identities = 279/373 (74%), Positives = 331/373 (88%), Gaps = 2/373 (0%)
Query: 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
+GMRLG+YELG+TLGEGNFGKVK A+D SG FAVKIL+K++II L TDQIKREI TL
Sbjct: 12 QGMRLGKYELGKTLGEGNFGKVKLARDTHSGKLFAVKILDKSKIIDLNNTDQIKREIFTL 71
Query: 69 KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
KLLKHPNVVRL+EVLASK+KIYMVLEYV GGELFDKIASKG+L+EA GRK+FQQLID VS
Sbjct: 72 KLLKHPNVVRLYEVLASKTKIYMVLEYVNGGELFDKIASKGKLKEAVGRKIFQQLIDCVS 131
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
+CHNKGVFHRDLKLEN+L+D+KGNIKI+DF LSALPQHFR DGLLHTTCGSPNYVAPE+L
Sbjct: 132 FCHNKGVFHRDLKLENVLVDAKGNIKITDFNLSALPQHFRADGLLHTTCGSPNYVAPEIL 191
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 248
AN+GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI +G+ ++P+WLSPG+QN++
Sbjct: 192 ANKGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKILKGEVQIPRWLSPGSQNII 251
Query: 249 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGR-TP 307
+++L+ N RIT+A IK DEWF++ Y+PANP+D+EE +++D E FS+H+V + + +P
Sbjct: 252 KRMLDVNLKTRITMAMIKEDEWFKEGYSPANPEDEEESVYID-EDFSIHDVSLEADQGSP 310
Query: 308 GSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRV 367
SP LINAFQLI MSS LDLSG FE+EDVSERKIRFTS HS KDL+ER+EDIVTEMGFRV
Sbjct: 311 RSPTLINAFQLISMSSSLDLSGLFEQEDVSERKIRFTSIHSPKDLVERLEDIVTEMGFRV 370
Query: 368 QKKNGKVNISSQL 380
QKKNG + + ++
Sbjct: 371 QKKNGMLKVVQEI 383
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477295|ref|XP_002275061.2| PREDICTED: CBL-interacting serine/threonine-protein kinase 1-like [Vitis vinifera] gi|229609839|gb|ACQ83535.1| CBL-interacting protein kinase 19 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 574 bits (1479), Expect = e-161, Method: Compositional matrix adjust.
Identities = 266/316 (84%), Positives = 298/316 (94%)
Query: 61 IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
IKREIATLKLLKHPNVVRLHEVLASK+KIYMVLEYVTGGELFD+IAS G+L EAEGRKLF
Sbjct: 14 IKREIATLKLLKHPNVVRLHEVLASKTKIYMVLEYVTGGELFDRIASNGKLSEAEGRKLF 73
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
QQLID VSYCHNKGVFHRDLKLEN+L+DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP
Sbjct: 74 QQLIDAVSYCHNKGVFHRDLKLENVLVDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 133
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL 240
NYVAPE+LANRGYDG+TSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF+GD ++PKWL
Sbjct: 134 NYVAPEILANRGYDGSTSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFKGDAQMPKWL 193
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVP 300
S GA+N++++IL+P P RIT+AGIKADEWF+Q YTPA P+++EEDI VD+EAFS++EVP
Sbjct: 194 SSGAKNIIKRILDPKPETRITMAGIKADEWFKQQYTPAYPEEEEEDIHVDDEAFSIYEVP 253
Query: 301 SDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIV 360
+ ++PGSP LINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNH KDLLE+IEDIV
Sbjct: 254 MEAKKSPGSPNLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHCPKDLLEKIEDIV 313
Query: 361 TEMGFRVQKKNGKVNI 376
TEMGFRV+KKNG++ +
Sbjct: 314 TEMGFRVEKKNGRLKV 329
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297736814|emb|CBI26015.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 568 bits (1464), Expect = e-159, Method: Compositional matrix adjust.
Identities = 265/316 (83%), Positives = 297/316 (93%), Gaps = 1/316 (0%)
Query: 61 IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
IKREIATLKLLKHPNVVRLHEVLASK+KIYMVLEYVTGGELFD+IAS G+L EAEGRKLF
Sbjct: 14 IKREIATLKLLKHPNVVRLHEVLASKTKIYMVLEYVTGGELFDRIASNGKLSEAEGRKLF 73
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
QQLID VSYCHNKGVFHRDLKLEN+L+DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP
Sbjct: 74 QQLIDAVSYCHNKGVFHRDLKLENVLVDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 133
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL 240
NYVAPE+LANRGYDG+TSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF+GD ++PKWL
Sbjct: 134 NYVAPEILANRGYDGSTSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFKGDAQMPKWL 193
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVP 300
S GA+N++++IL+P P RIT+AGIKADEWF+Q YTPA P+++EEDI VD+EAFS++E P
Sbjct: 194 SSGAKNIIKRILDPKPETRITMAGIKADEWFKQQYTPAYPEEEEEDIHVDDEAFSIYE-P 252
Query: 301 SDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIV 360
+ ++PGSP LINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNH KDLLE+IEDIV
Sbjct: 253 MEAKKSPGSPNLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHCPKDLLEKIEDIV 312
Query: 361 TEMGFRVQKKNGKVNI 376
TEMGFRV+KKNG++ +
Sbjct: 313 TEMGFRVEKKNGRLKV 328
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357479181|ref|XP_003609876.1| CBL-interacting protein kinase [Medicago truncatula] gi|355510931|gb|AES92073.1| CBL-interacting protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 565 bits (1457), Expect = e-158, Method: Compositional matrix adjust.
Identities = 271/369 (73%), Positives = 328/369 (88%), Gaps = 1/369 (0%)
Query: 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
EG+RLG+YELGR LGEGNFGKVKFA++ DSG P+A+KI++KN+II L IT+QIKREI L
Sbjct: 19 EGVRLGKYELGRILGEGNFGKVKFARNTDSGQPYAIKIIDKNKIIDLNITNQIKREICAL 78
Query: 69 KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
KLL+HPNVV+L+EVLASK+KIYMVLEYVTG ELFDKIASKG+L E EGRKLFQQLIDGVS
Sbjct: 79 KLLRHPNVVKLYEVLASKTKIYMVLEYVTGEELFDKIASKGKLPEGEGRKLFQQLIDGVS 138
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
YCH+KGVFHRDLKLEN+L+D+KGN+KI+DFGLSALPQ FR DGLLHTTCGS NYVAPE+L
Sbjct: 139 YCHSKGVFHRDLKLENVLVDAKGNLKITDFGLSALPQQFRADGLLHTTCGSANYVAPEIL 198
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 248
ANRGY+GA+SD+WSCGVILYV+LTG+LPFDDRNLAVLYQK+ +GDF+ PKWLS GAQN++
Sbjct: 199 ANRGYNGASSDVWSCGVILYVVLTGFLPFDDRNLAVLYQKVLKGDFQKPKWLSAGAQNII 258
Query: 249 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPG 308
++IL+PNP RIT+A IK D WF++ Y A +D+E+ ++VD++AF++HE+ + ++
Sbjct: 259 KRILDPNPKTRITMAEIKEDLWFKEGYNQAYHEDEEDGVYVDDQAFNIHELSHEEEKSSS 318
Query: 309 SPPL-INAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRV 367
P+ INAFQLIGMSSCLDLSGFFEKEDVSERKIRFT+N SAK L+E+IED VTEM FRV
Sbjct: 319 QSPIRINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTANLSAKVLMEKIEDSVTEMEFRV 378
Query: 368 QKKNGKVNI 376
QKKNGK+ +
Sbjct: 379 QKKNGKMKV 387
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 426 | ||||||
| TAIR|locus:2090537 | 444 | CIPK1 "CBL-interacting protein | 0.880 | 0.844 | 0.732 | 3e-149 | |
| TAIR|locus:2007685 | 432 | CIPK17 "CBL-interacting protei | 0.854 | 0.842 | 0.702 | 2.7e-139 | |
| TAIR|locus:2059279 | 451 | CIPK3 "CBL-interacting protein | 0.899 | 0.849 | 0.533 | 3.8e-110 | |
| TAIR|locus:1005716172 | 439 | CIPK26 "calcineurin B-like pro | 0.861 | 0.835 | 0.540 | 1.3e-107 | |
| TAIR|locus:2009812 | 482 | CIPK23 "CBL-interacting protei | 0.856 | 0.757 | 0.543 | 2.1e-107 | |
| TAIR|locus:2135962 | 445 | CIPK8 "CBL-interacting protein | 0.870 | 0.833 | 0.516 | 5.4e-102 | |
| TAIR|locus:2155233 | 446 | SOS2 "SALT OVERLY SENSITIVE 2" | 0.852 | 0.813 | 0.513 | 1.9e-99 | |
| TAIR|locus:2181047 | 421 | CIPK15 "CBL-interacting protei | 0.915 | 0.926 | 0.475 | 1.4e-94 | |
| TAIR|locus:2126749 | 441 | SIP3 "SOS3-interacting protein | 0.847 | 0.818 | 0.474 | 1.7e-91 | |
| TAIR|locus:2152380 | 439 | CIPK20 "CBL-interacting protei | 0.821 | 0.797 | 0.482 | 2.1e-91 |
| TAIR|locus:2090537 CIPK1 "CBL-interacting protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1457 (517.9 bits), Expect = 3.0e-149, P = 3.0e-149
Identities = 276/377 (73%), Positives = 328/377 (87%)
Query: 5 EKKQE-GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
EKK E GMRLG+YELGRTLGEGNFGKVKFA+D SG FAVKI++K+RI L + QIKR
Sbjct: 8 EKKAEKGMRLGKYELGRTLGEGNFGKVKFAKDTVSGHSFAVKIIDKSRIADLNFSLQIKR 67
Query: 64 EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
EI TLK+LKHP++VRLHEVLASK+KI MV+E VTGGELFD+I S G+L E +GRK+FQQL
Sbjct: 68 EIRTLKMLKHPHIVRLHEVLASKTKINMVMELVTGGELFDRIVSNGKLTETDGRKMFQQL 127
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
IDG+SYCH+KGVFHRDLKLEN+LLD+KG+IKI+DFGLSALPQHFRDDGLLHTTCGSPNYV
Sbjct: 128 IDGISYCHSKGVFHRDLKLENVLLDAKGHIKITDFGLSALPQHFRDDGLLHTTCGSPNYV 187
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPG 243
APEVLANRGYDGA SDIWSCGVILYVILTG LPFDDRNLAVLYQKI +GD +P+WLSPG
Sbjct: 188 APEVLANRGYDGAASDIWSCGVILYVILTGCLPFDDRNLAVLYQKICKGDPPIPRWLSPG 247
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDD-EEDIFVDNEAFSMHEVPSD 302
A+ +++++L+PNPV RIT+ GIKA EWF+ +Y P+ PDDD EE++ D++AFS+ E+ S+
Sbjct: 248 ARTMIKRMLDPNPVTRITVVGIKASEWFKLEYIPSIPDDDDEEEVDTDDDAFSIQELGSE 307
Query: 303 GGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTE 362
G+ SP +INAFQLIGMSS LDLSGFFE+E+VSER+IRFTSN SAKDLLE+IE VTE
Sbjct: 308 EGKGSDSPTIINAFQLIGMSSFLDLSGFFEQENVSERRIRFTSNSSAKDLLEKIETAVTE 367
Query: 363 MGFRVQKKNGKVNISSQ 379
MGF VQKK+ K+ + +
Sbjct: 368 MGFSVQKKHAKLRVKQE 384
|
|
| TAIR|locus:2007685 CIPK17 "CBL-interacting protein kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1363 (484.9 bits), Expect = 2.7e-139, P = 2.7e-139
Identities = 257/366 (70%), Positives = 310/366 (84%)
Query: 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
+GMR+G+YELGRTLGEGN KVKFA D +G FA+KI+EK+ I L ++ QIKREI TL
Sbjct: 4 KGMRVGKYELGRTLGEGNSAKVKFAIDTLTGESFAIKIIEKSCITRLNVSFQIKREIRTL 63
Query: 69 KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
K+LKHPN+VRLHEVLASK+KIYMVLE VTGG+LFD+I SKG+L E +GRK+FQQLIDGVS
Sbjct: 64 KVLKHPNIVRLHEVLASKTKIYMVLECVTGGDLFDRIVSKGKLSETQGRKMFQQLIDGVS 123
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
YCHNKGVFHRDLKLEN+LLD+KG+IKI+DFGLSAL QH+R+DGLLHTTCGSPNYVAPEVL
Sbjct: 124 YCHNKGVFHRDLKLENVLLDAKGHIKITDFGLSALSQHYREDGLLHTTCGSPNYVAPEVL 183
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 248
AN GYDGA SDIWSCGVILYVILTG LPFDD NLAV+ +KIF+GD +P+W+S GA+ ++
Sbjct: 184 ANEGYDGAASDIWSCGVILYVILTGCLPFDDANLAVICRKIFKGDPPIPRWISLGAKTMI 243
Query: 249 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPG 308
+++L+PNPV R+TIAGIKA +WF+ DYTP+N DDD++ + + F M E + ++P
Sbjct: 244 KRMLDPNPVTRVTIAGIKAHDWFKHDYTPSNYDDDDDVYLIQEDVFMMKEYEEE--KSPD 301
Query: 309 SPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQ 368
SP +INAFQLIGMSS LDLSGFFE E +SER+IRFTSN AKDLLE IE I TEMGF +Q
Sbjct: 302 SPTIINAFQLIGMSSFLDLSGFFETEKLSERQIRFTSNSLAKDLLENIETIFTEMGFCLQ 361
Query: 369 KKNGKV 374
KK+ K+
Sbjct: 362 KKHAKL 367
|
|
| TAIR|locus:2059279 CIPK3 "CBL-interacting protein kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1088 (388.1 bits), Expect = 3.8e-110, P = 3.8e-110
Identities = 208/390 (53%), Positives = 283/390 (72%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
++Q R+G+YE+GRT+GEG F KVKFA++ ++G P A+KIL+K +++ K+ +QI+REI
Sbjct: 14 RQQVKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREI 73
Query: 66 ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID 125
AT+KL+KHPNVV+L+EV+ASK+KI+++LEYVTGGELFDKI + GR++E E R+ FQQLI
Sbjct: 74 ATMKLIKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIH 133
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
V YCH++GV+HRDLK EN+LLDS GN+KISDFGLSAL Q RDDGLLHT+CG+PNYVAP
Sbjct: 134 AVDYCHSRGVYHRDLKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAP 193
Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ 245
EVL +RGYDGAT+D+WSCGV+LYV+L GYLPFDD NL LY+KI G+F P WLS GA
Sbjct: 194 EVLNDRGYDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLYKKISSGEFNCPPWLSLGAM 253
Query: 246 NLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEA-FSMHEVPSDGG 304
L+ +IL+PNP+ R+T + DEWF++DY P ++ ++ D +A F E
Sbjct: 254 KLITRILDPNPMTRVTPQEVFEDEWFKKDYKPPVFEERDDSNMDDIDAVFKDSEEHLVTE 313
Query: 305 RTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMG 364
+ P INAF++I MS L+L F+ E +R+ R T A +++E+IE+ +G
Sbjct: 314 KREEQPAAINAFEIISMSRGLNLENLFDPEQEFKRETRITLRGGANEIIEKIEEAAKPLG 373
Query: 365 FRVQKKNGKVNISSQLTHFNIKTSVISNIN 394
F VQKKN K+ + N+K N+N
Sbjct: 374 FDVQKKNYKMRLE------NVKAGRKGNLN 397
|
|
| TAIR|locus:1005716172 CIPK26 "calcineurin B-like protein (CBL)-interacting protein kinase 26" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1064 (379.6 bits), Expect = 1.3e-107, P = 1.3e-107
Identities = 199/368 (54%), Positives = 274/368 (74%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
R+G+YE+G+TLG+G F KV+ A + ++G A+KIL+K +++ K+ +QI+REI T+KL+
Sbjct: 9 RVGKYEVGKTLGQGTFAKVRCAVNTETGERVALKILDKEKVLKHKMAEQIRREICTMKLI 68
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
HPNVVRL+EVLASK+KIY+VLE+ TGGELFDKI GRL+E RK FQQLI+ V YCH
Sbjct: 69 NHPNVVRLYEVLASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKYFQQLINAVDYCH 128
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
++GV+HRDLK EN+LLD++GN+K+SDFGLSAL + R DGLLHT CG+PNY APEVL ++
Sbjct: 129 SRGVYHRDLKPENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGTPNYAAPEVLNDQ 188
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251
GYDGAT+D+WSCGVIL+V+L GYLPF+D NL LY+KI G++ P WLSPGA+NL+ +I
Sbjct: 189 GYDGATADLWSCGVILFVLLAGYLPFEDSNLMTLYKKIIAGEYHCPPWLSPGAKNLIVRI 248
Query: 252 LEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEA-FSMHEVPSDGGRTPGSP 310
L+PNP+ RITI + D WF+++Y PA ++ EE D +A F E + P
Sbjct: 249 LDPNPMTRITIPEVLGDAWFKKNYKPAVFEEKEEANLDDVDAVFKDSEEHHVTEKKEEQP 308
Query: 311 PLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKK 370
+NAF+LI MS LDL FE+E+ +R+ RF + +A DL+++IE+ +GF +QKK
Sbjct: 309 TSMNAFELISMSRALDLGNLFEEEEGFKRETRFAAKGAANDLVQKIEEASKPLGFDIQKK 368
Query: 371 NGKVNISS 378
N K+ + +
Sbjct: 369 NYKMRLEN 376
|
|
| TAIR|locus:2009812 CIPK23 "CBL-interacting protein kinase 23" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1062 (378.9 bits), Expect = 2.1e-107, P = 2.1e-107
Identities = 205/377 (54%), Positives = 283/377 (75%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
R+G+YELGRTLGEG F KVKFA+++++G A+K+++K +++ K+ QIKREI+T+KL+
Sbjct: 27 RVGKYELGRTLGEGTFAKVKFARNVENGDNVAIKVIDKEKVLKNKMIAQIKREISTMKLI 86
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
KHPNV+R+ EV+ASK+KIY VLE+VTGGELFDKI+S GRL+E E RK FQQLI+ V YCH
Sbjct: 87 KHPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDYCH 146
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
++GV+HRDLK EN+LLD+ G +K+SDFGLSALPQ R+DGLLHTTCG+PNYVAPEV+ N+
Sbjct: 147 SRGVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVINNK 206
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251
GYDGA +D+WSCGVIL+V++ GYLPF+D NL LY+KIF+ +F P W S A+ L+++I
Sbjct: 207 GYDGAKADLWSCGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTCPPWFSASAKKLIKRI 266
Query: 252 LEPNPVKRITIAGIKADEWFEQDY-TPA--NPD---DDEEDIFVDN-EAFSMH-EVPSDG 303
L+PNP RIT A + +EWF++ Y P N D DD + IF D+ E+ ++ E +G
Sbjct: 267 LDPNPATRITFAEVIENEWFKKGYKAPKFENADVSLDDVDAIFDDSGESKNLVVERREEG 326
Query: 304 GRTPGSPPLINAFQLIGMSSCLDLSGFFEKE-DVSERKIRFTSNHSAKDLLERIEDIVTE 362
+TP + +NAF+LI S L+L FEK+ + +RK RFTS SA +++ +IE
Sbjct: 327 LKTPVT---MNAFELISTSQGLNLGSLFEKQMGLVKRKTRFTSKSSANEIVTKIEAAAAP 383
Query: 363 MGFRVQKKNGKVNISSQ 379
MGF V+ N K+ ++ +
Sbjct: 384 MGFDVKTNNYKMKLTGE 400
|
|
| TAIR|locus:2135962 CIPK8 "CBL-interacting protein kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1011 (360.9 bits), Expect = 5.4e-102, P = 5.4e-102
Identities = 198/383 (51%), Positives = 278/383 (72%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
++G+YELGRT+GEG F KVKFAQ+ ++G A+KI++++ II K+ DQIKREI+ +KL+
Sbjct: 5 KVGKYELGRTIGEGTFAKVKFAQNTETGESVAMKIVDRSTIIKRKMVDQIKREISIMKLV 64
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
+HP VVRL+EVLAS++KIY++LEY+TGGELFDKI GRL E+E RK F QLIDGV YCH
Sbjct: 65 RHPCVVRLYEVLASRTKIYIILEYITGGELFDKIVRNGRLSESEARKYFHQLIDGVDYCH 124
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
+KGV+HRDLK EN+LLDS+GN+KISDFGLSALP+ + +L TTCG+PNYVAPEVL+++
Sbjct: 125 SKGVYHRDLKPENLLLDSQGNLKISDFGLSALPE--QGVTILKTTCGTPNYVAPEVLSHK 182
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251
GY+GA +DIWSCGVILYV++ GYLPFD+ +L LY KI + +F P + + GA++L+ +I
Sbjct: 183 GYNGAVADIWSCGVILYVLMAGYLPFDEMDLPTLYSKIDKAEFSCPSYFALGAKSLINRI 242
Query: 252 LEPNPVKRITIAGIKADEWFEQDYTPANPDDDE----EDIFVDNEAFSMHEVPSDGGRTP 307
L+PNP RITIA I+ DEWF +DYTP D E +D++ + DG R
Sbjct: 243 LDPNPETRITIAEIRKDEWFLKDYTPVQLIDYEHVNLDDVYAAFDDPEEQTYAQDGTRDT 302
Query: 308 GSPPLINAFQLIGMSSCLDLSGFFEK-EDVSERKIRFTSNHSAKDLLERIEDIVTEMGFR 366
G P +NAF LI +S L+L+ F++ +D + + RF S+ A +L +E + MGF+
Sbjct: 303 G-PLTLNAFDLIILSQGLNLATLFDRGKDSMKHQTRFISHKPANVVLSSMEVVSQSMGFK 361
Query: 367 VQKKNGKVNI----SSQLTHFNI 385
+N K+ + +++ +HF++
Sbjct: 362 THIRNYKMRVEGLSANKTSHFSV 384
|
|
| TAIR|locus:2155233 SOS2 "SALT OVERLY SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 987 (352.5 bits), Expect = 1.9e-99, P = 1.9e-99
Identities = 190/370 (51%), Positives = 261/370 (70%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
R+G+YE+GRT+GEG F KVKFA++ D+G A+KI+ K+ I+ ++ DQIKREI+ +K++
Sbjct: 7 RVGKYEVGRTIGEGTFAKVKFARNTDTGDNVAIKIMAKSTILKNRMVDQIKREISIMKIV 66
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
+HPN+VRL+EVLAS SKIY+VLE+VTGGELFD+I KGRL+E+E RK FQQL+D V++CH
Sbjct: 67 RHPNIVRLYEVLASPSKIYIVLEFVTGGELFDRIVHKGRLEESESRKYFQQLVDAVAHCH 126
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
KGV+HRDLK EN+LLD+ GN+K+SDFGLSALPQ + LL TTCG+PNYVAPEVL+ +
Sbjct: 127 CKGVYHRDLKPENLLLDTNGNLKVSDFGLSALPQEGVE--LLRTTCGTPNYVAPEVLSGQ 184
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251
GYDG+ +DIWSCGVIL+VIL GYLPF + +L LY+KI +F P W S + L+ +I
Sbjct: 185 GYDGSAADIWSCGVILFVILAGYLPFSETDLPGLYRKINAAEFSCPPWFSAEVKFLIHRI 244
Query: 252 LEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE----DIFVDNEAFSMHEVPSDGGRTP 307
L+PNP RI I GIK D WF +Y P ++EE DI + V + R
Sbjct: 245 LDPNPKTRIQIQGIKKDPWFRLNYVPIRAREEEEVNLDDIRAVFDGIEGSYVAENVERND 304
Query: 308 GSPPLINAFQLIGMSSCLDLSGFFEK-EDVSERKIRFTSNHSAKDLLERIEDIVTEMGFR 366
P ++NAF++I +S L+LS F++ +D +R+ RF S +++ IE + MGF+
Sbjct: 305 EGPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFK 364
Query: 367 VQKKNGKVNI 376
+N K +
Sbjct: 365 SHTRNFKTRL 374
|
|
| TAIR|locus:2181047 CIPK15 "CBL-interacting protein kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 941 (336.3 bits), Expect = 1.4e-94, P = 1.4e-94
Identities = 190/400 (47%), Positives = 270/400 (67%)
Query: 5 EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
EKK + L RYE+G+ LG+G F KV A+ L +G A+K+++K RI+ + +T+QIKRE
Sbjct: 2 EKKGSVLML-RYEVGKFLGQGTFAKVYHARHLKTGDSVAIKVIDKERILKVGMTEQIKRE 60
Query: 65 IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
I+ ++LL+HPN+V LHEV+A+KSKIY V+E+V GGELF+K+ S G+L+E RK FQQL+
Sbjct: 61 ISAMRLLRHPNIVELHEVMATKSKIYFVMEHVKGGELFNKV-STGKLREDVARKYFQQLV 119
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
V +CH++GV HRDLK EN+LLD GN+KISDFGLSAL R DGLLHTTCG+P YVA
Sbjct: 120 RAVDFCHSRGVCHRDLKPENLLLDEHGNLKISDFGLSALSDSRRQDGLLHTTCGTPAYVA 179
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
PEV++ GYDG +D+WSCGVIL+V+L GYLPF D NL LY+KI + + K P WL+PGA
Sbjct: 180 PEVISRNGYDGFKADVWSCGVILFVLLAGYLPFRDSNLMELYKKIGKAEVKFPNWLAPGA 239
Query: 245 QNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGG 304
+ LL++IL+PNP R++ I WF + + EE+ VD EA +
Sbjct: 240 KRLLKRILDPNPNTRVSTEKIMKSSWFRKGLQEEVKESVEEETEVDAEAEGNASAEKEKK 299
Query: 305 RTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMG 364
R +NAF++I +S+ DLSG FEK + E ++RFTSN A ++ E++ +I ++
Sbjct: 300 RCIN----LNAFEIISLSTGFDLSGLFEKGEEKE-EMRFTSNREASEITEKLVEIGKDLK 354
Query: 365 FRVQKKNG--KVNISSQLTHFNIKTSVIS-NINYVIYHKS 401
+V+KK +V +S++ T + I+ + + V+ KS
Sbjct: 355 MKVRKKEHEWRVKMSAEATVVEAEVFEIAPSYHMVVLKKS 394
|
|
| TAIR|locus:2126749 SIP3 "SOS3-interacting protein 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 912 (326.1 bits), Expect = 1.7e-91, P = 1.7e-91
Identities = 178/375 (47%), Positives = 251/375 (66%)
Query: 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
G+ GRYELGR LG G F KV A+++ +G A+K++ K +++ + + DQIKREI+ ++
Sbjct: 18 GLLHGRYELGRLLGHGTFAKVYHARNIQTGKSVAMKVVGKEKVVKVGMVDQIKREISVMR 77
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
++KHPN+V LHEV+ASKSKIY +E V GGELF K+A KGRL+E R FQQLI V +
Sbjct: 78 MVKHPNIVELHEVMASKSKIYFAMELVRGGELFAKVA-KGRLREDVARVYFQQLISAVDF 136
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
CH++GV+HRDLK EN+LLD +GN+K++DFGLSA +H + DGLLHTTCG+P YVAPEV+
Sbjct: 137 CHSRGVYHRDLKPENLLLDEEGNLKVTDFGLSAFTEHLKQDGLLHTTCGTPAYVAPEVIL 196
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 249
+GYDGA +D+WSCGVIL+V+L GYLPF D NL +Y+KI+RGDFK P WLS A+ L+
Sbjct: 197 KKGYDGAKADLWSCGVILFVLLAGYLPFQDDNLVNMYRKIYRGDFKCPGWLSSDARRLVT 256
Query: 250 KILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEA--FSMHEVPSDGGRTP 307
K+L+PNP RITI + WF++ T + + I E F +H+ +
Sbjct: 257 KLLDPNPNTRITIEKVMDSPWFKKQATRSRNEPVAATITTTEEDVDFLVHKSKEE----- 311
Query: 308 GSPPLINAFQLIGMSSCLDLSGFFEKEDVSE-RKIRFTSNHSAKDLLERIEDIVTEMG-- 364
+NAF +I +S DLS FE++ E R++RF ++ A ++ +E+ +G
Sbjct: 312 --TETLNAFHIIALSEGFDLSPLFEEKKKEEKREMRFATSRPASSVISSLEE-AARVGNK 368
Query: 365 FRVQKKNGKVNISSQ 379
F V+K +V I +
Sbjct: 369 FDVRKSESRVRIEGK 383
|
|
| TAIR|locus:2152380 CIPK20 "CBL-interacting protein kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 911 (325.7 bits), Expect = 2.1e-91, P = 2.1e-91
Identities = 180/373 (48%), Positives = 254/373 (68%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+YELGR LG+G F KV A+++ +G A+K+++K ++ + + DQIKREI+ ++L++HP
Sbjct: 11 KYELGRLLGQGTFAKVYHARNIKTGESVAIKVIDKQKVAKVGLIDQIKREISVMRLVRHP 70
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
+VV LHEV+ASK+KIY +EYV GGELFDK+ SKG+L+E RK FQQLI + YCH++G
Sbjct: 71 HVVFLHEVMASKTKIYFAMEYVKGGELFDKV-SKGKLKENIARKYFQQLIGAIDYCHSRG 129
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
V+HRDLK EN+LLD G++KISDFGLSAL + + DGLLHTTCG+P YVAPEV+ +GYD
Sbjct: 130 VYHRDLKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAPEVIGKKGYD 189
Query: 195 GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEP 254
GA +D+WSCGV+LYV+L G+LPF ++NL +Y+KI +G+FK P W P + LL +IL+P
Sbjct: 190 GAKADVWSCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVKKLLSRILDP 249
Query: 255 NPVKRITIAGIKADEWFEQDY----TPANPDDDEEDIFVDN--EAFSMHEVPSDGGRTPG 308
NP RI I I + WF++ + TP +P+ + D + + AFS+
Sbjct: 250 NPNSRIKIEKIMENSWFQKGFKKIETPKSPESHQIDSLISDVHAAFSV------------ 297
Query: 309 SPPLINAFQLIG-MSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMG-FR 366
P NAF LI +S DLSG FEKE+ SE K FT+ AK+++ + E+I T F
Sbjct: 298 KPMSYNAFDLISSLSQGFDLSGLFEKEERSESK--FTTKKDAKEIVSKFEEIATSSERFN 355
Query: 367 VQKKNGKVNISSQ 379
+ K + V + +
Sbjct: 356 LTKSDVGVKMEDK 368
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q94C40 | CIPKH_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7021 | 0.8544 | 0.8425 | no | no |
| Q8RWC9 | CIPK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7260 | 0.8802 | 0.8445 | yes | no |
| Q9LGV5 | CIPK1_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.6939 | 0.8755 | 0.8091 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 426 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-106 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-90 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-77 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-75 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-69 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-67 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-65 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-63 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-63 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-59 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-56 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-55 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-50 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-50 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-50 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-50 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-49 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-48 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-48 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-47 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-47 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-47 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-47 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-47 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-47 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-46 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-46 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-46 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-46 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-45 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-45 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-45 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-45 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-45 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-45 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-45 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 9e-45 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-44 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-44 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-43 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-43 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-43 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-42 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-42 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-42 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-42 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-42 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-41 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-41 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-41 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-40 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-40 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-39 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-39 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-39 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-39 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-39 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-38 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-38 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-38 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-38 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-37 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-37 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-37 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-37 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-36 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-36 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-36 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-36 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-36 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-35 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-35 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-35 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-35 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-35 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-35 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-34 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-34 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-34 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-34 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-34 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-33 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-33 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-32 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-32 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-32 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-32 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-32 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-32 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-32 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-32 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-31 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-31 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-31 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-30 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-30 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-30 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-30 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-30 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-30 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-30 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-30 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-30 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-30 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-30 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-29 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-29 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-29 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-29 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-29 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-29 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-28 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-28 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-28 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-28 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-28 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-28 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-28 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-27 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-27 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-27 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-27 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-27 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-27 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-27 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-26 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-26 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-26 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-26 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-26 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-26 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-26 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-26 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 9e-26 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-26 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-25 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-25 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-25 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-25 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-25 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-25 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-25 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-25 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-25 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-24 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-24 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-24 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-24 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-24 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-24 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-24 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-24 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-24 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-24 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-23 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-23 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-23 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-23 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-23 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-23 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-23 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-23 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-23 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-22 | |
| pfam03822 | 58 | pfam03822, NAF, NAF domain | 1e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-22 | |
| cd12195 | 116 | cd12195, CIPK_C, C-terminal regulatory domain of C | 2e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-22 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-22 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-22 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-22 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-21 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-21 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-21 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-21 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-21 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-20 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-20 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-20 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-20 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-20 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-20 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-20 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-20 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-20 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 9e-20 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-19 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-19 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-19 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-19 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-19 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-19 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-19 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-19 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-19 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-19 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-18 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-18 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-18 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-18 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-18 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-18 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-16 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-16 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-16 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-15 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-15 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-15 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-15 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-15 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-15 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-14 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-14 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 9e-14 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-13 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-12 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-12 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-12 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-11 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-10 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 7e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-09 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-09 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-07 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 5e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 9e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 9e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 3e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 8e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.003 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 314 bits (807), Expect = e-106
Identities = 115/260 (44%), Positives = 162/260 (62%), Gaps = 10/260 (3%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
YE+ LGEG+FGKV A+D +G A+K+++K +I K ++I REI LK LKHPN
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIK--KDRERILREIKILKKLKHPN 58
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
+VRL++V + K+Y+V+EY GG+LFD + +GRL E E R +Q++ + Y H+KG+
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
HRDLK ENILLD G++K++DFGL+ L T G+P Y+APEVL +GY
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 196 ATSDIWSCGVILYVILTGYLPFDDR-NLAVLYQKIFRGDFKLPKW---LSPGAQNLLRKI 251
A DIWS GVILY +LTG PF L L++KI + P +SP A++L+RK+
Sbjct: 176 A-VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234
Query: 252 LEPNPVKRITIAGIKADEWF 271
L +P KR+T +F
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 274 bits (703), Expect = 1e-90
Identities = 107/263 (40%), Positives = 147/263 (55%), Gaps = 10/263 (3%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
YEL R LG G+FG V A+ +G AVKIL+K K +REI L+ L HPN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKK-DQTARREIRILRRLSHPN 59
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
+VRL + K +Y+V+EY GG+LFD ++ G L E E +K+ Q++ G+ Y H+ G+
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
HRDLK ENILLD G +KI+DFGL+ + + L T G+P Y+APEVL G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAK--KLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLA---VLYQKIFRGDFKLPKW----LSPGAQNLL 248
D+WS GVILY +LTG PF N+ L ++I + + S A++L+
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 249 RKILEPNPVKRITIAGIKADEWF 271
+K L +P KR T I WF
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 240 bits (614), Expect = 2e-77
Identities = 101/253 (39%), Positives = 156/253 (61%), Gaps = 6/253 (2%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LG+G+FGKV + D+G +A+K+L+K +II K + E L + HP +V+LH
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
++ K+Y+VLEY GGELF ++ +GR E R +++ + Y H+ G+ +RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
ENILLD+ G+IK++DFGL+ + + +T CG+P Y+APEVL +GY G D W
Sbjct: 121 PENILLDADGHIKLTDFGLAK--ELSSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVDWW 177
Query: 202 SCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 261
S GV+LY +LTG PF + +Y+KI + + P++LSP A++L+ +L+ +P KR+
Sbjct: 178 SLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237
Query: 262 IAG---IKADEWF 271
G IKA +F
Sbjct: 238 SGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 235 bits (602), Expect = 4e-75
Identities = 100/262 (38%), Positives = 153/262 (58%), Gaps = 11/262 (4%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E +TLG G+FG+V + SG +A+KIL K +I+ LK + + E L+ ++HP
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
+V L+ S +Y+V+EYV GGELF + GR E R Q++ + Y H+ +
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDI 122
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
+RDLK EN+LLDS G IKI+DFG + R G +T CG+P Y+APE++ ++GY
Sbjct: 123 VYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGTPEYLAPEIILSKGYGK 177
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
A D W+ G+++Y +L GY PF D N +Y+KI G + P + SP A++L+R +L+ +
Sbjct: 178 A-VDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVD 236
Query: 256 PVKRI-----TIAGIKADEWFE 272
KR+ + IK WF
Sbjct: 237 LTKRLGNLKNGVNDIKNHPWFA 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 218 bits (559), Expect = 9e-69
Identities = 91/279 (32%), Positives = 148/279 (53%), Gaps = 24/279 (8%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHP 74
++ G+ +GEG+F V A++ ++ +A+KIL+K ++I K +K E L +L HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
+++L+ + +Y VLEY GEL I G L E R +++ + Y H+KG
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLS------ALPQHFRDDGLLHTT------------ 176
+ HRDLK ENILLD +IKI+DFG + + P+ + D +
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182
Query: 177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL 236
G+ YV+PE+L N G +SD+W+ G I+Y +LTG PF N + +QKI + ++
Sbjct: 183 VGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSF 241
Query: 237 PKWLSPGAQNLLRKILEPNPVKRITIAG----IKADEWF 271
P P A++L+ K+L +P R+ + +KA +F
Sbjct: 242 PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 213 bits (544), Expect = 2e-67
Identities = 96/247 (38%), Positives = 136/247 (55%), Gaps = 37/247 (14%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LGEG FG V A+D +G A+KI++K L +++ REI LK L HPN+V+L+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLL--EELLREIEILKKLNHPNIVKLYG 58
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140
V ++ +Y+V+EY GG L D + G+L E E ++ Q+++G+ Y H+ G+ HRDL
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 141 KLENILLDSK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 199
K ENILLDS G +K++DFGLS D LL T G+P Y+APEVL +GY SD
Sbjct: 119 KPENILLDSDNGKVKLADFGLSK--LLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 200 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259
IWS GVILY + P ++L+RK+L+ +P KR
Sbjct: 177 IWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR 205
Query: 260 ITIAGIK 266
+ I
Sbjct: 206 PSAKEIL 212
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 210 bits (536), Expect = 2e-65
Identities = 89/254 (35%), Positives = 140/254 (55%), Gaps = 7/254 (2%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+ G LG G+FG V A D D+G AVK +E + ++ + ++REI L L+HP
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEEL-EALEREIRILSSLQHP 59
Query: 75 NVVRL--HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
N+VR E K+ + + LEYV+GG L + G+L E RK +Q+++G++Y H+
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
G+ HRD+K NIL+DS G +K++DFG + + G+P ++APEV+
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI-RGE 178
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRGDF-KLPKWLSPGAQNLLR 249
G +DIWS G + + TG P+ + +A LY+ G+ ++P+ LS A++ LR
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238
Query: 250 KILEPNPVKRITIA 263
K L +P KR T
Sbjct: 239 KCLRRDPKKRPTAD 252
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 204 bits (522), Expect = 2e-63
Identities = 93/260 (35%), Positives = 144/260 (55%), Gaps = 13/260 (5%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LG G FG+V+ + FA+K ++K I+ + I E L+ HP +V+L+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
K IYM++EY GGEL+ + +G E R ++ Y HN+G+ +RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
EN+LLDS G +K+ DFG + + + T CG+P YVAPE++ N+GYD + D W
Sbjct: 121 PENLLLDSNGYVKLVDFGFA---KKLKSGQKTWTFCGTPEYVAPEIILNKGYDFS-VDYW 176
Query: 202 SCGVILYVILTGYLPF--DDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPV 257
S G++LY +LTG PF DD + +Y I +G+ KL P ++ A++L++++L NP
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236
Query: 258 KRI-----TIAGIKADEWFE 272
+R+ I IK +WF
Sbjct: 237 ERLGNLKGGIKDIKKHKWFN 256
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 203 bits (519), Expect = 5e-63
Identities = 87/262 (33%), Positives = 139/262 (53%), Gaps = 21/262 (8%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL------EKNRIIHLKITDQIKREIATL 68
+YE+ + +G+G+FGKV + G + +K + EK R + E+ L
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKER-------EDALNEVKIL 53
Query: 69 KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR----LQEAEGRKLFQQLI 124
K L HPN+++ +E K K+ +V+EY GG+L KI + + E + F QL
Sbjct: 54 KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLC 113
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
+ Y H++ + HRD+K +NI L S G +K+ DFG+S + L T G+P Y++
Sbjct: 114 LALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS--TVDLAKTVVGTPYYLS 171
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPG 243
PE+ N+ Y+ SDIWS G +LY + T PF+ NL L KI +G + +P S
Sbjct: 172 PELCQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSE 230
Query: 244 AQNLLRKILEPNPVKRITIAGI 265
+NL+ +L+ +P +R +IA I
Sbjct: 231 LRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 196 bits (501), Expect = 1e-59
Identities = 88/258 (34%), Positives = 147/258 (56%), Gaps = 6/258 (2%)
Query: 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
+ +L +E+G TLG G+FG+V+ A+ +G +A+K L+K I+ +K +
Sbjct: 7 FTKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVA 66
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
+E + L L HP +V + ++++Y +LE+V GGELF + GR + +
Sbjct: 67 QEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAE 126
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
L+ Y H+K + +RDLK EN+LLD+KG++K++DFG + + T CG+P Y
Sbjct: 127 LVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEY 181
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 242
+APEV+ ++G+ A D W+ GV+LY + GY PF D +Y+KI G K P W
Sbjct: 182 LAPEVIQSKGHGKAV-DWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDG 240
Query: 243 GAQNLLRKILEPNPVKRI 260
A++L++ +L+ + KR+
Sbjct: 241 RARDLVKGLLQTDHTKRL 258
|
Length = 329 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 2e-56
Identities = 91/262 (34%), Positives = 150/262 (57%), Gaps = 11/262 (4%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
E +T+G G FG+V +D S +A+K++ +I LK + E LK + HP
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
++RL + +YM++EYV GGELF + + GR + G +++ + Y H+K +
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEI 122
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
+RDLK ENILLD +G+IK++DFG + + RD T CG+P Y+APEV+ ++G++
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGFA---KKLRDR--TWTLCGTPEYLAPEVIQSKGHNK 177
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
A D W+ G+++Y +L GY PF D N +Y+KI G + P+ L A++L++K+L +
Sbjct: 178 AV-DWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVD 236
Query: 256 PVKRI-----TIAGIKADEWFE 272
+R+ +K WF+
Sbjct: 237 RTRRLGNMKNGADDVKNHRWFK 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 3e-55
Identities = 88/259 (33%), Positives = 142/259 (54%), Gaps = 12/259 (4%)
Query: 25 GNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84
G +G+V A+ +G +A+K+++K +I DQ+ E L + P VV+L+
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 85 SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLEN 144
K +Y+V+EY+ GG+L + + G L E R +++ + Y H+ G+ HRDLK +N
Sbjct: 64 GKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDN 123
Query: 145 ILLDSKGNIKISDFGLSAL----PQHFRDDGLLHT--TCGSPNYVAPEVLANRGYDGATS 198
IL+DS G++K++DFGLS + Q +D G+P+Y+APEV+ +G+ T
Sbjct: 124 ILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-SKTV 182
Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK--WLSPGAQNLLRKILEPNP 256
D WS G ILY L G PF ++Q I G + P+ +S A +L+ K+L P+P
Sbjct: 183 DWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDP 242
Query: 257 VKRI---TIAGIKADEWFE 272
KR+ +I IK +F+
Sbjct: 243 EKRLGAKSIEEIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 2e-50
Identities = 82/253 (32%), Positives = 139/253 (54%), Gaps = 13/253 (5%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E+ +G+G FG+V A+ +G A+K+++ + ++I EI LK KHPN
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLES---KEKKEKIINEIQILKKCKHPN 58
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKG 134
+V+ + K ++++V+E+ +GG L D + S + L E++ + ++L+ G+ Y H+ G
Sbjct: 59 IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG 118
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
+ HRD+K NILL S G +K+ DFGLSA D +T G+P ++APEV+ + YD
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEVINGKPYD 175
Query: 195 GATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFRGD---FKLPKWLSPGAQNLLRK 250
+DIWS G+ + G P+ + + L+ KI + P+ S ++ L+K
Sbjct: 176 YK-ADIWSLGITAIELAEGKPPYSELPPMKALF-KIATNGPPGLRNPEKWSDEFKDFLKK 233
Query: 251 ILEPNPVKRITIA 263
L+ NP KR T
Sbjct: 234 CLQKNPEKRPTAE 246
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 173 bits (439), Expect = 2e-50
Identities = 91/245 (37%), Positives = 145/245 (59%), Gaps = 7/245 (2%)
Query: 20 RTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLLKHPN 75
+ LG+G +GKV + + D+G FA+K+L+K I+ + K T K E L+ +KHP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
+V L + K+Y++LEY++GGELF + +G E ++ + + H +G+
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
+RDLK ENILLD++G++K++DFGL + + + HT CG+ Y+APE+L G+ G
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYMAPEILMRSGH-G 178
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
D WS G ++Y +LTG PF N KI +G LP +L+P A++LL+K+L+ N
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRN 238
Query: 256 PVKRI 260
P R+
Sbjct: 239 PSSRL 243
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 174 bits (441), Expect = 2e-50
Identities = 98/292 (33%), Positives = 149/292 (51%), Gaps = 27/292 (9%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP- 74
Y + R LGEG+FG+V A+D A+K+L K K ++ REI L L HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFD---KIASKGRLQEAEGRKLFQQLIDGVSYCH 131
N+V+L++ + +Y+V+EYV GG L D KI KG L E+E + Q++ + Y H
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 132 NKGVFHRDLKLENILLDSKGN-IKISDFGLSAL----PQHFRDDGLLHTTCGSPNYVAPE 186
+KG+ HRD+K ENILLD G +K+ DFGL+ L L T+ G+P Y+APE
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 187 VL--ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------ 232
VL + Y ++SDIWS G+ LY +LTG PF+ + + +
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238
Query: 233 -DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDD 283
P+ +S A +LL+K+L +P R++ + + + + D
Sbjct: 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSD 290
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 5e-50
Identities = 83/259 (32%), Positives = 132/259 (50%), Gaps = 7/259 (2%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y+LG +G G FG V +L++G A+K + +I + I +EI LK LKHP
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKS-IMQEIDLLKNLKHP 59
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+V+ + + +Y++LEY G L I G E+ Q++ G++Y H +G
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC-GSPNYVAPEVLANRGY 193
V HRD+K NIL G +K++DFG++ D + G+P ++APEV+ G
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA---TKLNDVSKDDASVVGTPYWMAPEVIEMSGA 176
Query: 194 DGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 252
A SDIWS G + +LTG P+ D N +A L++ + LP+ +SP ++ L +
Sbjct: 177 STA-SDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCF 235
Query: 253 EPNPVKRITIAGIKADEWF 271
+ +P R T + W
Sbjct: 236 QKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 3e-49
Identities = 107/324 (33%), Positives = 177/324 (54%), Gaps = 39/324 (12%)
Query: 20 RTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQI--KREIATLKLLKHP 74
+ LG+G+FGKV + + D+G +A+K+L+K LK+ D++ K E L + HP
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT---LKVRDRVRTKMERDILAEVNHP 58
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
+V+LH ++ K+Y++L+++ GG+LF +++ + E + + +L + + H+ G
Sbjct: 59 FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
+ +RDLK ENILLD +G+IK++DFGLS + ++ CG+ Y+APEV+ RG+
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAYSFCGTVEYMAPEVVNRRGHT 176
Query: 195 GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEP 254
+ +D WS GV+++ +LTG LPF ++ I + +P++LSP AQ+LLR + +
Sbjct: 177 QS-ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKR 235
Query: 255 NPVKRI-----TIAGIKADEWF-------------EQDYTPA--NPDDDEEDIFVDNEAF 294
NP R+ + IK +F + + PA PDD + D E
Sbjct: 236 NPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVGRPDD---TFYFDPEFT 292
Query: 295 SMHEVPSDGGRTPGSPPLINAFQL 318
S P D +PG PP NA QL
Sbjct: 293 S--RTPKD---SPGIPPSANAHQL 311
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 1e-48
Identities = 90/242 (37%), Positives = 144/242 (59%), Gaps = 4/242 (1%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVR 78
+ LG+G+FGKV A+ + +AVK+L+K+ I+ + E L L KHP + +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
LH +K +++ V+EYV GG+L I GR E R +++ G+ + H +G+ +R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
DLKL+N+LLDS+G+IKI+DFG+ + T CG+P+Y+APE+L+ + Y G
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAV 177
Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
D W+ GV+LY +L G PF+ + L+Q I + + P+WLS A+++L+ L NP K
Sbjct: 178 DWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237
Query: 259 RI 260
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 9e-48
Identities = 79/248 (31%), Positives = 128/248 (51%), Gaps = 7/248 (2%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+EL R +G+G FGKV Q D+ FA+K + K + + + E L+ L HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
+V L + +Y+V++ + GG+L ++ K + E + + +++ + Y H+KG+
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
HRD+K +NILLD +G++ I+DF ++ D L +T G+P Y+APEVL +GY
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIAT---KVTPDTLTTSTSGTPGYMAPEVLCRQGY-S 177
Query: 196 ATSDIWSCGVILYVILTGYLPFD--DRNLAVLYQKIF-RGDFKLPKWLSPGAQNLLRKIL 252
D WS GV Y L G P+ R + + D P S A + + K+L
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLL 237
Query: 253 EPNPVKRI 260
E +P KR+
Sbjct: 238 ERDPQKRL 245
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 1e-47
Identities = 85/262 (32%), Positives = 132/262 (50%), Gaps = 16/262 (6%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
YE+ T+G+G+FG V+ + G K ++ + K Q+ E+ L+ LKHPN
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE-KEKQQLVSEVNILRELKHPN 60
Query: 76 VVRL--HEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVSY 129
+VR + S +Y+V+EY GG+L I + ++E ++ QL+ +
Sbjct: 61 IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 130 CHNKG-----VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
CHN+ V HRDLK NI LD+ N+K+ DFGL+ + H D T G+P Y++
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH--DSSFAKTYVGTPYYMS 178
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPG 243
PE L + YD SDIWS G ++Y + PF RN L KI G F ++P S
Sbjct: 179 PEQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSE 237
Query: 244 AQNLLRKILEPNPVKRITIAGI 265
+++ +L +P KR + +
Sbjct: 238 LNEVIKSMLNVDPDKRPSTEEL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 2e-47
Identities = 84/241 (34%), Positives = 136/241 (56%), Gaps = 3/241 (1%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+ LG+G FGKV ++ +G +A+KIL+K II E L+ +HP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
+ ++ V+EY GGELF ++ + E R +++ + Y H+ V +RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 199
LKLEN++LD G+IKI+DFGL + D + T CG+P Y+APEVL + Y G D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 200 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259
W GV++Y ++ G LPF +++ L++ I + + P+ LSP A++LL +L+ +P +R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237
Query: 260 I 260
+
Sbjct: 238 L 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 3e-47
Identities = 94/297 (31%), Positives = 138/297 (46%), Gaps = 76/297 (25%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIATLKLL 71
YE LGEG +G V A+D +G A+K +I + I REI+ LK L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALK-----KIRLDNEEEGIPSTALREISLLKEL 55
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGE-----LFDKIASKGRLQEAEGRKLFQQLIDG 126
KHPN+V+L +V+ ++ K+Y+V EY + DK L + + QL+ G
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYC---DMDLKKYLDKRPGP--LSPNLIKSIMYQLLRG 110
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----- 181
++YCH+ + HRDLK +NIL++ G +K++DFGL+ G P
Sbjct: 111 LAYCHSHRILHRDLKPQNILINRDGVLKLADFGLA-------------RAFGIPLRTYTH 157
Query: 182 ------YVAPEVL-ANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFR-- 231
Y APE+L ++ Y A DIWS G I ++TG F D + L+ KIF+
Sbjct: 158 EVVTLWYRAPEILLGSKHYSTAV-DIWSVGCIFAEMITGKPLFPGDSEIDQLF-KIFQIL 215
Query: 232 --------------GDFK--LPKW-----------LSPGAQNLLRKILEPNPVKRIT 261
D+K PK+ L P +LL K+L+ NP KRI+
Sbjct: 216 GTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRIS 272
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 5e-47
Identities = 97/267 (36%), Positives = 145/267 (54%), Gaps = 10/267 (3%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVR 78
+ +G+G+FGKV A+ G +AVK+L+K I+ K + I E L K LKHP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
LH + K+Y VL+YV GGELF + + E R ++ + Y H+ + +R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
DLK ENILLDS+G++ ++DFGL + + T CG+P Y+APEVL YD T
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPYD-RTV 177
Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
D W G +LY +L G PF R+++ +Y I +LP + A +LL +L + +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237
Query: 259 RITIAGIKADEWFEQD---YTPANPDD 282
R+ G KAD ++ ++P N DD
Sbjct: 238 RL---GAKADFLEIKNHVFFSPINWDD 261
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 5e-47
Identities = 85/240 (35%), Positives = 139/240 (57%), Gaps = 4/240 (1%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN-VVRLH 80
LG+G+FGKV A+ + +A+KIL+K+ II + E L L P + +LH
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67
Query: 81 EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140
+ ++Y V+EYV GG+L I G+ +E ++ G+ + H+KG+ +RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDI 200
KL+N++LD++G+IKI+DFG+ ++ T CG+P+Y+APE++A + Y G + D
Sbjct: 128 KLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVDW 184
Query: 201 WSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 260
W+ GV+LY +L G PFD + L+Q I + PK LS A ++ + +L +P KR+
Sbjct: 185 WAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRL 244
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 9e-47
Identities = 91/274 (33%), Positives = 158/274 (57%), Gaps = 22/274 (8%)
Query: 16 YELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIH-LKITDQIKREIATLKLL 71
+EL R LG G +GKV + + D+G +A+K+L+K I+ K + + E L+ +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 72 KH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
+ P +V LH + +K++++L+YV GGELF + + E+E R +++ + +
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSAL---PQHFRDDGLLHTTCGSPNYVAPEV 187
H G+ +RD+KLENILLDS+G++ ++DFGLS + R ++ CG+ Y+APEV
Sbjct: 122 HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER----AYSFCGTIEYMAPEV 177
Query: 188 L--ANRGYDGATSDIWSCGVILYVILTGYLPF---DDRNL-AVLYQKIFRGDFKLPKWLS 241
+ + G+D A D WS GV+ + +LTG PF ++N + + ++I + PK +S
Sbjct: 178 IRGGSGGHDKAV-DWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMS 236
Query: 242 PGAQNLLRKILEPNPVKRITIAG---IKADEWFE 272
A++ ++K+LE +P KR+ G IK +F+
Sbjct: 237 AEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 1e-46
Identities = 86/266 (32%), Positives = 136/266 (51%), Gaps = 13/266 (4%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLK 72
R++ G +G G FGKV A +LD+G AVK ++ N K +I E+ L+LLK
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND---PKTIKEIADEMKVLELLK 57
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
HPN+V+ + V + K+Y+ +EY +GG L + + L E R QL++G++Y H+
Sbjct: 58 HPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS 117
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPNYVAPEVLAN 190
G+ HRD+K NI LD G IK+ DFG + + + G+P Y+APEV+
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 191 RGYDG--ATSDIWSCGVILYVILTGYLPFD--DRNLAVLYQKIFRGDFKLPK--WLSPGA 244
G +DIWS G ++ + TG P+ D +++ +P LSP
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEG 237
Query: 245 QNLLRKILEPNPVKRITIAGIKADEW 270
++ L + LE +P KR T + + +
Sbjct: 238 KDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 2e-46
Identities = 85/251 (33%), Positives = 138/251 (54%), Gaps = 4/251 (1%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL-LKHPNVVR 78
+ LG+G+FGKV A+ + +A+K+L+K+ I+ D E L L KHP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
LH +K +++ V+EYV GG+L +I + E R ++ + + H GV +R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
DLKL+NILLD++G+ K++DFG+ + + T CG+P+Y+APE+L Y G +
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQELEY-GPSV 177
Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
D W+ GV++Y ++ G PF+ N L++ I D P WLS A ++L+ + NP K
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237
Query: 259 RITIAGIKADE 269
R+ + E
Sbjct: 238 RLGCVASQGGE 248
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 4e-46
Identities = 93/250 (37%), Positives = 136/250 (54%), Gaps = 7/250 (2%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVR 78
+ +G+G+FGKV A+ G +AVK+L+K I+ K I E L K +KHP +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
LH + K+Y VL+YV GGELF + + E R ++ + Y H+ + +R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
DLK ENILLDS+G++ ++DFGL + T CG+P Y+APEVL + YD T
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RTV 177
Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
D W G +LY +L G PF R+ A +Y I +L +S A++LL +L+ + K
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237
Query: 259 RITIAGIKAD 268
R+ G K D
Sbjct: 238 RL---GAKDD 244
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 8e-46
Identities = 87/255 (34%), Positives = 144/255 (56%), Gaps = 7/255 (2%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVR 78
R LG+G+FGKV A+ +SG +AVK+L+K+ I+ + E L L + HP + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
L+ + +++ V+E+V GG+L I R EA R ++ + + H+KG+ +R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
DLKL+N+LLD +G+ K++DFG+ + + T CG+P+Y+APE+L Y G +
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSV 177
Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
D W+ GV+LY +L G+ PF+ N L++ I + P WLS A ++L+ + NP
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237
Query: 259 R---ITIAGIKADEW 270
R +T+ G +A
Sbjct: 238 RLGSLTLGGEEAILR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 3e-45
Identities = 82/258 (31%), Positives = 134/258 (51%), Gaps = 21/258 (8%)
Query: 25 GNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNVVRLHEVL 83
G FG V A+ +G FA+K+L+K+ +I +K E A + + P V +L+
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 84 ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLE 143
SK +Y+V+EY+ GG+ I + G L E ++ +++ GV H +G+ HRD+K E
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPE 126
Query: 144 NILLDSKGNIKISDFGLSA---LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDI 200
N+L+D G++K++DFGLS + F G+P+Y+APE + G D SD
Sbjct: 127 NLLIDQTGHLKLTDFGLSRNGLENKKF---------VGTPDYLAPETILGVGDDKM-SDW 176
Query: 201 WSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSPGAQNLLRKILEPNP 256
WS G +++ L GY PF ++ I P+ + SP A +L+ ++L +P
Sbjct: 177 WSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDP 236
Query: 257 VKRITIAG---IKADEWF 271
KR+ G IK+ +F
Sbjct: 237 AKRLGANGYQEIKSHPFF 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 3e-45
Identities = 98/332 (29%), Positives = 174/332 (52%), Gaps = 31/332 (9%)
Query: 16 YELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIH-LKITDQIKREIATLKLL 71
+EL + LG G +GKV + + D+G +A+K+L+K ++ K + + E L+ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 72 KH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
+ P +V LH +++K++++L+YV+GGE+F + + E E R ++I + +
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF--RDDGLLHTTCGSPNYVAPEVL 188
H G+ +RD+KLENILLDS+G++ ++DFGLS + F + ++ CG+ Y+APE++
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLS---KEFLSEEKERTYSFCGTIEYMAPEII 178
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFD---DRNL-AVLYQKIFRGDFKLPKWLSPGA 244
+G G D WS G++++ +LTG PF +RN + + ++I + D P ++ P A
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEA 238
Query: 245 QNLLRKILEPNPVKRITIAGIKADEWFEQDY---------------TPANPD-DDEEDIF 288
Q+LL K+L +P KR+ A E E + P P +E D+
Sbjct: 239 QDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVG 298
Query: 289 VDNEAFS-MHEVPSDGGRTPGSPPLINAFQLI 319
E F+ + V S G P + + +
Sbjct: 299 NFAEEFTNLEPVYSPAGTPPSGARVFQGYSFV 330
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 159 bits (402), Expect = 4e-45
Identities = 103/306 (33%), Positives = 158/306 (51%), Gaps = 19/306 (6%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI-ATLKLLKHPNVVR 78
+ +G+G+FGKV A+ +AVK+L+K I+ K I E LK +KHP +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
LH + K+Y VL+Y+ GGELF + + E R ++ + Y H+ + +R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
DLK ENILLDS+G+I ++DFGL ++ +G T CG+P Y+APEVL + YD T
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTV 177
Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
D W G +LY +L G PF RN A +Y I +L ++ A++LL +L+ + K
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237
Query: 259 RIT-------------IAGIKADEWFEQDYTPA-NPD-DDEEDIFVDNEAFSMHEVPSDG 303
R+ + I D+ + TP NP+ D+ + F+ VP+
Sbjct: 238 RLGAKDDFMEIKNHIFFSPINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNSI 297
Query: 304 GRTPGS 309
G++P S
Sbjct: 298 GQSPDS 303
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 4e-45
Identities = 90/253 (35%), Positives = 142/253 (56%), Gaps = 4/253 (1%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL-LKHPNVVR 78
+ LG+G+FGKV A+ + FA+K L+K+ ++ + E L L +HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
L +K ++ V+EY+ GG+L I S GR EA R ++I G+ + H KG+ +R
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
DLKL+N+LLD G+IKI+DFG+ ++ +G T CG+P+Y+APE+L + Y+ +
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCK--ENMNGEGKASTFCGTPDYIAPEILKGQKYNESV- 177
Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
D WS GV+LY +L G PF + L+ I P+W+S A++ L K+ E +P K
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237
Query: 259 RITIAGIKADEWF 271
R+ + G F
Sbjct: 238 RLGVDGDIRQHPF 250
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 4e-45
Identities = 83/241 (34%), Positives = 136/241 (56%), Gaps = 3/241 (1%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+ LG+G FGKV ++ +G +A+KIL K II E L+ +HP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
+ ++ V+EY GGELF ++ + E R +++ + Y H++ V +RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 199
+KLEN++LD G+IKI+DFGL + D + T CG+P Y+APEVL + Y G D
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 200 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259
W GV++Y ++ G LPF +++ L++ I + + P+ LSP A++LL +L+ +P +R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237
Query: 260 I 260
+
Sbjct: 238 L 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 5e-45
Identities = 86/282 (30%), Positives = 137/282 (48%), Gaps = 38/282 (13%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RY++ +GEG G V A+D ++G A+K + R + I +Q REI L+ +HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVA-LRRLEGGIPNQALREIKALQACQHP 59
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNK 133
VV+L +V S +V+EY+ L + + + R L EA+ + + L+ GV+Y H
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT-TCGSPNYVAPEVL-ANR 191
G+ HRDLK N+L+ + G +KI+DFGL+ L ++ L++ + Y APE+L R
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARL--FSEEEPRLYSHQVATRWYRAPELLYGAR 176
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRN--------LAVL---YQKIFRGDFKLPKW- 239
YD D+W+ G I +L G F N L ++ + G LP +
Sbjct: 177 KYDPGV-DLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235
Query: 240 ------------------LSPGAQNLLRKILEPNPVKRITIA 263
SP A +LL+ +L +P KR++ A
Sbjct: 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAA 277
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 6e-45
Identities = 87/242 (35%), Positives = 144/242 (59%), Gaps = 8/242 (3%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH---LKITDQIKREIATLKLLKHPNVVR 78
LG+G+FGKV A+ + +A+KIL+K+ +I ++ T KR +A K P + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD--KPPFLTQ 65
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
LH + ++Y V+EYV GG+L I G+ +E + ++ G+ + H +G+ +R
Sbjct: 66 LHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYR 125
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
DLKL+N++LDS+G+IKI+DFG+ +H D T CG+P+Y+APE++A + Y G +
Sbjct: 126 DLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSV 182
Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
D W+ GV+LY +L G PFD + L+Q I + PK LS A ++ + ++ +P K
Sbjct: 183 DWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSK 242
Query: 259 RI 260
R+
Sbjct: 243 RL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 9e-45
Identities = 89/241 (36%), Positives = 136/241 (56%), Gaps = 3/241 (1%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+ LG+G FGKV ++ SG +A+KIL+K II E LK +HP + L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
+K ++ V+EYV GGELF ++ + E R +++ + Y H+ + +RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 199
LKLEN++LD G+IKI+DFGL + D + T CG+P Y+APEVL + Y G D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 200 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259
W GV++Y ++ G LPF +++ L++ I D K P+ LS A++LL +L +P KR
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237
Query: 260 I 260
+
Sbjct: 238 L 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 1e-44
Identities = 91/255 (35%), Positives = 137/255 (53%), Gaps = 6/255 (2%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+G+G+FGKV + D+ +A+K + K I+ E L + P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
S K+Y+VL ++ GGELF + +GR + R +L+ + H V +RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
ENILLD +G+I + DFGL L + +DD +T CG+P Y+APE+L GY A D W
Sbjct: 121 PENILLDYQGHIALCDFGLCKL--NMKDDDKTNTFCGTPEYLAPELLLGHGYTKAV-DWW 177
Query: 202 SCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 261
+ GV+LY +LTG PF D N+ +Y+KI + + P A++LL +L +P +R+
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237
Query: 262 IAG---IKADEWFEQ 273
G IK +F Q
Sbjct: 238 YNGAQEIKNHPFFSQ 252
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 157 bits (397), Expect = 3e-44
Identities = 90/255 (35%), Positives = 136/255 (53%), Gaps = 7/255 (2%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKRE 64
K++ M+ + RTLG G+FG+V A + P A+K EK++II K D + E
Sbjct: 22 KRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSE 81
Query: 65 IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
L + HP V L+ +S +Y+VLE+V GGE F + R G Q++
Sbjct: 82 RKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIV 141
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
Y + + +RDLK EN+LLD G IK++DFG + + D +T CG+P Y+A
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIA 196
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
PE+L N G+ G +D W+ G+ +Y IL G PF ++YQKI G PK+L
Sbjct: 197 PEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNC 255
Query: 245 QNLLRKILEPNPVKR 259
++L++K+L + KR
Sbjct: 256 KHLMKKLLSHDLTKR 270
|
Length = 340 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 3e-43
Identities = 84/243 (34%), Positives = 144/243 (59%), Gaps = 10/243 (4%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL----KHPNVV 77
LG+G+FGKV A+ + +A+KIL+K+ +I D ++ + ++L K P +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ---DDDVECTMVEKRVLALSGKPPFLT 64
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
+LH + ++Y V+EYV GG+L +I GR +E ++ G+ + H+KG+ +
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIY 124
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT 197
RDLKL+N++LDS+G+IKI+DFG+ ++ D T CG+P+Y+APE++A + Y G +
Sbjct: 125 RDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKS 181
Query: 198 SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPV 257
D W+ GV+LY +L G PF+ + L+Q I + PK +S A + + ++ +P
Sbjct: 182 VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPG 241
Query: 258 KRI 260
KR+
Sbjct: 242 KRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 4e-43
Identities = 84/256 (32%), Positives = 132/256 (51%), Gaps = 13/256 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK--ILEKNRIIHLKITDQIKREIATLKLLK 72
R+ G LG G+FG V +LD G FAVK L + + Q+++EIA L L+
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
HPN+V+ + +Y+ LE V GG L + G E R +Q++ G+ Y H+
Sbjct: 61 HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
+ HRD+K NIL+D+ G +K++DFG++ + + + GSP ++APEV+A +G
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMA---KQVVEFSFAKSFKGSPYWMAPEVIAQQG 177
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-GDFK----LPKWLSPGAQNL 247
G +DIWS G + + TG P+ +F+ G K +P LS A++
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLE---GVAAVFKIGRSKELPPIPDHLSDEAKDF 234
Query: 248 LRKILEPNPVKRITIA 263
+ K L+ +P R T A
Sbjct: 235 ILKCLQRDPSLRPTAA 250
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 153 bits (387), Expect = 5e-43
Identities = 84/242 (34%), Positives = 138/242 (57%), Gaps = 4/242 (1%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+ LG+G FGKV ++ +G +A+KIL+K I+ E L+ +HP + L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHR 138
+ ++ V+EY GGELF ++ + E R +++ + Y H+ K V +R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
DLKLEN++LD G+IKI+DFGL + +D + T CG+P Y+APEVL + Y G
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAV 177
Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
D W GV++Y ++ G LPF +++ L++ I + + P+ LSP A++LL +L+ +P +
Sbjct: 178 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237
Query: 259 RI 260
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 2e-42
Identities = 76/258 (29%), Positives = 124/258 (48%), Gaps = 25/258 (9%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD----QIKREIATLKLLK 72
E + LG+G+ G V + +G +A+K IH+ + Q+ RE+ TL+ +
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKK------IHVDGDEEFRKQLLRELKTLRSCE 57
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
P VV+ + + +I +VLEY+ GG L D + G++ E + +Q++ G+ Y H
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117
Query: 133 K-GVFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
K + HRD+K N+L++SKG +KI+DFG+S L +T G+ Y++PE +
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN---TLDQCNTFVGTVTYMSPERIQG 174
Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGDFKLPKW----LSPG 243
+DIWS G+ L G PF L Q I G P SP
Sbjct: 175 E-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGP--PPSLPAEEFSPE 231
Query: 244 AQNLLRKILEPNPVKRIT 261
++ + L+ +P KR +
Sbjct: 232 FRDFISACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 2e-42
Identities = 83/249 (33%), Positives = 143/249 (57%), Gaps = 10/249 (4%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL----KHPN 75
+ LG+G+FGKV A+ + FA+K L+K+ ++ + D ++ + ++L +HP
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL---MDDDVECTMVEKRVLSLAWEHPF 57
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
+ L+ +K ++ V+EY+ GG+L I S + ++I G+ + H+KG+
Sbjct: 58 LTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGI 117
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
+RDLKL+NILLD+ G+IKI+DFG+ ++ D T CG+P+Y+APE+L + Y
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEILLGQKY-N 174
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
+ D WS GV+LY +L G PF + L+Q I + P+WL+ A+++L K+
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVRE 234
Query: 256 PVKRITIAG 264
P +R+ + G
Sbjct: 235 PERRLGVKG 243
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 2e-42
Identities = 87/267 (32%), Positives = 161/267 (60%), Gaps = 17/267 (6%)
Query: 16 YELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIH-LKITDQIKREIATLKLL 71
+EL + LG G +GKV + + DSG +A+K+L+K I+ K T+ + E L+ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 72 KH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
+ P +V LH + +K++++L+Y+ GGELF ++ + R +E E + +++ + +
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL--LHTTCGSPNYVAPEVL 188
H G+ +RD+KLENILLDS G++ ++DFGLS + F +D + ++ CG+ Y+AP+++
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLS---KEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 189 A--NRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGDFKLPKWLSP 242
+ G+D A D WS GV++Y +LTG PF + + A + ++I + + P+ +S
Sbjct: 179 RGGDGGHDKAV-DWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 237
Query: 243 GAQNLLRKILEPNPVKRITIAGIKADE 269
A+++++++L +P KR+ ADE
Sbjct: 238 LAKDIIQRLLMKDPKKRLGCGPSDADE 264
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 3e-42
Identities = 84/250 (33%), Positives = 138/250 (55%), Gaps = 8/250 (3%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-IHL-KITDQIKREIATLKLLKH 73
+ G+ LG+G FG+V D+D+G AVK + + K + ++ EI LK L+H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
+V+ + L + + +EY+ GG + D++ + G L E RK +Q+++GV Y H+
Sbjct: 64 ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEVLANRG 192
+ HRD+K NIL DS GN+K+ DFG S Q G + + G+P +++PEV++ G
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFR--GDFKLPKWLSPGAQNLLR 249
Y G +D+WS G + +LT P+ + +A ++ KI + +LP +SP A+N LR
Sbjct: 184 Y-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF-KIATQPTNPQLPSHVSPDARNFLR 241
Query: 250 KILEPNPVKR 259
+ N KR
Sbjct: 242 RTFVENAKKR 251
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 9e-42
Identities = 97/300 (32%), Positives = 142/300 (47%), Gaps = 57/300 (19%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----ITDQIKREIATLKLL 71
YE +GEG +G+V A++ +G A+K K R+ + K IT REI L+ L
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALK---KIRMENEKEGFPIT--AIREIKLLQKL 55
Query: 72 KHPNVVRLHEVLASKSK--IYMVLEYV----TGGELFDKIASKG-RLQEAEGRKLFQQLI 124
+HPN+VRL E++ SK K IYMV EY+ TG + S + E++ + +QL+
Sbjct: 56 RHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG-----LLDSPEVKFTESQIKCYMKQLL 110
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
+G+ Y H+ G+ HRD+K NIL+++ G +K++DFGL A P R+ + Y
Sbjct: 111 EGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGL-ARPYTKRNSADYTNRVITLWYRP 169
Query: 185 PEVL--ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR----------- 231
PE+L A R Y D+WS G IL + G F +KIF
Sbjct: 170 PELLLGATR-YGPE-VDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP 227
Query: 232 GDFKLP--------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271
G KLP + P A +LL K+L +P KRI+ E+F
Sbjct: 228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 4e-41
Identities = 83/258 (32%), Positives = 148/258 (57%), Gaps = 11/258 (4%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL----KHPN 75
+ LG+G+FGKV A+ G FAVK L+K+ ++ I D ++ + ++L ++P
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL---IDDDVECTMVEKRVLALAWENPF 57
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
+ L+ +K ++ V+E++ GG+L I KGR +++ G+ + H+KG+
Sbjct: 58 LTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGI 117
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
+RDLKL+N++LD G+IKI+DFG+ ++ D T CG+P+Y+APE+L Y
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEILQGLKYTF 175
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
+ D WS GV+LY +L G PF + L++ I P+W++ ++++L K+ E +
Sbjct: 176 SV-DWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERD 234
Query: 256 PVKRITIAG-IKADEWFE 272
P +R+ + G I+ +F+
Sbjct: 235 PTRRLGVVGNIRGHPFFK 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 5e-41
Identities = 100/312 (32%), Positives = 158/312 (50%), Gaps = 20/312 (6%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI-ATLKLLKHPNVVR 78
+ +G+G+FGKV A+ G +AVK+L+K +++ K I E LK +KHP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
LH + K+Y VL++V GGELF + + E R ++ + Y H+ + +R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
DLK ENILLDS+G++ ++DFGL + T CG+P Y+APEV+ + YD T
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN-TV 177
Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
D W G +LY +L G PF R++A +Y I L S A ++L ++LE + +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237
Query: 259 RI----TIAGIKADEWFEQ-DYT---------PANPD-DDEEDIFVDNEAFSMHEVPSDG 303
R+ I+ +FE +T P NP+ + +DI + F+ VP
Sbjct: 238 RLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISNFDAVFTEETVPYSV 297
Query: 304 GRTPGSPPLINA 315
+ ++NA
Sbjct: 298 CFSSD-YSIVNA 308
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 5e-41
Identities = 85/268 (31%), Positives = 131/268 (48%), Gaps = 31/268 (11%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD-----QIKR-----E 64
+++ + LG+G++G V + VK L N+ LK D Q +R E
Sbjct: 1 DFKVLKKLGKGSYGSV-----------YKVKRLSDNQFYALKEVDLGSMSQKEREDAVNE 49
Query: 65 IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLF 120
I L + HPN++ E +K+ +V+EY G+L I + + E E ++F
Sbjct: 50 IRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIF 109
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
QL+ G+ H + + HRDLK NILL + +KI D G+S + + + T G+P
Sbjct: 110 IQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLK----KNMAKTQIGTP 165
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKW 239
+Y+APEV R Y SDIWS G +LY + T PF+ R++ L K+ RG + +P
Sbjct: 166 HYMAPEVWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPI 224
Query: 240 LSPGAQNLLRKILEPNPVKRITIAGIKA 267
S QN +R +L+ P R I A
Sbjct: 225 YSQDLQNFIRSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 1e-40
Identities = 88/291 (30%), Positives = 143/291 (49%), Gaps = 34/291 (11%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+E+ + +G G FG+V +D D+G +A+K+L K+ +I ++ E L
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
P +V+L+ + +Y+V+EY+ GG+L + + K E R +L+ + H
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSA---------------LPQHFRDDGLLH---- 174
G HRD+K +NIL+D+ G+IK++DFGL FRD+ L+
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180
Query: 175 --------TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY 226
+T G+P+Y+APEVL Y D WS GVILY +L G+ PF L Y
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQETY 239
Query: 227 QKI--FRGDFKLP--KWLSPGAQNLLRKILEPNPVKRITIA-GIKADEWFE 272
KI ++ + P +SP A +L+ ++L P R+ IK+ +F+
Sbjct: 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLCD-PEDRLGSFEEIKSHPFFK 289
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 7e-40
Identities = 81/242 (33%), Positives = 127/242 (52%), Gaps = 7/242 (2%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI---KREIATLKLLKHPNVVR 78
LG G+FGKV A+ +G +A+K L+K II + + KR T +HP +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
L ++ + V+EY GG+L I E ++ G+ Y H + +R
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
DLKL+N+LLD++G +KI+DFGL F D T CG+P ++APEVL Y A
Sbjct: 126 DLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGTPEFLAPEVLTETSYTRAV- 182
Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
D W GV++Y +L G PF + ++ I + + P++LS A +++R++L NP +
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPER 242
Query: 259 RI 260
R+
Sbjct: 243 RL 244
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-39
Identities = 72/228 (31%), Positives = 116/228 (50%), Gaps = 14/228 (6%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+G+G +G+V A+ D+G A+K ++K+ + L + E L K +V+L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
+Y+ +EYV GG+ + + G L E R ++ + V H G HRDLK
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLK 128
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLL---HTTCGSPNYVAPEVLANRGYDGATS 198
EN L+D+ G+IK++DFGLS G++ ++ GSP+Y+APEVL +GYD T
Sbjct: 129 PENFLIDASGHIKLTDFGLSK--------GIVTYANSVVGSPDYMAPEVLRGKGYD-FTV 179
Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKI--FRGDFKLPKWLSPGA 244
D WS G +LY L G+ PF ++ + ++ + P + P
Sbjct: 180 DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRF 227
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 2e-39
Identities = 73/257 (28%), Positives = 115/257 (44%), Gaps = 25/257 (9%)
Query: 17 ELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
LG+ LGEG FG+V + + AVK L+++ ++ RE ++ L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQI--EEFLREARIMRKLD 59
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------- 125
HPNVV+L V + +Y+V+EY+ GG+L L++ + L+
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDL------LSYLRKNRPKLSLSDLLSFALQIAR 113
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVA 184
G+ Y +K HRDL N L+ +KISDFGLS + DD P ++A
Sbjct: 114 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSR--DLYDDDYYRKRGGKLPIRWMA 171
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDF-KLPKWLSP 242
PE L + SD+WS GV+L+ I T G P+ + + + + G P P
Sbjct: 172 PESLKEGKFTSK-SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPP 230
Query: 243 GAQNLLRKILEPNPVKR 259
+L+ + +P R
Sbjct: 231 ELYDLMLQCWAEDPEDR 247
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 3e-39
Identities = 71/224 (31%), Positives = 106/224 (47%), Gaps = 13/224 (5%)
Query: 17 ELGRTLGEGNFGKVK----FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
ELG+ LGEG FG+V + AVK L K + + E + +K L
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREE-FLEEASIMKKLS 59
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCH 131
HPN+VRL V +Y+V EY+ GG+L D + +L + ++ Q+ G+ Y
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG--SPNYVAPEVLA 189
+K HRDL N L+ +KISDFGLS + DD G ++APE L
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLS--RDIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 190 NRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 232
+ + SD+WS GV+L+ I T G P+ + + + + G
Sbjct: 178 DGKFTSK-SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG 220
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 3e-39
Identities = 75/261 (28%), Positives = 117/261 (44%), Gaps = 32/261 (12%)
Query: 17 ELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIK---REIATLK 69
LG+ LGEG FG+V + AVK L+++ QI+ RE ++
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKED-----ASEQQIEEFLREARIMR 56
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID--- 125
L HPN+V+L V + + +V+EY+ GG+L L++ ++L L+
Sbjct: 57 KLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDL------LDYLRKNRPKELSLSDLLSFAL 110
Query: 126 ----GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP- 180
G+ Y +K HRDL N L+ +KISDFGLS + DD P
Sbjct: 111 QIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSR--DLYDDDYYKVKGGKLPI 168
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDF-KLPK 238
++APE L + SD+WS GV+L+ I T G P+ + A + + + +G P
Sbjct: 169 RWMAPESLKEGKFTSK-SDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPP 227
Query: 239 WLSPGAQNLLRKILEPNPVKR 259
P L+ + +P R
Sbjct: 228 NCPPELYKLMLQCWAEDPEDR 248
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 5e-39
Identities = 97/317 (30%), Positives = 138/317 (43%), Gaps = 70/317 (22%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT-DQIK----REIATLK 69
RYE G+ LGEG + V A+D ++G A+K K ++ K D I REI L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIK---KIKLGERKEAKDGINFTALREIKLLQ 57
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVS 128
LKHPN++ L +V KS I +V E++ +L I K L A+ + + G+
Sbjct: 58 ELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLE 116
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN------- 181
Y H+ + HRDLK N+L+ S G +K++DFGL+ + GSPN
Sbjct: 117 YLHSNWILHRDLKPNNLLIASDGVLKLADFGLA-------------RSFGSPNRKMTHQV 163
Query: 182 ----YVAPEVLANRGYDGATSDIWSCGVILYVILTG--YLPFDD--RNLAVLYQKIFR-- 231
Y APE+L + G D+WS G I +L +LP D L KIF
Sbjct: 164 VTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLG----KIFEAL 219
Query: 232 ---------GDFKLPKWL----SPG-------------AQNLLRKILEPNPVKRITIAGI 265
G LP ++ P A +LL+++L NP KRIT
Sbjct: 220 GTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQA 279
Query: 266 KADEWFEQDYTPANPDD 282
+F D P P
Sbjct: 280 LEHPYFSNDPAPTPPSQ 296
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 1e-38
Identities = 90/263 (34%), Positives = 131/263 (49%), Gaps = 26/263 (9%)
Query: 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILE------KNRIIHLKITDQIKREIATLKLLK 72
G +G G+FG V + SG AVK +E ++ + D + REIA LK L+
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
H N+V+ + + LEYV GG + + + G +E R +Q++ G++Y HN
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC--------GSPNYVA 184
+G+ HRD+K NIL+D+KG IKISDFG+S + L T GS ++A
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEA----NSLSTKTNGARPSLQGSVFWMA 180
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-GDFKLPKW---L 240
PEV+ Y DIWS G ++ +LTG PF D Q IF+ G+ P+ +
Sbjct: 181 PEVVKQTSYTRKA-DIWSLGCLVVEMLTGKHPFPDCT---QLQAIFKIGENASPEIPSNI 236
Query: 241 SPGAQNLLRKILEPNPVKRITIA 263
S A + L K E + KR T A
Sbjct: 237 SSEAIDFLEKTFEIDHNKRPTAA 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 2e-38
Identities = 79/254 (31%), Positives = 139/254 (54%), Gaps = 7/254 (2%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+Y + +GEG+FGK + + G + +K + +++ K ++ ++E+A L +KHP
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHP 59
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRL-QEAEGRKLFQQLIDGVSYCHN 132
N+V+ E +Y+V++Y GG+L+ KI A +G L E + F Q+ + + H+
Sbjct: 60 NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
+ + HRD+K +NI L G IK+ DFG++ + + L T G+P Y++PE+ NR
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICENRP 177
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKI 251
Y+ SDIW+ G +LY + T F+ N+ L KI RG + + S +NL+ ++
Sbjct: 178 YNN-KSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236
Query: 252 LEPNPVKRITIAGI 265
+ NP R ++ I
Sbjct: 237 FKRNPRDRPSVNSI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 3e-38
Identities = 79/263 (30%), Positives = 146/263 (55%), Gaps = 18/263 (6%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVR 78
R +G G++ KV + + +A+K+++K + + D ++ E + HP +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
LH ++S+++ V+E+V+GG+L + + +L E R ++ +++ H +G+ +R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD-GAT 197
DLKL+N+LLD++G+IK++D+G+ + R T CG+PNY+APE+L RG D G +
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEIL--RGEDYGFS 176
Query: 198 SDIWSCGVILYVILTGYLPFD--------DRNLA-VLYQKIFRGDFKLPKWLSPGAQNLL 248
D W+ GV+++ ++ G PFD D+N L+Q I ++P+ LS A ++L
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVL 236
Query: 249 RKILEPNPVKRITIAGIKADEWF 271
+ L +P +R+ G F
Sbjct: 237 KGFLNKDPKERL---GCHPQTGF 256
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 7e-38
Identities = 80/287 (27%), Positives = 131/287 (45%), Gaps = 36/287 (12%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+ LG+G+ G+V + +G FA+K+L+K +I ++ E L L HP + L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 80 HEVLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
+ +++ + +V++Y GGELF + L E R +++ + Y H G+ +
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVY 126
Query: 138 RDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPN------------- 181
RDLK ENILL G+I +SDF LS + L + S
Sbjct: 127 RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186
Query: 182 -----------YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF 230
Y+APEV++ G+ A D W+ G++LY +L G PF N + I
Sbjct: 187 FRSNSFVGTEEYIAPEVISGDGHGSAV-DWWTLGILLYEMLYGTTPFKGSNRDETFSNIL 245
Query: 231 RGDFKLPK--WLSPGAQNLLRKILEPNPVKRITIAG----IKADEWF 271
+ + P +S A++L+RK+L +P KR+ IK +F
Sbjct: 246 KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 2e-37
Identities = 83/259 (32%), Positives = 134/259 (51%), Gaps = 18/259 (6%)
Query: 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-------HLKITDQIKREIATLKLL 71
G +G+G +G+V A ++ +G AVK +E I + ++ EI TLK L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
H N+V+ ++ + + LEYV GG + + + GR +E R +Q+++G++Y H
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN- 190
+KG+ HRDLK +N+L+D+ G KISDFG+S D+ + GS ++APEV+ +
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185
Query: 191 -RGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFRGDFKLP------KWLSP 242
+GY A DIWS G ++ + G P+ D+ +A ++ K+ P LSP
Sbjct: 186 SQGYS-AKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMF-KLGNKRSAPPIPPDVSMNLSP 243
Query: 243 GAQNLLRKILEPNPVKRIT 261
A + L NP R T
Sbjct: 244 VALDFLNACFTINPDNRPT 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-37
Identities = 84/279 (30%), Positives = 138/279 (49%), Gaps = 28/279 (10%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E + + G +G V + ++ FA+K + K +I Q+ E L ++P
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
VV + +K + MV+EYV GG+ + + G L R F + + + Y HN G+
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGI 122
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSAL-----------------PQHFRDDGLLHTTCG 178
HRDLK +N+L+ S G+IK++DFGLS + + F D + CG
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV----CG 178
Query: 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK 238
+P Y+APEV+ +GY G D W+ G+ILY L G +PF L+ ++ D + P+
Sbjct: 179 TPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237
Query: 239 W---LSPGAQNLLRKILEPNPVKRITIAG---IKADEWF 271
L AQ+L+ ++L NP++R+ G +K +F
Sbjct: 238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFF 276
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 7e-37
Identities = 83/248 (33%), Positives = 129/248 (52%), Gaps = 8/248 (3%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+Y + R +GEG+FG+ Q ++S +A+K + + + ++E L +KHP
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSS--AVEDSRKEAVLLAKMKHP 58
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIA-SKGRL-QEAEGRKLFQQLIDGVSYCHN 132
N+V E + +Y+V+EY GG+L KI +G+L E + F Q+ GV + H
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
K V HRD+K +NI L G +K+ DFG + L T G+P YV PE+ N
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS--PGAYACTYVGTPYYVPPEIWENMP 176
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKI 251
Y+ SDIWS G ILY + T PF + L K+ +G +K LP S ++L++++
Sbjct: 177 YNN-KSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235
Query: 252 LEPNPVKR 259
+ NP R
Sbjct: 236 FKRNPRSR 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 9e-37
Identities = 78/251 (31%), Positives = 141/251 (56%), Gaps = 13/251 (5%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVR 78
R +G G++ KV + + +A+K+++K + + D ++ E + HP +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
LH ++S+++ V+EYV GG+L + + +L E R ++ ++Y H +G+ +R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
DLKL+N+LLDS+G+IK++D+G+ + R T CG+PNY+APE+L Y G +
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSV 177
Query: 199 DIWSCGVILYVILTGYLPFD--------DRNLA-VLYQKIFRGDFKLPKWLSPGAQNLLR 249
D W+ GV+++ ++ G PFD D+N L+Q I ++P+ LS A ++L+
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237
Query: 250 KILEPNPVKRI 260
L +P +R+
Sbjct: 238 SFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 1e-36
Identities = 78/263 (29%), Positives = 121/263 (46%), Gaps = 23/263 (8%)
Query: 20 RTLGEGNFGKVKFA---QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+ LGEG FG+V AVK L K + D +E +K L HPNV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDASEEERKD-FLKEARVMKKLGHPNV 58
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLID-------GV 127
VRL V + +Y+VLEY+ GG+L D + + + + + L+ G+
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG-SPN-YVAP 185
Y +K HRDL N L+ +KISDFGLS + DD T G P ++AP
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLS--RDVYDDDYYRKKTGGKLPIRWMAP 176
Query: 186 EVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSP 242
E L + + SD+WS GV+L+ I T G P+ + + + + +G ++L P++
Sbjct: 177 ESLKDGIFTSK-SDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG-YRLPKPEYCPD 234
Query: 243 GAQNLLRKILEPNPVKRITIAGI 265
L+ + +P R T + +
Sbjct: 235 ELYELMLSCWQLDPEDRPTFSEL 257
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-36
Identities = 77/283 (27%), Positives = 118/283 (41%), Gaps = 40/283 (14%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVK---ILEKNRIIHLKITDQIKREIATLKL 70
+YE+ +GEG +G V ++ +G A+K E + + RE+ L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTAL----REVKVLRQ 56
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
L+H N+V L E K ++Y+V EYV L AS G L R QL+ ++YC
Sbjct: 57 LRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
H+ + HRD+K ENIL+ G +K+ DFG A R L + Y APE+L
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGF-ARALRARPASPLTDYVATRWYRAPELLVG 175
Query: 191 RGYDGATSDIWSCGVI-------------------LYVILTGYLPFDDRNLAVLYQ-KIF 230
G D+W+ G I LY+I P + + F
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235
Query: 231 RG------------DFKLPKWLSPGAQNLLRKILEPNPVKRIT 261
G + + P +S A + L+ L +P +R+T
Sbjct: 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 3e-36
Identities = 81/254 (31%), Positives = 126/254 (49%), Gaps = 10/254 (3%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LG+G FG+V Q +G +A K L+K R+ K E L+ + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFHRD 139
+K + +V+ + GG+L I + G E R +F Q+I G+ + H + + +RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 199
LK EN+LLD GN++ISD GL+ + + G+P Y+APEVL YD + D
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAV---ELKGGKKIKGRAGTPGYMAPEVLQGEVYD-FSVD 176
Query: 200 IWSCGVILYVILTGYLPFDDRNLAV----LYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
++ G LY ++ G PF R V L ++ + P SP A++L +L+ +
Sbjct: 177 WFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236
Query: 256 PVKRITIAGIKADE 269
P KR+ G ADE
Sbjct: 237 PEKRLGCRGGSADE 250
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 6e-36
Identities = 82/244 (33%), Positives = 133/244 (54%), Gaps = 8/244 (3%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-ITDQI-KREIATLKLLKH-PNVVR 78
+G+G FG+V + D+ +A+K+L K I+ K + I +R I LL P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
L + S +Y+V +Y++GGELF + +GR E + +L+ + + H + +R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN-RGYDGAT 197
DLK ENILLD+ G+I + DFGLS + D+ +T CG+ Y+APEVL + +GY
Sbjct: 121 DLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKGY-TKH 177
Query: 198 SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK-WLSPGAQNLLRKILEPNP 256
D WS GV+++ + G+ PF + +Y+ I G + PK LS + ++ +L NP
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNP 237
Query: 257 VKRI 260
R+
Sbjct: 238 QHRL 241
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 8e-36
Identities = 72/248 (29%), Positives = 127/248 (51%), Gaps = 9/248 (3%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E+ +G+G+FG V +A+K ++ +++ + + I E L L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI-DEARVLAKLDSSY 60
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNK 133
++R +E K K+ +V+EY G+L + L E + + F Q++ G+++ H+K
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL-HTTCGSPNYVAPEVLANRG 192
+ HRD+K N+ LD+ N+KI D G++ L D+ +T G+P Y++PE+ ++
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKL---LSDNTNFANTIVGTPYYLSPELCEDKP 177
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKI 251
Y+ SD+W+ GV+LY TG PFD N L KI RG F + + S L+ +
Sbjct: 178 YN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236
Query: 252 LEPNPVKR 259
L + +R
Sbjct: 237 LTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 1e-35
Identities = 76/248 (30%), Positives = 129/248 (52%), Gaps = 19/248 (7%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVK--ILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+GEG G+V A D +G A+K L K + I EI +K KHPN+V
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNK------ELIINEILIMKDCKHPNIVDY 80
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
++ ++++V+EY+ GG L D I + R+ E + + ++++ G+ Y H++ V HR
Sbjct: 81 YDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHR 140
Query: 139 DLKLENILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
D+K +NILL G++K++DFG +A + + ++ G+P ++APEV+ + Y
Sbjct: 141 DIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR----NSVVGTPYWMAPEVIKRKDYGPK 196
Query: 197 TSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILE 253
DIWS G++ + G P + L L+ +G K P+ SP ++ L K L
Sbjct: 197 V-DIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLV 255
Query: 254 PNPVKRIT 261
+P KR +
Sbjct: 256 KDPEKRPS 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 2e-35
Identities = 74/249 (29%), Positives = 139/249 (55%), Gaps = 11/249 (4%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVR 78
R +G G++ KV + + +A+K+++K + + D ++ E + +P +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
LH + S++++V+EYV GG+L + + +L E R ++ +++ H +G+ +R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
DLKL+N+LLD+ G+IK++D+G+ + T CG+PNY+APE+L Y G +
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSV 177
Query: 199 DIWSCGVILYVILTGYLPFD------DRNLA-VLYQKIFRGDFKLPKWLSPGAQNLLRKI 251
D W+ GV+++ ++ G PFD D N L+Q I ++P++LS A ++L+
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237
Query: 252 LEPNPVKRI 260
L +P +R+
Sbjct: 238 LNKDPKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 3e-35
Identities = 78/258 (30%), Positives = 122/258 (47%), Gaps = 9/258 (3%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+YE R +G G FG V + +K + ++ + E LKLL HP
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHP 59
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHN 132
N++ +E + +V+EY GG L + I + L E F Q++ + + H
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 133 KGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
K + HRDLK +NILLD + KI DFG+S + +T G+P Y++PE+ +
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKI---LSSKSKAYTVVGTPCYISPELCEGK 176
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRK 250
Y+ SDIW+ G +LY + + F+ NL L KI G F + SP + L+
Sbjct: 177 PYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235
Query: 251 ILEPNPVKRITIAGIKAD 268
+L +P KR ++ I A
Sbjct: 236 MLNLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 4e-35
Identities = 85/300 (28%), Positives = 127/300 (42%), Gaps = 50/300 (16%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+T+G G FG+V + +D+ +A+K L K ++ +K E L + VV+L
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
+ K +Y V++Y+ GG++ + G +E R +L + H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRD 126
Query: 140 LKLENILLDSKGNIKISDFGLSA------------LPQHFRDDG---------------- 171
+K +NIL+D G+IK++DFGL H R D
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLK 186
Query: 172 -------------LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 218
L H+ G+PNY+APEVL GY D WS GVILY +L G PF
Sbjct: 187 PLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQPPFL 245
Query: 219 DRNLAVLYQKI--FRGDFKLPKW--LSPGAQNLLRKILEPNPVKRI---TIAGIKADEWF 271
A K+ + +P LS A +L+ + L R+ IKA +F
Sbjct: 246 ADTPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRLGKNGADEIKAHPFF 304
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 5e-35
Identities = 82/285 (28%), Positives = 125/285 (43%), Gaps = 51/285 (17%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKH 73
Y+ +GEG +G V A+D +G A+K K ++ REI LK L H
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIK---KIKLRFESEGIPKTALREIKLLKELNH 57
Query: 74 PNVVRLHEVLASKSKIYMVLEYV-TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
PN+++L +V K +Y+V E++ T K +G L E+ + QL+ G+++CH+
Sbjct: 58 PNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRG-LPESLIKSYLYQLLQGLAFCHS 116
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV------APE 186
G+ HRDLK EN+L++++G +K++DFGL+ F +T +YV APE
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLARS---FGSPVRPYT-----HYVVTRWYRAPE 168
Query: 187 VLANRGYDGATSDIWSCGVILYVILTG--YLPFDD-----------------RNLAVLYQ 227
+L DIWS G I +L+ P
Sbjct: 169 LLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS 228
Query: 228 KIFRGDFKLPKW-----------LSPGAQNLLRKILEPNPVKRIT 261
F PK SP A +LL ++L +P KRIT
Sbjct: 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRIT 273
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 7e-35
Identities = 71/252 (28%), Positives = 124/252 (49%), Gaps = 12/252 (4%)
Query: 19 GRTLGEGNFGKVKFAQDLDSGLPFAVK---ILEKNRIIHLKITDQIKREIATLKLLKHPN 75
G+ LG G F A+D+ +G AVK + ++ + +++EI + L HP+
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
++R+ S + +E++ GG + ++ G +EA +QL+ G+SY H +
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124
Query: 136 FHRDLKLENILLDSKGN-IKISDFGLSA-LPQHFRDDGLLH-TTCGSPNYVAPEVLANRG 192
HRD+K N+L+DS G ++I+DFG +A L G G+ ++APEVL
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-----GDFKLPKWLSPGAQNL 247
Y G + D+WS G ++ + T P++ + IF+ +P+ LSPG +++
Sbjct: 185 Y-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDV 243
Query: 248 LRKILEPNPVKR 259
+ LE P R
Sbjct: 244 TLRCLELQPEDR 255
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 91/300 (30%), Positives = 149/300 (49%), Gaps = 45/300 (15%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E + +G G FG+V+ Q D+G +A+K L K+ ++ + ++ E L +P
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
VV+L+ ++ +Y+++EY+ GG++ + K E E R + I + H G
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY 122
Query: 136 FHRDLKLENILLDSKGNIKISDFGLS-----------------ALPQHFRDD-------- 170
HRD+K +N+LLD+KG+IK+SDFGL ALP +F D
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 171 -----------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD 219
L ++T G+P+Y+APEV GY D WS GVI+Y +L GY PF
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFCS 241
Query: 220 RNLAVLYQKI--FRGDFKLPK--WLSPGAQNLLRKILEPNPVKRITIAG---IKADEWFE 272
N Y+KI ++ + P LSP A++L++++ +R+ G IK+ +F+
Sbjct: 242 DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC-CEAERRLGNNGVNEIKSHPFFK 300
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 3e-34
Identities = 73/250 (29%), Positives = 125/250 (50%), Gaps = 16/250 (6%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+++ LGEG++G V A ++G A+K++ + +I +EI+ LK P
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ-----EIIKEISILKQCDSPY 59
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
+V+ + + +++V+EY G + D KI +K L E E + Q + G+ Y H+
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSN 118
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
HRD+K NILL+ +G K++DFG+S Q +T G+P ++APEV+ GY
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSG--QLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176
Query: 194 DGATSDIWSCGVILYVILTGYLPFDD----RNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 249
+ DIWS G+ + G P+ D R + ++ K P+ SP + ++
Sbjct: 177 NNKA-DIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPT-LSDPEKWSPEFNDFVK 234
Query: 250 KILEPNPVKR 259
K L +P +R
Sbjct: 235 KCLVKDPEER 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 4e-34
Identities = 83/259 (32%), Positives = 142/259 (54%), Gaps = 16/259 (6%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RYE+ + +GEG+FGK+ A+ +K ++ ++ +K + K+E+ L +KHP
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHP 59
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL--FQQLIDGVSYCHN 132
N+V ++++V+EY GG+L +I + + +E + L F Q+ G+ + H+
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 133 KGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTC-GSPNYVAPEVLAN 190
+ + HRD+K +NI L G + K+ DFG++ + D L TC G+P Y++PE+ N
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIA---RQLNDSMELAYTCVGTPYYLSPEICQN 176
Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPG----AQN 246
R Y+ T DIWS G +LY + T PF+ NL L KI +G F P +SP ++
Sbjct: 177 RPYNNKT-DIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA-P--ISPNFSRDLRS 232
Query: 247 LLRKILEPNPVKRITIAGI 265
L+ ++ + +P R +I I
Sbjct: 233 LISQLFKVSPRDRPSITSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 7e-34
Identities = 91/318 (28%), Positives = 134/318 (42%), Gaps = 70/318 (22%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKL 70
+L YE+ LGEG FG+V A+ + +G A+K IL N IT REI LK
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITAL--REIKILKK 63
Query: 71 LKHPNVVRLHEVLASKSK--------IYMVLEYVT---GGELFDKIASKGRLQEAEGRKL 119
LKHPNVV L ++ + +YMV Y+ G L + +L E++ +
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP---SVKLTESQIKCY 120
Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
QL++G++Y H + HRD+K NIL+D++G +KI+DFGL+ + + G
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA---RPYDGPPPNPKGGGG 177
Query: 180 PN------------YVAPE-VLANRGYDGATSDIWSCGVILYVILTG--YLP-FDDRNLA 223
Y PE +L R Y A DIW G + + T L D +
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAV-DIWGIGCVFAEMFTRRPILQGKSDIDQL 236
Query: 224 VLYQKIFR-----GDFKLPKWLS-PGAQN------------------------LLRKILE 253
IF+ + P W S PG + LL K+L
Sbjct: 237 ---HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLS 293
Query: 254 PNPVKRITIAGIKADEWF 271
+P KR+T + +F
Sbjct: 294 LDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 7e-34
Identities = 88/266 (33%), Positives = 134/266 (50%), Gaps = 31/266 (11%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL--------EKNRIIHLKITDQIKREIA 66
+Y + R LG G G V A+ + G PFAVK++ +KNR + E+
Sbjct: 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRA---------QAEVC 83
Query: 67 TLKLLKHPNVVRLHEVLASK--------SKIYMVLEYVTGGELFDKIASKGR----LQEA 114
L ++V+ HE A K I +VL+Y G+L +I S+ + +E
Sbjct: 84 CLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREH 143
Query: 115 EGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH 174
E LF Q++ V + H+K + HRD+K NILL S G +K+ DFG S + D +
Sbjct: 144 EAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGR 203
Query: 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF 234
T CG+P YVAPE+ + Y +D++S GV+LY +LT PFD N+ + K G +
Sbjct: 204 TFCGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY 262
Query: 235 K-LPKWLSPGAQNLLRKILEPNPVKR 259
LP +SP Q ++ +L +P +R
Sbjct: 263 DPLPPSISPEMQEIVTALLSSDPKRR 288
|
Length = 496 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 81/262 (30%), Positives = 134/262 (51%), Gaps = 21/262 (8%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR---EIATLKLLKHPNVVR 78
LG+G FGKV AQ ++GL A KI I ++ ++++ EI L KHPN+V
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKI------IQIESEEELEDFMVEIDILSECKHPNIVG 66
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKGVFH 137
L+E ++K+++++E+ GG L + R L E + R + +Q+++ +++ H+ V H
Sbjct: 67 LYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIH 126
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA-----NRG 192
RDLK NILL G++K++DFG+SA + T G+P ++APEV+A +
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKS--TLQKRDTFIGTPYWMAPEVVACETFKDNP 184
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNLLR 249
YD +DIWS G+ L + P + N + KI + + P S + L+
Sbjct: 185 YD-YKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLK 243
Query: 250 KILEPNPVKRITIAGIKADEWF 271
L +P R T A + +
Sbjct: 244 SCLVKDPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 4e-33
Identities = 80/262 (30%), Positives = 130/262 (49%), Gaps = 13/262 (4%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
LG +++ + +G+G F V A L G A+K ++ ++ K +EI LK L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGEL---FDKIASKGRL-QEAEGRKLFQQLIDGVS 128
HPNV++ +++ +VLE G+L + RL E K F QL +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEV 187
+ H+K + HRD+K N+ + + G +K+ D GL + F H+ G+P Y++PE
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGLG---RFFSSKTTAAHSLVGTPYYMSPER 177
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPF--DDRNLAVLYQKIFRGDFK-LPK-WLSPG 243
+ GY+ SDIWS G +LY + PF D NL L +KI + D+ LP S
Sbjct: 178 IHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEE 236
Query: 244 AQNLLRKILEPNPVKRITIAGI 265
++L+ + + P+P KR I+ +
Sbjct: 237 LRDLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 85/263 (32%), Positives = 135/263 (51%), Gaps = 29/263 (11%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-----IKREIATLK 69
YEL + +G G +G V A+D+ +G A+K++ K+ I++EI+ LK
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVI--------KLEPGDDFEIIQQEISMLK 55
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVS 128
+HPN+V + K+++V+EY GG L D ++G L E + + ++ + G++
Sbjct: 56 ECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLA 115
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
Y H G HRD+K NILL G++K++DFG+SA Q + G+P ++APEV
Sbjct: 116 YLHETGKIHRDIKGANILLTEDGDVKLADFGVSA--QLTATIAKRKSFIGTPYWMAPEVA 173
Query: 189 ANR---GYDGATSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFRGDFKLP------K 238
A GYDG DIW+ G+ + P FD + L+ I + +F P K
Sbjct: 174 AVERKGGYDGK-CDIWALGITAIELAELQPPMFDLHPMRALFL-ISKSNFPPPKLKDKEK 231
Query: 239 WLSPGAQNLLRKILEPNPVKRIT 261
W SP + ++K L +P KR T
Sbjct: 232 W-SPVFHDFIKKCLTKDPKKRPT 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 79/244 (32%), Positives = 130/244 (53%), Gaps = 8/244 (3%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL--EKNRIIHLKITDQIKREIATLKLLKH 73
+ LG+ LG G FG+V D D+G AVK + + + K + ++ EI LK L+H
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 74 PNVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
+V+ + L + K+ + +EY+ GG + D++ + G L E R+ +Q++ GVSY H
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEVLAN 190
+ + HRD+K NIL DS GN+K+ DFG S Q G + + G+P +++PEV++
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183
Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK--LPKWLSPGAQNLL 248
GY G +D+WS + +LT P+ + KI K LP +S ++ L
Sbjct: 184 EGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFL 242
Query: 249 RKIL 252
++I
Sbjct: 243 KQIF 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 2e-32
Identities = 90/283 (31%), Positives = 134/283 (47%), Gaps = 59/283 (20%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ------IKREIATLKLLKHPN 75
+GEG +G V A+D +G A+K I L+ D+ I REI+ LK L HPN
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKK------IRLETEDEGVPSTAI-REISLLKELNHPN 59
Query: 76 VVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
+VRL +V+ S++K+Y+V E++ + D G L + QL+ G++YCH+
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKSYLYQLLQGIAYCHSH 118
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL-----LHTTCGSPNYVAPEVL 188
V HRDLK +N+L+D +G +K++DFGL+ R G+ H + Y APE+L
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLA------RAFGVPVRTYTHEVV-TLWYRAPEIL 171
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFR---------------- 231
DIWS G I ++ F D + L+ +IFR
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLF-RIFRTLGTPDEDVWPGVTSL 230
Query: 232 GDFK--LPKW-----------LSPGAQNLLRKILEPNPVKRIT 261
D+K PKW L +LL K+L +P KRI+
Sbjct: 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRIS 273
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 2e-32
Identities = 87/301 (28%), Positives = 131/301 (43%), Gaps = 75/301 (24%)
Query: 24 EGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK-------REIATLKLLKHPNV 76
EG +G V A+D +G A+K LK+ + + REI L L+HPN+
Sbjct: 15 EGTYGVVYRARDKKTGEIVALK--------KLKMEKEKEGFPITSLREINILLKLQHPNI 66
Query: 77 VRLHEVLASKS--KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNK 133
V + EV+ + KIYMV+EYV +L + + K ++E + L QL+ GV++ H+
Sbjct: 67 VTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN 125
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN-----------Y 182
+ HRDLK N+LL+++G +KI DFGL+ R+ GSP Y
Sbjct: 126 WILHRDLKTSNLLLNNRGILKICDFGLA------RE-------YGSPLKPYTQLVVTLWY 172
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR----------- 231
APE+L D+WS G I +LT F ++ KIF+
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP 232
Query: 232 GDFKLPKW---------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEW 270
G +LP LS +LL ++L +P KRI+ +
Sbjct: 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292
Query: 271 F 271
F
Sbjct: 293 F 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 89/291 (30%), Positives = 138/291 (47%), Gaps = 55/291 (18%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIATLKLLKHPNVV 77
LGEG + V ++ +G A+K IHL + REI+ +K LKH N+V
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKE------IHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 78 RLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
RLH+V+ +++K+ +V EY+ + D +G L + QL+ G+++CH V
Sbjct: 62 RLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRV 121
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVL-AN 190
HRDLK +N+L++ +G +K++DFGL+ R G+ T + Y AP+VL +
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLA------RAFGIPVNTFSNEVVTLWYRAPDVLLGS 175
Query: 191 RGYDGATS-DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-----------GDFKLPK 238
R Y +TS DIWS G I+ ++TG F N KIFR G +LP+
Sbjct: 176 RTY--STSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233
Query: 239 W------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271
+ P +LL ++L+ NP RI+ WF
Sbjct: 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 4e-32
Identities = 66/210 (31%), Positives = 110/210 (52%), Gaps = 16/210 (7%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-----ITDQIKREIATLK 69
+ L +G+G+FG+V A D + A+K+ I L+ I D I++EI L
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKV------IDLEEAEDEIED-IQQEIQFLS 54
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
+ P + + + SK+++++EY GG D + G+L E + ++++ G+ Y
Sbjct: 55 QCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP-GKLDETYIAFILREVLLGLEY 113
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
H +G HRD+K NILL +G++K++DFG+S Q +T G+P ++APEV+
Sbjct: 114 LHEEGKIHRDIKAANILLSEEGDVKLADFGVSG--QLTSTMSKRNTFVGTPFWMAPEVIK 171
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDD 219
GYD +DIWS G+ + G P D
Sbjct: 172 QSGYDEK-ADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 4e-32
Identities = 77/241 (31%), Positives = 131/241 (54%), Gaps = 8/241 (3%)
Query: 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILE--KNRIIHLKITDQIKREIATLKLLKHPNV 76
G+ LG+G FG+V D+D+G A K ++ K ++ EI LK L+H +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 77 VRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
V+ + L +++ + + +EY+ GG + D++ + G L E+ RK +Q+++G+SY H+
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEVLANRGY 193
+ HRD+K NIL DS GN+K+ DFG S Q G + + G+P +++PEV++ GY
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY 186
Query: 194 DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--GDFKLPKWLSPGAQNLLRKI 251
G +D+WS G + +LT P+ + KI + +LP +S A++ L I
Sbjct: 187 -GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFLGCI 245
Query: 252 L 252
Sbjct: 246 F 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 5e-32
Identities = 79/244 (32%), Positives = 135/244 (55%), Gaps = 8/244 (3%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKN--RIIHLKITDQIKREIATLKLLKH 73
+ LG+ LG+G FG+V D D+G AVK ++ + K + ++ EI LK L H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 74 PNVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
+V+ + L + + + +E++ GG + D++ S G L E RK +Q+++GVSY H
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEVLAN 190
+ + HRD+K NIL DS GN+K+ DFG S Q G + + G+P +++PEV++
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFR-GDFKLPKWLSPGAQNLL 248
GY G +DIWS G + +LT P+ + +A +++ + + LP +S ++ L
Sbjct: 184 EGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFL 242
Query: 249 RKIL 252
++I
Sbjct: 243 KRIF 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-31
Identities = 83/284 (29%), Positives = 137/284 (48%), Gaps = 41/284 (14%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+GEG +G V A++ +G A+K + + + I REI+ LK L HPN+V+L +
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 66
Query: 82 VLASKSKIYMVLEYVTGG-ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140
V+ +++K+Y+V E++ + F + + + QL+ G+++CH+ V HRDL
Sbjct: 67 VIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 126
Query: 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANRGYDGA 196
K +N+L++++G IK++DFGL+ R G+ T Y APE+L Y
Sbjct: 127 KPQNLLINTEGAIKLADFGLA------RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 180
Query: 197 TSDIWSCGVILYVILT--GYLPFDD---------RNLAVLYQKIFRG-----DFK--LPK 238
DIWS G I ++T P D R L + ++ G D+K PK
Sbjct: 181 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPK 240
Query: 239 W-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271
W L ++LL ++L +P KRI+ A +F
Sbjct: 241 WARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 6e-31
Identities = 81/263 (30%), Positives = 129/263 (49%), Gaps = 25/263 (9%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLKH 73
YEL +G G V A L + A+K LEK + D++++E+ + H
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS----VDELRKEVQAMSQCNH 58
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGVSYC 130
PNVV+ + ++++V+ Y++GG L D + S G L EA + ++++ G+ Y
Sbjct: 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG-----LLHTTCGSPNYVAP 185
H+ G HRD+K NILL G++KI+DFG+SA D G + T G+P ++AP
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGVSAS---LADGGDRTRKVRKTFVGTPCWMAP 175
Query: 186 EVLAN-RGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFKLP-----K 238
EV+ GYD +DIWS G+ + TG P+ + VL + L K
Sbjct: 176 EVMEQVHGYD-FKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK 234
Query: 239 WLSPGAQNLLRKILEPNPVKRIT 261
S + ++ L+ +P KR T
Sbjct: 235 KYSKSFRKMISLCLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 9e-31
Identities = 68/257 (26%), Positives = 124/257 (48%), Gaps = 15/257 (5%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+ L R LG G FG+V + + A+KIL+ + ++ ++E+ LK L+H +
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNR-VRVAIKILKSDDLLKQ---QDFQKEVQALKRLRHKH 63
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGR-LQEAEGRKLFQQLIDGVSYCHNK 133
++ L V + +Y++ E + G L + S +G+ L A + Q+ +G++Y +
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRG 192
HRDL NIL+ K++DFGL+ L ++D L + P + APE A+ G
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARL---IKEDVYLSSDKKIPYKWTAPEA-ASHG 179
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLS--PGAQNLLR 249
SD+WS G++LY + T G +P+ N +Y +I G +++P ++
Sbjct: 180 TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG-YRMPCPAKCPQEIYKIML 238
Query: 250 KILEPNPVKRITIAGIK 266
+ P R + ++
Sbjct: 239 ECWAAEPEDRPSFKALR 255
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 97/324 (29%), Positives = 132/324 (40%), Gaps = 90/324 (27%)
Query: 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--------REIATLK 69
L R +GEG +G V A+D SG A+K K R D + REI L
Sbjct: 12 LNR-IGEGTYGIVYRARDTTSGEIVALK---KVR------MDNERDGIPISSLREITLLL 61
Query: 70 LLKHPNVVRLHEVLASKS--KIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLID 125
L+HPN+V L EV+ K I++V+EY L D + + E++ + L QL+
Sbjct: 62 NLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLR 119
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPN- 181
G+ Y H + HRDLK+ N+LL KG +KI+DFGL+ LP +P
Sbjct: 120 GLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM----------TPKV 169
Query: 182 ----YVAPEVL-ANRGYDGATSDIWSCGVILYVILTG--YLP------------------ 216
Y APE+L Y A D+W+ G IL +L LP
Sbjct: 170 VTLWYRAPELLLGCTTYTTAI-DMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTP 228
Query: 217 -------FDDRNLAVLYQKIFRGDFKLPK-----------WLSPGAQNLLRKILEPNPVK 258
F D L G F LPK WLS LL +L +P K
Sbjct: 229 NESIWPGFSDLPLV--------GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKK 280
Query: 259 RITIAGIKADEWFEQDYTPANPDD 282
R T +F++ P P+
Sbjct: 281 RATAEEALESSYFKEKPLPCEPEM 304
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 95/312 (30%), Positives = 132/312 (42%), Gaps = 68/312 (21%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+TLG G FG+V A+ +D+ +A+K L K ++ +K E L + VVRL
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
+ K +Y V++Y+ GG++ + G E R +L V H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126
Query: 140 LKLENILLDSKGNIKISDFGL---------SALPQ---HFRDDG---------------- 171
+K +NIL+D G+IK++DFGL S Q H R D
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186
Query: 172 -----------------LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 214
L H+ G+PNY+APEVL GY D WS GVILY +L G
Sbjct: 187 DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQ 245
Query: 215 LPFDDRNLAVLYQKIFRGDFKLPKW-----------LSPGAQNLLRKILEPNPVKRITIA 263
PF L Q K+ W LSP A +L+ K+ P R+
Sbjct: 246 PPF-------LAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCR-GPEDRLGKN 297
Query: 264 G---IKADEWFE 272
G IKA +F+
Sbjct: 298 GADEIKAHPFFK 309
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 1e-30
Identities = 86/259 (33%), Positives = 132/259 (50%), Gaps = 13/259 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI--TDQIKREIATLKLLK 72
RY L + LG+G+FG V +D + +K+L++ + L T Q +E L L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVS 128
HP +V+ H + ++ EY G +L K+ + L E + + F QL+ GV
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 129 YCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
Y H + + HRDLK +NI L K N+ KI DFG+S L D L T G+P Y++PE
Sbjct: 121 YMHQRRILHRDLKAKNIFL--KNNLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEA 176
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQN 246
L ++GYD + SDIWS G ILY + F+ +N + +I G LP+ S +
Sbjct: 177 LKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNS 235
Query: 247 LLRKILEPNPVKRITIAGI 265
+++ +L +P R + A I
Sbjct: 236 IMQSMLNKDPSLRPSAAEI 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-30
Identities = 76/235 (32%), Positives = 117/235 (49%), Gaps = 14/235 (5%)
Query: 37 DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL-HEVLASKSKIYMVLEY 95
+G A+K+L + + +RE A L HPN+V L A ++ V EY
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---N 152
V G L + +A+ G L E +L Q++D ++ HN+G+ HRDLK +NI++ G +
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 153 IKISDFGLSALPQHFRDDGLLHTT-----CGSPNYVAPEVLANRGYDGATSDIWSCGVIL 207
K+ DFG+ L RD + T G+P Y APE L SD+++ G+I
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVT-PNSDLYAWGLIF 179
Query: 208 YVILTGYLPFDDRNLA-VLYQKIFRGDFKLPKWLS--PGAQNLLRKILEPNPVKR 259
LTG ++A +LYQ++ D LP W++ P Q +LRK L +P +R
Sbjct: 180 LECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQ-VLRKALNKDPRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 65/204 (31%), Positives = 107/204 (52%), Gaps = 27/204 (13%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK-REI-ATLKLLKH 73
Y++ + LG+G FG V A++ ++G A+K + K + + + + RE+ + KL +H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWE--ECMNLREVKSLRKLNEH 57
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGR-LQEAEGRKLFQQLIDGVSYCH 131
PN+V+L EV ++Y V EY+ G L+ + KG+ E+ R + Q++ G+++ H
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYV------ 183
G FHRDLK EN+L+ +KI+DFGL+ R P +YV
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLA------R-----EIRSRPPYTDYVSTRWYR 165
Query: 184 APEVLANRGYDGATSDIWSCGVIL 207
APE+L + DIW+ G I+
Sbjct: 166 APEILLRSTSYSSPVDIWALGCIM 189
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 85/282 (30%), Positives = 144/282 (51%), Gaps = 29/282 (10%)
Query: 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI----KREIA 66
M+ +++ + +G G FG+V+ + S +A+K+L K +I K +D +R+I
Sbjct: 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI--KRSDSAFFWEERDI- 96
Query: 67 TLKLLKHPN---VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
+ H N +V+LH +YMV+EY+ GG+L + + S + E R ++
Sbjct: 97 ----MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEV 151
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH--TTCGSPN 181
+ + H+ G HRD+K +N+LLD G++K++DFG +G++ T G+P+
Sbjct: 152 VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM---KMDANGMVRCDTAVGTPD 208
Query: 182 YVAPEVLANRGYD---GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--RGDFKL 236
Y++PEVL ++G D G D WS GV LY +L G PF +L Y KI +
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTF 268
Query: 237 PK--WLSPGAQNLLRKILEPNPVK--RITIAGIKADEWFEQD 274
P +S A++L+ L V+ R + IK+ +F+ D
Sbjct: 269 PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 86/293 (29%), Positives = 134/293 (45%), Gaps = 56/293 (19%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKH 73
+++ +GEG +G+V A+D D+G A+K K R+ + K I REI L+ L H
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALK---KVRLDNEKEGFPITAIREIKILRQLNH 65
Query: 74 PNVVRLHEVLASKSK----------IYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQ 122
N+V L E++ K Y+V EY+ +L + S E + +Q
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQ 124
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPN 181
L++G++YCH K HRD+K NILL++KG IK++DFGL+ L + ++ +T +
Sbjct: 125 LLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL--YNSEESRPYTNKVITLW 182
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD-DRNLAVL--------------- 225
Y PE+L G D+WSCG IL + T F ++ LA L
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242
Query: 226 -----------------YQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 261
Y++ R +F + A +LL +L +P KR T
Sbjct: 243 PDVIKLPYFNTMKPKKQYRRRLREEFSF---IPTPALDLLDHMLTLDPSKRCT 292
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-30
Identities = 76/259 (29%), Positives = 135/259 (52%), Gaps = 26/259 (10%)
Query: 15 RYELGR--TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE-----IAT 67
R L +GEG+ G V A D +G AVK ++ + Q +RE +
Sbjct: 18 RSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMD--------LRKQQRRELLFNEVVI 69
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
++ +HPN+V ++ ++++V+E++ GG L D I + R+ E + + ++ +
Sbjct: 70 MRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKAL 128
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
S+ H +GV HRD+K ++ILL S G +K+SDFG A Q ++ + G+P ++APEV
Sbjct: 129 SFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPEV 186
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFRGD----FKLPKWLSP 242
++ Y G DIWS G+++ ++ G P F++ L + K R + K +SP
Sbjct: 187 ISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM--KRIRDNLPPKLKNLHKVSP 243
Query: 243 GAQNLLRKILEPNPVKRIT 261
++ L ++L +P +R T
Sbjct: 244 RLRSFLDRMLVRDPAQRAT 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 4e-30
Identities = 75/247 (30%), Positives = 118/247 (47%), Gaps = 34/247 (13%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E + +G G FG+V+ Q D+G +A+KIL K ++ + I+ E L
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
VV++ K +Y+++E++ GG++ + K L E E + + + + H G
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 136 FHRDLKLENILLDSKGNIKISDFGLS-----------------ALPQHFRDDG------- 171
HRD+K +N+LLDSKG++K+SDFGL +LP F
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 172 ---------LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL 222
L +T G+P+Y+APEV GY+ D WS GVI+Y +L GY PF
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 223 AVLYQKI 229
Y+K+
Sbjct: 242 QETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 5e-30
Identities = 72/247 (29%), Positives = 119/247 (48%), Gaps = 34/247 (13%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E + +G G FG+V+ Q D+G +A+KIL K ++ + I+ E L
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
VV++ K +Y+++E++ GG++ + K L E + + + + H G
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 136 FHRDLKLENILLDSKGNIKISDFGL-SALPQHFRDD------------------------ 170
HRD+K +N+LLD+KG++K+SDFGL + L + R +
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 171 --------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL 222
L ++T G+P+Y+APEV GY+ D WS GVI+Y +L GY PF
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 223 AVLYQKI 229
Y+K+
Sbjct: 242 QETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 6e-30
Identities = 71/268 (26%), Positives = 134/268 (50%), Gaps = 16/268 (5%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+++ +G G+FG+V+ ++ +G +A+K+++K+ ++ + + E L + P
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
+ +L K +Y+V+EY GG+L + + + E + +L+ + H G
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVL-ANR 191
HRD+K EN+L+D G+IK++DFG +A + ++++ G+P+Y+APEVL
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAA---RLTANKMVNSKLPVGTPDYIAPEVLTTMN 179
Query: 192 GYDGATSDI----WSCGVILYVILTGYLPFDDRNLAVLYQKI--FRGDFKLPKWL--SPG 243
G T + WS GVI Y ++ G PF + A Y I F+ K P+ S
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWF 271
+L++ +L +R+ G+ +F
Sbjct: 240 FLDLIQSLL-CGQKERLGYEGLCCHPFF 266
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 86/293 (29%), Positives = 137/293 (46%), Gaps = 65/293 (22%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK-------REIAT 67
+YE +GEG +G V A++ ++ A+K +++ D + REI
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALK--------RVRLDDDDEGVPSSALREICL 52
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLID 125
LK LKH N+VRL++VL S K+ +V EY + FD + G + + QL+
Sbjct: 53 LKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFD--SCNGDIDPEIVKSFMFQLLK 110
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN---- 181
G+++CH+ V HRDLK +N+L++ G +K++DFGL+ R G + C S
Sbjct: 111 GLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLA------RAFG-IPVRCYSAEVVTL 163
Query: 182 -YVAPEVL-ANRGYDGATS-DIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFR------ 231
Y P+VL + Y TS D+WS G I + P F ++ ++IFR
Sbjct: 164 WYRPPDVLFGAKLYS--TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT 221
Query: 232 -----GDFKLPKW------------------LSPGAQNLLRKILEPNPVKRIT 261
G KLP + L+ ++LL+ +L NPV+RI+
Sbjct: 222 EESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRIS 274
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-29
Identities = 83/257 (32%), Positives = 128/257 (49%), Gaps = 21/257 (8%)
Query: 15 RYELGRTLGEGNFGK-VKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR-----EIATL 68
Y R LG+G FG+ + + D L V E ++L + +R EI L
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSL---VVWKE----VNLTRLSEKERRDALNEIVIL 53
Query: 69 KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIA-SKGRL-QEAEGRKLFQQLIDG 126
LL+HPN++ + + + + +EY GG L+DKI KG+L +E Q++
Sbjct: 54 SLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSA 113
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC-GSPNYVAP 185
VSY H G+ HRD+K NI L G IK+ DFG+S + + + T G+P Y++P
Sbjct: 114 VSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGIS---KILGSEYSMAETVVGTPYYMSP 170
Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGA 244
E+ Y+ SDIW+ G +LY +LT FD N L KI +G++ + S
Sbjct: 171 ELCQGVKYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSEL 229
Query: 245 QNLLRKILEPNPVKRIT 261
+L+ +L+ +P KR T
Sbjct: 230 ISLVHSLLQQDPEKRPT 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 3e-29
Identities = 81/284 (28%), Positives = 143/284 (50%), Gaps = 15/284 (5%)
Query: 2 VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI 61
++ + ++ M+ Y++ + +G G FG+V+ + S +A+K+L K +I +
Sbjct: 31 IVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFF 90
Query: 62 KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ 121
E + P VV+L +YMV+EY+ GG+L + + S + E +
Sbjct: 91 WEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTA 149
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH--TTCGS 179
+++ + H+ G+ HRD+K +N+LLD G++K++DFG + G++ T G+
Sbjct: 150 EVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC---MKMDETGMVRCDTAVGT 206
Query: 180 PNYVAPEVLANR---GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--RGDF 234
P+Y++PEVL ++ GY G D WS GV L+ +L G PF +L Y KI +
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL 266
Query: 235 KLPK--WLSPGAQNLLRKILEPNPVK--RITIAGIKADEWFEQD 274
P+ +S A+NL+ L V+ R + IK +F+ D
Sbjct: 267 NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 4e-29
Identities = 71/208 (34%), Positives = 111/208 (53%), Gaps = 23/208 (11%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLK 72
G +EL +GEG +GKV A+ +G A+KI++ II + + IK E L K
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD---IIEDEEEE-IKEEYNILRKYSN 61
Query: 73 HPNVVRLHEVLASKS------KIYMVLEYVTGG---ELFDKIASKG-RLQEAEGRKLFQQ 122
HPN+ + K+ ++++V+E GG +L + KG RL+E + ++
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
+ G++Y H V HRD+K +NILL +K+ DFG+SA Q G +T G+P +
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDSTLGRRNTFIGTPYW 179
Query: 183 VAPEVLA-----NRGYDGATSDIWSCGV 205
+APEV+A + YD A SD+WS G+
Sbjct: 180 MAPEVIACDEQPDASYD-ARSDVWSLGI 206
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 4e-29
Identities = 81/264 (30%), Positives = 125/264 (47%), Gaps = 18/264 (6%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
LG GN G V +G AVK + I+ I QI RE+ L P +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKCNSPYIVGF 64
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKI--ASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVF 136
+ + I + +EY+ GG L DKI +GR+ E K+ ++ G++Y H K +
Sbjct: 65 YGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKII 123
Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
HRD+K NIL++S+G IK+ DFG+S + L T G+ +Y+APE + Y
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSG----QLVNSLAKTFVGTSSYMAPERIQGNDY-SV 178
Query: 197 TSDIWSCGVILYVILTGYLPF---DDRNLAV--LYQKIFRGDF-KLPK-WLSPGAQNLLR 249
SDIWS G+ L + TG P+ +D + L Q I +LP SP Q+ +
Sbjct: 179 KSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVN 238
Query: 250 KILEPNPVKRITIAGIKADEWFEQ 273
L +P +R + + + ++
Sbjct: 239 LCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 5e-29
Identities = 89/329 (27%), Positives = 133/329 (40%), Gaps = 67/329 (20%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-HLKITDQIKREIATLKLLKH 73
RYEL + +G G +G V A D +G A+K + + + L +I REI L+ L+H
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI--SNVFDDLIDAKRILREIKLLRHLRH 58
Query: 74 PNVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
N++ L ++L S +Y+V E + +L I S L + + Q++ G+
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQILRGLK 117
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYV--- 183
Y H+ V HRDLK NIL++S ++KI DFGL+ P L YV
Sbjct: 118 YLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE-------YVVTR 170
Query: 184 ---APEV-LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--------- 230
APE+ L++ Y A DIWS G I +LT F R+ I
Sbjct: 171 WYRAPELLLSSSRYTKAI-DIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE 229
Query: 231 ----------------RGDFKLPKW------LSPGAQNLLRKILEPNPVKRITIAGIKAD 268
SP A +LL K+L +P KRIT A
Sbjct: 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289
Query: 269 EWFEQDYTPA----------NPDDDEEDI 287
+ Q + P D++++
Sbjct: 290 PYLAQLHDPEDEPVAKPPFDFDFFDDDEL 318
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 8e-29
Identities = 67/206 (32%), Positives = 111/206 (53%), Gaps = 14/206 (6%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
E +G G G V +G +A+K++ N ++ QI REI L+ + HPNV
Sbjct: 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR--QICREIEILRDVNHPNV 134
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFD-KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
V+ H++ +I ++LE++ GG L IA + L + + +Q++ G++Y H + +
Sbjct: 135 VKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD-----VARQILSGIAYLHRRHI 189
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL---ANRG 192
HRD+K N+L++S N+KI+DFG+S + D +++ G+ Y++PE + N G
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP--CNSSVGTIAYMSPERINTDLNHG 247
Query: 193 -YDGATSDIWSCGVILYVILTGYLPF 217
YDG DIWS GV + G PF
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 82/256 (32%), Positives = 126/256 (49%), Gaps = 10/256 (3%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
R LG+G FG+V Q +G +A K LEK RI K E L+ + VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFH 137
+K + +VL + GG+L I G EGR +F ++ G+ H + + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT 197
RDLK ENILLD G+I+ISD GL+ H + + G+ Y+APEV+ N Y +
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEVVKNERYT-FS 181
Query: 198 SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR----GDFKLPKWLSPGAQNLLRKILE 253
D W+ G +LY ++ G PF R + +++ R + + SP A++L + +L
Sbjct: 182 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLC 241
Query: 254 PNPVKRITIAGIKADE 269
+P +R+ G A E
Sbjct: 242 KDPKERLGCQGGGARE 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 73/243 (30%), Positives = 107/243 (44%), Gaps = 46/243 (18%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+TLG G FG+V A +D+ +A+K L K +++ +K E L + VV+L
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
+ K +Y V++Y+ GG++ + E R +L + H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126
Query: 140 LKLENILLDSKGNIKISDFGL----------------------SALPQHFRDD------- 170
+K +NIL+D G+IK++DFGL S P DD
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186
Query: 171 ----------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 214
L H+ G+PNY+APEVL +GY D WS GVIL+ +L G
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQ 245
Query: 215 LPF 217
PF
Sbjct: 246 PPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-28
Identities = 82/244 (33%), Positives = 124/244 (50%), Gaps = 12/244 (4%)
Query: 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILE---KNRIIHLKITDQIKREIATLKLLKHPN 75
G LG+G +G V + + G AVK +E N + K ++++ E+ LK LKH N
Sbjct: 5 GEVLGKGAYGTV-YCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
+V+ + I + +E+V GG + + G L E K +Q++DGV+Y HN V
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 136 FHRDLKLENILLDSKGNIKISDFG----LSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
HRD+K N++L G IK+ DFG L+ + H +L + G+P ++APEV+
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFD--DRNLAVLYQKIFRGDF-KLPKWLSPGAQNLL 248
GY G SDIWS G ++ + TG P DR A+ Y RG +LP S A + +
Sbjct: 184 GY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFV 242
Query: 249 RKIL 252
L
Sbjct: 243 TSCL 246
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 94/269 (34%), Positives = 144/269 (53%), Gaps = 37/269 (13%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
LG+G +G V A+DL + + A+K I E++ + + EIA LKH N+V+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDS----RYVQPLHEEIALHSYLKHRNIVQY- 70
Query: 81 EVLASKS-----KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLF--QQLIDGVSYCHN 132
L S S KI+M E V GG L + SK G L++ E +F +Q+++G+ Y H+
Sbjct: 71 --LGSDSENGFFKIFM--EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD 126
Query: 133 KGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHFRDDGL---LHTTCGSPNYVAPEVL 188
+ HRD+K +N+L+++ G +KISDFG S R G+ T G+ Y+APEV+
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK-----RLAGINPCTETFTGTLQYMAPEVI 181
Query: 189 --ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-GDFK----LPKWLS 241
RGY GA +DIWS G + + TG PF + L +F+ G FK +P+ LS
Sbjct: 182 DKGPRGY-GAPADIWSLGCTIVEMATGKPPFIE--LGEPQAAMFKVGMFKIHPEIPESLS 238
Query: 242 PGAQNLLRKILEPNPVKRITIAGIKADEW 270
A+N + + EP+P KR + + D +
Sbjct: 239 AEAKNFILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 83/275 (30%), Positives = 136/275 (49%), Gaps = 15/275 (5%)
Query: 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
M+ YE+ + +G G FG+V+ + + +A+K+L K +I + E +
Sbjct: 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
P VV+L +YMV+EY+ GG+L + + S + E R +++ +
Sbjct: 100 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAI 158
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH--TTCGSPNYVAPEVL 188
H+ G HRD+K +N+LLD G++K++DFG +G++ T G+P+Y++PEVL
Sbjct: 159 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTC---MKMNKEGMVRCDTAVGTPDYISPEVL 215
Query: 189 ANR---GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--RGDFKLP--KWLS 241
++ GY G D WS GV LY +L G PF +L Y KI + P +S
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 275
Query: 242 PGAQNLLRKILEPNPVK--RITIAGIKADEWFEQD 274
A+NL+ L V+ R + IK +F+ D
Sbjct: 276 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 5e-28
Identities = 79/256 (30%), Positives = 124/256 (48%), Gaps = 10/256 (3%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
R LG+G FG+V Q +G +A K LEK RI K E L+ + VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFH 137
+K + +VL + GG+L I + G E R +F ++ G+ H + + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT 197
RDLK ENILLD G+I+ISD GL+ + + G+ Y+APEV+ N Y +
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAV---EIPEGETIRGRVGTVGYMAPEVVKNERY-TFS 181
Query: 198 SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR----GDFKLPKWLSPGAQNLLRKILE 253
D W G ++Y ++ G PF R V +++ R + + S A+++ R++L
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLT 241
Query: 254 PNPVKRITIAGIKADE 269
+P R+ G A+E
Sbjct: 242 KDPGFRLGCRGEGAEE 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 7e-28
Identities = 86/290 (29%), Positives = 137/290 (47%), Gaps = 57/290 (19%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-----IKREIATLKL 70
YE +GEG +G V A+DL++G A+K + + ++++ REIA LK
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKK------VRVPLSEEGIPLSTLREIALLKQ 54
Query: 71 LK---HPNVVRLHEVLA-----SKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLF 120
L+ HPN+VRL +V + K+ +V E+V K G L + L
Sbjct: 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LPPETIKDLM 113
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
+QL+ GV + H+ + HRDLK +NIL+ S G +KI+DFGL+ + + + L + +
Sbjct: 114 RQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI---YSFEMALTSVVVTL 170
Query: 181 NYVAPEVLANRGYDGATS-DIWSCGVILYVI---------------------LTGYLPFD 218
Y APEVL Y AT D+WS G I + + G +
Sbjct: 171 WYRAPEVLLQSSY--ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEE 228
Query: 219 D--RNLAVL---YQKIFRGDFK--LPKWLSPGAQNLLRKILEPNPVKRIT 261
+ RN+++ + FK +P+ + +LL+K+L NP KRI+
Sbjct: 229 EWPRNVSLPRSSFPSYTPRSFKSFVPE-ICEEGLDLLKKMLTFNPHKRIS 277
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 75/282 (26%), Positives = 124/282 (43%), Gaps = 50/282 (17%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+ +G+G FG+V+ Q D+G +A+K L K+ + +K E L P VV L
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
+ +Y+++E++ GG+L + E R + + + H G HRD
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRD 126
Query: 140 LKLENILLDSKGNIKISDFGL--------------------SALPQHFRDDGLL------ 173
+K +NIL+D G+IK+SDFGL S + + +
Sbjct: 127 IKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINL 186
Query: 174 -------------------HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 214
++T G+P+Y+APE+ +GY G D WS G I++ L G+
Sbjct: 187 TMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIGW 245
Query: 215 LPFDDRNLAVLYQKI--FRGDFKLPK--WLSPGAQNLLRKIL 252
PF N Y+KI +R P LS A++L+R+++
Sbjct: 246 PPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLI 287
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 91/322 (28%), Positives = 137/322 (42%), Gaps = 71/322 (22%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDS--GLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+YE+ +G G +G+V A+ + G +A+K + ++ + I+ REIA L+ LK
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 73 HPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKI-----ASKGRLQEAEGRKLFQQLID 125
H NVV L EV + +Y++ +Y +L+ I A + + + + L Q+++
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119
Query: 126 GVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGL-----SALPQHFRDDGLLHTT 176
GV Y H+ V HRDLK NIL+ +G +KI D GL + L D ++ T
Sbjct: 120 GVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI 179
Query: 177 CGSPNYVAPEV-LANRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQ---- 227
Y APE+ L R Y A DIW+ G I +LT F + +Q
Sbjct: 180 W----YRAPELLLGARHYTKAI-DIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL 234
Query: 228 -KIFR-----------------------GDFK--------LPKW------LSPGAQNLLR 249
+IF DFK L KW +LLR
Sbjct: 235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLR 294
Query: 250 KILEPNPVKRITIAGIKADEWF 271
K+LE +P KRIT +F
Sbjct: 295 KLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 71/209 (33%), Positives = 110/209 (52%), Gaps = 18/209 (8%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL--EKNRIIHLKITDQIKREIATLKLLKHP 74
EL R LGEG G V + ++G+ FA+K + + N + QI RE+ K K P
Sbjct: 5 ELSR-LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQ----KQILRELEINKSCKSP 59
Query: 75 NVVRLHE--VLASKSKIYMVLEYVTGGEL---FDKIASKG-RLQEAEGRKLFQQLIDGVS 128
+V+ + + S S I + +EY GG L + K+ +G R+ E K+ + ++ G+S
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
Y H++ + HRD+K NILL KG +K+ DFG+S + L T G+ Y+APE +
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV----NSLAGTFTGTSFYMAPERI 175
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPF 217
+ Y TSD+WS G+ L + PF
Sbjct: 176 QGKPYS-ITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 81/275 (29%), Positives = 133/275 (48%), Gaps = 40/275 (14%)
Query: 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
L R LG G FG+V + + AVK L+ + + +E +K L+H +V
Sbjct: 10 LERKLGAGQFGEV-WMGTWNGTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLV 64
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVSY 129
+L+ V + + IY+V EY++ G L D L+ EG+KL QL+D G++Y
Sbjct: 65 QLYAVCSEEEPIYIVTEYMSKGSLLD------FLKSGEGKKLRLPQLVDMAAQIAEGMAY 118
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY----VAP 185
++ HRDL NIL+ KI+DFGL+ L DD +T + AP
Sbjct: 119 LESRNYIHRDLAARNILVGENLVCKIADFGLARL---IEDD--EYTAREGAKFPIKWTAP 173
Query: 186 EVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
E AN G SD+WS G++L I+T G +P+ + +++ RG +++P+ P
Sbjct: 174 EA-ANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG-YRMPR--PPNC 229
Query: 245 ----QNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
+L+ + + +P +R T ++ F +DY
Sbjct: 230 PEELYDLMLQCWDKDPEERPTFEYLQ---SFLEDY 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 84/282 (29%), Positives = 133/282 (47%), Gaps = 56/282 (19%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-----IKREIATLKLLKHPNV 76
+GEG +G V ++ +G A+K I L+ ++ REI+ LK L+HPN+
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKK------IRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 77 VRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
V L +VL +S++Y++ E+++ + D + + + Q++ G+ +CH++
Sbjct: 62 VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR 121
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL-----LHTTCGSPNYVAPEVLA 189
V HRDLK +N+L+D+KG IK++DFGL+ R G+ H + Y APEVL
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLA------RAFGIPVRVYTHEVV-TLWYRAPEVLL 174
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFR----------------G 232
DIWS G I + T F D + L+ +IFR
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLF-RIFRILGTPTEDVWPGVTSLP 233
Query: 233 DFK--LPKW-----------LSPGAQNLLRKILEPNPVKRIT 261
D+K PKW L +LL K+L +P KRI+
Sbjct: 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRIS 275
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 89/324 (27%), Positives = 142/324 (43%), Gaps = 50/324 (15%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
RY+ +G G +G+V A D +G A+K L + IH K T RE+ LK +
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRT---YRELRLLKHMD 72
Query: 73 HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H NV+ L +V L +Y+V + G +L + + + +L + + L Q++ G
Sbjct: 73 HENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQ-KLSDDHIQFLVYQILRG 130
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
+ Y H+ G+ HRDLK NI ++ +KI DFGL+ D + + Y APE
Sbjct: 131 LKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT-----DDEMTGYVATRWYRAPE 185
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF----------------------------- 217
++ N + T DIWS G I+ +LTG F
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245
Query: 218 -DDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
RN ++ + DFK + +P A +LL K+L +P KRIT A A + + +
Sbjct: 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305
Query: 276 TPAN-PDDDEEDIFVDNEAFSMHE 298
P + P D ++ ++ E
Sbjct: 306 DPEDEPVAPPYDQSFESRDLTVDE 329
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 5e-27
Identities = 85/285 (29%), Positives = 131/285 (45%), Gaps = 48/285 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL---EKNRIIHLKITDQIKREIATLKLL 71
+YE +GEG++G V ++ ++G A+K E + +I KI REI LK L
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIK-KIA---LREIRMLKQL 57
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
KHPN+V L EV K K+++V EY L + + + E +K+ Q + V++CH
Sbjct: 58 KHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH 117
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN-YVAPEVLAN 190
HRD+K ENIL+ +G IK+ DFG + + DD +T + Y APE+L
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD---YTDYVATRWYRAPELLVG 174
Query: 191 RGYDGATSDIWSCGVILYVILTG-------------YLPFDDRNLAVLY---QKIFR-GD 233
G D+W+ G + +LTG YL + L L Q+IF
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLI--RKTLGDLIPRHQQIFSTNQ 232
Query: 234 F-----------------KLPKWLSPGAQNLLRKILEPNPVKRIT 261
F K P +S A + L+ L+ +P +R++
Sbjct: 233 FFKGLSIPEPETREPLESKFPN-ISSPALSFLKGCLQMDPTERLS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 78/257 (30%), Positives = 124/257 (48%), Gaps = 15/257 (5%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
L + + + +G G F +V A L G+P A+K ++ ++ K +EI LK L
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVS 128
HPNV++ + +++ +VLE G+L I K + E K F QL +
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
+ H++ V HRD+K N+ + + G +K+ D GL H+ G+P Y++PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPERI 178
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPF--DDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246
GY+ SDIWS G +LY + PF D NL L +KI + D+ P S
Sbjct: 179 HENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY--PPLPSDHYSE 235
Query: 247 LLRKILE----PNPVKR 259
LR+++ P+P KR
Sbjct: 236 ELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 73/249 (29%), Positives = 130/249 (52%), Gaps = 15/249 (6%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E+ + +G G FG+V + ++ FA+KIL K ++ T + E L +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
+ LH ++ +Y+V++Y GG+L ++ + RL E R +++ + H
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVLA--- 189
HRD+K +NIL+D G+I+++DFG S L +DG + ++ G+P+Y++PE+L
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFG-SCL--KLMEDGTVQSSVAVGTPDYISPEILQAME 179
Query: 190 -NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--RGDFKLPKW---LSPG 243
+G G D WS GV +Y +L G PF +L Y KI + F+ P +S
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239
Query: 244 AQNLLRKIL 252
A++L+R+++
Sbjct: 240 AKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-26
Identities = 75/259 (28%), Positives = 133/259 (51%), Gaps = 18/259 (6%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-----LKL 70
Y R +G+G++G+V + G + +K L +L+ + +R+ A L
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKL------NLRNASRRERKAAEQEAQLLSQ 55
Query: 71 LKHPNVVRLHEVLASKS-KIYMVLEYVTGGELFDKIA-SKGRL-QEAEGRKLFQQLIDGV 127
LKHPN+V E + +Y+V+ + GG+L+ K+ KG+L E + + F Q+ +
Sbjct: 56 LKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL 115
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
Y H K + HRDLK +N+ L IK+ D G++ + ++ D + T G+P Y++PE+
Sbjct: 116 QYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPEL 173
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQN 246
+N+ Y+ SD+W+ G +Y + T F+ +++ L +I G +PK SP
Sbjct: 174 FSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGE 232
Query: 247 LLRKILEPNPVKRITIAGI 265
L+ +L P KR ++ I
Sbjct: 233 LIATMLSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 77/248 (31%), Positives = 132/248 (53%), Gaps = 13/248 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RYE +G+G G V A D+ +G A+K + + ++ I EI +K LK+P
Sbjct: 23 RYE---KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL---IINEILVMKELKNP 76
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+V + ++++V+EY+ GG L D + ++ + EA+ + ++ + + + H
Sbjct: 77 NIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEFLHANQ 135
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
V HRD+K +N+LL G++K++DFG A Q + T G+P ++APEV+ + Y
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY- 192
Query: 195 GATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKL--PKWLSPGAQNLLRKI 251
G DIWS G++ ++ G P+ + N L LY G +L P+ LSP ++ L +
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRC 252
Query: 252 LEPNPVKR 259
LE + KR
Sbjct: 253 LEMDVEKR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 87/260 (33%), Positives = 134/260 (51%), Gaps = 26/260 (10%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ---IKREIATLKLLK 72
YEL + +G G +G V A++L +G AVKI I L+ D I++EI +K K
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKI------IKLEPGDDFSLIQQEIFMVKECK 64
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
H N+V S+ K+++ +EY GG L D G L E + + ++ + G++Y H+
Sbjct: 65 HCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHS 124
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA--- 189
KG HRD+K NILL G++K++DFG++A + + G+P ++APEV A
Sbjct: 125 KGKMHRDIKGANILLTDNGDVKLADFGVAA--KITATIAKRKSFIGTPYWMAPEVAAVEK 182
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLP--FDDRNLAVLYQKIFRGDFKLP------KWLS 241
N GY+ DIW+ G I + L P FD + L+ + + +F+ P KW S
Sbjct: 183 NGGYN-QLCDIWAVG-ITAIELAELQPPMFDLHPMRALFL-MSKSNFQPPKLKDKTKW-S 238
Query: 242 PGAQNLLRKILEPNPVKRIT 261
N ++ L NP KR T
Sbjct: 239 STFHNFVKISLTKNPKKRPT 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 73/253 (28%), Positives = 129/253 (50%), Gaps = 20/253 (7%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE-----IATLK 69
+Y +G+G G V A D+ +G A+K + + Q K+E I ++
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIK--------QMNLQQQPKKELIINEILVMR 71
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
KHPN+V + ++++V+EY+ GG L D + ++ + E + + ++ + + +
Sbjct: 72 ENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 130
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
H+ V HRD+K +NILL G++K++DFG A Q + T G+P ++APEV+
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVT 188
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRG--DFKLPKWLSPGAQN 246
+ Y G DIWS G++ ++ G P+ + N L LY G + + P+ LS ++
Sbjct: 189 RKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 247
Query: 247 LLRKILEPNPVKR 259
L + LE + KR
Sbjct: 248 FLNRCLEMDVEKR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-26
Identities = 82/269 (30%), Positives = 124/269 (46%), Gaps = 39/269 (14%)
Query: 22 LGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR 78
LG+G+FG V+ + SG +P AVK L+ +++ I D +E A + L H N++R
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL--SDIMDDFLKEAAIMHSLDHENLIR 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ---QLIDGVSYCHNKGV 135
L+ V+ + + MV E G L D++ K L L Q+ +G+ Y +K
Sbjct: 61 LYGVVLTHP-LMMVTELAPLGSLLDRL-RKDALGHFLISTLCDYAVQIANGMRYLESKRF 118
Query: 136 FHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYV----------- 183
HRDL NILL S +KI DFGL ALPQ +YV
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQ------------NEDHYVMEEHLKVPFAW 166
Query: 184 -APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKW 239
APE L R + A SD+W GV L+ + T G P+ + + + +KI + +L P+
Sbjct: 167 CAPESLRTRTFSHA-SDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEA 225
Query: 240 LSPGAQNLLRKILEPNPVKRITIAGIKAD 268
N++ + NP R T A ++
Sbjct: 226 CPQDIYNVMLQCWAHNPADRPTFAALREF 254
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 8e-26
Identities = 85/295 (28%), Positives = 135/295 (45%), Gaps = 48/295 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL---EKNRIIHLKITDQIKREIATLKLL 71
+YE +GEG++G V + ++G A+K E ++++ KI REI LK L
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVK-KIA---MREIRMLKQL 57
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
+H N+V L EV K ++Y+V E+V L D L E+ RK Q++ G+ +CH
Sbjct: 58 RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH 117
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEVL 188
+ + HRD+K ENIL+ G +K+ DFG + A P D + + Y APE+L
Sbjct: 118 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-----ATRWYRAPELL 172
Query: 189 ANRGYDGATSDIWSCGVILYVILTG--YLPFDDR------------NLAVLYQKIFRG-- 232
G DIW+ G ++ +LTG P D NL +Q+IF+
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232
Query: 233 ----------------DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271
+ + PK S +L ++ L +P R + + + E+F
Sbjct: 233 LFAGMRLPEVKEIEPLEKRFPKL-SGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 9e-26
Identities = 88/322 (27%), Positives = 137/322 (42%), Gaps = 57/322 (17%)
Query: 15 RYE-LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----------- 62
RY G LGEG +GKV+ A D +G A+K ++ I + D+
Sbjct: 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTL 68
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
RE+ + +KH N++ L +V I +V++ + +L + K RL E++ + + Q
Sbjct: 69 RELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQ 127
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGS 179
+++G++ H HRDL NI ++SKG KI+DFGL+ P + T
Sbjct: 128 ILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187
Query: 180 PN---------YVAPEVL--ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK 228
Y APE+L A + Y A D+WS G I +LTG F N +
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEK-YHFAV-DMWSVGCIFAELLTGKPLFPGENEIDQLGR 245
Query: 229 IF--RG-------------------DFKLPKWLSPGAQN-------LLRKILEPNPVKRI 260
IF G + PK L N LL+ +L+ NP++RI
Sbjct: 246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERI 305
Query: 261 TIAGIKADEWFEQDYTPANPDD 282
+ E+F+ D P +P
Sbjct: 306 SAKEALKHEYFKSDPLPCDPSQ 327
|
Length = 335 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 9e-26
Identities = 77/251 (30%), Positives = 135/251 (53%), Gaps = 26/251 (10%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE-----IATLKLLKHPNV 76
+GEG+ G V A++ SG AVK+++ + Q +RE + ++ +H NV
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMD--------LRKQQRRELLFNEVVIMRDYQHQNV 80
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVF 136
V +++ ++++++E++ GG L D I S+ RL E + + + ++ + Y H++GV
Sbjct: 81 VEMYKSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVI 139
Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
HRD+K ++ILL G +K+SDFG A Q +D + G+P ++APEV++ Y G
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPEVISRTPY-GT 196
Query: 197 TSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFRGDFKLPKW-----LSPGAQNLLRK 250
DIWS G+++ ++ G P F D + + K R D PK +SP ++ L +
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAM--KRLR-DSPPPKLKNAHKISPVLRDFLER 253
Query: 251 ILEPNPVKRIT 261
+L P +R T
Sbjct: 254 MLTREPQERAT 264
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 79/259 (30%), Positives = 124/259 (47%), Gaps = 11/259 (4%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
L +++ + +G G F +V A L P A+K ++ ++ K +EI LK L
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVS 128
HPNV++ + +++ +VLE G+L I K + E K F QL V
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
+ H++ V HRD+K N+ + + G +K+ D GL H+ G+P Y++PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPERI 178
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPF--DDRNLAVLYQKIFRGDF-KLPK-WLSPGA 244
GY+ SDIWS G +LY + PF D NL L QKI + D+ LP S
Sbjct: 179 HENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237
Query: 245 QNLLRKILEPNPVKRITIA 263
+ L+ + P+P +R I
Sbjct: 238 RELVSMCIYPDPDQRPDIG 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 1e-25
Identities = 71/210 (33%), Positives = 109/210 (51%), Gaps = 16/210 (7%)
Query: 62 KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRL------QEAE 115
+ E+ L H +V+ + S K+ +++EY +GG+L +I K RL QE E
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI--KQRLKEHLPFQEYE 170
Query: 116 GRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL-- 173
LF Q++ + H++ + HRDLK NI L G IK+ DFG S + + D L
Sbjct: 171 VGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFS---KQYSDSVSLDV 227
Query: 174 -HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG 232
+ CG+P Y+APE+ + Y +D+WS GVILY +LT + PF + + Q++ G
Sbjct: 228 ASSFCGTPYYLAPELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG 286
Query: 233 DFK-LPKWLSPGAQNLLRKILEPNPVKRIT 261
+ P +S G + LL +L NP R T
Sbjct: 287 KYDPFPCPVSSGMKALLDPLLSKNPALRPT 316
|
Length = 478 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 17/204 (8%)
Query: 20 RTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+ LGEG+FGKV+ ++G AVK L + +D +REI L+ L H N
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSD-FEREIEILRTLDHEN 67
Query: 76 VVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF----QQLIDGVSY 129
+V+ V + +++EY+ G L D + R ++ K Q+ G+ Y
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ---RHRDQINLKRLLLFSSQICKGMDY 124
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVL 188
++ HRDL NIL++S+ +KISDFGL+ + +D + SP + APE L
Sbjct: 125 LGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECL 184
Query: 189 ANRGYDGATSDIWSCGVILYVILT 212
+ A SD+WS GV LY + T
Sbjct: 185 RTSKFSSA-SDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 78/261 (29%), Positives = 132/261 (50%), Gaps = 12/261 (4%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH---PNVVR 78
+G G FG+V + D+G +A+K L+K RI + E L L+ P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
+ + K+ +L+ + GG+L ++ G EAE R ++I G+ + HN+ V +R
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN-RGYDGAT 197
DLK NILLD G+++ISD GL+ + H + G+ Y+APEVL YD ++
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYD-SS 176
Query: 198 SDIWSCGVILYVILTGYLPF---DDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEP 254
+D +S G +L+ +L G+ PF ++ + + +LP SP ++LL +L+
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 236
Query: 255 NPVKRITIAGIKADEWFEQDY 275
+ +R+ G A E E +
Sbjct: 237 DVNRRLGCLGRGAQEVKEHPF 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-25
Identities = 95/306 (31%), Positives = 139/306 (45%), Gaps = 62/306 (20%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-----IKREIATLKL 70
YE +GEG +GKV A+D ++G A+K K R L++ ++ REI+ L++
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALK---KTR---LEMDEEGIPPTALREISLLQM 56
Query: 71 LKH-PNVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIASKGR-----LQEAEGRKL 119
L +VRL +V + K +Y+V EY+ +L + S GR L +
Sbjct: 57 LSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLS---ALPQHFRDDGLLHT 175
QL+ GV++CH GV HRDLK +N+L+D KG +KI+D GL ++P H
Sbjct: 116 MYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV----KSYTHE 171
Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFR--- 231
+ Y APEVL + DIWS G I + F D L L IF+
Sbjct: 172 IV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL-HIFKLLG 229
Query: 232 --------GDFKL------PKW-----------LSPGAQNLLRKILEPNPVKRITIAGIK 266
G KL P+W LSP +LL+K+L +P KRI+
Sbjct: 230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAAL 289
Query: 267 ADEWFE 272
+F+
Sbjct: 290 THPYFD 295
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 76/260 (29%), Positives = 130/260 (50%), Gaps = 10/260 (3%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH---PNVVR 78
+G G FG+V + D+G +A+K L+K RI + E L L+ P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
+ + K+ +L+ + GG+L ++ G E E R ++I G+ + HN+ V +R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
DLK NILLD G+++ISD GL+ + H + G+ Y+APEVL +++
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSSA 177
Query: 199 DIWSCGVILYVILTGYLPF---DDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
D +S G +L+ +L G+ PF ++ + + + +LP SP ++LL +L+ +
Sbjct: 178 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRD 237
Query: 256 PVKRITIAGIKADEWFEQDY 275
KR+ G A E E +
Sbjct: 238 VSKRLGCLGRGAQEVKEHVF 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-25
Identities = 76/258 (29%), Positives = 133/258 (51%), Gaps = 21/258 (8%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR---EIATLKLLK 72
+E+ LG+G FGKV AQ+ ++G +L ++I K ++++ EI L
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETG------VLAAAKVIDTKSEEELEDYMVEIDILASCD 60
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCH 131
HPN+V+L + ++ +++++E+ GG + + R L E + R + +Q ++ ++Y H
Sbjct: 61 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH 120
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL--- 188
+ HRDLK NIL G+IK++DFG+SA ++ R + G+P ++APEV+
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCE 178
Query: 189 --ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPG 243
+R YD +D+WS G+ L + P + N + KI + + P S
Sbjct: 179 TSKDRPYD-YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSE 237
Query: 244 AQNLLRKILEPNPVKRIT 261
++ L+K LE N R T
Sbjct: 238 FKDFLKKCLEKNVDARWT 255
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 5e-25
Identities = 74/255 (29%), Positives = 131/255 (51%), Gaps = 16/255 (6%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+EL + +G G +G V A+++++G A+K++ ++ + +++EI +K KH N
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
+V + K+++ +E+ GG L D G L E++ + ++ + G+ Y H+KG
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA--NRGY 193
HRD+K NILL G++K++DFG+SA Q + G+P ++APEV A +G
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSA--QITATIAKRKSFIGTPYWMAPEVAAVERKGG 185
Query: 194 DGATSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFRGDFKLP------KWLSPGAQN 246
DIW+ G+ + P FD + L+ + + +F+ P KW S +
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-MTKSNFQPPKLKDKMKW-SNSFHH 243
Query: 247 LLRKILEPNPVKRIT 261
++ L NP KR T
Sbjct: 244 FVKMALTKNPKKRPT 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 6e-25
Identities = 84/292 (28%), Positives = 130/292 (44%), Gaps = 66/292 (22%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLK- 72
Y++ +GEG F +V AQ +G +A+K ++K H K +Q+ REI L+ L
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKK----HFKSLEQVNNLREIQALRRLSP 56
Query: 73 HPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGV 127
HPN++RL EVL + ++ +V E + L++ I KGR L E + QL+ +
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELMDM-NLYELI--KGRKRPLPEKRVKSYMYQLLKSL 113
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV---- 183
+ H G+FHRD+K ENIL+ +K++DFG S P Y
Sbjct: 114 DHMHRNGIFHRDIKPENILIK-DDILKLADFG-SC-----------RGIYSKPPYTEYIS 160
Query: 184 -----APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN----------------- 221
APE L GY G DIW+ G + + IL+ + F N
Sbjct: 161 TRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDA 220
Query: 222 -LAVLYQKIFRGDFKLPK-------WL----SPGAQNLLRKILEPNPVKRIT 261
+ ++K ++ P L S +LL+K+L +P +RIT
Sbjct: 221 EVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERIT 272
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 9e-25
Identities = 73/215 (33%), Positives = 108/215 (50%), Gaps = 8/215 (3%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
R LG+G FG+V Q +G +A K LEK RI K E L+ + VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFH 137
+K + +VL + GG+L I + G E R LF +++ G+ H + +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVY 125
Query: 138 RDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
RDLK ENILLD G+I+ISD GL+ +P+ + G+ Y+APEVL N+ Y
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAVKIPE----GESIRGRVGTVGYMAPEVLNNQRY-TL 180
Query: 197 TSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR 231
+ D W G ++Y ++ G PF R V +++ R
Sbjct: 181 SPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 74/259 (28%), Positives = 129/259 (49%), Gaps = 19/259 (7%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E+ LG+G FGKV A++ ++G A K++E L + EI L HP
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYMVEIEILATCNHPY 70
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKG 134
+V+L K+++++E+ GG + + R L E + + + +Q+++ + Y H+
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK 130
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSA--LPQHFRDDGLLHTTCGSPNYVAPEV----- 187
+ HRDLK N+LL G+IK++DFG+SA + R D + G+P ++APEV
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI----GTPYWMAPEVVMCET 186
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGA 244
+ + YD +DIWS G+ L + P + N + KI + + P S
Sbjct: 187 MKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEF 245
Query: 245 QNLLRKILEPNPVKRITIA 263
++ L+ L+ +P R + A
Sbjct: 246 RDFLKTALDKHPETRPSAA 264
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 66/213 (30%), Positives = 111/213 (52%), Gaps = 21/213 (9%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD----QIKREIATLKL 70
R EL +G G +G V + + +G A+KI I+L D I+RE+A L
Sbjct: 5 RLEL---IGRGAYGAVYRGKHVPTGRVVALKI------INLDTPDDDVSDIQREVALLSQ 55
Query: 71 LKH---PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
L+ PN+ + + ++++++EY GG + + G + E + ++++ +
Sbjct: 56 LRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVAL 114
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
Y H GV HRD+K NIL+ + GN+K+ DFG++AL T G+P ++APEV
Sbjct: 115 KYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SKRSTFVGTPYWMAPEV 172
Query: 188 LAN-RGYDGATSDIWSCGVILYVILTGYLPFDD 219
+ + YD +DIWS G+ +Y + TG P+ D
Sbjct: 173 ITEGKYYD-TKADIWSLGITIYEMATGNPPYSD 204
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 80/272 (29%), Positives = 137/272 (50%), Gaps = 19/272 (6%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E+ + +G G FG+V + ++G +A+KIL K ++ T + E L
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKG 134
+ LH ++ +Y+V++Y GG+L ++ RL E R +++ + H G
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVLA--- 189
HRD+K +N+LLD G+I+++DFG S L DG + + G+P+Y++PE+L
Sbjct: 123 YVHRDIKPDNVLLDKNGHIRLADFG-SCL--RLLADGTVQSNVAVGTPDYISPEILQAME 179
Query: 190 -NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI--FRGDFKLP---KWLSPG 243
+G G D WS GV +Y +L G PF +L Y KI + F+ P +S
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239
Query: 244 AQNLLRKILEPNPVKRITIAGI---KADEWFE 272
A++L+R+++ P R+ G+ K +FE
Sbjct: 240 AKDLIRRLICS-PETRLGRNGLQDFKDHPFFE 270
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-24
Identities = 67/202 (33%), Positives = 94/202 (46%), Gaps = 19/202 (9%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+G+GNFG V + L AVK LK + +E LK HPN+V+L
Sbjct: 1 EKIGKGNFGDV-YKGVLKGNTEVAVKTCRSTLPPDLKR--KFLQEAEILKQYDHPNIVKL 57
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLID---GVSYCHNKGV 135
V K IY+V+E V GG L + K RL +KL Q +D G+ Y +K
Sbjct: 58 IGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTV---KKLLQMSLDAAAGMEYLESKNC 114
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANR 191
HRDL N L+ +KISDFG+S + G+ + G + APE L N
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMS----REEEGGIYTVSDGLKQIPIKWTAPEAL-NY 169
Query: 192 GYDGATSDIWSCGVILYVILTG 213
G + SD+WS G++L+ +
Sbjct: 170 GRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 81/257 (31%), Positives = 125/257 (48%), Gaps = 12/257 (4%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
R LG+G FG+V Q +G +A K LEK RI K E L+ + VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFH 137
+K + +VL + GG+L I + G E R +F +L G+ + + +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125
Query: 138 RDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
RDLK ENILLD +G+I+ISD GL+ +P+ G + G+ Y+APEV+ N Y
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV----GTVGYMAPEVINNEKY-TF 180
Query: 197 TSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR----GDFKLPKWLSPGAQNLLRKIL 252
+ D W G ++Y ++ G PF R V +++ R + + S A+++ R +L
Sbjct: 181 SPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLL 240
Query: 253 EPNPVKRITIAGIKADE 269
NP +R+ G A
Sbjct: 241 TKNPKERLGCRGNGAAG 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 26/202 (12%)
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
+PN ++L+ + + ++++Y+ G+LFD + +G+L EAE +K+ +QL++ ++ H
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH 126
Query: 132 NKGVFHRDLKLENILLD-SKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEV 187
+ H D+KLEN+L D +K I + D+GL P + DG L +Y +PE
Sbjct: 127 KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY--DGTL-------DYFSPEK 177
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--------LAVLYQKIFRGDFKLPKW 239
+ YD + D W+ GV+ Y +LTG PF + L QK K
Sbjct: 178 IKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK----KLPFIKN 232
Query: 240 LSPGAQNLLRKILEPNPVKRIT 261
+S A + ++ +L+ N R+T
Sbjct: 233 VSKNANDFVQSMLKYNINYRLT 254
|
Length = 267 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 4e-24
Identities = 78/254 (30%), Positives = 124/254 (48%), Gaps = 14/254 (5%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+G GNFG+V + P AVK + LK + +E LK HPN+VRL
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLK--AKFLQEARILKQYSHPNIVRLIG 60
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140
V K IY+V+E V GG+ + ++G RL+ E ++ + G+ Y +K HRDL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANRGYDGA 196
N L+ K +KISDFG+S +DG+ +T G + APE L N G +
Sbjct: 121 AARNCLVTEKNVLKISDFGMS----REEEDGVYASTGGMKQIPVKWTAPEAL-NYGRYSS 175
Query: 197 TSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA-QNLLRKILEP 254
SD+WS G++L+ + G +P+ + + + I +G L P A L+ + E
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEY 235
Query: 255 NPVKRITIAGIKAD 268
+P +R + + + +
Sbjct: 236 DPGQRPSFSTVHQE 249
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 6e-24
Identities = 70/251 (27%), Positives = 119/251 (47%), Gaps = 20/251 (7%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+LG T+G+G FG V G AVK L+ E + + L+HPN+
Sbjct: 9 KLGATIGKGEFGDVM--LGDYRGQKVAVKCLKD----DSTAAQAFLAEASVMTTLRHPNL 62
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQ-QLIDGVSYCHNKG 134
V+L V+ + +Y+V EY+ G L D + S+GR + + F + +G+ Y K
Sbjct: 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGY 193
HRDL N+L+ K+SDFGL+ ++ + P + APE L + +
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLA------KEASQGQDSGKLPVKWTAPEALREKKF 176
Query: 194 DGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRK 250
SD+WS G++L+ I + G +P+ L + + +G +++ P+ P +++
Sbjct: 177 S-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG-YRMEAPEGCPPEVYKVMKD 234
Query: 251 ILEPNPVKRIT 261
E +P KR T
Sbjct: 235 CWELDPAKRPT 245
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 7e-24
Identities = 71/249 (28%), Positives = 127/249 (51%), Gaps = 15/249 (6%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E+ + +G G FG+V + + +A+KIL K ++ T + E L
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
+ LH ++ +Y+V++Y GG+L ++ + RL E R +++ + H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVLA--- 189
HRD+K +N+LLD G+I+++DFG S L + DG + ++ G+P+Y++PE+L
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFG-SCLKMN--QDGTVQSSVAVGTPDYISPEILQAME 179
Query: 190 -NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPKWL---SPG 243
G G D WS GV +Y +L G PF +L Y KI + F+ P + S
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239
Query: 244 AQNLLRKIL 252
A++L+++++
Sbjct: 240 AKDLIQRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 8e-24
Identities = 93/302 (30%), Positives = 142/302 (47%), Gaps = 60/302 (19%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-----IKREIATLK 69
+YE +GEG +G V A+D + A+K I L+ D+ REI+ LK
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKK------IRLEQEDEGVPSTAIREISLLK 56
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ----QLID 125
++H N+VRL +V+ S+ ++Y+V EY+ +L K A+ +L + Q++
Sbjct: 57 EMQHGNIVRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQILR 113
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGN-IKISDFGLSALPQHFRDDGLLHTTCGSPN--- 181
G++YCH+ V HRDLK +N+L+D + N +K++DFGL+ R G+ T
Sbjct: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA------RAFGIPVRTFTHEVVTL 167
Query: 182 -YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFR-------- 231
Y APE+L + DIWS G I ++ F D + L+ KIFR
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF-KIFRILGTPNEE 226
Query: 232 --------GDFK--LPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEW 270
D+K PKW L P +LL K+L +P KRIT E+
Sbjct: 227 TWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEY 286
Query: 271 FE 272
F+
Sbjct: 287 FK 288
|
Length = 294 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 9e-24
Identities = 62/196 (31%), Positives = 110/196 (56%), Gaps = 7/196 (3%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+GEG+ G V A + +G AVK ++ + + + + E+ ++ H NVV ++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
++++V+E++ GG L D I + R+ E + + ++ +SY HN+GV HRD+K
Sbjct: 87 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 145
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
++ILL S G IK+SDFG A Q ++ + G+P ++APEV++ Y G DIW
Sbjct: 146 SDSILLTSDGRIKLSDFGFCA--QVSKEVPKRKSLVGTPYWMAPEVISRLPY-GTEVDIW 202
Query: 202 SCGVILYVILTGYLPF 217
S G+++ ++ G P+
Sbjct: 203 SLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 47/137 (34%), Positives = 81/137 (59%)
Query: 25 GNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84
G FGKV + ++ +AVK+++K +I+ + Q++ E L L K P +V L+ L
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74
Query: 85 SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLEN 144
S + +Y+V+EY+ GG++ + G E K ++ + Y H G+ HRDLK +N
Sbjct: 75 SANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDN 134
Query: 145 ILLDSKGNIKISDFGLS 161
+L+ ++G+IK++DFGLS
Sbjct: 135 MLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 99.8 bits (248), Expect = 1e-23
Identities = 72/253 (28%), Positives = 130/253 (51%), Gaps = 20/253 (7%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL--- 71
+Y +G+G G V A D+ +G A+K + + Q K+E+ ++L
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIK--------QMNLQQQPKKELIINEILVMR 71
Query: 72 --KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
K+PN+V + ++++V+EY+ GG L D + ++ + E + + ++ + + +
Sbjct: 72 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDF 130
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
H+ V HRD+K +NILL G++K++DFG A Q + T G+P ++APEV+
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVT 188
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKL--PKWLSPGAQN 246
+ Y G DIWS G++ ++ G P+ + N L LY G +L P+ LS ++
Sbjct: 189 RKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRD 247
Query: 247 LLRKILEPNPVKR 259
L + LE + +R
Sbjct: 248 FLNRCLEMDVDRR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 2e-23
Identities = 66/209 (31%), Positives = 102/209 (48%), Gaps = 21/209 (10%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLK 72
+YE +G+G FG+V A+ + A+K +L +N IT REI L+LLK
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITAL--REIKILQLLK 69
Query: 73 HPNVVRLHEVLASKSK--------IYMVLEYVT---GGELFDKIASKGRLQEAEGRKLFQ 121
H NVV L E+ +K+ Y+V E+ G L +K + +E +K+ +
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNK---NVKFTLSEIKKVMK 126
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTT-CGS 179
L++G+ Y H + HRD+K NIL+ G +K++DFGL+ A +T +
Sbjct: 127 MLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVT 186
Query: 180 PNYVAPEVLAN-RGYDGATSDIWSCGVIL 207
Y PE+L R Y G D+W G I+
Sbjct: 187 LWYRPPELLLGERDY-GPPIDMWGAGCIM 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 6e-23
Identities = 84/270 (31%), Positives = 135/270 (50%), Gaps = 29/270 (10%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HP 74
+E+ T+G+G +GKV + +G AVKIL+ IH I ++I+ E LK L HP
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDP---IH-DIDEEIEAEYNILKALSDHP 75
Query: 75 NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRK------LFQQL 123
NVV+ + + K ++++VLE GG + D + KG L+ E + + +
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV--KGFLKRGERMEEPIIAYILHEA 133
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
+ G+ + H HRD+K NILL ++G +K+ DFG+SA R +T+ G+P ++
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWM 191
Query: 184 APEVLA-----NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFK 235
APEV+A + YD A D+WS G+ + G P D + KI R
Sbjct: 192 APEVIACEQQLDSTYD-ARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLH 250
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGI 265
P+ S + +RK L + KR T++ +
Sbjct: 251 QPELWSNEFNDFIRKCLTKDYEKRPTVSDL 280
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 97.9 bits (243), Expect = 7e-23
Identities = 70/255 (27%), Positives = 132/255 (51%), Gaps = 24/255 (9%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL--- 71
+Y +G+G G V A D+ +G A++ + + Q K+E+ ++L
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIR--------QMNLQQQPKKELIINEILVMR 72
Query: 72 --KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
K+PN+V + ++++V+EY+ GG L D + ++ + E + + ++ + + +
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 131
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSA--LPQHFRDDGLLHTTCGSPNYVAPEV 187
H+ V HRD+K +NILL G++K++DFG A P+ + ++ G+P ++APEV
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV----GTPYWMAPEV 187
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKL--PKWLSPGA 244
+ + Y G DIWS G++ ++ G P+ + N L LY G +L P+ LS
Sbjct: 188 VTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246
Query: 245 QNLLRKILEPNPVKR 259
++ L + L+ + KR
Sbjct: 247 RDFLNRCLDMDVEKR 261
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 8e-23
Identities = 77/268 (28%), Positives = 126/268 (47%), Gaps = 20/268 (7%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPF-AVK-------ILEKNRIIHLKITDQIKREIAT 67
Y + LG G FG V + ++G A+K K++ K I E+
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 68 LK-LLKHPNVVRLHEVLASKSKIYMVLEYVTG---GELFDKIASKG-RLQEAEGRKLFQQ 122
+K L+HPN+VR ++ ++Y+V++ + G GE F+ + K R E +F Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 123 LIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
++ + Y H K + HRDL NI+L + I+DFGL+ Q + L + G+
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ---PESKLTSVVGTIL 178
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWL 240
Y PE++ N Y G +D+W+ G ILY + T PF N+ L KI ++ LP+ +
Sbjct: 179 YSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237
Query: 241 -SPGAQNLLRKILEPNPVKRITIAGIKA 267
S +++ L P+ R I + A
Sbjct: 238 YSEDVTDVITSCLTPDAEARPDIIQVSA 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 8e-23
Identities = 88/304 (28%), Positives = 132/304 (43%), Gaps = 56/304 (18%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RY++ +G+G++G V A D +G A+K + + H+ +I REI L+LL+HP
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-NDVFEHVSDATRILREIKLLRLLRHP 59
Query: 75 NVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
++V + ++ S+ IY+V E + +L I + L + QL+ + Y
Sbjct: 60 DIVEIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQFFLYQLLRALKY 118
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV------ 183
H VFHRDLK +NIL ++ +KI DFGL+ + F D T +YV
Sbjct: 119 IHTANVFHRDLKPKNILANADCKLKICDFGLARV--AFNDTP---TAIFWTDYVATRWYR 173
Query: 184 APEVLANRGYDGATS--DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF------- 234
APE L + T DIWS G I +LTG F +N V++Q D
Sbjct: 174 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN--VVHQLDLITDLLGTPSPE 230
Query: 235 -------------------KLPKWLS-------PGAQNLLRKILEPNPVKRITIAGIKAD 268
K P S P A LL ++L +P R T AD
Sbjct: 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290
Query: 269 EWFE 272
+F+
Sbjct: 291 PYFK 294
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 8e-23
Identities = 84/296 (28%), Positives = 127/296 (42%), Gaps = 55/296 (18%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
RY R LG G+ G V A D D AVK + +K REI ++ L H
Sbjct: 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVK---HALREIKIIRRLDH 61
Query: 74 PNVVRLHEVLASKSK--------------IYMVLEYVTGGELFDKIASKGRLQEAEGRKL 119
N+V+++EVL +Y+V EY+ + +G L E R
Sbjct: 62 DNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHARLF 119
Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLS-ALPQHFRDDGLLHTTC 177
QL+ G+ Y H+ V HRDLK N+ ++++ + KI DFGL+ + H+ G L
Sbjct: 120 MYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGL 179
Query: 178 GSPNYVAPE-VLANRGYDGATSDIWSCGVILYVILTGYLPF------------------- 217
+ Y +P +L+ Y A D+W+ G I +LTG F
Sbjct: 180 VTKWYRSPRLLLSPNNYTKAI-DMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238
Query: 218 --DDRN--LAVLYQKIFRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRIT 261
+DRN L V+ + R D P+ ++P A + L +IL NP+ R+T
Sbjct: 239 REEDRNELLNVIPSFV-RNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT 293
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 9e-23
Identities = 80/270 (29%), Positives = 127/270 (47%), Gaps = 26/270 (9%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LG+G FG+V Q +G +A K L K R+ K + E L + +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQE-----AEGRKLF--QQLIDGVSYCHNKG 134
+K+ + +V+ + GG+L I + + E E R F Q+I G+ + H +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYN---VDEENPGFPEPRACFYTAQIISGLEHLHQRR 117
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVLANRG 192
+ +RDLK EN+LLD+ GN++ISD GL+ + DG T G+P ++APE+L
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELK----DGQSKTKGYAGTPGFMAPELLQGEE 173
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAV----LYQKIFRGDFKLPKWLSPGAQNLL 248
YD + D ++ GV LY ++ PF R V L Q+I P SP +++
Sbjct: 174 YDFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFC 232
Query: 249 RKILEPNPVKRI-----TIAGIKADEWFEQ 273
+L +P KR+ G++ F
Sbjct: 233 EALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 1e-22
Identities = 77/245 (31%), Positives = 121/245 (49%), Gaps = 31/245 (12%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-K 72
+E+ T+G+G +GKV + G AVKIL+ + ++I+ E L+ L
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPN 77
Query: 73 HPNVVRLHEVL-----ASKSKIYMVLEYVTGG---ELFDKIASKG-RLQEAEGRKLFQQL 123
HPNVV+ + + ++++VLE GG EL + G RL EA +
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
+ G+ + HN + HRD+K NILL ++G +K+ DFG+SA R +T+ G+P ++
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWM 195
Query: 184 APEVLA-----NRGYDGATSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFRGDFKLP 237
APEV+A + YD A D+WS G+ + G P FD + L FK+P
Sbjct: 196 APEVIACEQQYDYSYD-ARCDVWSLGITAIELGDGDPPLFDMHPVKTL--------FKIP 246
Query: 238 KWLSP 242
+ P
Sbjct: 247 RNPPP 251
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|217748 pfam03822, NAF, NAF domain | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 1e-22
Identities = 29/58 (50%), Positives = 43/58 (74%), Gaps = 1/58 (1%)
Query: 313 INAFQLIGMSSCLDLSGFFEKEDVSERK-IRFTSNHSAKDLLERIEDIVTEMGFRVQK 369
+NAF LI +SS LDLSG FE+E S++K RFTS A +++ ++E+I E+GF+V+K
Sbjct: 1 LNAFDLISLSSGLDLSGLFEEEKKSKKKETRFTSRKPASEIISKLEEIAKELGFKVKK 58
|
Length = 58 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 1e-22
Identities = 79/264 (29%), Positives = 126/264 (47%), Gaps = 23/264 (8%)
Query: 16 YELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
+E+ RT LG G +G+V L AVK L+++ + ++ +E A +
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVM 56
Query: 69 KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ---QLID 125
K +KHPN+V+L V + Y++ E++T G L D + R QE L Q+
Sbjct: 57 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISS 115
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVA 184
+ Y K HRDL N L+ +K++DFGLS L D H P + A
Sbjct: 116 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTA 173
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLS 241
PE LA + SD+W+ GV+L+ I T G P+ +L+ +Y+ + +G +++ P+
Sbjct: 174 PESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG-YRMERPEGCP 231
Query: 242 PGAQNLLRKILEPNPVKRITIAGI 265
P L+R + NP R + A I
Sbjct: 232 PKVYELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|213380 cd12195, CIPK_C, C-terminal regulatory domain of Calcineurin B-Like (CBL)-interacting protein kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-22
Identities = 30/59 (50%), Positives = 44/59 (74%)
Query: 314 NAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNG 372
NAF LI +SS LDLSG FE+ED +R+ RFTS A++++E++E+ ++GFRV+KK
Sbjct: 1 NAFDLISLSSGLDLSGLFEEEDEVKRETRFTSRKPAEEIIEKLEEAAKKLGFRVRKKKE 59
|
CIPKs are serine/threonine protein kinases (STKs), catalyzing the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. They comprise a unique family in higher plants of proteins that interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. The specificity of the response relies on differences in expression and localization of both CBLs and CIPKs, as well as on the interaction specificity of CBL-CIPK combinations. There are 25, 30, and 43 CIPK genes identified in the Arabidopsis thaliana, Oryza sativa, and Zea mays genomes, respectively. The founding member of the CIPK family is Arabidopsis thaliana CIPK24, also called SOS2 (Salt Overlay Sensitive 2). CIPKs contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain that contains the FISL (also called NAF for Asn-Ala-Phe) and PPI-binding motifs, which are involved in the interaction with CBLs and PP2C-type protein phosphatases, respectively. Studies using SOS2, SOS3, and ABI2 phosphatase show that the binding of CBL and PP2C-type protein phosphatase to CIPK is mutually exclusive. The binding of CBL to CIPK is inhibitory to kinase activity. Length = 116 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 2e-22
Identities = 59/199 (29%), Positives = 106/199 (53%), Gaps = 8/199 (4%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+G+G+FG+V D + A+KI++ +I D I++EI L P + R +
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIED-IQQEITVLSQCDSPYITRYYG 69
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
+K+++++EY+ GG D + G L+E + ++++ G+ Y H++ HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIK 128
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDI 200
N+LL +G++K++DFG++ D + T G+P ++APEV+ YD +DI
Sbjct: 129 AANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-FKADI 184
Query: 201 WSCGVILYVILTGYLPFDD 219
WS G+ + G P D
Sbjct: 185 WSLGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 3e-22
Identities = 95/310 (30%), Positives = 143/310 (46%), Gaps = 52/310 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
RY+ +G G +G V A D +GL AVK L + IIH K T RE+ LK +K
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 74
Query: 73 HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H NV+ L +V +Y+V ++ G +L + I +L + + L Q++ G
Sbjct: 75 HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 132
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
+ Y H+ + HRDLK N+ ++ +KI DFGL+ +H D+ + + Y APE
Sbjct: 133 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 187
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKIFR 231
++ N + T DIWS G I+ +LTG F D L A L +KI
Sbjct: 188 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247
Query: 232 GDFK--------LPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
+ +PK +P A +LL K+L + KRIT A A +F Q +
Sbjct: 248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307
Query: 276 TPANPDDDEE 285
+PDD+
Sbjct: 308 ---DPDDEPV 314
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 5e-22
Identities = 68/204 (33%), Positives = 106/204 (51%), Gaps = 19/204 (9%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LG+GNFG+V F L P AVK +++ LKI + E LK HPN+V+L
Sbjct: 3 LGKGNFGEV-FKGTLKDKTPVAVKTCKEDLPQELKI--KFLSEARILKQYDHPNIVKLIG 59
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---GVSYCHNKGVFHR 138
V + IY+V+E V GG+ + K E + ++L + +D G++Y +K HR
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESKNCIHR 117
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANRGYD 194
DL N L+ +KISDFG+S ++D ++++ G + APE L N G
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR-----QEDDGIYSSSGLKQIPIKWTAPEAL-NYGRY 171
Query: 195 GATSDIWSCGVILYVILT-GYLPF 217
+ SD+WS G++L+ + G P+
Sbjct: 172 SSESDVWSYGILLWETFSLGVCPY 195
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 9e-22
Identities = 90/314 (28%), Positives = 135/314 (42%), Gaps = 50/314 (15%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RY + +G G +G V A D +G A+K L + L + RE+ LK +KH
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSEL-FAKRAYRELRLLKHMKHE 74
Query: 75 NVVRLHEVLASKSKI------YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
NV+ L +V + Y+V+ ++ G K+ +L E + L Q++ G+
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
Y H G+ HRDLK N+ ++ +KI DFGL+ + D + + Y APEV+
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYRAPEVI 187
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPF------------------------------D 218
N + T DIWS G I+ +LTG F D
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED 247
Query: 219 DRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ---- 273
+N + + DF+ L +P A N+L K+L + RIT A A +FE+
Sbjct: 248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307
Query: 274 -DYTPANPDDDEED 286
D T A P DD D
Sbjct: 308 EDETEAPPYDDSFD 321
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 67/201 (33%), Positives = 103/201 (51%), Gaps = 11/201 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RY + +G G FG V A+D +G A+K + K + + + RE+ LK L+H
Sbjct: 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPV-LAKRTYRELKLLKHLRHE 69
Query: 75 NVVRLHEVLASKSK-IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
N++ L ++ S + IY V E + G ++ + L++ + Q++ G+ Y H+
Sbjct: 70 NIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA 127
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV-LANRG 192
GV HRDLK NIL++ ++KI DFGL A Q + G + T Y APE+ L +
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGL-ARIQDPQMTGYVSTR----YYRAPEIMLTWQK 182
Query: 193 YDGATSDIWSCGVILYVILTG 213
YD DIWS G I +L G
Sbjct: 183 YDVEV-DIWSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-21
Identities = 90/288 (31%), Positives = 132/288 (45%), Gaps = 51/288 (17%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILE-KNRIIHLKITDQIKREIATLKLLK- 72
+YE +G G +G V A+D SG A+K + + L ++ RE+A LK L+
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLS--TVREVALLKRLEA 58
Query: 73 --HPNVVRLHEVLAS-----KSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQL 123
HPN+VRL +V A+ ++K+ +V E+V DK+ G L + L +Q
Sbjct: 59 FDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQF 117
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ-HFRDDGLLHTTCGSPNY 182
+ G+ + H + HRDLK ENIL+ S G +K++DFGL+ + ++ T Y
Sbjct: 118 LRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLW----Y 173
Query: 183 VAPEVLANRGYDGATS-DIWSCGVILYVILTGYLPFDDRNLAVLYQKIF----------- 230
APEVL Y AT D+WS G I + F + A KIF
Sbjct: 174 RAPEVLLQSTY--ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 231
Query: 231 -------RGDFK----------LPKWLSPGAQNLLRKILEPNPVKRIT 261
RG F +P+ GAQ LL ++L NP KRI+
Sbjct: 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQ-LLLEMLTFNPHKRIS 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-21
Identities = 75/204 (36%), Positives = 109/204 (53%), Gaps = 22/204 (10%)
Query: 22 LGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
LG+GNFG V+ QD ++G AVK L+ + HL+ +REI LK L+H N+
Sbjct: 12 LGKGNFGSVELCRYDPLQD-NTGEVVAVKKLQHSTAEHLR---DFEREIEILKSLQHDNI 67
Query: 77 VRLHEVLASKSK--IYMVLEYVTGGELFDK-IASKGRLQEAEGRKLFQ---QLIDGVSYC 130
V+ V S + + +V+EY+ G L D + RL + RKL Q+ G+ Y
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL---DHRKLLLYASQICKGMEYL 124
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNY-VAPEVL 188
+K HRDL NIL++S+ +KI DFGL+ LPQ ++ + SP + APE L
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD-KEYYKVREPGESPIFWYAPESL 183
Query: 189 ANRGYDGATSDIWSCGVILYVILT 212
+ A SD+WS GV+LY + T
Sbjct: 184 TESKFSVA-SDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 3e-21
Identities = 75/207 (36%), Positives = 108/207 (52%), Gaps = 25/207 (12%)
Query: 20 RTLGEGNFGKVKF-----AQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
R LGEG+FGKV A D +G AVK L++ T K+EI LK L H
Sbjct: 10 RVLGEGHFGKVSLYCYDPAND-GTGEMVAVKTLKRECGQQN--TSGWKKEINILKTLYHE 66
Query: 75 NVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
N+V+ + + + +++EYV G L D + K +L A+ QQ+ +G++Y H+
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAYLHS 125
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQ-----HFRDDGLLHTTCGSPNY-VAP 185
+ HRDL N+LLD+ +KI DFGL+ A+P+ R+DG SP + A
Sbjct: 126 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG------DSPVFWYAV 179
Query: 186 EVLANRGYDGATSDIWSCGVILYVILT 212
E L + A SD+WS GV LY +LT
Sbjct: 180 ECLKENKFSYA-SDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 4e-21
Identities = 72/248 (29%), Positives = 131/248 (52%), Gaps = 16/248 (6%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+GEG+ G V A SG AVK ++ + + + + E+ ++ +H NVV ++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
++++V+E++ GG L D I + R+ E + + ++ +S H +GV HRD+K
Sbjct: 85 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
++ILL G +K+SDFG A Q ++ + G+P ++APE+++ Y G DIW
Sbjct: 144 SDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIW 200
Query: 202 SCGVILYVILTGYLP-FDDRNLAVLYQKIFRGDFKLPKW-----LSPGAQNLLRKILEPN 255
S G+++ ++ G P F++ L + K+ R + PK +SP + L ++L +
Sbjct: 201 SLGIMVIEMVDGEPPYFNEPPLKAM--KMIRDNLP-PKLKNLHKVSPSLKGFLDRLLVRD 257
Query: 256 PVKRITIA 263
P +R T A
Sbjct: 258 PAQRATAA 265
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 4e-21
Identities = 57/173 (32%), Positives = 94/173 (54%), Gaps = 10/173 (5%)
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ- 121
RE++ LK LKH N+V LH+++ ++ + +V EY+ +L + + G L K+F
Sbjct: 52 REVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMF 110
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCG 178
QL+ G+SYCH + + HRDLK +N+L++ KG +K++DFGL+ ++P + ++
Sbjct: 111 QLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV----- 165
Query: 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR 231
+ Y P+VL D+W G ILY + TG F + IFR
Sbjct: 166 TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFR 218
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 4e-21
Identities = 95/329 (28%), Positives = 144/329 (43%), Gaps = 65/329 (19%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RY+ +GEG +G V A +G+ A+K + H + REI L+ KH
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISP--FEHQTFCQRTLREIKILRRFKHE 63
Query: 75 NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
N++ + +++ S +Y+V E + +L+ I ++ L + Q++ G+ Y
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQ-HLSNDHIQYFLYQILRGLKY 121
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGL--SALPQHFRDDGLLHTTCGSPNYVAPEV 187
H+ V HRDLK N+LL++ ++KI DFGL A P+H G L + Y APE+
Sbjct: 122 IHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH-DHTGFLTEYVATRWYRAPEI 180
Query: 188 -LANRGYDGATSDIWSCGVILYVILTG--------Y------------------------ 214
L ++GY A DIWS G IL +L+ Y
Sbjct: 181 MLNSKGYTKAI-DIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239
Query: 215 ---------LPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI 265
LPF + V + K+F P P A +LL K+L NP KRIT+
Sbjct: 240 LRARNYIKSLPFKPK---VPWNKLF------PN-ADPKALDLLDKMLTFNPHKRITVEEA 289
Query: 266 KADEWFEQDYTPANPDDDEEDIFVDNEAF 294
A + EQ + P++ EE D E F
Sbjct: 290 LAHPYLEQYHDPSDEPVAEEPFPFDFELF 318
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 4e-21
Identities = 65/205 (31%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 20 RTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+ LG GNFG V L + AVK L++ I K + RE + + L HP +
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK--KEFLREASVMAQLDHPCI 58
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVF 136
VRL V + + +V+E G L + + + ++ ++L Q+ G++Y +K
Sbjct: 59 VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 137 HRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGS-P-NYVAPEVLANRGY 193
HRDL N+LL ++ KISDFG+S AL D TT G P + APE + +
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRAL--GAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 194 DGATSDIWSCGVILYVILT-GYLPF 217
SD+WS GV L+ + G P+
Sbjct: 176 SSK-SDVWSYGVTLWEAFSYGAKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 105/346 (30%), Positives = 146/346 (42%), Gaps = 83/346 (23%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK---------R 63
L +YE+ + LG+G +G V A D + A+K KI D + R
Sbjct: 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALK----------KIFDAFRNATDAQRTFR 55
Query: 64 EIATLK-LLKHPNVVRLHEVL-ASKSK-IYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
EI L+ L HPN+V+L V+ A K IY+V EY+ +L I L++ R +
Sbjct: 56 EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVI-RANILEDVHKRYIM 113
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGS 179
QL+ + Y H+ V HRDLK NILL+S +K++DFGL+ +L + + T
Sbjct: 114 YQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT--- 170
Query: 180 PNYVA------PEVL-ANRGYDGATSDIWSCGVILYVILTG------------------- 213
+YVA PE+L + Y D+WS G IL +L G
Sbjct: 171 -DYVATRWYRAPEILLGSTRYTKGV-DMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEV 228
Query: 214 ------------YLPFDDRNLAVLYQ-KIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 260
PF L L D LPK S A +LL+K+L NP KR+
Sbjct: 229 IGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPK-ASDDALDLLKKLLVFNPNKRL 287
Query: 261 TIAGIKADEWFEQDYTPA--NPDDDE---EDI---FVDNEAFSMHE 298
T A+E E Y NP D+ I DN S+ E
Sbjct: 288 T-----AEEALEHPYVAQFHNPSDEPVLPYPITIPLDDNVKLSVAE 328
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 1e-20
Identities = 66/230 (28%), Positives = 109/230 (47%), Gaps = 28/230 (12%)
Query: 13 LGRYELGRTLGEGNFGKV---------------KFAQDLDSGLPFAVKILEKNRIIHLKI 57
L + + L G FGK+ + + G P +++ K +
Sbjct: 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRA 206
Query: 58 TDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV---LEYVTGGELFDK-IASKGRLQE 113
Q++ EI L L H N++++ E+L S++ YM+ ++ ++D+ K R
Sbjct: 207 AIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLL 266
Query: 114 AEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL---PQHFRDD 170
+ R + +QL+ V Y H+K + HRD+KLENI L+ G I + DFG + + D
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY 326
Query: 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD 219
G + T + +PE+LA GY T DIWSCG+IL +L+ + P D
Sbjct: 327 GWVGTVATN----SPEILAGDGYCEIT-DIWSCGLILLDMLSHDFCPIGD 371
|
Length = 501 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 1e-20
Identities = 72/254 (28%), Positives = 121/254 (47%), Gaps = 20/254 (7%)
Query: 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-IKREIATLK 69
+ L + LG +GEG FG V + G AVK I +T Q E A +
Sbjct: 3 LNLQKLTLGEIIGEGEFGAVLQGEYT--GQKVAVKN------IKCDVTAQAFLEETAVMT 54
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGV 127
L H N+VRL V+ +Y+V+E ++ G L + + ++GR + + + + +G+
Sbjct: 55 KLHHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGM 113
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
Y +K + HRDL NIL+ G K+SDFGL+ + D+ L + APE
Sbjct: 114 EYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV-----KWTAPEA 168
Query: 188 LANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ 245
L ++ + + SD+WS GV+L+ + + G P+ +L + + + +G + P+
Sbjct: 169 LKHKKFS-SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVY 227
Query: 246 NLLRKILEPNPVKR 259
L+ E P KR
Sbjct: 228 VLMTSCWETEPKKR 241
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 1e-20
Identities = 74/281 (26%), Positives = 124/281 (44%), Gaps = 34/281 (12%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD----QIKREIATLKLLKHPNVV 77
LG+GN+G V +G+ A+K I L++ + QI E+ L P +V
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKE------IRLELDESKFNQIIMELDILHKAVSPYIV 62
Query: 78 RLHEVLASKSKIYMVLEYVTGG---ELFDKIASKGRLQEAEGRKLFQQLIDGVSYC---H 131
+ + +YM +EY+ G +L+ + + E R++ ++ G+ + H
Sbjct: 63 DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH 122
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
N + HRD+K N+L++ G +K+ DFG+S L T G +Y+APE + +
Sbjct: 123 N--IIHRDVKPTNVLVNGNGQVKLCDFGVSGN----LVASLAKTNIGCQSYMAPERIKSG 176
Query: 192 GYDGA-----TSDIWSCGVILYVILTGYLPFDDRNLAVLY---QKIFRGD-FKLPKWLSP 242
G + SD+WS G+ + + G P+ A ++ I GD LP S
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSD 236
Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDD 283
AQ+ + K L P +R T A + W + N D D
Sbjct: 237 DAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY---KNADVD 274
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 2e-20
Identities = 62/250 (24%), Positives = 113/250 (45%), Gaps = 20/250 (8%)
Query: 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
+ LG G FG V + + A+K++ + + D E + L HPN+V
Sbjct: 8 FLKELGSGQFGVVHLGKWRGK-IDVAIKMIREGAMSE----DDFIEEAKVMMKLSHPNLV 62
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVF 136
+L+ V + I++V EY+ G L + + KG+L + + + + Y + G
Sbjct: 63 QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFI 122
Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGY 193
HRDL N L+ +K+SDFGL+ ++ DD + G+ + PEV +
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLA---RYVLDDQYTSSQ-GTKFPVKWAPPEVF-DYSR 177
Query: 194 DGATSDIWSCGVILYVILT-GYLPFDDR-NLAVLYQKIFRGDFKL--PKWLSPGAQNLLR 249
+ SD+WS GV+++ + + G +P++ N V+ + + G ++L PK ++
Sbjct: 178 FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV-ESVSAG-YRLYRPKLAPTEVYTIMY 235
Query: 250 KILEPNPVKR 259
P R
Sbjct: 236 SCWHEKPEDR 245
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 3e-20
Identities = 75/254 (29%), Positives = 127/254 (50%), Gaps = 38/254 (14%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
RL YE+ + +G G FG+V + + F K + R + + Q+ E+ ++ L
Sbjct: 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISY-RGLKEREKSQLVIEVNVMREL 69
Query: 72 KHPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLID 125
KH N+VR + +K+ K+Y+++E+ G+L I G+++E + +QL+
Sbjct: 70 KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH 129
Query: 126 GVSYCHN-------KGVFHRDLKLENILLDSK----GNI-------------KISDFGLS 161
++YCHN + V HRDLK +NI L + G I KI DFGLS
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189
Query: 162 ALPQHFRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDD 219
++ + + H+ G+P Y +PE+L + + YD SD+W+ G I+Y + +G PF
Sbjct: 190 ---KNIGIESMAHSCVGTPYYWSPELLLHETKSYDD-KSDMWALGCIIYELCSGKTPFHK 245
Query: 220 -RNLAVLYQKIFRG 232
N + L ++ RG
Sbjct: 246 ANNFSQLISELKRG 259
|
Length = 1021 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 3e-20
Identities = 62/218 (28%), Positives = 117/218 (53%), Gaps = 15/218 (6%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+ LG G FG VK+ + A+K++++ + D+ E + L H +V+L
Sbjct: 10 KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMKLSHEKLVQL 64
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
+ V + IY+V EY++ G L + + G R Q ++ ++ + + +G++Y +K HR
Sbjct: 65 YGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHR 124
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDG 195
DL N L+D +G +K+SDFGLS ++ DD ++ GS + PEVL +
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLS---RYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFS- 179
Query: 196 ATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 232
+ SD+W+ GV+++ + + G +P++ N + +K+ +G
Sbjct: 180 SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG 217
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 3e-20
Identities = 64/223 (28%), Positives = 116/223 (52%), Gaps = 17/223 (7%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+G+G+FG+V D + A+KI++ +I D I++EI L P V + +
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIED-IQQEITVLSQCDSPYVTKYYG 69
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
+K+++++EY+ GG D + + G E + + ++++ G+ Y H++ HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 128
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDI 200
N+LL +G++K++DFG++ D + T G+P ++APEV+ YD + +DI
Sbjct: 129 AANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIQQSAYD-SKADI 184
Query: 201 WSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKLPKWLSP 242
WS G+ + G P D + + VL F +PK P
Sbjct: 185 WSLGITAIELAKGEPPNSDMHPMRVL--------FLIPKNNPP 219
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 4e-20
Identities = 70/207 (33%), Positives = 104/207 (50%), Gaps = 23/207 (11%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFA----VKILEKNRIIHLKITDQIKREIATLKL 70
+YE +GEG +GKV A+DL +G F V++ + L RE+A L+
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI----REVAVLRH 57
Query: 71 LK---HPNVVRLHEVLA-----SKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLF 120
L+ HPNVVRL +V ++K+ +V E+V DK+ G E + +
Sbjct: 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI-KDMM 116
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
QL+ G+ + H+ V HRDLK +NIL+ S G IK++DFGL+ + + L + +
Sbjct: 117 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTL 173
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVIL 207
Y APEVL Y D+WS G I
Sbjct: 174 WYRAPEVLLQSSY-ATPVDLWSVGCIF 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 4e-20
Identities = 73/274 (26%), Positives = 124/274 (45%), Gaps = 33/274 (12%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL----KITDQIKREIATLKLLKHPN 75
LG GN G V + + +G A K+ +H+ + QI RE+ + + P
Sbjct: 11 SDLGAGNGGSVSKVKHIPTGTVMAKKV------VHIGAKSSVRKQILRELQIMHECRSPY 64
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNK- 133
+V + +++ I M +E++ G L D+I K G + K+ +++G++Y +N
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
+ HRD+K NIL++S+G IK+ DFG+S L D T G+ Y++PE +
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD-----TFVGTSTYMSPERIQGGK 178
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRN------------LAVLYQKIFRGDFKLPK-W 239
Y SD+WS G+ + + G PF N L +L Q + +LP
Sbjct: 179 YT-VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD 237
Query: 240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
++ + L +P +R T + A F Q
Sbjct: 238 FPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 5e-20
Identities = 58/199 (29%), Positives = 105/199 (52%), Gaps = 8/199 (4%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+G+G+FG+V D + A+KI++ +I D I++EI L P V + +
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIED-IQQEITVLSQCDSPYVTKYYG 69
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
+K+++++EY+ GG D + G L E + + ++++ G+ Y H++ HRD+K
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 128
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDI 200
N+LL G +K++DFG++ D + T G+P ++APEV+ YD + +DI
Sbjct: 129 AANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-SKADI 184
Query: 201 WSCGVILYVILTGYLPFDD 219
WS G+ + G P +
Sbjct: 185 WSLGITAIELAKGEPPHSE 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 5e-20
Identities = 66/219 (30%), Positives = 113/219 (51%), Gaps = 19/219 (8%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
G +EL +G G +G+V + + +G A+K+++ + ++IK EI LK H
Sbjct: 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSH 71
Query: 74 -PNVVRLHEVLASKS------KIYMVLEYVTGGELFDKIA-SKGR-LQEAEGRKLFQQLI 124
N+ + KS ++++V+E+ G + D + +KG L+E + ++++
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
G+++ H V HRD+K +N+LL +K+ DFG+SA Q R G +T G+P ++A
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMA 189
Query: 185 PEVLANRGYDGAT----SDIWSCGVILYVILTGYLPFDD 219
PEV+A AT SDIWS G+ + G P D
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 5e-20
Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 33/224 (14%)
Query: 17 ELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
L R LG+G+FG V K + A+K + +N + +I + E + +K
Sbjct: 9 TLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI--EFLNEASVMKEF 66
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR--------KLFQ-- 121
+VVRL V+++ +V+E + G+L + S+ R + K Q
Sbjct: 67 NCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSR-RPEAENNPGLGPPTLQKFIQMA 125
Query: 122 -QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL---PQHFRDDG--LLHT 175
++ DG++Y K HRDL N ++ +KI DFG++ ++R G LL
Sbjct: 126 AEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL-- 183
Query: 176 TCGSP-NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 217
P ++APE L + G SD+WS GV+L+ + T P+
Sbjct: 184 ----PVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPY 222
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 9e-20
Identities = 71/220 (32%), Positives = 108/220 (49%), Gaps = 19/220 (8%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT----DQIKREIATLKLLKHPNVV 77
LG GN G V SGL A K+ IHL+I +QI RE+ L P +V
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKL------IHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVF 136
+ S +I + +E++ GG L + GR+ E K+ +I G++Y K +
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 126
Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
HRD+K NIL++S+G IK+ DFG+S D + ++ G+ +Y++PE L Y
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQ----LIDSMANSFVGTRSYMSPERLQGTHYS-V 181
Query: 197 TSDIWSCGVILYVILTGYLPF---DDRNLAVLYQKIFRGD 233
SDIWS G+ L + G P D + L +++ GD
Sbjct: 182 QSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGD 221
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 9e-20
Identities = 60/190 (31%), Positives = 98/190 (51%), Gaps = 12/190 (6%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILE-KNRIIHLKITDQIKREIATLKLLKHPNVVR 78
R +G G+FG V FA+D+ + A+K + + + K D IK E+ L+ L+HPN ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK-EVRFLQKLRHPNTIQ 79
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
+ ++V+EY G K LQE E + + G++Y H+ + HR
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL--ANRG-YDG 195
D+K NILL G +K+ DFG +++ + G+P ++APEV+ + G YDG
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASIMAP------ANXFVGTPYWMAPEVILAMDEGQYDG 193
Query: 196 ATSDIWSCGV 205
D+WS G+
Sbjct: 194 KV-DVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 9e-20
Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 26/208 (12%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH----LKITDQIKREIATLKL 70
RY+ +G G +G V A D SG A+K +I H + + RE+ L+
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIK-----KIPHAFDVPTLAKRTLRELKILRH 60
Query: 71 LKHPNVVRLHEVLASKSK----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
KH N++ + ++L +Y+V++ + +L I S L E R QL+ G
Sbjct: 61 FKHDNIIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLLRG 119
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 183
+ Y H+ V HRDLK N+L++ ++I DFG++ + T YV
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMT----EYVATR 175
Query: 184 ---APEVL-ANRGYDGATSDIWSCGVIL 207
APE+L + Y A D+WS G I
Sbjct: 176 WYRAPELLLSLPEYTTAI-DMWSVGCIF 202
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 86/313 (27%), Positives = 136/313 (43%), Gaps = 51/313 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-- 72
RYEL + LG+G +G V A++ ++ V I + + KI KR + LKLL+
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKIL--AKRALRELKLLRHF 58
Query: 73 --HPNVVRLHE---VLASK-SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H N+ L++ V +++Y+ E + +L I S L +A + Q++ G
Sbjct: 59 RGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCG 117
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA--LPQHFRDDGLLHTTCGSPNYVA 184
+ Y H+ V HRDLK N+L+++ +KI DFGL+ + G + + Y A
Sbjct: 118 LKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRA 177
Query: 185 PEV-LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--------LAVL---------- 225
PE+ L+ + Y A D+WS G IL +L F ++ L VL
Sbjct: 178 PEIMLSFQSYTKAI-DVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236
Query: 226 ------YQKIFRGDFKLPK---WLSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFE 272
I K + P A +LL K+L +P KRI++ +E E
Sbjct: 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISV-----EEALE 291
Query: 273 QDYTPANPDDDEE 285
Y D D+E
Sbjct: 292 HPYLAIWHDPDDE 304
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 1e-19
Identities = 68/201 (33%), Positives = 103/201 (51%), Gaps = 18/201 (8%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT----DQIKREIATLKLLKHPNVV 77
LG GN G V SGL A K+ IHL+I +QI RE+ L P +V
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKL------IHLEIKPAIRNQIIRELKVLHECNSPYIV 62
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNK-GV 135
+ S +I + +E++ GG L D++ K GR+ E K+ ++ G++Y K +
Sbjct: 63 GFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYLREKHKI 121
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
HRD+K NIL++S+G IK+ DFG+S D + ++ G+ +Y++PE L Y
Sbjct: 122 MHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQGTHY-T 176
Query: 196 ATSDIWSCGVILYVILTGYLP 216
SDIWS G+ L + G P
Sbjct: 177 VQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 97/328 (29%), Positives = 144/328 (43%), Gaps = 59/328 (17%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI-TDQIKREIATLKLLKH 73
RY + +G G +G V A D +G A+K L +R +I + RE+ LK ++H
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL--SRPFQSEIFAKRAYRELTLLKHMQH 73
Query: 74 PNVVRLHEVLASKS------KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
NV+ L +V S Y+V+ Y+ KI L E + + L Q++ G+
Sbjct: 74 ENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGH-PLSEDKVQYLVYQMLCGL 130
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
Y H+ G+ HRDLK N+ ++ +KI DFGL+ +H D + + Y APEV
Sbjct: 131 KYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA---RH--ADAEMTGYVVTRWYRAPEV 185
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQ------------------- 227
+ N + T DIWS G I+ +LTG F ++ L L Q
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245
Query: 228 ----------KIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ-- 273
K R DF PK SP A +LL K+LE + KR+T +F+
Sbjct: 246 AAKSYIKSLPKYPRKDFSTLFPK-ASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304
Query: 274 ---DYTPANPDDDEEDIFVDNEAFSMHE 298
+ T P DD ++NE S+ E
Sbjct: 305 DADEETEQQPYDDS----LENEKLSVDE 328
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 90/331 (27%), Positives = 147/331 (44%), Gaps = 64/331 (19%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
RY+ +G G +G V A D AVK L + +IH + T RE+ LK +K
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRT---YRELRLLKHMK 72
Query: 73 HPNVVRLHEVLASK------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H NV+ L +V +++Y+V + G +L + I +L + + L QL+ G
Sbjct: 73 HENVIGLLDVFTPATSIENFNEVYLVTN-LMGADL-NNIVKCQKLSDEHVQFLIYQLLRG 130
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
+ Y H+ G+ HRDLK N+ ++ ++I DFGL+ + D + + Y APE
Sbjct: 131 LKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWYRAPE 185
Query: 187 VLANRGYDGATSDIWSCGVILYVILTG--YLPFDD------RNLAVL------------- 225
++ N + T DIWS G I+ +L G P +D R + V+
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245
Query: 226 -----------------YQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268
+KIFRG +P A +LL K+L + KRI+ + A
Sbjct: 246 EHARKYIQSLPHMPQQDLKKIFRG-------ANPLAIDLLEKMLVLDSDKRISASEALAH 298
Query: 269 EWFEQDYTPAN-PDDDEEDIFVDNEAFSMHE 298
+F Q + P + P+ + D +N+ ++ E
Sbjct: 299 PYFSQYHDPEDEPEAEPYDESPENKERTIEE 329
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-19
Identities = 64/226 (28%), Positives = 113/226 (50%), Gaps = 13/226 (5%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+L + LG G FG+V ++ AVK L+ + E +K L+H +
Sbjct: 9 KLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKL 63
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKG 134
VRL+ V+ + IY++ EY+ G L D + S G++ + Q+ +G++Y K
Sbjct: 64 VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 123
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGY 193
HRDL+ N+L+ KI+DFGL+ + + ++ P + APE + N G
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAI-NFGS 180
Query: 194 DGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
SD+WS G++LY I+T G +P+ + + + + RG +++P+
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-YRMPR 225
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 2e-19
Identities = 67/239 (28%), Positives = 113/239 (47%), Gaps = 27/239 (11%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLK 69
E + LG G FG V + G +P A+K+L + K +I E +
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMA 64
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELF-------DKIASKGRLQEAEGRKLFQQ 122
+ HP+VVRL + S S++ ++ + + G L D I S+ L Q
Sbjct: 65 SVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCV------Q 117
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P- 180
+ G+SY K + HRDL N+L+ + ++KI+DFGL+ L D+ H G P
Sbjct: 118 IAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD--VDEKEYHAEGGKVPI 175
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
++A E + +R Y SD+WS GV ++ ++T G P++ + + +G+ +LP+
Sbjct: 176 KWMALESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE-RLPQ 232
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 64/199 (32%), Positives = 105/199 (52%), Gaps = 20/199 (10%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKN-RIIHLKITDQIKREIATLKLLKH 73
+ R +G G+FG V FA+D+ + A+K + + + + K D IK E+ L+ L+H
Sbjct: 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIK-EVRFLQQLRH 74
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
PN + + ++V+EY G ++ + K LQE E + + G++Y H
Sbjct: 75 PNTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLH 132
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPNYVAPEV-L 188
+ HRD+K NILL G +K++DFG ++L P ++ G+P ++APEV L
Sbjct: 133 SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--------NSFVGTPYWMAPEVIL 184
Query: 189 A-NRG-YDGATSDIWSCGV 205
A + G YDG D+WS G+
Sbjct: 185 AMDEGQYDGKV-DVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 2e-19
Identities = 66/219 (30%), Positives = 114/219 (52%), Gaps = 19/219 (8%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
G +EL +G G +G+V + + +G A+K+++ + ++IK+EI LK H
Sbjct: 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 61
Query: 74 -PNVVRLHEVLASKS------KIYMVLEYVTGGELFDKIA-SKGR-LQEAEGRKLFQQLI 124
N+ + K+ ++++V+E+ G + D I +KG L+E + ++++
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 121
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
G+S+ H V HRD+K +N+LL +K+ DFG+SA Q R G +T G+P ++A
Sbjct: 122 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMA 179
Query: 185 PEVLANRGYDGAT----SDIWSCGVILYVILTGYLPFDD 219
PEV+A AT SD+WS G+ + G P D
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 218
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 73/230 (31%), Positives = 113/230 (49%), Gaps = 20/230 (8%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT----DQIKREIATLKLLKHPNVV 77
LG GN G V Q SGL A K+ IHL+I +QI RE+ L P +V
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKL------IHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVF 136
+ S +I + +E++ GG L + R+ E K+ ++ G++Y K +
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIM 126
Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
HRD+K NIL++S+G IK+ DFG+S D + ++ G+ +Y++PE L Y
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQ----LIDSMANSFVGTRSYMSPERLQGTHYS-V 181
Query: 197 TSDIWSCGVILYVILTGYLPF---DDRNL-AVLYQKIFRGDFKLPKWLSP 242
SDIWS G+ L + G P D + L A+ + + G+ P +SP
Sbjct: 182 QSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISP 231
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 87.5 bits (216), Expect = 3e-19
Identities = 57/189 (30%), Positives = 97/189 (51%), Gaps = 10/189 (5%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
R +G G+FG V FA+D+ + A+K + + + I +E+ L+ +KHPN +
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
+ ++V+EY G K LQE E + + G++Y H+ + HRD
Sbjct: 91 KGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL--ANRG-YDGA 196
+K NILL G +K++DFG +++ ++ G+P ++APEV+ + G YDG
Sbjct: 151 IKAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGK 204
Query: 197 TSDIWSCGV 205
D+WS G+
Sbjct: 205 V-DVWSLGI 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 3e-19
Identities = 54/173 (31%), Positives = 91/173 (52%), Gaps = 10/173 (5%)
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ- 121
RE++ LK LKH N+V LH+++ ++ + +V EY+ +L + G KLF
Sbjct: 53 REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLF 111
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCG 178
QL+ G++YCH + V HRDLK +N+L++ +G +K++DFGL+ ++P + ++
Sbjct: 112 QLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV----- 166
Query: 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR 231
+ Y P++L D+W G I Y + TG F + IFR
Sbjct: 167 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFR 219
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 4e-19
Identities = 65/256 (25%), Positives = 116/256 (45%), Gaps = 48/256 (18%)
Query: 29 KVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88
KV D + F +K L K + + RE T+ PN+V LH+ + S+
Sbjct: 8 KVLLVMDTRTQQTFILKGLRK--------SSEYSRERLTIIPHCVPNMVCLHKYIVSEDS 59
Query: 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 148
+++VL++ GG+L+ I+ + E ++ +++ + H +G+ RDL NILLD
Sbjct: 60 VFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD 119
Query: 149 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANRGYDGATS------ 198
+G+I+++ F + + + +C Y APEV G S
Sbjct: 120 DRGHIQLTYFS------RWSE---VEDSCDGEAVENMYCAPEV-------GGISEETEAC 163
Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-----DFKLPKWLSPGAQNLLRKILE 253
D WS G IL+ +LTG L + G +P+W+S A++LL+++L+
Sbjct: 164 DWWSLGAILFELLTG---------KTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQ 214
Query: 254 PNPVKRITIAGIKADE 269
NP +R+ ++
Sbjct: 215 FNPTERLGAGVAGVED 230
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 4e-19
Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 6/212 (2%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LG+G FG+V Q ++G +A K L+K R+ E L+ + P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFHRD 139
SK+ + +V+ + GG+L I + G R + Q+ G+ + H+ + +RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 199
+K EN+LLD +GN ++SD GL+ +D + G+ Y+APE+L Y D
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAV---ELKDGKTITQRAGTNGYMAPEILKEEPYSYPV-D 176
Query: 200 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFR 231
++ G +Y ++ G PF D V +++ R
Sbjct: 177 WFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 5e-19
Identities = 60/188 (31%), Positives = 95/188 (50%), Gaps = 12/188 (6%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILE-KNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
+G G+FG V FA + + AVK + + + K D IK E+ L+ LKHPN +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIK-EVKFLQQLKHPNTIEYK 87
Query: 81 EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140
+ ++V+EY G K LQE E + + G++Y H+ + HRD+
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDI 147
Query: 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL--ANRG-YDGAT 197
K NILL G +K++DFG ++ ++ G+P ++APEV+ + G YDG
Sbjct: 148 KAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKV 201
Query: 198 SDIWSCGV 205
D+WS G+
Sbjct: 202 -DVWSLGI 208
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 5e-19
Identities = 78/275 (28%), Positives = 130/275 (47%), Gaps = 38/275 (13%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+L R LG G FG+V + ++ P AVK L+ + D + E +K L+HP +
Sbjct: 9 QLLRKLGAGQFGEV-WEGLWNNTTPVAVKTLKPGT---MDPKDFL-AEAQIMKKLRHPKL 63
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
++L+ V + IY+V E + G L + LQ GR L QLID G++
Sbjct: 64 IQLYAVCTLEEPIYIVTELMKYGSLLE------YLQGGAGRALKLPQLIDMAAQVASGMA 117
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAP 185
Y + HRDL N+L+ K++DFGL+ + ++D + G+ + AP
Sbjct: 118 YLEAQNYIHRDLAARNVLVGENNICKVADFGLARV---IKED-IYEAREGAKFPIKWTAP 173
Query: 186 EVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
E A SD+WS G++L I+T G +P+ A + Q++ +G +++P PG
Sbjct: 174 EA-ALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-YRMPC--PPGC 229
Query: 245 QNLLRKIL----EPNPVKRITIAGIKADEWFEQDY 275
L I+ + +P R T ++ W +D+
Sbjct: 230 PKELYDIMLDCWKEDPDDRPTFETLQ---WKLEDF 261
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 7e-19
Identities = 56/167 (33%), Positives = 86/167 (51%), Gaps = 34/167 (20%)
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ- 121
RE + LK LKH N+V LH+++ +K + +V EY+ +L + G +LF
Sbjct: 52 REASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLF 110
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQH----------FR 168
QL+ G++YCH + V HRDLK +N+L+ +G +K++DFGL+ ++P +R
Sbjct: 111 QLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYR 170
Query: 169 -DDGLLHTTCGSPNYVAPEVLANRGYDGATS-DIWSCGVILYVILTG 213
D LL GS Y +TS D+W G I Y + TG
Sbjct: 171 PPDVLL----GSTEY-------------STSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 8e-19
Identities = 73/260 (28%), Positives = 125/260 (48%), Gaps = 17/260 (6%)
Query: 17 ELGRTLGEGNFGKVK---FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
LGR +GEG FG V + + + AVK + + ++ +E ++ H
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC--TSPSVREKFLQEAYIMRQFDH 66
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHN 132
P++V+L V+ +++ +++V+E GEL + +K L A QL ++Y +
Sbjct: 67 PHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVAPEVLAN 190
K HRD+ N+L+ S +K+ DFGLS ++ D+ + G P ++APE +
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLS---RYLEDESYYKASKGKLPIKWMAPESINF 182
Query: 191 RGYDGATSDIWSCGVILYVILT-GYLPFDD-RNLAVLYQKIFRGD-FKLPKWLSPGAQNL 247
R + A SD+W GV ++ IL G PF +N V+ +I G+ +P P +L
Sbjct: 183 RRFTSA-SDVWMFGVCMWEILMLGVKPFQGVKNNDVI-GRIENGERLPMPPNCPPTLYSL 240
Query: 248 LRKILEPNPVKRITIAGIKA 267
+ K +P KR +KA
Sbjct: 241 MTKCWAYDPSKRPRFTELKA 260
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 9e-19
Identities = 71/239 (29%), Positives = 115/239 (48%), Gaps = 39/239 (16%)
Query: 20 RTLGEGNFGKVKFAQDLDSG---LPFAVKIL-----EKNRIIHLKITDQIKREIATLKLL 71
+ +G G FG+V + G + A+K L +K R+ L E + +
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFL-------TEASIMGQF 62
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------ 125
HPN++RL V+ + ++ EY+ G L DK L+E +G+ QL+
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSL-DKF-----LRENDGKFTVGQLVGMLRGIA 116
Query: 126 -GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG--SP-N 181
G+ Y HRDL NIL++S K+SDFGLS + D +TT G P
Sbjct: 117 SGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLS---RRLEDSEATYTTKGGKIPIR 173
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD-RNLAVLYQKIFRGDFKLPK 238
+ APE +A R + A SD+WS G++++ +++ G P+ D N V+ + + G ++LP
Sbjct: 174 WTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWDMSNQDVI-KAVEDG-YRLPP 229
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 1e-18
Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
YE LGEG++ V + +G A+K++ T RE + LK LKH N
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFT--AIREASLLKGLKHAN 64
Query: 76 VVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
+V LH+++ +K + +V EYV + DK G L + QL+ G+SY H +
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQR 122
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
+ HRDLK +N+L+ G +K++DFGL+ ++P H + ++ + Y P+VL
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-----TLWYRPPDVLLG 177
Query: 191 RGYDGATSDIWSCGVILYVILTGYLPF 217
D+W G I ++ G F
Sbjct: 178 STEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 63/233 (27%), Positives = 109/233 (46%), Gaps = 30/233 (12%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ RY++ R +G+G G+V A D A+K + ++ + + + RE L
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGEL-------FDKIASKGRLQEAEGRK----LFQ 121
HP +V ++ + + +Y + Y+ G L + K + L E +F
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD---------GL 172
++ + Y H+KGV HRDLK +NILL G + I D+G + + +D +
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 173 LHTT-------CGSPNYVAPEVLANRGYDGATS-DIWSCGVILYVILTGYLPF 217
+++ G+P+Y+APE L G + S DI++ GVILY +LT P+
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERL--LGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 82/287 (28%), Positives = 126/287 (43%), Gaps = 44/287 (15%)
Query: 18 LGRTLGEGNFGKV--KFAQDLDSGLP----FAVKILEKNRIIHLKITDQIKREIATLKLL 71
LG+TLGEG FGKV A L G AVK+L++N ++ D + E LK +
Sbjct: 4 LGKTLGEGEFGKVVKATAFRL-KGRAGYTTVAVKMLKENAS-SSELRDLLS-EFNLLKQV 60
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGEL--FDKIASK------GRLQEAEGRKLFQ-- 121
HP+V++L+ + + +++EY G L F + + K G L
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 122 --------------QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167
Q+ G+ Y + HRDL N+L+ +KISDFGLS +
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR--DVY 178
Query: 168 RDDGLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD---RN 221
+D + + G ++A E L + Y SD+WS GV+L+ I+T G P+
Sbjct: 179 EEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237
Query: 222 LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268
L L + +R + P+ S NL+ + P KR T A I +
Sbjct: 238 LFNLLKTGYRME--RPENCSEEMYNLMLTCWKQEPDKRPTFADISKE 282
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 51/173 (29%), Positives = 91/173 (52%), Gaps = 10/173 (5%)
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF-Q 121
RE++ LK LKH N+V LH+++ + + +V EY+ +L + G + K+F
Sbjct: 53 REVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLY 111
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCG 178
Q++ G++YCH + V HRDLK +N+L++ +G +K++DFGL+ ++P + ++
Sbjct: 112 QILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV----- 166
Query: 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR 231
+ Y P+VL D+W G I + + +G F + IFR
Sbjct: 167 TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFR 219
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 4e-18
Identities = 74/238 (31%), Positives = 116/238 (48%), Gaps = 26/238 (10%)
Query: 16 YELGRTLGEGNFGKVKFAQ---DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ LGR LG+G FG V+ AQ + S AVK+L K I ++ RE A +K
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59
Query: 73 HPNVVRLHEV-LASKSK----IYMV-LEYVTGGELFDKIASKGRLQE----AEGRKLFQQ 122
HPNV++L V L S++K I MV L ++ G+L + R+ E + L +
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMS-RIGEEPFTLPLQTLVRF 118
Query: 123 LID---GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
+ID G+ Y +K HRDL N +L+ + ++DFGLS + C S
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS---KKIYSGDYYRQGCAS 175
Query: 180 P---NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD 233
++A E LA+ Y SD+W+ GV ++ I+T G P+ + +Y + +G+
Sbjct: 176 KLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN 232
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 4e-18
Identities = 77/281 (27%), Positives = 118/281 (41%), Gaps = 53/281 (18%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIATLKLLKHPNVV 77
LGEG++ V +G A+K+ I +K + + RE + LK LKH N+V
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKV------ISMKTEEGVPFTAIREASLLKGLKHANIV 66
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
LH+++ +K + V EY+ I G L R QL+ G++Y H + + H
Sbjct: 67 LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILH 126
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANRGY 193
RDLK +N+L+ G +K++DFGL+ R + T S Y P+VL
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLA------RAKSIPSQTYSSEVVTLWYRPPDVLLGATD 180
Query: 194 DGATSDIWSCGVILYVILTGYLPFDDRN------------LAVLYQKIFRGDFKLPKW-- 239
+ DIW G I +L G F + L V + + G KLP +
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP 240
Query: 240 -----------------LS--PGAQNLLRKILEPNPVKRIT 261
LS P A++L ++L P RI+
Sbjct: 241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRIS 281
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 5e-18
Identities = 71/226 (31%), Positives = 109/226 (48%), Gaps = 37/226 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLP-----FAVKILEKNRIIHLKITDQIKREIATLK 69
R LG+ LGEG FG+V A+ + P AVK+L+ + ++D + E+ +K
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK-DLSDLVS-EMEMMK 70
Query: 70 LL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAE--------GRKLF 120
++ KH N++ L V + +Y+V+EY G L D + ++ E L
Sbjct: 71 MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130
Query: 121 Q--------QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--- 169
Q Q+ G+ + +K HRDL N+L+ +KI+DFGL+ RD
Sbjct: 131 QKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA------RDIHH 184
Query: 170 -DGLLHTTCGS-P-NYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
D TT G P ++APE L +R Y SD+WS GV+L+ I T
Sbjct: 185 IDYYRKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 5e-18
Identities = 69/270 (25%), Positives = 123/270 (45%), Gaps = 24/270 (8%)
Query: 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
+ + +L +T+G+G FG V G AVK ++ + + E + +
Sbjct: 3 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLA-----EASVMTQ 55
Query: 71 LKHPNVVRLHEVLAS-KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---G 126
L+H N+V+L V+ K +Y+V EY+ G L D + S+GR G L + +D
Sbjct: 56 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEA 114
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
+ Y HRDL N+L+ K+SDFGL+ +D G L + APE
Sbjct: 115 MEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPE 169
Query: 187 VLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPG 243
L + + SD+WS G++L+ I + G +P+ L + ++ +G +K+ P P
Sbjct: 170 ALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPV 227
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
+++++ + R + ++ E E
Sbjct: 228 VYDVMKQCWHLDAATRPSFLQLR--EQLEH 255
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 6e-18
Identities = 79/278 (28%), Positives = 133/278 (47%), Gaps = 35/278 (12%)
Query: 20 RTLGEGNFGKVKFA----QDLDSGLPFAVKILE-KNRIIHLKITDQIKREIATLKLLKHP 74
R LGEG+FGKV+ + ++G AVK L+ ++ H+ +K+EI L+ L H
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI---ADLKKEIEILRNLYHE 66
Query: 75 NVVRLHEVLASK--SKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCH 131
N+V+ + + I +++E++ G L + + +K ++ + K Q+ G+ Y
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY-VAPEVLAN 190
++ HRDL N+L++S+ +KI DFGL+ + ++ + SP + APE L
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI--FRGDF---KLPKWLSPGAQ 245
+ A SD+WS GV LY +LT Y + + + + I G +L + L G +
Sbjct: 187 SKFYIA-SDVWSFGVTLYELLT-YCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKR 244
Query: 246 ------------NLLRKILEPNPVKRIT----IAGIKA 267
L+RK E P KR T I G +A
Sbjct: 245 LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 6e-18
Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 17/198 (8%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
Y + +TL G+ G+V A P +KI +K + E L+ + HP+
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTL---------IEAMLLQNVNHPS 118
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKG 134
V+R+ + L S + MVL + + +L+ + + L + + +Q+++G+ Y H +
Sbjct: 119 VIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD-GLLHTTCGSPNYVAPEVLANRGY 193
+ HRD+K ENI ++ + I D G + P GL G+ APEVLA Y
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL----AGTVETNAPEVLARDKY 233
Query: 194 DGATSDIWSCGVILYVIL 211
+ + +DIWS G++L+ +L
Sbjct: 234 N-SKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 7e-18
Identities = 73/272 (26%), Positives = 121/272 (44%), Gaps = 27/272 (9%)
Query: 18 LGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
LG+ LGEG FG V + +QD S L AVK ++ + + +I + + E A +K HP
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFL-SEAACMKDFDHP 61
Query: 75 NVVRLHEV---LASKSKI---YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID--- 125
NV++L V +S KI ++L ++ G+L + RL + Q L+
Sbjct: 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYS-RLGGLPEKLPLQTLLKFMV 120
Query: 126 ----GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP- 180
G+ Y N+ HRDL N +L + ++DFGLS + +
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS---KKIYSGDYYRQGRIAKM 177
Query: 181 --NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKL 236
++A E LA+R Y + SD+W+ GV ++ I T G P+ +Y + G+ K
Sbjct: 178 PVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQ 236
Query: 237 PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268
P+ +L+ +P R T ++
Sbjct: 237 PEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 8e-18
Identities = 70/259 (27%), Positives = 113/259 (43%), Gaps = 27/259 (10%)
Query: 21 TLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
TLG G FG+V K ++ VK L+K + +L+ + +RE+ + L H N
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQS--EFRRELDMFRKLSHKN 69
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGEL--FDKIASKGR-------LQEAEGRKLFQQLIDG 126
VVRL + YM+LEY G+L F + L + L Q+ G
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAP 185
+ + N HRDL N L+ S+ +K+S LS + + P ++AP
Sbjct: 130 MDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDV--YNSEYYKLRNALIPLRWLAP 187
Query: 186 EVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
E + + SD+WS GV+++ + T G LPF + + ++ G +LP + G
Sbjct: 188 EAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP--VPEGC 244
Query: 245 QNLLRKILE----PNPVKR 259
+ L K++ NP R
Sbjct: 245 PSRLYKLMTRCWAVNPKDR 263
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 4e-17
Identities = 70/232 (30%), Positives = 115/232 (49%), Gaps = 26/232 (11%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+L + LG G FG+V + A+K L++ + + E +K L+HP +
Sbjct: 9 KLVKKLGAGQFGEVWMGY-YNGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRL 63
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
VRL+ V+ ++ IY++ EY+ G L D L+ EG KL +LID G++
Sbjct: 64 VRLYAVV-TQEPIYIITEYMENGSLVD------FLKTPEGIKLTINKLIDMAAQIAEGMA 116
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEV 187
+ K HRDL+ NIL+ KI+DFGL+ L + ++ P + APE
Sbjct: 117 FIERKNYIHRDLRAANILVSETLCCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEA 174
Query: 188 LANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
+ N G SD+WS G++L I+T G +P+ + Q + RG +++P+
Sbjct: 175 I-NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG-YRMPR 224
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 7e-17
Identities = 60/220 (27%), Positives = 109/220 (49%), Gaps = 17/220 (7%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+ LG G FG V + + + A+K + + + + E + L HP +V+L
Sbjct: 10 KELGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSE----EDFIEEAKVMMKLSHPKLVQL 64
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
+ V + +Y+V E++ G L + + + G+L + + Q + +G+ Y HR
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR 124
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDG 195
DL N L+ S G +K+SDFG++ ++ DD ++ G+ + PEV Y
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMT---RYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYS- 179
Query: 196 ATSDIWSCGVILYVILT-GYLPFDDR-NLAVLYQKIFRGD 233
+ SD+WS GV+++ + T G +PF+ + N V+ + I RG
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVV-EMISRGF 218
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 8e-17
Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 19/201 (9%)
Query: 21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
LG GN G V A L + AVK++ + I +++ QI E+ L P ++ +
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLD--ITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 81 EVLASKSKIYMVLEYVTGGEL--FDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVF 136
+++I + E++ GG L + KI GR+ A ++ G++Y + +
Sbjct: 66 GAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVA--------VVKGLTYLWSLKIL 117
Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
HRD+K N+L++++G +K+ DFG+S + + T G+ Y+APE ++ Y G
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQLV----NSIAKTYVGTNAYMAPERISGEQY-GI 172
Query: 197 TSDIWSCGVILYVILTGYLPF 217
SD+WS G+ + G P+
Sbjct: 173 HSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 2e-16
Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 25/217 (11%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSG---LPFAVKIL-----EKNRIIHLKITDQIKREIA 66
++ + +G G FG+V + G +P A+K L EK R L E +
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFL-------SEAS 57
Query: 67 TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLI 124
+ HPN++ L V+ + +V EY+ G L D K G+ + + + +
Sbjct: 58 IMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIA 116
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---N 181
G+ Y + G HRDL NIL++S K+SDFGLS + + D +TT G
Sbjct: 117 SGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIR 174
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 217
+ APE +A R + A SD+WS G++++ +++ G P+
Sbjct: 175 WTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPY 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-16
Identities = 59/222 (26%), Positives = 110/222 (49%), Gaps = 16/222 (7%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+G G FG V L+ A+K + + + + E + L HP +V+L+
Sbjct: 12 IGSGQFGLVWLGYWLEKR-KVAIKTIREGAMSE----EDFIEEAQVMMKLSHPKLVQLYG 66
Query: 82 VLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140
V +S I +V E++ G L D + A +G+ + + + +G++Y + V HRDL
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126
Query: 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGAT 197
N L+ +K+SDFG++ F D ++ G+ + +PEV + Y +
Sbjct: 127 AARNCLVGENQVVKVSDFGMT----RFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYS-SK 181
Query: 198 SDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
SD+WS GV+++ + + G P+++R+ + + + I G F+L K
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG-FRLYK 222
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 5e-16
Identities = 57/195 (29%), Positives = 96/195 (49%), Gaps = 7/195 (3%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
++E+ +GEG +G V + ++ A+K K+ + ++ + RE+ L+ LK
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQE 60
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
N+V L E + K+Y+V EYV EL +++ + G E + R QLI + +CH
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPN-GVPPE-KVRSYIYQLIKAIHWCHK 118
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
+ HRD+K EN+L+ +K+ DFG + + + Y +PE+L
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV-ATRWYRSPELLLGAP 177
Query: 193 YDGATSDIWSCGVIL 207
Y G D+WS G IL
Sbjct: 178 Y-GKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 5e-16
Identities = 61/226 (26%), Positives = 112/226 (49%), Gaps = 14/226 (6%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+L + LG G FG+V A + AVK ++ + E +K L+H +
Sbjct: 9 KLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLA----EANVMKTLQHDKL 63
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKG 134
V+LH V+ +K IY++ E++ G L D + S + + Q+ +G+++ +
Sbjct: 64 VKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 122
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGY 193
HRDL+ NIL+ + KI+DFGL+ + + ++ P + APE + N G
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAI-NFGS 179
Query: 194 DGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
SD+WS G++L I+T G +P+ + + + + RG +++P+
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMPR 224
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 9e-16
Identities = 70/250 (28%), Positives = 113/250 (45%), Gaps = 8/250 (3%)
Query: 22 LGEGNFGKVK--FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
LG GNFG VK + S AVKIL KN + D++ RE ++ L +P +VR+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKIL-KNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
+ ++S + +V+E G L + + E +L Q+ G+ Y HRD
Sbjct: 62 IGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATS 198
L N+LL ++ KISDFGLS + T P + APE + N + S
Sbjct: 121 LAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM-NYYKFSSKS 179
Query: 199 DIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNP 256
D+WS GV+++ + G P+ + Q I G+ + P+ P +L++
Sbjct: 180 DVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGV 239
Query: 257 VKRITIAGIK 266
+R A ++
Sbjct: 240 DERPGFAVVE 249
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 9e-16
Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 18/213 (8%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
L RY+ + +G G G V A D G+ AVK L + H K + RE+ LK
Sbjct: 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAK---RAYRELVLLKC 76
Query: 71 LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
+ H N++ L V + +Y+V+E + L I + L L Q++
Sbjct: 77 VNHKNIISLLNVFTPQKSLEEFQDVYLVME-LMDANLCQVIHME--LDHERMSYLLYQML 133
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
G+ + H+ G+ HRDLK NI++ S +KI DFGL+ + ++ + Y A
Sbjct: 134 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC---TNFMMTPYVVTRYYRA 190
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217
PEV+ GY DIWS G I+ ++ G + F
Sbjct: 191 PEVILGMGYK-ENVDIWSVGCIMGELVKGSVIF 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 69/224 (30%), Positives = 108/224 (48%), Gaps = 31/224 (13%)
Query: 15 RYELGRTLGEGNFGKVKFAQ--DLDSGLP-----FAVKILEKNRIIHLKITDQIKREIAT 67
R LG+ LGEG FG+V A+ LD P AVK+L K+ ++D I E+
Sbjct: 19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEM 76
Query: 68 LKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-------------GRLQE 113
+K++ KH N++ L +Y+++EY + G L + + ++ ++
Sbjct: 77 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQ 136
Query: 114 AEGRKLFQ---QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
+ L Q+ G+ Y +K HRDL N+L+ +KI+DFGL+ H D
Sbjct: 137 LSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--D 194
Query: 171 GLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
TT G ++APE L +R Y SD+WS GV+L+ I T
Sbjct: 195 YYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-15
Identities = 77/272 (28%), Positives = 128/272 (47%), Gaps = 33/272 (12%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+L + LG G FG+V + + AVK L+ + + E +K L+H +
Sbjct: 9 QLIKKLGNGQFGEV-WMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKL 63
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
V+L+ V+ S+ IY+V EY++ G L D L++ EGR L L+D G++
Sbjct: 64 VQLYAVV-SEEPIYIVTEYMSKGSLLD------FLKDGEGRALKLPNLVDMAAQVAAGMA 116
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAP 185
Y HRDL+ NIL+ KI+DFGL+ L + D G+ + AP
Sbjct: 117 YIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIE----DNEYTARQGAKFPIKWTAP 172
Query: 186 EVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPG 243
E A G SD+WS G++L ++T G +P+ N + +++ RG P+
Sbjct: 173 EA-ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPIS 231
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
L+ + + +P +R T +++ F +DY
Sbjct: 232 LHELMLQCWKKDPEERPTFEYLQS---FLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 75/262 (28%), Positives = 121/262 (46%), Gaps = 26/262 (9%)
Query: 18 LGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
LG+TLGEG FG V + QD DS L AVK ++ ++ D + E +K HP
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQD-DSILKVAVKTMKIAICTRSEMEDFL-SEAVCMKEFDHP 60
Query: 75 NVVRLHEVL--ASKSKIY----MVLEYVTGGEL-----FDKIASKGRLQEAEGR-KLFQQ 122
NV+RL V +S+ Y ++L ++ G+L + ++ + + K
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL---PQHFRDDGLLHTTCGS 179
+ G+ Y +K HRDL N +L+ N+ ++DFGLS ++R +
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV-- 178
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLP 237
++A E LA+R Y SD+WS GV ++ I T G P+ + +Y + +G+ K P
Sbjct: 179 -KWIAIESLADRVYT-TKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQP 236
Query: 238 KWLSPGAQNLLRKILEPNPVKR 259
G +L+ NP R
Sbjct: 237 PDCLDGLYSLMSSCWLLNPKDR 258
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 71/255 (27%), Positives = 115/255 (45%), Gaps = 30/255 (11%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK--LLKH--PNVV 77
+G G G+V + +G AVK + + ++ KR + L L H P +V
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRT-----GNKEENKRILMDLDVVLKSHDCPYIV 77
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIA--SKGRLQEAEGRKLFQQLIDGVSYCHNK-G 134
+ + + S +++ +E + DK+ +G + E K+ ++ + Y K G
Sbjct: 78 KCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG 135
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT-TCGSPNYVAPEVL----A 189
V HRD+K NILLD+ GN+K+ DFG+S D T + G Y+APE +
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISG----RLVDSKAKTRSAGCAAYMAPERIDPPDP 191
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFD--DRNLAVLYQKIFRGDF-KLP--KWLSPGA 244
N YD +D+WS G+ L + TG P+ VL KI + + LP + SP
Sbjct: 192 NPKYD-IRADVWSLGISLVELATGQFPYKNCKTEFEVL-TKILQEEPPSLPPNEGFSPDF 249
Query: 245 QNLLRKILEPNPVKR 259
+ + L + KR
Sbjct: 250 CSFVDLCLTKDHRKR 264
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 3e-15
Identities = 66/233 (28%), Positives = 104/233 (44%), Gaps = 19/233 (8%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFA-VKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
+G G FGKV + G+ A V + E +E+ + L HPNV++
Sbjct: 3 IGNGWFGKV-LLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 81 EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ-----LIDGVSYCHNKGV 135
+VLE+ G+L + + S + +K Q + G+ + H
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADF 121
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVAPEVLANRGY 193
H DL L N L + ++KI D+GL AL Q + +D + C + P ++APE++ RG
Sbjct: 122 IHSDLALRNCQLTADLSVKIGDYGL-ALEQ-YPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 194 DGAT------SDIWSCGVILYVILT-GYLPFDD-RNLAVLYQKIFRGDFKLPK 238
D S+IWS GV ++ + T P+ D + VL Q + D KLPK
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPK 232
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 68/234 (29%), Positives = 107/234 (45%), Gaps = 51/234 (21%)
Query: 15 RYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
R LG+ LGEG FG+V A+ D + AVK+L+ N + D I E+
Sbjct: 13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLIS-EMEL 70
Query: 68 LKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQE------------- 113
+KL+ KH N++ L V + +Y+++EY A+KG L+E
Sbjct: 71 MKLIGKHKNIINLLGVCTQEGPLYVIVEY----------AAKGNLREFLRARRPPGPDYT 120
Query: 114 ------AEGRKLFQQLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL 160
E + F+ L+ G+ Y ++ HRDL N+L+ +KI+DFGL
Sbjct: 121 FDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGL 180
Query: 161 SALPQHFRDDGLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
+ D T+ G ++APE L +R Y SD+WS G++++ I T
Sbjct: 181 ARGVHDI--DYYKKTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 49/162 (30%), Positives = 78/162 (48%), Gaps = 16/162 (9%)
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
REI LK + H ++ L KS + MV+ +LF + G L + + ++
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRR 193
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA-------LPQHFRDDGLLHT 175
L++ ++Y H +G+ HRD+K ENI LD N + DFG + PQ + G L T
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253
Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217
+PE+LA Y A +DIWS G++L+ + +
Sbjct: 254 N-------SPELLALDPY-CAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 35/209 (16%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEK---NRIIHLKITDQIKREIATLKLLKHPNVVR 78
+G G +G V A++ ++ A+K + NRI + REI L+ L H NV+
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL----REIKLLRHLDHENVIA 68
Query: 79 LHEVLASKSK-----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
+ +++ + +Y+V E + +L I S L + + QL+ G+ Y H+
Sbjct: 69 IKDIMPPPHREAFNDVYIVYE-LMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA 127
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----------YV 183
V HRDLK N+LL++ ++KI DFGL+ TT + Y
Sbjct: 128 NVLHRDLKPSNLLLNANCDLKICDFGLA------------RTTSEKGDFMTEYVVTRWYR 175
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILT 212
APE+L N D+WS G I +L
Sbjct: 176 APELLLNCSEYTTAIDVWSVGCIFAELLG 204
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 74/279 (26%), Positives = 118/279 (42%), Gaps = 44/279 (15%)
Query: 18 LGRTLGEGNFGKVKFAQDLDSGLP------FAVKILEKNRIIHLKITDQIKREIATLKLL 71
L R LGEG FGKV F + P AVK L++ + +RE L
Sbjct: 9 LKRELGEGAFGKV-FLGECYHLEPENDKELVAVKTLKETASNDAR--KDFEREAELLTNF 65
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS--------------KGRLQEAEGR 117
+H N+V+ + V MV EY+ G+L + S G L ++
Sbjct: 66 QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 118 KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT- 176
++ Q+ G+ Y ++ HRDL N L+ +KI DFG+S RD ++TT
Sbjct: 126 QIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS------RD---VYTTD 176
Query: 177 ----CGSP----NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQ 227
G ++ PE + R + SD+WS GV+L+ I T G P+ + + +
Sbjct: 177 YYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE 235
Query: 228 KIFRGDFKL-PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
I +G P+ +++ + +P +RI I I
Sbjct: 236 CITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 4e-15
Identities = 71/218 (32%), Positives = 105/218 (48%), Gaps = 25/218 (11%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSG--LPFAVKILEKNRIIHLKITDQIKREIATLKL 70
L YE G +G G +G V A+ D +A+K +E I+ REIA L+
Sbjct: 1 LFEYE-GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT-----GISMSACREIALLRE 54
Query: 71 LKHPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKI----ASKG-----RLQEAEGRKL 119
LKHPNV+ L +V S S K++++ +Y +L+ I ASK +L + + L
Sbjct: 55 LKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSL 113
Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGLSAL-PQHFRDDGLLH 174
Q++DG+ Y H V HRDLK NIL+ +G +KI+D G + L + L
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
+ Y APE+L + DIW+ G I +LT
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 72/275 (26%), Positives = 121/275 (44%), Gaps = 40/275 (14%)
Query: 15 RYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
G+TLG G FGKV A D+ + AVK+L+ H + + E+ +
Sbjct: 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT--AHSSEREALMSELKIMS 93
Query: 70 LL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ---QLID 125
L H N+V L I ++ EY G+L + + K R L Q+
Sbjct: 94 HLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAK 152
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV-- 183
G+++ +K HRDL N+LL +KI DFGL+ RD +++ + NYV
Sbjct: 153 GMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA------RD--IMNDS----NYVVK 200
Query: 184 ----------APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 232
APE + N Y SD+WS G++L+ I + G P+ + + K+ +
Sbjct: 201 GNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE 259
Query: 233 DFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
+++ P+ ++++ + +P+KR T I
Sbjct: 260 GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
E R +G G FG V D G A+K + N +L ++ RE+ L KH NV
Sbjct: 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKM-PNVFQNLVSCKRVFRELKMLCFFKHDNV 61
Query: 77 VRLHEVLASK-----SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF-QQLIDGVSYC 130
+ ++L +IY+V E + +L I S L ++ K+F Q++ G+ Y
Sbjct: 62 LSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLS-SDHVKVFLYQILRGLKYL 119
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL-A 189
H+ G+ HRD+K N+L++S +KI DFGL+ + + + + + Y APE+L
Sbjct: 120 HSAGILHRDIKPGNLLVNSNCVLKICDFGLARV-EEPDESKHMTQEVVTQYYRAPEILMG 178
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPF 217
+R Y A DIWS G I +L + F
Sbjct: 179 SRHYTSAV-DIWSVGCIFAELLGRRILF 205
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 4e-15
Identities = 75/273 (27%), Positives = 111/273 (40%), Gaps = 35/273 (12%)
Query: 20 RTLGEGNFGKVKFAQDLD-----SG-LPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
LG G FG+V D SG + AVK L K K + +E + H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK--EFLKEAHLMSNFNH 58
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG-----RKLFQQLID--- 125
PN+V+L V Y+++E + GG+L + R++ ++L +D
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYL-RDARVERFGPPLLTLKELLDICLDVAK 117
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGN-----IKISDFGL-----SALPQHFRDDGLLHT 175
G Y HRDL N L+ KG +KI DFGL + +GLL
Sbjct: 118 GCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDR-NLAVLYQKIFRGD 233
++APE L + G SD+WS GV+++ ILT G P+ N VL G
Sbjct: 178 -----RWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGR 231
Query: 234 FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 266
+ P+ L+ +P +R T I+
Sbjct: 232 LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQ 264
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 5e-15
Identities = 70/218 (32%), Positives = 105/218 (48%), Gaps = 25/218 (11%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLD--SGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
L YE G +G G +G V A+ D +A+K +E I+ REIA L+
Sbjct: 1 LFEYE-GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT-----GISMSACREIALLRE 54
Query: 71 LKHPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKI-------ASKGRLQEAEG--RKL 119
LKHPNV+ L +V S + K++++ +Y +L+ I A+K +Q G + L
Sbjct: 55 LKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSL 113
Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGLSAL-PQHFRDDGLLH 174
Q++DG+ Y H V HRDLK NIL+ +G +KI+D G + L + L
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
+ Y APE+L + DIW+ G I +LT
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 7e-15
Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 31/221 (14%)
Query: 22 LGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
LGEG FGKV + + S A+K L++N K+ + ++E + L+HPN+
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP--KVQQEFRQEAELMSDLQHPNI 70
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIAS----------------KGRLQEAEGRKLF 120
V L V + M+ EY+ G+L + + K L ++ +
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL---PQHFRDDGLLHTTC 177
Q+ G+ Y + HRDL N L+ +KISDFGLS ++R + +
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYR---VQSKSL 187
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 217
++ PE + G SDIWS GV+L+ I + G P+
Sbjct: 188 LPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 8e-15
Identities = 90/341 (26%), Positives = 150/341 (43%), Gaps = 60/341 (17%)
Query: 4 AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLK 56
A+ K E R R LG+ LGEG FG+V A+ + + + AVK+L K+
Sbjct: 3 ADPKWELSR-TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML-KDDATDKD 60
Query: 57 ITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK------- 108
++D + E+ +K++ KH N++ L +Y+++EY + G L + + ++
Sbjct: 61 LSDLVS-EMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDY 119
Query: 109 --GRLQEAEGRKLFQQLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG 159
+ E + F+ L+ G+ Y ++ HRDL N+L+ +KI+DFG
Sbjct: 120 SFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFG 179
Query: 160 LSALPQHFRD----DGLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVILYVILT- 212
L+ RD D TT G ++APE L +R Y SD+WS GV+L+ I T
Sbjct: 180 LA------RDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTL 232
Query: 213 GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGI------ 265
G P+ + L++ + G P + ++R+ P +R T +
Sbjct: 233 GGSPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDR 292
Query: 266 -----KADEW------FEQDYTPANPDDDEEDIFVDNEAFS 295
DE+ FEQ Y+P PD D+ F+
Sbjct: 293 VLTVTSTDEYLDLSVPFEQ-YSPGCPDSPSSCSSGDDSVFA 332
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 76/270 (28%), Positives = 123/270 (45%), Gaps = 37/270 (13%)
Query: 22 LGEGNFGKVKFAQDLDSGLPF--AVKILEK--NRIIHLKITDQIKREIATLKLLKHPNVV 77
+GEGNFG+V A GL A+K+L++ + H +++ KL HPN++
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELE---VLCKLGHHPNII 66
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAE--------------GRKLFQQL 123
L ++ +Y+ +EY G L D + K R+ E + ++L Q
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFL-RKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 124 ID---GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS- 179
D G+ Y K HRDL N+L+ KI+DFGLS + + + T G
Sbjct: 126 SDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY-----VKKTMGRL 180
Query: 180 -PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL- 236
++A E L Y SD+WS GV+L+ I++ G P+ A LY+K+ +G +++
Sbjct: 181 PVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRME 238
Query: 237 -PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
P+ L+R+ P +R A I
Sbjct: 239 KPRNCDDEVYELMRQCWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 68/237 (28%), Positives = 110/237 (46%), Gaps = 36/237 (15%)
Query: 20 RTLGEGNFGKVKFAQDLDSG---LPFAVKIL-----EKNRIIHLKITDQIKREIATLKLL 71
+ +G G FG+V G + A+K L EK R L E + +
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLS-------EASIMGQF 63
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------ 125
H N++RL V+ ++ EY+ G L DK L++ +G QL+
Sbjct: 64 SHHNIIRLEGVVTKFKPAMIITEYMENGAL-DKY-----LRDHDGEFSSYQLVGMLRGIA 117
Query: 126 -GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---N 181
G+ Y + HRDL NIL++S K+SDFGLS + + + +TT G
Sbjct: 118 AGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG--TYTTSGGKIPIR 175
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 237
+ APE +A R + A SD+WS G++++ +++ G P+ D + + + I G F+LP
Sbjct: 176 WTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG-FRLP 230
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-14
Identities = 75/269 (27%), Positives = 121/269 (44%), Gaps = 35/269 (13%)
Query: 22 LGEGNFGKVKFAQDLDSGLPF--AVKILEK--NRIIHLKITDQIKREIATLKLLKHPNVV 77
+GEGNFG+V A+ GL A+K +++ ++ H +++ KL HPN++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE---VLCKLGHHPNII 59
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAE--------------GRKLFQQL 123
L + +Y+ +EY G L D + K R+ E + ++L
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 124 ID---GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS- 179
D G+ Y K HRDL NIL+ KI+DFGLS + + + T G
Sbjct: 119 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-----VKKTMGRL 173
Query: 180 -PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKL 236
++A E L Y SD+WS GV+L+ I++ G P+ A LY+K+ +G +
Sbjct: 174 PVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 232
Query: 237 PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
P +L+R+ P +R + A I
Sbjct: 233 PLNCDDEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 3e-14
Identities = 62/235 (26%), Positives = 108/235 (45%), Gaps = 34/235 (14%)
Query: 22 LGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKHP 74
+G G FG+V + G + A+K L+ T++ +R E + + HP
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG------YTEKQRRDFLSEASIMGQFDHP 65
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI-------DGV 127
N++ L V+ + ++ E++ G L L++ +G+ QL+ G+
Sbjct: 66 NIIHLEGVVTKSRPVMIITEFMENGAL------DSFLRQNDGQFTVIQLVGMLRGIAAGM 119
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVA 184
Y HRDL NIL++S K+SDFGLS + D ++ G + A
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILT-GYLPF-DDRNLAVLYQKIFRGDFKLP 237
PE +A R + A SD+WS G++++ +++ G P+ D N V+ D++LP
Sbjct: 180 PEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVI--NAIEQDYRLP 231
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 66/225 (29%), Positives = 109/225 (48%), Gaps = 39/225 (17%)
Query: 18 LGRTLGEGNFGKVKFAQDL--DSGLP-----FAVKILEKNRIIHLKITDQIKREIATLKL 70
LG+ LGEG FG+V A+ L D P AVK+L K+ ++D + E+ +K+
Sbjct: 19 LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKM 76
Query: 71 L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRL---------QEAEGRKLF 120
+ KH N++ L +Y+++EY + G L + + ++ + + + F
Sbjct: 77 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTF 136
Query: 121 QQLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD---- 169
+ L+ G+ Y ++ HRDL N+L+ +KI+DFGL+ RD
Sbjct: 137 KDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------RDVNNI 190
Query: 170 DGLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
D TT G ++APE L +R Y SD+WS GV+++ I T
Sbjct: 191 DYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 4e-14
Identities = 78/267 (29%), Positives = 118/267 (44%), Gaps = 31/267 (11%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVRLH 80
+GEGNFG+V A+ GL I E+ L KL HPN++ L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 81 EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF----------QQLID----- 125
+ +Y+ +EY G L D + K R+ E + QQL+
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 126 --GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PN 181
G+ Y K HRDL NIL+ KI+DFGLS + + + T G
Sbjct: 134 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-----VKKTMGRLPVR 188
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWL 240
++A E L Y SD+WS GV+L+ I++ G P+ A LY+K+ +G ++L K L
Sbjct: 189 WMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKPL 246
Query: 241 SPGAQ--NLLRKILEPNPVKRITIAGI 265
+ + +L+R+ P +R + A I
Sbjct: 247 NCDDEVYDLMRQCWREKPYERPSFAQI 273
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 64/219 (29%), Positives = 96/219 (43%), Gaps = 31/219 (14%)
Query: 18 LGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
L R LGEG FGKV A+ + AVK L+ L +RE L L+
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQ 65
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELF----------------DKIASKGRLQEAEG 116
H ++V+ + V + MV EY+ G+L +KG L ++
Sbjct: 66 HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRDDGLL 173
+ Q+ G+ Y ++ HRDL N L+ + +KI DFG+S ++R G
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG-- 183
Query: 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
HT ++ PE + R + SD+WS GVIL+ I T
Sbjct: 184 HTML-PIRWMPPESIMYRKFT-TESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 6e-14
Identities = 75/267 (28%), Positives = 127/267 (47%), Gaps = 33/267 (12%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LG+G FG+V + + A+K L+ ++ + +E +K L+H +V L+
Sbjct: 14 LGQGCFGEV-WMGTWNGTTKVAIKTLKPGTMM----PEAFLQEAQIMKKLRHDKLVPLYA 68
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR--KLFQ------QLIDGVSYCHNK 133
V+ S+ IY+V E++ G L D L+E +G+ KL Q Q+ DG++Y
Sbjct: 69 VV-SEEPIYIVTEFMGKGSLLD------FLKEGDGKYLKLPQLVDMAAQIADGMAYIERM 121
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLAN 190
HRDL+ NIL+ KI+DFGL+ L + D G+ + APE A
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLARLIE----DNEYTARQGAKFPIKWTAPEA-AL 176
Query: 191 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLL 248
G SD+WS G++L ++T G +P+ + +++ RG P+ L+
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELM 236
Query: 249 RKILEPNPVKRITIAGIKADEWFEQDY 275
+ + +P +R T I++ F +DY
Sbjct: 237 KLCWKKDPDERPTFEYIQS---FLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 9e-14
Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
L RY+ + +G G G V A D +G A+K L + + H K + RE+ +KL
Sbjct: 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAK---RAYRELVLMKL 71
Query: 71 LKHPNVVRLHEV------LASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQ 122
+ H N++ L V L +Y+V+E + ++ R+ L Q
Sbjct: 72 VNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQ 126
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN- 181
++ G+ + H+ G+ HRDLK NI++ S +KI DFGL+ R G + +P
Sbjct: 127 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAG--TSFMMTPYV 178
Query: 182 ----YVAPEVLANRGYDGATSDIWSCGVIL 207
Y APEV+ GY DIWS G I+
Sbjct: 179 VTRYYRAPEVILGMGYK-ENVDIWSVGCIM 207
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 9e-14
Identities = 44/147 (29%), Positives = 78/147 (53%), Gaps = 5/147 (3%)
Query: 64 EIATLKLLKHPNVVRLHEVLASKSKIYMVL-EYVTGGELFDKIASKGR-LQEAEGRKLFQ 121
E L+ L HP V+ L +V +VL +Y + +L+ + ++ R L A+ + +
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS--DLYTYLGARLRPLGLAQVTAVAR 267
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
QL+ + Y H +G+ HRD+K EN+L++ +I + DFG + + + G+ +
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILY 208
APEVLA Y + DIWS G++++
Sbjct: 328 TNAPEVLAGDPYT-PSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 40/152 (26%), Positives = 76/152 (50%), Gaps = 5/152 (3%)
Query: 64 EIATLKLLKHPNVVRLHEVLASKSKIYMVL-EYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
E L+ + HP++++L ++L Y T +L+ +A+K + + + +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT--DLYCYLAAKRNIAICDILAIERS 190
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
++ + Y H + HRD+K ENI ++ G++ + DFG + P + + G+
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK-YYGWAGTIAT 249
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGY 214
APE+LA Y G DIWS G++L+ + T +
Sbjct: 250 NAPELLARDPY-GPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 1e-13
Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 24/214 (11%)
Query: 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK---REIATLKLLKHP 74
L R LGEG FGKV F + + P KIL + + + K RE L L+H
Sbjct: 9 LKRELGEGAFGKV-FLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHE 67
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-------------RLQEAEGRKLFQ 121
++V+ + V + MV EY+ G+L + + G L +++ + Q
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRDDGLLHTTCG 178
Q+ G+ Y ++ HRDL N L+ +KI DFG+S ++R G HT
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG--HTML- 184
Query: 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
++ PE + R + SD+WS GV+L+ I T
Sbjct: 185 PIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 75/272 (27%), Positives = 117/272 (43%), Gaps = 34/272 (12%)
Query: 22 LGEGNFGKVKFAQ------DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
LGEG FGKV A+ + D L AVK L++ +RE L +L+H +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKML-VAVKALKE---ASESARQDFQREAELLTVLQHQH 68
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR----LQEAEGRKLFQ---------- 121
+VR + V + MV EY+ G+L + S G L E Q
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 122 -QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRDDGLLHTTC 177
Q+ G+ Y + HRDL N L+ +KI DFG+S ++R G T
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG---RTM 185
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFK 235
++ PE + R + SDIWS GV+L+ I T G P+ + + I +G + +
Sbjct: 186 LPIRWMPPESILYRKFT-TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELE 244
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267
P+ P +++ + P +R+ I I +
Sbjct: 245 RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 15/209 (7%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-KITDQIKREI-ATLKLLKHPNVVRL 79
+G G FG V SG AVK + R K ++ ++ ++ P +V+
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVK---RIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKF 68
Query: 80 HEVLASKSKIYMVLEYV-TGGELFDKIA---SKGRLQEAEGRKLFQQLIDGVSYCHNK-G 134
+ L + ++ +E + + F K K + E K+ + ++Y +
Sbjct: 69 YGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK 128
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
+ HRD+K NILLD GNIK+ DFG+S D G Y+APE + D
Sbjct: 129 IIHRDVKPSNILLDRNGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPERIDPSARD 185
Query: 195 G--ATSDIWSCGVILYVILTGYLPFDDRN 221
G SD+WS G+ LY + TG P+ N
Sbjct: 186 GYDVRSDVWSLGITLYEVATGKFPYPKWN 214
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-13
Identities = 58/194 (29%), Positives = 95/194 (48%), Gaps = 14/194 (7%)
Query: 22 LGEGNFGKVK--FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
LG GNFG VK + + A+K+L+ + D++ RE + L +P +VR+
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
V +++ + +V+E +GG L ++ K + + +L Q+ G+ Y K HR
Sbjct: 61 IGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR 119
Query: 139 DLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYD 194
DL N+LL ++ KISDFGLS AL DD + APE + R +
Sbjct: 120 DLAARNVLLVNQHYAKISDFGLSKALGA---DDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 195 GATSDIWSCGVILY 208
+ SD+WS G+ ++
Sbjct: 177 -SRSDVWSYGITMW 189
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 3e-13
Identities = 77/259 (29%), Positives = 123/259 (47%), Gaps = 28/259 (10%)
Query: 20 RTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
R +G+G+FG V +DS + AVK L NRI L+ +Q +E +K HPNV
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSL--NRITDLEEVEQFLKEGIIMKDFSHPNV 58
Query: 77 VRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCHN 132
+ L + L S+ +VL Y+ G+L + I S+ +++ G L Q+ G+ Y +
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL--QVAKGMEYLAS 116
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-------DGLLHTTCGSP-NYVA 184
K HRDL N +LD +K++DFGL+ RD HT P ++A
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLA------RDIYDKEYYSVHNHTGAKLPVKWMA 170
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL-PKWLSP 242
E L + + SD+WS GV+L+ ++T G P+ D + + + +G L P++
Sbjct: 171 LESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPD 229
Query: 243 GAQNLLRKILEPNPVKRIT 261
++ P P R T
Sbjct: 230 PLYEVMLSCWHPKPEMRPT 248
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 5e-13
Identities = 59/236 (25%), Positives = 88/236 (37%), Gaps = 50/236 (21%)
Query: 14 GRYELGRTLGEGNFGKVKFA-----QDLDSGLP-----------FAVKILEKNRIIHLKI 57
LGEG FG+V QD AVK+L + + +
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE 64
Query: 58 TDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL---------FDKIASK 108
D +K E+ L L PN+ RL V + M++EY+ G+L +
Sbjct: 65 -DFLK-EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC 122
Query: 109 GRLQEAEGRKLFQ--QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---L 163
+ L+ Q+ G+ Y + HRDL N L+ IKI+DFG+S
Sbjct: 123 NSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182
Query: 164 PQHFRDDGLLHTTCGSPNYVAP-------EVLANRGYDGATSDIWSCGVILYVILT 212
++R G P VL + + SD+W+ GV L+ ILT
Sbjct: 183 SDYYRVQG---------RAPLPIRWMAWESVLLGK-FTTK-SDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 62/234 (26%), Positives = 93/234 (39%), Gaps = 47/234 (20%)
Query: 17 ELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKIL-----EKNRIIHLKITDQIKREIA 66
L R LG G FG+V L AVK L E++ L E
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLM-------EAL 61
Query: 67 TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR--------- 117
+ H N+VRL V + +++LE + GG+L K L+E R
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDL------KSFLRENRPRPERPSSLTM 115
Query: 118 ----KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSA---LPQHF 167
+ + G Y HRD+ N LL KG KI+DFG++ ++
Sbjct: 116 KDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYY 175
Query: 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDR 220
R G ++ PE + G + +D+WS GV+L+ I + GY+P+ R
Sbjct: 176 RKGG---RAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGR 225
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 69/269 (25%), Positives = 120/269 (44%), Gaps = 24/269 (8%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI----ATLKLLKHPN 75
LG G +G V + + +G AVK + + +Q KR + +++ + P
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRAT----VNSQEQ-KRLLMDLDISMRSVDCPY 61
Query: 76 VVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHN 132
V + L + +++ +E + + + K+ KG + E K+ ++ + Y H+
Sbjct: 62 TVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121
Query: 133 K-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE----V 187
K V HRD+K N+L++ G +K+ DFG+S + D G Y+APE
Sbjct: 122 KLSVIHRDVKPSNVLINRNGQVKLCDFGISG---YLVDSVAKTIDAGCKPYMAPERINPE 178
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRGDFKLPK-WLSPGA 244
L +GYD SD+WS G+ + + TG P+D L Q + +LP SP
Sbjct: 179 LNQKGYD-VKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEF 237
Query: 245 QNLLRKILEPNPVKRITIAGIKADEWFEQ 273
Q+ + K L+ N +R + +FE
Sbjct: 238 QDFVNKCLKKNYKERPNYPELLQHPFFEL 266
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 65/238 (27%), Positives = 102/238 (42%), Gaps = 47/238 (19%)
Query: 15 RYELGRTLGEGNFGKV--KFAQDLDSGLPF---AVKILEKNRIIHLKITDQIKREIATLK 69
Y R +G+G FG+V A L PF AVK+L++ ++ Q RE A +
Sbjct: 8 EYV--RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ--REAALMA 63
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS---------------------- 107
HPN+V+L V A + ++ EY+ G+L + +
Sbjct: 64 EFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123
Query: 108 KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167
L E + +Q+ G++Y + HRDL N L+ +KI+DFGLS
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS------ 177
Query: 168 RDDGLLHTTCGSPN------YVAPE-VLANRGYDGATSDIWSCGVILYVILT-GYLPF 217
R+ S N ++ PE + NR Y SD+W+ GV+L+ I + G P+
Sbjct: 178 RNIYSADYYKASENDAIPIRWMPPESIFYNR-YT-TESDVWAYGVVLWEIFSYGMQPY 233
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 74/284 (26%), Positives = 123/284 (43%), Gaps = 30/284 (10%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
L RY+ + +G G G V A D A+K L + H K + RE+ +K
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 72
Query: 71 LKHPNVVRLHEVLASK------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
+ H N++ L V + +Y+V+E + L I + L L Q++
Sbjct: 73 VNHKNIISLLNVFTPQKSLEEFQDVYLVME-LMDANLCQVIQME--LDHERMSYLLYQML 129
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
G+ + H+ G+ HRDLK NI++ S +KI DFGL+ R G ++ +
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRY 183
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-DFKLPKWL 240
Y APEV+ GY DIWS G I+ ++ + F R+ + K+ P+++
Sbjct: 184 YRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDE 284
Q +R +E P AG+ + F PA+ + ++
Sbjct: 243 KK-LQPTVRNYVENRP----KYAGLTFPKLFPDSLFPADSEHNK 281
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 19/217 (8%)
Query: 17 ELGRTLGEGNFGK--VKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
EL +G+ V A+ + AVK + + + +++EI T + L+HP
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLK-LLQQEIITSRQLQHP 59
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHN 132
N++ S++Y+V + G D + + L E + + +++ + Y H+
Sbjct: 60 NILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS 119
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--------NYVA 184
KG HR +K +ILL G + +S GL G +++
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLS--GLRYS-VSMIKHGKRQRVVHDFPKSSVKNLPWLS 176
Query: 185 PEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDD 219
PEVL +GY+ SDI+S G+ + G++PF D
Sbjct: 177 PEVLQQNLQGYN-EKSDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 20 RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+ LG G FG V + G +P A+K+L +N K +I E + + P
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN--TSPKANKEILDEAYVMAGVGSPY 70
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
V RL + + S + +V + + G L D + +K R+ + Q+ G+SY
Sbjct: 71 VCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR 129
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
+ HRDL N+L+ S ++KI+DFGL+ L D+ H G ++A E + +R
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLD--IDETEYHADGGKVPIKWMALESILHRR 187
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFD 218
+ SD+WS GV ++ ++T G P+D
Sbjct: 188 FT-HQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 62/225 (27%), Positives = 100/225 (44%), Gaps = 18/225 (8%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
L RY+ + +G G G V A D A+K L + H K + RE+ +K
Sbjct: 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 79
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK---LFQQLIDGV 127
+ H N++ L V + + + EL D + E + + L Q++ G+
Sbjct: 80 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPNYVA 184
+ H+ G+ HRDLK NI++ S +KI DFGL+ R G ++ + Y A
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI 229
PEV+ GY DIWS G I+ ++ G + F + + K+
Sbjct: 194 PEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 7e-12
Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 39/225 (17%)
Query: 22 LGEGNFGKVKFAQDLDSGLP------FAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
LGE FGKV + L P A+K L+ + ++ K E L+HPN
Sbjct: 13 LGEDRFGKV-YKGHLFGTAPGEQTQAVAIKTLKDK--AEGPLREEFKHEAMMRSRLQHPN 69
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELF----------------DKIASKGRLQEAEGRKL 119
+V L V+ + + M+ Y + +L D K L+ A+ +
Sbjct: 70 IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129
Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD------DGLL 173
Q+ G+ + + V H+DL N+L+ K N+KISD GL FR+ L+
Sbjct: 130 VTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGL------FREVYAADYYKLM 183
Query: 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 217
+ +++PE + G SDIWS GV+L+ + + G P+
Sbjct: 184 GNSLLPIRWMSPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 7e-12
Identities = 65/237 (27%), Positives = 111/237 (46%), Gaps = 34/237 (14%)
Query: 18 LGRTLGEGNFGKV-KFAQDLDSG--LPFAVKILEKNRIIHLKITDQIKR----EIATLKL 70
+ R LG G FG++ + L S LP A+ L +D+ +R E TL
Sbjct: 9 IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG------CSDKQRRGFLAEALTLGQ 62
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID----- 125
H N+VRL V+ + + +V EY++ G L L++ EG+ + QL+
Sbjct: 63 FDHSNIVRLEGVITRGNTMMIVTEYMSNGAL------DSFLRKHEGQLVAGQLMGMLPGL 116
Query: 126 --GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG-SPN- 181
G+ Y G H+ L +L++S KIS F L + + + + T G SP
Sbjct: 117 ASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQED-KSEAIYTTMSGKSPVL 173
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 237
+ APE + + A SD+WS G++++ +++ G P+ D + + + + G F+LP
Sbjct: 174 WAAPEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG-FRLP 228
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 15 RYELGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
R L L EG FG++ + + VK + K+ +++T ++ E L
Sbjct: 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTV-KDHASEIQVTLLLQ-ESCLLYG 64
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG------RKLFQ--- 121
L H N++ + V + VL + RL EA ++L
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI 124
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
Q+ G+SY H +GV H+D+ N ++D + +KI+D LS RD + C N
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALS------RDLFPMDYHCLGDN 178
Query: 182 ------YVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD 219
++A E L N+ Y A SD+WS GV+L+ ++T G P+ +
Sbjct: 179 ENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVE 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 75/284 (26%), Positives = 127/284 (44%), Gaps = 32/284 (11%)
Query: 20 RTLGEGNFGKV--KFAQDLDSGLP---FAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
R LG+G+FG V A+D+ G AVK + ++ + +I + E + +K
Sbjct: 12 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFTCH 69
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGR---------KLFQQLI 124
+VVRL V++ +V+E + G+L + S + + GR ++ ++
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRD--DGLLHTTCGS 179
DG++Y + K HRDL N ++ +KI DFG++ ++R GLL
Sbjct: 130 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV---- 185
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD-RNLAVLYQKIFRGDFKLP 237
++APE L + G +SD+WS GV+L+ I + P+ N VL + G P
Sbjct: 186 -RWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP 243
Query: 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPD 281
+L+R + NP R T I + D P+ P+
Sbjct: 244 DNCPERVTDLMRMCWQFNPKMRPTFLEIV--NLLKDDLHPSFPE 285
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 66/223 (29%), Positives = 109/223 (48%), Gaps = 20/223 (8%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LG+G FG+V + + A+K L+ + + +E +K L+H +V+L+
Sbjct: 14 LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 68
Query: 82 VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
V+ S+ IY+V EY++ G L D K L+ + + Q+ G++Y HRD
Sbjct: 69 VV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
L+ NIL+ K++DFGL+ L + D G+ + APE A G
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIE----DNEYTARQGAKFPIKWTAPEA-ALYGRFTI 182
Query: 197 TSDIWSCGVILYVILT-GYLPFDDR-NLAVLYQKIFRGDFKLP 237
SD+WS G++L + T G +P+ N VL Q + RG +++P
Sbjct: 183 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERG-YRMP 223
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 20 RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+ LG G FG V + G +P A+K L + K +I E + + +P+
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE--ATSPKANKEILDEAYVMASVDNPH 70
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
V RL + + S + ++ + + G L D + K + Q+ G++Y +
Sbjct: 71 VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR 129
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
+ HRDL N+L+ + ++KI+DFGL+ L D+ H G ++A E + +R
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--ADEKEYHAEGGKVPIKWMALESILHRI 187
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFD 218
Y SD+WS GV ++ ++T G P+D
Sbjct: 188 YT-HQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 8e-11
Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 20 RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+ LG G FG V + G +P A+KIL N K + E + + HP+
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKIL--NETTGPKANVEFMDEALIMASMDHPH 70
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ----QLIDGVSYCH 131
+VRL V S + I +V + + G L D + ++ G +L Q+ G+ Y
Sbjct: 71 LVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLE 126
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSAL-----PQHFRDDGLLHTTCGSPNYVAPE 186
+ + HRDL N+L+ S ++KI+DFGL+ L ++ D G + ++A E
Sbjct: 127 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI-----KWMALE 181
Query: 187 VLANRGYDGATSDIWSCGVILYVILT-GYLPFD 218
+ R + SD+WS GV ++ ++T G P+D
Sbjct: 182 CIHYRKFT-HQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 63/266 (23%), Positives = 116/266 (43%), Gaps = 36/266 (13%)
Query: 22 LGEGNFGKVK----FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
LGE FGK+ + +D A+K L+ I + + + ++E + + L HPN+V
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKD--INNPQQWGEFQQEASLMAELHHPNIV 70
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKI-----------------ASKGRLQEAEGRKLF 120
L V+ + + M+ EY+ G+L + + K L + +
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRDDGLLHTTC 177
Q+ G+ Y + H+DL NIL+ + ++KISD GLS ++R + +
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYR---VQPKSL 187
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVI----LTGYLPFDDRNLAVLYQKIFRGD 233
++ PE + + + SDIWS GV+L+ I L Y F ++ + + +K R
Sbjct: 188 LPIRWMPPEAIMYGKFS-SDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK--RQL 244
Query: 234 FKLPKWLSPGAQNLLRKILEPNPVKR 259
+ P +L+ + + P +R
Sbjct: 245 LPCSEDCPPRMYSLMTECWQEGPSRR 270
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 48/173 (27%), Positives = 72/173 (41%), Gaps = 28/173 (16%)
Query: 15 RYELGRTLGEGNFGKVKF------AQDLDSGLP--------FAVKILEKNRIIHLKITDQ 60
+ L LGEG FG+V A+ L G P AVK+L + + +
Sbjct: 6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD--VTKTARND 63
Query: 61 IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG---------ELFDKIASKGRL 111
+EI + LK+PN++RL V S + M+ EY+ G E+ +
Sbjct: 64 FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123
Query: 112 QEAEGRKLFQ---QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS 161
L Q+ G+ Y + HRDL N L+ + IKI+DFG+S
Sbjct: 124 PSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 4e-10
Identities = 57/236 (24%), Positives = 103/236 (43%), Gaps = 26/236 (11%)
Query: 22 LGEGNFGKVKFAQ-DLDSGLPFA-VKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+G G FGKV ++ D+G+ VK L+ N K ++ ++ ++L+HPN+++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKAN--ASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
+V EY G+L ++ + Q +++ ++ GV++ H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNF 120
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL--HTTCGSPNYVAPEVLANRGY 193
H DL L N L S +K+ D+G+ P +++D + C ++APE++ +
Sbjct: 121 LHSDLALRNCFLTSDLTVKVGDYGIG--PSRYKEDYIETEDDKCVPLRWLAPELVGEF-H 177
Query: 194 DGAT-------SDIWSCGVILYVILTG----YLPFDDRNLAVLYQKIFRGDFKLPK 238
G S++W+ GV L+ + Y DR VL I KL K
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE--VLNHVIKDQQVKLFK 231
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 6e-10
Identities = 64/231 (27%), Positives = 96/231 (41%), Gaps = 56/231 (24%)
Query: 22 LGEGNFGKV---------KFAQD-------LDSGLPFAVKILEKNRIIHLKITDQIKREI 65
LGEG FG+V KF + + AVK+L ++ + + D +K EI
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNAR-NDFLK-EI 70
Query: 66 ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG--------- 116
+ LK PN++RL V + + M+ EY+ G+L ++ S+ QEA
Sbjct: 71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL-NQFLSRHEPQEAAEKADVVTISY 129
Query: 117 ---RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRDD 170
+ Q+ G+ Y + HRDL N L+ IKI+DFG+S ++R
Sbjct: 130 STLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 171 GLLHTTCGSPNYVAPEVLANR---------GYDGATSDIWSCGVILYVILT 212
G VL R G SD+W+ GV L+ ILT
Sbjct: 190 G-------------RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 7e-10
Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 23/217 (10%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLKHP 74
E+GR G N V A+ +G V+I LE HLK ++ E+ +HP
Sbjct: 5 EIGR--GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKA---LQNEVVLSHFFRHP 59
Query: 75 NVVRLHEVLASKSKIYMV---LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
N++ V + S ++++ + Y + L +G + EA + + G++Y H
Sbjct: 60 NIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLH 118
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY-------VA 184
G HR++K +IL+ G + +S GLS L R+ P + ++
Sbjct: 119 QNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLS 176
Query: 185 PEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDD 219
PE+L GY+ SDI+S G+ + TG +PF D
Sbjct: 177 PELLRQDLYGYN-VKSDIYSVGITACELATGRVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 65/229 (28%), Positives = 98/229 (42%), Gaps = 46/229 (20%)
Query: 22 LGEGNFGKVKFA-----QDLDS-GLPF----------AVKILEKNRIIHLKITDQIKREI 65
LGEG FG+V QDL + PF AVKIL + + + D +K E+
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNAR-NDFLK-EV 70
Query: 66 ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR-------- 117
L LK PN++RL V + + M+ EY+ G+L ++ S L + E
Sbjct: 71 KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL-NQFLSSHHLDDKEENGNDAVPPA 129
Query: 118 ------------KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA--- 162
+ Q+ G+ Y + HRDL N L+ IKI+DFG+S
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 211
++R G ++A E + + A SD+W+ GV L+ IL
Sbjct: 190 AGDYYRIQG---RAVLPIRWMAWECILMGKFTTA-SDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 19 GRTLGEGNFGKVK---FAQDLDS-GLPFAVKILE--KNRIIHLKITDQIKREIATLKLLK 72
+ LG G FG V + + DS +P A+K ++ R +ITD + + L
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHM----LAMGSLD 67
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCH 131
H +VRL + S + +V + G L D + + L Q+ G+ Y
Sbjct: 68 HAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE 126
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSP-NYVAPEVL 188
+ HR+L NILL S ++I+DFG++ L P D ++ +P ++A E +
Sbjct: 127 EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD---DKKYFYSEHKTPIKWMALESI 183
Query: 189 ANRGYDGATSDIWSCGVILYVILT 212
Y SD+WS GV ++ +++
Sbjct: 184 LFGRYT-HQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 45/167 (26%), Positives = 76/167 (45%), Gaps = 14/167 (8%)
Query: 64 EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQ 121
E+ KL HPN+V + +++++V ++ G D I + + E + Q
Sbjct: 49 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQ 108
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
++ + Y H+ G HR +K +IL+ G + +S GL + L P
Sbjct: 109 GVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPK 166
Query: 182 Y-------VAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDD 219
Y ++PEVL +GYD A SDI+S G+ + G++PF D
Sbjct: 167 YSVKVLPWLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 37/119 (31%), Positives = 56/119 (47%), Gaps = 14/119 (11%)
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP 237
G+P+Y+APE+L + + A D W+ GV L+ LTG PF+D ++Q I D P
Sbjct: 542 GTPDYLAPELLLGKPHGPAV-DWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
Query: 238 ---KWLSPGAQNLLRKILEPNPVKRITIAGIKAD------EWFEQDYTP----ANPDDD 283
+ LS AQN + +L +P KR + +K +W PDD+
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLFHGVDWENLQNQTMPFIPQPDDE 659
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 77/303 (25%), Positives = 125/303 (41%), Gaps = 51/303 (16%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
Y+LG +G G+FG V A +D+ A+K + L+ RE+ +K L H N
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV-------LQDPQYKNRELLIMKNLNHIN 120
Query: 76 VVRLHEVLASKS------KIYM--VLEYV--TGGELFDKIASKGRLQEAEGRKLFQ-QLI 124
++ L + ++ I++ V+E++ T + A KL+ QL
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLC 180
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGN-IKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
++Y H+K + HRDLK +N+L+D + +K+ DFG + + C S Y
Sbjct: 181 RALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG--SAKNLLAGQRSVSYIC-SRFYR 237
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD--------RNLAVL---------- 225
APE++ D+WS G I+ ++ GY F R + VL
Sbjct: 238 APELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKE 297
Query: 226 ----YQKIFRGDFK-------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274
Y I D K PK A N + + L+ P+KR+ AD +F+
Sbjct: 298 MNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357
Query: 275 YTP 277
P
Sbjct: 358 RDP 360
|
Length = 440 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 56/215 (26%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 18 LGRTLGEGNFGKV--KFAQDLDSGLP---FAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ R LG+G+FG V A+ + P A+K + + + +I + E + +K
Sbjct: 10 MSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMKEFN 67
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEG------RKLFQ---Q 122
+VVRL V++ +++E +T G+L + S + ++ +K+ Q +
Sbjct: 68 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRD--DGLLHTTC 177
+ DG++Y + HRDL N ++ +KI DFG++ ++R GLL
Sbjct: 128 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-- 185
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
+++PE L + G SD+WS GV+L+ I T
Sbjct: 186 ---RWMSPESLKD-GVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 65/228 (28%), Positives = 98/228 (42%), Gaps = 36/228 (15%)
Query: 55 LKITDQIKREIA-----TLKLLK---HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI- 105
LK+ D R+IA T L+ H ++ +H V S+ MV E+V G L D
Sbjct: 49 LKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DVCL 107
Query: 106 -ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-------NIKISD 157
KGR+ A + QQL +SY +K + H ++ +NILL G IK+SD
Sbjct: 108 RKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSD 167
Query: 158 FGLS--ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI-LTGY 214
G+S AL + R + + ++APE + +D WS G L I G
Sbjct: 168 PGVSFTALSREERVERI--------PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGE 219
Query: 215 LPFDDRNLAV---LYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259
+P +R + Y+K R LP+ L+ + L P +R
Sbjct: 220 VPLKERTPSEKERFYEKKHR----LPEPSCKELATLISQCLTYEPTQR 263
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 70/279 (25%), Positives = 101/279 (36%), Gaps = 97/279 (34%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILE--------KNRIIHLKITDQI 61
R +LG+ LG G FGKV A S AVK+L+ K + LKI I
Sbjct: 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHI 67
Query: 62 KREIATLKLL-----------------KHPNVVRLHEVLASKSKIYMV--LEYVTGGELF 102
+ + LL K N L L SK + + + E+
Sbjct: 68 GHHLNVVNLLGACTKPGGPLMVIVEYCKFGN---LSNYLRSKRECFSPYRNKSTRKREMK 124
Query: 103 DKIASKGRL------------------------QEAEGRKLFQ-------------QLID 125
K K RL ++ EG +L++ Q+
Sbjct: 125 QKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVAR 184
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV-- 183
G+ + ++ HRDL NILL +KI DFGL+ RD P+YV
Sbjct: 185 GMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA------RD------IYKDPDYVRK 232
Query: 184 ----------APEVLANRGYDGATSDIWSCGVILYVILT 212
APE + ++ Y SD+WS GV+L+ I +
Sbjct: 233 GDARLPLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 54/216 (25%), Positives = 90/216 (41%), Gaps = 36/216 (16%)
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF-- 120
+ + L H ++V+L+ V I MV EYV G L D + + + KL
Sbjct: 50 ETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPL-DVFLHREKNNVSLHWKLDVA 107
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILL----DSKGN---IKISDFG--LSALPQHFRDDG 171
+QL + Y +K + H ++ +NIL+ ++G IK+SD G ++ L + R +
Sbjct: 108 KQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE- 166
Query: 172 LLHTTCGSPNYVAPEVLANRGYDGATSDI----WSCGVILYVILT-GYLPFDDRNLA--- 223
P ++APE + N A+ I WS G L I + G P + +
Sbjct: 167 ------RIP-WIAPECIRN---GQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE 216
Query: 224 VLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259
YQ + +P NL+ + +P KR
Sbjct: 217 RFYQD--QHRLPMPDC--AELANLINQCWTYDPTKR 248
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 5e-07
Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 33/228 (14%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
R+++ LGEG FGKV A D AVKI+ K T K EI ++ ++
Sbjct: 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQ 184
Query: 74 PNV------VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
+ +++ +++ ++ G L D I G ++ Q +
Sbjct: 185 ADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVAL 244
Query: 128 SYCHNK-GVFHRDLKLENILLDSKGN----------------IKISDFGLSALPQHFRDD 170
Y H + + H DLK ENIL+++ ++I D G +H R
Sbjct: 245 DYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRT- 303
Query: 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 218
+ +Y +PEV+ G+ +T D+WS G I+Y + TG L +D
Sbjct: 304 ----AIVSTRHYRSPEVVLGLGWMYST-DMWSMGCIIYELYTGKLLYD 346
|
Length = 467 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 35/102 (34%), Positives = 52/102 (50%), Gaps = 12/102 (11%)
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS----ALPQHFRD-DGLLHTT 176
Q+ G+ + ++ HRDL NILL +KI DFGL+ P + R D L
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL- 245
Query: 177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 217
++APE + +R Y SD+WS GV+L+ I + G P+
Sbjct: 246 ----KWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 28/159 (17%)
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
Q+ G+S+ +K HRDL NILL KI DFGL+ + R+D N
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLA---RDIRNDS---------N 269
Query: 182 YV------------APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQK 228
YV APE + N Y SD+WS G++L+ I + G P+ + + K
Sbjct: 270 YVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYK 328
Query: 229 IFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
+ + +++ P+ ++++ + +P+KR T I
Sbjct: 329 MIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQI 367
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 37/115 (32%), Positives = 58/115 (50%), Gaps = 7/115 (6%)
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH--TTCGS 179
Q+ +G+ + +K HRDL N+L+ +KI DFGL+ RD + +T
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLAR--DIMRDSNYISKGSTFLP 304
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNL-AVLYQKIFRG 232
++APE + N Y SD+WS G++L+ I T G P+ + + Y I RG
Sbjct: 305 LKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRG 358
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 58/243 (23%), Positives = 107/243 (44%), Gaps = 35/243 (14%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKHPNVV 77
+ +G G FGKV +++SG A +++ K + + +Q+K E + L+H N++
Sbjct: 1 KEIGNGWFGKV-ILGEVNSGYTPA-QVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLL 58
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLID---GVSYCHN 132
+ + +V+E+ G+L + S K L + L + + G+ + H
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN-------YVAP 185
H DL L N LL + +KI D+GLS +++D + +P+ ++AP
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHN--KYKEDYYV-----TPDQLWVPLRWIAP 171
Query: 186 EVLANRGYD------GATSDIWSCGVILYVILT-GYLPF---DDRNLAVLYQKIFRGDFK 235
E++ + S++WS GV ++ + G P+ D VL + K
Sbjct: 172 ELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--VLTYTVREQQLK 229
Query: 236 LPK 238
LPK
Sbjct: 230 LPK 232
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 35/109 (32%), Positives = 51/109 (46%), Gaps = 26/109 (23%)
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
Q+ G+ + ++ HRDL NILL +KI DFGL+ RD P+
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA------RD------IYKDPD 229
Query: 182 YV------------APEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 217
YV APE + ++ Y SD+WS GV+L+ I + G P+
Sbjct: 230 YVRKGSARLPLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 40/153 (26%), Positives = 66/153 (43%), Gaps = 20/153 (13%)
Query: 99 GELFDKIASKGRLQEAEGRKLFQ-----------------QLIDGVSYCHNKGVFHRDLK 141
+D+ AS ++E + L Q+ G+ + +K HRDL
Sbjct: 205 RSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLA 264
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
N+LL +KI DFGL+ H + +T ++APE + + Y SD+W
Sbjct: 265 ARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYT-TLSDVW 323
Query: 202 SCGVILYVILT-GYLPFDDRNL-AVLYQKIFRG 232
S G++L+ I + G P+ + + Y KI G
Sbjct: 324 SYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSG 356
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 9e-06
Identities = 33/120 (27%), Positives = 53/120 (44%), Gaps = 26/120 (21%)
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR---KLFQQLIDGVSYCHNKGV 135
L +++ SK Y V Y L K+ + E E + + +Q++ + H+ G+
Sbjct: 222 LADLMQSKEFPYNVEPY-----LLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGI 276
Query: 136 FHRDLKLENILLD-SKGNIKISDFGLSA--------LPQHFRDDGLLHTTCGSPNYVAPE 186
HRD+K +NI+ G+ KI D G +A +P+ F D P Y APE
Sbjct: 277 VHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLD---------PRYAAPE 327
|
Length = 566 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 9e-06
Identities = 52/196 (26%), Positives = 88/196 (44%), Gaps = 29/196 (14%)
Query: 48 EKNRIIHLKITDQIKREIA--------TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG 99
EK + LK+ D R+I+ ++ + H ++V L+ V + MV E+V G
Sbjct: 30 EKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFG 89
Query: 100 --ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL-----DSKGN 152
+LF S L K+ +QL +SY +K + H ++ +NILL D +
Sbjct: 90 PLDLFMHRKSD-VLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECG 148
Query: 153 --IKISDFG--LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
IK+SD G ++ L + + + ++APE + + +D WS G L+
Sbjct: 149 PFIKLSDPGIPITVLSRQECVERI--------PWIAPECVEDSKNLSIAADKWSFGTTLW 200
Query: 209 VI-LTGYLPFDDRNLA 223
I G +P D+ LA
Sbjct: 201 EICYNGEIPLKDKTLA 216
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 45/158 (28%), Positives = 71/158 (44%), Gaps = 14/158 (8%)
Query: 64 EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
EIA + L+HPN+V+L + S+ Y++ EY+ G L + + + L RK+ +
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGI 789
Query: 124 IDGVSYCH---NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
+ + H + V +L E I++D K + +LP D S
Sbjct: 790 AKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL----RLSLPGLLCTD---TKCFISS 842
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 218
YVAPE + SDI+ G+IL +LTG P D
Sbjct: 843 AYVAPETRETKDIT-EKSDIYGFGLILIELLTGKSPAD 879
|
Length = 968 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 40/139 (28%), Positives = 59/139 (42%), Gaps = 37/139 (26%)
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
Q+ G+ + +K HRD+ N+LL KI DFGL+ RD N
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLA------RD------IMNDSN 267
Query: 182 YV------------APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV---L 225
YV APE + + Y SD+WS G++L+ I + G P+ + V
Sbjct: 268 YVVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGKSPYP--GILVNSKF 324
Query: 226 YQKIFRG------DFKLPK 238
Y+ + RG DF P+
Sbjct: 325 YKMVKRGYQMSRPDFAPPE 343
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 3e-04
Identities = 17/43 (39%), Positives = 28/43 (65%)
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG 159
+ + +Q++ G+ H G+ HRD+K EN+L+ G +KI DFG
Sbjct: 312 KGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 44/241 (18%), Positives = 89/241 (36%), Gaps = 29/241 (12%)
Query: 41 PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH----EVLASKSKIYMVLEYV 96
++ +K H + D + EI L+ + N+++++ +++ ++ ++LEY
Sbjct: 45 EVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104
Query: 97 TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKI 155
T G L + + + L + G+ + +++L + L+ +KI
Sbjct: 105 TRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKI 164
Query: 156 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT---------SDIWSCGVI 206
GL SP + + Y DI+S GV+
Sbjct: 165 ICHGL-------------EKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVV 211
Query: 207 LYVILTGYLPFDDRNLAVLYQKIFR--GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAG 264
L+ I TG +PF++ +Y I KLP + ++ + +KR I
Sbjct: 212 LWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKE 271
Query: 265 I 265
I
Sbjct: 272 I 272
|
Length = 283 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 7e-04
Identities = 53/217 (24%), Positives = 91/217 (41%), Gaps = 41/217 (18%)
Query: 21 TLGEGNFGKVKFAQDLDSG-------LPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+LG+G F K+ + G +K+L+K+ H ++ + + L H
Sbjct: 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSH 58
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGEL-------FDKIASKGRLQEAEGRKLFQQLIDG 126
++V + V + MV EYV G L + I +L+ A +QL
Sbjct: 59 KHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVA------KQLAWA 112
Query: 127 VSYCHNKGVFHRDLKLENILL-----DSKGN---IKISDFGLS--ALPQHFRDDGLLHTT 176
+ + +KG+ H ++ +N+LL GN IK+SD G+S LP+ + +
Sbjct: 113 LHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERI---- 168
Query: 177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 213
+V PE + N +D WS G L+ I +G
Sbjct: 169 ----PWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 8e-04
Identities = 28/132 (21%), Positives = 52/132 (39%), Gaps = 17/132 (12%)
Query: 37 DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVV-RLHEVLASKSKIYMVLE 94
+ +KI +RE+A L+LL + V ++ S Y+++E
Sbjct: 19 TKDEDYVLKINPSREKGA-----DREREVAILQLLARKGLPVPKVLASGESDGWSYLLME 73
Query: 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN---KGVFHRDLKLENILLDSKG 151
++ G L + E E + +QL + ++ H + H DL NIL+D
Sbjct: 74 WIEGETL-------DEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK 126
Query: 152 NIKISDFGLSAL 163
+ I D+ +
Sbjct: 127 ILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 0.003
Identities = 29/87 (33%), Positives = 43/87 (49%), Gaps = 7/87 (8%)
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
NV ++ V I V+EY+ G L D I S G + R++ + V H+ G
Sbjct: 62 NVPAVYFVDPENFII--VMEYIEGEPLKDLINSNGMEELELSREIGRL----VGKLHSAG 115
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLS 161
+ H DL N++L S G I + DFGL+
Sbjct: 116 IIHGDLTTSNMIL-SGGKIYLIDFGLA 141
|
Length = 211 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.004
Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 14/101 (13%)
Query: 17 ELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
+ G+TLG G FGKV A D+ L AVK+L+ + H TD+ + ++ LK+L
Sbjct: 41 QFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKAS--AH---TDEREALMSELKIL 95
Query: 72 ----KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK 108
+H N+V L + ++ EY G+L + + K
Sbjct: 96 SHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKK 136
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 426 | |||
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.88 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.85 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.84 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.81 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.79 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.77 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.74 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.74 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.72 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.6 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.58 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.58 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.55 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.54 | |
| PF03822 | 63 | NAF: NAF domain; InterPro: IPR004041 The NAF domai | 99.52 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.48 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.48 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.41 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.34 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.27 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.26 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.15 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.12 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.07 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.06 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.05 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.03 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.89 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.75 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.69 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.67 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.62 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.57 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.51 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.44 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.38 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.35 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.31 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.26 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.15 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.14 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.11 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.11 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.09 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.94 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.89 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.88 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.88 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.87 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.83 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.78 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.76 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.74 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.59 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.53 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.46 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.43 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.28 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.21 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.17 | |
| PLN02236 | 344 | choline kinase | 97.02 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.85 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.79 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.48 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.38 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.29 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.2 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.18 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.09 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.57 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.23 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.18 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.58 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.46 |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-64 Score=499.11 Aligned_cols=265 Identities=54% Similarity=1.008 Sum_probs=248.6
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccc--hhHHHHHHHHHHHHHhCC-CCCccceEEEEEeC
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH--LKITDQIKREIATLKLLK-HPNVVRLHEVLASK 86 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~ 86 (426)
....|+|.+++.||+|+||+|++|.+..+|+.||+|++++..... ....+.+.+|+.++++++ ||||+++++++.+.
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 467899999999999999999999999999999999888763321 134677889999999999 99999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCC-CCeEEeeccCccCCc
Q 014347 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQ 165 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~-g~vkL~DFGla~~~~ 165 (426)
+.+|+|||||.||+|+++|.+.++++|.+++++|+||++||+|||++||+||||||||||++.+ +++||+|||++....
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 9999999999999999999999999999999999999999999999999999999999999999 999999999999754
Q ss_pred cccCCCccccccCCCcccchhhhccCC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCC-CHH
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL-SPG 243 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~-s~~ 243 (426)
..+..+.+.||||.|+|||++.+.+ |.+.++|||||||+||.|++|+.||++.+...++.+|.++.+.+|.|+ |++
T Consensus 173 --~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~ 250 (370)
T KOG0583|consen 173 --GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPE 250 (370)
T ss_pred --CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHH
Confidence 3567889999999999999999988 999999999999999999999999999999999999999999999999 999
Q ss_pred HHHHHHHccccCccCCCCHHHHhcCccccc-cCC
Q 014347 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQ-DYT 276 (426)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~eil~h~~f~~-~~~ 276 (426)
+++|+++||.+||.+|+|+.+|+.||||+. +..
T Consensus 251 ~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~~~~ 284 (370)
T KOG0583|consen 251 ARSLIEKMLVPDPSTRITLLEILEHPWFQKENPL 284 (370)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhhChhhccCCCC
Confidence 999999999999999999999999999998 443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-63 Score=500.65 Aligned_cols=264 Identities=48% Similarity=0.843 Sum_probs=250.6
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (426)
..-.+|-|++++.||.|+-|.|.+|++..||+.+|||++.+...........+.+||-+|+.+.||||+++|+++++..+
T Consensus 7 ~~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ 86 (786)
T KOG0588|consen 7 HKNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQH 86 (786)
T ss_pred ccccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCce
Confidence 45578999999999999999999999999999999999987744444446789999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
+|+|+||++||+||+++.+.|++++.++.++|+||+.|+.|||..+|+||||||||+|||..+++||+|||+|.+- .
T Consensus 87 lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe---~ 163 (786)
T KOG0588|consen 87 LYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE---V 163 (786)
T ss_pred EEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc---c
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999863 3
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 248 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li 248 (426)
.+..+.+.||+|.|.|||++.+.+|+|.++||||||||||.||+|++||++.|...++.++.+|.+.+|..+|+++++||
T Consensus 164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLL 243 (786)
T KOG0588|consen 164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLL 243 (786)
T ss_pred CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHH
Confidence 56789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHccccCccCCCCHHHHhcCccccccC
Q 014347 249 RKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 249 ~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
++||+.||.+|+|.++|++|||+....
T Consensus 244 r~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 244 RRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred HHHhccCccccccHHHHhhCchhhcCC
Confidence 999999999999999999999997643
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-63 Score=492.60 Aligned_cols=263 Identities=37% Similarity=0.704 Sum_probs=251.9
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
.+|..++.||+|+|+.||.+++..+|+.||+|++.+.........+++.+||+|++.|+|||||+++++|++.+.+|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 56999999999999999999999999999999999988888888999999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcc
Q 014347 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 173 (426)
|+|..++|..+++++++++|.+|+.+++||+.||.|||+++|+|||||..||+|+++.+|||+|||||+.... ++...
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~--~~Erk 175 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY--DGERK 175 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecC--ccccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999997543 44667
Q ss_pred ccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccc
Q 014347 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE 253 (426)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 253 (426)
.+.||||.|.|||++...++ +..+||||+||+||.||.|++||+..+..+.|.+|...++.+|..+|.++++||.+||+
T Consensus 176 ~TlCGTPNYIAPEVl~k~gH-sfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~ 254 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGH-SFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLR 254 (592)
T ss_pred ceecCCCcccChhHhccCCC-CCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhc
Confidence 89999999999999998777 79999999999999999999999999999999999999999999999999999999999
Q ss_pred cCccCCCCHHHHhcCccccccCCCCC
Q 014347 254 PNPVKRITIAGIKADEWFEQDYTPAN 279 (426)
Q Consensus 254 ~dP~~R~t~~eil~h~~f~~~~~~~~ 279 (426)
+||.+|||+++||.|+||..++.|..
T Consensus 255 ~~P~~Rpsl~~vL~h~Ff~~g~~p~~ 280 (592)
T KOG0575|consen 255 PNPSERPSLDEVLDHPFFKSGFTPAR 280 (592)
T ss_pred CCcccCCCHHHHhcCHhhhCCCcCCC
Confidence 99999999999999999988887764
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-64 Score=478.39 Aligned_cols=262 Identities=39% Similarity=0.717 Sum_probs=235.5
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchh----HHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----ITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~----~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (426)
...+.|.+.+.||+|+||.|.+|.++.||+.||||++++....... -...+.+|+.+|++|+|||||+++++++..
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 3557899999999999999999999999999999999887654311 234578999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCC---CCeEEeeccCccC
Q 014347 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---GNIKISDFGLSAL 163 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~---g~vkL~DFGla~~ 163 (426)
+..|+||||+.||+|++.+..++.+.+...+.+++||+.||.|||++||+||||||+|||+..+ ..+||+|||+|+.
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 9999999999999999999999999999999999999999999999999999999999999766 6799999999997
Q ss_pred CccccCCCccccccCCCcccchhhhccCCC--CCCcchhhhHHHHHHHHHhCCCCCCCCcHHH-HHHHHHcCCCCC--CC
Q 014347 164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGY--DGATSDIWSCGVILYVILTGYLPFDDRNLAV-LYQKIFRGDFKL--PK 238 (426)
Q Consensus 164 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~--~~~~~DIwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~~~--p~ 238 (426)
.. ....+.+.||||.|+|||++.++++ +..++||||+|||||.+|+|++||.+..... +.++|.++.+.+ |.
T Consensus 329 ~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~ 405 (475)
T KOG0615|consen 329 SG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ 405 (475)
T ss_pred cc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh
Confidence 53 4667889999999999999987654 3457899999999999999999999876655 899999998765 34
Q ss_pred C--CCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 239 W--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 239 ~--~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
| +|.++++||.+||..||++|||++++|+||||+...
T Consensus 406 w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 406 WDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 4 899999999999999999999999999999998643
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-60 Score=452.70 Aligned_cols=261 Identities=38% Similarity=0.708 Sum_probs=244.5
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
....++|++++.||+|+||+|++++.+.|++.+|+|+++|..+......+....|..||..++||.||+++..|++...+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 45678999999999999999999999999999999999999988877789999999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
|+|+||+.||+|+.+|++.+.+++..++.|+..|+.||.|||++||+||||||||||||.+|+++|+||||++..- ..
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~--~~ 178 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL--KD 178 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc--cC
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998532 23
Q ss_pred CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC-CCCCCCCHHHHHHH
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLL 248 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li 248 (426)
+....+.|||+.|||||++.+.+| +..+|+||||+++|+|++|.+||.+.+...++++|.++.. ..|..+++++++||
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~~gy-~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll 257 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLGKGY-DKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLL 257 (357)
T ss_pred CCccccccCCccccChHHHhcCCC-CcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHH
Confidence 445677899999999999999988 5889999999999999999999999999999999999994 44555999999999
Q ss_pred HHccccCccCCC----CHHHHhcCccccc
Q 014347 249 RKILEPNPVKRI----TIAGIKADEWFEQ 273 (426)
Q Consensus 249 ~~~L~~dP~~R~----t~~eil~h~~f~~ 273 (426)
+++|..||.+|. .+.+|.+||||..
T Consensus 258 ~~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 258 KKLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred HHHhccCHHHhcCCCCChHHhhcCccccc
Confidence 999999999996 6899999999974
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-61 Score=441.00 Aligned_cols=257 Identities=39% Similarity=0.751 Sum_probs=246.6
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (426)
..+++|+++++||.|+||.|.+++++.+|..+|+|++++..+.+.+.+++..+|.++|+.+.||+++++++.+.+.+.+|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 67889999999999999999999999999999999999999999889999999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCC
Q 014347 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 170 (426)
+||||++||+|+.++++.+++++..++.|+.||+.||+|||+++|++|||||||||+|.+|.+||+|||+|+.. .
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v-----~ 195 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRV-----S 195 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEe-----c
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999843 3
Q ss_pred CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 014347 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 250 (426)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~ 250 (426)
+...+.||||.|+|||++..++| +.++|+|||||++|||++|++||.+.+...+|++|..++..+|+.+++++++||++
T Consensus 196 ~rT~TlCGTPeYLAPEii~sk~y-nkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~ 274 (355)
T KOG0616|consen 196 GRTWTLCGTPEYLAPEIIQSKGY-NKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKK 274 (355)
T ss_pred CcEEEecCCccccChHHhhcCCC-CcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHH
Confidence 45778999999999999999998 58899999999999999999999999999999999999999999999999999999
Q ss_pred ccccCccCCC-----CHHHHhcCccccc
Q 014347 251 ILEPNPVKRI-----TIAGIKADEWFEQ 273 (426)
Q Consensus 251 ~L~~dP~~R~-----t~~eil~h~~f~~ 273 (426)
+|+.|-.+|. ...+|..||||+.
T Consensus 275 LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 275 LLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred HHhhhhHhhhcCcCCCccccccCccccc
Confidence 9999999994 5789999999974
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-59 Score=458.78 Aligned_cols=263 Identities=35% Similarity=0.642 Sum_probs=244.9
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSK 88 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 88 (426)
.....+|.+++.||+|+|++|++|+++.+++.||||+++|..+..+..++-+.+|-.+|.+| .||+|++|+..|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 45677999999999999999999999999999999999998888877788899999999999 79999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
+|+|+||+++|+|.++|.+.|.|++..++.|+.||+.||+|||++|||||||||||||||.||++||+|||-|+.+....
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998764321
Q ss_pred CC-----------CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCC
Q 014347 169 DD-----------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP 237 (426)
Q Consensus 169 ~~-----------~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p 237 (426)
.. ....+.+||-.|++||+|.+... ++.+|||+||||||+|++|.+||.+.+.-.++++|..-.+.+|
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~-~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp 307 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA-GPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP 307 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCC-CcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC
Confidence 11 11245789999999999887554 7999999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 238 ~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
+.+++.+++||+++|..||++|+|+.+|.+||||..
T Consensus 308 ~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 308 EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred CCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 999999999999999999999999999999999975
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-57 Score=432.83 Aligned_cols=261 Identities=39% Similarity=0.654 Sum_probs=239.8
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
...+++|.+.+.||+|+||+||+|+++.++..||||.+.+... ..+..+.+..||.+|+.++|||||.+++++.+++.+
T Consensus 6 ~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i 84 (429)
T KOG0595|consen 6 MRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFI 84 (429)
T ss_pred ccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeE
Confidence 4568999999999999999999999999999999999988765 455678899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCC------CCeEEeeccCccC
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK------GNIKISDFGLSAL 163 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~------g~vkL~DFGla~~ 163 (426)
|+|||||.||+|.++|.+.+.+++..++.+++||+.||++||+++|+||||||+||||+.. -.+||+|||+|+.
T Consensus 85 ~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999999999999999999999999999999999999999999999999999999865 3589999999996
Q ss_pred CccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC---CCCCCC
Q 014347 164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWL 240 (426)
Q Consensus 164 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~ 240 (426)
.. ......+.||+|.|||||++....|+ .|+|+||+|+|||+|++|+.||+..+..+++..+.++.. .+|.++
T Consensus 165 L~---~~~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~ 240 (429)
T KOG0595|consen 165 LQ---PGSMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAEL 240 (429)
T ss_pred CC---chhHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhc
Confidence 54 56678899999999999999888885 899999999999999999999999999999998887753 445678
Q ss_pred CHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 241 s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
++...+|+...|+.+|..|.+..+-..|++.....
T Consensus 241 s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 241 SNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred cCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 88999999999999999999999999999987654
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-57 Score=434.72 Aligned_cols=259 Identities=44% Similarity=0.788 Sum_probs=247.6
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
-||++.++||+|+||+|.+|.+...|+.||||.++++.+.+....-++++||+||..|+||||+.+|++|+..+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 58999999999999999999999999999999999999999888999999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcc
Q 014347 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 173 (426)
||..||+|+|+|.+++.+++.+++++|+||.+|+.|||.++++|||||.+|||+|.|+++||+||||+.++. ....+
T Consensus 133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~---~~kfL 209 (668)
T KOG0611|consen 133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA---DKKFL 209 (668)
T ss_pred EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc---cccHH
Confidence 999999999999999999999999999999999999999999999999999999999999999999998753 56788
Q ss_pred ccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccc
Q 014347 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE 253 (426)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 253 (426)
.++||+|.|.+||++.+.+|.|+.+|-|||||+||.|+.|..||++.+...+..+|.++.+.-|.. +..+.-||+.||.
T Consensus 210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~-PSdA~gLIRwmLm 288 (668)
T KOG0611|consen 210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET-PSDASGLIRWMLM 288 (668)
T ss_pred HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC-CchHHHHHHHHHh
Confidence 999999999999999999999999999999999999999999999999999999999998887764 6788999999999
Q ss_pred cCccCCCCHHHHhcCccccccCC
Q 014347 254 PNPVKRITIAGIKADEWFEQDYT 276 (426)
Q Consensus 254 ~dP~~R~t~~eil~h~~f~~~~~ 276 (426)
.||.+|.|+++|-.|=|.+-++.
T Consensus 289 VNP~RRATieDiAsHWWvNwgy~ 311 (668)
T KOG0611|consen 289 VNPERRATIEDIASHWWVNWGYN 311 (668)
T ss_pred cCcccchhHHHHhhhheeecccc
Confidence 99999999999999999876554
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-56 Score=440.41 Aligned_cols=262 Identities=35% Similarity=0.634 Sum_probs=239.4
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
...+++|++++.||+|+||.||+|+.+.||+.+|+|+++|......+.++.++.|-.+|...++|+||++|..|++...+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 45678999999999999999999999999999999999999888888899999999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcc---
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH--- 166 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~--- 166 (426)
||||||++||++..+|.+.+.|++..++.|+.+++.||+.+|+.|++||||||+|+|||..|++||+||||++-...
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999863211
Q ss_pred -----------------ccCC-------------------------CccccccCCCcccchhhhccCCCCCCcchhhhHH
Q 014347 167 -----------------FRDD-------------------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCG 204 (426)
Q Consensus 167 -----------------~~~~-------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlG 204 (426)
...+ ......+|||.|+|||++.+++| +..+|+||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY-~~~cDwWSLG 375 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY-GKECDWWSLG 375 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC-CccccHHHHH
Confidence 0000 01123479999999999999997 6899999999
Q ss_pred HHHHHHHhCCCCCCCCcHHHHHHHHHcCC--CCCCCC--CCHHHHHHHHHccccCccCCCC---HHHHhcCccccc
Q 014347 205 VILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPKW--LSPGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQ 273 (426)
Q Consensus 205 vil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~--~s~~~~~Li~~~L~~dP~~R~t---~~eil~h~~f~~ 273 (426)
||+||||.|++||.++++.+.+.+|.... +.+|.. +++++++||.+||. ||++|.. ++||.+||||+.
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence 99999999999999999999999998876 667754 78999999999999 9999985 899999999975
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-56 Score=422.25 Aligned_cols=260 Identities=29% Similarity=0.504 Sum_probs=236.3
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC-E
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-K 88 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~ 88 (426)
+..+++.+.++.||+|+.|+||+++|+.|++.+|+|++..+ .+....+++.+|+++++..+||+||++|+.|..+. .
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence 45566888999999999999999999999999999999433 25566889999999999999999999999999998 5
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-cCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~-~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
++|+||||.||+|.+.+...++++|.....++.|+++||.|||. ++|+||||||+|||++..|.+||||||.+....
T Consensus 153 isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv-- 230 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV-- 230 (364)
T ss_pred EEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh--
Confidence 99999999999999999988999999999999999999999995 999999999999999999999999999998542
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCC-----cHHHHHHHHHcC-CCCCCCC-C
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-----NLAVLYQKIFRG-DFKLPKW-L 240 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~-----~~~~~~~~i~~~-~~~~p~~-~ 240 (426)
+....+..||..|||||.+.+..| +.++||||||+.++||.+|+.||... +..+++..|..+ .+.+|.. +
T Consensus 231 --nS~a~tfvGT~~YMsPERi~g~~Y-s~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~f 307 (364)
T KOG0581|consen 231 --NSIANTFVGTSAYMSPERISGESY-SVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEF 307 (364)
T ss_pred --hhhcccccccccccChhhhcCCcC-CcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccC
Confidence 236688999999999999998877 68899999999999999999999874 667888889885 4667876 9
Q ss_pred CHHHHHHHHHccccCccCCCCHHHHhcCccccccCC
Q 014347 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (426)
Q Consensus 241 s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 276 (426)
|+++++||..||++||.+|||+.|+++|||+++...
T Consensus 308 S~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 308 SPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 999999999999999999999999999999987543
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-57 Score=404.85 Aligned_cols=258 Identities=39% Similarity=0.746 Sum_probs=235.7
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
.-+.|++-+.||+|+|+.||++.+..||+.+|+|+++....... ..+.+.+|++|-+.|+||||+++++.+.+....|+
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 44689999999999999999999999999999999987665443 46889999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCC---CCeEEeeccCccCCcccc
Q 014347 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFR 168 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~---g~vkL~DFGla~~~~~~~ 168 (426)
|+|++.|++|+.-|..+.-++|..+-++++||++||+|||.+||+|||+||+|+|+... .-+||+|||+|....
T Consensus 88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--- 164 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--- 164 (355)
T ss_pred EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC---
Confidence 99999999998888777789999999999999999999999999999999999999643 359999999998543
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCC--C--CCHHH
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK--W--LSPGA 244 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~--~s~~~ 244 (426)
.........|||.|+|||++...+| +..+|||+||||||-||.|++||.+++...+|+.|..+.+.+|+ | +++++
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkdpy-~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~A 243 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEA 243 (355)
T ss_pred CccccccccCCCcccCHHHhhcCCC-CCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHH
Confidence 4556778899999999999988877 68899999999999999999999999999999999999877764 4 89999
Q ss_pred HHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 245 QNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
++|+++||..||.+|+|+.|+|+|||..+.
T Consensus 244 k~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 244 KSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 999999999999999999999999999763
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-54 Score=436.05 Aligned_cols=260 Identities=32% Similarity=0.627 Sum_probs=243.4
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCCE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSK 88 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 88 (426)
...+.+|.++++||+|+||+|++|..+.+++.+|||+++|..+...+.++..+.|.+|+.... ||.+++++..|.+.++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 567889999999999999999999999999999999999999998888999999999999886 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
+|+||||+.||++. .+...+.+++..++.|+..++.||.|||++||||||||.+|||||.+|.+||+|||+++.- ..
T Consensus 444 l~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~--m~ 520 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG--MG 520 (694)
T ss_pred EEEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccccc--CC
Confidence 99999999999954 4455588999999999999999999999999999999999999999999999999999842 22
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 248 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li 248 (426)
.+....|.||||.|+|||++....| +..+|+|||||+||+||.|..||.+++.++++..|...++.+|.|+|.++.+++
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~~Y-t~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il 599 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQSY-TRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIM 599 (694)
T ss_pred CCCccccccCChhhcChhhhccCcc-cchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHH
Confidence 4457789999999999999998888 699999999999999999999999999999999999999999999999999999
Q ss_pred HHccccCccCCCC-----HHHHhcCccccc
Q 014347 249 RKILEPNPVKRIT-----IAGIKADEWFEQ 273 (426)
Q Consensus 249 ~~~L~~dP~~R~t-----~~eil~h~~f~~ 273 (426)
+++|.+||.+|.. +.+|..||||..
T Consensus 600 ~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 600 RRLLRKNPEKRLGSGERDAEDIKKHPFFRS 629 (694)
T ss_pred HHHhccCcccccCCCCCCchhhhhCCcccc
Confidence 9999999999986 478999999974
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-54 Score=422.19 Aligned_cols=271 Identities=39% Similarity=0.662 Sum_probs=237.7
Q ss_pred ccCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccch-----------hHHHHHHHHHHHHHhCCCCC
Q 014347 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-----------KITDQIKREIATLKLLKHPN 75 (426)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~-----------~~~~~~~~Ei~il~~l~hpn 75 (426)
......+++|++++.||+|.||+|.+|++..+++.||||++.+...... .-.+++++||.||+++.|||
T Consensus 90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n 169 (576)
T KOG0585|consen 90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN 169 (576)
T ss_pred cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence 3456778999999999999999999999999999999999987543211 11468999999999999999
Q ss_pred ccceEEEEEeC--CEEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCC
Q 014347 76 VVRLHEVLASK--SKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN 152 (426)
Q Consensus 76 Iv~l~~~~~~~--~~~~lV~Ey~~gg~L~~~i~~~~~-l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~ 152 (426)
||+|+++..+. +.+|+|+|||..|++...-. ..+ +++.+++.|++.++.||+|||.+||+||||||.|+||+++|+
T Consensus 170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~-d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP-DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred eeEEEEeecCcccCceEEEEEeccCCccccCCC-CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc
Confidence 99999999764 68999999999998865433 344 999999999999999999999999999999999999999999
Q ss_pred eEEeeccCccCCccc---cCCCccccccCCCcccchhhhcc---CCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHH
Q 014347 153 IKISDFGLSALPQHF---RDDGLLHTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY 226 (426)
Q Consensus 153 vkL~DFGla~~~~~~---~~~~~~~~~~gt~~y~APE~l~~---~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~ 226 (426)
+||+|||.+..+... ..+..+....|||.|+|||.+.. ..+.|.+.||||+||+||.|+.|++||-+....+++
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~ 328 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF 328 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence 999999998865322 12234555899999999999876 557789999999999999999999999999999999
Q ss_pred HHHHcCCCCCCCC--CCHHHHHHHHHccccCccCCCCHHHHhcCccccccCCCC
Q 014347 227 QKIFRGDFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 278 (426)
Q Consensus 227 ~~i~~~~~~~p~~--~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~~ 278 (426)
.+|....+.+|.. +.+.+++||.+||++||.+|+++.+|..|||........
T Consensus 329 ~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~ 382 (576)
T KOG0585|consen 329 DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP 382 (576)
T ss_pred HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence 9999999999876 799999999999999999999999999999998765444
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-55 Score=403.49 Aligned_cols=250 Identities=32% Similarity=0.535 Sum_probs=225.0
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEE-EE-EeC
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE-VL-ASK 86 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~-~~-~~~ 86 (426)
....+..|++.++||+|+||.||++.+..+|..||.|.+.-... +....+.+..|+.+|++|+|||||++++ .+ ++.
T Consensus 14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN 92 (375)
T ss_pred CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence 45567789999999999999999999999999999999874443 5556788999999999999999999998 34 344
Q ss_pred CEEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhh--cC--ceeccCCCCcEEecCCCCeEEeec
Q 014347 87 SKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHN--KG--VFHRDLKLENILLDSKGNIKISDF 158 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~----~~~l~~~~~~~i~~Ql~~aL~~LH~--~g--IiHrDLKp~NILl~~~g~vkL~DF 158 (426)
..++||||||.+|+|...|+. ...++|..+++++.||+.||.+||+ .. |+||||||.||+|+.+|.+||+||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 449999999999999999864 4569999999999999999999999 44 999999999999999999999999
Q ss_pred cCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCC-CC
Q 014347 159 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LP 237 (426)
Q Consensus 159 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p 237 (426)
||+++++. .....++.+|||.||+||++...+|+ +++||||+||++|||++-++||.+.+...+.++|.+++++ +|
T Consensus 173 GL~r~l~s--~~tfA~S~VGTPyYMSPE~i~~~~Y~-~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 173 GLGRFLSS--KTTFAHSLVGTPYYMSPERIHESGYN-FKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP 249 (375)
T ss_pred hhHhHhcc--hhHHHHhhcCCCcccCHHHHhcCCCC-cchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc
Confidence 99998765 34566788999999999999999994 9999999999999999999999999999999999999876 77
Q ss_pred -CCCCHHHHHHHHHccccCccCCCCH
Q 014347 238 -KWLSPGAQNLLRKILEPNPVKRITI 262 (426)
Q Consensus 238 -~~~s~~~~~Li~~~L~~dP~~R~t~ 262 (426)
..+|.++..||..|+.+||.+||+.
T Consensus 250 ~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 250 DEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHhhhHHHHHHHHHccCCcccCCCc
Confidence 5689999999999999999999986
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-53 Score=416.59 Aligned_cols=263 Identities=35% Similarity=0.711 Sum_probs=240.5
Q ss_pred ccccCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEE
Q 014347 5 EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84 (426)
Q Consensus 5 ~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 84 (426)
........+++|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 88 (329)
T PTZ00263 9 KPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ 88 (329)
T ss_pred ccccCCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 33455677899999999999999999999999999999999998765444455678899999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCC
Q 014347 85 SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (426)
Q Consensus 85 ~~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~ 164 (426)
+++..|+||||+.||+|.+.+.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 89 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 168 (329)
T PTZ00263 89 DENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV 168 (329)
T ss_pred cCCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEc
Confidence 99999999999999999999998889999999999999999999999999999999999999999999999999998753
Q ss_pred ccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHH
Q 014347 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244 (426)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 244 (426)
.. ...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+.++..+.+.+|.++++.+
T Consensus 169 ~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 242 (329)
T PTZ00263 169 PD-----RTFTLCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRA 242 (329)
T ss_pred CC-----CcceecCChhhcCHHHHcCCCC-CCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHH
Confidence 21 2335689999999999987776 68999999999999999999999999888889999999999999999999
Q ss_pred HHHHHHccccCccCCCC-----HHHHhcCccccc
Q 014347 245 QNLLRKILEPNPVKRIT-----IAGIKADEWFEQ 273 (426)
Q Consensus 245 ~~Li~~~L~~dP~~R~t-----~~eil~h~~f~~ 273 (426)
++||.+||+.||.+|++ +++++.||||..
T Consensus 243 ~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 243 RDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 99999999999999997 799999999975
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-54 Score=388.50 Aligned_cols=263 Identities=35% Similarity=0.689 Sum_probs=247.5
Q ss_pred cccCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe
Q 014347 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (426)
Q Consensus 6 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 85 (426)
.....-.+++|++++.||+|-||.||+|+.+.++-.||+|++.+..+.......++.||++|...|+||||+++|++|-+
T Consensus 14 ~~~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd 93 (281)
T KOG0580|consen 14 RATKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD 93 (281)
T ss_pred ccccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec
Confidence 34456778999999999999999999999999999999999999888777778899999999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccC
Q 014347 86 KSKIYMVLEYVTGGELFDKIA--SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (426)
Q Consensus 86 ~~~~~lV~Ey~~gg~L~~~i~--~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~ 163 (426)
...+|+++||.++|+|+..+. +..++++..+..|++|++.||.|||.++|+||||||+|+|++.+|.+|++|||-+..
T Consensus 94 ~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~ 173 (281)
T KOG0580|consen 94 SKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVH 173 (281)
T ss_pred cceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceee
Confidence 999999999999999999998 667899999999999999999999999999999999999999999999999999875
Q ss_pred CccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHH
Q 014347 164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPG 243 (426)
Q Consensus 164 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 243 (426)
. +...-.+.|||..|.+||+..+.+++ ..+|+|++|++.||++.|.+||...+..+.|++|.+.++.+|..++.+
T Consensus 174 ~----p~~kR~tlcgt~dyl~pEmv~~~~hd-~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~ 248 (281)
T KOG0580|consen 174 A----PSNKRKTLCGTLDYLPPEMVEGRGHD-KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGG 248 (281)
T ss_pred c----CCCCceeeecccccCCHhhcCCCCcc-chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChh
Confidence 3 23455788999999999999988885 789999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
+.+||.+||.++|.+|.+..|++.|||...
T Consensus 249 a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 249 AADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 999999999999999999999999999865
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-53 Score=416.37 Aligned_cols=265 Identities=37% Similarity=0.676 Sum_probs=246.3
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
+..-|=|++.+.||+|-|+.|.+|++.-||+.||||++++.+.... ...++.+|++.|+.++|||||++|++..+...+
T Consensus 14 gkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~-st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKl 92 (864)
T KOG4717|consen 14 GKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKL 92 (864)
T ss_pred cceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh-hhhHHHHHHHHHHHhcCcCeeeeeehhcccceE
Confidence 4566789999999999999999999999999999999999876543 356788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEec-CCCCeEEeeccCccCCccc
Q 014347 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~-~~g~vkL~DFGla~~~~~~ 167 (426)
|+|+|+-.||+|+|+|.+ ...+.|..+++||.||+.|+.|||+..++||||||||+.+. .-|-+||+|||++..+
T Consensus 93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf--- 169 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF--- 169 (864)
T ss_pred EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccC---
Confidence 999999999999999976 45799999999999999999999999999999999998775 5689999999999864
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L 247 (426)
.++..+.+.||+..|-|||++.+..|+.+++||||||||||.|++|++||+..+..+....|..+.+..|..++.++++|
T Consensus 170 ~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdL 249 (864)
T KOG4717|consen 170 QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDL 249 (864)
T ss_pred CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHH
Confidence 35667899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHccccCccCCCCHHHHhcCccccccCCCC
Q 014347 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPA 278 (426)
Q Consensus 248 i~~~L~~dP~~R~t~~eil~h~~f~~~~~~~ 278 (426)
|..||..||.+|.+.++|..++|++....+.
T Consensus 250 I~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~ 280 (864)
T KOG4717|consen 250 IQSMLVRDPKKRASLEEIVSTSWLQAGDRGL 280 (864)
T ss_pred HHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence 9999999999999999999999998765443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-54 Score=396.53 Aligned_cols=256 Identities=28% Similarity=0.447 Sum_probs=220.4
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (426)
|++|+.+.++|+|+||.||+++++.||+.||||.+... ..+....+-..|||++|++++|||+|.++++|.....+++|
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es-edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES-EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC-CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 57899999999999999999999999999999998543 33444556688999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCC
Q 014347 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 171 (426)
+|||+. ++.+.+++ ...+++..++.|+.|++.|+.|||+++++||||||||||++.+|.+||||||+|+.... ++.
T Consensus 80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd 156 (396)
T KOG0593|consen 80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGD 156 (396)
T ss_pred eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC--Ccc
Confidence 999977 45455554 56799999999999999999999999999999999999999999999999999997653 455
Q ss_pred ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHc--------------CCC---
Q 014347 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--------------GDF--- 234 (426)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--------------~~~--- 234 (426)
....++.|.+|+|||.+.+...+|.++||||+||++.||++|.+.|.+.+..+..-.|.+ .+.
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 667789999999999998855558999999999999999999999999876655433332 111
Q ss_pred --CCC------------CCCCHHHHHHHHHccccCccCCCCHHHHhcCcccc
Q 014347 235 --KLP------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 272 (426)
Q Consensus 235 --~~p------------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~ 272 (426)
.+| +.++..+.+|+++||+.||++|++.++++.|++|.
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 122 12567889999999999999999999999999994
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-53 Score=420.70 Aligned_cols=257 Identities=31% Similarity=0.587 Sum_probs=241.1
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (426)
+++|-+.+.||+|+||.||+|+.+.+.+.||+|.++|..... +..+.+.+|++|++.++||||+.++++|++..++++|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~-k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE-KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch-HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 578999999999999999999999999999999998876543 4578899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
.|||.| +|+.+++.++.++|+.++.++.|+++||.|||+++|+|||+||.|||++..|.+|+||||+|+.... ....
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~v 156 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSV 156 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc--Ccee
Confidence 999988 9999999999999999999999999999999999999999999999999999999999999997544 4456
Q ss_pred cccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcc
Q 014347 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 252 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L 252 (426)
+....|||.|||||++.+.+| +..+|+||+|||+|||++|++||-..+...+.+.|.......|...+..+.+|+..+|
T Consensus 157 ltsikGtPlYmAPElv~e~py-d~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL 235 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPY-DHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLL 235 (808)
T ss_pred eeeccCcccccCHHHHcCCCc-cchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHh
Confidence 667789999999999998777 4889999999999999999999999999999999999999999999999999999999
Q ss_pred ccCccCCCCHHHHhcCcccccc
Q 014347 253 EPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 253 ~~dP~~R~t~~eil~h~~f~~~ 274 (426)
.+||.+|.|-.+++.|||.+..
T Consensus 236 ~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 236 IKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred hcChhhcccHHHHhcChHHhhh
Confidence 9999999999999999998754
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-52 Score=404.27 Aligned_cols=254 Identities=35% Similarity=0.661 Sum_probs=233.2
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999997655444445677899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcc
Q 014347 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 173 (426)
||++||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++..... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-----~~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RT 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-----Cc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999875321 22
Q ss_pred ccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccc
Q 014347 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE 253 (426)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 253 (426)
...+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+..+...+|..+++.+++||++||+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 234 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLV 234 (291)
T ss_pred ccccCChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcC
Confidence 34689999999999887766 68899999999999999999999999998999999999999999999999999999999
Q ss_pred cCccCCCC-----HHHHhcCccccc
Q 014347 254 PNPVKRIT-----IAGIKADEWFEQ 273 (426)
Q Consensus 254 ~dP~~R~t-----~~eil~h~~f~~ 273 (426)
.||.+|++ +++++.||||..
T Consensus 235 ~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 235 VDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred CCHHHccCCccCCHHHHhcCccccC
Confidence 99999995 999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-53 Score=406.59 Aligned_cols=261 Identities=34% Similarity=0.542 Sum_probs=224.2
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC--EEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS--KIY 90 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~~~ 90 (426)
..+|..++.||+|+||.||++.+..+|+..|||.+...... ..+.+.+|+.+|++++|||||++++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~---~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP---TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccch---hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 45699999999999999999999999999999998766322 2678999999999999999999999754444 699
Q ss_pred EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecC-CCCeEEeeccCccCCccc-
Q 014347 91 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHF- 167 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~~~-~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~-~g~vkL~DFGla~~~~~~- 167 (426)
++|||++||+|.+++.+.+ ++++..++++.+|+++||+|||++||+||||||+|||++. +|.+||+|||++......
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999999876 7999999999999999999999999999999999999999 799999999999865531
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCC-CcHHHHHHHHHcC--CCCCCCCCCHHH
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRG--DFKLPKWLSPGA 244 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~--~~~~p~~~s~~~ 244 (426)
..........|||.|||||++......++++||||+||++.||+||+.||.+ .......-++... .+.+|.++|+++
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA 252 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence 1122344578999999999998633334589999999999999999999998 4444444444433 367899999999
Q ss_pred HHHHHHccccCccCCCCHHHHhcCccccccCC
Q 014347 245 QNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (426)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 276 (426)
++||.+|+..||++|||++++|.|||......
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 99999999999999999999999999987543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-53 Score=411.89 Aligned_cols=262 Identities=33% Similarity=0.532 Sum_probs=229.9
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC--CE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SK 88 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~ 88 (426)
...+.|+.+++||+|+||.||+|++..+|+.||+|.+..+.. +.+......|||.||++|+||||++|.++..+. ..
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 456789999999999999999999999999999999987654 345567788999999999999999999998776 78
Q ss_pred EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 89 IYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
+|+|+|||+. +|.-++.. .-.|++.+++.|++||+.||+|||++||+|||||..|||||.+|.+||+|||||+++...
T Consensus 193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999999977 88888776 447999999999999999999999999999999999999999999999999999977553
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC--CC--------CCC
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DF--------KLP 237 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~--------~~p 237 (426)
....+...+-|.+|+|||.+.+..-++.++|+||+||||.||++|++.|.+.+..+...+|++- .+ .+|
T Consensus 272 -~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 272 -GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred -CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 2334667788999999999998887799999999999999999999999999998888888641 11 112
Q ss_pred -------------------CCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 238 -------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 238 -------------------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
..+++.+.+|+..||..||.+|.|+.++|.++||....
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p 407 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEP 407 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCC
Confidence 12578899999999999999999999999999995443
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-53 Score=390.18 Aligned_cols=258 Identities=36% Similarity=0.694 Sum_probs=233.2
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeeccccc-----chhHHHHHHHHHHHHHhCC-CCCccceEEEEEe
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLKLLK-HPNVVRLHEVLAS 85 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~ 85 (426)
.+.+|+-.+.||+|..+.|..+.++.+|..+|+|++...... ..+..+.-.+|+.||+++. ||+|+++.+++++
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 457889999999999999999999999999999999743221 2345566788999999985 9999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 86 ~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
+...++|+|.|+.|+|+|++.+...+++++++++++||.+|++|||.++|+||||||+|||+|++.++||+|||+|+..
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l- 173 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL- 173 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999999854
Q ss_pred cccCCCccccccCCCcccchhhhcc------CCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCC--C
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLAN------RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--P 237 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~------~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--p 237 (426)
..+..+...||||+|+|||.+.. .+| +..+|+||||||+|.||+|.+||-.....-+...|..|++++ |
T Consensus 174 --~~GekLrelCGTPgYLAPEtikC~m~e~~pGY-s~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 174 --EPGEKLRELCGTPGYLAPETIKCSMYENHPGY-SKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP 250 (411)
T ss_pred --CCchhHHHhcCCCcccChhheeeecccCCCCc-cchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence 34567788999999999999853 334 688999999999999999999999998889999999998665 6
Q ss_pred CC--CCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 238 KW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 238 ~~--~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
.| +|..+++||++||+.||.+|+|++|+|+||||.+
T Consensus 251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 67 7899999999999999999999999999999964
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-53 Score=411.49 Aligned_cols=261 Identities=30% Similarity=0.505 Sum_probs=227.1
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCC
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKS 87 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 87 (426)
....++||.++++||.|+||.||+|+.+.+|+.||||.+++.... .+.. .=.||+..|++|+ |||||++.+++.+.+
T Consensus 5 ~~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~-~nLREvksL~kln~hpniikL~Evi~d~~ 82 (538)
T KOG0661|consen 5 QVIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDND 82 (538)
T ss_pred ehhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence 345678999999999999999999999999999999999765432 2222 2357999999999 999999999998877
Q ss_pred -EEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 88 -KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 88 -~~~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
.+|+||||++ .+|+++++. +..|++..++.|+.||++||+|+|.+|++|||+||||||+..+..+||+|||+|+...
T Consensus 83 ~~L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 83 RILYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred ceEeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc
Confidence 9999999995 599999976 4569999999999999999999999999999999999999999999999999999543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHc--C-----------
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--G----------- 232 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~----------- 232 (426)
.......++.|.+|+|||++.+.++++.+.||||+|||++|+.+-++.|.|.+..+...+|.. |
T Consensus 162 ---SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 162 ---SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred ---cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 334566788999999999999999999999999999999999999999999888777766653 1
Q ss_pred ------CCCCC-----------CCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 233 ------DFKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 233 ------~~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
.+.+| +.+++++.+||.+||.+||++|||+.++++||||+...
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 12232 22688999999999999999999999999999998654
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-51 Score=410.74 Aligned_cols=258 Identities=41% Similarity=0.765 Sum_probs=237.0
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCCEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 90 (426)
.-..|++++.||+|.||.||+++++.||+.+|+|++.+.........+.+.+|+++|+++. ||||+.+++++++...+|
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3458999999999999999999999999999999999887766556688999999999999 999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCC----CCeEEeeccCccCCcc
Q 014347 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK----GNIKISDFGLSALPQH 166 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~----g~vkL~DFGla~~~~~ 166 (426)
+|||+|.||+|++.|.+. .+++.++..+++|++.++.|||+.||+||||||||+|+... +.+|++|||+|.....
T Consensus 113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 999999999999999876 49999999999999999999999999999999999999643 4799999999996543
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCC--CC--CCH
Q 014347 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP--KW--LSP 242 (426)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p--~~--~s~ 242 (426)
.....+.||||.|+|||++...+| +..+||||+|+++|.|++|.+||.+.+....+.++..+++.++ .| ++.
T Consensus 192 ---~~~~~~~~Gtp~y~APEvl~~~~y-~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~ 267 (382)
T KOG0032|consen 192 ---GERLHTIVGTPEYVAPEVLGGRPY-GDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE 267 (382)
T ss_pred ---CceEeeecCCccccCchhhcCCCC-CcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence 557889999999999999987777 6899999999999999999999999999999999999987654 34 789
Q ss_pred HHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
.+++||++||..||.+|+|+.++|+|||+...
T Consensus 268 ~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 268 SAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 99999999999999999999999999998764
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-51 Score=406.24 Aligned_cols=251 Identities=34% Similarity=0.641 Sum_probs=228.6
Q ss_pred ceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEeccCCC
Q 014347 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG 99 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~gg 99 (426)
+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444445667889999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccCC
Q 014347 100 ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179 (426)
Q Consensus 100 ~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt 179 (426)
+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ........+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCcccceecC
Confidence 9999999888999999999999999999999999999999999999999999999999999874211 22234457899
Q ss_pred CcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccccCccCC
Q 014347 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259 (426)
Q Consensus 180 ~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R 259 (426)
+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+..+...+|..+++++.+||++||+.||++|
T Consensus 159 ~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05571 159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred ccccChhhhcCCCC-CccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 99999999887766 68999999999999999999999999888888888888899999999999999999999999999
Q ss_pred C-----CHHHHhcCccccc
Q 014347 260 I-----TIAGIKADEWFEQ 273 (426)
Q Consensus 260 ~-----t~~eil~h~~f~~ 273 (426)
| ++.++++||||..
T Consensus 238 ~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 238 LGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 9 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-51 Score=408.10 Aligned_cols=260 Identities=35% Similarity=0.627 Sum_probs=236.3
Q ss_pred cCCccCCCeeeeceEeecCceEEEEEEECCCC-CeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 014347 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSG-LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (426)
+....+++|++.+.||+|+||.||+|.+..++ ..||+|.+.+.........+.+.+|+.+++.++||||+++++++.+.
T Consensus 24 ~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 103 (340)
T PTZ00426 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE 103 (340)
T ss_pred CCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence 34667889999999999999999999876654 68999999876554445567889999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcc
Q 014347 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 166 (426)
+..|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999999975321
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHH
Q 014347 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246 (426)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 246 (426)
...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+.++..+...+|..+++.+.+
T Consensus 184 -----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 257 (340)
T PTZ00426 184 -----RTYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKH 257 (340)
T ss_pred -----CcceecCChhhcCHHHHhCCCC-CccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence 2345689999999999887666 6899999999999999999999999998889999999998999999999999
Q ss_pred HHHHccccCccCCC-----CHHHHhcCccccc
Q 014347 247 LLRKILEPNPVKRI-----TIAGIKADEWFEQ 273 (426)
Q Consensus 247 Li~~~L~~dP~~R~-----t~~eil~h~~f~~ 273 (426)
+|++||+.||.+|+ |++++++||||..
T Consensus 258 li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 258 LMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred HHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 99999999999996 8999999999975
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-53 Score=393.30 Aligned_cols=263 Identities=33% Similarity=0.638 Sum_probs=248.1
Q ss_pred cCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 014347 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (426)
+..+.+++|+.+++||+|+||+|-+++.+.+|+.+|+|++++.-+...+.+..-..|-++|+..+||.+..+...|++.+
T Consensus 162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d 241 (516)
T KOG0690|consen 162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD 241 (516)
T ss_pred cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence 34578999999999999999999999999999999999999998888878888899999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
++++||||+.||+|+-++.+...++++.++.|...|++||.|||+++|++||||.+|+|+|.+|++||+||||++- ..
T Consensus 242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE--~I 319 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKE--EI 319 (516)
T ss_pred eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchh--cc
Confidence 9999999999999999999988999999999999999999999999999999999999999999999999999983 23
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L 247 (426)
.......+.||||.|+|||++.+..| +..+|+|.+||++|||++|++||.+.+...++..|..+++.+|..++++++.|
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktL 398 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTL 398 (516)
T ss_pred cccceeccccCChhhcCchhhccccc-cceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHH
Confidence 34556789999999999999998888 69999999999999999999999999999999999999999999999999999
Q ss_pred HHHccccCccCCCC-----HHHHhcCccccc
Q 014347 248 LRKILEPNPVKRIT-----IAGIKADEWFEQ 273 (426)
Q Consensus 248 i~~~L~~dP~~R~t-----~~eil~h~~f~~ 273 (426)
+..+|.+||.+|.. +.+|.+|+||..
T Consensus 399 LsGLL~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 399 LSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred HHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 99999999999974 889999999964
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-51 Score=375.36 Aligned_cols=261 Identities=33% Similarity=0.483 Sum_probs=227.5
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
.+|...+.||+|+||.||+|++..||+.||||.++..+..+ .......|||..|+.++|+||+.++++|...+.+.+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 58999999999999999999999999999999998765432 33467889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 94 Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
||++. +|...|+. ...++..+++.|+.|+++||+|||++.|+||||||.|+|++.+|.+||+|||+|+.+... +..
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p--~~~ 157 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP--NRI 157 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCC--Ccc
Confidence 99976 99998875 457999999999999999999999999999999999999999999999999999987652 333
Q ss_pred cccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC--CC---C------C-----
Q 014347 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DF---K------L----- 236 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~---~------~----- 236 (426)
....+-|.+|+|||.+.+...++..+||||.|||+.||+-|.+-|.+.+..+....|++. .+ . +
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 344488999999999988777789999999999999999999999999888887777652 11 0 1
Q ss_pred ----C--------CCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccCCCC
Q 014347 237 ----P--------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 278 (426)
Q Consensus 237 ----p--------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~~ 278 (426)
| +..++++.+|+.+||..||.+|+|+.|+++|+||.....|.
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt 291 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPT 291 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCC
Confidence 1 11467889999999999999999999999999999755443
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-52 Score=416.42 Aligned_cols=265 Identities=42% Similarity=0.792 Sum_probs=250.1
Q ss_pred cCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 014347 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (426)
.....++.|.+.++||+|.|++|.+|++..++..||||++++...... ....+.+|+++|+.++|||||+++.+..+..
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~-~~~k~~rev~imk~l~HPnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS-KRQKLGREVDIMKSLNHPNIVKLFSVIETEA 128 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH-HHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence 456778999999999999999999999999999999999998766443 3456899999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
.+|+||||+.||++++++.+.+++.+..++.+|.|+.+|++|||+++|+|||||++||||+.+-++||+|||++..+.
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-- 206 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD-- 206 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999999765
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L 247 (426)
....+.++||++.|.|||++.+..|+++++|+||+|++||.|++|.+||++.+...+....+.+.+.+|-.++.++.+|
T Consensus 207 -~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~l 285 (596)
T KOG0586|consen 207 -YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDL 285 (596)
T ss_pred -ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHH
Confidence 4567889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHccccCccCCCCHHHHhcCccccccCC
Q 014347 248 LRKILEPNPVKRITIAGIKADEWFEQDYT 276 (426)
Q Consensus 248 i~~~L~~dP~~R~t~~eil~h~~f~~~~~ 276 (426)
|+++|..+|.+|++.++|+.|.|......
T Consensus 286 Lrk~lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 286 LRKFLVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred HHHhhccCccccCCHHHhhhhcccchhhh
Confidence 99999999999999999999999976543
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-51 Score=395.58 Aligned_cols=266 Identities=31% Similarity=0.504 Sum_probs=240.1
Q ss_pred ccCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 014347 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (426)
....+.++.|++++.||.|.-|.||+|+...++..+|+|++++......+...++..|-.||.+++||.+..||..++++
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD 149 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence 44567788999999999999999999999999999999999998887777788899999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCC
Q 014347 87 SKIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~--~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~ 164 (426)
...|++||||+||+|+.+.++ .+.+++..++.|+..++.||+|||-.|||+||||||||||.++|++.|+||.|+...
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 999999999999999998876 356999999999999999999999999999999999999999999999999987431
Q ss_pred cc----------------------------------cc--------------------CCCccccccCCCcccchhhhcc
Q 014347 165 QH----------------------------------FR--------------------DDGLLHTTCGSPNYVAPEVLAN 190 (426)
Q Consensus 165 ~~----------------------------------~~--------------------~~~~~~~~~gt~~y~APE~l~~ 190 (426)
.. .. .+......+||-.|+|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 00 00 0012234579999999999999
Q ss_pred CCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCC--CCHHHHHHHHHccccCccCCCC----HHH
Q 014347 191 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW--LSPGAQNLLRKILEPNPVKRIT----IAG 264 (426)
Q Consensus 191 ~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~--~s~~~~~Li~~~L~~dP~~R~t----~~e 264 (426)
.+. +.++|+|+|||+|||||.|..||.+.+..+.+.+|......+|.. ++..+++||+++|.+||.+|.. ++|
T Consensus 310 ~GH-gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~e 388 (459)
T KOG0610|consen 310 EGH-GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAE 388 (459)
T ss_pred CCC-CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHH
Confidence 888 688999999999999999999999999999999999999888864 7899999999999999999998 999
Q ss_pred HhcCccccc
Q 014347 265 IKADEWFEQ 273 (426)
Q Consensus 265 il~h~~f~~ 273 (426)
|.+||||+.
T Consensus 389 IK~HpFF~g 397 (459)
T KOG0610|consen 389 IKRHPFFEG 397 (459)
T ss_pred hhcCccccC
Confidence 999999986
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-51 Score=398.61 Aligned_cols=250 Identities=36% Similarity=0.629 Sum_probs=227.3
Q ss_pred EeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEeccCCCCh
Q 014347 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL 101 (426)
Q Consensus 22 LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~gg~L 101 (426)
||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+..|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999999999999999999865544445567788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccCCCc
Q 014347 102 FDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181 (426)
Q Consensus 102 ~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~ 181 (426)
.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+||+.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc--CCCccccccCCcc
Confidence 99999888999999999999999999999999999999999999999999999999999875322 2223445689999
Q ss_pred ccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccccCccCCC-
Q 014347 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI- 260 (426)
Q Consensus 182 y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~- 260 (426)
|+|||++.+..+ +.++||||+||++|+|++|+.||.+.+....+..+......+|..+++.+.+||.+||+.||.+||
T Consensus 159 y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~ 237 (312)
T cd05585 159 YLAPELLLGHGY-TKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237 (312)
T ss_pred cCCHHHHcCCCC-CCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence 999999987766 688999999999999999999999999889999999999999999999999999999999999997
Q ss_pred --CHHHHhcCcccccc
Q 014347 261 --TIAGIKADEWFEQD 274 (426)
Q Consensus 261 --t~~eil~h~~f~~~ 274 (426)
++.+++.||||.+.
T Consensus 238 ~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 238 YNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCHHHHHcCCCcCCC
Confidence 57999999999863
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=399.56 Aligned_cols=251 Identities=36% Similarity=0.639 Sum_probs=227.8
Q ss_pred ceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEeccCCC
Q 014347 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG 99 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~gg 99 (426)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444455678889999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccCC
Q 014347 100 ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179 (426)
Q Consensus 100 ~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt 179 (426)
+|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC--cccccccccCC
Confidence 9999998888899999999999999999999999999999999999999999999999999874221 22233456899
Q ss_pred CcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccccCccCC
Q 014347 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259 (426)
Q Consensus 180 ~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R 259 (426)
+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......+|..+++++.+||++||++||++|
T Consensus 159 ~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (328)
T cd05593 159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237 (328)
T ss_pred cCccChhhhcCCCC-CccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHc
Confidence 99999999887666 68999999999999999999999998888888888888889999999999999999999999999
Q ss_pred C-----CHHHHhcCccccc
Q 014347 260 I-----TIAGIKADEWFEQ 273 (426)
Q Consensus 260 ~-----t~~eil~h~~f~~ 273 (426)
+ ++.++++||||..
T Consensus 238 ~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 238 LGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred CCCCCCCHHHHhcCCCcCC
Confidence 7 8999999999965
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-50 Score=402.84 Aligned_cols=258 Identities=31% Similarity=0.552 Sum_probs=225.1
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765444455678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC----
Q 014347 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD---- 169 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~---- 169 (426)
||++||+|.+++.+.+++++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999875321100
Q ss_pred -----------------------------CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCC
Q 014347 170 -----------------------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR 220 (426)
Q Consensus 170 -----------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 220 (426)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCC-CCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 001234689999999999987776 58899999999999999999999999
Q ss_pred cHHHHHHHHHcC--CCCCCCC--CCHHHHHHHHHccccCcc---CCCCHHHHhcCccccc
Q 014347 221 NLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPV---KRITIAGIKADEWFEQ 273 (426)
Q Consensus 221 ~~~~~~~~i~~~--~~~~p~~--~s~~~~~Li~~~L~~dP~---~R~t~~eil~h~~f~~ 273 (426)
+....+.++... ...+|++ +++++++||.+|+. +|. .||++++|++||||+.
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~ 298 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEG 298 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCC
Confidence 888888888763 3455553 78999999999775 444 4689999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-50 Score=396.70 Aligned_cols=251 Identities=33% Similarity=0.642 Sum_probs=227.2
Q ss_pred ceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEeccCCC
Q 014347 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG 99 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~gg 99 (426)
+.||+|+||.||++++..+|+.||+|++.+...........+.+|+.+++.++||||+++++.+...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444445667888999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccCC
Q 014347 100 ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179 (426)
Q Consensus 100 ~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt 179 (426)
+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC--CCCccccccCC
Confidence 9999998888899999999999999999999999999999999999999999999999999874211 22233456899
Q ss_pred CcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccccCccCC
Q 014347 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259 (426)
Q Consensus 180 ~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R 259 (426)
+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.......+......+|..+++.+.+||.+||+.||.+|
T Consensus 159 ~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05595 159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred cCcCCcccccCCCC-CchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHh
Confidence 99999999877666 68899999999999999999999998888888888888888999999999999999999999999
Q ss_pred C-----CHHHHhcCccccc
Q 014347 260 I-----TIAGIKADEWFEQ 273 (426)
Q Consensus 260 ~-----t~~eil~h~~f~~ 273 (426)
+ ++.++++|+||..
T Consensus 238 ~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 238 LGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 8 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-50 Score=395.57 Aligned_cols=251 Identities=34% Similarity=0.649 Sum_probs=226.4
Q ss_pred ceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEEEEEEeccCC
Q 014347 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~Ey~~g 98 (426)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|..++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876544444466778898888876 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccC
Q 014347 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (426)
Q Consensus 99 g~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~g 178 (426)
|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTTSTFCG 158 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCCccccccc
Confidence 99999998888999999999999999999999999999999999999999999999999999874221 2223445689
Q ss_pred CCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccccCccC
Q 014347 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258 (426)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 258 (426)
|+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+.+...++..+..+....|.++++++.+||++||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 237 (320)
T cd05590 159 TPDYIAPEILQEMLY-GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237 (320)
T ss_pred CccccCHHHHcCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHH
Confidence 999999999887666 6889999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCH------HHHhcCccccc
Q 014347 259 RITI------AGIKADEWFEQ 273 (426)
Q Consensus 259 R~t~------~eil~h~~f~~ 273 (426)
||++ ++++.||||..
T Consensus 238 R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 238 RLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred CCCCCCCCCHHHHHcCCCcCC
Confidence 9998 89999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-50 Score=394.04 Aligned_cols=256 Identities=34% Similarity=0.630 Sum_probs=230.3
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCC-CccceEEEEEeCCEEEEEE
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP-NVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~lV~ 93 (426)
+|++++.||+|+||.||+|.+..+++.||+|++.+.........+.+..|+.+++.+.|+ +|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999999876544444567788899999999865 5888999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcc
Q 014347 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 173 (426)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF--GGKTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC--CCCce
Confidence 9999999999998888899999999999999999999999999999999999999999999999999864211 22234
Q ss_pred ccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccc
Q 014347 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE 253 (426)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 253 (426)
...+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+.+....+..+......+|..+++.+.+|+++||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 237 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLT 237 (324)
T ss_pred eeecCCccccChhhhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 45689999999999987766 68899999999999999999999999988999999988889999999999999999999
Q ss_pred cCccCCCCH-----HHHhcCccccc
Q 014347 254 PNPVKRITI-----AGIKADEWFEQ 273 (426)
Q Consensus 254 ~dP~~R~t~-----~eil~h~~f~~ 273 (426)
+||.+|++. +++++||||..
T Consensus 238 ~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 238 KHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred cCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 999999986 89999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=391.50 Aligned_cols=254 Identities=31% Similarity=0.578 Sum_probs=226.2
Q ss_pred eeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHH---HhCCCCCccceEEEEEeCCEEEEE
Q 014347 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL---KLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il---~~l~hpnIv~l~~~~~~~~~~~lV 92 (426)
|++++.||+|+||.||+|.+..+|+.||+|++++.........+.+.+|+.++ +.++||||+++++++.+....|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78999999999999999999999999999999866544444456777777765 456799999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
|||++|++|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~ 157 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG--FGDR 157 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC--CCCc
Confidence 999999999988764 6799999999999999999999999999999999999999999999999999874221 2223
Q ss_pred cccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcc
Q 014347 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 252 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L 252 (426)
....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+..+...+|..+++.+.+||.+||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L 236 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLL 236 (324)
T ss_pred ccccccCccccCHhHhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHh
Confidence 446789999999999887666 6889999999999999999999999998888888988888899999999999999999
Q ss_pred ccCccCCC-----CHHHHhcCccccc
Q 014347 253 EPNPVKRI-----TIAGIKADEWFEQ 273 (426)
Q Consensus 253 ~~dP~~R~-----t~~eil~h~~f~~ 273 (426)
+.||.+|| ++.++++||||..
T Consensus 237 ~~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 237 RRNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred hcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 99999999 6999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=390.31 Aligned_cols=251 Identities=33% Similarity=0.631 Sum_probs=223.4
Q ss_pred ceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHh-CCCCCccceEEEEEeCCEEEEEEeccCC
Q 014347 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL-LKHPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~lV~Ey~~g 98 (426)
+.||+|+||.||+|++..+|+.||+|++++...........+..|..++.. ++||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 479999999999999999999999999986543323335567778888875 4899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccC
Q 014347 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (426)
Q Consensus 99 g~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~g 178 (426)
|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCceeccCC
Confidence 99999998888899999999999999999999999999999999999999999999999999873211 1223456789
Q ss_pred CCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccccCccC
Q 014347 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258 (426)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 258 (426)
|+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+......+|.++++++++||++||+.||++
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (316)
T cd05620 159 TPDYIAPEILQGLKY-TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237 (316)
T ss_pred CcCccCHHHHcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 999999999987766 6889999999999999999999999888888888888888899999999999999999999999
Q ss_pred CCCH-HHHhcCccccc
Q 014347 259 RITI-AGIKADEWFEQ 273 (426)
Q Consensus 259 R~t~-~eil~h~~f~~ 273 (426)
|+++ +++++||||..
T Consensus 238 R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 238 RLGVVGNIRGHPFFKT 253 (316)
T ss_pred cCCChHHHHcCCCcCC
Confidence 9998 58999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-50 Score=394.07 Aligned_cols=251 Identities=35% Similarity=0.642 Sum_probs=226.9
Q ss_pred ceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEEEEEEeccCC
Q 014347 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~Ey~~g 98 (426)
+.||+|+||.||+|++..+++.||+|++.+...........+..|..+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999876544444566778899999866 799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccC
Q 014347 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (426)
Q Consensus 99 g~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~g 178 (426)
|+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL--NGVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc--CCcccccccc
Confidence 99999998888999999999999999999999999999999999999999999999999999874321 2223445689
Q ss_pred CCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccccCccC
Q 014347 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258 (426)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 258 (426)
|+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+....+..+..+...+|.++++++.+||++||++||++
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~ 237 (321)
T cd05591 159 TPDYIAPEILQELEY-GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237 (321)
T ss_pred CccccCHHHHcCCCC-CCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHH
Confidence 999999999887666 6889999999999999999999999999999999999999999999999999999999999999
Q ss_pred CC-------CHHHHhcCccccc
Q 014347 259 RI-------TIAGIKADEWFEQ 273 (426)
Q Consensus 259 R~-------t~~eil~h~~f~~ 273 (426)
|+ ++.++++||||..
T Consensus 238 R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 238 RLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred cCCCCCCCCCHHHHhcCCccCC
Confidence 99 9999999999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-50 Score=400.17 Aligned_cols=258 Identities=33% Similarity=0.613 Sum_probs=226.1
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
++|++++.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998765444455677889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCC---
Q 014347 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD--- 170 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~--- 170 (426)
||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998643211000
Q ss_pred ---------------------------------CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCC
Q 014347 171 ---------------------------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217 (426)
Q Consensus 171 ---------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf 217 (426)
....+.+||+.|+|||++...++ +.++|||||||++|+|++|..||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCC-CCeeeeecchhHHHHhhcCCCCC
Confidence 01123579999999999887776 68999999999999999999999
Q ss_pred CCCcHHHHHHHHHcCC--CCCCC--CCCHHHHHHHHHccccCccCCCC---HHHHhcCccccc
Q 014347 218 DDRNLAVLYQKIFRGD--FKLPK--WLSPGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQ 273 (426)
Q Consensus 218 ~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~Li~~~L~~dP~~R~t---~~eil~h~~f~~ 273 (426)
.+.+....+.++.... +.+|. .+++++.+||++||. +|.+|++ +.+++.||||+.
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~ 301 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 9988887777776543 34444 368999999999997 9999998 999999999975
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-50 Score=395.09 Aligned_cols=254 Identities=30% Similarity=0.530 Sum_probs=226.7
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999998765444445677889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcc
Q 014347 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 173 (426)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~ 155 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YA 155 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----cc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999975322 33
Q ss_pred ccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC--CCCCC------CCCHHHH
Q 014347 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPK------WLSPGAQ 245 (426)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~------~~s~~~~ 245 (426)
...+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+.... ...|. .+++++.
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGY-DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred CCcccCccccChhHhcCCCC-CCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 45689999999999987766 688999999999999999999999988877776665432 22232 3589999
Q ss_pred HHHHHccccCccCCCCHHHHhcCccccc
Q 014347 246 NLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
+||.+||..+|.+|||+.++++||||..
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 9999999999999999999999999985
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-51 Score=385.63 Aligned_cols=262 Identities=31% Similarity=0.474 Sum_probs=224.8
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe-----CCE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-----KSK 88 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~~~ 88 (426)
.+|..++.||+|+||.|+.|.++.+|+.||||.+.. ...+.-..++..||+.+|+.++|+||+.+++++.. -..
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~-~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN-PFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhh-hhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 456668999999999999999999999999998853 23445567899999999999999999999999865 457
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
+|+|+|++ +.+|...|+.+..+++..++.++.||+.||.|+|+.||+||||||.|+|++.++.+||+|||+|+..+...
T Consensus 101 vYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred eEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccC
Confidence 99999999 56999999887779999999999999999999999999999999999999999999999999999765433
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHc-----------------
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR----------------- 231 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~----------------- 231 (426)
....+...+-|.+|.|||++....-++...||||+|||+.||++|++.|.+.+.....+.|..
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ 259 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK 259 (359)
T ss_pred cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence 455667788999999999987766668999999999999999999999998776555544432
Q ss_pred ------CCCCCC--------CCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccCCC
Q 014347 232 ------GDFKLP--------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (426)
Q Consensus 232 ------~~~~~p--------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 277 (426)
..+..| +..++.+.+|+.+||..||.+|+|++|+|+||||.....|
T Consensus 260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp 319 (359)
T KOG0660|consen 260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP 319 (359)
T ss_pred HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence 111111 2478999999999999999999999999999999876544
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-50 Score=401.39 Aligned_cols=259 Identities=32% Similarity=0.531 Sum_probs=223.7
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
+.|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 36999999999999999999999999999999998766555556778999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC----
Q 014347 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD---- 169 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~---- 169 (426)
||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999999763211000
Q ss_pred -----------------------------------------CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHH
Q 014347 170 -----------------------------------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208 (426)
Q Consensus 170 -----------------------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ 208 (426)
.....+.+||+.|+|||++.+.++ +.++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlG~il~ 239 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY-TQLCDWWSVGVILF 239 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCC-CCccceeehhhHHH
Confidence 001134579999999999987776 58899999999999
Q ss_pred HHHhCCCCCCCCcHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHcc--ccCccCCCCHHHHhcCccccc
Q 014347 209 VILTGYLPFDDRNLAVLYQKIFR--GDFKLPK--WLSPGAQNLLRKIL--EPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 209 elltG~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~Li~~~L--~~dP~~R~t~~eil~h~~f~~ 273 (426)
+|++|..||...+......++.. ....+|. .+++++.+||.+|| ..+|..|+++.++++||||..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred HHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence 99999999998877666666653 3345554 47999999999955 556666999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-49 Score=390.49 Aligned_cols=258 Identities=33% Similarity=0.625 Sum_probs=223.9
Q ss_pred CeeeeceEeecCceEEEEEEEC---CCCCeEEEEEeeccccc-chhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCCEE
Q 014347 15 RYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKI 89 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 89 (426)
+|++++.||+|+||.||++++. .+++.||+|++.+.... .....+.+.+|+.+++.++ ||||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999864 47899999999764432 2334567889999999995 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... .
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~-~ 159 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE-E 159 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc-C
Confidence 999999999999999988888999999999999999999999999999999999999999999999999998754221 1
Q ss_pred CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCC----cHHHHHHHHHcCCCCCCCCCCHHHH
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR----NLAVLYQKIFRGDFKLPKWLSPGAQ 245 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~~ 245 (426)
.......+||+.|+|||++.+....+.++|||||||++|+|++|+.||... ........+......+|..+++.+.
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQ 239 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHH
Confidence 222345689999999999876655578899999999999999999999642 3345556667777888888999999
Q ss_pred HHHHHccccCccCCC-----CHHHHhcCccccc
Q 014347 246 NLLRKILEPNPVKRI-----TIAGIKADEWFEQ 273 (426)
Q Consensus 246 ~Li~~~L~~dP~~R~-----t~~eil~h~~f~~ 273 (426)
+||.+||+.||++|| +++++++||||+.
T Consensus 240 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred HHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 999999999999999 7889999999976
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=399.57 Aligned_cols=258 Identities=31% Similarity=0.548 Sum_probs=224.0
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
++|++++.||+|+||.||+|.+..+|+.||||++.+......+..+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999997655444455678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCC---
Q 014347 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD--- 170 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~--- 170 (426)
||++||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.+......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998632110000
Q ss_pred ------------------------------------------CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHH
Q 014347 171 ------------------------------------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208 (426)
Q Consensus 171 ------------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ 208 (426)
......+||+.|+|||++.+..+ +.++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC-CCceeeEecchhhh
Confidence 00113579999999999987776 68999999999999
Q ss_pred HHHhCCCCCCCCcHHHHHHHHHcC--CCCCCCC--CCHHHHHHHHHccccCccCC---CCHHHHhcCccccc
Q 014347 209 VILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKR---ITIAGIKADEWFEQ 273 (426)
Q Consensus 209 elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~--~s~~~~~Li~~~L~~dP~~R---~t~~eil~h~~f~~ 273 (426)
+|++|..||.+.+....+.++... ...+|.. +++++.+||.+||. +|.+| +|+.+++.||||..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 999999999988887777777653 3455553 78999999999998 77765 59999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-50 Score=395.46 Aligned_cols=251 Identities=34% Similarity=0.647 Sum_probs=227.1
Q ss_pred ceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEeccCCC
Q 014347 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG 99 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~gg 99 (426)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444445667888999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-cCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccC
Q 014347 100 ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (426)
Q Consensus 100 ~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~-~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~g 178 (426)
+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCG 158 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC--CCcccccccC
Confidence 999999888889999999999999999999997 7999999999999999999999999999874211 2223345689
Q ss_pred CCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccccCccC
Q 014347 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258 (426)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 258 (426)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......+|..+++++.+||++||+.||++
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 237 (325)
T cd05594 159 TPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237 (325)
T ss_pred CcccCCHHHHccCCC-CCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence 999999999987766 6899999999999999999999999988888888888888999999999999999999999999
Q ss_pred CC-----CHHHHhcCccccc
Q 014347 259 RI-----TIAGIKADEWFEQ 273 (426)
Q Consensus 259 R~-----t~~eil~h~~f~~ 273 (426)
|+ ++.++++||||..
T Consensus 238 R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 238 RLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred hCCCCCCCHHHHhcCCCcCC
Confidence 97 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=390.17 Aligned_cols=252 Identities=37% Similarity=0.681 Sum_probs=225.2
Q ss_pred eceEeecCceEEEEEEEC---CCCCeEEEEEeeccccc-chhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEe
Q 014347 19 GRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (426)
++.||+|+||.||+|++. .+++.||+|++.+.... .......+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 468999999999999864 47889999999765432 22334567899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccc
Q 014347 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH 174 (426)
Q Consensus 95 y~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 174 (426)
|++|++|.+.+.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~ 158 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH--EGTVTH 158 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc--CCCccc
Confidence 999999999999888899999999999999999999999999999999999999999999999999874221 223344
Q ss_pred cccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcccc
Q 014347 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEP 254 (426)
Q Consensus 175 ~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~ 254 (426)
..+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+..+...+|..+++.+.+||++||++
T Consensus 159 ~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 237 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKR 237 (323)
T ss_pred ccCCCccccChhhccCCCC-CCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccc
Confidence 5689999999999887666 688999999999999999999999998888888999999999999999999999999999
Q ss_pred CccCCC-----CHHHHhcCccccc
Q 014347 255 NPVKRI-----TIAGIKADEWFEQ 273 (426)
Q Consensus 255 dP~~R~-----t~~eil~h~~f~~ 273 (426)
||++|| ++++++.||||..
T Consensus 238 ~p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 238 NPSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred CHhHcCCCCCCCHHHHhcCCCcCC
Confidence 999999 8999999999975
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=400.14 Aligned_cols=258 Identities=34% Similarity=0.556 Sum_probs=224.1
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+++.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999999999999999998765444555678999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc-----
Q 014347 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR----- 168 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~----- 168 (426)
||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999975321100
Q ss_pred ----------------------------------------CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHH
Q 014347 169 ----------------------------------------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208 (426)
Q Consensus 169 ----------------------------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ 208 (426)
......+.+||+.|+|||++.+.++ +.++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlGvil~ 239 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILY 239 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCC-CCeeeEEechHHHH
Confidence 0001124579999999999988777 58899999999999
Q ss_pred HHHhCCCCCCCCcHHHHHHHHHcC--CCCCC--CCCCHHHHHHHHHccccCccCCCC---HHHHhcCccccc
Q 014347 209 VILTGYLPFDDRNLAVLYQKIFRG--DFKLP--KWLSPGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQ 273 (426)
Q Consensus 209 elltG~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~Li~~~L~~dP~~R~t---~~eil~h~~f~~ 273 (426)
+|++|+.||.+.+......++... ....| ..+++++.+||.+|+ .+|.+|++ ++++++||||+.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 999999999988877766666653 33444 348999999999987 59999997 999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=384.12 Aligned_cols=255 Identities=30% Similarity=0.448 Sum_probs=221.0
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEe
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (426)
.|++.+.||+|+||.||+|.+..+|+.||+|.+.+...........+.+|+.+++.++|+||+++++++.+.+..|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 38899999999999999999999999999999986654443444567899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 95 YVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 95 y~~gg~L~~~i~~--~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
|++||+|.+.+.. ...+++..+..++.|++.||+|||++||+||||||+|||+++++.+||+|||++..... ...
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~---~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE---GET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC---CCe
Confidence 9999999888764 34689999999999999999999999999999999999999999999999999875321 222
Q ss_pred cccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcH----HHHHHHHHcCCCCCCCCCCHHHHHHH
Q 014347 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL----AVLYQKIFRGDFKLPKWLSPGAQNLL 248 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~Li 248 (426)
....+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+.+. ......+......++..+++.+.+||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 236 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKY-TFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC 236 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCC-CcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence 345679999999999987766 6889999999999999999999987543 23334444555667778999999999
Q ss_pred HHccccCccCCCC-----HHHHhcCccccc
Q 014347 249 RKILEPNPVKRIT-----IAGIKADEWFEQ 273 (426)
Q Consensus 249 ~~~L~~dP~~R~t-----~~eil~h~~f~~ 273 (426)
++||+.||.+||| ++++++||||..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 237 RMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred HHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 9999999999997 899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-49 Score=386.85 Aligned_cols=251 Identities=36% Similarity=0.684 Sum_probs=222.7
Q ss_pred ceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHh-CCCCCccceEEEEEeCCEEEEEEeccCC
Q 014347 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL-LKHPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~lV~Ey~~g 98 (426)
+.||+|+||.||+|++..+++.||+|++++.........+.+..|..++.. .+||||+++++++......|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999999999999999986544333445566677777765 4799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccC
Q 014347 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (426)
Q Consensus 99 g~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~g 178 (426)
|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~--~~~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN--GEGKASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC--CCCccccccC
Confidence 99999998888999999999999999999999999999999999999999999999999999874321 1233445689
Q ss_pred CCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccccCccC
Q 014347 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258 (426)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 258 (426)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+......+|.++++++.+||.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~ 237 (316)
T cd05592 159 TPDYIAPEILKGQKY-NESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237 (316)
T ss_pred CccccCHHHHcCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 999999999887766 6889999999999999999999999988888888888888889999999999999999999999
Q ss_pred CCCHH-HHhcCccccc
Q 014347 259 RITIA-GIKADEWFEQ 273 (426)
Q Consensus 259 R~t~~-eil~h~~f~~ 273 (426)
||++. +++.||||..
T Consensus 238 R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 238 RLGVDGDIRQHPFFRG 253 (316)
T ss_pred cCCChHHHHcCcccCC
Confidence 99864 8999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-49 Score=390.34 Aligned_cols=256 Identities=34% Similarity=0.621 Sum_probs=230.0
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCCEEEEEE
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~ 93 (426)
+|++++.||+|+||.||+|++..+++.||+|++.+...........+..|..++..+. |++|+++++++.+.+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5899999999999999999999999999999998765444444566778888888774 899999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcc
Q 014347 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 173 (426)
||++||+|.+.+...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~--~~~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW--DGVTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC--CCCcc
Confidence 9999999999998888899999999999999999999999999999999999999999999999999874321 22234
Q ss_pred ccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccc
Q 014347 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE 253 (426)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 253 (426)
...+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+....+..+......+|..+++++.+|+.+||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~ 237 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 237 (323)
T ss_pred ccCCCChhhcCHHHhcCCCC-CCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcc
Confidence 45689999999999987776 68999999999999999999999999999999999999999999999999999999999
Q ss_pred cCccCCCCH-----HHHhcCccccc
Q 014347 254 PNPVKRITI-----AGIKADEWFEQ 273 (426)
Q Consensus 254 ~dP~~R~t~-----~eil~h~~f~~ 273 (426)
.||.+|++. .++++||||..
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 238 KHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred cCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 999999984 89999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=384.08 Aligned_cols=255 Identities=27% Similarity=0.437 Sum_probs=215.2
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
.+++|++.+.||+|+||.||+|++..+++.||+|+++..... .....+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL 80 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 478899999999999999999999999999999998754321 224567889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCC
Q 014347 92 VLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~~-~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 170 (426)
||||+.| +|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 81 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~--~~ 157 (288)
T cd07871 81 VFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV--PT 157 (288)
T ss_pred EEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC--CC
Confidence 9999975 8999887644 579999999999999999999999999999999999999999999999999875322 12
Q ss_pred CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC-----------------
Q 014347 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD----------------- 233 (426)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~----------------- 233 (426)
.......|++.|+|||++.+....+.++||||+||++|+|++|+.||.+.+..+....+....
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 223456789999999998765545789999999999999999999998877655544432210
Q ss_pred --CCCC-----------CCCCHHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 234 --FKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 234 --~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
..+| ..+++++++||++||++||.+|||++|+++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0111 2357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=390.97 Aligned_cols=251 Identities=30% Similarity=0.611 Sum_probs=222.0
Q ss_pred ceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEEEEEEeccCC
Q 014347 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~Ey~~g 98 (426)
+.||+|+||.||+|++..+++.||+|++++...........+.+|..+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876554555567788999999988 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccC
Q 014347 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (426)
Q Consensus 99 g~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~g 178 (426)
|+|.+++.+.+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... .......+.+|
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~--~~~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI--RPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccc--cCCCccccccC
Confidence 9999999888899999999999999999999999999999999999999999999999999987321 12233456789
Q ss_pred CCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCC---------cHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 014347 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR---------NLAVLYQKIFRGDFKLPKWLSPGAQNLLR 249 (426)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~---------~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 249 (426)
|+.|+|||++.+..+ +.++|+||+||++|+|++|+.||+.. .....++.+......+|..+++.+.+||+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~ 237 (329)
T cd05588 159 TPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237 (329)
T ss_pred CccccCHHHHcCCCC-CCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999999987766 58899999999999999999999631 22345666777788899999999999999
Q ss_pred HccccCccCCCC------HHHHhcCccccc
Q 014347 250 KILEPNPVKRIT------IAGIKADEWFEQ 273 (426)
Q Consensus 250 ~~L~~dP~~R~t------~~eil~h~~f~~ 273 (426)
+||+.||.+|+| ++++++||||..
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999999997 789999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-49 Score=386.68 Aligned_cols=251 Identities=37% Similarity=0.706 Sum_probs=226.8
Q ss_pred ceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEEEEEEeccCC
Q 014347 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~Ey~~g 98 (426)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876544444566778899999887 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccC
Q 014347 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (426)
Q Consensus 99 g~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~g 178 (426)
|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL--GGVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc--CCCcccceec
Confidence 99999998888999999999999999999999999999999999999999999999999999864211 2223445689
Q ss_pred CCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccccCccC
Q 014347 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258 (426)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 258 (426)
|+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+.+....+..+......+|..+++.+.+||++||+.||++
T Consensus 159 ~~~y~aPE~~~~~~~-~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (318)
T cd05570 159 TPDYIAPEILSYQPY-GPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237 (318)
T ss_pred CccccCHHHhcCCCC-CcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHH
Confidence 999999999987776 5889999999999999999999999888888888888888889999999999999999999999
Q ss_pred CCCH-----HHHhcCccccc
Q 014347 259 RITI-----AGIKADEWFEQ 273 (426)
Q Consensus 259 R~t~-----~eil~h~~f~~ 273 (426)
|||+ .+++.||||..
T Consensus 238 R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 238 RLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred cCCCCCCCHHHHhcCCCcCC
Confidence 9999 99999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=395.70 Aligned_cols=258 Identities=33% Similarity=0.618 Sum_probs=229.0
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
++|++++.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998765444445678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc-----
Q 014347 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR----- 168 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~----- 168 (426)
||++|++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 999999999999988899999999999999999999999999999999999999999999999999987543321
Q ss_pred ----------------------CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHH
Q 014347 169 ----------------------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY 226 (426)
Q Consensus 169 ----------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~ 226 (426)
.........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCC-CCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 0012334679999999999987766 68999999999999999999999998888888
Q ss_pred HHHHc--CCCCCCCC--CCHHHHHHHHHccccCccCCCC-HHHHhcCccccc
Q 014347 227 QKIFR--GDFKLPKW--LSPGAQNLLRKILEPNPVKRIT-IAGIKADEWFEQ 273 (426)
Q Consensus 227 ~~i~~--~~~~~p~~--~s~~~~~Li~~~L~~dP~~R~t-~~eil~h~~f~~ 273 (426)
.++.. ....+|.. +++++.+||.+||. ||.+|++ +.++++||||+.
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 77776 44555544 59999999999997 9999999 999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=399.04 Aligned_cols=258 Identities=32% Similarity=0.533 Sum_probs=222.9
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+|+.++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997654434444677889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC----
Q 014347 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD---- 169 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~---- 169 (426)
||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+.....
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 9999999999999888899999999999999999999999999999999999999999999999999753211000
Q ss_pred -------------------------------------CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh
Q 014347 170 -------------------------------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212 (426)
Q Consensus 170 -------------------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt 212 (426)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCC-Ccceeeeeccceeeehhh
Confidence 001123579999999999987776 689999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHcC--CCCCCC--CCCHHHHHHHHHccccCccCCC---CHHHHhcCccccc
Q 014347 213 GYLPFDDRNLAVLYQKIFRG--DFKLPK--WLSPGAQNLLRKILEPNPVKRI---TIAGIKADEWFEQ 273 (426)
Q Consensus 213 G~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~Li~~~L~~dP~~R~---t~~eil~h~~f~~ 273 (426)
|+.||.+.+......++... ...+|. .+++.+.+||.+|+ .+|.+|+ |+.++++||||+.
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 99999998877766666543 233333 47999999999976 5999999 9999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-50 Score=399.91 Aligned_cols=258 Identities=27% Similarity=0.511 Sum_probs=230.4
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
+....+|....+||+|+.|.||.|+...+++.||||.++...... .+-+.+|+.+|+..+|+|||++++.|.-.+.+
T Consensus 269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deL 345 (550)
T KOG0578|consen 269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDEL 345 (550)
T ss_pred CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhccccee
Confidence 455678999999999999999999999999999999998876554 35688999999999999999999999888999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
|.||||++||+|.|.+.. ..++|.++..+.++++.||+|||.+||+|||||.+|||++.+|.+||+|||++......
T Consensus 346 WVVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~-- 422 (550)
T KOG0578|consen 346 WVVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE-- 422 (550)
T ss_pred EEEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc--
Confidence 999999999999998876 55999999999999999999999999999999999999999999999999999865442
Q ss_pred CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHH-cCC--CCCCCCCCHHHHH
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF-RGD--FKLPKWLSPGAQN 246 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~-~~~--~~~p~~~s~~~~~ 246 (426)
...-.+.+|||.|||||++..+.| |+++||||||++.+||+-|.+||-.++.-.....|. ++. +..|..+|+.+++
T Consensus 423 ~~KR~TmVGTPYWMAPEVvtrk~Y-G~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kd 501 (550)
T KOG0578|consen 423 QSKRSTMVGTPYWMAPEVVTRKPY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKD 501 (550)
T ss_pred cCccccccCCCCccchhhhhhccc-CccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHH
Confidence 224567899999999999998888 799999999999999999999999877665555554 343 4557789999999
Q ss_pred HHHHccccCccCCCCHHHHhcCcccccc
Q 014347 247 LLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 247 Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
||.+||+.||.+|+++.++|+||||+..
T Consensus 502 FL~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 502 FLDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred HHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 9999999999999999999999999543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-49 Score=381.90 Aligned_cols=262 Identities=29% Similarity=0.497 Sum_probs=230.7
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
-...+.|++...||.|..+.||+|+..-+++.||||+++.+++.+. .+.+.+|+..|+.++||||++++..|..+..+
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L 99 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL 99 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence 3456799999999999999999999999999999999998887654 78899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 90 YMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~--~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
|+||.|+.+|++++.+.. ...++|..+..++++++.||.|||++|-||||||+.||||+.+|.|||+|||.+......
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 999999999999999986 345999999999999999999999999999999999999999999999999987644332
Q ss_pred cCC-C-ccccccCCCcccchhhhc-c-CCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCC-----
Q 014347 168 RDD-G-LLHTTCGSPNYVAPEVLA-N-RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----- 238 (426)
Q Consensus 168 ~~~-~-~~~~~~gt~~y~APE~l~-~-~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----- 238 (426)
+.. . ..++..|||+|+|||++. . .+| +.|+||||||++..||.+|..||....+..+.-.-+++.++.|.
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GY-dfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~ 258 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGY-DFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLD 258 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCc-cchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCC
Confidence 211 1 226679999999999953 3 466 58999999999999999999999998888777777777765432
Q ss_pred -----CCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 239 -----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 239 -----~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
.++..++.+|..||++||.+|||++++++|+||++.
T Consensus 259 ~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 259 KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 267789999999999999999999999999999863
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-49 Score=395.95 Aligned_cols=264 Identities=29% Similarity=0.513 Sum_probs=229.6
Q ss_pred cCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 014347 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (426)
......++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~ 116 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK 116 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 34556789999999999999999999999999999999997654434444566889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
..|+||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999999998865 56899999999999999999999999999999999999999999999999998754321
Q ss_pred cCCCccccccCCCcccchhhhccCC---CCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC--CCCCC--CC
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRG---YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPK--WL 240 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~---~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~ 240 (426)
. .......+||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||.+.+....+.++.... ..+|. .+
T Consensus 196 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 274 (370)
T cd05596 196 G-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEI 274 (370)
T ss_pred C-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCC
Confidence 1 11224568999999999986532 34789999999999999999999999999888888887643 45565 47
Q ss_pred CHHHHHHHHHccccCccC--CCCHHHHhcCccccc
Q 014347 241 SPGAQNLLRKILEPNPVK--RITIAGIKADEWFEQ 273 (426)
Q Consensus 241 s~~~~~Li~~~L~~dP~~--R~t~~eil~h~~f~~ 273 (426)
|.++.+||++||+.+|.+ |+|++++++||||..
T Consensus 275 s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 275 SKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred CHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 999999999999999998 999999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-50 Score=374.99 Aligned_cols=265 Identities=30% Similarity=0.405 Sum_probs=227.3
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEE--eCC
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA--SKS 87 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~ 87 (426)
...++.|+.+..|++|+||.||+|+|+.|++.||+|.++.+. ....+--.-.|||.+|.+.+|||||.+-++.. +-+
T Consensus 72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d 150 (419)
T KOG0663|consen 72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMD 150 (419)
T ss_pred cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence 345678999999999999999999999999999999987654 23333445678999999999999999999865 446
Q ss_pred EEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcc
Q 014347 88 KIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~~-~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 166 (426)
.+|+|||||+. +|...+...+ +|...+++.++.|+++||+|||.+.|+||||||+|+|+...|.+||+|||+|+.++.
T Consensus 151 ~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 151 KIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred eeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcC
Confidence 79999999976 9999998744 899999999999999999999999999999999999999999999999999997654
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC--C-----------
Q 014347 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--D----------- 233 (426)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~----------- 233 (426)
........+-|.+|+|||.+.+...++.+.|+||+|||+.||+++++.|.+....+...+|++- .
T Consensus 230 --p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 230 --PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred --CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 2234556678999999999998887789999999999999999999999999888888777641 0
Q ss_pred ------CCCCC------------C-CCHHHHHHHHHccccCccCCCCHHHHhcCccccccCCCC
Q 014347 234 ------FKLPK------------W-LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 278 (426)
Q Consensus 234 ------~~~p~------------~-~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~~ 278 (426)
..+|+ . ++....+|++.+|..||.+|.|+.+.|+|+||.+...|.
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~ 371 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPI 371 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCC
Confidence 11111 1 457889999999999999999999999999999865554
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-49 Score=379.83 Aligned_cols=255 Identities=25% Similarity=0.407 Sum_probs=214.0
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++..++..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 579999999999999999999999999999999976432 2234567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcc
Q 014347 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 173 (426)
||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~ 158 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG-SNANY 158 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccc-ccccc
Confidence 99999877666555567999999999999999999999999999999999999999999999999999854321 11223
Q ss_pred ccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC-------------------C
Q 014347 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-------------------F 234 (426)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-------------------~ 234 (426)
....||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+.+.......+.... .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPY-GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcCCCC-CCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 34579999999999987776 688999999999999999999998765443322221100 0
Q ss_pred CCC-------------CCCCHHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 235 KLP-------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 235 ~~p-------------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
..| ..+|+++.+||++||++||++|||++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 111 1267889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-49 Score=387.70 Aligned_cols=251 Identities=31% Similarity=0.617 Sum_probs=221.2
Q ss_pred ceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEEEEEEeccCC
Q 014347 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~Ey~~g 98 (426)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876555555567788999998776 799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccC
Q 014347 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (426)
Q Consensus 99 g~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~g 178 (426)
|+|.+++...+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC--CCCccccccC
Confidence 99999998888999999999999999999999999999999999999999999999999999874221 2223345789
Q ss_pred CCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCC---------CcHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 014347 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD---------RNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 249 (426)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~---------~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 249 (426)
|+.|+|||++.+..+ +.++|||||||++|+|++|+.||.. .......+.+......+|..++..+.+||+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~ 237 (329)
T cd05618 159 TPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237 (329)
T ss_pred CccccCHHHHcCCCC-CCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 999999999987766 6889999999999999999999952 123345666777788899999999999999
Q ss_pred HccccCccCCCC------HHHHhcCccccc
Q 014347 250 KILEPNPVKRIT------IAGIKADEWFEQ 273 (426)
Q Consensus 250 ~~L~~dP~~R~t------~~eil~h~~f~~ 273 (426)
+||+.||.+||| ++++++||||..
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 238 SFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred HHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999999998 589999999965
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-49 Score=387.84 Aligned_cols=251 Identities=37% Similarity=0.625 Sum_probs=222.5
Q ss_pred ceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHH-HHHhCCCCCccceEEEEEeCCEEEEEEeccCC
Q 014347 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA-TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~g 98 (426)
+.||+|+||.||+|++..+|+.||+|++.+...........+.+|.. +++.++||||+++++.+.+.+..|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999999999999999998654433333445555555 56789999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccC
Q 014347 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (426)
Q Consensus 99 g~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~g 178 (426)
|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCccccccC
Confidence 99999999888999999999999999999999999999999999999999999999999999874211 2223445689
Q ss_pred CCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccccCccC
Q 014347 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258 (426)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 258 (426)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+.......++.+++.+.+||++||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (323)
T cd05575 159 TPEYLAPEVLRKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237 (323)
T ss_pred ChhhcChhhhcCCCC-CccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHh
Confidence 999999999887766 5889999999999999999999999998899999998888888889999999999999999999
Q ss_pred CCCH----HHHhcCccccc
Q 014347 259 RITI----AGIKADEWFEQ 273 (426)
Q Consensus 259 R~t~----~eil~h~~f~~ 273 (426)
||++ .+++.||||..
T Consensus 238 R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 238 RLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 9997 69999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-49 Score=385.87 Aligned_cols=256 Identities=34% Similarity=0.627 Sum_probs=228.8
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCCEEEEEE
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~ 93 (426)
+|++.+.||+|+||.||+|.+..+|+.||+|++.+.........+.+..|..+++.+. |++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999999999999999998755434444567788999998886 577888999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcc
Q 014347 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 173 (426)
||++||+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~--~~~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV--DGVTT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC--CCccc
Confidence 9999999999998888999999999999999999999999999999999999999999999999999874221 12233
Q ss_pred ccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccc
Q 014347 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE 253 (426)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 253 (426)
...+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.....+.+......+|..+++.+.+|+.+||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~ 237 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPY-GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMT 237 (323)
T ss_pred cCccCCccccCHHHHcCCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcc
Confidence 45679999999999887666 68899999999999999999999999988889999998889999999999999999999
Q ss_pred cCccCCCC-----HHHHhcCccccc
Q 014347 254 PNPVKRIT-----IAGIKADEWFEQ 273 (426)
Q Consensus 254 ~dP~~R~t-----~~eil~h~~f~~ 273 (426)
+||.+|++ .+++++||||..
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~f~~ 262 (323)
T cd05615 238 KHPSKRLGCGPEGERDIREHAFFRR 262 (323)
T ss_pred cCHhhCCCCCCCCHHHHhcCcccCC
Confidence 99999997 478999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-49 Score=385.74 Aligned_cols=251 Identities=34% Similarity=0.618 Sum_probs=222.7
Q ss_pred ceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHh-CCCCCccceEEEEEeCCEEEEEEeccCC
Q 014347 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL-LKHPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~lV~Ey~~g 98 (426)
+.||+|+||+||+|++..+++.||+|++.+..............|..+++. ++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999986543323334566778888876 5899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccC
Q 014347 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (426)
Q Consensus 99 g~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~g 178 (426)
|+|.+.+.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML--GDAKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC--CCCceeeecC
Confidence 99999998888899999999999999999999999999999999999999999999999999874211 1223445689
Q ss_pred CCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccccCccC
Q 014347 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258 (426)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 258 (426)
|+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+..+......+|.+++.++.+||.+||+.||++
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 237 (316)
T cd05619 159 TPDYIAPEILLGQKY-NTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER 237 (316)
T ss_pred CccccCHHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhh
Confidence 999999999887666 6889999999999999999999999888888888887778888999999999999999999999
Q ss_pred CCCHH-HHhcCccccc
Q 014347 259 RITIA-GIKADEWFEQ 273 (426)
Q Consensus 259 R~t~~-eil~h~~f~~ 273 (426)
||++. ++++||||..
T Consensus 238 R~~~~~~l~~h~~~~~ 253 (316)
T cd05619 238 RLGVKGDIRQHPFFRE 253 (316)
T ss_pred cCCChHHHHcCcccCC
Confidence 99996 8999999976
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-49 Score=394.03 Aligned_cols=258 Identities=31% Similarity=0.576 Sum_probs=225.8
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
++|++++.||+|+||.||+|.+..+++.||+|++.+......+....+.+|+.++..++||||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998655444455678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC----
Q 014347 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD---- 169 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~---- 169 (426)
||++||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999874321100
Q ss_pred -----------------------------CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCC
Q 014347 170 -----------------------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR 220 (426)
Q Consensus 170 -----------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 220 (426)
.....+.+||+.|+|||++.+.++ +.++|||||||++|+|++|+.||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCC-CCcceeccccceeeecccCCCCCCCC
Confidence 011224589999999999988777 58899999999999999999999999
Q ss_pred cHHHHHHHHHcC--CCCCCCC--CCHHHHHHHHHccccCccCCC---CHHHHhcCccccc
Q 014347 221 NLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRI---TIAGIKADEWFEQ 273 (426)
Q Consensus 221 ~~~~~~~~i~~~--~~~~p~~--~s~~~~~Li~~~L~~dP~~R~---t~~eil~h~~f~~ 273 (426)
+....+.++... ...+|+. +++++++||.+|+. ||.+|+ ++.++++||||..
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCC
Confidence 888888887753 3445543 78999999999874 999998 4899999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-49 Score=382.15 Aligned_cols=257 Identities=28% Similarity=0.432 Sum_probs=211.1
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (426)
.++|++.+.||+|+||.||+|++..+++.||+|++...... .....+.+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 47899999999999999999999999999999998754322 1234677899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCC
Q 014347 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 171 (426)
|||+. ++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... ...
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~ 158 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV--PSH 158 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC--CCc
Confidence 99995 588887765 45799999999999999999999999999999999999999999999999999874322 122
Q ss_pred ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcH-HHHHHHHHc--CCC---------C----
Q 014347 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFR--GDF---------K---- 235 (426)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~--~~~---------~---- 235 (426)
.....+||+.|+|||++.+....+.++||||+||++|+|++|..||.+... ......+.. +.. .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 234567899999999987655557889999999999999999999987432 222222211 000 0
Q ss_pred --------CCC---------CCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 236 --------LPK---------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 236 --------~p~---------~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
.|. ..++.+.+||.+||++||.+|||+.++++||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 010 135678999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-49 Score=394.41 Aligned_cols=264 Identities=30% Similarity=0.530 Sum_probs=227.7
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (426)
.....++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.++..
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 34556899999999999999999999999999999999976544444445678899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
.|+||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|......
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~- 195 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET- 195 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccC-
Confidence 9999999999999999865 46899999999999999999999999999999999999999999999999999754321
Q ss_pred CCCccccccCCCcccchhhhccCC---CCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC--CCCCC--CCC
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRG---YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPK--WLS 241 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~---~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s 241 (426)
......+.+||+.|+|||++.+.+ +.+.++||||+||++|+|++|+.||.+.+....+.++.... +.+|. .++
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 275 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEIS 275 (370)
T ss_pred CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCC
Confidence 111234678999999999987543 34689999999999999999999999988888888887643 55555 369
Q ss_pred HHHHHHHHHccccCccC--CCCHHHHhcCcccccc
Q 014347 242 PGAQNLLRKILEPNPVK--RITIAGIKADEWFEQD 274 (426)
Q Consensus 242 ~~~~~Li~~~L~~dP~~--R~t~~eil~h~~f~~~ 274 (426)
+.+++|+.+||..+|.+ |+|+.++++||||+..
T Consensus 276 ~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 276 KHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 99999999999866654 8999999999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=384.17 Aligned_cols=251 Identities=34% Similarity=0.656 Sum_probs=224.2
Q ss_pred eceEeecCceEEEEEEEC---CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEec
Q 014347 19 GRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (426)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey 95 (426)
++.||+|+||.||++++. .+|+.||+|++.+.... ......+.+|+.++++++||||+++++++.+.+.+|+||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 368999999999999863 57899999999865432 22345677899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcccc
Q 014347 96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT 175 (426)
Q Consensus 96 ~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 175 (426)
++||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .......
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~--~~~~~~~ 157 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAYS 157 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCC--CCCceec
Confidence 99999999998888899999999999999999999999999999999999999999999999999875322 1223445
Q ss_pred ccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccccC
Q 014347 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255 (426)
Q Consensus 176 ~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~d 255 (426)
.+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+......+|..+++.+.+||++||++|
T Consensus 158 ~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~ 236 (318)
T cd05582 158 FCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRN 236 (318)
T ss_pred ccCChhhcCHHHHcCCCC-CCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 689999999999887666 6889999999999999999999999988888888888888999999999999999999999
Q ss_pred ccCCCC-----HHHHhcCccccc
Q 014347 256 PVKRIT-----IAGIKADEWFEQ 273 (426)
Q Consensus 256 P~~R~t-----~~eil~h~~f~~ 273 (426)
|.+||| +.+++.||||..
T Consensus 237 P~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 237 PANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred HhHcCCCCCCCHHHHhCCCCcCC
Confidence 999999 788999999975
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-49 Score=387.31 Aligned_cols=258 Identities=28% Similarity=0.532 Sum_probs=224.7
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
++|++.+.||+|+||.||+|.+..+|+.||+|++++...........+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765444445677889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 94 EYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
||++||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....... ...
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~-~~~ 159 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVN 159 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC-cee
Confidence 999999999999875 689999999999999999999999999999999999999999999999999997543211 112
Q ss_pred cccccCCCcccchhhhcc-----CCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC--CCCCC--CCCHH
Q 014347 173 LHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPK--WLSPG 243 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~-----~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~ 243 (426)
....+||+.|+|||++.. ....+.++|||||||++|+|++|..||...+....+.++.... ..+|. .+++.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHH
Confidence 234579999999999863 2334688999999999999999999999888877777776542 33343 57999
Q ss_pred HHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
+.+||.+||. ||.+|||+++++.||||..
T Consensus 240 ~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 240 FLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred HHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 9999999998 9999999999999999975
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=385.23 Aligned_cols=251 Identities=35% Similarity=0.597 Sum_probs=222.0
Q ss_pred ceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHH-HHHhCCCCCccceEEEEEeCCEEEEEEeccCC
Q 014347 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA-TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~g 98 (426)
+.||+|+||.||+|++..+|+.||+|++.+...........+.+|.. +++.++||||+++++++...+..|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 47999999999999999999999999997654433333455566655 56789999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccC
Q 014347 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (426)
Q Consensus 99 g~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~g 178 (426)
|+|.+++.+.+++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCCcccccC
Confidence 99999998888999999999999999999999999999999999999999999999999999874221 1223345689
Q ss_pred CCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccccCccC
Q 014347 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258 (426)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 258 (426)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||...+...++.++.......++..+..+.++|++||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~ 237 (325)
T cd05604 159 TPEYLAPEVIRKQPY-DNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237 (325)
T ss_pred ChhhCCHHHHcCCCC-CCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHh
Confidence 999999999987776 5889999999999999999999999988888999988888888889999999999999999999
Q ss_pred CCCH----HHHhcCccccc
Q 014347 259 RITI----AGIKADEWFEQ 273 (426)
Q Consensus 259 R~t~----~eil~h~~f~~ 273 (426)
||++ .+++.||||..
T Consensus 238 R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 238 RLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred cCCCCCCHHHHhcCCCcCC
Confidence 9986 58999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-49 Score=388.19 Aligned_cols=250 Identities=32% Similarity=0.562 Sum_probs=220.8
Q ss_pred EeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCccceEEEEEeCCEEEEEEeccCC
Q 014347 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL---KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 22 LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~lV~Ey~~g 98 (426)
||+|+||.||+|++..+|+.||+|++.+.............+|..++... +||||+++++++.+.+..|+||||++|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999765544333445566677777665 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccC
Q 014347 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (426)
Q Consensus 99 g~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~g 178 (426)
|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT--DNKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC--CCCCccCccC
Confidence 99999999888999999999999999999999999999999999999999999999999999874321 2233456789
Q ss_pred CCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHccccCcc
Q 014347 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW-LSPGAQNLLRKILEPNPV 257 (426)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~-~s~~~~~Li~~~L~~dP~ 257 (426)
|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..+..+...+|.. +++++.+||++||++||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 238 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQ 238 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHH
Confidence 9999999998765545789999999999999999999999999888888888888877754 799999999999999999
Q ss_pred CCC----CHHHHhcCccccc
Q 014347 258 KRI----TIAGIKADEWFEQ 273 (426)
Q Consensus 258 ~R~----t~~eil~h~~f~~ 273 (426)
+|| ++.++++||||..
T Consensus 239 ~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 239 HRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred HCCCCCCCHHHHhcCccccC
Confidence 998 7999999999975
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-49 Score=373.25 Aligned_cols=260 Identities=32% Similarity=0.484 Sum_probs=223.6
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-ccceEEEEEeCC----
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN-VVRLHEVLASKS---- 87 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~---- 87 (426)
+..|+.+++||+|+||+||+|+++.+|+.||+|.+..+... +..-....+|+.+|+.++|+| |+.+++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 56788899999999999999999999999999999865432 223456789999999999999 999999998877
Q ss_pred --EEEEEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCc
Q 014347 88 --KIYMVLEYVTGGELFDKIASKG----RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS 161 (426)
Q Consensus 88 --~~~lV~Ey~~gg~L~~~i~~~~----~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla 161 (426)
..|+|+||+. .+|..++.... .++...++.+++||+.||+|||++||+||||||+|||++++|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 8999999995 49999998744 5888899999999999999999999999999999999999999999999999
Q ss_pred cCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC---------
Q 014347 162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--------- 232 (426)
Q Consensus 162 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--------- 232 (426)
+.+.. +........+|.+|+|||++.+...++...||||+|||++||++++..|.+.+......+|.+-
T Consensus 168 ra~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 168 RAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 96542 2233556689999999999998877789999999999999999999999998887777777641
Q ss_pred ---------CCCCCCC------------CCHHHHHHHHHccccCccCCCCHHHHhcCccccccCC
Q 014347 233 ---------DFKLPKW------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (426)
Q Consensus 233 ---------~~~~p~~------------~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 276 (426)
...+|.| .+++..+|+.+||+.+|.+|.|+..++.||||.....
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 1122322 2358899999999999999999999999999987543
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=382.88 Aligned_cols=251 Identities=36% Similarity=0.620 Sum_probs=221.9
Q ss_pred ceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHH-HHHhCCCCCccceEEEEEeCCEEEEEEeccCC
Q 014347 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA-TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~g 98 (426)
+.||+|+||.||+|++..+|+.||+|++.+...........+.+|.. +++.++||||+++++++.+.+..|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999998655433333455556654 67889999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccC
Q 014347 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (426)
Q Consensus 99 g~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~g 178 (426)
++|.+.+.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCCccccccC
Confidence 99999998888899999999999999999999999999999999999999999999999999874211 2223445689
Q ss_pred CCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccccCccC
Q 014347 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258 (426)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 258 (426)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+......+|...+..+.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (321)
T cd05603 159 TPEYLAPEVLRKEPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237 (321)
T ss_pred CcccCCHHHhcCCCC-CCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhh
Confidence 999999999887666 5889999999999999999999999998888899988888888889999999999999999999
Q ss_pred CCCH----HHHhcCccccc
Q 014347 259 RITI----AGIKADEWFEQ 273 (426)
Q Consensus 259 R~t~----~eil~h~~f~~ 273 (426)
|+++ .++++|+||..
T Consensus 238 R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 238 RLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred cCCCCCCHHHHhCCCCcCC
Confidence 9975 59999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-48 Score=382.62 Aligned_cols=251 Identities=30% Similarity=0.611 Sum_probs=221.8
Q ss_pred ceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEEEEEEeccCC
Q 014347 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~Ey~~g 98 (426)
+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++.++ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876555555567788999999888 599999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccC
Q 014347 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (426)
Q Consensus 99 g~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~g 178 (426)
|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC--CCCceecccC
Confidence 99999998888999999999999999999999999999999999999999999999999999874211 2233456789
Q ss_pred CCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCC-------CcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Q 014347 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-------RNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251 (426)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~-------~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~ 251 (426)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||.. ......++.+......+|..+++.+.++|++|
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 237 (327)
T cd05617 159 TPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237 (327)
T ss_pred CcccCCHHHHCCCCC-CchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 999999999887766 6899999999999999999999953 22345666677777888999999999999999
Q ss_pred cccCccCCCC------HHHHhcCccccc
Q 014347 252 LEPNPVKRIT------IAGIKADEWFEQ 273 (426)
Q Consensus 252 L~~dP~~R~t------~~eil~h~~f~~ 273 (426)
|+.||.+|++ +++++.||||..
T Consensus 238 L~~dP~~R~~~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 238 LNKDPKERLGCQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred hccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence 9999999998 579999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-48 Score=382.13 Aligned_cols=251 Identities=37% Similarity=0.625 Sum_probs=220.5
Q ss_pred ceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHH-HHHHhCCCCCccceEEEEEeCCEEEEEEeccCC
Q 014347 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI-ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei-~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~g 98 (426)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|. .+++.++||||+++++++...+..|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4799999999999999999999999999865433322334444444 456889999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccC
Q 014347 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (426)
Q Consensus 99 g~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~g 178 (426)
++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCCcccccC
Confidence 99999999888899999999999999999999999999999999999999999999999999874221 2233456789
Q ss_pred CCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccccCccC
Q 014347 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258 (426)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 258 (426)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+......+++.+++.+.+||.+||++||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (325)
T cd05602 159 TPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237 (325)
T ss_pred CccccCHHHHcCCCC-CCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHH
Confidence 999999999987766 5889999999999999999999999988888888888888888889999999999999999999
Q ss_pred CCCHH----HHhcCccccc
Q 014347 259 RITIA----GIKADEWFEQ 273 (426)
Q Consensus 259 R~t~~----eil~h~~f~~ 273 (426)
|+++. ++++|+||..
T Consensus 238 R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 238 RLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred CCCCCCCHHHHhcCcccCC
Confidence 99876 8999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-48 Score=387.11 Aligned_cols=264 Identities=31% Similarity=0.527 Sum_probs=226.9
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (426)
..+..++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+++.
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 45566899999999999999999999999999999999976544444445668899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
.|+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~- 195 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE- 195 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC-
Confidence 9999999999999998865 56899999999999999999999999999999999999999999999999998754321
Q ss_pred CCCccccccCCCcccchhhhccCC---CCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC--CCCCC--CCC
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRG---YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPK--WLS 241 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~---~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s 241 (426)
......+.+||+.|+|||++.... ..+.++|||||||++|+|++|..||.+.+....+.++.... ..+|. .++
T Consensus 196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 275 (371)
T cd05622 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 275 (371)
T ss_pred CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCC
Confidence 111234568999999999987543 34689999999999999999999999999888888887643 44443 589
Q ss_pred HHHHHHHHHccccCccC--CCCHHHHhcCcccccc
Q 014347 242 PGAQNLLRKILEPNPVK--RITIAGIKADEWFEQD 274 (426)
Q Consensus 242 ~~~~~Li~~~L~~dP~~--R~t~~eil~h~~f~~~ 274 (426)
+.+++||.+||..++.+ |+++++|++|+||+..
T Consensus 276 ~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 276 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 99999999999855543 7899999999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-48 Score=381.44 Aligned_cols=257 Identities=30% Similarity=0.459 Sum_probs=209.8
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC-----CEE
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----SKI 89 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~ 89 (426)
+|++.+.||+|+||.||+|++..+|+.||+|.+..... ......++.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 69999999999999999999999999999999864322 222345788999999999999999999987543 358
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
|+||||+. ++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 99999995 69999998888899999999999999999999999999999999999999999999999999975322111
Q ss_pred -CCccccccCCCcccchhhhccC-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHc----------------
Q 014347 170 -DGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR---------------- 231 (426)
Q Consensus 170 -~~~~~~~~gt~~y~APE~l~~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~---------------- 231 (426)
.......+||+.|+|||++.+. ...+.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 238 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE 238 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 1122346799999999998652 3346889999999999999999999987654332211110
Q ss_pred ----------CCCC--CC---CCCCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 232 ----------GDFK--LP---KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 232 ----------~~~~--~p---~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
...+ ++ +.+++.+.+||.+||+.||++|||++++++||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~ 295 (338)
T cd07859 239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG 295 (338)
T ss_pred hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence 0001 10 236788999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-48 Score=371.77 Aligned_cols=249 Identities=29% Similarity=0.476 Sum_probs=215.2
Q ss_pred EeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEeccCCCCh
Q 014347 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL 101 (426)
Q Consensus 22 LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~gg~L 101 (426)
||+|+||+||++.+..+|+.||+|.+.+.........+.+..|+.+++.++||||+++++++..+...|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999999999999999999765544444456778899999999999999999999999999999999999999
Q ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcccccc
Q 014347 102 FDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 177 (426)
Q Consensus 102 ~~~i~~----~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 177 (426)
.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ........
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG--QSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC--CccccccC
Confidence 887743 356999999999999999999999999999999999999999999999999998754321 12234567
Q ss_pred CCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcH----HHHHHHHHcCCCCCCCCCCHHHHHHHHHccc
Q 014347 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL----AVLYQKIFRGDFKLPKWLSPGAQNLLRKILE 253 (426)
Q Consensus 178 gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 253 (426)
||+.|+|||++.+..+ +.++||||+||++|+|++|+.||..... ......+......+|..+++.+.+|+.+||+
T Consensus 159 g~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 159 GTPGFMAPELLQGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CCcCccCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence 9999999999987776 5889999999999999999999976432 3344455555667777899999999999999
Q ss_pred cCccCCC-----CHHHHhcCccccc
Q 014347 254 PNPVKRI-----TIAGIKADEWFEQ 273 (426)
Q Consensus 254 ~dP~~R~-----t~~eil~h~~f~~ 273 (426)
.||++|| |++++++||||+.
T Consensus 238 ~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 238 KDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred CCHHHhcCCCCCCHHHHhcChhhhc
Confidence 9999999 8899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=376.43 Aligned_cols=256 Identities=29% Similarity=0.437 Sum_probs=219.3
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
..++|++++.||+|+||.||+|++..+|..||+|++.... ......++.+|+.+++.++||||+++++++..++..|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4679999999999999999999999999999999987542 23446789999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc-CceeccCCCCcEEecCCCCeEEeeccCccCCccccCC
Q 014347 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~-gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 170 (426)
||||++|++|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---- 156 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 156 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc----
Confidence 999999999999998888899999999999999999999986 699999999999999999999999999874322
Q ss_pred CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHH--------------------
Q 014347 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF-------------------- 230 (426)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~-------------------- 230 (426)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+...+...+.
T Consensus 157 ~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 157 SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred cccccCCCCcCcCCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccc
Confidence 23345679999999999887665 689999999999999999999998765543322111
Q ss_pred --------------------------cCC-CCCC-CCCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 231 --------------------------RGD-FKLP-KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 231 --------------------------~~~-~~~p-~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
... ...+ ..+++++.+||.+||++||++|||+.++++||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 000 1111 1367899999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=369.86 Aligned_cols=255 Identities=29% Similarity=0.442 Sum_probs=220.4
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEe
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (426)
.|++.+.||+|+||.||++.+..+++.||+|.+.+...........+.+|+.+++.++||||+++++.+.+++..|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48999999999999999999999999999999976554433334567889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 95 y~~gg~L~~~i~~~--~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
|++||+|.+.+... ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++..... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE---GET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC---CCc
Confidence 99999999888653 4699999999999999999999999999999999999999999999999999875322 222
Q ss_pred cccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHH----HHHHHHcCCCCCCCCCCHHHHHHH
Q 014347 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV----LYQKIFRGDFKLPKWLSPGAQNLL 248 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~----~~~~i~~~~~~~p~~~s~~~~~Li 248 (426)
....+|++.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+... ....+......+|..+++.+.+||
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~-~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERY-TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred cccccCCCCccCcHHhcCCCC-CccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 345589999999999877665 688999999999999999999998765432 233344445566777899999999
Q ss_pred HHccccCccCCC-----CHHHHhcCccccc
Q 014347 249 RKILEPNPVKRI-----TIAGIKADEWFEQ 273 (426)
Q Consensus 249 ~~~L~~dP~~R~-----t~~eil~h~~f~~ 273 (426)
.+||+.||++|| ++++++.||||..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=377.33 Aligned_cols=259 Identities=29% Similarity=0.534 Sum_probs=221.0
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
++|++++.||+|+||.||++++..+++.||+|++.+.........+.+.+|+.+++.++|+||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998654444444667889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 94 Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
||++||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++....... ...
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~ 159 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG-TVQ 159 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC-Ccc
Confidence 99999999999976 5679999999999999999999999999999999999999999999999999986432211 111
Q ss_pred cccccCCCcccchhhhcc----CCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC--CCCC---CCCCHH
Q 014347 173 LHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLP---KWLSPG 243 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~----~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p---~~~s~~ 243 (426)
....+||+.|+|||++.. .+..+.++||||+||++|+|++|+.||.+.+....+.++.... ..+| ..+++.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHH
Confidence 223579999999999863 3344688999999999999999999999988887777776543 3333 347999
Q ss_pred HHHHHHHccccCccC--CCCHHHHhcCccccc
Q 014347 244 AQNLLRKILEPNPVK--RITIAGIKADEWFEQ 273 (426)
Q Consensus 244 ~~~Li~~~L~~dP~~--R~t~~eil~h~~f~~ 273 (426)
+++||++||..++++ |+++.++++||||..
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 240 AKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred HHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 999999998764444 889999999999975
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=379.87 Aligned_cols=249 Identities=31% Similarity=0.507 Sum_probs=215.4
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCe-EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC-EEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-KIY 90 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~-vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~ 90 (426)
.....+.+.||+|+||+||+|.. .|+. ||+|++......... .+.+.+|+.+|.+++|||||++++++.... ...
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~ 116 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC 116 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence 44556777899999999999986 4555 999999876654444 779999999999999999999999998887 799
Q ss_pred EEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcC-ceeccCCCCcEEecCCC-CeEEeeccCccCCcc
Q 014347 91 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKG-VFHRDLKLENILLDSKG-NIKISDFGLSALPQH 166 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~--~~~l~~~~~~~i~~Ql~~aL~~LH~~g-IiHrDLKp~NILl~~~g-~vkL~DFGla~~~~~ 166 (426)
+||||+++|+|.+++.. ...++...+..++.||+.|+.|||+++ ||||||||+|||++.++ ++||+|||+++....
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999999999999987 678999999999999999999999999 99999999999999998 999999999986432
Q ss_pred ccCCCccccccCCCcccchhhhc--cCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHH-cC-CCCCCCCCCH
Q 014347 167 FRDDGLLHTTCGSPNYVAPEVLA--NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF-RG-DFKLPKWLSP 242 (426)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~--~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~-~~-~~~~p~~~s~ 242 (426)
.. .......||+.|||||++. ...| +.++||||||++||||+||..||.+.........+. .+ .+.+|..+++
T Consensus 197 ~~--~~~~~~~GT~~wMAPEv~~~~~~~~-~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~ 273 (362)
T KOG0192|consen 197 SK--TSMTSVAGTYRWMAPEVLRGEKSPY-TEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPP 273 (362)
T ss_pred cc--ccccCCCCCccccChhhhcCCCCcC-CccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCH
Confidence 11 2233368999999999998 4466 699999999999999999999999988755554443 33 5667888999
Q ss_pred HHHHHHHHccccCccCCCCHHHHhc
Q 014347 243 GAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
.+..|+.+||+.||.+||++.+|+.
T Consensus 274 ~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 274 HLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 9999999999999999999999864
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=384.25 Aligned_cols=255 Identities=21% Similarity=0.350 Sum_probs=210.9
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (426)
.+...++|++++.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+++.++||||+++++++.....
T Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 157 (391)
T PHA03212 87 AGIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKF 157 (391)
T ss_pred cccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCe
Confidence 34566789999999999999999999999999999996532 346789999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
.++|||++. ++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|......
T Consensus 158 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~- 235 (391)
T PHA03212 158 TCLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI- 235 (391)
T ss_pred eEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc-
Confidence 999999995 689999988788999999999999999999999999999999999999999999999999999753221
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCc-------HHHHHHHH------------
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-------LAVLYQKI------------ 229 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~-------~~~~~~~i------------ 229 (426)
........+||+.|+|||++.+..+ +.++||||+||++|+|++|..||-... .......+
T Consensus 236 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 236 NANKYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred cccccccccCccCCCChhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 1123345689999999999887666 689999999999999999998864321 01111111
Q ss_pred --------------HcCCC----CCCCC-----CCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 230 --------------FRGDF----KLPKW-----LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 230 --------------~~~~~----~~p~~-----~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
..... ..|.| ++.++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 11111 11111 466899999999999999999999999999998643
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=370.38 Aligned_cols=259 Identities=25% Similarity=0.421 Sum_probs=216.1
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
.+++|++++.||+|+||.||+|++..+++.||+|.++..... .....+.+|+.+++.++||||+++++++..++..|+
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 81 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL 81 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence 467899999999999999999999999999999998754322 223457789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCC
Q 014347 92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 170 (426)
||||+.+ +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~ 158 (309)
T cd07872 82 VFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV--PT 158 (309)
T ss_pred EEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCC--Cc
Confidence 9999975 888887654 4589999999999999999999999999999999999999999999999999875322 11
Q ss_pred CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC------------------
Q 014347 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------------ 232 (426)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------ 232 (426)
.......+|+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+..+....+...
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 22334578999999999876555578999999999999999999999887655443333210
Q ss_pred -CCCCC-----------CCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 233 -DFKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 233 -~~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
...+| +.+++++.+||.+||+.||.+|||+.+++.||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 01111 23688999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-47 Score=365.82 Aligned_cols=254 Identities=39% Similarity=0.746 Sum_probs=232.2
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
++|++.+.||+|+||.||++.+..+++.||+|++.+.........+.+.+|+.++++++||||+++++++..+...|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998765545555678999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcc
Q 014347 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 173 (426)
||++|++|.+++.+.+.+++..+..++.||+.||.|||++|++||||+|.|||++.++.+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~ 155 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----T 155 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----C
Confidence 99999999999998889999999999999999999999999999999999999999999999999998754321 3
Q ss_pred ccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccc
Q 014347 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE 253 (426)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 253 (426)
...+|++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+.....+++..+...+|..+++.+.++|.+||+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 234 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQ 234 (290)
T ss_pred CCCCCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHcc
Confidence 45579999999999876654 68899999999999999999999988877788888888888999999999999999999
Q ss_pred cCccCCC-----CHHHHhcCccccc
Q 014347 254 PNPVKRI-----TIAGIKADEWFEQ 273 (426)
Q Consensus 254 ~dP~~R~-----t~~eil~h~~f~~ 273 (426)
.||.+|+ +++++++||||..
T Consensus 235 ~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 235 VDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred CCHHHccCcccCCHHHHHcCccccc
Confidence 9999999 9999999999965
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=379.88 Aligned_cols=258 Identities=28% Similarity=0.447 Sum_probs=216.4
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
...+++|++++.||+|+||.||+|++..+|+.||||++.... .......+.+|+.+++.++|+||+++++++...+.+
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 147 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI 147 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence 445788999999999999999999999999999999986543 233457789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
|+||||+.|++|.+. ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 148 ~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~-- 221 (353)
T PLN00034 148 QVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT-- 221 (353)
T ss_pred EEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc--
Confidence 999999999998653 34678888999999999999999999999999999999999999999999999854321
Q ss_pred CCccccccCCCcccchhhhcc----CCCCCCcchhhhHHHHHHHHHhCCCCCCCCcH---HHHHHHHH-cCCCCCCCCCC
Q 014347 170 DGLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNL---AVLYQKIF-RGDFKLPKWLS 241 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~----~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~---~~~~~~i~-~~~~~~p~~~s 241 (426)
........||+.|+|||++.. ..+.+.++|||||||++|+|++|+.||..... ......+. ......+..++
T Consensus 222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (353)
T PLN00034 222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATAS 301 (353)
T ss_pred cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccC
Confidence 112345679999999998743 34556789999999999999999999974332 22222222 23345566789
Q ss_pred HHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 242 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
+++.+||.+||+.||++|||+.++++||||....
T Consensus 302 ~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 302 REFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 9999999999999999999999999999998754
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=391.35 Aligned_cols=252 Identities=26% Similarity=0.376 Sum_probs=208.1
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC-----
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK----- 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 86 (426)
..++|++++.||+|+||.||+|.+..+++.||||.+.... ....+|+.+|+.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 3468999999999999999999999999999999885432 2345799999999999999999886432
Q ss_pred ---CEEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCC-CeEEeec
Q 014347 87 ---SKIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDF 158 (426)
Q Consensus 87 ---~~~~lV~Ey~~gg~L~~~i~----~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g-~vkL~DF 158 (426)
..+++||||+++ +|.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 247799999975 6766664 346799999999999999999999999999999999999999765 6999999
Q ss_pred cCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC------
Q 014347 159 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------ 232 (426)
Q Consensus 159 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------ 232 (426)
|+|+.... .......+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+......++...
T Consensus 216 Gla~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 216 GSAKNLLA---GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred ccchhccC---CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 99985432 223345678999999999876554578999999999999999999999987665544443321
Q ss_pred -----------CC------------CCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 233 -----------DF------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 233 -----------~~------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
.. .+|...++++.+||.+||++||.+|||+.++++||||...
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 01 1234567899999999999999999999999999999764
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-47 Score=374.28 Aligned_cols=259 Identities=28% Similarity=0.507 Sum_probs=221.7
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
++|++.+.||+|+||.||++++..+++.||+|++.+...........+.+|+.++..++|+||+++++.+.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999997654434444566888999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 94 Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
||++||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~-~~~~ 159 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQ 159 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC-Ccce
Confidence 99999999999976 467999999999999999999999999999999999999999999999999998643211 1112
Q ss_pred cccccCCCcccchhhhcc----CCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC--CCCCC---CCCHH
Q 014347 173 LHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPK---WLSPG 243 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~----~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~---~~s~~ 243 (426)
....+||+.|+|||++.. ....+.++|||||||++|+|++|+.||.+.+....+.++.... ..+|. .++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~ 239 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHH
Confidence 234689999999999862 3334688999999999999999999999998888888887653 33343 47999
Q ss_pred HHHHHHHccccCccC--CCCHHHHhcCccccc
Q 014347 244 AQNLLRKILEPNPVK--RITIAGIKADEWFEQ 273 (426)
Q Consensus 244 ~~~Li~~~L~~dP~~--R~t~~eil~h~~f~~ 273 (426)
+++||++||..+|++ |++++++++||||..
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 240 AKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred HHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 999999999765554 789999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-47 Score=393.16 Aligned_cols=262 Identities=32% Similarity=0.530 Sum_probs=228.2
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC--
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-- 87 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-- 87 (426)
...-++|++.+.||+|+||.||+|++..+|+.||||++..... .......+.+|+.++..++|+||+++++.+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 3455799999999999999999999999999999999976554 3344667889999999999999999988765332
Q ss_pred ------EEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEee
Q 014347 88 ------KIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISD 157 (426)
Q Consensus 88 ------~~~lV~Ey~~gg~L~~~i~~----~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~D 157 (426)
.+++||||+++|+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEe
Confidence 47899999999999998864 34689999999999999999999999999999999999999999999999
Q ss_pred ccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC-CC
Q 014347 158 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KL 236 (426)
Q Consensus 158 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~ 236 (426)
||+++............+.+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+......++..+.. ++
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 265 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY-SKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPL 265 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence 999986543222333456789999999999987766 6899999999999999999999999988888887776654 56
Q ss_pred CCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 237 PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 237 p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
|..+++++.+|+.+||+.||.+|||+.++++|||++.
T Consensus 266 ~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 266 PPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 7789999999999999999999999999999999864
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-47 Score=390.52 Aligned_cols=257 Identities=28% Similarity=0.439 Sum_probs=224.8
Q ss_pred CCCeeeeceEeecCceEEEEEEECCC-CCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
...|.+.+.||+|+||.||+|.+..+ ++.||+|.+... .......+.+|+.+++.++||||+++++++..++..|+
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 44599999999999999999998877 788999977543 23345678889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 92 VLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~----~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
||||++||+|.+++.. ..++++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999999987753 457899999999999999999999999999999999999999999999999999864332
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC-CCCCCCCHHHHH
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQN 246 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~ 246 (426)
.......+.+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+...+...+..+.. ++|..+++++.+
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 301 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRY-SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKA 301 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHH
Confidence 22223456789999999999887666 6889999999999999999999999888888888776654 456678999999
Q ss_pred HHHHccccCccCCCCHHHHhcCccccc
Q 014347 247 LLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 247 Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
||.+||++||++|||+++++.|+|++.
T Consensus 302 li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 302 LLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 999999999999999999999999864
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-47 Score=374.18 Aligned_cols=259 Identities=27% Similarity=0.494 Sum_probs=221.8
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
++|++.+.||+|+||.||++++..+++.||+|++.+...........+.+|+.+++.++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999997654434444566888999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 94 Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
||++||+|.+++.+ .+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~~ 159 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD-GTVQ 159 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC-Ccee
Confidence 99999999999987 567999999999999999999999999999999999999999999999999998754221 1112
Q ss_pred cccccCCCcccchhhhccC----CCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC--CCCCC---CCCHH
Q 014347 173 LHTTCGSPNYVAPEVLANR----GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPK---WLSPG 243 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~----~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~---~~s~~ 243 (426)
....+||+.|+|||++.+. +..+.++||||+||++|+|++|+.||...+....+.++.... +++|. .++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~ 239 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHH
Confidence 2345799999999998652 234688999999999999999999999988888888777643 34443 36899
Q ss_pred HHHHHHHccccCccC--CCCHHHHhcCccccc
Q 014347 244 AQNLLRKILEPNPVK--RITIAGIKADEWFEQ 273 (426)
Q Consensus 244 ~~~Li~~~L~~dP~~--R~t~~eil~h~~f~~ 273 (426)
+++||.+||..++.+ |++++++++|+||+.
T Consensus 240 ~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 240 AKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred HHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 999999999976655 579999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-47 Score=379.61 Aligned_cols=258 Identities=28% Similarity=0.417 Sum_probs=216.9
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC-----EE
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-----KI 89 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~ 89 (426)
+|++++.||+|+||.||+|.+..+|+.||+|.+.... .+.....++.+|+.+++.++||||+++++++.... ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 4789999999999999999999999999999986432 22334567889999999999999999999998776 79
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
|+||||+. ++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~-~ 157 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD-E 157 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC-c
Confidence 99999996 589898888788999999999999999999999999999999999999999999999999999754321 1
Q ss_pred CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHc------------------
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR------------------ 231 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~------------------ 231 (426)
........+|+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 12233456899999999988766557899999999999999999999988766544433321
Q ss_pred -----CCC---------CCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 232 -----GDF---------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 232 -----~~~---------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
... .+....++++.+||.+||+.||.+|||+.++++||||....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 111 12234578999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=359.61 Aligned_cols=253 Identities=36% Similarity=0.643 Sum_probs=216.0
Q ss_pred eeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEec
Q 014347 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (426)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey 95 (426)
|++++.||+|+||.||++++..+++.||+|++......... .....+|+.++++++||||+++++++......+++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 89999999999999999999999999999999876543322 23345699999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcccc
Q 014347 96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT 175 (426)
Q Consensus 96 ~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 175 (426)
+.+++|.+++...+.+++..+..++.||+.||.+||++|++||||||+||+++.++.++|+|||.+... .........
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~~~~ 157 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNENFNP 157 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTSEBSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccc
Confidence 999999999998889999999999999999999999999999999999999999999999999998743 112334556
Q ss_pred ccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCC---cHHHHHHHHHcCCCCCC----CCCCHHHHHHH
Q 014347 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR---NLAVLYQKIFRGDFKLP----KWLSPGAQNLL 248 (426)
Q Consensus 176 ~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~---~~~~~~~~i~~~~~~~p----~~~s~~~~~Li 248 (426)
..+++.|+|||++......+.++||||||+++|+|++|..||... +......+........+ ...++.+.++|
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI 237 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence 789999999999873445579999999999999999999999987 33334433333222211 11248999999
Q ss_pred HHccccCccCCCCHHHHhcCccc
Q 014347 249 RKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 249 ~~~L~~dP~~R~t~~eil~h~~f 271 (426)
.+||+.||++|||+.++++||||
T Consensus 238 ~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 238 KKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHccCChhHCcCHHHHhcCCCC
Confidence 99999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-47 Score=364.47 Aligned_cols=252 Identities=31% Similarity=0.436 Sum_probs=207.8
Q ss_pred CCeeeeceEeecCceEEEEEEECC-CCCeEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCccceEEEEE-----
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL---KHPNVVRLHEVLA----- 84 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~----- 84 (426)
.+|++++.||+|+||.||+|++.. +++.||+|.++...... .....+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999864 57889999987543322 2234566788777765 6999999999885
Q ss_pred eCCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCcc
Q 014347 85 SKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (426)
Q Consensus 85 ~~~~~~lV~Ey~~gg~L~~~i~~~--~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~ 162 (426)
....+++||||+. ++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3456899999996 5899988753 458999999999999999999999999999999999999999999999999997
Q ss_pred CCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC-----C--
Q 014347 163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-----K-- 235 (426)
Q Consensus 163 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-----~-- 235 (426)
.... ........||+.|+|||++.+..+ +.++||||+||++|+|++|++||.+.+......++..... .
T Consensus 159 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 159 IYSF---QMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eccC---CcccccccccccccChHHHhCCCC-CCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 5432 223445679999999999877666 5889999999999999999999998877666655543210 0
Q ss_pred --------------------CCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 236 --------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 236 --------------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
..+.+++.+.+|+.+||+.||++|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 112467888999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=356.14 Aligned_cols=257 Identities=32% Similarity=0.536 Sum_probs=222.0
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccc--hhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH--LKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
+.|++.+.||+|++|.||.|.+..+++.||+|.+....... ......+.+|+.++++++||||+++++++......|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46999999999999999999999999999999987543221 2234678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCC-
Q 014347 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD- 170 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~- 170 (426)
++||++|++|.+.+...+.+++..++.++.|++.||.|||++|++||||+|+||++++++.++|+|||++.........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 9999999999999988888999999999999999999999999999999999999999999999999998754321111
Q ss_pred CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC--CCCCCCCCCHHHHHHH
Q 014347 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLL 248 (426)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li 248 (426)
.......|++.|+|||++.+..+ +.++||||+|+++|+|++|+.||.+.+......++... ...+|..+++.+.++|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240 (263)
T ss_pred ccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence 11134568899999999887664 68999999999999999999999887665555444433 4456777899999999
Q ss_pred HHccccCccCCCCHHHHhcCccc
Q 014347 249 RKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 249 ~~~L~~dP~~R~t~~eil~h~~f 271 (426)
++||..+|.+|||+.++++|+||
T Consensus 241 ~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 241 RRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHhhcCcccCCCHHHHhhCCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-49 Score=380.86 Aligned_cols=255 Identities=27% Similarity=0.453 Sum_probs=227.6
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
..|...+.||+|+||.||+|.+..+++.||+|+++.+... +.++.+.+|+.+|..++++||.++|+.+..+..++++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~--deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE--DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcc--hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 4688889999999999999999999999999999877643 34788999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcc
Q 014347 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 173 (426)
|||.||++.+.++....+++.++.-++++++.||.|||.++.+|||||+.|||+..+|.+||+|||++..... .....
T Consensus 91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~--~~~rr 168 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTN--TVKRR 168 (467)
T ss_pred HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeec--hhhcc
Confidence 9999999999999888789999999999999999999999999999999999999999999999999985443 22233
Q ss_pred ccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHcc
Q 014347 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKIL 252 (426)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L 252 (426)
.+..|||.|||||++...+|+ .++||||||++.+||++|.+||.+.+++.....|-+.. +.+...+++.+++|+..||
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~-~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL 247 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYD-TKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACL 247 (467)
T ss_pred ccccccccccchhhhcccccc-chhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHh
Confidence 789999999999999987885 88999999999999999999999988765444444333 3334468999999999999
Q ss_pred ccCccCCCCHHHHhcCccccc
Q 014347 253 EPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 253 ~~dP~~R~t~~eil~h~~f~~ 273 (426)
++||+.||++.++|+|+|.+.
T Consensus 248 ~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 248 DKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred hcCcccCcCHHHHhhhHHHHh
Confidence 999999999999999999976
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-48 Score=380.18 Aligned_cols=258 Identities=30% Similarity=0.508 Sum_probs=237.7
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE-EE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK-IY 90 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-~~ 90 (426)
.+++|.+++.+|+|+||.+++++++..++.+++|.+........ ..+...+|+.+++++.|||||.+.+.+..++. .+
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~-~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~ 80 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP-ERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC 80 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch-hhHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence 47899999999999999999999999999999999987765443 34578899999999999999999999998888 99
Q ss_pred EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 91 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~~--~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
|||+||+||+|.+.|.+. .-++++.+..||.|++.||.|||+++|+|||||+.||+++.++.+||+|||+|+....
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~-- 158 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP-- 158 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCC--
Confidence 999999999999999764 3589999999999999999999999999999999999999999999999999997644
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHHHH
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNL 247 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~L 247 (426)
......+..|||.|+.||++.+.+| +.|+|||||||++|||++-+.+|.+.+...+..+|.++. .+.|..++.+++.|
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pY-n~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~l 237 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPY-NEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSL 237 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCC-CccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHH
Confidence 3346778999999999999999998 599999999999999999999999999999999999987 67888899999999
Q ss_pred HHHccccCccCCCCHHHHhcCccccc
Q 014347 248 LRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 248 i~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
|+.||.++|..||++.++|.+|.+..
T Consensus 238 v~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 238 VKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred HHHHhhcCCccCCCHHHHhhChhhhh
Confidence 99999999999999999999988764
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=374.22 Aligned_cols=259 Identities=29% Similarity=0.455 Sum_probs=212.1
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC---
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS--- 87 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 87 (426)
..+++|++.+.||+|+||.||+|.+..+|+.||+|.+.+... .......+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 457899999999999999999999999999999999875432 3334567889999999999999999999986443
Q ss_pred ---EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCC
Q 014347 88 ---KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (426)
Q Consensus 88 ---~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~ 164 (426)
..|+||||+.+ +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 57999999975 6766664 35899999999999999999999999999999999999999999999999998743
Q ss_pred ccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHc-------------
Q 014347 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR------------- 231 (426)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~------------- 231 (426)
. .........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 174 ~---~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 174 C---TNFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred c---cCccCCCCcccCCCCCchhccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 2 2223345688999999999987776 5889999999999999999999987654333222111
Q ss_pred ---------CCCC---------CCC-----------CCCHHHHHHHHHccccCccCCCCHHHHhcCccccccCCC
Q 014347 232 ---------GDFK---------LPK-----------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (426)
Q Consensus 232 ---------~~~~---------~p~-----------~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 277 (426)
.... +|. ..++.+++||.+||+.||++|||+.|+++||||...+.+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~ 324 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDP 324 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCc
Confidence 1111 111 135789999999999999999999999999999865433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=369.88 Aligned_cols=257 Identities=29% Similarity=0.439 Sum_probs=217.8
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
..++|++.+.||+|+||.||+|.+..++..+|+|++.... .......+.+|+++++.++||||+++++++.+.+..|+
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 4578999999999999999999999999999999987542 23345678999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc-CceeccCCCCcEEecCCCCeEEeeccCccCCccccCC
Q 014347 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~-gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 170 (426)
||||++|++|.+++...+.+++..+..++.|++.||.|||++ +|+||||||+|||++.+|.+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~---- 156 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 156 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh----
Confidence 999999999999998888899999999999999999999985 799999999999999999999999999874322
Q ss_pred CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHH----------------------
Q 014347 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK---------------------- 228 (426)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~---------------------- 228 (426)
......+||+.|+|||++.+..+ +.++|+|||||++|+|++|+.||...........
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 157 SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred hccccCCCCccccCHHHhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence 22334579999999999877655 6889999999999999999999986554332111
Q ss_pred ----------------------HHcC-CCCCC-CCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 229 ----------------------IFRG-DFKLP-KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 229 ----------------------i~~~-~~~~p-~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
+... ....+ ..+++++++||.+||+.||++|||+.+++.||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 1111 11111 13678899999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=360.68 Aligned_cols=255 Identities=30% Similarity=0.447 Sum_probs=216.8
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEe
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (426)
.|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++|+||+++++.+.+.+..|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 47888999999999999999999999999999876654444445667889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 95 y~~gg~L~~~i~~~--~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
|++|++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..... ...
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC---Ccc
Confidence 99999999988643 3589999999999999999999999999999999999999999999999999874321 122
Q ss_pred cccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHH---HHHHHH-HcCCCCCCCCCCHHHHHHH
Q 014347 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA---VLYQKI-FRGDFKLPKWLSPGAQNLL 248 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~---~~~~~i-~~~~~~~p~~~s~~~~~Li 248 (426)
.....|++.|+|||++.+..+ +.++||||+||++|+|++|+.||...... ...... .......+..+++++.+|+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence 234579999999999887665 68899999999999999999999864321 111111 2223345667899999999
Q ss_pred HHccccCccCCCC-----HHHHhcCccccc
Q 014347 249 RKILEPNPVKRIT-----IAGIKADEWFEQ 273 (426)
Q Consensus 249 ~~~L~~dP~~R~t-----~~eil~h~~f~~ 273 (426)
++||+.||.+||| ++++++||||+.
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 9999999999999 899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-48 Score=356.21 Aligned_cols=254 Identities=34% Similarity=0.648 Sum_probs=221.1
Q ss_pred CccCCCeeee-ceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEEe--
Q 014347 10 GMRLGRYELG-RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLAS-- 85 (426)
Q Consensus 10 ~~~~~~y~i~-~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~-- 85 (426)
....++|.+- ++||-|-.|+|-.+.++.||+.+|+|++.- ....++|+++.=+.. |||||.++++|+.
T Consensus 57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~ 128 (400)
T KOG0604|consen 57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--------SPKARREVELHWMASGHPHIVSIIDVYENSY 128 (400)
T ss_pred ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--------CHHHHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence 3455678764 579999999999999999999999998842 356788998876654 9999999999853
Q ss_pred --CCEEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecC---CCCeEEeec
Q 014347 86 --KSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KGNIKISDF 158 (426)
Q Consensus 86 --~~~~~lV~Ey~~gg~L~~~i~~~~~--l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~---~g~vkL~DF 158 (426)
...+.+|||.++||+||++|+.++. ++|.++..+++||..|+.|||+.+|.||||||||+|... |..+||+||
T Consensus 129 ~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 129 QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccc
Confidence 4568899999999999999998664 999999999999999999999999999999999999975 446999999
Q ss_pred cCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCc----HHHHHHHHHcCCC
Q 014347 159 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRGDF 234 (426)
Q Consensus 159 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~~~~ 234 (426)
|+|+... ....+.+.|.||.|+|||++....|+ ..+|+||+||++|.||+|++||.... ...+..+|..+.+
T Consensus 209 GFAK~t~---~~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy 284 (400)
T KOG0604|consen 209 GFAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQY 284 (400)
T ss_pred ccccccC---CCccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCc
Confidence 9999643 24578899999999999999887774 78999999999999999999997643 3467788999988
Q ss_pred CCC--CC--CCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 235 KLP--KW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 235 ~~p--~~--~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
.|| +| +|..++++|+++|..+|.+|.|+.+++.|||..+..
T Consensus 285 ~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 285 EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 776 45 899999999999999999999999999999998754
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=362.00 Aligned_cols=258 Identities=26% Similarity=0.435 Sum_probs=216.1
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
.+++|++.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++..+...|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 578899999999999999999999999999999998754322 223467789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCC
Q 014347 92 VLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 170 (426)
||||+. ++|.+.+.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 82 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~--~~ 158 (301)
T cd07873 82 VFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI--PT 158 (301)
T ss_pred EEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC--CC
Confidence 999997 589888875 45689999999999999999999999999999999999999999999999999874322 11
Q ss_pred CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC------------------
Q 014347 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------------ 232 (426)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------ 232 (426)
.......+++.|+|||++.+....+.++|||||||++|+|++|++||.+.+.......+...
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 22234567899999999876655578899999999999999999999887765444332210
Q ss_pred -CCCCC-----------CCCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 233 -DFKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 233 -~~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
....| ..+++.+.+||.+||+.||.+|||++++++||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 01111 2368889999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-48 Score=404.58 Aligned_cols=262 Identities=29% Similarity=0.512 Sum_probs=234.9
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
.+.-++|++++.||+|+||.|.+++++.|++.||+|++++-..........|..|-.+|.--+.+.|++++..|.++..+
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence 45667999999999999999999999999999999999875444444467789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
|+||||++||+|..++.+.++++++.|+.|+..|+.||+-+|+.|+|||||||+|||||..|++||+|||.+-..... .
T Consensus 151 YlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d-G 229 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD-G 229 (1317)
T ss_pred EEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC-C
Confidence 999999999999999998889999999999999999999999999999999999999999999999999988754321 1
Q ss_pred CCccccccCCCcccchhhhcc----CCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC--CCCCC--CCCC
Q 014347 170 DGLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLP--KWLS 241 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~----~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s 241 (426)
.-.....+|||.|++||++.. .+.+|+.+|+||+||++|||+.|..||..++....|.+|... .+.|| ..+|
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VS 309 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVS 309 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccC
Confidence 224456789999999999863 356689999999999999999999999999999999999987 67888 4599
Q ss_pred HHHHHHHHHccccCccCCCC---HHHHhcCccccc
Q 014347 242 PGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQ 273 (426)
Q Consensus 242 ~~~~~Li~~~L~~dP~~R~t---~~eil~h~~f~~ 273 (426)
+++++||++++. +|..|.. +++|..||||..
T Consensus 310 eeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g 343 (1317)
T KOG0612|consen 310 EEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEG 343 (1317)
T ss_pred HHHHHHHHHHhc-ChhhhcccccHHHHHhCccccC
Confidence 999999999886 7888988 999999999975
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=386.20 Aligned_cols=252 Identities=25% Similarity=0.366 Sum_probs=204.4
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCC------CCccceEEEEEeC
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH------PNVVRLHEVLASK 86 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h------pnIv~l~~~~~~~ 86 (426)
.++|++++.||+|+||.||+|.+..+++.||||+++... ........|+.+++.++| ++++++++++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 478999999999999999999999999999999996432 123445667777777654 4588888888764
Q ss_pred -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-cCceeccCCCCcEEecCCC-------------
Q 014347 87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKG------------- 151 (426)
Q Consensus 87 -~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~-~gIiHrDLKp~NILl~~~g------------- 151 (426)
..+|+|||++ |++|.+++.+.+.+++..++.++.||+.||+|||+ .||+||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 5789999988 78999999888899999999999999999999998 5999999999999998765
Q ss_pred ---CeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHH
Q 014347 152 ---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK 228 (426)
Q Consensus 152 ---~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~ 228 (426)
.+||+|||++.... ......+||+.|+|||++.+..| +.++|||||||++|+|++|+.||++.+.......
T Consensus 283 ~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~-~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 283 DPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGW-MYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred CCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 49999999876321 22345789999999999988777 5889999999999999999999988665443322
Q ss_pred HHcCCCCCC----------------------------C--------------CCCHHHHHHHHHccccCccCCCCHHHHh
Q 014347 229 IFRGDFKLP----------------------------K--------------WLSPGAQNLLRKILEPNPVKRITIAGIK 266 (426)
Q Consensus 229 i~~~~~~~p----------------------------~--------------~~s~~~~~Li~~~L~~dP~~R~t~~eil 266 (426)
+......+| . ..++.+.+||.+||++||.+|||++|+|
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 211100000 0 0145678999999999999999999999
Q ss_pred cCccccccC
Q 014347 267 ADEWFEQDY 275 (426)
Q Consensus 267 ~h~~f~~~~ 275 (426)
+||||.+.+
T Consensus 437 ~Hp~~~~~~ 445 (467)
T PTZ00284 437 THPYVLKYY 445 (467)
T ss_pred cCccccccC
Confidence 999998754
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-46 Score=371.58 Aligned_cols=257 Identities=28% Similarity=0.408 Sum_probs=212.6
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC-----
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK----- 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 86 (426)
.+++|++.+.||+|+||.||+|.+..+++.||||.+.+... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 56899999999999999999999999999999999875432 233356788999999999999999999987543
Q ss_pred -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 87 -~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
...|+||||+.+ +|.+.+. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHH--hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 457999999965 7777775 358899999999999999999999999999999999999999999999999997532
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC------------
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD------------ 233 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------ 233 (426)
. ........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+....+.++....
T Consensus 178 ~---~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 178 T---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred C---CCcccCCcccCCcCCHHHHhCCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 2 223345679999999999987766 588999999999999999999998877655554443210
Q ss_pred ----------CC--------------C------CCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccCC
Q 014347 234 ----------FK--------------L------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (426)
Q Consensus 234 ----------~~--------------~------p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 276 (426)
.. + +...+..+++||.+||+.||.+|||+.++++||||...+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 326 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 326 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccC
Confidence 00 0 0113467899999999999999999999999999976443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-47 Score=360.51 Aligned_cols=253 Identities=31% Similarity=0.485 Sum_probs=213.7
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC-----E
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-----K 88 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~ 88 (426)
=.|.-.+++|.|+||.||.|....+++.||||.+-.+.. --.+|+.+|+.++|||||++.-+|.... .
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 368999999999999999999999999999997754432 2236999999999999999988875432 2
Q ss_pred EEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCC-CCeEEeeccCccC
Q 014347 89 IYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSAL 163 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~----~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~-g~vkL~DFGla~~ 163 (426)
..+||||++- +|.+.++. +.+++...++-|..||.+||+|||+.||+||||||.|||+|.+ |.+||||||.|+.
T Consensus 97 lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 97 LNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 3479999965 99888874 5789999999999999999999999999999999999999976 8999999999997
Q ss_pred CccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC-----------
Q 014347 164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG----------- 232 (426)
Q Consensus 164 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~----------- 232 (426)
... +....++..|..|+|||.+.+...++.+.||||+|||+.||+.|++.|.+++.......|.+-
T Consensus 176 L~~---~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 176 LVK---GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred ecc---CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 543 333466777999999999998777789999999999999999999999998877666555421
Q ss_pred ------CCCCC------------CCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccCCC
Q 014347 233 ------DFKLP------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (426)
Q Consensus 233 ------~~~~p------------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 277 (426)
+..+| ...++++.+|+.++|+.+|.+|.++.+++.||||..-..+
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 11122 2368999999999999999999999999999999876544
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=357.90 Aligned_cols=248 Identities=27% Similarity=0.449 Sum_probs=209.2
Q ss_pred EeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEeccCCCCh
Q 014347 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL 101 (426)
Q Consensus 22 LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~gg~L 101 (426)
||+|+||.||++++..+|+.||+|.+.+...........+..|+.+++.++||||+++++++.++...|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999999999999999999765443333344566799999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccCC
Q 014347 102 FDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179 (426)
Q Consensus 102 ~~~i~~~~--~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt 179 (426)
.+.+...+ .+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++..... ........|+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~---~~~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD---GKTITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCC---CceeeccCCC
Confidence 98886533 588999999999999999999999999999999999999999999999999875432 2223346799
Q ss_pred CcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcH----HHHHHHHHcCCCCCC-CCCCHHHHHHHHHcccc
Q 014347 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL----AVLYQKIFRGDFKLP-KWLSPGAQNLLRKILEP 254 (426)
Q Consensus 180 ~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~p-~~~s~~~~~Li~~~L~~ 254 (426)
+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+... ..............+ ..+++++.+||++||++
T Consensus 158 ~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 158 NGYMAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCccCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence 99999999887775 6889999999999999999999976432 334444444444333 35899999999999999
Q ss_pred CccCCCCH----HHHhcCccccc
Q 014347 255 NPVKRITI----AGIKADEWFEQ 273 (426)
Q Consensus 255 dP~~R~t~----~eil~h~~f~~ 273 (426)
||.+||++ ++++.|+||+.
T Consensus 237 ~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 237 KPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred CHhhCCCCccchhhhhcChhhcC
Confidence 99999999 67889999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=370.77 Aligned_cols=258 Identities=28% Similarity=0.424 Sum_probs=211.8
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC----
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK---- 86 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 86 (426)
..+++|++++.||+|+||.||+|.+..+++.||+|.+.+... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 457899999999999999999999999999999999865432 233456788999999999999999999988643
Q ss_pred --CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCC
Q 014347 87 --SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (426)
Q Consensus 87 --~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~ 164 (426)
...|+||||+.+ +|.+.+. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 357999999975 6777665 35899999999999999999999999999999999999999999999999999753
Q ss_pred ccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC------------
Q 014347 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------ 232 (426)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------ 232 (426)
. .........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 170 ~---~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 170 G---TSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred C---CccccCCccccCCccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 2 2223345689999999999987776 58899999999999999999999887654433222110
Q ss_pred ----------C-----CC---------------CCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccCC
Q 014347 233 ----------D-----FK---------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (426)
Q Consensus 233 ----------~-----~~---------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 276 (426)
. .. .+...+..+++||.+||+.||++|||+.|+++||||...+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~ 319 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD 319 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccC
Confidence 0 00 11123567899999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=370.78 Aligned_cols=256 Identities=29% Similarity=0.427 Sum_probs=212.0
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC-----
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK----- 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 86 (426)
..++|++++.||+|+||.||+|.+..+++.||+|.+.+... .......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34789999999999999999999999999999999875432 222345678899999999999999999987543
Q ss_pred -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 87 -~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
...|++++++ |++|.+.+. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 4579999998 779987765 4679999999999999999999999999999999999999999999999999987532
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC------------
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD------------ 233 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------ 233 (426)
. .....+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 170 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 170 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred C-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 2 23456799999999998775555789999999999999999999998766544443332110
Q ss_pred -----------CCCC--------CCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 234 -----------FKLP--------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 234 -----------~~~p--------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
...| ...++.+.+||.+||+.||.+|||+.++++||||....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 0011 13567789999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=358.73 Aligned_cols=251 Identities=32% Similarity=0.445 Sum_probs=206.5
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCccceEEEEEe-----C
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL---KHPNVVRLHEVLAS-----K 86 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~-----~ 86 (426)
+|++.+.||+|+||.||+|++..+|+.||+|.++...... .....+.+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 6999999999999999999999999999999987543222 1233456777777665 69999999998764 3
Q ss_pred CEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCC
Q 014347 87 SKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~--~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~ 164 (426)
...+++|||+.+ +|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 568999999975 898888753 35899999999999999999999999999999999999999999999999999854
Q ss_pred ccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC-----------C
Q 014347 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-----------D 233 (426)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-----------~ 233 (426)
.. ........||+.|+|||++.+..+ +.++||||+||++|+|++|++||.+.+......++... .
T Consensus 159 ~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 159 SC---QMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cC---cccCCCccccccccCchHhhCCCC-CCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 32 122334578999999999887665 68999999999999999999999887665555444321 0
Q ss_pred C----------------CCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 234 F----------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 234 ~----------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
. .+.+.++..+.+||.+||++||.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0112357788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=369.29 Aligned_cols=253 Identities=26% Similarity=0.399 Sum_probs=206.2
Q ss_pred cCCCeeeeceEeecCceEEEEEEEC-----CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEe
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS 85 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 85 (426)
..++|++++.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+++.+ +||||+++++++..
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 4468999999999999999999752 456789999986432 223356789999999999 89999999998865
Q ss_pred C-CEEEEEEeccCCCChHHHHHhc--------------------------------------------------------
Q 014347 86 K-SKIYMVLEYVTGGELFDKIASK-------------------------------------------------------- 108 (426)
Q Consensus 86 ~-~~~~lV~Ey~~gg~L~~~i~~~-------------------------------------------------------- 108 (426)
. ..+|++|||++||+|.+++...
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 4 4689999999999999998742
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccCCCcc
Q 014347 109 ------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182 (426)
Q Consensus 109 ------~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y 182 (426)
.++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...............+++.|
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 24778889999999999999999999999999999999999999999999999754221111112234567889
Q ss_pred cchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHH-HHHHHHcC-CCCCCCCCCHHHHHHHHHccccCccCC
Q 014347 183 VAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV-LYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKR 259 (426)
Q Consensus 183 ~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R 259 (426)
+|||++.+..+ +.++|||||||++|+|++ |..||.+..... ....+..+ ....|..+++.+.+|+.+||+.||.+|
T Consensus 243 ~aPE~~~~~~~-~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 321 (338)
T cd05102 243 MAPESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKER 321 (338)
T ss_pred cCcHHhhcCCC-CcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence 99999887666 689999999999999997 999998765433 33333333 345567789999999999999999999
Q ss_pred CCHHHHhc
Q 014347 260 ITIAGIKA 267 (426)
Q Consensus 260 ~t~~eil~ 267 (426)
||+.++++
T Consensus 322 Ps~~el~~ 329 (338)
T cd05102 322 PTFSALVE 329 (338)
T ss_pred cCHHHHHH
Confidence 99999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=356.43 Aligned_cols=256 Identities=29% Similarity=0.447 Sum_probs=220.2
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEe
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (426)
.|+..+.||+|+||+||+|.+..+++.||+|.+.+...........+.+|+.+++.++|+||+.+++.+..++..|++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 47888999999999999999999999999999976654444445667889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 95 y~~gg~L~~~i~~~--~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
|+.+++|.+.+... .++++..+..++.|++.||.|||++||+||||||+||++++++.+||+|||++..... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~---~~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE---GES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC---CCc
Confidence 99999999888653 3699999999999999999999999999999999999999999999999999864321 122
Q ss_pred cccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHH----HHHHHHcCCCCCCCCCCHHHHHHH
Q 014347 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV----LYQKIFRGDFKLPKWLSPGAQNLL 248 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~----~~~~i~~~~~~~p~~~s~~~~~Li 248 (426)
.....|++.|+|||++.+..+ +.++|+||+||++|+|++|..||.+..... ....+......++..+++.+.+|+
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRY-TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236 (285)
T ss_pred ccCCCCCcCccChHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence 234579999999999877665 688999999999999999999998765433 233334444556677899999999
Q ss_pred HHccccCccCCCC-----HHHHhcCcccccc
Q 014347 249 RKILEPNPVKRIT-----IAGIKADEWFEQD 274 (426)
Q Consensus 249 ~~~L~~dP~~R~t-----~~eil~h~~f~~~ 274 (426)
.+||+.||.+||| +.+++.|+||...
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 9999999999999 8899999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=348.48 Aligned_cols=253 Identities=28% Similarity=0.542 Sum_probs=219.5
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe-CCEEEEEE
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-KSKIYMVL 93 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~lV~ 93 (426)
+|++++.||+|++|.||++.+..+++.||+|.+..... .....+.+.+|+.++++++|||++++++.+.. ...+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 59999999999999999999999999999999875443 22335678899999999999999999998764 45789999
Q ss_pred eccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCC
Q 014347 94 EYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (426)
Q Consensus 94 Ey~~gg~L~~~i~~--~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 171 (426)
||+++++|.+.+.. ...+++.+++.++.|++.||++||++|++||||||+||+++.++.++|+|||++..... ...
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~--~~~ 157 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN--QCD 157 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecc--cCC
Confidence 99999999999875 34689999999999999999999999999999999999999999999999999875432 122
Q ss_pred ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC-CCCCCCCHHHHHHHHH
Q 014347 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRK 250 (426)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~ 250 (426)
......|++.|+|||++.+..+ +.++|+||+|+++|+|++|+.||...+.......+..+.. ..|..+++.+.+++.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPY-NYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIAT 236 (257)
T ss_pred ccccccCCcCccChhHhcCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 3345678999999999877665 5889999999999999999999998877766666666544 4566789999999999
Q ss_pred ccccCccCCCCHHHHhcCccc
Q 014347 251 ILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 251 ~L~~dP~~R~t~~eil~h~~f 271 (426)
||++||.+|||+.++++||||
T Consensus 237 ~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 237 MLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HhccCcccCCCHHHHhcCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=351.03 Aligned_cols=256 Identities=34% Similarity=0.520 Sum_probs=220.9
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccc------hhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH------LKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~------~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (426)
+|.+...||+|+||.||+|.+..+++.||+|.+....... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 5889999999999999999999999999999887543322 2334678899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
.+++|||+++++|.+++...+.+++..++.++.|++.||+|||++|++||||+|+||++++++.+||+|||++.......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999987553211
Q ss_pred C----CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHH
Q 014347 169 D----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPG 243 (426)
Q Consensus 169 ~----~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 243 (426)
. ........|++.|+|||.+.+..+ +.++|+|||||++|+|++|+.||.+.+......++... ....|..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSY-TRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCC-CchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence 1 111223468899999999887666 58899999999999999999999887655444444333 44567778999
Q ss_pred HHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 244 AQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
+.++|++||++||.+||++.++++||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=366.02 Aligned_cols=262 Identities=34% Similarity=0.617 Sum_probs=242.1
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCC
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKS 87 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 87 (426)
..+...+|.++..||+|+||+|-+|..+.+.+.+|||+++++-+...+.++--..|-++|.... .|.+++++..|++-+
T Consensus 344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD 423 (683)
T KOG0696|consen 344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD 423 (683)
T ss_pred cceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence 3566788999999999999999999999999999999999988877777777778888888775 688999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
++|+||||+.||+|.-.|++-+++.|..|..|+..|+-||-|||++||++||||.+|||||.+|++||+|||+++. ..
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE--ni 501 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NI 501 (683)
T ss_pred heeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccc--cc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999983 33
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L 247 (426)
..+....+.||||.|+|||++...+| +..+|+||+||+|||||+|++||++++..++++.|...+..+|+.+|.++.++
T Consensus 502 ~~~~TTkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~i 580 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAI 580 (683)
T ss_pred cCCcceeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHH
Confidence 34556778999999999999998887 78999999999999999999999999999999999999999999999999999
Q ss_pred HHHccccCccCCCC-----HHHHhcCccccc
Q 014347 248 LRKILEPNPVKRIT-----IAGIKADEWFEQ 273 (426)
Q Consensus 248 i~~~L~~dP~~R~t-----~~eil~h~~f~~ 273 (426)
.+..|.+.|.+|.. -.+|..||||..
T Consensus 581 ckg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 581 CKGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred HHHHhhcCCccccCCCCccccchhhCcchhh
Confidence 99999999999975 467999999964
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-47 Score=352.05 Aligned_cols=257 Identities=31% Similarity=0.610 Sum_probs=224.3
Q ss_pred Ceee-eceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCCEEEEE
Q 014347 15 RYEL-GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 15 ~y~i-~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV 92 (426)
-|++ .+.||+|+||.|-.+.+..+|..||||++++.. .....++.||+.++...+ |+||++++++|++++.+|+|
T Consensus 78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLV 154 (463)
T KOG0607|consen 78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLV 154 (463)
T ss_pred HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEE
Confidence 3554 467999999999999999999999999998873 334688999999999986 99999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCC---CeEEeeccCccCCcccc-
Q 014347 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFR- 168 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g---~vkL~DFGla~~~~~~~- 168 (426)
||-+.||+|..+|.++.-+++.++.++.+.|++||+|||.+||.||||||+|||-.... -+|||||.|..-.....
T Consensus 155 fEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 155 FEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred EecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 99999999999999999999999999999999999999999999999999999996554 48999999876432211
Q ss_pred ----CCCccccccCCCcccchhhhc----cCCCCCCcchhhhHHHHHHHHHhCCCCCCCC---------------cHHHH
Q 014347 169 ----DDGLLHTTCGSPNYVAPEVLA----NRGYDGATSDIWSCGVILYVILTGYLPFDDR---------------NLAVL 225 (426)
Q Consensus 169 ----~~~~~~~~~gt~~y~APE~l~----~~~~~~~~~DIwSlGvil~elltG~~Pf~~~---------------~~~~~ 225 (426)
....+.+.||+..|||||+.. ...++..++|.||||+|||-||+|++||.+. -...+
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L 314 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL 314 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH
Confidence 223456789999999999963 3345568899999999999999999999752 13467
Q ss_pred HHHHHcCCCCCCC--C--CCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 226 YQKIFRGDFKLPK--W--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 226 ~~~i~~~~~~~p~--~--~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
+..|..+.+++|. | +|.++++||+.+|..|+.+|.++.++++|||++..
T Consensus 315 FesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~ 367 (463)
T KOG0607|consen 315 FESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC 367 (463)
T ss_pred HHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence 8889999999995 4 89999999999999999999999999999999754
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=357.98 Aligned_cols=260 Identities=31% Similarity=0.528 Sum_probs=227.0
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
.+|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++||||+++++.+......|++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999998765544345678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC--
Q 014347 94 EYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-- 169 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~--~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-- 169 (426)
||+.|++|.+++... ..+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998753 5789999999999999999999999999999999999999999999999999875322110
Q ss_pred -------------------------CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHH
Q 014347 170 -------------------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV 224 (426)
Q Consensus 170 -------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~ 224 (426)
........||..|+|||++.+..+ +.++||||||+++|+|++|+.||.+.+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 001123468899999999887665 688999999999999999999999888877
Q ss_pred HHHHHHcCCCCCCCC--CCHHHHHHHHHccccCccCCCC----HHHHhcCcccccc
Q 014347 225 LYQKIFRGDFKLPKW--LSPGAQNLLRKILEPNPVKRIT----IAGIKADEWFEQD 274 (426)
Q Consensus 225 ~~~~i~~~~~~~p~~--~s~~~~~Li~~~L~~dP~~R~t----~~eil~h~~f~~~ 274 (426)
.+..+......+|.. +++.+.++|.+||+.||++||| +++++.||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 777777666666654 6999999999999999999999 9999999999763
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=356.91 Aligned_cols=254 Identities=30% Similarity=0.447 Sum_probs=216.0
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
++|++.+.||+|+||.||++.+..++..+|+|.+.... ......++.+|+.+++.++||||+++++.+.+++.+|++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 47999999999999999999999999999999986432 2344567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-cCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~-~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
||++|++|.+++.+.+.+++..++.++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++.... ...
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~----~~~ 154 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSM 154 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccc----ccc
Confidence 999999999999888889999999999999999999997 599999999999999999999999999987432 222
Q ss_pred cccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC--------------------
Q 014347 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------------- 232 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------------- 232 (426)
....+|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred cccCCCCcCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 345689999999999876655 68899999999999999999999765543332222110
Q ss_pred -----------------CCCCCC-CCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 233 -----------------DFKLPK-WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 233 -----------------~~~~p~-~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
....|. .+++++.+|+.+||..||++|||+.++++||||...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 111121 267889999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=349.82 Aligned_cols=253 Identities=32% Similarity=0.560 Sum_probs=224.8
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEe
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (426)
+|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++++++||||+++++.+.++...|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 59999999999999999999999999999999987665554567889999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccc
Q 014347 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH 174 (426)
Q Consensus 95 y~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 174 (426)
|+.|++|.+++....++++..+..++.||++||.|||++|++|+||+|+||++++++.++|+|||++..... .....
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~---~~~~~ 157 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP---DTLTT 157 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCC---Ccccc
Confidence 999999999998877899999999999999999999999999999999999999999999999999875432 22334
Q ss_pred cccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Q 014347 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL---AVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251 (426)
Q Consensus 175 ~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~p~~~s~~~~~Li~~~ 251 (426)
...|+..|+|||++....+ +.++|+||+|+++|+|++|..||...+. ..............|..+++.+.++|.+|
T Consensus 158 ~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKL 236 (258)
T ss_pred ccCCChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHH
Confidence 5678899999999877665 6889999999999999999999988763 33333333356677788899999999999
Q ss_pred cccCccCCCCH--HHHhcCccc
Q 014347 252 LEPNPVKRITI--AGIKADEWF 271 (426)
Q Consensus 252 L~~dP~~R~t~--~eil~h~~f 271 (426)
|+.||.+||++ .++++||||
T Consensus 237 l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 237 LERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ccCChhHcCCccHHHHhcCCCC
Confidence 99999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-45 Score=355.35 Aligned_cols=259 Identities=32% Similarity=0.581 Sum_probs=224.4
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
++|++.+.||+|+||.||++.+..+++.||+|.+.+...........+.+|+.+++.++||||+++++.+..++..|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46999999999999999999999999999999987665433444667889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc-----
Q 014347 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR----- 168 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~----- 168 (426)
||++|++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999886311000
Q ss_pred --------CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCC--
Q 014347 169 --------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK-- 238 (426)
Q Consensus 169 --------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~-- 238 (426)
.........|+..|+|||.+....+ +.++|+|||||++|+|++|..||.+.+.......+..+....|.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 0001123468889999999876655 68999999999999999999999988888878877766544443
Q ss_pred -CCCHHHHHHHHHccccCccCCCC---HHHHhcCccccc
Q 014347 239 -WLSPGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQ 273 (426)
Q Consensus 239 -~~s~~~~~Li~~~L~~dP~~R~t---~~eil~h~~f~~ 273 (426)
.+++++.++|.+||++||++||+ +.++++||||..
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 47899999999999999999998 789999999965
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-45 Score=343.46 Aligned_cols=253 Identities=28% Similarity=0.477 Sum_probs=222.5
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEe
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (426)
+|++.+.||+|++|.||+|.+..+++.|++|.+...... ......+.+|+.+++.++||||+++++.+.+.+..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 488999999999999999999999999999998765433 3346778899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 95 y~~gg~L~~~i~~~--~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
|++|++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...... ...
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~--~~~ 157 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNF 157 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc--cch
Confidence 99999999999764 57899999999999999999999999999999999999999999999999998754321 122
Q ss_pred cccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHc
Q 014347 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKI 251 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~ 251 (426)
....+|++.|+|||++.+..+ +.++|+||||+++|+|++|+.||...+......++..+.. .++..+++.+.+++.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPY-NEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236 (256)
T ss_pred hhccccCccccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 334578999999999887665 5889999999999999999999998887777777766654 34456889999999999
Q ss_pred cccCccCCCCHHHHhcCccc
Q 014347 252 LEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 252 L~~dP~~R~t~~eil~h~~f 271 (426)
|+.+|++||++.+++.|||+
T Consensus 237 l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 237 LTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ccCCcccCcCHHHHhhCCCC
Confidence 99999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=353.55 Aligned_cols=260 Identities=26% Similarity=0.453 Sum_probs=222.3
Q ss_pred cCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 014347 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (426)
..+....+|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++.+....
T Consensus 14 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~ 90 (296)
T cd06654 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (296)
T ss_pred ccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC
Confidence 4456678999999999999999999999999999999998765432 2467889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
..|+||||++|++|.+++.. ..+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 91 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred EEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 99999999999999998865 56899999999999999999999999999999999999999999999999998753221
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHc-C--CCCCCCCCCHHH
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-G--DFKLPKWLSPGA 244 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~-~--~~~~p~~~s~~~ 244 (426)
........|++.|+|||.+.+..+ +.++||||+||++|+|++|+.||...+.......+.. . ....|..+++.+
T Consensus 170 --~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (296)
T cd06654 170 --QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246 (296)
T ss_pred --ccccCcccCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHH
Confidence 112234578999999999877655 6899999999999999999999988765433323322 2 223456688999
Q ss_pred HHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 245 QNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
.+|+.+||.+||.+|||+.+++.||||...
T Consensus 247 ~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 247 RDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 999999999999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-46 Score=375.76 Aligned_cols=249 Identities=32% Similarity=0.447 Sum_probs=214.0
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-C-----CCccceEEEEEeCCE
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-H-----PNVVRLHEVLASKSK 88 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h-----pnIv~l~~~~~~~~~ 88 (426)
+|++.+.||+|+||.|-+|.|..|++.||||+++.. .....+...|+.+|..|+ | -|+|+++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 899999999999999999999999999999999754 345678888999999998 4 489999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCC--CeEEeeccCccCC
Q 014347 89 IYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG--NIKISDFGLSALP 164 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~--~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g--~vkL~DFGla~~~ 164 (426)
.|||+|.+ +.+|.++|+.+. +++...++.+++||+.||.+||+.||||+|||||||||.+-+ .+||+|||.|+..
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999999 559999998753 689999999999999999999999999999999999997644 6999999999853
Q ss_pred ccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC------------
Q 014347 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------ 232 (426)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------ 232 (426)
. ....+++-+..|+|||++.+.+|+ .+.||||||||++||++|.+.|.+.+..+....|..-
T Consensus 342 ~-----q~vytYiQSRfYRAPEVILGlpY~-~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 342 S-----QRVYTYIQSRFYRAPEVILGLPYD-TAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred C-----CcceeeeeccccccchhhccCCCC-CccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 2 234488889999999999999995 7899999999999999999999998877766555420
Q ss_pred ----------------------------------------CCCCCCC-----------CCHHHHHHHHHccccCccCCCC
Q 014347 233 ----------------------------------------DFKLPKW-----------LSPGAQNLLRKILEPNPVKRIT 261 (426)
Q Consensus 233 ----------------------------------------~~~~p~~-----------~s~~~~~Li~~~L~~dP~~R~t 261 (426)
....|.. -...+.+||++||++||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 0001100 1235689999999999999999
Q ss_pred HHHHhcCcccccc
Q 014347 262 IAGIKADEWFEQD 274 (426)
Q Consensus 262 ~~eil~h~~f~~~ 274 (426)
+.++|+||||...
T Consensus 496 p~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 496 PAQALNHPFLTGT 508 (586)
T ss_pred HHHHhcCcccccc
Confidence 9999999999853
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=351.03 Aligned_cols=253 Identities=30% Similarity=0.451 Sum_probs=209.5
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEe
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (426)
+|++.+.||+|++|.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++.++...|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 58999999999999999999999999999999865432 22234678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCC
Q 014347 95 YVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (426)
Q Consensus 95 y~~gg~L~~~i~~~---~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 171 (426)
|+. ++|.+++... ..+++..++.++.||+.||.|||++|++||||||+|||++.+|.+||+|||++..... ...
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--~~~ 156 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI--PVR 156 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCC--Ccc
Confidence 997 5888887642 5689999999999999999999999999999999999999999999999999874322 112
Q ss_pred ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC------------------C
Q 014347 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------------D 233 (426)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------~ 233 (426)
......+++.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+... .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 2233467899999999876555568899999999999999999999876543322221110 0
Q ss_pred C-----------CCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 234 F-----------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 234 ~-----------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
. .....+++++.+||++||+.||.+|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0 0122368899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=370.65 Aligned_cols=254 Identities=24% Similarity=0.383 Sum_probs=208.6
Q ss_pred ccCCCeeeeceEeecCceEEEEEEEC--CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (426)
..-.+|++++.||+|+||.||+|... .++..||+|.+... ....+|+.+++.++||||+++++++.....
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 160 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKST 160 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence 34467999999999999999999754 45678999987543 234689999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
.|++||++. ++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 161 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 999999995 6899999877889999999999999999999999999999999999999999999999999987543322
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHc--------------
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL---AVLYQKIFR-------------- 231 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~-------------- 231 (426)
.........||+.|+|||++....+ +.++|||||||++|+|++|..||.+... ...+..+.+
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPY-CAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred ccccccccccccCccCHhHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 2222335679999999999987776 5889999999999999999999976431 111111111
Q ss_pred ---------------CCCCCCC-----CCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 232 ---------------GDFKLPK-----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 232 ---------------~~~~~p~-----~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
..+..|. .++.++.+||++||..||.+|||+.+++.||||.+.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 0111221 246788999999999999999999999999999763
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=352.26 Aligned_cols=256 Identities=30% Similarity=0.457 Sum_probs=221.5
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
++|++.+.||.|+||.||+|.+..+++.+|+|++... .....+.+.+|+.+++.++||||+++++.+..+...|+||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 5799999999999999999999889999999998643 2334567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 94 Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
||+++++|.+++.+ ...+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++..... ....
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~--~~~~ 159 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS--TLQK 159 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcc--cccc
Confidence 99999999999876 45799999999999999999999999999999999999999999999999998875322 1122
Q ss_pred cccccCCCcccchhhhccC----CCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC---CCCCCCCHHHH
Q 014347 173 LHTTCGSPNYVAPEVLANR----GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWLSPGAQ 245 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~----~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~ 245 (426)
.....|++.|+|||++... ...+.++|+||||+++|+|++|+.||.+.+......++..+.. ..|..++.++.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN 239 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHH
Confidence 2345789999999997532 2235789999999999999999999998877766666665532 34566899999
Q ss_pred HHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 246 NLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
++|.+||+.+|.+|||+.++++||||...
T Consensus 240 ~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 240 DFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 99999999999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=349.23 Aligned_cols=254 Identities=30% Similarity=0.429 Sum_probs=213.5
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
..++|++++.||+|+||.||+|++..+++.||+|++..... .....+.+|+.+++.++||||+++++++......|+
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 34689999999999999999999999999999999865432 224568899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCC
Q 014347 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 171 (426)
||||+++++|.+.+...+++++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..... ...
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~--~~~ 161 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA--TIA 161 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecc--ccc
Confidence 999999999999998888899999999999999999999999999999999999999999999999999875422 111
Q ss_pred ccccccCCCcccchhhhcc--CCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCC-----CCCCHHH
Q 014347 172 LLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP-----KWLSPGA 244 (426)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~--~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~~ 244 (426)
......|++.|+|||.+.. ....+.++|+||+||++|+|++|..||...+.......+....+..| ..++..+
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTF 241 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHH
Confidence 2234578999999999742 22235789999999999999999999976554433333323322222 2368899
Q ss_pred HHHHHHccccCccCCCCHHHHhcCcc
Q 014347 245 QNLLRKILEPNPVKRITIAGIKADEW 270 (426)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~eil~h~~ 270 (426)
.+||++||+.||++|||++++++|+|
T Consensus 242 ~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 242 HNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 99999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=350.21 Aligned_cols=255 Identities=27% Similarity=0.423 Sum_probs=214.7
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (426)
...++|++.+.||+|+||.||+|.+..+++.||+|+++... ......+.+|+.+++.++||||+++++.+...+..|
T Consensus 6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06645 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW 82 (267)
T ss_pred CcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Confidence 34568999999999999999999999999999999987543 222456788999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCC
Q 014347 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 170 (426)
++|||+++++|.+++...+.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++..... ..
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~--~~ 160 (267)
T cd06645 83 ICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA--TI 160 (267)
T ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccC--cc
Confidence 9999999999999998888999999999999999999999999999999999999999999999999999864322 11
Q ss_pred CccccccCCCcccchhhhc--cCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCC-----CCCCHH
Q 014347 171 GLLHTTCGSPNYVAPEVLA--NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP-----KWLSPG 243 (426)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~--~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~ 243 (426)
.......|++.|+|||++. .....+.++|+||+||++|+|++|..||...................+ ..++..
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNS 240 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHH
Confidence 2223457999999999974 223336889999999999999999999976554333333333332222 136788
Q ss_pred HHHHHHHccccCccCCCCHHHHhcCcc
Q 014347 244 AQNLLRKILEPNPVKRITIAGIKADEW 270 (426)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~eil~h~~ 270 (426)
+.++|.+||+.||++|||++++++|||
T Consensus 241 ~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 241 FHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=358.59 Aligned_cols=247 Identities=32% Similarity=0.469 Sum_probs=195.2
Q ss_pred eceEeecCceEEEEEEEC--CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe--CCEEEEEEe
Q 014347 19 GRTLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KSKIYMVLE 94 (426)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lV~E 94 (426)
+++||+|+||.||+|++. .+++.||+|.+..... ...+.+|+.+++.++||||+++++++.. +..+|++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 578999999999999965 4678999999865432 3457789999999999999999998854 467899999
Q ss_pred ccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEe----cCCCCeEEeeccCc
Q 014347 95 YVTGGELFDKIASK---------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGLS 161 (426)
Q Consensus 95 y~~gg~L~~~i~~~---------~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl----~~~g~vkL~DFGla 161 (426)
|+. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 995 4888877532 258999999999999999999999999999999999999 45678999999999
Q ss_pred cCCcccc-CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHH---------HHHHHHHc
Q 014347 162 ALPQHFR-DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA---------VLYQKIFR 231 (426)
Q Consensus 162 ~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~---------~~~~~i~~ 231 (426)
....... ........+||+.|+|||++.+....+.++||||+||++|+|++|++||...... .....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 8643221 1123345689999999999887665578999999999999999999999643210 11111111
Q ss_pred C----------------------------CCCC----------CCCCCHHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 232 G----------------------------DFKL----------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 232 ~----------------------------~~~~----------p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
. .... ....++.+.+||++||++||.+|||++|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0000 01135678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-45 Score=345.12 Aligned_cols=256 Identities=29% Similarity=0.476 Sum_probs=220.6
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
++|++++.||.|+||.||+|.+..++..+|+|++....... ..+.+.+|+.+++.++|+||+++++.+..+...|++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999998899999999987554322 4678999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCC
Q 014347 94 EYVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~---~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 170 (426)
||++|++|.+++... ..+++..++.++.||+.||.|||++|++||||+|+||++++++.++|+|||++.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999999763 45899999999999999999999999999999999999999999999999998754432221
Q ss_pred --CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCC-CC-----CCCCH
Q 014347 171 --GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LP-----KWLSP 242 (426)
Q Consensus 171 --~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p-----~~~s~ 242 (426)
.......|++.|+|||++......+.++|+|||||++|+|++|+.||...+....+.+....... ++ ..+++
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK 238 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence 12344578999999999876644578999999999999999999999987776666665554322 22 24678
Q ss_pred HHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 243 GAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
.+.+++.+||+.||++|||+.+++.||||
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 239 SFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=352.59 Aligned_cols=262 Identities=31% Similarity=0.426 Sum_probs=219.9
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (426)
+|++++.||+|+||.||+|.+..+|+.||+|.+...... .......+.+|+.+++.++|+||+++++++.+....|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 589999999999999999999999999999999765433 123345678899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCC
Q 014347 93 LEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~~~-~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 171 (426)
|||+ +++|.+++.... .+++..++.++.||++||.|||++|++||||||+||+++.+|.+||+|||++...... ..
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP--NR 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC--Cc
Confidence 9999 899999998765 7999999999999999999999999999999999999999999999999998754321 12
Q ss_pred ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC-----------------
Q 014347 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF----------------- 234 (426)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----------------- 234 (426)
......+++.|+|||.+.+....+.++|+||+||++|+|++|.+||.+.+......++.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 223345788999999986655557889999999999999999999987766555544432100
Q ss_pred ------C-----CCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccCCCCC
Q 014347 235 ------K-----LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 279 (426)
Q Consensus 235 ------~-----~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~~~ 279 (426)
. .....+..+.+||.+||++||++|||+.+++.|+||.....+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~ 293 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP 293 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence 0 01224678999999999999999999999999999998766553
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=348.56 Aligned_cols=255 Identities=28% Similarity=0.442 Sum_probs=212.9
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
++|++.+.||+|+||.||+|.+..+|+.||+|.+..... .....+.+.+|+.+++.++|||++++++++......|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 579999999999999999999999999999999865432 1222456789999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcc
Q 014347 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 173 (426)
||++++.|...+.....+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++...... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~~ 157 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGP--GDDY 157 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCC--cccc
Confidence 99999888887777678999999999999999999999999999999999999999999999999999854331 1122
Q ss_pred ccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC-------------------CC
Q 014347 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------------DF 234 (426)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------------~~ 234 (426)
....++..|+|||++.+....+.++||||+|+++|+|++|..||.+.+..+....+... ..
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 34467889999999876555578999999999999999999999876544332222110 00
Q ss_pred CCC------------CCCCHHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 235 KLP------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 235 ~~p------------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
..| +.++..+.+|+.+||++||++|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 001 2357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=354.01 Aligned_cols=253 Identities=29% Similarity=0.472 Sum_probs=209.5
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEe
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (426)
+|++.+.||+|+||.||+|++..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+....|+++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 69999999999999999999999999999999875432 22234567889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcc
Q 014347 95 YVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (426)
Q Consensus 95 y~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 173 (426)
|+.+ +|.+.+.+ .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ....
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~--~~~~ 156 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VRCY 156 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC--CCCc
Confidence 9975 78887764 567999999999999999999999999999999999999999999999999998754321 1222
Q ss_pred ccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCC-CCCcHHHHHHHHHcCC-------------------
Q 014347 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFRGD------------------- 233 (426)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf-~~~~~~~~~~~i~~~~------------------- 233 (426)
....+++.|+|||++.+....+.++|||||||++|+|++|..|| .+.+....+..+.+..
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 34567899999999877655578899999999999999988885 4444444433332110
Q ss_pred C----------CCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 234 F----------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 234 ~----------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
. ...+.+++++.+||.+||+.||.+|||+++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 0112367899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=345.64 Aligned_cols=255 Identities=29% Similarity=0.468 Sum_probs=216.9
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeeccccc---chhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
+|++++.||+|+||.||+|.+ .+|+.+|+|.+...... ......++.+|+.+++.++|+||+++++++.+.+..|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 589999999999999999986 57889999998754321 22335678999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc---
Q 014347 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR--- 168 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~--- 168 (426)
++||++|++|.+++.+.+++++..++.++.|++.||+|||++||+|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999987432111
Q ss_pred -CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC---CCCCCCCCCHHH
Q 014347 169 -DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPGA 244 (426)
Q Consensus 169 -~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~ 244 (426)
.........|++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.......+... ....|..++..+
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred cccccccccCCCccccChhhhcCCCC-cchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 1122334568999999999877665 58899999999999999999999876654443333332 234566789999
Q ss_pred HHHHHHccccCccCCCCHHHHhcCccc
Q 014347 245 QNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
.++|++||+++|++|||+.+++.||||
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=351.96 Aligned_cols=258 Identities=28% Similarity=0.477 Sum_probs=221.9
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
+....+|++.+.||.|+||.||+|.+..+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++.+......
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (296)
T cd06655 15 GDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDEL 91 (296)
T ss_pred CCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceE
Confidence 4455679999999999999999999999999999999875432 2356788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
|+|+||++|++|.+++.. ..+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 92 ~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~-- 168 (296)
T cd06655 92 FVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE-- 168 (296)
T ss_pred EEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc--
Confidence 999999999999998865 56999999999999999999999999999999999999999999999999998754321
Q ss_pred CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC---CCCCCCCCCHHHHH
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPGAQN 246 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~ 246 (426)
.......+|++.|+|||.+.+..+ +.++|+|||||++|+|++|+.||.+.+.......+... ....|..+++.+.+
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (296)
T cd06655 169 QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRD 247 (296)
T ss_pred cccCCCcCCCccccCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHH
Confidence 112234578999999999877665 68899999999999999999999987765444444332 23345668999999
Q ss_pred HHHHccccCccCCCCHHHHhcCcccccc
Q 014347 247 LLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 247 Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
||++||..||.+|||+.+++.||||+..
T Consensus 248 li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 248 FLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred HHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 9999999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-45 Score=354.30 Aligned_cols=262 Identities=26% Similarity=0.445 Sum_probs=222.2
Q ss_pred ccCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 014347 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (426)
...+...++|++++.||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++.+..+
T Consensus 12 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 88 (297)
T cd06656 12 VSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVG 88 (297)
T ss_pred cccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 34456668999999999999999999999999999999998754432 246688999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcc
Q 014347 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 166 (426)
...|+||||++|++|.+++.+ ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++.....
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 89 DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred CEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 999999999999999998865 5689999999999999999999999999999999999999999999999999875332
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHc-C--CCCCCCCCCHH
Q 014347 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-G--DFKLPKWLSPG 243 (426)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~-~--~~~~p~~~s~~ 243 (426)
. ........+++.|+|||.+.+..+ +.++|+||+||++|+|++|..||.+.+.......+.. + ....|..+++.
T Consensus 168 ~--~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (297)
T cd06656 168 E--QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAV 244 (297)
T ss_pred C--ccCcCcccCCccccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHH
Confidence 1 112234578999999999887665 6889999999999999999999987665332222222 1 22345568899
Q ss_pred HHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
+.+|+.+||+.||++|||+.+++.||||+...
T Consensus 245 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 245 FRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 99999999999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=350.94 Aligned_cols=240 Identities=19% Similarity=0.256 Sum_probs=210.7
Q ss_pred ceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe----CCEEEEEEec
Q 014347 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----KSKIYMVLEY 95 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~lV~Ey 95 (426)
..||+|++|.||+|.. +|+.||||.+.+.........+.+.+|+.+|++++||||+++++++.+ ....++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6799999999999986 788999999987655455556788999999999999999999999876 4578999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc-CceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccc
Q 014347 96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH 174 (426)
Q Consensus 96 ~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~-gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 174 (426)
++||+|.+++.+.+.+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||++..... ...
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~-----~~~ 178 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS-----PPF 178 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc-----ccc
Confidence 99999999999888899999999999999999999985 999999999999999999999999999875322 123
Q ss_pred cccCCCcccchhhhcc--CCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC--CCCCCCCCCHHHHHHHHH
Q 014347 175 TTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRK 250 (426)
Q Consensus 175 ~~~gt~~y~APE~l~~--~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~ 250 (426)
...|++.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+...++..+... .+.+|..+++.+.+|+.+
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 257 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA 257 (283)
T ss_pred cccCcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHH
Confidence 4578999999999875 344 68999999999999999999999998888888777544 455666789999999999
Q ss_pred ccccCccCCCCHHHHhc
Q 014347 251 ILEPNPVKRITIAGIKA 267 (426)
Q Consensus 251 ~L~~dP~~R~t~~eil~ 267 (426)
||+.||++|||+.+++.
T Consensus 258 cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 258 CTSHDSIKRPNIKEILY 274 (283)
T ss_pred HhcCCcccCcCHHHHHH
Confidence 99999999999999975
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=345.72 Aligned_cols=257 Identities=31% Similarity=0.501 Sum_probs=216.1
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeeccccc-------chhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-------HLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-------~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (426)
+|.+.+.||.|+||.||+|.+..+|+.||+|.+...... .....+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 689999999999999999999999999999988643211 1123457889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
..++||||++|++|.+++.+.+.+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999998754322
Q ss_pred cCCCccccccCCCcccchhhhccCC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC--CCCCCC----CC
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPK----WL 240 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~----~~ 240 (426)
..........|+..|+|||.+.... ..+.++|+||||+++|+|++|..||...........+... ...+|. .+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence 2222233457899999999987654 3468899999999999999999999876554433333222 223333 35
Q ss_pred CHHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 241 s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
+..+.++|.+||+++|++|||++++++||||
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 242 SPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 8899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=350.32 Aligned_cols=255 Identities=25% Similarity=0.376 Sum_probs=218.5
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCC-----CeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSG-----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 85 (426)
+.+++|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 79 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK 79 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence 45678999999999999999999976555 679999886443 33445678999999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecC
Q 014347 86 KSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 149 (426)
Q Consensus 86 ~~~~~lV~Ey~~gg~L~~~i~~~----------------~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~ 149 (426)
....|++|||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||++++
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 99999999999999999999764 45788999999999999999999999999999999999999
Q ss_pred CCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHH
Q 014347 150 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQK 228 (426)
Q Consensus 150 ~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 228 (426)
++.+||+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+..+....
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF-TTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcC-chhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999874322111122334567889999999877665 689999999999999998 9999999888888777
Q ss_pred HHcCC-CCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 229 IFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 229 i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
+..+. ...|..+++++.+|+.+||+.||.+|||+.+|+++
T Consensus 239 i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 239 IRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 76654 45567789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=342.34 Aligned_cols=253 Identities=30% Similarity=0.589 Sum_probs=221.8
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEe
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (426)
+|++.+.||+|+||.||++++..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++...+..|+|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 699999999999999999999999999999998754432 2335678999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 95 y~~gg~L~~~i~~~--~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
|++|++|.+.+... ..+++..+..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++...... ...
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~--~~~ 157 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST--VEL 157 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc--hhh
Confidence 99999999998753 35899999999999999999999999999999999999999999999999998754321 112
Q ss_pred cccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHc
Q 014347 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKI 251 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~ 251 (426)
.....|++.|+|||++.+..+ +.++|+|||||++|+|++|+.||...+.......+..+.. ..|..++.++.++|.+|
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPY-NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236 (256)
T ss_pred hhhccCCccccCHHHhCCCCC-CCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHH
Confidence 223468899999999876655 6889999999999999999999998888777777766654 45667899999999999
Q ss_pred cccCccCCCCHHHHhcCccc
Q 014347 252 LEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 252 L~~dP~~R~t~~eil~h~~f 271 (426)
|+.+|++||++.++++||||
T Consensus 237 l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 237 FKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred hhCChhhCcCHHHHhhCcCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=348.02 Aligned_cols=255 Identities=27% Similarity=0.444 Sum_probs=218.2
Q ss_pred eeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEec
Q 014347 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (426)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey 95 (426)
|++.+.||+|+||.||+|.+..++..+|+|.+.... ....+.+.+|+.+++.++||||+++++.+..+...|+|+||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 788999999999999999999999999999986442 33456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccc
Q 014347 96 VTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH 174 (426)
Q Consensus 96 ~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 174 (426)
+++++|.+.+.+ ..++++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++..... ......
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~--~~~~~~ 161 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQRRD 161 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccc--cccccc
Confidence 999999888764 56799999999999999999999999999999999999999999999999999875322 112233
Q ss_pred cccCCCcccchhhhcc----CCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC---CCCCCCCCHHHHHH
Q 014347 175 TTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNL 247 (426)
Q Consensus 175 ~~~gt~~y~APE~l~~----~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~L 247 (426)
...|++.|+|||++.. ....+.++||||+||++|+|++|..||...+.......+.... ...|..++..+.+|
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDF 241 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHH
Confidence 4578999999999742 2223578999999999999999999999877666555554432 23456688999999
Q ss_pred HHHccccCccCCCCHHHHhcCccccccC
Q 014347 248 LRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 248 i~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
|.+||+.||.+|||++++++||||....
T Consensus 242 i~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 242 LKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred HHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 9999999999999999999999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=345.04 Aligned_cols=248 Identities=35% Similarity=0.688 Sum_probs=221.2
Q ss_pred EeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEeccCCCCh
Q 014347 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL 101 (426)
Q Consensus 22 LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~gg~L 101 (426)
||.|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++.+.++...|+++||++|++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999999999999999876655445567899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccCCCc
Q 014347 102 FDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181 (426)
Q Consensus 102 ~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~ 181 (426)
.+++.+...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...... ......+|++.
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~ 157 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG---QKTWTFCGTPE 157 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc---cccccccCCcC
Confidence 999988788999999999999999999999999999999999999999999999999998854321 12234578999
Q ss_pred ccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCc--HHHHHHHHH--cCCCCCCCCCCHHHHHHHHHccccCcc
Q 014347 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIF--RGDFKLPKWLSPGAQNLLRKILEPNPV 257 (426)
Q Consensus 182 y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~--~~~~~~~i~--~~~~~~p~~~s~~~~~Li~~~L~~dP~ 257 (426)
|+|||.+....+ +.++|+||+|+++|+|++|..||.... ....+.++. .....+|...++.+.++|.+||+.||+
T Consensus 158 ~~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 236 (262)
T cd05572 158 YVAPEIILNKGY-DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236 (262)
T ss_pred ccChhHhcCCCC-CChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence 999999877665 588999999999999999999998776 666777776 445677777899999999999999999
Q ss_pred CCCC-----HHHHhcCccccc
Q 014347 258 KRIT-----IAGIKADEWFEQ 273 (426)
Q Consensus 258 ~R~t-----~~eil~h~~f~~ 273 (426)
+||| +.++++||||++
T Consensus 237 ~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 237 ERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred hCcCCcccCHHHHhcChhhhC
Confidence 9999 999999999975
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=349.06 Aligned_cols=249 Identities=29% Similarity=0.459 Sum_probs=207.2
Q ss_pred eEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHH---hCCCCCccceEEEEEeCCEEEEEEeccC
Q 014347 21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK---LLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (426)
Q Consensus 21 ~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~---~l~hpnIv~l~~~~~~~~~~~lV~Ey~~ 97 (426)
.||+|+||.||++.+..+++.+|+|.+.+.............+|..+++ ..+||||+.+++.+...+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999997654432222233445554444 3479999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcccccc
Q 014347 98 GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 177 (426)
Q Consensus 98 gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 177 (426)
|++|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||+++++.++|+|||++..... .......
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccc----cCccCcC
Confidence 999999998888899999999999999999999999999999999999999999999999999874322 1223457
Q ss_pred CCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCc---HHHHHHHHHcCCCCCCCCCCHHHHHHHHHcccc
Q 014347 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEP 254 (426)
Q Consensus 178 gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~ 254 (426)
||+.|+|||.+......+.++||||+||++|+|++|..||.... ..............+|..+++++.++|++||+.
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 236 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcC
Confidence 99999999998644444688999999999999999999997532 223333333445667778999999999999999
Q ss_pred CccCCC-----CHHHHhcCccccc
Q 014347 255 NPVKRI-----TIAGIKADEWFEQ 273 (426)
Q Consensus 255 dP~~R~-----t~~eil~h~~f~~ 273 (426)
||.+|+ |+.++++||||+.
T Consensus 237 ~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 237 DVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred CHHHhcCCCCCCHHHHHhCccccC
Confidence 999999 6999999999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=358.22 Aligned_cols=256 Identities=21% Similarity=0.363 Sum_probs=207.9
Q ss_pred eeeceEeec--CceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEe
Q 014347 17 ELGRTLGEG--NFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 17 ~i~~~LG~G--~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (426)
+++++||+| +|++||++.+..+|+.||+|.++..... ......+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence 367899999 7899999999999999999999765432 3345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC---
Q 014347 95 YVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--- 169 (426)
Q Consensus 95 y~~gg~L~~~i~~--~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~--- 169 (426)
|+++|+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.++++|||.+........
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 9999999999865 34589999999999999999999999999999999999999999999999986543211100
Q ss_pred --CCccccccCCCcccchhhhccC-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCC-----------
Q 014347 170 --DGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK----------- 235 (426)
Q Consensus 170 --~~~~~~~~gt~~y~APE~l~~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~----------- 235 (426)
........++..|+|||++.+. ...+.++||||+||++|+|++|+.||.+............+..+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 0111234577889999998753 22368899999999999999999999875544333222221110
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 236 -----------------------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 236 -----------------------------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
....+++.+.+||++||+.||++|||++++++||||++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 11124678999999999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=345.90 Aligned_cols=253 Identities=27% Similarity=0.404 Sum_probs=211.5
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEe------
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS------ 85 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~------ 85 (426)
-|+|++.+.||+|+||.||+|.+..+++.||+|.+..... ....+.+|+.+++++ +||||+++++.+..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 3689999999999999999999999999999999875431 235688899999998 69999999999865
Q ss_pred CCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccC
Q 014347 86 KSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (426)
Q Consensus 86 ~~~~~lV~Ey~~gg~L~~~i~~~--~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~ 163 (426)
...+|++|||+.+++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||++++++.+||+|||++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 35689999999999999998863 4689999999999999999999999999999999999999999999999999875
Q ss_pred CccccCCCccccccCCCcccchhhhccC----CCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC--CCC
Q 014347 164 PQHFRDDGLLHTTCGSPNYVAPEVLANR----GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF--KLP 237 (426)
Q Consensus 164 ~~~~~~~~~~~~~~gt~~y~APE~l~~~----~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~p 237 (426)
... .........|++.|+|||++... ...+.++||||+||++|+|++|..||...........+..... ..+
T Consensus 161 ~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06637 161 LDR--TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS 238 (272)
T ss_pred ccc--ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCC
Confidence 432 11223456799999999998632 2235789999999999999999999987665544444333221 123
Q ss_pred CCCCHHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 238 ~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
..++..+.+|+.+||..||.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 239 KKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 3478899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=343.60 Aligned_cols=256 Identities=30% Similarity=0.508 Sum_probs=215.7
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCccceEEEEEe--CCEEE
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--HLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KSKIY 90 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~ 90 (426)
.|++.+.||+|+||.||+|.+..++..||+|.+...... ..+....+.+|+.+++.++||||+++++++.. ....|
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 689999999999999999999999999999998754322 22345678999999999999999999998865 46789
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc-C
Q 014347 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR-D 169 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~-~ 169 (426)
+++||+++++|.+.+...+.+++...+.++.|++.||+|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS 162 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence 999999999999999887889999999999999999999999999999999999999999999999999987543211 1
Q ss_pred CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC--CCCCCCCCCHHHHHH
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNL 247 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~L 247 (426)
........++..|+|||.+.+..+ +.++|+||+||++|+|++|+.||..........+.... ...+|..+++.+.+|
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (266)
T cd06651 163 GTGIRSVTGTPYWMSPEVISGEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF 241 (266)
T ss_pred CCccccCCccccccCHHHhCCCCC-CchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHH
Confidence 112233568899999999877665 68899999999999999999999876554444333322 355677789999999
Q ss_pred HHHccccCccCCCCHHHHhcCcccc
Q 014347 248 LRKILEPNPVKRITIAGIKADEWFE 272 (426)
Q Consensus 248 i~~~L~~dP~~R~t~~eil~h~~f~ 272 (426)
+ +||..+|++|||+++++.||||+
T Consensus 242 i-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 242 L-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred H-HHhcCChhhCcCHHHHhcCcccc
Confidence 9 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=345.35 Aligned_cols=257 Identities=27% Similarity=0.479 Sum_probs=217.2
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeeccccc---chhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
+|+.++.||+|+||.||+|.+..+++.||+|++...... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 588999999999999999999999999999998754322 12345789999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCC-CeEEeeccCccCCccccC-
Q 014347 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQHFRD- 169 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g-~vkL~DFGla~~~~~~~~- 169 (426)
|+||++|++|.+.+.+.+++++..+..++.||+.||.|||++|++||||+|+||+++.++ .+||+|||++........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999998888899999999999999999999999999999999999998876 599999999875433211
Q ss_pred -CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHH---H--cCCCCCCCCCCHH
Q 014347 170 -DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI---F--RGDFKLPKWLSPG 243 (426)
Q Consensus 170 -~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i---~--~~~~~~p~~~s~~ 243 (426)
........|+..|+|||++.+..+ +.++|+||+|+++|+|++|..||...........+ . ......|..++++
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239 (268)
T ss_pred CCccccccccccceeCHhHhccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence 111223468899999999876665 68899999999999999999999765432222222 1 2234566778999
Q ss_pred HHHHHHHccccCccCCCCHHHHhcCcccc
Q 014347 244 AQNLLRKILEPNPVKRITIAGIKADEWFE 272 (426)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~eil~h~~f~ 272 (426)
+.+++.+||+.+|++|||+.++++||||.
T Consensus 240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 240 LRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=347.26 Aligned_cols=255 Identities=32% Similarity=0.488 Sum_probs=215.9
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEe
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (426)
+|++.+.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++..+...|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 699999999999999999999999999999998765432 2335678999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcc
Q 014347 95 YVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (426)
Q Consensus 95 y~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 173 (426)
|+ |++|.+++.. ...+++.+++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... ....
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~ 157 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE-PRLY 157 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC-CCcc
Confidence 99 9999999865 4579999999999999999999999999999999999999999999999999988653321 1223
Q ss_pred ccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC-------------------CC
Q 014347 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------------DF 234 (426)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------------~~ 234 (426)
....|+..|+|||++......+.++||||+|+++|+|++|.+||.+.+....+..+... ..
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 45678999999999876665578999999999999999999999877655444433321 00
Q ss_pred CC-----------CCCCCHHHHHHHHHccccCccCCCCHHHHhcCcccc
Q 014347 235 KL-----------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 272 (426)
Q Consensus 235 ~~-----------p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~ 272 (426)
.+ .+..+..+.+||.+||+.||.+|||+++++.||||.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 00 123578899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=350.52 Aligned_cols=255 Identities=29% Similarity=0.431 Sum_probs=214.7
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
++|++.+.||+|+||.||+|.+..+++.||+|.+.+..... ...+.+.+|+.+++.++||||+++++++..+...|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 47999999999999999999999899999999986543322 34567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcc
Q 014347 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 173 (426)
||++++.|.+.......+++..++.++.|++.||+|||++|++||||+|+||++++++.++|+|||++...... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~--~~~~ 157 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--GEVY 157 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC--cccc
Confidence 99999999887776667999999999999999999999999999999999999999999999999998754321 1223
Q ss_pred ccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC-------------------CC
Q 014347 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------------DF 234 (426)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------------~~ 234 (426)
....++..|+|||++.+....+.++||||||+++|+|++|++||...........+... ..
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 34568899999999876555578899999999999999999999876544333222210 00
Q ss_pred C------------CCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 235 K------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 235 ~------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
. .++.++..+.+|+.+||+.+|++|||+.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0 123467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=348.87 Aligned_cols=258 Identities=26% Similarity=0.406 Sum_probs=219.5
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
.-++|++++.||+|+||.||+|.+..+++.||+|.+... .......+.+|+.+++.++||||+++++.+..+...|+
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI 86 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence 346799999999999999999999999999999998654 33446778899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCC
Q 014347 92 VLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 170 (426)
||||++|++|..++.+ ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++..... ..
T Consensus 87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~--~~ 164 (292)
T cd06644 87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK--TL 164 (292)
T ss_pred EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc--cc
Confidence 9999999999887754 46789999999999999999999999999999999999999999999999998864322 11
Q ss_pred CccccccCCCcccchhhhccC----CCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC---CCCCCCCHH
Q 014347 171 GLLHTTCGSPNYVAPEVLANR----GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWLSPG 243 (426)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~----~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~ 243 (426)
.......+++.|+|||++... ...+.++|+|||||++|+|++|..||...+......++..... ..|..++.+
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSME 244 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHH
Confidence 122345688999999997532 2235789999999999999999999988776666655554432 335567889
Q ss_pred HHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
+.+||.+||+.||++||+++++++||||...
T Consensus 245 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 245 FRDFLKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 9999999999999999999999999999653
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=361.29 Aligned_cols=261 Identities=30% Similarity=0.467 Sum_probs=233.3
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (426)
..+..+.|+.-+.||+|+||+||-++.+.||+-+|+|.+++..+....-.....+|-.+|.+++.+.||.+-..|++.+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 34567789999999999999999999999999999999988777655555667889999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcc
Q 014347 89 IYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~--~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 166 (426)
+++||..|.||+|.-+|.+.+ .+++..++.|+.+|+.||++||+++|++|||||+|||||+.|+++|+|+|||..+.
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~- 338 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP- 338 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC-
Confidence 999999999999998888765 79999999999999999999999999999999999999999999999999998543
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCc----HHHHHHHHHcCCCCCCCCCCH
Q 014347 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRGDFKLPKWLSP 242 (426)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~ 242 (426)
........+||.+|||||++.+..| +...|+|||||+||+|+.|+.||.... ..++-+.+......+|..+|+
T Consensus 339 --~g~~~~~rvGT~GYMAPEvl~ne~Y-~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~ 415 (591)
T KOG0986|consen 339 --EGKPIRGRVGTVGYMAPEVLQNEVY-DFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSE 415 (591)
T ss_pred --CCCccccccCcccccCHHHHcCCcc-cCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCH
Confidence 3344556699999999999998886 588999999999999999999997633 235556677778889999999
Q ss_pred HHHHHHHHccccCccCCCC-----HHHHhcCccccc
Q 014347 243 GAQNLLRKILEPNPVKRIT-----IAGIKADEWFEQ 273 (426)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t-----~~eil~h~~f~~ 273 (426)
++++|.+.+|++||.+|.. ++++.+||||+.
T Consensus 416 eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 416 EAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred HHHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 9999999999999999974 779999999986
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-45 Score=347.70 Aligned_cols=257 Identities=34% Similarity=0.638 Sum_probs=229.5
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCCEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV 92 (426)
++|.+.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|..+++.+. ||||+++++++...+..|++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998765544445577889999999999 99999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCC--
Q 014347 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD-- 170 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~-- 170 (426)
|||+.+++|.+.+.+.+.+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 999999999999998889999999999999999999999999999999999999999999999999998754332110
Q ss_pred ----------------CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC
Q 014347 171 ----------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF 234 (426)
Q Consensus 171 ----------------~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~ 234 (426)
.......|+..|+|||++....+ +.++|+||||++++++++|..||...+....++.+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC
Confidence 12233467899999999876554 6889999999999999999999998887777778777788
Q ss_pred CCCCCCCHHHHHHHHHccccCccCCCCH----HHHhcCccc
Q 014347 235 KLPKWLSPGAQNLLRKILEPNPVKRITI----AGIKADEWF 271 (426)
Q Consensus 235 ~~p~~~s~~~~~Li~~~L~~dP~~R~t~----~eil~h~~f 271 (426)
.+|..+++.+.+||.+||+.||++|||+ .++++||||
T Consensus 240 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 8888899999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=389.85 Aligned_cols=266 Identities=27% Similarity=0.456 Sum_probs=219.8
Q ss_pred cccCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe
Q 014347 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (426)
Q Consensus 6 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 85 (426)
.......+++|++++.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d 83 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLN 83 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence 34566788999999999999999999999999999999999976543 23345778999999999999999999998854
Q ss_pred --CCEEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhc-------CceeccCCCCcEEecC---
Q 014347 86 --KSKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNK-------GVFHRDLKLENILLDS--- 149 (426)
Q Consensus 86 --~~~~~lV~Ey~~gg~L~~~i~~----~~~l~~~~~~~i~~Ql~~aL~~LH~~-------gIiHrDLKp~NILl~~--- 149 (426)
...+|+||||+++|+|.++|.. .+.+++..++.|+.||+.||.|||+. +|+||||||+||||+.
T Consensus 84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 4679999999999999999865 35799999999999999999999985 4999999999999964
Q ss_pred --------------CCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccC-CCCCCcchhhhHHHHHHHHHhCC
Q 014347 150 --------------KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGY 214 (426)
Q Consensus 150 --------------~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~~DIwSlGvil~elltG~ 214 (426)
.+.+||+|||++..... .......+||+.|+|||++... ...+.++||||||||||+|++|.
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~---~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk 240 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240 (1021)
T ss_pred ccccccccccccCCCCceEEccCCccccccc---cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence 23489999999975422 2233456799999999998643 33468999999999999999999
Q ss_pred CCCCCCcHHHHHHHHHcCCCCCC-CCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 215 LPFDDRNLAVLYQKIFRGDFKLP-KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 215 ~Pf~~~~~~~~~~~i~~~~~~~p-~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
.||...+............+.+| ...++++.+||.+||+.+|.+|||+.++|.|+|+....
T Consensus 241 ~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 241 TPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred CCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 99986554433333333333333 34789999999999999999999999999999997543
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=345.92 Aligned_cols=250 Identities=24% Similarity=0.398 Sum_probs=211.2
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
.+|++++.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.++++++||||+++++.+......++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 36899999999999999999999999999999987543 2334567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcc
Q 014347 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 173 (426)
||+++++|..+ ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.+||+|||++.... ....
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~----~~~~ 150 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV----NSIA 150 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecc----cccc
Confidence 99999998654 457899999999999999999999999999999999999999999999999987432 2233
Q ss_pred ccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcH-------HHHHHHHHcCC-CCC-CCCCCHHH
Q 014347 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL-------AVLYQKIFRGD-FKL-PKWLSPGA 244 (426)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~-------~~~~~~i~~~~-~~~-p~~~s~~~ 244 (426)
...+||+.|+|||++.+..+ +.++|+||+|+++|+|++|+.||..... ......+.... ... ....++++
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQY-GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKF 229 (279)
T ss_pred cCCCCChhhcCceeecCCCC-CCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHH
Confidence 45689999999999887665 6899999999999999999999965321 12222222222 222 23478899
Q ss_pred HHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 245 QNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
.+++.+||+.||.+||++++++.||||...
T Consensus 230 ~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 230 VHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=346.04 Aligned_cols=255 Identities=25% Similarity=0.456 Sum_probs=222.0
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
++|++.+.||.|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++||||+++++.+.++...|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 57999999999999999999999999999999987543 2233567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcc
Q 014347 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 173 (426)
||+++++|.+++... ++++..++.++.|++.||.|||++|++||||+|+||++++++.++|+|||+++...... ...
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~ 155 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKR 155 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--ccc
Confidence 999999999998864 89999999999999999999999999999999999999999999999999997654321 223
Q ss_pred ccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC-CCCCCC-CCHHHHHHHHHc
Q 014347 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKW-LSPGAQNLLRKI 251 (426)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~-~s~~~~~Li~~~ 251 (426)
....|++.|+|||.+.+..+ +.++||||+|+++|+|++|..||...+.......+.... ...+.. +++.+.+++.+|
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 234 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLC 234 (274)
T ss_pred ccccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHH
Confidence 34578899999999887665 689999999999999999999998877665555554443 334444 789999999999
Q ss_pred cccCccCCCCHHHHhcCcccccc
Q 014347 252 LEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 252 L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
|..||++|||+++++.||||...
T Consensus 235 l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 235 LNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred hhCChhhCcCHHHHhhChhhcCC
Confidence 99999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=348.72 Aligned_cols=256 Identities=27% Similarity=0.442 Sum_probs=218.1
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
++|++++.||+|+||.||+|.+..+|+.||+|.+.... .......+.+|+.++++++||||+++++.+...+..|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 47999999999999999999999999999999886432 2333567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhh-cCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 94 EYVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~---~~l~~~~~~~i~~Ql~~aL~~LH~-~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
||++|++|.+++... ..+++..++.++.||+.||.|||+ +||+||||||+||+++.++.+||+|||++....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~---- 154 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV---- 154 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc----
Confidence 999999998888763 379999999999999999999996 599999999999999999999999999987432
Q ss_pred CCccccccCCCcccchhhhccCCC-----CCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHH---HHcC-CCCCCCCC
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRGY-----DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK---IFRG-DFKLPKWL 240 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~-----~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~---i~~~-~~~~p~~~ 240 (426)
........|++.|+|||.+.+... .+.++|+|||||++|+|++|..||...+....+.. +..+ ....|..+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd06622 155 ASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY 234 (286)
T ss_pred CCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence 223345678899999999854332 36789999999999999999999987655443332 3333 34566678
Q ss_pred CHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 241 s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
++++.+||.+||+.+|++||++.+++.||||....
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 99999999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=347.01 Aligned_cols=250 Identities=29% Similarity=0.447 Sum_probs=211.1
Q ss_pred eEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHH---HHHHhCCCCCccceEEEEEeCCEEEEEEeccC
Q 014347 21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI---ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (426)
Q Consensus 21 ~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei---~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~ 97 (426)
.||+|+||.||+|.+..+++.||+|.+.+..............|. ..++...||||+.+++.+...+..|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999999999999999865443222222233343 44555679999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcccccc
Q 014347 98 GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 177 (426)
Q Consensus 98 gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 177 (426)
|++|.+++.+.+.+++..++.++.|++.||.|||+++|+||||||+||+++.++.+||+|||++..... ......+
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~----~~~~~~~ 156 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASV 156 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCc----cCCcCcC
Confidence 999999998888899999999999999999999999999999999999999999999999999874322 1233567
Q ss_pred CCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCC---cHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcccc
Q 014347 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR---NLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEP 254 (426)
Q Consensus 178 gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~---~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~ 254 (426)
|++.|+|||++.+....+.++||||+|+++|+|++|+.||.+. ........+......+|..+++.+.+++.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~ 236 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 236 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhc
Confidence 9999999999875544468899999999999999999999876 3444444555556777777899999999999999
Q ss_pred CccCCC-----CHHHHhcCcccccc
Q 014347 255 NPVKRI-----TIAGIKADEWFEQD 274 (426)
Q Consensus 255 dP~~R~-----t~~eil~h~~f~~~ 274 (426)
+|.+|| ++.++++||||+..
T Consensus 237 ~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 237 DVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred CHHhccCCCCCCHHHHHhCccccCC
Confidence 999999 99999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=350.50 Aligned_cols=264 Identities=31% Similarity=0.444 Sum_probs=217.9
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC--CE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SK 88 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~ 88 (426)
..+++|++.+.||+|+||.||+|.+..+|+.||+|.+...... ......+.+|+.+++.++|+||+++++++... +.
T Consensus 4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (309)
T cd07845 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDS 82 (309)
T ss_pred ccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC-CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence 4678999999999999999999999999999999998754322 22234566899999999999999999998654 56
Q ss_pred EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 89 IYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
.|+||||+.+ +|.+.+.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 83 ~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 83 IFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 8999999965 88888775 467999999999999999999999999999999999999999999999999998854321
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC---------------
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--------------- 232 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--------------- 232 (426)
. .......+++.|+|||++.+....+.++||||+||++|+|++|..||.+.+....+..+...
T Consensus 162 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 162 A--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred c--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence 1 12223346788999999876555578899999999999999999999988777666555431
Q ss_pred ----CCCCC-----------CCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccCCCC
Q 014347 233 ----DFKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 278 (426)
Q Consensus 233 ----~~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~~ 278 (426)
.+..+ .+.++.+.+||.+||++||++|||+.+++.||||++...+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~ 300 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPC 300 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCC
Confidence 11111 23588899999999999999999999999999998765543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-45 Score=364.68 Aligned_cols=254 Identities=25% Similarity=0.414 Sum_probs=208.4
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCC-----CCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA 84 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 84 (426)
...++|++++.||+|+||.||+|++..+ +..||+|.+.... ..+....+.+|+.+++.+ +||||+++++.+.
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 3456799999999999999999986543 3579999997543 223356788999999999 8999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHhc--------------------------------------------------------
Q 014347 85 SKSKIYMVLEYVTGGELFDKIASK-------------------------------------------------------- 108 (426)
Q Consensus 85 ~~~~~~lV~Ey~~gg~L~~~i~~~-------------------------------------------------------- 108 (426)
.....|+||||+++|+|.+++...
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 999999999999999999988542
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccc
Q 014347 109 --------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH 174 (426)
Q Consensus 109 --------------~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 174 (426)
.++++..++.++.||+.||.|||++||+||||||+|||+++++.+||+|||+++............
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 247888999999999999999999999999999999999999999999999987542211111112
Q ss_pred cccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHc
Q 014347 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRKI 251 (426)
Q Consensus 175 ~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~~ 251 (426)
...+++.|+|||++.+..+ +.++|||||||++|+|++ |+.||........+.+.... ....|..+++++.+++.+|
T Consensus 273 ~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 351 (374)
T cd05106 273 NARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMC 351 (374)
T ss_pred CCCCccceeCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHH
Confidence 2335668999999877665 689999999999999997 99999876544333333333 3456677899999999999
Q ss_pred cccCccCCCCHHHHhc
Q 014347 252 LEPNPVKRITIAGIKA 267 (426)
Q Consensus 252 L~~dP~~R~t~~eil~ 267 (426)
|+.||.+|||+.++++
T Consensus 352 l~~dp~~RPs~~~l~~ 367 (374)
T cd05106 352 WNLEPTERPTFSQISQ 367 (374)
T ss_pred cCCChhhCcCHHHHHH
Confidence 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=338.36 Aligned_cols=253 Identities=30% Similarity=0.503 Sum_probs=223.0
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEe
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (426)
+|++++.||.|+||.||.+++..+++.+++|.+....... .....+.+|+.++++++|+||+++++++.+.+..+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 6999999999999999999999999999999987654332 345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 95 y~~gg~L~~~i~~~--~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
|++|++|.+.+.+. ..+++..+..++.|++.||.|||+.|++||||+|+||++++++.+||+|||++....... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~--~~ 157 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY--SM 157 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc--cc
Confidence 99999999999764 468999999999999999999999999999999999999999999999999987543311 12
Q ss_pred cccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCC-CCCCCCHHHHHHHHHc
Q 014347 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKI 251 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~Li~~~ 251 (426)
.....|++.|+|||++.+..+ +.++|+||+|+++|+|++|..||...+.......+..+.+. .+..++..+.+++.+|
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKY-NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSL 236 (256)
T ss_pred ccccCCCccccCHhhcCCCCC-CCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 345678999999999877665 57899999999999999999999998888777777766543 3455789999999999
Q ss_pred cccCccCCCCHHHHhcCccc
Q 014347 252 LEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 252 L~~dP~~R~t~~eil~h~~f 271 (426)
|.++|++|||+.++++|+|+
T Consensus 237 l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 237 LQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred cccCcccCCCHHHHhhCcCC
Confidence 99999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=338.56 Aligned_cols=254 Identities=33% Similarity=0.506 Sum_probs=219.7
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (426)
+|+..+.||+|+||.||+|.+..+++.|++|.+...... ..+..+.+.+|+.+++.++||||+++++++.+....|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 588899999999999999999889999999998754321 233467889999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
+||++|++|.+++.+.+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++...... ..
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~---~~ 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF---SF 157 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc---cc
Confidence 999999999999988788999999999999999999999999999999999999999999999999998754321 12
Q ss_pred cccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHc--CCCCCCCCCCHHHHHHHHH
Q 014347 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--GDFKLPKWLSPGAQNLLRK 250 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~Li~~ 250 (426)
.....|++.|+|||.+......+.++|+||+|+++|+|++|..||..........++.. ....+|..+++.+.+++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHH
Confidence 34567899999999987655346889999999999999999999987664444333333 2345567789999999999
Q ss_pred ccccCccCCCCHHHHhcCccc
Q 014347 251 ILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 251 ~L~~dP~~R~t~~eil~h~~f 271 (426)
||+.+|++|||+.+++.|||+
T Consensus 238 ~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 238 CLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=340.34 Aligned_cols=257 Identities=31% Similarity=0.501 Sum_probs=216.5
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccc--cchhHHHHHHHHHHHHHhCCCCCccceEEEEEe--CCEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI--IHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KSKI 89 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~ 89 (426)
.+|++.+.||+|+||.||.|.+..+|..||+|.+..... ......+.+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 479999999999999999999999999999998864322 122346788999999999999999999998865 3578
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
|++|||++|++|.+++.+...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 89999999999999998878899999999999999999999999999999999999999999999999999875432111
Q ss_pred -CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC--CCCCCCCCCHHHHH
Q 014347 170 -DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQN 246 (426)
Q Consensus 170 -~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ 246 (426)
........|+..|+|||++.+..+ +.++|+|||||++|+|++|+.||.+........++... ....|..++..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240 (265)
T ss_pred cccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 112334568999999999877665 68899999999999999999999876555444444332 23456667889999
Q ss_pred HHHHccccCccCCCCHHHHhcCcccc
Q 014347 247 LLRKILEPNPVKRITIAGIKADEWFE 272 (426)
Q Consensus 247 Li~~~L~~dP~~R~t~~eil~h~~f~ 272 (426)
+|++||. +|++|||++++++|||+.
T Consensus 241 ~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 241 FLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 9999995 999999999999999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=337.64 Aligned_cols=252 Identities=31% Similarity=0.509 Sum_probs=220.6
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEe
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (426)
+|++.+.||+|+||.||+|.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 6999999999999999999999999999999997654433 346789999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCC-CeEEeeccCccCCccccCCC
Q 014347 95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQHFRDDG 171 (426)
Q Consensus 95 y~~gg~L~~~i~~~--~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g-~vkL~DFGla~~~~~~~~~~ 171 (426)
|++|++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||++++++ .+||+|||++..... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~---~~ 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS---KS 156 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC---Cc
Confidence 99999999999763 3589999999999999999999999999999999999998655 579999999885432 12
Q ss_pred ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHHHHHHH
Q 014347 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRK 250 (426)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~ 250 (426)
......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|+.||...+.......+.... .+++..+++.+.+++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 235 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235 (256)
T ss_pred cccccccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHH
Confidence 2234578999999999876655 688999999999999999999999888777776666553 45667789999999999
Q ss_pred ccccCccCCCCHHHHhcCccc
Q 014347 251 ILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 251 ~L~~dP~~R~t~~eil~h~~f 271 (426)
||++||++|||+.++++||||
T Consensus 236 ~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 236 MLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HccCChhhCCCHHHHhhCCCC
Confidence 999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=339.50 Aligned_cols=251 Identities=30% Similarity=0.483 Sum_probs=216.5
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
++|++.+.||.|+||.||+|.+..+++.+|+|++..... ...+.+.+|+.+++.++||||+++++.+......|++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 689999999999999999999999999999999975532 24678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 94 EYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
||++|++|.+++... .++++..++.++.|++.||.|||++|++||||+|+||+++.++.+||+|||++...... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--~~~ 157 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT--IAK 157 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh--hhc
Confidence 999999999998775 78999999999999999999999999999999999999999999999999998754321 112
Q ss_pred cccccCCCcccchhhhccC---CCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCC-----CCCCCCHHH
Q 014347 173 LHTTCGSPNYVAPEVLANR---GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-----LPKWLSPGA 244 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~---~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s~~~ 244 (426)
.....++..|+|||.+... .+ +.++|+||||+++|+|++|..||.+.+.......+....+. .+..++.++
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~-~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGY-DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVF 236 (262)
T ss_pred cccccCCccccCchhhcccccCCc-CchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHH
Confidence 2345788999999998765 45 57899999999999999999999887655544444444222 223357889
Q ss_pred HHHHHHccccCccCCCCHHHHhcCcc
Q 014347 245 QNLLRKILEPNPVKRITIAGIKADEW 270 (426)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~eil~h~~ 270 (426)
.+|+++||..+|.+|||+.+++.|+|
T Consensus 237 ~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 237 HDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 99999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=373.20 Aligned_cols=254 Identities=28% Similarity=0.445 Sum_probs=227.0
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
+-|+|+..||.|+||+||+|.++.++-.-|-|+|... ..+..+.+.-||.||..++||+|+++++.|.-++.+++..
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 3589999999999999999999999999999998644 3455788899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 94 Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
|||.||-....+.. ...+++.+++.+++|++.||.|||+++|||||||..|||++-+|.++|+|||.+..... ....
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qk 186 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQK 186 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh--HHhh
Confidence 99999999887765 56799999999999999999999999999999999999999999999999999874322 2234
Q ss_pred cccccCCCcccchhhhc-----cCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCC---CCCCCCHHH
Q 014347 173 LHTTCGSPNYVAPEVLA-----NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK---LPKWLSPGA 244 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~-----~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~ 244 (426)
-.++.|||+|||||++. +.+| ..++||||||+.|.+|..+.+|....+.+....+|.+..++ -|+.++..+
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PY-DykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F 265 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSF 265 (1187)
T ss_pred hccccCCcccccchheeeccccCCCc-hhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHH
Confidence 45789999999999974 3566 48999999999999999999999999999999999887654 367789999
Q ss_pred HHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 245 QNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
.+++++||.+||..||+++++++||||..
T Consensus 266 ~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~ 294 (1187)
T KOG0579|consen 266 SDFLKRCLVKNPRNRPPAAQLLKHPFVQN 294 (1187)
T ss_pred HHHHHHHHhcCCccCCCHHHHhhCccccc
Confidence 99999999999999999999999999984
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=338.48 Aligned_cols=249 Identities=33% Similarity=0.569 Sum_probs=217.8
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEe
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (426)
+|++.+.||+|+||.||++.+..+++.+|+|.++.... ....+.+.+|+.+++.++||||+++++.+.+++..|++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 58999999999999999999999999999999865432 2346778899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 95 YVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 95 y~~gg~L~~~i~~--~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
|+++++|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+||++++++.++|+|||++..... ....
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~--~~~~ 156 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS--PGAY 156 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecc--cccc
Confidence 9999999998864 34589999999999999999999999999999999999999999999999999875432 1122
Q ss_pred cccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHc
Q 014347 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKI 251 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~ 251 (426)
.....|++.|+|||++.+..+ +.++|+||+|+++|+|++|..||...+.......+..+.. +.|..++..+.+||.+|
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235 (255)
T ss_pred cccccCCccccCHHHHccCCc-CchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHH
Confidence 234578999999999877665 6889999999999999999999999888777777766644 45667899999999999
Q ss_pred cccCccCCCCHHHHhcC
Q 014347 252 LEPNPVKRITIAGIKAD 268 (426)
Q Consensus 252 L~~dP~~R~t~~eil~h 268 (426)
|+.||++|||+.+++..
T Consensus 236 l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 236 FKRNPRSRPSATTILSR 252 (255)
T ss_pred HhCCcccCCCHHHHhhc
Confidence 99999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=361.54 Aligned_cols=242 Identities=30% Similarity=0.483 Sum_probs=212.2
Q ss_pred eeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEec
Q 014347 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (426)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey 95 (426)
+.+++.||+|-||+||+|... ....||+|.+...... .+.+.+|+.+|+.|+|+|||++++++..+..+||||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred HHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 456889999999999999973 3447999999764332 35677999999999999999999999998899999999
Q ss_pred cCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc-
Q 014347 96 VTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL- 172 (426)
Q Consensus 96 ~~gg~L~~~i~~--~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~- 172 (426)
++.|+|.++++. .+.+...+...++.||++|++||+++++|||||...||||+++..+||+|||||+... ++..
T Consensus 283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~---d~~Y~ 359 (468)
T KOG0197|consen 283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG---DDEYT 359 (468)
T ss_pred cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC---CCcee
Confidence 999999999987 5578999999999999999999999999999999999999999999999999999432 1111
Q ss_pred -cccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHHHHH
Q 014347 173 -LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLR 249 (426)
Q Consensus 173 -~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~ 249 (426)
....--...|.|||.+....+ +.++|||||||+||||+| |+.||.+.+..+..+.+.+| +++.|..+|+.+.+++.
T Consensus 360 ~~~~~kfPIkWtAPEa~~~~~F-S~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~ 438 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNYGKF-SSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMK 438 (468)
T ss_pred ecCCCCCCceecCHHHHhhCCc-ccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHH
Confidence 111223457999999988877 689999999999999999 99999999999999999887 68999999999999999
Q ss_pred HccccCccCCCCHHHHh
Q 014347 250 KILEPNPVKRITIAGIK 266 (426)
Q Consensus 250 ~~L~~dP~~R~t~~eil 266 (426)
.||..+|++|||++.+.
T Consensus 439 ~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 439 SCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHhhCCcccCCCHHHHH
Confidence 99999999999998654
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=349.27 Aligned_cols=252 Identities=24% Similarity=0.342 Sum_probs=205.1
Q ss_pred cCCCeeeeceEeecCceEEEEEEECC----------------CCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLD----------------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~----------------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn 75 (426)
..++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+++.++|||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCC
Confidence 45789999999999999999998532 34479999986543 2334567899999999999999
Q ss_pred ccceEEEEEeCCEEEEEEeccCCCChHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHhhcCce
Q 014347 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-------------------RLQEAEGRKLFQQLIDGVSYCHNKGVF 136 (426)
Q Consensus 76 Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~i~~~~-------------------~l~~~~~~~i~~Ql~~aL~~LH~~gIi 136 (426)
|+++++++.+.+..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999986532 367788999999999999999999999
Q ss_pred eccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh--CC
Q 014347 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT--GY 214 (426)
Q Consensus 137 HrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt--G~ 214 (426)
||||||+|||++.++.+||+|||++................+++.|+|||++....+ +.++||||||+++|+|++ |.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-CchhhhHHHHHHHHHHHHccCC
Confidence 999999999999999999999999875322111112233456789999999877665 689999999999999987 67
Q ss_pred CCCCCCcHHHHHHHHHc--------CCCCCCCCCCHHHHHHHHHccccCccCCCCHHHHh
Q 014347 215 LPFDDRNLAVLYQKIFR--------GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 266 (426)
Q Consensus 215 ~Pf~~~~~~~~~~~i~~--------~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil 266 (426)
.||.+.+.......+.. .....|+.+++.+.+|+.+||+.||.+|||+.+|.
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 88887665544433221 11234556789999999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-47 Score=368.54 Aligned_cols=260 Identities=32% Similarity=0.618 Sum_probs=243.8
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
.+.+.+.+++.+||-|+||.|-++.-......+|+|++++..+.+.+..+.+..|-.||-..+.|.||++|-.|.+...+
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 46678889999999999999999986655556999999999998888899999999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
|+.||-|-||+|+..+..++.|++..++.|+.-+++|++|||++||++|||||||+++|.+|.+||.|||+|+... .
T Consensus 496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~---~ 572 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG---S 572 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc---c
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999643 4
Q ss_pred CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC--CCCCCCCCCHHHHHH
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNL 247 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~L 247 (426)
+....+.||||.|+|||++.+++.+ .++|.||||+++||||+|.+||.+.++...|..|+++ .+.+|..++..+.+|
T Consensus 573 g~KTwTFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~L 651 (732)
T KOG0614|consen 573 GRKTWTFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDL 651 (732)
T ss_pred CCceeeecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHH
Confidence 5667889999999999999999986 8899999999999999999999999999999999998 478899999999999
Q ss_pred HHHccccCccCCCC-----HHHHhcCccccc
Q 014347 248 LRKILEPNPVKRIT-----IAGIKADEWFEQ 273 (426)
Q Consensus 248 i~~~L~~dP~~R~t-----~~eil~h~~f~~ 273 (426)
|+++...+|.+|.. +.+|..|.||..
T Consensus 652 ik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 652 IKKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred HHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 99999999999986 899999999964
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=368.59 Aligned_cols=250 Identities=24% Similarity=0.340 Sum_probs=204.7
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (426)
..+|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|+.+|++++||||+++++++...+..++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 458999999999999999999999999999999542 23456899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCC
Q 014347 93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 171 (426)
||++. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 99995 6888888653 569999999999999999999999999999999999999999999999999997543322222
Q ss_pred ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCC--------CcHHHHHHHHHcCCC---------
Q 014347 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD--------RNLAVLYQKIFRGDF--------- 234 (426)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~--------~~~~~~~~~i~~~~~--------- 234 (426)
.....+||+.|+|||++.+..+ +.++|||||||+||+|++|..|+-. .....+.+.+.....
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~-~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPY-TPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCC-CchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 2234679999999999987776 6889999999999999998765422 112222222222111
Q ss_pred --------------------CCCCC-----CCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 235 --------------------KLPKW-----LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 235 --------------------~~p~~-----~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
..+.| +++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 11111 4568999999999999999999999999999974
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=337.83 Aligned_cols=256 Identities=33% Similarity=0.544 Sum_probs=218.1
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEe
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (426)
||++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++.++|+||+++++.....+..++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 699999999999999999999889999999999766543 3457889999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCC-c-
Q 014347 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG-L- 172 (426)
Q Consensus 95 y~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~-~- 172 (426)
|+++++|.+++.+...+++..++.++.|++.||.|||++|++||||+|+||++++++.+||+|||++.......... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 99999999999887789999999999999999999999999999999999999999999999999988643321111 1
Q ss_pred cccccCCCcccchhhhccCC--CCCCcchhhhHHHHHHHHHhCCCCCCCCcH-HHHHHHHH-cCCCCCCCCC--CHHHHH
Q 014347 173 LHTTCGSPNYVAPEVLANRG--YDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIF-RGDFKLPKWL--SPGAQN 246 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~--~~~~~~DIwSlGvil~elltG~~Pf~~~~~-~~~~~~i~-~~~~~~p~~~--s~~~~~ 246 (426)
.....+++.|+|||++.... ..+.++||||||+++|+|++|+.||..... ......+. .....+|.+. ++.+.+
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD 239 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence 22457889999999987654 236889999999999999999999976532 22222222 2234556654 899999
Q ss_pred HHHHccccCccCCCCHHHHhcCccc
Q 014347 247 LLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 247 Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
+|.+||+.+|.+|||+.+++.|||+
T Consensus 240 li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 240 FLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHccCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=345.74 Aligned_cols=248 Identities=30% Similarity=0.490 Sum_probs=213.7
Q ss_pred EeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEeccCCCCh
Q 014347 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL 101 (426)
Q Consensus 22 LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~gg~L 101 (426)
||+|+||.||+|.+..+|+.||+|.+.+...........+.+|+.+++.++||||+++++++...+..|+||||++|++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999765443333455677899999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccCC
Q 014347 102 FDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179 (426)
Q Consensus 102 ~~~i~~~~--~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt 179 (426)
.+++.+.. .+++..++.++.|++.||.|||++|++||||+|+||++++++.+||+|||++..... ........++
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccccCC
Confidence 99997755 799999999999999999999999999999999999999999999999999875432 2223345678
Q ss_pred CcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcH----HHHHHHHHcCCCCCCCCCCHHHHHHHHHccccC
Q 014347 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL----AVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255 (426)
Q Consensus 180 ~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~d 255 (426)
..|+|||++.+..+ +.++||||+|+++|+|++|+.||..... ..+...+.......|..+++.+.++|.+||+.|
T Consensus 158 ~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 158 PGYMAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCcCCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 89999999877664 6889999999999999999999977543 333344444455667778999999999999999
Q ss_pred ccCCC-----CHHHHhcCccccc
Q 014347 256 PVKRI-----TIAGIKADEWFEQ 273 (426)
Q Consensus 256 P~~R~-----t~~eil~h~~f~~ 273 (426)
|.+|| ++.+++.||||..
T Consensus 237 p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 237 PEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred hhHccCCCcccHHHHHhChhhhc
Confidence 99999 8888999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=337.35 Aligned_cols=253 Identities=32% Similarity=0.561 Sum_probs=220.6
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEE--eCCEEEEE
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA--SKSKIYMV 92 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~lV 92 (426)
+|++.+.||.|+||.||+|.+..+++.||+|.+..... .....+++.+|+.+++.++||||+++++.+. .....|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 58999999999999999999999999999999876543 2334577889999999999999999999775 34678999
Q ss_pred EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHh-----hcCceeccCCCCcEEecCCCCeEEeeccCccC
Q 014347 93 LEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCH-----NKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~----~~~l~~~~~~~i~~Ql~~aL~~LH-----~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~ 163 (426)
|||+++++|.+++.. ..++++..++.++.||+.||.||| +.+++||||||+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999875 467999999999999999999999 89999999999999999999999999999986
Q ss_pred CccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC-CCCCCCCH
Q 014347 164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSP 242 (426)
Q Consensus 164 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~ 242 (426)
.... ........|++.|+|||++....+ +.++|+||||+++|+|++|+.||...+.....+.+..+.. .+|..+++
T Consensus 160 ~~~~--~~~~~~~~~~~~~~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd08217 160 LGHD--SSFAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSS 236 (265)
T ss_pred ccCC--cccccccccCCCccChhhhcCCCC-CchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCH
Confidence 5432 111334578999999999877665 6889999999999999999999999887777777766654 45667899
Q ss_pred HHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 243 GAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
.+.+++.+||+.+|++|||+.+|++|||+
T Consensus 237 ~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 237 ELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 99999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=340.23 Aligned_cols=251 Identities=34% Similarity=0.630 Sum_probs=221.9
Q ss_pred EeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEeccCCCCh
Q 014347 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL 101 (426)
Q Consensus 22 LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~gg~L 101 (426)
||.|+||.||++.+..+|+.+|+|++.............+.+|+.++++++||||+++++.+..+...|+++||++|++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999989999999999766544445567899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC------CCcccc
Q 014347 102 FDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD------DGLLHT 175 (426)
Q Consensus 102 ~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~------~~~~~~ 175 (426)
.+++.+.+.+++..+..++.|++.||.|||++|++||||+|+||++++++.++|+|||++........ ......
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 99998878899999999999999999999999999999999999999999999999999875322111 112234
Q ss_pred ccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHccc
Q 014347 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL--SPGAQNLLRKILE 253 (426)
Q Consensus 176 ~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~--s~~~~~Li~~~L~ 253 (426)
..+++.|+|||.+....+ +.++|+||||+++|+|++|..||........+..+..+....|... ++.+.+++.+||+
T Consensus 161 ~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (265)
T cd05579 161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239 (265)
T ss_pred cccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence 568889999999877664 6889999999999999999999999888888888877777777665 9999999999999
Q ss_pred cCccCCCCH---HHHhcCccccc
Q 014347 254 PNPVKRITI---AGIKADEWFEQ 273 (426)
Q Consensus 254 ~dP~~R~t~---~eil~h~~f~~ 273 (426)
.+|++|||+ .++++||||++
T Consensus 240 ~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 240 PDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred CCHhhcCCCccHHHHhcCccccC
Confidence 999999999 99999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=361.85 Aligned_cols=253 Identities=28% Similarity=0.429 Sum_probs=207.5
Q ss_pred CCCeeeeceEeecCceEEEEEEE-----CCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEeC
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK 86 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 86 (426)
.++|++++.||+|+||.||+|++ ..++..||+|+++.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 45899999999999999999974 34677899999864432 23356788999999999 899999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcC---------------------------------------------------------
Q 014347 87 SKIYMVLEYVTGGELFDKIASKG--------------------------------------------------------- 109 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~~--------------------------------------------------------- 109 (426)
+..|+||||++||+|.+++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 99999999999999999886421
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCC
Q 014347 110 ------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (426)
Q Consensus 110 ------------------~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 171 (426)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 46788899999999999999999999999999999999999999999999987543211111
Q ss_pred ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHH-HHHHHHcC-CCCCCCCCCHHHHHHH
Q 014347 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV-LYQKIFRG-DFKLPKWLSPGAQNLL 248 (426)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~~Li 248 (426)
......++..|+|||++.+..+ +.++|||||||++|+|++ |..||....... ..+.+..+ ....|...+.++.+|+
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~-~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 350 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIM 350 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCC-CCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHH
Confidence 1122345678999999877666 689999999999999998 999998765443 33333333 2344666789999999
Q ss_pred HHccccCccCCCCHHHHhcC
Q 014347 249 RKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 249 ~~~L~~dP~~R~t~~eil~h 268 (426)
.+||+.||++|||+.++++.
T Consensus 351 ~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 351 KSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHccCChhHCcCHHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=344.60 Aligned_cols=255 Identities=30% Similarity=0.487 Sum_probs=208.0
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
.+++|++++.||+|+||.||+|.+..+++.||+|.+....... ....+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL 80 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence 4689999999999999999999999899999999987543211 23456789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCC
Q 014347 92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 170 (426)
||||+.+ +|.+++... ..+++..++.++.|+++||.|||++||+||||||+||+++.++.+||+|||++..... ..
T Consensus 81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~--~~ 157 (291)
T cd07844 81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV--PS 157 (291)
T ss_pred EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCC--CC
Confidence 9999975 999988753 4689999999999999999999999999999999999999999999999999874321 11
Q ss_pred CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCc-HHHHHHHHHcC-----------------
Q 014347 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRG----------------- 232 (426)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~----------------- 232 (426)
.......+++.|+|||++.+....+.++||||+|+++|+|++|+.||.+.. .......+...
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 112233578899999998765544688999999999999999999997655 22222222110
Q ss_pred ----CCCC---------CCCCC--HHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 233 ----DFKL---------PKWLS--PGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 233 ----~~~~---------p~~~s--~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
.... ...++ +.+.+++.+||++||.+|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000 01234 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=340.51 Aligned_cols=252 Identities=22% Similarity=0.321 Sum_probs=212.6
Q ss_pred cCCCeeeeceEeecCceEEEEEEEC---CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (426)
...+|++.+.||+|+||.||+|.+. ..+..||+|.++... .......+.+|+.+++.++||||+++++++..++.
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 3467999999999999999999865 456789999987543 23335678899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 89 IYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
.|+||||+++|+|.+++.. .+.+++..++.++.||+.||+|||++|++||||||+|||++.++.+|++|||.+......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 9999999999999999876 357899999999999999999999999999999999999999999999999987642211
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHH
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ 245 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 245 (426)
.........++..|+|||++.+..+ +.++||||+||++|++++ |..||.+.+.......+..+ ..+.|..++..+.
T Consensus 161 -~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (266)
T cd05064 161 -AIYTTMSGKSPVLWAAPEAIQYHHF-SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLH 238 (266)
T ss_pred -chhcccCCCCceeecCHHHHhhCCc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 0011112345678999999877666 689999999999999875 99999988877777766554 3456677899999
Q ss_pred HHHHHccccCccCCCCHHHHhc
Q 014347 246 NLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~eil~ 267 (426)
+++.+||+++|.+|||+.+|++
T Consensus 239 ~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 239 QLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHcCCCchhCCCHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=340.49 Aligned_cols=253 Identities=30% Similarity=0.450 Sum_probs=213.0
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCC----
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS---- 87 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~---- 87 (426)
.++|++.+.||+|+||.||+|.+..+++.+++|++..... ..+.+.+|+.+++++ .||||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 4899999999999999999999998999999999875432 246788999999998 6999999999986544
Q ss_pred --EEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCc
Q 014347 88 --KIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS 161 (426)
Q Consensus 88 --~~~lV~Ey~~gg~L~~~i~~----~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla 161 (426)
.+|+||||+++++|.+++.. +..+++..++.++.|++.||.|||++|++||||+|+||+++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 58999999999999998865 357999999999999999999999999999999999999999999999999998
Q ss_pred cCCccccCCCccccccCCCcccchhhhccC----CCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC---
Q 014347 162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANR----GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF--- 234 (426)
Q Consensus 162 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~----~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--- 234 (426)
..... .........|++.|+|||++... ...+.++||||||+++|+|++|+.||...+......++.....
T Consensus 161 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd06608 161 AQLDS--TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL 238 (275)
T ss_pred eeccc--chhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC
Confidence 75322 11223345789999999997542 2235789999999999999999999987665555555544422
Q ss_pred CCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 235 KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 235 ~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
..+..++..+.+||.+||..||++|||+.++++|||+
T Consensus 239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 2233367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=342.94 Aligned_cols=257 Identities=28% Similarity=0.414 Sum_probs=214.5
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEeC--
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK-- 86 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~-- 86 (426)
+...++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++++ +|||++++++++...
T Consensus 18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred CCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 445789999999999999999999999999999999986532 1245678899999998 799999999998653
Q ss_pred ---CEEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeecc
Q 014347 87 ---SKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG 159 (426)
Q Consensus 87 ---~~~~lV~Ey~~gg~L~~~i~~----~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFG 159 (426)
...|+||||++|++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg 173 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG 173 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecc
Confidence 468999999999999998753 4578999999999999999999999999999999999999999999999999
Q ss_pred CccCCccccCCCccccccCCCcccchhhhccCC----CCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC-
Q 014347 160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG----YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF- 234 (426)
Q Consensus 160 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~----~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~- 234 (426)
++...... ........|+..|+|||++.... ..+.++|||||||++|+|++|+.||...+.......+.....
T Consensus 174 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~ 251 (291)
T cd06639 174 VSAQLTST--RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPP 251 (291)
T ss_pred cchhcccc--cccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCC
Confidence 98754321 11223457899999999976432 136889999999999999999999988766555445544322
Q ss_pred --CCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCcccc
Q 014347 235 --KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 272 (426)
Q Consensus 235 --~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~ 272 (426)
..+..++..+.+||.+||+.||++||++.++++||||+
T Consensus 252 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 252 TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 23445778899999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=337.58 Aligned_cols=250 Identities=27% Similarity=0.457 Sum_probs=216.0
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
++|++.+.||+|+||.||+|.+..+++.+|+|.+..... .+.+.+|+.+++.++||||+++++.+.+....|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 579999999999999999999988899999999865421 578999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 94 Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++...... ...
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~--~~~ 155 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT--MAK 155 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC--ccc
Confidence 99999999999975 457899999999999999999999999999999999999999999999999998854321 112
Q ss_pred cccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC---CCCCCCCCCHHHHHHHH
Q 014347 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPGAQNLLR 249 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~Li~ 249 (426)
.....|+..|+|||++.+..+ +.++||||+|+++|+|++|+.||...........+... ....+..++..+.++|.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~-~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 234 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGY-NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVK 234 (256)
T ss_pred cccccCCccccCHHHHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHH
Confidence 234458899999999877765 68899999999999999999999876655443333222 22334557889999999
Q ss_pred HccccCccCCCCHHHHhcCccc
Q 014347 250 KILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 250 ~~L~~dP~~R~t~~eil~h~~f 271 (426)
+||+.||++|||+.+++.||||
T Consensus 235 ~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 235 KCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHhcChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=343.92 Aligned_cols=256 Identities=29% Similarity=0.468 Sum_probs=215.8
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
++|++.+.||+|+||.||+|.+..+++.||+|.++.... .....+.+.+|+.+++.++|+||+++++++..++..|++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 589999999999999999999999999999998865432 2334578899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcc
Q 014347 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 173 (426)
||++++.+.....+...+++..+..++.|++.||.|||++|++||||+|+||++++++.+||+|||++........ ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPL 158 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccc
Confidence 9999877777676667799999999999999999999999999999999999999999999999999886443211 123
Q ss_pred ccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC---------------------
Q 014347 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--------------------- 232 (426)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--------------------- 232 (426)
....+++.|+|||++......+.++|+||+|+++|+|++|+.||.+.+.......+...
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 34678899999999887745578999999999999999999999876554333222110
Q ss_pred CC-----------CCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 233 DF-----------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 233 ~~-----------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
.+ .+|..+++.+.+||++||..+|++|||+++++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00 1233458899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=344.68 Aligned_cols=253 Identities=29% Similarity=0.457 Sum_probs=210.6
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEe
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (426)
.|++++.||.|++|.||+|++..+|+.||||.+..... .......+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 48999999999999999999999999999998865432 22234578899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 95 YVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 95 y~~gg~L~~~i~~--~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
|+. ++|.+++.. .+.+++..++.++.|++.||+|||++|++||||+|+||+++.++.+||+|||++...... ...
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~--~~~ 156 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRT 156 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC--ccc
Confidence 996 589888865 456899999999999999999999999999999999999999999999999998754321 122
Q ss_pred cccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC------------------CC
Q 014347 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------------DF 234 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------~~ 234 (426)
.....+++.|+|||++.+....+.++||||||+++|+|+||+.||.+.+......++... ..
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 234467889999999876665578899999999999999999999876654333222210 00
Q ss_pred CC-----------CCCCCHHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 235 KL-----------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 235 ~~-----------p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
.+ .+.+++.++++|.+||+.||.+|||+++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 11 12367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=345.85 Aligned_cols=261 Identities=28% Similarity=0.416 Sum_probs=209.8
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC-
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS- 87 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~- 87 (426)
.+..+++|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.++++++||||+++++++....
T Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (310)
T cd07865 7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKAT 85 (310)
T ss_pred ccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCCCCCccceEEEEecccc
Confidence 345678999999999999999999999999999999998654322 222345678999999999999999999986543
Q ss_pred -------EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeecc
Q 014347 88 -------KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG 159 (426)
Q Consensus 88 -------~~~lV~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFG 159 (426)
..|+||||+.+ +|.+.+... ..+++.+++.++.||+.||.|||++|++||||||+||+++.++.+||+|||
T Consensus 86 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 86 PYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred cccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCC
Confidence 45999999965 888877654 378999999999999999999999999999999999999999999999999
Q ss_pred CccCCccccCC--CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHc--CC--
Q 014347 160 LSALPQHFRDD--GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--GD-- 233 (426)
Q Consensus 160 la~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~-- 233 (426)
++......... .......++..|+|||.+.+....+.++||||+|+++|+|++|..||.+.+.......+.. +.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99754322111 1223446788999999987655456889999999999999999999988765433322211 10
Q ss_pred ---------------CCCC-------------CCCCHHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 234 ---------------FKLP-------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 234 ---------------~~~p-------------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
..+| ...++.+.+||.+||..||.+|||++++++||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0111 1135678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=343.98 Aligned_cols=257 Identities=27% Similarity=0.428 Sum_probs=219.6
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
..++|++++.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++.+...+..|+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 4578999999999999999999999999999999986543 23346788999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-cCceeccCCCCcEEecCCCCeEEeeccCccCCccccCC
Q 014347 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~-~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 170 (426)
||||+++++|.+++.+.+.+++..++.++.|++.||.|||+ .|++||||||+||++++++.++|+|||++.....
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~---- 156 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN---- 156 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh----
Confidence 99999999999999887889999999999999999999997 5999999999999999999999999999864321
Q ss_pred CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHH-----------HHHHHHHcCC-CCCCC
Q 014347 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-----------VLYQKIFRGD-FKLPK 238 (426)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~-----------~~~~~i~~~~-~~~p~ 238 (426)
......+|+..|+|||++.+..+ +.++||||+||++|+|++|..||...... .....+.... ..++.
T Consensus 157 ~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd06620 157 SIADTFVGTSTYMSPERIQGGKY-TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS 235 (284)
T ss_pred hccCccccCcccCCHHHHccCCC-CccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCc
Confidence 12234679999999999876655 68899999999999999999999865431 2333333332 23333
Q ss_pred C-CCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 239 W-LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 239 ~-~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
. ++..+.+|+.+||++||++|||+.++++|+||.+..
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 3 788999999999999999999999999999997754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=358.63 Aligned_cols=247 Identities=27% Similarity=0.399 Sum_probs=200.7
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (426)
..+|++++.||+|+||.||+|++..+++.||+|+..+. ....|+.+++.++||||+++++++......|+|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 45799999999999999999999999999999985432 234689999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCC
Q 014347 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 171 (426)
|||+. ++|.+++.. ..++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---~~ 211 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---AP 211 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc---Cc
Confidence 99995 588888765 46799999999999999999999999999999999999999999999999999874321 12
Q ss_pred ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhC-CCCCCCCcH----------HHHHHHHHc---CCCCCC
Q 014347 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNL----------AVLYQKIFR---GDFKLP 237 (426)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG-~~Pf~~~~~----------~~~~~~i~~---~~~~~p 237 (426)
......||+.|+|||++.+..+ +.++|||||||++|+|+++ ..+|..... ..+...+.. ....+|
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKY-NSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred ccccccccccccCCeecCCCCC-CchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 2335679999999999887776 6889999999999999985 444443211 011111100 000111
Q ss_pred ------------------------------CCCCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 238 ------------------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 238 ------------------------------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
..++.++.+||.+||+.||.+|||+.|+++||||++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 124667788999999999999999999999999975
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=341.23 Aligned_cols=256 Identities=26% Similarity=0.491 Sum_probs=218.2
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCccceEEEEEeCCEEEE
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK---HPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~l 91 (426)
.|++.+.||+|+||.||+|.+..+++.||+|.++... .......+.+|+.+++.++ |||++++++++..+...|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 5888999999999999999999999999999986543 2233567889999999997 9999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCC
Q 014347 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 171 (426)
+|||++|++|.+++.. +.+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++...... ..
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~--~~ 156 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN--SS 156 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC--cc
Confidence 9999999999998865 57999999999999999999999999999999999999999999999999998754332 12
Q ss_pred ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC-CCCCCC-CCHHHHHHHH
Q 014347 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKW-LSPGAQNLLR 249 (426)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~-~s~~~~~Li~ 249 (426)
......|+..|+|||.+......+.++|+||||+++|+|++|..||.+.+.......+.... ..++.. ++.++.+++.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVA 236 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHH
Confidence 23345789999999998765555789999999999999999999998876655444333322 233332 7889999999
Q ss_pred HccccCccCCCCHHHHhcCccccccC
Q 014347 250 KILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 250 ~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
+||+.||++|||+.+++.|+||+...
T Consensus 237 ~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 237 ACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHcCCCcccCcCHHHHhhChHhhccc
Confidence 99999999999999999999997654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=342.02 Aligned_cols=253 Identities=27% Similarity=0.379 Sum_probs=215.2
Q ss_pred cCCCeeeeceEeecCceEEEEEEECC-----CCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (426)
..++|.+.+.||+|+||.||+|.+.. +++.||+|.+.... ..+..+.+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 45789999999999999999998753 46789999986543 223457899999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCC
Q 014347 87 SKIYMVLEYVTGGELFDKIASKG--------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN 152 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~~--------------~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~ 152 (426)
...|++|||++|++|.+++...+ .+++..+..++.|++.||.|||++|++||||||+||+++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 99999999999999999997542 4788999999999999999999999999999999999999999
Q ss_pred eEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHc
Q 014347 153 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFR 231 (426)
Q Consensus 153 vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~ 231 (426)
+||+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCc-chhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 99999999874322111112233456788999999887666 688999999999999999 9999988887777777776
Q ss_pred CCCC-CCCCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 232 GDFK-LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 232 ~~~~-~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
+... .|..++..+.+|+.+||+.||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 240 GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 6543 35568999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=337.41 Aligned_cols=247 Identities=32% Similarity=0.586 Sum_probs=211.1
Q ss_pred ceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHH-HhCCCCCccceEEEEEeCCEEEEEEeccCC
Q 014347 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~g 98 (426)
+.||+|+||.||+|.+..+|+.||+|++.+...........+..|..++ ...+|||++++++++..++..|+++||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999999999999998765433222333445555544 456899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccC
Q 014347 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (426)
Q Consensus 99 g~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~g 178 (426)
++|.+++...+.+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++..... .....|
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVG 155 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCC
Confidence 99999998888899999999999999999999999999999999999999999999999999874321 234568
Q ss_pred CCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCC----CCCCCHHHHHHHHHcccc
Q 014347 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL----PKWLSPGAQNLLRKILEP 254 (426)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~Li~~~L~~ 254 (426)
++.|+|||.+.+..+ +.++||||+|+++|+|++|..||...+....+..+....... +..+++.+.+++.+||+.
T Consensus 156 ~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 156 TPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234 (260)
T ss_pred CcCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence 899999999877664 689999999999999999999999888877777766554433 335789999999999999
Q ss_pred CccCCC---CHHHHhcCccccc
Q 014347 255 NPVKRI---TIAGIKADEWFEQ 273 (426)
Q Consensus 255 dP~~R~---t~~eil~h~~f~~ 273 (426)
||++|| +++|++.||||.+
T Consensus 235 ~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 235 DPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred CHHHccCCCcHHHHHcChHhhc
Confidence 999999 4579999999965
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=341.40 Aligned_cols=255 Identities=24% Similarity=0.427 Sum_probs=219.4
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
+.|+.++.||.|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++.+.++...|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 468899999999999999999999999999999875432 234578899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcc
Q 014347 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 173 (426)
||++|++|.+++.. +++++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++...... ....
T Consensus 82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~ 158 (277)
T cd06640 82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIKR 158 (277)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCC--cccc
Confidence 99999999998875 67999999999999999999999999999999999999999999999999998754321 1122
Q ss_pred ccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHcc
Q 014347 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKIL 252 (426)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L 252 (426)
....++..|+|||++.+..+ +.++|+|||||++|+|++|..||...+.......+... ....+..++..+.+++.+||
T Consensus 159 ~~~~~~~~y~apE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAY-DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACL 237 (277)
T ss_pred ccccCcccccCHhHhccCCC-ccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHc
Confidence 33468889999999876655 68899999999999999999999887765555444333 23344557889999999999
Q ss_pred ccCccCCCCHHHHhcCcccccc
Q 014347 253 EPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 253 ~~dP~~R~t~~eil~h~~f~~~ 274 (426)
+.+|++||++.+++.|+||...
T Consensus 238 ~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 238 NKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred ccCcccCcCHHHHHhChHhhhc
Confidence 9999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=339.52 Aligned_cols=253 Identities=30% Similarity=0.470 Sum_probs=218.4
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++.+...+..|+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 478999999999999999999999999999999876542 234567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhh-cCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCC
Q 014347 94 EYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~-~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 171 (426)
||++|++|.+++... ..+++..+..++.|++.||+|||+ .|++||||||+||+++.++.++|+|||.+......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~---- 154 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---- 154 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH----
Confidence 999999999999875 789999999999999999999999 99999999999999999999999999998744221
Q ss_pred ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCC-----cHHHHHHHHHcC-CCCCCCC-CCHHH
Q 014347 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-----NLAVLYQKIFRG-DFKLPKW-LSPGA 244 (426)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~-----~~~~~~~~i~~~-~~~~p~~-~s~~~ 244 (426)
......++..|+|||.+.+..+ +.++||||+|+++|+|++|..||... ......+.+... ....|.. +++.+
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd06605 155 LAKTFVGTSSYMAPERIQGNDY-SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF 233 (265)
T ss_pred HhhcccCChhccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 1122678999999999877665 68899999999999999999999764 233344444443 2344444 88999
Q ss_pred HHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 245 QNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
.++|.+||..||++|||+.+++.||||+.
T Consensus 234 ~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 234 QDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 99999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=341.76 Aligned_cols=254 Identities=28% Similarity=0.403 Sum_probs=205.5
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (426)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+...... .....+.+|+.+++.++|+||+++++++..+...|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 36799999999999999999999999999999998654322 2234567899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCC
Q 014347 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 171 (426)
|||+. ++|.+.+.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++++||+|||+++..... ..
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~~ 158 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP--SQ 158 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC--CC
Confidence 99996 577776654 456889999999999999999999999999999999999999999999999998753221 12
Q ss_pred ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHH-HHHHHHHc--C------------C---
Q 014347 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFR--G------------D--- 233 (426)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~--~------------~--- 233 (426)
......+++.|+|||++.+....+.++||||||+++|+|++|..||.+.+.. +...++.. + .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY 238 (291)
T ss_pred CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence 2234567899999999876444467899999999999999999999865432 11111110 0 0
Q ss_pred ------CCCCC---------CCCHHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 234 ------FKLPK---------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 234 ------~~~p~---------~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
...+. ..++.+.+++.+||+.||.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00000 125688999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=345.04 Aligned_cols=256 Identities=32% Similarity=0.439 Sum_probs=214.3
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC--CEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKI 89 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 89 (426)
.+++|++.+.||+|+||.||+|.+..+++.+|+|.++..... ......+.+|+.++++++||||+++++++... ...
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI 81 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence 356899999999999999999999999999999999754432 23345677899999999999999999998877 899
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
|+||||+.+ +|.+.+... ..+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++......
T Consensus 82 ~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~- 159 (293)
T cd07843 82 YMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP- 159 (293)
T ss_pred EEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC-
Confidence 999999975 998888764 45999999999999999999999999999999999999999999999999998854321
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC---------------
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--------------- 233 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--------------- 233 (426)
........+++.|+|||.+.+....+.++|+||+|+++|+|++|..||...+......++....
T Consensus 160 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 160 -LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred -ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 1223345678999999998766555788999999999999999999998877655554433210
Q ss_pred ----------------CCCCCC-CCHHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 234 ----------------FKLPKW-LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 234 ----------------~~~p~~-~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
..+|.. +++.+.+||++||+.||++|||+.|++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 112222 58889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=349.37 Aligned_cols=247 Identities=32% Similarity=0.466 Sum_probs=193.6
Q ss_pred eceEeecCceEEEEEEECC--CCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEE--eCCEEEEEEe
Q 014347 19 GRTLGEGNFGKVKFAQDLD--SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA--SKSKIYMVLE 94 (426)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~lV~E 94 (426)
+.+||+|+||.||+|++.. ++..||+|.+..... ...+.+|+.+++.++||||+++++++. .+...|++||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 4689999999999999654 668899998865432 345778999999999999999999884 4567899999
Q ss_pred ccCCCChHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEe----cCCCCeEEeeccCc
Q 014347 95 YVTGGELFDKIAS---------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGLS 161 (426)
Q Consensus 95 y~~gg~L~~~i~~---------~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl----~~~g~vkL~DFGla 161 (426)
|+.+ +|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 9865 78777742 1248899999999999999999999999999999999999 56678999999999
Q ss_pred cCCcccc-CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHH---------HHHHHHHc
Q 014347 162 ALPQHFR-DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA---------VLYQKIFR 231 (426)
Q Consensus 162 ~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~---------~~~~~i~~ 231 (426)
+...... .........||+.|+|||++.+....+.++||||+||++|+|++|.+||...... ....++..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 8643221 1112344578999999999877665578999999999999999999999753211 00000000
Q ss_pred ----------------------------CCC----------CCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 232 ----------------------------GDF----------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 232 ----------------------------~~~----------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
... ......+..+.+||.+||+.||.+|||++|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 0011235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=340.58 Aligned_cols=252 Identities=31% Similarity=0.486 Sum_probs=211.9
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEe
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (426)
+|++.+.||.|++|.||+|++..+|+.||+|.+...... .....+.+|+.+++.++||||+++++.+.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 589999999999999999999999999999998765422 224567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCC
Q 014347 95 YVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (426)
Q Consensus 95 y~~gg~L~~~i~~~---~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 171 (426)
|+++ +|.+++... ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++...... ..
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~--~~ 155 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP--VN 155 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC--cc
Confidence 9985 888887653 36899999999999999999999999999999999999999999999999998754321 11
Q ss_pred ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC------------------
Q 014347 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD------------------ 233 (426)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------------ 233 (426)
......+++.|++||++.+....+.++||||||+++|+|++|+.||.+.+..+...++....
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 22345678999999998765555788999999999999999999999877655544433210
Q ss_pred CC-----------CCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 234 FK-----------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 234 ~~-----------~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
.. ..+.+++.+.++|.+||+.||.+|||+.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00 112357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=336.09 Aligned_cols=253 Identities=30% Similarity=0.485 Sum_probs=214.1
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (426)
+++|++.+.||+|+||.||+|++..+++.||+|.+........+....+.+|+.+++.++||||+++++++.+.+..|++
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 47899999999999999999999999999999988765444555567789999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 93 LEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~----~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
+||+++++|.+.+.. ...+++..+..++.|++.||+|||++|++||||||+|||++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~- 159 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK- 159 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch-
Confidence 999999999988753 345899999999999999999999999999999999999999999999999998754321
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCc--HHHHHHHHHcCC-CCCC-CCCCHHH
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRGD-FKLP-KWLSPGA 244 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~~~-~~~p-~~~s~~~ 244 (426)
........|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||.... .......+.... .+.+ ...+..+
T Consensus 160 -~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08228 160 -TTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237 (267)
T ss_pred -hHHHhcCCCCccccChhhhccCCC-CchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 122334578899999999877666 588999999999999999999996643 234444444332 2222 3578899
Q ss_pred HHHHHHccccCccCCCCHHHHhcC
Q 014347 245 QNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
.+++.+||+.+|++|||+.++++.
T Consensus 238 ~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 238 RELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHCCCCcccCcCHHHHHHH
Confidence 999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=341.76 Aligned_cols=255 Identities=32% Similarity=0.452 Sum_probs=209.1
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCCE----
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSK---- 88 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~---- 88 (426)
++|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 579999999999999999999999999999999865432 2223457888999999996 6999999999877665
Q ss_pred -EEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecC-CCCeEEeeccCc
Q 014347 89 -IYMVLEYVTGGELFDKIASK-----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLS 161 (426)
Q Consensus 89 -~~lV~Ey~~gg~L~~~i~~~-----~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~-~g~vkL~DFGla 161 (426)
.|++|||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 898887642 35799999999999999999999999999999999999998 889999999998
Q ss_pred cCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC--------
Q 014347 162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-------- 233 (426)
Q Consensus 162 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-------- 233 (426)
..... .........+++.|+|||++.+....+.++||||+|+++|+|++|..||.+.+......++....
T Consensus 159 ~~~~~--~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 159 RAFSI--PVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred eecCC--CccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 74322 11122234678899999998765545789999999999999999999998876655444433210
Q ss_pred ---------CCCC-----------CCCCHHHHHHHHHccccCccCCCCHHHHhcCcccc
Q 014347 234 ---------FKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 272 (426)
Q Consensus 234 ---------~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~ 272 (426)
...| +.+++.+.+||.+||++||.+|||+.+++.||||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 0001 23688899999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=341.42 Aligned_cols=256 Identities=30% Similarity=0.445 Sum_probs=211.6
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEE----
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA---- 84 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~---- 84 (426)
....++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 346679999999999999999999999999999999875432 1235678899999998 6999999999873
Q ss_pred -eCCEEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeecc
Q 014347 85 -SKSKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG 159 (426)
Q Consensus 85 -~~~~~~lV~Ey~~gg~L~~~i~~----~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFG 159 (426)
.+...|+||||++|++|.+.+.. ...+++..++.++.|++.||.|||+++++||||||+||+++.++.+||+|||
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg 169 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG 169 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCC
Confidence 45678999999999999988752 3568999999999999999999999999999999999999999999999999
Q ss_pred CccCCccccCCCccccccCCCcccchhhhccC----CCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC--
Q 014347 160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANR----GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-- 233 (426)
Q Consensus 160 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~----~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-- 233 (426)
++..... .........|++.|+|||++... ...+.++||||+||++|+|++|+.||...+......++....
T Consensus 170 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (286)
T cd06638 170 VSAQLTS--TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPP 247 (286)
T ss_pred ceeeccc--CCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCC
Confidence 9875432 11122345799999999997532 223678999999999999999999998776544443333221
Q ss_pred -CCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 234 -FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 234 -~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
...|..++..+.+||.+||+.||++|||+.++++|+||
T Consensus 248 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 248 TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 22345578899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=340.12 Aligned_cols=249 Identities=32% Similarity=0.501 Sum_probs=206.3
Q ss_pred eeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEEeC--CEEEEE
Q 014347 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASK--SKIYMV 92 (426)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~--~~~~lV 92 (426)
|++.+.||+|+||.||+|.+..+++.||+|.+.+... ... .....+|+.+++++. |||++++++++.+. +..++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 7889999999999999999999999999999865432 111 223457888888885 99999999999887 889999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCC
Q 014347 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 171 (426)
|||+.+ +|.+.+.. ...+++..++.++.|++.||.|||++|++||||||+||+++. +.+||+|||++..... ..
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~---~~ 153 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS---KP 153 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccccccc---CC
Confidence 999975 88888775 457899999999999999999999999999999999999999 9999999999875432 12
Q ss_pred ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHc------------------CC
Q 014347 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR------------------GD 233 (426)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~------------------~~ 233 (426)
......+++.|+|||++...+..+.++||||+||++|+|++|..||.+.+..+....+.. ..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 223456889999999876666667899999999999999999999988766554433321 11
Q ss_pred CCCC-----------CCCCHHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 234 FKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 234 ~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
+.+| ..++..+.+||.+||++||++|||+.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1122 2357899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=352.15 Aligned_cols=258 Identities=29% Similarity=0.460 Sum_probs=212.2
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC-----
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK----- 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 86 (426)
..++|++.+.||+|+||.||+|.+..+|+.||+|.+.+... .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 46889999999999999999999999999999999865432 233456778899999999999999999988543
Q ss_pred -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 87 -~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
...|+||||+.+ +|.+.+... +++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 357999999965 888887643 8999999999999999999999999999999999999999999999999997532
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC-------------
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------- 232 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------- 232 (426)
. ........|++.|+|||++.+..+ +.++|||||||++|+|++|+.||...+....+.++...
T Consensus 170 ~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 170 T---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred C---CCCCCCCcccccccCHHHHhCCCC-CCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 2 222344578999999999987776 58899999999999999999999876654443333210
Q ss_pred ---------CC-----C---------C-------CCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccCCC
Q 014347 233 ---------DF-----K---------L-------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (426)
Q Consensus 233 ---------~~-----~---------~-------p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 277 (426)
.. . + +...++.+++||.+||+.||++|||+.+++.||||+..+.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~ 320 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP 320 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence 00 0 0 11235678999999999999999999999999999866543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=340.48 Aligned_cols=253 Identities=26% Similarity=0.411 Sum_probs=210.3
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEE------
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA------ 84 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~------ 84 (426)
..|.|++.+.||.|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++++ +||||+++++++.
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 4589999999999999999999999999999999986542 2245688899999988 6999999999984
Q ss_pred eCCEEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCcc
Q 014347 85 SKSKIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (426)
Q Consensus 85 ~~~~~~lV~Ey~~gg~L~~~i~~--~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~ 162 (426)
....+|++|||+.+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||++++++.++|+|||++.
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 35678999999999999999875 3458899999999999999999999999999999999999999999999999987
Q ss_pred CCccccCCCccccccCCCcccchhhhcc-----CCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC-CC-
Q 014347 163 LPQHFRDDGLLHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FK- 235 (426)
Q Consensus 163 ~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~- 235 (426)
.... .........|++.|+|||++.. ..+ +.++|+|||||++|+|++|..||...........+.... ..
T Consensus 170 ~~~~--~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~-~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 246 (282)
T cd06636 170 QLDR--TVGRRNTFIGTPYWMAPEVIACDENPDATY-DYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 246 (282)
T ss_pred hhhc--cccCCCcccccccccCHhhcCcccCcCcCC-CcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCC
Confidence 5322 1122345678999999999753 233 578999999999999999999997765444333333221 11
Q ss_pred CCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 236 ~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
.+..+++.+.+||.+||+.||.+|||+.+|+.||||
T Consensus 247 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 247 KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred cccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 123478999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=340.48 Aligned_cols=263 Identities=30% Similarity=0.606 Sum_probs=241.5
Q ss_pred ccCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEe
Q 014347 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS 85 (426)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 85 (426)
.+.++-+.+|++++.||+|+|++|-+++.+.|.+.+|+|++++.-..+.+.++.++.|-.+...- +||.+|.++..|.+
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 34567788999999999999999999999999999999999998888888888899999988765 59999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 86 ~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
++++++|.||++||+|.-.++++.+++++.++.|...|+.||.|||++||++||||.+|+|+|..|++||+|+|+++.
T Consensus 323 esrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke-- 400 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE-- 400 (593)
T ss_pred cceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhc--
Confidence 999999999999999998899989999999999999999999999999999999999999999999999999999873
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCC--------CcHHHHHHHHHcCCCCCC
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD--------RNLAVLYQKIFRGDFKLP 237 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~--------~~~~~~~~~i~~~~~~~p 237 (426)
..++.....+.||||.|.|||++.+..| +..+|+|+|||+++||++|+.||+- .+..-+++-|+...+.+|
T Consensus 401 ~l~~gd~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqirip 479 (593)
T KOG0695|consen 401 GLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIP 479 (593)
T ss_pred CCCCCcccccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccc
Confidence 3455667789999999999999998887 7999999999999999999999962 234567888899999999
Q ss_pred CCCCHHHHHHHHHccccCccCCCC------HHHHhcCcccc
Q 014347 238 KWLSPGAQNLLRKILEPNPVKRIT------IAGIKADEWFE 272 (426)
Q Consensus 238 ~~~s~~~~~Li~~~L~~dP~~R~t------~~eil~h~~f~ 272 (426)
..+|-.+..+++..|++||.+|.. .+++..|+||.
T Consensus 480 rslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr 520 (593)
T KOG0695|consen 480 RSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFR 520 (593)
T ss_pred ceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhh
Confidence 999999999999999999999964 78999999996
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=339.70 Aligned_cols=255 Identities=23% Similarity=0.370 Sum_probs=213.9
Q ss_pred ccCCCeeeeceEeecCceEEEEEEEC----CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDL----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (426)
+.+.+|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++..+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 45678999999999999999999853 456789999986432 233456788999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecC
Q 014347 87 SKIYMVLEYVTGGELFDKIASK-----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 149 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~-----------------~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~ 149 (426)
...|++|||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~ 159 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE 159 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence 9999999999999999998532 24788899999999999999999999999999999999999
Q ss_pred CCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHH
Q 014347 150 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQK 228 (426)
Q Consensus 150 ~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 228 (426)
++.+||+|||+++...............++..|+|||++.+..+ +.++|+||||+++|+|++ |..||.+.+.......
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999975422111112233456778999999876665 689999999999999998 9999988776666666
Q ss_pred HHcCC-CCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 229 IFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 229 i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
+.... .+.|..+++.+.+++.+||++||.+||++.+|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 239 VRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 55443 45677789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=345.95 Aligned_cols=257 Identities=27% Similarity=0.451 Sum_probs=218.3
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
+.|.....||+|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++||||+++++.+...+..|+||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 45666788999999999999999999999999986533 233567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcc
Q 014347 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 173 (426)
||++|++|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+||++++++.++|+|||++..... .....
T Consensus 99 e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~--~~~~~ 175 (292)
T cd06658 99 EFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK--EVPKR 175 (292)
T ss_pred eCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccc--ccccC
Confidence 99999999998754 5799999999999999999999999999999999999999999999999999874322 12223
Q ss_pred ccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC---CCCCCCCCHHHHHHHHH
Q 014347 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNLLRK 250 (426)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~Li~~ 250 (426)
....|++.|+|||.+.+..+ +.++|+||+|+++|+|++|+.||.+.+.......+.... ...+...+..+.+++.+
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 254 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDL 254 (292)
T ss_pred ceeecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHH
Confidence 44678999999999877665 688999999999999999999998877665555444322 22223478899999999
Q ss_pred ccccCccCCCCHHHHhcCccccccCCC
Q 014347 251 ILEPNPVKRITIAGIKADEWFEQDYTP 277 (426)
Q Consensus 251 ~L~~dP~~R~t~~eil~h~~f~~~~~~ 277 (426)
||..||.+|||++++++||||.....|
T Consensus 255 ~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 255 MLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred HccCChhHCcCHHHHhhChhhhccCCc
Confidence 999999999999999999999875544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=349.00 Aligned_cols=260 Identities=30% Similarity=0.463 Sum_probs=210.7
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC-----C
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----S 87 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~ 87 (426)
-++|++.+.||+|+||.||+|.+..+|+.||+|.+.... .......+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 368999999999999999999999999999999986422 223456788899999999999999999987544 3
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
..|+++||+.+ +|.+.+.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 82 DVYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred eEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 58999999965 88887754 67999999999999999999999999999999999999999999999999998754321
Q ss_pred cC-CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHc---------------
Q 014347 168 RD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--------------- 231 (426)
Q Consensus 168 ~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--------------- 231 (426)
.. .......+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 11 11223457899999999876554457899999999999999999999987654332221110
Q ss_pred C-----------CCC-----CCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccCC
Q 014347 232 G-----------DFK-----LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (426)
Q Consensus 232 ~-----------~~~-----~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 276 (426)
. ... ..+..++.+.+||.+||+.||.+|||+.++++||||+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 0 000 01235788999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=343.53 Aligned_cols=260 Identities=25% Similarity=0.389 Sum_probs=219.1
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (426)
......+|++.+.||+|+||.||+|.+..+|+.||+|.+........+....+.+|+.+++.++||||+++++++.+.+.
T Consensus 10 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~ 89 (307)
T cd06607 10 KDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHT 89 (307)
T ss_pred CCCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCe
Confidence 34455679999999999999999999999999999999876554445556778999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 89 IYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
.|+||||+.| +|.+.+.. .+++++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++.....
T Consensus 90 ~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~- 167 (307)
T cd06607 90 AWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP- 167 (307)
T ss_pred EEEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC-
Confidence 9999999974 77776653 56799999999999999999999999999999999999999999999999999874321
Q ss_pred cCCCccccccCCCcccchhhhcc--CCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC-CCC-CCCCCHH
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKL-PKWLSPG 243 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~-p~~~s~~ 243 (426)
.....|++.|+|||++.+ ....+.++||||+|+++|+|++|+.||.+.+.......+.... ... +..++..
T Consensus 168 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (307)
T cd06607 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDY 242 (307)
T ss_pred -----CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHH
Confidence 234568899999998742 2334688999999999999999999998877655444444332 222 2346889
Q ss_pred HHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
+.++|.+||+.||++|||+.+++.||||....
T Consensus 243 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 243 FRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 99999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=332.82 Aligned_cols=255 Identities=29% Similarity=0.493 Sum_probs=221.7
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
++|++.+.||+|++|.||+|.+..+++.||+|.+...... .....+.+|+..++.++||||+++++++......|++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 3689999999999999999999999999999998765432 34678999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-cCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~-~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
||++|++|.+++....++++..+..++.|++.||.|||+ +|++||||+|+||+++.++.++|+|||++...... ...
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~ 156 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT--LDQ 156 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccC--CCc
Confidence 999999999999888889999999999999999999999 99999999999999999999999999998854321 122
Q ss_pred cccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCC---cHHHHHHHHHcC-CCCCCCC-CCHHHHHH
Q 014347 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR---NLAVLYQKIFRG-DFKLPKW-LSPGAQNL 247 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~---~~~~~~~~i~~~-~~~~p~~-~s~~~~~L 247 (426)
.....++..|+|||.+....+ +.++|+||||+++|+|++|..||... ........+... ....+.. ++..+.++
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred ccceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 234568899999999876644 68899999999999999999999876 444444454433 3445555 78999999
Q ss_pred HHHccccCccCCCCHHHHhcCccccc
Q 014347 248 LRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 248 i~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
|.+||.++|++|||+.++++|||++.
T Consensus 236 i~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 236 ISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHHHccCChhhCCCHHHHHhCHHHHh
Confidence 99999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=343.99 Aligned_cols=253 Identities=27% Similarity=0.416 Sum_probs=211.2
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCe--EEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEeC
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLP--FAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK 86 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~--vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 86 (426)
...+++|++.+.||+|+||.||+|.+..++.. +|+|.+... ........+.+|+.++.++ +||||+++++++..+
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~ 80 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 80 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence 35678999999999999999999998877765 466665432 2334456788999999999 899999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCC
Q 014347 87 SKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 150 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~~----------------~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~ 150 (426)
+.+|+||||+++++|.+++.+.+ .+++..++.++.||+.||+|||++|++||||||+|||++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 160 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence 99999999999999999997532 47899999999999999999999999999999999999999
Q ss_pred CCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHH
Q 014347 151 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKI 229 (426)
Q Consensus 151 g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i 229 (426)
+.+||+|||++....... ......++..|+|||++....+ +.++|||||||++|+|++ |..||.+.+....+..+
T Consensus 161 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 236 (303)
T cd05088 161 YVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236 (303)
T ss_pred CcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence 999999999986322110 1111234567999999876554 688999999999999998 99999888777777666
Q ss_pred HcC-CCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 230 FRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 230 ~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
..+ ....|..+++.+.+|+.+||+.+|++|||+++++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 237 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 544 234555688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=339.11 Aligned_cols=259 Identities=24% Similarity=0.323 Sum_probs=213.7
Q ss_pred cCCCeeeeceEeecCceEEEEEEECC-----CCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (426)
.-++|++.+.||+|+||.||+|.++. .+..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 34689999999999999999997542 34589999876443 222345678899999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEe
Q 014347 87 SKIYMVLEYVTGGELFDKIASK----------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKIS 156 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~----------~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~ 156 (426)
...|+||||+++|+|.+++.+. ..++...+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence 9999999999999999999752 234567889999999999999999999999999999999999999999
Q ss_pred eccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CC
Q 014347 157 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DF 234 (426)
Q Consensus 157 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~ 234 (426)
|||+++...............++..|+|||.+.+..+ +.++|+|||||++|+|++ |..||.+.+.......+..+ ..
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 240 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCC-ChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999875322111111122345678999999876665 689999999999999999 89999988877777766654 34
Q ss_pred CCCCCCCHHHHHHHHHccccCccCCCCHHHHhc------Cccccc
Q 014347 235 KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA------DEWFEQ 273 (426)
Q Consensus 235 ~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~------h~~f~~ 273 (426)
..|...++.+.+++.+||+.||++|||+.++++ ||||..
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 241 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 566778899999999999999999999999986 777753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=332.56 Aligned_cols=253 Identities=30% Similarity=0.568 Sum_probs=217.6
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEe
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (426)
+|++.+.||+|+||.||++.+..+|..+|+|.+....... ...+.+.+|+.+++.++|+||+++++.+......|+++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 6899999999999999999999999999999987653322 235678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCC-eEEeeccCccCCccccCCC
Q 014347 95 YVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN-IKISDFGLSALPQHFRDDG 171 (426)
Q Consensus 95 y~~gg~L~~~i~~~~--~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~-vkL~DFGla~~~~~~~~~~ 171 (426)
|+++++|.+++.+.. .+++..+..++.|++.||.|||+++++|+||||+||++++++. +||+|||.+..... ...
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~--~~~ 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND--SME 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccC--Ccc
Confidence 999999999987643 5799999999999999999999999999999999999998865 69999999875432 111
Q ss_pred ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC-CCCCCCCHHHHHHHHH
Q 014347 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRK 250 (426)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~ 250 (426)
......|++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.......+..... ..++.++..+.++|.+
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 236 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPY-NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQ 236 (257)
T ss_pred cccccCCCccccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHH
Confidence 2233468999999999876665 5889999999999999999999998777666666555433 3445678899999999
Q ss_pred ccccCccCCCCHHHHhcCccc
Q 014347 251 ILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 251 ~L~~dP~~R~t~~eil~h~~f 271 (426)
||+.+|++|||+.+++.||||
T Consensus 237 ~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 237 LFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=345.06 Aligned_cols=254 Identities=21% Similarity=0.327 Sum_probs=211.1
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCe----EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLP----FAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~----vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (426)
....+|++.+.||+|+||.||+|.+..+++. ||+|.+.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 3456899999999999999999998766654 8999986432 234457788999999999999999999998764
Q ss_pred CEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 87 SKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
..++++||+++|+|.+++... ..++...+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 578999999999999999863 468999999999999999999999999999999999999999999999999998643
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHH
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPG 243 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 243 (426)
............++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+..+ ..+.|..++..
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 239 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHH
Confidence 2211111222345678999999877666 688999999999999998 99999987766555444333 34556778999
Q ss_pred HHHHHHHccccCccCCCCHHHHhcC
Q 014347 244 AQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
+.+++.+||..||.+|||+.+++.+
T Consensus 240 ~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 240 VYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=337.80 Aligned_cols=254 Identities=22% Similarity=0.309 Sum_probs=211.2
Q ss_pred cCCCeeeeceEeecCceEEEEEEEC-----CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (426)
.-++|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 3468999999999999999999864 245679999885432 223345688999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEe
Q 014347 87 SKIYMVLEYVTGGELFDKIASKG----------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKIS 156 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~~----------~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~ 156 (426)
...++||||+++++|.+++.+.. .++...+..++.|++.||.|||++|++||||||+|||+++++.+||+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 99999999999999999987532 35678889999999999999999999999999999999999999999
Q ss_pred eccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcCC-C
Q 014347 157 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-F 234 (426)
Q Consensus 157 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~ 234 (426)
|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+.... .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL 240 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 9999874322111111122356788999999876655 688999999999999999 799999888777776665554 4
Q ss_pred CCCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 235 KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 235 ~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
..|..+++.+.+++.+||+.||++|||+.+++++
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 241 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5667789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=336.76 Aligned_cols=255 Identities=24% Similarity=0.420 Sum_probs=219.4
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEe
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (426)
-|++.+.||.|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++.+..+...|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 37788999999999999999988999999999865432 2335678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccc
Q 014347 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH 174 (426)
Q Consensus 95 y~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 174 (426)
|+++++|.+++.+ +.+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++...... .....
T Consensus 83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~--~~~~~ 159 (277)
T cd06641 83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--QIKRN 159 (277)
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccc--hhhhc
Confidence 9999999998865 57899999999999999999999999999999999999999999999999998744321 11223
Q ss_pred cccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHccc
Q 014347 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILE 253 (426)
Q Consensus 175 ~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~ 253 (426)
...|+..|+|||.+....+ +.++|+||+||++|+|++|..||...+.......+... ...++..++.++.+++.+||+
T Consensus 160 ~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN 238 (277)
T ss_pred cccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcc
Confidence 4568899999999876655 57899999999999999999999887766555555443 334566789999999999999
Q ss_pred cCccCCCCHHHHhcCccccccC
Q 014347 254 PNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 254 ~dP~~R~t~~eil~h~~f~~~~ 275 (426)
.+|.+||++.++++||||....
T Consensus 239 ~~p~~Rp~~~~~l~~~~~~~~~ 260 (277)
T cd06641 239 KEPSFRPTAKELLKHKFIVRFA 260 (277)
T ss_pred CChhhCcCHHHHHhCHHHhhhh
Confidence 9999999999999999998743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=343.67 Aligned_cols=256 Identities=32% Similarity=0.477 Sum_probs=207.3
Q ss_pred CeeeeceEeecCceEEEEEEECC--CCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC--CEEE
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLD--SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKIY 90 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~ 90 (426)
+|++.+.||+|+||.||+|.+.. +++.||+|.+.............+.+|+.+++.++||||+++++++.+. ...|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 69999999999999999999988 8999999999864423333456788899999999999999999999888 8899
Q ss_pred EEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecC----CCCeEEeeccCc
Q 014347 91 MVLEYVTGGELFDKIAS-----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS----KGNIKISDFGLS 161 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~-----~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~----~g~vkL~DFGla 161 (426)
+||||+.+ +|.+.+.. ...+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 77776642 136899999999999999999999999999999999999999 899999999998
Q ss_pred cCCccccC-CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHH---------HHHHHH-
Q 014347 162 ALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV---------LYQKIF- 230 (426)
Q Consensus 162 ~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~---------~~~~i~- 230 (426)
........ .......++++.|+|||++.+....+.++|||||||++|+|++|+.||.+..... ....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 86433211 1123345789999999998765545788999999999999999999997644321 000000
Q ss_pred -------------------------cCCCCCC-----------CCCCHHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 231 -------------------------RGDFKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 231 -------------------------~~~~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
.....++ ...++.+.+++.+||++||++|||+.+++.||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0011111 1456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=332.30 Aligned_cols=245 Identities=28% Similarity=0.440 Sum_probs=205.1
Q ss_pred ceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEeccCCC
Q 014347 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG 99 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~gg 99 (426)
+.||+|+||.||+|++..+++.||+|.+.... ..+....+.+|+.+++.++||||+++++++......|+||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 46999999999999999999999999876432 3344577999999999999999999999999999999999999999
Q ss_pred ChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccC
Q 014347 100 ELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (426)
Q Consensus 100 ~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~g 178 (426)
+|.+++... ..+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++................+
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 999999764 4689999999999999999999999999999999999999999999999999874321100000011123
Q ss_pred CCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHccccCc
Q 014347 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNP 256 (426)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP 256 (426)
+..|+|||.+.+..+ +.++||||||+++|+|++ |..||...+.......+... ....|..++..+.+|+.+||++||
T Consensus 159 ~~~y~aPE~~~~~~~-~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (252)
T cd05084 159 PVKWTAPEALNYGRY-SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP 237 (252)
T ss_pred ceeecCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence 456999999877665 688999999999999998 99999877665555555443 455667789999999999999999
Q ss_pred cCCCCHHHHhc
Q 014347 257 VKRITIAGIKA 267 (426)
Q Consensus 257 ~~R~t~~eil~ 267 (426)
++|||+.++++
T Consensus 238 ~~Rps~~~~~~ 248 (252)
T cd05084 238 GQRPSFSTVHQ 248 (252)
T ss_pred hhCcCHHHHHH
Confidence 99999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=341.73 Aligned_cols=255 Identities=24% Similarity=0.418 Sum_probs=217.1
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
..|+..+.||+|+||.||+|.+..+++.||+|.++.... ....+.+.+|+.+++.++||||+++++.+..++..|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 457888999999999999999999999999999865432 234567899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcc
Q 014347 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 173 (426)
||++|++|.+++.. +.+++..++.++.|++.||.|||++|++|+||+|+||++++++.++|+|||++...... ....
T Consensus 82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~--~~~~ 158 (277)
T cd06642 82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIKR 158 (277)
T ss_pred EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc--chhh
Confidence 99999999998865 67899999999999999999999999999999999999999999999999998754321 1122
Q ss_pred ccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHcc
Q 014347 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKIL 252 (426)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L 252 (426)
....|+..|+|||.+.+..+ +.++|+|||||++|+|++|..||...........+... ....+..++..+.++|.+||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAY-DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACL 237 (277)
T ss_pred hcccCcccccCHHHhCcCCC-chhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHc
Confidence 23468899999999887665 58899999999999999999999876655444443333 23344457889999999999
Q ss_pred ccCccCCCCHHHHhcCcccccc
Q 014347 253 EPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 253 ~~dP~~R~t~~eil~h~~f~~~ 274 (426)
+.+|++|||+.++++||||...
T Consensus 238 ~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 238 NKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred cCCcccCcCHHHHHHhHHHHHH
Confidence 9999999999999999999753
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=327.80 Aligned_cols=253 Identities=32% Similarity=0.537 Sum_probs=222.1
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEe
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (426)
+|++.+.||+|++|.||+|.+..+++.||+|.+...... ....+.+.+|+.++++++|||++++++++.+....|++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 589999999999999999999999999999999766432 2446789999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccc
Q 014347 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH 174 (426)
Q Consensus 95 y~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 174 (426)
|+++++|.+++...+.+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++....... ....
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--~~~~ 157 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS--KDDA 157 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCc--cccc
Confidence 99999999999888899999999999999999999999999999999999999999999999999998654321 1234
Q ss_pred cccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHH-cCCCCCCCCCCHHHHHHHHHccc
Q 014347 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF-RGDFKLPKWLSPGAQNLLRKILE 253 (426)
Q Consensus 175 ~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~-~~~~~~p~~~s~~~~~Li~~~L~ 253 (426)
...++..|+|||.+.... .+.++|+||+|+++|+|++|..||...+......+.. .....+|..+++.+.+++.+||.
T Consensus 158 ~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 236 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQ 236 (254)
T ss_pred ccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHh
Confidence 457899999999987666 4688999999999999999999998766544443333 34456677789999999999999
Q ss_pred cCccCCCCHHHHhcCccc
Q 014347 254 PNPVKRITIAGIKADEWF 271 (426)
Q Consensus 254 ~dP~~R~t~~eil~h~~f 271 (426)
.+|++|||+.+++.||||
T Consensus 237 ~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 237 KDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred CChhhCcCHHHHhcCCCC
Confidence 999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=337.17 Aligned_cols=255 Identities=26% Similarity=0.457 Sum_probs=218.6
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEe
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (426)
.|.-.+.||+|++|.||++.+..+++.+|+|.++... ....+.+.+|+.+++.++||||+++++++...+..|+++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 4555679999999999999999999999999886433 2234668899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccc
Q 014347 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH 174 (426)
Q Consensus 95 y~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 174 (426)
|++|++|.+++.. +++++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++...... .....
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~--~~~~~ 173 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--VPRRK 173 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC--Ccccc
Confidence 9999999999887 77999999999999999999999999999999999999999999999999987643221 11223
Q ss_pred cccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCC---CCCCCHHHHHHHHHc
Q 014347 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL---PKWLSPGAQNLLRKI 251 (426)
Q Consensus 175 ~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~---p~~~s~~~~~Li~~~ 251 (426)
...|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+......++....... +..+++.+.+++.+|
T Consensus 174 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 252 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRM 252 (285)
T ss_pred cccCCccccCHHHhcCCCC-CCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHH
Confidence 4578999999999877665 688999999999999999999998887766666666553222 233788999999999
Q ss_pred cccCccCCCCHHHHhcCccccccCC
Q 014347 252 LEPNPVKRITIAGIKADEWFEQDYT 276 (426)
Q Consensus 252 L~~dP~~R~t~~eil~h~~f~~~~~ 276 (426)
|+.+|++|||+.++++||||.+...
T Consensus 253 l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 253 LVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred cccChhhCcCHHHHccCcccccCCC
Confidence 9999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=338.99 Aligned_cols=258 Identities=30% Similarity=0.455 Sum_probs=211.9
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (426)
+++|++.+.||+|++|.||+|.+..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 5789999999999999999999999999999999865432 223346788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecC-CCCeEEeeccCccCCccccC
Q 014347 93 LEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~~~--~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~-~g~vkL~DFGla~~~~~~~~ 169 (426)
|||++ ++|.+.+.... .+++..++.++.||+.||+|||++|++||||+|+||+++. ++.+||+|||++..... .
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~--~ 156 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI--P 156 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCC--C
Confidence 99996 58888876544 3578889999999999999999999999999999999985 45799999999975322 1
Q ss_pred CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC--C--------------
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--D-------------- 233 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~-------------- 233 (426)
........+++.|+|||++.+....+.++||||+|+++|+|++|..||...+......++... .
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 112233467899999999876555578899999999999999999999876655444443211 0
Q ss_pred -----CC--------CCCCCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 234 -----FK--------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 234 -----~~--------~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
.. ..+.+++.+.+++.+||+.||.+||++.+++.||||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 00 112367889999999999999999999999999999764
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=328.46 Aligned_cols=253 Identities=34% Similarity=0.592 Sum_probs=223.6
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEe
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (426)
+|++.+.||.|+||.||++.+..+++.||+|.+..... .......+.+|+++++.++|||++++++.+......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 68999999999999999999999999999999876543 23446778899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCC
Q 014347 95 YVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (426)
Q Consensus 95 y~~gg~L~~~i~~~----~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 170 (426)
|++|++|.+.+.+. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 99999999999763 679999999999999999999999999999999999999999999999999988654321
Q ss_pred CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHHHHHH
Q 014347 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLR 249 (426)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~ 249 (426)
......+|++.|+|||.+....+ +.++|+||+|+++|+|++|..||...+............ ..+|..++..+.+++.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPY-NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVS 236 (258)
T ss_pred ceecceeeeecccChhHhccCCC-CccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 23345678999999999877665 688999999999999999999999888777777666553 4556678999999999
Q ss_pred HccccCccCCCCHHHHhcCccc
Q 014347 250 KILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 250 ~~L~~dP~~R~t~~eil~h~~f 271 (426)
+||..+|++|||+.++++||||
T Consensus 237 ~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 237 SLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHcCCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=337.30 Aligned_cols=246 Identities=27% Similarity=0.478 Sum_probs=205.9
Q ss_pred cCCCeeeeceE--eecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCE
Q 014347 12 RLGRYELGRTL--GEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSK 88 (426)
Q Consensus 12 ~~~~y~i~~~L--G~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 88 (426)
..++|++.+.+ |+|+||.||++.+..++..+|+|++....... .|+.....+ +||||+++++.+...+.
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 34678888877 99999999999999999999999987543221 122222222 69999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCC-CeEEeeccCccCCccc
Q 014347 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQHF 167 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g-~vkL~DFGla~~~~~~ 167 (426)
.|+||||++|++|.+++.....+++.+++.++.|+++||.|||+.|++||||||+||+++.++ .++|+|||++.....
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~- 162 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT- 162 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC-
Confidence 999999999999999998877999999999999999999999999999999999999999998 999999999874321
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHH----HHHHHcCCCCCCCCCCHH
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVL----YQKIFRGDFKLPKWLSPG 243 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~----~~~i~~~~~~~p~~~s~~ 243 (426)
.....|++.|+|||++.+..+ +.++|+||+|+++|+|++|..||........ ...........++.+++.
T Consensus 163 -----~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T PHA03390 163 -----PSCYDGTLDYFSPEKIKGHNY-DVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKN 236 (267)
T ss_pred -----CccCCCCCcccChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHH
Confidence 123468999999999987776 5889999999999999999999986543221 112223444566678999
Q ss_pred HHHHHHHccccCccCCCC-HHHHhcCcccc
Q 014347 244 AQNLLRKILEPNPVKRIT-IAGIKADEWFE 272 (426)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t-~~eil~h~~f~ 272 (426)
+.+||.+||++||.+||+ ++++++||||+
T Consensus 237 ~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 237 ANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 999999999999999996 69999999996
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=338.19 Aligned_cols=251 Identities=27% Similarity=0.402 Sum_probs=212.9
Q ss_pred CCCeeeeceEeecCceEEEEEEEC-----CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (426)
-.+|.+.+.||+|+||.||++.+. .++..+|+|.+.... ......+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 357999999999999999999853 345679999886432 334567899999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeE
Q 014347 88 KIYMVLEYVTGGELFDKIASKG-------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 154 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~~-------------~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vk 154 (426)
..|++|||+++++|.+++...+ .+++..++.++.|++.||+|||++|++||||||+|||+++++.+|
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 9999999999999999997543 489999999999999999999999999999999999999999999
Q ss_pred EeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcCC
Q 014347 155 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD 233 (426)
Q Consensus 155 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~ 233 (426)
|+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+.
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999874322111112223446788999999876655 688999999999999998 999999888777777777765
Q ss_pred -CCCCCCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 234 -FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 234 -~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
...+..+++++.+|+.+||++||.+|||+.+++.
T Consensus 240 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 240 VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 3456678999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=333.34 Aligned_cols=253 Identities=23% Similarity=0.356 Sum_probs=214.0
Q ss_pred CCCeeeeceEeecCceEEEEEEECCC---CCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
.++|++.+.||+|+||.||+|.+..+ ...||+|.++... .......+.+|+.+++.++||||+++++.+......
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 46799999999999999999998654 4579999886543 233456788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
|++|||+++++|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+|||+++++.++|+|||++.......
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 999999999999999876 4578999999999999999999999999999999999999999999999999998653211
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHH
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 246 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 246 (426)
.........+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+... ..+.|...++.+.+
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQ 239 (266)
T ss_pred cceeccCCCCCccccChhhhccCCC-ccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1111112345678999999877665 688999999999999998 99999887777776666654 34556678999999
Q ss_pred HHHHccccCccCCCCHHHHhcC
Q 014347 247 LLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 247 Li~~~L~~dP~~R~t~~eil~h 268 (426)
|+.+||+.+|++||++.+++++
T Consensus 240 li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 240 LMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=362.21 Aligned_cols=249 Identities=31% Similarity=0.539 Sum_probs=218.1
Q ss_pred eEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEeccCCCC
Q 014347 21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGE 100 (426)
Q Consensus 21 ~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~gg~ 100 (426)
.||+|+||+||-|+|..|...+|||-+.... ....+-+..||.+.++|+|.|||+++|.+..++++-|+||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 5999999999999999999999999986543 3457789999999999999999999999999999999999999999
Q ss_pred hHHHHHh-cCCC--CHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEec-CCCCeEEeeccCccCCccccCCCccccc
Q 014347 101 LFDKIAS-KGRL--QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTT 176 (426)
Q Consensus 101 L~~~i~~-~~~l--~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~-~~g~vkL~DFGla~~~~~~~~~~~~~~~ 176 (426)
|.++++. -|++ +|...-.|.+||++||.|||++.|+|||||-+|+|++ -.|.+||+|||-++.... .+....+.
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TETF 736 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTETF 736 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc--CCcccccc
Confidence 9999985 5788 8889999999999999999999999999999999996 578999999998875443 34566788
Q ss_pred cCCCcccchhhhcc--CCCCCCcchhhhHHHHHHHHHhCCCCCCCC-cH-HHHHHH-HHcCCCCCCCCCCHHHHHHHHHc
Q 014347 177 CGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDR-NL-AVLYQK-IFRGDFKLPKWLSPGAQNLLRKI 251 (426)
Q Consensus 177 ~gt~~y~APE~l~~--~~~~~~~~DIwSlGvil~elltG~~Pf~~~-~~-~~~~~~-i~~~~~~~p~~~s~~~~~Li~~~ 251 (426)
-||.-|||||++.. .+| |.++|||||||++.||.||++||... ++ ..+++- .++..+++|..++.+++++|.+|
T Consensus 737 TGTLQYMAPEvIDqG~RGY-G~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filrc 815 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGY-GKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRC 815 (1226)
T ss_pred ccchhhhChHhhccCCcCC-CchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHH
Confidence 99999999999864 344 89999999999999999999999753 22 233332 23456788999999999999999
Q ss_pred cccCccCCCCHHHHhcCccccccC
Q 014347 252 LEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 252 L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
+.+||.+||++.++|.+||++.+.
T Consensus 816 Fepd~~~R~sA~~LL~DpFlq~~~ 839 (1226)
T KOG4279|consen 816 FEPDPCDRPSAKDLLQDPFLQHNN 839 (1226)
T ss_pred cCCCcccCccHHHhccCcccccCC
Confidence 999999999999999999998763
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=342.53 Aligned_cols=258 Identities=26% Similarity=0.467 Sum_probs=218.8
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
.-|+....||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++.+..++..|++|
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence 446667789999999999999999999999999865432 22466889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcc
Q 014347 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 173 (426)
||+++++|.+.+.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... ....
T Consensus 98 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~--~~~~ 174 (297)
T cd06659 98 EFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKR 174 (297)
T ss_pred ecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc--cccc
Confidence 99999999887754 67999999999999999999999999999999999999999999999999998743221 1122
Q ss_pred ccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC---CCCCCCCHHHHHHHHH
Q 014347 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWLSPGAQNLLRK 250 (426)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~Li~~ 250 (426)
...+|++.|+|||++.+..+ +.++||||+||++|+|++|+.||...+.......+..... ..+..+++.+.++|.+
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~ 253 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLER 253 (297)
T ss_pred cceecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHH
Confidence 34678999999999877665 6889999999999999999999988776655555543322 2234578899999999
Q ss_pred ccccCccCCCCHHHHhcCccccccCCCC
Q 014347 251 ILEPNPVKRITIAGIKADEWFEQDYTPA 278 (426)
Q Consensus 251 ~L~~dP~~R~t~~eil~h~~f~~~~~~~ 278 (426)
||+.+|.+|||+.++++||||.+...+.
T Consensus 254 ~l~~~P~~Rps~~~ll~~~~~~~~~~~~ 281 (297)
T cd06659 254 MLTREPQERATAQELLDHPFLLQTGLPE 281 (297)
T ss_pred HhcCCcccCcCHHHHhhChhhccCCCcc
Confidence 9999999999999999999998765443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=327.90 Aligned_cols=255 Identities=34% Similarity=0.539 Sum_probs=220.3
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC--CEEEEE
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKIYMV 92 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lV 92 (426)
+|++.+.||+|++|.||+|.+..+++.|++|++...... ....+.+.+|+.++++++||||+++++.+... ...+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 588999999999999999999989999999998765432 34467899999999999999999999999988 899999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
+||+++++|.+++.+...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+...........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 99999999999998877999999999999999999999999999999999999999999999999999886543221112
Q ss_pred cccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCc-HHHHHHHHH--cCCCCCCCCCCHHHHHHHH
Q 014347 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIF--RGDFKLPKWLSPGAQNLLR 249 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~-~~~~~~~i~--~~~~~~p~~~s~~~~~Li~ 249 (426)
.....++..|+|||.+....+ +.++|+||+|+++|+|++|..||.... .......+. ......|..+++.+.++|.
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 238 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238 (260)
T ss_pred ccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence 345678999999999876654 688999999999999999999998765 223333333 2345567778999999999
Q ss_pred HccccCccCCCCHHHHhcCccc
Q 014347 250 KILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 250 ~~L~~dP~~R~t~~eil~h~~f 271 (426)
+||+.||++||++.+++.||||
T Consensus 239 ~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 239 KCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HhCcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=330.32 Aligned_cols=247 Identities=40% Similarity=0.754 Sum_probs=223.3
Q ss_pred EeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEeccCCCCh
Q 014347 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL 101 (426)
Q Consensus 22 LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~gg~L 101 (426)
||+|+||.||.+.+..+++.+|+|++.+...........+.+|+.+++.++||||+++++.+..+...|++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999889999999999877655555677899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccCCCc
Q 014347 102 FDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181 (426)
Q Consensus 102 ~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~ 181 (426)
.+++.....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...... ........++..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSE--GSRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccC--CCcccCCcCCcc
Confidence 999998878999999999999999999999999999999999999999999999999998754321 122345578899
Q ss_pred ccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccccCccCCCC
Q 014347 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 261 (426)
Q Consensus 182 y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t 261 (426)
|+|||.+.+... +.++|+||||+++|+|++|..||...+.......+......+|..++..+.+++++||..||++|||
T Consensus 159 ~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~ 237 (250)
T cd05123 159 YLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237 (250)
T ss_pred ccChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCC
Confidence 999999876654 6889999999999999999999988887777888888888888889999999999999999999999
Q ss_pred H---HHHhcCccc
Q 014347 262 I---AGIKADEWF 271 (426)
Q Consensus 262 ~---~eil~h~~f 271 (426)
+ .++++||||
T Consensus 238 ~~~~~~l~~~~~f 250 (250)
T cd05123 238 SGGAEEIKAHPFF 250 (250)
T ss_pred cccHHHHHhCCCC
Confidence 9 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=335.96 Aligned_cols=256 Identities=23% Similarity=0.377 Sum_probs=207.1
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHH-HHhCCCCCccceEEEEEeCCEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~lV 92 (426)
++|++.+.||+|+||.||+|.+..+|+.||+|.++...... ...++..|+.+ ++.++||||+++++++..++..|++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 47999999999999999999999999999999987653222 23345556664 6778899999999999999999999
Q ss_pred EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhc-CceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 93 LEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~----~~~l~~~~~~~i~~Ql~~aL~~LH~~-gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
|||++ |+|.+.+.. ...+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||++.....
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~- 156 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD- 156 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc-
Confidence 99996 578777653 34689999999999999999999998 999999999999999999999999999875322
Q ss_pred cCCCccccccCCCcccchhhhccC---CCCCCcchhhhHHHHHHHHHhCCCCCCCC-cHHHHHHHHHc-CCCCCC-CCCC
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANR---GYDGATSDIWSCGVILYVILTGYLPFDDR-NLAVLYQKIFR-GDFKLP-KWLS 241 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~---~~~~~~~DIwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~-~~~~~p-~~~s 241 (426)
........|+..|+|||++.+. ...+.++|+||+||++|+|++|+.||... +.......+.. ....+| ..+|
T Consensus 157 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd06617 157 --SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFS 234 (283)
T ss_pred --ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccC
Confidence 1112235688999999987542 22368899999999999999999999753 22222223332 233444 3478
Q ss_pred HHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 242 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
.++.+||.+||..+|++|||+.++++||||....
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 9999999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=330.68 Aligned_cols=252 Identities=31% Similarity=0.507 Sum_probs=214.7
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (426)
.++|++.+.||+|+||.||+|.+..+|+.||+|.++..........+.+.+|+.++++++|+|++++++.+...+..+++
T Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 36899999999999999999999989999999998765444455567899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 93 LEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~----~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
|||++|++|.+++.. ...+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~- 159 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK- 159 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC-
Confidence 999999999998864 345899999999999999999999999999999999999999999999999998754321
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCc--HHHHHHHHHcCCC-CCCC-CCCHHH
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRGDF-KLPK-WLSPGA 244 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~~~~-~~p~-~~s~~~ 244 (426)
........|++.|+|||.+.+..+ +.++|+||||+++|+|++|+.||.... .......+..+.. +.|. .++..+
T Consensus 160 -~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08224 160 -TTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEEL 237 (267)
T ss_pred -CcccceecCCccccCHHHhccCCC-CchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHH
Confidence 122334578999999999887666 578999999999999999999996543 3344444444332 3444 678899
Q ss_pred HHHHHHccccCccCCCCHHHHhc
Q 014347 245 QNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
.++|.+||.++|++|||+.+|++
T Consensus 238 ~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 238 RDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHcCCCcccCCCHHHHHH
Confidence 99999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=332.42 Aligned_cols=250 Identities=28% Similarity=0.421 Sum_probs=214.9
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
...+|++.+.||+|+||.||+|.+..+++.||+|.+..+. .....+.+|+.+++.++||||+++++++..++.+++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 79 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEE
Confidence 4467999999999999999999999999999999986432 224678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~--~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
+|||+++++|.+++... ..+++..++.++.|++.||+|||++|++||||||+|||+++++.+||+|||++........
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 99999999999998753 3589999999999999999999999999999999999999999999999999875432111
Q ss_pred CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHHH
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 247 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 247 (426)
.......+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+....+..+..+ ....|..+++.+.++
T Consensus 160 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (263)
T cd05052 160 -TAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYEL 237 (263)
T ss_pred -eccCCCCCccccCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence 11112234568999999877665 688999999999999998 99999988887777777654 456677789999999
Q ss_pred HHHccccCccCCCCHHHHhc
Q 014347 248 LRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 248 i~~~L~~dP~~R~t~~eil~ 267 (426)
|.+||+.||++|||+.++++
T Consensus 238 i~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 238 MRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHccCCcccCCCHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=335.48 Aligned_cols=253 Identities=24% Similarity=0.336 Sum_probs=214.0
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCC-----CCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (426)
..++|++.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 457899999999999999999987643 4789999986443 223356788999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEe
Q 014347 87 SKIYMVLEYVTGGELFDKIASK----------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKIS 156 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~----------~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~ 156 (426)
...|+||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence 9999999999999999998642 236788999999999999999999999999999999999999999999
Q ss_pred eccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CC
Q 014347 157 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DF 234 (426)
Q Consensus 157 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~ 234 (426)
|||+++...............++..|+|||.+....+ +.++|||||||++|+|++ |..||.+.+.....+.+..+ ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL 240 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCC
Confidence 9999875432111122234457889999999876655 688999999999999998 99999988877776666644 34
Q ss_pred CCCCCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 235 KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 235 ~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
..|..++..+.+++.+||+.+|++|||+.++++
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 241 DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 567778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=337.89 Aligned_cols=252 Identities=31% Similarity=0.459 Sum_probs=210.6
Q ss_pred eeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEec
Q 014347 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (426)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey 95 (426)
|++.+.||.|++|.||+|.+..+|..||+|++..... .......+.+|+.+++.++|||++++++++.+++..|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 6789999999999999999999999999999875432 222345678899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcc
Q 014347 96 VTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (426)
Q Consensus 96 ~~gg~L~~~i~~~~--~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 173 (426)
+. ++|.+++.... .+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++...... ....
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~ 156 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP--VRTY 156 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC--cccc
Confidence 95 68999987655 7999999999999999999999999999999999999999999999999998754321 1122
Q ss_pred ccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC--------------------
Q 014347 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-------------------- 233 (426)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-------------------- 233 (426)
....+++.|+|||++.+....+.++||||||+++|+|++|+.||...+......++.+..
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 334578899999988765555688999999999999999999998766544333332210
Q ss_pred ---------CCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 234 ---------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 234 ---------~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
....+.+++.+.++|.+||++||.+|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 01123467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=339.24 Aligned_cols=255 Identities=24% Similarity=0.365 Sum_probs=216.0
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCC-----CCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 85 (426)
+.+.+|++.+.||+|+||.||+|.+..+ ++.||+|.+.... .......+.+|+.+++.++||||+++++++.+
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 79 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK 79 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 3567899999999999999999987543 5789999987443 23345678899999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecC
Q 014347 86 KSKIYMVLEYVTGGELFDKIAS----------------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 149 (426)
Q Consensus 86 ~~~~~lV~Ey~~gg~L~~~i~~----------------~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~ 149 (426)
....++++||+.+++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||+++
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD 159 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence 9999999999999999999853 234788899999999999999999999999999999999999
Q ss_pred CCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHH
Q 014347 150 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQK 228 (426)
Q Consensus 150 ~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 228 (426)
++.+||+|||+++...............+++.|+|||++....+ +.++|||||||++|+|++ |..||.+.+.......
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999875432211122233456789999999876665 688999999999999998 9999998888888887
Q ss_pred HHcCCC-CCCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 229 IFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 229 i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
+..... ..|..++..+.+|+.+||+.+|.+||++.+|+..
T Consensus 239 i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 239 IRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 776653 4577799999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=333.65 Aligned_cols=250 Identities=30% Similarity=0.481 Sum_probs=208.9
Q ss_pred eeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEecc
Q 014347 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYV 96 (426)
Q Consensus 17 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~ 96 (426)
.....||+|+||.||+|++..++..||+|.+.... ....+.+.+|+.+++.++|+||+++++++..++..|+++||+
T Consensus 11 ~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 87 (268)
T cd06624 11 GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQV 87 (268)
T ss_pred CceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecC
Confidence 33468999999999999999999999999886543 233567899999999999999999999999999999999999
Q ss_pred CCCChHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecC-CCCeEEeeccCccCCccccCCCc
Q 014347 97 TGGELFDKIASK-GRL--QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 97 ~gg~L~~~i~~~-~~l--~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~-~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
+|++|.+.+... ..+ ++..+..++.||+.||+|||++||+||||||+||+++. ++.++|+|||++..... ....
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~--~~~~ 165 (268)
T cd06624 88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPC 165 (268)
T ss_pred CCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc--CCCc
Confidence 999999999764 455 88899999999999999999999999999999999986 67999999999875432 1222
Q ss_pred cccccCCCcccchhhhccCC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcHH--HHHHH-HHcCCCCCCCCCCHHHHHHH
Q 014347 173 LHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRNLA--VLYQK-IFRGDFKLPKWLSPGAQNLL 248 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~~~--~~~~~-i~~~~~~~p~~~s~~~~~Li 248 (426)
.....|++.|+|||++.... ..+.++|+||+|+++|+|++|..||...... ..+.. .......+|..+++.+.+|+
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 245 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFI 245 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHH
Confidence 33446899999999986533 2468899999999999999999999754322 22221 22334566778899999999
Q ss_pred HHccccCccCCCCHHHHhcCccc
Q 014347 249 RKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 249 ~~~L~~dP~~R~t~~eil~h~~f 271 (426)
.+||+.+|++|||+.+++.||||
T Consensus 246 ~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 246 LRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHcCCCchhCCCHHHHHhCCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=336.82 Aligned_cols=254 Identities=24% Similarity=0.341 Sum_probs=212.4
Q ss_pred cCCCeeeeceEeecCceEEEEEEECC-----CCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (426)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 34679999999999999999999877 77889999876433 222345688899999999999999999999988
Q ss_pred CEEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCC---CeEEe
Q 014347 87 SKIYMVLEYVTGGELFDKIASKG-------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKIS 156 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~~-------~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g---~vkL~ 156 (426)
...|++|||++|++|.+++...+ .+++..+..++.||+.||.|||++|++||||||+|||++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 99999999999999999997643 489999999999999999999999999999999999998765 58999
Q ss_pred eccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CC
Q 014347 157 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DF 234 (426)
Q Consensus 157 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~ 234 (426)
|||+++...............+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF-TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL 240 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 9999885421111111112233568999999877665 689999999999999997 99999988777766665543 45
Q ss_pred CCCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 235 KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 235 ~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
..|..+++.+.+++.+||+.||++|||+.++++|
T Consensus 241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 5677789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=330.53 Aligned_cols=256 Identities=31% Similarity=0.502 Sum_probs=217.4
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeeccc--ccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC--CEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNR--IIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKI 89 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 89 (426)
.+|++.+.||+|+||.||+|.+..+++.||+|.+.... .........+.+|+.+++.++||||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47999999999999999999999999999999875432 11234467899999999999999999999998664 568
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
++++||++|++|.+++.+.+.+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 99999999999999998878899999999999999999999999999999999999999999999999999975432111
Q ss_pred -CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC--CCCCCCCCCHHHHH
Q 014347 170 -DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQN 246 (426)
Q Consensus 170 -~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ 246 (426)
........|+..|+|||.+.+..+ +.++|+|||||++|+|++|+.||.+........++... ...+|..+++.+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 240 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence 112234568999999999877665 68899999999999999999999887655555554432 34567889999999
Q ss_pred HHHHccccCccCCCCHHHHhcCccc
Q 014347 247 LLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 247 Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
+|.+||+ +|.+|||+.+++.|||.
T Consensus 241 ~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 241 FLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHhc-CcccCccHHHHhcCCCC
Confidence 9999999 57999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=329.92 Aligned_cols=246 Identities=29% Similarity=0.416 Sum_probs=215.3
Q ss_pred ceEeecCceEEEEEEECCC---CCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEecc
Q 014347 20 RTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYV 96 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~ 96 (426)
+.||+|+||.||+|.+... +..||+|.+....... ..+.+.+|+..++.++|+||+++++++.+....+++|||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4799999999999998865 8899999987654322 4678999999999999999999999999999999999999
Q ss_pred CCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 97 TGGELFDKIASK---------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 97 ~gg~L~~~i~~~---------~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999875 78999999999999999999999999999999999999999999999999999865432
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHH
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ 245 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 245 (426)
..........+++.|+|||.+....+ +.++||||||+++|+|++ |..||.+.........+..+ ....|..+++++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY 237 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence 21122344567889999999877655 688999999999999999 69999998887777777654 4566788899999
Q ss_pred HHHHHccccCccCCCCHHHHhcC
Q 014347 246 NLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~eil~h 268 (426)
+++.+||+.||++|||+.+++.+
T Consensus 238 ~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 238 ELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHccCCcccCcCHHHHHHh
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=341.67 Aligned_cols=260 Identities=27% Similarity=0.452 Sum_probs=219.4
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (426)
.+...++|++.+.||+|+||.||++.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 14 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~ 90 (293)
T cd06647 14 VGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKHPNIVNYLDSYLVGDE 90 (293)
T ss_pred ccCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc---hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCc
Confidence 35556899999999999999999999988999999999864332 224678899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
.|+|+||++|++|.+++.+ ..+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 91 ~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~- 168 (293)
T cd06647 91 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE- 168 (293)
T ss_pred EEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc-
Confidence 9999999999999998875 46899999999999999999999999999999999999999999999999988754321
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHc-CC--CCCCCCCCHHHH
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-GD--FKLPKWLSPGAQ 245 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~-~~--~~~p~~~s~~~~ 245 (426)
........|++.|+|||.+....+ +.++|+||||+++|++++|+.||...+.......+.. +. ...+..+++.+.
T Consensus 169 -~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 246 (293)
T cd06647 169 -QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 246 (293)
T ss_pred -ccccccccCChhhcCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHH
Confidence 122234568899999999877665 6889999999999999999999987665433322222 22 222344688999
Q ss_pred HHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 246 NLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
++|.+||+.+|.+||++.+++.|+||+...
T Consensus 247 ~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 247 DFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=348.68 Aligned_cols=262 Identities=27% Similarity=0.409 Sum_probs=214.9
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEE----eCCEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA----SKSKI 89 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~----~~~~~ 89 (426)
++|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.++++++||||+++++++. .....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 689999999999999999999999999999999875432 2234567888999999999999999999875 34578
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
|+||||+. ++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++........
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99999995 58999998778899999999999999999999999999999999999999999999999999875422111
Q ss_pred --CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHc----------------
Q 014347 170 --DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR---------------- 231 (426)
Q Consensus 170 --~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~---------------- 231 (426)
........|+..|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~ 242 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence 11223457899999999987644457899999999999999999999987664433222111
Q ss_pred ----------CCCCC-----CCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccCCC
Q 014347 232 ----------GDFKL-----PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (426)
Q Consensus 232 ----------~~~~~-----p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 277 (426)
..... .+..++.+.++|++||+.+|.+|||+.+++.||||++...+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~ 303 (334)
T cd07855 243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303 (334)
T ss_pred hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence 00011 12368899999999999999999999999999999865433
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=334.09 Aligned_cols=252 Identities=30% Similarity=0.501 Sum_probs=213.5
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (426)
+++|++.+.||+|+||.||+|.+..+++.+|||.+......+......+.+|+.+++.++||||+++++++..++..|++
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 47899999999999999999999999999999988765444444567888999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 93 LEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~----~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
|||++|++|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~- 159 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK- 159 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC-
Confidence 999999999998863 356899999999999999999999999999999999999999999999999998754321
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcH--HHHHHHHHcCCC-CC-CCCCCHHH
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL--AVLYQKIFRGDF-KL-PKWLSPGA 244 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~--~~~~~~i~~~~~-~~-p~~~s~~~ 244 (426)
.......+|++.|+|||.+.+..+ +.++|+||||+++|+|++|..||.+... ......+..... +. +..+++.+
T Consensus 160 -~~~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08229 160 -TTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 237 (267)
T ss_pred -CcccccccCCcCccCHHHhcCCCc-cchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHH
Confidence 222345679999999999877666 5889999999999999999999976543 333344433322 22 24588999
Q ss_pred HHHHHHccccCccCCCCHHHHhc
Q 014347 245 QNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
.+++.+||+.||++|||+.+|++
T Consensus 238 ~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 238 RQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHhcCCCcccCCCHHHHHH
Confidence 99999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=345.71 Aligned_cols=257 Identities=30% Similarity=0.403 Sum_probs=214.6
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC---
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS--- 87 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 87 (426)
...++|++++.||+|+||.||+|.+..+|+.||+|.+.+.. ........+.+|+.+++.++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 35678999999999999999999999999999999986532 22333567889999999999999999999987543
Q ss_pred ---EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCC
Q 014347 88 ---KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (426)
Q Consensus 88 ---~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~ 164 (426)
.+++||||+ |++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 468999999 7799887764 67999999999999999999999999999999999999999999999999998753
Q ss_pred ccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC----------
Q 014347 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---------- 234 (426)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------- 234 (426)
.. ......+++.|+|||.+.+....+.++|+||||+++|+|++|..||.+.+....+.++.....
T Consensus 169 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 169 DS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243 (343)
T ss_pred cc-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 22 223456789999999987644457889999999999999999999988765544444332111
Q ss_pred ---------------------CCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 235 ---------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 235 ---------------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
...+.+++.+.++|.+||+.||.+|||+.+++.||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 11235688899999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=337.05 Aligned_cols=259 Identities=32% Similarity=0.596 Sum_probs=219.9
Q ss_pred CeeeeceEeecCceEEEEEEEC---CCCCeEEEEEeeccccc-chhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEE
Q 014347 15 RYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 89 (426)
.|++.+.||.|+||.||+|.+. .+|+.||+|++...... .....+.+.+|+.+++.+ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999975 47899999998754322 223356788999999999 599999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
|+||||+++++|.+++....++++..+..++.|++.||.|||++|++||||+|+|||++.++.+||+|||++...... .
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-~ 159 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED-E 159 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc-c
Confidence 999999999999999988888999999999999999999999999999999999999999999999999998754321 1
Q ss_pred CCccccccCCCcccchhhhccC-CCCCCcchhhhHHHHHHHHHhCCCCCCCC----cHHHHHHHHHcCCCCCCCCCCHHH
Q 014347 170 DGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDR----NLAVLYQKIFRGDFKLPKWLSPGA 244 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~ 244 (426)
.......+|+..|+|||.+... ...+.++||||+|+++|+|++|..||... ....+...+.....++|..+++.+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 239 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHH
Confidence 1223356789999999998653 23467899999999999999999999743 234445555556667778899999
Q ss_pred HHHHHHccccCccCCC-----CHHHHhcCcccccc
Q 014347 245 QNLLRKILEPNPVKRI-----TIAGIKADEWFEQD 274 (426)
Q Consensus 245 ~~Li~~~L~~dP~~R~-----t~~eil~h~~f~~~ 274 (426)
.+|+.+||+.||++|| ++.+++.||||+..
T Consensus 240 ~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 9999999999999997 89999999999763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=376.09 Aligned_cols=255 Identities=25% Similarity=0.395 Sum_probs=209.8
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (426)
+++|++++.||+|+||.||+|.+..+|+.||+|++..+........+++.+|+.+++.++||||+++++++.+.+..|++
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 58999999999999999999999999999999999765444445567899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCc
Q 014347 93 LEYVTGGELFDKIASK-----------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS 161 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~~-----------~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla 161 (426)
|||++|++|.+++... .+++...+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999999988641 23556778899999999999999999999999999999999999999999999
Q ss_pred cCCccccC----------------CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHH
Q 014347 162 ALPQHFRD----------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVL 225 (426)
Q Consensus 162 ~~~~~~~~----------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~ 225 (426)
........ .......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||........
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~-S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 75421100 001123579999999999887766 6899999999999999999999987654433
Q ss_pred HHHH-HcCCCCC--CCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 226 YQKI-FRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 226 ~~~i-~~~~~~~--p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
.... ....... ...+++.+.+++.+||++||++|++..+.+.+
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2221 1111111 13478899999999999999999987665544
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=333.03 Aligned_cols=251 Identities=27% Similarity=0.372 Sum_probs=209.1
Q ss_pred eeeeceEeecCceEEEEEEECC---CCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE----
Q 014347 16 YELGRTLGEGNFGKVKFAQDLD---SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK---- 88 (426)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~---- 88 (426)
|++++.||+|+||.||.|.... ++..||+|.+..+.. .......+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 6789999999999999998764 347899999875433 23345778999999999999999999998765544
Q ss_pred --EEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccC
Q 014347 89 --IYMVLEYVTGGELFDKIASK------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL 160 (426)
Q Consensus 89 --~~lV~Ey~~gg~L~~~i~~~------~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGl 160 (426)
.+++|||+++|+|..++... ..+++..++.++.|++.||.|||++|++||||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 79999999999999888532 3589999999999999999999999999999999999999999999999999
Q ss_pred ccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCC
Q 014347 161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPK 238 (426)
Q Consensus 161 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~ 238 (426)
++...............++..|+|||.+....+ +.++|||||||++|+|++ |..||.+.+....+..+..+ ....|.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE 238 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 875432111111222345678999999876555 689999999999999999 99999988777777766654 455677
Q ss_pred CCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 239 WLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 239 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
.+++.+.+++.+||+.||++|||+.+++.+
T Consensus 239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 239 DCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=338.19 Aligned_cols=255 Identities=29% Similarity=0.457 Sum_probs=214.5
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCC-----CCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA 84 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 84 (426)
+..++|++.+.||+|+||.||++.+... ...+|+|.+.... .......+.+|+.+++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 4457899999999999999999987643 3689999987543 233456788999999999 7999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEec
Q 014347 85 SKSKIYMVLEYVTGGELFDKIAS----------------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 148 (426)
Q Consensus 85 ~~~~~~lV~Ey~~gg~L~~~i~~----------------~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~ 148 (426)
.++..|++|||+++|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT 166 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence 99999999999999999999864 24588999999999999999999999999999999999999
Q ss_pred CCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHH
Q 014347 149 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQ 227 (426)
Q Consensus 149 ~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~ 227 (426)
.++.+||+|||++................++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+....++
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCc-CcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 999999999999985433211111122335678999999876655 688999999999999998 999999888877777
Q ss_pred HHHcCC-CCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 228 KIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 228 ~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
.+..+. ...|...+..+.+|+.+||..||++|||+.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 246 LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 766553 45566788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=330.27 Aligned_cols=248 Identities=25% Similarity=0.431 Sum_probs=210.6
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (426)
.++|++.+.||+|+||.||+|... .+..+|+|.+...... ...+.+|+.++++++||||+++++++......|++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 467999999999999999999874 4567999987644321 35688899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCC
Q 014347 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 171 (426)
|||++||+|.+++.. .+.+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+++...... ..
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~-~~ 156 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YT 156 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc-ee
Confidence 999999999999875 4568999999999999999999999999999999999999999999999999987432111 11
Q ss_pred ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHHHHHH
Q 014347 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLR 249 (426)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~ 249 (426)
......++..|+|||++....+ +.++|+||||+++|+|++ |+.||...+.......+..+. ...|...+..+.+|+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKY-SSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMY 235 (256)
T ss_pred ccCCCCCchhhCChhhcccCcc-chhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 1112234568999999876665 588999999999999999 999999988887777777653 3446667889999999
Q ss_pred HccccCccCCCCHHHHhc
Q 014347 250 KILEPNPVKRITIAGIKA 267 (426)
Q Consensus 250 ~~L~~dP~~R~t~~eil~ 267 (426)
+||+.||.+|||++++++
T Consensus 236 ~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 236 SCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHccCCcccCcCHHHHHH
Confidence 999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=345.49 Aligned_cols=257 Identities=30% Similarity=0.424 Sum_probs=209.7
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC------
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------ 86 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------ 86 (426)
-++|++.+.||.|+||.||+|.+..+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 4799999999999999999999999999999999865543 3356788999999999999999999876543
Q ss_pred --------CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecC-CCCeEEee
Q 014347 87 --------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISD 157 (426)
Q Consensus 87 --------~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~-~g~vkL~D 157 (426)
...|++|||+. ++|.+.+.. +.+++..++.++.||++||.|||++||+||||||+||+++. ++.+||+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 35799999997 489887754 57999999999999999999999999999999999999985 55789999
Q ss_pred ccCccCCccccC-CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC---
Q 014347 158 FGLSALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--- 233 (426)
Q Consensus 158 FGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--- 233 (426)
||++........ ........|+..|+|||++......+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999875422111 1112234678899999987665555789999999999999999999998776554444332211
Q ss_pred ----------------------CC-----CCCCCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 234 ----------------------FK-----LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 234 ----------------------~~-----~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
.. +.+.++.++.+||.+||++||.+|||+.+++.||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 00 112467889999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=346.50 Aligned_cols=258 Identities=27% Similarity=0.413 Sum_probs=213.2
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC-----C
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----S 87 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~ 87 (426)
..+|.+.+.||+|+||.||+|++..+++.||||.+..... .......+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 3589999999999999999999999999999999875432 222345677899999999999999999987543 3
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
..|+++||+. ++|.+.+...+++++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~- 160 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE- 160 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC-
Confidence 5899999995 68999998888899999999999999999999999999999999999999999999999999885432
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHc----------------
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR---------------- 231 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~---------------- 231 (426)
.........++..|+|||.+......+.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 161 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07858 161 -KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239 (337)
T ss_pred -CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence 112234457899999999987644457899999999999999999999987654332222211
Q ss_pred -------C-----CC---CCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 232 -------G-----DF---KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 232 -------~-----~~---~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
. .. ...+.+++.+.+||++||++||++|||++++++||||...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0 00 0123478899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=339.47 Aligned_cols=255 Identities=27% Similarity=0.445 Sum_probs=212.9
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECC-------CCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLD-------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEV 82 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~ 82 (426)
...++|.+++.||+|+||.||+|++.. ++..+|+|.+.... .......+.+|+.+++.+ +||||++++++
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 445799999999999999999998643 23569999987543 223356788899999999 79999999999
Q ss_pred EEeCCEEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEE
Q 014347 83 LASKSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 146 (426)
Q Consensus 83 ~~~~~~~~lV~Ey~~gg~L~~~i~~~~----------------~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NIL 146 (426)
+...+..|+||||+++|+|.+++.... .++..++..++.|++.||+|||++|++||||||+|||
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 172 (307)
T cd05098 93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 172 (307)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence 999999999999999999999997532 4788999999999999999999999999999999999
Q ss_pred ecCCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHH
Q 014347 147 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVL 225 (426)
Q Consensus 147 l~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~ 225 (426)
++.++.+||+|||++................+++.|+|||++.+..+ +.++|+|||||++|+|++ |..||.+.+....
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~ 251 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC-CcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 99999999999999875432111111112234578999999877665 688999999999999998 9999998887777
Q ss_pred HHHHHcCC-CCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 226 YQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 226 ~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
...+.... ...|..++.++.+|+.+||..+|.+|||+.+++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 252 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 76665553 46677789999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=336.46 Aligned_cols=253 Identities=23% Similarity=0.293 Sum_probs=211.3
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCC----------------CeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSG----------------LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~----------------~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn 75 (426)
..++|++++.||+|+||.||+|.+..++ ..||+|.+..... ....+.+.+|+++++.++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCC
Confidence 4579999999999999999999876544 4589999875432 244678899999999999999
Q ss_pred ccceEEEEEeCCEEEEEEeccCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCc
Q 014347 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-----------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLEN 144 (426)
Q Consensus 76 Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~i~~~~-----------~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~N 144 (426)
|+++++++..++..+++|||+.+++|.+++.... .+++..++.++.|++.||+|||++|++||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999997755 68999999999999999999999999999999999
Q ss_pred EEecCCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh--CCCCCCCCcH
Q 014347 145 ILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT--GYLPFDDRNL 222 (426)
Q Consensus 145 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt--G~~Pf~~~~~ 222 (426)
|+++.++.++|+|||++................+++.|+|||.+....+ +.++|||||||++|+|++ |..||...+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 9999999999999999875322111122234456789999999876555 689999999999999998 7889987766
Q ss_pred HHHHHHHHcC--------CCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 223 AVLYQKIFRG--------DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 223 ~~~~~~i~~~--------~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
.......... ....|..++.++.+|+.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 6555544322 12345567899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=352.29 Aligned_cols=254 Identities=26% Similarity=0.401 Sum_probs=207.9
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCC-----CCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLA 84 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~ 84 (426)
..-++|++++.||+|+||.||+|.+... +..||+|++.... .....+.+.+|+.+++.+. ||||+++++++.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 4456889999999999999999987533 3469999986543 2333567899999999996 999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHhc--------------------------------------------------------
Q 014347 85 SKSKIYMVLEYVTGGELFDKIASK-------------------------------------------------------- 108 (426)
Q Consensus 85 ~~~~~~lV~Ey~~gg~L~~~i~~~-------------------------------------------------------- 108 (426)
.....|+||||+++|+|.+++..+
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 999999999999999999988642
Q ss_pred ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEec
Q 014347 109 ----------------------------------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 148 (426)
Q Consensus 109 ----------------------------------------~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~ 148 (426)
..+++..+..++.|++.||.|||++||+||||||+|||++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~ 271 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe
Confidence 2367788899999999999999999999999999999999
Q ss_pred CCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHH-HH
Q 014347 149 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV-LY 226 (426)
Q Consensus 149 ~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~-~~ 226 (426)
.++.+||+|||+++...............+++.|+|||++.+..+ +.++|||||||++|+|++ |..||....... .+
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~ 350 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY-TTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence 999999999999875432211112233457788999999877665 689999999999999997 999998765433 33
Q ss_pred HHHHcC-CCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 227 QKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 227 ~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
..+..+ ....|..+++.+.+++.+||+.||++|||+.++.+
T Consensus 351 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 351 NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 333333 34556678999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=332.78 Aligned_cols=251 Identities=27% Similarity=0.380 Sum_probs=207.3
Q ss_pred eeeeceEeecCceEEEEEEECCCCC--eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe------CC
Q 014347 16 YELGRTLGEGNFGKVKFAQDLDSGL--PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------KS 87 (426)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------~~ 87 (426)
|.+++.||+|+||.||+|.+..++. .+|+|.++.... .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 4578999999999999999877765 699998865432 33446788899999999999999999997643 23
Q ss_pred EEEEEEeccCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCc
Q 014347 88 KIYMVLEYVTGGELFDKIAS------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS 161 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~------~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla 161 (426)
..+++|||+.+|+|.+.+.. ...+++..+..++.|++.||+|||++||+||||||+|||+++++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 57899999999999988742 234889999999999999999999999999999999999999999999999998
Q ss_pred cCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcCC-CCCCCC
Q 014347 162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKW 239 (426)
Q Consensus 162 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~ 239 (426)
................+++.|+|||.+....+ +.++||||||+++|+|++ |..||.+......+..+..+. ...+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVY-TTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD 238 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCc-ChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 86432111111123346778999999877665 689999999999999999 899999887777777776654 355667
Q ss_pred CCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 240 LSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 240 ~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
++..+.++|.+||++||++|||+.+++++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 239 CLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 88999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=336.79 Aligned_cols=253 Identities=27% Similarity=0.403 Sum_probs=212.8
Q ss_pred ccCCCeeeeceEeecCceEEEEEEEC-----CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 85 (426)
+..++|.+.+.||+|+||.||+|.+. .++..+++|.+.... ....+.+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGD 78 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence 45678999999999999999999854 345668999875433 2334678899999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecC
Q 014347 86 KSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 149 (426)
Q Consensus 86 ~~~~~lV~Ey~~gg~L~~~i~~~~----------------~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~ 149 (426)
....++||||+++++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA 158 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence 999999999999999999997532 3889999999999999999999999999999999999999
Q ss_pred CCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHH
Q 014347 150 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQK 228 (426)
Q Consensus 150 ~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 228 (426)
++.+||+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999875332111112233456789999999877665 688999999999999999 9999988777777776
Q ss_pred HHcCCC-CCCCCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 229 IFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 229 i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
+..+.. ..+..++..+.+++.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 238 ITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 666544 345567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=347.03 Aligned_cols=253 Identities=27% Similarity=0.410 Sum_probs=205.2
Q ss_pred CCCeeeeceEeecCceEEEEEEEC-----CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEe-
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS- 85 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~- 85 (426)
-++|++.+.||+|+||.||+|.+. .+++.||+|+++... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 358999999999999999999743 345789999986433 223356788899999999 79999999998764
Q ss_pred CCEEEEEEeccCCCChHHHHHhc---------------------------------------------------------
Q 014347 86 KSKIYMVLEYVTGGELFDKIASK--------------------------------------------------------- 108 (426)
Q Consensus 86 ~~~~~lV~Ey~~gg~L~~~i~~~--------------------------------------------------------- 108 (426)
+..+|++|||++|++|.+++...
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 46789999999999999988542
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccCCCcccc
Q 014347 109 ----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184 (426)
Q Consensus 109 ----~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~A 184 (426)
.++++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++................++..|+|
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 2678999999999999999999999999999999999999999999999999985432111111223456678999
Q ss_pred hhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHH-HHHHcC-CCCCCCCCCHHHHHHHHHccccCccCCCC
Q 014347 185 PEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLY-QKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRIT 261 (426)
Q Consensus 185 PE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~-~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t 261 (426)
||++.+..+ +.++|||||||++|+|++ |..||.+....+.. ..+..+ ....|...++++.+++.+||+.+|++||+
T Consensus 244 PE~~~~~~~-~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs 322 (337)
T cd05054 244 PESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPT 322 (337)
T ss_pred cHHhcCCCC-CccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcC
Confidence 999887776 588999999999999998 99999875443333 222222 33456668899999999999999999999
Q ss_pred HHHHhcC
Q 014347 262 IAGIKAD 268 (426)
Q Consensus 262 ~~eil~h 268 (426)
+.++++|
T Consensus 323 ~~ell~~ 329 (337)
T cd05054 323 FSELVEI 329 (337)
T ss_pred HHHHHHH
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=332.58 Aligned_cols=254 Identities=30% Similarity=0.455 Sum_probs=211.1
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe--CCEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KSKIYM 91 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~l 91 (426)
++|+..+.||.|++|.||+|.+..+++.+|+|.+..... .....++.+|+++++.++||||+++++++.. ...+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 579999999999999999999999999999999875432 2345778999999999999999999998854 447899
Q ss_pred EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 92 VLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~----~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
||||++|++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~- 157 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN- 157 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccc-
Confidence 9999999999887653 35689999999999999999999999999999999999999999999999999874322
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCC-----cHHHHHHHHHcCC-CCCC----
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-----NLAVLYQKIFRGD-FKLP---- 237 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~-----~~~~~~~~i~~~~-~~~p---- 237 (426)
.......++..|+|||.+.+..+ +.++|||||||++|+|++|..||... ........+.... ..++
T Consensus 158 ---~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 158 ---SLAGTFTGTSFYMAPERIQGKPY-SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred ---cccccccCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 12224567889999999877666 58899999999999999999999865 2233333333321 1111
Q ss_pred --CCCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 238 --KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 238 --~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
..+++.+.++|.+||++||++|||+.|++.||||+..
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 1246789999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=371.19 Aligned_cols=151 Identities=31% Similarity=0.588 Sum_probs=142.3
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
.+++|.+++.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+++.++||||+++++++.....+|+
T Consensus 2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 36899999999999999999999999999999999987665566667889999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCcc
Q 014347 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~ 162 (426)
||||+.|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=352.89 Aligned_cols=248 Identities=33% Similarity=0.653 Sum_probs=219.7
Q ss_pred eceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEeccCC
Q 014347 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~g 98 (426)
-+.||.|-||.||-|+++.+|+.||||+++|.+..... ..++++|+.||+.+.||+||.+--.+++.++++.|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 46899999999999999999999999999998776544 47899999999999999999999999999999999999965
Q ss_pred CChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCC---CeEEeeccCccCCccccCCCcc
Q 014347 99 GELFDKIA--SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLL 173 (426)
Q Consensus 99 g~L~~~i~--~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g---~vkL~DFGla~~~~~~~~~~~~ 173 (426)
+..+.|- +.+++++...+.++.||+.||.|||-+||+|+||||||||+.... .+||||||+|++... ....
T Consensus 648 -DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE---ksFR 723 (888)
T KOG4236|consen 648 -DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE---KSFR 723 (888)
T ss_pred -hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch---hhhh
Confidence 6666664 368999999999999999999999999999999999999997654 699999999997543 3455
Q ss_pred ccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCC--C--CCHHHHHHHH
Q 014347 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK--W--LSPGAQNLLR 249 (426)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~--~s~~~~~Li~ 249 (426)
.+.+|||.|+|||++.+++|+ ..-|+||.|||+|.-|+|..||.... ++..+|.+..+-+|+ | +++++.+||.
T Consensus 724 rsVVGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~AidlIn 800 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPEAIDLIN 800 (888)
T ss_pred hhhcCCccccCHHHHhhcccc-ccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHHHHHHHH
Confidence 678999999999999999996 77899999999999999999997643 355667777666653 4 8999999999
Q ss_pred HccccCccCCCCHHHHhcCcccccc
Q 014347 250 KILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 250 ~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
.+|+..-.+|+|++..+.|||++..
T Consensus 801 ~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 801 NLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHHhcchHhhccchhhhcc
Confidence 9999999999999999999999864
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=308.03 Aligned_cols=257 Identities=31% Similarity=0.495 Sum_probs=220.0
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
.+|+-.++||+|+||+|++|++..+++.||+|.++.+.- ++..-....+||.+++.++|.|||+++++..++..+-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 467788999999999999999999999999999976543 3334567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 94 Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
|||. .+|..+... ++.++.+.++.++.|++.||.|||++++.||||||.|+|++.+|.+|++|||+++.+.- .-..
T Consensus 81 e~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgi--pvrc 157 (292)
T KOG0662|consen 81 EFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGI--PVRC 157 (292)
T ss_pred HHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCC--ceEe
Confidence 9995 488888776 67899999999999999999999999999999999999999999999999999986543 2223
Q ss_pred cccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC--CC---------CCCC--
Q 014347 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG--DF---------KLPK-- 238 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~--~~---------~~p~-- 238 (426)
....+-|.+|.+|.++.+...++...|+||.|||+.|+.. |.+.|.+.+..+...+|++- .+ .+|.
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 3345678999999999988877888999999999999987 99999999988888887642 11 1111
Q ss_pred ----------------CCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 239 ----------------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 239 ----------------~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
.++..-++|++++|.-+|.+|++++++++||||.+.
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 123345899999999999999999999999999764
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=338.95 Aligned_cols=259 Identities=30% Similarity=0.451 Sum_probs=209.2
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC----
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK---- 86 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 86 (426)
..+++|++.+.||+|+||.||+|.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKS 83 (311)
T ss_pred cccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence 34799999999999999999999999999999999986543222 1234567899999999999999999887433
Q ss_pred ----CEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCc
Q 014347 87 ----SKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS 161 (426)
Q Consensus 87 ----~~~~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla 161 (426)
..+|+||||+.+ +|.+.+.. ...+++..++.++.|+++||+|||++||+||||||+|||+++++.+||+|||++
T Consensus 84 ~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 84 KRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred cccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 357999999965 67776654 457999999999999999999999999999999999999999999999999998
Q ss_pred cCCccccCC---------CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC
Q 014347 162 ALPQHFRDD---------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG 232 (426)
Q Consensus 162 ~~~~~~~~~---------~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~ 232 (426)
......... .......|++.|+|||.+.+....+.++||||+||++|+|++|++||.+.+.......+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 754322111 11123357889999999876554578899999999999999999999987776555544321
Q ss_pred CC-----------------------CCC-------CCCCHHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 233 DF-----------------------KLP-------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 233 ~~-----------------------~~p-------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
.. ..+ ..+++.+.++|.+||+.||.+|||+.+++.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 00 000 1244678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=367.84 Aligned_cols=250 Identities=32% Similarity=0.526 Sum_probs=209.6
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEE-E---e---C
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVL-A---S---K 86 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~-~---~---~ 86 (426)
+++|.+.|.+|||+.||+|.+...|..||+|.+-.. ++...+.+.+||.+|+.|+ |+|||.+++.. . . .
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 567899999999999999999888899999987544 5666889999999999998 99999999932 1 1 1
Q ss_pred CEEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcC--ceeccCCCCcEEecCCCCeEEeeccCcc
Q 014347 87 SKIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDSKGNIKISDFGLSA 162 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~--~~~l~~~~~~~i~~Ql~~aL~~LH~~g--IiHrDLKp~NILl~~~g~vkL~DFGla~ 162 (426)
-.++|.||||.||.|-|++.. ..+|++.++.+||.|+++||.+||... |||||||-|||||..+|+.||||||.|+
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 357899999999999999974 456999999999999999999999997 9999999999999999999999999987
Q ss_pred CCccccCC--C--c---cccccCCCcccchhhhc--cCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC
Q 014347 163 LPQHFRDD--G--L---LHTTCGSPNYVAPEVLA--NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD 233 (426)
Q Consensus 163 ~~~~~~~~--~--~---~~~~~gt~~y~APE~l~--~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 233 (426)
..-..... + . --...-|+.|+|||++. ++...+.|+|||+|||+||-|+....||++... ..|+.+.
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----laIlng~ 270 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----LAILNGN 270 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEEecc
Confidence 43221100 0 0 01234789999999963 344558999999999999999999999998633 2567888
Q ss_pred CCCCC--CCCHHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 234 FKLPK--WLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 234 ~~~p~--~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
+.+|+ .++..+.+||+.||++||++||++.+++.+-+-
T Consensus 271 Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 271 YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 88886 589999999999999999999999998876443
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=331.30 Aligned_cols=248 Identities=25% Similarity=0.422 Sum_probs=213.5
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (426)
-.+|++++.||.|+||.||+|.+.. +..+|+|++..... .....+.+|+.+++.++||||+++++++.+....|+|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 3579999999999999999999877 88999999876542 2356788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCC
Q 014347 93 LEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~--~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 170 (426)
|||+++++|.+++.+ ...+++..++.++.||+.||.|||++|++||||||+||++++++.+||+|||++...... .
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~--~ 158 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED--V 158 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc--c
Confidence 999999999999975 346899999999999999999999999999999999999999999999999998754221 1
Q ss_pred CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHHHH
Q 014347 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLL 248 (426)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li 248 (426)
.......++..|+|||++....+ +.++||||||+++|+|++ |+.||...+....+..+..+ ..+.|..+++.+.+++
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 237 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTF-STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIM 237 (261)
T ss_pred ccccCCCCceEecCHHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHH
Confidence 11223345678999999877665 688999999999999998 89999988877777766654 3455667899999999
Q ss_pred HHccccCccCCCCHHHHhc
Q 014347 249 RKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 249 ~~~L~~dP~~R~t~~eil~ 267 (426)
.+||+.||.+|||+.++++
T Consensus 238 ~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 238 LECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHcCCCchhCcCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=336.03 Aligned_cols=249 Identities=28% Similarity=0.427 Sum_probs=209.5
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCC--eEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGL--PFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 90 (426)
++|++.+.||+|+||.||+|.+..++. .+++|.++... .....+.+.+|+.+++++ +||||+++++++...+..|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 689999999999999999999877765 46888775322 233456788999999999 6999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeE
Q 014347 91 MVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 154 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~~~----------------~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vk 154 (426)
++|||+++++|.+++.+.. .+++..++.++.|++.||+|||++||+||||||+|||+++++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999997532 488899999999999999999999999999999999999999999
Q ss_pred EeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-
Q 014347 155 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG- 232 (426)
Q Consensus 155 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~- 232 (426)
|+|||++....... .......+..|+|||++....+ +.++|||||||++|+|++ |..||.+.+......++..+
T Consensus 160 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 160 IADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVY-TTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred ECCcCCCcccccee---ccCCCCcCccccCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 99999986322110 0111223457999999877665 688999999999999997 99999998888777777655
Q ss_pred CCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 233 DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 233 ~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
....|..+++.+.+|+.+||+.+|.+|||++++++.
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 345566789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=344.60 Aligned_cols=256 Identities=30% Similarity=0.416 Sum_probs=215.0
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE---
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK--- 88 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~--- 88 (426)
.-++|++.+.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 45789999999999999999999999999999999865422 23345678889999999999999999988765554
Q ss_pred ---EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 89 ---IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 89 ---~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
.|+|+||+ |++|.+++.. .++++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 89999999 6799998875 679999999999999999999999999999999999999999999999999987542
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC-----------
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF----------- 234 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----------- 234 (426)
. ......+++.|+|||.+.+....+.++||||||+++|+|++|+.||.+.+....+..+.....
T Consensus 170 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 170 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred c-----cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence 2 234457889999999987644557899999999999999999999988776555544432110
Q ss_pred --------------------CCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 235 --------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 235 --------------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
.....+++.+.+||.+||+.||++|||+.++++||||.+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 00123588999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=358.58 Aligned_cols=244 Identities=36% Similarity=0.599 Sum_probs=214.8
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 90 (426)
....|++...+|.|+|+.|..+.+..+++..++|++.+.. ....+|+.++.+. +||||+++++++.+....|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceee
Confidence 4678999999999999999999999999999999998762 2234577665554 6999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEe-cCCCCeEEeeccCccCCccccC
Q 014347 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL-DSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl-~~~g~vkL~DFGla~~~~~~~~ 169 (426)
+|||++.|+.|.+.+.....+. .++..|+.||+.|+.|||++||+||||||+|||+ +..|+++|+|||.++....
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~--- 468 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER--- 468 (612)
T ss_pred eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCch---
Confidence 9999999999999998765555 8888999999999999999999999999999999 5889999999999985332
Q ss_pred CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcH-HHHHHHHHcCCCCCCCCCCHHHHHHH
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRGDFKLPKWLSPGAQNLL 248 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~p~~~s~~~~~Li 248 (426)
...+.|-|..|+|||++...+| ++++||||||++||+||+|+.||..... .++...+..+.+. .++|..+++||
T Consensus 469 --~~~tp~~t~~y~APEvl~~~~y-t~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl 543 (612)
T KOG0603|consen 469 --SCDTPALTLQYVAPEVLAIQEY-TEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLL 543 (612)
T ss_pred --hhcccchhhcccChhhhccCCC-CcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHH
Confidence 2567788999999999998887 5999999999999999999999976443 4677776655554 88999999999
Q ss_pred HHccccCccCCCCHHHHhcCccc
Q 014347 249 RKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 249 ~~~L~~dP~~R~t~~eil~h~~f 271 (426)
++||+.||.+|+++.+++.||||
T Consensus 544 ~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 544 QQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHhccCChhhCcChhhhccCcch
Confidence 99999999999999999999999
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=335.65 Aligned_cols=254 Identities=26% Similarity=0.402 Sum_probs=214.9
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
+.|...+.||+|+||.||+|++..+|+.||+|.+.............+.+|+.+++.++|||++++++++.+....|+||
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 35777889999999999999999999999999997655444455677889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 94 Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
||+. ++|.+.+.. ..++++..+..++.||+.||.|||++|++||||+|+||+++.++.+||+|||++.... .
T Consensus 101 e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------~ 173 (313)
T cd06633 101 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------P 173 (313)
T ss_pred ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC------C
Confidence 9996 477777764 4578999999999999999999999999999999999999999999999999886321 2
Q ss_pred cccccCCCcccchhhhcc--CCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC-CC-CCCCCHHHHHHH
Q 014347 173 LHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KL-PKWLSPGAQNLL 248 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~--~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~-p~~~s~~~~~Li 248 (426)
.....|+..|+|||++.. .+..+.++|||||||++|+|++|..||.+.+......++..... .. ...++..+.+|+
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 253 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFV 253 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence 234578999999999742 23346789999999999999999999988766555444444322 22 233678899999
Q ss_pred HHccccCccCCCCHHHHhcCcccccc
Q 014347 249 RKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 249 ~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
.+||+++|.+||++.+++.||||...
T Consensus 254 ~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 254 DYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred HHHccCChhhCcCHHHHhcCcccCCC
Confidence 99999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=342.24 Aligned_cols=265 Identities=30% Similarity=0.385 Sum_probs=216.6
Q ss_pred cCCCeee-eceEeecCceEEEEEEECCCCCeEEEEEeecccccchh-----------HHHHHHHHHHHHHhCCCCCccce
Q 014347 12 RLGRYEL-GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-----------ITDQIKREIATLKLLKHPNVVRL 79 (426)
Q Consensus 12 ~~~~y~i-~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~-----------~~~~~~~Ei~il~~l~hpnIv~l 79 (426)
.-++|.. .+.||+|+||.||+|.+..+++.||+|.+......... ....+.+|+.+++.++||||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 3468874 57799999999999999999999999998654322110 11257789999999999999999
Q ss_pred EEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeecc
Q 014347 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG 159 (426)
Q Consensus 80 ~~~~~~~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFG 159 (426)
++++..++..|++|||+. ++|.+.+.....+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 999999999999999997 5999999888889999999999999999999999999999999999999999999999999
Q ss_pred CccCCccc------------cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHH
Q 014347 160 LSALPQHF------------RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQ 227 (426)
Q Consensus 160 la~~~~~~------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~ 227 (426)
++...... ..........+++.|+|||.+.+....+.++|+|||||++|+|++|+.||.+.+......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 244 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 98754310 011122334578899999998765555789999999999999999999999877665554
Q ss_pred HHHcCC--C--------------------------CCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccCCC
Q 014347 228 KIFRGD--F--------------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (426)
Q Consensus 228 ~i~~~~--~--------------------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 277 (426)
.+.... . ......+..+.++|.+||+.+|++|||+++++.||||+....+
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP 322 (335)
T ss_pred HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence 443210 0 0012357889999999999999999999999999999865433
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=333.03 Aligned_cols=253 Identities=32% Similarity=0.499 Sum_probs=212.3
Q ss_pred eeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC--CEEEEEE
Q 014347 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKIYMVL 93 (426)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lV~ 93 (426)
|++.+.||+|+||.||+|.+..+|+.+|+|.+.... ........+.+|+.+++.++|||++++++++... +..|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 788999999999999999999999999999998654 2333456788999999999999999999999888 8999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 94 EYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
||+++ +|.+.+.+. ..+++..++.++.||+.||+|||++|++|+||||+||++++++.+||+|||++........ ..
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-AD 157 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-cc
Confidence 99975 898888764 5799999999999999999999999999999999999999999999999999885533211 12
Q ss_pred cccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC--C----------------
Q 014347 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--F---------------- 234 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~---------------- 234 (426)
.....++..|+|||.+.+....+.++||||||+++|+|++|+.||...+.......+.... .
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 2344678899999987665445789999999999999999999998877665554443210 0
Q ss_pred -----CC-------CCC-CCHHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 235 -----KL-------PKW-LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 235 -----~~-------p~~-~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
.. ... +++.+.+++++||+.||.+|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00 011 37889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=327.68 Aligned_cols=245 Identities=26% Similarity=0.370 Sum_probs=206.3
Q ss_pred ceEeecCceEEEEEEE--CCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEeccC
Q 014347 20 RTLGEGNFGKVKFAQD--LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~ 97 (426)
+.||+|+||.||+|.+ ..++..+|+|+++... .+....+.+.+|+.+++.++||||+++++++. ....++||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~ 78 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAE 78 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCC
Confidence 3689999999999964 4578899999986443 23445678999999999999999999999875 456789999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCC-Cccccc
Q 014347 98 GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD-GLLHTT 176 (426)
Q Consensus 98 gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~-~~~~~~ 176 (426)
+++|.+++.....+++..+..++.|++.||+|||++||+||||||.|||++.++.+||+|||++......... ......
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence 9999999988788999999999999999999999999999999999999999999999999998754321110 011223
Q ss_pred cCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHcccc
Q 014347 177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEP 254 (426)
Q Consensus 177 ~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~ 254 (426)
.+++.|+|||.+....+ +.++|+|||||++|+|++ |..||.+.+.......+..+ ..+.|..+++++.+||.+||+.
T Consensus 159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~ 237 (257)
T cd05116 159 KWPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTY 237 (257)
T ss_pred CCCccccCHhHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhcc
Confidence 44678999999866554 688999999999999998 99999988777777777654 3567778999999999999999
Q ss_pred CccCCCCHHHHhc
Q 014347 255 NPVKRITIAGIKA 267 (426)
Q Consensus 255 dP~~R~t~~eil~ 267 (426)
||++||++++|..
T Consensus 238 ~p~~Rp~~~~i~~ 250 (257)
T cd05116 238 GVDERPGFAVVEL 250 (257)
T ss_pred CchhCcCHHHHHH
Confidence 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=330.95 Aligned_cols=253 Identities=24% Similarity=0.346 Sum_probs=210.5
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCC----eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGL----PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (426)
+...+|++++.||+|+||.||+|++..+|+ .||+|++.... .......+.+|+.+++.+.||||+++++++...
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS 81 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC
Confidence 345689999999999999999999877776 48999886443 233456788999999999999999999998754
Q ss_pred CEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 87 SKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
..++++||+++|+|.+.+.. .+.+++..+..++.|++.||.|||++||+||||||+|||+++++.+||+|||+++...
T Consensus 82 -~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 82 -TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred -CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 57899999999999999976 4569999999999999999999999999999999999999999999999999988543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHH
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPG 243 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 243 (426)
............+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||...........+..+ ..+.+..+++.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRF-THQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTID 239 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHH
Confidence 2111111122345678999999877666 588999999999999998 99999887766666555544 34556678999
Q ss_pred HHHHHHHccccCccCCCCHHHHhc
Q 014347 244 AQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
+.+++.+||+.||++|||+.+++.
T Consensus 240 ~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 240 VYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=336.82 Aligned_cols=254 Identities=27% Similarity=0.439 Sum_probs=212.1
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECC-------CCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLD-------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEV 82 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~ 82 (426)
...++|.+++.||+|+||.||+|++.. .+..+|+|.+.... .......+.+|+.+++.+ +||||++++++
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 345789999999999999999998642 34579999886433 233456788999999999 59999999999
Q ss_pred EEeCCEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEE
Q 014347 83 LASKSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 146 (426)
Q Consensus 83 ~~~~~~~~lV~Ey~~gg~L~~~i~~~----------------~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NIL 146 (426)
+...+..|++|||+++|+|.+++... ..++...+..++.||+.||.|||++|++||||||+|||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 166 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL 166 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEE
Confidence 99999999999999999999999753 34788999999999999999999999999999999999
Q ss_pred ecCCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHH
Q 014347 147 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVL 225 (426)
Q Consensus 147 l~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~ 225 (426)
++.++.+||+|||+++...............+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+....
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~ 245 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY-THQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCc-CccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999975432111111122234568999999877655 688999999999999999 9999998887777
Q ss_pred HHHHHcCC-CCCCCCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 226 YQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 226 ~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
+..+..+. ...|..++.++.+|+.+||+.||++|||+.++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 246 FKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 77766553 4556678899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=342.70 Aligned_cols=257 Identities=31% Similarity=0.437 Sum_probs=210.7
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC-----
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK----- 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 86 (426)
.-++|++.+.||+|+||.||+|.+..+|+.||+|.+.+... .....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 34799999999999999999999999999999999875432 222346788899999999999999999988543
Q ss_pred -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 87 -~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
...|++++++ |++|.+.+.. ..+++..++.++.|++.||.|||++||+||||||+||++++++.+||+|||++....
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 3478888887 7899887764 569999999999999999999999999999999999999999999999999987432
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC------------
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD------------ 233 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------ 233 (426)
.......|++.|+|||++.+....+.++||||+||++|+|++|+.||...+.......+....
T Consensus 172 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 172 -----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred -----ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence 123345789999999998764445788999999999999999999998765544333322110
Q ss_pred -----------CCCC--------CCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccCC
Q 014347 234 -----------FKLP--------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (426)
Q Consensus 234 -----------~~~p--------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 276 (426)
...| ...++.+.+||.+||+.||.+|||+.+++.||||.+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 0011 125788999999999999999999999999999987443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=328.28 Aligned_cols=248 Identities=23% Similarity=0.427 Sum_probs=209.0
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
.+|++.+.||+|+||.||+|.+. ++..+|+|.+.+.... ...+.+|+.+++.++||||+++++++...+..|+||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 46899999999999999999875 5668999998654321 346778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 94 Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
||++|++|.+++.. .+.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++...... ...
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~-~~~ 157 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTS 157 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccc-ccc
Confidence 99999999999975 3568999999999999999999999999999999999999999999999999987432110 001
Q ss_pred cccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHHHHHH
Q 014347 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRK 250 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~ 250 (426)
.....++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...+.......+..+ ....|...++.+.+++.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRF-SSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYS 236 (256)
T ss_pred cCCCCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 111123457999999887666 688999999999999999 89999887777666666554 345667789999999999
Q ss_pred ccccCccCCCCHHHHhcC
Q 014347 251 ILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 251 ~L~~dP~~R~t~~eil~h 268 (426)
||..+|++|||+.++++.
T Consensus 237 cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 237 CWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HhcCChhhCcCHHHHHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=343.12 Aligned_cols=260 Identities=33% Similarity=0.431 Sum_probs=219.0
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC-----EE
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-----KI 89 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~ 89 (426)
+|++.+.||.|+||.||+|++..+++.||+|.+.... ......+.+.+|+.+++.++||||+++++++.... ..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 6999999999999999999999999999999987543 12334577899999999999999999999987765 78
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
|++|||+. ++|.+.+.+..++++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++........
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 99999997 48999998877999999999999999999999999999999999999999999999999999986443211
Q ss_pred -CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCC-------------
Q 014347 170 -DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK------------- 235 (426)
Q Consensus 170 -~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~------------- 235 (426)
........+++.|+|||++.+....+.++|+||+|+++|+|++|..||.+.+....+..+......
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence 012344568999999999887644578999999999999999999999988776655554431100
Q ss_pred ------------------CCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccCC
Q 014347 236 ------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (426)
Q Consensus 236 ------------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 276 (426)
..+.+++.+.+||.+||+++|++|||+++++.||||+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 11235788999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=335.77 Aligned_cols=255 Identities=26% Similarity=0.410 Sum_probs=211.1
Q ss_pred CccCCCeeeeceEeecCceEEEEEEEC-----CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVL 83 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 83 (426)
....++|++.+.||+|+||.||+|.+. .++..||+|.++... .....+.+.+|+.+++++ +||||+++++.+
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 445568999999999999999999853 345689999886543 233456789999999999 799999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCc
Q 014347 84 ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS 161 (426)
Q Consensus 84 ~~~~~~~lV~Ey~~gg~L~~~i~~~~--~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla 161 (426)
...+..|++|||+++|+|.+++.... .+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999999999997533 3899999999999999999999999999999999999999999999999998
Q ss_pred cCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC--CCCCCC
Q 014347 162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG--DFKLPK 238 (426)
Q Consensus 162 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~--~~~~p~ 238 (426)
................+++.|+|||.+....+ +.++||||+||++|+|++ |..||.+......+.+.... ....|.
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 267 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPE 267 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCC-CcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCC
Confidence 75432111111222346788999999877665 688999999999999998 99999887665544444433 234456
Q ss_pred CCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 239 WLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 239 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
..++.+.+|+.+||+++|++|||+.+++.
T Consensus 268 ~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 78999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=325.00 Aligned_cols=251 Identities=32% Similarity=0.535 Sum_probs=220.8
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEe
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (426)
+|++.+.||+|+||.||++.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++++.+....|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 5899999999999999999999999999999987654432 335677889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCC
Q 014347 95 YVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (426)
Q Consensus 95 y~~gg~L~~~i~~----~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 170 (426)
|+++++|.+++.+ ...+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999999998866 356899999999999999999999999999999999999999999999999998764332
Q ss_pred CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC-CCCCCCCHHHHHHHH
Q 014347 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLR 249 (426)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~ 249 (426)
......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|+.||...+.......+....+ ..+..++.++.+++.
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPY-SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR 234 (256)
T ss_pred -CcccccCCccccCHHHHCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHH
Confidence 3334568999999999877665 5789999999999999999999999887777666665553 355568899999999
Q ss_pred HccccCccCCCCHHHHhcCccc
Q 014347 250 KILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 250 ~~L~~dP~~R~t~~eil~h~~f 271 (426)
+||+.+|++|||+.++++||++
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 235 SMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=335.42 Aligned_cols=257 Identities=26% Similarity=0.436 Sum_probs=215.3
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEEC-------CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceE
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLH 80 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~ 80 (426)
-....++|++++.||+|+||.||+|++. ..+..||+|.+.... .......+.+|+.+++.+ +||||++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchhee
Confidence 3566789999999999999999999753 234579999886432 223356789999999999 799999999
Q ss_pred EEEEeCCEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCc
Q 014347 81 EVLASKSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLEN 144 (426)
Q Consensus 81 ~~~~~~~~~~lV~Ey~~gg~L~~~i~~~----------------~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~N 144 (426)
+++......|++|||+++|+|.+++.+. ..++...+..++.||+.||.|||++|++||||||+|
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 167 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence 9999999999999999999999999753 246788899999999999999999999999999999
Q ss_pred EEecCCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHH
Q 014347 145 ILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLA 223 (426)
Q Consensus 145 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~ 223 (426)
||++.++.+||+|||++................+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+..
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 9999999999999999875433222222233456778999999877666 588999999999999998 89999988888
Q ss_pred HHHHHHHcCC-CCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 224 VLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 224 ~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
.....+..+. ...|..++..+.+|+.+||.++|++|||+.++++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 247 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 8777776543 34566789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=336.20 Aligned_cols=259 Identities=30% Similarity=0.490 Sum_probs=211.8
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC--
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-- 87 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-- 87 (426)
...+++|++.+.||+|+||.||+|.+..+|+.||+|.++..... ......+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 45678999999999999999999999999999999998754322 222456778999999999999999999987654
Q ss_pred --------EEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeec
Q 014347 88 --------KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDF 158 (426)
Q Consensus 88 --------~~~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DF 158 (426)
.+|+++||+++ +|.+.+.. ...+++..++.++.|++.||.|||++||+||||||+||++++++.+||+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcc
Confidence 79999999976 77777765 346999999999999999999999999999999999999999999999999
Q ss_pred cCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC---CC-
Q 014347 159 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DF- 234 (426)
Q Consensus 159 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~- 234 (426)
|++........ .......+++.|+|||.+.+....+.++|||||||++|+|++|+.||...+.......+... ..
T Consensus 161 g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (302)
T cd07864 161 GLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239 (302)
T ss_pred cccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 99875432111 11222356788999999876554578899999999999999999999877655544333321 00
Q ss_pred --------------------------CCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 235 --------------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 235 --------------------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
.....+++.+.+|+.+||+.||++|||+.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0012367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=335.64 Aligned_cols=255 Identities=25% Similarity=0.403 Sum_probs=217.7
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
..|+..+.||+|+||.||+|++..++..||+|.+........+....+.+|+.+++.++|||++++++++..+...|+||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34889999999999999999999999999999997665445555678999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 94 Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
||+.| +|.+.+.. ..++++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||++.... .
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~------~ 177 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS------P 177 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC------C
Confidence 99975 77777654 5679999999999999999999999999999999999999999999999999987432 1
Q ss_pred cccccCCCcccchhhhcc--CCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC-CC-CCCCCHHHHHHH
Q 014347 173 LHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KL-PKWLSPGAQNLL 248 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~--~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~-p~~~s~~~~~Li 248 (426)
.....|++.|+|||++.. .+..+.++|+||+||++|+|++|+.||.+.+.......+..... .. +..+++.+.+|+
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 257 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 257 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHH
Confidence 234578999999999742 23346889999999999999999999988776665555555432 22 234788999999
Q ss_pred HHccccCccCCCCHHHHhcCccccccC
Q 014347 249 RKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 249 ~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
.+||+.+|.+|||+.++++|+|+....
T Consensus 258 ~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 258 DSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred HHHccCCcccCcCHHHHHhChhhhccC
Confidence 999999999999999999999997644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=348.60 Aligned_cols=259 Identities=26% Similarity=0.388 Sum_probs=211.2
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCCEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 90 (426)
.-..|+++++||.||.++||++.....+ .||+|.+... ..+...+.-+.+||..|.+|+ |.+||+++++-..++.+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 3457999999999999999999975444 4565544322 235667889999999999997 999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 91 MVLEYVTGGELFDKIASKGRL-QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~~~~l-~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
+||||- .-+|...|.+.... +....+.|.+|++.|+.++|++||||.||||.|.|+ -.|.+||+|||+|........
T Consensus 437 mvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred EEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCcccc
Confidence 999986 45999998876554 446889999999999999999999999999999988 578999999999987655444
Q ss_pred CCccccccCCCcccchhhhccCCC----------CCCcchhhhHHHHHHHHHhCCCCCCCC-cHHHHHHHHHcC--CCCC
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRGY----------DGATSDIWSCGVILYVILTGYLPFDDR-NLAVLYQKIFRG--DFKL 236 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~----------~~~~~DIwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~--~~~~ 236 (426)
.-...+.+||+.||+||.+....+ .+.++||||||||||+|+.|+.||..- +...-+..|... .+++
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ief 594 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEF 594 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccc
Confidence 445567899999999999864333 267899999999999999999999763 233444445444 3466
Q ss_pred CCCCCHH-HHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 237 PKWLSPG-AQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 237 p~~~s~~-~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
|..-+.. +.++++.||..||++|||+.++|+|||++-.
T Consensus 595 p~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 595 PDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ 633 (677)
T ss_pred cCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence 6654444 9999999999999999999999999998753
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=327.30 Aligned_cols=249 Identities=24% Similarity=0.418 Sum_probs=209.7
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (426)
.++|++++.||+|+||.||+|.+.. +..+|+|.+...... .+.+.+|+.++++++||||+++++++......|++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 4679999999999999999998643 456999988654321 35688999999999999999999999998999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCC
Q 014347 93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 171 (426)
|||+.+++|.+++... ..+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||+++....... .
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~ 156 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-T 156 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-e
Confidence 9999999999999763 4689999999999999999999999999999999999999999999999999874321110 0
Q ss_pred ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHHHHHH
Q 014347 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLR 249 (426)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~ 249 (426)
......++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...+.......+..+. ...+...++.+.+++.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKF-SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMY 235 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 1111234567999999876665 588999999999999999 999999887777777776654 3345567899999999
Q ss_pred HccccCccCCCCHHHHhcC
Q 014347 250 KILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 250 ~~L~~dP~~R~t~~eil~h 268 (426)
+||++||.+|||+.+++.+
T Consensus 236 ~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 236 SCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHcCCCcccCCCHHHHHHh
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=320.03 Aligned_cols=249 Identities=32% Similarity=0.529 Sum_probs=214.5
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEe
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (426)
.|++.+.||+|++|.||++.+..+++.+++|.+..... .....+.+|+.+++.++|||++++++++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 48899999999999999999988999999999876542 346788999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcc
Q 014347 95 YVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (426)
Q Consensus 95 y~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 173 (426)
|++|++|.+.+... ..+++..+..++.|++.||.+||++|++||||+|+||++++++.++|+|||.+........ .
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 99999999998775 5899999999999999999999999999999999999999999999999999875433211 3
Q ss_pred ccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC-CCCCCC--CCCHHHHHHHHH
Q 014347 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-DFKLPK--WLSPGAQNLLRK 250 (426)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~p~--~~s~~~~~Li~~ 250 (426)
....|+..|+|||.+....+ +.++|+||||+++|+|++|..||...+........... ....+. .++..+.++|.+
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 233 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233 (253)
T ss_pred cceecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHH
Confidence 45678999999999876554 68899999999999999999999887544433333322 222332 248899999999
Q ss_pred ccccCccCCCCHHHHhcCcc
Q 014347 251 ILEPNPVKRITIAGIKADEW 270 (426)
Q Consensus 251 ~L~~dP~~R~t~~eil~h~~ 270 (426)
||+.||++|||+.+++.|||
T Consensus 234 ~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 234 CLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HccCChhhCCCHHHHhcCCC
Confidence 99999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=331.38 Aligned_cols=256 Identities=29% Similarity=0.473 Sum_probs=220.7
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (426)
..-+.|++.+.||+|+||.||+|.+..++..||+|++..... ....+.+|+.+++.++|+|++++++.+......|
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence 355679999999999999999999988899999999975432 3567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 91 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~~~-~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
+++||++|++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~-- 169 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE-- 169 (286)
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccc--
Confidence 9999999999999998866 8999999999999999999999999999999999999999999999999988643321
Q ss_pred CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC-CCC--CCCCCHHHHH
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKL--PKWLSPGAQN 246 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~--p~~~s~~~~~ 246 (426)
........+++.|+|||++.+..+ +.++|+||||+++|+|++|+.||...+.......+.... ... +..++..+.+
T Consensus 170 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 248 (286)
T cd06614 170 KSKRNSVVGTPYWMAPEVIKRKDY-GPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKD 248 (286)
T ss_pred hhhhccccCCcccCCHhHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHH
Confidence 112234468899999999877665 688999999999999999999999877655554444332 222 2337889999
Q ss_pred HHHHccccCccCCCCHHHHhcCccccc
Q 014347 247 LLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 247 Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
+|.+||+.+|.+|||+.+++.|+||.+
T Consensus 249 li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 249 FLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred HHHHHhccChhhCcCHHHHhhChHhhc
Confidence 999999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=331.63 Aligned_cols=252 Identities=28% Similarity=0.408 Sum_probs=211.3
Q ss_pred cCCCeeeeceEeecCceEEEEEEEC-----CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (426)
...+|++.++||+|+||.||++... .++..+|+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 3467899999999999999999743 356789999876432 33467899999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCC
Q 014347 87 SKIYMVLEYVTGGELFDKIASKG---------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 151 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~~---------------~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g 151 (426)
+..|++|||+++++|.+++.... .+++..++.++.||+.||+|||++|++||||||+|||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 99999999999999999987643 478999999999999999999999999999999999999999
Q ss_pred CeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHH
Q 014347 152 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIF 230 (426)
Q Consensus 152 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~ 230 (426)
.+||+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |.+||...........+.
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 999999999874322111111223345688999999877666 688999999999999998 999998877766666665
Q ss_pred cC-CCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 231 RG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 231 ~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
.+ ....|..+++.+.+||.+||+.||.+||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 239 QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 54 34556778999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=327.62 Aligned_cols=253 Identities=22% Similarity=0.365 Sum_probs=212.2
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCC---eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (426)
.++.|++.+.||+|+||.||+|.+..+++ .||+|.+.... .......+.+|+.+++.++||||+++++++.++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 79 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP 79 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence 35689999999999999999999877665 59999986542 34446789999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 89 IYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
.++||||+++++|.+++.. .+.+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 9999999999999999875 456899999999999999999999999999999999999999999999999998754321
Q ss_pred cCCCcccccc---CCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCH
Q 014347 168 RDDGLLHTTC---GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSP 242 (426)
Q Consensus 168 ~~~~~~~~~~---gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 242 (426)
.......... .+..|+|||.+....+ +.++||||+||++|+|++ |..||...+.......+... ..+.|..+++
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 238 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPT 238 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcc-cchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCH
Confidence 1111111111 2457999999887666 688999999999999887 99999888777766666443 3344566889
Q ss_pred HHHHHHHHccccCccCCCCHHHHhc
Q 014347 243 GAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
.+.+++.+||+.+|++||++.+++.
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 239 ALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=326.63 Aligned_cols=249 Identities=25% Similarity=0.401 Sum_probs=209.6
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
..++|+++++||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++.+...+..|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI 78 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence 4578999999999999999999964 567799998764322 24678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 92 VLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~--~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
+|||+++++|.+++.. ...++...+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++........
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 9999999999999875 35688999999999999999999999999999999999999999999999999985432111
Q ss_pred CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHHH
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 247 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 247 (426)
.......++..|+|||.+....+ +.++|||||||++|+|++ |..||...+.......+... ..+.+..++.++.++
T Consensus 159 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (261)
T cd05072 159 -TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDI 236 (261)
T ss_pred -eccCCCccceecCCHHHhccCCC-ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 11122345678999999876655 688999999999999998 99999887776666666544 233445578999999
Q ss_pred HHHccccCccCCCCHHHHhc
Q 014347 248 LRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 248 i~~~L~~dP~~R~t~~eil~ 267 (426)
+.+||..+|++|||++++.+
T Consensus 237 i~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 237 MKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHccCCcccCcCHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=329.96 Aligned_cols=253 Identities=21% Similarity=0.312 Sum_probs=208.3
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCe----EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLP----FAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~----vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (426)
...++|++++.||+|+||.||+|.+..+++. +++|.+.... .......+..|+.+++.++||||+++++++. .
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~ 80 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G 80 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence 3557899999999999999999998877774 6667664221 2233467888999999999999999999875 4
Q ss_pred CEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 87 SKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
...++++||+++|+|.+++.. .+.+++..+..++.|++.||+|||++|++||||||+|||+++++.+||+|||+++...
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 557889999999999999975 4578999999999999999999999999999999999999999999999999997543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHH
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPG 243 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~ 243 (426)
............++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.......+.+..+. ...|..++..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRY-THQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTID 239 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHH
Confidence 2111112233457788999999877665 689999999999999998 999998877666555555443 3445567889
Q ss_pred HHHHHHHccccCccCCCCHHHHhc
Q 014347 244 AQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
+.+++.+||..||++|||+.++++
T Consensus 240 ~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 240 VYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHH
Confidence 999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=332.05 Aligned_cols=250 Identities=29% Similarity=0.389 Sum_probs=209.2
Q ss_pred CeeeeceEeecCceEEEEEEECC-----CCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
+|++.+.||+|+||.||+|.+.. ....+|+|.+..... ......+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 58899999999999999998753 235799998865432 23356789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcE
Q 014347 90 YMVLEYVTGGELFDKIASK------------------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENI 145 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~------------------------~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NI 145 (426)
|+++||+.+++|.+++... .++++..+..++.|++.||.|||++|++||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999988642 2478889999999999999999999999999999999
Q ss_pred EecCCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHH
Q 014347 146 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV 224 (426)
Q Consensus 146 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~ 224 (426)
|+++++.+||+|||++...............+++..|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCc-chHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999875422111111223456778999999876655 688999999999999999 999999888777
Q ss_pred HHHHHHcC-CCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 225 LYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 225 ~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
+...+... ....|..++..+.+++.+||++||++||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 66665543 34556778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=325.94 Aligned_cols=249 Identities=24% Similarity=0.371 Sum_probs=209.8
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
..++|++.+.||+|+||.||+|.+. +++.||+|.++.... ..+.+.+|+.++++++||||+++++++...+..|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI 78 (261)
T ss_pred chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence 3467999999999999999999964 457899999865432 14568899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 92 VLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~~--~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
+|||++|++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||++........
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 999999999999997643 689999999999999999999999999999999999999999999999999875432110
Q ss_pred CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHHH
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 247 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 247 (426)
. ......++..|+|||++.+..+ +.++||||||+++|+|++ |+.||.+.+.......+... ..+.+..++..+.++
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (261)
T cd05068 159 E-AREGAKFPIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDI 236 (261)
T ss_pred c-ccCCCcCceeccCccccccCCC-CchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence 0 1111223457999999876655 688999999999999999 99999988877777666544 344566688999999
Q ss_pred HHHccccCccCCCCHHHHhc
Q 014347 248 LRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 248 i~~~L~~dP~~R~t~~eil~ 267 (426)
+.+||+.+|++||++.+++.
T Consensus 237 i~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 237 MLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHhhcCcccCCCHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=340.73 Aligned_cols=256 Identities=21% Similarity=0.341 Sum_probs=205.4
Q ss_pred ceEeec--CceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEeccC
Q 014347 20 RTLGEG--NFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (426)
Q Consensus 20 ~~LG~G--~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~ 97 (426)
..||+| +||.||+|.+..+|+.||+|++...... .+..+.+.+|+.+++.++||||+++++++..++..|+++||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 456666 9999999999999999999998765432 2345789999999999999999999999999999999999999
Q ss_pred CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCC-C---
Q 014347 98 GGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD-G--- 171 (426)
Q Consensus 98 gg~L~~~i~~~--~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~-~--- 171 (426)
+++|.+++.+. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+|++|||.+......... .
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 99999998763 35899999999999999999999999999999999999999999999999865422111100 0
Q ss_pred -ccccccCCCcccchhhhccCC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCC--------------
Q 014347 172 -LLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-------------- 235 (426)
Q Consensus 172 -~~~~~~gt~~y~APE~l~~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-------------- 235 (426)
......++..|+|||++.+.. ..+.++||||+||++|+|++|+.||.+................
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 011123567799999987542 2368899999999999999999999876554443333222110
Q ss_pred ---------------------------------CCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccCC
Q 014347 236 ---------------------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (426)
Q Consensus 236 ---------------------------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 276 (426)
.+..+++.+.+||++||+.||++|||+.++++||||.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 11225678999999999999999999999999999976543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-45 Score=387.15 Aligned_cols=259 Identities=33% Similarity=0.526 Sum_probs=226.2
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEe
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (426)
||+-+..||.|.||.||.|.+..||+..|+|-+.-+... ....+.+.+|..++..++|||+|++|++=.++...||+||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 688899999999999999999999999999988765544 4456788999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc--CCCc
Q 014347 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR--DDGL 172 (426)
Q Consensus 95 y~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~--~~~~ 172 (426)
||+||+|.+.++..+-.++...+.|..|++.|++|||++||+||||||+||+|+.+|-+|++|||.|....... ..+.
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence 99999999999987778888899999999999999999999999999999999999999999999987543321 2345
Q ss_pred cccccCCCcccchhhhccCC--CCCCcchhhhHHHHHHHHHhCCCCCCCCc--HHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 014347 173 LHTTCGSPNYVAPEVLANRG--YDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRGDFKLPKWLSPGAQNLL 248 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~--~~~~~~DIwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~~~~~~p~~~s~~~~~Li 248 (426)
+....|||.|||||++.+.. -.+-++||||||||+.||+||+.||..-+ ..-+|.--....+++|..+|++.+++|
T Consensus 1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFl 1474 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFL 1474 (1509)
T ss_pred HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHH
Confidence 66789999999999997533 22567999999999999999999997643 334454445557899999999999999
Q ss_pred HHccccCccCCCCHHHHhcCcccccc
Q 014347 249 RKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 249 ~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
.+||+.||++|+++.|+++|.|-+..
T Consensus 1475 e~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1475 EHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred HHHHhcCchhhhHHHHHHHhhccccc
Confidence 99999999999999999999876543
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=338.76 Aligned_cols=252 Identities=28% Similarity=0.457 Sum_probs=220.9
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEe
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (426)
-|+++++||+|+||.||+|.++.+|+.+|||.+..+. ..+.+.+||.||++++.|++|++|+.+.....+|+|||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 3789999999999999999999999999999876432 36788999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcc
Q 014347 95 YVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (426)
Q Consensus 95 y~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 173 (426)
||..|++.|.++- +.++++.++..+++.-+.||+|||...-+|||||..|||++.+|..||+|||.|..... .-...
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAKR 186 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAKR 186 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh--hHHhh
Confidence 9999999999874 67899999999999999999999999999999999999999999999999999874221 11233
Q ss_pred ccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC---CCCCCCCCHHHHHHHHH
Q 014347 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNLLRK 250 (426)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~Li~~ 250 (426)
++..|||.|||||++..-+|+ .++||||||+...||..|++||.+-.+....-.|-... +.-|..+|.++.+++++
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~-~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~ 265 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYD-TKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRS 265 (502)
T ss_pred CccccCcccccHHHHHHhccc-hhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHH
Confidence 577899999999999999996 77999999999999999999999877665433333222 33456689999999999
Q ss_pred ccccCccCCCCHHHHhcCcccccc
Q 014347 251 ILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 251 ~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
||.++|++|.|+.++++|+|.+..
T Consensus 266 CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 266 CLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred HhcCCHHHHHHHHHHhhhhhhcCC
Confidence 999999999999999999998753
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=333.57 Aligned_cols=256 Identities=24% Similarity=0.334 Sum_probs=207.9
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCCEEEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~l 91 (426)
..+|+..+.||+|+||.||++.+..+++.||+|.+...... .....+.+|+.++.++. ||||+++++++..+...++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 45678889999999999999999999999999998754422 33567889999999986 9999999999999999999
Q ss_pred EEeccCCCChHHHH---H--hcCCCCHHHHHHHHHHHHHHHHHHhhc-CceeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 92 VLEYVTGGELFDKI---A--SKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 92 V~Ey~~gg~L~~~i---~--~~~~l~~~~~~~i~~Ql~~aL~~LH~~-gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
+|||+.+ ++.+.. . ....+++..+..++.|++.||+|||+. |++||||||+|||++.++.+||+|||++....
T Consensus 81 ~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 81 CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9999864 554432 2 246799999999999999999999975 99999999999999999999999999987432
Q ss_pred cccCCCccccccCCCcccchhhhccC--CCCCCcchhhhHHHHHHHHHhCCCCCCCCcH-HHHHHHHHcCC-CCCC----
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRGD-FKLP---- 237 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~~~DIwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~-~~~p---- 237 (426)
. ........|++.|+|||++... ...+.++||||+||++|+|++|+.||..... .....++..+. ...+
T Consensus 160 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd06616 160 D---SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEE 236 (288)
T ss_pred c---CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCC
Confidence 1 1222344689999999998765 2446889999999999999999999976542 12222222222 1222
Q ss_pred CCCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 238 ~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
..+++.+.+||.+||++||++|||+++++.||||...
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 237 REFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 2378899999999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=348.71 Aligned_cols=261 Identities=33% Similarity=0.530 Sum_probs=227.0
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (426)
+.-.-|..++.||-|+||+|.+++...|...||+|.++|........+..++.|-.||..-+.+.||+||..|.+++.+|
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 34456889999999999999999999999999999999988887778889999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC-
Q 014347 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD- 169 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~- 169 (426)
+||+|++||++..++.+.+-|+|..|+.|+..|..|+++.|..|+|||||||+|||||.+|++||+||||++-+..-.+
T Consensus 706 FVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred EEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999975422100
Q ss_pred -----------C----------------------------CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHH
Q 014347 170 -----------D----------------------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 210 (426)
Q Consensus 170 -----------~----------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~el 210 (426)
+ ...+..+||+.|+|||++...+| +.-+|+||.|||||+|
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~-~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGY-TQLCDWWSVGVILYEM 864 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCc-cccchhhHhhHHHHHH
Confidence 0 01233479999999999999998 4889999999999999
Q ss_pred HhCCCCCCCCcHHHHHHHHHcC--CCCCC--CCCCHHHHHHHHHccccCccCCCC---HHHHhcCccccc
Q 014347 211 LTGYLPFDDRNLAVLYQKIFRG--DFKLP--KWLSPGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQ 273 (426)
Q Consensus 211 ltG~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~Li~~~L~~dP~~R~t---~~eil~h~~f~~ 273 (426)
+.|++||.+.+..+...++.+. .+.+| ..+|+++.+||.++.. +++.|.. ++++..||||+.
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred hhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccc
Confidence 9999999887776655555443 23444 4589999999998664 7888874 678999999975
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=342.37 Aligned_cols=254 Identities=26% Similarity=0.388 Sum_probs=205.5
Q ss_pred cCCCeeeeceEeecCceEEEEEEE-----CCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEe
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS 85 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 85 (426)
.-++|++++.||+|+||.||+|.+ ..+++.||||.++.... ......+.+|+.++..+ +||||+++++++..
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 457899999999999999999984 35678999999975432 23356788999999999 58999999998754
Q ss_pred -CCEEEEEEeccCCCChHHHHHhc--------------------------------------------------------
Q 014347 86 -KSKIYMVLEYVTGGELFDKIASK-------------------------------------------------------- 108 (426)
Q Consensus 86 -~~~~~lV~Ey~~gg~L~~~i~~~-------------------------------------------------------- 108 (426)
+...+++|||+++|+|.+++...
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 45689999999999999998642
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcccccc
Q 014347 109 -----------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 177 (426)
Q Consensus 109 -----------~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 177 (426)
..++...+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++................
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 136778888999999999999999999999999999999999999999999987542211111122334
Q ss_pred CCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHH-HHHHHHcC-CCCCCCCCCHHHHHHHHHcccc
Q 014347 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV-LYQKIFRG-DFKLPKWLSPGAQNLLRKILEP 254 (426)
Q Consensus 178 gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~ 254 (426)
+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+..... ....+..+ ....|.+.++.+.+++.+||+.
T Consensus 243 ~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~ 321 (343)
T cd05103 243 LPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG 321 (343)
T ss_pred CCcceECcHHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccC
Confidence 5678999999877666 688999999999999997 999998754332 22223222 3456777899999999999999
Q ss_pred CccCCCCHHHHhcC
Q 014347 255 NPVKRITIAGIKAD 268 (426)
Q Consensus 255 dP~~R~t~~eil~h 268 (426)
||++|||+.+|++|
T Consensus 322 ~p~~Rps~~eil~~ 335 (343)
T cd05103 322 EPSQRPTFSELVEH 335 (343)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=342.07 Aligned_cols=261 Identities=31% Similarity=0.429 Sum_probs=213.5
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEeC--C
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK--S 87 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~--~ 87 (426)
...++|++.+.||+|+||.||+|.+..+|+.+|+|.+.+... .......+.+|+.+++.+ +||||+++++++... .
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 356789999999999999999999998999999998864322 222345677899999999 999999999988643 4
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
..|+||||+. ++|.+.+... .+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++......
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 6899999997 4999988765 7899999999999999999999999999999999999999999999999998854332
Q ss_pred cCC---CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC-----------
Q 014347 168 RDD---GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD----------- 233 (426)
Q Consensus 168 ~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~----------- 233 (426)
... .......||+.|+|||++.+....+.++||||||+++|+|++|+.||.+........++....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 111 233345789999999988765555788999999999999999999998765444333221110
Q ss_pred -----------------C---CCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 234 -----------------F---KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 234 -----------------~---~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
. ...+.++.++.+||.+||+.||++|||+.++++|||+++-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0 0112268899999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=330.33 Aligned_cols=258 Identities=33% Similarity=0.599 Sum_probs=217.3
Q ss_pred CeeeeceEeecCceEEEEEEEC---CCCCeEEEEEeeccccc-chhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEE
Q 014347 15 RYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 89 (426)
+|++.+.||+|+||.||++++. .+++.||+|++.+.... .....+.+.+|+.+++++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 46789999998754332 223356788999999999 599999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
|+||||++|++|.+.+.....+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++...... .
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~ 159 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-E 159 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc-c
Confidence 999999999999999988788999999999999999999999999999999999999999999999999998754321 1
Q ss_pred CCccccccCCCcccchhhhccCC-CCCCcchhhhHHHHHHHHHhCCCCCCCCc----HHHHHHHHHcCCCCCCCCCCHHH
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRGDFKLPKWLSPGA 244 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~~ 244 (426)
.......+|++.|+|||.+.+.. ..+.++|+||+|+++|+|++|..||.... .....+.+.....+.|..+++.+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA 239 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHH
Confidence 11223456899999999986543 24678999999999999999999996432 23444555566677788899999
Q ss_pred HHHHHHccccCccCCCC---HHHHhcCccccc
Q 014347 245 QNLLRKILEPNPVKRIT---IAGIKADEWFEQ 273 (426)
Q Consensus 245 ~~Li~~~L~~dP~~R~t---~~eil~h~~f~~ 273 (426)
.++|.+||+.||++||| +.++++||||+.
T Consensus 240 ~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~ 271 (288)
T cd05583 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271 (288)
T ss_pred HHHHHHHhcCCHhhccCcchHHHHhcCccccc
Confidence 99999999999999998 567899999975
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=333.25 Aligned_cols=254 Identities=26% Similarity=0.457 Sum_probs=214.3
Q ss_pred eeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEecc
Q 014347 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYV 96 (426)
Q Consensus 17 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~ 96 (426)
+-...||+|+||.||++.+..+|+.||+|.+.... ......+.+|+.+++.++||||+++++.+...+..|++|||+
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 33468999999999999999999999999875432 233567889999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccc
Q 014347 97 TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 176 (426)
Q Consensus 97 ~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 176 (426)
++++|.+++.. +++++..++.++.|++.||+|||++|++||||+|+||+++.++.++|+|||++..... ........
T Consensus 100 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~--~~~~~~~~ 176 (292)
T cd06657 100 EGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKSL 176 (292)
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccc--cccccccc
Confidence 99999987754 5789999999999999999999999999999999999999999999999998764322 11122345
Q ss_pred cCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC---CCCCCCCCCHHHHHHHHHccc
Q 014347 177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPGAQNLLRKILE 253 (426)
Q Consensus 177 ~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~Li~~~L~ 253 (426)
.|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||.+.........+... .......+++.+.+++.+||+
T Consensus 177 ~~~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 255 (292)
T cd06657 177 VGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV 255 (292)
T ss_pred ccCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHh
Confidence 78999999999876555 68899999999999999999999887665544444332 222334578999999999999
Q ss_pred cCccCCCCHHHHhcCccccccCCC
Q 014347 254 PNPVKRITIAGIKADEWFEQDYTP 277 (426)
Q Consensus 254 ~dP~~R~t~~eil~h~~f~~~~~~ 277 (426)
.||.+||++.+++.||||.+...|
T Consensus 256 ~~P~~R~~~~~ll~~~~~~~~~~~ 279 (292)
T cd06657 256 RDPAQRATAAELLKHPFLAKAGPP 279 (292)
T ss_pred CCcccCcCHHHHhcChHHhccCCC
Confidence 999999999999999999887643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=330.70 Aligned_cols=253 Identities=26% Similarity=0.383 Sum_probs=212.3
Q ss_pred cCCCeeeeceEeecCceEEEEEEEC-----CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (426)
..++|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++..+
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 4578999999999999999999874 367889999986543 233456788999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCc
Q 014347 87 SKIYMVLEYVTGGELFDKIASKG----------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLEN 144 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~~----------------------~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~N 144 (426)
...|++|||+++++|.+++.... .+++..+..++.||+.||.|||++|++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999997432 36788899999999999999999999999999999
Q ss_pred EEecCCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHH
Q 014347 145 ILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLA 223 (426)
Q Consensus 145 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~ 223 (426)
||++.++.+||+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+..
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999874322111111222334667999999877666 688999999999999998 88999888777
Q ss_pred HHHHHHHcCCC-CCCCCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 224 VLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 224 ~~~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
+....+..+.. ..|..++..+.+|+.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 240 EVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 77777665543 456778999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=326.39 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=207.5
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
..++|++.+.||+|+||.||+|++..+ ..||+|.+...... .+.+.+|+.+++.++||||+++++.+. ....|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYI 77 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEE
Confidence 457899999999999999999998655 45999998754321 356889999999999999999999875 456899
Q ss_pred EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~--~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
||||+++|+|.+++.+. ..+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~- 156 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE- 156 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc-
Confidence 99999999999999753 358999999999999999999999999999999999999999999999999987543211
Q ss_pred CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHHH
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 247 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 247 (426)
........++..|+|||++.+..+ +.++||||+|+++|+|++ |..||.+.........+..+ ..+.+..++..+.+|
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 235 (262)
T ss_pred cccccCCcccceecCHhHhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHH
Confidence 111123346678999999876666 688999999999999999 99999888777666666544 244556689999999
Q ss_pred HHHccccCccCCCCHHHHhc
Q 014347 248 LRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 248 i~~~L~~dP~~R~t~~eil~ 267 (426)
+.+||++||++|||+.++++
T Consensus 236 i~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 236 MCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHccCCcccCCCHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=325.77 Aligned_cols=248 Identities=26% Similarity=0.395 Sum_probs=208.2
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
..++|++.+.||+|+||.||+|.+. .+..+|+|.+...... .+.+.+|+.++++++|||++++++++. ....|+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYI 77 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEE
Confidence 4568999999999999999999865 5667999998754331 356889999999999999999999875 456899
Q ss_pred EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~--~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
+|||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||++++++.++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~- 156 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE- 156 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc-
Confidence 99999999999998753 458999999999999999999999999999999999999999999999999997543211
Q ss_pred CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHHH
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 247 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 247 (426)
........++..|+|||.+....+ +.++||||||+++|+|++ |..||.+.+.......+... ..+.|...+..+.+|
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHEL 235 (260)
T ss_pred cccccCCCCCccccChHHHhcCCC-cchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence 111112235567999999876555 688999999999999999 99999988777777766654 455677789999999
Q ss_pred HHHccccCccCCCCHHHHhc
Q 014347 248 LRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 248 i~~~L~~dP~~R~t~~eil~ 267 (426)
+.+||.+||++|||++++.+
T Consensus 236 i~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 236 MLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHcccCcccCcCHHHHHH
Confidence 99999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=360.61 Aligned_cols=261 Identities=28% Similarity=0.396 Sum_probs=196.8
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCC-CCeEEEEEe--------------ecccccchhHHHHHHHHHHHHHhCCCCC
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDS-GLPFAVKIL--------------EKNRIIHLKITDQIKREIATLKLLKHPN 75 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~-~~~vAvK~i--------------~~~~~~~~~~~~~~~~Ei~il~~l~hpn 75 (426)
...++|++++.||+|+||+||+|..+.. +...+.|.+ .+...........+.+|+.+|+.++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 3457899999999999999999876432 222333311 1111112234567889999999999999
Q ss_pred ccceEEEEEeCCEEEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCC
Q 014347 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 150 (426)
Q Consensus 76 Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~i~~~-----~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~ 150 (426)
|+++++++...+..|++++++. ++|.+++... .......++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 9999999999999999999995 5787776532 234567788999999999999999999999999999999999
Q ss_pred CCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCC-CCCCC--cHHHHHH
Q 014347 151 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL-PFDDR--NLAVLYQ 227 (426)
Q Consensus 151 g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~-Pf~~~--~~~~~~~ 227 (426)
|.+||+|||++...... ........+||+.|+|||++.+..+ +.++|||||||++|+|++|.. ||.+. +......
T Consensus 304 ~~vkL~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKE-REAFDYGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCEEEEeCCCceecCcc-cccccccccCCcCCCCchhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 99999999999754321 1112334689999999999988776 688999999999999999875 44322 1111111
Q ss_pred HHHcC----CCCC-----------------------C-----CCCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 228 KIFRG----DFKL-----------------------P-----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 228 ~i~~~----~~~~-----------------------p-----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
++... ...+ + ..++.++.++|.+||+.||.+|||+.|++.||||...
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 11110 0000 0 1145678889999999999999999999999999764
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=329.90 Aligned_cols=248 Identities=34% Similarity=0.528 Sum_probs=205.2
Q ss_pred eeeceEeecCceEEEEEEEC----CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 014347 17 ELGRTLGEGNFGKVKFAQDL----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 17 ~i~~~LG~G~fg~Vy~a~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (426)
.+.+.||.|+||.||+|... ..+..|+||.+... ...+..+.+.+|+..+++++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 46789999999999999987 45678999999432 2344478899999999999999999999999988889999
Q ss_pred EeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCC
Q 014347 93 LEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~~--~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 170 (426)
+||+++|+|.+++... ..+++.....++.||+.||.|||+++++||||+|.|||++.++.+||+|||++.........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999886 68999999999999999999999999999999999999999999999999998754211111
Q ss_pred CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHHHHH
Q 014347 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLL 248 (426)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li 248 (426)
.......+...|+|||.+....+ +.++||||||+++||+++ |+.||.+.+......++..+. ...|..++..+.++|
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI 238 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence 12233456778999999877665 689999999999999999 789999988888777775553 456677899999999
Q ss_pred HHccccCccCCCCHHHHhc
Q 014347 249 RKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 249 ~~~L~~dP~~R~t~~eil~ 267 (426)
.+||..||++|||+.+|++
T Consensus 239 ~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 239 QQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHT-SSGGGS--HHHHHH
T ss_pred HHHcCCChhhCcCHHHHHh
Confidence 9999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=350.99 Aligned_cols=253 Identities=26% Similarity=0.412 Sum_probs=222.9
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEe
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (426)
.|.=++.||+|+||.||.|++..|.+.||||.+........+....+.+|++.|++++|||+|.+-++|-.+...|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 46678999999999999999999999999999987776666677889999999999999999999999999999999999
Q ss_pred ccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcc
Q 014347 95 YVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (426)
Q Consensus 95 y~~gg~L~~~i~-~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 173 (426)
||-| +-.|++. ...++-+.++..+..+.+.||+|||+++.||||||..|||+++.|.|||+|||.|.+.. ..
T Consensus 107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~------PA 179 (948)
T KOG0577|consen 107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA------PA 179 (948)
T ss_pred HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC------ch
Confidence 9965 7778775 35789999999999999999999999999999999999999999999999999988543 35
Q ss_pred ccccCCCcccchhhhc---cCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC-CCCCC-CCCHHHHHHH
Q 014347 174 HTTCGSPNYVAPEVLA---NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPK-WLSPGAQNLL 248 (426)
Q Consensus 174 ~~~~gt~~y~APE~l~---~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~-~~s~~~~~Li 248 (426)
++++|||.|||||++. .+.|+ -++||||||++..+|...++|+-+.|.......|...+ +.+++ .+|..+++|+
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYd-gkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fv 258 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 258 (948)
T ss_pred hcccCCccccchhHheeccccccC-CccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHH
Confidence 6789999999999975 24554 67999999999999999999988888776666666554 44443 3799999999
Q ss_pred HHccccCccCCCCHHHHhcCccccccC
Q 014347 249 RKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 249 ~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
..||++-|..|||.++++.|+|.....
T Consensus 259 d~CLqKipqeRptse~ll~H~fv~R~R 285 (948)
T KOG0577|consen 259 DSCLQKIPQERPTSEELLKHRFVLRER 285 (948)
T ss_pred HHHHhhCcccCCcHHHHhhcchhccCC
Confidence 999999999999999999999986543
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=332.74 Aligned_cols=252 Identities=23% Similarity=0.324 Sum_probs=205.2
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCC--------------CeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccc
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSG--------------LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR 78 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~--------------~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~ 78 (426)
.++|++.+.||+|+||.||+|++..++ ..||+|.+.... .......+.+|++++++++|||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 468999999999999999999875432 358999986542 2334567999999999999999999
Q ss_pred eEEEEEeCCEEEEEEeccCCCChHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEE
Q 014347 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKG------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 146 (426)
Q Consensus 79 l~~~~~~~~~~~lV~Ey~~gg~L~~~i~~~~------------~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NIL 146 (426)
+++++......|+||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999886432 3678889999999999999999999999999999999
Q ss_pred ecCCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh--CCCCCCCCcHHH
Q 014347 147 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT--GYLPFDDRNLAV 224 (426)
Q Consensus 147 l~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt--G~~Pf~~~~~~~ 224 (426)
+++++.+||+|||++................+++.|+|||++....+ +.++|||||||++|+|++ |..||...+...
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999999875322111111223345678999999876665 689999999999999988 778998766555
Q ss_pred HHHHHHc-----C---CCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 225 LYQKIFR-----G---DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 225 ~~~~i~~-----~---~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
....+.. . ....++.+++.+.+|+.+||+.||++|||+++|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 4433321 1 12335557899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=331.01 Aligned_cols=266 Identities=33% Similarity=0.486 Sum_probs=214.3
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCC----eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe-CC
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGL----PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-KS 87 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~ 87 (426)
+..|++++.||+|+||.||+|..++++. .+|+|.++-++- ........-||+.++|.++|||++.+..++-+ +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 4579999999999999999997555433 789998865432 22345678899999999999999999999877 88
Q ss_pred EEEEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCC----CCeEEeec
Q 014347 88 KIYMVLEYVTGGELFDKIAS-----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK----GNIKISDF 158 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~-----~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~----g~vkL~DF 158 (426)
.+++++||++. +|...|.- ...++...++.++.||+.|+.|||++-|+||||||.|||+..+ |.|||+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999999987 89888852 2468999999999999999999999999999999999999877 89999999
Q ss_pred cCccCCcccc-CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcH---------HHHHHH
Q 014347 159 GLSALPQHFR-DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL---------AVLYQK 228 (426)
Q Consensus 159 Gla~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~---------~~~~~~ 228 (426)
|+++++...- .-......+-|.+|+|||.+.+...++++.||||.|||+.||+|-.+.|.+... .+..++
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 9999865421 112344567899999999999988889999999999999999999888865321 122233
Q ss_pred HHc--CCC---------CCCCC--------------------------CCHHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 229 IFR--GDF---------KLPKW--------------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 229 i~~--~~~---------~~p~~--------------------------~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
|+. |.+ ..|.+ -++.+.+|+.+||+.||.+|+|++++++|+||
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF 340 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF 340 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence 321 100 11111 25668999999999999999999999999999
Q ss_pred cccCCCCCC
Q 014347 272 EQDYTPANP 280 (426)
Q Consensus 272 ~~~~~~~~~ 280 (426)
.....|+.|
T Consensus 341 ~~d~lpp~p 349 (438)
T KOG0666|consen 341 TEDPLPPLP 349 (438)
T ss_pred ccCCCCCCc
Confidence 988766443
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=325.82 Aligned_cols=252 Identities=23% Similarity=0.395 Sum_probs=210.6
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCC---eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
.++|++.+.||+|+||.||+|.+..++. .+|+|.++... .......+.+|+.+++.++||||+++++++..++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4689999999999999999999865543 79999886543 233456889999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
|++|||++|++|.+++.+. +.+++.++..++.|++.||+|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999999764 468999999999999999999999999999999999999999999999999988643321
Q ss_pred CCCc-cccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHH
Q 014347 169 DDGL-LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ 245 (426)
Q Consensus 169 ~~~~-~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 245 (426)
.... .....++..|+|||.+.+..+ +.++|+||||+++|++++ |..||.+.........+..+ ..+.+..+++.+.
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH 239 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHH
Confidence 1110 111223568999999877665 689999999999999887 99999887766666666554 2344455789999
Q ss_pred HHHHHccccCccCCCCHHHHhc
Q 014347 246 NLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~eil~ 267 (426)
+++.+||+++|.+|||+.++++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 240 QLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHcccCchhCCCHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=347.18 Aligned_cols=256 Identities=27% Similarity=0.379 Sum_probs=210.2
Q ss_pred CccCCCeeeeceEeecCceEEEEEEEC-----CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVL 83 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~ 83 (426)
.+..++|.+++.||+|+||.||+|++. .+++.||+|+++... .....+.+.+|+.+|.++. ||||+++++.+
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 455678999999999999999999854 355689999997543 2233457889999999997 99999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHHhcC------------------------------------------------------
Q 014347 84 ASKSKIYMVLEYVTGGELFDKIASKG------------------------------------------------------ 109 (426)
Q Consensus 84 ~~~~~~~lV~Ey~~gg~L~~~i~~~~------------------------------------------------------ 109 (426)
...+..|+||||+++|+|.+++.+.+
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 99999999999999999999986431
Q ss_pred --------------------------------------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcE
Q 014347 110 --------------------------------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENI 145 (426)
Q Consensus 110 --------------------------------------------~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NI 145 (426)
.++...++.++.||+.||.|||++|++||||||+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni 270 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV 270 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence 256677889999999999999999999999999999
Q ss_pred EecCCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHH
Q 014347 146 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV 224 (426)
Q Consensus 146 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~ 224 (426)
|+++++.+||+|||+++...............+++.|+|||.+....+ +.++||||||+++|+|++ |..||.......
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 999999999999999975422111111223467889999999877665 688999999999999998 899998755444
Q ss_pred HHHH-HHcC-CCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 225 LYQK-IFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 225 ~~~~-i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
.... +..+ .+..|..++..+.+|+.+||.++|.+||++.+|+..
T Consensus 350 ~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 350 QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4333 3333 345677789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=323.10 Aligned_cols=244 Identities=26% Similarity=0.393 Sum_probs=205.0
Q ss_pred ceEeecCceEEEEEEECCCC---CeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEecc
Q 014347 20 RTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYV 96 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~ 96 (426)
+.||+|+||.||+|....++ ..+|+|.+...... ...+.+.+|+.+++.++||||+++++++. ....++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 47999999999999876554 78999998765432 34567889999999999999999999876 45689999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCC-cccc
Q 014347 97 TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG-LLHT 175 (426)
Q Consensus 97 ~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~-~~~~ 175 (426)
.+++|.+++.+...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.......... ....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 999999999887789999999999999999999999999999999999999999999999999988543211110 0111
Q ss_pred ccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHccc
Q 014347 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILE 253 (426)
Q Consensus 176 ~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~ 253 (426)
..++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...+.......+.... ...|..+++.+.++|.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 236 (257)
T cd05060 158 GRWPLKWYAPECINYGKF-SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWK 236 (257)
T ss_pred ccccccccCHHHhcCCCC-CccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence 123467999999876665 688999999999999998 999999887776666665543 45677789999999999999
Q ss_pred cCccCCCCHHHHhc
Q 014347 254 PNPVKRITIAGIKA 267 (426)
Q Consensus 254 ~dP~~R~t~~eil~ 267 (426)
+||++|||+.++++
T Consensus 237 ~~p~~Rp~~~~l~~ 250 (257)
T cd05060 237 YRPEDRPTFSELES 250 (257)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=323.42 Aligned_cols=244 Identities=25% Similarity=0.469 Sum_probs=208.0
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEE-EeCCEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL-ASKSKI 89 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~~~~~ 89 (426)
+.+.+|++.+.||+|+||.||++.. .|..||+|.+.... ..+.+.+|+.++++++|+|++++++++ ..++..
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 4567899999999999999999975 47889999885432 245788999999999999999999975 455679
Q ss_pred EEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 90 YMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~--~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
|++|||+++++|.+++.+.. .+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||++.....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~- 154 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS- 154 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc-
Confidence 99999999999999987643 488999999999999999999999999999999999999999999999999874321
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHH
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ 245 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 245 (426)
......++..|+|||++....+ +.++|||||||++|+|++ |+.||...+.......+..+ ....++.+++.+.
T Consensus 155 ----~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (256)
T cd05082 155 ----TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVY 229 (256)
T ss_pred ----cCCCCccceeecCHHHHccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 1223445678999999876665 688999999999999998 99999988877776666554 3445667899999
Q ss_pred HHHHHccccCccCCCCHHHHhc
Q 014347 246 NLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~eil~ 267 (426)
+++.+||+.+|++|||+.++++
T Consensus 230 ~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 230 DVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=326.72 Aligned_cols=253 Identities=25% Similarity=0.369 Sum_probs=213.6
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCC----eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGL----PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (426)
...++|++++.||+|+||.||+|.+..+|+ .+|+|.+..... ......+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 345789999999999999999999877665 589998765532 3345678899999999999999999999887
Q ss_pred CEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 87 SKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
...+++|||+++|+|.+++.. ...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 789999999999999999976 3569999999999999999999999999999999999999999999999999998543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHH
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPG 243 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~ 243 (426)
............++..|+|||.+....+ +.++|+||||+++|++++ |..||.+.+.....+.+..+. .+.|...+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIY-THKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTID 239 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCc-CchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHH
Confidence 2111111112234568999999876665 588999999999999999 999999988877777776553 5566778899
Q ss_pred HHHHHHHccccCccCCCCHHHHhc
Q 014347 244 AQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
+.+++.+||..||+.|||+.++++
T Consensus 240 ~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 240 VYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHHHcCCChhhCCCHHHHHH
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=322.49 Aligned_cols=244 Identities=28% Similarity=0.503 Sum_probs=211.8
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
..++|++.+.||.|+||.||+|.. .|+.||+|.+..... ..+++.+|+.+++.++|+||+++++++.+.+..|+
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence 456899999999999999999986 478999999865432 35788999999999999999999999998999999
Q ss_pred EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 92 VLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~~--~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
||||+++++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~-- 155 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG-- 155 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc--
Confidence 999999999999998755 6999999999999999999999999999999999999999999999999998854211
Q ss_pred CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHHH
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 247 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 247 (426)
.....++..|+|||.+....+ +.++||||||+++|+|++ |..||...+.......+..+ ....|..+++.+.++
T Consensus 156 ---~~~~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (256)
T cd05039 156 ---QDSGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKV 231 (256)
T ss_pred ---cccCCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHH
Confidence 113345667999999876655 688999999999999998 99999988777766665544 345567789999999
Q ss_pred HHHccccCccCCCCHHHHhc
Q 014347 248 LRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 248 i~~~L~~dP~~R~t~~eil~ 267 (426)
|.+||..+|++|||+.++++
T Consensus 232 i~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 232 MKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHhccChhhCcCHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=333.41 Aligned_cols=256 Identities=25% Similarity=0.387 Sum_probs=215.1
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
.-..|+..+.||+|+||.||+|++..+++.+|+|.+............++.+|+.+++.++|+|++++++++......|+
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 34568889999999999999999999999999999875443344445678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCC
Q 014347 92 VLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 170 (426)
||||+. |+|.+.+.. ..++++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 93 v~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---- 167 (308)
T cd06634 93 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (308)
T ss_pred EEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC----
Confidence 999996 578777653 45689999999999999999999999999999999999999999999999999874321
Q ss_pred CccccccCCCcccchhhhcc--CCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC-CC-CCCCCHHHHH
Q 014347 171 GLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KL-PKWLSPGAQN 246 (426)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~--~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~-p~~~s~~~~~ 246 (426)
.....|++.|+|||.+.+ ....+.++|||||||++|+|++|..||.+.+.......+..... .. +..++..+.+
T Consensus 168 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (308)
T cd06634 168 --ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 245 (308)
T ss_pred --cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHH
Confidence 234568899999999752 23346789999999999999999999987665544444444332 22 3357889999
Q ss_pred HHHHccccCccCCCCHHHHhcCcccccc
Q 014347 247 LLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 247 Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
||++||+.+|++||++.+++.|+|+...
T Consensus 246 li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 246 FVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 9999999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=336.89 Aligned_cols=256 Identities=27% Similarity=0.439 Sum_probs=212.5
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCC-------CCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDS-------GLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEV 82 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~ 82 (426)
+.-.+|++++.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+++++ +||||++++++
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 3445899999999999999999986432 2368999886432 233457889999999999 79999999999
Q ss_pred EEeCCEEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEE
Q 014347 83 LASKSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 146 (426)
Q Consensus 83 ~~~~~~~~lV~Ey~~gg~L~~~i~~~~----------------~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NIL 146 (426)
+...+..|++|||+++|+|.+++.+.. .++...+..++.|++.||.|||++|++||||||+|||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 166 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVL 166 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEE
Confidence 999999999999999999999997532 3677888999999999999999999999999999999
Q ss_pred ecCCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHH
Q 014347 147 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVL 225 (426)
Q Consensus 147 l~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~ 225 (426)
++.++.+||+|||+++...............++..|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+....
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 245 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCc-CchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 99999999999999875432111111222334567999999877666 588999999999999998 9999999888887
Q ss_pred HHHHHcCC-CCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCc
Q 014347 226 YQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE 269 (426)
Q Consensus 226 ~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~ 269 (426)
...+..+. ...|..++..+.+|+.+||+.+|.+|||+.+++.+-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 246 FKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 77776543 455667889999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=328.39 Aligned_cols=252 Identities=34% Similarity=0.513 Sum_probs=212.3
Q ss_pred eeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEec
Q 014347 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (426)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey 95 (426)
|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+.+|+.+++.++|+|++++++++.+....|+|+||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 678899999999999999999999999999997654 2233356778899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccc
Q 014347 96 VTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH 174 (426)
Q Consensus 96 ~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 174 (426)
+. ++|.+.+.+. ..+++..++.++.|++.||.|||++||+||||+|+||++++++.+||+|||++...... .....
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~--~~~~~ 156 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP--LRTYT 156 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCC--ccccC
Confidence 97 4899999875 57999999999999999999999999999999999999999999999999998754321 11223
Q ss_pred cccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC------------------CCCC
Q 014347 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------------DFKL 236 (426)
Q Consensus 175 ~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------~~~~ 236 (426)
...++..|+|||.+......+.++|+||||+++|+|++|..||...+......++... ...+
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 3456788999999876645578999999999999999999999887765554443220 0011
Q ss_pred C-----------CCCCHHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 237 P-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 237 p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
+ +.++..+.++|++||+.||++||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1 1247789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=330.68 Aligned_cols=252 Identities=23% Similarity=0.338 Sum_probs=204.8
Q ss_pred CCCeeeeceEeecCceEEEEEEECC----------------CCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLD----------------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~----------------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI 76 (426)
.++|++.+.||+|+||.||++.+.. ++..||+|++.... .......+.+|+.+++.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 4689999999999999999986432 34579999986542 23345788999999999999999
Q ss_pred cceEEEEEeCCEEEEEEeccCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcE
Q 014347 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-----------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENI 145 (426)
Q Consensus 77 v~l~~~~~~~~~~~lV~Ey~~gg~L~~~i~~~~-----------~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NI 145 (426)
+++++++...+..|++|||+++++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999999999999999999999999999987532 366778999999999999999999999999999999
Q ss_pred EecCCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh--CCCCCCCCcHH
Q 014347 146 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT--GYLPFDDRNLA 223 (426)
Q Consensus 146 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt--G~~Pf~~~~~~ 223 (426)
|++.++.++|+|||++................+++.|+|||+.....+ +.++|||||||++|+|++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999875422111111223345678999998776655 689999999999999998 78999876655
Q ss_pred HHHHHHH--------cCCCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 224 VLYQKIF--------RGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 224 ~~~~~i~--------~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
....... ....+.|..+++.+.+|+.+||+.||++|||+.+|.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 4433221 1123445668899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=323.12 Aligned_cols=248 Identities=25% Similarity=0.397 Sum_probs=206.9
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
..++|++.+.||+|+||.||+|.+..+ ..+|+|.+..... ..+.+.+|+.+++.++|||++++++++. .+..|+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI 77 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence 457899999999999999999997654 4699998764432 2356888999999999999999999875 456899
Q ss_pred EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~--~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
+|||+.+++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~- 156 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE- 156 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc-
Confidence 99999999999999753 347899999999999999999999999999999999999999999999999987543211
Q ss_pred CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHHH
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 247 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 247 (426)
........++..|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.........+... ..+.|..++..+.++
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHEL 235 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHH
Confidence 111122345678999999876555 688999999999999999 99999988777776666554 345566789999999
Q ss_pred HHHccccCccCCCCHHHHhc
Q 014347 248 LRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 248 i~~~L~~dP~~R~t~~eil~ 267 (426)
+++||++||++||+++++++
T Consensus 236 i~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 236 MKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHccCCcccCcCHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=327.12 Aligned_cols=250 Identities=33% Similarity=0.463 Sum_probs=207.4
Q ss_pred eeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCccceEEEEEeCCE----
Q 014347 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL---KHPNVVRLHEVLASKSK---- 88 (426)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~---- 88 (426)
|++.+.||+|+||.||+|++..+++.||+|.+..... .......+.+|+.+++++ +|||++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 7899999999999999999988899999999975433 222344566788877766 59999999999988776
Q ss_pred -EEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 89 -IYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 89 -~~lV~Ey~~gg~L~~~i~~~~--~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
.|++|||+.+ +|.+++.... .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999975 8988887643 58999999999999999999999999999999999999999999999999987643
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC-----CC-----
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-----FK----- 235 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-----~~----- 235 (426)
. ........+++.|+|||++.+..+ +.++|+||+||++|+|++|.+||.+.+..+...++.... ..
T Consensus 159 ~---~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 159 F---EMALTSVVVTLWYRAPEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred C---CcccccccccccccChHHhccCCC-CCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 2 122234457889999999877665 688999999999999999999999887766665554310 00
Q ss_pred ------C-----------CCCCCHHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 236 ------L-----------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 236 ------~-----------p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
+ .+.+++.+.++|.+||+.||++||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 01245788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=325.43 Aligned_cols=253 Identities=32% Similarity=0.523 Sum_probs=214.5
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (426)
||.+.+.||+|+||.||++.+..++..+++|+++..... ......++.+|+.+++.++||||+++++.+.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 699999999999999999999888888888887643321 122345677899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 93 LEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~----~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
+||+++++|.+.+.. ...+++..++.++.|++.||.|||++|++|+||||+||+++. +.+||+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~-- 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG-- 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC--
Confidence 999999999988853 456999999999999999999999999999999999999975 5799999999875422
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHHHH
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNL 247 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~L 247 (426)
.........|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+......++..+. ...|..++.++.++
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGY-DSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHH
Confidence 1223334568899999999876665 578999999999999999999998877766666665553 34456688999999
Q ss_pred HHHccccCccCCCCHHHHhcCccc
Q 014347 248 LRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 248 i~~~L~~dP~~R~t~~eil~h~~f 271 (426)
|.+||+.||++||++.++++||||
T Consensus 237 i~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 237 MQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHhcCChhhCcCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=338.31 Aligned_cols=253 Identities=31% Similarity=0.438 Sum_probs=208.6
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC------
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------ 86 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------ 86 (426)
.++|.+.+.||+|+||.||+|.+..+|+.||+|.+.+... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 4799999999999999999999999999999999875432 223345688999999999999999999998654
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcc
Q 014347 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 166 (426)
..+|+|+||+.+ +|.+.+ ...+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 93 ~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred ceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 356999999964 776654 34689999999999999999999999999999999999999999999999999874321
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC--------------
Q 014347 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------- 232 (426)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------- 232 (426)
......+++.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+...
T Consensus 170 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 170 -----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred -----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 2234567899999999876444578899999999999999999999987655444333221
Q ss_pred ---------CCCCC--------CCCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 233 ---------DFKLP--------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 233 ---------~~~~p--------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
...++ +..++.+.+||.+||+.||.+|||+++++.||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 00111 2357789999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=334.49 Aligned_cols=259 Identities=31% Similarity=0.454 Sum_probs=211.9
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe-CCEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-KSKIY 90 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~ 90 (426)
.-++|++.+.||.|+||.||+|.+..+++.||+|.+.+... .......+.+|+.+++.++||||+++++++.. ....|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 34689999999999999999999999999999998865432 22335678899999999999999999999865 56789
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCC
Q 014347 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 170 (426)
+++||+ +++|.+.+.. .++++..+..++.|+++||.|||++||+||||+|.|||+++++.+||+|||++....
T Consensus 87 lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~----- 159 (328)
T cd07856 87 FVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD----- 159 (328)
T ss_pred EEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccC-----
Confidence 999998 5688877754 568999999999999999999999999999999999999999999999999987432
Q ss_pred CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHc-------------------
Q 014347 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR------------------- 231 (426)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~------------------- 231 (426)
.......+++.|+|||++.+....+.++||||+|+++|+|++|+.||...+....+..+.+
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 160 PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred CCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 1223456788999999976644457899999999999999999999987654322211110
Q ss_pred -------CCCCCC-----CCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccCCCC
Q 014347 232 -------GDFKLP-----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 278 (426)
Q Consensus 232 -------~~~~~p-----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~~ 278 (426)
.....| +.+++.+.++|++||+.+|++|||+++++.||||.....+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~ 298 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPT 298 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCc
Confidence 001111 24678999999999999999999999999999998765543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=335.19 Aligned_cols=259 Identities=26% Similarity=0.378 Sum_probs=209.2
Q ss_pred CeeeeceEeecCceEEEEEEECCC--CCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEe----CC
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDS--GLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS----KS 87 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~----~~ 87 (426)
+|++.+.||+|+||.||++++..+ +..||+|.+.... ........+.+|+.+++.+ .||||+++++.... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 589999999999999999999888 8999999986432 2223356778899999999 49999999987532 24
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
..|+++||+. ++|.+.+....++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 5789999985 699999988888999999999999999999999999999999999999999999999999999754321
Q ss_pred cC--CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC-------------
Q 014347 168 RD--DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------- 232 (426)
Q Consensus 168 ~~--~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------- 232 (426)
.. ........||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+...
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 11 112334578999999998766444468899999999999999999999876644333222210
Q ss_pred ---------------CCCC---CCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 233 ---------------DFKL---PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 233 ---------------~~~~---p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
...+ .+..++.+.+|+.+||+.||.+|||+.+++.||||.+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 0011 122578999999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=321.10 Aligned_cols=249 Identities=27% Similarity=0.407 Sum_probs=211.5
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
..++|++.+.||+|+||.||+|.+. .++.||+|.+...... .+.+.+|+.+++.++||||+++++++......|+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 4578999999999999999999975 5578999998754321 3568899999999999999999999999899999
Q ss_pred EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~--~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
+|||+++++|.+++... ..++...+..++.|++.||.|||++|++||||||+||++++++.+||+|||++.......
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE- 157 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh-
Confidence 99999999999999764 368999999999999999999999999999999999999999999999999987543211
Q ss_pred CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHHH
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 247 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 247 (426)
........++..|+|||.+.+..+ +.++|+||+|+++|+|++ |+.||.+.+......++..+ ..+.|...+..+.++
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDL 236 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 011112234568999999876655 688999999999999999 99999988777777777654 345566678999999
Q ss_pred HHHccccCccCCCCHHHHhc
Q 014347 248 LRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 248 i~~~L~~dP~~R~t~~eil~ 267 (426)
+.+||+.+|++||++.++.+
T Consensus 237 i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 237 MLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHcccCcccCCCHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=317.60 Aligned_cols=255 Identities=27% Similarity=0.417 Sum_probs=208.7
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEE-----e
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA-----S 85 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-----~ 85 (426)
+.-.||++.+.||+|+|+.||++++..+++.||+|.+.... .+..+...+|+...++++|||+++++++.. .
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 44569999999999999999999999999999999987654 345788999999999999999999987653 3
Q ss_pred CCEEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcC--ceeccCCCCcEEecCCCCeEEeecc
Q 014347 86 KSKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDSKGNIKISDFG 159 (426)
Q Consensus 86 ~~~~~lV~Ey~~gg~L~~~i~~----~~~l~~~~~~~i~~Ql~~aL~~LH~~g--IiHrDLKp~NILl~~~g~vkL~DFG 159 (426)
....|+++.|...|+|.+.|+. ...+++.++..||.++++||++||+.. ..||||||.|||+.+.+.++|.|||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEecc
Confidence 3459999999999999999975 236999999999999999999999998 9999999999999999999999999
Q ss_pred CccCCccccCCC----c---cccccCCCcccchhhhccC--CCCCCcchhhhHHHHHHHHHhCCCCCCCCcH--HHHHHH
Q 014347 160 LSALPQHFRDDG----L---LHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYVILTGYLPFDDRNL--AVLYQK 228 (426)
Q Consensus 160 la~~~~~~~~~~----~---~~~~~gt~~y~APE~l~~~--~~~~~~~DIwSlGvil~elltG~~Pf~~~~~--~~~~~~ 228 (426)
.++...-.-.+. . ...-..|..|+|||.+.-+ ...+.++|||||||+||+|+.|..||+..-. ..+.-.
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA 254 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA 254 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe
Confidence 987543211111 0 1112357889999997543 3347899999999999999999999964211 112223
Q ss_pred HHcCCCCCCCC--CCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 229 IFRGDFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 229 i~~~~~~~p~~--~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
+.++.+.+|.. +|..+.+||+.||++||.+||++.+++.+
T Consensus 255 v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 255 VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 44556666644 89999999999999999999999999875
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=321.70 Aligned_cols=243 Identities=26% Similarity=0.390 Sum_probs=202.3
Q ss_pred eEeecCceEEEEEEEC--CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEeccCC
Q 014347 21 TLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 21 ~LG~G~fg~Vy~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~g 98 (426)
.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.++++++||||+++++++. ....++||||++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 4899999999999765 445679999986542 2344567899999999999999999999875 4578999999999
Q ss_pred CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCC-ccccc
Q 014347 99 GELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG-LLHTT 176 (426)
Q Consensus 99 g~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~-~~~~~ 176 (426)
++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++.......... .....
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 999999874 4579999999999999999999999999999999999999999999999999987543211110 11112
Q ss_pred cCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHcccc
Q 014347 177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEP 254 (426)
Q Consensus 177 ~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~ 254 (426)
.+++.|+|||.+....+ +.++|||||||++|+|++ |..||.+.........+..+ ...+|...++++.+++.+||..
T Consensus 159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~ 237 (257)
T cd05115 159 KWPLKWYAPECINFRKF-SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY 237 (257)
T ss_pred CCCcccCCHHHHccCCC-CchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 33578999999876665 688999999999999996 99999988777776666654 4567788899999999999999
Q ss_pred CccCCCCHHHHhc
Q 014347 255 NPVKRITIAGIKA 267 (426)
Q Consensus 255 dP~~R~t~~eil~ 267 (426)
||++||++.+|.+
T Consensus 238 ~~~~Rp~~~~i~~ 250 (257)
T cd05115 238 KWEDRPNFAKVEE 250 (257)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=327.46 Aligned_cols=252 Identities=33% Similarity=0.496 Sum_probs=211.6
Q ss_pred eeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEec
Q 014347 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (426)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey 95 (426)
|++.+.||+|++|.||+|.+..+|+.+|+|.+...... ......+.+|+.+++.++||||+++++++..++..|+++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 67889999999999999999999999999998754432 23456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccc
Q 014347 96 VTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH 174 (426)
Q Consensus 96 ~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 174 (426)
+.+ +|.+.+.. ...+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||.+....... ....
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~ 156 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYT 156 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cccc
Confidence 975 88888766 4689999999999999999999999999999999999999999999999999987543211 1223
Q ss_pred cccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC-------------------CCC
Q 014347 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------------DFK 235 (426)
Q Consensus 175 ~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------------~~~ 235 (426)
...++..|+|||.+.+....+.++|+||+|+++|+|++|+.||...+..+...++... ...
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence 3457889999999876644578999999999999999999999887765554443221 000
Q ss_pred C-----------CCCCCHHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 236 L-----------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 236 ~-----------p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
+ .+.++..+.++|.+||++||.+||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 1 12367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=324.77 Aligned_cols=253 Identities=22% Similarity=0.308 Sum_probs=210.6
Q ss_pred cCCCeeeeceEeecCceEEEEEEECC----CCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe-C
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLD----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-K 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~ 86 (426)
.-++|++.+.||+|+||.||+|.+.. ++..|++|.+.... .......+.+|+.+++.++||||+++++++.. +
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 34689999999999999999999876 36789999886432 34446778999999999999999999998765 5
Q ss_pred CEEEEEEeccCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeec
Q 014347 87 SKIYMVLEYVTGGELFDKIASK--------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDF 158 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~--------~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DF 158 (426)
...++++||+++++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||++++++.+||+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence 7789999999999999998653 45899999999999999999999999999999999999999999999999
Q ss_pred cCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCC
Q 014347 159 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKL 236 (426)
Q Consensus 159 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~ 236 (426)
|+++...............++..|+|||++.+..+ +.++||||||+++|++++ |+.||...+...+...+..+ .+..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 240 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY-SSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQ 240 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCC-CchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCC
Confidence 99975422111111122345678999999877665 688999999999999999 99999988777766665554 2344
Q ss_pred CCCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 237 PKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 237 p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
+..+++.+.+++.+||..||++|||+.++++
T Consensus 241 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 241 PINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 5567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=321.44 Aligned_cols=248 Identities=27% Similarity=0.427 Sum_probs=207.9
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
.-++|+++++||+|+||.||+|.+ .+++.||+|.+...... ...+.+|+.++++++||||+++++++. .+..|+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI 77 (260)
T ss_pred chHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence 346899999999999999999986 45778999998754432 357889999999999999999999874 567899
Q ss_pred EEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 92 VLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~--~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
+|||+.+++|.+++.. ...+++.++..++.|++.||+|||++|++||||||+||+++.++.++|+|||++...... .
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~-~ 156 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN-E 156 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC-C
Confidence 9999999999999865 346899999999999999999999999999999999999999999999999998754311 1
Q ss_pred CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHHH
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 247 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 247 (426)
........++..|+|||++....+ +.++||||||+++|+|++ |+.||.+.+.......+..+ ..+.+...+.++.++
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYEL 235 (260)
T ss_pred cccccCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 111122345678999999876655 688999999999999999 99999988777666665544 345566688999999
Q ss_pred HHHccccCccCCCCHHHHhc
Q 014347 248 LRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 248 i~~~L~~dP~~R~t~~eil~ 267 (426)
+.+||+.+|++|||+++++.
T Consensus 236 i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 236 MRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHccCChhhCCCHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=318.79 Aligned_cols=244 Identities=27% Similarity=0.382 Sum_probs=206.8
Q ss_pred ceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEeccCCC
Q 014347 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG 99 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~gg 99 (426)
+.||+|+||.||+|.+.. ++.||+|.+...... .....+.+|+.+++.++||||+++++++.+....|+||||+.|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 479999999999999877 999999988755432 34578899999999999999999999999999999999999999
Q ss_pred ChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccC
Q 014347 100 ELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (426)
Q Consensus 100 ~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~g 178 (426)
+|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++................+
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 99999965 45689999999999999999999999999999999999999999999999999875432111111112234
Q ss_pred CCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHccccCc
Q 014347 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNP 256 (426)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP 256 (426)
+..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...........+... ....|..++..+.+++.+||..+|
T Consensus 158 ~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence 567999999876655 689999999999999999 89999887776666666544 345566789999999999999999
Q ss_pred cCCCCHHHHhc
Q 014347 257 VKRITIAGIKA 267 (426)
Q Consensus 257 ~~R~t~~eil~ 267 (426)
++|||+.++++
T Consensus 237 ~~Rp~~~ell~ 247 (251)
T cd05041 237 ENRPSFSEIYN 247 (251)
T ss_pred hhCcCHHHHHH
Confidence 99999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=324.25 Aligned_cols=253 Identities=26% Similarity=0.390 Sum_probs=213.2
Q ss_pred cCCCeeeeceEeecCceEEEEEEECC-----CCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (426)
..++|++++.||+|+||.||+|+... +.+.||+|.+.... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 34689999999999999999999754 34679999886533 223467799999999999999999999999998
Q ss_pred CEEEEEEeccCCCChHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEee
Q 014347 87 SKIYMVLEYVTGGELFDKIASKG---------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISD 157 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~~---------~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~D 157 (426)
...|+||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++++|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999999998655 689999999999999999999999999999999999999999999999
Q ss_pred ccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcCCC--
Q 014347 158 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDF-- 234 (426)
Q Consensus 158 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~-- 234 (426)
||++...... .........+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.........+..+..
T Consensus 161 ~~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd05046 161 LSLSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDF-STKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL 238 (275)
T ss_pred cccccccCcc-cccccCCceeEEeecChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence 9998643211 1112233456778999999876665 588999999999999999 8999988776666666665553
Q ss_pred CCCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 235 KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 235 ~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
..+..++..+.+++.+||+.||.+|||+.+++.+
T Consensus 239 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 239 PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 3355688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=324.56 Aligned_cols=251 Identities=29% Similarity=0.374 Sum_probs=200.8
Q ss_pred CCCe-eeeceEeecCceEEEEEE----ECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe--
Q 014347 13 LGRY-ELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-- 85 (426)
Q Consensus 13 ~~~y-~i~~~LG~G~fg~Vy~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-- 85 (426)
.+|| ++.+.||+|+||.||++. ...+++.||+|++..... ......+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQG 79 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 3567 999999999999998765 345788999999875432 2235678899999999999999999998765
Q ss_pred CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 86 ~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
....|++|||+++++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||+++++.+||+|||++....
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccC
Confidence 3468999999999999999876 469999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCC-ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHH--H-------------HHHHH
Q 014347 166 HFRDDG-LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA--V-------------LYQKI 229 (426)
Q Consensus 166 ~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~--~-------------~~~~i 229 (426)
...... ......++..|+|||.+....+ +.++||||||+++|+|++|..||...... . .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCC-CcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence 211111 1122345677999999876655 68999999999999999999998653311 0 00111
Q ss_pred Hc-CCCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 230 FR-GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 230 ~~-~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
.. ...+.|..++..+.+++.+||++||++|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11 122345667899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=326.45 Aligned_cols=250 Identities=30% Similarity=0.482 Sum_probs=208.0
Q ss_pred eeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCCEEEEEEe
Q 014347 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E 94 (426)
|++.+.||+|+||.||+|.+..+++.||+|.+...... . ......+|+..+++++ ||||+++++++..++..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-W-EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-h-hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 78899999999999999999889999999988654321 1 1234557999999999 9999999999999999999999
Q ss_pred ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 95 YVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 95 y~~gg~L~~~i~~~~--~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
|+ +|+|.+.+.... .+++..+..++.|++.+|.|||++|++|+||+|+||++++++.++|+|||++..... ...
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~---~~~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS---RPP 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccC---CCC
Confidence 99 789999887754 789999999999999999999999999999999999999999999999999875432 122
Q ss_pred cccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC-------------------C
Q 014347 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------------D 233 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------------~ 233 (426)
.....++..|+|||++......+.++|+||||+++|+|++|+.||...+....+.++... .
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 234568899999999865554578999999999999999999999877655444333211 0
Q ss_pred CCC-----------CCCCCHHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 234 FKL-----------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 234 ~~~-----------p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
... .+..++.+.+||++||+.||++|||+.|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 000 11236789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=321.32 Aligned_cols=252 Identities=23% Similarity=0.362 Sum_probs=210.6
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCC---eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
.++|+..+.||+|+||.||+|.+..++. .+|+|.+.... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 4578999999999999999999876655 69999886442 233356788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
|+||||+++++|.+++.. .+.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 999999999999999875 4678999999999999999999999999999999999999999999999999987543221
Q ss_pred CCCcc-ccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHH
Q 014347 169 DDGLL-HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ 245 (426)
Q Consensus 169 ~~~~~-~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 245 (426)
..... .....++.|+|||++....+ +.++|||||||++|+|++ |+.||...+.......+... ..+.+..++..+.
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 240 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY 240 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCc-ChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 11111 11123457999999877665 688999999999999998 99999887777777666554 2334455789999
Q ss_pred HHHHHccccCccCCCCHHHHhc
Q 014347 246 NLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~eil~ 267 (426)
+++.+||+.+|++||++.++++
T Consensus 241 ~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 241 QLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=326.00 Aligned_cols=239 Identities=23% Similarity=0.299 Sum_probs=199.8
Q ss_pred ceEeecCceEEEEEEECCCCC-------eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 014347 20 RTLGEGNFGKVKFAQDLDSGL-------PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~-------~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (426)
+.||+|+||.||+|.+..++. .||+|.+.... ....+.+.+|+.+++.++||||+++++++..+...++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 469999999999999865544 48888875432 33456788899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCC--------eEEeeccCccC
Q 014347 93 LEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN--------IKISDFGLSAL 163 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~~~-~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~--------vkL~DFGla~~ 163 (426)
|||+.+|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++. ++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999999997644 5899999999999999999999999999999999999987765 69999998864
Q ss_pred CccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhC-CCCCCCCcHHHHHHHHHcCCCCCCCCCCH
Q 014347 164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLAVLYQKIFRGDFKLPKWLSP 242 (426)
Q Consensus 164 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 242 (426)
.. ......+++.|+|||++.+....+.++||||||+++|+|++| ..||...+..... ........+|...++
T Consensus 158 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 230 (258)
T cd05078 158 VL------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYEDRHQLPAPKWT 230 (258)
T ss_pred cC------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHHHccccCCCCCcH
Confidence 32 123456889999999988755557889999999999999998 5777665554332 234445667777788
Q ss_pred HHHHHHHHccccCccCCCCHHHHhcC
Q 014347 243 GAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
.+.+|+.+||+.||++|||+++|++.
T Consensus 231 ~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 231 ELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHh
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=322.91 Aligned_cols=242 Identities=29% Similarity=0.433 Sum_probs=202.2
Q ss_pred ceEeecCceEEEEEEECCCCC--eEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEEEEEEecc
Q 014347 20 RTLGEGNFGKVKFAQDLDSGL--PFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYV 96 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~Ey~ 96 (426)
+.||+|+||.||+|.+..++. .+|+|.+.... .....+.+.+|+.++.++ +||||+++++++...+..|++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 468999999999999988776 46888775322 233456788999999999 7999999999999999999999999
Q ss_pred CCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccC
Q 014347 97 TGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL 160 (426)
Q Consensus 97 ~gg~L~~~i~~~~----------------~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGl 160 (426)
++|+|.+++.... .+++..++.++.|++.||+|||++|++||||||+|||+++++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999997532 478999999999999999999999999999999999999999999999999
Q ss_pred ccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCC
Q 014347 161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPK 238 (426)
Q Consensus 161 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~ 238 (426)
+....... .......+..|+|||++....+ +.++|||||||++|+|++ |..||.+.+....+..+... ....+.
T Consensus 159 ~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 234 (270)
T cd05047 159 SRGQEVYV---KKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 234 (270)
T ss_pred ccccchhh---hccCCCCccccCChHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCC
Confidence 86322110 1111234567999999876655 688999999999999997 99999888777777766554 344566
Q ss_pred CCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 239 WLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 239 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
.++.++.+|+.+||..||.+|||+.+++.
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 235 NCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred cCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 68899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=317.68 Aligned_cols=248 Identities=28% Similarity=0.431 Sum_probs=211.8
Q ss_pred eeeeceEeecCceEEEEEEECCCC----CeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 16 YELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
+++.+.||.|+||.||++.+...+ ..||+|.+..... ......+.+|+..++.++|+||+++++++.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 467899999999999999998766 8999999865432 2246789999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 92 VLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~~~--l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
+|||++|++|.+.+..... +++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999999976444 99999999999999999999999999999999999999999999999999875433211
Q ss_pred CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHHHH
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNL 247 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~L 247 (426)
.. .....+++.|+|||.+....+ +.++|+||||+++|+|++ |..||...+.....+.+.... ...+...+..+.++
T Consensus 159 ~~-~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (258)
T smart00219 159 YK-KKGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKL 236 (258)
T ss_pred cc-cccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHH
Confidence 11 111236789999999865544 689999999999999998 899999888777777776553 45566789999999
Q ss_pred HHHccccCccCCCCHHHHhc
Q 014347 248 LRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 248 i~~~L~~dP~~R~t~~eil~ 267 (426)
+.+||..||++|||+.++++
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 237 MLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHCcCChhhCcCHHHHHh
Confidence 99999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=319.30 Aligned_cols=244 Identities=29% Similarity=0.457 Sum_probs=206.2
Q ss_pred ceEeecCceEEEEEEECC-CCC--eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEecc
Q 014347 20 RTLGEGNFGKVKFAQDLD-SGL--PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYV 96 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~-~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~ 96 (426)
+.||+|++|.||+|.+.. +++ .||+|.+...... ...+.+.+|+.++++++||||+++++++.. ...+++|||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999765 333 6999999765543 557789999999999999999999999988 8899999999
Q ss_pred CCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCC-Ccc
Q 014347 97 TGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD-GLL 173 (426)
Q Consensus 97 ~gg~L~~~i~~~~--~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~-~~~ 173 (426)
++++|.+.+.+.. .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......... ...
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 9999999998754 6899999999999999999999999999999999999999999999999998864331111 111
Q ss_pred ccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC--CCCCCCCCCHHHHHHHHH
Q 014347 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRK 250 (426)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~ 250 (426)
....++..|+|||.+....+ +.++|||||||++|+|++ |..||...+..+....+... ....|...+..+.+++.+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTF-SHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred cCCCCCceecCHHHhcccCc-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 23457789999999877665 688999999999999999 99999887777766666532 234455678999999999
Q ss_pred ccccCccCCCCHHHHhc
Q 014347 251 ILEPNPVKRITIAGIKA 267 (426)
Q Consensus 251 ~L~~dP~~R~t~~eil~ 267 (426)
||+.+|++|||+.++++
T Consensus 237 ~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 237 CWAHNPADRPTFAALRE 253 (257)
T ss_pred HCCCCcccCCCHHHHHH
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=325.49 Aligned_cols=260 Identities=23% Similarity=0.361 Sum_probs=211.3
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCC
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKS 87 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 87 (426)
....+++|++.+.||+|+||.||+|.+..+++.||+|.+.+... ......+.+|+.++.... ||||+++++++.+..
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 87 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS 87 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence 35677899999999999999999999998899999999975432 222455666777666664 999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhh-cCceeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 88 KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~-~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
..|++|||+. +.|.+.+.. .+.+++..+..++.|++.||.|||+ .||+||||+|+||++++++.+||+|||++....
T Consensus 88 ~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 88 DVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 9999999985 477776655 4679999999999999999999997 599999999999999999999999999987532
Q ss_pred cccCCCccccccCCCcccchhhhccCC---CCCCcchhhhHHHHHHHHHhCCCCCCCCcH-HHHHHHHHcCC-CCCC--C
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLANRG---YDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRGD-FKLP--K 238 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~---~~~~~~DIwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~-~~~p--~ 238 (426)
. ........+++.|+|||.+.+.. ..+.++||||||+++|+|++|+.||..... ......+.... ...+ .
T Consensus 167 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (296)
T cd06618 167 D---SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNE 243 (296)
T ss_pred C---CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCC
Confidence 2 11223345788999999986542 236789999999999999999999976432 33444444433 2223 2
Q ss_pred CCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 239 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 239 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
.++.++.+|+.+||+.||.+|||+.+++.|+||...
T Consensus 244 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 244 GFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 368899999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=317.65 Aligned_cols=249 Identities=24% Similarity=0.420 Sum_probs=210.6
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (426)
.++|++.+.||+|+||.||+|.+. ++..+|+|.+...... ...+.+|+.+++.++|||++++++++......|++
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 457999999999999999999875 4778999988654332 35688899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCC
Q 014347 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 171 (426)
|||+.+++|.+++.. .+.+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++....... ..
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~ 156 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YT 156 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc-cc
Confidence 999999999999875 3568999999999999999999999999999999999999999999999999987432210 11
Q ss_pred ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHHHHH
Q 014347 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLR 249 (426)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~ 249 (426)
......++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...+.......+..+ ....|...+..+.+|+.
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKY-SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQ 235 (256)
T ss_pred ccCCCccchhhcCHhHhccCCc-ChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence 1112335578999999876665 688999999999999998 99999988877777776654 33445667899999999
Q ss_pred HccccCccCCCCHHHHhcC
Q 014347 250 KILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 250 ~~L~~dP~~R~t~~eil~h 268 (426)
+||+.+|++|||+.+++++
T Consensus 236 ~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 236 HCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHcccChhhCCCHHHHHHh
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=315.19 Aligned_cols=244 Identities=26% Similarity=0.424 Sum_probs=204.6
Q ss_pred ceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEeccCCC
Q 014347 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG 99 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~gg 99 (426)
+.||+|+||.||+|.. .++..+|+|.+.... .......+.+|+.+++.++||||+++++++...+..++||||++|+
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 4689999999999986 468899999886543 2333457889999999999999999999999999999999999999
Q ss_pred ChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccC
Q 014347 100 ELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178 (426)
Q Consensus 100 ~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~g 178 (426)
+|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... .........+
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~ 156 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG-IYSSSGLKQI 156 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccc-ccccCCCCCC
Confidence 99999875 346899999999999999999999999999999999999999999999999998643211 0111112244
Q ss_pred CCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHccccCc
Q 014347 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNP 256 (426)
Q Consensus 179 t~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP 256 (426)
++.|+|||++....+ +.++||||+|+++|++++ |..||.+.+.......+... ....|..+++.+.+++.+||+.+|
T Consensus 157 ~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (250)
T cd05085 157 PIKWTAPEALNYGRY-SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKP 235 (250)
T ss_pred cccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCc
Confidence 677999999876655 688999999999999998 99999988777666666554 345567789999999999999999
Q ss_pred cCCCCHHHHhcC
Q 014347 257 VKRITIAGIKAD 268 (426)
Q Consensus 257 ~~R~t~~eil~h 268 (426)
++|||+.++++.
T Consensus 236 ~~Rp~~~~l~~~ 247 (250)
T cd05085 236 ENRPKFSELQKE 247 (250)
T ss_pred ccCCCHHHHHHH
Confidence 999999998753
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=329.98 Aligned_cols=255 Identities=21% Similarity=0.347 Sum_probs=201.1
Q ss_pred eeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEeccC
Q 014347 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (426)
Q Consensus 18 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~ 97 (426)
+++.+|. +|.||.+++..+++.||+|++..... .......+.+|+.+++.++||||+++++++......|++|||++
T Consensus 6 i~~~~~~--~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 6 IGKCFED--LMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhHhhcC--CceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 4444444 45566666667999999999976532 33456789999999999999999999999999999999999999
Q ss_pred CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC-----C
Q 014347 98 GGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-----D 170 (426)
Q Consensus 98 gg~L~~~i~~~--~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-----~ 170 (426)
+++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.+|.+||+|||.+........ .
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 99999999753 4689999999999999999999999999999999999999999999999998864321111 1
Q ss_pred CccccccCCCcccchhhhccC-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC---------------
Q 014347 171 GLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF--------------- 234 (426)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--------------- 234 (426)
.......++..|+|||++... ...+.++|+||+||++|+|++|+.||.+............+..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDS 242 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCC
Confidence 112334577899999998653 2236889999999999999999999987654333221111110
Q ss_pred -------------------CCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 235 -------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 235 -------------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
..+..+++++.+|+.+||+.||++|||+.++++||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 01112456789999999999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=320.43 Aligned_cols=229 Identities=28% Similarity=0.446 Sum_probs=195.1
Q ss_pred cCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEeccCCCChHHH
Q 014347 25 GNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDK 104 (426)
Q Consensus 25 G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~gg~L~~~ 104 (426)
|+||+||+|++..+++.||+|.+.+.. ...+|...+....||||+++++++.+....|++|||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 899999999999999999999987543 223445555556799999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccCCCcccc
Q 014347 105 IASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184 (426)
Q Consensus 105 i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~A 184 (426)
+.+..++++..+..++.|+++||.|||++||+||||||+||+++.++.++++|||.+..... ......++..|+|
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~-----~~~~~~~~~~y~a 150 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-----SCDGEAVENMYCA 150 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc-----ccccCCcCccccC
Confidence 98877899999999999999999999999999999999999999999999999998764322 1233456788999
Q ss_pred hhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccccCccCCCCH--
Q 014347 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI-- 262 (426)
Q Consensus 185 PE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~-- 262 (426)
||.+....+ +.++|+||+|+++|+|++|+.||....... .......+|.++++.+.+||.+||+.||++|||+
T Consensus 151 PE~~~~~~~-~~~~DvwslG~il~el~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 151 PEVGGISEE-TEACDWWSLGAILFELLTGKTLVECHPSGI----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred CcccCCCCC-CchhhHHHHHHHHHHHHHCcchhhcCchhc----ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence 999876655 688999999999999999999886532210 0112346788899999999999999999999996
Q ss_pred ---HHHhcCccc
Q 014347 263 ---AGIKADEWF 271 (426)
Q Consensus 263 ---~eil~h~~f 271 (426)
++++.||||
T Consensus 226 ~~~~~~~~h~~~ 237 (237)
T cd05576 226 AGVEDIKSHPFF 237 (237)
T ss_pred cchHHHHcCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=319.91 Aligned_cols=252 Identities=26% Similarity=0.403 Sum_probs=209.0
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCC---CCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (426)
...+|.+.+.||+|+||.||+|.+... ...||+|...... .....+.+.+|+.+++.++||||+++++++.+ ..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 345799999999999999999987544 3468999875432 23446788999999999999999999999875 45
Q ss_pred EEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 89 IYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~-~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
.|++|||+++++|.+++.+.. .+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 789999999999999997643 5899999999999999999999999999999999999999999999999998753321
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHH
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ 245 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 245 (426)
.. .......+++.|+|||.+....+ +.++||||||+++|+|++ |..||.+.+.......+..+ ....|..+++.+.
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (270)
T cd05056 161 SY-YKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 238 (270)
T ss_pred cc-eecCCCCccccccChhhhccCCC-CchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHH
Confidence 10 01112234568999999876665 688999999999999996 99999988777666666554 3566777899999
Q ss_pred HHHHHccccCccCCCCHHHHhcC
Q 014347 246 NLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~eil~h 268 (426)
+++.+||..+|++|||+.+++..
T Consensus 239 ~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 239 SLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=343.75 Aligned_cols=238 Identities=26% Similarity=0.422 Sum_probs=207.1
Q ss_pred eeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEec
Q 014347 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (426)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey 95 (426)
..-++-||.|+.|.||+|+- .++.||||.++.- -+.+|.-|+.|+||||+.+.++|.....++|||||
T Consensus 126 IsELeWlGSGaQGAVF~Grl--~netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEf 193 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRL--HNETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEF 193 (904)
T ss_pred hhhhhhhccCcccceeeeec--cCceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeec
Confidence 34467799999999999984 5788999976421 23578999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcccc
Q 014347 96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT 175 (426)
Q Consensus 96 ~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 175 (426)
|..|.|...++...++.......|..+|+.|+.|||.+.|||||||.-||||..+..+||+|||-++... +......
T Consensus 194 Ca~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~---~~STkMS 270 (904)
T KOG4721|consen 194 CAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELS---DKSTKMS 270 (904)
T ss_pred cccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhh---hhhhhhh
Confidence 9999999999999999999999999999999999999999999999999999999999999999887432 2244557
Q ss_pred ccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHccc
Q 014347 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILE 253 (426)
Q Consensus 176 ~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~~L~ 253 (426)
++||..|||||++.+.+. +.|+|||||||||||||||..||.+-+...+..-+-.. .++.|..++..++-||+.||+
T Consensus 271 FaGTVaWMAPEvIrnePc-sEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~ 349 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPC-SEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWN 349 (904)
T ss_pred hhhhHhhhCHHHhhcCCc-ccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHh
Confidence 899999999999987665 79999999999999999999999886654433222222 356788999999999999999
Q ss_pred cCccCCCCHHHHhcCc
Q 014347 254 PNPVKRITIAGIKADE 269 (426)
Q Consensus 254 ~dP~~R~t~~eil~h~ 269 (426)
-.|..||++.+|+.|-
T Consensus 350 sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 350 SKPRNRPSFRQILLHL 365 (904)
T ss_pred cCCCCCccHHHHHHHH
Confidence 9999999999999983
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=320.07 Aligned_cols=245 Identities=23% Similarity=0.306 Sum_probs=193.2
Q ss_pred ceEeecCceEEEEEEECC--CCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEeccC
Q 014347 20 RTLGEGNFGKVKFAQDLD--SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~ 97 (426)
+.||+|+||.||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+......|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 469999999999996432 34568888765432 23335678899999999999999999999999999999999999
Q ss_pred CCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 98 GGELFDKIASKG-----RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 98 gg~L~~~i~~~~-----~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
+|+|.+++.... ..++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999999997633 246788899999999999999999999999999999999999999999999864321111111
Q ss_pred cccccCCCcccchhhhccC------CCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHc-CCCC-----CCCC
Q 014347 173 LHTTCGSPNYVAPEVLANR------GYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFR-GDFK-----LPKW 239 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~------~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~-~~~~-----~p~~ 239 (426)
.....+++.|+|||++... ...+.++|||||||++|+|++ |..||..........+... .... .+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 1233467789999997532 233678999999999999999 8999987765554444433 3222 2335
Q ss_pred CCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 240 LSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 240 ~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
+++.+.+++..|+ .||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 7888999999998 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=323.76 Aligned_cols=238 Identities=25% Similarity=0.320 Sum_probs=195.2
Q ss_pred eEeecCceEEEEEEECCC------------------------CCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc
Q 014347 21 TLGEGNFGKVKFAQDLDS------------------------GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76 (426)
Q Consensus 21 ~LG~G~fg~Vy~a~~~~~------------------------~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI 76 (426)
.||+|+||.||+|....+ ...||+|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 699999999999974321 2358899886432 2334678889999999999999
Q ss_pred cceEEEEEeCCEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCC----
Q 014347 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---- 151 (426)
Q Consensus 77 v~l~~~~~~~~~~~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g---- 151 (426)
+++++++......|+||||+++|+|.+.+.. .+.+++..+..++.|++.||+|||++||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999998865 56789999999999999999999999999999999999998654
Q ss_pred ---CeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHH-hCCCCCCCCcHHHHHH
Q 014347 152 ---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL-TGYLPFDDRNLAVLYQ 227 (426)
Q Consensus 152 ---~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ell-tG~~Pf~~~~~~~~~~ 227 (426)
.+|++|||++..... .....+++.|+|||.+.+....+.++|||||||++|+|+ +|..||.+.......
T Consensus 159 ~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~- 231 (274)
T cd05076 159 TSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE- 231 (274)
T ss_pred ccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH-
Confidence 389999998763211 123457888999999876554578999999999999985 699999876654432
Q ss_pred HHHcCCCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 228 KIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 228 ~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
.........|...++.+.++|.+||+.+|++|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 232 RFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 23334445566667899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=319.54 Aligned_cols=239 Identities=23% Similarity=0.301 Sum_probs=195.7
Q ss_pred ceEeecCceEEEEEEECC------------CCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 014347 20 RTLGEGNFGKVKFAQDLD------------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~------------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (426)
+.||+|+||.||+|+... ....||+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 468999999999998432 23358889875432 334567888999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCC-------eEEeecc
Q 014347 88 KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN-------IKISDFG 159 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~-------vkL~DFG 159 (426)
..+++|||+++++|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +|++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999999888875 456999999999999999999999999999999999999987664 8999999
Q ss_pred CccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHH-hCCCCCCCCcHHHHHHHHHcCCCCCCC
Q 014347 160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL-TGYLPFDDRNLAVLYQKIFRGDFKLPK 238 (426)
Q Consensus 160 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ell-tG~~Pf~~~~~~~~~~~i~~~~~~~p~ 238 (426)
++..... .....++..|+|||.+......+.++|||||||++|+|+ .|..||......... ...........
T Consensus 158 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~ 230 (262)
T cd05077 158 IPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLVT 230 (262)
T ss_pred CCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCCC
Confidence 9864321 123467889999999875555578899999999999998 599999876654432 23334444444
Q ss_pred CCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 239 WLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 239 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
..++++.+|+.+||+.||.+||++.+|+.+
T Consensus 231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 231 PSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=325.53 Aligned_cols=254 Identities=24% Similarity=0.350 Sum_probs=208.4
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCC----eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGL----PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (426)
...++|+..+.||+|+||.||+|.+..+|+ .||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 345789999999999999999999887776 46888875433 223345688999999999999999999998654
Q ss_pred CEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 87 SKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
..++++||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence 467899999999999998764 368999999999999999999999999999999999999999999999999998543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHH
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPG 243 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 243 (426)
............++..|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.........+..+ .++.+...+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKF-THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTID 239 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCC-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHH
Confidence 2211112223456778999999876665 688999999999999998 99999887655554444433 24445667899
Q ss_pred HHHHHHHccccCccCCCCHHHHhcC
Q 014347 244 AQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
+.+++.+||..+|++||++.++++.
T Consensus 240 ~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 240 VYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=316.43 Aligned_cols=242 Identities=27% Similarity=0.486 Sum_probs=205.5
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
.+++|++.+.||+|+||.||++. .+++.||+|.+.... ....+.+|+.+++.++|||++++++++... ..|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 45789999999999999999986 478889999986432 245788999999999999999999998654 4799
Q ss_pred EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 92 VLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~~--~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
+|||++|++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~--- 152 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM--- 152 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccc---
Confidence 999999999999997643 589999999999999999999999999999999999999999999999999874321
Q ss_pred CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHHHH
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNL 247 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~L 247 (426)
.......+..|+|||.+.+..+ +.++|+||||+++|+|++ |+.||...+.......+.++. ...+..+++.+.++
T Consensus 153 --~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (254)
T cd05083 153 --GVDNSKLPVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVL 229 (254)
T ss_pred --cCCCCCCCceecCHHHhccCCc-CchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHH
Confidence 1122334568999999876655 688999999999999998 999999888777766665542 34455688999999
Q ss_pred HHHccccCccCCCCHHHHhc
Q 014347 248 LRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 248 i~~~L~~dP~~R~t~~eil~ 267 (426)
+.+||+.+|++|||+++++.
T Consensus 230 i~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 230 MTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=344.36 Aligned_cols=252 Identities=25% Similarity=0.393 Sum_probs=215.4
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (426)
...+...++..||+|.||+||+|++-. .||||+++...... +..+.|++|+.+++.-+|.||+-+.|++..+.. .
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A 463 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A 463 (678)
T ss_pred cCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence 344566789999999999999999744 49999998776544 478999999999999999999999999988776 9
Q ss_pred EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
||+.+|+|-+|+.++.- ..+|.....+.|++|++.|+.|||.++|||||||..||++.+++.|||+||||+........
T Consensus 464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 99999999999999864 45789999999999999999999999999999999999999999999999999987665545
Q ss_pred CCccccccCCCcccchhhhcc--CCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCC-----CCCCCCH
Q 014347 170 DGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-----LPKWLSP 242 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s~ 242 (426)
...+...-|...|||||++.. ...+++.+||||||||+|||+||.+||...+.+.+.-.+-+|... .-..++.
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk 623 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPK 623 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHH
Confidence 555666778899999999853 233478999999999999999999999987776665555555221 1234677
Q ss_pred HHHHHHHHccccCccCCCCHHHHhc
Q 014347 243 GAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
++++|+..||..++++||++.+||.
T Consensus 624 ~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 624 AMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHHhcCcccCccHHHHHH
Confidence 9999999999999999999999986
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=320.04 Aligned_cols=245 Identities=27% Similarity=0.393 Sum_probs=203.4
Q ss_pred ceEeecCceEEEEEEECCCC------CeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 20 RTLGEGNFGKVKFAQDLDSG------LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~------~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
+.||+|+||.||+|++...+ +.+|+|.+.+... ......+.+|+.+++.++||||+++++++......|++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 46899999999999976544 6899998864321 223567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCC-----CeEEeeccCc
Q 014347 94 EYVTGGELFDKIASK-------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-----NIKISDFGLS 161 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~-------~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g-----~vkL~DFGla 161 (426)
||++|++|.+++... ..+++..+..++.|++.||.|||+++++|+||||+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999998642 3478899999999999999999999999999999999999887 8999999998
Q ss_pred cCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCC
Q 014347 162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKW 239 (426)
Q Consensus 162 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~ 239 (426)
................++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+ .+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN 237 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence 74322111111223356788999999877665 689999999999999998 99999887766666665443 4556677
Q ss_pred CCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 240 LSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 240 ~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
+++.+.+||.+||.++|.+||++.++++
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 238 CPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred chHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 8999999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=341.51 Aligned_cols=251 Identities=28% Similarity=0.433 Sum_probs=215.8
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCC---e-EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGL---P-FAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~-vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (426)
.++-.+.++||+|+||+||+|+-+..+. . ||+|..........+....+.+|+++|+.++|||||++||+......
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3455667999999999999998664322 3 89999876454556678899999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 89 IYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~-~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
+|+|||+|.||+|.+++++.+ .++..+...++.+.+.||+|||+++++||||-..|+|++.++.+||+|||+++.-...
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~ 315 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY 315 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcce
Confidence 999999999999999999876 4999999999999999999999999999999999999999999999999999853211
Q ss_pred cCCCcccccc-CCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcCC--CCCCCCCCHH
Q 014347 168 RDDGLLHTTC-GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD--FKLPKWLSPG 243 (426)
Q Consensus 168 ~~~~~~~~~~-gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~ 243 (426)
. .....+ -...|+|||.+...-| +.++||||+||++||+++ |..||.+........++.... .+.|...+..
T Consensus 316 ~---~~~~~~klPirWLAPEtl~~~~~-s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~ 391 (474)
T KOG0194|consen 316 V---MKKFLKKLPIRWLAPETLNTGIF-SFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKE 391 (474)
T ss_pred e---eccccccCcceecChhhhccCcc-ccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHH
Confidence 1 111122 3468999999987755 799999999999999999 899999999999999996544 4556677889
Q ss_pred HHHHHHHccccCccCCCCHHHHhc
Q 014347 244 AQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
+..++.+|+..||++|||+.++.+
T Consensus 392 ~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 392 LAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHHhccCChhhccCHHHHHH
Confidence 999999999999999999999865
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=318.31 Aligned_cols=245 Identities=21% Similarity=0.277 Sum_probs=193.9
Q ss_pred ceEeecCceEEEEEEEC--CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEeccC
Q 014347 20 RTLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~ 97 (426)
+.||+|+||.||+|... .++..+|+|.++.... ......+.+|+.+++.++||||+++++.+.+....|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 46899999999999854 3556799998865432 2234578889999999999999999999999999999999999
Q ss_pred CCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 98 GGELFDKIASKG-----RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 98 gg~L~~~i~~~~-----~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
+|+|.+++.... ..++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999999987522 456778889999999999999999999999999999999999999999999874322111111
Q ss_pred cccccCCCcccchhhhccCC------CCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHc-CCCCC--C---CC
Q 014347 173 LHTTCGSPNYVAPEVLANRG------YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFR-GDFKL--P---KW 239 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~------~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~-~~~~~--p---~~ 239 (426)
.....|++.|+|||++.... ..+.++||||+|+++|+|++ |..||...+.......... ..... | ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 22346788999999986432 13678999999999999996 9999987665554433322 22222 2 23
Q ss_pred CCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 240 LSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 240 ~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
.++.+.+++++|+ .+|++|||+++|+.
T Consensus 239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 6788999999999 68999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=321.19 Aligned_cols=250 Identities=27% Similarity=0.409 Sum_probs=201.3
Q ss_pred eeeeceEeecCceEEEEEEE----CCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC--CEE
Q 014347 16 YELGRTLGEGNFGKVKFAQD----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKI 89 (426)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 89 (426)
|++++.||+|+||.||+|+. ..++..||+|.+.... .......+.+|+.+++.++||||+++++++... ...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 68999999999999999974 4578899999986443 234457799999999999999999999998765 578
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
|+||||++|++|.+++.+. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 9999999999999998764 368999999999999999999999999999999999999999999999999988543211
Q ss_pred CC-CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCc---------------HHHHHHHHHcC
Q 014347 169 DD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN---------------LAVLYQKIFRG 232 (426)
Q Consensus 169 ~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~---------------~~~~~~~i~~~ 232 (426)
.. .......++..|+|||++.+..+ +.++||||||+++|+|+++..|+.... .......+..+
T Consensus 164 ~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05079 164 EYYTVKDDLDSPVFWYAPECLIQSKF-YIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242 (284)
T ss_pred cceeecCCCCCCccccCHHHhccCCC-CccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC
Confidence 11 11223456778999999877655 688999999999999999877653211 11111111111
Q ss_pred -CCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 233 -DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 233 -~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
..+.+..+++.+.+|+.+||+.||++|||+.+++.+
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 233455689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=314.20 Aligned_cols=249 Identities=25% Similarity=0.410 Sum_probs=207.3
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (426)
...++|++.+.||+|+||.||+|.+. .+..+|+|.+.... .....+.+|+.+++.++|+||+++++++.. ...|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 35689999999999999999999854 55679999876432 224678899999999999999999999877 7789
Q ss_pred EEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 91 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~--~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
++|||+++++|.+++.+ ...++...+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999999999999976 3457888999999999999999999999999999999999999999999999987543211
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHH
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 246 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 246 (426)
........++..|+|||++....+ +.++|+|||||++|++++ |..||.+.+.......+..+ ..+.+...+.++.+
T Consensus 157 -~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd05073 157 -YTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN 234 (260)
T ss_pred -cccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHH
Confidence 111112335577999999876554 688999999999999999 99999988777666666554 23445668899999
Q ss_pred HHHHccccCccCCCCHHHHhc
Q 014347 247 LLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 247 Li~~~L~~dP~~R~t~~eil~ 267 (426)
++.+||++||++||++.++++
T Consensus 235 ~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 235 IMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHcccCcccCcCHHHHHH
Confidence 999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=315.19 Aligned_cols=246 Identities=26% Similarity=0.374 Sum_probs=200.0
Q ss_pred ceEeecCceEEEEEEECC---CCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEE-eCCEEEEEEec
Q 014347 20 RTLGEGNFGKVKFAQDLD---SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA-SKSKIYMVLEY 95 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~~lV~Ey 95 (426)
+.||+|+||.||+|.+.. .+..||+|.+.... .....+.+.+|+.+++.++||||+++++++. .++..|++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998653 34579999875322 3344678889999999999999999999765 45668999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC--CCc
Q 014347 96 VTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGL 172 (426)
Q Consensus 96 ~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~--~~~ 172 (426)
+.+++|.+++.+. ..+++..+..++.|+++||.|||++|++||||||+|||+++++.+||+|||+++....... ...
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 9999999999763 3567888899999999999999999999999999999999999999999999874321110 011
Q ss_pred cccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHHHHHHH
Q 014347 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRK 250 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~ 250 (426)
.....+++.|+|||.+....+ +.++|||||||++|+|++ |.+||...+.......+..+. ...|..+++.+.+++.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS 237 (262)
T ss_pred cccCcCCccccChhHhccCcc-chHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 123345778999999877665 688999999999999999 577888877766666665553 44466688999999999
Q ss_pred ccccCccCCCCHHHHhcC
Q 014347 251 ILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 251 ~L~~dP~~R~t~~eil~h 268 (426)
||+.+|++||++.+++..
T Consensus 238 cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 238 CWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HcCCChhhCCCHHHHHHH
Confidence 999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=344.07 Aligned_cols=256 Identities=27% Similarity=0.515 Sum_probs=223.0
Q ss_pred cCCCe-eeeceEeecCceEEEEEEECCCCCeEEEEEeecccc-cchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE-
Q 014347 12 RLGRY-ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-IHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK- 88 (426)
Q Consensus 12 ~~~~y-~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~- 88 (426)
.-||| +....||+|+|-+||+|.|..+|..||+-.++.... ..++..+++..|+.+|+.|+||||+++|+.+.+...
T Consensus 37 p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~ 116 (632)
T KOG0584|consen 37 PTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNK 116 (632)
T ss_pred CCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCc
Confidence 34555 345789999999999999999999999876654333 345567899999999999999999999999987655
Q ss_pred -EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc--CceeccCCCCcEEecCC-CCeEEeeccCccCC
Q 014347 89 -IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK--GVFHRDLKLENILLDSK-GNIKISDFGLSALP 164 (426)
Q Consensus 89 -~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~--gIiHrDLKp~NILl~~~-g~vkL~DFGla~~~ 164 (426)
+-+|+|.+..|+|+.|+.+.++++...++.|++||+.||.|||++ .|+|||||-+||+|+.+ |.|||+|+|||++.
T Consensus 117 ~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 117 TINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred eeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 889999999999999999999999999999999999999999998 49999999999999764 89999999999975
Q ss_pred ccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCC-CcHHHHHHHHHcCCCC--CCCCCC
Q 014347 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFK--LPKWLS 241 (426)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s 241 (426)
.. .......|||.|||||++. ..|+ ..+||||||..+.||+|+..||.. .+...+|+++..|..+ +.+--+
T Consensus 197 r~----s~aksvIGTPEFMAPEmYE-E~Yn-E~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~d 270 (632)
T KOG0584|consen 197 RK----SHAKSVIGTPEFMAPEMYE-ENYN-ELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKD 270 (632)
T ss_pred hc----cccceeccCccccChHHHh-hhcc-hhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCC
Confidence 33 3344578999999999976 5675 889999999999999999999976 6788999999988543 334458
Q ss_pred HHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 242 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
|++++||.+||.. .+.|+|+.|+|.||||..+
T Consensus 271 Pevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 271 PEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 9999999999999 9999999999999999875
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=318.71 Aligned_cols=267 Identities=28% Similarity=0.426 Sum_probs=219.0
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe---
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--- 85 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--- 85 (426)
.....+.|+-..+||+|.||+||+|+.+.+|+.||+|.+--++. ...+-....+|+.+|..|+|+|++.++++|.+
T Consensus 12 ~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene-KeGfpitalreikiL~~lkHenv~nliEic~tk~T 90 (376)
T KOG0669|consen 12 FCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKAT 90 (376)
T ss_pred ceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc-ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccC
Confidence 34567889999999999999999999999999999986543221 22334567789999999999999999988743
Q ss_pred -----CCEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeecc
Q 014347 86 -----KSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG 159 (426)
Q Consensus 86 -----~~~~~lV~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFG 159 (426)
...+|+|+.+|+. +|+-++... .+++..++++++++|++||.|+|++.|+|||+||+|+||+.+|.+||+|||
T Consensus 91 p~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 91 PTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred CcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccc
Confidence 3458999999976 888888764 689999999999999999999999999999999999999999999999999
Q ss_pred CccCCccccCC--CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHc--CCC-
Q 014347 160 LSALPQHFRDD--GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--GDF- 234 (426)
Q Consensus 160 la~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~~- 234 (426)
+++.+...... ......+-|.+|++||.+.+..-++++.|||+.|||+.+|++|.+.|++.+.......|.. +.+
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 99765443221 1233456799999999999877779999999999999999999999998776655444431 111
Q ss_pred -------------------CCCCC-------------CCHHHHHHHHHccccCccCCCCHHHHhcCccccccCCC
Q 014347 235 -------------------KLPKW-------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (426)
Q Consensus 235 -------------------~~p~~-------------~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 277 (426)
++|+. -++++.+|+.++|..||.+|++++++++|.||.++..|
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 11111 25688999999999999999999999999999887655
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=352.44 Aligned_cols=253 Identities=27% Similarity=0.401 Sum_probs=218.2
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECC-----CCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 84 (426)
....++-++.+.||+|+||+||+|+-.. ..+.||||.++... +.....+|+||++++..++|||||+++|++.
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~ 559 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCR 559 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence 4555677889999999999999998432 34679999997554 3446789999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCC
Q 014347 85 SKSKIYMVLEYVTGGELFDKIASKG--------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 150 (426)
Q Consensus 85 ~~~~~~lV~Ey~~gg~L~~~i~~~~--------------~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~ 150 (426)
.++.+|+|+||+..|+|.+++...+ +++..+...++.||+.|+.||-++.++||||-..|+||.++
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN 639 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc
Confidence 9999999999999999999986432 27889999999999999999999999999999999999999
Q ss_pred CCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHH
Q 014347 151 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKI 229 (426)
Q Consensus 151 g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i 229 (426)
-.|||+||||++-.-...--.......-...|||||.+....| +.++||||+||+|||+++ |+.||.+.+.++..+.+
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kF-TteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i 718 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKF-TTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI 718 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcc-cchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence 9999999999984322111111112223468999999998888 688999999999999999 99999999999999999
Q ss_pred HcCC-CCCCCCCCHHHHHHHHHccccCccCCCCHHHH
Q 014347 230 FRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGI 265 (426)
Q Consensus 230 ~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~ei 265 (426)
..+. ++.|+.+|+++++|+..||+.+|.+||++.||
T Consensus 719 ~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 719 RAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred HcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 8876 68899999999999999999999999999997
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=311.61 Aligned_cols=258 Identities=24% Similarity=0.386 Sum_probs=214.0
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCCEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKI 89 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 89 (426)
...+..+.+..||.|+.|.|++++.+.+|...|||.+.+.. +.+..+++...+.++-... .|+||+.+++|..+...
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV 166 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV 166 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence 44456677889999999999999999999999999998765 4555788888888876654 89999999999999999
Q ss_pred EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhh-cCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~-~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
++.||.+. ..+..++.+ .++++|..+-++...+++||.||.. +||+|||+||+|||+|+.|++|+||||++...-
T Consensus 167 ~IcMelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv-- 243 (391)
T KOG0983|consen 167 FICMELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV-- 243 (391)
T ss_pred HHHHHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceee--
Confidence 99999884 244444433 5789999999999999999999975 599999999999999999999999999987431
Q ss_pred cCCCccccccCCCcccchhhhcc---CCCCCCcchhhhHHHHHHHHHhCCCCCCCCc-HHHHHHHHHcCCCCC-C--CCC
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKL-P--KWL 240 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~---~~~~~~~~DIwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~~~~~-p--~~~ 240 (426)
+........|.+.|||||.+.- ..| ...+||||||+.|+||.||..||.+.+ ..+...++.+..++. | ..+
T Consensus 244 -dSkAhtrsAGC~~YMaPERidp~~~~kY-DiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gF 321 (391)
T KOG0983|consen 244 -DSKAHTRSAGCAAYMAPERIDPPDKPKY-DIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGF 321 (391)
T ss_pred -cccccccccCCccccCccccCCCCCCcc-chhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCc
Confidence 2222334579999999999853 245 478999999999999999999999854 446777777765543 3 238
Q ss_pred CHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 241 s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
|+.+.+|+..||++|+.+||...++|+|||.....
T Consensus 322 Sp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 322 SPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred CHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 99999999999999999999999999999987643
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=316.47 Aligned_cols=251 Identities=26% Similarity=0.392 Sum_probs=206.0
Q ss_pred eeeeceEeecCceEEEEEEEC---CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC-----
Q 014347 16 YELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----- 87 (426)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----- 87 (426)
|.+.+.||+|+||.||+|.+. .+++.||||++..+.. .....+++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 678899999999999999864 3578999999865432 3334677889999999999999999999875432
Q ss_pred -EEEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccC
Q 014347 88 -KIYMVLEYVTGGELFDKIASK------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL 160 (426)
Q Consensus 88 -~~~lV~Ey~~gg~L~~~i~~~------~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGl 160 (426)
..+++++|+.+|+|.+++... ..++...++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 347889999999998887431 2478999999999999999999999999999999999999999999999999
Q ss_pred ccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCC
Q 014347 161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPK 238 (426)
Q Consensus 161 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~ 238 (426)
+................+++.|++||.+....+ +.++|||||||++|+|++ |+.||.+.+....+..+... ....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVY-TTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCcc-chhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence 885422111111122345678999999876665 578999999999999999 99999988877777766654 345566
Q ss_pred CCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 239 WLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 239 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
..++.+.+++.+||+.+|++|||+.+++.+
T Consensus 239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 239 DCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=314.31 Aligned_cols=236 Identities=22% Similarity=0.249 Sum_probs=194.3
Q ss_pred ceEeecCceEEEEEEECCCC----------CeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 20 RTLGEGNFGKVKFAQDLDSG----------LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~----------~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
+.||+|+||.||+|.+..++ ..+++|++..... ....+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 47999999999999998776 3578887654321 15678899999999999999999999887 778
Q ss_pred EEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCC-------CeEEeeccCc
Q 014347 90 YMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-------NIKISDFGLS 161 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~-~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g-------~vkL~DFGla 161 (426)
++||||+++|+|.+++.... .++...+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999998755 799999999999999999999999999999999999999888 7999999998
Q ss_pred cCCccccCCCccccccCCCcccchhhhccC-CCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcCCCCCCCC
Q 014347 162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKW 239 (426)
Q Consensus 162 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~ 239 (426)
..... .....++..|+|||++... ...+.++||||||+++|+|++ |..||...+......... .....|..
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~ 228 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMP 228 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCC
Confidence 74322 2234577889999998765 344788999999999999999 688887765433322222 22223332
Q ss_pred CCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 240 LSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 240 ~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
....+.+++.+||+.+|.+|||+.++++
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 229 DCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 3488999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=316.89 Aligned_cols=250 Identities=26% Similarity=0.412 Sum_probs=199.7
Q ss_pred CCeeeeceEeecCceEEEEEE----ECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe--CC
Q 014347 14 GRYELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KS 87 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~ 87 (426)
.+|++.+.||+|+||.||+|. +..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 479999999999999999997 45678899999986442 3345678999999999999999999998643 35
Q ss_pred EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcc
Q 014347 88 KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 166 (426)
.+|+||||+++++|.+++.+. ..+++..++.++.|++.||+|||++|++||||||+||++++++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 689999999999999999763 5689999999999999999999999999999999999999999999999999986432
Q ss_pred ccCCCc-cccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHH---------------HHHHH
Q 014347 167 FRDDGL-LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVL---------------YQKIF 230 (426)
Q Consensus 167 ~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~---------------~~~i~ 230 (426)
...... .....++..|+|||++.+..+ +.++||||||+++|+|++|..|+........ ...+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 111100 111223456999999876665 6889999999999999998877654321100 01111
Q ss_pred cC--CCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 231 RG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 231 ~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
.. .++.+..++..+.+|+.+||+.+|++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11 23445668899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=313.41 Aligned_cols=250 Identities=30% Similarity=0.498 Sum_probs=210.5
Q ss_pred CeeeeceEeecCceEEEEEEECC-CCCeEEEEEeecccc-------cchhHHHHHHHHHHHHHh-CCCCCccceEEEEEe
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRI-------IHLKITDQIKREIATLKL-LKHPNVVRLHEVLAS 85 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~-------~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~ 85 (426)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+..... ........+.+|+.+++. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999887 788999998864321 122335567788888865 789999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhh-cCceeccCCCCcEEecCCCCeEEeeccC
Q 014347 86 KSKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGL 160 (426)
Q Consensus 86 ~~~~~lV~Ey~~gg~L~~~i~~----~~~l~~~~~~~i~~Ql~~aL~~LH~-~gIiHrDLKp~NILl~~~g~vkL~DFGl 160 (426)
++..|++|||++|++|.+.+.. ...+++..++.++.|++.||.|||+ .|++||||+|+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988743 4568999999999999999999996 7899999999999999999999999999
Q ss_pred ccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCC-CC-C
Q 014347 161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LP-K 238 (426)
Q Consensus 161 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p-~ 238 (426)
+...... .......|+..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+...... .+ .
T Consensus 161 ~~~~~~~---~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd08528 161 AKQKQPE---SKLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG 236 (269)
T ss_pred eeecccc---cccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcc
Confidence 8754321 13345678999999999887655 68999999999999999999999888777666666555433 22 2
Q ss_pred CCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 239 WLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 239 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
.+++.+.++|.+||+.||++||++.++.++
T Consensus 237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 237 MYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred cCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 578999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=357.47 Aligned_cols=255 Identities=32% Similarity=0.532 Sum_probs=208.5
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEE---------
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL--------- 83 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~--------- 83 (426)
+.+|+.++.||+||||.||+++++-+|+.||||.|.... ......++.+|+..|.+|+|||||++|..+
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 456788999999999999999999999999999997654 344567899999999999999999988321
Q ss_pred ------------------------------------------------E---------------------eC--------
Q 014347 84 ------------------------------------------------A---------------------SK-------- 86 (426)
Q Consensus 84 ------------------------------------------------~---------------------~~-------- 86 (426)
. ++
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0 00
Q ss_pred ---------------------------------CEEEEEEeccCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHhh
Q 014347 87 ---------------------------------SKIYMVLEYVTGGELFDKIASKGRL-QEAEGRKLFQQLIDGVSYCHN 132 (426)
Q Consensus 87 ---------------------------------~~~~lV~Ey~~gg~L~~~i~~~~~l-~~~~~~~i~~Ql~~aL~~LH~ 132 (426)
..+||-||||+...|.++|.++... ....++++|+||++||.|+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 1268999999998888888775544 478899999999999999999
Q ss_pred cCceeccCCCCcEEecCCCCeEEeeccCccCCc----------------cccCCCccccccCCCcccchhhhccCC--CC
Q 014347 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQ----------------HFRDDGLLHTTCGSPNYVAPEVLANRG--YD 194 (426)
Q Consensus 133 ~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~----------------~~~~~~~~~~~~gt~~y~APE~l~~~~--~~ 194 (426)
.|||||||||.||++|+++.|||+|||+|+... ...+++.....+||--|+|||++.+.. .+
T Consensus 716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 999999999999999999999999999998611 011222455678999999999998765 34
Q ss_pred CCcchhhhHHHHHHHHHhCCCCCCC-CcHHHHHHHHHcCCCCCCCCC----CHHHHHHHHHccccCccCCCCHHHHhcCc
Q 014347 195 GATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFKLPKWL----SPGAQNLLRKILEPNPVKRITIAGIKADE 269 (426)
Q Consensus 195 ~~~~DIwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~p~~~----s~~~~~Li~~~L~~dP~~R~t~~eil~h~ 269 (426)
..|+|+||||+||+||+ .||.- .........+.++.++.|..+ -+.-..+|++||+.||++|||+.|+|++.
T Consensus 796 n~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~ 872 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSE 872 (1351)
T ss_pred cchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhcc
Confidence 68999999999999998 45754 344456666667777766332 24568999999999999999999999999
Q ss_pred ccc
Q 014347 270 WFE 272 (426)
Q Consensus 270 ~f~ 272 (426)
||.
T Consensus 873 llp 875 (1351)
T KOG1035|consen 873 LLP 875 (1351)
T ss_pred CCC
Confidence 986
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=311.66 Aligned_cols=245 Identities=21% Similarity=0.313 Sum_probs=193.2
Q ss_pred ceEeecCceEEEEEEECCC--CCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEeccC
Q 014347 20 RTLGEGNFGKVKFAQDLDS--GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~ 97 (426)
+.||+|+||.||+|..... ...+++|.+.... .....+.+.+|+.+++.++||||+++++.+......|+||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 4699999999999975432 2345666655432 22345788999999999999999999999999999999999999
Q ss_pred CCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcc
Q 014347 98 GGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (426)
Q Consensus 98 gg~L~~~i~~~----~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 173 (426)
+|+|.+++.+. ..+++..++.++.||+.||+|||+++++||||||+|||++.++.+||+|||++............
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999999753 24567788899999999999999999999999999999999999999999998632111111122
Q ss_pred ccccCCCcccchhhhccCC------CCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcCC------CCCCCCC
Q 014347 174 HTTCGSPNYVAPEVLANRG------YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD------FKLPKWL 240 (426)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~------~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~------~~~p~~~ 240 (426)
...+|++.|+|||++.... ..+.++|||||||++|+|++ |..||...+....+..+..+. ...+..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 3457889999999975321 12578999999999999997 688998777666665554332 2233347
Q ss_pred CHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 241 SPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 241 s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
++.+.+++..|| .+|++|||+.++++
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 889999999999 67999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=314.77 Aligned_cols=254 Identities=13% Similarity=0.154 Sum_probs=192.9
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCC---CCeEEEEEeecccccch-h-H------HHHHHHHHHHHHhCCCCCccce
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHL-K-I------TDQIKREIATLKLLKHPNVVRL 79 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAvK~i~~~~~~~~-~-~------~~~~~~Ei~il~~l~hpnIv~l 79 (426)
..-++|++.+.||+|+||.||+|.+..+ +..+|+|+......... + . ......+...++.+.|+|++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 3446899999999999999999998777 67788886543221100 0 0 0112233445567789999999
Q ss_pred EEEEEeCC----EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEE
Q 014347 80 HEVLASKS----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKI 155 (426)
Q Consensus 80 ~~~~~~~~----~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL 155 (426)
++.+.... ..+++++++. .++.+.+......++..++.++.|++.||+|||++||+||||||+|||++.++.++|
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred EEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence 98765443 4578888874 467777766556789999999999999999999999999999999999999999999
Q ss_pred eeccCccCCccccC-----CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcH-H------
Q 014347 156 SDFGLSALPQHFRD-----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL-A------ 223 (426)
Q Consensus 156 ~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~-~------ 223 (426)
+|||+|+....... ........||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+. .
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~-~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV-TRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 99999975432110 111233479999999999887666 6899999999999999999999987632 1
Q ss_pred --HHHHHHHcCCCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 224 --VLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 224 --~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
....++..+...++ ..++.+.++++.|+..+|++||+.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 247 KCDFIKRLHEGKIKIK-NANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHHHHhhhhhhccC-CCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 12233333333333 45889999999999999999999999875
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=313.62 Aligned_cols=252 Identities=26% Similarity=0.400 Sum_probs=204.1
Q ss_pred CCCeeeeceEeecCceEEEEEEEC----CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe--C
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDL----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--K 86 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~ 86 (426)
...|++.+.||+|+||.||+|... .+++.||+|++...... .....+.+|+.+++.+.||||+++++++.. .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 357889999999999999999864 34789999998755432 346789999999999999999999999877 5
Q ss_pred CEEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 87 SKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~~-~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
...+++|||+++++|.+++.... .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 67999999999999999997644 69999999999999999999999999999999999999999999999999998643
Q ss_pred cccCC-CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHH--------------HHHHHH
Q 014347 166 HFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV--------------LYQKIF 230 (426)
Q Consensus 166 ~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~--------------~~~~i~ 230 (426)
..... .......++..|+|||.+....+ +.++||||||+++|+|++|..||....... ......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCC-CcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 21111 01112244567999999876655 688999999999999999999987643211 111122
Q ss_pred cC--CCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 231 RG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 231 ~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
.. ..+.|..++..+.+|+.+||+++|++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 22 23445567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=324.97 Aligned_cols=247 Identities=30% Similarity=0.417 Sum_probs=195.8
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC-EEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-KIYMV 92 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~lV 92 (426)
+.|.-...||+|+||.||+|.- .+|..||||.+....... ...|.+|+.++.+++|||+++++|+|.+.+ ..++|
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV 150 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV 150 (361)
T ss_pred hCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence 4566678999999999999995 445899999776544321 345999999999999999999999999988 59999
Q ss_pred EeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcC---ceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 93 LEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKG---VFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~~~--~l~~~~~~~i~~Ql~~aL~~LH~~g---IiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
+||+++|+|.+++.... ++++....+|+.+++.||+|||... |+||||||+|||||++.+.||+|||+|+.....
T Consensus 151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG 230 (361)
T ss_pred EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence 99999999999998644 8999999999999999999999853 999999999999999999999999999753220
Q ss_pred cCCCccccc-cCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCc------HHHHH-HHHHcCC------
Q 014347 168 RDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN------LAVLY-QKIFRGD------ 233 (426)
Q Consensus 168 ~~~~~~~~~-~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~------~~~~~-~~i~~~~------ 233 (426)
.....+. .||.+|+|||++..... +.++||||||++|.||++|+.|.+... ..... ..+..+.
T Consensus 231 --~~~~~~~~~gt~gY~~PEy~~~g~l-t~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD 307 (361)
T KOG1187|consen 231 --DTSVSTTVMGTFGYLAPEYASTGKL-TEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVD 307 (361)
T ss_pred --ccceeeecCCCCccCChhhhccCCc-CcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeC
Confidence 2222223 89999999999876444 789999999999999999999887532 22211 1222221
Q ss_pred CCCC-CCCC--H---HHHHHHHHccccCccCCCCHHHHhc
Q 014347 234 FKLP-KWLS--P---GAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 234 ~~~p-~~~s--~---~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
..+. ...+ . .+..+..+|++.+|..||++.+++.
T Consensus 308 ~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 308 PRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 1111 1222 2 2557788999999999999999754
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=318.64 Aligned_cols=252 Identities=30% Similarity=0.466 Sum_probs=206.0
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCC--C----CccceEEEEEe
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH--P----NVVRLHEVLAS 85 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--p----nIv~l~~~~~~ 85 (426)
.-+||.+..++|+|+||+|-.+.|..++..||||+++.- ....+..+-|+.+|.++.+ | -++.+.++|.-
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 467999999999999999999999999999999998632 2334556679999999842 2 36778888999
Q ss_pred CCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecC--------------
Q 014347 86 KSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-------------- 149 (426)
Q Consensus 86 ~~~~~lV~Ey~~gg~L~~~i~~~~--~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~-------------- 149 (426)
.++++||+|.+ |.+++|.+.+++ +++...++.+.+||+++++|||+.+++|-||||||||+.+
T Consensus 163 rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 163 RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccc
Confidence 99999999998 779999998754 6899999999999999999999999999999999999842
Q ss_pred ------CCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHH
Q 014347 150 ------KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 223 (426)
Q Consensus 150 ------~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~ 223 (426)
+..++|+|||.|+... ..-.+.+.|..|+|||++.+-++ +.++||||+||||+||.+|...|+..+..
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~-----e~hs~iVsTRHYRAPEViLgLGw-S~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDH-----EHHSTIVSTRHYRAPEVILGLGW-SQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred eeccCCCcceEEEecCCcceec-----cCcceeeeccccCCchheeccCc-CCccCceeeeeEEEEeeccceecccCCcH
Confidence 2348999999998532 23356788999999999999999 58899999999999999999999764322
Q ss_pred ---HHHHHHHc------------------CCCCCCCC-------------------------CCHHHHHHHHHccccCcc
Q 014347 224 ---VLYQKIFR------------------GDFKLPKW-------------------------LSPGAQNLLRKILEPNPV 257 (426)
Q Consensus 224 ---~~~~~i~~------------------~~~~~p~~-------------------------~s~~~~~Li~~~L~~dP~ 257 (426)
.+.+.|+. +.+..|.. -..++.+||++||..||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 34444432 11111111 012578999999999999
Q ss_pred CCCCHHHHhcCcccccc
Q 014347 258 KRITIAGIKADEWFEQD 274 (426)
Q Consensus 258 ~R~t~~eil~h~~f~~~ 274 (426)
+|+|+.|+|.||||...
T Consensus 396 ~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 396 RRITLREALSHPFFARL 412 (415)
T ss_pred ccccHHHHhcCHHhhcC
Confidence 99999999999999753
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=347.46 Aligned_cols=250 Identities=26% Similarity=0.405 Sum_probs=213.3
Q ss_pred CCCeeeeceEeecCceEEEEEEECCC-CC----eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDS-GL----PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (426)
-..-++++.||+|+||.||.|.-... |. .||+|.+.+.. +......|.+|..+|+.++||||+++++++-+..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~--~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS--SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 34567889999999999999986543 32 48888876543 5566788999999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccC
Q 014347 88 KIYMVLEYVTGGELFDKIASK-------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL 160 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~-------~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGl 160 (426)
..+|++|||+||+|..+|++. ..++..+...++.|++.|..||+++++|||||...|+||+....+||+|||+
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999999875 3588999999999999999999999999999999999999999999999999
Q ss_pred ccCCccccCCCcccc--ccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHH-HcCCCCC
Q 014347 161 SALPQHFRDDGLLHT--TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKI-FRGDFKL 236 (426)
Q Consensus 161 a~~~~~~~~~~~~~~--~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i-~~~~~~~ 236 (426)
|+... ..+-.... ..-...|||||.+.+..+ +.++|||||||+|||+++ |..||.+.+..++.... ..++++.
T Consensus 849 ArDiy--~~~yyr~~~~a~lPvkWm~PEsl~d~iF-tskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~ 925 (1025)
T KOG1095|consen 849 ARDIY--DKDYYRKHGEAMLPVKWMPPESLKDGIF-TSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDP 925 (1025)
T ss_pred hHhhh--hchheeccCccccceecCCHHHHhhccc-ccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCC
Confidence 99321 11111111 122357999999998666 689999999999999999 99999998877777644 4567888
Q ss_pred CCCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 237 PKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 237 p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
|..++..+.+++..||+.+|++||++..|++
T Consensus 926 P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 926 PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 9999999999999999999999999999987
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=334.54 Aligned_cols=242 Identities=35% Similarity=0.557 Sum_probs=198.4
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC------C
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------S 87 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------~ 87 (426)
+-|..-+.||+||||.||+++++.+|+.||||.+++.. .....+..-+|+++|++++|||||+++++=++. .
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 66888999999999999999999999999999998755 333467888999999999999999999985443 3
Q ss_pred EEEEEEeccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEec--CCCC--eEEeeccC
Q 014347 88 KIYMVLEYVTGGELFDKIAS---KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD--SKGN--IKISDFGL 160 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~---~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~--~~g~--vkL~DFGl 160 (426)
...+|||||.||+|+..+++ ..++++.+.+.++..+..||.|||++||+||||||.||++- .+|+ .||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 56899999999999999974 45799999999999999999999999999999999999984 3454 69999999
Q ss_pred ccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCC-----cHHHHHHHHHc----
Q 014347 161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-----NLAVLYQKIFR---- 231 (426)
Q Consensus 161 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~-----~~~~~~~~i~~---- 231 (426)
|+-.+ ++....+..||+.|.+||++...++++..+|.||+||++|++.||..||... +...++..+.+
T Consensus 171 Arel~---d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 171 ARELD---DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred cccCC---CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 99543 4557788999999999999986566689999999999999999999999532 22233333221
Q ss_pred ----------C------CCCCCCCCCHHH----HHHHHHccccCccCCC
Q 014347 232 ----------G------DFKLPKWLSPGA----QNLLRKILEPNPVKRI 260 (426)
Q Consensus 232 ----------~------~~~~p~~~s~~~----~~Li~~~L~~dP~~R~ 260 (426)
+ .+++|..+++.+ -..+..+|..+|.+|.
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 1 123344455543 4567788999999998
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=334.29 Aligned_cols=258 Identities=21% Similarity=0.274 Sum_probs=181.6
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCC----CCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEE--
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDS----GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEV-- 82 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~-- 82 (426)
.....++|++.+.||+|+||.||+|++..+ +..||+|.+...... +....| .++...+.++..++..
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~ 199 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFL 199 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhh
Confidence 345678999999999999999999999988 999999987543211 111111 1122222222222211
Q ss_pred ----EEeCCEEEEEEeccCCCChHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHhhcCceec
Q 014347 83 ----LASKSKIYMVLEYVTGGELFDKIASKGR--------------------LQEAEGRKLFQQLIDGVSYCHNKGVFHR 138 (426)
Q Consensus 83 ----~~~~~~~~lV~Ey~~gg~L~~~i~~~~~--------------------l~~~~~~~i~~Ql~~aL~~LH~~gIiHr 138 (426)
...+...++|+||+.+++|.+++..... .....++.++.||+.||.|||++||+||
T Consensus 200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHR 279 (566)
T PLN03225 200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHR 279 (566)
T ss_pred cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 2456789999999999999998875321 1234567899999999999999999999
Q ss_pred cCCCCcEEecC-CCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCC---------------------CCC
Q 014347 139 DLKLENILLDS-KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY---------------------DGA 196 (426)
Q Consensus 139 DLKp~NILl~~-~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~---------------------~~~ 196 (426)
||||+|||++. ++.+||+|||+|+..... ........+||+.|+|||.+..... .+.
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~ 358 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 358 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCC
Confidence 99999999986 579999999999754321 1223456789999999997643221 123
Q ss_pred cchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCC---------------------CCCCCHHHHHHHHHccccC
Q 014347 197 TSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL---------------------PKWLSPGAQNLLRKILEPN 255 (426)
Q Consensus 197 ~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------------p~~~s~~~~~Li~~~L~~d 255 (426)
++||||+||+||+|+++..|++... ......+....... ....+....+||.+||++|
T Consensus 359 k~DVwSlGviL~el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 359 RFDIYSAGLIFLQMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred CcccHHHHHHHHHHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 5699999999999999887765432 11111111111110 1112234568999999999
Q ss_pred ccCCCCHHHHhcCccccccC
Q 014347 256 PVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 256 P~~R~t~~eil~h~~f~~~~ 275 (426)
|.+|||+.++|+||||....
T Consensus 438 P~kR~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 438 GRQRISAKAALAHPYFDREG 457 (566)
T ss_pred cccCCCHHHHhCCcCcCCCC
Confidence 99999999999999997643
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=290.22 Aligned_cols=240 Identities=45% Similarity=0.786 Sum_probs=208.8
Q ss_pred CceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEeccCCCChHHHH
Q 014347 26 NFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI 105 (426)
Q Consensus 26 ~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~gg~L~~~i 105 (426)
+||.||+|.+..+|+.+|+|++........ .+.+.+|+..+++++|+||+++++.+......++++||+.+++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999988999999999876543221 578899999999999999999999999999999999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccCCCcccch
Q 014347 106 ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185 (426)
Q Consensus 106 ~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~AP 185 (426)
.....++...+..++.|++.++.+||+.|++|+||+|.||+++.++.++|+|||.+...... .......++..|++|
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~~p 155 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPG---GLLTTFVGTPEYMAP 155 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccc---cccccccCCcCCCCH
Confidence 87666999999999999999999999999999999999999999999999999998854321 134456788999999
Q ss_pred hhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCC-CcHHHHHHHHHcCCCCCCCC---CCHHHHHHHHHccccCccCCCC
Q 014347 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFKLPKW---LSPGAQNLLRKILEPNPVKRIT 261 (426)
Q Consensus 186 E~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~p~~---~s~~~~~Li~~~L~~dP~~R~t 261 (426)
|.+....+ +.++||||+|+++|+|++|..||.. .+...............+.. ++..+.+++.+||..+|++||+
T Consensus 156 E~~~~~~~-~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 234 (244)
T smart00220 156 EVLLGKGY-GKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT 234 (244)
T ss_pred HHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence 99876666 5799999999999999999999988 56666666665555443332 7899999999999999999999
Q ss_pred HHHHhcCccc
Q 014347 262 IAGIKADEWF 271 (426)
Q Consensus 262 ~~eil~h~~f 271 (426)
+.++++||||
T Consensus 235 ~~~~~~~~~~ 244 (244)
T smart00220 235 AEEALQHPFF 244 (244)
T ss_pred HHHHhhCCCC
Confidence 9999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=314.82 Aligned_cols=262 Identities=29% Similarity=0.431 Sum_probs=218.0
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccc----hhHHHHHHHHHHHHHhCCCCCccceEEEEEe-C
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH----LKITDQIKREIATLKLLKHPNVVRLHEVLAS-K 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~ 86 (426)
.-.||-++.+||+|+|++||+|.|...++.||+|+-..++-.. +...+...+|.+|.+.|+||.||++|+++.- .
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 4468999999999999999999999999999999876544332 3345678899999999999999999999975 4
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc--CceeccCCCCcEEecC---CCCeEEeeccCc
Q 014347 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK--GVFHRDLKLENILLDS---KGNIKISDFGLS 161 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~--gIiHrDLKp~NILl~~---~g~vkL~DFGla 161 (426)
+.++-|+|||+|.+|.-++....-+++.+++.|+-||+.||.||... .|+|-||||.||||-. -|.+||+||||+
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 56889999999999999999988999999999999999999999976 5999999999999953 467999999999
Q ss_pred cCCccccCC-----CccccccCCCcccchhhhcc---CCCCCCcchhhhHHHHHHHHHhCCCCCCCCcH-HHHH--HHHH
Q 014347 162 ALPQHFRDD-----GLLHTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLY--QKIF 230 (426)
Q Consensus 162 ~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~---~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~-~~~~--~~i~ 230 (426)
++++....+ .......||-+|++||.+.- .+-.+.++||||.|||+|.++.|+.||...-. ..+. .-|+
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl 700 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL 700 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence 987543222 13344679999999998742 34457899999999999999999999976432 2222 2233
Q ss_pred c-CCCCCCC--CCCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 231 R-GDFKLPK--WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 231 ~-~~~~~p~--~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
+ .+..||+ .+++++++||++||+..-..|....++-.||+|..
T Consensus 701 kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 701 KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 2 2455654 48999999999999999999999999999999864
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=323.55 Aligned_cols=257 Identities=26% Similarity=0.428 Sum_probs=222.5
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEE-----
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLA----- 84 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~----- 84 (426)
..-+.|++.++||.|.+|+||+++++.+++..|+|+++... +..+.++-|..+|+.+. |||++.+++++.
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 34567999999999999999999999999999999986543 23467888999999875 999999999985
Q ss_pred eCCEEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCcc
Q 014347 85 SKSKIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (426)
Q Consensus 85 ~~~~~~lV~Ey~~gg~L~~~i~~--~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~ 162 (426)
.++.+|||||||.||+..|+++. ..++.|..+..+++.++.||.|||.+.++|||||-.|||++.+|.|||+|||++.
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeee
Confidence 35789999999999999999975 5679999999999999999999999999999999999999999999999999988
Q ss_pred CCccccCCCccccccCCCcccchhhhccC-----CCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCC--
Q 014347 163 LPQHFRDDGLLHTTCGSPNYVAPEVLANR-----GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-- 235 (426)
Q Consensus 163 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-- 235 (426)
-... .-+...+..|||.|||||++... .| ...+|+||||++..||-.|.+|+-+..+....-+|-+..++
T Consensus 172 Qlds--T~grRnT~iGtP~WMAPEViac~e~~d~ty-d~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkL 248 (953)
T KOG0587|consen 172 QLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATY-DYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 248 (953)
T ss_pred eeec--ccccccCcCCCcccccceeeecccCCCCCc-ccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccc
Confidence 5443 23455678999999999998643 23 46799999999999999999999999888766666554332
Q ss_pred -CCCCCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 236 -LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 236 -~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
-|+.++.++.++|..||.+|-.+||+..+++.|||....
T Consensus 249 krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 249 KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 355689999999999999999999999999999999743
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=284.49 Aligned_cols=251 Identities=25% Similarity=0.465 Sum_probs=205.4
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEEeC--CE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASK--SK 88 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~--~~ 88 (426)
..++|++.+++|+|.|++|+.|.+..+++.++||+++.-+ .+.++||+.||+.|+ ||||++++++..+. ..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 4578999999999999999999999999999999986433 468999999999998 99999999998764 44
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCC-CCeEEeeccCccCCccc
Q 014347 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQHF 167 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~-g~vkL~DFGla~~~~~~ 167 (426)
..+++||+.+.+...+- ..++..+++.++.||+.||.|||+.||+|||+||.|+++|.. -.++|+|+|+|.++..
T Consensus 110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp- 185 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP- 185 (338)
T ss_pred chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCC-
Confidence 67899999887665543 458899999999999999999999999999999999999965 4699999999987543
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCC-CCcHHHHHHHHH-------------cCC
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIF-------------RGD 233 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~-~~~~~~~~~~i~-------------~~~ 233 (426)
....+..+.+..|--||.+.+-+.+...-|+|||||+|..|+..+-||- +.+..+...+|. +-.
T Consensus 186 --~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 186 --GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred --CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence 3344556778889999999887776788999999999999999999983 322222221211 111
Q ss_pred CCCC-------------CC-----------CCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 234 FKLP-------------KW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 234 ~~~p-------------~~-----------~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
+.++ +| .+|++.+|+.++|..|-.+|+|+.|++.||||..-
T Consensus 264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 1111 11 47999999999999999999999999999999753
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=312.67 Aligned_cols=264 Identities=20% Similarity=0.254 Sum_probs=190.9
Q ss_pred CccCCCeeeeceEeecCceEEEEEEEC----------------CCCCeEEEEEeecccccch-h----------HHHHHH
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDL----------------DSGLPFAVKILEKNRIIHL-K----------ITDQIK 62 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~----------------~~~~~vAvK~i~~~~~~~~-~----------~~~~~~ 62 (426)
....++|++.++||+|+||.||+|... ..++.||||.+........ + ..+...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 356789999999999999999999752 2456799999864321110 0 012233
Q ss_pred HHHHHHHhCCCCCc-----cceEEEEEe--------CCEEEEEEeccCCCChHHHHHhc---------------------
Q 014347 63 REIATLKLLKHPNV-----VRLHEVLAS--------KSKIYMVLEYVTGGELFDKIASK--------------------- 108 (426)
Q Consensus 63 ~Ei~il~~l~hpnI-----v~l~~~~~~--------~~~~~lV~Ey~~gg~L~~~i~~~--------------------- 108 (426)
.|+.++.+++|.++ +++++++.. ....|+||||+++++|.+++...
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 46777777776554 566666542 35689999999999999988642
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccCCCcccch
Q 014347 109 ---GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185 (426)
Q Consensus 109 ---~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~AP 185 (426)
..+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||++....... ........+|+.|+||
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeCh
Confidence 123567788999999999999999999999999999999999999999999987432211 1111123458999999
Q ss_pred hhhccCC--------------------CC-CCcchhhhHHHHHHHHHhCCC-CCCCCcH-----------HHHHHHHHcC
Q 014347 186 EVLANRG--------------------YD-GATSDIWSCGVILYVILTGYL-PFDDRNL-----------AVLYQKIFRG 232 (426)
Q Consensus 186 E~l~~~~--------------------~~-~~~~DIwSlGvil~elltG~~-Pf~~~~~-----------~~~~~~i~~~ 232 (426)
|++.... |. ..+.||||+||++|+|++|.+ ||.+... ...+..+...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 9975422 11 124799999999999999986 7764221 1112222233
Q ss_pred CCCCC--CCCCHHHHHHHHHccccCc---cCCCCHHHHhcCcccccc
Q 014347 233 DFKLP--KWLSPGAQNLLRKILEPNP---VKRITIAGIKADEWFEQD 274 (426)
Q Consensus 233 ~~~~p--~~~s~~~~~Li~~~L~~dP---~~R~t~~eil~h~~f~~~ 274 (426)
.+.++ ...++.+++|+.+||..+| .+|+|++|+|+||||...
T Consensus 460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~ 506 (507)
T PLN03224 460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE 506 (507)
T ss_pred CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence 44444 3478999999999999866 689999999999999643
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=310.06 Aligned_cols=244 Identities=27% Similarity=0.427 Sum_probs=213.4
Q ss_pred eeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEec
Q 014347 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (426)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey 95 (426)
..+..+||-|-||.||.|.++.-.-.||||.++.+.. .++.|.+|..+|+.++|||+|+++++|..+..+|||+||
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 3456789999999999999999888999999875542 367899999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcc
Q 014347 96 VTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (426)
Q Consensus 96 ~~gg~L~~~i~~~~--~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 173 (426)
|..|+|.|++++.. -++.-...+++.||.+|++||..+++|||||-..|+|+.++..+||+||||++++...... ..
T Consensus 345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT-AH 423 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT-AH 423 (1157)
T ss_pred ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCcee-cc
Confidence 99999999998744 4677777889999999999999999999999999999999999999999999975431110 00
Q ss_pred ccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHc
Q 014347 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKI 251 (426)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~ 251 (426)
........|.|||-+..+.+ +.++|||+|||+|||+.| |-.||.+-+....|....++ .+.-|+.+++.+.+|++.|
T Consensus 424 AGAKFPIKWTAPEsLAyNtF-SiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraC 502 (1157)
T KOG4278|consen 424 AGAKFPIKWTAPESLAYNTF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRAC 502 (1157)
T ss_pred cCccCcccccCccccccccc-ccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHHH
Confidence 11223467999999987777 689999999999999999 99999999999999887766 5778999999999999999
Q ss_pred cccCccCCCCHHHH
Q 014347 252 LEPNPVKRITIAGI 265 (426)
Q Consensus 252 L~~dP~~R~t~~ei 265 (426)
|+++|..||++++|
T Consensus 503 W~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 503 WNWSPSDRPSFAEI 516 (1157)
T ss_pred hcCCcccCccHHHH
Confidence 99999999999987
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=311.31 Aligned_cols=244 Identities=28% Similarity=0.456 Sum_probs=206.5
Q ss_pred eeeeceEeecCceEEEEEEECC--CC--CeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 16 YELGRTLGEGNFGKVKFAQDLD--SG--LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~--~~--~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
..+.++||.|-||.||.|.... .| -.||||..+.+.. .+..+.|..|..+|+.++||||++++|++.+ ...||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t--~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT--PDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC--hhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 3456789999999999998543 23 3589999876553 3447899999999999999999999999975 56899
Q ss_pred EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCC
Q 014347 92 VLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 170 (426)
|||.++-|+|..+++. ...++......|..||+.||.|||+.+++||||-..|||+....-+||+|||+++..+. +
T Consensus 468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed---~ 544 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED---D 544 (974)
T ss_pred EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccc---c
Confidence 9999999999999986 45799999999999999999999999999999999999999999999999999996432 2
Q ss_pred CccccccC--CCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHH
Q 014347 171 GLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 246 (426)
Q Consensus 171 ~~~~~~~g--t~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 246 (426)
...+...| ...|||||-+.-..+ +.++|||-|||.+||++. |..||.+-...+....+-+| ++++|+.++|.+..
T Consensus 545 ~yYkaS~~kLPIKWmaPESINfRrF-TtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYs 623 (974)
T KOG4257|consen 545 AYYKASRGKLPIKWMAPESINFRRF-TTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYS 623 (974)
T ss_pred chhhccccccceeecCccccchhcc-cchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHH
Confidence 22222223 357999999877777 578999999999999988 99999987666666666665 58999999999999
Q ss_pred HHHHccccCccCCCCHHHHh
Q 014347 247 LLRKILEPNPVKRITIAGIK 266 (426)
Q Consensus 247 Li~~~L~~dP~~R~t~~eil 266 (426)
|+.+||+.+|.+||++.+|.
T Consensus 624 lmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 624 LMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred HHHHHhccCcccCCcHHHHH
Confidence 99999999999999987764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=292.25 Aligned_cols=253 Identities=28% Similarity=0.442 Sum_probs=212.3
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC-----
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK----- 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 86 (426)
.-.||.-++.+|.|+- .|..|.|..+++.||+|.+... ..+....++..+|...+..+.|+||++++.++.-.
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 3458999999999999 7888999999999999988665 33344467899999999999999999999998543
Q ss_pred -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 87 -~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
...|+||||+.+ +|...+. -.++-..+..++.|++.|++|||+.||+||||||+||++..++.+||.|||+|+...
T Consensus 93 ~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 93 FQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence 358999999954 8888776 447888999999999999999999999999999999999999999999999998532
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC--C----------
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--D---------- 233 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~---------- 233 (426)
.+-.+...+.|..|.|||++.+.+| .+.+||||+||++.||++|+..|.+.+....+.++... .
T Consensus 170 ---~~~~mtpyVvtRyyrapevil~~~~-ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 170 ---TDFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred ---cccccCchhheeeccCchheeccCC-cccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 2235667889999999999999886 68899999999999999999999987766666554320 0
Q ss_pred ---------------CC----CCCC-----------CCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 234 ---------------FK----LPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 234 ---------------~~----~p~~-----------~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
+. +|.+ -+..+++|+.+||..||++|.+++++|.|||++-
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~v 315 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKV 315 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeee
Confidence 11 1211 1346899999999999999999999999999983
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=313.32 Aligned_cols=254 Identities=30% Similarity=0.428 Sum_probs=217.5
Q ss_pred CCeeeeceEeecCceEEEEEEECC-CCC--eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLD-SGL--PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~-~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (426)
++..+.++||+|+||.|+.|.++. +|+ .||||.+....... ....|.+|+.+|-+|+|||+++||++..+ ...-
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m 186 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM 186 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence 466778999999999999998875 333 69999997655433 47889999999999999999999999877 6788
Q ss_pred EEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 91 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~--~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
+|+|++++|+|.+.+.+ ...|.......|+.||+.|+.||.++++|||||-..||||.....+||+||||.+......
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 99999999999999986 4468888899999999999999999999999999999999999999999999998655432
Q ss_pred CCCcc-ccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHH
Q 014347 169 DDGLL-HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ 245 (426)
Q Consensus 169 ~~~~~-~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 245 (426)
+.-.+ ....-...|+|||.+....+ +.++|+|++||+||||++ |..||.+.+...+.++|-.+ .++-|+.++.++.
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kF-ShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY 345 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKF-SHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIY 345 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccc-cccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHH
Confidence 21111 11223457999999988887 688999999999999999 99999999999888888754 4788899999999
Q ss_pred HHHHHccccCccCCCCHHHHhcCccc
Q 014347 246 NLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
+++..||..+|.+|||+..|.++-+.
T Consensus 346 ~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 346 QIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred HHHHHhccCCccccccHHHHHHhHHH
Confidence 99999999999999999999765444
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=291.69 Aligned_cols=257 Identities=28% Similarity=0.423 Sum_probs=212.5
Q ss_pred eeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC-----EEE
Q 014347 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-----KIY 90 (426)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~~ 90 (426)
.+--+.||.|+||.||.++|..+|+.||+|.+.. -..+....+++.+|+.+|..++|.|++..+++..... .+|
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 4556899999999999999999999999998753 2223344678999999999999999999999876543 467
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCC
Q 014347 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 170 (426)
.++|.+.. +|...|.....++.+.++-+++||+.||+|||+.||.||||||.|+|++.|..+||||||+++..+.. +.
T Consensus 134 V~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d-~~ 211 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR-DR 211 (449)
T ss_pred HHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh-hh
Confidence 88888854 88888888889999999999999999999999999999999999999999999999999999975432 22
Q ss_pred CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHH--------------------
Q 014347 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF-------------------- 230 (426)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~-------------------- 230 (426)
..+...+-|..|+|||++.+...++.+.||||.|||+.||+-.+..|+..++....+.|.
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~ 291 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN 291 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence 333445678999999999988877899999999999999999999998877655544443
Q ss_pred ---cCCCCCCC-----------CCCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 231 ---RGDFKLPK-----------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 231 ---~~~~~~p~-----------~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
++....|+ ....++..++.++|.+||++|++.++.+.|++.....
T Consensus 292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 22222221 2334788999999999999999999999999887653
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=308.74 Aligned_cols=209 Identities=33% Similarity=0.600 Sum_probs=188.1
Q ss_pred ccCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhH-----HHHHHHHHHHHHhCC---CCCccc
Q 014347 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI-----TDQIKREIATLKLLK---HPNVVR 78 (426)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~-----~~~~~~Ei~il~~l~---hpnIv~ 78 (426)
...-..+..|..++.+|+|+||+|++|.++.+...|+||.+.|+++.-... .-.+-.||+||..++ |+||++
T Consensus 554 e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlK 633 (772)
T KOG1152|consen 554 EKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILK 633 (772)
T ss_pred eeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhh
Confidence 334456778999999999999999999999999999999998877653222 223567999999998 999999
Q ss_pred eEEEEEeCCEEEEEEecc-CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEee
Q 014347 79 LHEVLASKSKIYMVLEYV-TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISD 157 (426)
Q Consensus 79 l~~~~~~~~~~~lV~Ey~-~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~D 157 (426)
++++|++++.+||+||-- +|-+||++|+....++|.+++.+|+|++.|+++||+.||+|||||-||+.++.+|-+||+|
T Consensus 634 lLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 634 LLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred hhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEee
Confidence 999999999999999965 6779999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCC
Q 014347 158 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD 219 (426)
Q Consensus 158 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 219 (426)
||.|... ..+......||..|.|||++.+.+|-|.+-|||++|++||.++....||.+
T Consensus 714 fgsaa~~----ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 714 FGSAAYT----KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ccchhhh----cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9998853 456778899999999999999999999999999999999999998888753
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=301.61 Aligned_cols=250 Identities=25% Similarity=0.399 Sum_probs=206.3
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
++..+.++||+|-||+|.++.- ..+..||+|.++.....+ ....|.+||++|.+|+||||+.++++|..++.+++++
T Consensus 538 s~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~--~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKN--ARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred hheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchh--HHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 4567889999999999999984 557999999997665433 3688999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCC
Q 014347 94 EYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~--l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 171 (426)
||++.|+|.+++.+... .......+++.||++|++||.+.+++||||.+.|+|+|.++++||+|||+++-.-....-.
T Consensus 615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 99999999999987643 3445567799999999999999999999999999999999999999999998432211111
Q ss_pred ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh--CCCCCCCCcHHHHHHHH---HcC-----CCCCCCCCC
Q 014347 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT--GYLPFDDRNLAVLYQKI---FRG-----DFKLPKWLS 241 (426)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt--G~~Pf~~~~~~~~~~~i---~~~-----~~~~p~~~s 241 (426)
.-...+-...|+|||.+...++ +.++|+|++|+++||+++ ...||...+.+...... ... -+..|.-++
T Consensus 695 vqgr~vlpiRwmawEsillgkF-ttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp 773 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACP 773 (807)
T ss_pred eecceeeeeeehhHHHHHhccc-cchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCc
Confidence 1122344578999999988787 688999999999999765 88999887665544333 222 235577799
Q ss_pred HHHHHHHHHccccCccCCCCHHHHhc
Q 014347 242 PGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 242 ~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
..+.+|+.+||..+..+||+++++-.
T Consensus 774 ~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 774 QGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred HHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 99999999999999999999999843
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=303.13 Aligned_cols=252 Identities=28% Similarity=0.409 Sum_probs=210.0
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC------CCCccceEEEEEe
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK------HPNVVRLHEVLAS 85 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~------hpnIv~l~~~~~~ 85 (426)
.=++|.+....|+|-|++|..|.+..-|+.||||+|..+.. +.+.=.+|++||++|. .-|+++++-.|..
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 33689999999999999999999999999999999976543 3455678999999996 3489999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCC-CeEEeeccCc
Q 014347 86 KSKIYMVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLS 161 (426)
Q Consensus 86 ~~~~~lV~Ey~~gg~L~~~i~~~~---~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g-~vkL~DFGla 161 (426)
.+++|+|+|-+ ..+|.+.+.+-| .|....++.|++||.-||..|..+||+|.||||+|||+++.. .+||||||.|
T Consensus 506 knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 506 KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccc
Confidence 99999999988 468999998744 588999999999999999999999999999999999999765 5899999998
Q ss_pred cCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCC--
Q 014347 162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW-- 239 (426)
Q Consensus 162 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~-- 239 (426)
.... ......+.-+..|.|||++.+.+|+ ...|+||.||.||||.||+..|.+.+...+........-++|..
T Consensus 585 ~~~~----eneitPYLVSRFYRaPEIiLG~~yd-~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml 659 (752)
T KOG0670|consen 585 SFAS----ENEITPYLVSRFYRAPEIILGLPYD-YPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML 659 (752)
T ss_pred cccc----cccccHHHHHHhccCcceeecCccc-CCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence 7532 2334455667789999999999996 77999999999999999999999977665554433211111100
Q ss_pred ----------------------------------------------------------CCHHHHHHHHHccccCccCCCC
Q 014347 240 ----------------------------------------------------------LSPGAQNLLRKILEPNPVKRIT 261 (426)
Q Consensus 240 ----------------------------------------------------------~s~~~~~Li~~~L~~dP~~R~t 261 (426)
+-..+++||.+||..||.+|.|
T Consensus 660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit 739 (752)
T KOG0670|consen 660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT 739 (752)
T ss_pred hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence 0135789999999999999999
Q ss_pred HHHHhcCccccc
Q 014347 262 IAGIKADEWFEQ 273 (426)
Q Consensus 262 ~~eil~h~~f~~ 273 (426)
..++|.||||..
T Consensus 740 ~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 740 VNQALKHPFITE 751 (752)
T ss_pred HHHHhcCCcccC
Confidence 999999999964
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=283.97 Aligned_cols=254 Identities=27% Similarity=0.402 Sum_probs=205.1
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHH-HhCCCCCccceEEEEEeCCEEEEEE
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
..+-+..||.|+||.|++-.++.+|+..|||.++.... .....++..|.... +.-+.||||++|+....++..|+.|
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 44556789999999999999999999999999987654 34467788888765 4556999999999999999999999
Q ss_pred eccCCCChHHH---H--HhcCCCCHHHHHHHHHHHHHHHHHHhh-cCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 94 EYVTGGELFDK---I--ASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 94 Ey~~gg~L~~~---i--~~~~~l~~~~~~~i~~Ql~~aL~~LH~-~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
|++.- +|..+ + ..+..++|.-.-.+.--.+.||+||.. ..|+|||+||+|||++..|.+||||||++....
T Consensus 143 ELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv-- 219 (361)
T KOG1006|consen 143 ELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV-- 219 (361)
T ss_pred HHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHH--
Confidence 99943 55322 1 235679999998999899999999975 489999999999999999999999999986321
Q ss_pred cCCCccccccCCCcccchhhhcc--CCCCCCcchhhhHHHHHHHHHhCCCCCCCCc-HHHHHHHHHcCCCCC---CCC--
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKL---PKW-- 239 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DIwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~~~~~---p~~-- 239 (426)
+.-....-.|...|+|||.+.. .+|+ -++|+||||++|||+.||..|+.+-+ ..+....+..+.++. +..
T Consensus 220 -~SiAkT~daGCrpYmAPERi~p~~~gyD-iRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~ 297 (361)
T KOG1006|consen 220 -DSIAKTVDAGCRPYMAPERIDPSDKGYD-IRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECV 297 (361)
T ss_pred -HHHHhhhccCCccccChhccCCccCCcc-hhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccccc
Confidence 1112223468899999999863 4564 88999999999999999999998743 344555556666543 222
Q ss_pred -CCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 240 -LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 240 -~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
++..+..+|.-||.+|-+.||...+++.+||+...-
T Consensus 298 ~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 298 HYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred ccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 789999999999999999999999999999997653
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=309.70 Aligned_cols=252 Identities=24% Similarity=0.404 Sum_probs=220.3
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCC---eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
...-.|.+.||.|.||+|++|+-+..|+ .||||.++... .++....|..|+.||-+++||||++|.++.......
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv 705 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV 705 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee
Confidence 3456788999999999999999876664 69999996543 455678899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
.||.|||++|+|..+++. ++.|+.-+...+++.|++|++||-+.|.+||||...|||++.+-..|++||||++..+...
T Consensus 706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 999999999999999975 6789999999999999999999999999999999999999999999999999999764422
Q ss_pred CCCccccccCC--CcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHH
Q 014347 169 DDGLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGA 244 (426)
Q Consensus 169 ~~~~~~~~~gt--~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 244 (426)
.....+.-|- ..|.|||.+....+ +.++||||+|+++||.++ |..||-+.+..+..+.|..+ .++.|..++..+
T Consensus 786 -~~~ytt~GGKIPiRWTAPEAIa~RKF-TsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL 863 (996)
T KOG0196|consen 786 -EAAYTTLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAAL 863 (996)
T ss_pred -CccccccCCccceeecChhHhhhccc-CchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHH
Confidence 1222222232 57999999998888 578999999999999888 99999998888888888776 577788899999
Q ss_pred HHHHHHccccCccCCCCHHHHhcC
Q 014347 245 QNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
.+|+..||++|-.+||++.||+.+
T Consensus 864 ~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 864 YQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHHHHhhcCCCHHHHHHH
Confidence 999999999999999999999875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=288.94 Aligned_cols=130 Identities=31% Similarity=0.480 Sum_probs=114.8
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-----C---CCccceEEEEE-
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-----H---PNVVRLHEVLA- 84 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----h---pnIv~l~~~~~- 84 (426)
+||-+.++||.|-|++||+|.|..+.+.||+|+.+.. ....+....||.+|++++ | .+||+|++.|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 7999999999999999999999999999999998653 234677888999999885 2 47999999986
Q ss_pred ---eCCEEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhc-CceeccCCCCcEEec
Q 014347 85 ---SKSKIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLD 148 (426)
Q Consensus 85 ---~~~~~~lV~Ey~~gg~L~~~i~~--~~~l~~~~~~~i~~Ql~~aL~~LH~~-gIiHrDLKp~NILl~ 148 (426)
.+.++++|+|++ |..|...|.. ...++...++.|++|++.||.|||.. ||||-||||+|||+.
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 456899999999 7799999976 34799999999999999999999965 999999999999983
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=333.69 Aligned_cols=237 Identities=23% Similarity=0.333 Sum_probs=187.8
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
..|...+.||+|+||.||+|++..++..||+|.+..... ...+|+.++++++||||+++++++.+....|+||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 346667889999999999999999999999998864321 1234688999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh---hcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCC
Q 014347 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH---NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH---~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 170 (426)
||++||+|.+++.. +++..+..++.|++.||+||| +.+|+||||||+||+++.++..++. ||.+.....
T Consensus 763 Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---- 834 (968)
T PLN00113 763 EYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---- 834 (968)
T ss_pred eCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence 99999999999863 889999999999999999999 6699999999999999999888875 665543211
Q ss_pred CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCc-----HHHHHHHHHcC-------CCCC--
Q 014347 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-----LAVLYQKIFRG-------DFKL-- 236 (426)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~-----~~~~~~~i~~~-------~~~~-- 236 (426)
.....||+.|+|||++.+..+ +.++||||+||++|||++|+.||+... ........... +...
T Consensus 835 --~~~~~~t~~y~aPE~~~~~~~-~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 835 --DTKCFISSAYVAPETRETKDI-TEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred --CCCccccccccCcccccCCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence 123368899999999887666 689999999999999999999996421 11111111100 0011
Q ss_pred ----CCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 237 ----PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 237 ----p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
+.....++.+++.+||+.||++|||+.++++.
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 11112356789999999999999999999875
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=308.79 Aligned_cols=243 Identities=31% Similarity=0.433 Sum_probs=195.0
Q ss_pred eceEeecCceE-EEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCCEEEEEEecc
Q 014347 19 GRTLGEGNFGK-VKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVLEYV 96 (426)
Q Consensus 19 ~~~LG~G~fg~-Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~Ey~ 96 (426)
-+.+|.|+-|+ ||+|. -.|+.||||.+-.. ..+.+.|||..|+..+ |||||++|+.=.++.+.||..|.|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGV--YEGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred HHHcccCCCCcEEEEEe--eCCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 45689999985 78887 47889999987433 3567889999999886 999999999999999999999999
Q ss_pred CCCChHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecC---CC--CeEEeeccCccCCccc
Q 014347 97 TGGELFDKIASKGR----LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KG--NIKISDFGLSALPQHF 167 (426)
Q Consensus 97 ~gg~L~~~i~~~~~----l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~---~g--~vkL~DFGla~~~~~~ 167 (426)
. .+|.|+++..+. ......+....|+++||+|||+.+|+||||||.||||+. ++ +++|+|||+++.....
T Consensus 586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 5 499999987411 112456889999999999999999999999999999976 34 5899999999875443
Q ss_pred cC-CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhC-CCCCCCCcHHHHHHHHHcCCCCCCC---CCCH
Q 014347 168 RD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLAVLYQKIFRGDFKLPK---WLSP 242 (426)
Q Consensus 168 ~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~p~---~~s~ 242 (426)
.. -....+..||-+|+|||++..... ..++||+|+|||+|+.++| ..||.+.-.. ..+|.++...+-. .-+.
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~~~~d~ 741 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLEPLPDC 741 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhcccc-CcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeeccCchH
Confidence 22 123556789999999999876554 4689999999999999995 9999875432 2345566544321 1122
Q ss_pred HHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
++.+||.+||+++|..||++.++|.||+|=.
T Consensus 742 eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 742 EAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 8999999999999999999999999999953
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=301.30 Aligned_cols=258 Identities=29% Similarity=0.429 Sum_probs=222.7
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (426)
-.-++|++++.+|.|+||.||+|+|+.+++..|+|+++...- +...-+.+|+-+++..+||||+.+++.+-..+..+
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~---dd~~~iqqei~~~~dc~h~nivay~gsylr~dklw 88 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG---DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW 88 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCC---ccccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence 345789999999999999999999999999999999986643 33567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCC
Q 014347 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 170 (426)
+.||||.||+|.|.-.-.+++++.++.++.+..+.||+|||+.|-+|||||-.|||+++.|.+|++|||.+..+.. .-
T Consensus 89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti 166 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TI 166 (829)
T ss_pred EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh--hh
Confidence 9999999999999777778999999999999999999999999999999999999999999999999999874322 11
Q ss_pred CccccccCCCcccchhhhc--cCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCC-----CCCCHH
Q 014347 171 GLLHTTCGSPNYVAPEVLA--NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP-----KWLSPG 243 (426)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~--~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~ 243 (426)
.......|||.|+|||+-. .++-+...+|||++|+.-.|+-.-++|--+...........+..+..| ..+++.
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~ 246 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEF 246 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHH
Confidence 2335678999999999853 333335899999999999999988888777776665555555555544 347899
Q ss_pred HHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
+.+|++.+|.++|++|||++.+|.|||...
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 999999999999999999999999999854
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=276.36 Aligned_cols=245 Identities=27% Similarity=0.439 Sum_probs=194.4
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHH--hCCCCCccceEEEEEe----CC
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK--LLKHPNVVRLHEVLAS----KS 87 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~--~l~hpnIv~l~~~~~~----~~ 87 (426)
.+.++.+.||+|.||+||+|.+ .|+.||||++.... .....||.+|.+ .|+|+||+.+++.-.. -+
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred heeEEEEEecCccccceeeccc--cCCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 5788999999999999999986 68899999996432 356777777776 5799999999976432 24
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc--------CceeccCCCCcEEecCCCCeEEeecc
Q 014347 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK--------GVFHRDLKLENILLDSKGNIKISDFG 159 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~--------gIiHrDLKp~NILl~~~g~vkL~DFG 159 (426)
.+|||.+|.+.|+|+|++.+ ..++...+.+++..+++||+|||.. .|.|||||..|||+..+|..-|+|+|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 69999999999999999987 7899999999999999999999952 49999999999999999999999999
Q ss_pred CccCCccccC--CCccccccCCCcccchhhhccC----CCCC-CcchhhhHHHHHHHHHhC----------CCCCCC---
Q 014347 160 LSALPQHFRD--DGLLHTTCGSPNYVAPEVLANR----GYDG-ATSDIWSCGVILYVILTG----------YLPFDD--- 219 (426)
Q Consensus 160 la~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~----~~~~-~~~DIwSlGvil~elltG----------~~Pf~~--- 219 (426)
||....+..+ +...+..+||..|||||++... .+.+ ..+||||||.|+||+... ++||.+
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 9986554322 3345678999999999998542 2222 348999999999999862 678854
Q ss_pred --CcHHHHHHHHHcC--CCCCCC-CCCH----HHHHHHHHccccCccCCCCHHHHhc
Q 014347 220 --RNLAVLYQKIFRG--DFKLPK-WLSP----GAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 220 --~~~~~~~~~i~~~--~~~~p~-~~s~----~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
++.+++.+-+.-. .+.+|. |-+. .+-.|++.||..||.-|.|+--|.+
T Consensus 442 ~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 442 SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 4555665544333 344454 4332 3457899999999999999877754
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=265.93 Aligned_cols=256 Identities=27% Similarity=0.436 Sum_probs=204.7
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEE-EEeCC
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEV-LASKS 87 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~-~~~~~ 87 (426)
-...+.|.+.+.||+|.||++.+++++.+++.+++|.+.+... ....|.+|...--.| .|.||+.-|++ |++.+
T Consensus 20 v~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d 95 (378)
T KOG1345|consen 20 VDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD 95 (378)
T ss_pred cchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence 3455789999999999999999999999999999999876543 246677887654444 48999998887 56778
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecC--CCCeEEeeccCccCCc
Q 014347 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS--KGNIKISDFGLSALPQ 165 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~--~g~vkL~DFGla~~~~ 165 (426)
.+.+++||++.|+|.+-+.. .++-|...++++.|+++||.|+|+.+++|||||.+||||-. ..++||||||+.+..
T Consensus 96 ~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~- 173 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV- 173 (378)
T ss_pred eEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc-
Confidence 88899999999999998876 55899999999999999999999999999999999999943 347999999998742
Q ss_pred cccCCCccccccCCCcccchhhhccCC---C-CCCcchhhhHHHHHHHHHhCCCCCCCCcH----HHHHHHHHcC-CCCC
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLANRG---Y-DGATSDIWSCGVILYVILTGYLPFDDRNL----AVLYQKIFRG-DFKL 236 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~---~-~~~~~DIwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~-~~~~ 236 (426)
+...+..--+..|.+||++.... + ..+.+|+|.||+++|.+|||.+||+.... -..+.++..+ ....
T Consensus 174 ----g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~ 249 (378)
T KOG1345|consen 174 ----GTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPAL 249 (378)
T ss_pred ----CceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccC
Confidence 22334445567899999864321 1 13668999999999999999999985332 2344455444 3455
Q ss_pred CCC---CCHHHHHHHHHccccCccCC---CCHHHHhcCccccccC
Q 014347 237 PKW---LSPGAQNLLRKILEPNPVKR---ITIAGIKADEWFEQDY 275 (426)
Q Consensus 237 p~~---~s~~~~~Li~~~L~~dP~~R---~t~~eil~h~~f~~~~ 275 (426)
|.. +++.+..+.++-|.++|++| .++..-....|.+..-
T Consensus 250 P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i 294 (378)
T KOG1345|consen 250 PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLI 294 (378)
T ss_pred chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhh
Confidence 654 78999999999999999999 6677778888876543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=277.99 Aligned_cols=247 Identities=24% Similarity=0.360 Sum_probs=199.7
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHh--CCCCCccceEEEEEeCC-
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL--LKHPNVVRLHEVLASKS- 87 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~~- 87 (426)
..+...++.+.||+|.||.||+|.- +++.||||++.... .+.+..|-.|.+. ++|+||+++++.-...+
T Consensus 207 ~~l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~ 278 (534)
T KOG3653|consen 207 LELDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA 278 (534)
T ss_pred ccCCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence 3456678899999999999999984 56999999996433 5677888888775 57999999998765444
Q ss_pred ---EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh---------cCceeccCCCCcEEecCCCCeEE
Q 014347 88 ---KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN---------KGVFHRDLKLENILLDSKGNIKI 155 (426)
Q Consensus 88 ---~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~---------~gIiHrDLKp~NILl~~~g~vkL 155 (426)
.++||+||.+.|+|.+++.. ..+++.+..+++.-++.||+|||+ -.|+|||||..||||..|++.-|
T Consensus 279 ~~~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI 357 (534)
T KOG3653|consen 279 DRMEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI 357 (534)
T ss_pred cccceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence 79999999999999999986 669999999999999999999996 35999999999999999999999
Q ss_pred eeccCccCCccccCCCccccccCCCcccchhhhccCCCC-----CCcchhhhHHHHHHHHHhC------------CCCCC
Q 014347 156 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD-----GATSDIWSCGVILYVILTG------------YLPFD 218 (426)
Q Consensus 156 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-----~~~~DIwSlGvil~elltG------------~~Pf~ 218 (426)
+|||||..+......+.....+||..|||||++.+.--. -.+.||||+|.||||+++. ++||+
T Consensus 358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe 437 (534)
T KOG3653|consen 358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE 437 (534)
T ss_pred eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence 999999987766666677778999999999998653211 1358999999999999985 23443
Q ss_pred -----CCcHHHHHHHHHc--CCCCCCCCC-----CHHHHHHHHHccccCccCCCCHHHHh
Q 014347 219 -----DRNLAVLYQKIFR--GDFKLPKWL-----SPGAQNLLRKILEPNPVKRITIAGIK 266 (426)
Q Consensus 219 -----~~~~~~~~~~i~~--~~~~~p~~~-----s~~~~~Li~~~L~~dP~~R~t~~eil 266 (426)
.++.+++.....+ .++.+|..+ -..+.+.+..||+.||+-|.|+.=+.
T Consensus 438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~ 497 (534)
T KOG3653|consen 438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVE 497 (534)
T ss_pred HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence 2445555555543 355666432 34678999999999999999986543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=288.99 Aligned_cols=246 Identities=24% Similarity=0.359 Sum_probs=210.4
Q ss_pred eeeceEeecCceEEEEEEECCCCC----eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 014347 17 ELGRTLGEGNFGKVKFAQDLDSGL----PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 17 ~i~~~LG~G~fg~Vy~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (426)
+..++||.|+||.||+|...-.|+ +||+|++...... +....+.+|+-+|.+++|||++++++++.... +-||
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~--~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP--KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc--hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 446789999999999998764454 6899988755432 33578899999999999999999999998766 7889
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCC
Q 014347 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 171 (426)
++|+++|.|.|+++. +..+-......|..||++|+.|||.++++||||-..|+|+..-..+||.|||++++.......-
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 999999999999975 5678899999999999999999999999999999999999999999999999999876533222
Q ss_pred ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHHHHH
Q 014347 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLR 249 (426)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~ 249 (426)
......-.+.|+|=|.+....| +.++||||+||.+||++| |..|+++....++-..+..+ +++.|+.++-++..++.
T Consensus 856 ~~~~gK~pikwmale~i~~~~~-thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mv 934 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKY-THQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMV 934 (1177)
T ss_pred cccccccCcHHHHHHHhhccCC-CchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHH
Confidence 2222233567999999887777 689999999999999999 99999998888877777665 47889999999999999
Q ss_pred HccccCccCCCCHHHHh
Q 014347 250 KILEPNPVKRITIAGIK 266 (426)
Q Consensus 250 ~~L~~dP~~R~t~~eil 266 (426)
+||..|++.||+++++-
T Consensus 935 kCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 935 KCWMIDADSRPTFKELA 951 (1177)
T ss_pred HHhccCcccCccHHHHH
Confidence 99999999999988764
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=292.47 Aligned_cols=247 Identities=29% Similarity=0.460 Sum_probs=206.3
Q ss_pred eeeceEeecCceEEEEEEEC----C---CCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCCE
Q 014347 17 ELGRTLGEGNFGKVKFAQDL----D---SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSK 88 (426)
Q Consensus 17 ~i~~~LG~G~fg~Vy~a~~~----~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 88 (426)
.+.+.||+|+||.|++|.-. . ....||||.++..... ...+.+..|+.+|+.+. ||||+.+++.+..++.
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 56679999999999999732 1 1457999998654432 45788999999999985 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCC
Q 014347 89 IYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN 152 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~----------------~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~ 152 (426)
.++|+||+..|+|.++++..+ .++..+...++.||+.|++||++.+++||||-..|||+..+..
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~ 456 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKV 456 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCE
Confidence 999999999999999998754 3888999999999999999999999999999999999999999
Q ss_pred eEEeeccCccCCccccCCCccccccC--CCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCc-HHHHHHH
Q 014347 153 IKISDFGLSALPQHFRDDGLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRN-LAVLYQK 228 (426)
Q Consensus 153 vkL~DFGla~~~~~~~~~~~~~~~~g--t~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~-~~~~~~~ 228 (426)
+||+|||+|+....... .......| ...|||||.+....| +.++||||+||+|||+++ |..||.+-. ..++++.
T Consensus 457 ~kIaDFGlar~~~~~~~-y~~~~~~~~LP~kWmApEsl~~~~f-t~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~ 534 (609)
T KOG0200|consen 457 IKIADFGLARDHYNKDY-YRTKSSAGTLPVKWMAPESLFDRVF-TSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEF 534 (609)
T ss_pred EEEccccceeccCCCCc-eEecCCCCccceeecCHHHhccCcc-cccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHH
Confidence 99999999984322111 01111222 234999999988655 789999999999999999 999999844 5566776
Q ss_pred HHcC-CCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 229 IFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 229 i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
+..| ....|..+++++.++++.||+.+|.+||++.++..
T Consensus 535 l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 535 LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 7666 46889999999999999999999999999999864
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=273.84 Aligned_cols=254 Identities=28% Similarity=0.433 Sum_probs=202.6
Q ss_pred cCCCeeeeceEeecCceEEEEEEECC---CCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCC
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLD---SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKS 87 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 87 (426)
....|.++.+||+|+|+.||+|.+.. .++.||+|.+..... ..++.+|+++|..+. +.||+++.+.+..++
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 34578999999999999999999877 788999998865432 467999999999986 899999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecC-CCCeEEeeccCccCCcc
Q 014347 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQH 166 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~-~g~vkL~DFGla~~~~~ 166 (426)
...+||||.+..+..++... ++..+++.|++.++.||.++|.+||+||||||.|+|.+. .+.-.|+|||||.-.+.
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred eeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 99999999999888887754 779999999999999999999999999999999999985 46789999999872100
Q ss_pred cc--------------C-----------------C-----------CccccccCCCcccchhhhccCCCCCCcchhhhHH
Q 014347 167 FR--------------D-----------------D-----------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCG 204 (426)
Q Consensus 167 ~~--------------~-----------------~-----------~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlG 204 (426)
.. . . .......||++|.|||++...+-.+.++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 00 0 0 0011235999999999999888778999999999
Q ss_pred HHHHHHHhCCCCCCCCc-----HHHH---------H------HH--HHc-CC-------------C------C-------
Q 014347 205 VILYVILTGYLPFDDRN-----LAVL---------Y------QK--IFR-GD-------------F------K------- 235 (426)
Q Consensus 205 vil~elltG~~Pf~~~~-----~~~~---------~------~~--i~~-~~-------------~------~------- 235 (426)
||+..++++..||-... ..++ . .+ +.. .+ . +
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 99999999999993211 0000 0 00 000 00 0 0
Q ss_pred ---CCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 236 ---LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 236 ---~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
..+.++..+.+|+.+||+.||.+|+|++++|.||||..
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 00124668999999999999999999999999999974
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=250.86 Aligned_cols=220 Identities=45% Similarity=0.752 Sum_probs=188.2
Q ss_pred eeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEec
Q 014347 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (426)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey 95 (426)
|.+.+.||.|++|.||++.+..+++.+|+|.+...... ...+.+.+|+..++.++|+|++++++.+......++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67889999999999999999888999999999765432 2467899999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccc
Q 014347 96 VTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH 174 (426)
Q Consensus 96 ~~gg~L~~~i~~~~~-l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 174 (426)
+++++|.+.+..... +++..+..++.|++.++.+||++|++|+||+|.||+++.++.++|+|||++....... .....
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~-~~~~~ 157 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL-AALLK 157 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-ccccc
Confidence 999999999987666 8999999999999999999999999999999999999999999999999988643321 01234
Q ss_pred cccCCCcccchhhh-ccCCCCCCcchhhhHHHHHHHHHhCCCCCCC--CcHHHHHHHHHcCCCCCCCC
Q 014347 175 TTCGSPNYVAPEVL-ANRGYDGATSDIWSCGVILYVILTGYLPFDD--RNLAVLYQKIFRGDFKLPKW 239 (426)
Q Consensus 175 ~~~gt~~y~APE~l-~~~~~~~~~~DIwSlGvil~elltG~~Pf~~--~~~~~~~~~i~~~~~~~p~~ 239 (426)
...++..|++||.+ ....+ +.++|+|+||+++++|++|+.||.. .+...+.+.+..+.+...+|
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~-~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 224 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGY-GEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLWEW 224 (225)
T ss_pred ceeccCCcCCHhHhcCCCCC-CchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcccccc
Confidence 56788899999998 44444 5689999999999999999999987 44457778887776554443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=246.18 Aligned_cols=213 Identities=45% Similarity=0.786 Sum_probs=186.8
Q ss_pred EeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEeccCCCCh
Q 014347 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL 101 (426)
Q Consensus 22 LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~gg~L 101 (426)
||+|++|.||++.+..+++.+++|++....... ....+.+|+..++.++|++++++++++......++++||+.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999987654321 346799999999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecC-CCCeEEeeccCccCCccccCCCccccccCC
Q 014347 102 FDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHFRDDGLLHTTCGS 179 (426)
Q Consensus 102 ~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~-~g~vkL~DFGla~~~~~~~~~~~~~~~~gt 179 (426)
.+++... ..++...++.++.|++.+|.+||++|++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~ 156 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGT 156 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCC
Confidence 9999875 57999999999999999999999999999999999999999 89999999999875432110 13345678
Q ss_pred CcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccccCccCC
Q 014347 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259 (426)
Q Consensus 180 ~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R 259 (426)
..|++||.+......+.++|+|++|+++++| ..+.+++.+||+.||++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R 205 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR 205 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccC
Confidence 8999999987653446889999999999999 678999999999999999
Q ss_pred CCHHHHhcCc
Q 014347 260 ITIAGIKADE 269 (426)
Q Consensus 260 ~t~~eil~h~ 269 (426)
|++.++++++
T Consensus 206 ~~~~~l~~~~ 215 (215)
T cd00180 206 PSAKEILEHL 215 (215)
T ss_pred cCHHHHhhCC
Confidence 9999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=243.08 Aligned_cols=211 Identities=24% Similarity=0.434 Sum_probs=172.0
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHh-CCCCCccceEEEEEeCCEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL-LKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~lV 92 (426)
+...-+..||+|++|.|-+.++..+|+..|+|.+...- +.....+..+|+.+..+ ...|.+|.+|+.+.....+++.
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 34455778999999999999999999999999986432 33445677888887654 5699999999999999999999
Q ss_pred EeccCCCChHH----HHHhcCCCCHHHHHHHHHHHHHHHHHHhhc-CceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 93 LEYVTGGELFD----KIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 93 ~Ey~~gg~L~~----~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~-gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
||.+.. +|.. .+.+.+.++|...-+++..++.||.|||++ .++|||+||+|||++.+|++|+||||++...
T Consensus 124 ME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L--- 199 (282)
T KOG0984|consen 124 MELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL--- 199 (282)
T ss_pred HHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee---
Confidence 999954 6633 334567899999999999999999999987 8999999999999999999999999998743
Q ss_pred cCCCcccc-ccCCCcccchhhhc----cCCCCCCcchhhhHHHHHHHHHhCCCCCCC-CcHHHHHHHHHcC
Q 014347 168 RDDGLLHT-TCGSPNYVAPEVLA----NRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRG 232 (426)
Q Consensus 168 ~~~~~~~~-~~gt~~y~APE~l~----~~~~~~~~~DIwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~ 232 (426)
.++...+ ..|...|+|||.+. ..+| +-++||||||+.++||.+++.||+. .++.+..+++...
T Consensus 200 -~dSiAkt~daGCkpYmaPEri~~e~n~~gY-~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 200 -VDSIAKTMDAGCKPYMAPERINPELNQKGY-SVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred -hhhhHHHHhcCCCccCChhhcCcccCcccc-eeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 2233333 56889999999974 3455 5899999999999999999999975 4555555665544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-33 Score=292.69 Aligned_cols=261 Identities=31% Similarity=0.535 Sum_probs=212.1
Q ss_pred CCCe-eeeceEeecCceEEEEEEECCCCCeEEEEEeecc---cccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 014347 13 LGRY-ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKN---RIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 13 ~~~y-~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~---~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (426)
..+| ...+.+|.|++|.|+.+......+.++.|..... ..........+..|..+-..+.|||++..+..+.+...
T Consensus 316 ~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~ 395 (601)
T KOG0590|consen 316 SEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG 395 (601)
T ss_pred ccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc
Confidence 3456 4678899999999998888777777777755421 11122233347778888899999999888777777666
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
.+-+||||++ +|+..+...+.++..++..+++||+.||+|+|+.||.|||+||+|+++..+|.+||+|||.+..+....
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 6767999999 999999988899999999999999999999999999999999999999999999999999998765544
Q ss_pred CC--CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHH--HHHHc-------CCCCCC
Q 014347 169 DD--GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY--QKIFR-------GDFKLP 237 (426)
Q Consensus 169 ~~--~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~--~~i~~-------~~~~~p 237 (426)
.. ......+|+..|+|||++....|+....||||+|++++.|.+|+.||.-....+.. ..... +...+-
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLL 554 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHH
Confidence 43 45667899999999999999999999999999999999999999999765433221 11111 111222
Q ss_pred CCCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 238 ~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
..++...+.+|.+||++||.+|+|+++|++++||+..
T Consensus 555 ~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 555 SLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred HhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 3377889999999999999999999999999999864
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=294.42 Aligned_cols=200 Identities=16% Similarity=0.208 Sum_probs=146.5
Q ss_pred CCC-CCccceEEEE-------EeCCEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCC
Q 014347 71 LKH-PNVVRLHEVL-------ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141 (426)
Q Consensus 71 l~h-pnIv~l~~~~-------~~~~~~~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLK 141 (426)
++| +||.++++++ .....++.++||+ +++|.+++.. ...+++.+++.+++||+.||+|||++||+|||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 345 5777777766 2234577788887 6699999975 4569999999999999999999999999999999
Q ss_pred CCcEEecCCC-------------------CeEEeeccCccCCccccC--------------CCccccccCCCcccchhhh
Q 014347 142 LENILLDSKG-------------------NIKISDFGLSALPQHFRD--------------DGLLHTTCGSPNYVAPEVL 188 (426)
Q Consensus 142 p~NILl~~~g-------------------~vkL~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~APE~l 188 (426)
|+||||+..| .+|++|||+++....... .......+||+.|+|||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 9999996544 455666666543211000 0001124689999999998
Q ss_pred ccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 189 ~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
.+..| +.++|||||||+||||++|..|+..... ....+..... +.+....+...+++.+||++||.+|||+.++++
T Consensus 188 ~~~~~-~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 188 NGSSS-NCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred ccCCC-CchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 88777 6899999999999999999999764321 1111211111 111112456789999999999999999999999
Q ss_pred Ccccccc
Q 014347 268 DEWFEQD 274 (426)
Q Consensus 268 h~~f~~~ 274 (426)
||||...
T Consensus 265 h~~~~~~ 271 (793)
T PLN00181 265 SEFINEP 271 (793)
T ss_pred chhhhhh
Confidence 9999753
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-28 Score=231.68 Aligned_cols=257 Identities=37% Similarity=0.618 Sum_probs=214.0
Q ss_pred eeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCC-CccceEEEEEeCCEEEEEEe
Q 014347 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP-NVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~lV~E 94 (426)
|.+.+.||.|+||.||++.+. ..+++|.+.............+.+|+.+++.+.|+ +++++++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 789999999999999999986 78999999876655444578899999999999988 79999999988888899999
Q ss_pred ccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCC-CeEEeeccCccCCccccCC
Q 014347 95 YVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQHFRDD 170 (426)
Q Consensus 95 y~~gg~L~~~i~~~~---~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g-~vkL~DFGla~~~~~~~~~ 170 (426)
|+.++++.+.+.... .+++..+..++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||++.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999998777654 799999999999999999999999999999999999999998 6999999998754332211
Q ss_pred ----CccccccCCCcccchhhhccC--CCCCCcchhhhHHHHHHHHHhCCCCCCCCcH----HHHHHHHHcCCCC-CCCC
Q 014347 171 ----GLLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYVILTGYLPFDDRNL----AVLYQKIFRGDFK-LPKW 239 (426)
Q Consensus 171 ----~~~~~~~gt~~y~APE~l~~~--~~~~~~~DIwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~-~p~~ 239 (426)
......+||+.|+|||.+... .+.+...|+||+|++++++++|..||..... ......+.....+ ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 134677899999999998874 4557889999999999999999999987763 4555555444433 2222
Q ss_pred CC--------HHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 240 LS--------PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 240 ~s--------~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
.. ..+.+++.+++..+|..|.+..+...++|.....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~ 282 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK 282 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence 22 4789999999999999999999998887665433
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=238.20 Aligned_cols=252 Identities=20% Similarity=0.241 Sum_probs=205.4
Q ss_pred CCCeeeeceEeecCceEEEEEEECC-----CCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEE-eC
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA-SK 86 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~ 86 (426)
-.|+++.-.+-+|+||.||.|...+ +.+.|-+|.++... ..-.+..+..|...+..+.|||+..+.++.. +.
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY 360 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence 3578888899999999999996553 23456777664332 3344678889999999999999999999874 45
Q ss_pred CEEEEEEeccCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeec
Q 014347 87 SKIYMVLEYVTGGELFDKIASK--------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDF 158 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~--------~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DF 158 (426)
...+.++.+..-|+|..++... +.++..+...++.|++.|++|||++||+|.||-..|.+||+.-++||+|=
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDs 440 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDS 440 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccc
Confidence 6677788888889999988721 23667778889999999999999999999999999999999999999999
Q ss_pred cCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCC
Q 014347 159 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKL 236 (426)
Q Consensus 159 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~ 236 (426)
.+++-.-...-...-..--....||+||.+.+..| +.++|+|||||+||||+| |+.|+..-++.+++..+..| +..-
T Consensus 441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~y-ssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQ 519 (563)
T KOG1024|consen 441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHY-SSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQ 519 (563)
T ss_pred hhccccCcccccccCCCCCCcccccCHHHHhhhhh-cchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecC
Confidence 99984322111111111223457999999998888 588999999999999999 99999999999998888877 4677
Q ss_pred CCCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 237 PKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 237 p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
|-.+|+++..++..||..+|++||+.+|+..
T Consensus 520 P~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 520 PFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred CCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 8889999999999999999999999999754
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=225.15 Aligned_cols=159 Identities=23% Similarity=0.280 Sum_probs=129.6
Q ss_pred CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcccccc
Q 014347 99 GELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 177 (426)
Q Consensus 99 g~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 177 (426)
|+|.+++.. ..++++.+++.++.|++.||.|||+++ ||+|||++.++.+|+ ||++..... ....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~-------~~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP-------EQSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc-------ccCC
Confidence 689999986 456999999999999999999999999 999999999999999 999875432 1236
Q ss_pred CCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcH-HHHHHHHHcCCCCC-------CCCCCH--HHHHH
Q 014347 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRGDFKL-------PKWLSP--GAQNL 247 (426)
Q Consensus 178 gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~-------p~~~s~--~~~~L 247 (426)
||+.|+|||++.+..+ +.++||||+||++|+|++|..||..... ......+....... +..++. .+.++
T Consensus 66 g~~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (176)
T smart00750 66 VDPYFMAPEVIQGQSY-TEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADF 144 (176)
T ss_pred CcccccChHHhcCCCC-cchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence 8999999999988776 5899999999999999999999976543 23333333222111 222344 69999
Q ss_pred HHHccccCccCCCCHHHHhcCccccc
Q 014347 248 LRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 248 i~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
+.+||+.||.+|||+.+++.|+|+..
T Consensus 145 i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 145 MRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHHhcccccccCHHHHHHHHHHHH
Confidence 99999999999999999999999853
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-30 Score=257.51 Aligned_cols=239 Identities=33% Similarity=0.630 Sum_probs=210.0
Q ss_pred eEeecCceEEEEEEE---CCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCCEEEEEEecc
Q 014347 21 TLGEGNFGKVKFAQD---LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVLEYV 96 (426)
Q Consensus 21 ~LG~G~fg~Vy~a~~---~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~Ey~ 96 (426)
.+|+|+||+|++++. ...|..+|+|+..+......... ....|-.++...+ ||.+++++..++++...|++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 479999999998763 34678899999987655443323 5666888888887 999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccc
Q 014347 97 TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 176 (426)
Q Consensus 97 ~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 176 (426)
.||+|+..+.....+.+...+.+...++-+++++|+.||+|||+|++||+++.+|++++.|||+++..-. ....
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~------~~~~ 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK------EKIA 153 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHh------hhhc
Confidence 9999999998888899999999999999999999999999999999999999999999999999985321 1222
Q ss_pred cCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccccCc
Q 014347 177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNP 256 (426)
Q Consensus 177 ~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP 256 (426)
|||..|||||++. +. ...+|.||+|++.|+|++|..||.. ++...|.+..+..|..+++.+++++..++..+|
T Consensus 154 cgt~eymApEI~~--gh-~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p 226 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GH-LSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNP 226 (612)
T ss_pred ccchhhhhhHhhh--cc-CCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCH
Confidence 9999999999987 44 4679999999999999999999998 677788888999999999999999999999999
Q ss_pred cCCCC-----HHHHhcCccccc
Q 014347 257 VKRIT-----IAGIKADEWFEQ 273 (426)
Q Consensus 257 ~~R~t-----~~eil~h~~f~~ 273 (426)
.+|.- ..+|++|++|+.
T Consensus 227 ~nrLg~~~~~~~eik~h~f~~~ 248 (612)
T KOG0603|consen 227 ENRLGAGPDGVDEIKQHEFFQS 248 (612)
T ss_pred HHHhccCcchhHHHhccchhee
Confidence 99975 578999999975
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-28 Score=240.09 Aligned_cols=172 Identities=22% Similarity=0.167 Sum_probs=135.5
Q ss_pred cCCccCCCeeeeceEeecCceEEEEEEECC-CCCeEEEEEeecccc--cchhHHHHHHHHHHHHHhCCCCCccc-eEEEE
Q 014347 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRI--IHLKITDQIKREIATLKLLKHPNVVR-LHEVL 83 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~-l~~~~ 83 (426)
+.....++|++.+.||+|+||+||+|.+.. +++.||||.+..... ........+.+|+.+|+.++|+|++. +++.
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 345677899999999999999999999876 678889998753311 12234567999999999999999985 4432
Q ss_pred EeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccC-CCCcEEecCCCCeEEeeccCcc
Q 014347 84 ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL-KLENILLDSKGNIKISDFGLSA 162 (426)
Q Consensus 84 ~~~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDL-Kp~NILl~~~g~vkL~DFGla~ 162 (426)
+..|+||||++|++|.. +.. .. ...++.|+++||.|||++||+|||| ||+|||++.++.+||+|||+|+
T Consensus 91 ---~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred ---CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 45899999999999963 211 11 2568899999999999999999999 9999999999999999999998
Q ss_pred CCccccCCC------ccccccCCCcccchhhhcc
Q 014347 163 LPQHFRDDG------LLHTTCGSPNYVAPEVLAN 190 (426)
Q Consensus 163 ~~~~~~~~~------~~~~~~gt~~y~APE~l~~ 190 (426)
......... ...+.++++.|+|||.+..
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 654322111 2245678999999999753
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-26 Score=224.43 Aligned_cols=249 Identities=23% Similarity=0.297 Sum_probs=193.5
Q ss_pred CeeeeceEeecCceEEEEEEECCCC-CeEEEEEeecccccchhHHHHHHHHHHHHHhCCC----CCccceEEEE-EeCCE
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSG-LPFAVKILEKNRIIHLKITDQIKREIATLKLLKH----PNVVRLHEVL-ASKSK 88 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h----pnIv~l~~~~-~~~~~ 88 (426)
+|.+.+.||+|+||.||++.+..++ ..+|+|+......... ..+..|+.++..+.. +++..+++.+ ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999988775 6799998765432221 267788999988873 6899999999 57888
Q ss_pred EEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCC-----CCeEEeeccCc
Q 014347 89 IYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-----GNIKISDFGLS 161 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~--~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~-----g~vkL~DFGla 161 (426)
.|+||+.+ |.+|.++.... +.++...+.+++.|++.+|+++|+.|++||||||+|+++... ..+.|.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999998 88999987543 589999999999999999999999999999999999999865 35899999999
Q ss_pred cCCccccCC-------Cc-cccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHH---HHHHHH
Q 014347 162 ALPQHFRDD-------GL-LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV---LYQKIF 230 (426)
Q Consensus 162 ~~~~~~~~~-------~~-~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~---~~~~i~ 230 (426)
+........ .. .....||..|+++.+..+... +.+.|+||++.++.+++.|.+||.+..... .+.+..
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 832211111 11 223459999999999877666 799999999999999999999997755322 222222
Q ss_pred cCCC-C-CCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 231 RGDF-K-LPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 231 ~~~~-~-~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
.... . +....+..+..+...+-..+...+|....+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 2211 1 233345677777777777899999988777554
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.6e-26 Score=203.75 Aligned_cols=251 Identities=21% Similarity=0.296 Sum_probs=196.7
Q ss_pred ccccCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCC-CCccceEEEE
Q 014347 5 EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNVVRLHEVL 83 (426)
Q Consensus 5 ~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~ 83 (426)
.+..+-+..|+|.++++||.|+||.+|+|....+|+.||||+=... ..+ .++..|..+.+.|++ ..|..+..++
T Consensus 6 ~s~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-a~h----pqL~yEskvY~iL~~g~GiP~i~~y~ 80 (341)
T KOG1163|consen 6 GSLEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-AKH----PQLLYESKVYRILQGGVGIPHIRHYG 80 (341)
T ss_pred cchhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-CCC----cchhHHHHHHHHhccCCCCchhhhhc
Confidence 3445567789999999999999999999999999999999985432 222 467789999999985 6788888888
Q ss_pred EeCCEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCC---CCeEEeecc
Q 014347 84 ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---GNIKISDFG 159 (426)
Q Consensus 84 ~~~~~~~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~---g~vkL~DFG 159 (426)
.+...-.+||+.. |.+|.++..- ...++...+.-++-|++.-++|+|.++++||||||+|.|..-+ ..+.++|||
T Consensus 81 ~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFG 159 (341)
T KOG1163|consen 81 TEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFG 159 (341)
T ss_pred cccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEecc
Confidence 8888999999998 8899888763 4579999999999999999999999999999999999999643 468999999
Q ss_pred CccCCccccCCC-----ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCc---HHHHHHHHHc
Q 014347 160 LSALPQHFRDDG-----LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFR 231 (426)
Q Consensus 160 la~~~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~ 231 (426)
+|+.+....... .-....||..|.+--...+... +...|+=|+|.+|..+..|.+||++-. ...-+.+|..
T Consensus 160 LaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~E 238 (341)
T KOG1163|consen 160 LAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISE 238 (341)
T ss_pred chhhhccccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHH
Confidence 998754332211 1123468999998766554443 577899999999999999999999854 3455667766
Q ss_pred CCCCCC-----CCCCHHHHHHHHHccccCccCCCCH
Q 014347 232 GDFKLP-----KWLSPGAQNLLRKILEPNPVKRITI 262 (426)
Q Consensus 232 ~~~~~p-----~~~s~~~~~Li~~~L~~dP~~R~t~ 262 (426)
...+.| +.+|.++...+.-|=..--++-|..
T Consensus 239 kK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy 274 (341)
T KOG1163|consen 239 KKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDY 274 (341)
T ss_pred hhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence 666554 3467777777777755554555553
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-27 Score=246.73 Aligned_cols=221 Identities=32% Similarity=0.606 Sum_probs=178.6
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
.-.+|+.+++|..|+||.||+++|+.+.+.+|+|+ ++++.. +++ ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~li-------lRn---ilt~a~npfvv-------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLI-------LRN---ILTFAGNPFVV-------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcc-cccchh-------hhc---cccccCCccee--------------
Confidence 34679999999999999999999999999999954 443321 111 33444444444
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc----
Q 014347 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF---- 167 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~---- 167 (426)
|+-...+..-++++... +.+++|+|+.||+|||+||+|+||+.-|++|++|||+++..-..
T Consensus 136 -------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 -------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred -------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 45555566556666554 78999999999999999999999999999999999998742100
Q ss_pred ---------cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCC
Q 014347 168 ---------RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK 238 (426)
Q Consensus 168 ---------~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~ 238 (426)
...-.-...||||.|.|||++...+| |..+|+|++|+|+|+.+-|..||.+++.++++.+.......+|+
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 279 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence 00011234599999999999999998 78999999999999999999999999999999999988887775
Q ss_pred C---CCHHHHHHHHHccccCccCCC---CHHHHhcCccccc
Q 014347 239 W---LSPGAQNLLRKILEPNPVKRI---TIAGIKADEWFEQ 273 (426)
Q Consensus 239 ~---~s~~~~~Li~~~L~~dP~~R~---t~~eil~h~~f~~ 273 (426)
. ++++++++|.++|+.+|..|. .+-++.+|+||+.
T Consensus 280 ~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 280 EDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL 320 (1205)
T ss_pred cCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence 4 789999999999999999996 4778999999975
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-24 Score=204.04 Aligned_cols=213 Identities=23% Similarity=0.370 Sum_probs=177.7
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCCEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV 92 (426)
-.|+++++||+|+||+.++|.+..+++.||||.=.... ...+++.|.+..+.|. .++|...|.+...+.+-.+|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 48999999999999999999999999999999754322 1467888999999886 69999999999998899999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCC-----CeEEeeccCccCCcc
Q 014347 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-----NIKISDFGLSALPQH 166 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g-----~vkL~DFGla~~~~~ 166 (426)
||++ |.+|.|+..- ..+|+.+.+..++.|++.-++|+|++.+|+|||||+|.||..-+ .+.++|||+|+.+..
T Consensus 103 idLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred hhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 9998 8899998875 45799999999999999999999999999999999999997544 489999999986533
Q ss_pred ccC-----CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCC---CcHHHHHHHHHcCC
Q 014347 167 FRD-----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD---RNLAVLYQKIFRGD 233 (426)
Q Consensus 167 ~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~---~~~~~~~~~i~~~~ 233 (426)
... -+...+..||..||+--...++.. +...|+=|||-++++.|.|.+||++ .+...-|++|-...
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ-SRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K 255 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK 255 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchh-hhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence 211 122345579999999777666655 6889999999999999999999987 45556677775443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-25 Score=201.60 Aligned_cols=141 Identities=21% Similarity=0.281 Sum_probs=113.6
Q ss_pred eceEeecCceEEEEEEECCCCCeEEEEEeecccccchh-----------------------HHHHHHHHHHHHHhCCCCC
Q 014347 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-----------------------ITDQIKREIATLKLLKHPN 75 (426)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~-----------------------~~~~~~~Ei~il~~l~hpn 75 (426)
.+.||+|+||.||+|.+. +|+.||+|+++........ ......+|+.++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 578999999999999986 8999999999765321111 0123456999999998887
Q ss_pred ccceEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-hhcCceeccCCCCcEEecCCCCeE
Q 014347 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC-HNKGVFHRDLKLENILLDSKGNIK 154 (426)
Q Consensus 76 Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~L-H~~gIiHrDLKp~NILl~~~g~vk 154 (426)
+.....+... ..++||||++|+++...+...+++++..+..++.|++.+|.++ |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 7544433222 2389999999988876655567899999999999999999999 799999999999999998 57899
Q ss_pred EeeccCccC
Q 014347 155 ISDFGLSAL 163 (426)
Q Consensus 155 L~DFGla~~ 163 (426)
|+|||+|..
T Consensus 158 LiDFG~a~~ 166 (190)
T cd05147 158 IIDVSQSVE 166 (190)
T ss_pred EEEcccccc
Confidence 999999974
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.7e-25 Score=202.94 Aligned_cols=174 Identities=14% Similarity=0.195 Sum_probs=136.6
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHH------HHHHHHHHHhCCCCCccceEEEEEe
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ------IKREIATLKLLKHPNVVRLHEVLAS 85 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~------~~~Ei~il~~l~hpnIv~l~~~~~~ 85 (426)
.-++|++.+.||.|+||.||++.+ ++..+|+|++............. +.+|+..+.++.||+|..+.+++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 457999999999999999999765 46689999997665544444444 6899999999999999999988654
Q ss_pred C--------CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEee
Q 014347 86 K--------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISD 157 (426)
Q Consensus 86 ~--------~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~D 157 (426)
. +..+++|||++|.+|.+... +++ ....+++.+|..||+.|++|||+||+||+++++| ++|+|
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence 3 35899999999999977632 333 2456999999999999999999999999999999 99999
Q ss_pred ccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHH
Q 014347 158 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 211 (426)
Q Consensus 158 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ell 211 (426)
||......... ....++....|. .++|+||||+.+..+.
T Consensus 178 fg~~~~~~e~~--------------a~d~~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQRK--------------AKDRIDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccchh--------------hHHHHHHHhHhc-ccccccceeEeehHHH
Confidence 99876432110 001133445565 7899999999887664
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=5e-24 Score=194.08 Aligned_cols=143 Identities=22% Similarity=0.268 Sum_probs=115.9
Q ss_pred eeceEeecCceEEEEEEECCCCCeEEEEEeecccccch-----------------------hHHHHHHHHHHHHHhCCCC
Q 014347 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-----------------------KITDQIKREIATLKLLKHP 74 (426)
Q Consensus 18 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~-----------------------~~~~~~~~Ei~il~~l~hp 74 (426)
+.+.||+|+||.||+|.+. +|+.||||+++....... .....+.+|...+.++.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 899999999986532100 0123356899999999999
Q ss_pred CccceEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-cCceeccCCCCcEEecCCCCe
Q 014347 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNI 153 (426)
Q Consensus 75 nIv~l~~~~~~~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~-~gIiHrDLKp~NILl~~~g~v 153 (426)
++.....+.... .|+||||++|+++........+++..++..++.|++.++.++|+ +||+||||||+|||++ ++.+
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence 886555443332 48999999998665543345678999999999999999999999 9999999999999999 8999
Q ss_pred EEeeccCccCC
Q 014347 154 KISDFGLSALP 164 (426)
Q Consensus 154 kL~DFGla~~~ 164 (426)
+|+|||++...
T Consensus 157 ~liDFG~a~~~ 167 (190)
T cd05145 157 YIIDVSQAVEL 167 (190)
T ss_pred EEEEcccceec
Confidence 99999999854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-25 Score=234.30 Aligned_cols=246 Identities=28% Similarity=0.398 Sum_probs=187.4
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeeccc-ccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNR-IIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
.|...+.||.+.|=+|.+|++. .|. |+||++-+.. ........+..+|++ ...++|||.+++.-+..++...|+|-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 6888999999999999999974 455 9999987655 223333344445666 67789999999999888888899999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCC--ccccCCC
Q 014347 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP--QHFRDDG 171 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~--~~~~~~~ 171 (426)
+|+.. +|+|++..+.-+...+.+-|+.||+.||.-||..||+|||||.|||||+.-+.+.|+||..-+-. .+..+..
T Consensus 101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 99976 99999988778889999999999999999999999999999999999999999999999854321 1101110
Q ss_pred ---ccccccCCCcccchhhhccCC----------CCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcCCCCCC
Q 014347 172 ---LLHTTCGSPNYVAPEVLANRG----------YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 237 (426)
Q Consensus 172 ---~~~~~~gt~~y~APE~l~~~~----------~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p 237 (426)
...+...-.+|.|||.+.... .-+++.||||+||++.||++ |++||.-...- ....+.-..|
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~----aYr~~~~~~~ 255 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLL----AYRSGNADDP 255 (1431)
T ss_pred ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHH----hHhccCccCH
Confidence 112233445899999975422 12578999999999999999 89999642211 1111111111
Q ss_pred -----CCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 238 -----KWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 238 -----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
.--+..+++||..|++.||++|.++++.|+.
T Consensus 256 e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 256 EQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1125589999999999999999999999876
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=5e-24 Score=203.18 Aligned_cols=235 Identities=26% Similarity=0.352 Sum_probs=152.8
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCC----------CCccceEEEEE
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH----------PNVVRLHEVLA 84 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h----------pnIv~l~~~~~ 84 (426)
....++.||.|+++.||.++|..||+.+|+|+............+++++|.-....+.+ -.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 45778899999999999999999999999999876554444557788887766555432 13333333322
Q ss_pred ---------eC---CE-----EEEEEeccCCCChHHHHH---hcCCC---CHHHH-HHHHHHHHHHHHHHhhcCceeccC
Q 014347 85 ---------SK---SK-----IYMVLEYVTGGELFDKIA---SKGRL---QEAEG-RKLFQQLIDGVSYCHNKGVFHRDL 140 (426)
Q Consensus 85 ---------~~---~~-----~~lV~Ey~~gg~L~~~i~---~~~~l---~~~~~-~~i~~Ql~~aL~~LH~~gIiHrDL 140 (426)
.. +. .+++|.-+. ++|.+.+. ..... ....+ ..+..|++..+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11 11 256677664 48877654 22222 11223 444589999999999999999999
Q ss_pred CCCcEEecCCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCC-------CCCCcchhhhHHHHHHHHHhC
Q 014347 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG-------YDGATSDIWSCGVILYVILTG 213 (426)
Q Consensus 141 Kp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-------~~~~~~DIwSlGvil~elltG 213 (426)
+|+|++++.+|.++|+||+.....+. .......+..|.+||...... ..+.+.|.|+||+++|.|+||
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~-----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGT-----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTE-----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCc-----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 99999999999999999987663221 111134557899999864421 226788999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccccCccCC
Q 014347 214 YLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259 (426)
Q Consensus 214 ~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R 259 (426)
..||+.......... .+..-..++..++.||+.+|++||.+|
T Consensus 247 ~lPf~~~~~~~~~~~----~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW----DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG----GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc----cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 999987544321111 222222688999999999999999988
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-26 Score=241.47 Aligned_cols=260 Identities=33% Similarity=0.528 Sum_probs=220.7
Q ss_pred CCCeeeeceEeecCceEEEEEEECC-CCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCCEEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 90 (426)
...|.+.+.||+|+|+.|-++.+.. +...+|+|.+.... .......++..|..+-+.+. |+|++.+++........+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 6789999999999999999888753 44567777765443 23445667778999999888 999999999999999999
Q ss_pred EEEeccCCCChHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHh-hcCceeccCCCCcEEecCCC-CeEEeeccCccCCcc
Q 014347 91 MVLEYVTGGELFDKI-ASKG-RLQEAEGRKLFQQLIDGVSYCH-NKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQH 166 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i-~~~~-~l~~~~~~~i~~Ql~~aL~~LH-~~gIiHrDLKp~NILl~~~g-~vkL~DFGla~~~~~ 166 (426)
++++|..|+++++.+ .... .++...+..++.|+..++.|+| ..++.|||+||+|.+++..+ ++|++|||+|+.+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999999 6655 7889999999999999999999 99999999999999999999 999999999998766
Q ss_pred -ccCCCccccccC-CCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHH-HHHHcC--C--CCCCCC
Q 014347 167 -FRDDGLLHTTCG-SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY-QKIFRG--D--FKLPKW 239 (426)
Q Consensus 167 -~~~~~~~~~~~g-t~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~-~~i~~~--~--~~~p~~ 239 (426)
.+........|| ++.|.|||...+..|.++..|+||+|+++..+++|..||+........ ..+... . ......
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 455566778899 999999999988888899999999999999999999999875543221 111111 1 222344
Q ss_pred CCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 240 ~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
++..+.+++.++|..+|..|.+.+++..++|+..
T Consensus 258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred CChhhhhcccccccCCchhccccccccccccccc
Confidence 8899999999999999999999999999999987
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=201.48 Aligned_cols=254 Identities=25% Similarity=0.434 Sum_probs=176.5
Q ss_pred ccCCccCCCeeeeceEeecCceEEEEEEECCCCC-----------------------------------eEEEEEeeccc
Q 014347 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGL-----------------------------------PFAVKILEKNR 51 (426)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~-----------------------------------~vAvK~i~~~~ 51 (426)
...++++++|++++.||+|.-+.||.|+-...|. +.|||.+-.-.
T Consensus 150 ~dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~ 229 (598)
T KOG4158|consen 150 IDSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFE 229 (598)
T ss_pred hhcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccc
Confidence 3457788999999999999999999987443221 24555442211
Q ss_pred cc--chhHHHHHHHHHH------H--------HHh--------CCCCCccceEEEEE-----------------------
Q 014347 52 II--HLKITDQIKREIA------T--------LKL--------LKHPNVVRLHEVLA----------------------- 84 (426)
Q Consensus 52 ~~--~~~~~~~~~~Ei~------i--------l~~--------l~hpnIv~l~~~~~----------------------- 84 (426)
.. +....+..-+|.- . .+. -+|||||++...|.
T Consensus 230 ~~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p 309 (598)
T KOG4158|consen 230 HDSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYP 309 (598)
T ss_pred cCCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecc
Confidence 11 1122222333321 0 111 24999999987652
Q ss_pred ----eCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEec--CCC--CeEEe
Q 014347 85 ----SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD--SKG--NIKIS 156 (426)
Q Consensus 85 ----~~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~--~~g--~vkL~ 156 (426)
.+..+|+||...+. +|..++..+ ..+....+-++.|+++|+.|||++||.|||+|.+|||+. +|+ .+.|+
T Consensus 310 ~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVva 387 (598)
T KOG4158|consen 310 SGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVA 387 (598)
T ss_pred cccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEc
Confidence 23458999987754 899998763 467788889999999999999999999999999999994 443 47899
Q ss_pred eccCccCCccc--cC--CCccccccCCCcccchhhhccCC-----CCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHH
Q 014347 157 DFGLSALPQHF--RD--DGLLHTTCGSPNYVAPEVLANRG-----YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQ 227 (426)
Q Consensus 157 DFGla~~~~~~--~~--~~~~~~~~gt~~y~APE~l~~~~-----~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~ 227 (426)
|||.+-.-+.. .- ....-..-|.-.-+|||+....+ .+-.++|.|++|.+-||++....||.......+-.
T Consensus 388 DFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~ 467 (598)
T KOG4158|consen 388 DFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT 467 (598)
T ss_pred ccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech
Confidence 99976432110 00 01111235777899999975322 12257999999999999999999998744332211
Q ss_pred HHH--cCCCCCCCCCCHHHHHHHHHccccCccCCCCH
Q 014347 228 KIF--RGDFKLPKWLSPGAQNLLRKILEPNPVKRITI 262 (426)
Q Consensus 228 ~i~--~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~ 262 (426)
.-+ ..-+.+|+.+++.+++|+..+|+.||++|++.
T Consensus 468 r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp 504 (598)
T KOG4158|consen 468 RTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSP 504 (598)
T ss_pred hhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCc
Confidence 111 22456788899999999999999999999984
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=184.09 Aligned_cols=191 Identities=18% Similarity=0.184 Sum_probs=142.2
Q ss_pred eeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchh-HHHHHHHHHHHHHhCC-CCCccceEEEEEeCCEEEEEEe
Q 014347 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-ITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 17 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~-~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E 94 (426)
.+...|++|+||+||++.. .+..++.+.+......... ....+.+|+++|++|. |+++.+++++ ...|++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4678899999999998774 6777887766544332111 1235889999999996 5889999886 44799999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccC-CCCcEEecCCCCeEEeeccCccCCccccCC---
Q 014347 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL-KLENILLDSKGNIKISDFGLSALPQHFRDD--- 170 (426)
Q Consensus 95 y~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDL-Kp~NILl~~~g~vkL~DFGla~~~~~~~~~--- 170 (426)
|+.|.+|.+.+.. . ...++.|++.+|.+||++||+|||| ||+|||++.+|.++|+|||+|........-
T Consensus 79 yI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~ 151 (218)
T PRK12274 79 YLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL 151 (218)
T ss_pred eecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence 9999998754321 1 2357899999999999999999999 799999999999999999999854331110
Q ss_pred ---C-----ccccccCCCcccchhhhccC-CCCCCcchhhhHHHHHHHHHhCCCCCCCC
Q 014347 171 ---G-----LLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDR 220 (426)
Q Consensus 171 ---~-----~~~~~~gt~~y~APE~l~~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~ 220 (426)
. .......++.|++|+...-- ...-...++++.|+-+|.++|+..|+-++
T Consensus 152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 01123478899999864321 11125679999999999999999887543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.9e-23 Score=189.08 Aligned_cols=248 Identities=20% Similarity=0.348 Sum_probs=201.3
Q ss_pred ccCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 014347 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (426)
...|+.++...++.+|.+...|+.|+|+.. |..++.|++..... .......|..|.-.|+.+.||||+.+++.+.+.
T Consensus 183 r~~gid~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~-t~risrdfneefp~lrifshpnilpvlgacnsp 259 (448)
T KOG0195|consen 183 RYTGIDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREV-TARISRDFNEEFPALRIFSHPNILPVLGACNSP 259 (448)
T ss_pred cccCcchhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhc-chhhcchhhhhCcceeeecCCchhhhhhhccCC
Confidence 345667777888999999999999999974 44577788865443 333456788899999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcC--ceeccCCCCcEEecCCCCeEEe--eccC
Q 014347 87 SKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDSKGNIKIS--DFGL 160 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~~--~l~~~~~~~i~~Ql~~aL~~LH~~g--IiHrDLKp~NILl~~~g~vkL~--DFGl 160 (426)
....++..|++-|+|+..+.... -.+..++.+++.+++.|++|||+.. |.---|....+++|++-+.+|+ |--+
T Consensus 260 pnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kf 339 (448)
T KOG0195|consen 260 PNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKF 339 (448)
T ss_pred CCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheeccccee
Confidence 99999999999999999998644 3677899999999999999999974 4444688899999999876654 3222
Q ss_pred ccCCccccCCCccccccCCCcccchhhhccCCCC--CCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC--CCCC
Q 014347 161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD--GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKL 236 (426)
Q Consensus 161 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~--~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~ 236 (426)
+. .. ....-.|.|++||.++.++-+ -.++|+|||.++||||.|...||.+-...+.-.++.-. ...+
T Consensus 340 sf-----qe----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~i 410 (448)
T KOG0195|consen 340 SF-----QE----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHI 410 (448)
T ss_pred ee-----ec----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccC
Confidence 21 11 123457899999999876644 35699999999999999999999998887776666443 5678
Q ss_pred CCCCCHHHHHHHHHccccCccCCCCHHHHh
Q 014347 237 PKWLSPGAQNLLRKILEPNPVKRITIAGIK 266 (426)
Q Consensus 237 p~~~s~~~~~Li~~~L~~dP~~R~t~~eil 266 (426)
|+.+++....|++-|++.||.+||.+..|.
T Consensus 411 ppgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 411 PPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred CCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 999999999999999999999999987653
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.7e-22 Score=181.14 Aligned_cols=134 Identities=18% Similarity=0.212 Sum_probs=108.2
Q ss_pred eceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-----CCCCccceEEEEEeCC---EEE
Q 014347 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-----KHPNVVRLHEVLASKS---KIY 90 (426)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-----~hpnIv~l~~~~~~~~---~~~ 90 (426)
.+.||+|+||.||. ++.++.. +||++..... ...+.+.+|+.+++.+ +||||++++++++++. .++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 57899999999995 7777666 6998876432 2346789999999999 5799999999998874 434
Q ss_pred -EEEec--cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHhhcCceeccCCCCcEEecCC----CCeEEeeccCc
Q 014347 91 -MVLEY--VTGGELFDKIASKGRLQEAEGRKLFQQLIDGV-SYCHNKGVFHRDLKLENILLDSK----GNIKISDFGLS 161 (426)
Q Consensus 91 -lV~Ey--~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL-~~LH~~gIiHrDLKp~NILl~~~----g~vkL~DFGla 161 (426)
+|+|| +.+++|.+++.+ +.+++. ..++.|++.++ +|||+++|+||||||+|||++.+ ++++|+||+-+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 78999 558999999976 456666 35678888777 99999999999999999999743 37999995433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-21 Score=183.85 Aligned_cols=144 Identities=22% Similarity=0.251 Sum_probs=116.0
Q ss_pred CeeeeceEeecCceEEEEEE-ECCCCCeEEEEEeecccccc---------------------hhHHHHHHHHHHHHHhCC
Q 014347 15 RYELGRTLGEGNFGKVKFAQ-DLDSGLPFAVKILEKNRIIH---------------------LKITDQIKREIATLKLLK 72 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~-~~~~~~~vAvK~i~~~~~~~---------------------~~~~~~~~~Ei~il~~l~ 72 (426)
-|++.+.||+|+||.||+|. +..+|+.||+|+++...... ......+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47899999999999999999 77899999999987543210 001234678999999997
Q ss_pred CCC--ccceEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC-ceeccCCCCcEEecC
Q 014347 73 HPN--VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG-VFHRDLKLENILLDS 149 (426)
Q Consensus 73 hpn--Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~g-IiHrDLKp~NILl~~ 149 (426)
+.+ +.++++. ...|+||||+.|++|.........+...++..++.|++.+|.+||++| |+||||||+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 633 3344432 235899999999888776545566777788999999999999999999 99999999999999
Q ss_pred CCCeEEeeccCccC
Q 014347 150 KGNIKISDFGLSAL 163 (426)
Q Consensus 150 ~g~vkL~DFGla~~ 163 (426)
++.++|+|||.+..
T Consensus 184 ~~~i~LiDFg~a~~ 197 (237)
T smart00090 184 DGKVVIIDVSQSVE 197 (237)
T ss_pred CCCEEEEEChhhhc
Confidence 88999999999874
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.4e-21 Score=207.27 Aligned_cols=196 Identities=22% Similarity=0.295 Sum_probs=161.3
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCccceEEEEEeCCE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK---HPNVVRLHEVLASKSK 88 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~ 88 (426)
...+|.|-+.||+|+||+||.|.+.. |+.||+|+=+......--... +++.+|+ -+.|..+...+.-.+.
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~------q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICL------QVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehH------HHHHhhchhhhcchHHHHHHHccCCc
Confidence 34589999999999999999999866 999999987655543321122 2333333 3455566555555677
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecC-------CCCeEEeeccCc
Q 014347 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-------KGNIKISDFGLS 161 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~-------~g~vkL~DFGla 161 (426)
-++|+||.+-|+|.|++...+.+++..+..+..|++..|++||..+|||+||||+|.||.. +--++|+|||.+
T Consensus 769 S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred ceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 7899999999999999998889999999999999999999999999999999999999942 234899999998
Q ss_pred cCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCC
Q 014347 162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 215 (426)
Q Consensus 162 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~ 215 (426)
.-+..+.+.......++|-.+-.+|+..++++ +..+|.|.++.+++.||.|+.
T Consensus 849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grpW-tYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRPW-TYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeeEcCCCcEEeeeeccccchhHHHhcCCCC-chhhhhHHHHHHHHHHHHHHH
Confidence 86655555557778899999999999999998 589999999999999999953
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.7e-20 Score=169.49 Aligned_cols=138 Identities=24% Similarity=0.354 Sum_probs=116.2
Q ss_pred eceEeecCceEEEEEEECCCCCeEEEEEeecccccchh-----HHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-----ITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~-----~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
++.||+|++|.||+|.+ .|..+++|+.......... ...++.+|+.++..+.|+++.....++...+..+++|
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 36799999999999986 6778999986543322211 1246788999999999999888777777778889999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccC
Q 014347 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~ 163 (426)
||++|++|.+.+..... ....++.+++.+|.++|+.|++|||++|.|||++ ++.++|+|||++..
T Consensus 79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999998875332 7889999999999999999999999999999999 78999999999874
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-19 Score=164.48 Aligned_cols=133 Identities=21% Similarity=0.277 Sum_probs=108.6
Q ss_pred eEeecCceEEEEEEECCCCCeEEEEEeecccccch-----hHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEec
Q 014347 21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-----KITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (426)
Q Consensus 21 ~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey 95 (426)
.||+|+||.||+|. .+|..+++|.......... ....++.+|+.+++.+.|+++.....++...+..+++|||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 48999999999998 4678899998654322211 1236678899999999988766555555566678999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccC
Q 014347 96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (426)
Q Consensus 96 ~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~ 163 (426)
++|++|.+.+..... .++.|++.+|.+||+.|++|||++|.||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999988765321 7899999999999999999999999999999 88999999999874
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-19 Score=165.77 Aligned_cols=138 Identities=25% Similarity=0.349 Sum_probs=109.5
Q ss_pred eeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccch-------------------hHHHHHHHHHHHHHhCCCCC-
Q 014347 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-------------------KITDQIKREIATLKLLKHPN- 75 (426)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~-------------------~~~~~~~~Ei~il~~l~hpn- 75 (426)
|.+.+.||+|+||.||++.+. +|+.||||+++.....-. .......+|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 888999999999999999874 799999999765331000 01123678999999988774
Q ss_pred -ccceEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeE
Q 014347 76 -VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 154 (426)
Q Consensus 76 -Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vk 154 (426)
+...++ ....+++|||++|++|.+.... .....++.|++.++.++|+.||+||||||+||++++++.++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 444443 2456899999999998765321 44678899999999999999999999999999999999999
Q ss_pred EeeccCccCC
Q 014347 155 ISDFGLSALP 164 (426)
Q Consensus 155 L~DFGla~~~ 164 (426)
|+|||++...
T Consensus 166 liDfg~~~~~ 175 (198)
T cd05144 166 IIDWPQMVST 175 (198)
T ss_pred EEECCccccC
Confidence 9999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.3e-20 Score=184.77 Aligned_cols=251 Identities=22% Similarity=0.295 Sum_probs=171.9
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCC---CCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEE------
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE------ 81 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~------ 81 (426)
...+.+.+.+..+..+++.+....-..+ .+.++-+..+.+. ........+++-.+....|-+..-+.+
T Consensus 241 ~~~~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~---~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~ 317 (516)
T KOG1033|consen 241 EESGSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDS---LCACKYTFRQLGVLVDSSHSNRSILEDLRPSLF 317 (516)
T ss_pred cccccccccccccccccCCchhhhhcccchhhhhccchhhhccc---hhhhhhhhhhhhheeccccCCcccccCCCCchh
Confidence 3445566777777788877776554333 3444444433322 122334455555555444433333333
Q ss_pred -EEE-----eCCEEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCC
Q 014347 82 -VLA-----SKSKIYMVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN 152 (426)
Q Consensus 82 -~~~-----~~~~~~lV~Ey~~gg~L~~~i~~~~---~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~ 152 (426)
... .....||.|++|.-.+|.+.|.++. ..+......++.|+..|++| +|.+|||+||.||+...++.
T Consensus 318 ~~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q 394 (516)
T KOG1033|consen 318 ESSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQ 394 (516)
T ss_pred hhccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchh
Confidence 111 1235789999999999999997533 35778889999999999999 99999999999999999999
Q ss_pred eEEeeccCccCCcccc----CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhC-CCCCCCCcHHHHHH
Q 014347 153 IKISDFGLSALPQHFR----DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLAVLYQ 227 (426)
Q Consensus 153 vkL~DFGla~~~~~~~----~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG-~~Pf~~~~~~~~~~ 227 (426)
+||.|||+.+...... .........||..||+||.+.+..| +.++||||||+||+||+.- ..+|. ......
T Consensus 395 ~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y-~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~ 470 (516)
T KOG1033|consen 395 LKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQY-SEKVDIYALGLILAELLIQFSTQFE---RIATLT 470 (516)
T ss_pred hhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhh-hhhcchhhHHHHHHHHHHHhccHHH---HHHhhh
Confidence 9999999988544322 1123445689999999999998888 6999999999999999972 22221 122233
Q ss_pred HHHcCCCCCCCC-CCHHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 228 KIFRGDFKLPKW-LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 228 ~i~~~~~~~p~~-~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
.+..+.++.--+ =.|.-..|+..||.+.|.+||++.+.-.|.|.
T Consensus 471 d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 471 DIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 333343331112 13566799999999999999987777666664
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.6e-19 Score=179.40 Aligned_cols=200 Identities=28% Similarity=0.412 Sum_probs=157.2
Q ss_pred HHhCCCCCccceEEEEEeCCEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCc-eeccCCCCcE
Q 014347 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGV-FHRDLKLENI 145 (426)
Q Consensus 68 l~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gI-iHrDLKp~NI 145 (426)
|+.+.|.|+.++++.+.++...+.|.+||.-|+|.|.+.. ...++.--...+++.|+.||.|+|...| +|+.++..|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4678899999999999999999999999999999999987 4567777888889999999999998865 9999999999
Q ss_pred EecCCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCC------CCCcchhhhHHHHHHHHHhCCCCCCC
Q 014347 146 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY------DGATSDIWSCGVILYVILTGYLPFDD 219 (426)
Q Consensus 146 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~------~~~~~DIwSlGvil~elltG~~Pf~~ 219 (426)
++|....+||+|||+..+..............-...|.|||.+..... .+.++||||+|++++|+++...||+.
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 999999999999999876532111111112223456999999876322 35679999999999999999999976
Q ss_pred Cc----HHHHHHHHHc-CCC-CCCC-----CCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 220 RN----LAVLYQKIFR-GDF-KLPK-----WLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 220 ~~----~~~~~~~i~~-~~~-~~p~-----~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
.. ..++..++.+ +.. ..|. .+.+.+..+++.||..+|.+||++++|..
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 32 2345555555 322 1221 24567999999999999999999998743
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.79 E-value=1e-18 Score=183.59 Aligned_cols=138 Identities=21% Similarity=0.268 Sum_probs=112.1
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccc-----hhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-----LKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
.|...+.||+|+||.||++.... ..+++|......... ....+++.+|+.+++.++|++++....+..+....
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 45668899999999999998643 344555432221111 11235688999999999999999887777777788
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccC
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~ 163 (426)
++||||++|++|.+.+. ....++.|++.+|.+||++|++||||||+|||+ .++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999998875 357799999999999999999999999999999 678999999999985
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.6e-18 Score=156.73 Aligned_cols=138 Identities=27% Similarity=0.399 Sum_probs=100.6
Q ss_pred eeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHH---------------------HHHHHHHHHHhCCCCC-
Q 014347 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD---------------------QIKREIATLKLLKHPN- 75 (426)
Q Consensus 18 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~---------------------~~~~Ei~il~~l~hpn- 75 (426)
+++.||+|+||.||+|.+. +|+.||||++............ ....|...+..+.+.+
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 3578999999999999976 8999999998754322111111 1145666666665433
Q ss_pred -ccceEEEEEeCCEEEEEEeccCCCChHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHhh-cCceeccCCCCcEEecCCCC
Q 014347 76 -VVRLHEVLASKSKIYMVLEYVTGGELFD-KIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGN 152 (426)
Q Consensus 76 -Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~-~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~-~gIiHrDLKp~NILl~~~g~ 152 (426)
+.+.++. ...+++|||++|+.+.. .+.. .... .+++.++.|++.++.++|+ +||+||||||+||+++ ++.
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~-~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKD-VRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhh-hhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence 4444443 23589999999954422 1211 1111 6789999999999999999 9999999999999999 899
Q ss_pred eEEeeccCccC
Q 014347 153 IKISDFGLSAL 163 (426)
Q Consensus 153 vkL~DFGla~~ 163 (426)
++|+|||.+..
T Consensus 153 ~~liDfg~a~~ 163 (187)
T cd05119 153 VYIIDVPQAVE 163 (187)
T ss_pred EEEEECccccc
Confidence 99999999874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.1e-19 Score=187.58 Aligned_cols=264 Identities=26% Similarity=0.414 Sum_probs=216.9
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
....+.+.+.+-+-.|+++.++.+.-..+|...+.|+..+.........+.+.++-.++-...+|-++...-.+......
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 35667889999999999999999998888988888877655443333344445555555545567777665556667889
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc--
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF-- 167 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~-- 167 (426)
+++++|+.|++|...+...+..+++-++.+...+..++++||+..+.|||++|.|+|...+|..+++|||........
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence 999999999999999999888999999999999999999999999999999999999999999999999843211000
Q ss_pred --------------------c-----C--CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCC
Q 014347 168 --------------------R-----D--DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR 220 (426)
Q Consensus 168 --------------------~-----~--~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 220 (426)
. . ........||+.|.+||.+.+... +..+|+|+.|+++++.++|..||...
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 0 0 011234579999999999988776 67899999999999999999999999
Q ss_pred cHHHHHHHHHcCCCCCCC---CCCHHHHHHHHHccccCccCCCCHH---HHhcCcccccc
Q 014347 221 NLAVLYQKIFRGDFKLPK---WLSPGAQNLLRKILEPNPVKRITIA---GIKADEWFEQD 274 (426)
Q Consensus 221 ~~~~~~~~i~~~~~~~p~---~~s~~~~~Li~~~L~~dP~~R~t~~---eil~h~~f~~~ 274 (426)
.....++.+.++..+.|. ..++.+++++.++|..+|.+|..+. +...|+||+..
T Consensus 1039 tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1039 TPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred chhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence 999999999999888764 4789999999999999999999987 89999999863
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.74 E-value=3e-17 Score=154.73 Aligned_cols=137 Identities=23% Similarity=0.362 Sum_probs=105.4
Q ss_pred ceEe-ecCceEEEEEEECCCCCeEEEEEeecccc----c------chhHHHHHHHHHHHHHhCCCCCc--cceEEEEEeC
Q 014347 20 RTLG-EGNFGKVKFAQDLDSGLPFAVKILEKNRI----I------HLKITDQIKREIATLKLLKHPNV--VRLHEVLASK 86 (426)
Q Consensus 20 ~~LG-~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~------~~~~~~~~~~Ei~il~~l~hpnI--v~l~~~~~~~ 86 (426)
..|| .|+.|.||.+.. .+..++||.+..... . ......++.+|+.++..+.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 788888888775 377899998864321 0 11223568899999999998875 6666664332
Q ss_pred -C---EEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCc
Q 014347 87 -S---KIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS 161 (426)
Q Consensus 87 -~---~~~lV~Ey~~g-g~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla 161 (426)
. ..++||||++| .+|.+++.. .++++.. +.||+.+|.+||++||+||||||+|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 2 23599999998 688888765 4566543 678999999999999999999999999999999999999988
Q ss_pred cC
Q 014347 162 AL 163 (426)
Q Consensus 162 ~~ 163 (426)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 74
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.72 E-value=2e-17 Score=142.48 Aligned_cols=132 Identities=24% Similarity=0.292 Sum_probs=112.8
Q ss_pred eeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCC--CCccceEEEEEeCCEEEEEEec
Q 014347 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH--PNVVRLHEVLASKSKIYMVLEY 95 (426)
Q Consensus 18 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~lV~Ey 95 (426)
+++.||+|.++.||++.+.. ..+++|....... ...+.+|+.+++.+.| .++.+++.+....+..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 46789999999999999743 7899998865432 3578899999999986 5899999988888889999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc---CceeccCCCCcEEecCCCCeEEeeccCccC
Q 014347 96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK---GVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (426)
Q Consensus 96 ~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~---gIiHrDLKp~NILl~~~g~vkL~DFGla~~ 163 (426)
+.|+++... +......++.+++.+|+.+|.. +++|||++|+||++++.+.++++|||.+..
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 999877543 5566778899999999999984 799999999999999989999999998874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.1e-15 Score=158.31 Aligned_cols=145 Identities=24% Similarity=0.376 Sum_probs=101.6
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeeccccc--------------------------c-h----hHHHH
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--------------------------H-L----KITDQ 60 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--------------------------~-~----~~~~~ 60 (426)
.+..|+. +.||.|++|.||.|+.+.+|+.||||+.+..-.. + . +..+.
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3556777 8999999999999999888999999999754210 0 0 11222
Q ss_pred ------HHHHHHHHHhCC----CCCccceEEEEEe-CCEEEEEEeccCCCChHHH--HHhcC----CCCHHHHHHHHHHH
Q 014347 61 ------IKREIATLKLLK----HPNVVRLHEVLAS-KSKIYMVLEYVTGGELFDK--IASKG----RLQEAEGRKLFQQL 123 (426)
Q Consensus 61 ------~~~Ei~il~~l~----hpnIv~l~~~~~~-~~~~~lV~Ey~~gg~L~~~--i~~~~----~l~~~~~~~i~~Ql 123 (426)
+.+|+..+.+++ +.+.+.+-.++.+ .+..++||||+.|+.+.+. +...+ .+.+..+..++.|+
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 334444444432 3344444444433 4567899999999999774 33333 25555566666676
Q ss_pred HHHHHHHhhcCceeccCCCCcEEecCCC----CeEEeeccCccCC
Q 014347 124 IDGVSYCHNKGVFHRDLKLENILLDSKG----NIKISDFGLSALP 164 (426)
Q Consensus 124 ~~aL~~LH~~gIiHrDLKp~NILl~~~g----~vkL~DFGla~~~ 164 (426)
+ ..|++|+|+||.||+++.+| .+++.|||++...
T Consensus 277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 5 58999999999999999988 9999999998754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.4e-14 Score=148.20 Aligned_cols=142 Identities=25% Similarity=0.312 Sum_probs=97.7
Q ss_pred ceEeecCceEEEEEEECCCCCeEEEEEeecccccc---------------------------hh----HHH------HHH
Q 014347 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH---------------------------LK----ITD------QIK 62 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~---------------------------~~----~~~------~~~ 62 (426)
+.||.|++|.||+|+. .+|+.||||+.+..-... .. ... .+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 6799999999999986 579999999985431000 00 000 244
Q ss_pred HHHHHHHhCC----CCCccceEEEE-EeCCEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHhhcCc
Q 014347 63 REIATLKLLK----HPNVVRLHEVL-ASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLID-GVSYCHNKGV 135 (426)
Q Consensus 63 ~Ei~il~~l~----hpnIv~l~~~~-~~~~~~~lV~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~-aL~~LH~~gI 135 (426)
+|...+.++. |.+-+.+-.++ ...+..++||||++|++|.+..... ... ....++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCc
Confidence 5565555543 32223322232 2234579999999999998876431 122 23446666665 4678899999
Q ss_pred eeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 136 FHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 136 iHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
+|+|+||.||+++.+|.++++|||++....
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 999999999999999999999999987543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.9e-15 Score=153.39 Aligned_cols=255 Identities=20% Similarity=0.211 Sum_probs=191.9
Q ss_pred CCeeeeceEee--cCceEEEEEEE--CCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCCE
Q 014347 14 GRYELGRTLGE--GNFGKVKFAQD--LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSK 88 (426)
Q Consensus 14 ~~y~i~~~LG~--G~fg~Vy~a~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 88 (426)
..+.+.+.+|. |.+|.||.+.. ..++..+|+|.-+.. ........+=.+|+...+.++ |+|.++.+..++..+.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p-~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIP-FSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCC-CCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 45677888999 99999999998 788999999963221 111112233446777777775 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHhhcCceeccCCCCcEEecCC-CCeEEeeccCcc
Q 014347 89 IYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLID----GVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSA 162 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~~-l~~~~~~~i~~Ql~~----aL~~LH~~gIiHrDLKp~NILl~~~-g~vkL~DFGla~ 162 (426)
.|+-+|+| |.+|..+...... +++..++..+.+..+ ||.++|+.+++|-|+||.||++..+ ...+++|||+..
T Consensus 193 lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred ceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 99999999 4788888876544 899999999999999 9999999999999999999999999 789999999987
Q ss_pred CCccccCCC---ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCC-cHHHHH-HHHHcCCCCCC
Q 014347 163 LPQHFRDDG---LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-NLAVLY-QKIFRGDFKLP 237 (426)
Q Consensus 163 ~~~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~-~~~~~~-~~i~~~~~~~p 237 (426)
......-.. ......|...|++||...+ ..+...|||++|.++.+..+|..++... +..... .+++ -..++-
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-ip~e~~ 348 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-IPLEFC 348 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-Cchhhh
Confidence 554322111 1122357788999998653 3468899999999999999886655432 111100 0000 111222
Q ss_pred CCCCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 238 ~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
...+..+...+..|++.+|-.|++.+.+++|++...
T Consensus 349 ~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 349 EGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred cCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 334667777999999999999999999999998764
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.55 E-value=9.7e-14 Score=142.49 Aligned_cols=232 Identities=19% Similarity=0.296 Sum_probs=159.5
Q ss_pred eeeeceEeecCceEEE-EEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEe
Q 014347 16 YELGRTLGEGNFGKVK-FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 16 y~i~~~LG~G~fg~Vy-~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (426)
|++ ...+-++.+ +| .|..+.++.+|.|.+.+.... .....+.+-+.-|+.++||||+++++.++..+.+|+|+|
T Consensus 15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTE 89 (690)
T KOG1243|consen 15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTE 89 (690)
T ss_pred ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEee
Confidence 555 333334444 34 456678899999999876543 445678888999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh-hcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcc
Q 014347 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH-NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173 (426)
Q Consensus 95 y~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH-~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 173 (426)
.+. .|..++.+.+ ...+..-+.||+.||.||| +.+++|++|.-..|+++..|.+||++|-++........ ..
T Consensus 90 rV~--Pl~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~ 162 (690)
T KOG1243|consen 90 RVR--PLETVLKELG---KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PA 162 (690)
T ss_pred ccc--cHHHHHHHhH---HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--cc
Confidence 985 5666776533 6677777899999999997 56899999999999999999999999998864333221 11
Q ss_pred ccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccc
Q 014347 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE 253 (426)
Q Consensus 174 ~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 253 (426)
....---.|..|+.+.... -..|.|.|||++++++.|..+ ... ....+..++.....+..+-+-
T Consensus 163 ~~~~~~~s~~~P~~~~~s~---~s~D~~~Lg~li~el~ng~~~--~~~-----------~~~~~~~ipk~~~~~~~k~~~ 226 (690)
T KOG1243|consen 163 KSLYLIESFDDPEEIDPSE---WSIDSWGLGCLIEELFNGSLL--TKT-----------DLSNTGKIPKALIELYCKKLG 226 (690)
T ss_pred ccchhhhcccChhhcCccc---cchhhhhHHHHHHHHhCcccC--cch-----------hhhccCccchhHHHHHHHHhc
Confidence 2222223466777643333 236999999999999999333 111 112223334344444444444
Q ss_pred cCccCCCCHH-----HHhcCccccccC
Q 014347 254 PNPVKRITIA-----GIKADEWFEQDY 275 (426)
Q Consensus 254 ~dP~~R~t~~-----eil~h~~f~~~~ 275 (426)
-.+..||... -.+-|.||+..+
T Consensus 227 ~~~~~r~n~~~~~~~~~~~~gff~n~f 253 (690)
T KOG1243|consen 227 ATELKRPNKLRFILECRLLGGFFRNDF 253 (690)
T ss_pred cccccccchhhHHHHHHhccccccchH
Confidence 4555555522 234477777644
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=9e-14 Score=126.32 Aligned_cols=142 Identities=16% Similarity=0.212 Sum_probs=104.8
Q ss_pred eceEeecCceEEEEEEECC------CCCeEEEEEeeccccc-------------------chhHHH----HHHHHHHHHH
Q 014347 19 GRTLGEGNFGKVKFAQDLD------SGLPFAVKILEKNRII-------------------HLKITD----QIKREIATLK 69 (426)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~------~~~~vAvK~i~~~~~~-------------------~~~~~~----~~~~Ei~il~ 69 (426)
...||.|--+.||.|.... .+..+|||+.+..... ...... ..++|.+.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4679999999999998643 3578999987532110 001122 2448999999
Q ss_pred hCCC--CCccceEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-hhcCceeccCCCCcEE
Q 014347 70 LLKH--PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC-HNKGVFHRDLKLENIL 146 (426)
Q Consensus 70 ~l~h--pnIv~l~~~~~~~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~L-H~~gIiHrDLKp~NIL 146 (426)
++.. -++..++++ ...++||||+.+..+.....++..+++.++..++.|++.+|..+ |+.|++||||+|.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 8863 456666654 45789999997755533222334566777888899999999998 8999999999999999
Q ss_pred ecCCCCeEEeeccCccCCc
Q 014347 147 LDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 147 l~~~g~vkL~DFGla~~~~ 165 (426)
++ ++.+.|+|||.+...+
T Consensus 158 ~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EE-CCcEEEEECCCceeCC
Confidence 97 5789999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF03822 NAF: NAF domain; InterPro: IPR004041 The NAF domain is a 24 amino acid domain that is found in a plant-specific subgroup of serine-threonine protein kinases (CIPKs), that interact with calcineurin B-like calcium sensor proteins (CBLs) | Back alignment and domain information |
|---|
Probab=99.52 E-value=6.1e-15 Score=107.03 Aligned_cols=60 Identities=47% Similarity=0.866 Sum_probs=48.8
Q ss_pred CCccccceeeeccccccCCcccccccc--cccccccccccCHHHHHHHHHHHHHHcCcEEEE
Q 014347 310 PPLINAFQLIGMSSCLDLSGFFEKEDV--SERKIRFTSNHSAKDLLERIEDIVTEMGFRVQK 369 (426)
Q Consensus 310 ~~~~~~~~~~~~s~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (426)
|..+|||++|++|+|+|||+||+..+. .++.+||+|..+|++|+++||++|+.+||+|+|
T Consensus 2 p~~lNAFdiIS~S~G~DLSgLFe~~~~~~~~~~~RF~S~~~~~~Ii~klEe~a~~~~~~V~K 63 (63)
T PF03822_consen 2 PKSLNAFDIISLSSGFDLSGLFEEKDKSSVKRETRFTSKEPASEIIEKLEEIAKKLGFRVKK 63 (63)
T ss_dssp -EE--HHHHHCTSTTTSCGGGGGCG-S-SS---EEEEESS-HHHHHHHHHHHHHHTTEEEEE
T ss_pred CccccHHHHHHhccCCChHHhcCccccccccccceEecCCCHHHHHHHHHHHHHhcCceeeC
Confidence 667899999999999999999987643 467899999999999999999999999999986
|
Whereas the N-terminal part of CIPKs comprises a conserved catalytic domain typical of Ser-Thr kinases, the much less conserved C-terminal domain appears to be unique to this subgroup of kinases. The only exception is the NAF domain that forms an 'island of conservation' in this otherwise variable region. The NAF domain has been named after the prominent conserved amino acids Asn-Ala-Phe. It represents a minimum protein interaction module that is both necessary and sufficient to mediate the interaction with the CBL calcium sensor proteins []. The secondary structure of the NAF domain is currently not known, but secondary structure computation of the C-terminal region of Arabidopsis thaliana CBL-interacting protein kinase 1 revealed a long helical structure [].; GO: 0007165 signal transduction; PDB: 2ZFD_B 2EHB_D. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.4e-13 Score=122.07 Aligned_cols=127 Identities=18% Similarity=0.220 Sum_probs=96.7
Q ss_pred eceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcc-ceEEEEEeCCEEEEEEeccC
Q 014347 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV-RLHEVLASKSKIYMVLEYVT 97 (426)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv-~l~~~~~~~~~~~lV~Ey~~ 97 (426)
++.|+.|.++.||+++.. +..|++|+...... ....+.+|+.+++.+.+.+++ +++... .+..++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecC
Confidence 467899999999999863 77899998754321 123467899999988765544 455443 234589999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCc-----eeccCCCCcEEecCCCCeEEeeccCcc
Q 014347 98 GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV-----FHRDLKLENILLDSKGNIKISDFGLSA 162 (426)
Q Consensus 98 gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gI-----iHrDLKp~NILl~~~g~vkL~DFGla~ 162 (426)
|.++.+. .......+.+++.+|+.||+.++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9888643 11123467899999999999985 9999999999999 6789999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.5e-14 Score=145.41 Aligned_cols=254 Identities=20% Similarity=0.183 Sum_probs=191.0
Q ss_pred CccCCCeeeeceEeecCceEEEEEEEC-CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCC
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDL-DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKS 87 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 87 (426)
....++|.++..||.|.|+.|+..... .++..|++|-..+.-....+.+ .-..|+.+...+. |.++++.+..+....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhh-cchhhhhHhhHhhcccccCCCCCCccccc
Confidence 345788999999999999999987654 6788999998765544333322 2335666666654 999999998888888
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCC-CCeEEeeccCccCCcc
Q 014347 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQH 166 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~-g~vkL~DFGla~~~~~ 166 (426)
..|+-.|||.|+++...+.-...+.+...++...|++.++.++|+..++|+|+||+||++..+ +..++.|||..+....
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce
Confidence 889999999999987776555678899999999999999999999999999999999999886 7789999998863111
Q ss_pred ccCCCccccccCCCccc-chhhhccCCCCCCcchhhhHHHHHHHHHhCCCC-CCCCcHHHHHHHHHcCCCCCCCCCCHHH
Q 014347 167 FRDDGLLHTTCGSPNYV-APEVLANRGYDGATSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFRGDFKLPKWLSPGA 244 (426)
Q Consensus 167 ~~~~~~~~~~~gt~~y~-APE~l~~~~~~~~~~DIwSlGvil~elltG~~P-f~~~~~~~~~~~i~~~~~~~p~~~s~~~ 244 (426)
......++..+. .+|++........++|++|||.-+.+.++|..- +.+. ....+..+..+..+.....+
T Consensus 420 -----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----~~~~i~~~~~p~~~~~~~~~ 490 (524)
T KOG0601|consen 420 -----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----QSLTIRSGDTPNLPGLKLQL 490 (524)
T ss_pred -----ecccccccccccccchhhccccccccccccccccccccccccCcccCcccc----cceeeecccccCCCchHHhh
Confidence 011112233344 255544444446889999999999999998543 2222 12334455555555556889
Q ss_pred HHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 245 QNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
..+.+.+..+++..|+.+.++..|.-|..
T Consensus 491 q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 491 QVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred hhhhhhhcCCccccchhhhhhcccchhhh
Confidence 99999999999999999999888876654
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.3e-14 Score=134.49 Aligned_cols=201 Identities=19% Similarity=0.263 Sum_probs=141.0
Q ss_pred HhCCCCCccceEEEEEe-----CCEEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhc--Ccee
Q 014347 69 KLLKHPNVVRLHEVLAS-----KSKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNK--GVFH 137 (426)
Q Consensus 69 ~~l~hpnIv~l~~~~~~-----~~~~~lV~Ey~~gg~L~~~i~~----~~~l~~~~~~~i~~Ql~~aL~~LH~~--gIiH 137 (426)
-.+.|.|+++++.++.+ .....++.||+..|+|..++++ ...+.....++|..||++||.|||+. -|+|
T Consensus 122 lqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiih 201 (458)
T KOG1266|consen 122 LQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIH 201 (458)
T ss_pred HHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcccc
Confidence 34569999999998754 4457899999999999999875 34688999999999999999999998 4999
Q ss_pred ccCCCCcEEecCCCCeEEeeccCccCCccccC--CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCC
Q 014347 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 215 (426)
Q Consensus 138 rDLKp~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~ 215 (426)
+++.-.-|++..+|-+|+.--.-...-..... ........+-++|.|||.=..... ..++|||++|....+|..|..
T Consensus 202 gnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 202 GNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGMCALEMAILEI 280 (458)
T ss_pred CCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccc-ccchhhhhhhHHHHHHHHhee
Confidence 99999999999999888743221111111111 111112346788999997333333 356999999999899988755
Q ss_pred CC-CCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 216 PF-DDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 216 Pf-~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
-- ...+....-..+.+..+.+. .+.-+.++.+||+..|..||++.+++.||.+-.
T Consensus 281 q~tnseS~~~~ee~ia~~i~~le---n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 281 QSTNSESKVEVEENIANVIIGLE---NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred ccCCCcceeehhhhhhhheeecc---CccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 32 22222222222222212111 233467899999999999999999999998753
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.6e-11 Score=108.59 Aligned_cols=134 Identities=25% Similarity=0.329 Sum_probs=100.8
Q ss_pred ceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHH-----HHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEe
Q 014347 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT-----DQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~-----~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (426)
..+++|+-+.+|.+.. -|..+.+|.-.+...-+++.. .+..+|.++++.++--.|.-..-+..+.....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 4678999999998854 455577776544433333332 456679999998876555544444456677789999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccC
Q 014347 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (426)
Q Consensus 95 y~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~ 163 (426)
|++|..|.+.+... . -.+++.+-.-+.-||..||+|+||.++||++..++ +.++||||+..
T Consensus 80 ~I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA---R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999888764 2 44566666777889999999999999999997665 99999999974
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.8e-11 Score=111.72 Aligned_cols=140 Identities=22% Similarity=0.341 Sum_probs=106.9
Q ss_pred ceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCC--CccceEEEEEeC---CEEEEEEe
Q 014347 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP--NVVRLHEVLASK---SKIYMVLE 94 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~~~~---~~~~lV~E 94 (426)
+.||.|..+.||++... +|+.+++|........ .....+.+|..+++.+.+. ++.+++.+.... +..+++||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 67899999999999864 3688999987544321 1245688999999999763 456777776553 26789999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh------------------------------------------
Q 014347 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN------------------------------------------ 132 (426)
Q Consensus 95 y~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~------------------------------------------ 132 (426)
|++|.++.+.+.. ..+++.....++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999888765432 456777777778888888888873
Q ss_pred --------------cCceeccCCCCcEEecC--CCCeEEeeccCccC
Q 014347 133 --------------KGVFHRDLKLENILLDS--KGNIKISDFGLSAL 163 (426)
Q Consensus 133 --------------~gIiHrDLKp~NILl~~--~g~vkL~DFGla~~ 163 (426)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 56689999998874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.1e-10 Score=102.93 Aligned_cols=144 Identities=24% Similarity=0.253 Sum_probs=107.8
Q ss_pred eeceEeecCceEEEEEEECCCCCeEEEEEeecccccchh-----HHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 014347 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-----ITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 18 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~-----~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (426)
.+..|-+|+-+.|+.+.. .|+...||.-.....-++. ...+.++|+++|.++.--.|.-..-++.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 577899999999998874 7888888854333332322 245678899999988755555444455566666788
Q ss_pred EeccCC-CChHHHHHhc-CCCCHHH-HHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCC---eEEeeccCccC
Q 014347 93 LEYVTG-GELFDKIASK-GRLQEAE-GRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSAL 163 (426)
Q Consensus 93 ~Ey~~g-g~L~~~i~~~-~~l~~~~-~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~---vkL~DFGla~~ 163 (426)
|||++| .++.+++... ..-.++. ...++++|-+.|.-||.++|+|+||..+||++..+|. +.++|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999987 4778877652 2223333 3788999999999999999999999999999977663 58999999874
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=2e-11 Score=126.15 Aligned_cols=154 Identities=22% Similarity=0.338 Sum_probs=115.6
Q ss_pred HHHHHHHHhhc-CceeccCCCCcEEecCCCCeEEeeccCccCCccccC-------CCccccccCCCcccchhhhccCCCC
Q 014347 123 LIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-------DGLLHTTCGSPNYVAPEVLANRGYD 194 (426)
Q Consensus 123 l~~aL~~LH~~-gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-------~~~~~~~~gt~~y~APE~l~~~~~~ 194 (426)
.+.|+.|+|.. +++|++|.|++|.++.+|.+||+.|+.+........ ........-...|.|||++.. ...
T Consensus 108 v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~~ 186 (700)
T KOG2137|consen 108 VADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TTN 186 (700)
T ss_pred ccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-ccc
Confidence 34899999976 899999999999999999999999998764322100 001111124568999999877 445
Q ss_pred CCcchhhhHHHHHHHHH-hCCCCCCCCcHHHHHHHHHc----CCCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCc
Q 014347 195 GATSDIWSCGVILYVIL-TGYLPFDDRNLAVLYQKIFR----GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE 269 (426)
Q Consensus 195 ~~~~DIwSlGvil~ell-tG~~Pf~~~~~~~~~~~i~~----~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~ 269 (426)
++++|++|+|+++|.+. .|+..+...+....+..-.. +.+..+..+++++++=+.++|..++..||++..++..+
T Consensus 187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ 266 (700)
T KOG2137|consen 187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIP 266 (700)
T ss_pred cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhccc
Confidence 78999999999999999 57766665543333322211 22345577999999999999999999999999999999
Q ss_pred cccccCCC
Q 014347 270 WFEQDYTP 277 (426)
Q Consensus 270 ~f~~~~~~ 277 (426)
||.+...+
T Consensus 267 ff~D~~~~ 274 (700)
T KOG2137|consen 267 FFSDPGLK 274 (700)
T ss_pred ccCCchhh
Confidence 99876543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.7e-10 Score=101.53 Aligned_cols=127 Identities=29% Similarity=0.377 Sum_probs=84.8
Q ss_pred EEEEEEECCCCCeEEEEEeecccc-----------------------cchhHHHHHHHHHHHHHhCCCC--CccceEEEE
Q 014347 29 KVKFAQDLDSGLPFAVKILEKNRI-----------------------IHLKITDQIKREIATLKLLKHP--NVVRLHEVL 83 (426)
Q Consensus 29 ~Vy~a~~~~~~~~vAvK~i~~~~~-----------------------~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~ 83 (426)
.||.|.. ..|..+|+|+.+.... .........++|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899986 5677999998754210 0011234678899999999865 456666552
Q ss_pred EeCCEEEEEEeccC--CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HhhcCceeccCCCCcEEecCCCCeEEeeccC
Q 014347 84 ASKSKIYMVLEYVT--GGELFDKIASKGRLQEAEGRKLFQQLIDGVSY-CHNKGVFHRDLKLENILLDSKGNIKISDFGL 160 (426)
Q Consensus 84 ~~~~~~~lV~Ey~~--gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~-LH~~gIiHrDLKp~NILl~~~g~vkL~DFGl 160 (426)
..++||||+. |..+..+.. ..++......++.+++..+.. +|+.||+|+||.+.|||++++ .+.++|||.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~--~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKD--VDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHH--CGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhhHHh--ccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 3479999998 655544332 222355677888888885555 589999999999999999887 899999998
Q ss_pred ccC
Q 014347 161 SAL 163 (426)
Q Consensus 161 a~~ 163 (426)
+..
T Consensus 153 av~ 155 (188)
T PF01163_consen 153 AVD 155 (188)
T ss_dssp EEE
T ss_pred cee
Confidence 873
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=4.6e-09 Score=100.51 Aligned_cols=131 Identities=16% Similarity=0.097 Sum_probs=93.3
Q ss_pred EEEEEECCCCCeEEEEEeecccccc---h-----hHHHHHHHHHHHHHhCCCCCc--cceEEEEEe-----CCEEEEEEe
Q 014347 30 VKFAQDLDSGLPFAVKILEKNRIIH---L-----KITDQIKREIATLKLLKHPNV--VRLHEVLAS-----KSKIYMVLE 94 (426)
Q Consensus 30 Vy~a~~~~~~~~vAvK~i~~~~~~~---~-----~~~~~~~~Ei~il~~l~hpnI--v~l~~~~~~-----~~~~~lV~E 94 (426)
|.... -.|+.|.||......... . .-...+.+|...+.++..-+| ..++.+++. ...-++|||
T Consensus 38 vvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 38 TLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred EEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 44443 356788888653222100 0 001137789998888753333 334444432 235789999
Q ss_pred ccCCC-ChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecC-------CCCeEEeeccCcc
Q 014347 95 YVTGG-ELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-------KGNIKISDFGLSA 162 (426)
Q Consensus 95 y~~gg-~L~~~i~~--~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~-------~g~vkL~DFGla~ 162 (426)
+++|. +|.+++.. ..+.+......++.+++..+.-||..||+|+|+++.|||++. ++.+.++||+.+.
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99886 79888864 345677888899999999999999999999999999999975 4578999999875
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.06 E-value=3.7e-09 Score=106.18 Aligned_cols=211 Identities=21% Similarity=0.222 Sum_probs=153.3
Q ss_pred ceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe----CCEEEEEEeccCC-CCh
Q 014347 27 FGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----KSKIYMVLEYVTG-GEL 101 (426)
Q Consensus 27 fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~lV~Ey~~g-g~L 101 (426)
-.+.|++....+|..|++|.+.-.+.... .....-+++++++.|+|+|++.+++.+ +..+.+|++|.++ ++|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 35789999999999999999843332222 223345778899999999999999863 4568999999876 577
Q ss_pred HHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcc
Q 014347 102 FDKIA---------------SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (426)
Q Consensus 102 ~~~i~---------------~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 166 (426)
.++-- .+...+|...|.|+.||..||.++|+.|+..+-|.|.+||++.+-+++|+..|...+...
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 76542 122467899999999999999999999999999999999999998999988887654322
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCC-CCCCcHHHH-HHHHHcCCCCCCCCCCHHH
Q 014347 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP-FDDRNLAVL-YQKIFRGDFKLPKWLSPGA 244 (426)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~P-f~~~~~~~~-~~~i~~~~~~~p~~~s~~~ 244 (426)
. . + |-+... .+-|.=.||.++..|.||..- +........ ...| -...+.++
T Consensus 446 d--~-------~-------~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I-------~~~yS~D~ 498 (655)
T KOG3741|consen 446 D--P-------T-------EPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI-------TTTYSTDL 498 (655)
T ss_pred C--C-------C-------cchhHH----hhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh-------hhhhhHHH
Confidence 1 0 1 112221 346999999999999999543 211222211 1111 23468889
Q ss_pred HHHHHHccccCccCCCCHHHHhcC
Q 014347 245 QNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
+++|.-+...+++. -++.+++.+
T Consensus 499 rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 499 RNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHhcCccc-ccHHHHHHH
Confidence 99999998888886 677777654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.6e-09 Score=101.47 Aligned_cols=138 Identities=25% Similarity=0.357 Sum_probs=105.5
Q ss_pred eeeeceEeecCceEEEEEEECCCCCeEEEEEeeccccc-----------------c--hhHHHHHHHHHHHHHhCCCC--
Q 014347 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----------------H--LKITDQIKREIATLKLLKHP-- 74 (426)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-----------------~--~~~~~~~~~Ei~il~~l~hp-- 74 (426)
+.++..||-|--|.||.|.+. .|.++|||.-+..... . .-.....++|..+|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 357789999999999999974 7889999965321100 0 01134578899999998754
Q ss_pred CccceEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeE
Q 014347 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 154 (426)
Q Consensus 75 nIv~l~~~~~~~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vk 154 (426)
.+.+.+++ +...+||||++|-.|... +++...+..++..|+.-+..+-..|++|+|+++-||+++++|.+.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 67777764 567899999999877542 234556666777777777777789999999999999999999999
Q ss_pred EeeccCccC
Q 014347 155 ISDFGLSAL 163 (426)
Q Consensus 155 L~DFGla~~ 163 (426)
++||-.+..
T Consensus 243 vIDwPQ~v~ 251 (304)
T COG0478 243 VIDWPQAVP 251 (304)
T ss_pred EEeCccccc
Confidence 999987763
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=6.7e-09 Score=102.04 Aligned_cols=233 Identities=18% Similarity=0.218 Sum_probs=150.9
Q ss_pred eeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHH-hCCCCCccceEEE------EEeC-CE
Q 014347 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK-LLKHPNVVRLHEV------LASK-SK 88 (426)
Q Consensus 17 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~-~l~hpnIv~l~~~------~~~~-~~ 88 (426)
..++.||+|+-+.+|-.-. -+..|| |+..+..... +.+ -...|. .-.||-+-.=+.+ ..++ ..
T Consensus 14 ~~gr~LgqGgea~ly~l~e--~~d~VA-KIYh~Pppa~-----~aq-k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE--VRDQVA-KIYHAPPPAA-----QAQ-KVAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred CCCccccCCccceeeecch--hhchhh-eeecCCCchH-----HHH-HHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 4578899999999996542 233344 8876544321 111 122232 3346544321111 1122 23
Q ss_pred EEEEEeccCCCChHHHHH----hc---CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCc
Q 014347 89 IYMVLEYVTGGELFDKIA----SK---GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS 161 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~----~~---~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla 161 (426)
+-+.|..++|..--..+- ++ .-..+.-+.+..+.|+.+.+.||..|..-+|+.++|+|+.+++.+.|.|=..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 778899888864322221 11 22567888999999999999999999999999999999999999999875533
Q ss_pred cCCccccCCCccccccCCCcccchhhhccCCC----CCCcchhhhHHHHHHHHHhC-CCCCCCC-------cHHHHHHHH
Q 014347 162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY----DGATSDIWSCGVILYVILTG-YLPFDDR-------NLAVLYQKI 229 (426)
Q Consensus 162 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~----~~~~~DIwSlGvil~elltG-~~Pf~~~-------~~~~~~~~i 229 (426)
.+- .++...-..+|.+.|.+||.-.-..+ .++..|.|.||+++|++|.| +.||.+- +.-+ ..|
T Consensus 165 qi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E--~~I 239 (637)
T COG4248 165 QIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE--TDI 239 (637)
T ss_pred eec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch--hhh
Confidence 221 23344456789999999997431211 14678999999999999996 9999762 1111 011
Q ss_pred HcC-----------CCCCC---CC--CCHHHHHHHHHcccc--CccCCCCHH
Q 014347 230 FRG-----------DFKLP---KW--LSPGAQNLLRKILEP--NPVKRITIA 263 (426)
Q Consensus 230 ~~~-----------~~~~p---~~--~s~~~~~Li~~~L~~--dP~~R~t~~ 263 (426)
..+ ..+-| +| +++++..|..+|+.. ++.-|||++
T Consensus 240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 111 11112 22 789999999999875 356899965
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.4e-08 Score=93.61 Aligned_cols=105 Identities=23% Similarity=0.378 Sum_probs=84.9
Q ss_pred HHHHHHHHHHHhCCCCC--ccceEEEEEeC----CEEEEEEeccCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh
Q 014347 59 DQIKREIATLKLLKHPN--VVRLHEVLASK----SKIYMVLEYVTGG-ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131 (426)
Q Consensus 59 ~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~----~~~~lV~Ey~~gg-~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH 131 (426)
.+..+|...+..|..-+ +...+.+.... ...++|+|+++|. +|.+.+.....++......++.+++..+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 46778888888775333 34455555442 2458999999884 79998887555788888999999999999999
Q ss_pred hcCceeccCCCCcEEecCCC---CeEEeeccCccC
Q 014347 132 NKGVFHRDLKLENILLDSKG---NIKISDFGLSAL 163 (426)
Q Consensus 132 ~~gIiHrDLKp~NILl~~~g---~vkL~DFGla~~ 163 (426)
++||+|+|++|.|||++.++ .+.++||+-+..
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999999887 799999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.2e-07 Score=88.20 Aligned_cols=140 Identities=20% Similarity=0.237 Sum_probs=98.9
Q ss_pred eceEeecCceEEEEEEECCCCCeEEEEEeecccccchh---------------------HHHHHHHHHHHHHhCC--CCC
Q 014347 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---------------------ITDQIKREIATLKLLK--HPN 75 (426)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~---------------------~~~~~~~Ei~il~~l~--hpn 75 (426)
...|..|--+.||+|.. ..+..+|+|+.......-.. ......+|...|+++. +-.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34677888889999984 66889999998643211100 1123567888888775 344
Q ss_pred ccceEEEEEeCCEEEEEEeccCCCCh-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-cCceeccCCCCcEEecCCCCe
Q 014347 76 VVRLHEVLASKSKIYMVLEYVTGGEL-FDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNI 153 (426)
Q Consensus 76 Iv~l~~~~~~~~~~~lV~Ey~~gg~L-~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~-~gIiHrDLKp~NILl~~~g~v 153 (426)
+.+.+.+. ...+||||+..... .-.+ +..++...++..+..+++..+.-|-. .|++|+||+.-|||+. +|.+
T Consensus 132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~L-kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 132 VPEPIAFR----NNVLVMEFIGDDGLPAPRL-KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred CCCceeec----CCeEEEEeccCCCCCCCCc-ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 55555543 34789999954311 1111 12344555899999999999998876 8999999999999999 8899
Q ss_pred EEeeccCccCCc
Q 014347 154 KISDFGLSALPQ 165 (426)
Q Consensus 154 kL~DFGla~~~~ 165 (426)
.++|||.|....
T Consensus 206 ~iID~~QaV~~~ 217 (268)
T COG1718 206 YIIDVSQAVTID 217 (268)
T ss_pred EEEECccccccC
Confidence 999999988544
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.8e-07 Score=86.02 Aligned_cols=140 Identities=18% Similarity=0.248 Sum_probs=90.8
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHH------HHHHHHHHHhCCC---CCccceEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ------IKREIATLKLLKH---PNVVRLHEV 82 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~------~~~Ei~il~~l~h---pnIv~l~~~ 82 (426)
.-++|.+.+.+-......|.+.. ..|..+.+|..+............ ..+++..+.++.. .....++-+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 34678888888877777776655 467889999876433221111111 2334444444432 223333332
Q ss_pred EE-----eCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEee
Q 014347 83 LA-----SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISD 157 (426)
Q Consensus 83 ~~-----~~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~D 157 (426)
.. -....+++|||++|.+|.+... +++ .+...+.+++.-+|+.|++|+|..|.|+++++++ +++.|
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID 177 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIID 177 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEE
Confidence 22 1234568999999988876532 333 2446677889999999999999999999998655 99999
Q ss_pred ccCcc
Q 014347 158 FGLSA 162 (426)
Q Consensus 158 FGla~ 162 (426)
|+..+
T Consensus 178 ~~~k~ 182 (229)
T PF06176_consen 178 TQGKR 182 (229)
T ss_pred Ccccc
Confidence 98655
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.67 E-value=3.4e-07 Score=85.65 Aligned_cols=134 Identities=15% Similarity=0.221 Sum_probs=84.7
Q ss_pred ceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--ccceEEEEEeCCEEEEEEeccC
Q 014347 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLHEVLASKSKIYMVLEYVT 97 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~~~~~lV~Ey~~ 97 (426)
..||+|..+.||+. .|..+++|...... ....+.+|.++++.+..-+ +.+.+++....+...++||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 57899999999973 25567889875422 1345788999999886433 4677888888888899999999
Q ss_pred CCC-hH--------------HHHHh------c---CCCCHHH-HHHHHHHH----------HHH-HHHHh----hcCcee
Q 014347 98 GGE-LF--------------DKIAS------K---GRLQEAE-GRKLFQQL----------IDG-VSYCH----NKGVFH 137 (426)
Q Consensus 98 gg~-L~--------------~~i~~------~---~~l~~~~-~~~i~~Ql----------~~a-L~~LH----~~gIiH 137 (426)
|.+ +. ..+.+ . ...+... ...+..++ ... ..+|. ...++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 963 11 11100 0 0011111 01111111 111 11222 124789
Q ss_pred ccCCCCcEEecCCCCeEEeeccCccC
Q 014347 138 RDLKLENILLDSKGNIKISDFGLSAL 163 (426)
Q Consensus 138 rDLKp~NILl~~~g~vkL~DFGla~~ 163 (426)
+|+.|.||++++++ +.|+||+.+..
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCc
Confidence 99999999999888 99999998763
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.62 E-value=5.7e-07 Score=82.36 Aligned_cols=138 Identities=16% Similarity=0.150 Sum_probs=97.2
Q ss_pred eecCceEEEEEEECCCCCeEEEEEeecccc---cchhHHHHHHHHHHHHHhCCCCC--ccceEEE--EEe--CCEEEEEE
Q 014347 23 GEGNFGKVKFAQDLDSGLPFAVKILEKNRI---IHLKITDQIKREIATLKLLKHPN--VVRLHEV--LAS--KSKIYMVL 93 (426)
Q Consensus 23 G~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~--~~~--~~~~~lV~ 93 (426)
|+|+-+.|+.... .|+.+=+|.-...-. ..+--...+.+|+..++.|..-+ +.++... ... .-.-+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 5588888887653 344677775431100 00112467899999999886322 3444311 111 12367999
Q ss_pred eccCC-CChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCC--eEEeeccCcc
Q 014347 94 EYVTG-GELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN--IKISDFGLSA 162 (426)
Q Consensus 94 Ey~~g-g~L~~~i~~--~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~--vkL~DFGla~ 162 (426)
|-+.| .+|.+.+.. ..+.+......++.+++..++-||+.|+.|+|+-+.|||++.+|. ++++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97754 588888765 235678888899999999999999999999999999999987777 9999998655
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.57 E-value=7.2e-07 Score=82.59 Aligned_cols=137 Identities=26% Similarity=0.334 Sum_probs=82.5
Q ss_pred eceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--ccceEEEE---EeCCEEEEEE
Q 014347 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLHEVL---ASKSKIYMVL 93 (426)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~---~~~~~~~lV~ 93 (426)
++.|+.|..+.||++.... ..+++|..... .....+.+|..+++.+...+ +.+++... ......+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 4789999999999998644 48999986533 23567888999988886333 45666543 2334579999
Q ss_pred eccCCCChHH----------------HHH---hc----CCCCHHH------HHHH---------------HHHHHH-HHH
Q 014347 94 EYVTGGELFD----------------KIA---SK----GRLQEAE------GRKL---------------FQQLID-GVS 128 (426)
Q Consensus 94 Ey~~gg~L~~----------------~i~---~~----~~l~~~~------~~~i---------------~~Ql~~-aL~ 128 (426)
++++|..+.. .+. .. .++.... .... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987776 111 11 0111000 0000 111222 233
Q ss_pred HHh-------hcCceeccCCCCcEEec-CCCCeEEeeccCcc
Q 014347 129 YCH-------NKGVFHRDLKLENILLD-SKGNIKISDFGLSA 162 (426)
Q Consensus 129 ~LH-------~~gIiHrDLKp~NILl~-~~g~vkL~DFGla~ 162 (426)
.++ ...++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 333 24599999999999999 66667899998765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=4.1e-07 Score=94.32 Aligned_cols=139 Identities=23% Similarity=0.337 Sum_probs=89.9
Q ss_pred ceEeecCceEEEEEEECCCCCeEEEEEeeccccc---------------------------chh----HHH------HHH
Q 014347 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---------------------------HLK----ITD------QIK 62 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---------------------------~~~----~~~------~~~ 62 (426)
..|+.++-|.||.|+- .+|+.||||+.+..-.. -.+ ..+ .+.
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 6789999999999995 55999999997542100 000 111 244
Q ss_pred HHHHHHHhCC-----CCCccceEEEE-EeCCEEEEEEeccCCCChHHHH--HhcCCCCHHHHHHHHHHHHHH-HHHHhhc
Q 014347 63 REIATLKLLK-----HPNVVRLHEVL-ASKSKIYMVLEYVTGGELFDKI--ASKGRLQEAEGRKLFQQLIDG-VSYCHNK 133 (426)
Q Consensus 63 ~Ei~il~~l~-----hpnIv~l~~~~-~~~~~~~lV~Ey~~gg~L~~~i--~~~~~l~~~~~~~i~~Ql~~a-L~~LH~~ 133 (426)
+|...+.+++ .|++ .+=.++ +-.+.-.++|||+.|-.+.+.. .. ..++...+.. .++.+ +..+=..
T Consensus 210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~---~~~~~f~~q~~~d 284 (517)
T COG0661 210 REAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAE---LLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHH---HHHHHHHHHHHhc
Confidence 5555555543 2332 222333 2345668999999999888774 33 4455333222 22211 2223347
Q ss_pred CceeccCCCCcEEecCCCCeEEeeccCccCC
Q 014347 134 GVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (426)
Q Consensus 134 gIiHrDLKp~NILl~~~g~vkL~DFGla~~~ 164 (426)
|++|.|.+|.||+++.+|.+.+.|||+....
T Consensus 285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred CccccCCCccceEEecCCcEEEEcCcceecC
Confidence 9999999999999999999999999998754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.2e-08 Score=104.84 Aligned_cols=242 Identities=19% Similarity=0.172 Sum_probs=164.7
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-ccceEEEEEeCCEEEEEE
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN-VVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~lV~ 93 (426)
.|....-+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++-+..++..++++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~ 313 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPM 313 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhh
Confidence 4567788899999999999876665554 6665432 34456889999999999 777777777788899999
Q ss_pred eccCCC-ChHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCC
Q 014347 94 EYVTGG-ELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (426)
Q Consensus 94 Ey~~gg-~L~~~i-~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 171 (426)
+++.++ +-...+ ...-.+.+-+.....+.-..+++++|+.-=+||| |||..+ +..|..||+...-... ..
T Consensus 314 ~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~---~~ 385 (829)
T KOG0576|consen 314 RICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTR---TM 385 (829)
T ss_pred hhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCc---cc
Confidence 999887 221111 1111233334444556667889999998778998 887755 6789999998764332 11
Q ss_pred ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC--CCC---CCCCCHHHHH
Q 014347 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKL---PKWLSPGAQN 246 (426)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~---p~~~s~~~~~ 246 (426)
...+..+|+.++|||+.....+. ...|.|++|+--.++--|-+|-..+-.. ...+-.+. +.+ ..|-+..-++
T Consensus 386 ~~~t~~~~~~~~~pev~~~~~~~-~~p~~~~~~~~~~~~ap~~pPr~~P~~~--~~~~g~~p~s~~L~~~~aw~~~~~~~ 462 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQENTID-GCPDSGSLAVSAIQMAPGLPPRSSPPAV--LPMIGNGPNSPMLTDKSAWSPVFHRD 462 (829)
T ss_pred ccccCCCCCCCCCchhhcccccc-cCCCccCCCcchhhcCCCCCCCCCCccc--cCCCCCCCCccccchhhhcCcccccC
Confidence 34567899999999998877775 6789999998777777787775441110 00000000 000 0111112224
Q ss_pred HHHHccccCccCCCCHHHHhcCccccccCC
Q 014347 247 LLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (426)
Q Consensus 247 Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 276 (426)
+...|+..-|..|+....++.|.+|+....
T Consensus 463 ~~~~~~~g~P~~pkv~mgacfsKvfngCpl 492 (829)
T KOG0576|consen 463 FPAPCLNGLPPTPKVHMGACFSKVFNGCPL 492 (829)
T ss_pred CcccccCCCCCCCcchhhHHHHHHhccCcc
Confidence 778899999999999999999999976543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.8e-06 Score=93.08 Aligned_cols=205 Identities=19% Similarity=0.202 Sum_probs=144.7
Q ss_pred HHHHHHHHHHHhCCCCCccceEEEEEeCCEE----EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 014347 59 DQIKREIATLKLLKHPNVVRLHEVLASKSKI----YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134 (426)
Q Consensus 59 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~----~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~g 134 (426)
....-|+..+....|+|++.++.+....-.. .+..++|+..++.+.++.-+..+...++.+..++.+||+++|+..
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 3445567777888899999999987544332 344579999999999999999999999999999999999999996
Q ss_pred ceeccCCCC---cEEecCCCCeEEe--eccCccCCccccCCCccccccCCCcccchhhhccCCCC-CCcchhhhHHHHHH
Q 014347 135 VFHRDLKLE---NILLDSKGNIKIS--DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD-GATSDIWSCGVILY 208 (426)
Q Consensus 135 IiHrDLKp~---NILl~~~g~vkL~--DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~~~DIwSlGvil~ 208 (426)
..|.-|... +-..+..+.+..+ ||+.+..... ........-+..+.+||....+.+. +...|+|.+|..+.
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d---~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPD---NEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCC---cccchhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 666655554 4444556666666 8887764322 1222233445667888887655443 22369999999999
Q ss_pred HHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 209 VILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 209 elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
.+..|..+-..... .... .+........+++.+|+.-++++|+++.+++.|+|.....
T Consensus 384 ~~~~~~~i~~~~~~---~~~~------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 384 QLSQGEDISEKSAV---PVSL------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT 441 (1351)
T ss_pred hhhhcCcccccccc---hhhh------hccccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence 99987654221110 0000 1111222678899999999999999999999999987543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.35 E-value=4.4e-06 Score=78.74 Aligned_cols=134 Identities=19% Similarity=0.151 Sum_probs=82.6
Q ss_pred EeecCc-eEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCCEEEEEEeccCCC
Q 014347 22 LGEGNF-GKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVLEYVTGG 99 (426)
Q Consensus 22 LG~G~f-g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~Ey~~gg 99 (426)
|-.|.. +.||+... .+..+.+|+..... ...+.+|+.+++.+. +--+.+++++....+..++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcC--CCCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 444545 78998864 34678889875432 235678999988875 344557777777667789999999997
Q ss_pred ChHHHH----------------HhcCCCCH-------H------HHHHHHH----------------HHHHHHHHH----
Q 014347 100 ELFDKI----------------ASKGRLQE-------A------EGRKLFQ----------------QLIDGVSYC---- 130 (426)
Q Consensus 100 ~L~~~i----------------~~~~~l~~-------~------~~~~i~~----------------Ql~~aL~~L---- 130 (426)
+|.... .+-..++. . .....+. ++...+..|
T Consensus 78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 157 (244)
T cd05150 78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR 157 (244)
T ss_pred cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence 765321 10001110 0 0000000 011112222
Q ss_pred ---hhcCceeccCCCCcEEecCCCCeEEeeccCccC
Q 014347 131 ---HNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (426)
Q Consensus 131 ---H~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~ 163 (426)
....++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 123489999999999999977788999998763
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.31 E-value=8e-06 Score=90.43 Aligned_cols=144 Identities=17% Similarity=0.379 Sum_probs=90.8
Q ss_pred eceEeecCceEEEEEEECCCC--CeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCc--cceEEEEEeC---CEEE
Q 014347 19 GRTLGEGNFGKVKFAQDLDSG--LPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNV--VRLHEVLASK---SKIY 90 (426)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~--~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnI--v~l~~~~~~~---~~~~ 90 (426)
++.++.|.++.+|+......+ ..+++|......... ....+.+|..+|+.+. |+++ .+++.++.+. +..|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 677899999999998764432 467777654332111 1346889999999996 6664 7777777654 4678
Q ss_pred EEEeccCCCChHH--------------------HHHhcCCCC----------------HHHHHHHHHH------------
Q 014347 91 MVLEYVTGGELFD--------------------KIASKGRLQ----------------EAEGRKLFQQ------------ 122 (426)
Q Consensus 91 lV~Ey~~gg~L~~--------------------~i~~~~~l~----------------~~~~~~i~~Q------------ 122 (426)
+||||++|..+.+ .+..-..++ ..++..|..|
T Consensus 121 lVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 200 (822)
T PLN02876 121 YIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPR 200 (822)
T ss_pred EEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCC
Confidence 9999999864321 111000000 1122222222
Q ss_pred ---HHHHHHHHhh-----------cCceeccCCCCcEEecCC-CC-eEEeeccCccCC
Q 014347 123 ---LIDGVSYCHN-----------KGVFHRDLKLENILLDSK-GN-IKISDFGLSALP 164 (426)
Q Consensus 123 ---l~~aL~~LH~-----------~gIiHrDLKp~NILl~~~-g~-vkL~DFGla~~~ 164 (426)
+...+++|.. ..++|+|++|.|+|++.+ +. .-|.||+++..-
T Consensus 201 ~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 201 NPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred ChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 2233556632 249999999999999853 34 479999998763
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.1e-05 Score=73.36 Aligned_cols=128 Identities=24% Similarity=0.298 Sum_probs=91.9
Q ss_pred CCeeeeceEeecCc-eEEEEEEECCCCCeEEEEEeec---cc-------ccc-h-------hHHHHHHHHHHHHHhCC--
Q 014347 14 GRYELGRTLGEGNF-GKVKFAQDLDSGLPFAVKILEK---NR-------IIH-L-------KITDQIKREIATLKLLK-- 72 (426)
Q Consensus 14 ~~y~i~~~LG~G~f-g~Vy~a~~~~~~~~vAvK~i~~---~~-------~~~-~-------~~~~~~~~Ei~il~~l~-- 72 (426)
.+++.++.||.|+- |.||+++. .|+.+|+|++.. .. ... . .....|..|.++..+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68899999999999 99999984 678999999322 10 000 0 22346788998887775
Q ss_pred -CCCc--cceEEEEEeC------------------CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh
Q 014347 73 -HPNV--VRLHEVLASK------------------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131 (426)
Q Consensus 73 -hpnI--v~l~~~~~~~------------------~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH 131 (426)
+.++ ++.+++..-. ....||.||++... .+. ..-+.++.+-+..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~----~~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQ----IRDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccc----hhHHHHHHHHHHHHH
Confidence 4556 8999987322 12457788776543 122 233566777788899
Q ss_pred hcCceeccCCCCcEEecCCCCeEEeeccCc
Q 014347 132 NKGVFHRDLKLENILLDSKGNIKISDFGLS 161 (426)
Q Consensus 132 ~~gIiHrDLKp~NILl~~~g~vkL~DFGla 161 (426)
..||+-+|+++.|.. .-||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999986 3489999864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.15 E-value=2e-05 Score=69.77 Aligned_cols=129 Identities=18% Similarity=0.245 Sum_probs=90.7
Q ss_pred eeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccc-eEEEEEeCCEEEEEEec
Q 014347 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR-LHEVLASKSKIYMVLEY 95 (426)
Q Consensus 17 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~-l~~~~~~~~~~~lV~Ey 95 (426)
++.+.||+|++|.||++.. .|..+|+|+-..+.. ...+..|.++|..+.-.++.+ +|.+.. .++.|||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~-----r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~ 93 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSP-----RRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEY 93 (201)
T ss_pred hhhhhhhcccccEEEEeec--cCceEEEEEecCCcc-----hhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhh
Confidence 3567899999999999985 456899998755432 567899999999998776654 454432 3455999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCC-CCcEEecCCCCeEEeeccCccC
Q 014347 96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK-LENILLDSKGNIKISDFGLSAL 163 (426)
Q Consensus 96 ~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLK-p~NILl~~~g~vkL~DFGla~~ 163 (426)
+.|.+|.+.-... + ++-...++++---|-..||-|+.|. |...++-.++.+.|+||.-|++
T Consensus 94 i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 94 IDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 9998886653311 2 2233345555444667799999886 4445555555899999998874
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.14 E-value=2e-07 Score=103.63 Aligned_cols=210 Identities=18% Similarity=0.070 Sum_probs=148.4
Q ss_pred HHHHHHHHHhCCCCCccceEEEEE--eCCEEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhc-
Q 014347 61 IKREIATLKLLKHPNVVRLHEVLA--SKSKIYMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNK- 133 (426)
Q Consensus 61 ~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~lV~Ey~~gg~L~~~i~~~----~~l~~~~~~~i~~Ql~~aL~~LH~~- 133 (426)
...|..-++...|+++...+.-.. +....|..++|+.+|.+++.|-+. .++...-+....++.+.+..-+|+.
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 334555556678988887665543 345578999999999999998652 3455555666666768888888865
Q ss_pred ----CceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHH
Q 014347 134 ----GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYV 209 (426)
Q Consensus 134 ----gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~e 209 (426)
-.+|++||+-|.+|..+.++|+.++|+.++..+ .........+++.|++|++...-.+ +.++|+|..|+-+|.
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~-t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKF-TKRSDILRRSLSLYL 1432 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhh-hhHHHHHHHHHHHHH
Confidence 278999999999999999999999999984332 2234456678899999999877776 466999999999999
Q ss_pred HHhCCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 210 ILTGYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 210 lltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
+..|..+|-......+...+..+ ..+.+.-.|.++-.+...+|-+.-..||.-..++.-+.|..
T Consensus 1433 rs~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1433 RSDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred HhcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccc
Confidence 99988776432222222222222 23344444556666666666677778888887777776643
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.11 E-value=2e-05 Score=81.75 Aligned_cols=141 Identities=21% Similarity=0.246 Sum_probs=87.6
Q ss_pred ceEeecCceEEEEEEECCCCCeEEEEEeecccccc-----------------------------hhHHHH------HHHH
Q 014347 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-----------------------------LKITDQ------IKRE 64 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-----------------------------~~~~~~------~~~E 64 (426)
+.||.-+.|.|++|+-+. |+.||||+-+..- .+ .+..+. |.+|
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l-~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGL-EKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcCh-HHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 679999999999999654 9999999864321 10 011111 3334
Q ss_pred HHHHHh----CCCCCc---cceEEEEE-eCCEEEEEEeccCCCChHHH--HHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 014347 65 IATLKL----LKHPNV---VRLHEVLA-SKSKIYMVLEYVTGGELFDK--IASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134 (426)
Q Consensus 65 i~il~~----l~hpnI---v~l~~~~~-~~~~~~lV~Ey~~gg~L~~~--i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~g 134 (426)
.+...+ +.|-+. |.+=.++. -.+...++|||++|..+.|. |.+ ..++...+...+.+... .-+=..|
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~~--~qIf~~G 321 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAYL--EQIFKTG 321 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHHH--HHHHhcC
Confidence 443332 335451 11222322 23457899999999877654 444 44666544333333222 1123468
Q ss_pred ceeccCCCCcEEecC----CCCeEEeeccCccCCc
Q 014347 135 VFHRDLKLENILLDS----KGNIKISDFGLSALPQ 165 (426)
Q Consensus 135 IiHrDLKp~NILl~~----~g~vkL~DFGla~~~~ 165 (426)
++|+|=+|.||+++. ++.+.+-|||+.....
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 999999999999984 5679999999987543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.6e-05 Score=74.66 Aligned_cols=74 Identities=12% Similarity=0.032 Sum_probs=46.1
Q ss_pred eceEeecCce-EEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCC---CccceEEEEEeC---CEEEE
Q 014347 19 GRTLGEGNFG-KVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP---NVVRLHEVLASK---SKIYM 91 (426)
Q Consensus 19 ~~~LG~G~fg-~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp---nIv~l~~~~~~~---~~~~l 91 (426)
++.|+.|+.. .||... ..+.+|+..... ....+.+|..+++.+... .+.++++..... ...++
T Consensus 2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 2 IEPVDSGGTDNATFRLG-----DDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred ceeccCCCcccceEEcC-----CceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 3567767766 488652 357778754321 135788999999887632 334444443332 23588
Q ss_pred EEeccCCCChH
Q 014347 92 VLEYVTGGELF 102 (426)
Q Consensus 92 V~Ey~~gg~L~ 102 (426)
+|++++|.++.
T Consensus 72 l~~~i~G~~l~ 82 (235)
T cd05155 72 VYRWLEGETAT 82 (235)
T ss_pred EEEeecCCCCC
Confidence 99999997663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.09 E-value=9.2e-05 Score=67.66 Aligned_cols=136 Identities=20% Similarity=0.260 Sum_probs=96.7
Q ss_pred eceEeecCceEEEEEEECCCCCeEEEEEeecccc-------------cchhHHHHHHHHHHHHHhCC------CCCccce
Q 014347 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-------------IHLKITDQIKREIATLKLLK------HPNVVRL 79 (426)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-------------~~~~~~~~~~~Ei~il~~l~------hpnIv~l 79 (426)
...||+|+.=.||. |+ .....+||++..... .......+..+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~--HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEE--CC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 35789999999984 33 344578999876650 00112456677777766665 7899999
Q ss_pred EEEEEeCCEEEEEEeccCC------CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCC--
Q 014347 80 HEVLASKSKIYMVLEYVTG------GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-- 151 (426)
Q Consensus 80 ~~~~~~~~~~~lV~Ey~~g------g~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g-- 151 (426)
+|+.+++...-+|+|.+.+ .+|.+++.+ +.+++ .+...|-.-..||-+++|+.+|++|.||++..++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 9999999999999997643 467888854 45665 3334445556778899999999999999996443
Q ss_pred --CeEEee-ccCcc
Q 014347 152 --NIKISD-FGLSA 162 (426)
Q Consensus 152 --~vkL~D-FGla~ 162 (426)
.+.|+| ||-..
T Consensus 158 ~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 158 EFRLVLIDGLGEKE 171 (199)
T ss_pred ceEEEEEeCCCCcc
Confidence 477777 56443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00019 Score=72.47 Aligned_cols=80 Identities=20% Similarity=0.211 Sum_probs=55.4
Q ss_pred eceEeecCceEEEEEEECCCCCeEEEEEeeccccc--c--hhHHHHHHHHHHHHHhCC---CCCccceEEEEEeCCEEEE
Q 014347 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--H--LKITDQIKREIATLKLLK---HPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~--~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~l 91 (426)
.+.||.|.+..||++.+...++.|.||.-...... . .-..++...|...|+.+. ..++.+++.+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 46899999999999998644468999974311100 0 113567788888888764 3456777776 4456789
Q ss_pred EEeccCCCC
Q 014347 92 VLEYVTGGE 100 (426)
Q Consensus 92 V~Ey~~gg~ 100 (426)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998744
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.0002 Score=66.93 Aligned_cols=137 Identities=20% Similarity=0.222 Sum_probs=80.7
Q ss_pred eceEeecCceEEEEEEECC-CCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-cceEEEEEeCCEEEEEEecc
Q 014347 19 GRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYMVLEYV 96 (426)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV~Ey~ 96 (426)
++.|..|-...+|++.... .++.|++|+...... . .-...+|+.+++.+...++ .+++.... + .++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---L-IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---c-eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 4567778888999987433 356899997653221 1 1234578999988864444 34444332 2 3799999
Q ss_pred CCCChHHH----------H----Hh---cC-CC----------C-HHHHHHHHHH----------------------HHH
Q 014347 97 TGGELFDK----------I----AS---KG-RL----------Q-EAEGRKLFQQ----------------------LID 125 (426)
Q Consensus 97 ~gg~L~~~----------i----~~---~~-~l----------~-~~~~~~i~~Q----------------------l~~ 125 (426)
+|.++... + .+ .. .. . ...+..+... +..
T Consensus 75 ~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 154 (235)
T cd05157 75 PGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRD 154 (235)
T ss_pred CCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHH
Confidence 99765211 1 11 00 11 1 1122222211 111
Q ss_pred HHHHH----h----hcCceeccCCCCcEEecC-CCCeEEeeccCccC
Q 014347 126 GVSYC----H----NKGVFHRDLKLENILLDS-KGNIKISDFGLSAL 163 (426)
Q Consensus 126 aL~~L----H----~~gIiHrDLKp~NILl~~-~g~vkL~DFGla~~ 163 (426)
.+..| . ..+++|+|+.|.|||+++ ++.+.++||..|..
T Consensus 155 ~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 155 EISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 11111 1 236999999999999998 57899999998763
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00016 Score=71.08 Aligned_cols=145 Identities=21% Similarity=0.298 Sum_probs=101.0
Q ss_pred eeceEeecCceEEEEEEECCCCCeEEEEEeecccc----------------------cchhHH-HHHHHHHHHHHhCCCC
Q 014347 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI----------------------IHLKIT-DQIKREIATLKLLKHP 74 (426)
Q Consensus 18 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----------------------~~~~~~-~~~~~Ei~il~~l~hp 74 (426)
+-..|..|--+.||.|.. .+|..+|||+.+..-. ....++ -...+|++-|+++...
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 456788899999999985 6788899998754211 011111 2366799999998765
Q ss_pred CccceEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-hhcCceeccCCCCcEEecCCCCe
Q 014347 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC-HNKGVFHRDLKLENILLDSKGNI 153 (426)
Q Consensus 75 nIv~l~~~~~~~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~L-H~~gIiHrDLKp~NILl~~~g~v 153 (426)
.|.-. ....- ....|||+|+.+..-..-.-++..++...+..+.+|++.-+.-| |.++++|.||+--|+|+ .+|.+
T Consensus 227 GIP~P-ePIlL-k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~l 303 (520)
T KOG2270|consen 227 GIPCP-EPILL-KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKL 303 (520)
T ss_pred CCCCC-Cceee-ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEE
Confidence 54321 11111 23578999995322111112345688889999999999988887 56799999999999998 46789
Q ss_pred EEeeccCccCCcc
Q 014347 154 KISDFGLSALPQH 166 (426)
Q Consensus 154 kL~DFGla~~~~~ 166 (426)
.++|-+.+.-.++
T Consensus 304 yiIDVSQSVE~DH 316 (520)
T KOG2270|consen 304 YIIDVSQSVEHDH 316 (520)
T ss_pred EEEEccccccCCC
Confidence 9999998875443
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.88 E-value=7.1e-05 Score=72.61 Aligned_cols=136 Identities=20% Similarity=0.237 Sum_probs=82.5
Q ss_pred eceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--ccceEEE------EEeCCEEE
Q 014347 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLHEV------LASKSKIY 90 (426)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~------~~~~~~~~ 90 (426)
++.|..|....+|+... .+..+++|+.... . ...+..|+.+++.+.+.+ +.+++.. ....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~---~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV---S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCC---C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 56778888889998864 3346899987531 1 345777888888775332 3444331 23345678
Q ss_pred EEEeccCCCChHH-----------HH---Hh-cCCCCH--------H--H--HH--------HHHHHHHHHHHHHhh---
Q 014347 91 MVLEYVTGGELFD-----------KI---AS-KGRLQE--------A--E--GR--------KLFQQLIDGVSYCHN--- 132 (426)
Q Consensus 91 lV~Ey~~gg~L~~-----------~i---~~-~~~l~~--------~--~--~~--------~i~~Ql~~aL~~LH~--- 132 (426)
.+++|++|..+.. .+ .. ...+.. . . .. .....+..++.++.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999876421 01 10 000000 0 0 00 011112233444442
Q ss_pred ----cCceeccCCCCcEEecCCCCeEEeeccCcc
Q 014347 133 ----KGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (426)
Q Consensus 133 ----~gIiHrDLKp~NILl~~~g~vkL~DFGla~ 162 (426)
.+++|+|+.|.|||+++++.+.|.||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999987777899999776
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00028 Score=68.77 Aligned_cols=78 Identities=13% Similarity=0.106 Sum_probs=55.5
Q ss_pred eeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCC---CCccceEEEEEe---CCEEE
Q 014347 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH---PNVVRLHEVLAS---KSKIY 90 (426)
Q Consensus 17 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h---pnIv~l~~~~~~---~~~~~ 90 (426)
.-.+.||.|..+.||.... .++ .+.+|..+ ... . ...+.+|...|+.+.. -.+.++++++.. .+..+
T Consensus 17 ~~~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~-~~~-~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 17 SRVECISEQPYAALWALYD-SQG-NPMPLMAR-SFS-T---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred heeeecCCccceeEEEEEc-CCC-CEEEEEec-ccc-c---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 3456799999999998864 223 47778743 211 1 2478889999998853 357778877654 36689
Q ss_pred EEEeccCCCCh
Q 014347 91 MVLEYVTGGEL 101 (426)
Q Consensus 91 lV~Ey~~gg~L 101 (426)
+|||+++|+++
T Consensus 90 LVmE~i~G~~~ 100 (297)
T PRK10593 90 LLLERLRGVSV 100 (297)
T ss_pred EEEeccCCEec
Confidence 99999998754
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.83 E-value=8.3e-05 Score=70.67 Aligned_cols=133 Identities=16% Similarity=0.171 Sum_probs=78.2
Q ss_pred eEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-cceEEEEEeCCEEEEEEeccCCC
Q 014347 21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYMVLEYVTGG 99 (426)
Q Consensus 21 ~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV~Ey~~gg 99 (426)
.+..|-.+.+|+.. .++..+++|....... ...-...+|..+++.+...++ .+++... . -++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCK---ALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccc---cccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCc
Confidence 45568888899886 4566788997543211 110134679999998864433 3344332 2 36899999986
Q ss_pred ChHH--------------HHHh---c----CCCCH-HHHHHHHHHHH---------HHHHHHhh--------cCceeccC
Q 014347 100 ELFD--------------KIAS---K----GRLQE-AEGRKLFQQLI---------DGVSYCHN--------KGVFHRDL 140 (426)
Q Consensus 100 ~L~~--------------~i~~---~----~~l~~-~~~~~i~~Ql~---------~aL~~LH~--------~gIiHrDL 140 (426)
.+.. .+.+ . .+++. .....+..++. ..+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 6531 1111 0 01121 12223322221 11222211 25899999
Q ss_pred CCCcEEecCCCCeEEeeccCccC
Q 014347 141 KLENILLDSKGNIKISDFGLSAL 163 (426)
Q Consensus 141 Kp~NILl~~~g~vkL~DFGla~~ 163 (426)
.|.||++++++ +.|+||..|..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999877 78999998874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.78 E-value=2e-05 Score=76.00 Aligned_cols=137 Identities=21% Similarity=0.288 Sum_probs=99.1
Q ss_pred eeeeceEeecCceEEEEEEECCCCCeEEEEEeeccccc-----------------chhH--HHHHHHHHHHHHhCC-C-C
Q 014347 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----------------HLKI--TDQIKREIATLKLLK-H-P 74 (426)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-----------------~~~~--~~~~~~Ei~il~~l~-h-p 74 (426)
|.+++.||-|--+.+|.+-+ ..|++.++|.-+..... ..-. .-...+|...|+.|. | -
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 57889999999999999986 56888999964322110 0000 123567888888875 3 2
Q ss_pred CccceEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeE
Q 014347 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 154 (426)
Q Consensus 75 nIv~l~~~~~~~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vk 154 (426)
-+.+.++ .++.++|||++.|-.|...-. ...+..+...++.-+--|-.+|+||+|..--||++++++.++
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 3445554 356789999999987754321 223445666777778888999999999999999999999999
Q ss_pred EeeccCccC
Q 014347 155 ISDFGLSAL 163 (426)
Q Consensus 155 L~DFGla~~ 163 (426)
++||-....
T Consensus 243 vIDFPQmvS 251 (465)
T KOG2268|consen 243 VIDFPQMVS 251 (465)
T ss_pred EeechHhhc
Confidence 999986553
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00045 Score=67.54 Aligned_cols=140 Identities=17% Similarity=0.224 Sum_probs=81.8
Q ss_pred eeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--ccceEEE------EEeCC
Q 014347 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLHEV------LASKS 87 (426)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~------~~~~~ 87 (426)
..-++.++.|.-..+|++.. .+| .+++|+..... . .+.+..|+++++.|...+ +.+++.. ....+
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~--~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g 96 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV--K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAG 96 (307)
T ss_pred ceeccccCCccccceEEEEe-CCC-cEEEEEecCCC--C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCC
Confidence 33466788888889998863 344 57889765421 1 234556777777664222 3343332 12245
Q ss_pred EEEEEEeccCCCChH-----------HHH---Hh-cCCC--------CHHH-----HH----------HHHHHHHHHHHH
Q 014347 88 KIYMVLEYVTGGELF-----------DKI---AS-KGRL--------QEAE-----GR----------KLFQQLIDGVSY 129 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~-----------~~i---~~-~~~l--------~~~~-----~~----------~i~~Ql~~aL~~ 129 (426)
..+++++|++|.++. ..+ .. ...+ .... .. .....+...+++
T Consensus 97 ~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 176 (307)
T TIGR00938 97 KPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDY 176 (307)
T ss_pred eEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHH
Confidence 678999999986531 111 11 0011 0000 00 001122334555
Q ss_pred Hh-------hcCceeccCCCCcEEecCCCCeEEeeccCcc
Q 014347 130 CH-------NKGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (426)
Q Consensus 130 LH-------~~gIiHrDLKp~NILl~~~g~vkL~DFGla~ 162 (426)
+. ..+++|+|+.+.||++++++...|+||+.+.
T Consensus 177 l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 177 LDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 53 2589999999999999998877899999876
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00011 Score=66.72 Aligned_cols=99 Identities=19% Similarity=0.239 Sum_probs=79.3
Q ss_pred HHHHHHHHhCCC-CCccceEEEEEeCCEEEEEEeccCCCChHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHhh---cC
Q 014347 62 KREIATLKLLKH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDK---IASKGRLQEAEGRKLFQQLIDGVSYCHN---KG 134 (426)
Q Consensus 62 ~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~lV~Ey~~gg~L~~~---i~~~~~l~~~~~~~i~~Ql~~aL~~LH~---~g 134 (426)
..|.-+|+.+.+ +++.+++|.|- .+++.||...+++... +..-...++....+++.|+++.+.+++. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888999886 69999999973 2568899987766421 1222346899999999999999999987 35
Q ss_pred ceeccCCCCcEEecCCCCeEEeeccCccCC
Q 014347 135 VFHRDLKLENILLDSKGNIKISDFGLSALP 164 (426)
Q Consensus 135 IiHrDLKp~NILl~~~g~vkL~DFGla~~~ 164 (426)
+.-.|++|+|+-++++|++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 778999999999999999999999977643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.0018 Score=63.55 Aligned_cols=136 Identities=15% Similarity=0.227 Sum_probs=74.6
Q ss_pred eceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--ccceEE------EEEeCCEEE
Q 014347 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLHE------VLASKSKIY 90 (426)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~------~~~~~~~~~ 90 (426)
.+.|+.|....+|.... .+| .+++|+... . . .+.+..|+.+++.|...+ +.+.+. +....+..+
T Consensus 27 ~~~l~~G~~n~~y~v~t-~~g-~~vLK~~~~--~-~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~ 98 (319)
T PRK05231 27 LKGIAEGIENSNFFLTT-TQG-EYVLTLFER--L-T---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA 98 (319)
T ss_pred cchhccccccceEEEEe-CCC-cEEEEEecc--C-C---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence 45677788889998874 334 689998751 1 1 233444555555553211 223332 123356789
Q ss_pred EEEeccCCCChH-----------HHHH---h-cCCC--------C--H-HH-HH-----------HHHHHHH-HHHHHHh
Q 014347 91 MVLEYVTGGELF-----------DKIA---S-KGRL--------Q--E-AE-GR-----------KLFQQLI-DGVSYCH 131 (426)
Q Consensus 91 lV~Ey~~gg~L~-----------~~i~---~-~~~l--------~--~-~~-~~-----------~i~~Ql~-~aL~~LH 131 (426)
++++|++|..+. ..+. . ...+ . . .. .. ..+.+.+ ..++.+.
T Consensus 99 ~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 178 (319)
T PRK05231 99 AIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLA 178 (319)
T ss_pred EEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhh
Confidence 999999987431 1111 0 0001 0 0 00 00 1111111 1122222
Q ss_pred -------hcCceeccCCCCcEEecCCCCeEEeeccCcc
Q 014347 132 -------NKGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (426)
Q Consensus 132 -------~~gIiHrDLKp~NILl~~~g~vkL~DFGla~ 162 (426)
..|++|+|+.|.|||++.+...-|+||+.+.
T Consensus 179 ~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 179 SAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 2389999999999999866556899999876
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00078 Score=65.56 Aligned_cols=76 Identities=13% Similarity=0.130 Sum_probs=48.3
Q ss_pred eceEeecCceEEEEEEECC------CCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-cceEEEEEeCCEEEE
Q 014347 19 GRTLGEGNFGKVKFAQDLD------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYM 91 (426)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~l 91 (426)
++.|..|-...||++.... +++.+++|+...... ......+|..+++.+...++ .+++..+. + ..
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE----LLIDRERELVVFARLSERNLGPKLYGIFP-N---GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc----ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cc
Confidence 3456667777899887433 267899998654321 12346788888888864333 34555543 2 35
Q ss_pred EEeccCCCChH
Q 014347 92 VLEYVTGGELF 102 (426)
Q Consensus 92 V~Ey~~gg~L~ 102 (426)
|+||++|..+.
T Consensus 75 v~e~i~G~~l~ 85 (302)
T cd05156 75 IEEFIPSRTLT 85 (302)
T ss_pred hhheeCCCcCC
Confidence 89999887653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0011 Score=64.84 Aligned_cols=139 Identities=19% Similarity=0.252 Sum_probs=84.0
Q ss_pred eeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCC--CCccceEEEEEeCC--EEEEE
Q 014347 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH--PNVVRLHEVLASKS--KIYMV 92 (426)
Q Consensus 17 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~--~~~lV 92 (426)
.+++.+-.|..-.+|...+. ++.+++. ... ............+|..+++.+.- .-+...++++.++. ..|.|
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred ceeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 34444544444455655543 7788888 331 12223345667788888887753 23334455555544 67999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHH-HHHHHHHHHhh---------------------------------------
Q 014347 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQ-QLIDGVSYCHN--------------------------------------- 132 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~-Ql~~aL~~LH~--------------------------------------- 132 (426)
|+|++|..+.+... +.....+++. .+...|+-||+
T Consensus 104 ~~~veGe~~~~~~~-----~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p 178 (321)
T COG3173 104 MEWVEGEVVWSALP-----PESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP 178 (321)
T ss_pred EEEecceeccCcCC-----cccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence 99999853322111 1111112222 44444444443
Q ss_pred -------------------cCceeccCCCCcEEecCCCCeEEeeccCccCC
Q 014347 133 -------------------KGVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (426)
Q Consensus 133 -------------------~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~ 164 (426)
..++|+|+.+.||++++++-+-|.||+++.+-
T Consensus 179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 24899999999999999988999999999863
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0012 Score=65.60 Aligned_cols=78 Identities=19% Similarity=0.135 Sum_probs=50.8
Q ss_pred ceEeecCceEEEEEEECCCCCeEEEEEeecccc----cchhHHHHHHHHHHHHHhCC--CC-CccceEEEEEeCCEEEEE
Q 014347 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI----IHLKITDQIKREIATLKLLK--HP-NVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~~~~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~lV 92 (426)
+.||.|....||++.+...++.|+||.-...-. .-+-..++..-|...|+... -| .+.++|.+ ++....+|
T Consensus 1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~v 78 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTV 78 (370)
T ss_pred CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceeh
Confidence 357999999999999754446899996431110 01223566777888887764 34 45555544 45566799
Q ss_pred EeccCCC
Q 014347 93 LEYVTGG 99 (426)
Q Consensus 93 ~Ey~~gg 99 (426)
||+++..
T Consensus 79 MEdL~~~ 85 (370)
T TIGR01767 79 MEDLSHH 85 (370)
T ss_pred HhhCccc
Confidence 9998653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.001 Score=67.96 Aligned_cols=162 Identities=23% Similarity=0.269 Sum_probs=104.3
Q ss_pred HHHHHHHHHHHhCCCCCccceEEEEEeC-CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcee
Q 014347 59 DQIKREIATLKLLKHPNVVRLHEVLASK-SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137 (426)
Q Consensus 59 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~-~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiH 137 (426)
.++.-...+++.+.|+|....+++.... .+..+|||++ +.+|.|.+..+. +...... .+|+.|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~--------------~~~~~~ 90 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL--------------AHGVLH 90 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc--------------ccccce
Confidence 4566677889999999999999887543 4478899999 669999877543 2211111 222222
Q ss_pred ccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCC
Q 014347 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217 (426)
Q Consensus 138 rDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf 217 (426)
- | ..+.+| -+++ . | | ...++++||||+|.++.++.-|...|
T Consensus 91 ~-----~-------~~~~td-~~~t-------~-----------~--~------~~~~pKsdVwsl~~i~~el~L~~~l~ 131 (725)
T KOG1093|consen 91 L-----N-------IIYITD-HFLT-------K-----------Y--P------SPIGPKSDVWSLGFIILELYLGISLE 131 (725)
T ss_pred e-----h-------hhhccc-cccc-------c-----------C--C------CCCCcchhhhhHHHHHHHHHHhhHHH
Confidence 1 2 223333 1111 0 0 0 11125899999999999999998877
Q ss_pred CCCcHHHHHHHHHcCCCCC------------CCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 218 DDRNLAVLYQKIFRGDFKL------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 218 ~~~~~~~~~~~i~~~~~~~------------p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
......+....+.+-...- --.++.....+..+|+-..|..||...+.+.++-|...+
T Consensus 132 ~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~ 201 (725)
T KOG1093|consen 132 AELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVY 201 (725)
T ss_pred HHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHH
Confidence 6654444333333211110 011466778999999999999999999999999887653
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0022 Score=61.77 Aligned_cols=30 Identities=23% Similarity=0.422 Sum_probs=25.7
Q ss_pred CceeccCCCCcEEecCCCCe-EEeeccCccC
Q 014347 134 GVFHRDLKLENILLDSKGNI-KISDFGLSAL 163 (426)
Q Consensus 134 gIiHrDLKp~NILl~~~g~v-kL~DFGla~~ 163 (426)
.++|+|++|.|||+++++++ -|.||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 48999999999999976664 6999998874
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0046 Score=62.50 Aligned_cols=77 Identities=16% Similarity=0.109 Sum_probs=52.5
Q ss_pred eeceEeecCceEEEEEEECCCCCeEEEEEeecccc-cch---hHHHHHHHHHHHHHhCC---CCCccceEEEEEeCCEEE
Q 014347 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-IHL---KITDQIKREIATLKLLK---HPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 18 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~---~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~ 90 (426)
-.+.||.|....||+..+ .+..++||.-..... ... ....+...|...|+.+. ..++.+++.++. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 367889999999999886 345689997542111 000 12456666788887664 347778888766 4467
Q ss_pred EEEeccCC
Q 014347 91 MVLEYVTG 98 (426)
Q Consensus 91 lV~Ey~~g 98 (426)
++|||+++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999977
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0057 Score=60.89 Aligned_cols=137 Identities=20% Similarity=0.197 Sum_probs=81.0
Q ss_pred eceEeecCceEEEEEEECC----CCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcc-ceEEEEEeCCEEEEEE
Q 014347 19 GRTLGEGNFGKVKFAQDLD----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV-RLHEVLASKSKIYMVL 93 (426)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv-~l~~~~~~~~~~~lV~ 93 (426)
++.|-.|-...+|++.... +++.|.+|+..... ...+++ .+|..+++.+..-++. ++++.+..+ .|.
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~ 112 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVE 112 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEE
Confidence 3455458888999986432 34689999875432 222333 6799999888754443 455655332 478
Q ss_pred eccCCCChHHH----------H----Hh--cCC------C-CHHHHHHHHHHHH-----------------HHHHHH---
Q 014347 94 EYVTGGELFDK----------I----AS--KGR------L-QEAEGRKLFQQLI-----------------DGVSYC--- 130 (426)
Q Consensus 94 Ey~~gg~L~~~----------i----~~--~~~------l-~~~~~~~i~~Ql~-----------------~aL~~L--- 130 (426)
+|++|.+|... + .+ ... . ....+..+..++. ..+..|
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 99987665311 1 11 000 1 1223333332221 111112
Q ss_pred -----hhcCceeccCCCCcEEecC-CCCeEEeeccCccC
Q 014347 131 -----HNKGVFHRDLKLENILLDS-KGNIKISDFGLSAL 163 (426)
Q Consensus 131 -----H~~gIiHrDLKp~NILl~~-~g~vkL~DFGla~~ 163 (426)
+...++|+|+++.|||+++ ++.+.++||..|..
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1236899999999999986 46899999998863
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.019 Score=55.95 Aligned_cols=29 Identities=31% Similarity=0.618 Sum_probs=25.8
Q ss_pred cCceeccCCCCcEEecCCCCeEEeeccCcc
Q 014347 133 KGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (426)
Q Consensus 133 ~gIiHrDLKp~NILl~~~g~vkL~DFGla~ 162 (426)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47999999999999987 678999999765
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.0074 Score=60.76 Aligned_cols=78 Identities=22% Similarity=0.224 Sum_probs=52.6
Q ss_pred eceEeecCceEEEEEEECCCCCeEEEEEeeccccc--c-hhHHHHHHHHHHHHHhCC--CC-CccceEEEEEeCCEEEEE
Q 014347 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--H-LKITDQIKREIATLKLLK--HP-NVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~-~~~~~~~~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~lV 92 (426)
.+.||.|.-.-||++.+...++.|+||.-...-.. + +-..++..-|..+|+... -| .+.++|.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 67899999999999998544678999954211101 1 123577788889988764 34 45556554 45566789
Q ss_pred EeccCC
Q 014347 93 LEYVTG 98 (426)
Q Consensus 93 ~Ey~~g 98 (426)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999864
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.016 Score=57.44 Aligned_cols=140 Identities=16% Similarity=0.245 Sum_probs=79.8
Q ss_pred CeeeeceEeecCceEEEEEEECCC---CCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcc-ceEEEEEeCCEEE
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV-RLHEVLASKSKIY 90 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv-~l~~~~~~~~~~~ 90 (426)
..++ +.|..|=...+|+...... +..|.+|+..... ...+ .-.+|..+++.+..-++. ++++++. .+
T Consensus 16 ~i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~-~G--- 86 (330)
T PLN02421 16 DFSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT---DYVI-DRERELQAIKYLSAAGFGAKLLGVFG-NG--- 86 (330)
T ss_pred ceEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCc---CeEe-chHHHHHHHHHHHhcCCCCceeEEeC-Cc---
Confidence 3443 3444477778898864332 3478999875432 1112 235788899888755553 4555553 22
Q ss_pred EEEeccCCCChHH----------HH----Hh--cCC------C-CHHHHHHHHHHHH----------------------H
Q 014347 91 MVLEYVTGGELFD----------KI----AS--KGR------L-QEAEGRKLFQQLI----------------------D 125 (426)
Q Consensus 91 lV~Ey~~gg~L~~----------~i----~~--~~~------l-~~~~~~~i~~Ql~----------------------~ 125 (426)
+|.+|++|..|.. .+ .+ ..+ + ....+.+++.++- .
T Consensus 87 ~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 166 (330)
T PLN02421 87 MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRD 166 (330)
T ss_pred EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHH
Confidence 4889998765521 11 11 111 1 1223333333321 1
Q ss_pred HHHHHh----hc----CceeccCCCCcEEecC-CCCeEEeeccCccC
Q 014347 126 GVSYCH----NK----GVFHRDLKLENILLDS-KGNIKISDFGLSAL 163 (426)
Q Consensus 126 aL~~LH----~~----gIiHrDLKp~NILl~~-~g~vkL~DFGla~~ 163 (426)
-+..+. .. -.+|+|+.+.|||+++ ++.++++||..|..
T Consensus 167 ~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 167 EIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 122221 11 2799999999999975 47899999998874
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.015 Score=56.45 Aligned_cols=75 Identities=17% Similarity=0.226 Sum_probs=48.5
Q ss_pred eeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCccceEEEEEeCCEEEEEE
Q 014347 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK---HPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 17 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~lV~ 93 (426)
+-.+.+|.|....+|... .+++.+-||+-.... ...+..|..-|+.|. .-.+.+++.+....+..|++|
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 345678889999999877 678889999876322 346778888888874 345778888888777789999
Q ss_pred eccCCC
Q 014347 94 EYVTGG 99 (426)
Q Consensus 94 Ey~~gg 99 (426)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 999776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.012 Score=57.99 Aligned_cols=85 Identities=28% Similarity=0.358 Sum_probs=61.4
Q ss_pred CCCccceEEEE-EeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc-CceeccCCCCcEEecCC
Q 014347 73 HPNVVRLHEVL-ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSK 150 (426)
Q Consensus 73 hpnIv~l~~~~-~~~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~-gIiHrDLKp~NILl~~~ 150 (426)
.++..+.+-+- .+....|++|++- |+.|. .+ ..-..+++..++.+.+..++-+..+ ..-|||+...||||+ +
T Consensus 284 ~~~~e~~~vv~~de~~y~yl~~kdh-gt~is-~i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~ 357 (488)
T COG5072 284 SVFLETLKVVSLDETLYLYLHFKDH-GTPIS-II---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-E 357 (488)
T ss_pred chhhhcceEEecCCceEEEEEEecC-Cceee-ee---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-c
Confidence 34444444333 2234456777775 44442 22 2245778889999998888888765 799999999999999 9
Q ss_pred CCeEEeeccCccC
Q 014347 151 GNIKISDFGLSAL 163 (426)
Q Consensus 151 g~vkL~DFGla~~ 163 (426)
|++.|+||-++++
T Consensus 358 GnvtLIDfklsRl 370 (488)
T COG5072 358 GNVTLIDFKLSRL 370 (488)
T ss_pred CceEEEEeeeeec
Confidence 9999999999985
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.037 Score=55.86 Aligned_cols=75 Identities=16% Similarity=0.171 Sum_probs=44.5
Q ss_pred eceEeecCceEEEEEEECCC-CCe-----EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-cceEEEEEeCCEEEE
Q 014347 19 GRTLGEGNFGKVKFAQDLDS-GLP-----FAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYM 91 (426)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~-~~~-----vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~l 91 (426)
++.|..|-...+|++..... +.. |.+++... .....-.-.+|+.+++.+...++ .++++.+.. ++
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~----~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~ 126 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST----YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FT 126 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccC----CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EE
Confidence 44555588889999874332 222 44443211 11111223578999999976555 455665532 58
Q ss_pred EEeccCCCCh
Q 014347 92 VLEYVTGGEL 101 (426)
Q Consensus 92 V~Ey~~gg~L 101 (426)
+.||++|.+|
T Consensus 127 l~efIeGr~l 136 (383)
T PTZ00384 127 IQEWVEGNTM 136 (383)
T ss_pred EEEEeccccC
Confidence 8999998766
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.09 Score=51.39 Aligned_cols=30 Identities=20% Similarity=0.292 Sum_probs=27.7
Q ss_pred CceeccCCCCcEEecCCCCeEEeeccCccC
Q 014347 134 GVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (426)
Q Consensus 134 gIiHrDLKp~NILl~~~g~vkL~DFGla~~ 163 (426)
+++|+|+.++|+|+++++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998763
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.0092 Score=54.85 Aligned_cols=31 Identities=32% Similarity=0.552 Sum_probs=22.1
Q ss_pred cCceeccCCCCcEEe-cCCCCeEEeeccCccC
Q 014347 133 KGVFHRDLKLENILL-DSKGNIKISDFGLSAL 163 (426)
Q Consensus 133 ~gIiHrDLKp~NILl-~~~g~vkL~DFGla~~ 163 (426)
.-++|+|+.|.|||+ +.++.++++||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 358999999999999 8889999999998863
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.29 Score=48.23 Aligned_cols=71 Identities=18% Similarity=0.114 Sum_probs=42.1
Q ss_pred cCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--ccceE---E--EEEeCCEEEEEEeccC
Q 014347 25 GNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLH---E--VLASKSKIYMVLEYVT 97 (426)
Q Consensus 25 G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~---~--~~~~~~~~~lV~Ey~~ 97 (426)
+.-..||.... .+|..+++|+.+.... . ...+..|+..+..|.... ++... + +...++..+.++++++
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~-~---~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~ 110 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPERW-S---DAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG 110 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCcccC-C---HHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence 44456888774 5567799998753321 1 345667777777664211 22211 1 1233567788999998
Q ss_pred CCC
Q 014347 98 GGE 100 (426)
Q Consensus 98 gg~ 100 (426)
|..
T Consensus 111 G~~ 113 (325)
T PRK11768 111 GRA 113 (325)
T ss_pred CCC
Confidence 864
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.23 E-value=0.059 Score=54.09 Aligned_cols=62 Identities=19% Similarity=0.194 Sum_probs=43.8
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-hhcCceeccCCCCcEEecCCC
Q 014347 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC-HNKGVFHRDLKLENILLDSKG 151 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~L-H~~gIiHrDLKp~NILl~~~g 151 (426)
..++-+|..|-++..++... ..+++..++++.-...|+--+ --.+++|.|+.|.||++..+.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~ 382 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNK 382 (565)
T ss_pred ceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecC
Confidence 45667789998888887653 345556666666555665443 346899999999999996443
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.18 E-value=0.24 Score=56.36 Aligned_cols=31 Identities=35% Similarity=0.494 Sum_probs=26.5
Q ss_pred cCceeccCCCCcEEecCCC--CeE-EeeccCccC
Q 014347 133 KGVFHRDLKLENILLDSKG--NIK-ISDFGLSAL 163 (426)
Q Consensus 133 ~gIiHrDLKp~NILl~~~g--~vk-L~DFGla~~ 163 (426)
.++||+|+.+.|||++.++ .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999875 555 999998763
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.58 E-value=0.13 Score=47.61 Aligned_cols=85 Identities=18% Similarity=0.178 Sum_probs=58.0
Q ss_pred HHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc--Cce
Q 014347 59 DQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK--GVF 136 (426)
Q Consensus 59 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~--gIi 136 (426)
.-+..+.+++.++. .|+++..- ..-.+-+++|+|--... + -..++..=+.+|.-.|+. +.+
T Consensus 103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i---------~----~~N~i~agi~~L~~fH~~~~~~l 165 (308)
T PF07387_consen 103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI---------N----FSNFITAGIKDLMDFHSENQHCL 165 (308)
T ss_pred hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc---------c----hhHHHHHhHHHHHHhhccCCCee
Confidence 34577888888764 57776632 34456688999843111 0 111222225667778843 799
Q ss_pred eccCCCCcEEecCCCCeEEeeccC
Q 014347 137 HRDLKLENILLDSKGNIKISDFGL 160 (426)
Q Consensus 137 HrDLKp~NILl~~~g~vkL~DFGl 160 (426)
|+|-.|+||+-|..|.+||.|=+.
T Consensus 166 HGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 166 HGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred cCCCChhheeecCCCCEEecChhh
Confidence 999999999999999999998763
|
The function of this family is unknown. |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.46 E-value=0.061 Score=48.58 Aligned_cols=29 Identities=17% Similarity=0.421 Sum_probs=26.0
Q ss_pred CceeccCCCCcEEecCCCCeEEeeccCccC
Q 014347 134 GVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (426)
Q Consensus 134 gIiHrDLKp~NILl~~~g~vkL~DFGla~~ 163 (426)
-.+|+|+.|.|++++++| ++|+||+.|..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 469999999999998877 99999999874
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 426 | ||||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-75 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-74 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-73 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-71 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-71 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-71 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-71 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-67 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-66 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-66 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-65 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-65 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-64 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-64 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-64 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-64 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-63 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-62 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-61 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-58 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-57 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-57 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-57 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-56 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-53 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-48 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-48 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-48 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-48 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-48 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-48 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-48 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-47 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-47 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-47 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-47 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-47 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-47 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-47 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-46 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-46 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-46 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-46 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-46 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-46 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-46 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-46 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-46 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-46 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-46 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-46 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-46 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-46 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-46 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-46 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-46 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-46 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-46 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-45 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-45 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-45 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-45 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-45 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-45 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-45 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 8e-45 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-45 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-44 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-44 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-44 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-44 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-44 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-44 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-44 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-44 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-44 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-44 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-44 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-44 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-44 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-44 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-44 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-44 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-44 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-44 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-44 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-44 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-44 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-44 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-43 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-43 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-43 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-43 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-43 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-43 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-43 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-43 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-43 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-43 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-43 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-43 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-43 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-43 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-43 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-43 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-43 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-43 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-43 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-43 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-43 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-43 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-43 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-43 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-43 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-43 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-42 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-42 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-42 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-42 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-42 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-42 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-42 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-42 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-42 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-42 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-42 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-42 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-42 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-42 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-42 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-42 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-42 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-42 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-42 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-42 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-42 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-42 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-42 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-42 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-42 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-42 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-42 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-42 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-42 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-42 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-42 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-42 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-42 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-42 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-42 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-42 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-42 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-42 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-42 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-42 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-42 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-42 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-42 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-42 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-42 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-42 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-42 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-42 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-41 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-41 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-41 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-41 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-41 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-41 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-41 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-41 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-40 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-40 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-40 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-40 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-40 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-40 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-39 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-39 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-39 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-39 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-39 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-39 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-39 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-39 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-39 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-39 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-39 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-38 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-38 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-38 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-38 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-38 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-38 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-38 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-38 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-38 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-38 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-38 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-38 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-38 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-38 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-38 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-38 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-37 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-37 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-37 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-37 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-37 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-37 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-37 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-37 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-37 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-37 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-37 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-37 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-37 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-37 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-37 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-37 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-37 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-37 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-37 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-37 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-37 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-37 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-37 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-37 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-37 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-37 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-37 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-37 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-37 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-37 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-37 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-36 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-36 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-36 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-36 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-36 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-36 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-36 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-36 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-36 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-36 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-36 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-36 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-36 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-36 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-36 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-36 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-36 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-36 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-36 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-36 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-36 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-36 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-36 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-36 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-35 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-35 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-35 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-35 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-35 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-34 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-34 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-34 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-34 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-34 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-34 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-33 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 9e-32 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-31 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-31 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-31 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-31 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-31 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-30 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-30 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-30 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-30 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-30 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-30 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-30 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-30 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-30 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-30 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-30 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-30 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-30 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-30 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-30 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-30 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-30 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-30 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-30 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-30 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-29 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-29 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-29 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-29 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-29 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-29 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-29 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-29 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-29 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-29 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-29 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-28 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-28 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-27 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-27 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-27 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-27 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-27 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-27 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-27 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-27 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-27 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-27 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-27 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-27 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-27 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 8e-27 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 8e-27 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-27 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-26 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-26 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-26 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-25 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-25 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-25 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-25 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-24 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-24 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-24 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-24 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-24 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-24 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-24 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-24 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-24 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-24 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-24 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-24 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 9e-24 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-23 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-23 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-23 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-23 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-23 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-23 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 7e-23 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-23 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-23 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-23 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-23 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-23 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-22 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-22 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-22 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-22 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-22 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-22 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-22 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-22 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-22 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-22 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-22 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-22 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-22 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-22 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-22 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-22 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-22 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-22 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-22 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-22 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-22 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-22 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-22 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-22 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-22 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-22 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-22 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-22 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-22 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-22 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-22 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-22 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-22 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-22 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-22 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-22 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-22 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-22 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-22 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-22 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-22 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-22 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-22 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-22 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 9e-22 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-21 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-21 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-21 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-21 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-21 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-21 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-21 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-21 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-21 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-21 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-21 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-21 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-21 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-21 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-21 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-21 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-21 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-21 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-21 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-21 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-21 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-21 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-21 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-21 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-21 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-21 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-21 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-21 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-21 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-21 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-21 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-21 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-21 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-21 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-21 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-21 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-21 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-21 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-21 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-21 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-21 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-21 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-21 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-21 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-21 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-21 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-21 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-21 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-21 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-21 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-21 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-21 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-21 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-21 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-21 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-21 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-21 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-21 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-21 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-21 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-21 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-20 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-20 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-20 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-20 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-20 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-20 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-20 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-20 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-20 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-20 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-20 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-20 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-20 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-20 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-20 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-20 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-20 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-20 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-20 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-20 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-20 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-20 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-20 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-20 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-20 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-20 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-20 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-20 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 5e-20 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-20 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-19 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-19 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-19 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-19 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-19 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-19 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-19 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-19 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-19 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-19 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-19 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-19 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-19 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-19 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-19 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-19 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-19 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-19 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-19 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-19 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-19 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-19 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-18 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-18 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-18 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-18 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-18 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-18 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-18 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-18 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-18 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-18 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-18 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-18 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-18 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-18 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-18 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-18 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-18 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-18 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-18 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-18 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-18 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-18 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-18 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-18 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-18 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-18 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-18 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-17 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-17 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-17 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-17 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-17 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-17 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-17 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-17 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-17 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-17 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-17 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-17 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-17 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-17 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-17 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-17 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-17 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-17 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-17 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-17 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-17 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-17 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-17 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-17 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-17 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-17 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-17 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-16 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-16 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-16 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-16 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-16 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-16 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-16 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-16 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-16 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-16 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-16 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-16 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-16 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-16 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-16 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-16 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-16 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-16 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-16 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-16 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-16 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-16 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-16 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 9e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-15 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-15 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-15 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-15 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-15 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-15 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-15 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 9e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 9e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-15 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-14 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-14 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-14 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-14 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-14 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-14 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-14 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-14 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-14 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-14 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-14 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-14 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-14 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-14 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-14 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-14 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-14 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-14 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-14 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-14 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-14 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-14 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-14 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-14 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-14 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-14 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-14 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 7e-14 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-14 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-14 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-14 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 9e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-14 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-14 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-13 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-13 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-13 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-13 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-13 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-13 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-13 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-13 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-13 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-13 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-13 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-13 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-13 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-13 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-13 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-13 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-13 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-12 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-12 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-12 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-12 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-12 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-12 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-12 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-12 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-12 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-12 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-12 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-12 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-12 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-12 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-12 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-12 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-12 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-12 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-12 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-12 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-12 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-12 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-12 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 8e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-11 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-11 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-11 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 5e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-11 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 6e-11 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 7e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-10 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-10 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-10 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-10 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-10 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-10 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 4e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-09 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-09 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 5e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-09 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 6e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-09 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 6e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-09 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 7e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-09 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 7e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-09 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 8e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-09 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-08 |
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 475 bits (1225), Expect = e-168
Identities = 117/345 (33%), Positives = 174/345 (50%), Gaps = 18/345 (5%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
RY+ + +G GNFG + +D + AVK +E+ I + ++REI + L
Sbjct: 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSL 73
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
+HPN+VR EV+ + + + +++EY +GGEL+++I + GR E E R FQQL+ GVSYCH
Sbjct: 74 RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH 133
Query: 132 NKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
+ + HRDLKLEN LLD +KI DFG S +T G+P Y+APEVL
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKSTVGTPAYIAPEVLL 190
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK----IFRGDFKLPK--WLSPG 243
+ YDG +D+WSCGV LYV+L G PF+D Y+K I + +P +SP
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPE 250
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP--ANPDDDEEDIFVDNEAFSMHEVPS 301
+L+ +I +P RI+I IK WF ++ N + + +
Sbjct: 251 CCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIM 310
Query: 302 DGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSN 346
P + N M+ LDL + D SE +I S+
Sbjct: 311 QIISEATIPAVRNRCLDDFMTDNLDLDDDMDDFD-SESEIDIDSS 354
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 472 bits (1216), Expect = e-168
Identities = 132/274 (48%), Positives = 182/274 (66%), Gaps = 3/274 (1%)
Query: 4 AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
K +++G Y LG TLG G FGKVK + +G AVKIL + +I L + +IKR
Sbjct: 1 GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60
Query: 64 EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
EI LKL +HP++++L++V+++ + +MV+EYV+GGELFD I GR++E E R+LFQQ+
Sbjct: 61 EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI 120
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
+ V YCH V HRDLK EN+LLD+ N KI+DFGLS + D L T+CGSPNY
Sbjct: 121 LSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYA 177
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPG 243
APEV++ R Y G DIWSCGVILY +L G LPFDD ++ L++KI G F +P++L+
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRS 237
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
LL +L+ +P+KR TI I+ EWF+QD
Sbjct: 238 VATLLMHMLQVDPLKRATIKDIREHEWFKQDLPS 271
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 478 bits (1233), Expect = e-168
Identities = 140/295 (47%), Positives = 192/295 (65%), Gaps = 5/295 (1%)
Query: 1 MVIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ 60
M +K +++G Y LG TLG G FGKVK + +G AVKIL + +I L + +
Sbjct: 3 MAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK 62
Query: 61 IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
I+REI LKL +HP++++L++V+++ S I+MV+EYV+GGELFD I GRL E E R+LF
Sbjct: 63 IRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLF 122
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
QQ++ GV YCH V HRDLK EN+LLD+ N KI+DFGLS + D L T+CGSP
Sbjct: 123 QQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSP 179
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL 240
NY APEV++ R Y G DIWS GVILY +L G LPFDD ++ L++KI G F P++L
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYL 239
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP--ANPDDDEEDIFVDNEA 293
+P +LL+ +L+ +P+KR TI I+ EWF+QD D +D+EA
Sbjct: 240 NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEA 294
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 463 bits (1194), Expect = e-165
Identities = 101/266 (37%), Positives = 150/266 (56%), Gaps = 5/266 (1%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ ++L +TLGEG +G+V+ A + + AVKI++ R + + IK+EI K+L
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
H NVV+ + + Y+ LEY +GGELFD+I + E + ++ F QL+ GV Y H
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
G+ HRD+K EN+LLD + N+KISDFGL+ + ++ + LL+ CG+ YVAPE+L R
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFKLPKW--LSPGAQNLLR 249
+ D+WSCG++L +L G LP+D + Y L W + LL
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 250 KILEPNPVKRITIAGIKADEWFEQDY 275
KIL NP RITI IK D W+ +
Sbjct: 244 KILVENPSARITIPDIKKDRWYNKPL 269
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 464 bits (1197), Expect = e-165
Identities = 108/309 (34%), Positives = 163/309 (52%), Gaps = 14/309 (4%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ ++L +TLGEG +G+V+ A + + AVKI++ R + + IK+EI K+L
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
H NVV+ + + Y+ LEY +GGELFD+I + E + ++ F QL+ GV Y H
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
G+ HRD+K EN+LLD + N+KISDFGL+ + ++ + LL+ CG+ YVAPE+L R
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFKLPKW--LSPGAQNLLR 249
+ D+WSCG++L +L G LP+D + Y L W + LL
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 250 KILEPNPVKRITIAGIKADEWFEQDYTP--------ANPDDDEEDIFVDNEAFSMHEVPS 301
KIL NP RITI IK D W+ + + + F + ++ P
Sbjct: 244 KILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPV 303
Query: 302 DGG-RTPGS 309
+ RTPGS
Sbjct: 304 NSASRTPGS 312
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 464 bits (1197), Expect = e-164
Identities = 122/290 (42%), Positives = 184/290 (63%), Gaps = 5/290 (1%)
Query: 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
+G Y + TLGEG+FGKVK A + A+K + + + + +++REI+
Sbjct: 2 AISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREIS 61
Query: 67 TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
LKLL+HP++++L++V+ + + I MV+EY GGELFD I K R+ E EGR+ FQQ+I
Sbjct: 62 YLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICA 120
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
+ YCH + HRDLK EN+LLD N+KI+DFGLS + D L T+CGSPNY APE
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNI---MTDGNFLKTSCGSPNYAAPE 177
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246
V+ + Y G D+WSCG++LYV+L G LPFDD + L++K+ + +P +LSPGAQ+
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQS 237
Query: 247 LLRKILEPNPVKRITIAGIKADEWFEQDYT-PANPDDDEEDIFVDNEAFS 295
L+R+++ +P++RITI I+ D WF + P ++ + + D+ S
Sbjct: 238 LIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVS 287
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 463 bits (1193), Expect = e-164
Identities = 104/289 (35%), Positives = 159/289 (55%), Gaps = 13/289 (4%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-ITDQIKREIATLKL 70
+G+Y +G LGEG++GKVK D ++ AVKIL+K ++ + +K+EI L+
Sbjct: 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 71 LKHPNVVRLHEVL--ASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDG 126
L+H NV++L +VL K K+YMV+EY G E+ D + + R + F QLIDG
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-EKRFPVCQAHGYFCQLIDG 121
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
+ Y H++G+ H+D+K N+LL + G +KIS G++ F D T+ GSP + PE
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 187 VLAN-RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ 245
+ + G DIWS GV LY I TG PF+ N+ L++ I +G + +P P
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLS 241
Query: 246 NLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN------PDDDEEDIF 288
+LL+ +LE P KR +I I+ WF + + PA P D +D +
Sbjct: 242 DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRW 290
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 450 bits (1159), Expect = e-159
Identities = 94/276 (34%), Positives = 145/276 (52%), Gaps = 3/276 (1%)
Query: 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
I E + RY GR LG+G F K D D+ FA KI+ K+ ++ +++
Sbjct: 4 IPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS 63
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
EI+ + L H +VV H +++VLE L + + L E E R +Q
Sbjct: 64 MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ 123
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
++ G Y H V HRDLKL N+ L+ +KI DFGL+ ++ D CG+PNY
Sbjct: 124 IVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNY 181
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 242
+APEVL+ +G+ D+WS G I+Y +L G PF+ L Y +I + ++ +PK ++P
Sbjct: 182 IAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINP 240
Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 278
A +L++K+L+ +P R TI + DE+F Y PA
Sbjct: 241 VAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 276
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 449 bits (1156), Expect = e-158
Identities = 94/276 (34%), Positives = 145/276 (52%), Gaps = 3/276 (1%)
Query: 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
I E + RY GR LG+G F K D D+ FA KI+ K+ ++ +++
Sbjct: 30 IPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS 89
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
EI+ + L H +VV H +++VLE L + + L E E R +Q
Sbjct: 90 MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ 149
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
++ G Y H V HRDLKL N+ L+ +KI DFGL+ ++ D CG+PNY
Sbjct: 150 IVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNY 207
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 242
+APEVL+ +G+ D+WS G I+Y +L G PF+ L Y +I + ++ +PK ++P
Sbjct: 208 IAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINP 266
Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 278
A +L++K+L+ +P R TI + DE+F Y PA
Sbjct: 267 VAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 302
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 440 bits (1135), Expect = e-155
Identities = 115/283 (40%), Positives = 177/283 (62%), Gaps = 4/283 (1%)
Query: 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
IA E +G Y L +T+G+GNF KVK A+ + +G A+KI++K ++ + ++
Sbjct: 4 IASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSL-QKLF 62
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
RE+ +K+L HPN+V+L EV+ ++ +Y+++EY +GGE+FD + + GR++E E R F+Q
Sbjct: 63 REVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ 122
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
++ V YCH K + HRDLK EN+LLD+ NIKI+DFG S F G L CG+P Y
Sbjct: 123 IVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNE---FTVGGKLDAFCGAPPY 179
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 242
APE+ + YDG D+WS GVILY +++G LPFD +NL L +++ RG +++P ++S
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMST 239
Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
+NLL++ L NP+KR T+ I D W + E
Sbjct: 240 DCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVE 282
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 436 bits (1124), Expect = e-154
Identities = 82/274 (29%), Positives = 152/274 (55%), Gaps = 4/274 (1%)
Query: 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
G ++ +++G LG+G+F V A+ + +GL A+K+++K + + +++ E+
Sbjct: 7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHC 66
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVS 128
LKHP+++ L+ + +Y+VLE GE+ + ++ E E R Q+I G+
Sbjct: 67 QLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
Y H+ G+ HRDL L N+LL NIKI+DFGL+ + +T CG+PNY++PE+
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM--PHEKHYTLCGTPNYISPEIA 184
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 248
+ G SD+WS G + Y +L G PFD + K+ D+++P +LS A++L+
Sbjct: 185 TRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLI 243
Query: 249 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 282
++L NP R++++ + + ++ + + D+
Sbjct: 244 HQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDE 277
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 429 bits (1106), Expect = e-151
Identities = 94/298 (31%), Positives = 153/298 (51%), Gaps = 32/298 (10%)
Query: 5 EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT------ 58
+ ++L +Y L +G+G++G VK A + + +A+K+L K ++I
Sbjct: 4 GSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPP 63
Query: 59 -----------------DQIKREIATLKLLKHPNVVRLHEVL--ASKSKIYMVLEYVTGG 99
+Q+ +EIA LK L HPNVV+L EVL ++ +YMV E V G
Sbjct: 64 RGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG 123
Query: 100 ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG 159
+ + + + L E + R FQ LI G+ Y H + + HRD+K N+L+ G+IKI+DFG
Sbjct: 124 PVME-VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPF 217
+S + D LL T G+P ++APE L+ + + G D+W+ GV LY + G PF
Sbjct: 183 VSNEFK--GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240
Query: 218 DDRNLAVLYQKIFRGDFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
D + L+ KI + P ++ ++L+ ++L+ NP RI + IK W +
Sbjct: 241 MDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 427 bits (1101), Expect = e-150
Identities = 88/278 (31%), Positives = 154/278 (55%), Gaps = 5/278 (1%)
Query: 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
+AE + + +++GR LG+G FG V A++ + A+K+L K+++ + Q++
Sbjct: 3 LAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR 62
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
REI L+HPN++R++ + +IY++LE+ GEL+ ++ GR E ++
Sbjct: 63 REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE 122
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
L D + YCH + V HRD+K EN+L+ KG +KI+DFG S R T CG+ +Y
Sbjct: 123 LADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDY 178
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 242
+ PE++ + +D D+W GV+ Y L G PFD + +++I D K P +LS
Sbjct: 179 LPPEMIEGKTHDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSD 237
Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
G+++L+ K+L +P +R+ + G+ W + + P
Sbjct: 238 GSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLP 275
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 417 bits (1075), Expect = e-147
Identities = 87/281 (30%), Positives = 152/281 (54%), Gaps = 5/281 (1%)
Query: 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
K+ L +E+GR LG+G FG V A++ S A+K+L K ++ + Q++RE+
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 67 TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
L+HPN++RL+ +++Y++LEY G ++ ++ + E +L +
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
+SYCH+K V HRD+K EN+LL S G +KI+DFG S R CG+ +Y+ PE
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPE 177
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246
++ R +D D+WS GV+ Y L G PF+ Y++I R +F P +++ GA++
Sbjct: 178 MIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
Query: 247 LLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 287
L+ ++L+ NP +R + + W + + + ++E
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 277
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 419 bits (1079), Expect = e-146
Identities = 84/312 (26%), Positives = 140/312 (44%), Gaps = 15/312 (4%)
Query: 4 AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD---- 59
EG +Y LG G FG V A D + VK ++K +++ +
Sbjct: 14 GLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKL 73
Query: 60 -QIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE-YVTGGELFDKIASKGRLQEAEGR 117
++ EIA L ++H N++++ ++ ++ +V+E + +G +LF I RL E
Sbjct: 74 GKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLAS 133
Query: 118 KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 177
+F+QL+ V Y K + HRD+K ENI++ IK+ DFG +A L +T C
Sbjct: 134 YIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY---LERGKLFYTFC 190
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP 237
G+ Y APEVL Y G ++WS GV LY ++ PF + ++ P
Sbjct: 191 GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPP 244
Query: 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMH 297
+S +L+ +L+P P +R T+ + D W Q A+ +E E+ +
Sbjct: 245 YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLS 304
Query: 298 EVPSDGGRTPGS 309
+ G S
Sbjct: 305 AASLEMGNRSLS 316
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 413 bits (1063), Expect = e-144
Identities = 89/292 (30%), Positives = 134/292 (45%), Gaps = 21/292 (7%)
Query: 4 AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ--- 60
K Y LG LG+G FG V L L A+K++ +NR++
Sbjct: 21 PGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVT 80
Query: 61 IKREIATLKLL----KHPNVVRLHEVLASKSKIYMVLEY-VTGGELFDKIASKGRLQEAE 115
E+A L + HP V+RL + ++ +VLE + +LFD I KG L E
Sbjct: 81 CPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGP 140
Query: 116 GRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQHFRDDGLLH 174
R F Q++ + +CH++GV HRD+K ENIL+D + G K+ DFG AL D
Sbjct: 141 SRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH----DEPYT 196
Query: 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF 234
G+ Y PE ++ Y + +WS G++LY ++ G +PF+ Q+I +
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAEL 250
Query: 235 KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY--TPANPDDDE 284
P +SP L+R+ L P P R ++ I D W + P NP
Sbjct: 251 HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGG 302
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 410 bits (1056), Expect = e-143
Identities = 89/291 (30%), Positives = 140/291 (48%), Gaps = 17/291 (5%)
Query: 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI---IHLKITD 59
+A K++ +Y++G LG G FG V + LP A+K +EK+RI L
Sbjct: 32 LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT 91
Query: 60 QIKREIATLKLLKH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEG 116
++ E+ LK + V+RL + ++LE +LFD I +G LQE
Sbjct: 92 RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 151
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHFRDDGLLHT 175
R F Q+++ V +CHN GV HRD+K ENIL+D +G +K+ DFG AL + D +
Sbjct: 152 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTD 207
Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK 235
G+ Y PE + Y G ++ +WS G++LY ++ G +PF+ ++I RG
Sbjct: 208 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVF 261
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEED 286
+ +S Q+L+R L P R T I+ W + P +
Sbjct: 262 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLH 312
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 388 bits (998), Expect = e-134
Identities = 74/324 (22%), Positives = 132/324 (40%), Gaps = 50/324 (15%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK--------- 56
K++ + Y + RTL +G F K+ + +A+K EK+ + +
Sbjct: 23 VKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDK 80
Query: 57 -----ITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRL 111
D K E+ + +K+ + ++ + ++Y++ EY+ + L
Sbjct: 81 ISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVL 140
Query: 112 Q--------EAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSA 162
+ + + +++ SY HN K + HRD+K NIL+D G +K+SDFG S
Sbjct: 141 DKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESE 200
Query: 163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDD-R 220
+ D + + G+ ++ PE +N Y+GA DIWS G+ LYV+ +PF
Sbjct: 201 ----YMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256
Query: 221 NLAVLYQKIFRGDFKLP-------------------KWLSPGAQNLLRKILEPNPVKRIT 261
+L L+ I + + P +LS + L+ L NP +RIT
Sbjct: 257 SLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERIT 316
Query: 262 IAGIKADEWFEQDYTPANPDDDEE 285
EW + +E
Sbjct: 317 SEDALKHEWLADTNIEDLREFSKE 340
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 331 bits (852), Expect = e-112
Identities = 98/283 (34%), Positives = 145/283 (51%), Gaps = 19/283 (6%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLK 69
Y + +TLG G G+VK A + + A+KI+ K + ++ EI LK
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
L HP ++++ ++ Y+VLE + GGELFDK+ RL+EA + F Q++ V Y
Sbjct: 71 KLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 130 CHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
H G+ HRDLK EN+LL S+ IKI+DFG S + + L+ T CG+P Y+APE
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS---KILGETSLMRTLCGTPTYLAPE 186
Query: 187 VLANRGYDGATS--DIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRG--DFKLPKW-- 239
VL + G G D WS GVIL++ L+GY PF + L +I G +F W
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 246
Query: 240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 282
+S A +L++K+L +P R T W + + D
Sbjct: 247 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQD 289
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 324 bits (833), Expect = e-110
Identities = 97/275 (35%), Positives = 154/275 (56%), Gaps = 16/275 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y L T+G G++G+VK A + + A K + K ++ D+ K+EI +K L HP
Sbjct: 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF---VEDVDRFKQEIEIMKSLDHP 66
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N++RL+E + IY+V+E TGGELF+++ K +E++ ++ + ++ V+YCH
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 126
Query: 135 VFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
V HRDLK EN L + +K+ DFGL+A F+ ++ T G+P YV+P+VL
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAA---RFKPGKMMRTKVGTPYYVSPQVL-EG 182
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
Y G D WS GV++YV+L GY PF + + KI G F W +SP A++L
Sbjct: 183 LY-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESL 241
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 282
+R++L +P +RIT EWF + ++P +
Sbjct: 242 IRRLLTKSPKQRITSLQALEHEWF-EKQLSSSPRN 275
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 323 bits (831), Expect = e-110
Identities = 100/280 (35%), Positives = 156/280 (55%), Gaps = 12/280 (4%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y++ LG+G F V+ +GL FA KI+ ++ +++RE + L+HP
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF-QKLEREARICRKLQHP 65
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+VRLH+ + +S Y+V + VTGGELF+ I ++ EA+ QQ+++ ++YCH+ G
Sbjct: 66 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 135 VFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
+ HR+LK EN+LL SK +K++DFGL+ D H G+P Y++PEVL
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGYLSPEVLKKD 182
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
Y DIW+CGVILY++L GY PF D + LY +I G D+ P+W ++P A++L
Sbjct: 183 PY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 241
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 287
+ +L NP KRIT W A+ ++ +
Sbjct: 242 IDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTV 281
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 323 bits (829), Expect = e-108
Identities = 89/275 (32%), Positives = 141/275 (51%), Gaps = 20/275 (7%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-----IHLKITDQIKREIATLK 69
+Y+ +G G V+ +G FAVKI+E ++ + +RE L+
Sbjct: 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 70 LLK-HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
+ HP+++ L + S S +++V + + GELFD + K L E E R + + L++ VS
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 214
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
+ H + HRDLK ENILLD I++SDFG S H L CG+P Y+APE+L
Sbjct: 215 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC---HLEPGEKLRELCGTPGYLAPEIL 271
Query: 189 ------ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW- 239
+ GY G D+W+CGVIL+ +L G PF R ++ + I G F P+W
Sbjct: 272 KCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD 330
Query: 240 -LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
S ++L+ ++L+ +P R+T +FE+
Sbjct: 331 DRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 325 bits (834), Expect = e-108
Identities = 98/283 (34%), Positives = 146/283 (51%), Gaps = 19/283 (6%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLK 69
Y + +TLG G G+VK A + + A++I+ K + ++ EI LK
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
L HP ++++ ++ Y+VLE + GGELFDK+ RL+EA + F Q++ V Y
Sbjct: 196 KLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 130 CHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
H G+ HRDLK EN+LL S+ IKI+DFG S + + L+ T CG+P Y+APE
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS---KILGETSLMRTLCGTPTYLAPE 311
Query: 187 VLANRGYDGATS--DIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFRG--DFKLPKW-- 239
VL + G G D WS GVIL++ L+GY PF + R L +I G +F W
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 371
Query: 240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 282
+S A +L++K+L +P R T W + + D
Sbjct: 372 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQD 414
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 318 bits (817), Expect = e-107
Identities = 86/283 (30%), Positives = 134/283 (47%), Gaps = 21/283 (7%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD------QIKREIATL 68
YE LG G V+ + +AVKI++ + +E+ L
Sbjct: 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 69 KLLK-HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
+ + HPN+++L + + + ++V + + GELFD + K L E E RK+ + L++ +
Sbjct: 78 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
H + HRDLK ENILLD NIK++DFG S L CG+P+Y+APE+
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS---CQLDPGEKLREVCGTPSYLAPEI 194
Query: 188 LA------NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW 239
+ + GY G D+WS GVI+Y +L G PF R ++ + I G F P+W
Sbjct: 195 IECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 253
Query: 240 --LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
S ++L+ + L P KR T A +F+Q
Sbjct: 254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVR 296
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 319 bits (819), Expect = e-107
Identities = 100/278 (35%), Positives = 154/278 (55%), Gaps = 12/278 (4%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y++ LG+G F V+ +GL FA KI+ ++ ++RE + L+HP
Sbjct: 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQHP 88
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+VRLH+ + +S Y+V + VTGGELF+ I ++ EA+ QQ+++ ++YCH+ G
Sbjct: 89 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 148
Query: 135 VFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
+ HR+LK EN+LL SK +K++DFGL+ D H G+P Y++PEVL
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVLKKD 205
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
Y DIW+CGVILY++L GY PF D + LY +I G D+ P+W ++P A++L
Sbjct: 206 PY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
+ +L NP KRIT W A+ ++
Sbjct: 265 IDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQD 302
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 316 bits (813), Expect = e-107
Identities = 95/277 (34%), Positives = 147/277 (53%), Gaps = 15/277 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+ LG G F +V + +G FA+K ++K+ ++ EIA LK +KH
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHE 66
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+V L ++ S + Y+V++ V+GGELFD+I +G E + + QQ++ V Y H G
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG 126
Query: 135 VFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
+ HRDLK EN+L + I I+DFGLS +G++ T CG+P YVAPEVLA +
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLS----KMEQNGIMSTACGTPGYVAPEVLAQK 182
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
Y D WS GVI Y++L GY PF + + L++KI G +F+ P W +S A++
Sbjct: 183 PY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF 241
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDE 284
+ +LE +P +R T + W + +
Sbjct: 242 ICHLLEKDPNERYTCEKALSHPWIDGNTALHRDIYPS 278
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 313 bits (803), Expect = e-105
Identities = 94/269 (34%), Positives = 142/269 (52%), Gaps = 17/269 (6%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+ R LG G FG V ++ SGL +K + K+R +QI+ EI LK L HP
Sbjct: 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPM--EQIEAEIEVLKSLDHP 80
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYC 130
N++++ EV +Y+V+E GGEL ++I S L E +L +Q+++ ++Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 131 HNKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
H++ V H+DLK ENIL IKI DFGL+ F+ D G+ Y+APEV
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE---LFKSDEHSTNAAGTALYMAPEV 197
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL---PKWLSPGA 244
R DIWS GV++Y +LTG LPF +L + QK + + L+P A
Sbjct: 198 F-KRDVTFKC-DIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQA 255
Query: 245 QNLLRKILEPNPVKRITIAGIKADEWFEQ 273
+LL+++L +P +R + A + EWF+Q
Sbjct: 256 VDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 312 bits (801), Expect = e-105
Identities = 72/290 (24%), Positives = 124/290 (42%), Gaps = 36/290 (12%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E LG+G FG+V A++ +A+K + + I E+ L L H
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNHQY 63
Query: 76 VVRLHEV-------------LASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQ 121
VVR + + KS +++ +EY G L+D I S+ Q E +LF+
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH------------FRD 169
Q+++ +SY H++G+ HRDLK NI +D N+KI DFGL+
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI 229
L + G+ YVA EVL G+ D++S G+I + ++ Y + +K+
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKKL 241
Query: 230 FRGDFKLPKWL----SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
+ P + ++R +++ +P KR + W +
Sbjct: 242 RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 310 bits (797), Expect = e-104
Identities = 104/267 (38%), Positives = 155/267 (58%), Gaps = 13/267 (4%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RY + LG+G+FG+V +D + +AVK++ K + K T I RE+ LK L HP
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHP 81
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+++L E+L S Y+V E TGGELFD+I + R E + ++ +Q+ G++Y H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 135 VFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
+ HRDLK ENILL+SK +IKI DFGLS F+ + + G+ Y+APEVL
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTKMKDRIGTAYYIAPEVL-RG 197
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
YD D+WS GVILY++L+G PF +N + +++ G F LP+W +S A++L
Sbjct: 198 TYDEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQD 274
+RK+L +P RIT W ++
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQKY 283
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 311 bits (798), Expect = e-102
Identities = 103/279 (36%), Positives = 156/279 (55%), Gaps = 13/279 (4%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y+L LG+G F V+ + +G +A I+ ++ ++RE +LLKHP
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK-LEREARICRLLKHP 70
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+VRLH+ ++ + Y++ + VTGGELF+ I ++ EA+ QQ+++ V +CH G
Sbjct: 71 NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130
Query: 135 VFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEVLAN 190
V HR+LK EN+LL SK +K++DFGL+ + G+P Y++PEVL
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAI---EVEGEQQAWFGFAGTPGYLSPEVLRK 187
Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQN 246
Y G D+W+CGVILY++L GY PF D + LYQ+I G DF P+W ++P A++
Sbjct: 188 DPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 246
Query: 247 LLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
L+ K+L NP KRIT A W T A+ +E
Sbjct: 247 LINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQE 285
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 304 bits (781), Expect = e-102
Identities = 67/280 (23%), Positives = 124/280 (44%), Gaps = 19/280 (6%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y + + +G G KV + + +A+K + + + D + EIA L L+
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQH 86
Query: 75 N--VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
+ ++RL++ + IYMV+E +L + K + E + ++ +++ V H
Sbjct: 87 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
G+ H DLK N L+ G +K+ DFG++ Q + + G+ NY+ PE + +
Sbjct: 146 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 193 YD----------GATSDIWSCGVILYVILTGYLPFDDR--NLAVLYQKI-FRGDFKLPKW 239
SD+WS G ILY + G PF ++ L+ I + + P
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 264
Query: 240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 279
Q++L+ L+ +P +RI+I + A + + P N
Sbjct: 265 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 304
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 302 bits (776), Expect = e-101
Identities = 88/271 (32%), Positives = 142/271 (52%), Gaps = 15/271 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
YE+G LG G F V+ + +G +A K ++K R+ ++I+RE+ L+ +
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
+HPN++ LH++ +K+ + ++LE V+GGELFD +A K L E E + +Q++DGV Y H
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 132 NKGVFHRDLKLENILLDSK----GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
+K + H DLK ENI+L K IK+ DFG++ G+P +VAPE+
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA---HKIEAGNEFKNIFGTPEFVAPEI 182
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPG 243
+ D+WS GVI Y++L+G PF I DF + S
Sbjct: 183 VNYEPLGLEA-DMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQD 274
A++ +R++L +P +R+TIA W +
Sbjct: 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 302 bits (776), Expect = e-101
Identities = 92/288 (31%), Positives = 145/288 (50%), Gaps = 15/288 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT---DQIKREIATLKLL 71
Y++G LG G F VK ++ +GL +A K ++K + + ++I+RE++ L+ +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
H NV+ LH+V +++ + ++LE V+GGELFD +A K L E E +Q++DGV+Y H
Sbjct: 73 LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 132 NKGVFHRDLKLENILLDSK----GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
K + H DLK ENI+L K +IK+ DFGL+ D G+P +VAPE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA---HEIEDGVEFKNIFGTPEFVAPEI 189
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPG 243
+ D+WS GVI Y++L+G PF I DF + S
Sbjct: 190 VNYEPLGLEA-DMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDN 291
A++ +RK+L KR+TI W E + ++N
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLEN 296
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 303 bits (779), Expect = e-101
Identities = 93/288 (32%), Positives = 146/288 (50%), Gaps = 15/288 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
Y++G LG G F VK ++ +GL +A K ++K + ++I+RE++ L+ +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
HPN++ LH+V +++ + ++LE V+GGELFD +A K L E E +Q++DGV+Y H
Sbjct: 73 LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 132 NKGVFHRDLKLENILLDSK----GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
K + H DLK ENI+L K +IK+ DFGL+ D G+P +VAPE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA---HEIEDGVEFKNIFGTPEFVAPEI 189
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPG 243
+ D+WS GVI Y++L+G PF I DF + S
Sbjct: 190 VNYEPLGLEA-DMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDN 291
A++ +RK+L KR+TI W T E + ++N
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLEN 296
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 302 bits (776), Expect = e-101
Identities = 90/312 (28%), Positives = 138/312 (44%), Gaps = 53/312 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ--IKREIATLKLLK 72
+Y L +G+G++G V+ A + + A+KI+ KN+I + D IK E+ +K L
Sbjct: 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQ-------------------- 112
HPN+ RL+EV + I +V+E GG L DK+
Sbjct: 87 HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 113 --------------------EAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN 152
E + +Q+ + Y HN+G+ HRD+K EN L + +
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206
Query: 153 --IKISDFGLSAL--PQHFRDDGLLHTTCGSPNYVAPEVL--ANRGYDGATSDIWSCGVI 206
IK+ DFGLS + + + T G+P +VAPEVL N Y D WS GV+
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC-DAWSAGVL 265
Query: 207 LYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITI 262
L+++L G +PF N A ++ F+ P + LSP A++LL +L N +R
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA 325
Query: 263 AGIKADEWFEQD 274
W Q
Sbjct: 326 MRALQHPWISQF 337
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 307 bits (788), Expect = e-100
Identities = 104/276 (37%), Positives = 156/276 (56%), Gaps = 13/276 (4%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RY + LG+G+FG+V +D + +AVK++ K + K T I RE+ LK L HP
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHP 81
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+++L E+L S Y+V E TGGELFD+I + R E + ++ +Q+ G++Y H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 135 VFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
+ HRDLK ENILL+SK +IKI DFGLS F+ + + G+ Y+APEVL
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRIGTAYYIAPEVL-RG 197
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
Y D+WS GVILY++L+G PF +N + +++ G F LP+W +S A++L
Sbjct: 198 TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDD 283
+RK+L +P RIT W ++ + D
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISD 292
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 302 bits (776), Expect = e-100
Identities = 94/278 (33%), Positives = 146/278 (52%), Gaps = 18/278 (6%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+E+ LG G V + + P+A+K+L+K ++ EI L L HP
Sbjct: 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT-----VDKKIVRTEIGVLLRLSHP 108
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+++L E+ + ++I +VLE VTGGELFD+I KG E + +Q+++ V+Y H G
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG 168
Query: 135 VFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
+ HRDLK EN+L + +KI+DFGLS + L+ T CG+P Y APE+L
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLS---KIVEHQVLMKTVCGTPGYCAPEILRGC 225
Query: 192 GYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFRG--DFKLPKW--LSPGAQN 246
Y G D+WS G+I Y++L G+ PF D+R ++++I F P W +S A++
Sbjct: 226 AY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKD 284
Query: 247 LLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDE 284
L+RK++ +P KR+T W D
Sbjct: 285 LVRKLIVLDPKKRLTTFQALQHPWV-TGKAANFVHMDT 321
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 302 bits (775), Expect = e-100
Identities = 87/284 (30%), Positives = 146/284 (51%), Gaps = 18/284 (6%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ--IKREIATLKLLK 72
YEL +G+G F V+ + ++G FAVKI++ + +KRE + +LK
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQ----EAEGRKLFQQLIDGVS 128
HP++V L E +S +YMV E++ G +L +I + EA +Q+++ +
Sbjct: 85 HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 129 YCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
YCH+ + HRD+K +LL SK N +K+ FG++ Q + G+P+++AP
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI--QLGESGLVAGGRVGTPHFMAP 202
Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LS 241
EV+ Y G D+W CGVIL+++L+G LPF L++ I +G +W +S
Sbjct: 203 EVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHIS 260
Query: 242 PGAQNLLRKILEPNPVKRITIAGIKADEWF-EQDYTPANPDDDE 284
A++L+R++L +P +RIT+ W E+D E
Sbjct: 261 ESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPE 304
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 300 bits (770), Expect = e-100
Identities = 72/309 (23%), Positives = 116/309 (37%), Gaps = 50/309 (16%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+ L LG+G V + +G FA+K+ L+ D RE LK L H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNH 66
Query: 74 PNVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVS 128
N+V+L + + +++E+ G L+ + L E+E + + ++ G++
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 129 YCHNKGVFHRDLKLENILL----DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
+ G+ HR++K NI+ D + K++DFG + DD + G+ Y+
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLYGTEEYLH 183
Query: 185 PEVLANRGYD-------GATSDIWSCGVILYVILTGYLPFDD----RNLAVLYQKIFRG- 232
P++ GAT D+WS GV Y TG LPF R + KI G
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243
Query: 233 ------------------DFKLPKW--LSPGAQN----LLRKILEPNPVKRITIAGIKAD 268
+P LS G Q +L ILE + K A+
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
Query: 269 EWFEQDYTP 277
Sbjct: 304 TSDILHRGN 312
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 306 bits (785), Expect = e-100
Identities = 94/292 (32%), Positives = 152/292 (52%), Gaps = 22/292 (7%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT----------DQIKRE 64
Y R LG G +G+V ++ + A+K+++K++ + + ++I E
Sbjct: 37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96
Query: 65 IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
I+ LK L HPN+++L +V K Y+V E+ GGELF++I ++ + E + + +Q++
Sbjct: 97 ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQIL 156
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
G+ Y H + HRD+K ENILL++K NIKI DFGLS F D L G+
Sbjct: 157 SGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLS---SFFSKDYKLRDRLGTAY 213
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW 239
Y+APEVL + Y D+WSCGVI+Y++L GY PF +N + +K+ +G F W
Sbjct: 214 YIAPEVL-KKKY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW 271
Query: 240 --LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFV 289
+S A+ L++ +L + KR T W ++ N D +
Sbjct: 272 KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGA 323
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 305 bits (783), Expect = e-100
Identities = 104/282 (36%), Positives = 158/282 (56%), Gaps = 12/282 (4%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RY+ R LG+G+FG+V +D +G AVK++ K ++ + + RE+ LK L HP
Sbjct: 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+++L+E K Y+V E TGGELFD+I S+ R E + ++ +Q++ G++Y H
Sbjct: 87 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 135 VFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
+ HRDLK EN+LL+SK NI+I DFGLS HF + G+ Y+APEVL +
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMKDKIGTAYYIAPEVL-HG 202
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
Y D+WS GVILY++L+G PF+ N + +K+ +G F+LP+W +S A++L
Sbjct: 203 TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 261
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFV 289
+RK+L P RI+ EW + D
Sbjct: 262 IRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNA 303
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 298 bits (764), Expect = 4e-99
Identities = 91/288 (31%), Positives = 145/288 (50%), Gaps = 15/288 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT---DQIKREIATLKLL 71
Y+ G LG G F VK ++ +GL +A K ++K R + + I+RE++ LK +
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
+HPNV+ LHEV +K+ + ++LE V GGELFD +A K L E E + +Q+++GV Y H
Sbjct: 72 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 132 NKGVFHRDLKLENILLDSK----GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
+ + H DLK ENI+L + IKI DFGL+ G+P +VAPE+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPEI 188
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPG 243
+ D+WS GVI Y++L+G PF + +F+ + S
Sbjct: 189 VNYEPLGLEA-DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDN 291
A++ +R++L +P KR+TI W + T + ++
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEK 295
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 296 bits (761), Expect = 2e-98
Identities = 95/284 (33%), Positives = 141/284 (49%), Gaps = 22/284 (7%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKH 73
YE+ +G G++ K + + FAVKI++K++ EI L + +H
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQH 75
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
PN++ L +V +Y+V E + GGEL DKI + E E + + V Y H +
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ 135
Query: 134 GVFHRDLKLENILLDSKG----NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
GV HRDLK NIL + +I+I DFG + Q ++GLL T C + N+VAPEVL
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAK--QLRAENGLLMTPCYTANFVAPEVLE 193
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFD---DRNLAVLYQKIFRG--DFKLPKW--LSP 242
+GYD A DIWS GV+LY +LTGY PF D + +I G W +S
Sbjct: 194 RQGYDAA-CDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD 252
Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEED 286
A++L+ K+L +P +R+T A + W + +D
Sbjct: 253 TAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQD 296
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 297 bits (763), Expect = 4e-98
Identities = 67/286 (23%), Positives = 124/286 (43%), Gaps = 19/286 (6%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
Y + + +G G KV + + +A+K + + + D + EIA L L+
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQ 113
Query: 74 PN--VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
+ ++RL++ + IYMV+E +L + K + E + ++ +++ V H
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
G+ H DLK N L+ G +K+ DFG++ Q + + G+ NY+ PE + +
Sbjct: 173 QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 192 GYD----------GATSDIWSCGVILYVILTGYLPFDDR--NLAVLYQKIFRG-DFKLPK 238
SD+WS G ILY + G PF ++ L+ I + + P
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291
Query: 239 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDE 284
Q++L+ L+ +P +RI+I + A + + P N
Sbjct: 292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 337
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 295 bits (758), Expect = 5e-98
Identities = 67/285 (23%), Positives = 124/285 (43%), Gaps = 19/285 (6%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y + + +G G KV + + +A+K + + + D + EIA L L+
Sbjct: 10 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQH 67
Query: 75 N--VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
+ ++RL++ + IYMV+E +L + K + E + ++ +++ V H
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
G+ H DLK N L+ G +K+ DFG++ Q + + G+ NY+ PE + +
Sbjct: 127 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 193 YD----------GATSDIWSCGVILYVILTGYLPFDDR--NLAVLYQKI-FRGDFKLPKW 239
SD+WS G ILY + G PF ++ L+ I + + P
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 245
Query: 240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDE 284
Q++L+ L+ +P +RI+I + A + + P N
Sbjct: 246 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 290
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 301 bits (772), Expect = 5e-98
Identities = 91/276 (32%), Positives = 153/276 (55%), Gaps = 13/276 (4%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y+ + LG G +G+V +D + + A+KI+ K + + + E+A LKLL HP
Sbjct: 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK-LLEEVAVLKLLDHP 96
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+++L++ K Y+V+E GGELFD+I + + E + + +Q++ GV+Y H
Sbjct: 97 NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 135 VFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
+ HRDLK EN+LL+SK IKI DFGLS F + + G+ Y+APEVL +
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLS---AVFENQKKMKERLGTAYYIAPEVL-RK 212
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
Y D+WS GVIL+++L GY PF + + +K+ +G F P+W +S GA++L
Sbjct: 213 KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDL 271
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDD 283
++++L+ + +RI+ W ++ + +
Sbjct: 272 IKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIE 307
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 306 bits (784), Expect = 6e-98
Identities = 76/298 (25%), Positives = 110/298 (36%), Gaps = 42/298 (14%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
G +E+ LG G FG V D+G A+K + K ++ EI +K L
Sbjct: 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP--KNRERWCLEIQIMKKL 69
Query: 72 KHPNVVRLHEVLASKSKI------YMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQ 122
HPNVV EV K+ + +EY GG+L + L+E R L
Sbjct: 70 NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGS 179
+ + Y H + HRDLK ENI+L KI D G + + L G+
Sbjct: 130 ISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA---KELDQGELCTEFVGT 186
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI---------- 229
Y+APE+L + Y T D WS G + + +TG+ PF V +
Sbjct: 187 LQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245
Query: 230 ----------FRGDFKLPKWLSPGAQNL----LRKILEPNPVKRITIAGIKADEWFEQ 273
F P LS L+ +L + +R T F+
Sbjct: 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 296 bits (760), Expect = 1e-97
Identities = 70/312 (22%), Positives = 117/312 (37%), Gaps = 55/312 (17%)
Query: 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
+ + L LG+G V + +G FA+K+ L+ D RE
Sbjct: 2 GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFE 59
Query: 67 TLKLLKHPNVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQ 121
LK L H N+V+L + + +++E+ G L+ + L E+E + +
Sbjct: 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGLSALPQHFRDDGLLHTTC 177
++ G+++ G+ HR++K NI+ D + K++DFG + DD +
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLY 176
Query: 178 GSPNYVAPEVLANRGYD-------GATSDIWSCGVILYVILTGYLPFDD----RNLAVLY 226
G+ Y+ P++ GAT D+WS GV Y TG LPF R +
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236
Query: 227 QKIFRGDF-------------------------KLPKWLSPGAQNLLRKILEPNPVKRIT 261
KI G L + L +L ILE + K
Sbjct: 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296
Query: 262 IAGIKADEWFEQ 273
D++F +
Sbjct: 297 F-----DQFFAE 303
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 291 bits (747), Expect = 1e-96
Identities = 66/274 (24%), Positives = 125/274 (45%), Gaps = 15/274 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+Y + LG G FG V + S + K ++ +K+EI+ L + +H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARHR 61
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNK 133
N++ LHE S ++ M+ E+++G ++F++I + L E E Q+ + + + H+
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 134 GVFHRDLKLENILLDSKGN--IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
+ H D++ ENI+ ++ + IKI +FG + + + +P Y APEV +
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQA---RQLKPGDNFRLLFTAPEYYAPEVHQHD 178
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
AT D+WS G ++YV+L+G PF + + I F + +S A +
Sbjct: 179 VVSTAT-DMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPD 281
+ ++L R+T + W +Q +
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQKIERVSTK 271
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 4e-96
Identities = 101/298 (33%), Positives = 158/298 (53%), Gaps = 28/298 (9%)
Query: 15 RYELG---RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
Y+L + LGEG+F + S FAVKI+ K ++EI LKL
Sbjct: 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEITALKLC 62
Query: 72 K-HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
+ HPN+V+LHEV + ++V+E + GGELF++I K E E + ++L+ VS+
Sbjct: 63 EGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 131 HNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
H+ GV HRDLK EN+L + IKI DFG + L D+ L T C + +Y APE+
Sbjct: 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP--DNQPLKTPCFTLHYAAPEL 180
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-------LAVLYQKIFRG--DFKLPK 238
L GYD + D+WS GVILY +L+G +PF + + +KI +G F+
Sbjct: 181 LNQNGYDES-CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239
Query: 239 W--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD-YTPANPDDDEEDIFVDNEA 293
W +S A++L++ +L +P KR+ ++G++ +EW + +NP + + A
Sbjct: 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAA 297
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 2e-94
Identities = 92/300 (30%), Positives = 138/300 (46%), Gaps = 39/300 (13%)
Query: 15 RYELGR-TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK- 72
Y+L LGEG +V+ +L + +AVKI+EK I ++ RE+ L +
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQG 69
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
H NV+ L E + + Y+V E + GG + I + E E + Q + + + HN
Sbjct: 70 HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129
Query: 133 KGVFHRDLKLENILLDSKGN---IKISDFGLSAL-----PQHFRDDGLLHTTCGSPNYVA 184
KG+ HRDLK ENIL + +KI DF L + L T CGS Y+A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 185 PEVL-----ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV--------------- 224
PEV+ YD D+WS GVILY++L+GY PF R +
Sbjct: 190 PEVVEAFSEEASIYDKR-CDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248
Query: 225 LYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
L++ I G +F W +S A++L+ K+L + +R++ A + W Q P N
Sbjct: 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV-QGCAPENT 307
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 286 bits (733), Expect = 2e-94
Identities = 94/282 (33%), Positives = 139/282 (49%), Gaps = 17/282 (6%)
Query: 15 RYEL-GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
Y L + LG G F V+ +G +A K L+K R + I EIA L+L K
Sbjct: 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAE-ILHEIAVLELAKS 87
Query: 74 -PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYC 130
P V+ LHEV + S+I ++LEY GGE+F + + E + +L +Q+++GV Y
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 131 HNKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
H + H DLK +NILL S G+IKI DFG+S + L G+P Y+APE+
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS---RKIGHACELREIMGTPEYLAPEI 204
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPG 243
L AT D+W+ G+I Y++LT PF + Y I + D+ + +S
Sbjct: 205 LNYDPITTAT-DMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQL 263
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
A + ++ +L NP KR T + W Q + N EE
Sbjct: 264 ATDFIQSLLVKNPEKRPTAEICLSHSWL-QQWDFENLFHPEE 304
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 287 bits (736), Expect = 5e-94
Identities = 77/278 (27%), Positives = 138/278 (49%), Gaps = 14/278 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y++ LG G FG V + +G F K + +K EI+ + L HP
Sbjct: 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHP 108
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNK 133
++ LH+ K ++ ++LE+++GGELFD+IA++ ++ EAE +Q +G+ + H
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 168
Query: 134 GVFHRDLKLENILLDSKGN--IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
+ H D+K ENI+ ++K +KI DFGL+ D ++ T + + APE++
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLA---TKLNPDEIVKVTTATAEFAAPEIVDRE 225
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
T D+W+ GV+ YV+L+G PF + Q + R +F + +SP A++
Sbjct: 226 PVGFYT-DMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 284
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
++ +L+ P KR+T+ W + D++
Sbjct: 285 IKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSS 322
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 283 bits (726), Expect = 1e-92
Identities = 85/269 (31%), Positives = 139/269 (51%), Gaps = 16/269 (5%)
Query: 15 RYELGRT--LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
Y + +T LG G FG+V ++ +GL A KI++ +K +++K EI+ + L
Sbjct: 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLD 144
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCH 131
H N+++L++ SK+ I +V+EYV GGELFD+I + L E + +Q+ +G+ + H
Sbjct: 145 HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH 204
Query: 132 NKGVFHRDLKLENILLDSKGN--IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
+ H DLK ENIL ++ IKI DFGL+ + ++ L G+P ++APEV+
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGLA---RRYKPREKLKVNFGTPEFLAPEVVN 261
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQ 245
T D+WS GVI Y++L+G PF N A I D + ++ +S A+
Sbjct: 262 YDFVSFPT-DMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAK 320
Query: 246 NLLRKILEPNPVKRITIAGIKADEWFEQD 274
+ K+L RI+ + W
Sbjct: 321 EFISKLLIKEKSWRISASEALKHPWLSDH 349
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 289 bits (740), Expect = 2e-92
Identities = 76/272 (27%), Positives = 132/272 (48%), Gaps = 14/272 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y++ LG G FG V + +G FA K + + +++EI T+ +L+HP
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHP 214
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNK 133
+V LH+ +++ M+ E+++GGELF+K+A + ++ E E + +Q+ G+ + H
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 134 GVFHRDLKLENILLDSKG--NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
H DLK ENI+ +K +K+ DFGL+ H + T G+ + APEV +
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLT---AHLDPKQSVKVTTGTAEFAAPEVAEGK 331
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
T D+WS GV+ Y++L+G PF N + + + + +S ++
Sbjct: 332 PVGYYT-DMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 390
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPAN 279
+RK+L +P R+TI W P
Sbjct: 391 IRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 422
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 281 bits (720), Expect = 2e-92
Identities = 84/301 (27%), Positives = 142/301 (47%), Gaps = 33/301 (10%)
Query: 15 RYELGR-TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLK 72
Y+L + LG G GKV +G A+K+L + + ++E+ +
Sbjct: 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHHWQASG 80
Query: 73 HPNVVRLHEV----LASKSKIYMVLEYVTGGELFDKIASKGRLQ--EAEGRKLFQQLIDG 126
P++V + +V K + +++E + GGELF +I +G E E ++ + +
Sbjct: 81 GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 127 VSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
+ + H+ + HRD+K EN+L SK +K++DFG + L T C +P YV
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK----ETTQNALQTPCYTPYYV 196
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRG--DFKLP 237
APEVL YD + D+WS GVI+Y++L G+ PF + ++I G F P
Sbjct: 197 APEVLGPEKYDKS-CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255
Query: 238 KW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD-YTPANPDDDEEDIFVDNEAF 294
+W +S A+ L+R +L+ +P +R+TI W Q P P + D + +
Sbjct: 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHW 315
Query: 295 S 295
Sbjct: 316 D 316
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 283 bits (725), Expect = 3e-92
Identities = 83/300 (27%), Positives = 141/300 (47%), Gaps = 30/300 (10%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK-LLKHP 74
+ LG G GKV + + FA+K+L+ + +RE+ + P
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCP 115
Query: 75 NVVRLHEV----LASKSKIYMVLEYVTGGELFDKIASKGRLQ--EAEGRKLFQQLIDGVS 128
++VR+ +V A + + +V+E + GGELF +I +G E E ++ + + + +
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 129 YCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
Y H+ + HRD+K EN+L SK +K++DFG + + L T C +P YVAP
Sbjct: 176 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAP 232
Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV----LYQKIFRG--DFKLPKW 239
EVL YD + D+WS GVI+Y++L GY PF + + +I G +F P+W
Sbjct: 233 EVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 291
Query: 240 --LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMH 297
+S + L+R +L+ P +R+TI W Q + +++
Sbjct: 292 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWED 351
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 270 bits (693), Expect = 1e-88
Identities = 86/272 (31%), Positives = 139/272 (51%), Gaps = 7/272 (2%)
Query: 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
+ R ++ G+ LGEG+F V A++L + +A+KILEK II + RE
Sbjct: 23 QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 82
Query: 67 TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
+ L HP V+L+ K+Y L Y GEL I G E R +++
Sbjct: 83 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 142
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
+ Y H KG+ HRDLK ENILL+ +I+I+DFG + + ++ G+ YV+PE
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 202
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246
+L + +SD+W+ G I+Y ++ G PF N +++QKI + ++ P+ P A++
Sbjct: 203 LLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 261
Query: 247 LLRKILEPNPVKRITI------AGIKADEWFE 272
L+ K+L + KR+ +KA +FE
Sbjct: 262 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 271 bits (693), Expect = 7e-88
Identities = 57/311 (18%), Positives = 100/311 (32%), Gaps = 53/311 (17%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
+ + G R G LG+ + A D ++G F V + Q+K E+
Sbjct: 65 ESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEV 124
Query: 66 ATLKLLK-------------------------HPNVVRLHEVLASKSKIYMVLEY----- 95
L+LL+ ++R+ + Y
Sbjct: 125 LRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQS 184
Query: 96 ---VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN 152
G L ++ L +L Q+I ++ H+ G+ H L+ +I+LD +G
Sbjct: 185 NLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG 244
Query: 153 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG----------YDGATSDIWS 202
+ ++ F DG + S + PE+ A R + D W+
Sbjct: 245 VFLTGFEHL------VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298
Query: 203 CGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI 262
G+++Y I LP + IFR K + + LL L R+
Sbjct: 299 LGLVIYWIWCADLPITKDAALGGSEWIFRS----CKNIPQPVRALLEGFLRYPKEDRLLP 354
Query: 263 AGIKADEWFEQ 273
+EQ
Sbjct: 355 LQAMETPEYEQ 365
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 257 bits (659), Expect = 5e-82
Identities = 79/295 (26%), Positives = 119/295 (40%), Gaps = 49/295 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKH 73
+ LG G+ G V F G P AVK + + D EI L + H
Sbjct: 16 LVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFC------DIALMEIKLLTESDDH 68
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-------RLQEAEGRKLFQQLIDG 126
PNV+R + + +Y+ LE L D + SK +E L +Q+ G
Sbjct: 69 PNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 127 VSYCHNKGVFHRDLKLENILLDSKG-------------NIKISDFGLSAL--PQHFRDDG 171
V++ H+ + HRDLK +NIL+ + I ISDFGL
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 172 LLHTTCGSPNYVAPEVL-------ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLA 223
L+ G+ + APE+L R + DI+S G + Y IL+ G PF D+
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRS-IDIFSMGCVFYYILSKGKHPFGDKYSR 246
Query: 224 VLYQKIFRGDFKLP-------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271
I RG F L + L A +L+ ++++ +P+KR T + F
Sbjct: 247 E--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 7e-82
Identities = 65/286 (22%), Positives = 112/286 (39%), Gaps = 23/286 (8%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y + LGEG F V + L G +A+K + + + + +RE +L HP
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE---EAQREADMHRLFNHP 86
Query: 75 NVVRLHEV----LASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDG 126
N++RL +K + +++L + G L+++I L E + L + G
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH-------FRDDGLLHTTCGS 179
+ H KG HRDLK NILL +G + D G +
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 180 PNYVAPEVLANRGYDGAT--SDIWSCGVILYVILTGYLPFDDRNLAV-LYQKIFRGDFKL 236
+Y APE+ + + + +D+WS G +LY ++ G P+D + +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266
Query: 237 PKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
P+ S LL ++ +P +R I + + Q P
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQH 312
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 8e-82
Identities = 84/308 (27%), Positives = 135/308 (43%), Gaps = 34/308 (11%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-H 73
R + R L EG F V AQD+ SG +A+K L N + I +E+ +K L H
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNR---AIIQEVCFMKKLSGH 85
Query: 74 PNVVRLH-------EVLASKSKIYMVLEYVTGGELFDKI---ASKGRLQEAEGRKLFQQL 123
PN+V+ E + +++L + G+L + + S+G L K+F Q
Sbjct: 86 PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 124 IDGVSYCHNKG--VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH------- 174
V + H + + HRDLK+EN+LL ++G IK+ DFG + H+ D
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 175 ---TTCGSPNYVAPEV--LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI 229
T +P Y PE+ L + G DIW+ G ILY++ PF+D +I
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK----LRI 261
Query: 230 FRGDFKLPKWL--SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 287
G + +P +L+R +L+ NP +R++IA + NP ++
Sbjct: 262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITEL 321
Query: 288 FVDNEAFS 295
N +
Sbjct: 322 LEQNGGYG 329
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 5e-80
Identities = 78/274 (28%), Positives = 128/274 (46%), Gaps = 16/274 (5%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
R YE+ T+G G++G+ + + G K L+ + + E+ L+ L
Sbjct: 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLREL 62
Query: 72 KHPNVVRLHE--VLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLID 125
KHPN+VR ++ + + + +Y+V+EY GG+L I + L E ++ QL
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 126 GVSYCHNKG-----VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
+ CH + V HRDLK N+ LD K N+K+ DFGL+ + H D T G+P
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKTFVGTP 180
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKW 239
Y++PE + Y+ SDIWS G +LY + PF + L KI G F ++P
Sbjct: 181 YYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 239
Query: 240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
S ++ ++L R ++ I + +
Sbjct: 240 YSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 2e-79
Identities = 78/298 (26%), Positives = 132/298 (44%), Gaps = 52/298 (17%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHP 74
+ LG G GKV + + FA+K+L+ + +RE+ + + P
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCP 71
Query: 75 NVVRLHEV----LASKSKIYMVLEYVTGGELFDKIASKGRLQ--EAEGRKLFQQLIDGVS 128
++VR+ +V A + + +V+E + GGELF +I +G E E ++ + + + +
Sbjct: 72 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 129 YCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
Y H+ + HRD+K EN+L SK +K++DFG A
Sbjct: 132 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-----------------------AK 168
Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV----LYQKIFRG--DFKLPKW 239
E YD + D+WS GVI+Y++L GY PF + + +I G +F P+W
Sbjct: 169 ETTG-EKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 226
Query: 240 --LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD-YTPANPDDDEEDIFVDNEAF 294
+S + L+R +L+ P +R+TI W Q P P + D E +
Sbjct: 227 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERW 284
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 2e-79
Identities = 91/272 (33%), Positives = 148/272 (54%), Gaps = 11/272 (4%)
Query: 5 EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
Q +L +++ +TLG G+FG+V + +SG +A+KIL+K +++ LK + E
Sbjct: 32 TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 65 IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
L+ + P +V+L S +YMV+EYV GGE+F + GR E R Q++
Sbjct: 92 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
Y H+ + +RDLK EN+L+D +G I+++DFG + R G T CG+P +A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALA 206
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
PE++ ++GY+ A D W+ GV++Y + GY PF +Y+KI G + P S
Sbjct: 207 PEIILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 245 QNLLRKILEPNPVKRI-----TIAGIKADEWF 271
++LLR +L+ + KR + IK +WF
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 250 bits (640), Expect = 3e-79
Identities = 61/272 (22%), Positives = 98/272 (36%), Gaps = 24/272 (8%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK-LLKH 73
+ LG G G + + D AVK + RE+ L+ +H
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFD-NRDVAVKRILPECF------SFADREVQLLRESDEH 77
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHN 132
PNV+R + Y+ +E L + + K E L QQ G+++ H+
Sbjct: 78 PNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 133 KGVFHRDLKLENILLDSKGN-----IKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPE 186
+ HRDLK NIL+ ISDFGL L G+ ++APE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 187 VL---ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKW--- 239
+L DI+S G + Y +++ G PF +
Sbjct: 197 MLSEDCKENPTYT-VDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH 255
Query: 240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271
A+ L+ K++ +P KR + + +F
Sbjct: 256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 4e-79
Identities = 73/264 (27%), Positives = 136/264 (51%), Gaps = 7/264 (2%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ +Y + +GEG+FGK + + G + +K + +R+ K ++ +RE+A L +K
Sbjct: 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMK 81
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI--ASKGRLQEAEGRKLFQQLIDGVSYC 130
HPN+V+ E +Y+V++Y GG+LF +I QE + F Q+ + +
Sbjct: 82 HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
H++ + HRD+K +NI L G +++ DFG++ + L G+P Y++PE+ N
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVELARACIGTPYYLSPEICEN 199
Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLR 249
+ Y+ SDIW+ G +LY + T F+ ++ L KI G F + S ++L+
Sbjct: 200 KPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVS 258
Query: 250 KILEPNPVKRITIAGIKADEWFEQ 273
++ + NP R ++ I + +
Sbjct: 259 QLFKRNPRDRPSVNSILEKGFIAK 282
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 1e-78
Identities = 81/262 (30%), Positives = 145/262 (55%), Gaps = 11/262 (4%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+++ RTLG G+FG+V + +G +A+K+L+K ++ LK + E L ++ HP
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
++R+ +I+M+++Y+ GGELF + R + ++ + Y H+K +
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 127
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
+RDLK ENILLD G+IKI+DFG + + +T CG+P+Y+APEV++ + Y
Sbjct: 128 IYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVSTKPY-N 181
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
+ D WS G+++Y +L GY PF D N Y+KI + + P + + ++LL +++ +
Sbjct: 182 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 241
Query: 256 PVKRI-----TIAGIKADEWFE 272
+R+ +K WF+
Sbjct: 242 LSQRLGNLQNGTEDVKNHPWFK 263
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 2e-76
Identities = 62/277 (22%), Positives = 117/277 (42%), Gaps = 33/277 (11%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
++ +G G FG+V A+ G + +K ++ N ++ +RE+ L L H
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHV 64
Query: 75 NVVRLHE----------------VLASKSKIYMVLEYVTGGELFDKI--ASKGRLQEAEG 116
N+V + + +++ +E+ G L I +L +
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 176
+LF+Q+ GV Y H+K + +RDLK NI L +KI DFGL ++DG +
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS---LKNDGKRTRS 181
Query: 177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL 236
G+ Y++PE ++++ Y D+++ G+IL +L + + + + G +
Sbjct: 182 KGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFETS--KFFTDLRDG--II 236
Query: 237 PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
+ LL+K+L P R + I +
Sbjct: 237 SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 4e-75
Identities = 66/261 (25%), Positives = 110/261 (42%), Gaps = 10/261 (3%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
++ LG G++G+V + + G +AVK ++ + K+ +HP
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNK 133
VRL + +Y+ E G L + G L EA+ + + +++ H++
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
G+ H D+K NI L +G K+ DFGL G G P Y+APE+L Y
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQEGDPRYMAPELLQG-SY 232
Query: 194 DGATSDIWSCGVILYVILTGY-LPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 252
A +D++S G+ + + LP L Q +F LS +++L +L
Sbjct: 233 GTA-ADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF--TAGLSSELRSVLVMML 289
Query: 253 EPNPVKRITIAGIKADEWFEQ 273
EP+P R T + A Q
Sbjct: 290 EPDPKLRATAEALLALPVLRQ 310
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 6e-74
Identities = 37/301 (12%), Positives = 82/301 (27%), Gaps = 47/301 (15%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+ +L L G+ V +D++ FA+K+ +++ L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 75 NVVRLHEVL--------------------------ASKSKIYMVLEYVTG------GELF 102
+ + + + +++ + L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 103 DKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA 162
+G L QLI + +KG+ H +N+ + G + + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242
Query: 163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD-GATSDIWSCGVILYVILTGYLPFDDRN 221
+ + Y E L + W G+ +Y + +LPF
Sbjct: 243 -----KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 222 LAV--LYQKIFRG-------DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 272
+ +++ F L + L+ + L + +R+ F
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357
Query: 273 Q 273
Q
Sbjct: 358 Q 358
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 236 bits (602), Expect = 9e-74
Identities = 61/346 (17%), Positives = 105/346 (30%), Gaps = 49/346 (14%)
Query: 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
G R G LG+ + A D ++G F V + Q+K E+ L+
Sbjct: 74 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLR 133
Query: 70 LL----------------------KHPNVVRLHEVLASKSKIYMVLEYVT---------- 97
LL K P ++ V + ++++ +
Sbjct: 134 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 193
Query: 98 -GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKIS 156
G L ++ L +L Q+I ++ H+ G+ H L+ +I+LD +G + ++
Sbjct: 194 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLT 253
Query: 157 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT----SDIWSCGVILYVILT 212
F + P A +L + D W+ G+ +Y I
Sbjct: 254 GFEHLVRDGASAVS-PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
Query: 213 GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 272
LP D + IFR +P + LL L R+ +E
Sbjct: 313 ADLPNTDDAALGGSEWIFRSCKNIP----QPVRALLEGFLRYPKEDRLLPLQAMETPEYE 368
Query: 273 Q------DYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPL 312
Q P D E S P + G +
Sbjct: 369 QLRTELSAALPLYQTDGEPTREGGAPP-SGTSQPDEAGAAEAVTAI 413
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 2e-73
Identities = 78/262 (29%), Positives = 126/262 (48%), Gaps = 11/262 (4%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
L + + + +G G F +V A L G+P A+K ++ ++ K +EI LK L
Sbjct: 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL 89
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGV 127
HPNV++ + +++ +VLE G+L I K + E K F QL +
Sbjct: 90 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
+ H++ V HRD+K N+ + + G +K+ D GL H+ G+P Y++PE
Sbjct: 150 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPER 207
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPF--DDRNLAVLYQKIFRGDFK-LPKW-LSPG 243
+ GY+ SDIWS G +LY + PF D NL L +KI + D+ LP S
Sbjct: 208 IHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 266
Query: 244 AQNLLRKILEPNPVKRITIAGI 265
+ L+ + P+P KR + +
Sbjct: 267 LRQLVNMCINPDPEKRPDVTYV 288
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 5e-72
Identities = 91/259 (35%), Positives = 146/259 (56%), Gaps = 7/259 (2%)
Query: 5 EKKQEGMRLGRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRII-HLKITDQ 60
+ E +R +EL R LG+G +GKV + ++G FA+K+L+K I+ + K T
Sbjct: 8 NRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH 67
Query: 61 IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
K E L+ +KHP +V L + K+Y++LEY++GGELF ++ +G E
Sbjct: 68 TKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYL 127
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
++ + + H KG+ +RDLK ENI+L+ +G++K++DFGL + D + HT CG+
Sbjct: 128 AEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTI 185
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL 240
Y+APE+L G+ D WS G ++Y +LTG PF N KI + LP +L
Sbjct: 186 EYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYL 244
Query: 241 SPGAQNLLRKILEPNPVKR 259
+ A++LL+K+L+ N R
Sbjct: 245 TQEARDLLKKLLKRNAASR 263
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 1e-71
Identities = 72/262 (27%), Positives = 131/262 (50%), Gaps = 11/262 (4%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
E+ R +G+G+FGKV Q D+ +A+K + K + + + +E+ ++ L+HP +
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVF 136
V L + ++MV++ + GG+L + +E + +L+ + Y N+ +
Sbjct: 78 VNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRII 137
Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR---GY 193
HRD+K +NILLD G++ I+DF ++A + + T G+ Y+APE+ ++R GY
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAA---MLPRETQITTMAGTKPYMAPEMFSSRKGAGY 194
Query: 194 DGATSDIWSCGVILYVILTGYLPFDDR---NLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 250
D WS GV Y +L G P+ R + + P S +LL+K
Sbjct: 195 -SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKK 253
Query: 251 ILEPNPVKRI-TIAGIKADEWF 271
+LEPNP +R ++ ++ +
Sbjct: 254 LLEPNPDQRFSQLSDVQNFPYM 275
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 2e-71
Identities = 68/293 (23%), Positives = 117/293 (39%), Gaps = 33/293 (11%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
L +E + LG G FG V A++ +A+K + + +++ RE+ L L+
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR--EKVMREVKALAKLE 61
Query: 73 HPNVVRLHEV------------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR--- 117
HP +VR + K +Y+ ++ L D + + ++E E
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 118 KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL----------PQHF 167
+F Q+ + V + H+KG+ HRDLK NI +K+ DFGL
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLY 226
G+ Y++PE + Y DI+S G+IL+ +L PF +
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQMERVRTL 237
Query: 227 QKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 278
+ F L P +++ +L P+P++R I + FE P
Sbjct: 238 TDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG 290
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 225 bits (577), Expect = 9e-71
Identities = 88/268 (32%), Positives = 147/268 (54%), Gaps = 5/268 (1%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
Q +++ + L + LG+G+FGKV A+ + FA+K L+K+ ++ + E
Sbjct: 9 SLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEK 68
Query: 66 ATLKL-LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
L L +HP + + +K ++ V+EY+ GG+L I S + + ++I
Sbjct: 69 RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEII 128
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
G+ + H+KG+ +RDLKL+NILLD G+IKI+DFG+ ++ D +T CG+P+Y+A
Sbjct: 129 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIA 186
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
PE+L + Y + D WS GV+LY +L G PF ++ L+ I + P+WL A
Sbjct: 187 PEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEA 245
Query: 245 QNLLRKILEPNPVKRITIAG-IKADEWF 271
++LL K+ P KR+ + G I+ F
Sbjct: 246 KDLLVKLFVREPEKRLGVRGDIRQHPLF 273
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 1e-70
Identities = 83/244 (34%), Positives = 137/244 (56%), Gaps = 3/244 (1%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
++ + LG+G FGKV ++ +G +A+KIL K II E L+ +HP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
+ L + ++ V+EY GGELF ++ + E R +++ + Y H++ V
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
+RD+KLEN++LD G+IKI+DFGL + D + T CG+P Y+APEVL + Y G
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY-G 183
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
D W GV++Y ++ G LPF +++ L++ I + + P+ LSP A++LL +L+ +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 243
Query: 256 PVKR 259
P +R
Sbjct: 244 PKQR 247
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 225 bits (577), Expect = 2e-70
Identities = 91/274 (33%), Positives = 142/274 (51%), Gaps = 8/274 (2%)
Query: 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
+ + + + +G+G+FGKV A+ + +AVK+L+K I+ K I
Sbjct: 27 LGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIM 86
Query: 63 REIATL-KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ 121
E L K +KHP +V LH + K+Y VL+Y+ GGELF + + E R
Sbjct: 87 SERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA 146
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
++ + Y H+ + +RDLK ENILLDS+G+I ++DFGL ++ + T CG+P
Sbjct: 147 EIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPE 204
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLS 241
Y+APEVL + Y T D W G +LY +L G PF RN A +Y I +L ++
Sbjct: 205 YLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNIT 263
Query: 242 PGAQNLLRKILEPNPVKRITIAG----IKADEWF 271
A++LL +L+ + KR+ IK+ +F
Sbjct: 264 NSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 5e-70
Identities = 86/259 (33%), Positives = 152/259 (58%), Gaps = 7/259 (2%)
Query: 4 AEKKQEGMRLGRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQ 60
++ E ++EL + LG+G+FGKV K D+ +A+K+L+K + + +
Sbjct: 14 VKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVR 72
Query: 61 IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
K E L + HP +V+LH ++ K+Y++L+++ GG+LF +++ + E + +
Sbjct: 73 TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 132
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
+L + + H+ G+ +RDLK ENILLD +G+IK++DFGLS + + ++ CG+
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTV 190
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL 240
Y+APEV+ RG+ ++D WS GV+++ +LTG LPF ++ I + +P++L
Sbjct: 191 EYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFL 249
Query: 241 SPGAQNLLRKILEPNPVKR 259
SP AQ+LLR + + NP R
Sbjct: 250 SPEAQSLLRMLFKRNPANR 268
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 1e-69
Identities = 88/286 (30%), Positives = 144/286 (50%), Gaps = 20/286 (6%)
Query: 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
I + + +E R LG+G+FGKV A+ ++G +AVK+L+K+ I+ +
Sbjct: 12 IGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTM 71
Query: 63 REIATLKL-LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ 121
E L L HP + +L + +++ V+E+V GG+L I R EA R
Sbjct: 72 TEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA 131
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
++I + + H+KG+ +RDLKL+N+LLD +G+ K++DFG+ + + T CG+P+
Sbjct: 132 EIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPD 189
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLS 241
Y+APE+L Y G D W+ GV+LY +L G+ PF+ N L++ I + P WL
Sbjct: 190 YIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLH 248
Query: 242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 287
A +L+ + NP R+ G + E I
Sbjct: 249 EDATGILKSFMTKNPTMRL---G-------------SLTQGGEHAI 278
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 223 bits (569), Expect = 2e-69
Identities = 52/298 (17%), Positives = 104/298 (34%), Gaps = 36/298 (12%)
Query: 6 KKQEGMRLG--RYELGRTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKIT 58
K + +LG + LGEG F +V A D + F +K+ + I
Sbjct: 55 KPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIG 114
Query: 59 DQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-----ASKGRLQE 113
Q+ LK ++ + ++ +V E + G L + I + + +
Sbjct: 115 TQLMER---LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQ 171
Query: 114 AEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL-----------DSKGNIKISDFGLSA 162
+++ + H+ + H D+K +N +L D + + D G S
Sbjct: 172 GLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRN 221
+ F + C + + E+L+N+ ++ D + +Y +L G Y+ +
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQI-DYFGVAATVYCMLFGTYMKVKNEG 290
Query: 222 LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI---KADEWFEQDYT 276
+ +FR L W +L + + K + F+Q YT
Sbjct: 291 GECKPEGLFRRLPHLDMW-----NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 3e-69
Identities = 86/255 (33%), Positives = 144/255 (56%), Gaps = 4/255 (1%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
++ M+L + LG+G+FGKV ++ + +AVKIL+K+ +I + E
Sbjct: 12 GNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEK 71
Query: 66 ATLKL-LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
L L K P + +LH + ++Y V+EYV GG+L I GR +E ++
Sbjct: 72 RVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIA 131
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
G+ + +KG+ +RDLKL+N++LDS+G+IKI+DFG+ ++ D T CG+P+Y+A
Sbjct: 132 IGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIA 189
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
PE++A + Y G + D W+ GV+LY +L G PF+ + L+Q I + PK +S A
Sbjct: 190 PEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEA 248
Query: 245 QNLLRKILEPNPVKR 259
+ + ++ +P KR
Sbjct: 249 VAICKGLMTKHPGKR 263
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 4e-68
Identities = 85/257 (33%), Positives = 142/257 (55%), Gaps = 4/257 (1%)
Query: 4 AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
K + + + +E + LG+G FGKV ++ +G +A+KIL+K I+
Sbjct: 138 LAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT 197
Query: 64 EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
E L+ +HP + L + ++ V+EY GGELF ++ + E R ++
Sbjct: 198 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 257
Query: 124 IDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
+ + Y H+ K V +RDLKLEN++LD G+IKI+DFGL + +D + T CG+P Y
Sbjct: 258 VSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEY 315
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 242
+APEVL + Y G D W GV++Y ++ G LPF +++ L++ I + + P+ L P
Sbjct: 316 LAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGP 374
Query: 243 GAQNLLRKILEPNPVKR 259
A++LL +L+ +P +R
Sbjct: 375 EAKSLLSGLLKKDPKQR 391
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 9e-68
Identities = 82/290 (28%), Positives = 149/290 (51%), Gaps = 29/290 (10%)
Query: 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
+ + L ++L R +G G++ KV + + +A+K+++K + + D ++ E
Sbjct: 3 MDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV 62
Query: 68 LKL-LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
+ HP +V LH ++S+++ V+EYV GG+L + + +L E R ++
Sbjct: 63 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 122
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
++Y H +G+ +RDLKL+N+LLDS+G+IK++D+G+ + R T CG+PNY+APE
Sbjct: 123 LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPE 180
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF---------DDRNLAVLYQKIFRGDFKLP 237
+L Y G + D W+ GV+++ ++ G PF D L+Q I ++P
Sbjct: 181 ILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 239
Query: 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 287
+ LS A ++L+ L +P +R+ G +P DI
Sbjct: 240 RSLSVKAASVLKSFLNKDPKERL---G-------------CHPQTGFADI 273
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 4e-67
Identities = 82/292 (28%), Positives = 149/292 (51%), Gaps = 29/292 (9%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
K + L ++L R +G G++ KV + + +A+++++K + + D ++ E
Sbjct: 44 KASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEK 103
Query: 66 ATLKL-LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
+ HP +V LH ++S+++ V+EYV GG+L + + +L E R ++
Sbjct: 104 HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 163
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
++Y H +G+ +RDLKL+N+LLDS+G+IK++D+G+ + R T CG+PNY+A
Sbjct: 164 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIA 221
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPF---------DDRNLAVLYQKIFRGDFK 235
PE+L Y G + D W+ GV+++ ++ G PF D L+Q I +
Sbjct: 222 PEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 280
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 287
+P+ LS A ++L+ L +P +R+ G +P DI
Sbjct: 281 IPRSLSVKAASVLKSFLNKDPKERL---G-------------CHPQTGFADI 316
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 224 bits (571), Expect = 8e-67
Identities = 86/255 (33%), Positives = 144/255 (56%), Gaps = 4/255 (1%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
++ M+L + LG+G+FGKV ++ + +AVKIL+K+ +I + E
Sbjct: 333 GNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEK 392
Query: 66 ATLKL-LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
L L K P + +LH + ++Y V+EYV GG+L I GR +E ++
Sbjct: 393 RVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIA 452
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
G+ + +KG+ +RDLKL+N++LDS+G+IKI+DFG+ ++ D T CG+P+Y+A
Sbjct: 453 IGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIA 510
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
PE++A + Y G + D W+ GV+LY +L G PF+ + L+Q I + PK +S A
Sbjct: 511 PEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEA 569
Query: 245 QNLLRKILEPNPVKR 259
+ + ++ +P KR
Sbjct: 570 VAICKGLMTKHPGKR 584
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 1e-66
Identities = 80/267 (29%), Positives = 128/267 (47%), Gaps = 15/267 (5%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+ R LG+G FG+V Q +G +A K LEK RI K E L+ +
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNK 133
VV L +K + +VL + GG+L I G+ E R +F ++ G+ H +
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
+ +RDLK ENILLD G+I+ISD GL+ H + + G+ Y+APEV+ N Y
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLA---VHVPEGQTIKGRVGTVGYMAPEVVKNERY 362
Query: 194 DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG----DFKLPKWLSPGAQNLLR 249
+ D W+ G +LY ++ G PF R + +++ R + + SP A++L
Sbjct: 363 TFSP-DWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCS 421
Query: 250 KILEPNPVKRI-----TIAGIKADEWF 271
++L +P +R+ + +K F
Sbjct: 422 QLLCKDPAERLGCRGGSAREVKEHPLF 448
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 5e-66
Identities = 81/347 (23%), Positives = 140/347 (40%), Gaps = 42/347 (12%)
Query: 6 KKQEGMRLGR--YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
K E +G + R LG G FG+V Q +G +A K L K R+ K
Sbjct: 175 KWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMV 234
Query: 64 EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQE--AEGRKLF- 120
E L + +V L +K+ + +V+ + GG++ I + E R +F
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 121 -QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
Q++ G+ + H + + +RDLK EN+LLD GN++ISD GL+ + G+
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAGT 352
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV----LYQKIFRGDFK 235
P ++APE+L YD + D ++ GV LY ++ PF R V L Q++
Sbjct: 353 PGFMAPELLLGEEYDFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVT 411
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAG-----IKADEWFEQDYTPANPDDDEEDIFVD 290
P SP +++ +L+ +P KR+ ++ F +
Sbjct: 412 YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD---------------IS 456
Query: 291 NEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVS 337
+ PP + + + + D+ F + V+
Sbjct: 457 WRQLEAGMLT---------PPFVPDSRTVYAKNIQDVGAFSTVKGVA 494
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 9e-66
Identities = 83/283 (29%), Positives = 137/283 (48%), Gaps = 17/283 (6%)
Query: 2 VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI 61
I + + M+ YE+ + +G G FG+V+ + + +A+K+L K +I +
Sbjct: 57 TINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFF 116
Query: 62 KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ 121
E + P VV+L +YMV+EY+ GG+L + S + E R
Sbjct: 117 WEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTA 175
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL--HTTCGS 179
+++ + H+ G HRD+K +N+LLD G++K++DFG +G++ T G+
Sbjct: 176 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM---KMNKEGMVRCDTAVGT 232
Query: 180 PNYVAPEVLANRGYD---GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI--FRGDF 234
P+Y++PEVL ++G D G D WS GV LY +L G PF +L Y KI +
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL 292
Query: 235 KLPK--WLSPGAQNLLRKILEPNPVKRITIAG---IKADEWFE 272
P +S A+NL+ L + R+ G IK +F+
Sbjct: 293 TFPDDNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFK 334
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 2e-65
Identities = 86/283 (30%), Positives = 159/283 (56%), Gaps = 18/283 (6%)
Query: 5 EKKQEGMRLGRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRII-HLKITDQ 60
E + + +EL + LG G +GKV + D+G +A+K+L+K I+ K T+
Sbjct: 45 TGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH 104
Query: 61 IKREIATLKLLKH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL 119
+ E L+ ++ P +V LH +++K++++L+Y+ GGELF ++ + R E E +
Sbjct: 105 TRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY 164
Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
+++ + + H G+ +RD+KLENILLDS G++ ++DFGLS + + CG+
Sbjct: 165 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGT 223
Query: 180 PNYVAPEVL--ANRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGD 233
Y+AP+++ + G+D A D WS GV++Y +LTG PF + + A + ++I + +
Sbjct: 224 IEYMAPDIVRGGDSGHDKAV-DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 282
Query: 234 FKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWF 271
P+ +S A++L++++L +P KR+ IK +F
Sbjct: 283 PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 8e-64
Identities = 74/278 (26%), Positives = 132/278 (47%), Gaps = 17/278 (6%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE- 64
+ + + + + R +G G FG+V + D+G +A+K L+K RI + E
Sbjct: 181 ELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNER 240
Query: 65 --IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
++ + P +V + + K+ +L+ + GG+L ++ G EA+ R +
Sbjct: 241 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE 300
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
+I G+ + HN+ V +RDLK NILLD G+++ISD GL+ H + G+ Y
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD----FSKKKPHASVGTHGY 356
Query: 183 VAPEVLA-NRGYDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGDFKLPK 238
+APEVL YD + D +S G +L+ +L G+ PF + + +LP
Sbjct: 357 MAPEVLQKGVAYDSSA-DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 415
Query: 239 WLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWF 271
SP ++LL +L+ + +R+ +K +F
Sbjct: 416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 1e-63
Identities = 77/287 (26%), Positives = 134/287 (46%), Gaps = 21/287 (7%)
Query: 2 VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI 61
++ KQ + +E+ + +G G FG+V + ++ FA+KIL K ++ T
Sbjct: 62 FTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACF 121
Query: 62 KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLF 120
+ E L + LH + +Y+V++Y GG+L ++ + RL E R
Sbjct: 122 REERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYL 181
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL--HTTCG 178
+++ + H HRD+K +NIL+D G+I+++DFG +DG + G
Sbjct: 182 AEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL---KLMEDGTVQSSVAVG 238
Query: 179 SPNYVAPEVL-----ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI--FR 231
+P+Y++PE+L Y G D WS GV +Y +L G PF +L Y KI +
Sbjct: 239 TPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK 297
Query: 232 GDFKLPKW---LSPGAQNLLRKILEPNPVKRITIAG---IKADEWFE 272
F+ P +S A++L+R+++ R+ G K +F
Sbjct: 298 ERFQFPTQVTDVSENAKDLIRRLICSRE-HRLGQNGIEDFKKHPFFS 343
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 3e-63
Identities = 71/288 (24%), Positives = 130/288 (45%), Gaps = 21/288 (7%)
Query: 2 VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI 61
++ K+ ++ +E+ + +G G F +V + +G +A+KI+ K ++
Sbjct: 49 IVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCF 108
Query: 62 KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLF 120
+ E L + +LH ++ +Y+V+EY GG+L ++ G R+ R
Sbjct: 109 REERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYL 168
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL--HTTCG 178
+++ + H G HRD+K +NILLD G+I+++DFG R DG + G
Sbjct: 169 AEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCL---KLRADGTVRSLVAVG 225
Query: 179 SPNYVAPEVLANRGYD------GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG 232
+P+Y++PE+L G G D W+ GV Y + G PF + A Y KI
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY 285
Query: 233 DFKLP-----KWLSPGAQNLLRKILEPNPVKRITIAG---IKADEWFE 272
L + + A++ ++++L P R+ G + +F
Sbjct: 286 KEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFF 332
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 2e-59
Identities = 58/274 (21%), Positives = 101/274 (36%), Gaps = 35/274 (12%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+ +G G FG V G +A+K +K + + ++ A L +H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVSYC 130
+VVR A + + EY GG L D I +EAE + L Q+ G+ Y
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 131 HNKGVFHRDLKLENILLDSKGNI-------------------KISDFGLSALPQHFRDDG 171
H+ + H D+K NI + KI D G
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR------IS 185
Query: 172 LLHTTCGSPNYVAPEVLA-NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF 230
G ++A EVL N + +DI++ + + + + + +I
Sbjct: 186 SPQVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPLPRNGD---QWHEIR 241
Query: 231 RGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIA 263
+G ++P+ LS LL+ ++ P+P +R +
Sbjct: 242 QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAM 275
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 4e-58
Identities = 59/255 (23%), Positives = 103/255 (40%), Gaps = 18/255 (7%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+G G+FG+V +D +G AVK + + E+ L P
Sbjct: 59 WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--------LEVFRVEELVACAGLSSP 110
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
+V L+ + + + +E + GG L I G L E Q ++G+ Y H +
Sbjct: 111 RIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR 170
Query: 135 VFHRDLKLENILLDSKGN-IKISDFGLSA---LPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
+ H D+K +N+LL S G+ + DFG + + G+ ++APEV+
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGD---FKLPKWLSPGAQN 246
+ D DIWS ++ +L G P+ + KI ++P +P
Sbjct: 231 KPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCL-KIASEPPPIREIPPSCAPLTAQ 288
Query: 247 LLRKILEPNPVKRIT 261
+++ L PV R +
Sbjct: 289 AIQEGLRKEPVHRAS 303
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 5e-58
Identities = 77/259 (29%), Positives = 128/259 (49%), Gaps = 17/259 (6%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
LG+G +G V +DL + + A+K + + + + + EIA K LK
Sbjct: 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ---PLHEEIALHKHLK 77
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEG--RKLFQQLIDGVSY 129
H N+V+ + I + +E V GG L + SK G L++ E +Q+++G+ Y
Sbjct: 78 HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKY 137
Query: 130 CHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
H+ + HRD+K +N+L+++ G +KISDFG S T G+ Y+APE++
Sbjct: 138 LHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEII 195
Query: 189 --ANRGYDGATSDIWSCGVILYVILTGYLPFDD--RNLAVLYQKIFRGDF--KLPKWLSP 242
RGY A +DIWS G + + TG PF + A ++ K+ ++P+ +S
Sbjct: 196 DKGPRGYGKA-ADIWSLGCTIIEMATGKPPFYELGEPQAAMF-KVGMFKVHPEIPESMSA 253
Query: 243 GAQNLLRKILEPNPVKRIT 261
A+ + K EP+P KR
Sbjct: 254 EAKAFILKCFEPDPDKRAC 272
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 8e-53
Identities = 65/272 (23%), Positives = 127/272 (46%), Gaps = 18/272 (6%)
Query: 14 GRYE-LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
GR+ +G G+F V D ++ + A L+ ++ + + K E LK L+
Sbjct: 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER-QRFKEEAEMLKGLQ 83
Query: 73 HPNVVRLH----EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
HPN+VR + + K I +V E +T G L + ++ R +Q++ G+
Sbjct: 84 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 143
Query: 129 YCHNKG--VFHRDLKLENILLDSK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
+ H + + HRDLK +NI + G++KI D GL+ L + G+P ++AP
Sbjct: 144 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAKAVIGTPEFMAP 199
Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGD--FKLPKWLSP 242
E+ YD + D+++ G+ + + T P+ + +N A +Y+++ G K P
Sbjct: 200 EMY-EEKYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257
Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274
+ ++ + N +R +I + +F+++
Sbjct: 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 7e-51
Identities = 84/323 (26%), Positives = 123/323 (38%), Gaps = 76/323 (23%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--------R 63
R RYE LGEG F V A+D ++ A+K K I L + K R
Sbjct: 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIK---K---IKLGHRSEAKDGINRTALR 61
Query: 64 EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQ 121
EI L+ L HPN++ L + KS I +V +++ + + L + +
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYML 119
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
+ G+ Y H + HRDLK N+LLD G +K++DFGL+ + GSPN
Sbjct: 120 MTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA-------------KSFGSPN 166
Query: 182 -----------YVAPEVL-ANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQ 227
Y APE+L R Y D+W+ G IL +L +LP D +L L
Sbjct: 167 RAYTHQVVTRWYRAPELLFGARMYGVGV-DMWAVGCILAELLLRVPFLPGDS-DLDQLT- 223
Query: 228 KIFR-----------GDFKLP-----------------KWLSPGAQNLLRKILEPNPVKR 259
+IF LP +L++ + NP R
Sbjct: 224 RIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCAR 283
Query: 260 ITIAGIKADEWFEQDYTPANPDD 282
IT ++F P
Sbjct: 284 ITATQALKMKYFSNRPGPTPGCQ 306
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 8e-51
Identities = 51/246 (20%), Positives = 93/246 (37%), Gaps = 17/246 (6%)
Query: 41 PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGE 100
+ + D +I + N V + + K +Y+ ++
Sbjct: 88 IWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKEN 147
Query: 101 LFDKIASKGRLQEAEG---RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISD 157
L D + + L++ E +F Q+ + V + H+KG+ HRDLK NI +K+ D
Sbjct: 148 LKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD 207
Query: 158 FGLSA----------LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 207
FGL + G+ Y++PE + Y DI+S G+IL
Sbjct: 208 FGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK-VDIFSLGLIL 266
Query: 208 YVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 266
+ +L + +R + + F L P +++ +L P+P +R I
Sbjct: 267 FELLYSFSTQMER--VRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDII 324
Query: 267 ADEWFE 272
+ FE
Sbjct: 325 ENAIFE 330
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 5e-08
Identities = 17/66 (25%), Positives = 32/66 (48%), Gaps = 2/66 (3%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E + +G G FG V A++ +A+K + + +++ RE+ L L+HP
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR--EKVMREVKALAKLEHPG 65
Query: 76 VVRLHE 81
+VR
Sbjct: 66 IVRYFN 71
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 5e-49
Identities = 79/314 (25%), Positives = 126/314 (40%), Gaps = 68/314 (21%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKH 73
+YE +GEG++G V ++ D+G A+K LE +K REI LK LKH
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL--REIRMLKQLKH 61
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
PN+V L EV K ++++V EY D+ + + E + + Q + V++CH
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-----NYV--- 183
HRD+K ENIL+ IK+ DFG + R P + V
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFA------R-------LLTGPSDYYDDEVATR 166
Query: 184 ---APEVL-ANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQKIFR------ 231
+PE+L + Y D+W+ G + +L+G P ++ LY I +
Sbjct: 167 WYRSPELLVGDTQYGPPV-DVWAIGCVFAELLSGVPLWPGKS-DVDQLY-LIRKTLGDLI 223
Query: 232 -------------GDFKLPKW------------LSPGAQNLLRKILEPNPVKRITIAGIK 266
K+P +S A LL+ L +P +R+T +
Sbjct: 224 PRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL 283
Query: 267 ADEWFEQDYTPANP 280
+FE +
Sbjct: 284 HHPYFENIREIEDL 297
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 3e-48
Identities = 81/312 (25%), Positives = 133/312 (42%), Gaps = 58/312 (18%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKH 73
+YE +GEG++G V ++ D+G A+K LE + +K REI LK L+H
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKI--AMREIKLLKQLRH 83
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
N+V L EV K + Y+V E+V + + L +K Q+I+G+ +CH
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCH 141
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV------AP 185
+ + HRD+K ENIL+ G +K+ DFG + + G ++ + V AP
Sbjct: 142 SHNIIHRDIKPENILVSQSGVVKLCDFGFA---RTLAAPGEVYD-----DEVATRWYRAP 193
Query: 186 EVL-ANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQKIFR----------- 231
E+L + Y A D+W+ G ++ + G P D ++ LY I
Sbjct: 194 ELLVGDVKYGKAV-DVWAIGCLVTEMFMGEPLFPGDS-DIDQLY-HIMMCLGNLIPRHQE 250
Query: 232 --------GDFKLPKW------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271
+LP+ LS +L +K L +P KR A + ++F
Sbjct: 251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310
Query: 272 EQDYTPANPDDD 283
+ D +
Sbjct: 311 QMDGFAERFSQE 322
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 5e-48
Identities = 82/296 (27%), Positives = 130/296 (43%), Gaps = 71/296 (23%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----ITDQIKREIATLKL 70
+YE +GEG +G V A++ ++ A+K + R+ + REI LK
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALK---RVRLDDDDEGVPSS--ALREICLLKE 57
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
LKH N+VRLH+VL S K+ +V E+ + FD G L + QL+ G+
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLG 115
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN------- 181
+CH++ V HRDLK +N+L++ G +K+++FGL+ R G P
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLA------R-------AFGIPVRCYSAEV 162
Query: 182 ----YVAPEVL-ANRGYDGATSDIWSCGVILYVILTGYLPF--DDRNLAVLYQKIFR--- 231
Y P+VL + Y + D+WS G I + P + L +IFR
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQLK-RIFRLLG 220
Query: 232 --------GDFKLPKW------------------LSPGAQNLLRKILEPNPVKRIT 261
KLP + L+ ++LL+ +L+ NPV+RI+
Sbjct: 221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-47
Identities = 76/324 (23%), Positives = 124/324 (38%), Gaps = 74/324 (22%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIATLKL 70
Y LGEG + V + + A+K + I L+ + RE++ LK
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALK---E---IRLEHEEGAPCTAIREVSLLKD 56
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
LKH N+V LH+++ ++ + +V EY+ + D + + QL+ G++
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGLA 114
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN------- 181
YCH + V HRDLK +N+L++ +G +K++DFGL+ R P
Sbjct: 115 YCHRQKVLHRDLKPQNLLINERGELKLADFGLA------R-------AKSIPTKTYDNEV 161
Query: 182 ----YVAPEVL-ANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQKIFR--- 231
Y P++L + Y D+W G I Y + TG P L+ IFR
Sbjct: 162 VTLWYRPPDILLGSTDYSTQI-DMWGVGCIFYEMATGRPLFPGST-VEEQLH-FIFRILG 218
Query: 232 ----------------GDFKLPKW-----------LSPGAQNLLRKILEPNPVKRITIAG 264
+ PK+ L +LL K+L+ RI+
Sbjct: 219 TPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAED 278
Query: 265 IKADEWFEQDYTPANPDDDEEDIF 288
+F + D IF
Sbjct: 279 AMKHPFFLSLGERIHKLPDTTSIF 302
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 2e-47
Identities = 80/323 (24%), Positives = 135/323 (41%), Gaps = 79/323 (24%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIATLKL 70
+++ LG G + V + +G+ A+K + L + REI+ +K
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKE------VKLDSEEGTPSTAIREISLMKE 59
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGG-----ELFDKIASKGRLQEAEGRKLFQQLID 125
LKH N+VRL++V+ +++K+ +V E++ + + L+ + QL+
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN---- 181
G+++CH + HRDLK +N+L++ +G +K+ DFGL+ R G P
Sbjct: 120 GLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA------R-------AFGIPVNTFS 166
Query: 182 -------YVAPEVL-ANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQKIFR 231
Y AP+VL +R Y + DIWSCG IL ++TG P + + L IF
Sbjct: 167 SEVVTLWYRAPDVLMGSRTYSTSI-DIWSCGCILAEMITGKPLFPGTN-DEEQLK-LIFD 223
Query: 232 -----------GDFKLPKW-----------------------LSPGAQNLLRKILEPNPV 257
KLPK+ L + L +L+ NP
Sbjct: 224 IMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPD 283
Query: 258 KRITIAGIKADEWFEQDYTPANP 280
R++ WF + Y A+
Sbjct: 284 MRLSAKQALHHPWFAEYYHHASM 306
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 7e-47
Identities = 74/250 (29%), Positives = 126/250 (50%), Gaps = 13/250 (5%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+ +G G+FG V A+ G AVKIL + H + ++ RE+A +K L+HPN+
Sbjct: 40 NIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNI 96
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---GVSYCHNK 133
V + + +V EY++ G L+ + G ++ + R+ D G++Y HN+
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 134 G--VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
+ HR+LK N+L+D K +K+ DFGLS L + G+P ++APEVL +
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS--TFLSSKSAAGTPEWMAPEVLRDE 214
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGD-FKLPKWLSPGAQNLLR 249
+ SD++S GVIL+ + T P+ + N V+ F+ ++P+ L+P ++
Sbjct: 215 PSNEK-SDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIE 273
Query: 250 KILEPNPVKR 259
P KR
Sbjct: 274 GCWTNEPWKR 283
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 161 bits (411), Expect = 7e-47
Identities = 85/318 (26%), Positives = 138/318 (43%), Gaps = 91/318 (28%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK------------ 62
+Y +GEG +G V AQ+ LK +I+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN------------NYGETFALK---KIRLEKEDEGIPSTT 47
Query: 63 -REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKL 119
REI+ LK LKH N+V+L++V+ +K ++ +V E++ +L D +G L+ +
Sbjct: 48 IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSF 105
Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
QL++G++YCH++ V HRDLK +N+L++ +G +KI+DFGL+ R G
Sbjct: 106 LLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLA------R-------AFGI 152
Query: 180 PN-----------YVAPEVL-ANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVL 225
P Y AP+VL ++ Y DIWS G I ++ G P L
Sbjct: 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTI-DIWSVGCIFAEMVNGTPLFPGVS-EADQL 210
Query: 226 YQKIFR-----------GDFKLPKW------------------LSPGAQNLLRKILEPNP 256
+IFR +LPK+ L +LL K+L+ +P
Sbjct: 211 M-RIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDP 269
Query: 257 VKRITIAGIKADEWFEQD 274
+RIT +F+++
Sbjct: 270 NQRITAKQALEHAYFKEN 287
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-46
Identities = 83/306 (27%), Positives = 132/306 (43%), Gaps = 92/306 (30%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK------------ 62
+Y+ +GEG +G V A+D + RI+ LK +I+
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKD------------SQGRIVALK---RIRLDAEDEGIPSTA 66
Query: 63 -REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKL 119
REI+ LK L HPN+V L +V+ S+ + +V E++ ++ D+ K LQ+++ +
Sbjct: 67 IREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDEN--KTGLQDSQIKIY 124
Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
QL+ GV++CH + HRDLK +N+L++S G +K++DFGL+ R G
Sbjct: 125 LYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA------R-------AFGI 171
Query: 180 PN-----------YVAPEVL-ANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVL 225
P Y AP+VL ++ Y + DIWS G I ++TG P + L
Sbjct: 172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSV-DIWSIGCIFAEMITGKPLFPGVT-DDDQL 229
Query: 226 YQKIFR-----------GDFKLP-------------------KWLSPGAQNLLRKILEPN 255
KIF +LP +LL +L +
Sbjct: 230 P-KIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFD 288
Query: 256 PVKRIT 261
P KRI+
Sbjct: 289 PNKRIS 294
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-46
Identities = 87/320 (27%), Positives = 132/320 (41%), Gaps = 76/320 (23%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----ITDQIKREIAT 67
+ RY LGEG +G+V A D + A+K + R+ H + T I RE++
Sbjct: 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIK---RIRLEHEEEGVPGT-AI-REVSL 86
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
LK L+H N++ L V+ +++++ EY +L + + + QLI+GV
Sbjct: 87 LKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGV 145
Query: 128 SYCHNKGVFHRDLKLENILLDS-----KGNIKISDFGLSALPQHFRDDGLLHTTCGSPN- 181
++CH++ HRDLK +N+LL +KI DFGL+ R G P
Sbjct: 146 NFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA------R-------AFGIPIR 192
Query: 182 ----------YVAPEVL-ANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQK 228
Y PE+L +R Y + DIWS I +L P D + L+ K
Sbjct: 193 QFTHEIITLWYRPPEILLGSRHYSTSV-DIWSIACIWAEMLMKTPLFPGDS-EIDQLF-K 249
Query: 229 IFR--G--------------DFK--------------LPKWLSPGAQNLLRKILEPNPVK 258
IF G D+K L L +LL +LE +PVK
Sbjct: 250 IFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVK 309
Query: 259 RITIAGIKADEWF-EQDYTP 277
RI+ +F D+ P
Sbjct: 310 RISAKNALEHPYFSHNDFDP 329
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 7e-46
Identities = 62/255 (24%), Positives = 119/255 (46%), Gaps = 20/255 (7%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+G+ +G G+FG V K+ D+ AVK+L + K E+ L+ +H
Sbjct: 27 TVGQRIGSGSFGTVYKGKWHGDV------AVKMLNVTAP-TPQQLQAFKNEVGVLRKTRH 79
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHN 132
N++ ++ ++ +V ++ G L+ + AS+ + + + + +Q G+ Y H
Sbjct: 80 VNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
K + HRDLK NI L +KI DFGL+ + GS ++APEV+ +
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 193 YDGAT--SDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFK-----LPKWLSPGA 244
+ + SD+++ G++LY ++TG LP+ + N + + + RG +
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM 258
Query: 245 QNLLRKILEPNPVKR 259
+ L+ + L+ +R
Sbjct: 259 KRLMAECLKKKRDER 273
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-45
Identities = 73/305 (23%), Positives = 121/305 (39%), Gaps = 45/305 (14%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
E+ +G G FG V A+ A+K +E E+ L + HPN+
Sbjct: 11 EVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNI 63
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---GVSYCHN- 132
V+L A + + +V+EY GG L++ + L + GV+Y H+
Sbjct: 64 VKL--YGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 133 --KGVFHRDLKLENILLDSKGN-IKISDFGLSALPQHFRD-DGLLHTTCGSPNYVAPEVL 188
K + HRDLK N+LL + G +KI DFG + D + GS ++APEV
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTA------CDIQTHMTNNKGSAAWMAPEVF 175
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-----LPKWLSPG 243
Y D++S G+IL+ ++T PFD+ + +I L K L
Sbjct: 176 EGSNYSEK-CDVFSWGIILWEVITRRKPFDE--IGGPAFRIMWAVHNGTRPPLIKNLPKP 232
Query: 244 AQNLLRKILEPNPVKR--------------ITIAGIKADEWFEQDYTPANPDDDEEDIFV 289
++L+ + +P +R G + ++ +D + +V
Sbjct: 233 IESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPYV 292
Query: 290 DNEAF 294
D F
Sbjct: 293 DFAEF 297
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-45
Identities = 86/313 (27%), Positives = 121/313 (38%), Gaps = 72/313 (23%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL----EKNRIIHLKITDQIKREIATLKL 70
RYE +G G +G V A+D SG A+K + L I+ RE+A L+
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPIS--TVREVALLRR 67
Query: 71 LK---HPNVVRLHEVLASKS-----KIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLF 120
L+ HPNVVRL +V A+ K+ +V E+V DK G L + L
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLM 126
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
+Q + G+ + H + HRDLK ENIL+ S G +K++DFGL+ R
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA------R-------IYSYQ 173
Query: 181 N----------YVAPEVLANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQK 228
Y APEVL Y D+WS G I + + L K
Sbjct: 174 MALTPVVVTLWYRAPEVLLQSTYATPV-DMWSVGCIFAEMFRRKPLFCGNS-EADQLG-K 230
Query: 229 IFR-----------GDFKLPKW----------------LSPGAQNLLRKILEPNPVKRIT 261
IF D LP+ + LL ++L NP KRI+
Sbjct: 231 IFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS 290
Query: 262 IAGIKADEWFEQD 274
+ +D
Sbjct: 291 AFRALQHSYLHKD 303
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 7e-45
Identities = 69/255 (27%), Positives = 119/255 (46%), Gaps = 15/255 (5%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
RY++ LG G V A+D + A+K + + + +RE+ L H
Sbjct: 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
N+V + +V Y+V+EY+ G L + I S G L Q++DG+ + H+
Sbjct: 71 QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTC--GSPNYVAPEVLAN 190
+ HRD+K +NIL+DS +KI DFG++ AL + L T G+ Y +PE A
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKAL----SETSLTQTNHVLGTVQYFSPE-QAK 185
Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRGDF-----KLPKWLSPGA 244
+DI+S G++LY +L G PF+ + +++ + I + + K +
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI-QDSVPNVTTDVRKDIPQSL 244
Query: 245 QNLLRKILEPNPVKR 259
N++ + E + R
Sbjct: 245 SNVILRATEKDKANR 259
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-44
Identities = 66/263 (25%), Positives = 115/263 (43%), Gaps = 21/263 (7%)
Query: 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI-----K 62
+EG + G Y L R +G G G V A+D A+K++ + L +D + +
Sbjct: 28 REGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSE----TLS-SDPVFRTRMQ 82
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
RE T L+ P+VV +H+ ++Y+ + + G +L + +G L + +Q
Sbjct: 83 REARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQ 142
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT--TCGSP 180
+ + H G HRD+K ENIL+ + + DFG++ D+ L T G+
Sbjct: 143 IGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIA---SATTDEKLTQLGNTVGTL 199
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK-- 238
Y+APE + +DI++ +LY LTG P+ L+V+ I P
Sbjct: 200 YYMAPERFSESHATYR-ADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIPRPSTV 257
Query: 239 --WLSPGAQNLLRKILEPNPVKR 259
+ ++ + + NP R
Sbjct: 258 RPGIPVAFDAVIARGMAKNPEDR 280
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 7e-44
Identities = 81/331 (24%), Positives = 134/331 (40%), Gaps = 79/331 (23%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----ITDQIKREIAT 67
+ +YE +G+G FG+V A+ +G A+K K + + K IT REI
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK---KVLMENEKEGFPITAL--REIKI 69
Query: 68 LKLLKHPNVVRLHEVLASKS--------KIYMVLEYV----TGGELFDKIASKGRLQEAE 115
L+LLKH NVV L E+ +K+ IY+V ++ G L + + +E
Sbjct: 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNV--LVKFTLSE 125
Query: 116 GRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLH 174
+++ Q L++G+ Y H + HRD+K N+L+ G +K++DFGL+ A +
Sbjct: 126 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 175 TTCGSPN------YVAPEVL-ANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVL 225
T N Y PE+L R Y D+W G I+ + T + +
Sbjct: 186 T-----NRVVTLWYRPPELLLGERDYGPPI-DLWGAGCIMAEMWTRSPIMQGNT----EQ 235
Query: 226 YQ--KIFR-------------------GDFKLPKW-------------LSPGAQNLLRKI 251
+Q I + +L K P A +L+ K+
Sbjct: 236 HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKL 295
Query: 252 LEPNPVKRITIAGIKADEWFEQDYTPANPDD 282
L +P +RI ++F D P++
Sbjct: 296 LVLDPAQRIDSDDALNHDFFWSDPMPSDLKG 326
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 8e-44
Identities = 78/281 (27%), Positives = 120/281 (42%), Gaps = 18/281 (6%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD----QIKREIATLKLL 71
+E LG GN G V SGL A K+ IHL+I QI RE+ L
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKL------IHLEIKPAIRNQIIRELQVLHEC 88
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
P +V + S +I + +E++ GG L + GR+ E K+ +I G++Y
Sbjct: 89 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 148
Query: 132 NKG-VFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLA 189
K + HRD+K NIL++S+G IK+ DFG+S L D + ++ G+ +Y++PE L
Sbjct: 149 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERLQ 203
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 249
Y SDIWS G+ L + G P + L P + R
Sbjct: 204 GTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262
Query: 250 KILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVD 290
+ + R +A + ++ + P P F D
Sbjct: 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQD 303
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-43
Identities = 84/309 (27%), Positives = 124/309 (40%), Gaps = 92/309 (29%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK------------ 62
+YE +GEG +GKV A+DL +G R + LK +++
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNG----------GRFVALK---RVRVQTGEEGMPLST 58
Query: 63 -REIATLKLLK---HPNVVRLHEVL-----ASKSKIYMVLEYVTG--GELFDKIASKGRL 111
RE+A L+ L+ HPNVVRL +V ++K+ +V E+V DK+ G +
Sbjct: 59 IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG-V 117
Query: 112 QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171
+ + QL+ G+ + H+ V HRDLK +NIL+ S G IK++DFGL+ R
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA------R--- 168
Query: 172 LLHTTCGSPN----------YVAPEVLANRGYDGATSDIWSCGVILYVILTG--YLPFDD 219
Y APEVL Y D+WS G I +
Sbjct: 169 ----IYSFQMALTSVVVTLWYRAPEVLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSS 223
Query: 220 RNLAVLYQKIFR-----------GDFKLPKW----------------LSPGAQNLLRKIL 252
++ L KI D LP+ + ++LL K L
Sbjct: 224 -DVDQLG-KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCL 281
Query: 253 EPNPVKRIT 261
NP KRI+
Sbjct: 282 TFNPAKRIS 290
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-43
Identities = 63/262 (24%), Positives = 108/262 (41%), Gaps = 26/262 (9%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
G LG+G FG+ ++G +K L + + +E+ ++ L+HPNV
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNV 69
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLID---GVSYCHN 132
++ VL ++ + EY+ GG L I S + D G++Y H+
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPW---SQRVSFAKDIASGMAYLHS 126
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQH------------FRDDGLLHTTCGSP 180
+ HRDL N L+ N+ ++DFGL+ L D +T G+P
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKL--P 237
++APE++ R YD D++S G++L I+ D + + RG P
Sbjct: 187 YWMAPEMINGRSYDEK-VDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP 245
Query: 238 KWLSPGAQNLLRKILEPNPVKR 259
P + + + +P KR
Sbjct: 246 PNCPPSFFPITVRCCDLDPEKR 267
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-43
Identities = 79/269 (29%), Positives = 121/269 (44%), Gaps = 25/269 (9%)
Query: 8 QEGMRL-GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI----- 61
L RYELG LG G +V A+DL AVK+L L D
Sbjct: 5 TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRA----DLA-RDPSFYLRF 59
Query: 62 KREIATLKLLKHPNVVRLHEV----LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR 117
+RE L HP +V +++ + Y+V+EYV G L D + ++G +
Sbjct: 60 RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI 119
Query: 118 KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 177
++ +++ H G+ HRD+K NI++ + +K+ DFG+ A + + T
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGI-ARAIADSGNSVTQTAA 178
Query: 178 --GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRGDF 234
G+ Y++PE A A SD++S G +LY +LTG PF D ++V YQ + R D
Sbjct: 179 VIGTAQYLSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV-REDP 236
Query: 235 KLPK----WLSPGAQNLLRKILEPNPVKR 259
P LS ++ K L NP R
Sbjct: 237 IPPSARHEGLSADLDAVVLKALAKNPENR 265
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 6e-43
Identities = 67/248 (27%), Positives = 118/248 (47%), Gaps = 11/248 (4%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLK 72
+ +G+G+FG+V D + A+KI LE+ +I D I++EI L
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA---EDEIED-IQQEITVLSQCD 78
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
P V + + +K+++++EY+ GG D + G L E + + ++++ G+ Y H+
Sbjct: 79 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHS 137
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
+ HRD+K N+LL G +K++DFG++ Q +T G+P ++APEV+
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQSA 195
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251
YD +DIWS G+ + G P + + + VL+ L S + +
Sbjct: 196 YDSK-ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEAC 254
Query: 252 LEPNPVKR 259
L P R
Sbjct: 255 LNKEPSFR 262
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 7e-43
Identities = 52/259 (20%), Positives = 99/259 (38%), Gaps = 32/259 (12%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
L E + G++ G VK+L K R + + E L++ HPNV
Sbjct: 13 NFLTKLNENHSGELWKG--RWQGNDIVVKVL-KVRDWSTRKSRDFNEECPRLRIFSHPNV 69
Query: 77 VRLHEVLAS--KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------G 126
+ + S ++ ++ G L++ L E + Q + G
Sbjct: 70 LPVLGACQSPPAPHPTLITHWMPYGSLYN------VLHEGTNFVVDQSQAVKFALDMARG 123
Query: 127 VSYCHNKG--VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
+++ H + L ++++D +IS + +P +VA
Sbjct: 124 MAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK----FSFQSP---GRMYAPAWVA 176
Query: 185 PEVLANRGYDGAT--SDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGD-FKLPKWL 240
PE L + D +D+WS V+L+ ++T +PF D N+ + + G +P +
Sbjct: 177 PEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGI 236
Query: 241 SPGAQNLLRKILEPNPVKR 259
SP L++ + +P KR
Sbjct: 237 SPHVSKLMKICMNEDPAKR 255
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 9e-43
Identities = 66/263 (25%), Positives = 116/263 (44%), Gaps = 30/263 (11%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL----EKNRIIHLKITDQIKREIATLKLLK 72
E + +G+G FG V + + A+K L + ++ + +RE+ + L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---GVSY 129
HPN+V+L + MV+E+V G+L+ ++ K + + ++D G+ Y
Sbjct: 82 HPNIVKL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEY 137
Query: 130 CHNKG--VFHRDLKLENILLDSKG-----NIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
N+ + HRDL+ NI L S K++DFGLS + G+ +
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLGNFQW 192
Query: 183 VAPEVLANRG--YDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGD-FKL 236
+APE + Y +D +S +ILY ILTG PFD+ + + + G +
Sbjct: 193 MAPETIGAEEESYTEK-ADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI 251
Query: 237 PKWLSPGAQNLLRKILEPNPVKR 259
P+ P +N++ +P KR
Sbjct: 252 PEDCPPRLRNVIELCWSGDPKKR 274
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-42
Identities = 72/257 (28%), Positives = 115/257 (44%), Gaps = 22/257 (8%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-KITDQIKREIATLKLLKHPN 75
L +G G FGKV A G AVK + + + + +++E +LKHPN
Sbjct: 10 TLEEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG- 134
++ L V + + +V+E+ GG L ++ K R+ Q+ G++Y H++
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 135 --VFHRDLKLENILLDSKG--------NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
+ HRDLK NIL+ K +KI+DFGL+ + G+ ++A
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWMA 182
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGD-FKLPKWLSP 242
PEV+ + SD+WS GV+L+ +LTG +PF LAV Y +P
Sbjct: 183 PEVIRASMFSKG-SDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPE 241
Query: 243 GAQNLLRKILEPNPVKR 259
L+ P+P R
Sbjct: 242 PFAKLMEDCWNPDPHSR 258
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-42
Identities = 58/260 (22%), Positives = 110/260 (42%), Gaps = 25/260 (9%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
E+G +G+G FG+V ++ ++ A+++++ R KRE+ + +H
Sbjct: 36 EIGELIGKGRFGQVYHGRWHGEV------AIRLIDIERDNE-DQLKAFKREVMAYRQTRH 88
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHN 132
NVV S + ++ G L+ + K L + R++ Q+++ G+ Y H
Sbjct: 89 ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA 148
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
KG+ H+DLK +N+ D G + I+DFGL + Q R + L G ++APE++
Sbjct: 149 KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207
Query: 190 NRGYDGAT--------SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--PKW 239
D SD+++ G I Y + PF + + ++ G
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIG 267
Query: 240 LSPGAQNLLRKILEPNPVKR 259
+ ++L +R
Sbjct: 268 MGKEISDILLFCWAFEQEER 287
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-40
Identities = 72/255 (28%), Positives = 131/255 (51%), Gaps = 17/255 (6%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+E+ LG+G FGKV A++ ++G A K++E ++ D EI L HP
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELED-YIVEIEILATCDHP 76
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
+V+L K+++++E+ GG + + L E + + + +Q+++ +++ H+K
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR-- 191
+ HRDLK N+L+ +G+I+++DFG+SA ++ + + G+P ++APEV+
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 192 ---GYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGD---FKLPKWLSPGA 244
YD +DIWS G+ L + P + N + VL KI + D P S
Sbjct: 195 KDTPYDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLL-KIAKSDPPTLLTPSKWSVEF 252
Query: 245 QNLLRKILEPNPVKR 259
++ L+ L+ NP R
Sbjct: 253 RDFLKIALDKNPETR 267
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-40
Identities = 68/252 (26%), Positives = 126/252 (50%), Gaps = 14/252 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+++ LGEG++G V A ++G A+K + + +I +EI+ ++ P
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL-----QEIIKEISIMQQCDSP 84
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
+VV+ + + +++V+EY G + D I L E E + Q + G+ Y H
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
HRD+K NILL+++G+ K++DFG++ Q +T G+P ++APEV+ GY
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAG--QLTDTMAKRNTVIGTPFWMAPEVIQEIGY 202
Query: 194 DGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGD---FKLPKWLSPGAQNLLR 249
+ +DIWS G+ + G P+ D + + ++ I F+ P+ S + ++
Sbjct: 203 NCV-ADIWSLGITAIEMAEGKPPYADIHPMRAIF-MIPTNPPPTFRKPELWSDNFTDFVK 260
Query: 250 KILEPNPVKRIT 261
+ L +P +R T
Sbjct: 261 QCLVKSPEQRAT 272
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-40
Identities = 71/252 (28%), Positives = 129/252 (51%), Gaps = 14/252 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLK 72
+Y +G+G G V A D+ +G A++ L++ L I EI ++ K
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-----IINEILVMRENK 75
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
+PN+V + ++++V+EY+ GG L D + ++ + E + + ++ + + + H+
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
V HRD+K +NILL G++K++DFG A Q + T G+P ++APEV+ +
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRG--DFKLPKWLSPGAQNLLR 249
Y DIWS G++ ++ G P+ + N L LY G + + P+ LS ++ L
Sbjct: 193 YGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251
Query: 250 KILEPNPVKRIT 261
+ LE + KR +
Sbjct: 252 RCLEMDVEKRGS 263
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 5e-40
Identities = 71/253 (28%), Positives = 133/253 (52%), Gaps = 16/253 (6%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLK 72
+ +GEG+ G V A++ SG AVK+ L K + L + E+ ++ +
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL-----LFNEVVIMRDYQ 100
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
H NVV +++ ++++++E++ GG L D I S+ RL E + + + ++ ++Y H
Sbjct: 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHA 159
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
+GV HRD+K ++ILL G +K+SDFG A Q +D + G+P ++APEV++
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPEVISRSL 217
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGD---FKLPKWLSPGAQNLL 248
Y DIWS G+++ ++ G P+ + + + ++ K +SP ++ L
Sbjct: 218 YA-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK-RLRDSPPPKLKNSHKVSPVLRDFL 275
Query: 249 RKILEPNPVKRIT 261
++L +P +R T
Sbjct: 276 ERMLVRDPQERAT 288
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-39
Identities = 94/371 (25%), Positives = 136/371 (36%), Gaps = 98/371 (26%)
Query: 15 RYE-LGRTLGEGNFGKVKFAQDLD--SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
+E G +G G +G V A+ D +A+K +E I REIA L+ L
Sbjct: 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC-----REIALLREL 75
Query: 72 KHPNVVRLHEVLASKS--KIYMVLEYV--------TGGELFDKIASKGRLQEAEGRKLFQ 121
KHPNV+ L +V S + K++++ +Y +L + L
Sbjct: 76 KHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 135
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDS----KGNIKISDFGLSALPQHFRDDGLLHTTC 177
Q++DG+ Y H V HRDLK NIL+ +G +KI+D G + R
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA------R-------LF 182
Query: 178 GSPN--------------YVAPEVL-ANRGYDGATSDIWSCGVILYVILTGYLPF----D 218
SP Y APE+L R Y A DIW+ G I +LT F +
Sbjct: 183 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAI-DIWAIGCIFAELLTSEPIFHCRQE 241
Query: 219 DRNLAVLYQ-----KIFR-----------GDFKLPKW----------------------- 239
D + Y +IF K+P+
Sbjct: 242 DIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEK 301
Query: 240 ----LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFS 295
A +LL+K+L +P+KRIT D +F +D P + I F
Sbjct: 302 HKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPKREFL 361
Query: 296 MHEVPSDGGRT 306
E P D G
Sbjct: 362 TEEEPDDKGDK 372
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-39
Identities = 75/270 (27%), Positives = 121/270 (44%), Gaps = 31/270 (11%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLK 72
YEL +G G V+ A A+K LEK + D++ +EI +
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ----TSMDELLKEIQAMSQCH 71
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI-------- 124
HPN+V + K ++++V++ ++GG + D I E + L + I
Sbjct: 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL---HTTCGSPN 181
+G+ Y H G HRD+K NILL G+++I+DFG+SA D T G+P
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 182 YVAPEVLA-NRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLY----------QKI 229
++APEV+ RGYD +DIWS G+ + TG P+ + VL +
Sbjct: 192 WMAPEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG 250
Query: 230 FRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259
+ L K+ + ++ L+ +P KR
Sbjct: 251 VQDKEMLKKY-GKSFRKMISLCLQKDPEKR 279
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-39
Identities = 61/255 (23%), Positives = 109/255 (42%), Gaps = 17/255 (6%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHP 74
E +G G G+V + +G AVK + ++ + + +I ++ + K P
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS--GNKEENKRILMDLDVVLKSHDCP 84
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK- 133
+V+ + + +++ +E + K +G + E K+ ++ + Y K
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
GV HRD+K NILLD +G IK+ DFG+S DD + G Y+APE +
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDP 201
Query: 194 DGAT----SDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRGD---FKLPKWLSPGA 244
+D+WS G+ L + TG P+ + VL K+ + + S
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVL-TKVLQEEPPLLPGHMGFSGDF 260
Query: 245 QNLLRKILEPNPVKR 259
Q+ ++ L + KR
Sbjct: 261 QSFVKDCLTKDHRKR 275
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-38
Identities = 67/253 (26%), Positives = 117/253 (46%), Gaps = 18/253 (7%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+ R +G G+FG V FA+D+ + A+K + + + I +E+ L+ L+HP
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 114
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N ++ + ++V+EY G K LQE E + + G++Y H+
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 174
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANR-- 191
+ HRD+K NILL G +K+ DFG ++ + ++ G+P ++APEV+
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NSFVGTPYWMAPEVILAMDE 227
Query: 192 -GYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGD---FKLPKWLSPGAQN 246
YDG D+WS G+ + P + N ++ LY I + + + W S +N
Sbjct: 228 GQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPALQSGHW-SEYFRN 284
Query: 247 LLRKILEPNPVKR 259
+ L+ P R
Sbjct: 285 FVDSCLQKIPQDR 297
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-38
Identities = 54/230 (23%), Positives = 101/230 (43%), Gaps = 18/230 (7%)
Query: 14 GRYELGRTLGEG--NFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLK 69
G YEL +G+G + V A+ +G V+ LE + ++ E+ K
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMV---TFLQGELHVSK 81
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGV 127
L HPN+V + +++++V ++ G D + E + Q ++ +
Sbjct: 82 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKAL 141
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTC----GSPNY 182
Y H+ G HR +K +IL+ G + +S + + H + ++H +
Sbjct: 142 DYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201
Query: 183 VAPEVLA--NRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKI 229
++PEVL +GYD SDI+S G+ + G++PF D +L +K+
Sbjct: 202 LSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKDMPATQMLLEKL 250
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 7e-38
Identities = 63/265 (23%), Positives = 108/265 (40%), Gaps = 38/265 (14%)
Query: 8 QEGMRL-GRYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRIIHLKITDQI---- 61
G + G+YE+ + G G + A D + +G P +K L + D
Sbjct: 73 NPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-------DAEAQAM 125
Query: 62 -KREIATLKLLKHPNVVRLHEV-----LASKSKIYMVLEYVTGGELFDKIASKGRLQEAE 115
E L + HP++V++ Y+V+EYV G L +L AE
Sbjct: 126 AMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAE 183
Query: 116 GRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL-SALPQHFRDDGLLH 174
+++ +SY H+ G+ + DLK ENI+L + +K+ D G S + G L
Sbjct: 184 AIAYLLEILPALSYLHSIGLVYNDLKPENIMLT-EEQLKLIDLGAVSRINS----FGYL- 237
Query: 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF 234
G+P + APE++ R +DI++ G L + + R + L +
Sbjct: 238 --YGTPGFQAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDD----- 288
Query: 235 KLPKWLSPGAQNLLRKILEPNPVKR 259
LLR+ ++P+P +R
Sbjct: 289 -PVLKTYDSYGRLLRRAIDPDPRQR 312
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-37
Identities = 74/264 (28%), Positives = 126/264 (47%), Gaps = 27/264 (10%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK-LLK 72
G +EL +G G +G+V + + +G A+K+++ + + + IK+EI LK
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEE-IKQEINMLKKYSH 79
Query: 73 HPNVVRLHE------VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLI 124
H N+ + ++++V+E+ G + D K L+E + ++++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
G+S+ H V HRD+K +N+LL +K+ DFG+SA Q R G +T G+P ++A
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMA 197
Query: 185 PEVLANR-----GYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGD---FK 235
PEV+A YD SD+WS G+ + G P D + + L+ I R K
Sbjct: 198 PEVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRNPAPRLK 255
Query: 236 LPKWLSPGAQNLLRKILEPNPVKR 259
KW S Q+ + L N +R
Sbjct: 256 SKKW-SKKFQSFIESCLVKNHSQR 278
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 5e-37
Identities = 67/268 (25%), Positives = 111/268 (41%), Gaps = 38/268 (14%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD----QIKREIAT-LKL 70
+ +G G +G V SG AVK I + + Q+ ++ ++
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKR------IRSTVDEKEQKQLLMDLDVVMRS 77
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI------ASKGRLQEAEGRKLFQQLI 124
P +V+ + L + ++ +E ++ FDK + E K+ +
Sbjct: 78 SDCPYIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATV 135
Query: 125 DGVSYCHNKG-VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
+++ + HRD+K NILLD GNIK+ DFG+S D G Y+
Sbjct: 136 KALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYM 192
Query: 184 APEVLA----NRGYDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRGD-FKL 236
APE + +GYD SD+WS G+ LY + TG P+ N L ++ +GD +L
Sbjct: 193 APERIDPSASRQGYD-VRSDVWSLGITLYELATGRFPYPKWNSVFDQL-TQVVKGDPPQL 250
Query: 237 P-----KWLSPGAQNLLRKILEPNPVKR 259
++ SP N + L + KR
Sbjct: 251 SNSEEREF-SPSFINFVNLCLTKDESKR 277
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 8e-37
Identities = 63/277 (22%), Positives = 114/277 (41%), Gaps = 32/277 (11%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD----QIKREIA-TLKL 70
E LG G +G V+ + + SG AVK I + ++ ++ +++
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKR------IRATVNSQEQKRLLMDLDISMRT 62
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-----ASKGRLQEAEGRKLFQQLID 125
+ P V + L + +++ +E + DK + E K+ ++
Sbjct: 63 VDCPFTVTFYGALFREGDVWICMELMDTS--LDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 126 GVSYCHNKG-VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
+ + H+K V HRD+K N+L+++ G +K+ DFG+S + DD G Y+A
Sbjct: 121 ALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMA 177
Query: 185 PEVLANR----GYDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRGDFKLP- 237
PE + GY SDIWS G+ + + P+D L Q + +LP
Sbjct: 178 PERINPELNQKGYS-VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA 236
Query: 238 -KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
K+ S + + L+ N +R T + +F
Sbjct: 237 DKF-SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 84/353 (23%), Positives = 131/353 (37%), Gaps = 100/353 (28%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKH 73
Y + +G G+FG V A+ DSG A+K +L+ R + RE+ ++ L H
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDH 106
Query: 74 PNVVRLHEVLASKS------KIYMVLEYVTG---GELFDKIASKGRLQEAEGRKLFQQLI 124
N+VRL S + +VL+YV +K L + QL
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPN-- 181
++Y H+ G+ HRD+K +N+LLD +K+ DFG + G PN
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA-----------KQLVRGEPNVS 215
Query: 182 YV------APEVLAN-RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD- 233
Y+ APE++ Y + D+WS G +L +L G Q IF GD
Sbjct: 216 YICSRYYRAPELIFGATDYTSSI-DVWSAGCVLAELLLG-------------QPIFPGDS 261
Query: 234 -----------------------------FKLPKW------------LSPGAQNLLRKIL 252
FK P+ P A L ++L
Sbjct: 262 GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLL 321
Query: 253 EPNPVKRITIAGIKADEWFEQDYTPAN--PDDDEEDIFVDNEAFSMHEVPSDG 303
E P R+T A +F++ P P+ + + F+ E+ S+
Sbjct: 322 EYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFN---FTTQELSSNP 371
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-35
Identities = 38/260 (14%), Positives = 75/260 (28%), Gaps = 43/260 (16%)
Query: 10 GMRL--GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
G R+ GRY L G + A D A+ ++ ++ + +
Sbjct: 25 GARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLR 84
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
L + P V R+ +V+ +++ +V E++ GG L + + Q L
Sbjct: 85 LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD--TSPSPVGAIRAMQSLAAAA 142
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
H GV + + G++ ++ +
Sbjct: 143 DAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDA- 179
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRGDFKLPKWLSPG 243
DI G LY +L P + LA + G P +
Sbjct: 180 -------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT-AGQPIEPADIDRD 231
Query: 244 A----QNLLRKILEPNPVKR 259
+ + ++ + R
Sbjct: 232 IPFQISAVAARSVQGDGGIR 251
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-35
Identities = 72/237 (30%), Positives = 106/237 (44%), Gaps = 26/237 (10%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
L LG+G+FG V ++ + AVK L+ + + + D RE+ + L H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G 126
N++RL+ V + MV E G L D RL++ +G L L G
Sbjct: 81 RNLIRLYGV-VLTPPMKMVTELAPLGSLLD------RLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYV-- 183
+ Y +K HRDL N+LL ++ +KI DFGL ALPQ +D
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ---NDDHYVMQEHRKVPFAW 190
Query: 184 -APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
APE L R + A SD W GV L+ + T G P+ N + + KI + +LP+
Sbjct: 191 CAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 246
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-34
Identities = 73/310 (23%), Positives = 126/310 (40%), Gaps = 74/310 (23%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK--ILEKNRIIHLKITDQIKREIATLKLLK 72
Y + +G G+FG V A+ ++S A+K + +K RE+ ++++K
Sbjct: 41 AYTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRFKN---------RELQIMRIVK 90
Query: 73 HPNVVRLHEVLASKS------KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ----Q 122
HPNVV L S + +VLEYV ++ +L++ L + Q
Sbjct: 91 HPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
L+ ++Y H+ G+ HRD+K +N+LLD G +K+ DFG + G PN
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA-----------KILIAGEPN 198
Query: 182 --YV------APEVLAN-RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR- 231
Y+ APE++ Y DIWS G ++ ++ G F + +I +
Sbjct: 199 VSYICSRYYRAPELIFGATNYTTNI-DIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKV 257
Query: 232 ----------------GDFKLPKW------------LSPGAQNLLRKILEPNPVKRITIA 263
+ K P+ P A +L+ ++LE P R+T
Sbjct: 258 LGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAI 317
Query: 264 GIKADEWFEQ 273
+F++
Sbjct: 318 EALCHPFFDE 327
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-33
Identities = 63/293 (21%), Positives = 112/293 (38%), Gaps = 52/293 (17%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
L +G+G +G+V G AVKI + + + E+ +L+H N+
Sbjct: 11 TLLECVGKGRYGEVWRGSW--QGENVAVKIFSS----RDEKSWFRETELYNTVMLRHENI 64
Query: 77 VRL----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
+ S ++++++ Y G L+D + L ++ + G+++ H
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHI 123
Query: 133 K--------GVFHRDLKLENILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPNY 182
+ + HRDLK +NIL+ G I+D GL+ + + D + G+ Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 183 VAPEVLANRGYDGAT-----SDIWSCGVILYVILTGY----------LPFDDRN------ 221
+APEVL DIW+ G++L+ + PF D
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 222 ----LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE----PNPVKRITIAGIK 266
V + R + +W S L K+++ NP R+T IK
Sbjct: 244 EDMRKVVCVDQQ-RPNIP-NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-33
Identities = 80/344 (23%), Positives = 130/344 (37%), Gaps = 75/344 (21%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
RY+ + +G G G V A D A+K L + H K + RE+ +K +
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKCVN 82
Query: 73 HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H N++ L V + +Y+V+E + L I + L L Q++ G
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI--QMELDHERMSYLLYQMLCG 139
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 183
+ + H+ G+ HRDLK NI++ S +KI DFGL+ R G YV
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTP---YVVTR 190
Query: 184 ---APEVLANRGYDGATSDIWSCGVILYVILTG--------------------------- 213
APEV+ GY DIWS G I+ ++ G
Sbjct: 191 YYRAPEVILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 249
Query: 214 ----------YL----PFDDRNLAVLYQK-IFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
Y+ + + L+ +F D + K + A++LL K+L + K
Sbjct: 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASK 309
Query: 259 RITIAGIKADEWFEQDYTPANPDDDEEDIF---VDNEAFSMHEV 299
RI++ + Y P+ + I +D ++ E
Sbjct: 310 RISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEW 353
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 82/344 (23%), Positives = 132/344 (38%), Gaps = 75/344 (21%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
RY+ + +G G G V A D A+K L + H K + RE+ +K +
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKCVN 119
Query: 73 HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H N++ L V + +Y+V+E + L I + L L Q++ G
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI--QMELDHERMSYLLYQMLCG 176
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 183
+ + H+ G+ HRDLK NI++ S +KI DFGL+ R G T+ YV
Sbjct: 177 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAG---TSFMMTPYVVTR 227
Query: 184 ---APEVLANRGYDGATSDIWSCGVILYVILTG--------------------------- 213
APEV+ GY DIWS G I+ ++
Sbjct: 228 YYRAPEVILGMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 286
Query: 214 ----------YL----PFDDRNLAVLYQK-IFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
Y+ + L+ +F D + K + A++LL K+L +P K
Sbjct: 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 346
Query: 259 RITIAGIKADEWFEQDYTPANPDDDEEDIF---VDNEAFSMHEV 299
RI++ + Y PA + I+ +D ++ E
Sbjct: 347 RISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEW 390
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 7e-33
Identities = 73/260 (28%), Positives = 113/260 (43%), Gaps = 20/260 (7%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
LG +G GNFG+V + AVK + LK + +E LK HPN+
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA--KFLQEARILKQYSHPNI 174
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF-QQLIDGVSYCHNKGV 135
VRL V K IY+V+E V GG+ + ++G + G+ Y +K
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGSPNY----VAPEVLA 189
HRDL N L+ K +KISDFG+S R+ DG+ + G APE L
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMS------REEADGVYAASGGLRQVPVKWTAPEALN 288
Query: 190 NRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQN 246
Y SD+WS G++L+ + G P+ + + + + +G +L P+
Sbjct: 289 YGRYSSE-SDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG-GRLPCPELCPDAVFR 346
Query: 247 LLRKILEPNPVKRITIAGIK 266
L+ + P +R + + I
Sbjct: 347 LMEQCWAYEPGQRPSFSTIY 366
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-33
Identities = 60/233 (25%), Positives = 107/233 (45%), Gaps = 26/233 (11%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+ LG G +G+V L AVK L+++ + ++ +E A +K +KHPN+
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV----EEFLKEAAVMKEIKHPNL 278
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
V+L V + Y++ E++T G L D L+E +++ L+ +
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLD------YLRECNRQEVSAVVLLYMATQISSAME 332
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY--VAPE 186
Y K HR+L N L+ +K++DFGLS + D APE
Sbjct: 333 YLEKKNFIHRNLAARNCLVGENHLVKVADFGLS---RLMTGDTYTAHAGAKFPIKWTAPE 389
Query: 187 VLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
LA + SD+W+ GV+L+ I T G P+ +L+ +Y+ + + +++ +
Sbjct: 390 SLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMER 440
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-32
Identities = 66/291 (22%), Positives = 120/291 (41%), Gaps = 58/291 (19%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-H 73
Y+L R LG G + +V A ++ + VKI + +IKREI L+ L+
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKI------LKPVKKKKIKREIKILENLRGG 90
Query: 74 PNVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
PN++ L +++ +V E+V + + L + + R +++ + YCH
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCH 147
Query: 132 NKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLA 189
+ G+ HRD+K N+++D + +++ D+GL+ F G + S + PE+L
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA----EFYHPGQEYNVRVASRYFKGPELLV 203
Query: 190 N-RGYDGATSDIWSCGVILYVILTGYLPF--------------------DDRNLAVLYQK 228
+ + YD + D+WS G +L ++ PF D + Y
Sbjct: 204 DYQMYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262
Query: 229 IFRGDFK--LPKW----------------LSPGAQNLLRKILEPNPVKRIT 261
F L + +SP A + L K+L + R+T
Sbjct: 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 313
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-32
Identities = 79/340 (23%), Positives = 127/340 (37%), Gaps = 63/340 (18%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD--QIKREIATLKLLK 72
++L LGEG +G V A +G A+K K K + REI LK K
Sbjct: 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIK---KIEPFD-KPLFALRTLREIKILKHFK 67
Query: 73 HPNVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
H N++ + + S +Y++ E + +L ++ S L + + Q + V
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQYFIYQTLRAV 125
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGL--SALPQHFRDDGLLHTTCGSPNYV-- 183
H V HRDLK N+L++S ++K+ DFGL + G +V
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 184 ----APEV-LANRGYDGATSDIWSCGVILYVILTG--------YL------------PFD 218
APEV L + Y A D+WSCG IL + Y P
Sbjct: 186 RWYRAPEVMLTSAKYSRAM-DVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 219 DRNLAVL-----------YQKIFRGDFK--LPKWLSPGAQNLLRKILEPNPVKRITIAGI 265
D +L + + P+ ++P +LL+++L +P KRIT
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR-VNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 266 KADEWFEQDYTP-----ANPDDDEEDIF-VDNEAFSMHEV 299
+ + + P P F EA + ++
Sbjct: 304 LEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDL 343
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 58/237 (24%), Positives = 110/237 (46%), Gaps = 29/237 (12%)
Query: 17 ELGRTLGEGNFGKVK----FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ + LG G FG V + +P A+K L + +I E + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVD 75
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------- 125
+P+V RL + S + ++ + + G L D ++E + Q L++
Sbjct: 76 NPHVCRLLGIC-LTSTVQLITQLMPFGCLLD------YVREHKDNIGSQYLLNWCVQIAK 128
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGS-P-NY 182
G++Y ++ + HRDL N+L+ + ++KI+DFGL+ L ++ H G P +
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA---EEKEYHAEGGKVPIKW 185
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
+A E + +R Y SD+WS GV ++ ++T G P+D + + + +G +LP+
Sbjct: 186 MALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLPQ 240
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-32
Identities = 63/235 (26%), Positives = 108/235 (45%), Gaps = 30/235 (12%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKHP 74
+ LG G +G+V L AVK L+++ + + +E A +K +KHP
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT------MEVEEFLKEAAVMKEIKHP 69
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------G 126
N+V+L V + Y++ E++T G L D L+E +++ L+
Sbjct: 70 NLVQLLGVCTREPPFYIITEFMTYGNLLD------YLRECNRQEVSAVVLLYMATQISSA 123
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVA 184
+ Y K HRDL N L+ +K++DFGLS L D P + A
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTA 180
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
PE LA + SD+W+ GV+L+ I T G P+ +L+ +Y+ + + +++ +
Sbjct: 181 PESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMER 233
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 70/285 (24%), Positives = 122/285 (42%), Gaps = 32/285 (11%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
L LG+G FG+V + A+K L+ + + +E +K L+H +
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKL 324
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
V+L+ V S+ IY+V EY++ G L D L+ G+ L QL+D G++
Sbjct: 325 VQLYAV-VSEEPIYIVTEYMSKGSLLD------FLKGETGKYLRLPQLVDMAAQIASGMA 377
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVAPE 186
Y HRDL+ NIL+ K++DFGL+ + D+ P + APE
Sbjct: 378 YVERMNYVHRDLRAANILVGENLVCKVADFGLA---RLIEDNEYTARQGAKFPIKWTAPE 434
Query: 187 VLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPG 243
+ SD+WS G++L + T G +P+ + ++ RG +++ P
Sbjct: 435 AALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPES 492
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIF 288
+L+ + P +R T ++ + E +T P +
Sbjct: 493 LHDLMCQCWRKEPEERPTFEYLQ--AFLEDYFTSTEPQYQPGENL 535
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 70/285 (24%), Positives = 122/285 (42%), Gaps = 32/285 (11%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
L LG+G FG+V + A+K L+ + + +E +K L+H +
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKL 241
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
V+L+ V S+ IY+V EY++ G L D L+ G+ L QL+D G++
Sbjct: 242 VQLYAV-VSEEPIYIVTEYMSKGSLLD------FLKGETGKYLRLPQLVDMAAQIASGMA 294
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVAPE 186
Y HRDL+ NIL+ K++DFGL+ + D+ P + APE
Sbjct: 295 YVERMNYVHRDLRAANILVGENLVCKVADFGLA---RLIEDNEYTARQGAKFPIKWTAPE 351
Query: 187 VLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPG 243
+ SD+WS G++L + T G +P+ + ++ RG +++ P
Sbjct: 352 AALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPES 409
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIF 288
+L+ + P +R T ++ + E +T P +
Sbjct: 410 LHDLMCQCWRKEPEERPTFEYLQ--AFLEDYFTSTEPQYQPGENL 452
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-32
Identities = 61/228 (26%), Positives = 99/228 (43%), Gaps = 14/228 (6%)
Query: 18 LGRTLGEGNFGKVKFA--QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+ LG GNFG VK Q AVKIL KN + D++ E ++ L +P
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPY 79
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
+VR+ + +V+E G L + +++ +L Q+ G+ Y
Sbjct: 80 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 138
Query: 136 FHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGS--P-NYVAPEVLANR 191
HRDL N+LL ++ KISDFGLS AL D+ P + APE +
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRA---DENYYKAQTHGKWPVKWYAPECINYY 195
Query: 192 GYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
+ SD+WS GV+++ + G P+ + + + +G ++
Sbjct: 196 KFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMGC 241
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-32
Identities = 64/236 (27%), Positives = 107/236 (45%), Gaps = 26/236 (11%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+ + +G G+ G+V + +P A+K L+ + E + + H
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR--RDFLSEASIMGQFDH 109
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G 126
PN++RL V+ +V EY+ G L L+ +G+ QL+ G
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDT------FLRTHDGQFTIMQLVGMLRGVGAG 163
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 183
+ Y + G HRDL N+L+DS K+SDFGLS + + D +TT G +
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE--DDPDAAYTTTGGKIPIRWT 221
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
APE +A R + A SD+WS GV+++ +L G P+ + + + G ++LP
Sbjct: 222 APEAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-YRLPA 275
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-31
Identities = 89/332 (26%), Positives = 138/332 (41%), Gaps = 64/332 (19%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
RY+ +G G +G V A D +GL AVK L + IIH K + RE+ LK +K
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 86
Query: 73 HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H NV+ L +V +Y+V + G +L + + + +L + + L Q++ G
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRG 144
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 183
+ Y H+ + HRDLK N+ ++ +KI DFGL+ YV
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG-----------YVATR 193
Query: 184 ---APEV-LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR------GD 233
APE+ L Y+ DIWS G I+ +LTG F + + I R +
Sbjct: 194 WYRAPEIMLNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252
Query: 234 F--------------KLPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKAD 268
L + +P A +LL K+L + KRIT A A
Sbjct: 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312
Query: 269 EWFEQDYTPAN-PDDDEEDIFVDNEAFSMHEV 299
+F Q + P + P D D +++ + E
Sbjct: 313 AYFAQYHDPDDEPVADPYDQSLESRDLLIDEW 344
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-31
Identities = 91/360 (25%), Positives = 137/360 (38%), Gaps = 80/360 (22%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
Y + +G G +G V A D +G A+K L + + K + RE+ LK ++
Sbjct: 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK---RAYRELRLLKHMR 82
Query: 73 HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H NV+ L +V Y+V+ ++ G +L K+ +L E + L Q++ G
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRIQFLVYQMLKG 140
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 183
+ Y H G+ HRDLK N+ ++ +KI DFGL+ R T YV
Sbjct: 141 LRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA------RQADSEMT-----GYVVTR 189
Query: 184 ---APEV-LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--------- 230
APEV L Y DIWS G I+ ++TG F + ++I
Sbjct: 190 WYRAPEVILNWMRYTQTV-DIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 248
Query: 231 ---------------------RGDFK--LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267
+ DF L SP A NLL K+L + +R+T A
Sbjct: 249 FVQRLQSDEAKNYMKGLPELEKKDFASILTN-ASPLAVNLLEKMLVLDAEQRVTAGEALA 307
Query: 268 DEWFEQDYTPA--------NPDDDEEDIFVD-------NEAFSMHEVPSDGGRTPGSPPL 312
+FE + + D+ D +D E S G R PL
Sbjct: 308 HPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 367
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-31
Identities = 65/238 (27%), Positives = 109/238 (45%), Gaps = 33/238 (13%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
ELGR +GEG FG V + + L A+K + ++ ++ +E T++ H
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDH 75
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G 126
P++V+L V+ +++ +++++E T GEL LQ + LI
Sbjct: 76 PHIVKLIGVI-TENPVWIIMELCTLGELRS------FLQVRKYSLDLASLILYAYQLSTA 128
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGS--P-N 181
++Y +K HRD+ N+L+ S +K+ DFGLS R D + P
Sbjct: 129 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS------RYMEDSTYYKASKGKLPIK 182
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
++APE + R + A SD+W GV ++ IL G PF + +I G +LP
Sbjct: 183 WMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ERLPM 238
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-31
Identities = 58/237 (24%), Positives = 106/237 (44%), Gaps = 29/237 (12%)
Query: 17 ELGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ LG G FG V + +P +K++E + + + + L
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLD 73
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------- 125
H ++VRL + S + +V +Y+ G L D +++ G Q L++
Sbjct: 74 HAHIVRLLGLC-PGSSLQLVTQYLPLGSLLD------HVRQHRGALGPQLLLNWGVQIAK 126
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCG-SP-NY 182
G+ Y G+ HR+L N+LL S ++++DFG++ LP DD L + +P +
Sbjct: 127 GMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP---DDKQLLYSEAKTPIKW 183
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
+A E + Y SD+WS GV ++ ++T G P+ LA + + +G +L +
Sbjct: 184 MALESIHFGKYTHQ-SDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG-ERLAQ 238
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-31
Identities = 64/236 (27%), Positives = 107/236 (45%), Gaps = 27/236 (11%)
Query: 18 LGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+ +G G FG+V +P A+K L+ + E + H
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR--VDFLGEAGIMGQFSH 105
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G 126
N++RL V++ + ++ EY+ G L L+E +G QL+ G
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDK------FLREKDGEFSVLQLVGMLRGIAAG 159
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 183
+ Y N HRDL NIL++S K+SDFGLS + + D +TT G +
Sbjct: 160 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE--DDPEATYTTSGGKIPIRWT 217
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
APE ++ R + A SD+WS G++++ ++T G P+ + + + + I G F+LP
Sbjct: 218 APEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRLPT 271
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-31
Identities = 77/325 (23%), Positives = 122/325 (37%), Gaps = 73/325 (22%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD--QIKREIATLKLLK 72
RY + LG G G V A D D A+K +I+ REI ++ L
Sbjct: 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK-----KIVLTDPQSVKHALREIKIIRRLD 66
Query: 73 HPNVVRLHEVLASKSK--------------IYMVLEYVTGGELFDKIASKGRLQEAEGRK 118
H N+V++ E+L +Y+V EY+ +L + +G L E R
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDL-ANVLEQGPLLEEHARL 124
Query: 119 LFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLS-ALPQHFRDDGLLHTT 176
QL+ G+ Y H+ V HRDLK N+ ++++ +KI DFGL+ + H+ G L
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL--- 181
Query: 177 CGSPNYV------APEV-LANRGYDGATSDIWSCGVILYVILTGYLPF------------ 217
+ +P + L+ Y A D+W+ G I +LTG F
Sbjct: 182 ---SEGLVTKWYRSPRLLLSPNNYTKAI-DMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237
Query: 218 -------DDRNLAVLYQKIFRGDFKLPKW-----------LSPGAQNLLRKILEPNPVKR 259
+ + L I +S A + L +IL +P+ R
Sbjct: 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDR 297
Query: 260 ITIAGIKADEWFEQDYTPANPDDDE 284
+T + + P DE
Sbjct: 298 LTAEEALSHPYMSIYSFP----MDE 318
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 8e-31
Identities = 60/237 (25%), Positives = 106/237 (44%), Gaps = 36/237 (15%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKHP 74
+ +G G FG V + A+K + + + E + L HP
Sbjct: 11 TFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGA------MSEEDFIEEAEVMMKLSHP 63
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GV 127
+V+L+ V ++ I +V E++ G L D L+ G + L+ G+
Sbjct: 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSD------YLRTQRGLFAAETLLGMCLDVCEGM 117
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGS--P-NY 182
+Y V HRDL N L+ IK+SDFG++ R D ++ G+ P +
Sbjct: 118 AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT------RFVLDDQYTSSTGTKFPVKW 171
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
+PEV + Y SD+WS GV+++ + + G +P+++R+ + + + I G F+L K
Sbjct: 172 ASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYK 226
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-31
Identities = 58/237 (24%), Positives = 110/237 (46%), Gaps = 29/237 (12%)
Query: 17 ELGRTLGEGNFGKVK----FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ + LG G FG V + +P A+K L + +I E + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVD 75
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------- 125
+P+V RL + S + ++ + + G L D ++E + Q L++
Sbjct: 76 NPHVCRLLGIC-LTSTVQLITQLMPFGCLLD------YVREHKDNIGSQYLLNWCVQIAK 128
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGS-P-NY 182
G++Y ++ + HRDL N+L+ + ++KI+DFGL+ L ++ H G P +
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA---EEKEYHAEGGKVPIKW 185
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
+A E + +R Y SD+WS GV ++ ++T G P+D + + + +G +LP+
Sbjct: 186 MALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLPQ 240
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 76/348 (21%), Positives = 135/348 (38%), Gaps = 90/348 (25%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILE----KNRIIHLKITDQIKREIATLK 69
R+++ R G+G FG V+ ++ +G+ A+K +++ +NR + + + L
Sbjct: 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL---------QIMQDLA 74
Query: 70 LLKHPNVVRLHEVLASKSK-------IYMVLEYV--TGGELFDKIASKGRLQEAEGRKLF 120
+L HPN+V+L + + + +V+EYV T + K+F
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVF 134
Query: 121 Q-QLIDGVSYCHNK--GVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTT 176
QLI + H V HRD+K N+L++ + G +K+ DFG + + + +
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK--KLSPSEPNVAYI 192
Query: 177 CGSPNYVAPEVLAN-RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-- 233
C S Y APE++ + Y A DIWS G I ++ G + IFRGD
Sbjct: 193 C-SRYYRAPELIFGNQHYTTAV-DIWSVGCIFAEMMLG-------------EPIFRGDNS 237
Query: 234 ----------------------------FKLPKW---------------LSPGAQNLLRK 250
L + A +LL
Sbjct: 238 AGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSA 297
Query: 251 ILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHE 298
+L+ P +R+ +F++ + PA + +D+ D F +E
Sbjct: 298 LLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNE 345
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 64/240 (26%), Positives = 111/240 (46%), Gaps = 36/240 (15%)
Query: 18 LGRTLGEGNFGKV---KFAQDLDSGLPFAVKIL-----EKNRIIHLKITDQIKREIATLK 69
+ + +G G FG+V + + A+K L EK R L E + +
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-------GEASIMG 101
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---- 125
HPN++RL V+ + +V EY+ G L L++ + + QL+
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF------LRKHDAQFTVIQLVGMLRG 155
Query: 126 ---GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
G+ Y + G HRDL NIL++S K+SDFGL + + D +TT G
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE--DDPEAAYTTRGGKIP 213
Query: 183 V---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
+ +PE +A R + A SD+WS G++L+ +++ G P+ + + + + + G ++LP
Sbjct: 214 IRWTSPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLPP 271
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 80/332 (24%), Positives = 140/332 (42%), Gaps = 59/332 (17%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKH 73
RY +GEG +G V A D + + A+K I + + + REI L +H
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ---RTLREIKILLRFRH 84
Query: 74 PNVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
N++ +++++ + + +Y+V + + +L+ + ++ L Q++ G+
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQ-HLSNDHICYFLYQILRGLK 142
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV----- 183
Y H+ V HRDLK N+LL++ ++KI DFGL+ + D T YV
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-----EYVATRWY 197
Query: 184 -APEV-LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--------LAVL-------Y 226
APE+ L ++GY + DIWS G IL +L+ F ++ L +L
Sbjct: 198 RAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256
Query: 227 QKIF---------------RGDFK--LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE 269
I + + P A +LL K+L NP KRI + A
Sbjct: 257 NCIINLKARNYLLSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHP 315
Query: 270 WFEQDYTPANPDDDEE--DIFVDNEAFSMHEV 299
+ EQ Y P++ E ++ + ++
Sbjct: 316 YLEQYYDPSDEPIAEAPFKFDMELDDLPKEKL 347
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 63/237 (26%), Positives = 110/237 (46%), Gaps = 36/237 (15%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKHP 74
+ LG G FG VK+ + A+K++++ + + E + L H
Sbjct: 27 TFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEG------SMSEDEFIEEAKVMMNLSHE 79
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GV 127
+V+L+ V + I+++ EY+ G L + L+E R QQL++ +
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLN------YLREMRHRFQTQQLLEMCKDVCEAM 133
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGS--P-NY 182
Y +K HRDL N L++ +G +K+SDFGLS R D ++ GS P +
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS------RYVLDDEYTSSVGSKFPVRW 187
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
PEVL + SDIW+ GV+++ I + G +P++ + + I +G +L +
Sbjct: 188 SPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-LRLYR 242
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 90/334 (26%), Positives = 139/334 (41%), Gaps = 68/334 (20%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
Y +G G +G V A D SG A+K L + I K + RE+ LK ++
Sbjct: 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK---RAYRELLLLKHMQ 81
Query: 73 HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H NV+ L +V S Y+V+ ++ +L + + E + + L Q++ G
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYLVYQMLKG 138
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 183
+ Y H+ GV HRDLK N+ ++ +KI DFGL+ R T YV
Sbjct: 139 LKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA------RHADAEMT-----GYVVTR 187
Query: 184 ---APEV-LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--------- 230
APEV L+ Y+ DIWS G I+ +LTG F ++ +I
Sbjct: 188 WYRAPEVILSWMHYNQTV-DIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 246
Query: 231 ---------------------RGDFK--LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267
R DF P+ SP A +LL K+LE + KR+T A
Sbjct: 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPR-ASPQAADLLEKMLELDVDKRLTAAQALT 305
Query: 268 DEWFEQDYTPANPDDDEE--DIFVDNEAFSMHEV 299
+FE P + ++ D +++E ++ E
Sbjct: 306 HPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEW 339
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-30
Identities = 69/293 (23%), Positives = 118/293 (40%), Gaps = 52/293 (17%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
L ++G+G FG+V + G AVKI + + + EI +L+H N+
Sbjct: 45 VLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENI 98
Query: 77 VRL----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH- 131
+ ++ + +++++V +Y G LFD + + KL G+++ H
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHM 157
Query: 132 -------NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGSPNY 182
+ HRDLK +NIL+ G I+D GL+ D D + G+ Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 183 VAPEVLANRGYDGAT-----SDIWSCGVILYVILTGY----------LPFDDRN------ 221
+APEVL + +DI++ G++ + I LP+ D
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277
Query: 222 ----LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE----PNPVKRITIAGIK 266
V QK+ R + +W S A ++ KI+ N R+T IK
Sbjct: 278 EEMRKVVCEQKL-RPNIP-NRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 64/248 (25%), Positives = 101/248 (40%), Gaps = 32/248 (12%)
Query: 5 EKKQEGMRLGRYELGRTLGEGNFGKVKFAQ--DLDSGLPFAVKILEKNRIIHLKITDQIK 62
K++ + + ELG GNFG V+ + A+K+L++ +++
Sbjct: 5 FLKRDNLLIADIELG----CGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMM 58
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
RE + L +P +VRL V + +V+E GG L L
Sbjct: 59 REAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHK------FLVGKREEIPVSN 111
Query: 123 LID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLH 174
+ + G+ Y K HRDL N+LL ++ KISDFGLS AL DD
Sbjct: 112 VAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA---DDSYYT 168
Query: 175 TTCGS--P-NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIF 230
P + APE + R + SD+WS GV ++ L+ G P+ + I
Sbjct: 169 ARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227
Query: 231 RGDFKLPK 238
+G ++
Sbjct: 228 QG-KRMEC 234
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 65/243 (26%), Positives = 108/243 (44%), Gaps = 48/243 (19%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+L LG G FG+V + AVK L++ + D E +K L+H +
Sbjct: 16 KLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRL 70
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
VRL+ V ++ IY++ EY+ G L D L+ G KL +L+D G++
Sbjct: 71 VRLYAV-VTQEPIYIITEYMENGSLVD------FLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV----- 183
+ + HRDL+ NIL+ + KI+DFGL+ + D+ Y
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLA---RLIEDN----------EYTAREGA 170
Query: 184 -------APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFK 235
APE + + SD+WS G++L I+T G +P+ + Q + RG ++
Sbjct: 171 KFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YR 228
Query: 236 LPK 238
+ +
Sbjct: 229 MVR 231
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 61/240 (25%), Positives = 105/240 (43%), Gaps = 37/240 (15%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
L R LGEG FG+V + + AVK +K+ + K ++ E +K L H
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNLDH 72
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G 126
P++V+L ++ + ++++E GEL L+ + L+
Sbjct: 73 PHIVKLIGII-EEEPTWIIMELYPYGELGH------YLERNKNSLKVLTLVLYSLQICKA 125
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGS--PNY 182
++Y + HRD+ + NIL+ S +K+ DFGLS R D + + P
Sbjct: 126 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLS------RYIEDEDYYKASVTRLP-- 177
Query: 183 V---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
+ +PE + R + A SD+W V ++ IL+ G PF + + +G +LPK
Sbjct: 178 IKWMSPESINFRRFTTA-SDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG-DRLPK 235
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-30
Identities = 57/299 (19%), Positives = 110/299 (36%), Gaps = 54/299 (18%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
+ +L G FG V AQ AVKI K + Q + E+ +L +
Sbjct: 22 QSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQD----KQSWQNEYEVYSLPGM 75
Query: 72 KHPNVVRL----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
KH N+++ + ++++ + G L D + + E + + + G+
Sbjct: 76 KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIAETMARGL 134
Query: 128 SYCHNK----------GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 177
+Y H + HRD+K +N+LL + I+DFGL+ + + G H
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV 194
Query: 178 GSPNYVAPEVLANRGYDGAT----SDIWSCGVILYVILTGYLP----------------- 216
G+ Y+APEVL D+++ G++L+ + +
Sbjct: 195 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254
Query: 217 ----FDDRNLAVLYQKIFRGDFKLPK-WLSPGAQNLLRKILE----PNPVKRITIAGIK 266
+D V+++K L W +L + +E + R++ +
Sbjct: 255 QHPSLEDMQEVVVHKKK---RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-30
Identities = 68/279 (24%), Positives = 127/279 (45%), Gaps = 44/279 (15%)
Query: 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKHPN 75
L + LG G FG VK + AVK++++ + + +E T+ L HP
Sbjct: 12 LLKELGSGQFGVVKLGK-WKGQYDVAVKMIKEG------SMSEDEFFQEAQTMMKLSHPK 64
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GVS 128
+V+ + V + + IY+V EY++ G L + L+ QL++ G++
Sbjct: 65 LVKFYGVCSKEYPIYIVTEYISNGCLLN------YLRSHGKGLEPSQLLEMCYDVCEGMA 118
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGS--P-NYV 183
+ + HRDL N L+D +K+SDFG++ R D ++ G+ P +
Sbjct: 119 FLESHQFIHRDLAARNCLVDRDLCVKVSDFGMT------RYVLDDQYVSSVGTKFPVKWS 172
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 242
APEV Y SD+W+ G++++ + + G +P+D + + K+ +G +L +
Sbjct: 173 APEVFHYFKYSSK-SDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG-HRLYR--PH 228
Query: 243 GAQNLLRKIL----EPNPVKRITIAGIKA--DEWFEQDY 275
A + + +I+ P KR T + + + E+D
Sbjct: 229 LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKDK 267
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-30
Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 17 ELGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ + LG+GNFG V+ ++G AVK L+ + + +REI LK L+
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ 69
Query: 73 HPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID----- 125
H N+V+ V S + + +++EY+ G L D LQ+ + R +L+
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD------YLQKHKERIDHIKLLQYTSQI 123
Query: 126 --GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NY 182
G+ Y K HRDL NIL++++ +KI DFGL+ + ++ + SP +
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFW 183
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILT 212
APE L + A SD+WS GV+LY + T
Sbjct: 184 YAPESLTESKFSVA-SDVWSFGVVLYELFT 212
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 66/233 (28%), Positives = 98/233 (42%), Gaps = 52/233 (22%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD---------QIKREI 65
RYE+ +G G++G V A D A+K KI +I REI
Sbjct: 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK----------KILRVFEDLIDCKRILREI 103
Query: 66 ATLKLLKHPNVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
A L L H +VV++ +++ K ++Y+VLE + + L E + L
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLL 162
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-----------ALPQHFRD 169
L+ GV Y H+ G+ HRDLK N L++ ++K+ DFGL+ LP R+
Sbjct: 163 YNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222
Query: 170 DGLLHTTCGSPN--------YV------APEV-LANRGYDGATSDIWSCGVIL 207
D + T +V APE+ L Y A D+WS G I
Sbjct: 223 DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI-DVWSIGCIF 274
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-30
Identities = 67/221 (30%), Positives = 102/221 (46%), Gaps = 35/221 (15%)
Query: 17 ELGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIK---REIATLK 69
+ LG+GNFG V+ ++G AVK L+ + DQ + REI LK
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG------PDQQRDFQREIQILK 79
Query: 70 LLKHPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-- 125
L +V+ V + + +V+EY+ G L D LQ R +L+
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD------FLQRHRARLDASRLLLYS 133
Query: 126 -----GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCG- 178
G+ Y ++ HRDL NIL++S+ ++KI+DFGL+ LP D + G
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD--KDYYVVREPGQ 191
Query: 179 SP-NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 217
SP + APE L++ + SD+WS GV+LY + T
Sbjct: 192 SPIFWYAPESLSDNIFSRQ-SDVWSFGVVLYELFTYCDKSC 231
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-30
Identities = 59/236 (25%), Positives = 101/236 (42%), Gaps = 38/236 (16%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+L +T+G+G FG V G AVK ++ + E + + L+H N+
Sbjct: 24 KLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNL 76
Query: 77 VRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GV 127
V+L V + K +Y+V EY+ G L D L+ L L+ +
Sbjct: 77 VQLLGVIVEEKGGLYIVTEYMAKGSLVD------YLRSRGRSVLGGDCLLKFSLDVCEAM 130
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY----V 183
Y HRDL N+L+ K+SDFGL+ ++ +T +
Sbjct: 131 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT------KEA---SSTQDTGKLPVKWT 181
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
APE L + + SD+WS G++L+ I + G +P+ L + ++ +G +K+
Sbjct: 182 APEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDA 235
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 70/339 (20%), Positives = 123/339 (36%), Gaps = 66/339 (19%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL------KITD--QIKREIA 66
Y + R + G++G V D G+P A+K + ++ REI
Sbjct: 23 PYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 67 TLKLLKHPNVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLF 120
L HPN++ L ++ + +Y+V E + +L I + + +
Sbjct: 82 LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFM 140
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
++ G+ H GV HRDL NILL +I I DF L+ + D
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA---REDTADANK------T 191
Query: 181 NYV------APEV-LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--------LAVL 225
+YV APE+ + +G+ D+WS G ++ + F + V+
Sbjct: 192 HYVTHRWYRAPELVMQFKGFTKLV-DMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV 250
Query: 226 ------------------YQKIFRGDFKLPKW------LSPGAQNLLRKILEPNPVKRIT 261
Y + + W P A +L+ K+LE NP +RI+
Sbjct: 251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIS 310
Query: 262 IAGIKADEWFEQDYTPAN-PDDDEEDIFVDNEAFSMHEV 299
+FE + P + + E D ++++
Sbjct: 311 TEQALRHPYFESLFDPLDLTEGLSERFHFDESVTDVYDM 349
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-29
Identities = 65/233 (27%), Positives = 111/233 (47%), Gaps = 28/233 (12%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+L + LG G FG+V A AVK ++ + + E +K L+H +
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSV----EAFLAEANVMKTLQHDKL 245
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
V+LH V +K IY++ E++ G L D L+ EG K +LID G++
Sbjct: 246 VKLHAV-VTKEPIYIITEFMAKGSLLD------FLKSDEGSKQPLPKLIDFSAQIAEGMA 298
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVAPE 186
+ + HRDL+ NIL+ + KI+DFGL+ + D+ P + APE
Sbjct: 299 FIEQRNYIHRDLRAANILVSASLVCKIADFGLA---RVIEDNEYTAREGAKFPIKWTAPE 355
Query: 187 VLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
+ + SD+WS G++L I+T G +P+ + + + + RG +++P+
Sbjct: 356 AINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMPR 406
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 17 ELGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ + LG+GNFG V+ ++G AVK L+ + + +REI LK L+
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ 100
Query: 73 HPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID----- 125
H N+V+ V S + + +++EY+ G L D LQ+ + R +L+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD------YLQKHKERIDHIKLLQYTSQI 154
Query: 126 --GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NY 182
G+ Y K HRDL NIL++++ +KI DFGL+ + ++ + SP +
Sbjct: 155 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFW 214
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILT 212
APE L + A SD+WS GV+LY + T
Sbjct: 215 YAPESLTESKFSVA-SDVWSFGVVLYELFT 243
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 64/293 (21%), Positives = 118/293 (40%), Gaps = 52/293 (17%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
++ + +G+G +G+V + G AVK+ + + + EI L++H N+
Sbjct: 40 QMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFT----TEEASWFRETEIYQTVLMRHENI 93
Query: 77 VRL----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
+ + S +++Y++ +Y G L+D + S L KL + G+ + H
Sbjct: 94 LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHT 152
Query: 133 K--------GVFHRDLKLENILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPNY 182
+ + HRDLK +NIL+ G I+D GL+ D +T G+ Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 183 VAPEVLANRGYDGAT-----SDIWSCGVILYVILTGYLP--------------------F 217
+ PEVL +D++S G+IL+ + + +
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272
Query: 218 DDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE----PNPVKRITIAGIK 266
+D V +K+ R F +W S + K++ NP R+T +K
Sbjct: 273 EDMREIVCIKKL-RPSFP-NRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 63/275 (22%), Positives = 107/275 (38%), Gaps = 43/275 (15%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
Y + +G G++G V A D ++ A+K + + +I K +I REI L LK
Sbjct: 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK---RILREITILNRLK 83
Query: 73 HPNVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
++RL++++ +Y+VLE +L + L E + + L+ G
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGE 142
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-----------ALPQHFRDDGLLHTT 176
++ H G+ HRDLK N LL+ ++K+ DFGL+ ++ H
Sbjct: 143 NFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 177 CGSP---NYV------APEV-LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY 226
++V APE+ L Y + DIWS G I +L +
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSI-DIWSTGCIFAELLNMLQSHINDPTN--R 259
Query: 227 QKIFRGDFKLPKWLSPGAQNL--------LRKILE 253
+F G P ++ + L I
Sbjct: 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFN 294
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-29
Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 23/210 (10%)
Query: 17 ELGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ R LGEG+FGKV+ + ++G AVK L K I D +K+EI L+ L
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIAD-LKKEIEILRNLY 81
Query: 73 HPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID----- 125
H N+V+ + I +++E++ G L + L + + + +Q +
Sbjct: 82 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE------YLPKNKNKINLKQQLKYAVQI 135
Query: 126 --GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NY 182
G+ Y ++ HRDL N+L++S+ +KI DFGL+ + ++ + SP +
Sbjct: 136 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFW 195
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILT 212
APE L + A SD+WS GV L+ +LT
Sbjct: 196 YAPECLMQSKFYIA-SDVWSFGVTLHELLT 224
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-29
Identities = 64/235 (27%), Positives = 109/235 (46%), Gaps = 27/235 (11%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
ELGR +GEG FG V + + + A+K + ++ ++ +E T++ H
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDH 450
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G 126
P++V+L V+ +++ +++++E T GEL LQ + LI
Sbjct: 451 PHIVKLIGVI-TENPVWIIMELCTLGELRS------FLQVRKFSLDLASLILYAYQLSTA 503
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG-SP-NYVA 184
++Y +K HRD+ N+L+ S +K+ DFGLS D + G P ++A
Sbjct: 504 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLPIKWMA 560
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
PE + R + A SD+W GV ++ IL G PF + +I G +LP
Sbjct: 561 PESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ERLPM 613
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 62/234 (26%), Positives = 103/234 (44%), Gaps = 34/234 (14%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-IKREIATLKLLKHPN 75
+L +T+G+G FG V G AVK ++ + T Q E + + L+H N
Sbjct: 196 KLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSN 247
Query: 76 VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------G 126
+V+L V + K +Y+V EY+ G L D L+ L L+
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVD------YLRSRGRSVLGGDCLLKFSLDVCEA 301
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAP 185
+ Y HRDL N+L+ K+SDFGL+ ++ T P + AP
Sbjct: 302 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT------KEASSTQDTGKLPVKWTAP 355
Query: 186 EVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
E L + + SD+WS G++L+ I + G +P+ L + ++ +G +K+
Sbjct: 356 EALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDA 407
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-29
Identities = 53/293 (18%), Positives = 97/293 (33%), Gaps = 55/293 (18%)
Query: 17 ELGRTLGEGNFGKV-------KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
+LG+G F K+ +K+L+K H ++ + +
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMS 67
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---- 125
L H ++V + V + +V E+V G L L++ + ++
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTY------LKKNKNCINILWKLEVAKQ 121
Query: 126 ---GVSYCHNKGVFHRDLKLENILLDSKGN--------IKISDFGLSALPQHFRDDGLLH 174
+ + + H ++ +NILL + + IK+SD G+S
Sbjct: 122 LAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS------IT----- 170
Query: 175 TTCGSPNY-------VAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLY 226
+ V PE + N +D WS G L+ I + G P +
Sbjct: 171 --VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL 228
Query: 227 QKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA--DEWFEQDYTP 277
Q +LP + NL+ ++ P R + I + F D P
Sbjct: 229 QFYEDR-HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 69/211 (32%), Positives = 104/211 (49%), Gaps = 27/211 (12%)
Query: 17 ELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ R LGEG+FGKV + +G AVK L+ + + K+EI L+ L
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLY 91
Query: 73 HPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
H ++++ + +V+EYV G L D + + + A+ QQ+ +G++Y
Sbjct: 92 HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYL 150
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQ-----HFRDDGLLHTTCGSPNYV- 183
H + HRDL N+LLD+ +KI DFGL+ A+P+ R+DG P V
Sbjct: 151 HAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS------P--VF 202
Query: 184 --APEVLANRGYDGATSDIWSCGVILYVILT 212
APE L + A SD+WS GV LY +LT
Sbjct: 203 WYAPECLKEYKFYYA-SDVWSFGVTLYELLT 232
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 65/251 (25%), Positives = 101/251 (40%), Gaps = 31/251 (12%)
Query: 5 EKKQEGMRLGRYEL---GRTLGEGNFGKVKFAQ--DLDSGLPFAVKILEKNRIIHLKITD 59
E K + + L R L LG GNFG V+ + A+K+L++ +
Sbjct: 324 ELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--E 381
Query: 60 QIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL 119
++ RE + L +P +VRL V + +V+E GG L L
Sbjct: 382 EMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHK------FLVGKREEIP 434
Query: 120 FQQLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDG 171
+ + G+ Y K HR+L N+LL ++ KISDFGLS AL DD
Sbjct: 435 VSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA---DDS 491
Query: 172 LLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQ 227
+ APE + R + SD+WS GV ++ L+ G P+ +
Sbjct: 492 YYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMA 550
Query: 228 KIFRGDFKLPK 238
I +G ++
Sbjct: 551 FIEQG-KRMEC 560
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 83/360 (23%), Positives = 135/360 (37%), Gaps = 81/360 (22%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
+YEL + LG+G +G V + D +G AVK + + + REI L L
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ---RTFREIMILTELS 66
Query: 73 -HPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
H N+V L VL + + +Y+V +Y+ +L I + L+ + + QLI + Y
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRAN-ILEPVHKQYVVYQLIKVIKY 124
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPN------- 181
H+ G+ HRD+K NILL+++ ++K++DFGLS + R + +
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 182 -----YV------APEV-LANRGYDGATSDIWSCGVILYVILTG---------------- 213
YV APE+ L + Y D+WS G IL IL G
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGI-DMWSLGCILGEILCGKPIFPGSSTMNQLERI 243
Query: 214 ----------------------YL---------PFDDRNLAVLYQKIFRGDFKLPKWLSP 242
+ ++ K +
Sbjct: 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNE 303
Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI---FVDNEAFSMHEV 299
A +LL K+L+ NP KRI+ + + P + + I DN S+ +
Sbjct: 304 EALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDY 363
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-28
Identities = 73/314 (23%), Positives = 130/314 (41%), Gaps = 50/314 (15%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
LGR LG+G FG V + Q+ S + AVK+L+ + I I + RE A +K H
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEE-FLREAACMKEFDH 84
Query: 74 PNVVRL------HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI--- 124
P+V +L ++L ++ G+L + + R+ E Q L+
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS-RIGENPFNLPLQTLVRFM 143
Query: 125 ----DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
G+ Y ++ HRDL N +L + ++DFGLS R +++
Sbjct: 144 VDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS------RK---IYSG---- 190
Query: 181 NY-------------VAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLY 226
+Y +A E LA+ Y SD+W+ GV ++ I+T G P+ A +Y
Sbjct: 191 DYYRQGCASKLPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPYAGIENAEIY 249
Query: 227 QKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
+ G+ K P +L+ + +P +R + ++ + E + +
Sbjct: 250 NYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRME--LENILGHLSVLSTSQ 307
Query: 286 D-IFVDNEAFSMHE 298
D ++++ E H
Sbjct: 308 DPLYINIERAHHHH 321
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-28
Identities = 54/225 (24%), Positives = 86/225 (38%), Gaps = 37/225 (16%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE--IATLKLLKHP 74
+L +G G +G V LD P AVK+ E I + L++H
Sbjct: 16 KLLELIGRGRYGAVYKGS-LD-ERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHD 67
Query: 75 NVVRL-----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
N+ R + + +V+EY G L + S +L + G++Y
Sbjct: 68 NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVTRGLAY 126
Query: 130 CH---------NKGVFHRDLKLENILLDSKGNIKISDFGLS------ALPQHFRDDGLLH 174
H + HRDL N+L+ + G ISDFGLS L + +D
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186
Query: 175 TTCGSPNYVAPEVL------ANRGYDGATSDIWSCGVILYVILTG 213
+ G+ Y+APEVL + D+++ G+I + I
Sbjct: 187 SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 70/343 (20%), Positives = 120/343 (34%), Gaps = 107/343 (31%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK---REIATLKLL 71
+Y LG+TLG G+FG V D++SG FA+K K+ + RE+ +K+L
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALK----------KVLQDPRYKNRELDIMKVL 57
Query: 72 KHPNVVRLHEVLASKSK--------------------------------------IYMVL 93
H N+++L + + + +++
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 94 EYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 149
EYV L + S + QL V + H+ G+ HRD+K +N+L++S
Sbjct: 118 EYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176
Query: 150 K-GNIKISDFGLSALPQHFRDDGLLHTTCGSPN--YV------APEVLAN-RGYDGATSD 199
K +K+ DFG + + P+ Y+ APE++ Y + D
Sbjct: 177 KDNTLKLCDFGSA------K-----KLIPSEPSVAYICSRFYRAPELMLGATEYTPSI-D 224
Query: 200 IWSCGVILYVILTGYLPFDDRNLAVLYQKIF-----------------RGDFKLPKW--- 239
+WS G + ++ G F +I + + P
Sbjct: 225 LWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAK 284
Query: 240 ---------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
A +LL +IL P RI A +F+
Sbjct: 285 DWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 63/246 (25%), Positives = 102/246 (41%), Gaps = 44/246 (17%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLL 71
+G G+FG V + + AVK L + I + + E +K
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDF 83
Query: 72 KHPNVVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI------ 124
HPNV+ L + L S+ +VL Y+ G+L + ++ + LI
Sbjct: 84 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTVKDLIGFGLQV 137
Query: 125 -DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL-------PQHFRDDGLLHTT 176
G+ Y +K HRDL N +LD K +K++DFGL+ H + L
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL--- 194
Query: 177 CGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 232
P V A E L + + SD+WS GV+L+ ++T G P+ D N + + +G
Sbjct: 195 ---P--VKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 248
Query: 233 DFKLPK 238
+L +
Sbjct: 249 -RRLLQ 253
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 63/249 (25%), Positives = 103/249 (41%), Gaps = 50/249 (20%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+G G+FG V + + AVK L NRI + Q E +K H
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSH 149
Query: 74 PNVVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI-------D 125
PNV+ L + L S+ +VL Y+ G+L + ++ + LI
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTVKDLIGFGLQVAK 203
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV-- 183
G+ + +K HRDL N +LD K +K++DFGL+ RD ++ +
Sbjct: 204 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA------RD---MYDK----EFDSV 250
Query: 184 -------------APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKI 229
A E L + + SD+WS GV+L+ ++T G P+ D N + +
Sbjct: 251 HNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309
Query: 230 FRGDFKLPK 238
+G +L +
Sbjct: 310 LQG-RRLLQ 317
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 71/312 (22%), Positives = 123/312 (39%), Gaps = 52/312 (16%)
Query: 17 ELGRTLGEGNFGKV--KFAQDLDSGLPF---AVKILEKNRIIHLKITDQIKREIATLKLL 71
+ R LG+G+FG V A+ + P A+K + + + +I + E + +K
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMKEF 85
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGEL--FDKIASKGRLQEAEGRKL-FQQLI---- 124
+VVRL V++ +++E +T G+L + + ++I
Sbjct: 86 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 125 ---DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-----------D 170
DG++Y + HRDL N ++ +KI DFG++ RD
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT------RDIYETDYYRKGGK 199
Query: 171 GLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLY 226
GLL P V +PE L + + SD+WS GV+L+ I T P+ + +
Sbjct: 200 GLL------P--VRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVL 250
Query: 227 QKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGIKA--DEWFEQDYTPANPDD 282
+ + G L P L+R + NP R + I + E E + +
Sbjct: 251 RFVMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYY 309
Query: 283 DEEDIFVDNEAF 294
EE+ + E
Sbjct: 310 SEENKLPEPEEL 321
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-26
Identities = 61/244 (25%), Positives = 105/244 (43%), Gaps = 40/244 (16%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
R +G+G+FG V ++ + + A+K L +RI ++ + RE ++ L H
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL--SRITEMQQVEAFLREGLLMRGLNH 81
Query: 74 PNVVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------- 125
PNV+ L + L + +++L Y+ G+L ++ + + LI
Sbjct: 82 PNVLALIGIMLPPEGLPHVLLPYMCHGDL------LQFIRSPQRNPTVKDLISFGLQVAR 135
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL-------PQHFRDDGLLHTTCG 178
G+ Y + HRDL N +LD +K++DFGL+ L
Sbjct: 136 GMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL----- 190
Query: 179 SPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDF 234
P V A E L + SD+WS GV+L+ +LT G P+ + L + +G
Sbjct: 191 -P--VKWTALESLQTYRFTTK-SDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG-R 245
Query: 235 KLPK 238
+LP+
Sbjct: 246 RLPQ 249
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 65/222 (29%), Positives = 99/222 (44%), Gaps = 29/222 (13%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
RYE+ + +G+G+FG+V A D A+K++ +N + Q EI L+ L+
Sbjct: 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV-RN---EKRFHRQAAEEIRILEHLRK 152
Query: 74 ------PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG------RKLFQ 121
NV+ + E ++ I M E + L++ I K + Q G RK
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELI-KKNKFQ---GFSLPLVRKFAH 207
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILL--DSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
++ + H + H DLK ENILL + IK+ DFG S + ++T S
Sbjct: 208 SILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-----CYEHQRVYTYIQS 262
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN 221
Y APEV+ Y D+WS G IL +LTGY +
Sbjct: 263 RFYRAPEVILGARYGMP-IDMWSLGCILAELLTGYPLLPGED 303
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-26
Identities = 68/250 (27%), Positives = 103/250 (41%), Gaps = 45/250 (18%)
Query: 18 LGRTLGEGNFGKVKFAQ--DLDSGLPFAVKILEKNRIIHLKITDQIK----REIATLK-L 70
+GEGNFG+V A+ + A+K +++ + E+ L L
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY------ASKDDHRDFAGELEVLCKL 82
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFD--------KIASKGRLQEAEGRKL-FQ 121
HPN++ L + +Y+ +EY G L D + + + L Q
Sbjct: 83 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 122 QLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH 174
QL+ G+ Y K HRDL NIL+ KI+DFGLS R +
Sbjct: 143 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS------RGQEVYV 196
Query: 175 TTCGS--PNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQK 228
P V A E L Y SD+WS GV+L+ I++ G P+ A LY+K
Sbjct: 197 KKTMGRLP--VRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 253
Query: 229 IFRGDFKLPK 238
+ +G ++L K
Sbjct: 254 LPQG-YRLEK 262
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-26
Identities = 65/246 (26%), Positives = 98/246 (39%), Gaps = 47/246 (19%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
LG+ LGEG FG V Q+ + L AVK + K + ++ E A +K H
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDFSH 95
Query: 74 PNVVRL-----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI---- 124
PNV+RL K ++L ++ G+L + RL+ Q L+
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS-RLETGPKHIPLQTLLKFMV 154
Query: 125 ---DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-----------D 170
G+ Y N+ HRDL N +L + ++DFGLS +
Sbjct: 155 DIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS------KKIYSGDYYRQGRI 208
Query: 171 GLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLY 226
+ P V A E LA+R Y SD+W+ GV ++ I T G P+ +Y
Sbjct: 209 AKM------P--VKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGMTPYPGVQNHEMY 259
Query: 227 QKIFRG 232
+ G
Sbjct: 260 DYLLHG 265
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-26
Identities = 67/313 (21%), Positives = 113/313 (36%), Gaps = 64/313 (20%)
Query: 17 ELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
L R LG G FG+V + S L AVK L + ++ E +
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKF 90
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLI------ 124
H N+VR V ++++E + GG+L + R + ++ L L+
Sbjct: 91 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRET-RPRPSQPSSLAMLDLLHVARDI 149
Query: 125 -DGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRD----------- 169
G Y HRD+ N LL G KI DFG++ RD
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------RDIYRASYYRKGG 203
Query: 170 DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVL 225
+L P V PE + +D WS GV+L+ I + GY+P+ ++ +
Sbjct: 204 CAML------P--VKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEV 254
Query: 226 YQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGIKA------------DEWF 271
+ + G ++ PK ++ + + P R A I +
Sbjct: 255 LEFVTSG-GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTAL 313
Query: 272 EQDYTPANPDDDE 284
+Y P ++++
Sbjct: 314 PIEYGPLVEEEEK 326
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 60/262 (22%), Positives = 95/262 (36%), Gaps = 62/262 (23%)
Query: 17 ELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIAT 67
LGE FGKV + A+K L+ ++ E
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK------AEGPLREEFRHEAML 65
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFD---------KIASKGRLQEAEGRK 118
L+HPNVV L V+ + M+ Y + G+L + + S + +
Sbjct: 66 RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 119 LFQQLI-------DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-- 169
+ G+ Y + V H+DL N+L+ K N+KISD GL R+
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF------REVY 179
Query: 170 ---------DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLP 216
+ LL P + APE + + SDIWS GV+L+ + + G P
Sbjct: 180 AADYYKLLGNSLL------P--IRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQP 230
Query: 217 FDDRNLAVLYQKIFRGDFKLPK 238
+ + + + I LP
Sbjct: 231 YCGYSNQDVVEMIRNR-QVLPC 251
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 69/317 (21%), Positives = 115/317 (36%), Gaps = 72/317 (22%)
Query: 17 ELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIAT 67
L R LG G FG+V + S L AVK L + ++Q + E
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV------CSEQDELDFLMEALI 127
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLI-- 124
+ H N+VR V +++LE + GG+L + R + ++ L L+
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRET-RPRPSQPSSLAMLDLLHV 186
Query: 125 -----DGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRD------- 169
G Y HRD+ N LL G KI DFG++ RD
Sbjct: 187 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------RDIYRAGYY 240
Query: 170 ----DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRN 221
+L P V PE + +D WS GV+L+ I + GY+P+ ++
Sbjct: 241 RKGGCAML------P--VKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKS 291
Query: 222 LAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGIKA------------ 267
+ + + G ++ PK ++ + + P R A I
Sbjct: 292 NQEVLEFVTSG-GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 350
Query: 268 DEWFEQDYTPANPDDDE 284
+ +Y P ++++
Sbjct: 351 NTALPIEYGPLVEEEEK 367
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 23/216 (10%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
RYE+ +G+G+FG+V A D A+KI+ KN +Q + E+ L+L+
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KN---KKAFLNQAQIEVRLLELMNK 109
Query: 74 P------NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLID 125
+V L ++ + +V E + L+D + + + RK QQ+
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 126 GVSYCHNK--GVFHRDLKLENILL--DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
+ + + H DLK ENILL + IKI DFG S+ R ++ S
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQLGQR----IYQYIQSRF 223
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217
Y +PEVL YD A D+WS G IL + TG F
Sbjct: 224 YRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLF 258
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 7e-25
Identities = 73/368 (19%), Positives = 131/368 (35%), Gaps = 95/368 (25%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK- 72
RY L R LG G+F V A+D+ + A+KI+ ++ T+ + EI L+ +
Sbjct: 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVND 74
Query: 73 ----------HPNVVRLHEVLASKSKIY----MVLEYVTGGELFD--KIASKGRLQEAEG 116
++++L + K MV E V G L K +
Sbjct: 75 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYV 133
Query: 117 RKLFQQLIDGVSYCHNK-GVFHRDLKLENILLD------SKGNIKISDFGLSALPQHFRD 169
+++ +QL+ G+ Y H + G+ H D+K EN+L++ + IKI+D G +
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW-----Y 188
Query: 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY--- 226
D + + Y +PEVL + DIWS +++ ++TG F+
Sbjct: 189 DEHYTNSIQTREYRSPEVLLGAPWGCGA-DIWSTACLIFELITGDFLFEPDEGHSYTKDD 247
Query: 227 ------------------------QKIF--RGDFK---------LPKWLSPGAQ------ 245
+ F RG + L L+ +
Sbjct: 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 307
Query: 246 ----NLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPS 301
+ L +L+ +P KR G+ W ++ + ++ E+
Sbjct: 308 KEISDFLSPMLQLDPRKRADAGGLVNHPWL------------KDTLGMEEIRVPDRELYG 355
Query: 302 DGGRTPGS 309
G PG
Sbjct: 356 SGSDIPGW 363
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 76/331 (22%), Positives = 134/331 (40%), Gaps = 72/331 (21%)
Query: 17 ELGRTLGEGNFGKVKFA-------QDLDSGLPFAVKILEKNRIIHLKITDQIK----REI 65
LG+ LGEG FG+V A + AVK+L+ + T++ E+
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD------ATEKDLSDLISEM 125
Query: 66 ATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFD--------KIASKGRLQEAEG 116
+K++ KH N++ L +Y+++EY + G L + +
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185
Query: 117 RKL-FQQLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168
+L + L+ G+ Y +K HRDL N+L+ +KI+DFGL+ R
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA------R 239
Query: 169 D-----------DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-G 213
D +G L P V APE L +R Y SD+WS GV+L+ I T G
Sbjct: 240 DIHHIDYYKKTTNGRL------P--VKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLG 290
Query: 214 YLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271
P+ + L++ + G ++ P + ++R P +R T + E
Sbjct: 291 GSPYPGVPVEELFKLLKEG-HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV--EDL 347
Query: 272 EQDYTPANPDDDEEDIFVDNEAFSMHEVPSD 302
++ ++E + + +++P+
Sbjct: 348 DRIVALT---SNQEMGYYHHHHHHDYDIPTT 375
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 72/262 (27%), Positives = 105/262 (40%), Gaps = 65/262 (24%)
Query: 17 ELGRTLGEGNFGKVK--FAQDLDSGLPF---AVKILEKNRIIHLKITDQIK----REIAT 67
LG+TLGEG FGKV A L + AVK+L++N + E
Sbjct: 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN------ASPSELRDLLSEFNV 79
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL----------------FDKIASKGRL 111
LK + HP+V++L+ + + +++EY G L + L
Sbjct: 80 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 112 QEAEGRKL-FQQLI-------DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163
+ R L LI G+ Y + HRDL NIL+ +KISDFGLS
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS-- 197
Query: 164 PQHFRDDGLLHTTCGSPNYV------------APEVLANRGYDGATSDIWSCGVILYVIL 211
RD ++ +YV A E L + Y SD+WS GV+L+ I+
Sbjct: 198 ----RD---VYEE---DSYVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIV 246
Query: 212 T-GYLPFDDRNLAVLYQKIFRG 232
T G P+ L+ + G
Sbjct: 247 TLGGNPYPGIPPERLFNLLKTG 268
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 67/265 (25%), Positives = 114/265 (43%), Gaps = 65/265 (24%)
Query: 17 ELGRTLGEGNFGKVKFA-------QDLDSGLPFAVKILEKNRIIHLKITDQIK----REI 65
LG+ LGEG FG+V A + AVK+L+ + T++ E+
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD------ATEKDLSDLVSEM 91
Query: 66 ATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFD--------KIASKGRLQEAEG 116
+K++ KH N++ L +Y+++EY + G L + + +
Sbjct: 92 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 117 RKL-FQQLI-------DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168
++ F+ L+ G+ Y ++ HRDL N+L+ +KI+DFGL+ R
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------R 205
Query: 169 D-----------DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-G 213
D +G L P V APE L +R Y SD+WS GV+++ I T G
Sbjct: 206 DINNIDYYKKTTNGRL------P--VKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLG 256
Query: 214 YLPFDDRNLAVLYQKIFRGDFKLPK 238
P+ + L++ + G ++ K
Sbjct: 257 GSPYPGIPVEELFKLLKEG-HRMDK 280
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 59/233 (25%), Positives = 96/233 (41%), Gaps = 48/233 (20%)
Query: 17 ELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
+ G+TLG G FGKV A D+ L AVK+L+ H + + E+ + L
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIMSHL 106
Query: 72 -KHPNVVRLHEVLASKSKIYMVLEYVTGGELFD------KIASKGRLQEAEGRKL-FQQL 123
+H N+V L + ++ EY G+L + ++ + L
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 124 ID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 176
+ G+++ +K HRD+ N+LL + KI DFGL+ RD +
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA------RD---IMND 217
Query: 177 CGSPNYV------------APEVLANRGYDGATSDIWSCGVILYVILT-GYLP 216
NY+ APE + + Y SD+WS G++L+ I + G P
Sbjct: 218 ---SNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNP 266
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 69/262 (26%), Positives = 105/262 (40%), Gaps = 63/262 (24%)
Query: 17 ELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIAT 67
L R LGEG FGKV + AVK L+ T + RE
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-------TLAARKDFQREAEL 70
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFD---------KIASKGRLQEAEGRK 118
L L+H ++V+ + V + MV EY+ G+L I G+ ++A+G
Sbjct: 71 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130
Query: 119 LFQQLI-------DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-- 169
Q++ G+ Y ++ HRDL N L+ + +KI DFG+S RD
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS------RDVY 184
Query: 170 ---------DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLP 216
+L P + PE + R + SD+WS GVIL+ I T G P
Sbjct: 185 STDYYRVGGHTML------P--IRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQP 235
Query: 217 FDDRNLAVLYQKIFRGDFKLPK 238
+ + + + I +G L +
Sbjct: 236 WFQLSNTEVIECITQG-RVLER 256
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 67/265 (25%), Positives = 114/265 (43%), Gaps = 65/265 (24%)
Query: 17 ELGRTLGEGNFGKVKFA-------QDLDSGLPFAVKILEKNRIIHLKITDQIK----REI 65
LG+ LGEG FG+V A + AVK+L+ + T++ E+
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD------ATEKDLSDLVSEM 137
Query: 66 ATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFD--------KIASKGRLQEAEG 116
+K++ KH N++ L +Y+++EY + G L + + +
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 117 RKL-FQQLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168
++ F+ L+ G+ Y ++ HRDL N+L+ +KI+DFGL+ R
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------R 251
Query: 169 D-----------DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-G 213
D +G L P V APE L +R Y SD+WS GV+++ I T G
Sbjct: 252 DINNIDYYKKTTNGRL------P--VKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLG 302
Query: 214 YLPFDDRNLAVLYQKIFRGDFKLPK 238
P+ + L++ + G ++ K
Sbjct: 303 GSPYPGIPVEELFKLLKEG-HRMDK 326
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 65/237 (27%), Positives = 95/237 (40%), Gaps = 52/237 (21%)
Query: 17 ELGRTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
G+TLG G FGKV A D+ + AVK+L+ + HL + + E+ L L
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLSYL 83
Query: 72 -KHPNVVRLHEVLASKSKIYMVLEYVTGGEL-----------FDKIASKGRLQEAEGRKL 119
H N+V L ++ EY G+L S +++ E
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 120 FQQLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172
+ L+ G+++ +K HRDL NILL KI DFGL+ RD
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA------RD--- 194
Query: 173 LHTTCGSPNYV------------APEVLANRGYDGATSDIWSCGVILYVILT-GYLP 216
+ NYV APE + N Y SD+WS G+ L+ + + G P
Sbjct: 195 IKND---SNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSP 247
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 61/264 (23%), Positives = 104/264 (39%), Gaps = 69/264 (26%)
Query: 17 ELGRTLGEGNFGKV--KFAQDLDSGLPF---AVKILEKNRIIHLKITDQIK----REIAT 67
E R +GEG FG+V A L PF AVK+L++ + ++ RE A
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE------ASADMQADFQREAAL 103
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL----------------FDKIASKGRL 111
+ +PN+V+L V A + ++ EY+ G+L ++++ R+
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 112 QEAEGRKL-FQQLI-------DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163
L + + G++Y + HRDL N L+ +KI+DFGLS
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS-- 221
Query: 164 PQHFRD-----------DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYV 209
R+ + + P + PE + Y SD+W+ GV+L+
Sbjct: 222 ----RNIYSADYYKADGNDAI------P--IRWMPPESIFYNRYTTE-SDVWAYGVVLWE 268
Query: 210 ILT-GYLPFDDRNLAVLYQKIFRG 232
I + G P+ + + G
Sbjct: 269 IFSYGLQPYYGMAHEEVIYYVRDG 292
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-24
Identities = 68/261 (26%), Positives = 98/261 (37%), Gaps = 62/261 (23%)
Query: 17 ELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIAT 67
L LGEG FGKV + AVK L++ ++ + RE
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-------SESARQDFQREAEL 96
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL--------FDKIASKGRLQEAEGRKL 119
L +L+H ++VR V + MV EY+ G+L D G A G
Sbjct: 97 LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156
Query: 120 FQQLI-------DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--- 169
QL+ G+ Y HRDL N L+ +KI DFG+S RD
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS------RDIYS 210
Query: 170 --------DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 217
+L P + PE + R + SD+WS GV+L+ I T G P+
Sbjct: 211 TDYYRVGGRTML------P--IRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPW 261
Query: 218 DDRNLAVLYQKIFRGDFKLPK 238
+ I +G +L +
Sbjct: 262 YQLSNTEAIDCITQG-RELER 281
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 3e-23
Identities = 64/225 (28%), Positives = 91/225 (40%), Gaps = 52/225 (23%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKHPNVV 77
+GEG FG V + ++ AVK L I + ++K+ EI + +H N+V
Sbjct: 39 MGEGGFGVV-YKGYVN-NTTVAVKKLAAMVDITTE---ELKQQFDQEIKVMAKCQHENLV 93
Query: 78 RL--------HEVLASKSKIYMVLEYVTGG----ELFDKIASKG-----RLQEAEG--RK 118
L L +Y Y+ G L + R + A+G
Sbjct: 94 ELLGFSSDGDDLCL-----VY---VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN- 144
Query: 119 LFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-- 176
G+++ H HRD+K NILLD KISDFGL+ T
Sbjct: 145 -------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARA---SEKFAQTVMTSR 194
Query: 177 -CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR 220
G+ Y+APE L RG SDI+S GV+L I+TG D+
Sbjct: 195 IVGTTAYMAPEAL--RGEITPKSDIYSFGVVLLEIITGLPAVDEH 237
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 4e-23
Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 37/223 (16%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+G G FGKV + L G A+K ++ + + EI TL +HP++V L
Sbjct: 47 IGHGVFGKV-YKGVLRDGAKVALKRRTPESSQGIE---EFETEIETLSFCRHPHLVSLIG 102
Query: 82 VLASKSKIYMVLEYVTGGE----LFDKIASKG------RLQEAEG--RKLFQQLIDGVSY 129
++++ ++ +Y+ G L+ RL+ G R G+ Y
Sbjct: 103 FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR--------GLHY 154
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT---CGSPNYVAPE 186
H + + HRD+K NILLD KI+DFG+S + H + G+ Y+ PE
Sbjct: 155 LHTRAIIHRDVKSINILLDENFVPKITDFGISKK---GTELDQTHLSTVVKGTLGYIDPE 211
Query: 187 VLANRGYDGATSDIWSCGVILYVILTG------YLPFDDRNLA 223
+G SD++S GV+L+ +L LP + NLA
Sbjct: 212 -YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 5e-23
Identities = 60/236 (25%), Positives = 99/236 (41%), Gaps = 43/236 (18%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+ + R +G+G FG+V Q +D+ +AVK++ +N K T K E LK +++
Sbjct: 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV-RN---IKKYTRSAKIEADILKKIQN 90
Query: 74 -----PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDG 126
N+V+ H + ++ E G L++ I + + +++
Sbjct: 91 DDINNNNIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149
Query: 127 VSYCHNKGVFHRDLKLENILLDS-------------------------KGNIKISDFGLS 161
++Y + H DLK ENILLD IK+ DFG
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-C 208
Query: 162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217
A + + + Y APEV+ N G+D + SD+WS G +L + TG L F
Sbjct: 209 ATFKSDY----HGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLF 259
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 5e-23
Identities = 65/241 (26%), Positives = 99/241 (41%), Gaps = 59/241 (24%)
Query: 17 ELGRTLGEGNFGKVK--FAQDLDSGLPF---AVKILEKNRIIHLKITDQIK----REIAT 67
+LG+ LG G FG+V A +D AVK+L++ T E+
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG------ATHSEHRALMSELKI 83
Query: 68 LKLL-KHPNVVRLHEV-LASKSKIYMVLEYVTGGELFD--------KIASKGRLQEAEGR 117
L + H NVV L + +++E+ G L + K ++
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 118 KL-FQQLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169
L + LI G+ + ++ HRDL NILL K +KI DFGL+ RD
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA------RD 197
Query: 170 DGLLHTTCGSPNYV------------APEVLANRGYDGATSDIWSCGVILYVILT-GYLP 216
++ P+YV APE + +R Y SD+WS GV+L+ I + G P
Sbjct: 198 ---IYKD---PDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASP 250
Query: 217 F 217
+
Sbjct: 251 Y 251
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 64/242 (26%), Positives = 95/242 (39%), Gaps = 57/242 (23%)
Query: 17 ELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
E G+ LG G FGKV A + AVK+L++ + + E+ + L
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSEREALMSELKMMTQL 105
Query: 72 -KHPNVVRLHEVLASKSKIYMVLEYVTGGEL---------------FDKIASKGRLQEAE 115
H N+V L IY++ EY G+L + K +E +
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 116 GRKL-FQQLI-------DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167
L F+ L+ G+ + K HRDL N+L+ +KI DFGL+
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA------ 219
Query: 168 RDDGLLHTTCGSPNYV------------APEVLANRGYDGATSDIWSCGVILYVILT-GY 214
RD + + NYV APE L Y SD+WS G++L+ I + G
Sbjct: 220 RD---IMSD---SNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGV 272
Query: 215 LP 216
P
Sbjct: 273 NP 274
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 5e-22
Identities = 69/238 (28%), Positives = 94/238 (39%), Gaps = 51/238 (21%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPF-AVKILEKNRIIHLKITDQIKREIATLKLLK 72
RYE+ TLGEG FGKV D +G AVKI+ KN + + + EI L+ L
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-KN---VDRYCEAARSEIQVLEHLN 69
Query: 73 HP------NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLI 124
V++ E I +V E + G +D I G + RK+ Q+
Sbjct: 70 TTDPNSTFRCVQMLEWFEHHGHICIVFE-LLGLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGN-------------------IKISDFGLSALPQ 165
V++ H+ + H DLK ENIL IK+ DFG SA
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-SATYD 187
Query: 166 HFRDDGLLHTTCGSPNYV------APEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217
H+T V APEV+ G+ D+WS G IL G+ F
Sbjct: 188 DEH-----HST-----LVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVF 234
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 3e-21
Identities = 64/220 (29%), Positives = 100/220 (45%), Gaps = 34/220 (15%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LG G FGKV + L G AVK L++ R Q + E+ + + H N++RL
Sbjct: 38 LGRGGFGKVYKGR-LADGTLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRG 94
Query: 82 VLASKSKIYMVLEYVTGG----ELFDKIASKG------RLQEAEG--RKLFQQLIDGVSY 129
+ ++ +V Y+ G L ++ S+ R + A G R G++Y
Sbjct: 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR--------GLAY 146
Query: 130 CH---NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT---CGSPNYV 183
H + + HRD+K NILLD + + DFGL+ L D H T G+ ++
Sbjct: 147 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL----MDYKDTHVTTAVRGTIGHI 202
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 223
APE + G +D++ GV+L ++TG FD LA
Sbjct: 203 APE-YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 241
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 4e-21
Identities = 63/238 (26%), Positives = 91/238 (38%), Gaps = 51/238 (21%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSG-LPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
RYE+ LGEG FGKV D G A+KI+ +N K + + EI LK +K
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII-RN---VGKYREAARLEINVLKKIK 74
Query: 73 HP------NVVRLHEVLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLI 124
V + + + + E + G F+ K + R + QL
Sbjct: 75 EKDKENKFLCVLMSDWFNFHGHMCIAFE-LLGKNTFEFLKENNFQPYPLPHVRHMAYQLC 133
Query: 125 DGVSYCHNKGVFHRDLKLENILLDS-------------------KGNIKISDFGLSALPQ 165
+ + H + H DLK ENIL + +I+++DFG SA
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-SATFD 192
Query: 166 HFRDDGLLHTTCGSPNYV------APEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217
H HTT V PEV+ G+ D+WS G IL+ G+ F
Sbjct: 193 HEH-----HTT-----IVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLF 239
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} Length = 123 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 5e-20
Identities = 25/82 (30%), Positives = 40/82 (48%), Gaps = 1/82 (1%)
Query: 309 SPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQ 368
+NAF +I S +LSG F +R RF S +A+ ++ER+E+IV+ V
Sbjct: 2 GARRMNAFDIISGSPGFNLSGLFGDARKYDRVERFVSAWTAERVVERLEEIVSAENLTVA 61
Query: 369 KK-NGKVNISSQLTHFNIKTSV 389
KK + I Q +F + +
Sbjct: 62 KKETWGMKIEGQKGNFAMVVEI 83
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 9e-19
Identities = 81/371 (21%), Positives = 117/371 (31%), Gaps = 125/371 (33%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK- 72
GRY + R LG G+F V + D+ A+K+++ T+ EI LK ++
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRN 92
Query: 73 ----HPN---VVRLHEVLASKSK----IYMVLEYVTGGELFDKIAS--KGRLQEAEGRKL 119
PN VV+L + I MV E V G L I L +K+
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKI 151
Query: 120 FQQLIDGVSYCHNK-GVFHRDLKLENILL------------------------------- 147
QQ++ G+ Y H K + H D+K ENILL
Sbjct: 152 IQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 148 ------------------DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN-YVAPEVL 188
K +KI+D G + T Y + EVL
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVL 265
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY---------------------- 226
GY+ +DIWS + + + TG F+ +
Sbjct: 266 IGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV 324
Query: 227 -----QKIF--RGDFKLPKWLSP-------------------GAQNLLRKILEPNPVKRI 260
++ F +GD K L P G + L +LE P KR
Sbjct: 325 AGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRA 384
Query: 261 TIAGIKADEWF 271
T A W
Sbjct: 385 TAAECLRHPWL 395
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} Length = 143 | Back alignment and structure |
|---|
Score = 80.1 bits (197), Expect = 3e-18
Identities = 22/70 (31%), Positives = 39/70 (55%), Gaps = 1/70 (1%)
Query: 308 GSPPLINAFQLIGMSSCLDLSGFFEKE-DVSERKIRFTSNHSAKDLLERIEDIVTEMGFR 366
P ++NAF++I +S L+LS F++ D +R+ RF S +++ IE + MGF+
Sbjct: 2 EGPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFK 61
Query: 367 VQKKNGKVNI 376
+N K +
Sbjct: 62 SHTRNFKTRL 71
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 81.6 bits (201), Expect = 6e-17
Identities = 52/223 (23%), Positives = 93/223 (41%), Gaps = 37/223 (16%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK- 72
++ LGR +G G+FG++ ++ + A+K+ E + H Q+ E ++L+
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKH----PQLLYESKIYRILQG 61
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-------LQEAEGRKLFQQLID 125
+ + +V++ + G L D R L A+ Q+I+
Sbjct: 62 GTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLAD------QMIN 114
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSAL------PQH--FRDDGLLH 174
V + H+K HRD+K +N L+ + I DFGL+ QH +R++
Sbjct: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN---K 171
Query: 175 TTCGSPNYVAPEVLANRGYD-GATSDIWSCGVILYVILTGYLP 216
G+ Y + V + G + D+ S G +L L G LP
Sbjct: 172 NLTGTARYAS--VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 60/242 (24%), Positives = 98/242 (40%), Gaps = 44/242 (18%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+ +G+ +G GNFG+++ ++L + A+K LE + Q+ E K L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRA----PQLHLEYRFYKQLGS 63
Query: 74 -PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK--------LFQQLI 124
+ +++ MVLE G L D L + R + QLI
Sbjct: 64 GDGIPQVYYFGPCGKYNAMVLEL-LGPSLED-------LFDLCDRTFSLKTVLMIAIQLI 115
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGN-----IKISDFGLS------ALPQH--FRDDG 171
+ Y H+K + +RD+K EN L+ GN I I DF L+ +H +R+
Sbjct: 116 SRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHK 175
Query: 172 LLHTTCGSPNYVAPEVLANRGYD-GATSDIWSCGVILYVILTGYLP---FDDRNLAVLYQ 227
L G+ Y++ + + G + D+ + G + L G LP L YQ
Sbjct: 176 SL---TGTARYMS--INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQ 230
Query: 228 KI 229
KI
Sbjct: 231 KI 232
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 59/239 (24%), Positives = 95/239 (39%), Gaps = 40/239 (16%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
RY LGR +G G+FG + D+ +G A+K+ E + H Q+ E K+++
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKH----PQLHIESKIYKMMQG 63
Query: 74 -PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-------LQEAEGRKLFQQLID 125
+ + A MV+E + G L D R L A+ Q+I
Sbjct: 64 GVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLAD------QMIS 116
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDD-GLLHTT----- 176
+ Y H+K HRD+K +N L+ + I DFGL+ + +RD H
Sbjct: 117 RIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA---KKYRDARTHQHIPYRENK 173
Query: 177 --CGSPNYVAPEVLANRGYD-GATSDIWSCGVILYVILTGYLP---FDDRNLAVLYQKI 229
G+ Y + + + G + D+ S G +L G LP Y++I
Sbjct: 174 NLTGTARYAS--INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 230
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 4e-15
Identities = 55/242 (22%), Positives = 95/242 (39%), Gaps = 44/242 (18%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
Y++GR +GEG+FG + +L + A+K E R Q++ E T KLL
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDA----PQLRDEYRTYKLLAG 64
Query: 74 -PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK--------LFQQLI 124
+ ++ +V++ G L D L + GRK +Q++
Sbjct: 65 CTGIPNVYYFGQEGLHNVLVIDL-LGPSLED-------LLDLCGRKFSVKTVAMAAKQML 116
Query: 125 DGVSYCHNKGVFHRDLKLENILL----DSKGN-IKISDFGLS------ALPQH--FRDDG 171
V H K + +RD+K +N L+ N I + DFG+ QH +R+
Sbjct: 117 ARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK- 175
Query: 172 LLHTTCGSPNYVAPEVLANRGYD-GATSDIWSCGVILYVILTGYLP---FDDRNLAVLYQ 227
G+ Y++ + + G + D+ + G + L G LP Y+
Sbjct: 176 --KNLSGTARYMS--INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE 231
Query: 228 KI 229
+I
Sbjct: 232 RI 233
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.1 bits (168), Expect = 3e-13
Identities = 38/192 (19%), Positives = 66/192 (34%), Gaps = 48/192 (25%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL-----EKNRIIHLKITDQIKREIATLK 69
+ + +GEG FG+V F Q + P A+KI+ + H K ++I EI K
Sbjct: 21 KLQRCEKIGEGVFGEV-F-QTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 70 LL---------KHPNVVRLHEV------------------------------LASKSKIY 90
L + + L+ V +++
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDS 149
+VLE+ GG +++ +K A + + QL ++ HRDL N+LL
Sbjct: 139 IVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK 197
Query: 150 KGNIKISDFGLS 161
K+
Sbjct: 198 TSLKKLHYTLNG 209
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 4e-13
Identities = 31/179 (17%), Positives = 69/179 (38%), Gaps = 29/179 (16%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
++ LG+ +G G FG + A + A +++ + + E+ + +
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN----GPLFSELKFYQRVAK 92
Query: 74 PNVVRLHEVLASKSKI-------------------YMVLEYVTGGELFDKIASKGRLQEA 114
+ ++ + +MV+E + G +L G +++
Sbjct: 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKS 151
Query: 115 EGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDG 171
+L +++D + Y H H D+K N+LL K + ++D+GLS + +G
Sbjct: 152 TVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLS---YRYCPNG 207
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 9e-12
Identities = 34/207 (16%), Positives = 74/207 (35%), Gaps = 55/207 (26%)
Query: 3 IAEKKQEGMRL-----GRYELGRTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRI 52
+AE+ G + +++G +G+G FG + A + + S P VK+ +
Sbjct: 19 LAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSD-- 76
Query: 53 IHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI-------------------YMVL 93
+ E+ + P ++ + +M++
Sbjct: 77 -----NGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIM 131
Query: 94 EYVTGGELFDKIASKGR-------LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 146
+ G +L + + LQ + +++D + Y H H D+K N+L
Sbjct: 132 DRF-GSDLQKIYEANAKRFSRKTVLQLSL------RILDILEYIHEHEYVHGDIKASNLL 184
Query: 147 LDSK--GNIKISDFGLSALPQHFRDDG 171
L+ K + + D+GL+ + +G
Sbjct: 185 LNYKNPDQVYLVDYGLA---YRYCPEG 208
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 36/258 (13%), Positives = 84/258 (32%), Gaps = 58/258 (22%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGL--------PFAVKILEKNRIIHLKI-------- 57
+++L N G + A + F++K+ K+ + +
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 58 TDQIKREIATLKLLKHPNVVRLHEVLASKSKI-YMVLEYVTGGELFDKIASKGRLQEAEG 116
Q+ + L + + K ++VL + G L +
Sbjct: 102 PLQVNKWK-KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-------ALDVSP 152
Query: 117 RKLF---------QQLIDGVSYCHNKGVFHRDLKLENILL--DSKGNIKISDFGLSALPQ 165
+ + +L+D + + H H ++ ENI + + + + ++ +G +
Sbjct: 153 KHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFA---F 209
Query: 166 HFRDDG----------LLHTTCGSPNYVAPEVLANRGYDGA-TSDIWSCGVILYVILTGY 214
+ G H G +++ + ++G + SD+ S G + L G+
Sbjct: 210 RYCPSGKHVAYVEGSRSPHE--GDLEFIS--MDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265
Query: 215 LP---FDDRNLAVLYQKI 229
LP ++ QK
Sbjct: 266 LPWTNCLPNTEDIMKQKQ 283
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 37/108 (34%), Positives = 51/108 (47%), Gaps = 26/108 (24%)
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
Q+ G+ + ++ HRDL NILL K +KI DFGL+ RD P+
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA------RD------IYKDPD 248
Query: 182 YV------------APEVLANRGYDGATSDIWSCGVILYVILT-GYLP 216
YV APE + +R Y SD+WS GV+L+ I + G P
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASP 295
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 5e-07
Identities = 32/171 (18%), Positives = 52/171 (30%), Gaps = 13/171 (7%)
Query: 17 ELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
+LG+ LG G FG+V A + AVK+L + E+ L +
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHI 82
Query: 72 -KHPNVVRLH-EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
H NVV L + +++E+ G L + R + E +
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----RSKRNEFVPYKTKGARFRQG 138
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
G DLK + S + S F ++
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDF 189
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.2 bits (106), Expect = 4e-05
Identities = 64/415 (15%), Positives = 117/415 (28%), Gaps = 152/415 (36%)
Query: 2 VIAEKKQEGMRLGRYELGRTLGEGN--FGKV--KFAQDL----DSGLPFAVKILEKNRII 53
++ + L + + T E K QDL + P + I
Sbjct: 280 FLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSI------- 332
Query: 54 HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQE 113
I + I+ +AT KH N +L ++ S L L+
Sbjct: 333 ---IAESIRDGLATWDNWKHVNCDKLTTIIESS------LNV---------------LEP 368
Query: 114 AEGRKLFQQL--------I------------------DGVSYCHNKGVFHRDLK-----L 142
AE RK+F +L I V+ H + + K +
Sbjct: 369 AEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISI 428
Query: 143 ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG-ATSDIW 201
+I L+ K ++ LH + +Y P + +D +
Sbjct: 429 PSIYLELK--------------VKLENEYALHRSIVD-HYNIP-----KTFDSDDLIPPY 468
Query: 202 SCGVILYVILTGY-LPFDDR-NLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259
I G+ L + L++ +F DF ++L +KI
Sbjct: 469 LDQYFYSHI--GHHLKNIEHPERMTLFRMVFL-DF---RFLE-------QKI-------- 507
Query: 260 ITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLI 319
D T N + + + + +D +L+
Sbjct: 508 ------------RHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYE----------RLV 545
Query: 320 GMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERI----EDIVTEMGFR-VQK 369
+ F K + E I S ++ DLL ++ + E + VQ+
Sbjct: 546 N-----AILDFLPK--IEENLIC--SKYT--DLLRIALMAEDEAIFEEAHKQVQR 589
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 426 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 2ehb_D | 143 | CBL-interacting serine/threonine-protein kinase 2; | 99.87 | |
| 2zfd_B | 123 | Putative uncharacterized protein T20L15_90; calciu | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.8 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.48 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.23 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.19 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.94 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.77 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.74 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.56 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.44 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.42 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.24 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.19 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.96 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.89 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.88 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.76 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.59 | |
| 3ose_A | 120 | Serine/threonine-protein kinase MARK1; kinase asso | 97.54 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.51 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.47 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.43 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.38 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.25 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.19 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.12 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.67 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.47 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.85 | |
| 1v5s_A | 126 | MAP/microtubule affinity-regulating kinase 3; Ka1 | 95.53 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.41 | |
| 4eai_A | 106 | 5'-AMP-activated protein kinase catalytic subunit | 91.56 | |
| 2v8q_A | 157 | 5'-AMP-activated protein kinase catalytic subunit; | 90.52 | |
| 4eag_A | 130 | EG:132E8.2 protein; AMPK, transferase; HET: ATP TA | 89.68 | |
| 2y8l_A | 173 | 5'-AMP-activated protein kinase catalytic subunit; | 89.66 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 87.86 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.63 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 84.49 | |
| 3ls8_A | 614 | Phosphatidylinositol 3-kinase catalytic subunit ty | 80.26 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-69 Score=527.62 Aligned_cols=263 Identities=32% Similarity=0.591 Sum_probs=244.6
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
....++|++++.||+|+||+||+|+++.+|+.||||++++....+....+.+.+|+.+|+.++|||||++++++.+++.+
T Consensus 28 ~~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 107 (311)
T 4aw0_A 28 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 107 (311)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 44567899999999999999999999999999999999877655555578899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
|+|||||+||+|+++|.+.+.+++.+++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.......
T Consensus 108 yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999986544334
Q ss_pred CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 249 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 249 (426)
.....+.|||+.|+|||++.+.+| +.++|||||||+||+|++|+.||.+.+...++.++.++.+.+|+.+|+++++||.
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~ 266 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVE 266 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCB-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHH
T ss_pred cccccCcccCcccCCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHH
Confidence 445678899999999999988877 6899999999999999999999999999999999999999999999999999999
Q ss_pred HccccCccCCCCHHH------HhcCccccc
Q 014347 250 KILEPNPVKRITIAG------IKADEWFEQ 273 (426)
Q Consensus 250 ~~L~~dP~~R~t~~e------il~h~~f~~ 273 (426)
+||++||++|||++| |++||||+.
T Consensus 267 ~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 267 KLLVLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp HHSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HHccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 999999999999987 589999974
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-69 Score=518.54 Aligned_cols=265 Identities=48% Similarity=0.909 Sum_probs=225.3
Q ss_pred cccCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe
Q 014347 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (426)
Q Consensus 6 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 85 (426)
.-..|..+|+|++++.||+|+||+||+|++..+|+.||||++++......+...++.+|+.+|+.++||||+++++++.+
T Consensus 5 ~l~~G~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~ 84 (275)
T 3hyh_A 5 SLADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS 84 (275)
T ss_dssp ---------CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCCCCEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 34557789999999999999999999999999999999999988766666667789999999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 86 ~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
++.+|+||||| +|+|.+++.+.+++++.+++.+++||+.||+|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus 85 ~~~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 85 KDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp SSEEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred CCEEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 99999999999 78999999999999999999999999999999999999999999999999999999999999998543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHH
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ 245 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 245 (426)
......+.+||+.|+|||++.+..|++.++|||||||++|+|++|+.||.+.+...+++++..+.+.+|+++|++++
T Consensus 164 ---~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 240 (275)
T 3hyh_A 164 ---DGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAA 240 (275)
T ss_dssp --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHH
T ss_pred ---CCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 23345678999999999999998888899999999999999999999999999999999999999999999999999
Q ss_pred HHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 246 NLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
+||.+||++||++|||++|+++||||+.+
T Consensus 241 ~li~~~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 241 GLIKRMLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred HHHHHHccCChhHCcCHHHHHcCcccccC
Confidence 99999999999999999999999999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-66 Score=514.33 Aligned_cols=260 Identities=28% Similarity=0.561 Sum_probs=230.3
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
.+++|++++.||+|+||+||+|+++.+|+.||||++++.... ....+++.+|+.+|+.++|||||++++++.+++.+||
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi 100 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI 100 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 467999999999999999999999999999999999876543 3456789999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~--~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
|||||+||+|+++|... ..+++.+++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.... .
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~ 178 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--T 178 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH--H
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecC--C
Confidence 99999999999999753 4579999999999999999999999999999999999999999999999999986532 1
Q ss_pred CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC-CCCCCCCHHHHHHH
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLL 248 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li 248 (426)
.....+.|||+.|+|||++.+.+| +.++|||||||+||+|++|+.||.+.+...++.++..+.+ +.+..+|+++++||
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y-~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li 257 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPY-NNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLV 257 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHH
T ss_pred cccccccCCCccccCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHH
Confidence 123456789999999999988877 5899999999999999999999999999999999988875 46677999999999
Q ss_pred HHccccCccCCCCHHHHhcCccccccC
Q 014347 249 RKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 249 ~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
.+||++||++|||++|+++||||++..
T Consensus 258 ~~~L~~dP~~R~s~~e~l~hp~~~~~~ 284 (350)
T 4b9d_A 258 SQLFKRNPRDRPSVNSILEKGFIAKRI 284 (350)
T ss_dssp HHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred HHHccCChhHCcCHHHHhcCHHhhcCC
Confidence 999999999999999999999998643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-66 Score=509.03 Aligned_cols=256 Identities=26% Similarity=0.425 Sum_probs=231.7
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (426)
..+|+++++||+|+||+||+|+++.+|+.||||++++..... .+.+.+|+.+|+.++|||||++++++.+++.+|||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 457999999999999999999999999999999998665433 35688999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
||||+||+|.+++.+ +++++.+++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.... ....
T Consensus 150 mEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~~~ 226 (346)
T 4fih_A 150 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPR 226 (346)
T ss_dssp ECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--SSCC
T ss_pred EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC--CCCc
Confidence 999999999999876 6799999999999999999999999999999999999999999999999999985432 2334
Q ss_pred cccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC---CCCCCCCHHHHHHHH
Q 014347 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWLSPGAQNLLR 249 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~Li~ 249 (426)
..+.|||+.|+|||++.+.+| +.++|||||||++|+|++|++||.+.+....+..+..... +.+..+|+++++||.
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~ 305 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 305 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHH
T ss_pred ccccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHH
Confidence 567899999999999988877 6999999999999999999999999999888888877643 333458999999999
Q ss_pred HccccCccCCCCHHHHhcCccccccC
Q 014347 250 KILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 250 ~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
+||++||++|||++|+++||||++..
T Consensus 306 ~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 306 RLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp HHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 99999999999999999999998754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-66 Score=504.02 Aligned_cols=258 Identities=34% Similarity=0.636 Sum_probs=228.8
Q ss_pred cCCCeeeeceEeecCceEEEEEEEC---CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (426)
.-++|++++.||+|+||+||+|++. .+++.||||++++....... ..++.+|+.+|++++|||||++++++.+++.
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 100 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEGK 100 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 3468999999999999999999984 46889999999876543222 3468899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
+|+|||||+||+|++++.+.+++++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 101 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~-- 178 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID-- 178 (304)
T ss_dssp EEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999985322
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 248 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li 248 (426)
......+.|||+.|+|||++.+.+| +.++|||||||+||+|++|+.||.+.+..+++.++.++.+.+|+.+|+++++||
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 257 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLL 257 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCccccccccCcccCCHHHhccCCC-CCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 2334567899999999999988877 589999999999999999999999999999999999999999999999999999
Q ss_pred HHccccCccCCCC-----HHHHhcCccccc
Q 014347 249 RKILEPNPVKRIT-----IAGIKADEWFEQ 273 (426)
Q Consensus 249 ~~~L~~dP~~R~t-----~~eil~h~~f~~ 273 (426)
++||++||++||| ++|+++||||+.
T Consensus 258 ~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 258 RMLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp HHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 9999999999998 579999999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-64 Score=508.89 Aligned_cols=257 Identities=26% Similarity=0.429 Sum_probs=232.6
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
..++|++++.||+|+||.||+|+++.+|+.||||++++..... .+.+.+|+.+|+.++|||||++++++.+++.+||
T Consensus 149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i 225 (423)
T 4fie_A 149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV 225 (423)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEE
Confidence 3467999999999999999999999999999999998665433 3568899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCC
Q 014347 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 171 (426)
|||||+||+|.+++.. +++++.+++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.... ...
T Consensus 226 VmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~--~~~ 302 (423)
T 4fie_A 226 VMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVP 302 (423)
T ss_dssp EEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS--SCC
T ss_pred EEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC--CCc
Confidence 9999999999999875 6799999999999999999999999999999999999999999999999999985432 233
Q ss_pred ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC---CCCCCCCCHHHHHHH
Q 014347 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNLL 248 (426)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~Li 248 (426)
...+.|||+.|+|||++.+..| +.++|||||||++|+|++|+.||.+.+....+..+.... +..+..+|+++++||
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli 381 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL 381 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHH
T ss_pred cccccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHH
Confidence 4567899999999999988877 699999999999999999999999999988888887763 334456899999999
Q ss_pred HHccccCccCCCCHHHHhcCccccccC
Q 014347 249 RKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 249 ~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
.+||++||++|||++|+|+||||++..
T Consensus 382 ~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 382 DRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp HHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 999999999999999999999998754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-64 Score=484.19 Aligned_cols=255 Identities=25% Similarity=0.477 Sum_probs=223.2
Q ss_pred CCCe-eeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe----CC
Q 014347 13 LGRY-ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----KS 87 (426)
Q Consensus 13 ~~~y-~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~ 87 (426)
-||| ++.++||+|+||.||+|.+..+++.||+|++.+.... ....+++.+|+.+|+.++|||||++++++.+ +.
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 102 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEE
T ss_pred CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCc
Confidence 4676 7888999999999999999999999999999866543 3446789999999999999999999999865 35
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC--ceeccCCCCcEEecC-CCCeEEeeccCccCC
Q 014347 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDS-KGNIKISDFGLSALP 164 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~g--IiHrDLKp~NILl~~-~g~vkL~DFGla~~~ 164 (426)
.+|+|||||+||+|.+++.+.+++++..++.++.||+.||+|||++| |+||||||+||||+. +|.+||+|||+|+..
T Consensus 103 ~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 68999999999999999999899999999999999999999999998 999999999999984 799999999999853
Q ss_pred ccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCC-cHHHHHHHHHcCCC--CCCCCCC
Q 014347 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-NLAVLYQKIFRGDF--KLPKWLS 241 (426)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~--~~p~~~s 241 (426)
......+.||||.|+|||++.+ +| +.++|||||||+||+|+||+.||.+. +...++..+..+.. .++..++
T Consensus 183 ----~~~~~~~~~GTp~YmAPE~~~~-~y-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 256 (290)
T 3fpq_A 183 ----RASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 256 (290)
T ss_dssp ----CTTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred ----CCCccCCcccCccccCHHHcCC-CC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCC
Confidence 2345567899999999999864 55 68999999999999999999999764 45566677666543 3456688
Q ss_pred HHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 242 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
+++++||.+||++||++|||++|+++||||++.
T Consensus 257 ~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 999999999999999999999999999999863
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-63 Score=490.03 Aligned_cols=257 Identities=25% Similarity=0.367 Sum_probs=226.0
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
.++.|++.++||+|+||+||+|+++.+|+.||||+++++.. ..+|+.+|+.++|||||++++++.+++.+||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45679999999999999999999999999999999986543 2469999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCC-CeEEeeccCccCCccccCC
Q 014347 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQHFRDD 170 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g-~vkL~DFGla~~~~~~~~~ 170 (426)
|||||+||+|+++|.+.+++++.+++.|+.||+.||+|||++||+||||||+||||+.+| .+||+|||+|+........
T Consensus 128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 999999999999999989999999999999999999999999999999999999999998 5999999999865432111
Q ss_pred C---ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC---CCCCCCCHHH
Q 014347 171 G---LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWLSPGA 244 (426)
Q Consensus 171 ~---~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~ 244 (426)
. ...+.|||+.|+|||++.+.+| +.++|||||||+||+|++|+.||.+.+...++.++..... .+|+.+|+.+
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~ 286 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPC-DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLT 286 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHH
T ss_pred cceecCCccccCccccCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHH
Confidence 1 2234689999999999998877 5899999999999999999999999887777888887764 3577899999
Q ss_pred HHHHHHccccCccCCCCHHHH-------------hcCccccccCCC
Q 014347 245 QNLLRKILEPNPVKRITIAGI-------------KADEWFEQDYTP 277 (426)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~ei-------------l~h~~f~~~~~~ 277 (426)
.+||.+||++||.+|||+.|+ ++|||+.+...|
T Consensus 287 ~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P 332 (336)
T 4g3f_A 287 AQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP 332 (336)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred HHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence 999999999999999999997 578998765433
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-61 Score=487.71 Aligned_cols=260 Identities=26% Similarity=0.356 Sum_probs=226.5
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe------CC
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------KS 87 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------~~ 87 (426)
++|++++.||+|+||+||+|+++.+|+.||||++++... .....+++.+|+.+|+.++|||||++++++.. .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 479999999999999999999999999999999976543 33446788999999999999999999999764 36
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
.+|+|||||. |+|++++.+.+++++.+++.|++||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 7999999995 689999999899999999999999999999999999999999999999999999999999999864321
Q ss_pred --cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCC---------
Q 014347 168 --RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--------- 236 (426)
Q Consensus 168 --~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------- 236 (426)
.......+.|||+.|+|||++.+..+++.++||||+||++|+|++|++||.+.+....+.+|.......
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~ 291 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG 291 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence 123345678999999999999887777899999999999999999999999999888887775421111
Q ss_pred ----------------------CCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 237 ----------------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 237 ----------------------p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
.+.+|+++.+||.+||++||.+|||++|+|+||||++..
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 123688999999999999999999999999999998653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-61 Score=505.85 Aligned_cols=261 Identities=27% Similarity=0.450 Sum_probs=232.8
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHH---HHHHHHHHhCCCCCccceEEEEEe
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI---KREIATLKLLKHPNVVRLHEVLAS 85 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~---~~Ei~il~~l~hpnIv~l~~~~~~ 85 (426)
..+.+++|++++.||+|+||+||+|+++.+|+.||||++++...........+ ++++.+++.++|||||++++++.+
T Consensus 184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263 (689)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence 46788999999999999999999999999999999999987654332223333 445677778899999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 86 ~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
.+.+|+|||||+||+|+++|.+.+.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+...
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCC---cHHHHHHHHHcCCCCCCCCCCH
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR---NLAVLYQKIFRGDFKLPKWLSP 242 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~---~~~~~~~~i~~~~~~~p~~~s~ 242 (426)
.....+.||||.|+|||++.+...++.++|||||||+||+|++|++||.+. +...+...+....+.+|..+|+
T Consensus 344 ----~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~ 419 (689)
T 3v5w_A 344 ----KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 419 (689)
T ss_dssp ----SCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred ----CCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCH
Confidence 234567899999999999976544479999999999999999999999764 4456778888899999999999
Q ss_pred HHHHHHHHccccCccCCCC-----HHHHhcCccccc
Q 014347 243 GAQNLLRKILEPNPVKRIT-----IAGIKADEWFEQ 273 (426)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t-----~~eil~h~~f~~ 273 (426)
++++||.+||++||.+|++ ++||++||||+.
T Consensus 420 ~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred HHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 9999999999999999998 799999999975
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-60 Score=463.25 Aligned_cols=257 Identities=25% Similarity=0.425 Sum_probs=205.2
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC----
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS---- 87 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 87 (426)
.+++|++++.||+|+||+||+|+++.+|+.||||+++... .....+++.+|+.+|+.++|||||++++++.+.+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 80 (299)
T 4g31_A 3 YLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEK 80 (299)
T ss_dssp HHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----
T ss_pred cchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccc
Confidence 3567999999999999999999999999999999997654 3344678999999999999999999999987544
Q ss_pred --------EEEEEEeccCCCChHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEe
Q 014347 88 --------KIYMVLEYVTGGELFDKIASKGRL---QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKIS 156 (426)
Q Consensus 88 --------~~~lV~Ey~~gg~L~~~i~~~~~l---~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~ 156 (426)
.+|+|||||+||+|.+++...+.+ ++..++.++.||++||+|||++||+||||||+|||++.+|.+||+
T Consensus 81 ~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 81 LQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred ccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEc
Confidence 379999999999999999876554 456789999999999999999999999999999999999999999
Q ss_pred eccCccCCccccCC----------CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcH-HHH
Q 014347 157 DFGLSALPQHFRDD----------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVL 225 (426)
Q Consensus 157 DFGla~~~~~~~~~----------~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~-~~~ 225 (426)
|||+|+........ ....+.|||+.|+|||++.+..| +.++|||||||++|+|++ ||.+... ...
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyell~---Pf~~~~~~~~~ 236 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY-SHKVDIFSLGLILFELLY---PFSTQMERVRT 236 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCC-CTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCC-CCHHHHHHHHHHHHHHcc---CCCCccHHHHH
Confidence 99999865432111 12345689999999999988777 689999999999999996 8876432 233
Q ss_pred HHHHHcCCCC-CCCCCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 226 YQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 226 ~~~i~~~~~~-~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
...+....++ .+...++.+.+||.+||++||.+|||+.|+++||||++-
T Consensus 237 ~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 237 LTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred HHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 3344433322 112356788999999999999999999999999999764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-59 Score=479.82 Aligned_cols=402 Identities=37% Similarity=0.632 Sum_probs=310.1
Q ss_pred cccCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe
Q 014347 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (426)
Q Consensus 6 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 85 (426)
...+...+++|.+++.||+|+||.||+|++..+|+.||||++.+......+....+.+|+.+++.++||||+++++++.+
T Consensus 8 ~~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~ 87 (476)
T 2y94_A 8 KHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST 87 (476)
T ss_dssp -CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccCCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 34556789999999999999999999999999999999999987654444456789999999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 86 ~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
.+.+|+||||++||+|.+++.+.+++++.+++.++.||+.||.|||++||+||||||+|||++.++++||+|||++....
T Consensus 88 ~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 88 PSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp SSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 99999999999999999999988899999999999999999999999999999999999999999999999999998543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHH
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ 245 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 245 (426)
......+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+....+.++..+.+..|..+++++.
T Consensus 168 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 244 (476)
T 2y94_A 168 ---DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVI 244 (476)
T ss_dssp ---TTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHH
T ss_pred ---ccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHH
Confidence 23345677999999999999888777889999999999999999999999999999999999999999999999999
Q ss_pred HHHHHccccCccCCCCHHHHhcCccccccCCCC----CCCCCcc--c---c--cccccccccCCC--------CCC----
Q 014347 246 NLLRKILEPNPVKRITIAGIKADEWFEQDYTPA----NPDDDEE--D---I--FVDNEAFSMHEV--------PSD---- 302 (426)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~~----~~~~~~~--~---~--~~~~~~~~~~~~--------~~~---- 302 (426)
+||++||+.||.+|||+.++++||||++..... .+..... + . ......+...+. ..+
T Consensus 245 ~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 324 (476)
T 2y94_A 245 SLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAV 324 (476)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTCHHHHTTCCTTTTTSSSCSSCSHHHHHHHHSCCCC-----------------------
T ss_pred HHHHHHcCCCchhCcCHHHHHhCHHhhhcCccccCCCCcccccccCCHHHHHHHHHHcCCCHHHHHHHHhCCCCCCHHHH
Confidence 999999999999999999999999998653211 0100000 0 0 000000000000 000
Q ss_pred -------CCC------------------------CCCCCCccccceeeecccccc--------CCccccccccccccccc
Q 014347 303 -------GGR------------------------TPGSPPLINAFQLIGMSSCLD--------LSGFFEKEDVSERKIRF 343 (426)
Q Consensus 303 -------~~~------------------------~~~~~~~~~~~~~~~~s~~~~--------~~~~~~~~~~~~~~~~~ 343 (426)
..+ ....|.........+.+.... ....+. ...++.+++
T Consensus 325 ~y~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~w~lgi 402 (476)
T 2y94_A 325 AYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSKHQGV--RKAKWHLGI 402 (476)
T ss_dssp --------CCTTCCSSHHHHHHHHHHSCGGGTSCCCCSSCTTTTCSCCCCCCSTTCTTTSSSTTTCSCC--CCCCEEESE
T ss_pred HHHHHHhchhhhhhhhccccccCCccccccccccccCCcccCCcccccCCccccccccccccccccccc--ccceeeecC
Confidence 000 000000000000000000000 011111 224678899
Q ss_pred ccccCHHHHHHHHHHHHHHcCcEEEEe-CCeEEEeec----CCceEEEEEEEEeecceeEEeeechhhhhhhhh
Q 014347 344 TSNHSAKDLLERIEDIVTEMGFRVQKK-NGKVNISSQ----LTHFNIKTSVISNINYVIYHKSINLTMCILMYL 412 (426)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (426)
.|+..|.+|+..|..+++.+||.|++. .+.|++... .+.+.|.+.+|++.+.-+-+--.++.+|.+.+|
T Consensus 403 ~s~~~p~~im~ev~~al~~lg~~Wk~~~~~~i~~r~~~~~~~~~~k~~lqly~~~~~~~llDf~~~~~~~~~~~ 476 (476)
T 2y94_A 403 RSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEILEVL 476 (476)
T ss_dssp EECSCHHHHHHHHHHHHHTTTCBCCEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC-----
T ss_pred ccCCCHHHHHHHHHHHHHHcCCeeccCCCEEEEEEECCCCCCceEEEEEEEEEecCCcEEEEeeecCCCccccC
Confidence 999999999999999999999999987 788887321 235679999999998888888888888888765
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-60 Score=460.88 Aligned_cols=258 Identities=27% Similarity=0.391 Sum_probs=224.3
Q ss_pred CccCCCeeeeceEeecCceEEEEEEEC-----CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 84 (426)
.+..++|.+.+.||+|+||+||+|++. .+++.||||+++.. .....+.+.+|+.+|++++|||||++++++.
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 85 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCV 85 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 445578999999999999999999865 35788999999754 3344678999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCC
Q 014347 85 SKSKIYMVLEYVTGGELFDKIASK-------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 151 (426)
Q Consensus 85 ~~~~~~lV~Ey~~gg~L~~~i~~~-------------~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g 151 (426)
+++.+|+|||||+||+|.++|.+. ..+++.++..++.|+++||.|||+++|+||||||+|||++.++
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence 999999999999999999999764 3699999999999999999999999999999999999999999
Q ss_pred CeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHH
Q 014347 152 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIF 230 (426)
Q Consensus 152 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~ 230 (426)
++||+|||+|+..............+||+.|+|||++.+..| +.++|||||||+||||+| |+.||.+.+..++...+.
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~-~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 244 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999985432222222334579999999999988877 689999999999999999 999999999888888888
Q ss_pred cCC-CCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 231 RGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 231 ~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
.+. ++.|+.+|+++.+|+.+||+.||++|||+++| ++|+++
T Consensus 245 ~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~ 286 (299)
T 4asz_A 245 QGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN 286 (299)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence 875 57788999999999999999999999999999 567764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-59 Score=465.18 Aligned_cols=253 Identities=25% Similarity=0.395 Sum_probs=208.8
Q ss_pred CCCeeeeceEeecCceEEEEEEEC---CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSK 88 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 88 (426)
-++|++++.||+|+||+||+|+++ .+++.||+|.+.+.. ...++.+|+.+|+.+ +||||+++++++.+.+.
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 468999999999999999999875 467899999986543 145688999999988 59999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCC-CCeEEeeccCccCCccc
Q 014347 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQHF 167 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~-g~vkL~DFGla~~~~~~ 167 (426)
+|+||||++||+|.+++. .+++.+++.+++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 95 ~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp EEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred EEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 999999999999999984 59999999999999999999999999999999999999877 79999999999743221
Q ss_pred c--------------------------CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCC-C
Q 014347 168 R--------------------------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-R 220 (426)
Q Consensus 168 ~--------------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~-~ 220 (426)
. ......+.|||+.|+|||++.+.++++.++||||+||++|+|++|+.||.. .
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 0 112234568999999999998877668999999999999999999999954 3
Q ss_pred cHHHHHHHHHc--------------------------------------CCC----------------CCCCCCCHHHHH
Q 014347 221 NLAVLYQKIFR--------------------------------------GDF----------------KLPKWLSPGAQN 246 (426)
Q Consensus 221 ~~~~~~~~i~~--------------------------------------~~~----------------~~p~~~s~~~~~ 246 (426)
+......+|.. ... .....+|+++++
T Consensus 252 ~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~D 331 (361)
T 4f9c_A 252 DDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYD 331 (361)
T ss_dssp SHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHH
T ss_pred CHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHH
Confidence 33333222211 000 112347899999
Q ss_pred HHHHccccCccCCCCHHHHhcCccccc
Q 014347 247 LLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 247 Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
||++||++||++|+|++|+|+||||++
T Consensus 332 Ll~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 332 LLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 999999999999999999999999975
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-59 Score=489.44 Aligned_cols=262 Identities=30% Similarity=0.588 Sum_probs=237.4
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
...+++|++++.||+|+||.||+|+++.+|+.||+|++.+.. ....+.+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 153 ~~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 229 (573)
T 3uto_A 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 229 (573)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEE
T ss_pred CcCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 345689999999999999999999999999999999997654 23357789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCC--CCeEEeeccCccCCcc
Q 014347 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQH 166 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~--g~vkL~DFGla~~~~~ 166 (426)
|+|||||+||+|+++|.. .+.+++.+++.|++||+.||.|||++||+||||||+|||++.+ |.+||+|||+|+...
T Consensus 230 ~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~- 308 (573)
T 3uto_A 230 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD- 308 (573)
T ss_dssp EEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC-
T ss_pred EEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc-
Confidence 999999999999999964 4689999999999999999999999999999999999999854 899999999998643
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCC----CCCCH
Q 014347 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSP 242 (426)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~ 242 (426)
......+.|||+.|+|||++.+.+| +.++|||||||++|+|++|+.||.+.+....+.++....+.++ ..+|+
T Consensus 309 --~~~~~~~~~GT~~y~APEv~~~~~y-~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 385 (573)
T 3uto_A 309 --PKQSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 385 (573)
T ss_dssp --TTSEEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCH
T ss_pred --CCCceeeeEECccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 3345667899999999999998887 6899999999999999999999999999999999998877665 35899
Q ss_pred HHHHHHHHccccCccCCCCHHHHhcCccccccCCCC
Q 014347 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 278 (426)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~~ 278 (426)
++++||++||++||.+|||+.|+|+||||+....+.
T Consensus 386 ~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~ 421 (573)
T 3uto_A 386 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 421 (573)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence 999999999999999999999999999998765543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-59 Score=457.50 Aligned_cols=254 Identities=28% Similarity=0.400 Sum_probs=216.6
Q ss_pred ccCCCeeeeceEeecCceEEEEEEEC-----CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 85 (426)
+...+|.+.++||+|+||+||+|+.. .+++.||||+++.. .....+.|.+|+.+|++++|||||++++++.+
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 114 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTE 114 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 44567999999999999999999864 36889999999654 34456789999999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCC
Q 014347 86 KSKIYMVLEYVTGGELFDKIASK---------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 150 (426)
Q Consensus 86 ~~~~~lV~Ey~~gg~L~~~i~~~---------------~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~ 150 (426)
.+.+|+|||||+||+|.+++.+. +++++.++..++.|++.||.|||+++|+||||||+||||+++
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG 194 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC
Confidence 99999999999999999999753 458999999999999999999999999999999999999999
Q ss_pred CCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHH
Q 014347 151 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKI 229 (426)
Q Consensus 151 g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i 229 (426)
+++||+|||+|+..............+||+.|+|||++.+..| +.++|||||||+||||+| |+.||.+.+..++...+
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~-~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 273 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 273 (329)
T ss_dssp TEEEECCCC----------------CCCCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCC-CccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999986543222233445789999999999988777 689999999999999999 99999999888888888
Q ss_pred HcC-CCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 230 FRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 230 ~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
..+ .++.|+.+++++.+|+.+||+.||++|||+.||+++
T Consensus 274 ~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 274 TQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 776 477888999999999999999999999999999764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-59 Score=453.51 Aligned_cols=256 Identities=25% Similarity=0.375 Sum_probs=224.9
Q ss_pred CccCCCeeeeceEeecCceEEEEEEEC-----CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 84 (426)
.+..++++++++||+|+||+||+|+.. .+++.||||.++... .....+.|.+|+.+|++++|||||++++++.
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence 456788999999999999999999853 467899999996543 2334578999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEec
Q 014347 85 SKSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 148 (426)
Q Consensus 85 ~~~~~~lV~Ey~~gg~L~~~i~~~----------------~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~ 148 (426)
+++.+|+|||||++|+|.++|... ..+++.++..++.||+.||+|||+++|+||||||+||||+
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 999999999999999999999642 3589999999999999999999999999999999999999
Q ss_pred CCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHH
Q 014347 149 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQ 227 (426)
Q Consensus 149 ~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~ 227 (426)
+++++||+|||+|+..............+||+.|+|||++.+..| +.++|||||||+||||+| |..||.+.+..++..
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~-s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999986543333334556789999999999988777 699999999999999998 999999999888888
Q ss_pred HHHcCC-CCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 228 KIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 228 ~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
.+..+. .+.|+.+++.+.+|+.+||+.||++|||+.+|+++
T Consensus 259 ~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 259 MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 887764 56788899999999999999999999999999765
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-57 Score=447.30 Aligned_cols=266 Identities=42% Similarity=0.821 Sum_probs=244.3
Q ss_pred cccCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe
Q 014347 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (426)
Q Consensus 6 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 85 (426)
.......+++|++++.||+|+||.||+|++..+|+.||||++.+... +....+++.+|+.+++.++||||+++++++.+
T Consensus 7 ~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 85 (328)
T 3fe3_A 7 CADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIET 85 (328)
T ss_dssp ----CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred ccccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 34556778999999999999999999999999999999999987544 34456788999999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 86 ~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
.+..|+||||++||+|.+++...+++++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||++....
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 86 EKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred CCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 99999999999999999999988999999999999999999999999999999999999999999999999999997532
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHH
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ 245 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 245 (426)
........+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+.+......++..+.+..|..+++++.
T Consensus 166 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 242 (328)
T 3fe3_A 166 ---VGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCE 242 (328)
T ss_dssp ---SSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred ---CCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 23455678999999999999988887789999999999999999999999999999999999999999999999999
Q ss_pred HHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 246 NLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
+||++||+.||.+|||++++++||||+...
T Consensus 243 ~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 243 NLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 999999999999999999999999998653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-58 Score=448.00 Aligned_cols=254 Identities=25% Similarity=0.369 Sum_probs=207.7
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (426)
+..+++++++.||+|+||+||+|+.. ..||||+++.... ..+..+.+.+|+.+|++++|||||++++++.. +.+|
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~ 107 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA 107 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence 34578899999999999999999853 3599999875443 34557889999999999999999999998754 5689
Q ss_pred EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
||||||+||+|.+++.. .+++++.++..++.|++.||+|||++||+||||||+||||++++++||+|||+|+.......
T Consensus 108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 99999999999999975 46799999999999999999999999999999999999999999999999999987554333
Q ss_pred CCccccccCCCcccchhhhccC--CCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHH-HHHcCC-----CCCCCCCC
Q 014347 170 DGLLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQ-KIFRGD-----FKLPKWLS 241 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~--~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~-~i~~~~-----~~~p~~~s 241 (426)
.....+.+||+.|+|||++... +.++.++|||||||+||||+||+.||.+.+...... .+..+. ...+..++
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 267 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCP 267 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSC
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccch
Confidence 3445677999999999998643 234689999999999999999999998866544433 333332 12345689
Q ss_pred HHHHHHHHHccccCccCCCCHHHHhcCc
Q 014347 242 PGAQNLLRKILEPNPVKRITIAGIKADE 269 (426)
Q Consensus 242 ~~~~~Li~~~L~~dP~~R~t~~eil~h~ 269 (426)
+.+.+|+.+||+.||++|||+.+|+++-
T Consensus 268 ~~l~~li~~cl~~dP~~RPs~~ei~~~L 295 (307)
T 3omv_A 268 KAMKRLVADCVKKVKEERPLFPQILSSI 295 (307)
T ss_dssp HHHHHHHHHHTCSSSTTSCCHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 9999999999999999999999987653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-56 Score=444.81 Aligned_cols=262 Identities=33% Similarity=0.633 Sum_probs=233.5
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCC
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS 87 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 87 (426)
..+.+++|++++.||+|+||.||+|++..+|+.||||++.+...........+.+|..+++.+ +||||+++++++.+.+
T Consensus 18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 97 (353)
T 3txo_A 18 NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD 97 (353)
T ss_dssp -----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence 356789999999999999999999999999999999999876554445567888999999988 6999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
.+|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~- 176 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC- 176 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc-
Confidence 9999999999999999999889999999999999999999999999999999999999999999999999999984322
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L 247 (426)
......+.|||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+...++.++..+...+|.++++.+.+|
T Consensus 177 -~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 254 (353)
T 3txo_A 177 -NGVTTATFCGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGI 254 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHC-TTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred -CCccccccCCCcCeEChhhcCCCCc-CCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 2334556799999999999987776 68999999999999999999999999999999999999999999999999999
Q ss_pred HHHccccCccCCCCH------HHHhcCccccc
Q 014347 248 LRKILEPNPVKRITI------AGIKADEWFEQ 273 (426)
Q Consensus 248 i~~~L~~dP~~R~t~------~eil~h~~f~~ 273 (426)
|++||++||.+||++ ++|++||||+.
T Consensus 255 i~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 255 LKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp HHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred HHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 999999999999998 89999999975
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-56 Score=437.81 Aligned_cols=260 Identities=32% Similarity=0.630 Sum_probs=239.5
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (426)
+.+++|++++.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 46789999999999999999999999999999999998765433444678899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCC
Q 014347 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 170 (426)
+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.... ..
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~ 159 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc--CC
Confidence 9999999999999999888999999999999999999999999999999999999999999999999999975322 23
Q ss_pred CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 014347 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 250 (426)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~ 250 (426)
....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...++..+......+|..+++++.+||.+
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 238 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred CcccccccChhhCChhhhcCCCC-CchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 34567799999999999987776 68999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCccCCC-----CHHHHhcCccccc
Q 014347 251 ILEPNPVKRI-----TIAGIKADEWFEQ 273 (426)
Q Consensus 251 ~L~~dP~~R~-----t~~eil~h~~f~~ 273 (426)
||++||.+|| +++++++||||..
T Consensus 239 lL~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 9999999999 9999999999964
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-57 Score=446.00 Aligned_cols=255 Identities=26% Similarity=0.385 Sum_probs=217.7
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCC-----CCeEEEEEeecccccchhHHHHHHHHHHHHHhCCC-CCccceEEEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNVVRLHEVLA 84 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~ 84 (426)
+..++|++++.||+|+||+||+|.+..+ ++.||||.+.... .....+.+.+|+.+|++++| ||||++++++.
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~ 138 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 138 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence 3457899999999999999999997654 3579999987543 23345779999999999975 89999999986
Q ss_pred e-CCEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEe
Q 014347 85 S-KSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL 147 (426)
Q Consensus 85 ~-~~~~~lV~Ey~~gg~L~~~i~~~----------------~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl 147 (426)
. ++.+|+|||||+||+|.++|... ..+++.++..++.||+.||+|||+++|+||||||+|||+
T Consensus 139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl 218 (353)
T 4ase_A 139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 218 (353)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee
Confidence 5 45789999999999999999752 348999999999999999999999999999999999999
Q ss_pred cCCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcH-HHH
Q 014347 148 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNL-AVL 225 (426)
Q Consensus 148 ~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~-~~~ 225 (426)
++++.+||+|||+|+............+.+||+.|+|||++.+..| +.++|||||||+||||+| |..||.+.+. ..+
T Consensus 219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y-~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~ 297 (353)
T 4ase_A 219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 297 (353)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCC-CCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999986543222223445689999999999988777 689999999999999998 9999988654 344
Q ss_pred HHHHHcC-CCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 226 YQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 226 ~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
...+..+ .++.|+.+++++.+|+.+||+.||++|||+.+|++|
T Consensus 298 ~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 298 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 4555554 577888999999999999999999999999999987
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-55 Score=437.12 Aligned_cols=262 Identities=33% Similarity=0.599 Sum_probs=237.3
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCC
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS 87 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 87 (426)
....+++|++++.||+|+||.||+|++..+|+.||+|++++...........+.+|..+++.+ +||||+++++++.+.+
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 457789999999999999999999999999999999999876543334466788899999876 8999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
.+|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 170 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML- 170 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc-
Confidence 9999999999999999999888999999999999999999999999999999999999999999999999999975322
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L 247 (426)
......+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...++.++..+...+|.++++++.+|
T Consensus 171 -~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 248 (345)
T 1xjd_A 171 -GDAKTNTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDL 248 (345)
T ss_dssp -TTCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred -CCCcccCCCCCcccCChhhhcCCCC-CChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHH
Confidence 2234567799999999999988776 68999999999999999999999999999999999999999999999999999
Q ss_pred HHHccccCccCCCCHH-HHhcCccccc
Q 014347 248 LRKILEPNPVKRITIA-GIKADEWFEQ 273 (426)
Q Consensus 248 i~~~L~~dP~~R~t~~-eil~h~~f~~ 273 (426)
|.+||+.||.+||++. +|++||||+.
T Consensus 249 i~~lL~~dp~~R~~~~~~i~~hp~f~~ 275 (345)
T 1xjd_A 249 LVKLFVREPEKRLGVRGDIRQHPLFRE 275 (345)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred HHHHhcCCHhHcCCChHHHHcCccccC
Confidence 9999999999999998 9999999975
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-55 Score=430.21 Aligned_cols=258 Identities=32% Similarity=0.686 Sum_probs=238.4
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
...+++|++++.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+
T Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 81 (318)
T 1fot_A 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI 81 (318)
T ss_dssp -CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred CCChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEE
Confidence 35678999999999999999999999999999999999876543334467788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~---- 157 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP---- 157 (318)
T ss_dssp EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS----
T ss_pred EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecC----
Confidence 9999999999999999988899999999999999999999999999999999999999999999999999998532
Q ss_pred CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 249 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 249 (426)
....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+.++......+|..+++++.+||+
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 235 (318)
T 1fot_A 158 -DVTYTLCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLS 235 (318)
T ss_dssp -SCBCCCCSCTTTCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred -CccccccCCccccCHhHhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 23456799999999999987776 6899999999999999999999999999999999999999999999999999999
Q ss_pred HccccCccCCC-----CHHHHhcCccccc
Q 014347 250 KILEPNPVKRI-----TIAGIKADEWFEQ 273 (426)
Q Consensus 250 ~~L~~dP~~R~-----t~~eil~h~~f~~ 273 (426)
+||+.||.+|| +++++++||||+.
T Consensus 236 ~lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 236 RLITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred HHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 99999999999 8999999999974
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-56 Score=442.07 Aligned_cols=262 Identities=45% Similarity=0.870 Sum_probs=237.5
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
+..+|+|++++.||+|+||.||+|.+..+|+.||+|++.+......+....+.+|+.+++.++||||+++++++.+.+..
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 84 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI 84 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 45789999999999999999999999999999999999865443333456789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
|+||||+ +|+|.+++...+++++.+++.++.||+.||.|||++||+||||||+|||++.++++||+|||++.....
T Consensus 85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~--- 160 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD--- 160 (336)
T ss_dssp EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT---
T ss_pred EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC---
Confidence 9999999 789999999889999999999999999999999999999999999999999999999999999986432
Q ss_pred CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 249 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 249 (426)
.....+.+||+.|+|||++.+..+.++++|||||||++|+|++|..||.+.+....+.++..+....|..+++.+.+||+
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 240 (336)
T 3h4j_B 161 GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIR 240 (336)
T ss_dssp SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHH
T ss_pred CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 33456779999999999998888778899999999999999999999998877666666666778889999999999999
Q ss_pred HccccCccCCCCHHHHhcCccccccC
Q 014347 250 KILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 250 ~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
+||+.||.+|||++|+++||||+...
T Consensus 241 ~~L~~dP~~Rpt~~eil~hp~~~~~~ 266 (336)
T 3h4j_B 241 RMIVADPMQRITIQEIRRDPWFNVNL 266 (336)
T ss_dssp TTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred HHcCCChhHCcCHHHHHhChhhccCC
Confidence 99999999999999999999998643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-55 Score=441.16 Aligned_cols=262 Identities=30% Similarity=0.602 Sum_probs=233.7
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCC
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS 87 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 87 (426)
..+.+++|++++.||+|+||+||+|++..+++.||+|++++.........+.+.+|..+++++ +||||+++++++.+.+
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence 456788999999999999999999999999999999999887665555566788999999876 8999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
.+|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~- 205 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR- 205 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc-
Confidence 9999999999999999999889999999999999999999999999999999999999999999999999999984221
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCC---------cHHHHHHHHHcCCCCCCC
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR---------NLAVLYQKIFRGDFKLPK 238 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~---------~~~~~~~~i~~~~~~~p~ 238 (426)
......+.|||+.|+|||++.+..| +.++|||||||++|+|++|+.||... ....+++.+....+.+|.
T Consensus 206 -~~~~~~~~~gt~~Y~aPE~l~~~~~-~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~ 283 (396)
T 4dc2_A 206 -PGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 283 (396)
T ss_dssp -TTCCBCCCCBCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT
T ss_pred -CCCccccccCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC
Confidence 2344567899999999999988777 68999999999999999999999632 345577888899999999
Q ss_pred CCCHHHHHHHHHccccCccCCCCH------HHHhcCccccc
Q 014347 239 WLSPGAQNLLRKILEPNPVKRITI------AGIKADEWFEQ 273 (426)
Q Consensus 239 ~~s~~~~~Li~~~L~~dP~~R~t~------~eil~h~~f~~ 273 (426)
.+++++.+||++||++||.+||++ ++|++||||+.
T Consensus 284 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 999999999999999999999985 79999999974
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-55 Score=434.35 Aligned_cols=264 Identities=34% Similarity=0.613 Sum_probs=237.5
Q ss_pred ccCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEe
Q 014347 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS 85 (426)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 85 (426)
....+.+++|++++.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|..++..+ +||||+++++++.+
T Consensus 13 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~ 92 (353)
T 2i0e_A 13 NRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT 92 (353)
T ss_dssp ------CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC
T ss_pred CcCCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc
Confidence 34467889999999999999999999999999999999999876543344467788999999987 79999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 86 ~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
.+..|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 99999999999999999999988899999999999999999999999999999999999999999999999999998532
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHH
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ 245 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 245 (426)
. ......+.+||+.|+|||++.+.++ +.++|||||||++|+|++|+.||.+.+...++.++....+.+|..+++++.
T Consensus 173 ~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 249 (353)
T 2i0e_A 173 W--DGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAV 249 (353)
T ss_dssp C--TTCCBCCCCSCGGGCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred c--CCcccccccCCccccChhhhcCCCc-CCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 2 2234567799999999999988777 689999999999999999999999999999999999999999999999999
Q ss_pred HHHHHccccCccCCCC-----HHHHhcCccccc
Q 014347 246 NLLRKILEPNPVKRIT-----IAGIKADEWFEQ 273 (426)
Q Consensus 246 ~Li~~~L~~dP~~R~t-----~~eil~h~~f~~ 273 (426)
+||.+||++||.+||+ +++|++||||+.
T Consensus 250 ~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 250 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp HHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred HHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 9999999999999995 699999999974
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=428.75 Aligned_cols=261 Identities=31% Similarity=0.605 Sum_probs=237.3
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSK 88 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 88 (426)
...+++|++++.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|..+++.+ +||||+++++++.+.+.
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 45688999999999999999999999999999999999987766666678899999999987 89999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
.|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~-- 162 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-- 162 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC--
Confidence 999999999999999999888999999999999999999999999999999999999999999999999999985322
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCC---------CcHHHHHHHHHcCCCCCCCC
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD---------RNLAVLYQKIFRGDFKLPKW 239 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~---------~~~~~~~~~i~~~~~~~p~~ 239 (426)
......+.+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.. .+...+++.+......+|..
T Consensus 163 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 241 (345)
T 3a8x_A 163 PGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 241 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTT
T ss_pred CCCcccccCCCccccCccccCCCCC-ChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCC
Confidence 2234566799999999999988776 6899999999999999999999975 34456778888888999999
Q ss_pred CCHHHHHHHHHccccCccCCCCH------HHHhcCccccc
Q 014347 240 LSPGAQNLLRKILEPNPVKRITI------AGIKADEWFEQ 273 (426)
Q Consensus 240 ~s~~~~~Li~~~L~~dP~~R~t~------~eil~h~~f~~ 273 (426)
+++.+.+||.+||+.||.+||++ +++++||||..
T Consensus 242 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 99999999999999999999995 89999999974
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-55 Score=432.34 Aligned_cols=260 Identities=34% Similarity=0.666 Sum_probs=240.6
Q ss_pred cCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 014347 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (426)
.....+++|++++.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+..
T Consensus 35 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 114 (350)
T 1rdq_E 35 QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114 (350)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34567899999999999999999999999999999999998765444445678899999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
.+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~- 193 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC-
Confidence 9999999999999999999888999999999999999999999999999999999999999999999999999985322
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L 247 (426)
...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+.++..+...+|..+++.+.+|
T Consensus 194 ----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 268 (350)
T 1rdq_E 194 ----RTWTLCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268 (350)
T ss_dssp ----CBCCCEECGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHH
T ss_pred ----CcccccCCccccCHHHhcCCCC-CCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 2346789999999999988776 68999999999999999999999999999999999999999999999999999
Q ss_pred HHHccccCccCCCC-----HHHHhcCccccc
Q 014347 248 LRKILEPNPVKRIT-----IAGIKADEWFEQ 273 (426)
Q Consensus 248 i~~~L~~dP~~R~t-----~~eil~h~~f~~ 273 (426)
|.+||+.||.+||+ +++|++||||..
T Consensus 269 i~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 99999999999998 999999999974
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-54 Score=428.59 Aligned_cols=261 Identities=34% Similarity=0.590 Sum_probs=235.3
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccch---hHHHHHHHHHHHHHhCCCCCccceEEEEEe
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 85 (426)
....-++|++++.||+|+||.||+|++..+|+.||+|++.+...... ...+.+.+|+.+|+.++||||+++++++.+
T Consensus 7 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 86 (361)
T 2yab_A 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN 86 (361)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe
Confidence 34556789999999999999999999999999999999987553221 135678999999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCC----CeEEeeccCc
Q 014347 86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG----NIKISDFGLS 161 (426)
Q Consensus 86 ~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g----~vkL~DFGla 161 (426)
...+|+||||++||+|++++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 999999999999999999999888999999999999999999999999999999999999998877 7999999999
Q ss_pred cCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCC----
Q 014347 162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP---- 237 (426)
Q Consensus 162 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p---- 237 (426)
..... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+..+.+.++
T Consensus 167 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (361)
T 2yab_A 167 HEIED---GVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF 242 (361)
T ss_dssp EECCT---TCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred eEcCC---CCccccCCCCccEECchHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence 85432 234456789999999999987766 6899999999999999999999999999999999998887776
Q ss_pred CCCCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 238 ~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
..+++.+++||.+||.+||.+|||+.++++||||..
T Consensus 243 ~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 458999999999999999999999999999999974
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-54 Score=430.72 Aligned_cols=262 Identities=35% Similarity=0.599 Sum_probs=230.3
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHH-HHhCCCCCccceEEEEEeCC
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~ 87 (426)
.....++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|..+ ++.++||||+++++++.+.+
T Consensus 33 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 33 PHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112 (373)
T ss_dssp TTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred CCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence 45678899999999999999999999999999999999988766555556677778877 57789999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
..|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~- 191 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE- 191 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC-
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc-
Confidence 9999999999999999999888999999999999999999999999999999999999999999999999999974221
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L 247 (426)
......+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...++.++......+|..+++.+.+|
T Consensus 192 -~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l 269 (373)
T 2r5t_A 192 -HNSTTSTFCGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHL 269 (373)
T ss_dssp -CCCCCCSBSCCCCCCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHH
T ss_pred -CCCccccccCCccccCHHHhCCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Confidence 2334567899999999999988776 68999999999999999999999999999999999999999999999999999
Q ss_pred HHHccccCccCCCCH----HHHhcCccccc
Q 014347 248 LRKILEPNPVKRITI----AGIKADEWFEQ 273 (426)
Q Consensus 248 i~~~L~~dP~~R~t~----~eil~h~~f~~ 273 (426)
|.+||+.||.+||++ .+|++||||+.
T Consensus 270 i~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 270 LEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp HHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred HHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 999999999999997 69999999974
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=408.67 Aligned_cols=265 Identities=32% Similarity=0.652 Sum_probs=238.0
Q ss_pred ccCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 014347 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (426)
++....+++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.
T Consensus 2 k~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 81 (279)
T 3fdn_A 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA 81 (279)
T ss_dssp --CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CcceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC
Confidence 45677899999999999999999999999999999999999765544444467789999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcc
Q 014347 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 166 (426)
+..|+||||+++++|.+.+....++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 82 TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999999864322
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHH
Q 014347 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246 (426)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 246 (426)
......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+......+|..+++.+.+
T Consensus 162 ----~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (279)
T 3fdn_A 162 ----SRRTDLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHH
T ss_pred ----ccccccCCCCCccCHhHhccCCC-CccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHH
Confidence 23345689999999999877655 6899999999999999999999999999999999999999999999999999
Q ss_pred HHHHccccCccCCCCHHHHhcCccccccCC
Q 014347 247 LLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (426)
Q Consensus 247 Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 276 (426)
||.+||+.||.+|||+.++++||||+....
T Consensus 237 li~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 237 LISRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp HHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred HHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence 999999999999999999999999987654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=428.37 Aligned_cols=263 Identities=27% Similarity=0.505 Sum_probs=237.2
Q ss_pred cCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 014347 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (426)
...+.+++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+|+.++||||+++++++.+..
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 88 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 45678899999999999999999999999999999999998765444445678999999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
..|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~-- 166 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP-- 166 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeecc--
Confidence 999999999999999999988899999999999999999999999999999999999999999999999999998543
Q ss_pred cCCCccccccCCCcccchhhhccC--CCCCCcchhhhHHHHHHHHHhCCCCCCC---CcHHHHHHHHHcCCCCCCCCCCH
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYVILTGYLPFDD---RNLAVLYQKIFRGDFKLPKWLSP 242 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~--~~~~~~~DIwSlGvil~elltG~~Pf~~---~~~~~~~~~i~~~~~~~p~~~s~ 242 (426)
......+.+||+.|+|||++... ..++.++|||||||++|+|++|..||.. .........+......+|..+++
T Consensus 167 -~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~ 245 (384)
T 4fr4_A 167 -RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQ 245 (384)
T ss_dssp -TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCH
T ss_pred -CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCH
Confidence 23445678999999999998642 2236899999999999999999999974 44566777777888899999999
Q ss_pred HHHHHHHHccccCccCCCC-HHHHhcCccccc
Q 014347 243 GAQNLLRKILEPNPVKRIT-IAGIKADEWFEQ 273 (426)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t-~~eil~h~~f~~ 273 (426)
.+.+||.+||++||.+||+ ++++++||||..
T Consensus 246 ~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 246 EMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp HHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred HHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 9999999999999999998 899999999975
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=434.86 Aligned_cols=261 Identities=36% Similarity=0.692 Sum_probs=233.3
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
....++|++++.||+|+||.||+|.+..+|+.||+|++.+.... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 85 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHH 85 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEE
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEE
Confidence 34457899999999999999999999999999999999876543 33467789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEec---CCCCeEEeeccCccCCcc
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD---SKGNIKISDFGLSALPQH 166 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~---~~g~vkL~DFGla~~~~~ 166 (426)
|+||||+.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 86 ~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 86 YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp EEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 99999999999999999989999999999999999999999999999999999999998 457899999999975433
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCC----CCCH
Q 014347 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSP 242 (426)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~ 242 (426)
........+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+....+..+..+...+|. .+++
T Consensus 166 --~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 242 (444)
T 3soa_A 166 --EQQAWFGFAGTPGYLSPEVLRKDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP 242 (444)
T ss_dssp --TCCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred --CCceeecccCCcccCCHHHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCH
Confidence 2233456789999999999987766 68999999999999999999999999999999999988766653 4899
Q ss_pred HHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
++.+||.+||++||.+|||+.++++||||...
T Consensus 243 ~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 243 EAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred HHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 99999999999999999999999999999754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-53 Score=410.49 Aligned_cols=259 Identities=26% Similarity=0.459 Sum_probs=228.9
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (426)
.+...++|++++.||+|+||.||+|.+..+|+.||+|++....... .+.+.+|+.+++.++||||+++++++...+.
T Consensus 15 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 91 (297)
T 3fxz_A 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDE 91 (297)
T ss_dssp SSCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cCChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCE
Confidence 4556789999999999999999999999999999999997654333 4678899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
.|+||||++||+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 92 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-- 168 (297)
T 3fxz_A 92 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-- 168 (297)
T ss_dssp EEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--
T ss_pred EEEEEECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC--
Confidence 9999999999999999876 4699999999999999999999999999999999999999999999999999875432
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC---CCCCCCCCCHHHH
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPGAQ 245 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~ 245 (426)
........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+... ....|..+++.+.
T Consensus 169 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (297)
T 3fxz_A 169 EQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247 (297)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHCSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHH
T ss_pred cccccCCccCCcCccChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHH
Confidence 2223456789999999999988776 68999999999999999999999988776655555433 3445677899999
Q ss_pred HHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 246 NLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
+||.+||+.||.+|||++++++||||+..
T Consensus 248 ~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 248 DFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 99999999999999999999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-54 Score=437.52 Aligned_cols=261 Identities=33% Similarity=0.629 Sum_probs=228.7
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
...+++|++++.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 45678999999999999999999999999999999999876544444567788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-cCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~-~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
|+||||++||+|.+++...+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|+....
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-- 301 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-- 301 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC--
Confidence 9999999999999999988899999999999999999999998 9999999999999999999999999999985322
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 248 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li 248 (426)
........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+......+|..+++++.+||
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 380 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLL 380 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCcccccccCCccccCHhhcCCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 2234556799999999999987776 689999999999999999999999999999999999999999999999999999
Q ss_pred HHccccCccCCC-----CHHHHhcCccccc
Q 014347 249 RKILEPNPVKRI-----TIAGIKADEWFEQ 273 (426)
Q Consensus 249 ~~~L~~dP~~R~-----t~~eil~h~~f~~ 273 (426)
.+||++||.+|| |++++++||||..
T Consensus 381 ~~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 381 SGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 999999999999 9999999999975
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-53 Score=416.80 Aligned_cols=263 Identities=36% Similarity=0.634 Sum_probs=226.3
Q ss_pred cCCccCCCeeeeceEeecCceEEEEEEEC---CCCCeEEEEEeeccccc-chhHHHHHHHHHHHHHhCCCCCccceEEEE
Q 014347 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLLKHPNVVRLHEVL 83 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 83 (426)
+..+..++|++++.||+|+||.||+|++. .+|+.||+|++++.... .......+.+|+.+++.++||||+++++++
T Consensus 11 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 90 (327)
T 3a62_A 11 PEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF 90 (327)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence 44667889999999999999999999985 68999999999865432 223356688999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccC
Q 014347 84 ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (426)
Q Consensus 84 ~~~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~ 163 (426)
.+.+..|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 91 QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp ECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 99999999999999999999999888999999999999999999999999999999999999999999999999999874
Q ss_pred CccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHH
Q 014347 164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPG 243 (426)
Q Consensus 164 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 243 (426)
... ........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+......++......+|..+++.
T Consensus 171 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 247 (327)
T 3a62_A 171 SIH--DGTVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQE 247 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHH
T ss_pred ccc--CCccccccCCCcCccCHhhCcCCCC-CCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHH
Confidence 322 2233456789999999999987766 6899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHccccCccCCC-----CHHHHhcCccccc
Q 014347 244 AQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 273 (426)
Q Consensus 244 ~~~Li~~~L~~dP~~R~-----t~~eil~h~~f~~ 273 (426)
+.+||.+||+.||.+|| ++.++++||||+.
T Consensus 248 ~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp HHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred HHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 99999999999999999 8899999999974
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-54 Score=419.39 Aligned_cols=262 Identities=39% Similarity=0.674 Sum_probs=226.3
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
.+++|++++.||+|+||.||+|++..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 578999999999999999999999999999999999755432 224678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCC
Q 014347 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 171 (426)
||||++||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999998654322333
Q ss_pred ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHH-HHHHHHHcCCCCCC--CCCCHHHHHHH
Q 014347 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDFKLP--KWLSPGAQNLL 248 (426)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~p--~~~s~~~~~Li 248 (426)
.....+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+.. ..+..+.......+ ..+++.+.+||
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHH
Confidence 4456789999999999988877778899999999999999999999876543 33444444443333 44899999999
Q ss_pred HHccccCccCCCCHHHHhcCccccccC
Q 014347 249 RKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 249 ~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
.+||+.||.+|||+.|+++||||++..
T Consensus 243 ~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 243 HKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHccCChhhCcCHHHHhhChhhcccc
Confidence 999999999999999999999998654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-53 Score=421.06 Aligned_cols=256 Identities=38% Similarity=0.718 Sum_probs=231.7
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (426)
.++|++++.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4589999999999999999999999999999999986654 334467899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCC---CeEEeeccCccCCccccC
Q 014347 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRD 169 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g---~vkL~DFGla~~~~~~~~ 169 (426)
|||++||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~--- 183 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--- 183 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT---
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC---
Confidence 99999999999999888899999999999999999999999999999999999998654 599999999985432
Q ss_pred CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCC----CCCHHHH
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSPGAQ 245 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~ 245 (426)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+..+.+.+|. .+++++.
T Consensus 184 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 262 (362)
T 2bdw_A 184 SEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 262 (362)
T ss_dssp CCSCCCSCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHH
T ss_pred CcccccCCCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 233456789999999999987766 68999999999999999999999999998999999888776653 3799999
Q ss_pred HHHHHccccCccCCCCHHHHhcCccccc
Q 014347 246 NLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
+||.+||++||.+|||+.++++||||..
T Consensus 263 ~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 263 SLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 9999999999999999999999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-53 Score=404.73 Aligned_cols=269 Identities=32% Similarity=0.675 Sum_probs=239.5
Q ss_pred ccccccCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEE
Q 014347 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEV 82 (426)
Q Consensus 3 ~~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 82 (426)
+++.......+++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||++++++
T Consensus 3 l~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 82 (284)
T 2vgo_A 3 LAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNY 82 (284)
T ss_dssp -------CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhCCccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEE
Confidence 45566778889999999999999999999999999999999999976544333345778999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCcc
Q 014347 83 LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (426)
Q Consensus 83 ~~~~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~ 162 (426)
+.+.+..|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 83 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~ 162 (284)
T 2vgo_A 83 FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV 162 (284)
T ss_dssp EECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEcCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccc
Confidence 99999999999999999999999988899999999999999999999999999999999999999999999999999986
Q ss_pred CCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCH
Q 014347 163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 242 (426)
Q Consensus 163 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 242 (426)
.... ......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+......+|..+++
T Consensus 163 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T 2vgo_A 163 HAPS----LRRRTMCGTLDYLPPEMIEGKTH-DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSD 237 (284)
T ss_dssp ECSS----SCBCCCCSCGGGCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCH
T ss_pred cCcc----cccccccCCCCcCCHHHhccCCC-CcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCH
Confidence 4322 22345689999999999887666 689999999999999999999999998888888888888999999999
Q ss_pred HHHHHHHHccccCccCCCCHHHHhcCccccccCC
Q 014347 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (426)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 276 (426)
.+.+||.+||+.||.+|||+.++++||||+....
T Consensus 238 ~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 238 GSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred HHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 9999999999999999999999999999987543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-53 Score=405.18 Aligned_cols=259 Identities=29% Similarity=0.476 Sum_probs=220.3
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (426)
+++|++++.||+|+||.||+|++..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 5799999999999999999999999999999999986553 334467888999999999999999999999999999999
Q ss_pred EeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCC
Q 014347 93 LEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~-~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 171 (426)
|||+.| +|.+.+. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~ 156 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVR 156 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS--CCS
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCC--ccc
Confidence 999976 5555554 467899999999999999999999999999999999999999999999999999975432 223
Q ss_pred ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCC-CCCCcHHHHHHHHHcC--C---------------
Q 014347 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFRG--D--------------- 233 (426)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~P-f~~~~~~~~~~~i~~~--~--------------- 233 (426)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..| |.+.+.......+... .
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 345568999999999998777568999999999999999987777 6666666666555431 0
Q ss_pred ------------CCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 234 ------------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 234 ------------~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
...++.+++.+++||.+||+.||++|||++|+++||||++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 011234788999999999999999999999999999998643
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-53 Score=414.10 Aligned_cols=256 Identities=25% Similarity=0.477 Sum_probs=231.3
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
..++|++++.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 78 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence 4689999999999999999999999999999999986432 234678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecC--CCCeEEeeccCccCCcccc
Q 014347 92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS--KGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~--~g~vkL~DFGla~~~~~~~ 168 (426)
||||++||+|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~--- 155 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--- 155 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC---
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC---
Confidence 99999999999999764 47999999999999999999999999999999999999987 7899999999998543
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCC----CCCCHHH
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGA 244 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~ 244 (426)
........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+..+...++ +.+++++
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 234 (321)
T 1tki_A 156 PGDNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred CCCccccccCChhhcCcHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHH
Confidence 2334456789999999999877655 6899999999999999999999999999999999988887766 3589999
Q ss_pred HHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 245 QNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
.+||.+||+.||.+|||+.++++||||++..
T Consensus 235 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred HHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 9999999999999999999999999998654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-53 Score=428.56 Aligned_cols=262 Identities=31% Similarity=0.529 Sum_probs=230.1
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
....++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 45678999999999999999999999999999999999764433222344588999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
|+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..... .
T Consensus 145 ~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~-~ 222 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE-G 222 (410)
T ss_dssp EEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-S
T ss_pred EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC-C
Confidence 999999999999999875 57999999999999999999999999999999999999999999999999999754321 1
Q ss_pred CCccccccCCCcccchhhhccCC---CCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC--CCCC--CCCCH
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRG---YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLP--KWLSP 242 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~---~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~ 242 (426)
.....+.+||+.|+|||++.+.+ +++.++|||||||++|+|++|+.||.+.+....+.++..+. +.+| ..+++
T Consensus 223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~ 302 (410)
T 3v8s_A 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK 302 (410)
T ss_dssp EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCH
T ss_pred cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccH
Confidence 11234679999999999987654 24689999999999999999999999999999999987652 4455 46899
Q ss_pred HHHHHHHHccccCccC--CCCHHHHhcCccccc
Q 014347 243 GAQNLLRKILEPNPVK--RITIAGIKADEWFEQ 273 (426)
Q Consensus 243 ~~~~Li~~~L~~dP~~--R~t~~eil~h~~f~~ 273 (426)
++++||++||+.+|.+ |+++++|++||||+.
T Consensus 303 ~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~ 335 (410)
T 3v8s_A 303 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 335 (410)
T ss_dssp HHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred HHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence 9999999999999999 999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-53 Score=403.25 Aligned_cols=266 Identities=49% Similarity=0.906 Sum_probs=232.0
Q ss_pred ccCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 014347 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (426)
..+.+..++|++++.||+|+||.||+|.+..+|+.||+|++........+..+.+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 83 (276)
T 2h6d_A 4 HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP 83 (276)
T ss_dssp ---CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred ccCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 45567889999999999999999999999999999999999765443334467899999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcc
Q 014347 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 166 (426)
+..|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999999985432
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHH
Q 014347 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246 (426)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 246 (426)
.......+||+.|+|||++.+..+.+.++||||||+++|+|++|..||.+.+.......+..+....|..+++.+.+
T Consensus 164 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 240 (276)
T 2h6d_A 164 ---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVAT 240 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred ---CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHH
Confidence 22334568999999999998777666889999999999999999999999998888888888888889999999999
Q ss_pred HHHHccccCccCCCCHHHHhcCccccccC
Q 014347 247 LLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 247 Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
||.+||+.||.+|||+.++++||||++..
T Consensus 241 li~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 241 LLMHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred HHHHHccCChhhCCCHHHHHhChhhccCc
Confidence 99999999999999999999999998754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-53 Score=432.81 Aligned_cols=263 Identities=27% Similarity=0.501 Sum_probs=229.6
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
....++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence 34568999999999999999999999999999999999865433333334588999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
|+||||++||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~- 228 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED- 228 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC-
Confidence 999999999999999987 578999999999999999999999999999999999999999999999999999753221
Q ss_pred CCCccccccCCCcccchhhhcc----CCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC--CCCCCCC---
Q 014347 169 DDGLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--- 239 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~----~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~--- 239 (426)
........+||+.|+|||++.. .+.++.++|||||||++|+|++|+.||.+.+....+.++... .+.+|..
T Consensus 229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 308 (437)
T 4aw2_A 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTD 308 (437)
T ss_dssp SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCC
T ss_pred CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCccccc
Confidence 1112334689999999999862 333478999999999999999999999999999988888753 3555544
Q ss_pred CCHHHHHHHHHccccCccC--CCCHHHHhcCccccc
Q 014347 240 LSPGAQNLLRKILEPNPVK--RITIAGIKADEWFEQ 273 (426)
Q Consensus 240 ~s~~~~~Li~~~L~~dP~~--R~t~~eil~h~~f~~ 273 (426)
+++++++||++||..+|++ |++++++++||||+.
T Consensus 309 ~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 309 VSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred CCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 8999999999999999988 999999999999975
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-53 Score=410.90 Aligned_cols=265 Identities=35% Similarity=0.641 Sum_probs=223.2
Q ss_pred cccCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccc-----------------------hhHHHHHH
Q 014347 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-----------------------LKITDQIK 62 (426)
Q Consensus 6 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-----------------------~~~~~~~~ 62 (426)
+....+.+++|++.+.||+|+||.||+|++..+|+.||+|++.+..... ....+.+.
T Consensus 5 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (298)
T 2zv2_A 5 SSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVY 84 (298)
T ss_dssp -----CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHH
T ss_pred cCCCceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHH
Confidence 3445677899999999999999999999999999999999997654321 11245688
Q ss_pred HHHHHHHhCCCCCccceEEEEEe--CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccC
Q 014347 63 REIATLKLLKHPNVVRLHEVLAS--KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140 (426)
Q Consensus 63 ~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDL 140 (426)
+|+.+++.++||||+++++++.+ ....|+||||+++++|.+++. .+++++..++.++.||+.||.|||++||+||||
T Consensus 85 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dl 163 (298)
T 2zv2_A 85 QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDI 163 (298)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence 99999999999999999999986 678999999999999988653 467999999999999999999999999999999
Q ss_pred CCCcEEecCCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCC--CCCcchhhhHHHHHHHHHhCCCCCC
Q 014347 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY--DGATSDIWSCGVILYVILTGYLPFD 218 (426)
Q Consensus 141 Kp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~--~~~~~DIwSlGvil~elltG~~Pf~ 218 (426)
||+|||++.++.+||+|||++..... ........+||+.|+|||++.+... .+.++|||||||++|+|++|..||.
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKG--SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSS--SSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CHHHEEECCCCCEEEecCCCcccccc--ccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 99999999999999999999975432 2223455689999999999876542 4678999999999999999999999
Q ss_pred CCcHHHHHHHHHcCCCCCC--CCCCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 219 DRNLAVLYQKIFRGDFKLP--KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 219 ~~~~~~~~~~i~~~~~~~p--~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
+.+.......+......+| ..+++.+.+||.+||++||++|||+.++++||||++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 242 DERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp CSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred CccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 9988888888877766655 458999999999999999999999999999999963
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-53 Score=419.30 Aligned_cols=260 Identities=40% Similarity=0.765 Sum_probs=219.9
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
....++|++++.||+|+||.||+|++..+++.||+|++.+.... .+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 91 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHL 91 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence 34568999999999999999999999999999999999765432 25688999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCC--eEEeeccCccCCccc
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN--IKISDFGLSALPQHF 167 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~--vkL~DFGla~~~~~~ 167 (426)
|+||||++||+|.+++...+++++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 92 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~-- 169 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-- 169 (361)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc--
Confidence 999999999999999988889999999999999999999999999999999999999987765 9999999987422
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCc----HHHHHHHHHcCCCCCCC--CCC
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRGDFKLPK--WLS 241 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~~~~~~p~--~~s 241 (426)
........+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+.+ .......+......+|. .++
T Consensus 170 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 248 (361)
T 3uc3_A 170 -LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRIS 248 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCC
T ss_pred -ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCC
Confidence 22234556899999999999888887666999999999999999999998743 34556666666666665 479
Q ss_pred HHHHHHHHHccccCccCCCCHHHHhcCccccccCC
Q 014347 242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (426)
Q Consensus 242 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 276 (426)
+.+.+||.+||+.||.+|||+.++++||||.+...
T Consensus 249 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 283 (361)
T 3uc3_A 249 PECCHLISRIFVADPATRISIPEIKTHSWFLKNLP 283 (361)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence 99999999999999999999999999999987543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=411.41 Aligned_cols=260 Identities=35% Similarity=0.605 Sum_probs=231.9
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccch---hHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (426)
...++|++++.||+|+||.||+|++..+|+.||+|++.+...... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 87 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 87 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 344689999999999999999999999999999999986543221 13567899999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCC----CeEEeeccCccC
Q 014347 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG----NIKISDFGLSAL 163 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g----~vkL~DFGla~~ 163 (426)
..|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 9999999999999999998888999999999999999999999999999999999999999887 799999999985
Q ss_pred CccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCC----CC
Q 014347 164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KW 239 (426)
Q Consensus 164 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~ 239 (426)
... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......++ ..
T Consensus 168 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (326)
T 2y0a_A 168 IDF---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243 (326)
T ss_dssp CCT---TSCCCCCCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred CCC---CCccccccCCcCcCCceeecCCCC-CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccccc
Confidence 432 223456789999999999877666 6899999999999999999999999988888888877776665 45
Q ss_pred CCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 240 ~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
+++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus 244 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 89999999999999999999999999999999753
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=413.82 Aligned_cols=248 Identities=24% Similarity=0.311 Sum_probs=195.2
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC----EE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----KI 89 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~~ 89 (426)
.+|.+.+.||+|+||+||+|++ +|+.||||+++.... .....++|+..+.+++|||||++++++..++ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4689999999999999999986 689999999965431 1223445677777899999999999997653 68
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc--------CceeccCCCCcEEecCCCCeEEeeccCc
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK--------GVFHRDLKLENILLDSKGNIKISDFGLS 161 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~--------gIiHrDLKp~NILl~~~g~vkL~DFGla 161 (426)
|||||||+||+|.+++.+ .++++..+.+++.|++.||+|||++ +|+||||||+||||+.++++||+|||+|
T Consensus 77 ~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 999999999999999976 5799999999999999999999987 9999999999999999999999999999
Q ss_pred cCCccccC--CCccccccCCCcccchhhhccCC-----CCCCcchhhhHHHHHHHHHhCCCCCCC---------------
Q 014347 162 ALPQHFRD--DGLLHTTCGSPNYVAPEVLANRG-----YDGATSDIWSCGVILYVILTGYLPFDD--------------- 219 (426)
Q Consensus 162 ~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~-----~~~~~~DIwSlGvil~elltG~~Pf~~--------------- 219 (426)
+....... .......+||+.|+|||++.+.. .++.++|||||||+||||+||..||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 85433211 11233568999999999987542 125789999999999999999776532
Q ss_pred CcHHHHHHHHHcCC--CCCCCC-----CCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 220 RNLAVLYQKIFRGD--FKLPKW-----LSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 220 ~~~~~~~~~i~~~~--~~~p~~-----~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
.....+...+.... +.+|.. .++.+.+|+.+||+.||++|||+.+|++.
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 12334444444433 344433 23468899999999999999999999764
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-52 Score=399.74 Aligned_cols=266 Identities=35% Similarity=0.607 Sum_probs=242.7
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
....++|++++.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence 45668999999999999999999999999999999999877665666678899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
|+||||++|++|.+++...+.+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~--~ 168 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--D 168 (294)
T ss_dssp EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS--T
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceeccc--C
Confidence 99999999999999998888999999999999999999999999999999999999999999999999999975432 1
Q ss_pred CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 249 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 249 (426)
.......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+....+..+.......|..+++.+.+||.
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 247 (294)
T 2rku_A 169 GERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 247 (294)
T ss_dssp TCCBCCCCSCCSSCCHHHHTTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHH
T ss_pred ccccccccCCCCcCCcchhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHH
Confidence 223445689999999999877665 6899999999999999999999999998888888888888999999999999999
Q ss_pred HccccCccCCCCHHHHhcCccccccCCCC
Q 014347 250 KILEPNPVKRITIAGIKADEWFEQDYTPA 278 (426)
Q Consensus 250 ~~L~~dP~~R~t~~eil~h~~f~~~~~~~ 278 (426)
+||+.||++|||++++++||||.....+.
T Consensus 248 ~~l~~~p~~Rps~~~ll~~~~~~~~~~~~ 276 (294)
T 2rku_A 248 KMLQTDPTARPTINELLNDEFFTSGYIPA 276 (294)
T ss_dssp HHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred HHcccChhhCcCHHHHhhChheecCCcCC
Confidence 99999999999999999999998776543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=450.66 Aligned_cols=262 Identities=34% Similarity=0.617 Sum_probs=238.4
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCC
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS 87 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 87 (426)
....+++|++++.||+|+||.||+|++..+++.||||++.+.........+.+.+|..++..+ +||+|+++++++.+.+
T Consensus 336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~ 415 (674)
T 3pfq_A 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415 (674)
T ss_dssp ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence 346788999999999999999999999999999999999876544444467788999999987 6999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
.+|+||||++||+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+....
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~- 494 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW- 494 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC-
T ss_pred EEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc-
Confidence 9999999999999999999889999999999999999999999999999999999999999999999999999984322
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L 247 (426)
......+.+||+.|+|||++.+..| +.++|||||||+||+|++|..||.+.+...+++++......+|..+++++.+|
T Consensus 495 -~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 572 (674)
T 3pfq_A 495 -DGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAI 572 (674)
T ss_dssp -TTCCBCCCCSCSSSCCHHHHTCCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHH
T ss_pred -CCcccccccCCCcccCHhhhcCCCC-CccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHH
Confidence 2334567899999999999988777 68999999999999999999999999999999999999999999999999999
Q ss_pred HHHccccCccCCCCH-----HHHhcCccccc
Q 014347 248 LRKILEPNPVKRITI-----AGIKADEWFEQ 273 (426)
Q Consensus 248 i~~~L~~dP~~R~t~-----~eil~h~~f~~ 273 (426)
|++||++||.+||++ ++|++||||+.
T Consensus 573 i~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 573 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp HHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred HHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 999999999999997 99999999975
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=414.74 Aligned_cols=257 Identities=33% Similarity=0.655 Sum_probs=223.9
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccc--hhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH--LKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (426)
-++|++++.||+|+||.||+|.+..+|+.||||++....... ....+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 468999999999999999999999999999999997543221 112567899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCC---eEEeeccCccC
Q 014347 91 MVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSAL 163 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~~----~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~---vkL~DFGla~~ 163 (426)
+||||++|++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999999888642 35899999999999999999999999999999999999987665 99999999975
Q ss_pred CccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCC----CC
Q 014347 164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KW 239 (426)
Q Consensus 164 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~ 239 (426)
... ........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.. ...+..+..+....+ ..
T Consensus 183 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~ 258 (351)
T 3c0i_A 183 LGE--SGLVAGGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSH 258 (351)
T ss_dssp CCT--TSCBCCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTT
T ss_pred ecC--CCeeecCCcCCcCccCHHHHcCCCC-CchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcccccc
Confidence 432 2223456789999999999987766 689999999999999999999998864 456677777766654 45
Q ss_pred CCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 240 ~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
+++.+.+||.+||+.||.+|||+.++++||||+.
T Consensus 259 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 8999999999999999999999999999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-52 Score=407.15 Aligned_cols=265 Identities=35% Similarity=0.612 Sum_probs=242.5
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (426)
...++|.+++.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 45678999999999999999999999999999999998776656666788999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCC
Q 014347 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 170 (426)
+||||+.|++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~--~~ 195 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DG 195 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS--TT
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceeccc--Cc
Confidence 9999999999999998888999999999999999999999999999999999999999999999999999975432 12
Q ss_pred CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 014347 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 250 (426)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~ 250 (426)
......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+....+..+......+|..+++.+.+||.+
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 274 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 274 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHH
T ss_pred ccccccCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence 23445689999999999887666 68999999999999999999999999888888888888899999999999999999
Q ss_pred ccccCccCCCCHHHHhcCccccccCCCC
Q 014347 251 ILEPNPVKRITIAGIKADEWFEQDYTPA 278 (426)
Q Consensus 251 ~L~~dP~~R~t~~eil~h~~f~~~~~~~ 278 (426)
||+.||.+|||++++++|+||...+.+.
T Consensus 275 ~l~~dp~~Rps~~ell~~~~~~~~~~~~ 302 (335)
T 2owb_A 275 MLQTDPTARPTINELLNDEFFTSGYIPA 302 (335)
T ss_dssp HTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred HccCChhHCcCHHHHhcCccccCCCccc
Confidence 9999999999999999999999876544
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-53 Score=425.97 Aligned_cols=262 Identities=25% Similarity=0.456 Sum_probs=228.0
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
....++|++++.||+|+||.||+|+++.+|+.||+|++++...........+.+|..++..++||||+++++++.+.+.+
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL 136 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 45678999999999999999999999999999999999865443333455688999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
|+||||++||+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~- 215 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD- 215 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCC-
Confidence 9999999999999999875 47999999999999999999999999999999999999999999999999999754321
Q ss_pred CCCccccccCCCcccchhhhcc------CCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC--CCCCC---
Q 014347 169 DDGLLHTTCGSPNYVAPEVLAN------RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLP--- 237 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~------~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p--- 237 (426)
........+||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+.+....+.++... ...+|
T Consensus 216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 295 (412)
T 2vd5_A 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVD 295 (412)
T ss_dssp SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC---
T ss_pred CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccc
Confidence 1112235689999999999873 233478999999999999999999999999998888888753 24444
Q ss_pred CCCCHHHHHHHHHccccCccCC---CCHHHHhcCccccc
Q 014347 238 KWLSPGAQNLLRKILEPNPVKR---ITIAGIKADEWFEQ 273 (426)
Q Consensus 238 ~~~s~~~~~Li~~~L~~dP~~R---~t~~eil~h~~f~~ 273 (426)
..+|+++++||++||. +|.+| +++++|++||||+.
T Consensus 296 ~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~ 333 (412)
T 2vd5_A 296 EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333 (412)
T ss_dssp -CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence 5799999999999999 99998 59999999999975
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=400.57 Aligned_cols=264 Identities=31% Similarity=0.632 Sum_probs=210.0
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (426)
.+..+++|++++.||+|+||.||+|++..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 6 ~g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (278)
T 3cok_A 6 IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNY 85 (278)
T ss_dssp HCSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSE
T ss_pred cccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCe
Confidence 35678899999999999999999999999999999999976544333445789999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 89 IYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
.|+||||+++++|.+++... .++++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999999999999864 67999999999999999999999999999999999999999999999999998754321
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L 247 (426)
.......+||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...+......++.......|..+++++.+|
T Consensus 166 --~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 242 (278)
T 3cok_A 166 --HEKHYTLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDL 242 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHH
T ss_pred --CCcceeccCCCCcCCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHH
Confidence 122345689999999999876655 68999999999999999999999987766666666666778888899999999
Q ss_pred HHHccccCccCCCCHHHHhcCccccccC
Q 014347 248 LRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 248 i~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
|.+||+.||.+|||++++++||||....
T Consensus 243 i~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 243 IHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp HHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 9999999999999999999999998643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-52 Score=407.55 Aligned_cols=262 Identities=27% Similarity=0.441 Sum_probs=209.0
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
..++|++++.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+.+++.++||||+++++++.+++..|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 80 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL 80 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence 35789999999999999999999999999999999976542 2224678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 92 VLEYVTGGELFDKIASK------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~------~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 999998 5999988753 359999999999999999999999999999999999999999999999999997543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC--CC---------
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DF--------- 234 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~--------- 234 (426)
. ........+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+... ..
T Consensus 160 ~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 I--PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp S--CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred C--CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 2 1223345689999999999877555578999999999999999999999998877766665431 00
Q ss_pred -----------------------CCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccCCCC
Q 014347 235 -----------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 278 (426)
Q Consensus 235 -----------------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~~ 278 (426)
..+..+++++.+||.+||+.||++|||+.++++||||.+.+.++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 304 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHA 304 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC--
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchh
Confidence 01224688999999999999999999999999999999876543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-52 Score=394.56 Aligned_cols=258 Identities=37% Similarity=0.685 Sum_probs=233.2
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
+...++|++.+.||+|+||.||+|.+..++..||+|.+.+..... .+.+.+|+.+++.++||||+++++++.+....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (277)
T 3f3z_A 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDI 81 (277)
T ss_dssp -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeE
Confidence 445678999999999999999999999999999999997654333 56789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEe---cCCCCeEEeeccCccCCcc
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL---DSKGNIKISDFGLSALPQH 166 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl---~~~g~vkL~DFGla~~~~~ 166 (426)
|+||||++|++|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~- 160 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK- 160 (277)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc-
Confidence 9999999999999999988899999999999999999999999999999999999999 788899999999997543
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCC----CCCH
Q 014347 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSP 242 (426)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~ 242 (426)
........+||+.|+|||++.+. .+.++||||||+++|+|++|..||.+.+......++..+...+|. .+++
T Consensus 161 --~~~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (277)
T 3f3z_A 161 --PGKMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSP 236 (277)
T ss_dssp --TTSCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCH
T ss_pred --CccchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCH
Confidence 23344567899999999998653 478999999999999999999999999988888899888887775 5899
Q ss_pred HHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
.+.+||.+||++||.+|||+.++++||||++..
T Consensus 237 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 237 QAESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 999999999999999999999999999998754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-52 Score=415.19 Aligned_cols=265 Identities=21% Similarity=0.343 Sum_probs=221.2
Q ss_pred CccCCCeeeeceEeec--CceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 014347 10 GMRLGRYELGRTLGEG--NFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G--~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (426)
-...++|++++.||+| +||.||+|++..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 99 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 99 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence 3466899999999999 999999999999999999999987544 3455778999999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 88 KIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~--~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
..|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999999999875 679999999999999999999999999999999999999999999999999876432
Q ss_pred ccc-----CCCccccccCCCcccchhhhccC-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC------
Q 014347 166 HFR-----DDGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD------ 233 (426)
Q Consensus 166 ~~~-----~~~~~~~~~gt~~y~APE~l~~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------ 233 (426)
... ........+||+.|+|||++.+. ...+.++|||||||++|+|++|+.||.+.+.......+..+.
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 111 11223345899999999998763 234689999999999999999999998755443333222211
Q ss_pred ----------------------------------------CCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 234 ----------------------------------------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 234 ----------------------------------------~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
.+.+..+++.+.+||.+||+.||++|||++++++||||+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~ 339 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence 1234557899999999999999999999999999999986
Q ss_pred cC
Q 014347 274 DY 275 (426)
Q Consensus 274 ~~ 275 (426)
..
T Consensus 340 ~~ 341 (389)
T 3gni_B 340 IK 341 (389)
T ss_dssp C-
T ss_pred Hh
Confidence 53
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-52 Score=435.24 Aligned_cols=260 Identities=30% Similarity=0.446 Sum_probs=234.0
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
.+..++|++++.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 259 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence 46678999999999999999999999999999999999876544444456788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 90 YMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~--~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
|+||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~-- 337 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP-- 337 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecc--
Confidence 99999999999999998754 49999999999999999999999999999999999999999999999999997543
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCC----cHHHHHHHHHcCCCCCCCCCCHH
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR----NLAVLYQKIFRGDFKLPKWLSPG 243 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~ 243 (426)
........+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+. ....+...+......+|..++++
T Consensus 338 -~~~~~~~~~GT~~Y~APEvl~~~~~-~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~ 415 (576)
T 2acx_A 338 -EGQTIKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQ 415 (576)
T ss_dssp -TTCCEECCCSCGGGCCHHHHTTCEE-SSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred -cCccccccCCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHH
Confidence 2233456799999999999987776 68999999999999999999999875 34667777788888889999999
Q ss_pred HHHHHHHccccCccCCC-----CHHHHhcCccccc
Q 014347 244 AQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 273 (426)
Q Consensus 244 ~~~Li~~~L~~dP~~R~-----t~~eil~h~~f~~ 273 (426)
+.+||.+||++||.+|| +++++++||||+.
T Consensus 416 ~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 416 ARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp HHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred HHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 99999999999999999 7999999999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=392.45 Aligned_cols=259 Identities=37% Similarity=0.704 Sum_probs=232.6
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
..++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++...+..|+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 82 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence 45899999999999999999999999999999999976554 33446788999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCC---eEEeeccCccCCcccc
Q 014347 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFR 168 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~---vkL~DFGla~~~~~~~ 168 (426)
||||++|++|.+.+.....+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||++.....
T Consensus 83 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~-- 160 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND-- 160 (284)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS--
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc--
Confidence 9999999999999998889999999999999999999999999999999999999987665 99999999975432
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCC----CCCCHHH
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGA 244 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~ 244 (426)
........||+.|+|||++.+..+ +.++||||+|+++|+|++|..||.+.+.......+..+....| ..+++.+
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T 3kk8_A 161 -SEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 238 (284)
T ss_dssp -SCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred -CccccCCCCCcCCcCchhhcCCCC-CcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHH
Confidence 233445689999999999987766 6899999999999999999999999998888888888766555 3579999
Q ss_pred HHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 245 QNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
.+||.+||++||++|||+.++++||||....
T Consensus 239 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 239 KSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred HHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 9999999999999999999999999997643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-52 Score=432.51 Aligned_cols=262 Identities=27% Similarity=0.441 Sum_probs=235.0
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (426)
..+..++|++++.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.
T Consensus 180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 259 (543)
T 3c4z_A 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD 259 (543)
T ss_dssp SCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence 45678899999999999999999999999999999999987654444446788999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCC
Q 014347 89 IYMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~----~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~ 164 (426)
+|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++...
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 99999999999999999763 36999999999999999999999999999999999999999999999999999854
Q ss_pred ccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCC----cHHHHHHHHHcCCCCCCCCC
Q 014347 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR----NLAVLYQKIFRGDFKLPKWL 240 (426)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~ 240 (426)
.. ........+||+.|+|||++.+.+| +.++|||||||++|+|++|+.||.+. +...+++.+......+|..+
T Consensus 340 ~~--~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~ 416 (543)
T 3c4z_A 340 KA--GQTKTKGYAGTPGFMAPELLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKF 416 (543)
T ss_dssp CT--TCCCBCCCCSCTTTSCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTS
T ss_pred cC--CCcccccccCCccccChhhhcCCCC-ChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCccc
Confidence 32 1223345699999999999988776 68999999999999999999999875 45678888888889999999
Q ss_pred CHHHHHHHHHccccCccCCCC-----HHHHhcCccccc
Q 014347 241 SPGAQNLLRKILEPNPVKRIT-----IAGIKADEWFEQ 273 (426)
Q Consensus 241 s~~~~~Li~~~L~~dP~~R~t-----~~eil~h~~f~~ 273 (426)
++.+.+||++||++||.+||+ +++|++||||+.
T Consensus 417 s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred CHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 999999999999999999996 589999999975
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=414.26 Aligned_cols=261 Identities=30% Similarity=0.573 Sum_probs=231.2
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (426)
.+...++|++++.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+|+.++||||+++++++.+...
T Consensus 46 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 122 (387)
T 1kob_A 46 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE 122 (387)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred CCccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCE
Confidence 3556789999999999999999999999999999999997653 2234678899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecC--CCCeEEeeccCccCCc
Q 014347 89 IYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS--KGNIKISDFGLSALPQ 165 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~--~g~vkL~DFGla~~~~ 165 (426)
.|+||||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 99999999999999999764 47999999999999999999999999999999999999974 4679999999998543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCC----CCCC
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLS 241 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 241 (426)
........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......++ ..++
T Consensus 203 ---~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 278 (387)
T 1kob_A 203 ---PDEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS 278 (387)
T ss_dssp ---TTSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSC
T ss_pred ---CCcceeeeccCCCccCchhccCCCC-CCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCC
Confidence 2234456789999999999987666 6899999999999999999999999988888888887765544 3589
Q ss_pred HHHHHHHHHccccCccCCCCHHHHhcCccccccCC
Q 014347 242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (426)
Q Consensus 242 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 276 (426)
+++.+||.+||+.||.+|||+.++++||||+....
T Consensus 279 ~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 279 PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence 99999999999999999999999999999987543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-52 Score=405.45 Aligned_cols=263 Identities=29% Similarity=0.395 Sum_probs=217.4
Q ss_pred ccCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 014347 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (426)
.......++|++++.||+|+||.||+|++. +|+.||+|++..... .......+.+|+.+++.++||||+++++++.++
T Consensus 14 ~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 91 (311)
T 3niz_A 14 LYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSE 91 (311)
T ss_dssp -CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS
T ss_pred eeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC
Confidence 344567899999999999999999999985 589999999975432 333457788999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 87 SKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
...|+||||++| +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 92 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 92 RCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp SCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred CEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 999999999985 888887654 469999999999999999999999999999999999999999999999999998543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC--CCC--------
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFK-------- 235 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~-------- 235 (426)
. ........+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+......++... ...
T Consensus 171 ~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 171 I--PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp S--CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGT
T ss_pred C--CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhh
Confidence 2 2233445689999999999877555579999999999999999999999886655544444321 100
Q ss_pred --------------------CCCCCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 236 --------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 236 --------------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
..+.+++++.+||.+||++||.+|||++|+++||||++-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 112367899999999999999999999999999999863
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-52 Score=400.11 Aligned_cols=257 Identities=32% Similarity=0.502 Sum_probs=215.7
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (426)
+++|++++.||+|+||.||+|++ .+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 57999999999999999999998 7799999999975542 222346788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCC
Q 014347 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 171 (426)
|||+.+ +|.+.+.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ...
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~ 155 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVR 155 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCc--ccc
Confidence 999976 99998876 36799999999999999999999999999999999999999999999999999874322 122
Q ss_pred ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC--CC---------------
Q 014347 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DF--------------- 234 (426)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~--------------- 234 (426)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+... ..
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 3345689999999999877655579999999999999999999999988776666555431 00
Q ss_pred ------------CCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 235 ------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 235 ------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
.++..+++++.+||.+||+.||++|||++++++||||++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0123478999999999999999999999999999999863
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=413.04 Aligned_cols=252 Identities=37% Similarity=0.649 Sum_probs=222.9
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 90 (426)
..++|++++.||+|+||.||+|.+..+|+.||+|++.+... ...+|+.++.++ +||||+++++++.+....|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~ 92 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVY 92 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence 45789999999999999999999999999999999976542 234688888777 7999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCC-C---CeEEeeccCccCCcc
Q 014347 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-G---NIKISDFGLSALPQH 166 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~-g---~vkL~DFGla~~~~~ 166 (426)
+||||++||+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||+.++ + .+||+|||++.....
T Consensus 93 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 999999999999999988899999999999999999999999999999999999998543 3 499999999985432
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCC---CcHHHHHHHHHcCCCCCC----CC
Q 014347 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD---RNLAVLYQKIFRGDFKLP----KW 239 (426)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~---~~~~~~~~~i~~~~~~~p----~~ 239 (426)
......+.+||+.|+|||++.+.+| +.++|||||||++|+|++|..||.+ .+...+...+..+.+.++ ..
T Consensus 173 --~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 249 (342)
T 2qr7_A 173 --ENGLLMTPCYTANFVAPEVLERQGY-DAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS 249 (342)
T ss_dssp --TTCCBCCSSCCSSCCCHHHHHHHHH-HHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTT
T ss_pred --CCCceeccCCCccccCHHHhcCCCC-CCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccccc
Confidence 2334567799999999999987666 5889999999999999999999986 456778888888877665 45
Q ss_pred CCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 240 ~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
+++++.+||++||++||.+|||+.++++||||..
T Consensus 250 ~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 250 VSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 8999999999999999999999999999999965
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=426.76 Aligned_cols=263 Identities=35% Similarity=0.650 Sum_probs=231.7
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccch----------hHHHHHHHHHHHHHhCCCCCccc
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL----------KITDQIKREIATLKLLKHPNVVR 78 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~----------~~~~~~~~Ei~il~~l~hpnIv~ 78 (426)
.+...++|++++.||+|+||.||+|++..+++.||+|++.+...... ...+.+.+|+.+++.++||||++
T Consensus 31 ~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 110 (504)
T 3q5i_A 31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIK 110 (504)
T ss_dssp CSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCC
T ss_pred CCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCe
Confidence 34567899999999999999999999999999999999986543321 23567899999999999999999
Q ss_pred eEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCC---CeEE
Q 014347 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKI 155 (426)
Q Consensus 79 l~~~~~~~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g---~vkL 155 (426)
+++++.+...+|+||||++||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 111 LFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence 9999999999999999999999999999889999999999999999999999999999999999999999876 6999
Q ss_pred eeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCC
Q 014347 156 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK 235 (426)
Q Consensus 156 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~ 235 (426)
+|||++..... .......+||+.|+|||++.+ .+ +.++||||+||++|+|++|..||.+.+.......+..+.+.
T Consensus 191 ~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 265 (504)
T 3q5i_A 191 VDFGLSSFFSK---DYKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYY 265 (504)
T ss_dssp CCCTTCEECCT---TSCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred EECCCCEEcCC---CCccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999985432 234556789999999999864 44 68999999999999999999999999999999999988876
Q ss_pred CC----CCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccCC
Q 014347 236 LP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (426)
Q Consensus 236 ~p----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 276 (426)
++ ..+|+++.+||++||++||.+|||++++++||||+....
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 266 FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 65 458999999999999999999999999999999987543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=398.79 Aligned_cols=259 Identities=28% Similarity=0.419 Sum_probs=217.5
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (426)
+++|++++.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 689999999999999999999999999999999986553 2334467788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
|||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~ 158 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG--PSDY 158 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC--cccc
Confidence 99999999999988888899999999999999999999999999999999999999999999999999975432 2223
Q ss_pred cccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC--------------------
Q 014347 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------------- 232 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------------- 232 (426)
....+||+.|+|||++.+....+.++||||+|+++|+|++|..||.+.+.......+...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 445689999999999877555579999999999999999999999987766554443221
Q ss_pred -CCCCC----------CCCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 233 -DFKLP----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 233 -~~~~p----------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
..+.+ +.+++.+.+||.+||++||.+|||++++++||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence 01111 2478889999999999999999999999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-52 Score=428.54 Aligned_cols=261 Identities=36% Similarity=0.652 Sum_probs=234.5
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
....++|++.+.||+|+||.||+|++..+|+.||||++.+.........+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 101 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF 101 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 34457899999999999999999999999999999999876654444567899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEe---cCCCCeEEeeccCccCCcc
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL---DSKGNIKISDFGLSALPQH 166 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl---~~~g~vkL~DFGla~~~~~ 166 (426)
|+||||+.||+|.+.+...+++++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~- 180 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE- 180 (484)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC-
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc-
Confidence 9999999999999999988899999999999999999999999999999999999999 567899999999997543
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCC--C--CCCH
Q 014347 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP--K--WLSP 242 (426)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p--~--~~s~ 242 (426)
........+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.+......++..+.+.++ . .+++
T Consensus 181 --~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 256 (484)
T 3nyv_A 181 --ASKKMKDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE 256 (484)
T ss_dssp --CCCSHHHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCH
T ss_pred --cccccccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCH
Confidence 2334556789999999999865 44 6899999999999999999999999999999999988865543 3 3899
Q ss_pred HHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
.+++||++||++||.+|||+.++++||||+...
T Consensus 257 ~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 257 SAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 999999999999999999999999999998653
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-52 Score=415.33 Aligned_cols=261 Identities=30% Similarity=0.400 Sum_probs=211.7
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCC--
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKS-- 87 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~-- 87 (426)
..+++|++++.||+|+||.||+|.+..+|+.||||++.+.. .......++.+|+.+++.+. ||||+++++++...+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 45689999999999999999999999999999999986542 33445678889999999997 999999999997544
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
.+|+||||+. ++|.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 7899999997 589988876 67999999999999999999999999999999999999999999999999999754221
Q ss_pred -------------------cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHH
Q 014347 168 -------------------RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK 228 (426)
Q Consensus 168 -------------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~ 228 (426)
.........+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+......+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 0112344568999999999998755557999999999999999999999999887776666
Q ss_pred HHcCC--C---------------------------------------------CCCCCCCHHHHHHHHHccccCccCCCC
Q 014347 229 IFRGD--F---------------------------------------------KLPKWLSPGAQNLLRKILEPNPVKRIT 261 (426)
Q Consensus 229 i~~~~--~---------------------------------------------~~p~~~s~~~~~Li~~~L~~dP~~R~t 261 (426)
+.... + ..+..+++++.+||.+||+.||.+|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 54210 0 011256889999999999999999999
Q ss_pred HHHHhcCcccccc
Q 014347 262 IAGIKADEWFEQD 274 (426)
Q Consensus 262 ~~eil~h~~f~~~ 274 (426)
++|+++||||...
T Consensus 323 ~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 323 ANDALKHPFVSIF 335 (388)
T ss_dssp HHHHTTSTTTTTT
T ss_pred HHHHhCCHHHHHh
Confidence 9999999999764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-52 Score=406.49 Aligned_cols=254 Identities=38% Similarity=0.723 Sum_probs=205.6
Q ss_pred cCCCeeee---ceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCC
Q 014347 12 RLGRYELG---RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKS 87 (426)
Q Consensus 12 ~~~~y~i~---~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 87 (426)
..++|++. +.||+|+||.||+|.+..+|+.||||++.+.. ...+.+|+.+++.+. ||||+++++++.+..
T Consensus 6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~ 79 (325)
T 3kn6_A 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQL 79 (325)
T ss_dssp HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence 34678875 78999999999999999999999999996542 467789999999997 999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCC---CeEEeeccCccCC
Q 014347 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALP 164 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g---~vkL~DFGla~~~ 164 (426)
..|+||||++||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 80 HTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 9999999999999999999988999999999999999999999999999999999999998766 7999999999754
Q ss_pred ccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCc-------HHHHHHHHHcCCCCCC
Q 014347 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-------LAVLYQKIFRGDFKLP 237 (426)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~-------~~~~~~~i~~~~~~~p 237 (426)
.. ........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+ ......++..+.+.++
T Consensus 160 ~~--~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~ 236 (325)
T 3kn6_A 160 PP--DNQPLKTPCFTLHYAAPELLNQNGY-DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE 236 (325)
T ss_dssp CC------------------------CCC-CHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC
T ss_pred CC--CCCcccccCCCcCccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC
Confidence 32 2234456789999999999987776 689999999999999999999998643 3567778887777665
Q ss_pred C----CCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 238 K----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 238 ~----~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
. .+++++.+||.+||++||.+|||++++++||||+..
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 3 489999999999999999999999999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=400.22 Aligned_cols=260 Identities=34% Similarity=0.581 Sum_probs=232.4
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccch---hHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (426)
....++|++++.||+|+||.||+|++..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR 87 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 4456789999999999999999999999999999999986543221 1356789999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCC----CeEEeeccCcc
Q 014347 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG----NIKISDFGLSA 162 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g----~vkL~DFGla~ 162 (426)
...|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 99999999999999999999888899999999999999999999999999999999999999888 79999999997
Q ss_pred CCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCC----C
Q 014347 163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----K 238 (426)
Q Consensus 163 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~ 238 (426)
.... .......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+......++ .
T Consensus 168 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (321)
T 2a2a_A 168 EIED---GVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS 243 (321)
T ss_dssp ECCT---TCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred ecCc---cccccccCCCCCccCcccccCCCC-CCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhc
Confidence 5432 223345679999999999887666 6899999999999999999999999988888888887776665 4
Q ss_pred CCCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 239 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 239 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
.+++.+.+||.+||+.||.+|||+.++++||||..
T Consensus 244 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp TCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 58999999999999999999999999999999974
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-52 Score=406.59 Aligned_cols=264 Identities=27% Similarity=0.402 Sum_probs=214.0
Q ss_pred ccCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 014347 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (426)
.+....+++|++++.||+|+||.||+|++..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (329)
T 3gbz_A 27 APSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHN 105 (329)
T ss_dssp -----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEET
T ss_pred CCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecC
Confidence 3456788999999999999999999999999999999999975543 233356778999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEec-----CCCCeEEeeccCc
Q 014347 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-----SKGNIKISDFGLS 161 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~-----~~g~vkL~DFGla 161 (426)
...|+||||+.| +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 106 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 106 HRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp TEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred CEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 999999999975 9999999888999999999999999999999999999999999999995 4455999999999
Q ss_pred cCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC--CCC----
Q 014347 162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFK---- 235 (426)
Q Consensus 162 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~---- 235 (426)
..... ........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+......++... .+.
T Consensus 185 ~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 185 RAFGI--PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW 262 (329)
T ss_dssp HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccCC--cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence 75322 1223445688999999999987665579999999999999999999999998877666665432 110
Q ss_pred -----CC-------------------CCCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 236 -----LP-------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 236 -----~p-------------------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
.+ ..+++++.+||.+||++||.+|||++|+++||||+..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 01 1167899999999999999999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=392.39 Aligned_cols=263 Identities=38% Similarity=0.670 Sum_probs=227.9
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
.+++|++++.||+|+||.||+|.+..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence 35789999999999999999999999999999999976543 2345788999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCC
Q 014347 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 171 (426)
||||++|++|.+++.....+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++..........
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 99999999999999887889999999999999999999999999999999999999999999999999997543322223
Q ss_pred ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHH-HHHHHHHcCCCCCC--CCCCHHHHHHH
Q 014347 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDFKLP--KWLSPGAQNLL 248 (426)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~p--~~~s~~~~~Li 248 (426)
.....+||+.|+|||++.+..+.+.++||||||+++|+|++|..||...+.. ..+..+.......+ ..+++.+.+||
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHH
Confidence 3456789999999999987777678899999999999999999999876543 33344444333333 45899999999
Q ss_pred HHccccCccCCCCHHHHhcCccccccCC
Q 014347 249 RKILEPNPVKRITIAGIKADEWFEQDYT 276 (426)
Q Consensus 249 ~~~L~~dP~~R~t~~eil~h~~f~~~~~ 276 (426)
.+||+.||.+|||++++++||||++...
T Consensus 243 ~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 243 HKILVENPSARITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHCCCCchhCCCHHHHhcCccccChhh
Confidence 9999999999999999999999987543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=425.47 Aligned_cols=262 Identities=37% Similarity=0.646 Sum_probs=231.0
Q ss_pred cCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 014347 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (426)
..+...++|++++.||+|+||.||+|++..+|+.||||++.+..... .....+.+|+.+++.++||||+++++++.+..
T Consensus 16 ~~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 94 (486)
T 3mwu_A 16 FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSS 94 (486)
T ss_dssp TCCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCC
Confidence 34556789999999999999999999999999999999997654322 23577899999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEec---CCCCeEEeeccCccCC
Q 014347 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD---SKGNIKISDFGLSALP 164 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~---~~g~vkL~DFGla~~~ 164 (426)
.+|+||||+.||+|.+.+...+++++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 95 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 9999999999999999999888999999999999999999999999999999999999995 4567999999999854
Q ss_pred ccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCC--C--CC
Q 014347 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP--K--WL 240 (426)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p--~--~~ 240 (426)
.. .......+||+.|+|||++.+ .| +.++|||||||++|+|++|..||.+.+.......+..+.+.++ . .+
T Consensus 175 ~~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 249 (486)
T 3mwu_A 175 QQ---NTKMKDRIGTAYYIAPEVLRG-TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTI 249 (486)
T ss_dssp CC---C----CCTTGGGGCCGGGGGS-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGS
T ss_pred CC---CCccCCCcCCCCCCCHHHhCC-CC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCC
Confidence 32 233456789999999999875 34 6899999999999999999999999999999988888765543 3 38
Q ss_pred CHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 241 s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
|+.+++||.+||++||.+|||+.++++||||+...
T Consensus 250 s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 250 SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 99999999999999999999999999999998754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-51 Score=391.25 Aligned_cols=259 Identities=36% Similarity=0.625 Sum_probs=223.0
Q ss_pred cCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 014347 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (426)
..|...++|++.+.||+|+||.||+|.+..++..||+|++...... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 16 ~~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 93 (285)
T 3is5_A 16 FQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH 93 (285)
T ss_dssp ESSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCC
Confidence 4466778999999999999999999999999999999999865432 22578899999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEe---cCCCCeEEeeccC
Q 014347 88 KIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL---DSKGNIKISDFGL 160 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~----~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl---~~~g~vkL~DFGl 160 (426)
..|+||||++||+|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~ 173 (285)
T 3is5_A 94 NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGL 173 (285)
T ss_dssp EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCC
T ss_pred eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeec
Confidence 99999999999999998854 3679999999999999999999999999999999999999 4567899999999
Q ss_pred ccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCC---
Q 014347 161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP--- 237 (426)
Q Consensus 161 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p--- 237 (426)
+..... .......+||+.|+|||++.. .+ +.++||||||+++|+|++|..||.+.+.......+.......+
T Consensus 174 a~~~~~---~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (285)
T 3is5_A 174 AELFKS---DEHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVEC 248 (285)
T ss_dssp CCC-------------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--
T ss_pred ceecCC---cccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccccc
Confidence 985432 223456689999999999753 44 6899999999999999999999999988887777766654443
Q ss_pred CCCCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 238 ~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
..+++.+.+||.+||++||.+|||+.|+++||||++
T Consensus 249 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 249 RPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred CcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 237899999999999999999999999999999975
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-51 Score=396.65 Aligned_cols=263 Identities=33% Similarity=0.577 Sum_probs=220.2
Q ss_pred CCccCCCeeee-ceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEeC
Q 014347 9 EGMRLGRYELG-RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK 86 (426)
Q Consensus 9 ~~~~~~~y~i~-~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 86 (426)
.+...++|++. +.||+|+||.||+|++..+++.||||++.+... .....+.+|+.+++++ +||||+++++++.+.
T Consensus 7 ~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~ 83 (316)
T 2ac3_A 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEE 83 (316)
T ss_dssp CCCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred CcccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 34556789995 789999999999999999999999999976532 2356788999999884 799999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCC---eEEeeccCccC
Q 014347 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSAL 163 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~---vkL~DFGla~~ 163 (426)
+..|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 84 DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 999999999999999999998889999999999999999999999999999999999999998876 99999999875
Q ss_pred CccccC-----CCccccccCCCcccchhhhccC----CCCCCcchhhhHHHHHHHHHhCCCCCCCCc-------------
Q 014347 164 PQHFRD-----DGLLHTTCGSPNYVAPEVLANR----GYDGATSDIWSCGVILYVILTGYLPFDDRN------------- 221 (426)
Q Consensus 164 ~~~~~~-----~~~~~~~~gt~~y~APE~l~~~----~~~~~~~DIwSlGvil~elltG~~Pf~~~~------------- 221 (426)
...... .......+||+.|+|||++... ...+.++|||||||++|+|++|..||.+.+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 432111 1123356799999999998641 223688999999999999999999998753
Q ss_pred --HHHHHHHHHcCCCCCC----CCCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 222 --LAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 222 --~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
....+..+..+...+| ..+++.+.+||.+||+.||.+|||++++++||||+..
T Consensus 244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred hHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 2446677777777776 3589999999999999999999999999999999863
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=423.46 Aligned_cols=257 Identities=28% Similarity=0.439 Sum_probs=213.8
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC-----
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK----- 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 86 (426)
..++|++++.||+|+||.||+|.+..+|+.||||++.+.. ......+++.+|+.+|+.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 4689999999999999999999999999999999997653 3444567899999999999999999999999654
Q ss_pred -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 87 -~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
..+|+||||+.+ +|.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred CCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 468999999976 5767664 459999999999999999999999999999999999999999999999999998543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC------------
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD------------ 233 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------ 233 (426)
........+||+.|+|||++.+.+| +.++|||||||++|+|++|+.||.+.+....+.++....
T Consensus 216 ---~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 216 ---TSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ----CCCC----CCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred ---CCcccCCCcccccccCHHHHcCCCC-CHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 2334566799999999999988777 589999999999999999999999988777666654310
Q ss_pred ---------------CCCCCC---------------CCHHHHHHHHHccccCccCCCCHHHHhcCccccccCC
Q 014347 234 ---------------FKLPKW---------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (426)
Q Consensus 234 ---------------~~~p~~---------------~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 276 (426)
..+|.. .++++++||.+||++||.+|||++|+++||||+....
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 364 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 364 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence 011111 1567999999999999999999999999999986543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-51 Score=403.78 Aligned_cols=256 Identities=35% Similarity=0.664 Sum_probs=210.5
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (426)
...++|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 34567999999999999999999999999999999997543 2356889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecC---CCCeEEeeccCccCCccc
Q 014347 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KGNIKISDFGLSALPQHF 167 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~---~g~vkL~DFGla~~~~~~ 167 (426)
+||||++|++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~- 203 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH- 203 (349)
T ss_dssp EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc-
Confidence 99999999999999998888999999999999999999999999999999999999975 88999999999985432
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHH-HHHHHHHcCCCCCC----CCCCH
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDFKLP----KWLSP 242 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~p----~~~s~ 242 (426)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.... ..+..+.......+ ..+++
T Consensus 204 --~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 280 (349)
T 2w4o_A 204 --QVLMKTVCGTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL 280 (349)
T ss_dssp -----------CGGGSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred --ccccccccCCCCccCHHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence 223456789999999999987666 68999999999999999999999776544 46677777655443 34789
Q ss_pred HHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
.+.+||.+||+.||++|||+.++++||||....
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 281 NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 999999999999999999999999999998643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=423.82 Aligned_cols=257 Identities=35% Similarity=0.658 Sum_probs=224.7
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (426)
...++|++++.||+|+||.||+|++..++..||+|++.+...... ....+.+|+.+++.++||||+++++++.+...+|
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 112 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY 112 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 344679999999999999999999999999999999986543222 2467889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCC---CCeEEeeccCccCCccc
Q 014347 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHF 167 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~---g~vkL~DFGla~~~~~~ 167 (426)
+||||++||+|.+.+....++++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus 113 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~- 191 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN- 191 (494)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT-
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC-
Confidence 999999999999999988899999999999999999999999999999999999999764 4599999999986432
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCC----CCCCHH
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPG 243 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~ 243 (426)
.......+||+.|+|||++.. .| +.++||||+||++|+|++|..||.+.+......++..+...++ ..+++.
T Consensus 192 --~~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 267 (494)
T 3lij_A 192 --QKKMKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEG 267 (494)
T ss_dssp --TBCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHH
T ss_pred --CccccccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHH
Confidence 233456789999999999863 44 6899999999999999999999999999999999988876654 248999
Q ss_pred HHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
+.+||++||++||.+|||+.++++||||+.
T Consensus 268 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 268 AKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred HHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 999999999999999999999999999976
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=402.31 Aligned_cols=260 Identities=25% Similarity=0.389 Sum_probs=213.7
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (426)
+++|++++.||+|+||.||+|++..+++.||+|++...... .....+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 57999999999999999999999999999999998654321 1122455799999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCC
Q 014347 93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 171 (426)
|||+.| +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~--~~~ 155 (324)
T 3mtl_A 79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSI--PTK 155 (324)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccC--Ccc
Confidence 999975 899988764 4599999999999999999999999999999999999999999999999999975432 222
Q ss_pred ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC--CC---C-----------
Q 014347 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DF---K----------- 235 (426)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~---~----------- 235 (426)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+... .+ .
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 3445689999999999887555579999999999999999999999998877766665431 10 0
Q ss_pred --------------CCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccCCC
Q 014347 236 --------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (426)
Q Consensus 236 --------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 277 (426)
.++.+++++.+||.+||+.||.+|||++|+++||||......
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 012367899999999999999999999999999999875433
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-51 Score=396.31 Aligned_cols=260 Identities=31% Similarity=0.409 Sum_probs=215.0
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeeccccc--chhHHHHHHHHHHHHHhCC---CCCccceEEEEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--HLKITDQIKREIATLKLLK---HPNVVRLHEVLA 84 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~ 84 (426)
.+..++|++++.||+|+||.||+|++..+|+.||+|++...... .......+.+|+.+++.++ ||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 34568999999999999999999999999999999999754321 1112345667888777665 999999999998
Q ss_pred eCC-----EEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEee
Q 014347 85 SKS-----KIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISD 157 (426)
Q Consensus 85 ~~~-----~~~lV~Ey~~gg~L~~~i~~~~~--l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~D 157 (426)
... ..++||||+. ++|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECS
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEee
Confidence 765 5899999997 599999987554 99999999999999999999999999999999999999999999999
Q ss_pred ccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC--CC
Q 014347 158 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FK 235 (426)
Q Consensus 158 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~ 235 (426)
||++..... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+......++.... .+
T Consensus 164 fg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (308)
T 3g33_A 164 FGLARIYSY---QMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239 (308)
T ss_dssp CSCTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCC-CSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred CccccccCC---CcccCCccccccccCchHHcCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999986432 334456789999999999987776 689999999999999999999999988877776665321 00
Q ss_pred -------------------------CCCCCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 236 -------------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 236 -------------------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
..+.+++.+.+||.+||++||.+|||+.++++||||++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 012467899999999999999999999999999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=394.00 Aligned_cols=254 Identities=26% Similarity=0.448 Sum_probs=223.9
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEe
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (426)
.|+..+.||+|+||.||+|++..+|+.||||++...... ..+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 488889999999999999999999999999999765432 25678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccc
Q 014347 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH 174 (426)
Q Consensus 95 y~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 174 (426)
|++|++|.+++.. .++++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ......
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~ 199 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK--DVPKRK 199 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--SSCCBC
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeeccc--Cccccc
Confidence 9999999998865 6799999999999999999999999999999999999999999999999999875432 122334
Q ss_pred cccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCC---CCCCCCHHHHHHHHHc
Q 014347 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK---LPKWLSPGAQNLLRKI 251 (426)
Q Consensus 175 ~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~Li~~~ 251 (426)
..+||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+.....+ .+..+++.+.+||.+|
T Consensus 200 ~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 278 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLY-ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERM 278 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHH
T ss_pred cccCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHH
Confidence 5689999999999877666 68999999999999999999999998887777777665432 2345889999999999
Q ss_pred cccCccCCCCHHHHhcCccccccC
Q 014347 252 LEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 252 L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
|+.||.+|||+.++++||||.+..
T Consensus 279 l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 279 LVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp SCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred ccCChhhCcCHHHHhcChhhccCC
Confidence 999999999999999999998643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=390.73 Aligned_cols=262 Identities=25% Similarity=0.387 Sum_probs=224.7
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (426)
+...-++|++++.||+|+||.||+|++..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 85 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC 85 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSE
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCe
Confidence 34556799999999999999999999999999999999977666666667889999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
.|+||||++|++|.+++...+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 164 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET- 164 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc-
Confidence 9999999999999999998889999999999999999999999999999999999999999999999999999864321
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCC-----CCCCCCHH
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-----LPKWLSPG 243 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s~~ 243 (426)
........+||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.+.+......+......+ .+..+++.
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243 (294)
T ss_dssp ----------CCSSCCHHHHHTCCC-CTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHH
T ss_pred cccccCccccCccccCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHH
Confidence 1122345679999999999887666 68899999999999999999999998877766666555432 34568999
Q ss_pred HHHHHHHccccCccCCCCHHHHhcCcccc
Q 014347 244 AQNLLRKILEPNPVKRITIAGIKADEWFE 272 (426)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~eil~h~~f~ 272 (426)
+.++|.+||++||.+||+..+.+.+.|..
T Consensus 244 l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 244 LSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp HHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred HHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 99999999999999999777777777754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-51 Score=394.42 Aligned_cols=265 Identities=37% Similarity=0.676 Sum_probs=229.5
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccc-hhHHHHHHHHHHHHHhCCCCCccceEEEE--EeCCE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-LKITDQIKREIATLKLLKHPNVVRLHEVL--ASKSK 88 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~--~~~~~ 88 (426)
.+++|++++.||+|+||.||+|.+..+++.||+|++....... ......+.+|+.+++.++||||+++++++ .+...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 5689999999999999999999999999999999997654221 23457899999999999999999999998 44567
Q ss_pred EEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcc
Q 014347 89 IYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~--~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 166 (426)
.|+||||+.++ |.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 89999999876 7777765 45799999999999999999999999999999999999999999999999999986543
Q ss_pred ccCCCccccccCCCcccchhhhccCC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHH
Q 014347 167 FRDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ 245 (426)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 245 (426)
...........||+.|+|||++.+.. +.+.++||||||+++|+|++|..||.+.+.......+..+...+|..+++.+.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 241 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLS 241 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHH
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHH
Confidence 33333445667999999999987533 34678999999999999999999999999989999999999999999999999
Q ss_pred HHHHHccccCccCCCCHHHHhcCccccccCCC
Q 014347 246 NLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (426)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 277 (426)
+||.+||+.||.+|||+.++++||||++...+
T Consensus 242 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 242 DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273 (305)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred HHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence 99999999999999999999999999875543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-51 Score=402.81 Aligned_cols=267 Identities=26% Similarity=0.372 Sum_probs=223.1
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe---
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--- 85 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--- 85 (426)
....+++|++++.||+|+||.||+|++..+|+.||+|++...... ......+.+|+.+++.++||||+++++++..
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 90 (351)
T 3mi9_A 12 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKAS 90 (351)
T ss_dssp TSCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred ccccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc-ccchHHHHHHHHHHHhccCCCcccHhheeecccc
Confidence 345789999999999999999999999999999999998665432 2234567899999999999999999999877
Q ss_pred -----CCEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeecc
Q 014347 86 -----KSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG 159 (426)
Q Consensus 86 -----~~~~~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFG 159 (426)
.+.+|+||||+.| +|.+.+.. ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 91 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 91 PYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp ------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccch
Confidence 4578999999976 77777765 4679999999999999999999999999999999999999999999999999
Q ss_pred CccCCcccc--CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCC
Q 014347 160 LSALPQHFR--DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP 237 (426)
Q Consensus 160 la~~~~~~~--~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p 237 (426)
++....... ........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.......+
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 997543221 122334568999999999987766557999999999999999999999999887776666654211111
Q ss_pred CC--------------------------------CCHHHHHHHHHccccCccCCCCHHHHhcCccccccCCC
Q 014347 238 KW--------------------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (426)
Q Consensus 238 ~~--------------------------------~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 277 (426)
.. .++.+.+||.+||+.||.+|||++|+++||||.....+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 321 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP 321 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence 10 26789999999999999999999999999999876544
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-51 Score=411.45 Aligned_cols=255 Identities=31% Similarity=0.593 Sum_probs=212.1
Q ss_pred CCccCCCeeee-ceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHH-HhCCCCCccceEEEEEe-
Q 014347 9 EGMRLGRYELG-RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVRLHEVLAS- 85 (426)
Q Consensus 9 ~~~~~~~y~i~-~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~- 85 (426)
.+..+++|.+. +.||+|+||.||+|.+..+|+.||||++... ..+.+|+.++ +..+||||+++++++..
T Consensus 56 ~~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~ 127 (400)
T 1nxk_A 56 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL 127 (400)
T ss_dssp CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred CCcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeec
Confidence 35567889987 7899999999999999999999999998632 3567888887 55689999999999876
Q ss_pred ---CCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecC---CCCeEEee
Q 014347 86 ---KSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KGNIKISD 157 (426)
Q Consensus 86 ---~~~~~lV~Ey~~gg~L~~~i~~~~--~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~---~g~vkL~D 157 (426)
...+|+||||++||+|.+++...+ .+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 128 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred ccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEe
Confidence 667999999999999999998643 5999999999999999999999999999999999999997 78899999
Q ss_pred ccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHH----HHHHHHHcCC
Q 014347 158 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA----VLYQKIFRGD 233 (426)
Q Consensus 158 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~----~~~~~i~~~~ 233 (426)
||+++... ......+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+.. .....+..+.
T Consensus 208 FG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~ 283 (400)
T 1nxk_A 208 FGFAKETT---SHNSLTTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 283 (400)
T ss_dssp CTTCEECC--------------CTTCCGGGSCCCCS-SSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTC
T ss_pred cccccccC---CCCccccCCCCCCccCHhhcCCCCC-CCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCc
Confidence 99998532 2233457799999999999877776 68999999999999999999999875432 2455566666
Q ss_pred CCCC----CCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 234 FKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 234 ~~~p----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
+.+| ..+++++.+||++||+.||.+|||+.++++||||....
T Consensus 284 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 284 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred ccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 5554 34899999999999999999999999999999998654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=406.77 Aligned_cols=256 Identities=30% Similarity=0.513 Sum_probs=225.6
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccch-----hHHHHHHHHHHHHHhCCCCCccceEEEEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-----KITDQIKREIATLKLLKHPNVVRLHEVLA 84 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 84 (426)
+...++|++++.||+|+||.||+|++..+++.||||++.+...... .....+.+|+.+++.++||||+++++++.
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 99 (335)
T 3dls_A 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE 99 (335)
T ss_dssp THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 4455789999999999999999999999999999999987643221 12345778999999999999999999999
Q ss_pred eCCEEEEEEeccCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccC
Q 014347 85 SKSKIYMVLEYVTGG-ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (426)
Q Consensus 85 ~~~~~~lV~Ey~~gg-~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~ 163 (426)
+.+..|+||||+.+| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 999999999998766 9999999888999999999999999999999999999999999999999999999999999985
Q ss_pred CccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHH
Q 014347 164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPG 243 (426)
Q Consensus 164 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 243 (426)
.. ........+||+.|+|||++.+..+.+.++|||||||++|+|++|..||..... ........|..++++
T Consensus 180 ~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~~~ 250 (335)
T 3dls_A 180 LE---RGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIHPPYLVSKE 250 (335)
T ss_dssp CC---TTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCCCSSCCCHH
T ss_pred CC---CCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccCCCcccCHH
Confidence 43 233445678999999999998888777899999999999999999999987432 233455667779999
Q ss_pred HHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
+.+||.+||++||.+|||+.++++||||.+.
T Consensus 251 l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 251 LMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 9999999999999999999999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=400.38 Aligned_cols=266 Identities=26% Similarity=0.420 Sum_probs=225.4
Q ss_pred cCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 014347 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (426)
+.....++|++++.||+|+||.||+|++..+++.||+|++.............+.+|+.+++.++||||+++++++....
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 85 (311)
T 3ork_A 6 TPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 85 (311)
T ss_dssp CCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred CcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence 34566789999999999999999999999999999999998766656666788999999999999999999999987543
Q ss_pred ----EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccC
Q 014347 88 ----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (426)
Q Consensus 88 ----~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~ 163 (426)
..|+||||++|++|.+++...+++++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 86 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 86 PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp TTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred CCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 3599999999999999999888999999999999999999999999999999999999999999999999999985
Q ss_pred CccccC-CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCC----C
Q 014347 164 PQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----K 238 (426)
Q Consensus 164 ~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~ 238 (426)
...... .......+||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.+.+.......+.......+ .
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 244 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHST
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccC
Confidence 433211 122334679999999999987766 6899999999999999999999999888777666666554433 4
Q ss_pred CCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 239 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 239 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
.+++++.+||.+||++||.+||++.+++.|+|+...
T Consensus 245 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 245 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 589999999999999999999999999999999753
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-51 Score=417.98 Aligned_cols=261 Identities=30% Similarity=0.398 Sum_probs=201.1
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe-----CC
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-----KS 87 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~~ 87 (426)
-++|++++.||+|+||.||+|++..+|+.||||++.+.. .+....+++.+|+.+|+.++||||+++++++.. ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 478999999999999999999999999999999986543 344456789999999999999999999999843 35
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
.+|+||||+ +++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred eEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 799999998 5699999998888999999999999999999999999999999999999999999999999999865321
Q ss_pred cCC-------------------------CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh----------
Q 014347 168 RDD-------------------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT---------- 212 (426)
Q Consensus 168 ~~~-------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt---------- 212 (426)
... ......+||+.|+|||++.....++.++|||||||+||+|++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~ 289 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA 289 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence 110 134456899999999987655545799999999999999999
Q ss_pred -CCCCCCCCcH--------------------HHHHHHHHc--CC--------------------C---------CCCCCC
Q 014347 213 -GYLPFDDRNL--------------------AVLYQKIFR--GD--------------------F---------KLPKWL 240 (426)
Q Consensus 213 -G~~Pf~~~~~--------------------~~~~~~i~~--~~--------------------~---------~~p~~~ 240 (426)
|.+||.+.+. ......+.. +. + ...+.+
T Consensus 290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (458)
T 3rp9_A 290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS 369 (458)
T ss_dssp GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence 7777766431 111111110 00 0 011336
Q ss_pred CHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 241 s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
++++.+||++||+.||.+|||++|+|+||||+...
T Consensus 370 s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 370 SADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 89999999999999999999999999999998643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=392.89 Aligned_cols=256 Identities=36% Similarity=0.682 Sum_probs=227.5
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (426)
...++|++++.||+|+||.||+|++..+|+.||+|++...... ....+.+|+.+++.++||||+++++++.+....|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYY 82 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEE
Confidence 3457899999999999999999999999999999999765322 2356889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEe---cCCCCeEEeeccCccCCccc
Q 014347 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL---DSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl---~~~g~vkL~DFGla~~~~~~ 167 (426)
+||||++|++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~-- 160 (304)
T 2jam_A 83 LVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ-- 160 (304)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC--
T ss_pred EEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC--
Confidence 999999999999999888899999999999999999999999999999999999999 778899999999987532
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCC----CCCCHH
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPG 243 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~ 243 (426)
.......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+..+...++ ..+++.
T Consensus 161 --~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (304)
T 2jam_A 161 --NGIMSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISES 237 (304)
T ss_dssp --CBTTHHHHSCCCBCCTTTBSSCSC-CHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHH
T ss_pred --CCccccccCCCCccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHH
Confidence 223455689999999999877666 6899999999999999999999999988888888887765443 458999
Q ss_pred HHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
+.+||.+||+.||.+|||+.++++||||...
T Consensus 238 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 238 AKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 9999999999999999999999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=387.32 Aligned_cols=266 Identities=30% Similarity=0.516 Sum_probs=230.3
Q ss_pred ccCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeeccccc------chhHHHHHHHHHHHHHhCC-CCCccce
Q 014347 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII------HLKITDQIKREIATLKLLK-HPNVVRL 79 (426)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~~Ei~il~~l~-hpnIv~l 79 (426)
.......++|++.+.||+|+||.||+|.+..+|+.||+|+++..... .....+.+.+|+.+++++. ||||+++
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (298)
T 1phk_A 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL 89 (298)
T ss_dssp -----CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred cCCcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 33456789999999999999999999999999999999999765311 1233567889999999996 9999999
Q ss_pred EEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeecc
Q 014347 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG 159 (426)
Q Consensus 80 ~~~~~~~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFG 159 (426)
++++......|+||||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 90 KDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred eeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEeccc
Confidence 99999999999999999999999999988899999999999999999999999999999999999999999999999999
Q ss_pred CccCCccccCCCccccccCCCcccchhhhcc-----CCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC
Q 014347 160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF 234 (426)
Q Consensus 160 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~ 234 (426)
++..... .......+||+.|+|||++.. ....+.++||||||+++|+|++|..||.+.+.......+..+..
T Consensus 170 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 246 (298)
T 1phk_A 170 FSCQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 246 (298)
T ss_dssp TCEECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred chhhcCC---CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCc
Confidence 9875432 233455689999999999852 23346899999999999999999999999888888888877765
Q ss_pred CCC----CCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 235 KLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 235 ~~p----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
.++ ..+++.+.+||.+||+.||.+|||+.++++||||++..
T Consensus 247 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 247 QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 544 24789999999999999999999999999999998643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=385.89 Aligned_cols=258 Identities=34% Similarity=0.627 Sum_probs=226.9
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccch---hHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
-++|++++.||+|+||.||+|++..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 4689999999999999999999999999999999986543321 1357889999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCC----CeEEeeccCccCCc
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG----NIKISDFGLSALPQ 165 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g----~vkL~DFGla~~~~ 165 (426)
|+||||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++....
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 99999999999999998888999999999999999999999999999999999999998877 79999999997543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCC----CCCC
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLS 241 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 241 (426)
. ........||+.|+|||++....+ +.++||||||+++|+|++|..||.+.+.......+.......+ ..++
T Consensus 164 ~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T 3bhy_A 164 A---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS 239 (283)
T ss_dssp -----------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred C---CCcccccCCCcCccCcceecCCCC-CcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCC
Confidence 2 223345679999999999877665 6899999999999999999999999988888888877766554 4578
Q ss_pred HHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 242 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
+.+.+||.+||+.||.+|||+.++++||||+..
T Consensus 240 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 999999999999999999999999999999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=399.97 Aligned_cols=252 Identities=26% Similarity=0.409 Sum_probs=217.8
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-----CCCccceEEEEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-----HPNVVRLHEVLA 84 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----hpnIv~l~~~~~ 84 (426)
...-++|++++.||+|+||.||+|++..+++.||||++... ......+.+|+.+++.+. ||||+++++++.
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~ 106 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM 106 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence 44568999999999999999999999999999999998642 233567788999999987 999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecC-------------
Q 014347 85 SKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS------------- 149 (426)
Q Consensus 85 ~~~~~~lV~Ey~~gg~L~~~i~~~~--~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~------------- 149 (426)
..+..|+||||+ |++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 107 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~ 185 (360)
T 3llt_A 107 YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRV 185 (360)
T ss_dssp ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcc
Confidence 999999999999 999999998754 5999999999999999999999999999999999999975
Q ss_pred ------------CCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCC
Q 014347 150 ------------KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217 (426)
Q Consensus 150 ------------~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf 217 (426)
++.+||+|||++..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||
T Consensus 186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf 259 (360)
T 3llt_A 186 TDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGW-DVSSDMWSFGCVLAELYTGSLLF 259 (360)
T ss_dssp TTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCC-CCccchHHHHHHHHHHHHCCCCC
Confidence 78999999999985322 2345689999999999988776 68999999999999999999999
Q ss_pred CCCcHHHHHHHHHcCCCCCCC----------------------------------------------CCCHHHHHHHHHc
Q 014347 218 DDRNLAVLYQKIFRGDFKLPK----------------------------------------------WLSPGAQNLLRKI 251 (426)
Q Consensus 218 ~~~~~~~~~~~i~~~~~~~p~----------------------------------------------~~s~~~~~Li~~~ 251 (426)
.+.+.......+.....+.|. ..++.+.+||.+|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 339 (360)
T 3llt_A 260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSI 339 (360)
T ss_dssp CCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHH
T ss_pred CCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHH
Confidence 988777666555443222221 1236788999999
Q ss_pred cccCccCCCCHHHHhcCcccc
Q 014347 252 LEPNPVKRITIAGIKADEWFE 272 (426)
Q Consensus 252 L~~dP~~R~t~~eil~h~~f~ 272 (426)
|++||.+|||++++++||||+
T Consensus 340 L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 340 LQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp CCSSGGGSCCHHHHTTSGGGC
T ss_pred hcCChhhCCCHHHHhcCcccC
Confidence 999999999999999999995
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=400.76 Aligned_cols=258 Identities=32% Similarity=0.591 Sum_probs=227.9
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeeccccc-----chhHHHHHHHHHHHHHhC-CCCCccceEEEEEeC
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLKLL-KHPNVVRLHEVLASK 86 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 86 (426)
.++|++.+.||+|+||.||+|++..+|+.||||++...... .....+.+.+|+.+++.+ +||||+++++++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 36799999999999999999999999999999999764321 122356788999999998 799999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcc
Q 014347 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 166 (426)
+..|+||||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCccccccCCCcccchhhhccC-----CCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCC----
Q 014347 167 FRDDGLLHTTCGSPNYVAPEVLANR-----GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP---- 237 (426)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p---- 237 (426)
.......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||.+.+.......+..+...++
T Consensus 253 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 329 (365)
T 2y7j_A 253 ---GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW 329 (365)
T ss_dssp ---TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred ---CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence 2334567899999999998632 2346889999999999999999999999888888888887766554
Q ss_pred CCCCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 238 ~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
..+++.+.+||.+||+.||.+|||+.++++||||++
T Consensus 330 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 330 DDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 357899999999999999999999999999999973
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=410.30 Aligned_cols=262 Identities=27% Similarity=0.380 Sum_probs=212.2
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC-----
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK----- 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 86 (426)
.-++|++++.||+|+||.||+|++..+|+.||||++.+.. ......+++.+|+.+|+.++||||+++++++...
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 3579999999999999999999999999999999997542 3444567899999999999999999999998766
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcc
Q 014347 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 166 (426)
...|+||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 103 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 103 DELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp CCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred CeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 57999999986 59999999888899999999999999999999999999999999999999999999999999986433
Q ss_pred ccCC--------------------CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhC-----------CC
Q 014347 167 FRDD--------------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-----------YL 215 (426)
Q Consensus 167 ~~~~--------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG-----------~~ 215 (426)
.... ......+||+.|+|||++.....++.++||||+||++|+|++| .+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p 261 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence 2111 1246678999999999976555557999999999999999984 44
Q ss_pred CCCCCcH-----------------HHHHHH------------------------HHcCCCCCC-------CCCCHHHHHH
Q 014347 216 PFDDRNL-----------------AVLYQK------------------------IFRGDFKLP-------KWLSPGAQNL 247 (426)
Q Consensus 216 Pf~~~~~-----------------~~~~~~------------------------i~~~~~~~p-------~~~s~~~~~L 247 (426)
+|.+.+. ...... +.......+ +.+++++.+|
T Consensus 262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 341 (432)
T 3n9x_A 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL 341 (432)
T ss_dssp SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence 4444320 111111 111111111 3479999999
Q ss_pred HHHccccCccCCCCHHHHhcCccccccC
Q 014347 248 LRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 248 i~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
|.+||+.||.+|||++|+++||||+...
T Consensus 342 l~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 342 LESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp HHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred HHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 9999999999999999999999998754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-51 Score=401.39 Aligned_cols=262 Identities=33% Similarity=0.533 Sum_probs=222.0
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
++|++++.||+|+||.||+|.+..+++.||+|++.+.... .....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 6899999999999999999999999999999999765432 23446789999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHHh
Q 014347 92 VLEYVTGGELFDKIAS----------------------------------------KGRLQEAEGRKLFQQLIDGVSYCH 131 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~----------------------------------------~~~l~~~~~~~i~~Ql~~aL~~LH 131 (426)
||||++||+|.+++.. ...+++..++.++.||+.||.|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 9999999999998842 112467889999999999999999
Q ss_pred hcCceeccCCCCcEEecCCC--CeEEeeccCccCCccccCC--CccccccCCCcccchhhhccC-CCCCCcchhhhHHHH
Q 014347 132 NKGVFHRDLKLENILLDSKG--NIKISDFGLSALPQHFRDD--GLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVI 206 (426)
Q Consensus 132 ~~gIiHrDLKp~NILl~~~g--~vkL~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~-~~~~~~~DIwSlGvi 206 (426)
++||+||||||+|||++.++ .+||+|||++......... ......+||+.|+|||++.+. ...+.++|||||||+
T Consensus 186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 265 (345)
T 3hko_A 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265 (345)
T ss_dssp HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence 99999999999999998777 8999999999754322111 123466899999999998652 344789999999999
Q ss_pred HHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 207 LYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 207 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
+|+|++|..||.+.+.......+......++. .+++.+.+||.+||+.||.+|||+.++++||||++..
T Consensus 266 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 99999999999999888888888777655442 3789999999999999999999999999999998643
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=398.47 Aligned_cols=262 Identities=29% Similarity=0.418 Sum_probs=221.1
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
-..+++|++++.||+|+||.||+|++..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 99 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRW 99 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEE
Confidence 3467899999999999999999999999999999999875542 334456788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
|+||||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~ 177 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA--P 177 (331)
T ss_dssp EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecC--C
Confidence 99999999999998888778899999999999999999999999999999999999999999999999999975432 2
Q ss_pred CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC-----------------
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG----------------- 232 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~----------------- 232 (426)
.......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 233455689999999999887655578999999999999999999999988766554443311
Q ss_pred --CCCCC------------CCCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 233 --DFKLP------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 233 --~~~~p------------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
....| +.+++.+.+||.+||++||.+|||+.++++||||+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 11111 2468899999999999999999999999999999763
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=404.86 Aligned_cols=254 Identities=33% Similarity=0.555 Sum_probs=219.8
Q ss_pred CCeee--eceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 14 GRYEL--GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 14 ~~y~i--~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
+.|++ .+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 163 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL 163 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 45555 6789999999999999999999999999976532 335788999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEe--cCCCCeEEeeccCccCCcccc
Q 014347 92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL--DSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl--~~~g~vkL~DFGla~~~~~~~ 168 (426)
||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~-- 241 (373)
T 2x4f_A 164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP-- 241 (373)
T ss_dssp EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT--
T ss_pred EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC--
Confidence 99999999999988653 469999999999999999999999999999999999999 5677899999999985432
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCC----CCCCHHH
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGA 244 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~ 244 (426)
.......+||+.|+|||++....+ +.++|||||||++|+|++|..||.+.+.......+......++ ..+++++
T Consensus 242 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 319 (373)
T 2x4f_A 242 -REKLKVNFGTPEFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA 319 (373)
T ss_dssp -TCBCCCCCSSCTTCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHH
T ss_pred -ccccccccCCCcEeChhhccCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHH
Confidence 233445689999999999876655 6899999999999999999999999998888888888776554 3589999
Q ss_pred HHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 245 QNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
.+||.+||++||.+|||+.++++||||.+.
T Consensus 320 ~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 320 KEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 999999999999999999999999999753
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=404.09 Aligned_cols=255 Identities=29% Similarity=0.405 Sum_probs=214.7
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC------
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------ 86 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------ 86 (426)
.++|++++.||+|+||.||+|.+..+|+.||||.+.... ......+++.+|+.+++.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 478999999999999999999999999999999986543 2444567899999999999999999999999765
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcc
Q 014347 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 166 (426)
..+|+||||+ |++|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~- 179 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD- 179 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc-
Confidence 3469999999 8899998876 679999999999999999999999999999999999999999999999999998532
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC------------
Q 014347 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF------------ 234 (426)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------------ 234 (426)
......+||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+.......+.....
T Consensus 180 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 180 ----SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp ----SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred ----cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 2244568999999999988744457899999999999999999999999887666655543110
Q ss_pred -------------------CCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 235 -------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 235 -------------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
..++..++.+.+||.+||+.||.+|||++++++||||+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 12234689999999999999999999999999999998643
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=383.17 Aligned_cols=254 Identities=23% Similarity=0.323 Sum_probs=216.3
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 89 (426)
...++|++++.||+|+||.||+|.+..+++.||+|++....... .....+.+|+..+..+ +||||+++++++.+.+..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 34578999999999999999999999999999999998654333 3356788999999998 899999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCC--------------
Q 014347 90 YMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-------------- 151 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~----~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g-------------- 151 (426)
|+||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999999999999764 6799999999999999999999999999999999999998544
Q ss_pred -----CeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHH
Q 014347 152 -----NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY 226 (426)
Q Consensus 152 -----~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~ 226 (426)
.+||+|||++..... .....||+.|+|||++.+....+.++|||||||++|+|++|..|+..... .
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~ 237 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISS------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---W 237 (289)
T ss_dssp ---CCCEEECCCTTCEETTC------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---H
T ss_pred cCCceEEEEcccccccccCC------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---H
Confidence 799999999875432 23456999999999988765556789999999999999999988765543 3
Q ss_pred HHHHcCC-CCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 227 QKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 227 ~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
..+..+. ..+|..+++.+.+||.+||+.||.+|||+.++++||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 238 HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 3344443 45677899999999999999999999999999999999864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-50 Score=396.77 Aligned_cols=255 Identities=25% Similarity=0.391 Sum_probs=223.3
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
++|++++.||+|+||.||+|++..+|+.||||++...........+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 46999999999999999999999999999999998765545555678999999999999999999999999999999999
Q ss_pred eccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 94 EYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 94 Ey~~gg~L~~~i~-~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
||+. |+|.+.+. ...++++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~------ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ 206 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC------
Confidence 9997 58888775 456899999999999999999999999999999999999999999999999999985432
Q ss_pred cccccCCCcccchhhhcc--CCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCC--CCCCCCHHHHHHH
Q 014347 173 LHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK--LPKWLSPGAQNLL 248 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~--~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~Li 248 (426)
....+||+.|+|||++.. ....+.++|||||||++|+|++|..||.+.+.......+.....+ .+..+++.+.+||
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 286 (348)
T 1u5q_A 207 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 286 (348)
T ss_dssp BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHH
T ss_pred CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 235689999999999852 233468999999999999999999999988777666666655432 2456899999999
Q ss_pred HHccccCccCCCCHHHHhcCccccccC
Q 014347 249 RKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 249 ~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
.+||+.||.+|||++++++||||....
T Consensus 287 ~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 287 DSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp HHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHHcccChhhCcCHHHHhhChhhhccC
Confidence 999999999999999999999997654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=399.51 Aligned_cols=265 Identities=27% Similarity=0.358 Sum_probs=216.9
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccc--hhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH--LKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (426)
+...++|++++.||+|+||.||+|++..+|+.||+|++....... ......+.+|+.+++.++||||+++++++.+.+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 446789999999999999999999999999999999997543221 112346789999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcc
Q 014347 88 KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 166 (426)
..|+||||+.+ +|.+.+... ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 99999999986 888888764 4699999999999999999999999999999999999999999999999999986432
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC--CCC---C-----
Q 014347 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFK---L----- 236 (426)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~---~----- 236 (426)
........+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+......++... ... +
T Consensus 165 --~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 242 (346)
T 1ua2_A 165 --PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 242 (346)
T ss_dssp --CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred --CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence 2233456789999999999876655578999999999999999999999998877777666542 110 0
Q ss_pred ------------------CCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccCCC
Q 014347 237 ------------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (426)
Q Consensus 237 ------------------p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 277 (426)
...+++++.+||.+||+.||.+|||+.|+++||||.....+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~ 301 (346)
T 1ua2_A 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 301 (346)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence 13357899999999999999999999999999999875433
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=396.26 Aligned_cols=263 Identities=25% Similarity=0.418 Sum_probs=216.9
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCC--CCccceEEEEEeCCE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH--PNVVRLHEVLASKSK 88 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~ 88 (426)
+.-++|++++.||+|+||.||+|.+ .+++.||+|++..... .....+.+.+|+.+++.++| |||+++++++.+...
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 3456799999999999999999997 5689999999976543 34446789999999999986 999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
.|+|||+ .+++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.......
T Consensus 84 ~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp EEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 9999994 5889999999988999999999999999999999999999999999999997 6789999999998654322
Q ss_pred CCCccccccCCCcccchhhhcc----------CCCCCCcchhhhHHHHHHHHHhCCCCCCCCc-HHHHHHHHHc--CCCC
Q 014347 169 DDGLLHTTCGSPNYVAPEVLAN----------RGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFR--GDFK 235 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~----------~~~~~~~~DIwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~--~~~~ 235 (426)
........+||+.|+|||++.+ ....+.++|||||||++|+|++|..||.+.. .......+.. ....
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 241 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccC
Confidence 2223446789999999999864 1334688999999999999999999998743 3333444443 3456
Q ss_pred CCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccCCC
Q 014347 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (426)
Q Consensus 236 ~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 277 (426)
+|...++.+.+||.+||+.||.+|||+.++++||||+....+
T Consensus 242 ~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~ 283 (343)
T 3dbq_A 242 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 283 (343)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC-
T ss_pred CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCCc
Confidence 778889999999999999999999999999999999865443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=382.95 Aligned_cols=254 Identities=25% Similarity=0.460 Sum_probs=219.1
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe----CCEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----KSKI 89 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~ 89 (426)
..|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 358999999999999999999999999999999976544 33446789999999999999999999999865 4668
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC--ceeccCCCCcEEec-CCCCeEEeeccCccCCcc
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLD-SKGNIKISDFGLSALPQH 166 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~g--IiHrDLKp~NILl~-~~g~vkL~DFGla~~~~~ 166 (426)
|+||||++|++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++....
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~- 183 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR- 183 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC-
T ss_pred EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc-
Confidence 999999999999999998889999999999999999999999999 99999999999998 78999999999997432
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCC-cHHHHHHHHHcCCC--CCCCCCCHH
Q 014347 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-NLAVLYQKIFRGDF--KLPKWLSPG 243 (426)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~--~~p~~~s~~ 243 (426)
.......+||+.|+|||++.+ .+ +.++||||||+++|+|++|..||.+. +....+..+..+.. .++...++.
T Consensus 184 ---~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (290)
T 1t4h_A 184 ---ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 258 (290)
T ss_dssp ---TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred ---ccccccccCCcCcCCHHHHhc-cC-CCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHH
Confidence 233456789999999998764 34 68999999999999999999999874 44455555544432 334557899
Q ss_pred HHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
+.+||.+||+.||.+|||++++++||||++.
T Consensus 259 l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 259 VKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 9999999999999999999999999999863
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-50 Score=403.38 Aligned_cols=259 Identities=25% Similarity=0.401 Sum_probs=217.8
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC--CCCccceEEEEEeCCEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK--HPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~l 91 (426)
.+|++++.||+|+||.||+|.+.. ++.||||++..... .....+.+.+|+.+|+.++ ||||+++++++...+.+|+
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 469999999999999999999765 89999999976543 3445678999999999997 5999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCC
Q 014347 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 171 (426)
||| +.+++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.........
T Consensus 134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 211 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 211 (390)
T ss_dssp EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence 999 56889999999888999999999999999999999999999999999999995 5899999999998654322222
Q ss_pred ccccccCCCcccchhhhccC----------CCCCCcchhhhHHHHHHHHHhCCCCCCCCc-HHHHHHHHHcC--CCCCCC
Q 014347 172 LLHTTCGSPNYVAPEVLANR----------GYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRG--DFKLPK 238 (426)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~----------~~~~~~~DIwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~--~~~~p~ 238 (426)
.....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.. .......+... ...+|.
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 291 (390)
T 2zmd_A 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291 (390)
T ss_dssp --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCC
T ss_pred cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCc
Confidence 34567899999999998652 234689999999999999999999998753 33444555544 456788
Q ss_pred CCCHHHHHHHHHccccCccCCCCHHHHhcCccccccCC
Q 014347 239 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (426)
Q Consensus 239 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 276 (426)
+.++.+.+||.+||+.||.+|||+.++++||||+....
T Consensus 292 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 329 (390)
T 2zmd_A 292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 329 (390)
T ss_dssp CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC-
T ss_pred cchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCc
Confidence 88999999999999999999999999999999986543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=400.52 Aligned_cols=263 Identities=31% Similarity=0.583 Sum_probs=226.6
Q ss_pred CccCCCeeeeceEeecCceEEEEEEEC---CCCCeEEEEEeeccccc-chhHHHHHHHHHHHHHhC-CCCCccceEEEEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLL-KHPNVVRLHEVLA 84 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 84 (426)
.+.+++|++++.||+|+||.||+|++. .+|+.||||++++.... .....+.+.+|+.+++.+ .||||+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 445689999999999999999999985 58999999998754321 112235677899999999 6999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCC
Q 014347 85 SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (426)
Q Consensus 85 ~~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~ 164 (426)
.....|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 130 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 130 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 99999999999999999999998889999999999999999999999999999999999999999999999999999754
Q ss_pred ccccCCCccccccCCCcccchhhhccC-CCCCCcchhhhHHHHHHHHHhCCCCCCCC----cHHHHHHHHHcCCCCCCCC
Q 014347 165 QHFRDDGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDR----NLAVLYQKIFRGDFKLPKW 239 (426)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~ 239 (426)
... ........+||+.|+|||++.+. ...+.++|||||||++|+|++|..||... ....+...+......+|..
T Consensus 210 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (355)
T 1vzo_A 210 VAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 288 (355)
T ss_dssp CGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred ccC-CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcc
Confidence 321 11233456899999999998753 33468899999999999999999999743 3456667777788888999
Q ss_pred CCHHHHHHHHHccccCccCCC-----CHHHHhcCccccc
Q 014347 240 LSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 273 (426)
Q Consensus 240 ~s~~~~~Li~~~L~~dP~~R~-----t~~eil~h~~f~~ 273 (426)
+++.+.+||.+||+.||.+|| |+.++++||||+.
T Consensus 289 ~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 289 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 999999999999999999999 9999999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-50 Score=398.06 Aligned_cols=259 Identities=29% Similarity=0.442 Sum_probs=219.7
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC-----CE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----SK 88 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~ 88 (426)
++|++++.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 59999999999999999999999999999999986433 344467889999999999999999999999765 46
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
.|+||||+.| +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 105 ~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 105 VYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 8999999975 99998875 679999999999999999999999999999999999999999999999999998654322
Q ss_pred C-CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC--C------------
Q 014347 169 D-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--D------------ 233 (426)
Q Consensus 169 ~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~------------ 233 (426)
. .......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+... .
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 262 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 1 223455689999999999776655578999999999999999999999987765555444321 0
Q ss_pred ------------CC-----CCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccCC
Q 014347 234 ------------FK-----LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (426)
Q Consensus 234 ------------~~-----~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 276 (426)
.. .++.+++++.+||.+||++||.+|||+.++++||||++.+.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 322 (364)
T 3qyz_A 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322 (364)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence 00 11347899999999999999999999999999999987643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-50 Score=389.12 Aligned_cols=258 Identities=29% Similarity=0.485 Sum_probs=216.5
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
.+..++|++.+.||+|+||.||+|++ +|+.||+|++..... .....+.+.+|+.++++++||||+++++++.+....
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 45678999999999999999999986 688999999976543 344467899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHhhcC--ceeccCCCCcEEecCCCCeEEeeccCccCC
Q 014347 90 YMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDSKGNIKISDFGLSALP 164 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~---l~~~~~~~i~~Ql~~aL~~LH~~g--IiHrDLKp~NILl~~~g~vkL~DFGla~~~ 164 (426)
|+||||++||+|.+++...+. +++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++...
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 999999999999999987553 999999999999999999999999 999999999999999999999999999753
Q ss_pred ccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHH--cCCCCCCCCCCH
Q 014347 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--RGDFKLPKWLSP 242 (426)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~ 242 (426)
.. ........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+. .....+|..+++
T Consensus 190 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (309)
T 3p86_A 190 AS--TFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP 266 (309)
T ss_dssp --------------CCTTSCHHHHTTCCC-CTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCH
T ss_pred cc--cccccccCCCCccccChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCH
Confidence 32 1223345689999999999987766 689999999999999999999999988877766663 345677888999
Q ss_pred HHHHHHHHccccCccCCCCHHHHhc--Cccccc
Q 014347 243 GAQNLLRKILEPNPVKRITIAGIKA--DEWFEQ 273 (426)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~eil~--h~~f~~ 273 (426)
.+.+||.+||+.||.+|||++++++ ++|++.
T Consensus 267 ~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999999987 555554
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=390.90 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=206.9
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHH-HhCCCCCccceEEEEEeCCEEEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
.++|+++++||+|+||.||+|++..+|+.||||++......... .....+|+..+ +..+||||+++++++.+++..|+
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH-HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 36899999999999999999999999999999998654433333 33444555555 44589999999999999999999
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCC
Q 014347 92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 170 (426)
||||+ +++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 135 v~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~---~ 210 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT---A 210 (311)
T ss_dssp EEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred EEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc---C
Confidence 99999 67998888764 4699999999999999999999999999999999999999999999999999875432 2
Q ss_pred CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC--CCCCCCCHHHHHHH
Q 014347 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF--KLPKWLSPGAQNLL 248 (426)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~Li 248 (426)
......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+... ...+..+.. .++..+++++.+||
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li 285 (311)
T 3p1a_A 211 GAGEVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSVL 285 (311)
T ss_dssp ----CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHH
T ss_pred CCCcccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHHH
Confidence 23445679999999999875 44 6899999999999999999776655432 233333322 23456899999999
Q ss_pred HHccccCccCCCCHHHHhcCccccc
Q 014347 249 RKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 249 ~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
.+||++||++|||++++++||||++
T Consensus 286 ~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 286 VMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHcCCChhhCcCHHHHHhCccccC
Confidence 9999999999999999999999975
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=393.14 Aligned_cols=257 Identities=24% Similarity=0.411 Sum_probs=210.7
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC----
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS---- 87 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 87 (426)
.+++|++++.||+|+||.||+|++..+|+.||||++.... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence 4678999999999999999999999999999999997654 2334678999999999999999999999985543
Q ss_pred -----------------------------------------------------EEEEEEeccCCCChHHHHHhcCC---C
Q 014347 88 -----------------------------------------------------KIYMVLEYVTGGELFDKIASKGR---L 111 (426)
Q Consensus 88 -----------------------------------------------------~~~lV~Ey~~gg~L~~~i~~~~~---l 111 (426)
..|+||||++|++|.+++..... .
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 161 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence 38999999999999999987543 4
Q ss_pred CHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC----------CCccccccCCCc
Q 014347 112 QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD----------DGLLHTTCGSPN 181 (426)
Q Consensus 112 ~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~----------~~~~~~~~gt~~ 181 (426)
++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .......+||+.
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred hhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 5667899999999999999999999999999999999999999999999986543211 112344679999
Q ss_pred ccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCC-CCCCCHHHHHHHHHccccCccCCC
Q 014347 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL-PKWLSPGAQNLLRKILEPNPVKRI 260 (426)
Q Consensus 182 y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-p~~~s~~~~~Li~~~L~~dP~~R~ 260 (426)
|+|||++.+..+ +.++|||||||++|+|++|..|+... ......+.....+. +...++.+.+||.+||++||.+||
T Consensus 242 y~aPE~~~~~~~-~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 318 (332)
T 3qd2_B 242 YMSPEQIHGNNY-SHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERP 318 (332)
T ss_dssp GSCHHHHHCCCC-CTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSC
T ss_pred ccChHHhcCCCC-cchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCC
Confidence 999999987766 68999999999999999998775332 22333333332221 133578899999999999999999
Q ss_pred CHHHHhcCccccc
Q 014347 261 TIAGIKADEWFEQ 273 (426)
Q Consensus 261 t~~eil~h~~f~~ 273 (426)
|+.++++||||++
T Consensus 319 s~~~~l~~~~f~~ 331 (332)
T 3qd2_B 319 EATDIIENAIFEN 331 (332)
T ss_dssp CHHHHHHSTTCCC
T ss_pred CHHHHhhchhhhc
Confidence 9999999999974
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=402.69 Aligned_cols=252 Identities=27% Similarity=0.401 Sum_probs=212.8
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe------
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------ 85 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 85 (426)
..++|++++.||+|+||.||+|++..+|+.||||++..+.. ...+|+.+++.++||||+++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 45789999999999999999999999999999999875432 23479999999999999999999843
Q ss_pred --------------------------------CCEEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHH
Q 014347 86 --------------------------------KSKIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVSY 129 (426)
Q Consensus 86 --------------------------------~~~~~lV~Ey~~gg~L~~~i~----~~~~l~~~~~~~i~~Ql~~aL~~ 129 (426)
....++||||++| +|.+.+. ....+++..++.++.||+.||.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 3448999999985 7766654 45789999999999999999999
Q ss_pred HhhcCceeccCCCCcEEec-CCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHH
Q 014347 130 CHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208 (426)
Q Consensus 130 LH~~gIiHrDLKp~NILl~-~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ 208 (426)
||++||+||||||+|||++ .++.+||+|||+|..... .......+||+.|+|||++.+....+.++||||+||++|
T Consensus 157 LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 157 IHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP---SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp HHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT---TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred HHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC---CCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 9999999999999999998 688999999999985432 233456689999999999887665579999999999999
Q ss_pred HHHhCCCCCCCCcHHHHHHHHHcC-----------------CCC------------CCCCCCHHHHHHHHHccccCccCC
Q 014347 209 VILTGYLPFDDRNLAVLYQKIFRG-----------------DFK------------LPKWLSPGAQNLLRKILEPNPVKR 259 (426)
Q Consensus 209 elltG~~Pf~~~~~~~~~~~i~~~-----------------~~~------------~p~~~s~~~~~Li~~~L~~dP~~R 259 (426)
+|++|+.||.+.+.......+... ... +|..+++++.+||.+||+.||.+|
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 999999999998877666655431 111 345578999999999999999999
Q ss_pred CCHHHHhcCcccccc
Q 014347 260 ITIAGIKADEWFEQD 274 (426)
Q Consensus 260 ~t~~eil~h~~f~~~ 274 (426)
||+.|+++||||+..
T Consensus 314 ~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 314 INPYEAMAHPFFDHL 328 (383)
T ss_dssp CCHHHHHTSGGGHHH
T ss_pred CCHHHHhcCHHHHHH
Confidence 999999999999764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=408.84 Aligned_cols=258 Identities=36% Similarity=0.631 Sum_probs=211.2
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccc-----hhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-----LKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (426)
..++|++.+.||+|+||.||+|.+..+++.||+|++.+..... ......+.+|+.+|+.++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 3578999999999999999999999999999999998654321 122335789999999999999999999975 4
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCC---CeEEeeccCccC
Q 014347 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSAL 163 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g---~vkL~DFGla~~ 163 (426)
...|+||||++||+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 56899999999999999998888999999999999999999999999999999999999997654 599999999986
Q ss_pred CccccCCCccccccCCCcccchhhhcc--CCCCCCcchhhhHHHHHHHHHhCCCCCCCCcH-HHHHHHHHcCCCCCC---
Q 014347 164 PQHFRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRGDFKLP--- 237 (426)
Q Consensus 164 ~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~p--- 237 (426)
... .....+.+||+.|+|||++.. ...++.++|||||||++|+|++|..||.+... ......+..+...++
T Consensus 292 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~ 368 (419)
T 3i6u_A 292 LGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368 (419)
T ss_dssp CC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH
T ss_pred cCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh
Confidence 432 334456789999999999853 23336789999999999999999999986543 244455566655543
Q ss_pred -CCCCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 238 -KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 238 -~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
..+++.+.+||.+||+.||.+|||++++++||||+.
T Consensus 369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred hcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 358999999999999999999999999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=390.40 Aligned_cols=257 Identities=35% Similarity=0.549 Sum_probs=221.8
Q ss_pred CCCeeee-ceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCCEEE
Q 014347 13 LGRYELG-RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 13 ~~~y~i~-~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 90 (426)
-++|.+. +.||+|+||.||+|.+..+|+.||+|++.+.... ......+.+|+.+++.+. ||||+++++++.+....|
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~ 105 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG-QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII 105 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT-EECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence 3578887 8999999999999999999999999999765432 233567889999999995 699999999999999999
Q ss_pred EEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecC---CCCeEEeeccCccCCc
Q 014347 91 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KGNIKISDFGLSALPQ 165 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~--~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~---~g~vkL~DFGla~~~~ 165 (426)
+||||+.||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 185 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence 99999999999999864 367999999999999999999999999999999999999988 7899999999998543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCC----CCCC
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLS 241 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 241 (426)
. .......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+....+..+.......+ ..++
T Consensus 186 ~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 261 (327)
T 3lm5_A 186 H---ACELREIMGTPEYLAPEILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVS 261 (327)
T ss_dssp -----------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred C---ccccccccCCcCccCCeeecCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccC
Confidence 2 223445689999999999987766 6899999999999999999999999988888877776654443 3588
Q ss_pred HHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 242 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
+.+.+||.+||++||.+|||++++++||||+..
T Consensus 262 ~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 262 QLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 999999999999999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-50 Score=396.17 Aligned_cols=260 Identities=29% Similarity=0.436 Sum_probs=222.6
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (426)
.....++|++++.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+++.
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 105 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 105 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE
Confidence 3556789999999999999999999999999999999997653 34456789999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc-CceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~-gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
.|+||||++|++|.+++...+.+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++.....
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 184 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 184 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc-
Confidence 999999999999999999888999999999999999999999996 999999999999999999999999999864321
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHH--------------------
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQ-------------------- 227 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~-------------------- 227 (426)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+......
T Consensus 185 ---~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 185 ---SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp ---HC----CCCCTTCCHHHHTTCCC-SHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred ---ccccCCCCCCCeECHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 12345689999999999987766 689999999999999999999998766543322
Q ss_pred ----------------------HHHcCC-CCCC-CCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 228 ----------------------KIFRGD-FKLP-KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 228 ----------------------~i~~~~-~~~p-~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
.+.... ...+ ..+++++.+||.+||+.||.+|||++++++||||+...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 222222 1222 33788999999999999999999999999999998643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-50 Score=382.40 Aligned_cols=260 Identities=30% Similarity=0.523 Sum_probs=227.2
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEE--eCCEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA--SKSKI 89 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~ 89 (426)
..++|++++.||+|+||.||+|.+..+|+.||+|.+..... .....+.+.+|+.+++.++||||+++++++. .....
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 56899999999999999999999999999999999986543 3344678999999999999999999999875 46789
Q ss_pred EEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcC-----ceeccCCCCcEEecCCCCeEEeeccC
Q 014347 90 YMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKG-----VFHRDLKLENILLDSKGNIKISDFGL 160 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~----~~l~~~~~~~i~~Ql~~aL~~LH~~g-----IiHrDLKp~NILl~~~g~vkL~DFGl 160 (426)
|+||||++|++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 9999999999999999753 34999999999999999999999999 99999999999999999999999999
Q ss_pred ccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC-CCCCC
Q 014347 161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKW 239 (426)
Q Consensus 161 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~ 239 (426)
+..... ........+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+..+.. .+|..
T Consensus 163 ~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 239 (279)
T 2w5a_A 163 ARILNH--DTSFAKTFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 239 (279)
T ss_dssp HHHC-----CHHHHHHHSCCTTCCHHHHHCC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred heeecc--ccccccccCCCccccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcc
Confidence 875332 1122345679999999999887666 6889999999999999999999999888888888877765 66778
Q ss_pred CCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 240 ~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
+++.+.+||.+||+.||.+|||+.++++|+|+....
T Consensus 240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 240 YSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 999999999999999999999999999999998653
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=397.84 Aligned_cols=256 Identities=27% Similarity=0.407 Sum_probs=210.1
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC----
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS---- 87 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 87 (426)
..++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 4689999999999999999999999999999999997643 23445678899999999999999999999997654
Q ss_pred --EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 88 --KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 88 --~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
..|+||||+.| +|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 102 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 102 FQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp CCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred ccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 78999999975 7888885 469999999999999999999999999999999999999999999999999998543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCC----------
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK---------- 235 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------- 235 (426)
. .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+.++......
T Consensus 179 ~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 179 T---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp --------------CTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred c---ccccCCceecCCccCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 2 223445789999999999988766 68999999999999999999999998877776666543111
Q ss_pred ------------C--------------CC------CCCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 236 ------------L--------------PK------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 236 ------------~--------------p~------~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
+ |. ..++.+.+||++||+.||.+|||++++++||||+..+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 326 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 326 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence 0 00 0156799999999999999999999999999998643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=397.60 Aligned_cols=261 Identities=26% Similarity=0.513 Sum_probs=228.9
Q ss_pred cCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchh--------------HHHHHHHHHHHHHhCCC
Q 014347 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK--------------ITDQIKREIATLKLLKH 73 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~--------------~~~~~~~Ei~il~~l~h 73 (426)
......++|++++.||+|+||.||+|.+ +|+.||+|++......... ..+.+.+|+.+++.++|
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 102 (348)
T 2pml_X 25 EKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN 102 (348)
T ss_dssp SSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC
T ss_pred hcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC
Confidence 3455679999999999999999999998 8999999999765432211 12789999999999999
Q ss_pred CCccceEEEEEeCCEEEEEEeccCCCChHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHhh-cCceeccCCCCc
Q 014347 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDK------IAS--KGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLEN 144 (426)
Q Consensus 74 pnIv~l~~~~~~~~~~~lV~Ey~~gg~L~~~------i~~--~~~l~~~~~~~i~~Ql~~aL~~LH~-~gIiHrDLKp~N 144 (426)
|||+++++++.+.+..|+||||++|++|.++ +.. ...+++..++.++.||+.||.|||+ +||+||||||+|
T Consensus 103 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 103 EYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp TTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred CCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 9999999999999999999999999999998 665 5789999999999999999999999 999999999999
Q ss_pred EEecCCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccC-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcH-
Q 014347 145 ILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDRNL- 222 (426)
Q Consensus 145 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~- 222 (426)
||++.++.+||+|||++..... .......||+.|+|||++.+. .+.+.++||||||+++|+|++|..||...+.
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVD----KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBT----TEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred EEEcCCCcEEEecccccccccc----ccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 9999999999999999975422 234566899999999998876 4443489999999999999999999998776
Q ss_pred HHHHHHHHcCCCCCC-------------------CCCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 223 AVLYQKIFRGDFKLP-------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 223 ~~~~~~i~~~~~~~p-------------------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
......+..+...+| ..+++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus 259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 777888887777777 5689999999999999999999999999999999753
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=410.64 Aligned_cols=249 Identities=19% Similarity=0.221 Sum_probs=207.6
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHH---HHHhCCCCCccceE-------EE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA---TLKLLKHPNVVRLH-------EV 82 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~---il~~l~hpnIv~l~-------~~ 82 (426)
.++|++++.||+|+||.||+|++..+|+.||||++.+.........+.+.+|+. +++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 478999999999999999999999999999999998765555556788999995 55555799999998 77
Q ss_pred EEeCCE-----------------EEEEEeccCCCChHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHhhcCceec
Q 014347 83 LASKSK-----------------IYMVLEYVTGGELFDKIASKGRLQE-------AEGRKLFQQLIDGVSYCHNKGVFHR 138 (426)
Q Consensus 83 ~~~~~~-----------------~~lV~Ey~~gg~L~~~i~~~~~l~~-------~~~~~i~~Ql~~aL~~LH~~gIiHr 138 (426)
+.+.+. .|+||||+ +|+|.+++...+.+++ ..++.++.||+.||+|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 766542 89999999 6799999987665665 7888899999999999999999999
Q ss_pred cCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccC-----------CCCCCcchhhhHHHHH
Q 014347 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR-----------GYDGATSDIWSCGVIL 207 (426)
Q Consensus 139 DLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----------~~~~~~~DIwSlGvil 207 (426)
||||+|||++.+|.+||+|||+|+.. .......+| +.|+|||++.+. .+ +.++|||||||++
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~-----~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSlG~il 303 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRD-----GARVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWALGLVI 303 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEET-----TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheec-----CCcccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHHHHHH
Confidence 99999999999999999999999842 234456788 999999998876 45 6899999999999
Q ss_pred HHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 208 YVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 208 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
|+|++|+.||.+.+.......+. ..+..+++.+.+||.+||+.||.+|||+.++++||||+.
T Consensus 304 ~elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHSSCCC------CCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHCCCCCcccccccchhhhh----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 99999999998765443333322 234568999999999999999999999999999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-50 Score=399.15 Aligned_cols=255 Identities=31% Similarity=0.446 Sum_probs=202.1
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC------
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------ 86 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------ 86 (426)
-++|++++.||+|+||.||+|.+..+|+.||||++.... .......++.+|+.+++.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 379999999999999999999999999999999986543 2344567888999999999999999999998654
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcc
Q 014347 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 166 (426)
...|+|+||+ |++|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 5689999999 7899998875 6799999999999999999999999999999999999999999999999999985322
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC--C-----------
Q 014347 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--D----------- 233 (426)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~----------- 233 (426)
.....+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+... .
T Consensus 185 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 185 -----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred -----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 2345689999999999887555578999999999999999999999998876665555431 0
Q ss_pred ----------CCCC--------CCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 234 ----------FKLP--------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 234 ----------~~~p--------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
...| ...++.+.+||.+||+.||.+|||+.++++||||....
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 0111 23688999999999999999999999999999998654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=388.00 Aligned_cols=251 Identities=25% Similarity=0.421 Sum_probs=211.9
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEEe--CCE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLAS--KSK 88 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~--~~~ 88 (426)
..++|++++.||+|+||.||+|++..+++.||+|++.... .+.+.+|+.+++.++ ||||+++++++.+ ...
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 3578999999999999999999999999999999986433 467889999999997 9999999999987 677
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCC-CeEEeeccCccCCccc
Q 014347 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQHF 167 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g-~vkL~DFGla~~~~~~ 167 (426)
.++||||+.+++|.+++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 108 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~- 183 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP- 183 (330)
T ss_dssp EEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT-
T ss_pred eEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC-
Confidence 999999999999998875 389999999999999999999999999999999999999777 899999999975432
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCC-cHHHHH-------------HHHHcCC
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-NLAVLY-------------QKIFRGD 233 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~-~~~~~~-------------~~i~~~~ 233 (426)
.......+||+.|+|||++.+....+.++|||||||++|+|++|..||... +..... ..+....
T Consensus 184 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 184 --GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp --TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred --CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence 233456689999999999887555579999999999999999999999542 221111 1111111
Q ss_pred CCC------------------------CCCCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 234 FKL------------------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 234 ~~~------------------------p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
... +..+++++.+||.+||++||.+|||++++++||||+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 111 12278999999999999999999999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=381.31 Aligned_cols=260 Identities=38% Similarity=0.660 Sum_probs=229.2
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (426)
.+...++|++++.||+|+||.||+|++..+++.||+|++...... ......+.+|+.+++.++||||+++++++.+...
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence 355668999999999999999999999999999999999765432 2235788999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCC---CCeEEeeccCccCCc
Q 014347 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQ 165 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~---g~vkL~DFGla~~~~ 165 (426)
.|+||||++|++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 99999999999999999888899999999999999999999999999999999999999764 469999999988543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCC----CCCC
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLS 241 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 241 (426)
. ........||+.|+|||++.+. + +.++||||||+++|+|++|..||.+.+.......+..+...++ ..++
T Consensus 176 ~---~~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (287)
T 2wei_A 176 Q---NTKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250 (287)
T ss_dssp C---CSSCSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSC
T ss_pred C---CCccccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcC
Confidence 2 2223445689999999998653 4 6899999999999999999999999988888888877765443 4589
Q ss_pred HHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 242 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
+.+.+||.+||++||.+|||+.++++||||++.
T Consensus 251 ~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 999999999999999999999999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=380.65 Aligned_cols=260 Identities=22% Similarity=0.318 Sum_probs=205.3
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
.+..++|++++.||+|+||.||+|++..+|+.||+|++..... .......+.++...++.++||||+++++++.+++..
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 3567899999999999999999999999999999999975432 222334455566668889999999999999999999
Q ss_pred EEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhc-CceeccCCCCcEEecCCCCeEEeeccCccCC
Q 014347 90 YMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~----~~~l~~~~~~~i~~Ql~~aL~~LH~~-gIiHrDLKp~NILl~~~g~vkL~DFGla~~~ 164 (426)
|+||||++| +|.+.+.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999975 88776643 56899999999999999999999998 9999999999999999999999999999754
Q ss_pred ccccCCCccccccCCCcccchhhhc---cCCCCCCcchhhhHHHHHHHHHhCCCCCCC-CcHH-HHHHHHHcCCCCCC-C
Q 014347 165 QHFRDDGLLHTTCGSPNYVAPEVLA---NRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLA-VLYQKIFRGDFKLP-K 238 (426)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~~~DIwSlGvil~elltG~~Pf~~-~~~~-~~~~~i~~~~~~~p-~ 238 (426)
.. .......+||+.|+|||++. .....+.++||||+|+++|+|++|..||.. .... .....+.......+ .
T Consensus 161 ~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (290)
T 3fme_A 161 VD---DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD 237 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTT
T ss_pred cc---cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccc
Confidence 32 22334457999999999972 333447899999999999999999999986 3333 33333344444443 4
Q ss_pred CCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 239 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 239 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
.+++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred cCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 589999999999999999999999999999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-49 Score=380.12 Aligned_cols=257 Identities=24% Similarity=0.423 Sum_probs=227.4
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (426)
-++|++++.||+|+||.||+|++..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++......|+|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 35799999999999999999999999999999999765432 2367899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
|||++|++|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 99 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~ 175 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--QIK 175 (303)
T ss_dssp EECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT--BCC
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc--ccc
Confidence 999999999998865 67999999999999999999999999999999999999999999999999999754321 122
Q ss_pred cccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHc
Q 014347 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKI 251 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~ 251 (426)
....+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+.... ..++..+++.+.+||.+|
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 254 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEAC 254 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHH
T ss_pred cCccCCCcCccCHHHHhcCCC-CchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHH
Confidence 345689999999999987666 589999999999999999999999887776666665543 455677899999999999
Q ss_pred cccCccCCCCHHHHhcCccccccC
Q 014347 252 LEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 252 L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
|+.||.+|||+.++++||||....
T Consensus 255 l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 255 LNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp CCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred cCCChhhCcCHHHHhhChhhhcCC
Confidence 999999999999999999997654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=402.22 Aligned_cols=254 Identities=28% Similarity=0.402 Sum_probs=215.0
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC------CCCCccceEEEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL------KHPNVVRLHEVLA 84 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l------~hpnIv~l~~~~~ 84 (426)
...++|++++.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+ +|+||+++++++.
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 34568999999999999999999999999999999996532 3346777888888876 5779999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCC--eEEeeccC
Q 014347 85 SKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN--IKISDFGL 160 (426)
Q Consensus 85 ~~~~~~lV~Ey~~gg~L~~~i~~~~--~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~--vkL~DFGl 160 (426)
....+|+||||+. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+
T Consensus 170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 9999999999996 59999988643 5999999999999999999999999999999999999999987 99999999
Q ss_pred ccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC--C----
Q 014347 161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--F---- 234 (426)
Q Consensus 161 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~---- 234 (426)
+... .....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.... +
T Consensus 249 a~~~-----~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~ 322 (429)
T 3kvw_A 249 SCYE-----HQRVYTYIQSRFYRAPEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL 322 (429)
T ss_dssp CEET-----TCCCCSSCSCGGGCCHHHHHTBCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ceec-----CCcccccCCCCCccChHHHhCCCC-CchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 9743 223456789999999999988776 689999999999999999999999988766555443210 0
Q ss_pred --------------C---------------------------------------CCCCCCHHHHHHHHHccccCccCCCC
Q 014347 235 --------------K---------------------------------------LPKWLSPGAQNLLRKILEPNPVKRIT 261 (426)
Q Consensus 235 --------------~---------------------------------------~p~~~s~~~~~Li~~~L~~dP~~R~t 261 (426)
. ++...++.+.+||++||++||++|||
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt 402 (429)
T 3kvw_A 323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT 402 (429)
T ss_dssp HHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC
Confidence 0 01123788999999999999999999
Q ss_pred HHHHhcCccccccC
Q 014347 262 IAGIKADEWFEQDY 275 (426)
Q Consensus 262 ~~eil~h~~f~~~~ 275 (426)
++|+++||||++..
T Consensus 403 a~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 403 PGQALRHPWLRRRL 416 (429)
T ss_dssp HHHHHTSTTTC---
T ss_pred HHHHhCChhhccCC
Confidence 99999999998754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=388.24 Aligned_cols=258 Identities=36% Similarity=0.643 Sum_probs=214.9
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeeccccc-----chhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (426)
..++|++++.||+|+||.||+|.+..+++.||||++...... .......+.+|+.+++.++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 447899999999999999999999999999999999764321 112234688999999999999999999998766
Q ss_pred CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCC---eEEeeccCccC
Q 014347 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSAL 163 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~---vkL~DFGla~~ 163 (426)
. .|+||||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred c-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 5 8999999999999999988889999999999999999999999999999999999999987665 99999999975
Q ss_pred CccccCCCccccccCCCcccchhhhcc--CCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHH-HHHHHHHcCCCCCC---
Q 014347 164 PQHFRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDFKLP--- 237 (426)
Q Consensus 164 ~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~p--- 237 (426)
... .......+||+.|+|||++.. ....+.++|||||||++|+|++|..||...... .....+..+...++
T Consensus 167 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (322)
T 2ycf_A 167 LGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243 (322)
T ss_dssp CCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHH
T ss_pred ccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchh
Confidence 422 223345689999999999742 333468999999999999999999999765432 34444555554432
Q ss_pred -CCCCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 238 -KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 238 -~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
..+++.+.+||.+||+.||.+|||++++++||||+.
T Consensus 244 ~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 457999999999999999999999999999999975
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=395.09 Aligned_cols=256 Identities=26% Similarity=0.443 Sum_probs=221.9
Q ss_pred CccCCCeeeeceEeecCceEEEEEEEC-------CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHE 81 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~ 81 (426)
....++|++++.||+|+||.||+|++. .++..||+|++.... .....+.+.+|+.+++.+ +||||+++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 445689999999999999999999974 345679999997543 344567899999999999 8999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcE
Q 014347 82 VLASKSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENI 145 (426)
Q Consensus 82 ~~~~~~~~~lV~Ey~~gg~L~~~i~~~~----------------~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NI 145 (426)
++.+.+.+|+||||++||+|.+++.... .+++.+++.++.||+.||.|||++||+||||||+||
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 234 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence 9999999999999999999999998643 479999999999999999999999999999999999
Q ss_pred EecCCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHH
Q 014347 146 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV 224 (426)
Q Consensus 146 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~ 224 (426)
|++.+|.+||+|||+++...............||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+...
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~p~~~~~~~~ 313 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 999999999999999985433222223334567889999999987766 689999999999999999 999999988777
Q ss_pred HHHHHHcCC-CCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 225 LYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 225 ~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
....+..+. ...|..+++++.+||.+||+.||.+|||+.+++++
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 314 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 777776653 56777899999999999999999999999999874
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=401.46 Aligned_cols=253 Identities=28% Similarity=0.390 Sum_probs=210.1
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC-----
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK----- 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 86 (426)
...+|++++.||+|+||.||+|++..+|+.||||.+..... ...+|+.+|+.++||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence 34579999999999999999999999999999999865431 234799999999999999999988532
Q ss_pred -CEEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCC-CCeEEeeccC
Q 014347 87 -SKIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGL 160 (426)
Q Consensus 87 -~~~~lV~Ey~~gg~L~~~i~----~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~-g~vkL~DFGl 160 (426)
..+++||||+++ +|.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchh
Confidence 236799999976 6666554 35679999999999999999999999999999999999999965 5689999999
Q ss_pred ccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHc---------
Q 014347 161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--------- 231 (426)
Q Consensus 161 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--------- 231 (426)
++.... .......+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+......++.+
T Consensus 204 a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 204 AKQLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp CEECCT---TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred hhhccc---CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 985432 22334568999999999987664557899999999999999999999999876655555433
Q ss_pred --------CCCCC------------CCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 232 --------GDFKL------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 232 --------~~~~~------------p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
..+.+ +..+++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 11222 334689999999999999999999999999999997654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=383.44 Aligned_cols=259 Identities=26% Similarity=0.408 Sum_probs=219.1
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (426)
...++|++++.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+..|
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 92 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW 92 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH---HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEE
Confidence 445789999999999999999999999999999999875432 23578889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
+||||++|++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++..... .
T Consensus 93 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~ 170 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK--T 170 (302)
T ss_dssp EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH--H
T ss_pred EEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccc--c
Confidence 99999999999998875 56799999999999999999999999999999999999999999999999998753211 1
Q ss_pred CCccccccCCCcccchhhhc----cCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCC---CCCCCCH
Q 014347 170 DGLLHTTCGSPNYVAPEVLA----NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK---LPKWLSP 242 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~----~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~ 242 (426)
.......+||+.|+|||++. .....+.++||||||+++|+|++|..||...+.......+.....+ .|..+++
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (302)
T 2j7t_A 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSV 250 (302)
T ss_dssp HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCH
T ss_pred ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCH
Confidence 11223457999999999984 2333468999999999999999999999998887777777665432 3556899
Q ss_pred HHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
.+.+||.+||+.||.+|||+.++++||||...
T Consensus 251 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 251 EFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 99999999999999999999999999999763
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=387.29 Aligned_cols=256 Identities=26% Similarity=0.413 Sum_probs=213.2
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC--
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-- 87 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-- 87 (426)
...-++|++++.||+|+||.||+|++..+|+.||||++....... ..+.+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCc
Confidence 345679999999999999999999999999999999997544322 2567889999999999999999999998765
Q ss_pred EEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEe----cCCCCeEEeeccC
Q 014347 88 KIYMVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGL 160 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~~---~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl----~~~g~vkL~DFGl 160 (426)
..|+||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 7899999999999999998643 39999999999999999999999999999999999999 7788899999999
Q ss_pred ccCCccccCCCccccccCCCcccchhhhcc-------CCCCCCcchhhhHHHHHHHHHhCCCCCCC----CcHHHHHHHH
Q 014347 161 SALPQHFRDDGLLHTTCGSPNYVAPEVLAN-------RGYDGATSDIWSCGVILYVILTGYLPFDD----RNLAVLYQKI 229 (426)
Q Consensus 161 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~-------~~~~~~~~DIwSlGvil~elltG~~Pf~~----~~~~~~~~~i 229 (426)
+..... .......+||+.|+|||++.. ....+.++|||||||++|+|++|..||.. ........++
T Consensus 163 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 239 (319)
T 4euu_A 163 ARELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (319)
T ss_dssp CEECCT---TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred ceecCC---CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence 985432 233445689999999999862 23447899999999999999999999964 2234444555
Q ss_pred HcCCC-------------------C------CCCCCCHHHHHHHHHccccCccCCCCHHHHhcCcc
Q 014347 230 FRGDF-------------------K------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 270 (426)
Q Consensus 230 ~~~~~-------------------~------~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~ 270 (426)
..+.+ . ++..+++.+.+||++||+.||++|||++|+++||-
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 44332 1 11224568899999999999999999999999973
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-49 Score=380.58 Aligned_cols=256 Identities=26% Similarity=0.438 Sum_probs=218.0
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (426)
...++|++++.||+|+||.||+|.+..+|+.||+|.+..... .+.+.+|+.+++.++||||+++++++...+..|
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 345789999999999999999999999999999999975431 357889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 91 MVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~-~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
+||||+.|++|.+++. ....+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT-- 178 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT--
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh--
Confidence 9999999999999997 4568999999999999999999999999999999999999999999999999999754321
Q ss_pred CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC---CCCCCCCCHHHHH
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQN 246 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~ 246 (426)
........||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+.... +..|..+++.+.+
T Consensus 179 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 257 (314)
T 3com_A 179 MAKRNTVIGTPFWMAPEVIQEIGY-NCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTD 257 (314)
T ss_dssp BSCBCCCCSCGGGCCHHHHSSSCB-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred ccccCccCCCCCccChhhcCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHH
Confidence 122345679999999999887766 688999999999999999999999877665554444432 3345568999999
Q ss_pred HHHHccccCccCCCCHHHHhcCcccccc
Q 014347 247 LLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 247 Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
||.+||+.||.+|||+.++++||||...
T Consensus 258 li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 258 FVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp HHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred HHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 9999999999999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=380.37 Aligned_cols=259 Identities=26% Similarity=0.390 Sum_probs=216.3
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEe---
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS--- 85 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~--- 85 (426)
....++|++++.||+|+||.||+|++..+|+.||+|++..... ....+.+|+.+++.+ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 3456899999999999999999999999999999999975432 236788999999998 79999999999977
Q ss_pred ---CCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccC
Q 014347 86 ---KSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL 160 (426)
Q Consensus 86 ---~~~~~lV~Ey~~gg~L~~~i~~~--~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGl 160 (426)
....|+||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 175 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV 175 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcC
Confidence 56899999999999999999863 5799999999999999999999999999999999999999999999999999
Q ss_pred ccCCccccCCCccccccCCCcccchhhhcc----CCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCC-
Q 014347 161 SALPQHFRDDGLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK- 235 (426)
Q Consensus 161 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~----~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~- 235 (426)
+..... ........+||+.|+|||++.. ....+.++|||||||++|+|++|..||.+.+.......+.....+
T Consensus 176 ~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 253 (326)
T 2x7f_A 176 SAQLDR--TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR 253 (326)
T ss_dssp TC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred ceecCc--CccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccc
Confidence 885432 1123345689999999999862 233468899999999999999999999988776666655554332
Q ss_pred -CCCCCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 236 -LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 236 -~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
.+..+++.+.+||.+||..||.+|||+.++++||||.+.
T Consensus 254 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 254 LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 245589999999999999999999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=398.20 Aligned_cols=256 Identities=27% Similarity=0.398 Sum_probs=211.2
Q ss_pred cCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 014347 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (426)
.+....++|++++.||+|+||.||+|++..+++ ||+|.+..... ...+|+.+++.++||||+++++++....
T Consensus 34 ~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~ 105 (394)
T 4e7w_A 34 TGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSNG 105 (394)
T ss_dssp SCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEES
T ss_pred CCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEecC
Confidence 344556789999999999999999999987766 88887765432 1237999999999999999999985543
Q ss_pred ------EEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEec-CCCCeEEe
Q 014347 88 ------KIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKIS 156 (426)
Q Consensus 88 ------~~~lV~Ey~~gg~L~~~i~----~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~-~~g~vkL~ 156 (426)
..|+||||++++ +.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+
T Consensus 106 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~ 184 (394)
T 4e7w_A 106 DKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLI 184 (394)
T ss_dssp SSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred CCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEe
Confidence 388999999874 433332 356899999999999999999999999999999999999999 78999999
Q ss_pred eccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC----
Q 014347 157 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---- 232 (426)
Q Consensus 157 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---- 232 (426)
|||+|+.... .......+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+.+.
T Consensus 185 DFG~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p 261 (394)
T 4e7w_A 185 DFGSAKILIA---GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP 261 (394)
T ss_dssp CCTTCEECCT---TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred eCCCcccccC---CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999985422 223446688999999999877665579999999999999999999999998876665555431
Q ss_pred -------------CCC------------CCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 233 -------------DFK------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 233 -------------~~~------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
... ++..+++++.+||.+||++||.+|||+.++++||||+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp CHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred CHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 011 2334789999999999999999999999999999998643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=384.86 Aligned_cols=263 Identities=25% Similarity=0.359 Sum_probs=203.8
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCC---eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (426)
....++|++++.||+|+||.||+|++..++. .||+|++....... ...+.+.+|+.+++.++||||+++++++...
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 3456789999999999999999999877765 89999997654332 3467899999999999999999999999877
Q ss_pred CEE------EEEEeccCCCChHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeE
Q 014347 87 SKI------YMVLEYVTGGELFDKIASKG------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 154 (426)
Q Consensus 87 ~~~------~lV~Ey~~gg~L~~~i~~~~------~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vk 154 (426)
... |+||||+.||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEE
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEE
Confidence 655 99999999999999986532 599999999999999999999999999999999999999999999
Q ss_pred EeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcCC
Q 014347 155 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD 233 (426)
Q Consensus 155 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~ 233 (426)
|+|||++................+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+.
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~ 256 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLY-TVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN 256 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCC-CCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC
Confidence 999999986433222222334457889999999887766 689999999999999999 999999988777777776654
Q ss_pred -CCCCCCCCHHHHHHHHHccccCccCCCC-------HHHHhcCcccccc
Q 014347 234 -FKLPKWLSPGAQNLLRKILEPNPVKRIT-------IAGIKADEWFEQD 274 (426)
Q Consensus 234 -~~~p~~~s~~~~~Li~~~L~~dP~~R~t-------~~eil~h~~f~~~ 274 (426)
...|..+++.+.+||.+||+.||.+||| +++++.|+|+...
T Consensus 257 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 257 RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 5677789999999999999999999999 7889999999764
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=385.91 Aligned_cols=261 Identities=26% Similarity=0.400 Sum_probs=217.3
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC----
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK---- 86 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 86 (426)
...++|++++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence 34579999999999999999999999999999999996432 344467788999999999999999999998654
Q ss_pred -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 87 -~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
...|+||||+. ++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 86 ~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 86 FNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp CCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 67999999997 589998876 679999999999999999999999999999999999999999999999999998543
Q ss_pred cccCC--------CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHc--CC--
Q 014347 166 HFRDD--------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--GD-- 233 (426)
Q Consensus 166 ~~~~~--------~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~-- 233 (426)
..... ......+||+.|+|||++......+.++|||||||++|+|++|..||.+.+.......+.. +.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence 21111 1123457999999999987655557899999999999999999999998876554443321 00
Q ss_pred --------------------CC--------CCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 234 --------------------FK--------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 234 --------------------~~--------~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
.. .++.+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 00 1135789999999999999999999999999999998643
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-49 Score=381.26 Aligned_cols=262 Identities=28% Similarity=0.388 Sum_probs=214.2
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEE------
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA------ 84 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~------ 84 (426)
...++|++++.||+|+||.||+|.+..+|+.||+|.+... +....+.+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence 4457999999999999999999999999999999998754 3445678899999999999999999999873
Q ss_pred --------eCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEec-CCCCeEE
Q 014347 85 --------SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKI 155 (426)
Q Consensus 85 --------~~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~-~~g~vkL 155 (426)
.....|+||||+. |+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++ +++.+||
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 85 TDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp CC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred ccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEE
Confidence 4478999999997 599998865 6799999999999999999999999999999999999997 5678999
Q ss_pred eeccCccCCcccc-CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC
Q 014347 156 SDFGLSALPQHFR-DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF 234 (426)
Q Consensus 156 ~DFGla~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~ 234 (426)
+|||++....... .........||+.|+|||++......+.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 242 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999998643211 122334567899999999987655557899999999999999999999999887666655543221
Q ss_pred C------------------------------CCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccCCC
Q 014347 235 K------------------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (426)
Q Consensus 235 ~------------------------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 277 (426)
. .++.+++++.+||.+||+.||.+|||++++++||||+....|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence 1 124578999999999999999999999999999999865443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-50 Score=385.47 Aligned_cols=265 Identities=26% Similarity=0.444 Sum_probs=199.2
Q ss_pred cCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 014347 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (426)
+.....++|++++.||+|+||.||+|.+..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 86 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD 86 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSS
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC
Confidence 445677899999999999999999999988999999999865432 223567889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeecc
Q 014347 88 KIYMVLEYVTGGELFDKIAS--------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG 159 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~--------~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFG 159 (426)
..|+||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEecc
Confidence 99999999999999999874 4569999999999999999999999999999999999999999999999999
Q ss_pred CccCCcccc---CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC--
Q 014347 160 LSALPQHFR---DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-- 234 (426)
Q Consensus 160 la~~~~~~~---~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-- 234 (426)
++....... ........+||+.|+|||++......+.++||||||+++|+|++|..||.................
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 246 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCC
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCc
Confidence 987543211 112234567999999999987633347899999999999999999999988665554444443322
Q ss_pred --------CCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 235 --------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 235 --------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
..+..+++.+.+||.+||+.||.+|||+.++++||||++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 1234578899999999999999999999999999999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-49 Score=388.12 Aligned_cols=260 Identities=24% Similarity=0.361 Sum_probs=206.3
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE-
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK- 88 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~- 88 (426)
...+++|++.+.||+|+||.||+|++..+|+.||||++...... ..+..+|+..++.++||||+++++++.....
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 45678999999999999999999999999999999998654322 2356678888888999999999999865433
Q ss_pred ------EEEEEeccCCCChHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHh--hcCceeccCCCCcEEecC-CCCeEE
Q 014347 89 ------IYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVSYCH--NKGVFHRDLKLENILLDS-KGNIKI 155 (426)
Q Consensus 89 ------~~lV~Ey~~gg~L~~~i----~~~~~l~~~~~~~i~~Ql~~aL~~LH--~~gIiHrDLKp~NILl~~-~g~vkL 155 (426)
.|+||||+.+ +|.+.+ .....+++..++.++.|++.||.||| ++||+||||||+|||++. ++.+||
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEE
Confidence 8899999987 544433 35667999999999999999999999 999999999999999997 899999
Q ss_pred eeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC--
Q 014347 156 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-- 233 (426)
Q Consensus 156 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-- 233 (426)
+|||++..... .......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+.+..
T Consensus 174 ~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 250 (360)
T 3e3p_A 174 CDFGSAKKLSP---SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC 250 (360)
T ss_dssp CCCTTCBCCCT---TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred eeCCCceecCC---CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCC
Confidence 99999986432 2233456899999999998776656799999999999999999999999988776666654310
Q ss_pred ------------------------------CCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccCCC
Q 014347 234 ------------------------------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (426)
Q Consensus 234 ------------------------------~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 277 (426)
...+...++.+.+||.+||+.||.+|||+.++++||||++...+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 324 (360)
T 3e3p_A 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP 324 (360)
T ss_dssp CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCT
T ss_pred CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCc
Confidence 01112256889999999999999999999999999999876543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-49 Score=383.87 Aligned_cols=256 Identities=30% Similarity=0.419 Sum_probs=215.4
Q ss_pred cCCccCCCeeeeceEeecCceEEEEEEE-CCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCC------CccceE
Q 014347 8 QEGMRLGRYELGRTLGEGNFGKVKFAQD-LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP------NVVRLH 80 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~-~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp------nIv~l~ 80 (426)
.+....++|++++.||+|+||.||+|.+ ..+++.||+|++... ....+.+.+|+.+++.++|+ ++++++
T Consensus 8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 8 SGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred cCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 3445568999999999999999999998 568899999998643 23456788999999988765 499999
Q ss_pred EEEEeCCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecC---------
Q 014347 81 EVLASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS--------- 149 (426)
Q Consensus 81 ~~~~~~~~~~lV~Ey~~gg~L~~~i~~~~--~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~--------- 149 (426)
+++...+..|+||||+ +++|.+++...+ ++++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 84 EWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred cccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCC
Confidence 9999999999999999 889999998765 6899999999999999999999999999999999999987
Q ss_pred ----------CCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCC
Q 014347 150 ----------KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD 219 (426)
Q Consensus 150 ----------~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 219 (426)
++.+||+|||++.... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||..
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~ 236 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDD-----EHHSTLVSTRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFPT 236 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETT-----SCCCSSCSCGGGCCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccCCCceEeeCcccccCc-----cccccccCCccccChHHhhCCCC-CcchhhHHHHHHHHHHHhCCCCCCC
Confidence 6689999999997532 22345689999999999987776 6899999999999999999999998
Q ss_pred CcHHHHHHHHHcCCCCC--------------------------------------------CCCCCHHHHHHHHHccccC
Q 014347 220 RNLAVLYQKIFRGDFKL--------------------------------------------PKWLSPGAQNLLRKILEPN 255 (426)
Q Consensus 220 ~~~~~~~~~i~~~~~~~--------------------------------------------p~~~s~~~~~Li~~~L~~d 255 (426)
.+.......+.....+. +...++.+.+||.+||+.|
T Consensus 237 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 316 (339)
T 1z57_A 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD 316 (339)
T ss_dssp SCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred CChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence 77655444332211111 1123567899999999999
Q ss_pred ccCCCCHHHHhcCcccccc
Q 014347 256 PVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 256 P~~R~t~~eil~h~~f~~~ 274 (426)
|.+|||+.|+++||||+.-
T Consensus 317 P~~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 317 PAKRITLREALKHPFFDLL 335 (339)
T ss_dssp TTTSCCHHHHTTSGGGGGG
T ss_pred cccccCHHHHhcCHHHHHH
Confidence 9999999999999999863
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=396.02 Aligned_cols=261 Identities=23% Similarity=0.306 Sum_probs=224.9
Q ss_pred CccCCCeeeeceEeecCceEEEEEE-----ECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~-----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 84 (426)
.+..++|++++.||+|+||.||+|+ +..+++.||||++.... .......+.+|+.+++.++||||+++++++.
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL 144 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 4556899999999999999999999 45678899999986432 3344567889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCC---CeE
Q 014347 85 SKSKIYMVLEYVTGGELFDKIASKG-------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIK 154 (426)
Q Consensus 85 ~~~~~~lV~Ey~~gg~L~~~i~~~~-------~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g---~vk 154 (426)
+....|+||||++||+|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||++.+| .+|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 9999999999999999999998643 589999999999999999999999999999999999999655 499
Q ss_pred EeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcCC
Q 014347 155 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD 233 (426)
Q Consensus 155 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~ 233 (426)
|+|||+++...............||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+.
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~ 303 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 303 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999974332222233445678999999999987776 689999999999999998 999999999888888887764
Q ss_pred -CCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 234 -FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 234 -~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
...|..+++.+.+||.+||+.||.+|||+.+++++.|+-.
T Consensus 304 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 304 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 5667789999999999999999999999999999988754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=398.52 Aligned_cols=261 Identities=32% Similarity=0.449 Sum_probs=198.0
Q ss_pred cCCCeee-eceEeecCceEEEEEEEC--CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe--C
Q 014347 12 RLGRYEL-GRTLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--K 86 (426)
Q Consensus 12 ~~~~y~i-~~~LG~G~fg~Vy~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~ 86 (426)
.-+.|++ +++||+|+||.||+|++. .+++.||+|++..... ...+.+|+.+|+.++||||+++++++.. .
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHAD 92 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTT
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCC
Confidence 3456887 568999999999999976 5789999999975432 2467899999999999999999999954 7
Q ss_pred CEEEEEEeccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEe----cCCCCe
Q 014347 87 SKIYMVLEYVTGGELFDKIASK---------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNI 153 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~---------~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl----~~~g~v 153 (426)
..+|+||||+.| +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 93 RKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp TEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred CeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcE
Confidence 789999999965 888887532 249999999999999999999999999999999999999 677899
Q ss_pred EEeeccCccCCcccc-CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHH---------
Q 014347 154 KISDFGLSALPQHFR-DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA--------- 223 (426)
Q Consensus 154 kL~DFGla~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~--------- 223 (426)
||+|||+|+...... ........+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 251 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence 999999998654321 1123456789999999999987665679999999999999999999999765431
Q ss_pred HHHHHHHc--CCCCCC------------------------------------CCCCHHHHHHHHHccccCccCCCCHHHH
Q 014347 224 VLYQKIFR--GDFKLP------------------------------------KWLSPGAQNLLRKILEPNPVKRITIAGI 265 (426)
Q Consensus 224 ~~~~~i~~--~~~~~p------------------------------------~~~s~~~~~Li~~~L~~dP~~R~t~~ei 265 (426)
.....+.. +.+... ...++.+.+||.+||++||.+|||++|+
T Consensus 252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 22222221 111100 0126789999999999999999999999
Q ss_pred hcCccccccCCCC
Q 014347 266 KADEWFEQDYTPA 278 (426)
Q Consensus 266 l~h~~f~~~~~~~ 278 (426)
|+||||.....+.
T Consensus 332 L~hp~f~~~~~~~ 344 (405)
T 3rgf_A 332 MQDPYFLEDPLPT 344 (405)
T ss_dssp HTSGGGTSSSCCC
T ss_pred hcChhhccCCCCc
Confidence 9999998765443
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=378.76 Aligned_cols=261 Identities=25% Similarity=0.382 Sum_probs=212.1
Q ss_pred ccccCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEE
Q 014347 5 EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84 (426)
Q Consensus 5 ~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 84 (426)
.....+..+++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.
T Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~ 104 (309)
T 2h34_A 25 AESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGE 104 (309)
T ss_dssp ---------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccCCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe
Confidence 34567888999999999999999999999999999999999998766555566788999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCC
Q 014347 85 SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (426)
Q Consensus 85 ~~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~ 164 (426)
.++..|+||||++|++|.+++...+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 105 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 105 IDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp ETTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred eCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 99999999999999999999998889999999999999999999999999999999999999999999999999998754
Q ss_pred ccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC---CCCCCCC
Q 014347 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWLS 241 (426)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s 241 (426)
... ........+||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+..... ..+..++
T Consensus 185 ~~~-~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (309)
T 2h34_A 185 TDE-KLTQLGNTVGTLYYMAPERFSESHA-TYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIP 262 (309)
T ss_dssp -------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCC
T ss_pred ccc-ccccccccCCCcCccCHHHHcCCCC-CchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCC
Confidence 321 1122345679999999999877665 6899999999999999999999998877655555444322 2356689
Q ss_pred HHHHHHHHHccccCccCCC-CHHHHhc
Q 014347 242 PGAQNLLRKILEPNPVKRI-TIAGIKA 267 (426)
Q Consensus 242 ~~~~~Li~~~L~~dP~~R~-t~~eil~ 267 (426)
+.+.+||.+||+.||.+|| |++++++
T Consensus 263 ~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 263 VAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp THHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 9999999999999999999 7777764
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=389.78 Aligned_cols=253 Identities=30% Similarity=0.425 Sum_probs=214.2
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE---
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI--- 89 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~--- 89 (426)
-++|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 368999999999999999999999999999999997543 2344567889999999999999999999999876654
Q ss_pred ---EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcc
Q 014347 90 ---YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (426)
Q Consensus 90 ---~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 166 (426)
|+||||+. ++|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~- 195 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD- 195 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred eeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc-
Confidence 99999997 58887764 459999999999999999999999999999999999999999999999999998532
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC-------------
Q 014347 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD------------- 233 (426)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------- 233 (426)
......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 196 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 271 (371)
T 4exu_A 196 ----AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 271 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred ----cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence 223456899999999998874555789999999999999999999999987766665553310
Q ss_pred ----------C--------CCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 234 ----------F--------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 234 ----------~--------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
. ..++.+++.+.+||.+||++||.+|||++++++||||+..
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 272 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp HHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 0 0123468999999999999999999999999999999854
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=382.83 Aligned_cols=255 Identities=24% Similarity=0.379 Sum_probs=220.1
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCe---EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLP---FAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~---vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (426)
.+..++|++.+.||+|+||.||+|.+..+++. ||||++.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 45678999999999999999999999866654 9999997543 334467899999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 87 SKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
+..|+||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999999999754 689999999999999999999999999999999999999999999999999998653
Q ss_pred cccCCC-ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCH
Q 014347 166 HFRDDG-LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSP 242 (426)
Q Consensus 166 ~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 242 (426)
...... ......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..+++
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTF-SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPH 281 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCH
Confidence 321111 1223456788999999987766 689999999999999999 99999998888888777765 4566778999
Q ss_pred HHHHHHHHccccCccCCCCHHHHhc
Q 014347 243 GAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
.+.+||.+||+.||.+|||+.++++
T Consensus 282 ~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 282 ALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999999999999876
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=393.60 Aligned_cols=253 Identities=28% Similarity=0.438 Sum_probs=208.8
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC--------CCCccceEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK--------HPNVVRLHE 81 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~--------hpnIv~l~~ 81 (426)
....++|++++.||+|+||.||+|++..+++.||||++... ....+.+.+|+.+++.++ ||||+++++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~ 108 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD 108 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence 34458999999999999999999999999999999999643 234577889999999886 788999999
Q ss_pred EEE----eCCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhc-CceeccCCCCcEEecCCC---
Q 014347 82 VLA----SKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKG--- 151 (426)
Q Consensus 82 ~~~----~~~~~~lV~Ey~~gg~L~~~i~~~--~~l~~~~~~~i~~Ql~~aL~~LH~~-gIiHrDLKp~NILl~~~g--- 151 (426)
++. ....+|+||||+ +++|.+.+... +.+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 109 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 109 DFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHH
T ss_pred ceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhh
Confidence 987 556899999999 66777777653 5699999999999999999999998 999999999999999776
Q ss_pred ----------------------------------------------CeEEeeccCccCCccccCCCccccccCCCcccch
Q 014347 152 ----------------------------------------------NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185 (426)
Q Consensus 152 ----------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~AP 185 (426)
.+||+|||++..... .....+||+.|+||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y~aP 262 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYRSL 262 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGGCCH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCcccCC
Confidence 799999999975432 23456899999999
Q ss_pred hhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCc------HHHHHHHHHc--C-------------------------
Q 014347 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN------LAVLYQKIFR--G------------------------- 232 (426)
Q Consensus 186 E~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~------~~~~~~~i~~--~------------------------- 232 (426)
|++.+..+ +.++|||||||++|+|++|..||...+ .......+.. +
T Consensus 263 E~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 341 (397)
T 1wak_A 263 EVLIGSGY-NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH 341 (397)
T ss_dssp HHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred hhhcCCCC-CcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence 99988776 689999999999999999999997643 1111211111 0
Q ss_pred ---------------CCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 233 ---------------DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 233 ---------------~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
....+...++.+.+||.+||++||.+|||++++++||||++
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 11122234567899999999999999999999999999963
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=371.11 Aligned_cols=253 Identities=23% Similarity=0.397 Sum_probs=221.0
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (426)
-.+..++|++++.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.++++++||||+++++++.+.+.
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 79 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred EEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence 3455679999999999999999999986 5778999999765432 3568899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 89 IYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
.|+||||++|++|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 9999999999999999975 456999999999999999999999999999999999999999999999999999754321
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHH
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ 245 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 245 (426)
. ........||+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+.......+..+ ....|..+++.+.
T Consensus 160 ~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T 4hcu_A 160 Q-YTSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVY 237 (269)
T ss_dssp H-HHSTTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHH
T ss_pred c-cccccCcccccccCCHHHhcCCCC-CchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHH
Confidence 1 112234567888999999987766 689999999999999999 99999999888888888776 4556777899999
Q ss_pred HHHHHccccCccCCCCHHHHhcC
Q 014347 246 NLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~eil~h 268 (426)
+|+.+||+.||.+|||+.+++++
T Consensus 238 ~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 238 QIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCcccCcCHHHHHHH
Confidence 99999999999999999999876
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=384.67 Aligned_cols=256 Identities=26% Similarity=0.363 Sum_probs=222.6
Q ss_pred CccCCCeeeeceEeecCceEEEEEEEC-----CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 84 (426)
....++|++++.||+|+||.||+|++. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 456689999999999999999999987 355899999997543 3445678999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccC
Q 014347 85 SKSKIYMVLEYVTGGELFDKIASK------------------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140 (426)
Q Consensus 85 ~~~~~~lV~Ey~~gg~L~~~i~~~------------------------~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDL 140 (426)
+.+..|+||||++||+|.+++... .++++.+++.++.||+.||.|||++||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 999999999999999999999763 57999999999999999999999999999999
Q ss_pred CCCcEEecCCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCC
Q 014347 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD 219 (426)
Q Consensus 141 Kp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~ 219 (426)
||+|||++.++.+||+|||++................||+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCc-CcccccHHHHHHHHHHHhcCCCcCCC
Confidence 99999999999999999999875432222223345578999999999887766 689999999999999999 9999999
Q ss_pred CcHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 220 RNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 220 ~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
.+.......+..+. ...|..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 280 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 88888887777765 45678899999999999999999999999999764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-49 Score=379.92 Aligned_cols=256 Identities=29% Similarity=0.384 Sum_probs=221.4
Q ss_pred CccCCCeeeeceEeecCceEEEEEEEC-----CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 84 (426)
....++|++++.||+|+||.||+|.+. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 96 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACS 96 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence 455689999999999999999999983 456899999997543 3445678999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHhhcCceeccC
Q 014347 85 SKSKIYMVLEYVTGGELFDKIASKGR------------------------LQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140 (426)
Q Consensus 85 ~~~~~~lV~Ey~~gg~L~~~i~~~~~------------------------l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDL 140 (426)
+.+..|+||||++|++|.+++..... +++.+++.++.||+.||.|||++||+||||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~di 176 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDL 176 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccccc
Confidence 99999999999999999999986443 899999999999999999999999999999
Q ss_pred CCCcEEecCCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCC
Q 014347 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD 219 (426)
Q Consensus 141 Kp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~ 219 (426)
||+|||++.++.+||+|||++................+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCc-CchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999975432211112234467889999999887665 689999999999999999 9999999
Q ss_pred CcHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 220 RNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 220 ~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
.+.......+..+ ....|..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 256 IPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp CCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 8877777776665 356677899999999999999999999999999875
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=386.79 Aligned_cols=256 Identities=33% Similarity=0.582 Sum_probs=224.3
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccch---hHHHHHHHHHHHHHhCC--CCCccceEEEEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLLK--HPNVVRLHEVLA 84 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~ 84 (426)
....++|++++.||+|+||.||+|++..+++.||||++........ .....+.+|+.+++.++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 4566899999999999999999999999999999999986543321 11245678999999996 599999999999
Q ss_pred eCCEEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEec-CCCCeEEeeccCcc
Q 014347 85 SKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSA 162 (426)
Q Consensus 85 ~~~~~~lV~Ey~~g-g~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~-~~g~vkL~DFGla~ 162 (426)
..+..++||||+.+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 99999999999976 89999999888999999999999999999999999999999999999999 78899999999998
Q ss_pred CCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCH
Q 014347 163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 242 (426)
Q Consensus 163 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 242 (426)
.... .......||+.|+|||++.+..+.+.++||||||+++|+|++|..||...+ .+......++..+++
T Consensus 199 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~ 268 (320)
T 3a99_A 199 LLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSS 268 (320)
T ss_dssp ECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCH
T ss_pred cccc----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccccccCCH
Confidence 5432 233456799999999999877776788999999999999999999998753 344566677888999
Q ss_pred HHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
.+.+||.+||+.||.+|||++++++||||++..
T Consensus 269 ~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 269 ECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 999999999999999999999999999998654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=388.31 Aligned_cols=262 Identities=25% Similarity=0.375 Sum_probs=211.0
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccc--------cchhHHHHHHHHHHHHHhCCCCCccceEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI--------IHLKITDQIKREIATLKLLKHPNVVRLHEV 82 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--------~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 82 (426)
...++|++++.||+|+||.||+|.+.. |+.||||.+..... .+....+.+.+|+.+++.++||||++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 345899999999999999999999854 99999999865332 123345789999999999999999999999
Q ss_pred EEe-----CCEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEe
Q 014347 83 LAS-----KSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKIS 156 (426)
Q Consensus 83 ~~~-----~~~~~lV~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~ 156 (426)
+.. ....|+||||+. |+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~ 176 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC 176 (362)
T ss_dssp EEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred EEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEE
Confidence 844 347899999997 5888887753 479999999999999999999999999999999999999999999999
Q ss_pred eccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC----
Q 014347 157 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---- 232 (426)
Q Consensus 157 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---- 232 (426)
|||++.... ........+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+......++...
T Consensus 177 Dfg~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 253 (362)
T 3pg1_A 177 DFNLAREDT---ADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253 (362)
T ss_dssp CTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ecCcccccc---cccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 999997432 2223445689999999999887455579999999999999999999999998776666555321
Q ss_pred --------------------CCC--------CCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccCCC
Q 014347 233 --------------------DFK--------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (426)
Q Consensus 233 --------------------~~~--------~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 277 (426)
... .++..++.+.+||.+||+.||.+|||+.++++||||+..+.+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 326 (362)
T 3pg1_A 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP 326 (362)
T ss_dssp CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence 001 123468899999999999999999999999999999876543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=372.63 Aligned_cols=255 Identities=29% Similarity=0.470 Sum_probs=209.8
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe-------
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------- 85 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------- 85 (426)
.++|++++.||+|+||.||+|++..+|+.||+|++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 46899999999999999999999999999999998643 2345788999999999999999999998754
Q ss_pred ------CCEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeec
Q 014347 86 ------KSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDF 158 (426)
Q Consensus 86 ------~~~~~lV~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DF 158 (426)
....|+||||++|++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeC
Confidence 46789999999999999999854 36889999999999999999999999999999999999999999999999
Q ss_pred cCccCCcccc------------CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCC-CcHHHH
Q 014347 159 GLSALPQHFR------------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVL 225 (426)
Q Consensus 159 Gla~~~~~~~------------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~-~~~~~~ 225 (426)
|++....... ........+||+.|+|||++.+.+..+.++|||||||++|+|++ ||.. .+....
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~ 237 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI 237 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence 9998643211 01223456799999999998876555799999999999999998 6654 334455
Q ss_pred HHHHHcCCCCCCC----CCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 226 YQKIFRGDFKLPK----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 226 ~~~i~~~~~~~p~----~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
...+......+|+ ..++.+.+||.+||+.||.+|||+.++++||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 5666655555443 456779999999999999999999999999999753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=390.18 Aligned_cols=256 Identities=25% Similarity=0.379 Sum_probs=216.4
Q ss_pred CccCCCeeeeceEeecCceEEEEEE-----ECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVL 83 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~-----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 83 (426)
....++|++++.||+|+||.||+|+ +..+++.||||++.... .....+.+.+|+.+++.+ +||||+++++++
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 95 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 95 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence 4556899999999999999999998 55677899999997543 333457799999999999 789999999998
Q ss_pred EeCC-EEEEEEeccCCCChHHHHHhcCC----------------------------------------------------
Q 014347 84 ASKS-KIYMVLEYVTGGELFDKIASKGR---------------------------------------------------- 110 (426)
Q Consensus 84 ~~~~-~~~lV~Ey~~gg~L~~~i~~~~~---------------------------------------------------- 110 (426)
.+.+ ..|+||||++||+|.+++.....
T Consensus 96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 8754 48999999999999999976433
Q ss_pred --------------CCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccc
Q 014347 111 --------------LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 176 (426)
Q Consensus 111 --------------l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 176 (426)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...............
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 255 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcccc
Confidence 899999999999999999999999999999999999999999999999999865332222233456
Q ss_pred cCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHH-HHHHHHc-CCCCCCCCCCHHHHHHHHHccc
Q 014347 177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV-LYQKIFR-GDFKLPKWLSPGAQNLLRKILE 253 (426)
Q Consensus 177 ~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~-~~~~i~~-~~~~~p~~~s~~~~~Li~~~L~ 253 (426)
.||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+... ....+.. .....|..+++++.+||.+||+
T Consensus 256 ~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 334 (359)
T 3vhe_A 256 RLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 334 (359)
T ss_dssp EECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCceeEChhhhcCCCC-CchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcc
Confidence 78999999999887766 689999999999999998 999998865433 3333333 3566788899999999999999
Q ss_pred cCccCCCCHHHHhcC
Q 014347 254 PNPVKRITIAGIKAD 268 (426)
Q Consensus 254 ~dP~~R~t~~eil~h 268 (426)
.||.+|||+.++++|
T Consensus 335 ~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 335 GEPSQRPTFSELVEH 349 (359)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred CChhhCCCHHHHHHH
Confidence 999999999999876
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=387.33 Aligned_cols=256 Identities=27% Similarity=0.448 Sum_probs=224.3
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCC-------CCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDS-------GLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHE 81 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~ 81 (426)
.+..++|++++.||+|+||.||+|++..+ +..||+|++.... .......+.+|+.+++.+ +||||+++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 142 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG 142 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence 45568999999999999999999997543 3579999997553 344567899999999999 8999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcE
Q 014347 82 VLASKSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENI 145 (426)
Q Consensus 82 ~~~~~~~~~lV~Ey~~gg~L~~~i~~~~----------------~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NI 145 (426)
++.+.+..|+||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||
T Consensus 143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 222 (382)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceE
Confidence 9999999999999999999999998743 499999999999999999999999999999999999
Q ss_pred EecCCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHH
Q 014347 146 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV 224 (426)
Q Consensus 146 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~ 224 (426)
|++.++.+||+|||+++...............||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+...
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999986544322233445578899999999987665 689999999999999999 999999998888
Q ss_pred HHHHHHcC-CCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 225 LYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 225 ~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
....+..+ ....|..+++++.+||.+||+.||++|||+.+++++
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 302 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 88877766 456677899999999999999999999999999886
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=383.85 Aligned_cols=253 Identities=30% Similarity=0.425 Sum_probs=213.7
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE----
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK---- 88 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~---- 88 (426)
.++|.+.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 478999999999999999999999999999999997543 234456788999999999999999999999977653
Q ss_pred --EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcc
Q 014347 89 --IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (426)
Q Consensus 89 --~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 166 (426)
.|+||||+. ++|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred eeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 599999997 58888764 4599999999999999999999999999999999999999999999999999985322
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC--------------
Q 014347 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------- 232 (426)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------- 232 (426)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 179 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 179 -----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred -----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence 2345689999999999887455578999999999999999999999988766555444321
Q ss_pred --------------C---CCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 233 --------------D---FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 233 --------------~---~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
. ...++.+++.+.+||.+||+.||.+|||++++++||||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0 12234578999999999999999999999999999999754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=377.17 Aligned_cols=255 Identities=24% Similarity=0.411 Sum_probs=214.7
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
....++|++++.||+|+||.||+|.+..+++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+++..
T Consensus 6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 82 (310)
T 3s95_A 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL 82 (310)
T ss_dssp EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence 35678999999999999999999999999999999988543 344567899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
|+||||++|++|.+++.. ...+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999999999987 5679999999999999999999999999999999999999999999999999997543211
Q ss_pred CC------------CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHH-----HHHHHHc
Q 014347 169 DD------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV-----LYQKIFR 231 (426)
Q Consensus 169 ~~------------~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~-----~~~~i~~ 231 (426)
.. ......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||....... ......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~- 240 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSY-DEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL- 240 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH-
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc-
Confidence 11 11125689999999999987766 689999999999999999999987532110 001111
Q ss_pred CCCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCcccc
Q 014347 232 GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 272 (426)
Q Consensus 232 ~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~ 272 (426)
....|..+++.+.+||.+||+.||.+|||+.++++ |++
T Consensus 241 -~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~ 278 (310)
T 3s95_A 241 -DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLE 278 (310)
T ss_dssp -HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHH
T ss_pred -cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHH
Confidence 11346778899999999999999999999999986 554
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=370.78 Aligned_cols=259 Identities=28% Similarity=0.460 Sum_probs=214.6
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
.+++|.....||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..|+
T Consensus 20 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 96 (295)
T 2clq_A 20 EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKI 96 (295)
T ss_dssp CBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEE
Confidence 3444555559999999999999999999999999997653 2335778999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecC-CCCeEEeeccCccCCccc
Q 014347 92 VLEYVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHF 167 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~---~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~-~g~vkL~DFGla~~~~~~ 167 (426)
||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 99999999999999864 24678999999999999999999999999999999999987 899999999999754321
Q ss_pred cCCCccccccCCCcccchhhhccCC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcHH--HHHH-HHHcCCCCCCCCCCHH
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRNLA--VLYQ-KIFRGDFKLPKWLSPG 243 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~~~--~~~~-~i~~~~~~~p~~~s~~ 243 (426)
........||+.|+|||++.+.. ..+.++||||||+++|+|++|..||...... .... ........+|..+++.
T Consensus 177 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (295)
T 2clq_A 177 --NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAE 254 (295)
T ss_dssp ------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHH
T ss_pred --CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHH
Confidence 12234567999999999987543 2368899999999999999999999764322 2222 2234456778889999
Q ss_pred HHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
+.+||.+||+.||.+|||+.++++||||+...
T Consensus 255 ~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 255 AKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp HHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred HHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 99999999999999999999999999998643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=395.32 Aligned_cols=254 Identities=15% Similarity=0.170 Sum_probs=196.2
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC--CCCCccceE-------EEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL--KHPNVVRLH-------EVLA 84 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l--~hpnIv~l~-------~~~~ 84 (426)
.+|++++.||+|+||.||+|++..+|+.||||++...........+.+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 3599999999999999999999999999999999887655555677888885544444 699987755 5554
Q ss_pred eC-----------------CEEEEEEeccCCCChHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHhhcCceeccC
Q 014347 85 SK-----------------SKIYMVLEYVTGGELFDKIASK-GRLQEAEG------RKLFQQLIDGVSYCHNKGVFHRDL 140 (426)
Q Consensus 85 ~~-----------------~~~~lV~Ey~~gg~L~~~i~~~-~~l~~~~~------~~i~~Ql~~aL~~LH~~gIiHrDL 140 (426)
.. ..+|+||||+. |+|.+++... ..+++... ..++.||+.||+|||++||+||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 43 34899999998 7999999863 33444444 566799999999999999999999
Q ss_pred CCCcEEecCCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhcc--CCCCCCcchhhhHHHHHHHHHhCCCCCC
Q 014347 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFD 218 (426)
Q Consensus 141 Kp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DIwSlGvil~elltG~~Pf~ 218 (426)
||+|||++.+|.+||+|||+|+... .......+|+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.
T Consensus 221 kp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 221 TPDNLFIMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp SGGGEEECTTSCEEECCGGGEEETT-----CEEEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred CHHHEEECCCCCEEEEecceeeecC-----CCccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999998532 22225567799999999976 445 789999999999999999999998
Q ss_pred CCcHHH--HHHH-----HHcCCCCCC--CCCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 219 DRNLAV--LYQK-----IFRGDFKLP--KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 219 ~~~~~~--~~~~-----i~~~~~~~p--~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
+..... .+.. .....+.+| ..+++.+.+||.+||++||++|||+.++++||||++.
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 764321 0100 011122233 4689999999999999999999999999999999753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=366.86 Aligned_cols=252 Identities=25% Similarity=0.420 Sum_probs=219.1
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
.+..++|++++.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++.+....
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 356689999999999999999999875 5778999999765432 35688999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 90 YMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~-~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
|+||||++|++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 99999999999999998754 59999999999999999999999999999999999999999999999999997543211
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHHH
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQN 246 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 246 (426)
........+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||...+.......+..+. ...|...++.+.+
T Consensus 159 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 236 (268)
T 3sxs_A 159 -YVSSVGTKFPVKWSAPEVFHYFKY-SSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQ 236 (268)
T ss_dssp -EEECCSCCCCGGGCCHHHHHHSEE-ETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred -hhcccCCCcCcccCCHHHHhccCC-chhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHH
Confidence 111223456778999999987666 588999999999999999 999999988888777777664 4556778999999
Q ss_pred HHHHccccCccCCCCHHHHhcC
Q 014347 247 LLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 247 Li~~~L~~dP~~R~t~~eil~h 268 (426)
||.+||+.||.+|||+.+++++
T Consensus 237 li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 237 IMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999886
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=381.83 Aligned_cols=256 Identities=32% Similarity=0.606 Sum_probs=214.1
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccch---hHHHHHHHHHHHHHhC----CCCCccceEE
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLL----KHPNVVRLHE 81 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l----~hpnIv~l~~ 81 (426)
.....++|++++.||+|+||.||+|.+..+++.||+|++........ .....+.+|+.+++.+ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 34566899999999999999999999999999999999976543221 1233466799999988 8999999999
Q ss_pred EEEeCCEEEEEEec-cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEec-CCCCeEEeecc
Q 014347 82 VLASKSKIYMVLEY-VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFG 159 (426)
Q Consensus 82 ~~~~~~~~~lV~Ey-~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~-~~g~vkL~DFG 159 (426)
++...+..++|||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 99999999999999 78999999999888999999999999999999999999999999999999999 88999999999
Q ss_pred CccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCC
Q 014347 160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW 239 (426)
Q Consensus 160 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~ 239 (426)
++..... .......||+.|+|||++.+..+.+.++||||||+++|+|++|+.||.... .+......+|..
T Consensus 186 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~ 255 (312)
T 2iwi_A 186 SGALLHD----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFPAH 255 (312)
T ss_dssp SCEECCS----SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCCTT
T ss_pred hhhhccc----CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCccc
Confidence 9885432 234456799999999998877776668999999999999999999998643 344567778888
Q ss_pred CCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 240 ~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
+++.+.+||.+||+.||++|||+.++++||||+..
T Consensus 256 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 256 VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 99999999999999999999999999999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=390.88 Aligned_cols=254 Identities=26% Similarity=0.394 Sum_probs=218.9
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (426)
...++|++++.||+|+||.||+|.+..+++.||||++.... .....+.+.+|+.+|+.++||||+++++++...+..|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 188 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence 34578999999999999999999999999999999986542 3344567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 91 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
+||||++||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 999999999999999864 4699999999999999999999999999999999999999999999999999874321100
Q ss_pred CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHHH
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 247 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 247 (426)
........+++.|+|||++....+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..+++.+.+|
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 347 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRY-SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRL 347 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred eecCCCCCCCcCcCCHhHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 011112235678999999887666 689999999999999998 99999998877777666654 467788899999999
Q ss_pred HHHccccCccCCCCHHHHhc
Q 014347 248 LRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 248 i~~~L~~dP~~R~t~~eil~ 267 (426)
|.+||+.||++|||+.++++
T Consensus 348 i~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 348 MEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCCchhCcCHHHHHH
Confidence 99999999999999999875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=373.41 Aligned_cols=249 Identities=21% Similarity=0.283 Sum_probs=214.6
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCC-------CeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSG-------LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEV 82 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-------~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 82 (426)
.+..++|++.+.||+|+||.||+|++..++ ..||+|++.... ....+.+.+|+.+++.++||||++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 356689999999999999999999998877 469999986543 2345789999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCC--------e
Q 014347 83 LASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN--------I 153 (426)
Q Consensus 83 ~~~~~~~~lV~Ey~~gg~L~~~i~~~~~-l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~--------v 153 (426)
+.+++..|+||||++|++|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++.++. +
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 9999999999999999999999987554 999999999999999999999999999999999999999887 9
Q ss_pred EEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhC-CCCCCCCcHHHHHHHHHcC
Q 014347 154 KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLAVLYQKIFRG 232 (426)
Q Consensus 154 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~ 232 (426)
||+|||++.... ......||+.|+|||++.+....+.++||||||+++|+|++| .+||...+... .......
T Consensus 161 kl~Dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~~~ 233 (289)
T 4fvq_A 161 KLSDPGISITVL------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KLQFYED 233 (289)
T ss_dssp EECCCCSCTTTS------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHHT
T ss_pred eeccCccccccc------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-HHHHhhc
Confidence 999999987432 223456899999999998745557899999999999999994 55665555443 3344455
Q ss_pred CCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 233 DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 233 ~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
....|...++++.+||.+||+.||.+|||+.+++++
T Consensus 234 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 234 RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 667777789999999999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-48 Score=375.82 Aligned_cols=257 Identities=31% Similarity=0.427 Sum_probs=215.6
Q ss_pred cCCCeeeeceEeecCceEEEEEEEC-CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCccceEEEEE---
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDL-DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL---KHPNVVRLHEVLA--- 84 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~--- 84 (426)
..++|++++.||+|+||.||+|++. .+|+.||+|++....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3479999999999999999999995 678999999997544221 1123456777777666 8999999999987
Q ss_pred --eCCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccC
Q 014347 85 --SKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL 160 (426)
Q Consensus 85 --~~~~~~lV~Ey~~gg~L~~~i~~~~--~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGl 160 (426)
.....|+||||+. |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 5677999999997 59999998643 499999999999999999999999999999999999999999999999999
Q ss_pred ccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC--C-----
Q 014347 161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--D----- 233 (426)
Q Consensus 161 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~----- 233 (426)
+..... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+......++... .
T Consensus 167 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 167 ARIYSF---QMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CCCCCG---GGGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cccccC---CCCccccccccceeCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 986432 123345689999999999887666 68999999999999999999999998877666665431 0
Q ss_pred --------------------CCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 234 --------------------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 234 --------------------~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
..++..+++.+.+||.+||+.||.+|||+.++++||||++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 01234578999999999999999999999999999999764
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-48 Score=386.50 Aligned_cols=254 Identities=28% Similarity=0.355 Sum_probs=213.4
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CC-----CccceEEEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HP-----NVVRLHEVL 83 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hp-----nIv~l~~~~ 83 (426)
....++|++++.||+|+||.||+|++..+++.||||++... ......+.+|+.+++.++ |+ +|+++++++
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 34568999999999999999999999999999999999643 234567788999988885 55 499999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHh--hcCceeccCCCCcEEec--CCCCeEEee
Q 014347 84 ASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCH--NKGVFHRDLKLENILLD--SKGNIKISD 157 (426)
Q Consensus 84 ~~~~~~~lV~Ey~~gg~L~~~i~~~--~~l~~~~~~~i~~Ql~~aL~~LH--~~gIiHrDLKp~NILl~--~~g~vkL~D 157 (426)
...+..|+||||+.| +|.+++... +.+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+||+|
T Consensus 126 ~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 126 MFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp EETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred ccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 999999999999965 999999864 46999999999999999999999 57999999999999995 477899999
Q ss_pred ccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCC-
Q 014347 158 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL- 236 (426)
Q Consensus 158 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~- 236 (426)
||++.... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+......++.......
T Consensus 205 FG~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 278 (382)
T 2vx3_A 205 FGSSCQLG-----QRIYQYIQSRFYRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP 278 (382)
T ss_dssp CTTCEETT-----CCCCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred ccCceecc-----cccccccCCccccChHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99997542 23446789999999999988776 689999999999999999999999988777666654321000
Q ss_pred ------------------------------------CCC---------------------------CCHHHHHHHHHccc
Q 014347 237 ------------------------------------PKW---------------------------LSPGAQNLLRKILE 253 (426)
Q Consensus 237 ------------------------------------p~~---------------------------~s~~~~~Li~~~L~ 253 (426)
|.. .++.+.+||.+||+
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 358 (382)
T 2vx3_A 279 AHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLD 358 (382)
T ss_dssp HHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTC
T ss_pred HHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcC
Confidence 000 01378999999999
Q ss_pred cCccCCCCHHHHhcCcccccc
Q 014347 254 PNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 254 ~dP~~R~t~~eil~h~~f~~~ 274 (426)
+||++|||++|+|+||||++.
T Consensus 359 ~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 359 YDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp SCTTTSCCHHHHTTSGGGCC-
T ss_pred CChhhCCCHHHHhcCcccccC
Confidence 999999999999999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=379.60 Aligned_cols=254 Identities=26% Similarity=0.407 Sum_probs=212.4
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCC-CeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC------ccceEEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSG-LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN------VVRLHEV 82 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn------Iv~l~~~ 82 (426)
....++|++++.||+|+||.||+|.+..++ +.||+|++... ....+.+.+|+.+++.++|++ ++.++++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 90 (355)
T 2eu9_A 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDW 90 (355)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence 345689999999999999999999998776 68999999643 234567888999999987665 8999999
Q ss_pred EEeCCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEe-------------
Q 014347 83 LASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL------------- 147 (426)
Q Consensus 83 ~~~~~~~~lV~Ey~~gg~L~~~i~~~--~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl------------- 147 (426)
+...+..|+||||+ +++|.+.+... .++++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 91 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 91 FNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccc
Confidence 99999999999999 66888877664 379999999999999999999999999999999999999
Q ss_pred ------cCCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCc
Q 014347 148 ------DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN 221 (426)
Q Consensus 148 ------~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 221 (426)
+.++.+||+|||++.... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDH-----EHHTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETT-----SCCCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccCCCcEEEeecCcccccc-----ccccCCcCCCcccCCeeeecCCC-CCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 567899999999997532 22345689999999999987776 689999999999999999999999877
Q ss_pred HHHHHHHHHcCCCCCC--------------------------------------------CCCCHHHHHHHHHccccCcc
Q 014347 222 LAVLYQKIFRGDFKLP--------------------------------------------KWLSPGAQNLLRKILEPNPV 257 (426)
Q Consensus 222 ~~~~~~~i~~~~~~~p--------------------------------------------~~~s~~~~~Li~~~L~~dP~ 257 (426)
.......+.......| ...++.+.+||.+||+.||.
T Consensus 244 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 323 (355)
T 2eu9_A 244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA 323 (355)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence 6554433322111111 11245788999999999999
Q ss_pred CCCCHHHHhcCcccccc
Q 014347 258 KRITIAGIKADEWFEQD 274 (426)
Q Consensus 258 ~R~t~~eil~h~~f~~~ 274 (426)
+|||+.++++||||+..
T Consensus 324 ~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 324 QRITLAEALLHPFFAGL 340 (355)
T ss_dssp TSCCHHHHTTSGGGGGC
T ss_pred hCcCHHHHhcChhhcCC
Confidence 99999999999999863
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=380.03 Aligned_cols=255 Identities=22% Similarity=0.327 Sum_probs=210.2
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeE----EEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPF----AVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~v----AvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 85 (426)
.+..++|++++.||+|+||.||+|++..+++.+ |+|.+.... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 88 (327)
T 3poz_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 355679999999999999999999998887765 666664322 22335789999999999999999999999987
Q ss_pred CCEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCC
Q 014347 86 KSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (426)
Q Consensus 86 ~~~~~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~ 164 (426)
.. .++++||+.+|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++..
T Consensus 89 ~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp SS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred CC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 65 7889999999999999986 467999999999999999999999999999999999999999999999999999754
Q ss_pred ccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCH
Q 014347 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSP 242 (426)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 242 (426)
.............||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..+++
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI 246 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCH
T ss_pred cCCcccccccCCCccccccChHHhccCCC-CchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCH
Confidence 33222223334567889999999987766 689999999999999999 99999988777666666554 3567778999
Q ss_pred HHHHHHHHccccCccCCCCHHHHhcC
Q 014347 243 GAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
.+.+|+.+||+.||.+|||+.+++++
T Consensus 247 ~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 247 DVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 99999999999999999999999876
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-48 Score=368.78 Aligned_cols=252 Identities=23% Similarity=0.391 Sum_probs=217.4
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
....++|++++.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI 94 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence 345679999999999999999999875 6778999999765432 35688999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
|+||||++|++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 999999999999999976 5679999999999999999999999999999999999999999999999999997543211
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHHH
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQN 246 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 246 (426)
........+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||...+.......+..+. ...|...++.+.+
T Consensus 175 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 252 (283)
T 3gen_A 175 -YTSSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT 252 (283)
T ss_dssp -HHSTTSTTSCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred -cccccCCccCcccCCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHH
Confidence 111223457788999999987766 689999999999999998 999999988888888877763 4556778999999
Q ss_pred HHHHccccCccCCCCHHHHhcC
Q 014347 247 LLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 247 Li~~~L~~dP~~R~t~~eil~h 268 (426)
||.+||+.||.+|||+.++++|
T Consensus 253 li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 253 IMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHccCChhHCcCHHHHHHH
Confidence 9999999999999999999876
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=369.28 Aligned_cols=255 Identities=27% Similarity=0.426 Sum_probs=208.6
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCC---CCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 85 (426)
.....++|++++.||+|+||.||+|.+..+ +..||+|.+.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 86 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 86 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence 356678999999999999999999998754 4569999886432 3445678999999999999999999999984
Q ss_pred CCEEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCC
Q 014347 86 KSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (426)
Q Consensus 86 ~~~~~lV~Ey~~gg~L~~~i~~~~-~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~ 164 (426)
++..|+||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccccc
Confidence 567899999999999999998644 6999999999999999999999999999999999999999999999999999864
Q ss_pred ccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCH
Q 014347 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSP 242 (426)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 242 (426)
.... ........+|+.|+|||++....+ +.++||||||+++|+|++ |..||.+.+.......+..+ ..+.|..+++
T Consensus 167 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (281)
T 1mp8_A 167 EDST-YYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 244 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred Cccc-ccccccCCCcccccChhhcccCCC-CCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 3211 112234467889999999887666 688999999999999997 99999988777777777665 3567788999
Q ss_pred HHHHHHHHccccCccCCCCHHHHhcC
Q 014347 243 GAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
.+.+||.+||+.||.+|||+.+++++
T Consensus 245 ~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 245 TLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999999864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=380.68 Aligned_cols=256 Identities=22% Similarity=0.341 Sum_probs=216.4
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCe----EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEE
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLP----FAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~----vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 84 (426)
.....++|++++.||+|+||.||+|.+..+++. ||+|.+..... ......+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 85 (325)
T 3kex_A 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP 85 (325)
T ss_dssp CBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 345668999999999999999999999988887 66666643321 122345778999999999999999999986
Q ss_pred eCCEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccC
Q 014347 85 SKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (426)
Q Consensus 85 ~~~~~~lV~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~ 163 (426)
....++||||+.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 86 -~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 86 -GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp -BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred -CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence 45689999999999999999763 5799999999999999999999999999999999999999999999999999986
Q ss_pred CccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCC
Q 014347 164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLS 241 (426)
Q Consensus 164 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s 241 (426)
..............||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ....|..++
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKY-THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICT 243 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBC
T ss_pred cCcccccccccCCCCcccccChHHhccCCC-ChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCc
Confidence 544333333455678889999999987766 689999999999999999 99999998877777777665 466677899
Q ss_pred HHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 242 PGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 242 ~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
+++.+||.+||+.||.+|||+.+++++
T Consensus 244 ~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 244 IDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999999887
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-48 Score=371.24 Aligned_cols=258 Identities=25% Similarity=0.386 Sum_probs=210.6
Q ss_pred cccCCccCCCeeeeceEeecCceEEEEEE----ECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEE
Q 014347 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81 (426)
Q Consensus 6 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 81 (426)
+.+..+..++|++++.||+|+||.||+|+ +..+++.||+|++... .....+.+.+|+.+++.++||||+++++
T Consensus 2 s~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 78 (295)
T 3ugc_A 2 SDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKG 78 (295)
T ss_dssp ----CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CCcCcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 44567778999999999999999999998 5678999999998654 3344678999999999999999999999
Q ss_pred EEEe--CCEEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeec
Q 014347 82 VLAS--KSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDF 158 (426)
Q Consensus 82 ~~~~--~~~~~lV~Ey~~gg~L~~~i~~~~-~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DF 158 (426)
++.. ....|+||||++||+|.+++.... ++++..+..++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 79 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Df 158 (295)
T 3ugc_A 79 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 158 (295)
T ss_dssp EECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCC
T ss_pred EEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccC
Confidence 9854 356899999999999999998743 5999999999999999999999999999999999999999999999999
Q ss_pred cCccCCccccCC-CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHH--------------
Q 014347 159 GLSALPQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-------------- 223 (426)
Q Consensus 159 Gla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~-------------- 223 (426)
|++......... .......+++.|+|||++.+..+ +.++||||||+++|+|++|..||......
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T 3ugc_A 159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 237 (295)
T ss_dssp CSCC-------------CTTCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHH
T ss_pred cccccccCCcceeeeccCCCCccceeCcHHhcCCCC-ChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchh
Confidence 999865332111 12233457788999999987776 68999999999999999999998764322
Q ss_pred --HHHHHHH-cCCCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 224 --VLYQKIF-RGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 224 --~~~~~i~-~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
.....+. ....+.|..+++++.+||.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 238 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1122222 2345667889999999999999999999999999875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=372.44 Aligned_cols=263 Identities=25% Similarity=0.403 Sum_probs=213.8
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC--CCCccceEEEEEeCCEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK--HPNVVRLHEVLASKSKI 89 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~ 89 (426)
.-++|++++.||+|+||.||+|.+. +++.||+|++..... .....+.+.+|+.+++.++ ||||+++++++......
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 4467999999999999999999974 588999999976543 3445678999999999997 59999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
|+||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++........
T Consensus 104 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~ 181 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 181 (313)
T ss_dssp EEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC------
T ss_pred EEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCccc
Confidence 99999 56889999999888999999999999999999999999999999999999996 48999999999986543222
Q ss_pred CCccccccCCCcccchhhhccC----------CCCCCcchhhhHHHHHHHHHhCCCCCCCCc-HHHHHHHHHcC--CCCC
Q 014347 170 DGLLHTTCGSPNYVAPEVLANR----------GYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRG--DFKL 236 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~----------~~~~~~~DIwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~--~~~~ 236 (426)
.......+||+.|+|||++.+. ...+.++||||||+++|+|++|..||.... .......+... ...+
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 261 (313)
T 3cek_A 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 261 (313)
T ss_dssp --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCC
T ss_pred cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCC
Confidence 2233456899999999998651 234688999999999999999999998753 23333444433 3456
Q ss_pred CCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccCCCC
Q 014347 237 PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 278 (426)
Q Consensus 237 p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~~ 278 (426)
|...++.+.+||.+||+.||.+|||+.++++||||+....+.
T Consensus 262 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~ 303 (313)
T 3cek_A 262 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 303 (313)
T ss_dssp CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC----
T ss_pred cccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCch
Confidence 777899999999999999999999999999999998765443
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=363.22 Aligned_cols=250 Identities=20% Similarity=0.325 Sum_probs=218.7
Q ss_pred cCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC-
Q 014347 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK- 86 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~- 86 (426)
..+..+++|++.+.||+|+||.||+|++. ++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (271)
T 3kmu_A 4 HSGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP 80 (271)
T ss_dssp CCCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT
T ss_pred cCCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC
Confidence 35678899999999999999999999984 88999999976543 334467899999999999999999999999877
Q ss_pred -CEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcC--ceeccCCCCcEEecCCCCeEEeeccCc
Q 014347 87 -SKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDSKGNIKISDFGLS 161 (426)
Q Consensus 87 -~~~~lV~Ey~~gg~L~~~i~~~~--~l~~~~~~~i~~Ql~~aL~~LH~~g--IiHrDLKp~NILl~~~g~vkL~DFGla 161 (426)
...++||||++||+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~ 160 (271)
T 3kmu_A 81 APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK 160 (271)
T ss_dssp SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccce
Confidence 78899999999999999998755 4899999999999999999999999 999999999999999999999999987
Q ss_pred cCCccccCCCccccccCCCcccchhhhccCCCCC--CcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC--CCCCC
Q 014347 162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG--ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLP 237 (426)
Q Consensus 162 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~--~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p 237 (426)
... ......||+.|+|||++.+..+.. .++||||||+++|+|++|..||.+.+.......+... ....|
T Consensus 161 ~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (271)
T 3kmu_A 161 FSF-------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP 233 (271)
T ss_dssp CTT-------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCC
T ss_pred eee-------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCC
Confidence 632 123457899999999988765532 2799999999999999999999998877776666544 45677
Q ss_pred CCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 238 ~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
..+++.+.+||.+||+.||.+|||+.++++
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 234 PGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 889999999999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=380.35 Aligned_cols=254 Identities=30% Similarity=0.563 Sum_probs=185.7
Q ss_pred CccCCCeeeec-eEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe---
Q 014347 10 GMRLGRYELGR-TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--- 85 (426)
Q Consensus 10 ~~~~~~y~i~~-~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--- 85 (426)
....++|++.+ .||+|+||.||+|.+..+|+.||||++.... ....+....++.+.||||+++++++..
T Consensus 24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 96 (336)
T 3fhr_A 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENMHH 96 (336)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence 44568999965 6999999999999999999999999986532 112223344677899999999999876
Q ss_pred -CCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCC---CCeEEeecc
Q 014347 86 -KSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---GNIKISDFG 159 (426)
Q Consensus 86 -~~~~~lV~Ey~~gg~L~~~i~~~~--~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~---g~vkL~DFG 159 (426)
....|+||||++||+|.+++...+ .+++.+++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||
T Consensus 97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 456899999999999999998753 69999999999999999999999999999999999999864 459999999
Q ss_pred CccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHH----HHHHHcCCCC
Q 014347 160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVL----YQKIFRGDFK 235 (426)
Q Consensus 160 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~----~~~i~~~~~~ 235 (426)
++.... .......+||+.|+|||++....+ +.++|||||||++|+|++|..||.+...... ...+......
T Consensus 177 ~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (336)
T 3fhr_A 177 FAKETT----QNALQTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYG 251 (336)
T ss_dssp TCEEC--------------------------CHH-HHHHHHHHHHHHHHHHHHSSCCC---------------------C
T ss_pred cceecc----ccccccCCCCcCccChhhhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccc
Confidence 997432 223456789999999999876666 5889999999999999999999987654433 2223333333
Q ss_pred CC----CCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 236 LP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 236 ~p----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
+| ..+++.+.+||.+||+.||.+|||+.++++||||++..
T Consensus 252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 33 35899999999999999999999999999999998653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=364.08 Aligned_cols=250 Identities=27% Similarity=0.440 Sum_probs=206.2
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccc-hhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-LKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
+..++|++.+.||+|+||.||+|.+ +|+.||+|++....... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 4678999999999999999999997 48899999987644322 23357789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC---ceeccCCCCcEEecC--------CCCeEEeec
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG---VFHRDLKLENILLDS--------KGNIKISDF 158 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~g---IiHrDLKp~NILl~~--------~g~vkL~DF 158 (426)
|+||||++|++|.+++. .+++++..++.++.|++.||.|||++| |+||||||+|||++. ++.+||+||
T Consensus 82 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999998885 468999999999999999999999999 999999999999986 678999999
Q ss_pred cCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC--CCC
Q 014347 159 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKL 236 (426)
Q Consensus 159 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~ 236 (426)
|++..... .......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.+.+.......+.... .+.
T Consensus 161 g~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 235 (271)
T 3dtc_A 161 GLAREWHR----TTKMSAAGAYAWMAPEVIRASMF-SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI 235 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHCCC-SHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC
T ss_pred Cccccccc----ccccCCCCccceeCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC
Confidence 99975432 22235679999999999887766 689999999999999999999999988777666665554 456
Q ss_pred CCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 237 PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 237 p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
|..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 67799999999999999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=380.89 Aligned_cols=257 Identities=24% Similarity=0.369 Sum_probs=215.6
Q ss_pred ccCCCeeeeceEeecCceEEEEEEE-----CCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA 84 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 84 (426)
...++|++++.||+|+||.||+|.+ ..++..||+|++.... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 4457999999999999999999997 3466789999997543 223357889999999999 8999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCC
Q 014347 85 SKSKIYMVLEYVTGGELFDKIASKG-----------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141 (426)
Q Consensus 85 ~~~~~~lV~Ey~~gg~L~~~i~~~~-----------------------~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLK 141 (426)
..+..|+||||++||+|.+++.... .+++..++.++.||+.||.|||++||+|||||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik 199 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 199 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 9999999999999999999997643 37999999999999999999999999999999
Q ss_pred CCcEEecCCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCC
Q 014347 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDR 220 (426)
Q Consensus 142 p~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~ 220 (426)
|+|||++.++.+||+|||++................||+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCC-ChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 9999999999999999999986543222222344567889999999887666 689999999999999998 99999887
Q ss_pred cHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCcc
Q 014347 221 NLAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 270 (426)
Q Consensus 221 ~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~ 270 (426)
............ ....|..+++.+.+||.+||+.||.+|||+.+++++-.
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 279 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp CCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 654444444333 34567789999999999999999999999999998643
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-48 Score=382.94 Aligned_cols=254 Identities=26% Similarity=0.463 Sum_probs=209.5
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-----------CCCccce
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-----------HPNVVRL 79 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----------hpnIv~l 79 (426)
...++|++++.||+|+||.||+|++..+++.||||++.... ...+.+.+|+.++++++ ||||+++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 45679999999999999999999999999999999997532 23567888999998886 8999999
Q ss_pred EEEEEeCC----EEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhc-CceeccCCCCcEEecC---
Q 014347 80 HEVLASKS----KIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDS--- 149 (426)
Q Consensus 80 ~~~~~~~~----~~~lV~Ey~~gg~L~~~i~~--~~~l~~~~~~~i~~Ql~~aL~~LH~~-gIiHrDLKp~NILl~~--- 149 (426)
++++...+ ..++||||+ |++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence 99987654 789999999 8999999986 34699999999999999999999998 9999999999999953
Q ss_pred ---CCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcH----
Q 014347 150 ---KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL---- 222 (426)
Q Consensus 150 ---~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~---- 222 (426)
.+.+||+|||++..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp TTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred CcCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 34799999999975432 2345689999999999987776 6899999999999999999999986541
Q ss_pred --HHHHHHH------------------------------------------HcCCCCCCCCCCHHHHHHHHHccccCccC
Q 014347 223 --AVLYQKI------------------------------------------FRGDFKLPKWLSPGAQNLLRKILEPNPVK 258 (426)
Q Consensus 223 --~~~~~~i------------------------------------------~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 258 (426)
......+ ......+|...++++.+||.+||+.||.+
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 1111111 11222344456778999999999999999
Q ss_pred CCCHHHHhcCccccccC
Q 014347 259 RITIAGIKADEWFEQDY 275 (426)
Q Consensus 259 R~t~~eil~h~~f~~~~ 275 (426)
|||++++++||||++..
T Consensus 325 Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 325 RADAGGLVNHPWLKDTL 341 (373)
T ss_dssp CBCHHHHHTCGGGTTCT
T ss_pred cCCHHHHhhChhhhccc
Confidence 99999999999998754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=375.72 Aligned_cols=256 Identities=26% Similarity=0.445 Sum_probs=220.1
Q ss_pred CccCCCeeeeceEeecCceEEEEEEEC-------CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHE 81 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~ 81 (426)
.+..++|++++.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++.+ +||||+++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 455689999999999999999999976 457789999997543 334467899999999999 8999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcE
Q 014347 82 VLASKSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENI 145 (426)
Q Consensus 82 ~~~~~~~~~lV~Ey~~gg~L~~~i~~~~----------------~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NI 145 (426)
++...+..|+||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence 9999999999999999999999998643 389999999999999999999999999999999999
Q ss_pred EecCCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHH
Q 014347 146 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV 224 (426)
Q Consensus 146 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~ 224 (426)
|++.++.+||+|||++................+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+...
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 267 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCc-ChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence 999999999999999975433211112233467889999999877665 689999999999999999 999999988888
Q ss_pred HHHHHHcCC-CCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 225 LYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 225 ~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
....+..+. ...|..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 777776653 56677899999999999999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=373.86 Aligned_cols=256 Identities=27% Similarity=0.425 Sum_probs=217.3
Q ss_pred CccCCCeeeeceEeecCceEEEEEEE-----CCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVL 83 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 83 (426)
....++|++++.||+|+||.||+|.+ ..+++.||+|++.... .....+.+.+|+.+++++ +||||+++++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 34567999999999999999999985 4578899999997543 233467899999999999 899999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcE
Q 014347 84 ASKSKIYMVLEYVTGGELFDKIASKG------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENI 145 (426)
Q Consensus 84 ~~~~~~~lV~Ey~~gg~L~~~i~~~~------------------~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NI 145 (426)
.+.+..|+||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 176 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence 99999999999999999999998644 489999999999999999999999999999999999
Q ss_pred EecCCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHH
Q 014347 146 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV 224 (426)
Q Consensus 146 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~ 224 (426)
|++.++.+||+|||++................||+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.....
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 999999999999999986543222222334567889999999887666 689999999999999999 999998866443
Q ss_pred HHHHHHc-C-CCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 225 LYQKIFR-G-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 225 ~~~~i~~-~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
....... . ....|..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 3333332 2 344567789999999999999999999999999874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=367.01 Aligned_cols=254 Identities=19% Similarity=0.232 Sum_probs=213.3
Q ss_pred cCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEeC
Q 014347 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK 86 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 86 (426)
...+.-++|++++.||+|+||.||+|.+..+|+.||+|++..... ...+.+|+.+++.+ +|+|++++++++...
T Consensus 4 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~ 78 (298)
T 1csn_A 4 QNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEG 78 (298)
T ss_dssp --CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred cCcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCC
Confidence 345567889999999999999999999999999999999865432 24578899999999 799999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCC-----eEEeeccC
Q 014347 87 SKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN-----IKISDFGL 160 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~~-~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~-----vkL~DFGl 160 (426)
...|+||||+ |++|.+++...+ ++++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 79 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 79 LHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred ceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 9999999999 999999998744 6999999999999999999999999999999999999988776 99999999
Q ss_pred ccCCccccCC-----CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCC---cHHHHHHHHHcC
Q 014347 161 SALPQHFRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR---NLAVLYQKIFRG 232 (426)
Q Consensus 161 a~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~---~~~~~~~~i~~~ 232 (426)
+......... ......+||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.+. +....+..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence 9865432111 12345689999999999887766 68999999999999999999999873 334444444332
Q ss_pred CC-----CCCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 233 DF-----KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 233 ~~-----~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
.. ..+..+++.+.+||.+||+.||.+|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 237 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred ccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 21 1234689999999999999999999999998753
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=374.62 Aligned_cols=253 Identities=27% Similarity=0.419 Sum_probs=217.9
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeE--EEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEeC
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPF--AVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK 86 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~v--AvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 86 (426)
....++|++.+.||+|+||.||+|++..+|..+ |+|.+.... .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 98 (327)
T 1fvr_A 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 98 (327)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeC
Confidence 456789999999999999999999998888865 999886432 233456789999999999 899999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCC
Q 014347 87 SKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 150 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~~----------------~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~ 150 (426)
+..|+||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 178 (327)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCC
Confidence 99999999999999999997654 69999999999999999999999999999999999999999
Q ss_pred CCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHH
Q 014347 151 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKI 229 (426)
Q Consensus 151 g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i 229 (426)
+.+||+|||++...... .......+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+.......+
T Consensus 179 ~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~ 254 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254 (327)
T ss_dssp GCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred CeEEEcccCcCcccccc---ccccCCCCCccccChhhhccccC-CchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh
Confidence 99999999998743221 12234467889999999877665 689999999999999998 99999999888888777
Q ss_pred HcC-CCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 230 FRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 230 ~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
..+ ....|..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 255 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 255 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 665 456677899999999999999999999999999886
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=372.88 Aligned_cols=256 Identities=21% Similarity=0.311 Sum_probs=221.6
Q ss_pred CccCCCeeeeceEeecCceEEEEEEEC-----CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 84 (426)
.+..++|++.+.||+|+||.||+|.+. .+++.||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 345578999999999999999999876 467889999987543 3334567899999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeE
Q 014347 85 SKSKIYMVLEYVTGGELFDKIASK----------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 154 (426)
Q Consensus 85 ~~~~~~lV~Ey~~gg~L~~~i~~~----------~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vk 154 (426)
+.+..|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEE
Confidence 999999999999999999998752 4579999999999999999999999999999999999999999999
Q ss_pred EeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcCC
Q 014347 155 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD 233 (426)
Q Consensus 155 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~ 233 (426)
|+|||++................||+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+.......+..+.
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 257 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 257 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCCC-CchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC
Confidence 999999975433221122334567899999999887666 689999999999999999 999999988888887777654
Q ss_pred -CCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 234 -FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 234 -~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
...|..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 258 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 258 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 45677899999999999999999999999999886
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=365.30 Aligned_cols=257 Identities=30% Similarity=0.487 Sum_probs=209.6
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (426)
+...+++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++...+.
T Consensus 27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 106 (310)
T 2wqm_A 27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE 106 (310)
T ss_dssp TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc
Confidence 34567899999999999999999999999999999999987555556667889999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCC
Q 014347 89 IYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~----~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~ 164 (426)
.|+||||+.+++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+|||++.+|.+||+|||++...
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 9999999999999998864 456999999999999999999999999999999999999999999999999998754
Q ss_pred ccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCC--cHHHHHHHHHcCCCC-C-CCCC
Q 014347 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR--NLAVLYQKIFRGDFK-L-PKWL 240 (426)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~--~~~~~~~~i~~~~~~-~-p~~~ 240 (426)
.. .........||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+. +.......+.....+ . +..+
T Consensus 187 ~~--~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (310)
T 2wqm_A 187 SS--KTTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHY 263 (310)
T ss_dssp --------------CCSSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTS
T ss_pred cC--CCccccccCCCeeEeChHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCccccc
Confidence 32 1223345679999999999887666 68999999999999999999999764 334455555554433 2 2558
Q ss_pred CHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 241 SPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 241 s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
++++.+||.+||+.||.+|||+.+++++
T Consensus 264 ~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 264 SEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 9999999999999999999999999864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=373.59 Aligned_cols=255 Identities=22% Similarity=0.336 Sum_probs=211.0
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeE----EEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPF----AVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~v----AvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 85 (426)
.+..++|++++.||+|+||.||+|.+..+++.+ |+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (327)
T 3lzb_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence 455689999999999999999999999888876 555543222 22346788999999999999999999999987
Q ss_pred CCEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCC
Q 014347 86 KSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (426)
Q Consensus 86 ~~~~~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~ 164 (426)
.. .++++||+.+|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 89 ~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp SS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred CC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 65 7889999999999999976 467999999999999999999999999999999999999999999999999999865
Q ss_pred ccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCH
Q 014347 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSP 242 (426)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 242 (426)
.............||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..+++
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI 246 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCH
T ss_pred cCccccccccCCCccccccCHHHHcCCCC-ChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCH
Confidence 43322223344567889999999987766 689999999999999999 99999998777776666655 3567778999
Q ss_pred HHHHHHHHccccCccCCCCHHHHhcC
Q 014347 243 GAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
++.+||.+||+.||.+|||+.++++.
T Consensus 247 ~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 247 DVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999999999863
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=375.75 Aligned_cols=261 Identities=22% Similarity=0.295 Sum_probs=218.9
Q ss_pred CccCCCeeeeceEeecCceEEEEEE-----ECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~-----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 84 (426)
.+..++|++++.||+|+||.||+|+ +..+++.||+|++.... ......++.+|+.+++.++||||+++++++.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 4567899999999999999999999 56788899999986433 3344567899999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCC---CCeE
Q 014347 85 SKSKIYMVLEYVTGGELFDKIASKG-------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---GNIK 154 (426)
Q Consensus 85 ~~~~~~lV~Ey~~gg~L~~~i~~~~-------~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~---g~vk 154 (426)
.....|+||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+|
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999999998653 48999999999999999999999999999999999999954 4699
Q ss_pred EeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-
Q 014347 155 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG- 232 (426)
Q Consensus 155 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~- 232 (426)
|+|||++................||+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+.......+..+
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 262 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 262 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC
Confidence 999999874322212222334578999999999887666 689999999999999998 99999998888777777665
Q ss_pred CCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 233 DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 233 ~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
....|..+++.+.+||.+||+.||.+|||+.+++++.|+..
T Consensus 263 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 263 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 45567779999999999999999999999999999998754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=377.91 Aligned_cols=249 Identities=22% Similarity=0.286 Sum_probs=211.4
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 89 (426)
+.-++|++++.||+|+||.||+|++..+|+.||||++..... .+.+.+|+.+++.+ +||||+++++++......
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 80 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN 80 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence 344789999999999999999999999999999999875432 23578999999999 899999999999999999
Q ss_pred EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCC-----eEEeeccCccC
Q 014347 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN-----IKISDFGLSAL 163 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~-----vkL~DFGla~~ 163 (426)
|+||||+ |++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++..
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9999999 9999999986 468999999999999999999999999999999999999999887 99999999985
Q ss_pred CccccCC-----CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCC---CcHHHHHHHHHcCCCC
Q 014347 164 PQHFRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD---RNLAVLYQKIFRGDFK 235 (426)
Q Consensus 164 ~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~---~~~~~~~~~i~~~~~~ 235 (426)
....... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+ .+....+.++......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQ-SRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCC-CchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence 4322111 12346789999999999988776 6899999999999999999999987 4445555555444333
Q ss_pred CC-----CCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 236 LP-----KWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 236 ~p-----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
.| ..++ ++.+|+.+||+.||.+||++++|++
T Consensus 239 ~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 239 TPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp SCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 22 2244 9999999999999999999998865
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=367.56 Aligned_cols=260 Identities=23% Similarity=0.352 Sum_probs=201.6
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
...+++|++++.||+|+||.||+|.+..+|+.||||++...... ....+.+.++..+++.++||||+++++++.+.+..
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~ 99 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV 99 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Confidence 45678999999999999999999999999999999999765422 22234455556678889999999999999999999
Q ss_pred EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhc-CceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~-gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
|+||||+ ++.+...... .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.....
T Consensus 100 ~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~- 177 (318)
T 2dyl_A 100 FIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD- 177 (318)
T ss_dssp EEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC-
Confidence 9999999 5555555443 57899999999999999999999995 999999999999999999999999999875432
Q ss_pred cCCCccccccCCCcccchhhhcc----CCCCCCcchhhhHHHHHHHHHhCCCCCCC-CcHHHHHHHHHcCCC-CCC--CC
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDF-KLP--KW 239 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~----~~~~~~~~DIwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~-~~p--~~ 239 (426)
.......+||+.|+|||++.. ....+.++||||||+++|+|++|..||.. .+.......+..... .+| ..
T Consensus 178 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (318)
T 2dyl_A 178 --DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMG 255 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSC
T ss_pred --CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCC
Confidence 223345679999999999852 23346899999999999999999999987 344455556655543 233 34
Q ss_pred CCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 240 ~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
+++.+.+||.+||+.||.+|||++++++||||+..
T Consensus 256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 256 FSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 79999999999999999999999999999999764
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=373.25 Aligned_cols=260 Identities=23% Similarity=0.358 Sum_probs=195.8
Q ss_pred cCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHH-HHHhCCCCCccceEEEEEeC
Q 014347 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA-TLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~ 86 (426)
......++|++++.||+|+||.||+|.+..+|+.||||++.... ......++.+|+. +++.++||||+++++++...
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~ 93 (327)
T 3aln_A 16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE 93 (327)
T ss_dssp EECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS
T ss_pred hcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC
Confidence 34567799999999999999999999999999999999997653 2233445556665 77888999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhhc-CceeccCCCCcEEecCCCCeEEeeccC
Q 014347 87 SKIYMVLEYVTGGELFDKIAS-----KGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGL 160 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~-----~~~l~~~~~~~i~~Ql~~aL~~LH~~-gIiHrDLKp~NILl~~~g~vkL~DFGl 160 (426)
+..|+||||+.| +|.+++.. ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 172 (327)
T 3aln_A 94 GDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGI 172 (327)
T ss_dssp SEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred CceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCC
Confidence 999999999986 88777763 56799999999999999999999999 999999999999999999999999999
Q ss_pred ccCCccccCCCccccccCCCcccchhhhc----cCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHH-HHHHHHHcCCC-
Q 014347 161 SALPQHFRDDGLLHTTCGSPNYVAPEVLA----NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDF- 234 (426)
Q Consensus 161 a~~~~~~~~~~~~~~~~gt~~y~APE~l~----~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~- 234 (426)
+..... ........||+.|+|||++. +..+ +.++||||||+++|+|++|..||.+.+.. .....+..+..
T Consensus 173 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 248 (327)
T 3aln_A 173 SGQLVD---SIAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPP 248 (327)
T ss_dssp SCC---------------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCC
T ss_pred ceeccc---ccccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCC
Confidence 975432 22233457999999999983 3334 68999999999999999999999875432 22222222221
Q ss_pred CCC----CCCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 235 KLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 235 ~~p----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
.++ ..+++.+.+||.+||+.||.+|||+.++++||||...
T Consensus 249 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 249 QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 222 3478999999999999999999999999999999764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=362.79 Aligned_cols=252 Identities=26% Similarity=0.400 Sum_probs=212.3
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhH----HHHHHHHHHHHHhCCCCCccceEEEEE
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI----TDQIKREIATLKLLKHPNVVRLHEVLA 84 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~----~~~~~~Ei~il~~l~hpnIv~l~~~~~ 84 (426)
.....++|++.+.||+|+||.||+|++..+++.||+|++.......... .+.+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (287)
T 4f0f_A 14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH 93 (287)
T ss_dssp CBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred hhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence 3456689999999999999999999999999999999987654332221 167899999999999999999999987
Q ss_pred eCCEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcC--ceeccCCCCcEEecCCCC-----eEEe
Q 014347 85 SKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDSKGN-----IKIS 156 (426)
Q Consensus 85 ~~~~~~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~g--IiHrDLKp~NILl~~~g~-----vkL~ 156 (426)
+.. ++||||++||+|.+.+.. ..++++..++.++.|++.||.|||++| |+||||||+|||++.++. +||+
T Consensus 94 ~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 94 NPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp TTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred CCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 665 799999999999998865 457999999999999999999999999 999999999999988876 9999
Q ss_pred eccCccCCccccCCCccccccCCCcccchhhhcc-CCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHH--HHHHHHcC-
Q 014347 157 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN-RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV--LYQKIFRG- 232 (426)
Q Consensus 157 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~--~~~~i~~~- 232 (426)
|||++.... ......+||+.|+|||++.. ....+.++|||||||++|+|++|..||...+... ....+...
T Consensus 172 Dfg~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 246 (287)
T 4f0f_A 172 DFGLSQQSV-----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246 (287)
T ss_dssp CCTTCBCCS-----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC
T ss_pred CCCcccccc-----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC
Confidence 999997432 23455789999999999843 2333688999999999999999999998754322 23333332
Q ss_pred -CCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 233 -DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 233 -~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
....|..+++.+.+||.+||+.||.+|||+.++++
T Consensus 247 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 247 LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 45667889999999999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=359.61 Aligned_cols=251 Identities=23% Similarity=0.404 Sum_probs=219.1
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (426)
+..++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence 34578999999999999999999985 6778999999765432 357889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 91 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
+||||++|++|.+++... +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~- 158 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ- 158 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-
T ss_pred EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc-
Confidence 999999999999999864 569999999999999999999999999999999999999999999999999987542211
Q ss_pred CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHHH
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 247 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 247 (426)
........||+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+.......+..+ ....|..+++.+.+|
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 237 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQI 237 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred ccccccccccccccChhhhcCCCc-cchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHH
Confidence 111233467889999999887666 689999999999999999 99999998888888877766 345567789999999
Q ss_pred HHHccccCccCCCCHHHHhcC
Q 014347 248 LRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 248 i~~~L~~dP~~R~t~~eil~h 268 (426)
+.+||+.||.+|||+.+++++
T Consensus 238 i~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 238 MNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999874
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=365.53 Aligned_cols=253 Identities=27% Similarity=0.396 Sum_probs=222.2
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (426)
-.+..++|++.+.||+|+||.||+|.+..++..||+|++.... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3456789999999999999999999999999999999986543 235778999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcc
Q 014347 89 IYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~--~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 166 (426)
.|+||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 99999999999999999863 4599999999999999999999999999999999999999999999999999986532
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHH
Q 014347 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGA 244 (426)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 244 (426)
. .........+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+.......+... ....|..+++.+
T Consensus 164 ~-~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (288)
T 3kfa_A 164 D-TYTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 241 (288)
T ss_dssp S-SSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred C-ccccccCCccccCcCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHH
Confidence 1 1122334567889999999987766 689999999999999999 99999988877776666555 456677899999
Q ss_pred HHHHHHccccCccCCCCHHHHhc
Q 014347 245 QNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
.+||.+||+.||.+|||+.++++
T Consensus 242 ~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 242 YELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhCCChhhCcCHHHHHH
Confidence 99999999999999999999976
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=372.20 Aligned_cols=256 Identities=26% Similarity=0.388 Sum_probs=216.4
Q ss_pred CccCCCeeeeceEeecCceEEEEEEE-----CCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVL 83 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 83 (426)
....++|++++.||+|+||.||+|.+ ..+++.||+|++.... .......+.+|+.+++.+ +||||+++++++
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 34567999999999999999999985 3577899999997543 333456789999999999 699999999998
Q ss_pred EeCC-EEEEEEeccCCCChHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEE
Q 014347 84 ASKS-KIYMVLEYVTGGELFDKIASKGR----------------LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 146 (426)
Q Consensus 84 ~~~~-~~~lV~Ey~~gg~L~~~i~~~~~----------------l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NIL 146 (426)
...+ ..|+||||++|++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil 180 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence 7654 58999999999999999987543 899999999999999999999999999999999999
Q ss_pred ecCCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHH-H
Q 014347 147 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLA-V 224 (426)
Q Consensus 147 l~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~-~ 224 (426)
++.++.+||+|||++................||+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.... .
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~ 259 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccc-cchhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence 99999999999999986433222222344578899999999987766 689999999999999998 99999876543 3
Q ss_pred HHHHHHcC-CCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 225 LYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 225 ~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
....+..+ ....|..+++.+.++|.+||+.||.+|||+.++++|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 260 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 33344333 456778899999999999999999999999999886
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=368.60 Aligned_cols=257 Identities=25% Similarity=0.372 Sum_probs=209.0
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECC---CCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLD---SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (426)
....++|++++.||+|+||.||+|.+.. +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 3455799999999999999999998765 556899999875543 334467899999999999999999999998765
Q ss_pred C-----EEEEEEeccCCCChHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEE
Q 014347 87 S-----KIYMVLEYVTGGELFDKIA------SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKI 155 (426)
Q Consensus 87 ~-----~~~lV~Ey~~gg~L~~~i~------~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL 155 (426)
+ ..|+||||+++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEE
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEE
Confidence 5 3599999999999999984 2356999999999999999999999999999999999999999999999
Q ss_pred eeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-C
Q 014347 156 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-D 233 (426)
Q Consensus 156 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~ 233 (426)
+|||++................+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+.......+..+ .
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 267 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR 267 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCc-cchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC
Confidence 99999985433221122334567889999999987666 689999999999999999 99999988877777777665 4
Q ss_pred CCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 234 FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 234 ~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
...|..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 268 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 268 LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 56677899999999999999999999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=363.87 Aligned_cols=253 Identities=23% Similarity=0.329 Sum_probs=214.9
Q ss_pred cCCCeeeec-eEeecCceEEEEEEE--CCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 014347 12 RLGRYELGR-TLGEGNFGKVKFAQD--LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 12 ~~~~y~i~~-~LG~G~fg~Vy~a~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (426)
..++|++.+ .||+|+||.||+|.+ ..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++ ..+.
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 346899998 999999999999954 56788999999975532 334467899999999999999999999999 5677
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
.|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence 89999999999999999988889999999999999999999999999999999999999999999999999997543211
Q ss_pred CC-CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHH
Q 014347 169 DD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQ 245 (426)
Q Consensus 169 ~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 245 (426)
.. .......+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+.......+..+. ...|..+++.+.
T Consensus 172 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 250 (291)
T 1xbb_A 172 NYYKAQTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY 250 (291)
T ss_dssp SEEEC----CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred CcccccccCCCCceeeChHHhccCCC-ChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 10 11123456789999999987666 588999999999999999 999999988887777776653 567788999999
Q ss_pred HHHHHccccCccCCCCHHHHhc
Q 014347 246 NLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~eil~ 267 (426)
+||.+||+.||.+|||+.++++
T Consensus 251 ~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 251 DLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=373.76 Aligned_cols=256 Identities=24% Similarity=0.394 Sum_probs=216.9
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCC-----eEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGL-----PFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVL 83 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~-----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 83 (426)
....++|++++.||+|+||.||+|.+..+++ .||+|++.... .....+.+.+|+.+++.+ +||||+++++++
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 3456789999999999999999999987665 79999987543 334467899999999999 899999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecC
Q 014347 84 ASKSKIYMVLEYVTGGELFDKIASK--------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 149 (426)
Q Consensus 84 ~~~~~~~lV~Ey~~gg~L~~~i~~~--------------~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~ 149 (426)
.+.+..|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN 199 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEG
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECC
Confidence 9999999999999999999998752 45899999999999999999999999999999999999999
Q ss_pred CCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHH
Q 014347 150 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQK 228 (426)
Q Consensus 150 ~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 228 (426)
++.+||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 278 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCC-ChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence 99999999999985433222222334567889999999887666 689999999999999999 9999988655444444
Q ss_pred HHcC--CCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 229 IFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 229 i~~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
+... ....|...++.+.+||.+||+.||.+|||+.+++++
T Consensus 279 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 279 LVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 4332 345577789999999999999999999999999863
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=379.31 Aligned_cols=255 Identities=22% Similarity=0.364 Sum_probs=208.6
Q ss_pred CccCCCeeeeceEeecCceEEEEEEEC---CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (426)
....++|++.+.||+|+||.||+|++. .++..||||+++... .....+.+.+|+.++++++||||+++++++...
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 445678999999999999999999976 467789999986543 344467899999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 87 SKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
...|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999999999864 479999999999999999999999999999999999999999999999999998653
Q ss_pred cccCC-CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCH
Q 014347 166 HFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSP 242 (426)
Q Consensus 166 ~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 242 (426)
..... .......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..+++
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~ 277 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKF-TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPA 277 (373)
T ss_dssp ---------------CTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBH
T ss_pred cCCccceeccCCCcCCCccChhhhccCCc-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccH
Confidence 32111 11122345788999999987776 689999999999999998 99999998888777777655 3555677899
Q ss_pred HHHHHHHHccccCccCCCCHHHHhc
Q 014347 243 GAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
.+.+|+.+||+.||.+|||+.++++
T Consensus 278 ~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 278 ALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhCcChhhCcCHHHHHH
Confidence 9999999999999999999999876
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=362.12 Aligned_cols=256 Identities=25% Similarity=0.362 Sum_probs=218.9
Q ss_pred ccCCCeeeec-eEeecCceEEEEEEEC--CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 014347 11 MRLGRYELGR-TLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 11 ~~~~~y~i~~-~LG~G~fg~Vy~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (426)
...++|.+.+ .||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.++||||+++++++ ..+
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE 82 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence 4457888887 9999999999999864 467889999997643 344567899999999999999999999999 456
Q ss_pred EEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcc
Q 014347 88 KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 166 (426)
..|+||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 68999999999999999965 45699999999999999999999999999999999999999999999999999985432
Q ss_pred ccC-CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHH
Q 014347 167 FRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPG 243 (426)
Q Consensus 167 ~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~ 243 (426)
... ........||+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+.......+..+. ..+|..+++.
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 241 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE 241 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHH
T ss_pred CcceeeccccccccccccCHHHhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHH
Confidence 111 111233457899999999877665 689999999999999998 999999988777777776654 5677889999
Q ss_pred HHHHHHHccccCccCCCCHHHHhcCcc
Q 014347 244 AQNLLRKILEPNPVKRITIAGIKADEW 270 (426)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~eil~h~~ 270 (426)
+.+||.+||+.||.+|||+.+++++.|
T Consensus 242 l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 242 LYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 999999999999999999999998754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=364.58 Aligned_cols=256 Identities=25% Similarity=0.371 Sum_probs=211.0
Q ss_pred CCccCCCeeeeceEeecCceEEEEEE----ECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEE
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 84 (426)
......+|++++.||+|+||.||+|+ +..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++.
T Consensus 16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (302)
T 4e5w_A 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICT 93 (302)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 34555679999999999999999999 567899999999975442 233578899999999999999999999998
Q ss_pred eC--CEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCc
Q 014347 85 SK--SKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS 161 (426)
Q Consensus 85 ~~--~~~~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla 161 (426)
.. ...|+||||++|++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 94 EDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp C---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred cCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccc
Confidence 76 678999999999999999954 567999999999999999999999999999999999999999999999999999
Q ss_pred cCCccccCC-CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCc---------------HHHH
Q 014347 162 ALPQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN---------------LAVL 225 (426)
Q Consensus 162 ~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~---------------~~~~ 225 (426)
......... .......||+.|+|||++.+..+ +.++||||||+++|+|++|..|+.... ....
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKF-YIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCC-CcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 854332110 12334578889999999887766 588999999999999999999864321 1222
Q ss_pred HHHHHc-CCCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 226 YQKIFR-GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 226 ~~~i~~-~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
...+.. ...+.|..+++.+.+||.+||+.||.+|||+.++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 233332 245677889999999999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=370.69 Aligned_cols=251 Identities=22% Similarity=0.276 Sum_probs=203.6
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC---
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS--- 87 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 87 (426)
+..++|++++.||+|+||.||+|++. ++.||||++.... .......+|+.+++.++||||+++++++....
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD 94 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence 45579999999999999999999874 7899999996543 22455677999999999999999999998743
Q ss_pred -EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc----------CceeccCCCCcEEecCCCCeEEe
Q 014347 88 -KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK----------GVFHRDLKLENILLDSKGNIKIS 156 (426)
Q Consensus 88 -~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~----------gIiHrDLKp~NILl~~~g~vkL~ 156 (426)
.+|+||||+++|+|.+++.. ..+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred ceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 47999999999999999976 5699999999999999999999999 99999999999999999999999
Q ss_pred eccCccCCccccCCCccccccCCCcccchhhhccCC----CCCCcchhhhHHHHHHHHHhCCCCCCCCc-----------
Q 014347 157 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG----YDGATSDIWSCGVILYVILTGYLPFDDRN----------- 221 (426)
Q Consensus 157 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~----~~~~~~DIwSlGvil~elltG~~Pf~~~~----------- 221 (426)
|||+++..............+||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||.+..
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 999997544333333344568999999999987632 22467899999999999999999997532
Q ss_pred -----HHHHHHHHHcCC--CCCCCC-----CCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 222 -----LAVLYQKIFRGD--FKLPKW-----LSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 222 -----~~~~~~~i~~~~--~~~p~~-----~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
.......+.... ...+.. .++.+.+||.+||+.||++|||+.++++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 222333332222 122221 23459999999999999999999999863
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=384.54 Aligned_cols=245 Identities=26% Similarity=0.478 Sum_probs=213.6
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC-E
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-K 88 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~ 88 (426)
.+..++|++++.||+|+||.||+|.+. |+.||||+++... ..+.+.+|+.+|+.++||||+++++++.... .
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 261 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 261 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence 355689999999999999999999874 7799999997543 2467899999999999999999999987655 7
Q ss_pred EEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcc
Q 014347 89 IYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~~--l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 166 (426)
.|+||||++||+|.+++...+. +++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 9999999999999999987554 79999999999999999999999999999999999999999999999999974321
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHH
Q 014347 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGA 244 (426)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 244 (426)
......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..+++.+
T Consensus 342 -----~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l 415 (450)
T 1k9a_A 342 -----TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV 415 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHH
T ss_pred -----cccCCCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHH
Confidence 1233467899999999987776 689999999999999998 99999988777777777665 467788899999
Q ss_pred HHHHHHccccCccCCCCHHHHhc
Q 014347 245 QNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
.+||.+||+.||.+|||+.+++.
T Consensus 416 ~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 416 YDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=359.35 Aligned_cols=255 Identities=24% Similarity=0.346 Sum_probs=214.2
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECC---CCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLD---SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 85 (426)
.+...++|++.+.||+|+||.||+|.+.. ++..||+|++.... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 46677899999999999999999998654 34469999987653 33446789999999999999999999999865
Q ss_pred CCEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCC
Q 014347 86 KSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (426)
Q Consensus 86 ~~~~~lV~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~ 164 (426)
+ ..|+||||++|++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 85 ~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 85 E-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp S-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred C-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 4 568999999999999999764 46999999999999999999999999999999999999999999999999999864
Q ss_pred ccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCH
Q 014347 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSP 242 (426)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 242 (426)
.... ........+|+.|+|||++.+..+ +.++||||||+++|+|++ |+.||...+.......+..+ ..+.|..+++
T Consensus 164 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (281)
T 3cc6_A 164 EDED-YYKASVTRLPIKWMSPESINFRRF-TTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPP 241 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCH
T ss_pred cccc-ccccccCCCCcceeCchhhccCCC-CchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCH
Confidence 3311 112234567889999999877666 689999999999999998 99999876666555555544 4566778999
Q ss_pred HHHHHHHHccccCccCCCCHHHHhcC
Q 014347 243 GAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
.+.+||.+||+.||.+|||+.+++++
T Consensus 242 ~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 242 VLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCCchhCcCHHHHHHH
Confidence 99999999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=366.88 Aligned_cols=256 Identities=23% Similarity=0.357 Sum_probs=213.5
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCC----CeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 85 (426)
....++|++.+.||+|+||.||+|.+..++ ..||+|++.... .......+.+|+.+++.++||||+++++++..
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 345578999999999999999999976553 359999987543 33445678999999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCC
Q 014347 86 KSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (426)
Q Consensus 86 ~~~~~lV~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~ 164 (426)
.+..|+||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999999999764 67999999999999999999999999999999999999999999999999999864
Q ss_pred ccccCC-CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCC
Q 014347 165 QHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLS 241 (426)
Q Consensus 165 ~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s 241 (426)
...... .......+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+.......+..+ ..+.|..++
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP 276 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCB
T ss_pred ccccccccccCCCCccccccCchhcccCCC-CchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCC
Confidence 332111 11223356789999999887666 689999999999999999 99999998888777777665 456677799
Q ss_pred HHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 242 PGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 242 ~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
+.+.+||.+||+.||.+|||+.+++++
T Consensus 277 ~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 277 SAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999999874
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=361.87 Aligned_cols=255 Identities=24% Similarity=0.406 Sum_probs=199.3
Q ss_pred cCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 014347 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (426)
...+.-++|++++.||+|+||.||+|++. ..||+|++..... .....+.+.+|+.+++.++||||++++++. ...
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~ 92 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAP 92 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCC
Confidence 34566789999999999999999999853 3599999975543 344567899999999999999999999965 556
Q ss_pred EEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcc
Q 014347 88 KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 166 (426)
..++||||+.|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccc
Confidence 68999999999999999964 45799999999999999999999999999999999999999999999999999986543
Q ss_pred ccCCCccccccCCCcccchhhhcc--CCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHH-HHHHHHHcCCCC-----CCC
Q 014347 167 FRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDFK-----LPK 238 (426)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~-----~p~ 238 (426)
..........+||+.|+|||++.. ....+.++||||||+++|+|++|..||.+.+.. .....+..+... .+.
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRS 252 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCT
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccc
Confidence 333334455689999999999862 223367899999999999999999999875443 444444443322 234
Q ss_pred CCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 239 WLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 239 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
.+++.+.+||.+||+.||.+|||+.++++
T Consensus 253 ~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 253 NCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 57899999999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=359.23 Aligned_cols=246 Identities=26% Similarity=0.428 Sum_probs=212.2
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe-------
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------- 85 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------- 85 (426)
.++|++++.||+|+||.||+|.+..+|+.||+|.+.... +.+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 368999999999999999999999999999999997543 346789999999999999999998854
Q ss_pred ---------CCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeE
Q 014347 86 ---------KSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 154 (426)
Q Consensus 86 ---------~~~~~lV~Ey~~gg~L~~~i~~~--~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vk 154 (426)
....|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence 45589999999999999999753 6799999999999999999999999999999999999999999999
Q ss_pred EeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC
Q 014347 155 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF 234 (426)
Q Consensus 155 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~ 234 (426)
|+|||++..... ........||+.|+|||++.+..+ +.++||||||+++|+|++|..||... ......+..+
T Consensus 163 l~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~-- 234 (284)
T 2a19_B 163 IGDFGLVTSLKN---DGKRTRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG-- 234 (284)
T ss_dssp ECCCTTCEESSC---CSCCCCCCSCCTTSCHHHHHCSCC-CTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT--
T ss_pred ECcchhheeccc---cccccccCCcccccChhhhccCCC-cchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc--
Confidence 999999875432 223345679999999999887666 68999999999999999999988542 2233333333
Q ss_pred CCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 235 KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 235 ~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
.++..+++.+.+||.+||+.||.+|||+.+++++.|.-.
T Consensus 235 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 235 IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 356678999999999999999999999999999988754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=358.01 Aligned_cols=251 Identities=24% Similarity=0.369 Sum_probs=212.4
Q ss_pred CeeeeceEeecCceEEEEEEECCCCC---eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE-E
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI-Y 90 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~-~ 90 (426)
.|++.+.||+|+||.||+|.+..+++ .||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+.. +
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 57788999999999999999765554 79999986432 344567899999999999999999999999776655 9
Q ss_pred EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc-
Q 014347 91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR- 168 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~- 168 (426)
++|||+.+++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999999999986 4578999999999999999999999999999999999999999999999999997543211
Q ss_pred -CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHH
Q 014347 169 -DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ 245 (426)
Q Consensus 169 -~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 245 (426)
.........+|+.|+|||.+.+..+ +.++||||||+++|+|++ |.+||...+.......+..+ ....|..+++.+.
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 258 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRF-TTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLY 258 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cccccCcCCCCCccccChhhhccCCC-ChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHH
Confidence 1223344578899999999987666 689999999999999999 66667777666666666555 3566778999999
Q ss_pred HHHHHccccCccCCCCHHHHhcC
Q 014347 246 NLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~eil~h 268 (426)
+||.+||+.||.+|||+.++++.
T Consensus 259 ~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 259 QVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999998763
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=358.80 Aligned_cols=245 Identities=25% Similarity=0.475 Sum_probs=207.4
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC-CE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-SK 88 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-~~ 88 (426)
....++|++++.||+|+||.||+|.+ +|+.||+|++.... ..+.+.+|+.+++.++||||+++++++... +.
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 89 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred cCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence 45678999999999999999999987 48899999986543 256789999999999999999999987544 57
Q ss_pred EEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcc
Q 014347 89 IYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~~--l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 166 (426)
.|+||||++|++|.+++...+. +++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 8999999999999999986543 89999999999999999999999999999999999999999999999999874322
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHH
Q 014347 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGA 244 (426)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 244 (426)
......+++.|+|||++.+..+ +.++||||||+++|+|++ |..||...+.......+..+ ....|..+++.+
T Consensus 170 -----~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (278)
T 1byg_A 170 -----TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV 243 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHH
T ss_pred -----cccCCCccccccCHHHhCCCCC-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHH
Confidence 2234568899999999887666 689999999999999998 99999988777777766655 456677899999
Q ss_pred HHHHHHccccCccCCCCHHHHhc
Q 014347 245 QNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
.+||.+||+.||.+|||+.++++
T Consensus 244 ~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 244 YEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCChhhCCCHHHHHH
Confidence 99999999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=359.54 Aligned_cols=249 Identities=22% Similarity=0.264 Sum_probs=206.5
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEE-EeCCEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL-ASKSKIY 90 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~~~~~~ 90 (426)
.-++|++++.||+|+||.||+|++..+|+.||+|++..... .+.+.+|+.+++.++|++++..+..+ ......|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence 45789999999999999999999999999999999875442 23588999999999988876655554 6778899
Q ss_pred EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEe---cCCCCeEEeeccCccCCcc
Q 014347 91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL---DSKGNIKISDFGLSALPQH 166 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl---~~~g~vkL~DFGla~~~~~ 166 (426)
+||||+ +++|.+++.. ..++++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 999999 9999999974 5679999999999999999999999999999999999999 4888999999999986443
Q ss_pred ccCC-----CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCc---HHHHHHHHHcCCCCC--
Q 014347 167 FRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGDFKL-- 236 (426)
Q Consensus 167 ~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~-- 236 (426)
.... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+ ....+..+.......
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred cccccccccccccccccccccCChhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 2111 12345689999999999887765 689999999999999999999998632 222333333322222
Q ss_pred ---CCCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 237 ---PKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 237 ---p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 3668999999999999999999999999875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=358.92 Aligned_cols=255 Identities=25% Similarity=0.346 Sum_probs=211.7
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCC---CeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEE-Ee
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL-AS 85 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~ 85 (426)
+....+|++.+.||+|+||.||+|.+..++ ..+|+|.+.... .....+.+.+|+.+++.++||||+++++++ ..
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (298)
T 3f66_A 21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 98 (298)
T ss_dssp CGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred CccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC
Confidence 334568999999999999999999976433 358999886532 444567899999999999999999999985 45
Q ss_pred CCEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCC
Q 014347 86 KSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (426)
Q Consensus 86 ~~~~~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~ 164 (426)
++..|+||||+.||+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence 6688999999999999999976 456899999999999999999999999999999999999999999999999999864
Q ss_pred cccc--CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCC
Q 014347 165 QHFR--DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWL 240 (426)
Q Consensus 165 ~~~~--~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~ 240 (426)
.... .........||+.|+|||++.+..+ +.++||||||+++|+|++ |.+||.+.+.......+..+. ...|..+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 257 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTC
T ss_pred cccchhccccccCCCCCccccChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccC
Confidence 3321 1122334567889999999987766 689999999999999999 788888877766666666654 4456778
Q ss_pred CHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 241 SPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 241 s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
++.+.+||.+||+.||.+|||+.++++
T Consensus 258 ~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 258 PDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999999876
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=372.57 Aligned_cols=255 Identities=22% Similarity=0.300 Sum_probs=210.1
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (426)
...++|++.+.||+|+||.||+|++ .+|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..|
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 3558999999999999999999996 578999999886543 233678999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcc
Q 014347 91 MVLEYVTGGELFDKIASKG----RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~~~----~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 166 (426)
+||||++||+|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE 191 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999999986533 589999999999999999999999999999999999999999999999999975433
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHH------H-HHHHHcCCC-----
Q 014347 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV------L-YQKIFRGDF----- 234 (426)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~------~-~~~i~~~~~----- 234 (426)
..........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+..... . ......+..
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFIKGRL-TEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHHHCBC-CTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred ccccccccccCCCccccCHHHhcCCCC-CcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence 222233345579999999999887766 689999999999999999999997643211 1 111111111
Q ss_pred -----CCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCcc
Q 014347 235 -----KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 270 (426)
Q Consensus 235 -----~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~ 270 (426)
..+...++.+.+|+.+||+.||++|||+.+++++-.
T Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 112224567899999999999999999999997643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=365.56 Aligned_cols=255 Identities=26% Similarity=0.398 Sum_probs=214.3
Q ss_pred CccCCCeeeeceEeecCceEEEEEE----ECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEE-
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA- 84 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~- 84 (426)
-+..++|++++.||+|+||.||+|+ +..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 95 (327)
T 3lxl_A 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYG 95 (327)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEec
Confidence 3455799999999999999999999 56789999999987543 344677999999999999999999999886
Q ss_pred -eCCEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCcc
Q 014347 85 -SKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (426)
Q Consensus 85 -~~~~~~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~ 162 (426)
.....|+||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 96 PGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp SSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred CCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccce
Confidence 55779999999999999999986 4569999999999999999999999999999999999999999999999999998
Q ss_pred CCccccCC-CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHH---------------HHH
Q 014347 163 LPQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA---------------VLY 226 (426)
Q Consensus 163 ~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~---------------~~~ 226 (426)
........ .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||...... ...
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIF-SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCC-ChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 54322111 12234568889999999887666 68999999999999999999999764432 222
Q ss_pred HHHHcC-CCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 227 QKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 227 ~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
..+..+ ..+.|..+++.+.+||.+||++||.+|||+.+++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 222222 456677899999999999999999999999999754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=381.52 Aligned_cols=254 Identities=26% Similarity=0.425 Sum_probs=209.0
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC--
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-- 87 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-- 87 (426)
...-++|++.+.||+|+||.||+|++..+|+.||||++....... ..+.+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 82 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCC
Confidence 345679999999999999999999999999999999997544322 2567789999999999999999999998755
Q ss_pred EEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEe----cCCCCeEEeeccC
Q 014347 88 KIYMVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGL 160 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~~---~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl----~~~g~vkL~DFGl 160 (426)
..|+||||++||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 7899999999999999997543 39999999999999999999999999999999999999 7777899999999
Q ss_pred ccCCccccCCCccccccCCCcccchhhhccC-------CCCCCcchhhhHHHHHHHHHhCCCCCCC----CcHHHHHHHH
Q 014347 161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANR-------GYDGATSDIWSCGVILYVILTGYLPFDD----RNLAVLYQKI 229 (426)
Q Consensus 161 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-------~~~~~~~DIwSlGvil~elltG~~Pf~~----~~~~~~~~~i 229 (426)
++.... .......+||+.|+|||++.+. ...+.++|||||||++|+|++|+.||.. ........++
T Consensus 163 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 239 (396)
T 4eut_A 163 ARELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (396)
T ss_dssp CEECCC---GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred ceEccC---CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence 985432 2233456899999999998641 2235789999999999999999999964 2233445555
Q ss_pred HcCCCC-------------------CC------CCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 230 FRGDFK-------------------LP------KWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 230 ~~~~~~-------------------~p------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
..+.+. +| ..+++.+.+||.+||+.||++|||+.+++++
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 544321 11 2245678999999999999999999987543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=364.01 Aligned_cols=254 Identities=24% Similarity=0.361 Sum_probs=206.7
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEE----eCC
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA----SKS 87 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~----~~~ 87 (426)
..++|++++.||+|+||.||+|.+..+|+.||+|++... .....+.+.+|+.+++.++||||+++++++. ...
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH 103 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence 346899999999999999999999999999999998654 2344678899999999999999999999986 345
Q ss_pred EEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccC
Q 014347 88 KIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~----~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~ 163 (426)
..|+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 78999999999999999875 46799999999999999999999999999999999999999999999999999875
Q ss_pred CccccCCC-------ccccccCCCcccchhhhccCCC--CCCcchhhhHHHHHHHHHhCCCCCCCCcHH--HHHHHHHc-
Q 014347 164 PQHFRDDG-------LLHTTCGSPNYVAPEVLANRGY--DGATSDIWSCGVILYVILTGYLPFDDRNLA--VLYQKIFR- 231 (426)
Q Consensus 164 ~~~~~~~~-------~~~~~~gt~~y~APE~l~~~~~--~~~~~DIwSlGvil~elltG~~Pf~~~~~~--~~~~~i~~- 231 (426)
........ ......||+.|+|||++..... .+.++||||||+++|+|++|..||...... .....+..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 263 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ 263 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc
Confidence 32211110 1123468999999999865432 368999999999999999999999642110 11111221
Q ss_pred CCCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 232 GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 232 ~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
...+.+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 264 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 264 LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 2234445689999999999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=355.09 Aligned_cols=249 Identities=27% Similarity=0.412 Sum_probs=213.9
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (426)
+..++|++++.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++++.. +..|
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 83 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcE
Confidence 45579999999999999999999974 567899999875432 24678999999999999999999999864 5589
Q ss_pred EEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 91 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~~~--~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
+||||++|++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 9999999999999987533 79999999999999999999999999999999999999999999999999998543211
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHH
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 246 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 246 (426)
........+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+.......+..+ ....|..+++.+.+
T Consensus 164 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 241 (279)
T 1qpc_A 164 -YTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 241 (279)
T ss_dssp -EECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred -cccccCCCCccCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHH
Confidence 111233457889999999876665 689999999999999999 99999998887777777665 34566779999999
Q ss_pred HHHHccccCccCCCCHHHHhc
Q 014347 247 LLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 247 Li~~~L~~dP~~R~t~~eil~ 267 (426)
||.+||+.||.+|||+.++++
T Consensus 242 li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 242 LMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhccChhhCCCHHHHHH
Confidence 999999999999999999875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=389.39 Aligned_cols=251 Identities=27% Similarity=0.407 Sum_probs=219.2
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (426)
+...+|++.+.||+|+||.||+|.+..++..||||++..... ..+.+.+|+.+|+.++||||+++++++.....+|
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 292 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 292 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence 345679999999999999999999998999999999975432 2567899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 91 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~~--~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
+||||++||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 999999999999999863 458999999999999999999999999999999999999999999999999998643211
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHH
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 246 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 246 (426)
........+++.|+|||++....+ +.++|||||||++|+|++ |..||.+.+.......+..+ ....|..+++.+.+
T Consensus 373 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 450 (495)
T 1opk_A 373 -YTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 450 (495)
T ss_dssp -EECCTTCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred -eeecCCCcCCcceeCHhHHhcCCC-CcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 111223456789999999987766 689999999999999999 99999988877777666554 45677889999999
Q ss_pred HHHHccccCccCCCCHHHHhc
Q 014347 247 LLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 247 Li~~~L~~dP~~R~t~~eil~ 267 (426)
||.+||+.||.+|||+.++++
T Consensus 451 li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 451 LMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCcChhHCcCHHHHHH
Confidence 999999999999999999975
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=370.76 Aligned_cols=255 Identities=18% Similarity=0.197 Sum_probs=202.1
Q ss_pred cCCCeeeeceEeecCceEEEEEEECC---CCCeEEEEEeecccccchh--------HHHHHHHHHHHHHhCCCCCccceE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLD---SGLPFAVKILEKNRIIHLK--------ITDQIKREIATLKLLKHPNVVRLH 80 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~--------~~~~~~~Ei~il~~l~hpnIv~l~ 80 (426)
.-++|++++.||+|+||.||+|.+.. ++..||+|++......... ....+.+|+.+++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 34689999999999999999999987 8889999998765321110 112466789999999999999999
Q ss_pred EEEEe----CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCC--CeE
Q 014347 81 EVLAS----KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG--NIK 154 (426)
Q Consensus 81 ~~~~~----~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g--~vk 154 (426)
+++.. ....|+||||+ |++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+|
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 99987 78899999999 999999998877999999999999999999999999999999999999999887 999
Q ss_pred EeeccCccCCccccC-----CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCC--cHHHHHH
Q 014347 155 ISDFGLSALPQHFRD-----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR--NLAVLYQ 227 (426)
Q Consensus 155 L~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~--~~~~~~~ 227 (426)
|+|||+++....... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+. +......
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL-SRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 999999975433211 112245689999999999887665 68999999999999999999999652 2222222
Q ss_pred HHHcCCCCCC---------CCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 228 KIFRGDFKLP---------KWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 228 ~i~~~~~~~p---------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
.........| ..+++++.+||.+||+.||++|||+.++++.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 273 AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 1111111222 2688999999999999999999999999863
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=382.37 Aligned_cols=249 Identities=25% Similarity=0.421 Sum_probs=215.0
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (426)
+..++|++.+.||+|+||.||+|.+. ++..||||+++.... ..+.+.+|+.+|+.++||||+++++++. ....|
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 44578999999999999999999985 577899999975432 2578899999999999999999999986 56789
Q ss_pred EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 91 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~~--~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 999999999999999753 368999999999999999999999999999999999999999999999999998543211
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHH
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 246 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 246 (426)
........+|+.|+|||++....+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..+++.+.+
T Consensus 339 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 416 (454)
T 1qcf_A 339 -YTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN 416 (454)
T ss_dssp -HHTTCSSSSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHH
T ss_pred -eeccCCCcccccccCHHHhccCCC-CcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 011123456788999999987666 689999999999999999 99999998888877777665 45667889999999
Q ss_pred HHHHccccCccCCCCHHHHhc
Q 014347 247 LLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 247 Li~~~L~~dP~~R~t~~eil~ 267 (426)
||.+||+.||.+|||+++|+.
T Consensus 417 li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 417 IMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhHCcCHHHHHH
Confidence 999999999999999999865
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=359.77 Aligned_cols=256 Identities=27% Similarity=0.397 Sum_probs=207.9
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECC-CCC--eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLD-SGL--PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~-~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (426)
....++|++++.||+|+||.||+|++.. +++ .||+|++...........+.+.+|+.+++.++||||+++++++.+.
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 3445789999999999999999998643 333 6999998766554555678899999999999999999999999876
Q ss_pred CEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 87 SKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
. .++||||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 5 8899999999999999976 3679999999999999999999999999999999999999999999999999987543
Q ss_pred cccCC-CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcCC--CCCCCCCC
Q 014347 166 HFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD--FKLPKWLS 241 (426)
Q Consensus 166 ~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s 241 (426)
..... .......+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+.......+.... .+.+..++
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 251 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcC
Confidence 22111 12234567889999999887666 589999999999999999 999999988888887776654 44556789
Q ss_pred HHHHHHHHHccccCccCCCCHHHHhc
Q 014347 242 PGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 242 ~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
+.+.++|.+||+.||.+|||+.++++
T Consensus 252 ~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 252 QDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHH
Confidence 99999999999999999999999987
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=358.81 Aligned_cols=249 Identities=22% Similarity=0.279 Sum_probs=202.6
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEE-EeCCEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL-ASKSKIY 90 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~~~~~~ 90 (426)
.-++|++++.||+|+||.||+|++..+++.||+|++..... ...+.+|+.+++.++|++++..+..+ ...+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 34789999999999999999999999999999998765432 23578899999999988777666554 7788899
Q ss_pred EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEe---cCCCCeEEeeccCccCCcc
Q 014347 91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL---DSKGNIKISDFGLSALPQH 166 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl---~~~g~vkL~DFGla~~~~~ 166 (426)
+||||+ +++|.+++.. ..++++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 999999 9999999985 5679999999999999999999999999999999999999 7889999999999986443
Q ss_pred ccCC-----CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHcCCCCCC-
Q 014347 167 FRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL---AVLYQKIFRGDFKLP- 237 (426)
Q Consensus 167 ~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~p- 237 (426)
.... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+. ......+.......|
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCC-CchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 2211 12345689999999999987766 6899999999999999999999976332 122233322222222
Q ss_pred ----CCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 238 ----KWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 238 ----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
..+++.+.+||.+||+.||++|||+.++++
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 567999999999999999999999999876
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=356.45 Aligned_cols=235 Identities=29% Similarity=0.576 Sum_probs=197.1
Q ss_pred cCCccCCCeeee-ceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHH-HhCCCCCccceEEEEEe
Q 014347 8 QEGMRLGRYELG-RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVRLHEVLAS 85 (426)
Q Consensus 8 ~~~~~~~~y~i~-~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~ 85 (426)
..+..+++|.+. +.||+|+||.||+|.+..+++.||+|++... ..+.+|+.++ +.++||||+++++++..
T Consensus 11 ~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 11 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence 456788999998 7899999999999999999999999998642 3567888888 66789999999999987
Q ss_pred ----CCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecC---CCCeEEe
Q 014347 86 ----KSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KGNIKIS 156 (426)
Q Consensus 86 ----~~~~~lV~Ey~~gg~L~~~i~~~~--~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~---~g~vkL~ 156 (426)
....|+||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEe
Confidence 678999999999999999998754 6999999999999999999999999999999999999998 7889999
Q ss_pred eccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHH----HHHcC
Q 014347 157 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQ----KIFRG 232 (426)
Q Consensus 157 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~----~i~~~ 232 (426)
|||++.... +..+ +.++|||||||++|+|++|..||.+.+...... .+...
T Consensus 163 Dfg~a~~~~------------------------~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 217 (299)
T 3m2w_A 163 DFGFAKETT------------------------GEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 217 (299)
T ss_dssp CCTTCEECT------------------------TCGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTT
T ss_pred ccccccccc------------------------cccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhc
Confidence 999986321 1223 578999999999999999999998765443321 11222
Q ss_pred CCCCC----CCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 233 DFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 233 ~~~~p----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
...+| ..+++++.+||.+||+.||.+|||+.++++||||.+..
T Consensus 218 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 218 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 33344 45899999999999999999999999999999998754
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=370.79 Aligned_cols=246 Identities=15% Similarity=0.194 Sum_probs=201.8
Q ss_pred cCCCeeeeceEeecCceEEEEE-----EECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCccceEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK---HPNVVRLHEVL 83 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a-----~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~ 83 (426)
.-++|++.+.||+|+||.||+| .+..+++.||+|++.... ...+.+|+.+++.++ |+||+++++++
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 3467999999999999999999 467889999999986543 356788888888887 99999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecC---------
Q 014347 84 ASKSKIYMVLEYVTGGELFDKIAS-----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS--------- 149 (426)
Q Consensus 84 ~~~~~~~lV~Ey~~gg~L~~~i~~-----~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~--------- 149 (426)
...+..|+||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC----
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccc
Confidence 999999999999999999999973 467999999999999999999999999999999999999998
Q ss_pred --CCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHH
Q 014347 150 --KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQ 227 (426)
Q Consensus 150 --~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~ 227 (426)
++.+||+|||+|+..............+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.........
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~- 294 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCMLFGTYMKVKNEGGECK- 294 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCC-CccccHHHHHHHHHHHHhCCCccccCCCCcee-
Confidence 89999999999975443333445566789999999999988776 68999999999999999999999654321000
Q ss_pred HHHcCCCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 228 KIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 228 ~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
....+. ..+.++.+.+++.+||+.+|.+|++..+.+.+
T Consensus 295 --~~~~~~-~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 295 --PEGLFR-RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp --ECSCCT-TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred --echhcc-ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 001111 12457889999999999999999765544443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=371.20 Aligned_cols=254 Identities=17% Similarity=0.205 Sum_probs=200.7
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCC-----CCeEEEEEeecccccchhH--------HHHHHHHHHHHHhCCCCCccc
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKI--------TDQIKREIATLKLLKHPNVVR 78 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAvK~i~~~~~~~~~~--------~~~~~~Ei~il~~l~hpnIv~ 78 (426)
..++|++++.||+|+||.||+|.+..+ ++.||||++.......... ...+.+|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 344899999999999999999998764 5889999987653211110 122345667778889999999
Q ss_pred eEEEEEeC----CEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEec--CCC
Q 014347 79 LHEVLASK----SKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD--SKG 151 (426)
Q Consensus 79 l~~~~~~~----~~~~lV~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~--~~g 151 (426)
+++++... ...|+||||+ |++|.+++... +++++..++.++.||+.||.|||++||+||||||+|||++ .++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 99998764 5689999999 99999999875 6799999999999999999999999999999999999999 889
Q ss_pred CeEEeeccCccCCccccCC-----CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHH
Q 014347 152 NIKISDFGLSALPQHFRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY 226 (426)
Q Consensus 152 ~vkL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~ 226 (426)
.+||+|||+++........ ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+......+
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~ 270 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP-SRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY 270 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence 9999999999764332111 12234569999999999987766 68999999999999999999999863221111
Q ss_pred HHHH----cCCC-------CCCCCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 227 QKIF----RGDF-------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 227 ~~i~----~~~~-------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
.... .... -.+..+++++.+|+.+||+.||.+|||+.+|++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 271 VRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 1110 0010 012457899999999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=360.97 Aligned_cols=254 Identities=28% Similarity=0.368 Sum_probs=209.5
Q ss_pred CccCCCe-eeeceEeecCceEEEEEE----ECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEE
Q 014347 10 GMRLGRY-ELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84 (426)
Q Consensus 10 ~~~~~~y-~i~~~LG~G~fg~Vy~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 84 (426)
.+.-++| ++++.||+|+||.||++. +..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCE 103 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEe
Confidence 4455666 999999999999998875 34578999999997653 3445678999999999999999999999998
Q ss_pred e--CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCcc
Q 014347 85 S--KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (426)
Q Consensus 85 ~--~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~ 162 (426)
+ ...+|+||||+++++|.+++.. .++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 104 ~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 104 DAGAASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp ETTTTEEEEEECCCTTCBHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred cCCCceEEEEEecccCCcHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccc
Confidence 7 4689999999999999999876 459999999999999999999999999999999999999999999999999998
Q ss_pred CCccccCC-CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHH---------------HHH
Q 014347 163 LPQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA---------------VLY 226 (426)
Q Consensus 163 ~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~---------------~~~ 226 (426)
........ .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||...... ...
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKF-YYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH
Confidence 64332110 12334568889999999987766 58899999999999999999999764322 112
Q ss_pred HHHHc-CCCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 227 QKIFR-GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 227 ~~i~~-~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
..+.. ...+.|..+++.+.+||.+||+.||.+|||+.++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 22222 245667789999999999999999999999999985
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=366.85 Aligned_cols=245 Identities=16% Similarity=0.216 Sum_probs=203.6
Q ss_pred CCeeeeceEeecCceEEEEEEECCC--------CCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccc-------
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDS--------GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR------- 78 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~--------~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~------- 78 (426)
++|++++.||+|+||.||+|++..+ ++.||+|++... ..+.+|+.+++.++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 7999999999999999999999874 889999998754 35778999999999999987
Q ss_pred --------eEEEEEe-CCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEe
Q 014347 79 --------LHEVLAS-KSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL 147 (426)
Q Consensus 79 --------l~~~~~~-~~~~~lV~Ey~~gg~L~~~i~~~--~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl 147 (426)
+++++.. ....|+||||+ |++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 6777766 78899999999 99999999875 789999999999999999999999999999999999999
Q ss_pred cCCC--CeEEeeccCccCCccccCC-----CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCC
Q 014347 148 DSKG--NIKISDFGLSALPQHFRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR 220 (426)
Q Consensus 148 ~~~g--~vkL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 220 (426)
+.++ .+||+|||++......... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCcccC
Confidence 9998 8999999999865432211 12234589999999999887666 68999999999999999999999875
Q ss_pred c--HHHHHHH---HHcCCCCCCC------CCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 221 N--LAVLYQK---IFRGDFKLPK------WLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 221 ~--~~~~~~~---i~~~~~~~p~------~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
. ...+... +......++. .+++.+.+||.+||+.||.+|||++++++.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp TTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred CcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 3 3222222 2223332222 368999999999999999999999998763
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=378.20 Aligned_cols=249 Identities=25% Similarity=0.384 Sum_probs=211.0
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (426)
...++|++.+.||+|+||.||+|.+.. +..||||+++..... .+.+.+|+.+|+.++||||+++++++.+ ...|
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 345689999999999999999999864 467999999764421 4678999999999999999999999876 6789
Q ss_pred EEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 91 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~--~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 333 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN- 333 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCC-
Confidence 99999999999999974 356999999999999999999999999999999999999999999999999999864321
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHH
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 246 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 246 (426)
.........+++.|+|||++....+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..+++.+.+
T Consensus 334 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 412 (452)
T 1fmk_A 334 EYTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 412 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred ceecccCCcccccccCHhHHhcCCC-CccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1112233457889999999887766 689999999999999999 99999998888777777665 45677889999999
Q ss_pred HHHHccccCccCCCCHHHHhc
Q 014347 247 LLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 247 Li~~~L~~dP~~R~t~~eil~ 267 (426)
||.+||+.||++|||++++++
T Consensus 413 li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 413 LMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999876
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=353.97 Aligned_cols=249 Identities=24% Similarity=0.355 Sum_probs=198.6
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHh--CCCCCccceEEEEEe--
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL--LKHPNVVRLHEVLAS-- 85 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~-- 85 (426)
....++|++++.||+|+||.||+|++ +|+.||||++.... ...+.+|.+++.. ++||||+++++++..
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 45678999999999999999999987 68999999986532 3455667777766 789999999998654
Q ss_pred --CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh--------hcCceeccCCCCcEEecCCCCeEE
Q 014347 86 --KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH--------NKGVFHRDLKLENILLDSKGNIKI 155 (426)
Q Consensus 86 --~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH--------~~gIiHrDLKp~NILl~~~g~vkL 155 (426)
....|+||||+++|+|.+++.. ..+++..++.++.|++.||.||| ++||+||||||+|||++.++.+||
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred CCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 3568999999999999999964 67999999999999999999999 999999999999999999999999
Q ss_pred eeccCccCCccccC--CCccccccCCCcccchhhhccCCCC-----CCcchhhhHHHHHHHHHhC----------CCCCC
Q 014347 156 SDFGLSALPQHFRD--DGLLHTTCGSPNYVAPEVLANRGYD-----GATSDIWSCGVILYVILTG----------YLPFD 218 (426)
Q Consensus 156 ~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~-----~~~~DIwSlGvil~elltG----------~~Pf~ 218 (426)
+|||++........ .......+||+.|+|||++.+.... +.++|||||||++|+|++| ..||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 99999975332111 0112345899999999998765322 3689999999999999999 88986
Q ss_pred CCc----HHHHHHHHHcC---CCCCCCC-----CCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 219 DRN----LAVLYQKIFRG---DFKLPKW-----LSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 219 ~~~----~~~~~~~i~~~---~~~~p~~-----~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
+.. ......+.... ....|.. .++.+.+||.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 521 12222232222 2233321 4568999999999999999999999976
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=356.71 Aligned_cols=243 Identities=28% Similarity=0.445 Sum_probs=200.7
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (426)
...++|++.+.||+|+||.||+|++ .++.||+|.+... ...+.+.+|+.++++++||||+++++++.+ ..|
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 75 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC 75 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence 4568999999999999999999987 4788999998643 235678999999999999999999998763 479
Q ss_pred EEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhh---cCceeccCCCCcEEecCCCC-eEEeeccCccC
Q 014347 91 MVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHN---KGVFHRDLKLENILLDSKGN-IKISDFGLSAL 163 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~~~---~l~~~~~~~i~~Ql~~aL~~LH~---~gIiHrDLKp~NILl~~~g~-vkL~DFGla~~ 163 (426)
+||||++|++|.+++.... .+++..+..++.|++.||.|||+ +||+||||||+|||++.++. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 9999999999999998654 37899999999999999999999 89999999999999999887 79999999974
Q ss_pred CccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCc--HHHHHHHHHc-CCCCCCCCC
Q 014347 164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIFR-GDFKLPKWL 240 (426)
Q Consensus 164 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~-~~~~~p~~~ 240 (426)
... ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.... .......+.. .....+..+
T Consensus 156 ~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (307)
T 2eva_A 156 IQT-----HMTNNKGSAAWMAPEVFEGSNY-SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL 229 (307)
T ss_dssp --------------CCTTSSCHHHHTCCCC-CTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTC
T ss_pred ccc-----ccccCCCCCceEChhhhCCCCC-CcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCccccc
Confidence 322 2234579999999999887666 689999999999999999999998542 2233333333 345566779
Q ss_pred CHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 241 SPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 241 s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
++.+.+||.+||+.||.+|||+++++++
T Consensus 230 ~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 230 PKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 9999999999999999999999999874
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=360.41 Aligned_cols=252 Identities=30% Similarity=0.436 Sum_probs=189.5
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEE--------
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLA-------- 84 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~-------- 84 (426)
.+|++.+.||+|+||.||+|++..+|+.||+|++.... ......+.+|+.+++.+. ||||+++++++.
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 48999999999999999999999999999999986543 344577899999999996 999999999984
Q ss_pred eCCEEEEEEeccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcC--ceeccCCCCcEEecCCCCeEEeecc
Q 014347 85 SKSKIYMVLEYVTGGELFDKIAS---KGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDSKGNIKISDFG 159 (426)
Q Consensus 85 ~~~~~~lV~Ey~~gg~L~~~i~~---~~~l~~~~~~~i~~Ql~~aL~~LH~~g--IiHrDLKp~NILl~~~g~vkL~DFG 159 (426)
....+|++|||+. |+|.+++.. .+++++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCc
Confidence 3456899999996 699888864 567999999999999999999999999 9999999999999999999999999
Q ss_pred CccCCccccCC----------CccccccCCCcccchhhhc--cCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHH
Q 014347 160 LSALPQHFRDD----------GLLHTTCGSPNYVAPEVLA--NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQ 227 (426)
Q Consensus 160 la~~~~~~~~~----------~~~~~~~gt~~y~APE~l~--~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~ 227 (426)
++......... ......+||+.|+|||++. .....+.++|||||||++|+|++|..||.+........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~ 263 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN 263 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc
Confidence 99865432111 1112457999999999983 22333689999999999999999999998765543332
Q ss_pred HHHcCCCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 228 KIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 228 ~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
.. ...+.+...++.+.+||.+||+.||.+|||+.+++++-+-
T Consensus 264 ~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 305 (337)
T 3ll6_A 264 GK--YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE 305 (337)
T ss_dssp ----CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred Cc--ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 21 1233445678899999999999999999999999988554
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=374.28 Aligned_cols=252 Identities=31% Similarity=0.410 Sum_probs=196.3
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 90 (426)
.-+.|.+.+.||+|+||+||.+. ..+|+.||||.+..+. .+.+.+|+.+++.+ +||||+++++++.+.+..|
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 85 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLY 85 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred hhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEE
Confidence 34556778899999999998764 4679999999986542 35678899999875 8999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCC-------------
Q 014347 91 MVLEYVTGGELFDKIASKGRL-------QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK------------- 150 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~~~~l-------~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~------------- 150 (426)
+||||+. |+|.+++...... ++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 86 lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 86 IALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp EEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred EEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCc
Confidence 9999996 5999999865433 233457899999999999999999999999999999754
Q ss_pred CCeEEeeccCccCCccccCC--CccccccCCCcccchhhhcc------CCCCCCcchhhhHHHHHHHHHh-CCCCCCCCc
Q 014347 151 GNIKISDFGLSALPQHFRDD--GLLHTTCGSPNYVAPEVLAN------RGYDGATSDIWSCGVILYVILT-GYLPFDDRN 221 (426)
Q Consensus 151 g~vkL~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~------~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 221 (426)
+.+||+|||++......... ......+||+.|+|||++.+ ....+.++|||||||++|+|++ |..||.+..
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 47999999999865332111 12345689999999999865 2344789999999999999999 999998765
Q ss_pred HHHHHHHHHcCCCCCCC-------CCCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 222 LAVLYQKIFRGDFKLPK-------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 222 ~~~~~~~i~~~~~~~p~-------~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
... ..+..+....+. .+++++.+||.+||+.||.+|||+.++++||||..
T Consensus 245 ~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 245 SRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp THH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred hhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 433 234444433322 24578999999999999999999999999999964
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=377.86 Aligned_cols=251 Identities=25% Similarity=0.346 Sum_probs=196.9
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEEEEEE
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
+|++.+.||+|+||.|+. ....+|+.||||.+..... ..+.+|+.+|+.+ +||||+++++++.+....|+||
T Consensus 25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 499999999999999764 3347899999999875443 2356899999999 7999999999999999999999
Q ss_pred eccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecC---CC--CeEEeeccCccCCccc
Q 014347 94 EYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KG--NIKISDFGLSALPQHF 167 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~-~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~---~g--~vkL~DFGla~~~~~~ 167 (426)
||+. |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++ .+||+|||+|+.....
T Consensus 98 E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp ECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred ECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 9996 59999997643 4666678899999999999999999999999999999953 23 5789999999865322
Q ss_pred cC-CCccccccCCCcccchhhhcc--CCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcCCCCC---CCCC
Q 014347 168 RD-DGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL---PKWL 240 (426)
Q Consensus 168 ~~-~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~---p~~~ 240 (426)
.. .......+||+.|+|||++.+ ....+.++|||||||++|+|++ |..||................... +...
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHE 256 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHH
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccc
Confidence 11 123345689999999999874 2233678999999999999999 999997765444333222222221 2234
Q ss_pred CHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 241 s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
++.+.+||.+||+.||.+|||+.++++||||..
T Consensus 257 ~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp HHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred cHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 667899999999999999999999999999964
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=370.36 Aligned_cols=252 Identities=25% Similarity=0.338 Sum_probs=203.3
Q ss_pred CCeeeeceEeecCceEEEEEEECCCC---CeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEE-eCCEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA-SKSKI 89 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~ 89 (426)
.+|++.+.||+|+||.||+|.+..++ ..||+|.++... .....+.+.+|+.+++.++||||+++++++. .++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 35889999999999999999875432 468999886432 3345678999999999999999999999864 45678
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999999999764 458999999999999999999999999999999999999999999999999997543211
Q ss_pred C--CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHH
Q 014347 169 D--DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGA 244 (426)
Q Consensus 169 ~--~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 244 (426)
. ........+|+.|+|||++.+..+ +.++|||||||++|+|++ |.+||.+.+.......+..+. ...|..+++.+
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l 325 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 325 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHH
T ss_pred cccccccCCCCCcccccChHHhcCCCC-CcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 1 111233467889999999887766 689999999999999999 889998876665655665553 45577799999
Q ss_pred HHHHHHccccCccCCCCHHHHhcC
Q 014347 245 QNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
.+|+.+||+.||.+|||+.+++++
T Consensus 326 ~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 326 YEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999864
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=358.45 Aligned_cols=250 Identities=27% Similarity=0.360 Sum_probs=205.0
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccc-cchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-IHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
.|..++.||+|+||.||+|.+ +++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 109 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVY 109 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEE
Confidence 355569999999999999985 688999999875432 23345678999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCC
Q 014347 94 EYVTGGELFDKIAS---KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (426)
Q Consensus 94 Ey~~gg~L~~~i~~---~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 170 (426)
||++|++|.+++.. ..++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 189 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence 99999999999874 346999999999999999999999999999999999999999999999999998754432222
Q ss_pred CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHH----HHHHHHHcCCC-----------C
Q 014347 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA----VLYQKIFRGDF-----------K 235 (426)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~----~~~~~i~~~~~-----------~ 235 (426)
......+||+.|+|||++.+ .+ +.++||||||+++|+|++|..||.+.... .+...+..... .
T Consensus 190 ~~~~~~~g~~~y~aPE~~~~-~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (307)
T 2nru_A 190 VMTSRIVGTTAYMAPEALRG-EI-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND 267 (307)
T ss_dssp EECSSCCSCGGGCCHHHHTT-EE-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSC
T ss_pred ccccccCCCcCcCChHHhcC-CC-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccc
Confidence 23345679999999999865 34 68999999999999999999999875432 22222222111 1
Q ss_pred CCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 236 ~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
.+...++.+.+|+.+||+.||.+|||+.+++++
T Consensus 268 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 268 ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 222345788999999999999999999999864
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=362.90 Aligned_cols=255 Identities=23% Similarity=0.339 Sum_probs=206.3
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (426)
...++|++.+.||+|+||.||+|++ .+|+.||+|++........ ...+.+|+.+++.++||||+++++++.+.+..+
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 103 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----C--CCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCE
T ss_pred HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchH--HHHHHHHHHHHHhccCCCccceEEEEecCCceE
Confidence 3457999999999999999999985 5689999999876543221 236889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhc---CceeccCCCCcEEecCCCCeEEeeccCccC
Q 014347 91 MVLEYVTGGELFDKIASKG----RLQEAEGRKLFQQLIDGVSYCHNK---GVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~~~----~l~~~~~~~i~~Ql~~aL~~LH~~---gIiHrDLKp~NILl~~~g~vkL~DFGla~~ 163 (426)
+||||+.||+|.+++.... ++++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++..
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 183 (326)
T 3uim_A 104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183 (326)
T ss_dssp EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccc
Confidence 9999999999999997643 499999999999999999999999 999999999999999999999999999985
Q ss_pred CccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcH----HHHHHHHHcCCC-----
Q 014347 164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL----AVLYQKIFRGDF----- 234 (426)
Q Consensus 164 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~----- 234 (426)
.... ........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||+.... ......+.....
T Consensus 184 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (326)
T 3uim_A 184 MDYK-DTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 261 (326)
T ss_dssp CCSS-SSCEECCCCSCGGGCCHHHHHHSEE-CHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCS
T ss_pred cCcc-cccccccccCCcCccCHHHhccCCC-CccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhh
Confidence 4321 2223445679999999999877665 6899999999999999999999963111 001111111100
Q ss_pred ----------CCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCcc
Q 014347 235 ----------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 270 (426)
Q Consensus 235 ----------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~ 270 (426)
..+...++.+.+|+.+||+.||.+|||+.++++|-+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 262 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp TTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred hhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 111223467999999999999999999999998854
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=356.17 Aligned_cols=250 Identities=23% Similarity=0.366 Sum_probs=198.3
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHh--CCCCCccceEEEEEeC-
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL--LKHPNVVRLHEVLASK- 86 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~- 86 (426)
....++|++++.||+|+||.||+|++. |+.||||++.... .....+|..++.. ++||||+++++++...
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 344578999999999999999999974 8999999986432 2344556666655 4899999999999887
Q ss_pred ---CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc--------CceeccCCCCcEEecCCCCeEE
Q 014347 87 ---SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK--------GVFHRDLKLENILLDSKGNIKI 155 (426)
Q Consensus 87 ---~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~--------gIiHrDLKp~NILl~~~g~vkL 155 (426)
...|+||||++||+|.+++.. ..+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 789999999999999999976 5799999999999999999999999 9999999999999999999999
Q ss_pred eeccCccCCccccCC--CccccccCCCcccchhhhccCCCCCC-----cchhhhHHHHHHHHHhC----------CCCCC
Q 014347 156 SDFGLSALPQHFRDD--GLLHTTCGSPNYVAPEVLANRGYDGA-----TSDIWSCGVILYVILTG----------YLPFD 218 (426)
Q Consensus 156 ~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~-----~~DIwSlGvil~elltG----------~~Pf~ 218 (426)
+|||++......... ......+||+.|+|||++.+..+... ++|||||||++|+|++| ..||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 999999754322111 11235689999999999877655322 38999999999999999 77776
Q ss_pred CC-----cHHHHHHHHHcC--CCCCCC-----CCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 219 DR-----NLAVLYQKIFRG--DFKLPK-----WLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 219 ~~-----~~~~~~~~i~~~--~~~~p~-----~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
.. ........+... ...+|. .+++.+.+||.+||+.||.+|||+.+++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 42 122222222222 233333 345679999999999999999999999876
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=388.48 Aligned_cols=245 Identities=24% Similarity=0.345 Sum_probs=209.2
Q ss_pred ceEeecCceEEEEEEE--CCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEeccC
Q 014347 20 RTLGEGNFGKVKFAQD--LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~ 97 (426)
+.||+|+||.||+|.+ ..+++.||||+++... ......+.+.+|+.+|+.++||||+++++++.. ...++||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 4899999999999954 4567899999997543 233446789999999999999999999999965 45889999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC-CCccccc
Q 014347 98 GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-DGLLHTT 176 (426)
Q Consensus 98 gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~~ 176 (426)
||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .......
T Consensus 453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 532 (635)
T 4fl3_A 453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 532 (635)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----------
T ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCC
Confidence 999999999888999999999999999999999999999999999999999999999999999985432211 1122334
Q ss_pred cCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHcccc
Q 014347 177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEP 254 (426)
Q Consensus 177 ~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~ 254 (426)
.||+.|+|||++....+ +.++|||||||++|+|++ |..||.+.+.......+..+ ....|..+++++.+||.+||+.
T Consensus 533 ~~t~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~ 611 (635)
T 4fl3_A 533 KWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 611 (635)
T ss_dssp --CGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCceeeeChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 57889999999987776 689999999999999998 99999999888888887766 4667888999999999999999
Q ss_pred CccCCCCHHHHhc
Q 014347 255 NPVKRITIAGIKA 267 (426)
Q Consensus 255 dP~~R~t~~eil~ 267 (426)
||++|||++++++
T Consensus 612 dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 612 DVENRPGFAAVEL 624 (635)
T ss_dssp STTTSCCHHHHHH
T ss_pred CHhHCcCHHHHHH
Confidence 9999999999865
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=357.44 Aligned_cols=259 Identities=22% Similarity=0.337 Sum_probs=195.3
Q ss_pred ccCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHH--HHhCCCCCccceEEEEE
Q 014347 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT--LKLLKHPNVVRLHEVLA 84 (426)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~i--l~~l~hpnIv~l~~~~~ 84 (426)
......+++|++++.||+|+||.||+|++ +++.||||++.... ...+..|..+ ++.++||||+++++.+.
T Consensus 6 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 77 (336)
T 3g2f_A 6 SEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDE 77 (336)
T ss_dssp ---CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred cCCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheeccc
Confidence 44578899999999999999999999976 68999999997543 2333444444 45689999999998654
Q ss_pred e-----CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc---------CceeccCCCCcEEecCC
Q 014347 85 S-----KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK---------GVFHRDLKLENILLDSK 150 (426)
Q Consensus 85 ~-----~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~---------gIiHrDLKp~NILl~~~ 150 (426)
. ...+|+||||++||+|.+++.. ...++..+..++.||+.||.|||++ ||+||||||+|||++.+
T Consensus 78 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~ 156 (336)
T 3g2f_A 78 RVTADGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND 156 (336)
T ss_dssp EECTTSCEEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT
T ss_pred ccccCCCceEEEEEecCCCCcHHHHHhh-cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC
Confidence 2 3367899999999999999976 4569999999999999999999999 99999999999999999
Q ss_pred CCeEEeeccCccCCcccc------CCCccccccCCCcccchhhhccC------CCCCCcchhhhHHHHHHHHHhCCCCCC
Q 014347 151 GNIKISDFGLSALPQHFR------DDGLLHTTCGSPNYVAPEVLANR------GYDGATSDIWSCGVILYVILTGYLPFD 218 (426)
Q Consensus 151 g~vkL~DFGla~~~~~~~------~~~~~~~~~gt~~y~APE~l~~~------~~~~~~~DIwSlGvil~elltG~~Pf~ 218 (426)
+.+||+|||++....... ........+||+.|+|||++.+. ...+.++|||||||++|+|++|..||.
T Consensus 157 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 236 (336)
T 3g2f_A 157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236 (336)
T ss_dssp SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence 999999999997543211 11223355799999999998752 223568999999999999999977653
Q ss_pred C-Cc-----------------HHHHHHHHHc--CCCCCCCC------CCHHHHHHHHHccccCccCCCCHHHH------h
Q 014347 219 D-RN-----------------LAVLYQKIFR--GDFKLPKW------LSPGAQNLLRKILEPNPVKRITIAGI------K 266 (426)
Q Consensus 219 ~-~~-----------------~~~~~~~i~~--~~~~~p~~------~s~~~~~Li~~~L~~dP~~R~t~~ei------l 266 (426)
. .. .......... ....+|.. +++.+.+||.+||+.||++|||+.++ +
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp TTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred CccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 2 11 1111111111 12333433 34579999999999999999999999 4
Q ss_pred cCcccccc
Q 014347 267 ADEWFEQD 274 (426)
Q Consensus 267 ~h~~f~~~ 274 (426)
.++|-++.
T Consensus 317 l~~~~~~~ 324 (336)
T 3g2f_A 317 MMIWERNK 324 (336)
T ss_dssp HHCCCC--
T ss_pred HHHHHhcc
Confidence 45665543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=356.74 Aligned_cols=257 Identities=25% Similarity=0.387 Sum_probs=210.9
Q ss_pred ccCCccCCCeeeeceEeecCceEEEEEE----ECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEE
Q 014347 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEV 82 (426)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 82 (426)
.+.....++|++++.||+|+||.||+|+ +..+|+.||+|++... .....+.+.+|+.+++.++||||++++++
T Consensus 34 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 110 (326)
T 2w1i_A 34 DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGV 110 (326)
T ss_dssp ---CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 3455667889999999999999999998 4668999999998754 23446789999999999999999999999
Q ss_pred EEeCC--EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeecc
Q 014347 83 LASKS--KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG 159 (426)
Q Consensus 83 ~~~~~--~~~lV~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFG 159 (426)
+...+ ..++||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 111 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg 190 (326)
T 2w1i_A 111 CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 190 (326)
T ss_dssp ECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred EEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCc
Confidence 86543 689999999999999999875 469999999999999999999999999999999999999999999999999
Q ss_pred CccCCccccCC-CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHH---------------
Q 014347 160 LSALPQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA--------------- 223 (426)
Q Consensus 160 la~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~--------------- 223 (426)
++......... .......+++.|+|||++.+..+ +.++||||||+++|+|++|..||......
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 269 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHH
T ss_pred chhhccccccccccccCCCCceeEECchhhcCCCC-CchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhH
Confidence 99864332111 11223467788999999887666 58899999999999999999998753211
Q ss_pred -HHHHHHHc-CCCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 224 -VLYQKIFR-GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 224 -~~~~~i~~-~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
.+...+.. ...+.|..+++.+.+||.+||+.||++|||+.++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11122222 245667789999999999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=385.24 Aligned_cols=249 Identities=25% Similarity=0.370 Sum_probs=209.1
Q ss_pred CCeeeec-eEeecCceEEEEEEEC--CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 014347 14 GRYELGR-TLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 14 ~~y~i~~-~LG~G~fg~Vy~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (426)
+++.+.+ .||+|+||.||+|.+. .++..||||+++... .....+.+.+|+.+|+.++||||+++++++.. +..|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~ 411 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 411 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence 4566666 8999999999999875 356679999997643 22346789999999999999999999999976 5689
Q ss_pred EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
+||||+.||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence 99999999999999975 35699999999999999999999999999999999999999999999999999986432111
Q ss_pred C-CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHH
Q 014347 170 D-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 246 (426)
Q Consensus 170 ~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 246 (426)
. .......+|+.|+|||++....+ +.++|||||||++|+|++ |..||.+.+..+....+..+ ...+|..+++++.+
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 570 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 570 (613)
T ss_dssp ----------CCTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred eeeeccCCCCccceeCHhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 1 11123346789999999987766 689999999999999998 99999998888888887766 46778889999999
Q ss_pred HHHHccccCccCCCCHHHHh
Q 014347 247 LLRKILEPNPVKRITIAGIK 266 (426)
Q Consensus 247 Li~~~L~~dP~~R~t~~eil 266 (426)
||.+||+.||.+|||+.+++
T Consensus 571 li~~cl~~dP~~RPs~~~l~ 590 (613)
T 2ozo_A 571 LMSDCWIYKWEDRPDFLTVE 590 (613)
T ss_dssp HHHHTTCSSTTTSCCHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHH
Confidence 99999999999999999974
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=380.40 Aligned_cols=249 Identities=25% Similarity=0.381 Sum_probs=214.8
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (426)
+..++|++.+.||+|+||.||+|.+.. +..||||+++..... .+.+.+|+.+|+.++||||+++++++.. ...|
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 345689999999999999999999864 467999999764421 4678999999999999999999999866 6789
Q ss_pred EEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 91 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~--~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
+||||+.+|+|.+++.. ...+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 99999999999999974 3569999999999999999999999999999999999999999999999999998643211
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHH
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 246 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 246 (426)
........++..|+|||++....+ +.++|||||||+||+|++ |..||.+....+....+..+ ..+.|..+++.+.+
T Consensus 418 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 495 (535)
T 2h8h_A 418 -YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 495 (535)
T ss_dssp -HHTTCSTTSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred -eecccCCcCcccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 001123456789999999887766 689999999999999999 99999998888877777665 45677889999999
Q ss_pred HHHHccccCccCCCCHHHHhc
Q 014347 247 LLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 247 Li~~~L~~dP~~R~t~~eil~ 267 (426)
||.+||+.||++|||+++|++
T Consensus 496 li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 496 LMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999876
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=356.69 Aligned_cols=255 Identities=22% Similarity=0.355 Sum_probs=211.2
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (426)
.....++|++++.||+|+||.||+|.+.. .||+|++...... ....+.+.+|+.+++.++||||+++++++.+...
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDN-EDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCC-CCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCC-HHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 35667899999999999999999999753 4999998754322 2224567789999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 89 IYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~-~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
.|+||||++|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++......
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 999999999999999997644 699999999999999999999999999999999999998 789999999998754321
Q ss_pred c---CCCccccccCCCcccchhhhcc--------CCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCC
Q 014347 168 R---DDGLLHTTCGSPNYVAPEVLAN--------RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL 236 (426)
Q Consensus 168 ~---~~~~~~~~~gt~~y~APE~l~~--------~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~ 236 (426)
. .........||+.|+|||++.. ....+.++||||||+++|+|++|..||.+.+.......+..+..+.
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 262 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN 262 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC
Confidence 1 1223344579999999999864 2234688999999999999999999999988887777776654332
Q ss_pred --CCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 237 --PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 237 --p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
+..+++.+.+||.+||+.||.+|||+.++++.
T Consensus 263 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 263 LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 23578999999999999999999999999863
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=383.38 Aligned_cols=253 Identities=26% Similarity=0.432 Sum_probs=214.6
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCC---CCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (426)
...++|++++.||+|+||.||+|.+..+ +..||+|.+.... .....+.+.+|+.+++.++||||+++++++. ++
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 4457899999999999999999998654 4579999876432 3445678999999999999999999999985 46
Q ss_pred EEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcc
Q 014347 88 KIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~~-~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 166 (426)
..|+||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 6899999999999999998643 699999999999999999999999999999999999999999999999999986432
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHH
Q 014347 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGA 244 (426)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 244 (426)
.. ........+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..+++.+
T Consensus 544 ~~-~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l 621 (656)
T 2j0j_A 544 ST-YYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 621 (656)
T ss_dssp -----------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHH
T ss_pred Cc-ceeccCCCCCcceeCHHHhcCCCC-CchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHH
Confidence 11 112233467889999999987766 689999999999999997 99999998888887777665 466788899999
Q ss_pred HHHHHHccccCccCCCCHHHHhcC
Q 014347 245 QNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
.+||.+||+.||.+|||+.++++.
T Consensus 622 ~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 622 YSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHHH
Confidence 999999999999999999998763
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=393.57 Aligned_cols=260 Identities=28% Similarity=0.402 Sum_probs=207.9
Q ss_pred cCCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe--
Q 014347 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-- 85 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-- 85 (426)
..+..+++|++.+.||+|+||.||+|.+..+|+.||||++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 8 ~pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~ 85 (676)
T 3qa8_A 8 LPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQ 85 (676)
T ss_dssp ---------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTC
T ss_pred CCCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccc
Confidence 34567799999999999999999999999999999999986542 34456789999999999999999999998755
Q ss_pred ----CCEEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCC---eEE
Q 014347 86 ----KSKIYMVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKI 155 (426)
Q Consensus 86 ----~~~~~lV~Ey~~gg~L~~~i~~~~---~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~---vkL 155 (426)
.+..|+||||++||+|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++. +||
T Consensus 86 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL 165 (676)
T 3qa8_A 86 KLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKI 165 (676)
T ss_dssp CCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred cccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEE
Confidence 677899999999999999998644 6999999999999999999999999999999999999998775 899
Q ss_pred eeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHH--------
Q 014347 156 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQ-------- 227 (426)
Q Consensus 156 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~-------- 227 (426)
+|||++..... .......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+......+.
T Consensus 166 ~DFG~a~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 166 IDLGYAKELDQ---GELCTEFVGTLQYLAPELLEQKKY-TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN 241 (676)
T ss_dssp CSCCCCCBTTS---CCCCCCCCSCCTTCSSCSSCCSCC-STTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC----
T ss_pred ccccccccccc---ccccccccCCcccCChHHhccCCC-CchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccc
Confidence 99999986432 233455789999999999887766 689999999999999999999997653322110
Q ss_pred -H-----HHcCCC------CCC----CCCCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 228 -K-----IFRGDF------KLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 228 -~-----i~~~~~------~~p----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
. ...+.. +.| ..+++.+.+||.+||++||.+|||++++++||||+.
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 0 001111 111 225688999999999999999999999999999964
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=368.13 Aligned_cols=250 Identities=20% Similarity=0.272 Sum_probs=207.6
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCC-CCccceEEEEEeCCEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNVVRLHEVLASKSKI 89 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~ 89 (426)
...++|++++.||+|+||.||+|++..+++.||||++...... .++.+|+.+++.+.| +++..+..++......
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYN 78 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence 3457999999999999999999999999999999998754432 347889999999987 5566666777888999
Q ss_pred EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEe---cCCCCeEEeeccCccCCc
Q 014347 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL---DSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl---~~~g~vkL~DFGla~~~~ 165 (426)
|+||||+ |++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9999999 9999999985 5679999999999999999999999999999999999999 688999999999998644
Q ss_pred cccCC-----CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCc---HHHHHHHHHcCCC---
Q 014347 166 HFRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGDF--- 234 (426)
Q Consensus 166 ~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~--- 234 (426)
..... ......+||+.|+|||++.+..+ +.++|||||||+||+|++|+.||.+.. ....+.++.....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 32211 12236689999999999987776 689999999999999999999998743 3334444333221
Q ss_pred --CCCCCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 235 --KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 235 --~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
.++..+++++.+||.+||+.||.+||++.+|++
T Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 223567899999999999999999999988754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=350.60 Aligned_cols=247 Identities=25% Similarity=0.356 Sum_probs=203.1
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHh--CCCCCccceEEEEEeCC---
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL--LKHPNVVRLHEVLASKS--- 87 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~~--- 87 (426)
.++|++.+.||+|+||.||+|++ +|+.||||++.... ...+.+|+.+++. ++||||+++++++....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 36899999999999999999997 58999999986432 3567789999887 78999999999998776
Q ss_pred -EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh--------hcCceeccCCCCcEEecCCCCeEEeec
Q 014347 88 -KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH--------NKGVFHRDLKLENILLDSKGNIKISDF 158 (426)
Q Consensus 88 -~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH--------~~gIiHrDLKp~NILl~~~g~vkL~DF 158 (426)
..|+||||+++|+|.+++.+ .++++..++.++.|++.||.||| ++||+||||||+|||++.++.+||+||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred ceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 89999999999999999976 57999999999999999999999 899999999999999999999999999
Q ss_pred cCccCCccccCC--CccccccCCCcccchhhhccCCCC-----CCcchhhhHHHHHHHHHhC----------CCCCCCC-
Q 014347 159 GLSALPQHFRDD--GLLHTTCGSPNYVAPEVLANRGYD-----GATSDIWSCGVILYVILTG----------YLPFDDR- 220 (426)
Q Consensus 159 Gla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~-----~~~~DIwSlGvil~elltG----------~~Pf~~~- 220 (426)
|++......... ......+||+.|+|||++.+.... +.++|||||||++|+|++| ..||...
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 999754321110 022455899999999998765322 2579999999999999999 8899764
Q ss_pred ----cHHHHHHHHHcCC--CCCCCC-----CCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 221 ----NLAVLYQKIFRGD--FKLPKW-----LSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 221 ----~~~~~~~~i~~~~--~~~p~~-----~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
........+.... ..+|.. .++.+.+||.+||+.||++|||+.+++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 3344444444332 233322 34578999999999999999999999876
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=370.78 Aligned_cols=250 Identities=21% Similarity=0.206 Sum_probs=196.5
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCC-CCc---------cceE--
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNV---------VRLH-- 80 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnI---------v~l~-- 80 (426)
...|.+++.||+|+||.||+|++..+|+.||||++...........+.+.+|+.+++.++| +|. +...
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3458899999999999999999999999999999875444444446789999999999987 221 1111
Q ss_pred ----------EEEEe-----CCEEEEEEeccCCCChHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHhhcCceec
Q 014347 81 ----------EVLAS-----KSKIYMVLEYVTGGELFDKIAS-------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138 (426)
Q Consensus 81 ----------~~~~~-----~~~~~lV~Ey~~gg~L~~~i~~-------~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHr 138 (426)
.++.. ...++++|+++ +++|.+++.. ...+++..+..++.||+.||+|||++||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 11111 12356777766 6799998851 2347788899999999999999999999999
Q ss_pred cCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhc---------cCCCCCCcchhhhHHHHHHH
Q 014347 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA---------NRGYDGATSDIWSCGVILYV 209 (426)
Q Consensus 139 DLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~---------~~~~~~~~~DIwSlGvil~e 209 (426)
||||+|||++.++.+||+|||+++.... .....+| +.|+|||++. .....+.++|||||||++|+
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred CcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 9999999999999999999999875332 2456788 9999999983 22223679999999999999
Q ss_pred HHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 210 ILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 210 lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
|++|+.||.+.+.......+.. ....+++.+.+||.+||++||.+|||+.++++||||+.
T Consensus 310 lltg~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 310 IWCADLPNTDDAALGGSEWIFR----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HHHSSCCCCTTGGGSCSGGGGS----SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHCCCCCCCcchhhhHHHHHh----hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 9999999988765444333332 22357899999999999999999999999999999975
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=366.23 Aligned_cols=245 Identities=22% Similarity=0.305 Sum_probs=198.3
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeeccccc-----chhHHHHHHHHHHHHHhCC---------CCCc
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLKLLK---------HPNV 76 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~---------hpnI 76 (426)
...++|++++.||+|+||.||+|++ +|+.||||++...... .....+.+.+|+.+++.++ ||||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 3457899999999999999999998 7899999999876431 2233577889999998886 8888
Q ss_pred cceEEEEE------------------------------eCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHH
Q 014347 77 VRLHEVLA------------------------------SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126 (426)
Q Consensus 77 v~l~~~~~------------------------------~~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~a 126 (426)
+++.+++. ..+..|+||||+++|++.+.+.+ +.+++..++.++.||+.|
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence 88877643 26889999999999988777754 678999999999999999
Q ss_pred HHHHh-hcCceeccCCCCcEEecCCC--------------------CeEEeeccCccCCccccCCCccccccCCCcccch
Q 014347 127 VSYCH-NKGVFHRDLKLENILLDSKG--------------------NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185 (426)
Q Consensus 127 L~~LH-~~gIiHrDLKp~NILl~~~g--------------------~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~AP 185 (426)
|.||| ++||+||||||+|||++.+| .+||+|||+|+.... ...+||+.|+||
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aP 246 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDE 246 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCS
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccCh
Confidence 99999 99999999999999999987 899999999985321 245899999999
Q ss_pred hhhccCCCCCCcchhhhHHHH-HHHHHhCCCCCCCCcH-HHHHHHHHcC-CC--CC----CCCCCHHHHHHHHHccccCc
Q 014347 186 EVLANRGYDGATSDIWSCGVI-LYVILTGYLPFDDRNL-AVLYQKIFRG-DF--KL----PKWLSPGAQNLLRKILEPNP 256 (426)
Q Consensus 186 E~l~~~~~~~~~~DIwSlGvi-l~elltG~~Pf~~~~~-~~~~~~i~~~-~~--~~----p~~~s~~~~~Li~~~L~~dP 256 (426)
|++.+.. +.++||||+|++ .+++++|..||.+... ......+... .. .. ++.+++++.+||++||+.|
T Consensus 247 E~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d- 323 (336)
T 2vuw_A 247 DLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS- 323 (336)
T ss_dssp GGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-
T ss_pred hhhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-
Confidence 9987654 688999998776 7889999999965321 2223333321 11 11 1237889999999999977
Q ss_pred cCCCCHHHHh-cCcccc
Q 014347 257 VKRITIAGIK-ADEWFE 272 (426)
Q Consensus 257 ~~R~t~~eil-~h~~f~ 272 (426)
|++|++ +||||+
T Consensus 324 ----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 ----SATDLLCQHSLFK 336 (336)
T ss_dssp ----SHHHHHHHCGGGC
T ss_pred ----CHHHHHhcCCCcC
Confidence 999999 999995
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=339.38 Aligned_cols=225 Identities=15% Similarity=0.175 Sum_probs=191.4
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (426)
+.-++|++.+.||+|+||.||+|++..+|+.||||++...........+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 34478999999999999999999999999999999998776655666788999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCC
Q 014347 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 170 (426)
+||||++|++|.+++.+ + ....++..++.||+.||+|||++||+||||||+|||++.+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 99999999999999854 3 4667889999999999999999999999999999999999999998554
Q ss_pred CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHH---HHHHcCCCC----CCCCCCHH
Q 014347 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY---QKIFRGDFK----LPKWLSPG 243 (426)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~---~~i~~~~~~----~p~~~s~~ 243 (426)
|++| .+.++|||||||++|+|++|+.||.+.+..... .+...+... .+..+++.
T Consensus 175 -----------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T 3uqc_A 175 -----------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQ 235 (286)
T ss_dssp -----------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHH
T ss_pred -----------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHH
Confidence 2222 368899999999999999999999876542211 011112221 23568999
Q ss_pred HHHHHHHccccCccCCCCHHHHhcC
Q 014347 244 AQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 244 ~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
+.+||.+||++||.+| |+.++++.
T Consensus 236 l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 236 ISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred HHHHHHHHcccCCccC-CHHHHHHH
Confidence 9999999999999999 99999874
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=375.92 Aligned_cols=241 Identities=25% Similarity=0.395 Sum_probs=202.0
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECC-CCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE-
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK- 88 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~- 88 (426)
...++|++++.||+|+||.||+|.+.. +|+.||||++.... .......+.+|+.+++.++||||+++++++...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 445899999999999999999999976 78999999986532 34456778999999999999999999999987655
Q ss_pred ----EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCC
Q 014347 89 ----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (426)
Q Consensus 89 ----~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~ 164 (426)
.|+||||++|++|.+.+.. ++++.+++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||++...
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred CCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 7999999999999987754 79999999999999999999999999999999999999875 8999999999853
Q ss_pred ccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCC-C-CCCCH
Q 014347 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL-P-KWLSP 242 (426)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-p-~~~s~ 242 (426)
.. ....+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+.... ..... + ...++
T Consensus 232 ~~------~~~~~gt~~y~aPE~~~~~-~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~~ 295 (681)
T 2pzi_A 232 NS------FGYLYGTPGFQAPEIVRTG-P-TVATDIYTVGRTLAALTLDLPTRNGRYVD--------GLPEDDPVLKTYD 295 (681)
T ss_dssp TC------CSCCCCCTTTSCTTHHHHC-S-CHHHHHHHHHHHHHHHHSCCCEETTEECS--------SCCTTCHHHHHCH
T ss_pred cc------CCccCCCccccCHHHHcCC-C-CCceehhhhHHHHHHHHhCCCCCcccccc--------cccccccccccCH
Confidence 22 2456899999999998754 3 68999999999999999999998764211 00000 0 11467
Q ss_pred HHHHHHHHccccCccCCCCHHHHhcCcccc
Q 014347 243 GAQNLLRKILEPNPVKRITIAGIKADEWFE 272 (426)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~eil~h~~f~ 272 (426)
.+.+||.+||++||.+||+..+.+.|+|+.
T Consensus 296 ~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 296 SYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 899999999999999999999999999985
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=323.08 Aligned_cols=233 Identities=14% Similarity=0.122 Sum_probs=163.7
Q ss_pred ceEeecCceEEEEEEECCCCCeEEEEEeecccccc-------hhHHHHHHHHHHHHHhC-CCCCccceEEEEEeCCEEEE
Q 014347 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-------LKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-------~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~l 91 (426)
..++.|++|.+..++....|+.||+|++.+..... ....+.+.+|+.+|+++ .|+||++++++++++...||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 34678888888888888899999999998753221 22346799999999999 59999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCC
Q 014347 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 171 (426)
||||++|++|.++|.+.+++++. +++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... ...
T Consensus 320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~--~~~ 394 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ--DCS 394 (569)
T ss_dssp EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----C
T ss_pred EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCC--CCc
Confidence 99999999999999998888865 5899999999999999999999999999999999999999999986543 233
Q ss_pred ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Q 014347 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251 (426)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~ 251 (426)
...+.+||+.|+|||++.+. + ..++|+||+|++++.|.+|..|| ...... .|.. ...+..+...+
T Consensus 395 ~~~t~vGTp~YmAPE~l~g~-~-~~~~d~~s~g~~~~~l~~~~~~~--------~~~l~~----~~~~-~~~~~~l~~~l 459 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAEN-K-SWNGFWRSAPVHPFNLPQPWSNW--------LYAVWQ----EPVE-RWNFVLLLALF 459 (569)
T ss_dssp CSHHHHHHHHHHHHHHC-------------------CCCCTTHHHH--------HHHHHT----SCGG-GCSHHHHHHHH
T ss_pred cccCceechhhccHHHhCCC-C-CCcccccccccchhhhccccchh--------HHHhhc----CCCC-CCcHHHHHHHH
Confidence 45678999999999998754 3 46799999999998887664443 111111 1111 11245667777
Q ss_pred cccCccCCCCHHHHhcCcccc
Q 014347 252 LEPNPVKRITIAGIKADEWFE 272 (426)
Q Consensus 252 L~~dP~~R~t~~eil~h~~f~ 272 (426)
+..+|..|+.......++|..
T Consensus 460 ~~~~~~~~~~~~~~~~~~~~~ 480 (569)
T 4azs_A 460 EKKAKLPSAEQQRGATEQWII 480 (569)
T ss_dssp HTGGGSCCGGGSSCCHHHHHH
T ss_pred hCCCCCCCCChhhhccchhHH
Confidence 778888888777766677654
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.4e-30 Score=268.35 Aligned_cols=188 Identities=18% Similarity=0.214 Sum_probs=145.2
Q ss_pred eeceEeecCceEEEEEEECCCCCeEEEEEeecccccchh-----HHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 014347 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-----ITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 18 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~-----~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (426)
..+.||+|+||.||+|. ..++.+|+|........... ..+++.+|+.++++++||||+++..++...+..|+|
T Consensus 340 ~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp --------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 45689999999999994 56788999987554332221 245689999999999999999555555567778999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCC-
Q 014347 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG- 171 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~- 171 (426)
|||++|++|.+++.. +..++.|+++||.|||++||+||||||+|||++. ++||+|||+|+.........
T Consensus 418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~ 487 (540)
T 3en9_A 418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV 487 (540)
T ss_dssp EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence 999999999999875 6789999999999999999999999999999998 99999999998653321110
Q ss_pred ----ccccccCCCcccchhhhcc--CCCCCCcchhhhHHHHHHHHHhCCCCCC
Q 014347 172 ----LLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFD 218 (426)
Q Consensus 172 ----~~~~~~gt~~y~APE~l~~--~~~~~~~~DIwSlGvil~elltG~~Pf~ 218 (426)
...+.+||+.|+|||++.. .+| +..+|+||..+-..+.+.++-+|.
T Consensus 488 ~~~~~~~~~~GT~~y~APEv~~~~~~~Y-~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 488 DLIVFKKAVLSTHHEKFDEIWERFLEGY-KSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHCGGGHHHHHHHHHHHH-HHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred chhhhhhhhcCCCCcCCHHHHHHHHHHH-HHHHhHHHHHHHHHHHHHhccccC
Confidence 1246789999999999876 555 467899999888888877766653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-27 Score=227.61 Aligned_cols=144 Identities=20% Similarity=0.255 Sum_probs=116.6
Q ss_pred eceEeecCceEEEEEEECCCCCeEEEEEeecccccch---------------hHHHHHHHHHHHHHhCCCCCccceEEEE
Q 014347 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---------------KITDQIKREIATLKLLKHPNVVRLHEVL 83 (426)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~---------------~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 83 (426)
++.||+|+||.||+|.+ .+|+.||+|+++....... .....+.+|+.+|+.++ | +++.+++
T Consensus 95 ~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~ 170 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY 170 (282)
T ss_dssp EEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred cCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence 39999999999999999 8899999999964332110 13567899999999999 4 5666655
Q ss_pred EeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccC
Q 014347 84 ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (426)
Q Consensus 84 ~~~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~ 163 (426)
.. +..|+||||++|++|.+ +. ......++.|++.||.|||++||+||||||+|||++ +|.+||+|||+|+.
T Consensus 171 ~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~ 241 (282)
T 1zar_A 171 AW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE 241 (282)
T ss_dssp EE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCEE
T ss_pred ec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCeE
Confidence 44 45699999999999987 42 234567999999999999999999999999999999 99999999999872
Q ss_pred CccccCCCccccccCCCcccchhhhcc
Q 014347 164 PQHFRDDGLLHTTCGSPNYVAPEVLAN 190 (426)
Q Consensus 164 ~~~~~~~~~~~~~~gt~~y~APE~l~~ 190 (426)
+..+.|||++.+
T Consensus 242 ---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 242 ---------------VGEEGWREILER 253 (282)
T ss_dssp ---------------TTSTTHHHHHHH
T ss_pred ---------------CCCCCHHHHHHH
Confidence 345789998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=5.9e-23 Score=194.48 Aligned_cols=139 Identities=21% Similarity=0.280 Sum_probs=109.6
Q ss_pred eeeeceEeecCceEEEEEEECCCCCe--EEEEEeecccccc---------------------hhHHHHHHHHHHHHHhCC
Q 014347 16 YELGRTLGEGNFGKVKFAQDLDSGLP--FAVKILEKNRIIH---------------------LKITDQIKREIATLKLLK 72 (426)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~--vAvK~i~~~~~~~---------------------~~~~~~~~~Ei~il~~l~ 72 (426)
|++.+.||+|+||.||+|.+..+|+. ||||+++...... ......+.+|+.+|+.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999998778999 9999975432110 011246889999999998
Q ss_pred CCCc--cceEEEEEeCCEEEEEEeccCC-C----ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh-hcCceeccCCCCc
Q 014347 73 HPNV--VRLHEVLASKSKIYMVLEYVTG-G----ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH-NKGVFHRDLKLEN 144 (426)
Q Consensus 73 hpnI--v~l~~~~~~~~~~~lV~Ey~~g-g----~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH-~~gIiHrDLKp~N 144 (426)
|+++ ..+++. ...++||||+.+ | +|.+.... .++..+..++.|++.||.||| ++||+||||||+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N 201 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN 201 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence 8764 344442 246899999942 3 66665432 345678899999999999999 9999999999999
Q ss_pred EEecCCCCeEEeeccCccC
Q 014347 145 ILLDSKGNIKISDFGLSAL 163 (426)
Q Consensus 145 ILl~~~g~vkL~DFGla~~ 163 (426)
||++. .++|+|||+|..
T Consensus 202 ILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 202 IMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp EEESS--SEEECCCTTCEE
T ss_pred EEEcC--cEEEEECccccc
Confidence 99998 999999999974
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.7e-22 Score=172.17 Aligned_cols=104 Identities=23% Similarity=0.415 Sum_probs=96.0
Q ss_pred CCCccccceeeeccccccCCcccccccc-cccccccccccCHHHHHHHHHHHHHHcCcEEEEeCCeEEE----eecCCce
Q 014347 309 SPPLINAFQLIGMSSCLDLSGFFEKEDV-SERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKVNI----SSQLTHF 383 (426)
Q Consensus 309 ~~~~~~~~~~~~~s~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 383 (426)
.|..+|||++|++|+|+|||+||+.... .++++||+|..+|++|+++||++|+++||+|++++++|++ +|++|+|
T Consensus 3 ~p~~lNAFdiIs~S~g~dLSgLFe~~~~~~~r~tRF~s~~~a~~ii~klEe~a~~lg~~V~kk~~~vkl~~~~~grkG~l 82 (143)
T 2ehb_D 3 GPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKSHTRNFKTRLEGLSSIKAGQL 82 (143)
T ss_dssp CCEECCHHHHHTTCTTTCGGGGGCSCCCSCCCCCEEEECSCHHHHHHHHHHHHHHTTEEEEESSSEEEEEECCSSGGGCC
T ss_pred CccccCHHHHHHHCcCCCchhhhccccccccccceEEeCCCHHHHHHHHHHHHHhcCcEEEEcCcEEEEEEecCCCcceE
Confidence 4667999999999999999999976532 5779999999999999999999999999999999888888 6689999
Q ss_pred EEEEEEEEeecceeEEeeechhhhhhhhh
Q 014347 384 NIKTSVISNINYVIYHKSINLTMCILMYL 412 (426)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (426)
.+.+||||++|++..||+.+-.+|.++|-
T Consensus 83 ~v~~EVfevapsl~vVEvrks~GD~lEy~ 111 (143)
T 2ehb_D 83 AVVIEIYEVAPSLFMVDVRKAAGETLEYH 111 (143)
T ss_dssp EEEEEEEEEETTEEEEEEEEEESCHHHHH
T ss_pred EEEEEEEEecCCEEEEEEEecCCChHHHH
Confidence 99999999999999999999999999985
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.8e-22 Score=167.95 Aligned_cols=104 Identities=24% Similarity=0.319 Sum_probs=90.2
Q ss_pred CCCccccceeeeccccccCCcccccccccccccccccccCHHHHHHHHHHHHHHcCcEEEEeCC-eEEEeecCCceEEEE
Q 014347 309 SPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNG-KVNISSQLTHFNIKT 387 (426)
Q Consensus 309 ~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 387 (426)
.|..+|||++|++|+|+|||+||+.+...++++||+|+.+|++|+++||++|+++||+|+++++ ....++++|+|.|++
T Consensus 2 ~~~~lNAFdiIs~S~g~dLSgLFe~~~~~~r~tRF~S~~~a~~ii~klEe~a~~lg~~v~kk~~~~~~~~g~kG~l~v~~ 81 (123)
T 2zfd_B 2 GARRMNAFDIISGSPGFNLSGLFGDARKYDRVERFVSAWTAERVVERLEEIVSAENLTVAKKETWGMKIEGQKGNFAMVV 81 (123)
T ss_dssp --CCCCHHHHHHTSTTSSSGGGGGGGCSSCCCEEEEESSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEGGGTEEEEE
T ss_pred CcccccHHHHHHHCcCCCchHhcCcccccccceEEEeCCCHHHHHHHHHHHHHHCCCEEEEcCCccccccCCCccEEEEE
Confidence 3567999999999999999999976433467899999999999999999999999999999865 344489999999999
Q ss_pred EEEEeecceeEEeeechhhhhhhhh
Q 014347 388 SVISNINYVIYHKSINLTMCILMYL 412 (426)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (426)
||||++|++..||+.+-.+|.++|-
T Consensus 82 EVfev~p~l~vVEvrks~GD~lEy~ 106 (123)
T 2zfd_B 82 EINQLTDELVMIEVRKRQRAAASGR 106 (123)
T ss_dssp EEEECSSSCEEEEEEEEESCC---C
T ss_pred EEEEecCCEEEEEEEecCCChHHHH
Confidence 9999999999999999999999984
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.80 E-value=9.3e-20 Score=181.13 Aligned_cols=139 Identities=20% Similarity=0.229 Sum_probs=103.3
Q ss_pred eeeeceEeecCceEEEEEEECCCCCeEEEEEeeccccc---------------chh----HHHHHHHHHHHHHhCCCCCc
Q 014347 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---------------HLK----ITDQIKREIATLKLLKHPNV 76 (426)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---------------~~~----~~~~~~~Ei~il~~l~hpnI 76 (426)
|++++.||.|+||.||+|.+ .+|+.||||+++..... ... ..-...+|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 89999999999999999997 46999999997643211 000 01123567888888865554
Q ss_pred cceEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCC----
Q 014347 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---- 152 (426)
Q Consensus 77 v~l~~~~~~~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~---- 152 (426)
.-..-+.... .++||||+.|++|.+.. ....+..++.||+.+|.+||++||+||||||.|||++++|.
T Consensus 176 ~vp~p~~~~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~ 247 (397)
T 4gyi_A 176 PVPEPIAQSR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP 247 (397)
T ss_dssp SCCCEEEEET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred CCCeeeeccC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence 3222221222 37999999999886542 22346778999999999999999999999999999988773
Q ss_pred ------eEEeeccCccC
Q 014347 153 ------IKISDFGLSAL 163 (426)
Q Consensus 153 ------vkL~DFGla~~ 163 (426)
+.|+||+.+..
T Consensus 248 ~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 248 SSITLTPIIIXFPQMVS 264 (397)
T ss_dssp TSEEEEEEECCCTTCEE
T ss_pred cccccceEEEEeCCccc
Confidence 89999998763
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=1.2e-13 Score=130.05 Aligned_cols=141 Identities=15% Similarity=0.112 Sum_probs=113.9
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCCEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 90 (426)
.++.|++...+|.|+.+.||++.. .+..+++|+........ ...+.+|+.+++.+. +..+.++++++.+.+..|
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 467899999999999999999974 36789999986432111 235889999999885 677889999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh--------------------------------------
Q 014347 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-------------------------------------- 132 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~-------------------------------------- 132 (426)
+||||++|.+|.+.+. +......++.++..+|..||+
T Consensus 87 lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999999876521 223345788999999999998
Q ss_pred ---------------------cCceeccCCCCcEEecCCCCeEEeeccCcc
Q 014347 133 ---------------------KGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (426)
Q Consensus 133 ---------------------~gIiHrDLKp~NILl~~~g~vkL~DFGla~ 162 (426)
..++|+|++|.|||+++++.+.|+||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876556799999775
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.35 E-value=1.5e-12 Score=121.40 Aligned_cols=136 Identities=19% Similarity=0.191 Sum_probs=102.5
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--ccceEEEEEeCCEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLHEVLASKSKI 89 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~~~~ 89 (426)
.+..|.+....+.|..+.||++. ..+|..+++|+..... ...+.+|+.+++.+.+.+ +.+++.+...++..
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~ 90 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRD 90 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred hcCCCceEecccCCCCceEEEEe-cCCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCC
Confidence 45667775555567779999986 3567889999975431 245778999999886544 55688888888889
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG----------------------------------- 134 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~g----------------------------------- 134 (426)
|+||||++|.+|. . ...+ ...++.+++..|..||+..
T Consensus 91 ~~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 91 WLLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EEEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 9999999998883 1 1122 2356777888888888643
Q ss_pred -----------------------ceeccCCCCcEEecCCCCeEEeeccCcc
Q 014347 135 -----------------------VFHRDLKLENILLDSKGNIKISDFGLSA 162 (426)
Q Consensus 135 -----------------------IiHrDLKp~NILl~~~g~vkL~DFGla~ 162 (426)
++|+|++|.|||+++++.+.|+|||.+.
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877666799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.23 E-value=2.1e-11 Score=120.09 Aligned_cols=142 Identities=17% Similarity=0.336 Sum_probs=107.2
Q ss_pred eeeeceEeecCceEEEEEEECCCCCeEEEEEee--cccccchhHHHHHHHHHHHHHhCC--CCCccceEEEEEeC---CE
Q 014347 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILE--KNRIIHLKITDQIKREIATLKLLK--HPNVVRLHEVLASK---SK 88 (426)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~--~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~---~~ 88 (426)
..-++.|+.|.++.||++... +..+++|... ..... .....+.+|..+++.+. +..+.+++.++.+. +.
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~ 115 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR 115 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence 334678899999999998753 4678888765 32211 11346888999999987 45578888888766 45
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh------------------------------------
Q 014347 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN------------------------------------ 132 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~------------------------------------ 132 (426)
.|+||||++|..+.+.. ...++..+...++.+++..|..||+
T Consensus 116 ~~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 116 AFYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp CEEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred eEEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 89999999998875421 2347888889999999999999997
Q ss_pred ----------------------cCceeccCCCCcEEecCCCC--eEEeeccCccC
Q 014347 133 ----------------------KGVFHRDLKLENILLDSKGN--IKISDFGLSAL 163 (426)
Q Consensus 133 ----------------------~gIiHrDLKp~NILl~~~g~--vkL~DFGla~~ 163 (426)
.+++|||++|.|||++.++. +.|+||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36999999999999998764 68999998874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.19 E-value=2.2e-11 Score=117.28 Aligned_cols=186 Identities=18% Similarity=0.216 Sum_probs=123.3
Q ss_pred eceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCC--ccceEEEEEeCC---EEEEE
Q 014347 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPN--VVRLHEVLASKS---KIYMV 92 (426)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpn--Iv~l~~~~~~~~---~~~lV 92 (426)
++.++.|....||++. ..+++|+.... .....+.+|..+|+.+. +.. +.+++....... ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 4569999999999763 46899986422 33567899999998874 333 344554433333 35889
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh----------------------------------------
Q 014347 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN---------------------------------------- 132 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~---------------------------------------- 132 (426)
|++++|.+|.+... ..++..+...++.|++..|..||+
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99999998876433 347888888899999999999986
Q ss_pred ------------------cCceeccCCCCcEEecC--CCCeEEeeccCccCCccccCCCccccccCCCcccchhhhcc--
Q 014347 133 ------------------KGVFHRDLKLENILLDS--KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN-- 190 (426)
Q Consensus 133 ------------------~gIiHrDLKp~NILl~~--~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-- 190 (426)
..++|+|++|.||++++ .+.+.|+||+.+..-+...+ +........-..|+....
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D---l~~~~~~~~~~~~~~~~~~l 249 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND---FISLMEDDEEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH---HHTTCCTTTSCCHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH---HHHHHhhccccCHHHHHHHH
Confidence 13799999999999998 45578999998864211100 000000000022322110
Q ss_pred CCCCC-----------CcchhhhHHHHHHHHHhCCCCCCC
Q 014347 191 RGYDG-----------ATSDIWSCGVILYVILTGYLPFDD 219 (426)
Q Consensus 191 ~~~~~-----------~~~DIwSlGvil~elltG~~Pf~~ 219 (426)
..|.. .-.+.|++|.++|.+.+|..+|-.
T Consensus 250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~ 289 (304)
T 3sg8_A 250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYE 289 (304)
T ss_dssp HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence 01111 125899999999999999877643
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.77 E-value=1.4e-07 Score=90.86 Aligned_cols=133 Identities=21% Similarity=0.224 Sum_probs=96.9
Q ss_pred eceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCC---CccceEEEEE-eCCEEEEEEe
Q 014347 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP---NVVRLHEVLA-SKSKIYMVLE 94 (426)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp---nIv~l~~~~~-~~~~~~lV~E 94 (426)
++.++.|....||+. |..+++|+-.. ......+.+|..+|+.+.+. .+.+.+.+.. ..+..|++||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 456889999999987 56789998522 23356889999999998752 2556666664 3456789999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc-----------------------------------------
Q 014347 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK----------------------------------------- 133 (426)
Q Consensus 95 y~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~----------------------------------------- 133 (426)
|++|..|.+..- ..++..+...+..|+...|..||+.
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999988876322 2355666666666666666666642
Q ss_pred -------------------CceeccCCCCcEEecC---CCCe-EEeeccCccC
Q 014347 134 -------------------GVFHRDLKLENILLDS---KGNI-KISDFGLSAL 163 (426)
Q Consensus 134 -------------------gIiHrDLKp~NILl~~---~g~v-kL~DFGla~~ 163 (426)
.++|+|++|.|||++. ++.+ .|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999987 4665 8999998874
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.74 E-value=1.2e-07 Score=88.91 Aligned_cols=132 Identities=15% Similarity=0.230 Sum_probs=98.2
Q ss_pred eEeecCce-EEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCCEEEEEEeccCC
Q 014347 21 TLGEGNFG-KVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 21 ~LG~G~fg-~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~Ey~~g 98 (426)
.+..|..| .||+......+..+.+|+-... ....+.+|..+|+.+. +-.+.+++.++.+.+..|+|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 34445554 6898887677788999986432 2456888999998875 33467888899999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh----------------------------------------------
Q 014347 99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN---------------------------------------------- 132 (426)
Q Consensus 99 g~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~---------------------------------------------- 132 (426)
.++.+.... .......+..++...|.-||+
T Consensus 105 ~~~~~~~~~----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 105 KTAFQVLEE----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EEHHHHHHH----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccccC----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 888776543 122334566677777777774
Q ss_pred ------------cCceeccCCCCcEEecCCCCeEEeeccCcc
Q 014347 133 ------------KGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (426)
Q Consensus 133 ------------~gIiHrDLKp~NILl~~~g~vkL~DFGla~ 162 (426)
..++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 126899999999999987767799999876
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=4.4e-07 Score=90.32 Aligned_cols=81 Identities=17% Similarity=0.160 Sum_probs=51.0
Q ss_pred eeceEeecCceEEEEEEECCCCCeEEEEEeecccc-cc---hhHHHHHHHHHHHHHhCCC--CC-ccceEEEEEeCCEEE
Q 014347 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-IH---LKITDQIKREIATLKLLKH--PN-VVRLHEVLASKSKIY 90 (426)
Q Consensus 18 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~---~~~~~~~~~Ei~il~~l~h--pn-Iv~l~~~~~~~~~~~ 90 (426)
-.+.||.|.++.||++....+++.+++|....... .. ....+++.+|..+++.+.. |. +.+++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 35689999999999997655678899998643211 00 0123456789999887742 33 3455543 344568
Q ss_pred EEEeccCCCC
Q 014347 91 MVLEYVTGGE 100 (426)
Q Consensus 91 lV~Ey~~gg~ 100 (426)
+||||++|..
T Consensus 112 lvmE~l~g~~ 121 (397)
T 2olc_A 112 TVMEDLSHLK 121 (397)
T ss_dssp EEECCCTTSE
T ss_pred EEEEeCCCcc
Confidence 9999998743
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=5.8e-07 Score=87.92 Aligned_cols=83 Identities=10% Similarity=0.172 Sum_probs=55.8
Q ss_pred eeeceE-eecCceEEEEEEEC--C----CCCeEEEEEeeccc---ccchhHHHHHHHHHHHHHhCC-C--CCccceEEEE
Q 014347 17 ELGRTL-GEGNFGKVKFAQDL--D----SGLPFAVKILEKNR---IIHLKITDQIKREIATLKLLK-H--PNVVRLHEVL 83 (426)
Q Consensus 17 ~i~~~L-G~G~fg~Vy~a~~~--~----~~~~vAvK~i~~~~---~~~~~~~~~~~~Ei~il~~l~-h--pnIv~l~~~~ 83 (426)
...+.| +.|....+|+.... . ++..+++|+..... ... ...+.+|..+++.+. + -.+.+++.+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~ 99 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIE 99 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEE
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEc
Confidence 345678 88999999988643 0 25678999765432 101 135678888888775 2 3466778776
Q ss_pred EeC---CEEEEEEeccCCCChH
Q 014347 84 ASK---SKIYMVLEYVTGGELF 102 (426)
Q Consensus 84 ~~~---~~~~lV~Ey~~gg~L~ 102 (426)
.+. +..|+||||++|..+.
T Consensus 100 ~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 100 TTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp CSSTTTSSCEEEEECCCCBCCC
T ss_pred cCCCccCCceEEEEecCCCChh
Confidence 654 3568999999986653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.19 E-value=1.1e-05 Score=77.68 Aligned_cols=135 Identities=13% Similarity=0.143 Sum_probs=77.7
Q ss_pred eceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-----CCCccceE-E--EEEeCCEEE
Q 014347 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-----HPNVVRLH-E--VLASKSKIY 90 (426)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----hpnIv~l~-~--~~~~~~~~~ 90 (426)
++.|+.|..+.||++.. .+| .+++|+.... ...+..|..+++.|. .|.++... + +....+..|
T Consensus 37 ~~~l~gG~~n~~~~v~~-~~~-~~vlk~~~~~-------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~ 107 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHT-DSG-AVCLKRIHRP-------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF 107 (346)
T ss_dssp EEECC----CEEEEEEE-TTE-EEEEEEECSC-------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred eeeccccccCcEEEEEe-CCC-CEEEEecCCC-------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence 34566678899999875 333 5899988642 123344555555443 34444310 0 123467889
Q ss_pred EEEeccCCCChH--------------HHHHh-cCCC--C-----------HH--------H-------------------
Q 014347 91 MVLEYVTGGELF--------------DKIAS-KGRL--Q-----------EA--------E------------------- 115 (426)
Q Consensus 91 lV~Ey~~gg~L~--------------~~i~~-~~~l--~-----------~~--------~------------------- 115 (426)
++|+|++|.++. ..+.. ...+ + .. .
T Consensus 108 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 187 (346)
T 2q83_A 108 VVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQL 187 (346)
T ss_dssp EEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHH
T ss_pred EEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHH
Confidence 999999986542 11111 0111 1 10 0
Q ss_pred ----HHHHHHHHHHHHHHHhh-------------cCceeccCCCCcEEecCCCCeEEeeccCcc
Q 014347 116 ----GRKLFQQLIDGVSYCHN-------------KGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (426)
Q Consensus 116 ----~~~i~~Ql~~aL~~LH~-------------~gIiHrDLKp~NILl~~~g~vkL~DFGla~ 162 (426)
...+..++..++.+|++ .+++|+|++|.|||++.++.+.|+||+.+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 188 YLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11122233445666652 579999999999999888899999999875
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.96 E-value=5.1e-05 Score=73.10 Aligned_cols=76 Identities=21% Similarity=0.236 Sum_probs=60.2
Q ss_pred eeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCccceEEEEEeCCEEEEEEe
Q 014347 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK---HPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 18 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~lV~E 94 (426)
-.+.|+.|....+|+... .+..+++|+.... ....+.+|...|+.|. ...+.+++.+....+..|+|||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 356789999999999874 4678899987542 1466888999888874 3567888888888889999999
Q ss_pred ccCCCCh
Q 014347 95 YVTGGEL 101 (426)
Q Consensus 95 y~~gg~L 101 (426)
|++|..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.89 E-value=3.9e-05 Score=76.85 Aligned_cols=79 Identities=13% Similarity=0.103 Sum_probs=47.0
Q ss_pred hhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccccccC--CCcccchhhhccCCC--CCCcchhhhHHHH
Q 014347 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG--SPNYVAPEVLANRGY--DGATSDIWSCGVI 206 (426)
Q Consensus 131 H~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~g--t~~y~APE~l~~~~~--~~~~~DIwSlGvi 206 (426)
+...++|+|++|.|||++.++ ++|+||+.+..-....+ +..... ...|++|+......- .....++.++...
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D---la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD---IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQ 305 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH---HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH---HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHH
Confidence 456799999999999998877 99999998874211100 011111 134566665431110 0112445577777
Q ss_pred HHHHHhC
Q 014347 207 LYVILTG 213 (426)
Q Consensus 207 l~elltG 213 (426)
+|..+++
T Consensus 306 ~~~~y~~ 312 (420)
T 2pyw_A 306 TWNLFNK 312 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 7877654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.88 E-value=0.00013 Score=66.07 Aligned_cols=122 Identities=19% Similarity=0.161 Sum_probs=81.7
Q ss_pred ChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH-hhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcccccc
Q 014347 100 ELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYC-HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 177 (426)
Q Consensus 100 ~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~L-H~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 177 (426)
+|.+.+.. +.+++|+++|.++.|.+.+|.-+ +.+.-..+=+.|..|++..+|+|-+.+ +.+. .
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------~ 98 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------A 98 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------c
Confidence 78888875 67899999999999999998776 222222344567899999999988763 2111 1
Q ss_pred CCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHccccC
Q 014347 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255 (426)
Q Consensus 178 gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~d 255 (426)
....+.|||... ...+.+.=|||||+++|.-+--.+| ..-+..+|+.+.+||..|..-.
T Consensus 99 ~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~-----------------e~eE~eLS~~LE~LL~~Mt~~~ 157 (229)
T 2yle_A 99 GEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLK-----------------ENEERELSPPLEQLIDHMANTV 157 (229)
T ss_dssp --------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCC-----------------TTEEECCCHHHHHHHHHHTTCC
T ss_pred cccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCC-----------------cccchhhCHHHHHHHHHHHhcc
Confidence 223567888753 2335778999999999999853332 1223458999999999998663
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.76 E-value=6.6e-05 Score=71.52 Aligned_cols=135 Identities=17% Similarity=0.109 Sum_probs=76.8
Q ss_pred eeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-cceEEEEEeCCEEEEEEe
Q 014347 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV~E 94 (426)
+.=++.|+.|....+|++ ..+++|+...... . .-...+|..+++.+...++ .+++.+ +.+.-++++|
T Consensus 20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~---~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e 87 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGTE---E-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTR 87 (301)
T ss_dssp CCSCEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEE
T ss_pred ccceeEcCCcccccccee------eeEEEECCCCCcc---c-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEe
Confidence 433788999999999998 5689998754211 0 1123468888877653333 355544 3334578999
Q ss_pred cc-CCCChHHH---------------H---HhcC-CC----C-HHHHHHHHHH--------------HHHHHHHHh----
Q 014347 95 YV-TGGELFDK---------------I---ASKG-RL----Q-EAEGRKLFQQ--------------LIDGVSYCH---- 131 (426)
Q Consensus 95 y~-~gg~L~~~---------------i---~~~~-~l----~-~~~~~~i~~Q--------------l~~aL~~LH---- 131 (426)
|+ +|.+|... + .... .+ + ......+..+ +...+..+.
T Consensus 88 ~i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~ 167 (301)
T 3dxq_A 88 YIAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALA 167 (301)
T ss_dssp CCTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHH
T ss_pred ecCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHH
Confidence 99 66554211 0 1101 01 1 1111111111 111111111
Q ss_pred ----hcCceeccCCCCcEEecCCCCeEEeeccCccC
Q 014347 132 ----NKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (426)
Q Consensus 132 ----~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~ 163 (426)
...++|+|+.|.||+ ..++.+.++||..+..
T Consensus 168 ~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 168 AHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp SSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred hcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 124899999999999 6677899999998764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00036 Score=65.83 Aligned_cols=79 Identities=15% Similarity=0.091 Sum_probs=55.3
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCC---CCccceEEEEEeCCEEEE
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH---PNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h---pnIv~l~~~~~~~~~~~l 91 (426)
+..-++.+|.|..+.||+.+. .+|+.|.+|+-....... ...+.+|...|+.|.. -.+.+++.+. . -++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEE
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceE
Confidence 456678899999999999984 678999999865433221 2457789999988752 2344555542 2 378
Q ss_pred EEeccCCCCh
Q 014347 92 VLEYVTGGEL 101 (426)
Q Consensus 92 V~Ey~~gg~L 101 (426)
||||+.++..
T Consensus 88 v~e~l~~~~~ 97 (288)
T 3f7w_A 88 AMEWVDERPP 97 (288)
T ss_dssp EEECCCCCCC
T ss_pred EEEeecccCC
Confidence 9999987654
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} SCOP: d.129.6.1 PDB: 1ul7_A | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00032 Score=57.50 Aligned_cols=72 Identities=10% Similarity=0.032 Sum_probs=62.7
Q ss_pred cccccccCHHHHHHHHHHHHHHcCcEEEEe-CCeEEEee----cCCceEEEEEEEEee-cceeEEeeechhhhhhhhh
Q 014347 341 IRFTSNHSAKDLLERIEDIVTEMGFRVQKK-NGKVNISS----QLTHFNIKTSVISNI-NYVIYHKSINLTMCILMYL 412 (426)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 412 (426)
...+|..+|++|+..|+.+++.+|+.++++ .+.+++.. .++.+.+.+|||++. +++.-++...+.+..+.|.
T Consensus 31 v~tTS~~~P~eIm~eI~rvL~~~gi~~~~~g~y~l~C~~~~~~~~~~v~fElEVckl~~~~l~gV~~kRi~Gd~~~yk 108 (120)
T 3ose_A 31 MKTTSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQDSLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFK 108 (120)
T ss_dssp CCCEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEESCTTTTCCEEEEEEEEEEGGGTEEEEEEEEEESCHHHHH
T ss_pred ecCcccCCHHHHHHHHHHHHHHCCCEEEEcCCEEEEEEecCCCCCccEEEEEEEEEecCCCceeEEEEecCCCHHHHH
Confidence 346789999999999999999999999988 47888732 346899999999996 8999999999999999985
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00018 Score=68.85 Aligned_cols=140 Identities=14% Similarity=0.184 Sum_probs=77.9
Q ss_pred eeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-----CCCccceE-E--EEEeCC
Q 014347 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-----HPNVVRLH-E--VLASKS 87 (426)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----hpnIv~l~-~--~~~~~~ 87 (426)
..-++.|+.|....+|+.... +| .+++|+..... . ...+..|..+++.+. -|.++... + +....+
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~--~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g 96 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV--E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSG 96 (322)
T ss_dssp EEEEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETT
T ss_pred ceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC--C---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECC
Confidence 334567788888999998753 34 68899886521 1 134556777776654 23333210 0 112346
Q ss_pred EEEEEEeccCCCChHH--------------HHHhc-CCC--------CHHHHHHHH---------------HHHHHHHHH
Q 014347 88 KIYMVLEYVTGGELFD--------------KIASK-GRL--------QEAEGRKLF---------------QQLIDGVSY 129 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~--------------~i~~~-~~l--------~~~~~~~i~---------------~Ql~~aL~~ 129 (426)
..+++|+|++|..+.. .+... ..+ ........+ ..+...++.
T Consensus 97 ~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~ 176 (322)
T 2ppq_A 97 RPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDY 176 (322)
T ss_dssp EEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHH
T ss_pred EEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHH
Confidence 7899999999865310 11110 011 111000000 113344555
Q ss_pred Hhh-------cCceeccCCCCcEEecCCCCeEEeeccCcc
Q 014347 130 CHN-------KGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (426)
Q Consensus 130 LH~-------~gIiHrDLKp~NILl~~~g~vkL~DFGla~ 162 (426)
+++ .+++|+|++|.|||+++++.+.|+||+.+.
T Consensus 177 l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 177 LAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 542 479999999999999877656899999775
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00022 Score=68.77 Aligned_cols=136 Identities=11% Similarity=0.152 Sum_probs=71.0
Q ss_pred eceEeecCceE-EEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCC--CccceEEEEEeCCEEEEEEec
Q 014347 19 GRTLGEGNFGK-VKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP--NVVRLHEVLASKSKIYMVLEY 95 (426)
Q Consensus 19 ~~~LG~G~fg~-Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~~~~~~~~lV~Ey 95 (426)
++.|+.|+... +|+... .+|..+++|...... ...+..|+.+++.+... .+.+++.+....+ +++||+
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~------~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~ 93 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE------GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIED 93 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTT------TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECC
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCC------CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEee
Confidence 45566665554 556642 236677777643321 02345567777666422 2455666533333 789999
Q ss_pred cCCCChHHHHHhc--------------------------CCCCHHHHH-------HHH-------------HHHHHHHHH
Q 014347 96 VTGGELFDKIASK--------------------------GRLQEAEGR-------KLF-------------QQLIDGVSY 129 (426)
Q Consensus 96 ~~gg~L~~~i~~~--------------------------~~l~~~~~~-------~i~-------------~Ql~~aL~~ 129 (426)
+.|..+.+.+... ..++..... .+. ..+...+..
T Consensus 94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 173 (333)
T 3csv_A 94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ 173 (333)
T ss_dssp CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 9776665443211 012221110 000 011112222
Q ss_pred H------hhcCceeccCCCCcEEecCC----CCeEEeeccCccC
Q 014347 130 C------HNKGVFHRDLKLENILLDSK----GNIKISDFGLSAL 163 (426)
Q Consensus 130 L------H~~gIiHrDLKp~NILl~~~----g~vkL~DFGla~~ 163 (426)
+ +...++|||+.+.|||++.+ +.+.|+||+.+..
T Consensus 174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 2 23469999999999999875 6789999998874
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00047 Score=66.10 Aligned_cols=135 Identities=24% Similarity=0.200 Sum_probs=77.7
Q ss_pred ceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--ccceEEE-----EEeCCEEEEE
Q 014347 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLHEV-----LASKSKIYMV 92 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~-----~~~~~~~~lV 92 (426)
+.|+ |....||++.. .+|+.+++|+...... . ...+..|..+++.+...+ +.+++.. ....+..+++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~-~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW-T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS-C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC-C---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 88889998763 4566899999863321 1 345667888777664211 3333322 2235677899
Q ss_pred EeccCCCChH----H-------H---HHh---cC------CCCHHHH----H------------------HHHHHHHHHH
Q 014347 93 LEYVTGGELF----D-------K---IAS---KG------RLQEAEG----R------------------KLFQQLIDGV 127 (426)
Q Consensus 93 ~Ey~~gg~L~----~-------~---i~~---~~------~l~~~~~----~------------------~i~~Ql~~aL 127 (426)
|+|++|..+. + . +.. .. ..+.... . ..+.+++..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 9999885431 0 1 111 00 1111110 1 1112222222
Q ss_pred HHH----hhcCceeccCCCCcEEecCCCCeEEeeccCcc
Q 014347 128 SYC----HNKGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (426)
Q Consensus 128 ~~L----H~~gIiHrDLKp~NILl~~~g~vkL~DFGla~ 162 (426)
.-+ +...++|+|++|.|||++ + .+.|+||+.+.
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 222 234589999999999998 4 89999999775
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00038 Score=70.01 Aligned_cols=74 Identities=11% Similarity=0.131 Sum_probs=49.5
Q ss_pred eceEeecCceEEEEEEECC-------CCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-cceEEEEEeCCEEE
Q 014347 19 GRTLGEGNFGKVKFAQDLD-------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIY 90 (426)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~ 90 (426)
++.|+.|....||++.... .+..+.+|+..... . .+.+.+|..+++.+...++ .++++.+. + .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFS--G--G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--C
Confidence 5678889899999998643 25789999874311 1 1344579998888763344 56666543 2 2
Q ss_pred EEEeccCCCCh
Q 014347 91 MVLEYVTGGEL 101 (426)
Q Consensus 91 lV~Ey~~gg~L 101 (426)
+|+||++|.+|
T Consensus 149 ~v~e~l~G~~l 159 (429)
T 1nw1_A 149 RLEEYIPSRPL 159 (429)
T ss_dssp EEECCCCEEEC
T ss_pred EEEEEeCCccc
Confidence 89999987443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00044 Score=68.38 Aligned_cols=137 Identities=17% Similarity=0.155 Sum_probs=82.3
Q ss_pred eceEeecCceEEEEEEECC-------CCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-ccceEEEEEeCCEEE
Q 014347 19 GRTLGEGNFGKVKFAQDLD-------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN-VVRLHEVLASKSKIY 90 (426)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~ 90 (426)
++.|..|-...+|++.... +++.+.+|+.-.. . .....+.+|..+++.+...+ ..++++.+.+ .
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-L---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----G 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-c---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence 3456668888899987532 3578999985321 1 11345668999998875322 3556665543 2
Q ss_pred EEEeccCCCChHH--------------HHH---hc----C-CCC--HHHHHHHHHHHHH-------------------HH
Q 014347 91 MVLEYVTGGELFD--------------KIA---SK----G-RLQ--EAEGRKLFQQLID-------------------GV 127 (426)
Q Consensus 91 lV~Ey~~gg~L~~--------------~i~---~~----~-~l~--~~~~~~i~~Ql~~-------------------aL 127 (426)
+||||++|..|.. .+. .. + ... ..++.++..|+.. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 8999999865421 111 10 1 111 3556666655532 23
Q ss_pred HHHhh--------cCceeccCCCCcEEecCC----CCeEEeeccCccC
Q 014347 128 SYCHN--------KGVFHRDLKLENILLDSK----GNIKISDFGLSAL 163 (426)
Q Consensus 128 ~~LH~--------~gIiHrDLKp~NILl~~~----g~vkL~DFGla~~ 163 (426)
..|.+ ..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 33321 359999999999999876 7899999998863
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.19 E-value=0.00056 Score=66.95 Aligned_cols=75 Identities=12% Similarity=0.051 Sum_probs=44.4
Q ss_pred eceEeecCceEEEEEEECC--------CCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-ccceEEEEEeCCEE
Q 014347 19 GRTLGEGNFGKVKFAQDLD--------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN-VVRLHEVLASKSKI 89 (426)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~--------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~ 89 (426)
++.|+.|....+|++.... .+..+++|+..... .. .....+|..+++.+...+ +.++++.. .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DE-LYNTISEFEVYKTMSKYKIAPQLLNTF--NG-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cc-eecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence 4567788889999988643 13678999865321 11 112357888888775334 34666544 22
Q ss_pred EEEEeccCCCCh
Q 014347 90 YMVLEYVTGGEL 101 (426)
Q Consensus 90 ~lV~Ey~~gg~L 101 (426)
++||||++|..+
T Consensus 110 ~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 GRIEEWLYGDPL 121 (369)
T ss_dssp EEEEECCCSEEC
T ss_pred cEEEEEecCCcC
Confidence 689999998543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0021 Score=62.36 Aligned_cols=31 Identities=26% Similarity=0.387 Sum_probs=27.6
Q ss_pred cCceeccCCCCcEEecCCCCeEEeeccCccC
Q 014347 133 KGVFHRDLKLENILLDSKGNIKISDFGLSAL 163 (426)
Q Consensus 133 ~gIiHrDLKp~NILl~~~g~vkL~DFGla~~ 163 (426)
..++|+|+.|.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3699999999999999888899999987763
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.67 E-value=0.016 Score=58.55 Aligned_cols=75 Identities=13% Similarity=0.194 Sum_probs=48.4
Q ss_pred eceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-cceEEEEEeCCEEEEEEeccC
Q 014347 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYMVLEYVT 97 (426)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV~Ey~~ 97 (426)
++.|+.|-...+|++.....+..+++|+..... .... ...+|..+++.|...++ .++++++. +. .||||++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DEII-NREREKKISCILYNKNIAKKIYVFFT--NG--RIEEFMD 184 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C---CSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECCC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEeeC
Confidence 567888999999999875445789999874321 1111 12579999998875554 46676653 32 4999998
Q ss_pred CCCh
Q 014347 98 GGEL 101 (426)
Q Consensus 98 gg~L 101 (426)
|.+|
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 8544
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.85 E-value=0.014 Score=58.39 Aligned_cols=75 Identities=15% Similarity=0.128 Sum_probs=47.5
Q ss_pred eceEeecCceEEEEEEECCC-------CCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-ccceEEEEEeCCEEE
Q 014347 19 GRTLGEGNFGKVKFAQDLDS-------GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN-VVRLHEVLASKSKIY 90 (426)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~ 90 (426)
++.|..|-...+|++..... +..+++|+..... .. .-...+|..+++.+...+ ..++++.+ .+ +
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GK-FYDSKVELDVFRYLSNINIAPNIIADF--PE--G 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---ch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--C
Confidence 45677788889999886421 5789999864321 11 112357888888775323 34555533 22 6
Q ss_pred EEEeccCCCCh
Q 014347 91 MVLEYVTGGEL 101 (426)
Q Consensus 91 lV~Ey~~gg~L 101 (426)
.||||++|..|
T Consensus 147 ~I~efI~G~~l 157 (424)
T 3mes_A 147 RIEEFIDGEPL 157 (424)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEeCCccC
Confidence 88999998653
|
| >1v5s_A MAP/microtubule affinity-regulating kinase 3; Ka1 domain, ELKL motif, MARK3, phosphorylation, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.129.6.1 | Back alignment and structure |
|---|
Probab=95.53 E-value=0.023 Score=46.60 Aligned_cols=70 Identities=7% Similarity=-0.023 Sum_probs=56.1
Q ss_pred cccccCHHHHHHHHHHHHHHcCcEEEEe-CCeEEE-ee---cCCceEEEEEEEEee-cceeEEeeechhhhhhhhh
Q 014347 343 FTSNHSAKDLLERIEDIVTEMGFRVQKK-NGKVNI-SS---QLTHFNIKTSVISNI-NYVIYHKSINLTMCILMYL 412 (426)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~---~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 412 (426)
.+|..+|++|+..|..+++.+|+.++++ .+.+++ .+ .++.+.|.+||+.+. ..+.-+.-..+++....|.
T Consensus 33 tTSsk~P~eIm~EI~rvL~~~~i~~k~~~~y~L~C~~~~~~~~~~vkfEiEVcKvp~l~l~GI~fKRisGd~w~YK 108 (126)
T 1v5s_A 33 QGSSGSSGDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFK 108 (126)
T ss_dssp CCCCSSHHHHHHHHHHHHHHTTEEEEEEETTEEEEEECSSSTTTCEEEEEECCCCTTTCSCCCEEEEEESCHHHHH
T ss_pred eecCCCHHHHHHHHHHHHHHcCCcEEEECCEEEEEEECCCCCCceEEEEEEEEEecCCCceeEEEeeccCchhHHH
Confidence 5688899999999999999999999976 677777 21 246899999999995 5666666677777777773
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.41 E-value=0.31 Score=47.98 Aligned_cols=29 Identities=34% Similarity=0.493 Sum_probs=25.2
Q ss_pred ceeccCCCCcEEe------cCCCCeEEeeccCccC
Q 014347 135 VFHRDLKLENILL------DSKGNIKISDFGLSAL 163 (426)
Q Consensus 135 IiHrDLKp~NILl------~~~g~vkL~DFGla~~ 163 (426)
++|+|+.+.|||+ ++++.+.++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4456799999999874
|
| >4eai_A 5'-AMP-activated protein kinase catalytic subunit linker, 5'-AMP-activated protein...; AMPK, transferase; HET: AMP; 2.29A {Rattus norvegicus} PDB: 4eaj_A* 4eak_A* 4eal_A* | Back alignment and structure |
|---|
Probab=91.56 E-value=1 Score=35.47 Aligned_cols=67 Identities=4% Similarity=0.063 Sum_probs=50.6
Q ss_pred ccccccccCHHHHHHHHHHHHHHcCcEEEEe-CCeEEEeec----CCceEEEEEEEEeecceeEEeeechhh
Q 014347 340 KIRFTSNHSAKDLLERIEDIVTEMGFRVQKK-NGKVNISSQ----LTHFNIKTSVISNINYVIYHKSINLTM 406 (426)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (426)
..-..|...|.+|+..|..+.+.+|+.|++. .+.|++.-. ...+.+.+++|.+-+.-+-...-++++
T Consensus 9 ~LGIrS~~~P~eiM~eIyraLk~lg~~Wk~~~~Y~lkcR~~~~~~~~~vK~~lQLYkv~~~~YLLDfq~i~g 80 (106)
T 4eai_A 9 HLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDD 80 (106)
T ss_dssp EESEEECSCHHHHHHHHHHHHHHHTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEECCS
T ss_pred eEcceeCCCHHHHHHHHHHHHHHcCCEEeeCCceEEEEEEcCCCCCceeEEEEEEEEecCCcEEEEEEeccC
Confidence 3456688889999999999999999999988 788888322 245788999999976544444444444
|
| >2v8q_A 5'-AMP-activated protein kinase catalytic subunit; phosphorylation, nucleotide-binding, serine/threonine-protei kinase, magnesium, CBS domain; HET: AMP; 2.10A {Rattus norvegicus} SCOP: d.129.6.2 PDB: 2v92_A* 2v9j_A* 2y94_C* | Back alignment and structure |
|---|
Probab=90.52 E-value=1.3 Score=37.20 Aligned_cols=72 Identities=4% Similarity=0.026 Sum_probs=53.4
Q ss_pred cccccccccCHHHHHHHHHHHHHHcCcEEEEe-CCeEEEeecCC----ceEEEEEEEEeecceeEEeeechhhhhhh
Q 014347 339 RKIRFTSNHSAKDLLERIEDIVTEMGFRVQKK-NGKVNISSQLT----HFNIKTSVISNINYVIYHKSINLTMCILM 410 (426)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (426)
......|+..|.+|+..|..+.+.+|+.|++. .+.|++.-.++ .+.+.+++|++-+..+-+..-.+.+...+
T Consensus 5 WhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~~~pY~IkcRw~~~~~~~~vKm~LQLYkv~~~~YLLDFk~l~g~~~e 81 (157)
T 2v8q_A 5 WHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 81 (157)
T ss_dssp EEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred ceeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCceEEEEEEEEEecCCCEEEEEEecCCCccc
Confidence 34556688899999999999999999999988 78888833222 57889999999877666666555554433
|
| >4eag_A EG:132E8.2 protein; AMPK, transferase; HET: ATP TAM; 2.70A {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=89.68 E-value=1.8 Score=35.16 Aligned_cols=72 Identities=7% Similarity=0.001 Sum_probs=51.6
Q ss_pred cccccccccCHHHHHHHHHHHHHHcCcEEEEe-CCeEEEe---ec-CCceEEEEEEEEeecceeEEeeechhhhhhh
Q 014347 339 RKIRFTSNHSAKDLLERIEDIVTEMGFRVQKK-NGKVNIS---SQ-LTHFNIKTSVISNINYVIYHKSINLTMCILM 410 (426)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~---~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (426)
...-..|+..|.+|+..|..+.+.+|+.|++. .+.|++. .. ...+.+..++|++.+.-+-...-++.....+
T Consensus 8 W~LGIrS~~~P~eIM~EVyrALk~Lg~eWK~~~pY~vkcR~~n~~~~~~vKm~LQLYqv~~~~YLLDfk~~~~~~~~ 84 (130)
T 4eag_A 8 WHLGIRSQSKPNDIMLEVYRAMKALSYEWKIINPYHVRVRRQNVKTGKFSKMSLQLYQVDAKSYLLDFKSLTNDEVE 84 (130)
T ss_dssp EEESBCCCSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEESSSSCEEEEEEECC-----
T ss_pred eeeeeecCCCHHHHHHHHHHHHHHCCCEEeeCCCEEEEEEecCCCCCceeEEEEEEEEecCCcEEEEeccCCcchhh
Confidence 34456678889999999999999999999988 7888873 22 2356788899998877666666666655443
|
| >2y8l_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, serine/threonine-protein KI; HET: ADP AMP; 2.50A {Rattus norvegicus} PDB: 2y8q_A* 2ya3_A* | Back alignment and structure |
|---|
Probab=89.66 E-value=1.7 Score=37.03 Aligned_cols=74 Identities=5% Similarity=0.029 Sum_probs=55.6
Q ss_pred cccccccccccCHHHHHHHHHHHHHHcCcEEEEe-CCeEEEeecC----CceEEEEEEEEeecceeEEeeechhhhhhh
Q 014347 337 SERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKK-NGKVNISSQL----THFNIKTSVISNINYVIYHKSINLTMCILM 410 (426)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (426)
.+......|+..|.+|+..|..+.+.+|+.|++. .+.|++.-.+ ..+.|.+++|++-+..+-+..-.+.+...+
T Consensus 17 ~kWhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~i~pY~IkcRw~~~~~~~~vKmeLQLYKv~~~~YLLDFk~l~Gd~~e 95 (173)
T 2y8l_A 17 MAWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 95 (173)
T ss_dssp CEEEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred ceeeeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCeeEEEEEEEEEEcCCCEEEEEEecCCCccc
Confidence 3566777788999999999999999999999988 7888883222 247888999999877666666555554433
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=87.86 E-value=1.5 Score=39.42 Aligned_cols=83 Identities=12% Similarity=0.107 Sum_probs=63.8
Q ss_pred CCCCccceEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHhhcCceeccCCCCcEEecCC
Q 014347 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS-YCHNKGVFHRDLKLENILLDSK 150 (426)
Q Consensus 72 ~hpnIv~l~~~~~~~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~-~LH~~gIiHrDLKp~NILl~~~ 150 (426)
.||++ -..+-.+++.+.+.++.-+++.=+..++ .++..+.++++.+|+.... ++ ..-+|--|+|+||+++.+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~ 120 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA 120 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC
Confidence 57888 5556678888888888776665566664 4789999999999888766 44 445677799999999999
Q ss_pred CCeEEeeccCc
Q 014347 151 GNIKISDFGLS 161 (426)
Q Consensus 151 g~vkL~DFGla 161 (426)
+.+++.=.|+-
T Consensus 121 ~~p~i~hRGi~ 131 (219)
T 4ano_A 121 LEPFFLHVGVK 131 (219)
T ss_dssp CCEEESCCEET
T ss_pred CcEEEEEcCCc
Confidence 99999877653
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.63 E-value=1.8 Score=38.78 Aligned_cols=115 Identities=12% Similarity=0.189 Sum_probs=78.6
Q ss_pred CCCCccceEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCC
Q 014347 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG 151 (426)
Q Consensus 72 ~hpnIv~l~~~~~~~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g 151 (426)
.||+.+.. .+-.+++.+.+.++.-+.+.=+..+. .++..+.++++.+|+....++ ..=+|--|+|+||+++.++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik---~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~~~ 116 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK---SFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTRDG 116 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG---GSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECTTS
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH---hcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcCCC
Confidence 58888876 67777787777777655443344443 478899999999998877444 4456778999999999999
Q ss_pred CeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhh-hHHHHHHHHHhCCCCCC
Q 014347 152 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW-SCGVILYVILTGYLPFD 218 (426)
Q Consensus 152 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIw-SlGvil~elltG~~Pf~ 218 (426)
.+++.=-|+-.. ++|. .-...|.| ..=|++..+++++..|+
T Consensus 117 ~p~i~~RGik~~-------------------l~P~-------~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 117 LPIAKTRGLQNV-------------------VDPL-------PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CEEESCCEETTT-------------------BSCC-------CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred CEEEEEccCccC-------------------CCCC-------CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999886665331 1111 11122333 35678888888887763
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=84.49 E-value=0.07 Score=53.89 Aligned_cols=64 Identities=9% Similarity=0.153 Sum_probs=18.9
Q ss_pred eeeceEeecCceEEEEEEECCCCCeEEE------EEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEE
Q 014347 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAV------KILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84 (426)
Q Consensus 17 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAv------K~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 84 (426)
.+.+.|| ||.||.+.......+||+ |....... ..+....+.+|..+++.++|||+++.+.+..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~-~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGV-SEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccc-cccccccccccccccccccccccCCCcceEE
Confidence 4566777 999999987655568888 65543222 2223456778999999999999999988754
|
| >3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A | Back alignment and structure |
|---|
Probab=80.26 E-value=32 Score=35.60 Aligned_cols=81 Identities=21% Similarity=0.355 Sum_probs=51.6
Q ss_pred cceEEEEEeCCEEEEEEeccCCCChHHHHHhcCC-----------------CCHHHHHHHHHHHHH--HHHHHhhcCcee
Q 014347 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-----------------LQEAEGRKLFQQLID--GVSYCHNKGVFH 137 (426)
Q Consensus 77 v~l~~~~~~~~~~~lV~Ey~~gg~L~~~i~~~~~-----------------l~~~~~~~i~~Ql~~--aL~~LH~~gIiH 137 (426)
+..|.+.......-+ .|++++.++.+.+...+. ........+.+.++- .+.|+ .||
T Consensus 402 i~~Y~Vipls~~~Gl-IE~V~~~tl~~il~~~~~l~~~f~~~~~~~~~~~~~~~~a~~nF~~S~A~ySvv~YI--LGi-- 476 (614)
T 3ls8_A 402 LTPYKVLATSTKHGF-MQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYI--LGV-- 476 (614)
T ss_dssp CCCCCEEESSSSEEE-EECCCCEEHHHHHHHTSSHHHHHHHHSBCTTSGGGBCHHHHHHHHHHHHHHHHHHHH--HTC--
T ss_pred eeccEEEEecCCCce-EEEeCCccHHHHHHccChHHHHHHHhCCCccccccccHHHHHHHHHHHHHHhHhhee--eec--
Confidence 556667666655554 478877666655543221 112344555565543 34443 344
Q ss_pred ccCCCCcEEecCCCCeEEeeccCcc
Q 014347 138 RDLKLENILLDSKGNIKISDFGLSA 162 (426)
Q Consensus 138 rDLKp~NILl~~~g~vkL~DFGla~ 162 (426)
+|=.++|||++.+|++.=+|||.+-
T Consensus 477 gDRH~~NILld~tG~v~HIDFG~~f 501 (614)
T 3ls8_A 477 GDRHLDNLLLTKTGKLFHIDFGYIL 501 (614)
T ss_dssp CCCCTTSEEECTTSCEEECCCSSCT
T ss_pred cCCCCcceeEcCCCCEeeeehHHhh
Confidence 5888999999999999999999874
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 426 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-89 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-86 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-85 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-82 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-82 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-80 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-80 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-79 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-78 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-78 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-76 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-76 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-76 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-75 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-74 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-74 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-74 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-73 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-73 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-71 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-70 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-70 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-69 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-67 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-65 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-64 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-64 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-64 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-63 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-63 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-62 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-62 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-61 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-61 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-61 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-61 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-61 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-61 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-61 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-60 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-60 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-60 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-59 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-59 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-58 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-58 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-58 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-57 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-57 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-56 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-55 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-55 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-54 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-53 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-53 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-53 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-50 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-49 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-48 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-41 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-22 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 269 bits (690), Expect = 2e-89
Identities = 85/262 (32%), Positives = 145/262 (55%), Gaps = 5/262 (1%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
L +E+GR LG+G FG V A++ S A+K+L K ++ + Q++RE+ L+
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
HPN++RL+ +++Y++LEY G ++ ++ + E +L + +SYCH+
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
K V HRD+K EN+LL S G +KI+DFG S T CG+ +Y+ PE++ R
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEMIEGRM 180
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 252
+D D+WS GV+ Y L G PF+ Y++I R +F P +++ GA++L+ ++L
Sbjct: 181 HDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 239
Query: 253 EPNPVKRITIAGIKADEWFEQD 274
+ NP +R + + W +
Sbjct: 240 KHNPSQRPMLREVLEHPWITAN 261
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 261 bits (669), Expect = 4e-86
Identities = 101/266 (37%), Positives = 150/266 (56%), Gaps = 5/266 (1%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ ++L +TLGEG +G+V+ A + + AVKI++ R + + IK+EI K+L
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 61
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
H NVV+ + + Y+ LEY +GGELFD+I + E + ++ F QL+ GV Y H
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
G+ HRD+K EN+LLD + N+KISDFGL+ + ++ + LL+ CG+ YVAPE+L R
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 193 YDGATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRGDFKLPKW--LSPGAQNLLR 249
+ D+WSCG++L +L G LP+D + Y L W + LL
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241
Query: 250 KILEPNPVKRITIAGIKADEWFEQDY 275
KIL NP RITI IK D W+ +
Sbjct: 242 KILVENPSARITIPDIKKDRWYNKPL 267
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 260 bits (665), Expect = 2e-85
Identities = 82/263 (31%), Positives = 135/263 (51%), Gaps = 1/263 (0%)
Query: 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
R ++ G+ LGEG+F V A++L + +A+KILEK II + RE +
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
L HP V+L+ K+Y L Y GEL I G E R +++ + Y
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 124
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
H KG+ HRDLK ENILL+ +I+I+DFG + + ++ G+ YV+PE+L
Sbjct: 125 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 250
+ + SD+W+ G I+Y ++ G PF N +++QKI + ++ P+ P A++L+ K
Sbjct: 185 KSACKS-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 243
Query: 251 ILEPNPVKRITIAGIKADEWFEQ 273
+L + KR+ ++ +
Sbjct: 244 LLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 255 bits (652), Expect = 2e-82
Identities = 77/275 (28%), Positives = 143/275 (52%), Gaps = 14/275 (5%)
Query: 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
++G Y++ LG G FG V + +G F K + + +K EI+
Sbjct: 23 KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY---TVKNEISI 79
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDG 126
+ L HP ++ LH+ K ++ ++LE+++GGELFD+IA++ ++ EAE +Q +G
Sbjct: 80 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEG 139
Query: 127 VSYCHNKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
+ + H + H D+K ENI+ ++K ++KI DFGL+ D ++ T + + A
Sbjct: 140 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLA---TKLNPDEIVKVTTATAEFAA 196
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WL 240
PE++ +D+W+ GV+ YV+L+G PF + Q + R D++ + +
Sbjct: 197 PEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 255
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
SP A++ ++ +L+ P KR+T+ W + D+
Sbjct: 256 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 255 bits (651), Expect = 2e-82
Identities = 79/280 (28%), Positives = 137/280 (48%), Gaps = 14/280 (5%)
Query: 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
+ L Y++ LG G FG V + +G FA K + H + +++EI T
Sbjct: 20 KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQT 76
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDG 126
+ +L+HP +V LH+ +++ M+ E+++GGELF+K+A + ++ E E + +Q+ G
Sbjct: 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136
Query: 127 VSYCHNKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
+ + H H DLK ENI+ +K +K+ DFGL+A H + T G+ + A
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAA 193
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWL 240
PEV + +D+WS GV+ Y++L+G PF N + + D+ + +
Sbjct: 194 PEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI 252
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
S ++ +RK+L +P R+TI W P
Sbjct: 253 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRD 292
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 247 bits (632), Expect = 2e-80
Identities = 73/269 (27%), Positives = 132/269 (49%), Gaps = 13/269 (4%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+E+ LG+G FGKV AQ+ ++ + A K+++ L+ EI L HP
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE---DYMVEIDILASCDHP 69
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNK 133
N+V+L + ++ +++++E+ GG + + R L E++ + + +Q +D ++Y H+
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
+ HRDLK NIL G+IK++DFG+SA ++ R + G+P ++APEV+
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETS 187
Query: 194 D----GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQN 246
+D+WS G+ L + P + N + KI + + P S ++
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247
Query: 247 LLRKILEPNPVKRITIAGIKADEWFEQDY 275
L+K LE N R T + + + D
Sbjct: 248 FLKKCLEKNVDARWTTSQLLQHPFVTVDS 276
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 247 bits (631), Expect = 5e-80
Identities = 64/272 (23%), Positives = 114/272 (41%), Gaps = 10/272 (3%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+ R +G G+FG V FA+D+ + A+K + + + I +E+ L+ L+HP
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N ++ + ++V+EY G K LQE E + + G++Y H+
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
+ HRD+K NILL G +K+ DFG + ++ G+P ++APEV+
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANSFVGTPYWMAPEVILAMDEG 189
Query: 195 GAT--SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW--LSPGAQNLLRK 250
D+WS G+ + P + N I + + + S +N +
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249
Query: 251 ILEPNPVKRITIAGIKADEWFEQDYTPANPDD 282
L+ P R T + + ++ P D
Sbjct: 250 CLQKIPQDRPTSEVLLKHRFVLRERPPTVIMD 281
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 243 bits (621), Expect = 7e-79
Identities = 84/275 (30%), Positives = 136/275 (49%), Gaps = 19/275 (6%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL------KITDQIKREIATL 68
YE LG G V+ + +AVKI++ ++ + +E+ L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 69 KLLK-HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
+ + HPN+++L + + + ++V + + GELFD + K L E E RK+ + L++ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
H + HRDLK ENILLD NIK++DFG S L CG+P+Y+APE+
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGTPSYLAPEI 180
Query: 188 LA-----NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--PKW- 239
+ N G D+WS GVI+Y +L G PF R ++ + I G+++ P+W
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240
Query: 240 -LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
S ++L+ + L P KR T A +F+Q
Sbjct: 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 243 bits (621), Expect = 1e-78
Identities = 64/261 (24%), Positives = 127/261 (48%), Gaps = 10/261 (3%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+Y +G+G G V A D+ +G A++ + + + I EI ++ K+
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE---LIINEILVMRENKN 76
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
PN+V + ++++V+EY+ GG L D + ++ + E + + ++ + + + H+
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
V HRD+K +NILL G++K++DFG A + T G+P ++APEV+ + Y
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 194 DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPGAQNLLRK 250
DIWS G++ ++ G P+ + N I + + P+ LS ++ L +
Sbjct: 194 GPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252
Query: 251 ILEPNPVKRITIAGIKADEWF 271
L+ + KR + + ++
Sbjct: 253 CLDMDVEKRGSAKELLQHQFL 273
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 243 bits (621), Expect = 2e-78
Identities = 100/273 (36%), Positives = 147/273 (53%), Gaps = 13/273 (4%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y+ LG G F +V A+D + A+K + K + ++ EIA L +KHP
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHP 67
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+V L ++ S +Y++++ V+GGELFD+I KG E + +L Q++D V Y H+ G
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 135 VFHRDLKLENILL---DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
+ HRDLK EN+L D I ISDFGLS + +L T CG+P YVAPEVLA +
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQK 184
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNL 247
Y A D WS GVI Y++L GY PF D N A L+++I + +++ +S A++
Sbjct: 185 PYSKA-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
+R ++E +P KR T W D
Sbjct: 244 IRHLMEKDPEKRFTCEQALQHPWIAGDTALDKN 276
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (611), Expect = 1e-76
Identities = 65/274 (23%), Positives = 126/274 (45%), Gaps = 15/274 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+Y + LG G FG V + S + K ++ +K+EI+ L + +H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARHR 61
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNK 133
N++ LHE S ++ M+ E+++G ++F++I + L E E Q+ + + + H+
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 134 GVFHRDLKLENILLDSKGN--IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
+ H D++ ENI+ ++ + IKI +FG + + + +P Y APEV +
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQA---RQLKPGDNFRLLFTAPEYYAPEVHQHD 178
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNL 247
A +D+WS G ++YV+L+G PF + + I ++ K +S A +
Sbjct: 179 VVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPD 281
+ ++L R+T + W +Q +
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQKIERVSTK 271
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (608), Expect = 3e-76
Identities = 87/261 (33%), Positives = 145/261 (55%), Gaps = 5/261 (1%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL-LKH 73
+ L + LG+G+FGKV A+ + FA+K L+K+ ++ + E L L +H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
P + + +K ++ V+EY+ GG+L I S + + ++I G+ + H+K
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
G+ +RDLKL+NILLD G+IKI+DFG+ ++ D +T CG+P+Y+APE+L + Y
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAPEILLGQKY 180
Query: 194 DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE 253
+ + D WS GV+LY +L G PF ++ L+ I + P+WL A++LL K+
Sbjct: 181 NHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFV 239
Query: 254 PNPVKRITIAG-IKADEWFEQ 273
P KR+ + G I+ F +
Sbjct: 240 REPEKRLGVRGDIRQHPLFRE 260
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (601), Expect = 6e-76
Identities = 77/271 (28%), Positives = 127/271 (46%), Gaps = 16/271 (5%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
R YE+ T+G G++G+ + + G K L+ + + + E+ L+ L
Sbjct: 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLREL 60
Query: 72 KHPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLID 125
KHPN+VR ++ + ++ +Y+V+EY GG+L I + L E ++ QL
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 126 GVSYCHNKG-----VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
+ CH + V HRDLK N+ LD K N+K+ DFGL+ + H D G+P
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFVGTP 178
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKW 239
Y++PE + Y+ SDIWS G +LY + PF + L KI G F ++P
Sbjct: 179 YYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 237
Query: 240 LSPGAQNLLRKILEPNPVKRITIAGIKADEW 270
S ++ ++L R ++ I +
Sbjct: 238 YSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (594), Expect = 6e-75
Identities = 85/274 (31%), Positives = 131/274 (47%), Gaps = 17/274 (6%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKL 70
+Y++G LG G FG V + LP A+K +EK+RI L ++ E+ LK
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 71 LK--HPNVVRLHEVLASKSKIYMVLEYVTGG-ELFDKIASKGRLQEAEGRKLFQQLIDGV 127
+ V+RL + ++LE +LFD I +G LQE R F Q+++ V
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 128 SYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
+CHN GV HRD+K ENIL+D ++G +K+ DFG D + G+ Y PE
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG----ALLKDTVYTDFDGTRVYSPPE 179
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246
+ Y G ++ +WS G++LY ++ G +PF+ +I RG + +S Q+
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQH 233
Query: 247 LLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
L+R L P R T I+ W + P
Sbjct: 234 LIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 267
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 233 bits (596), Expect = 1e-74
Identities = 81/263 (30%), Positives = 147/263 (55%), Gaps = 11/263 (4%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+++ RTLG G+FG+V + +G +A+K+L+K ++ LK + E L ++ HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
++R+ +I+M+++Y+ GGELF + R + ++ + Y H+K +
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
+RDLK ENILLD G+IKI+DFG + + +T CG+P+Y+APEV++ + Y+
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVSTKPYNK 180
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
+ D WS G+++Y +L GY PF D N Y+KI + + P + + ++LL +++ +
Sbjct: 181 S-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 239
Query: 256 PVKRI-----TIAGIKADEWFEQ 273
+R+ +K WF++
Sbjct: 240 LSQRLGNLQNGTEDVKNHPWFKE 262
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (589), Expect = 3e-74
Identities = 65/270 (24%), Positives = 125/270 (46%), Gaps = 18/270 (6%)
Query: 14 GRY-ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
GR+ + +G G+F V D ++ + A L+ ++ + K E LK L+
Sbjct: 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQ 66
Query: 73 HPNVVRLHEVLASKSK----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
HPN+VR ++ S K I +V E +T G L + ++ R +Q++ G+
Sbjct: 67 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 126
Query: 129 YCHNKG--VFHRDLKLENILLDSK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
+ H + + HRDLK +NI + G++KI D GL+ + G+P ++AP
Sbjct: 127 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMAP 182
Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRG--DFKLPKWLSP 242
E+ YD + D+++ G+ + + T P+ + +N A +Y+++ G K P
Sbjct: 183 EMY-EEKYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240
Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWFE 272
+ ++ + N +R +I + +F+
Sbjct: 241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (592), Expect = 5e-74
Identities = 77/308 (25%), Positives = 125/308 (40%), Gaps = 52/308 (16%)
Query: 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
++ +E LG GN G V SGL A K++ I I +QI RE+ L
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHE 60
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
P +V + S +I + +E++ GG L + GR+ E K+ +I G++Y
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 131 HNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
K + HRD+K NIL++S+G IK+ DFG+S D + ++ G+ +Y++PE L
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPERLQ 176
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPF---DDRNLAVLYQKIFRGDFKL---------- 236
Y SDIWS G+ L + G P D + L +++ GD
Sbjct: 177 GTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 237 -------------------------------PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
S Q+ + K L NP +R + +
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
Query: 266 KADEWFEQ 273
+ ++
Sbjct: 296 MVHAFIKR 303
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 232 bits (592), Expect = 2e-73
Identities = 91/373 (24%), Positives = 162/373 (43%), Gaps = 49/373 (13%)
Query: 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
+ + + + R +G G FG+V + D+G +A+K L+K RI + E L L
Sbjct: 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 71 LK---HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
+ P +V + + K+ +L+ + GG+L ++ G EA+ R ++I G+
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 120
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
+ HN+ V +RDLK NILLD G+++ISD GL+ H + G+ Y+APEV
Sbjct: 121 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC----DFSKKKPHASVGTHGYMAPEV 176
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDD---RNLAVLYQKIFRGDFKLPKWLSPGA 244
L +++D +S G +L+ +L G+ PF ++ + + +LP SP
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 236
Query: 245 QNLLRKILEPNPVKRITIAGIKADE-----WFEQDYTPANPDDDEEDIFVDNEAFSMHEV 299
++LL +L+ + +R+ G A E +F +D + + +
Sbjct: 237 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS---------------LDWQMVFLQKY 281
Query: 300 PSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKI---------RFTSNHSAK 350
P PPLI + + D+ F++ED K+ F S +
Sbjct: 282 P---------PPLIPPRGEVNAADAFDIG-SFDEEDTKGIKLLDSDQELYRNFPLTISER 331
Query: 351 DLLERIEDIVTEM 363
E E + +
Sbjct: 332 WQQEVAETVFDTI 344
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (585), Expect = 2e-73
Identities = 89/270 (32%), Positives = 141/270 (52%), Gaps = 15/270 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLL 71
Y+ G LG G F VK ++ +GL +A K ++K R + + I+RE++ LK +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
+HPNV+ LHEV +K+ + ++LE V GGELFD +A K L E E + +Q+++GV Y H
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 132 NKGVFHRDLKLENILLDSKG----NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
+ + H DLK ENI+L + IKI DFGL+ G+P +VAPE+
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPEI 187
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPG 243
+ +D+WS GVI Y++L+G PF + +++ S
Sbjct: 188 VNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
A++ +R++L +P KR+TI W +
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (574), Expect = 4e-71
Identities = 86/264 (32%), Positives = 142/264 (53%), Gaps = 8/264 (3%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ ++ + LG+G FGKV ++ +G +A+KIL K II E L+ +
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
HP + L + ++ V+EY GGELF ++ + E R +++ + Y H+
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
+ V +RD+KLEN++LD G+IKI+DFGL D + T CG+P Y+APEVL +
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGTPEYLAPEVLEDND 181
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 252
Y A D W GV++Y ++ G LPF +++ L++ I + + P+ LSP A++LL +L
Sbjct: 182 YGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 240
Query: 253 EPNPVKRITIAGIKADE-----WF 271
+ +P +R+ A E +F
Sbjct: 241 KKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 1e-70
Identities = 59/261 (22%), Positives = 116/261 (44%), Gaps = 14/261 (5%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
G+ +G+ +G G+FG V + AVK+L + K E+ L+ +H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRH 63
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHN 132
N++ ++ ++ +V ++ G L+ + + + + + + +Q G+ Y H
Sbjct: 64 VNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
K + HRDLK NI L +KI DFGL+ + + GS ++APEV+ +
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 193 YDGAT--SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF------KLPKWLSPGA 244
+ + SD+++ G++LY ++TG LP+ + N + + K+
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242
Query: 245 QNLLRKILEPNPVKRITIAGI 265
+ L+ + L+ +R I
Sbjct: 243 KRLMAECLKKKRDERPLFPQI 263
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 221 bits (565), Expect = 2e-70
Identities = 70/266 (26%), Positives = 118/266 (44%), Gaps = 10/266 (3%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
RYELG LG G +V A+DL AVK+L + + +RE L H
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 74 PNVVRLHEVLASKSK----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
P +V +++ +++ Y+V+EYV G L D + ++G + ++ +++
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVL 188
H G+ HRD+K NI++ + +K+ DFG++ + G+ Y++PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGA 244
D SD++S G +LY +LTG PF + + + R D P + LS
Sbjct: 187 RGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL 245
Query: 245 QNLLRKILEPNPVKRITIAGIKADEW 270
++ K L NP R A +
Sbjct: 246 DAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 220 bits (562), Expect = 4e-69
Identities = 89/272 (32%), Positives = 147/272 (54%), Gaps = 11/272 (4%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
Q +L +++ +TLG G+FG+V + +SG +A+KIL+K +++ LK + E
Sbjct: 33 PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 66 ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID 125
L+ + P +V+L S +YMV+EYV GGE+F + GR E R Q++
Sbjct: 93 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
Y H+ + +RDLK EN+L+D +G I+++DFG + + T CG+P +AP
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WTLCGTPEALAP 207
Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ 245
E++ ++GY+ A D W+ GV++Y + GY PF +Y+KI G + P S +
Sbjct: 208 EIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 246 NLLRKILEPNPVKRI-----TIAGIKADEWFE 272
+LLR +L+ + KR + IK +WF
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 2e-67
Identities = 79/301 (26%), Positives = 138/301 (45%), Gaps = 25/301 (8%)
Query: 8 QEGMRLGRYE-LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
++ + Y+ + LG G GKV + + FA+K+L+ + +RE+
Sbjct: 5 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVE 56
Query: 67 TL-KLLKHPNVVRLHEVL----ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKL 119
+ + P++VR+ +V A + + +V+E + GGELF +I +G E E ++
Sbjct: 57 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 116
Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
+ + + + Y H+ + HRD+K EN+L SK I + L T C +
Sbjct: 117 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 176
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRGDFK 235
P YVAPEVL YD + D+WS GVI+Y++L GY PF + + +I G ++
Sbjct: 177 PYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235
Query: 236 LP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDN 291
P +S + L+R +L+ P +R+TI W Q + ++
Sbjct: 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKED 295
Query: 292 E 292
+
Sbjct: 296 K 296
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 3e-65
Identities = 68/311 (21%), Positives = 115/311 (36%), Gaps = 43/311 (13%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
+ +YE +G+G FG+V A+ +G A+K + REI L+LL
Sbjct: 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLL 66
Query: 72 KHPNVVRLHEVLAS--------KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
KH NVV L E+ + K IY+V ++ + +E +++ Q L
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPN 181
++G+ Y H + HRD+K N+L+ G +K++DFGL+ +
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK--- 238
Y PE+L G D+W G I+ + T I + +
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 239 -----------------------------WLSPGAQNLLRKILEPNPVKRITIAGIKADE 269
P A +L+ K+L +P +RI +
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306
Query: 270 WFEQDYTPANP 280
+F D P++
Sbjct: 307 FFWSDPMPSDL 317
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 1e-64
Identities = 69/294 (23%), Positives = 109/294 (37%), Gaps = 32/294 (10%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK--ITDQIKREIATLKLLKHP 74
E LGEG F V A+D ++ A+K ++ K I REI L+ L HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N++ L + KS I +V +++ + L + + + G+ Y H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
+ HRDLK N+LLD G +K++DFGL+ + + Y APE+L
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 195 GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--GDFKLPKW------------- 239
G D+W+ G IL +L + +IF G +W
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 240 -------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
+L++ + NP RIT ++F P
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG 292
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 2e-64
Identities = 77/315 (24%), Positives = 127/315 (40%), Gaps = 39/315 (12%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
RY +GEG +G V A D + + A+K + H + REI L +H
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRH 65
Query: 74 PNVVRLHEVLASKS----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
N++ +++++ + + K ++ ++ G +L+ + L Q++ G+ Y
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKY 124
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVL 188
H+ V HRDLK N+LL++ ++KI DFGL+ + D T + Y APE++
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-------------- 234
N + DIWS G IL +L+ F ++ I
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244
Query: 235 -----------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
+L A +LL K+L NP KRI + A + EQ Y P
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304
Query: 278 ANPDDDEEDIFVDNE 292
++ E D E
Sbjct: 305 SDEPIAEAPFKFDME 319
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 2e-64
Identities = 64/257 (24%), Positives = 111/257 (43%), Gaps = 18/257 (7%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+L +T+G+G FG V G AVK ++ + E + + L+H
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHS 60
Query: 75 NVVRLHEVLA-SKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCH 131
N+V+L V+ K +Y+V EY+ G L D + S+GR L K + + + Y
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
HRDL N+L+ K+SDFGL+ +D T + APE L +
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREK 175
Query: 192 GYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLR 249
+ SD+WS G++L+ I + G +P+ L + ++ +G P P +++
Sbjct: 176 KFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 234
Query: 250 KILEPNPVKRITIAGIK 266
+ R + ++
Sbjct: 235 NCWHLDAAMRPSFLQLR 251
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 5e-63
Identities = 64/259 (24%), Positives = 107/259 (41%), Gaps = 8/259 (3%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
L LG+G+FG V+ + + AVK L+ + + + D RE+ + L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYC 130
H N++RL+ V+ + + MV E G L D++ G + Q+ +G+ Y
Sbjct: 69 DHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
+K HRDL N+LL ++ +KI DFGL D ++ P
Sbjct: 128 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 191 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKW--LSPGAQNL 247
SD W GV L+ + T G P+ N + + KI + +LP+ N+
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 247
Query: 248 LRKILEPNPVKRITIAGIK 266
+ + P R T ++
Sbjct: 248 MVQCWAHKPEDRPTFVALR 266
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 202 bits (515), Expect = 6e-63
Identities = 80/288 (27%), Positives = 131/288 (45%), Gaps = 33/288 (11%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+Y +GEG +G V AQ+ + G FA+K + + I REI+ LK LKH
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHS 60
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
N+V+L++V+ +K ++ +V E++ +G L+ + QL++G++YCH++
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
V HRDLK +N+L++ +G +KI+DFGL+ + Y AP+VL
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 195 GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-------------------- 234
T DIWS G I ++ G F + A +IFR
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 235 ---------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
K L +LL K+L+ +P +RIT +F++
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 2e-62
Identities = 63/261 (24%), Positives = 106/261 (40%), Gaps = 10/261 (3%)
Query: 20 RTLGEGNFGKVKFA--QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
+ LG GNFG VK Q AVKIL KN + D++ E ++ L +P +V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
R+ + +V+E G L + +++ +L Q+ G+ Y H
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 138 RDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
RDL N+LL ++ KISDFGLS AL + APE + +
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 190
Query: 197 TSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEP 254
SD+WS GV+++ + G P+ + + + +G+ P +L+
Sbjct: 191 -SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249
Query: 255 NPVKRITIAGIKA--DEWFEQ 273
+ R A ++ ++
Sbjct: 250 DVENRPGFAAVELRLRNYYYD 270
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 8e-62
Identities = 60/253 (23%), Positives = 114/253 (45%), Gaps = 14/253 (5%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+ LG G FG VK+ + A+K++++ + D+ E + L H
Sbjct: 6 LTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEK 60
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
+V+L+ V + I+++ EY+ G L + + + R Q + ++ + + + + Y +K
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVLANRG 192
HRDL N L++ +G +K+SDFGLS ++ DD + + PEVL
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLS---RYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRK 250
+ SDIW+ GV+++ I + G +P++ + + I +G P S ++
Sbjct: 178 FSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 236
Query: 251 ILEPNPVKRITIA 263
+R T
Sbjct: 237 CWHEKADERPTFK 249
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 1e-61
Identities = 72/302 (23%), Positives = 121/302 (40%), Gaps = 49/302 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y + +G G+FG V A+ DSG A+K + +++ RE+ ++ L H
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHC 73
Query: 75 NVVRLHEVLASKSK------IYMVLEYVTGG---ELFDKIASKGRLQEAEGRKLFQQLID 125
N+VRL S + + +VL+YV +K L + QL
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
++Y H+ G+ HRD+K +N+LLD + K+ DFG + + + S Y A
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA---KQLVRGEPNVSYICSRYYRA 190
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR------------- 231
PE++ ++ D+WS G +L +L G F + +I +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 232 ----GDFKLPKW------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
+FK P+ P A L ++LE P R+T A +F++
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310
Query: 276 TP 277
P
Sbjct: 311 DP 312
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 1e-61
Identities = 77/293 (26%), Positives = 133/293 (45%), Gaps = 33/293 (11%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
++ +GEG +G V A++ +G A+K + + + REI+ LK L HP
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHP 61
Query: 75 NVVRLHEVLASKSKIYMVLEYV-TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
N+V+L +V+ +++K+Y+V E++ + F ++ + + QL+ G+++CH+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
V HRDLK +N+L++++G IK++DFGL+ + Y APE+L Y
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLA--RAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 194 DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------------DFK 235
DIWS G I ++T F + +IFR
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 236 LPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
PKW L ++LL ++L +P KRI+ A +F+ P
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 2e-61
Identities = 80/282 (28%), Positives = 146/282 (51%), Gaps = 14/282 (4%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIH-LKITDQI 61
E + + +EL + LG G +GKV + + D+G +A+K+L+K I+ K T+
Sbjct: 16 GHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT 75
Query: 62 KREIATLKLLKH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
+ E L+ ++ P +V LH +++K++++L+Y+ GGELF ++ + R E E +
Sbjct: 76 RTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV 135
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
+++ + + H G+ +RD+KLENILLDS G++ ++DFGLS +
Sbjct: 136 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 195
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRGDFKL 236
V D WS GV++Y +LTG PF A + ++I + +
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 255
Query: 237 PKWLSPGAQNLLRKILEPNPVKRITIAGIKADE-----WFEQ 273
P+ +S A++L++++L +P KR+ ADE +F++
Sbjct: 256 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 3e-61
Identities = 64/283 (22%), Positives = 111/283 (39%), Gaps = 35/283 (12%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSG-----LPFAVKILEKNRIIHLKITDQIKREIATL- 68
E G+ LG G FGKV A + AVK+L++ + + E+ +
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMT 95
Query: 69 KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-------------------- 108
+L H N+V L IY++ EY G+L + + SK
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 109 ---GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165
L + Q+ G+ + K HRDL N+L+ +KI DFGL+
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV 224
+ + ++APE L Y SD+WS G++L+ I + G P+ +
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 225 LYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
+ K+ + FK+ P + + +++ + KR + +
Sbjct: 275 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 3e-61
Identities = 73/296 (24%), Positives = 114/296 (38%), Gaps = 25/296 (8%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKH 73
+ +GEGNFG+V A+ GL I E+ L KL H
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----------------ASKGRLQEAEGR 117
PN++ L + +Y+ +EY G L D + ++ L +
Sbjct: 71 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 118 KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 177
+ G+ Y K HRDL NIL+ KI+DFGLS +
Sbjct: 131 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS---RGQEVYVKKTMGR 187
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFK 235
++A E L N SD+WS GV+L+ I++ G P+ A LY+K+ +G +
Sbjct: 188 LPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 246
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA--DEWFEQDYTPANPDDDEEDIFV 289
P +L+R+ P +R + A I + E+ T N E+ +
Sbjct: 247 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYA 302
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 198 bits (503), Expect = 4e-61
Identities = 72/275 (26%), Positives = 123/275 (44%), Gaps = 12/275 (4%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+ LG G +G+V L AVK L+++ + ++ +E A +K +KHP
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHP 73
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHN 132
N+V+L V + Y++ E++T G L D + R + + Q+ + Y
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
K HRDL N L+ +K++DFGLS L + APE LA
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRK 250
+ SD+W+ GV+L+ I T G P+ +L+ +Y+ + + + P+ L+R
Sbjct: 193 FSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 251
Query: 251 ILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
+ NP R + A I + FE + ++ D+ E
Sbjct: 252 CWQWNPSDRPSFAEIH--QAFETMFQESSISDEVE 284
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 7e-61
Identities = 77/303 (25%), Positives = 123/303 (40%), Gaps = 45/303 (14%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y + +G G +G V A D +G A+K L + + RE+ LK ++H
Sbjct: 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE-LFAKRAYRELRLLKHMRHE 77
Query: 75 NVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
NV+ L +V L + Y+V+ ++ G K+ +L E + L Q++ G+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
Y H G+ HRDLK N+ ++ +KI DFGL+ D + + Y APEV+
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA-----DSEMTGYVVTRWYRAPEVI 190
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW--------- 239
N T DIWS G I+ ++TG F + ++I + P
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250
Query: 240 ----------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
SP A NLL K+L + +R+T A +FE +
Sbjct: 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310
Query: 278 ANP 280
+
Sbjct: 311 EDE 313
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (500), Expect = 1e-60
Identities = 75/295 (25%), Positives = 128/295 (43%), Gaps = 34/295 (11%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ +YE +GEG +G V A++ ++ A+K + + + REI LK LK
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELK 59
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
H N+VRLH+VL S K+ +V E+ + G L + QL+ G+ +CH+
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
+ V HRDLK +N+L++ G +K+++FGL+ + Y P+VL
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 193 YDGATSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFRGDF----------------- 234
+ D+WS G I + P F ++ ++IFR
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 235 ------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
+ L+ ++LL+ +L+ NPV+RI+ +F D+ P
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF-SDFCP 291
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 2e-60
Identities = 65/275 (23%), Positives = 120/275 (43%), Gaps = 14/275 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
L LG+G FG+V + A+K L+ + + +E +K L+H
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSP----EAFLQEAQVMKKLRHE 72
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHN 132
+V+L+ V+ S+ IY+V EY++ G L D + + L+ + + Q+ G++Y
Sbjct: 73 KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
HRDL+ NIL+ K++DFGL+ L + + + APE
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGR 190
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRK 250
+ SD+WS G++L + T G +P+ + ++ RG P +L+ +
Sbjct: 191 FTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 249
Query: 251 ILEPNPVKRITIAGIKA--DEWFEQDYTPANPDDD 283
P +R T ++A +++F P ++
Sbjct: 250 CWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 284
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 2e-60
Identities = 69/263 (26%), Positives = 120/263 (45%), Gaps = 14/263 (5%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+L LG G FG+V + AVK L++ + D E +K L+H
Sbjct: 14 TLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQ 68
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHN 132
+VRL+ V+ ++ IY++ EY+ G L D + + +L + + Q+ +G+++
Sbjct: 69 RLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
+ HRDL+ NIL+ + KI+DFGL+ L + + APE + N G
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPEAI-NYG 185
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRK 250
SD+WS G++L I+T G +P+ + Q + RG P L+R
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL 245
Query: 251 ILEPNPVKRITIAGIKA--DEWF 271
+ P R T +++ +++F
Sbjct: 246 CWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 4e-60
Identities = 66/250 (26%), Positives = 103/250 (41%), Gaps = 10/250 (4%)
Query: 22 LGEGNFGKVKFAQD--LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
LG GNFG V+ + A+K+L++ T+++ RE + L +P +VRL
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
V + +V+E GG L + K + + +L Q+ G+ Y K HR
Sbjct: 75 IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 133
Query: 139 DLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT 197
DL N+LL ++ KISDFGLS AL + APE + R +
Sbjct: 134 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR- 192
Query: 198 SDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPN 255
SD+WS GV ++ L+ G P+ + I +G + P P L+
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYK 252
Query: 256 PVKRITIAGI 265
R +
Sbjct: 253 WEDRPDFLTV 262
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 1e-59
Identities = 71/260 (27%), Positives = 120/260 (46%), Gaps = 11/260 (4%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
R ELGR +GEG FG V + P AV I + ++ +E T++ H
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHN 132
P++V+L V+ +++ +++++E T GEL + + L A QL ++Y +
Sbjct: 68 PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC--GSPNYVAPEVLAN 190
K HRD+ N+L+ S +K+ DFGLS ++ D + ++APE +
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 191 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLL 248
R + A SD+W GV ++ IL G PF + +I G+ +P P +L+
Sbjct: 184 RRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 242
Query: 249 RKILEPNPVKRITIAGIKAD 268
K +P +R +KA
Sbjct: 243 TKCWAYDPSRRPRFTELKAQ 262
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 4e-59
Identities = 57/252 (22%), Positives = 108/252 (42%), Gaps = 10/252 (3%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+ +G G FG V L+ A+K + + + + E + L HP
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHP 60
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQ-EAEGRKLFQQLIDGVSYCHNK 133
+V+L+ V ++ I +V E++ G L D + ++ L + + +G++Y
Sbjct: 61 KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
V HRDL N L+ IK+SDFG++ T + +PEV + Y
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 194 DGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKI 251
SD+WS GV+++ + + G +P+++R+ + + + I G P+ S ++
Sbjct: 180 SSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 238
Query: 252 LEPNPVKRITIA 263
+ P R +
Sbjct: 239 WKERPEDRPAFS 250
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 1e-58
Identities = 80/321 (24%), Positives = 128/321 (39%), Gaps = 51/321 (15%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RY+ +G G +G V A D +GL AVK L + + + RE+ LK +KH
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHE 77
Query: 75 NVVRLHEVLASKSKI-----YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
NV+ L +V + ++ ++ G + I +L + + L Q++ G+ Y
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
H+ + HRDLK N+ ++ +KI DFGL+ + Y APE++
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIML 191
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL--------- 240
N + T DIWS G I+ +LTG F + + I R L
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251
Query: 241 ----------------------SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 278
+P A +LL K+L + KRIT A A +F Q + P
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311
Query: 279 --------NPDDDEEDIFVDN 291
+ + D+ +D
Sbjct: 312 DEPVADPYDQSFESRDLLIDE 332
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (487), Expect = 1e-58
Identities = 78/295 (26%), Positives = 124/295 (42%), Gaps = 42/295 (14%)
Query: 15 RYELGRTLGEGNFGKVKFAQDL-DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK- 72
+YE +GEG +GKV A+DL + G A+K + + + + RE+A L+ L+
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLET 66
Query: 73 --HPNVVRLHEVLAS-----KSKIYMVLEYVTGGEL-FDKIASKGRLQEAEGRKLFQQLI 124
HPNVVRL +V ++K+ +V E+V + + + + + QL+
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
G+ + H+ V HRDLK +NIL+ S G IK++DFGL+ + + + Y A
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWYRA 183
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------ 232
PEVL Y D+WS G I + F + KI
Sbjct: 184 PEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242
Query: 233 ---------------DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 272
K + ++LL K L NP KRI+ + +F+
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 189 bits (481), Expect = 8e-58
Identities = 57/262 (21%), Positives = 106/262 (40%), Gaps = 12/262 (4%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLK 69
+ ++ + +G G FG+V G + A+K L+ K E + +
Sbjct: 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMG 82
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVS 128
HPNV+ L V+ + + ++ E++ G L + G+ + + + + G+
Sbjct: 83 QFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 142
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT---CGSPNYVAP 185
Y + HRDL NIL++S K+SDFGLS + D + + AP
Sbjct: 143 YLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 202
Query: 186 EVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPG 243
E + R + A SD+WS G++++ +++ G P+ D + I + P
Sbjct: 203 EAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSA 261
Query: 244 AQNLLRKILEPNPVKRITIAGI 265
L+ + + R I
Sbjct: 262 LHQLMLDCWQKDRNHRPKFGQI 283
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 2e-57
Identities = 55/285 (19%), Positives = 111/285 (38%), Gaps = 6/285 (2%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLKH 73
++ + LG G FG V + G + + K K +I E + + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
P+V RL + + + + G L K + Q+ G++Y ++
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
+ HRDL N+L+ + ++KI+DFGL+ L + ++A E + +R Y
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190
Query: 194 DGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKI 251
SD+WS GV ++ ++T G P+D + + + +G+ P + ++ K
Sbjct: 191 THQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 249
Query: 252 LEPNPVKRITIAGIKAD-EWFEQDYTPANPDDDEEDIFVDNEAFS 295
+ R + + +D +E + + + S
Sbjct: 250 WMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDS 294
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 187 bits (476), Expect = 5e-57
Identities = 65/282 (23%), Positives = 109/282 (38%), Gaps = 34/282 (12%)
Query: 15 RYELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
E R +GEG FG+V + AVK+L++ ++ +RE A +
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ--ADFQREAALMA 71
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR------------------- 110
+PN+V+L V A + ++ EY+ G+L + + S
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 111 -----LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165
L AE + +Q+ G++Y + HRDL N L+ +KI+DFGLS
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL-PFDDRNLAV 224
++ PE + Y SD+W+ GV+L+ I + L P+
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 225 LYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGI 265
+ + G+ P+ NL+R P R + I
Sbjct: 251 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSI 292
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 186 bits (473), Expect = 1e-56
Identities = 59/293 (20%), Positives = 100/293 (34%), Gaps = 27/293 (9%)
Query: 11 MRLG-RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
+R+G RY LGR +G G+FG + D+ +G A+K+ Q+ E K
Sbjct: 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-----TKHPQLHIESKIYK 57
Query: 70 LLKHPN-VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
+++ + + A MV+E + + L Q+I +
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIE 117
Query: 129 YCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLH-----TTCGSP 180
Y H+K HRD+K +N L+ + I DFGL+ + R + G+
Sbjct: 118 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK----- 235
Y + D+ S G +L G LP+ A QK R K
Sbjct: 178 RYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236
Query: 236 ---LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA---DEWFEQDYTPANPDD 282
L K L + + ++ + + Q ++ D
Sbjct: 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFD 289
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 185 bits (469), Expect = 1e-55
Identities = 64/299 (21%), Positives = 122/299 (40%), Gaps = 54/299 (18%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-H 73
Y+L R LG G + +V A ++ + VKIL+ + +IKREI L+ L+
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRGG 89
Query: 74 PNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
PN++ L +++ +V E+V + L + + R +++ + YCH
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 146
Query: 132 NKGVFHRDLKLENILLDSKGN-IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
+ G+ HRD+K N+++D + +++ D+GL+ + + + S + PE+L +
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA---EFYHPGQEYNVRVASRYFKGPELLVD 203
Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV--------------LYQKIFRGDFKL 236
+ D+WS G +L ++ PF + LY I + + +L
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263
Query: 237 PKW------------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271
+SP A + L K+L + R+T +F
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 5e-55
Identities = 68/278 (24%), Positives = 117/278 (42%), Gaps = 30/278 (10%)
Query: 15 RYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
R G+TLG G FGKV A D+ + AVK+L+ + HL + + E+ L
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLS 81
Query: 70 LLK-HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG------------------R 110
L H N+V L ++ EY G+L + + K
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
L + Q+ G+++ +K HRDL NILL KI DFGL+ ++ +
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKI 229
+ ++APE + N SD+WS G+ L+ + + G P+ + + K+
Sbjct: 202 VVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 230 FRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
+ F++ P+ ++++ + +P+KR T I
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 2e-54
Identities = 70/280 (25%), Positives = 118/280 (42%), Gaps = 29/280 (10%)
Query: 15 RYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
R LG+ LGEG FG+V A+ + + AVK+L+ + K + E+
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEM 71
Query: 68 LK-LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----------------ASKGR 110
+K + KH N++ L +Y+++EY + G L + + + +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
L + Q+ G+ Y +K HRDL N+L+ +KI+DFGL+ H
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKI 229
++APE L +R Y SD+WS GV+L+ I T G P+ + L++ +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
Query: 230 FRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268
G P + ++R P +R T + D
Sbjct: 251 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 178 bits (453), Expect = 1e-53
Identities = 50/290 (17%), Positives = 93/290 (32%), Gaps = 27/290 (9%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
Y++GR +GEG+FG + +L + A+K + Q++ E T KLL
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-----SDAPQLRDEYRTYKLLAG 59
Query: 74 -PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
+ ++ +V++ + + +Q++ V H
Sbjct: 60 CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 133 KGVFHRDLKLENILLDSK-----GNIKISDFGLSALPQHFRDDGLLH-----TTCGSPNY 182
K + +RD+K +N L+ I + DFG+ + + G+ Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK------- 235
++ R D+ + G + L G LP+ A QK R K
Sbjct: 180 MSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238
Query: 236 -LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDE 284
L + ++ F + N +DE
Sbjct: 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ--GLFSKVLERLNTTEDE 286
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 3e-53
Identities = 61/259 (23%), Positives = 107/259 (41%), Gaps = 11/259 (4%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKL 70
+ +G G FG+V S +P A+K L+ ++ E +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV--DFLGEAGIMGQ 65
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSY 129
H N++RL V++ + ++ EY+ G L + K G + + + + G+ Y
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVL 188
N HRDL NIL++S K+SDFGLS L + APE +
Sbjct: 126 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 189 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 246
+ R + A SD+WS G++++ ++T G P+ + + + + I G P
Sbjct: 186 SYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQ 244
Query: 247 LLRKILEPNPVKRITIAGI 265
L+ + + +R A I
Sbjct: 245 LMMQCWQQERARRPKFADI 263
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 7e-53
Identities = 69/281 (24%), Positives = 117/281 (41%), Gaps = 18/281 (6%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
+G G+FG V LD+ + AVK L NRI + Q E +K
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDF 85
Query: 72 KHPNVVRLHEV-LASKSKIYMVLEYVTGGELFD-KIASKGRLQEAEGRKLFQQLIDGVSY 129
HPNV+ L + L S+ +VL Y+ G+L + + Q+ G+ +
Sbjct: 86 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF 145
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEV 187
+K HRDL N +LD K +K++DFGL+ D + + T ++A E
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 188 LANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQ 245
L + + SD+WS GV+L+ ++T G P+ D N + + +G P++
Sbjct: 206 LQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 264
Query: 246 NLLRKILEPNPVKRITIAGIKA------DEWFEQDYTPANP 280
++ K P R + + + + + + Y N
Sbjct: 265 EVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNA 305
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (448), Expect = 3e-52
Identities = 75/338 (22%), Positives = 129/338 (38%), Gaps = 59/338 (17%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
L RY+ + +G G G V A D A+K L + + + RE+ +K +
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 74
Query: 73 HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H N++ L V + +Y+V+E + + L L Q++ G
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCG 131
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
+ + H+ G+ HRDLK NI++ S +KI DFGL+ + ++ + Y APE
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYYRAPE 188
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------- 232
V+ GY DIWS G I+ ++ + F R+ + K+
Sbjct: 189 VILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 233 ----------------------------DFKLPKWLSPGAQNLLRKILEPNPVKRITIAG 264
D + K + A++LL K+L +P KRI++
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307
Query: 265 IKADEWFEQDYTPANPDDDEEDIF---VDNEAFSMHEV 299
+ Y PA + I+ +D ++ E
Sbjct: 308 ALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEW 345
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 1e-50
Identities = 59/291 (20%), Positives = 116/291 (39%), Gaps = 22/291 (7%)
Query: 15 RYELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
+ + R LG+G+FG V K + A+K + + ++ + E + +K
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMK 78
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR----------LQEAEGRKL 119
+VVRL V++ +++E +T G+L + S ++ ++
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
++ DG++Y + HRDL N ++ +KI DFG++
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLAVLYQKIFRGD-FKLP 237
+++PE L + + + D+WS GV+L+ I T P+ + + + + G P
Sbjct: 199 VRWMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 257
Query: 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKA--DEWFEQDYTPANPDDDEED 286
L+R + NP R + I + E E + + EE+
Sbjct: 258 DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEEN 308
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 5e-49
Identities = 62/294 (21%), Positives = 111/294 (37%), Gaps = 48/294 (16%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
L ++G+G FG+V + G AVKI + EI +L+H
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSW----FREAEIYQTVMLRH 56
Query: 74 PNVVRLHEVL----ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
N++ + +++++V +Y G LFD + ++ + KL G+++
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAH 115
Query: 130 CH--------NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGS 179
H + HRDLK +NIL+ G I+D GL+ D D + G+
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
Query: 180 PNYVAPEVL-----ANRGYDGATSDIWSCGVILYVILTGYLPFD---------------D 219
Y+APEVL +DI++ G++ + I D
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235
Query: 220 RNLAVLYQKIFRGDFKLP---KWLSPGA----QNLLRKILEPNPVKRITIAGIK 266
++ + + + + +W S A ++R+ N R+T IK
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 4e-48
Identities = 63/276 (22%), Positives = 107/276 (38%), Gaps = 27/276 (9%)
Query: 15 RYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
R +LG+ LG G FG+V A + AVK+L++ H + + +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIH 72
Query: 70 LLKHPNVVRLHEVLASK-SKIYMVLEYVTGGELFDKIASKGR----------------LQ 112
+ H NVV L + +++E+ G L + SK L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 113 EAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172
Q+ G+ + ++ HRDL NILL K +KI DFGL+ D
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY-LPFDDRNLAVLYQKIFR 231
++APE + +R Y SD+WS GV+L+ I + P+ + + + +
Sbjct: 193 KGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251
Query: 232 GD--FKLPKWLSPGAQNLLRKILEPNPVKRITIAGI 265
+ P + +P + P +R T + +
Sbjct: 252 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 287
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 147 bits (372), Expect = 3e-41
Identities = 58/333 (17%), Positives = 117/333 (35%), Gaps = 72/333 (21%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
RY L R LG G+F V A+D+ + A+KI+ +++ T+ + EI L+ +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVND 68
Query: 74 PNVVRL-------------HEVLASKSKIYMVLEYVTGG---ELFDKIASKGRLQEAEGR 117
+ + H + +++V+ + G K + +
Sbjct: 69 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 128
Query: 118 KLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHT 175
++ +QL+ G+ Y H + G+ H D+K EN+L++ + + ++ L D
Sbjct: 129 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 188
Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY--------- 226
+ + Y +PEVL + +DIWS +++ ++TG F+
Sbjct: 189 SIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247
Query: 227 ---------------------------------------QKIFRGDFKLPKWLSPGAQNL 247
+ + +K K + +
Sbjct: 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
L +L+ +P KR G+ W +D
Sbjct: 308 LSPMLQLDPRKRADAGGLVNHPWL-KDTLGMEE 339
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 91.4 bits (226), Expect = 3e-22
Identities = 35/210 (16%), Positives = 71/210 (33%), Gaps = 36/210 (17%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD---------------Q 60
+G+ +GEG V VK + K+ +
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 61 IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
+ E L+ L+ V +++ +++E + EL+ + ++
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAW----EGNAVLMELIDAKELYRV-------RVENPDEVL 109
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
+++ V+ +++G+ H DL N+L+ +G I I DF S +L +
Sbjct: 110 DMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRNI 168
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVI 210
+R Y DI S I ++
Sbjct: 169 IT-----YFSRTY-RTEKDINS--AIDRIL 190
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 426 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.68 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.26 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.22 | |
| d1ul7a_ | 102 | Map/microtubule affinity-regulating kinase 3 {Mous | 98.15 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.3 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.08 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.67 | |
| d2v8qa1 | 153 | 5'-AMP-activated protein kinase catalytic subunit | 91.88 | |
| d2qrda1 | 127 | Snf1-like protein kinase ssp2 {Schizosaccharomyces | 80.94 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-66 Score=491.53 Aligned_cols=259 Identities=32% Similarity=0.667 Sum_probs=241.5
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (426)
-.+++|++++.||+|+||.||+|+++.+|+.||+|++.+....+....+.+.+|+.+++.++||||+++++++.+++.+|
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 82 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 82 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence 35789999999999999999999999999999999998766555555678999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCC
Q 014347 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 170 (426)
+|||||+||+|.+++.+.+++++.+++.++.||++||+|||++||+||||||+|||++.+|++||+|||+|.... .
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~----~ 158 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----S 158 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC----C
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecC----C
Confidence 999999999999999988999999999999999999999999999999999999999999999999999997543 2
Q ss_pred CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 014347 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 250 (426)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~ 250 (426)
......+||+.|+|||++.+..| +.++|||||||+||+|++|+.||.+.+....+.++.+..+.+|+.+|+++++||.+
T Consensus 159 ~~~~~~~Gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 237 (263)
T d2j4za1 159 SRRTTLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISR 237 (263)
T ss_dssp CCCEETTEEGGGCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred CcccccCCCCcccCHHHHcCCCC-CchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 34456789999999999988777 68999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCccCCCCHHHHhcCcccccc
Q 014347 251 ILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 251 ~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
||++||++|||++|+++||||..+
T Consensus 238 ~L~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 238 LLKHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp HTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HccCCHhHCcCHHHHHcCcCcCCc
Confidence 999999999999999999999764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-65 Score=491.69 Aligned_cols=264 Identities=33% Similarity=0.589 Sum_probs=237.5
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (426)
....-++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|++++||||+++++++.+++.
T Consensus 3 ~~~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 82 (288)
T d1uu3a_ 3 RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK 82 (288)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSE
T ss_pred CCCCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCE
Confidence 34455789999999999999999999999999999999987655444556789999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
+|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++++|.+||+|||+|+......
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998665433
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 248 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li 248 (426)
......+.+||+.|+|||++.+..| +.++|||||||++|+|++|+.||.+.+...++.++.++.+.+|+.+++++++||
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 241 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLV 241 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHH
T ss_pred cccccccccCCccccCceeeccCCC-CcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 4445567799999999999988777 689999999999999999999999999999999999999999999999999999
Q ss_pred HHccccCccCCCCHHH------HhcCccccc
Q 014347 249 RKILEPNPVKRITIAG------IKADEWFEQ 273 (426)
Q Consensus 249 ~~~L~~dP~~R~t~~e------il~h~~f~~ 273 (426)
++||++||++|||++| |++||||+.
T Consensus 242 ~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 242 EKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp HTTSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HHHccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 9999999999999987 578888864
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-65 Score=488.38 Aligned_cols=262 Identities=39% Similarity=0.674 Sum_probs=227.4
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
.+++|++++.||+|+||+||+|+++.+|+.||||++++.... +..+.+.+|+.+|+.++||||+++++++.+++.+|+
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence 367899999999999999999999999999999999865432 234678999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCC
Q 014347 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 171 (426)
|||||+||+|++++.+.+.+++.+++.++.||++||+|||++||+||||||+|||++++|++||+|||+|+.........
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 99999999999999888899999999999999999999999999999999999999999999999999998654433334
Q ss_pred ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHH-HHHHHHHcCCCCCC--CCCCHHHHHHH
Q 014347 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDFKLP--KWLSPGAQNLL 248 (426)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~p--~~~s~~~~~Li 248 (426)
...+.+||+.|+|||++.+.++++.++|||||||++|+|++|+.||...+.. ..+..+.......+ ..+|+++.+||
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 240 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHH
Confidence 4567799999999999998888778899999999999999999999876543 33334444333333 45899999999
Q ss_pred HHccccCccCCCCHHHHhcCccccccC
Q 014347 249 RKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 249 ~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
.+||+.||++|||++|+++||||++..
T Consensus 241 ~~~L~~dP~~R~t~~eil~hpwf~~~l 267 (271)
T d1nvra_ 241 HKILVENPSARITIPDIKKDRWYNKPL 267 (271)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence 999999999999999999999998653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-64 Score=493.13 Aligned_cols=260 Identities=32% Similarity=0.628 Sum_probs=242.9
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (426)
+.+++|++++.||+|+||.||+|+++.+|+.||||++++.........+++.+|+.+|+.++||||+++++++.+++.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 57899999999999999999999999999999999998766544555788999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCC
Q 014347 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 170 (426)
+||||++||+|++++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... ..
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~--~~ 159 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TT
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc--CC
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999985432 23
Q ss_pred CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 014347 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 250 (426)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~ 250 (426)
....+.|||+.|+|||++.+.+| +.++|||||||++|+|++|++||.+.+...+++++..+.+.+|+.+|+++++||++
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y-~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 238 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred cccccceeCHHHhhhhhccCCCC-ChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHh
Confidence 44567899999999999998888 68999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCccCCCC-----HHHHhcCccccc
Q 014347 251 ILEPNPVKRIT-----IAGIKADEWFEQ 273 (426)
Q Consensus 251 ~L~~dP~~R~t-----~~eil~h~~f~~ 273 (426)
||++||.+|++ ++++++||||+.
T Consensus 239 ~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred hccCCchhhcccccccHHHHHcCccccc
Confidence 99999999994 899999999965
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-63 Score=477.17 Aligned_cols=254 Identities=26% Similarity=0.467 Sum_probs=227.5
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (426)
-++|++++.||+|+||+||+|++..+|+.||||++.+..... .+.+.+|+.+|+.++||||+++++++.+++.+|+|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 458999999999999999999999999999999998665333 46789999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
||||+||+|.+++.+ +++++.+++.+++||+.||.|||++||+||||||+|||++.+|++||+|||+|+.... ....
T Consensus 96 mEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~--~~~~ 172 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSK 172 (293)
T ss_dssp EECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--TTCC
T ss_pred EEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc--cccc
Confidence 999999999998765 6799999999999999999999999999999999999999999999999999985432 2234
Q ss_pred cccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC---CCCCCCCCCHHHHHHHH
Q 014347 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPGAQNLLR 249 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~Li~ 249 (426)
....+||+.|+|||++.+..| +.++|||||||++|+|++|+.||.+.+.......+... .+..|+.+|+++++||.
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 251 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHH
T ss_pred ccccccCCCccChhhhcCCCC-CchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHH
Confidence 556789999999999988777 68999999999999999999999998877666555543 34556779999999999
Q ss_pred HccccCccCCCCHHHHhcCccccc
Q 014347 250 KILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 250 ~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
+||++||++|||++|+++||||+.
T Consensus 252 ~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 252 RCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp HHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHccCChhHCcCHHHHhcCHhhCC
Confidence 999999999999999999999974
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-62 Score=479.90 Aligned_cols=256 Identities=32% Similarity=0.693 Sum_probs=239.2
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
.+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|+.++||||+++++++.+++.+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 46789999999999999999999999999999999987655444557889999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCC
Q 014347 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 171 (426)
|||||.||+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+... .
T Consensus 82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~-----~ 156 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----D 156 (316)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS-----S
T ss_pred EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEec-----c
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998543 2
Q ss_pred ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Q 014347 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251 (426)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~ 251 (426)
...+.+||+.|+|||++.+..| +.++|||||||++|+|++|+.||.+.+....+.++..+...+|+.+|+++.+||.+|
T Consensus 157 ~~~~~~Gt~~Y~APE~l~~~~y-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 235 (316)
T d1fota_ 157 VTYTLCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRL 235 (316)
T ss_dssp CBCCCCSCTTTCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccccCcccccCHHHHcCCCC-CchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 3456799999999999988777 589999999999999999999999999999999999999999999999999999999
Q ss_pred cccCccCCC-----CHHHHhcCccccc
Q 014347 252 LEPNPVKRI-----TIAGIKADEWFEQ 273 (426)
Q Consensus 252 L~~dP~~R~-----t~~eil~h~~f~~ 273 (426)
|++||.+|+ |++++++||||++
T Consensus 236 L~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 236 ITRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp TCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred hhhCHHhccccchhhHHHHHcCccccc
Confidence 999999996 8999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-62 Score=474.49 Aligned_cols=257 Identities=38% Similarity=0.705 Sum_probs=216.1
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
.-++|++++.||+|+||+||+|+++.+|+.||||++.+..... ....+.+|+.+|+.++||||+++++++.+++.+|+
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL 84 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3467999999999999999999999999999999998765432 24578899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEec---CCCCeEEeeccCccCCcccc
Q 014347 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD---SKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~---~~g~vkL~DFGla~~~~~~~ 168 (426)
|||||+||+|.+++.+.+++++.+++.++.||+.||+|||++||+||||||+|||+. ++|.+||+|||+|+...
T Consensus 85 vmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~--- 161 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--- 161 (307)
T ss_dssp EECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred EEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc---
Confidence 999999999999999988999999999999999999999999999999999999994 57899999999998543
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCC----CCCCHHH
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGA 244 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~ 244 (426)
......+.+||+.|+|||++.+..| +.++|||||||++|+|++|+.||.+.+.......+.++...++ +.+|+++
T Consensus 162 ~~~~~~~~~GT~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 240 (307)
T d1a06a_ 162 PGSVLSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 240 (307)
T ss_dssp -----------CTTSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred CCCeeeeeeeCccccCcHHHcCCCC-CcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHH
Confidence 2334567899999999999988777 6899999999999999999999999999999999988876544 4589999
Q ss_pred HHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 245 QNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
.+||.+||++||++|||++|+++||||+..
T Consensus 241 ~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 241 KDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999999999754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-62 Score=466.66 Aligned_cols=256 Identities=30% Similarity=0.536 Sum_probs=218.6
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe--CCEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KSKI 89 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~ 89 (426)
+.++|++++.||+|+||+||+|+++.+|+.||+|++++.... ....+.+.+|+.+|++++||||+++++++.+ .+.+
T Consensus 2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence 457899999999999999999999999999999999876543 3446789999999999999999999999864 4568
Q ss_pred EEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcC-----ceeccCCCCcEEecCCCCeEEeeccC
Q 014347 90 YMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKG-----VFHRDLKLENILLDSKGNIKISDFGL 160 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~----~~~l~~~~~~~i~~Ql~~aL~~LH~~g-----IiHrDLKp~NILl~~~g~vkL~DFGl 160 (426)
|+|||||+||+|.+++.+ .+.+++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 999999999999999864 467999999999999999999999976 99999999999999999999999999
Q ss_pred ccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC-CCCCC
Q 014347 161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKW 239 (426)
Q Consensus 161 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~ 239 (426)
|+.... ......+.+||+.|+|||++.+..| +.++|||||||++|+|++|+.||.+.+..++..++..+.+ .+|..
T Consensus 161 a~~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 237 (269)
T d2java1 161 ARILNH--DTSFAKAFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 237 (269)
T ss_dssp HHHC-------------CCCSCCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred eeeccc--CCCccccCCCCcccCCHHHHcCCCC-ChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 986433 2234456799999999999988777 6899999999999999999999999999999999888765 46778
Q ss_pred CCHHHHHHHHHccccCccCCCCHHHHhcCccc
Q 014347 240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271 (426)
Q Consensus 240 ~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 271 (426)
+|+++.+||.+||++||.+|||++|+++|||.
T Consensus 238 ~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 238 YSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 99999999999999999999999999999995
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-62 Score=471.51 Aligned_cols=256 Identities=27% Similarity=0.432 Sum_probs=226.7
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
+.|++++.||+|+||.||+|++..+|+.||+|++++... ...+.+.+|+.+|+.++||||+++++++.+++.+|+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS---GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 469999999999999999999999999999999976532 23567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 94 Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
|||+||+|.+++.+ .+++++.+++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.... ....
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~~~~ 166 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQR 166 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH--HHHH
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCC--Cccc
Confidence 99999999999765 46799999999999999999999999999999999999999999999999999975332 1123
Q ss_pred cccccCCCcccchhhhcc----CCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCC---CCCCCCCHHHH
Q 014347 173 LHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWLSPGAQ 245 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~----~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~ 245 (426)
..+.+||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+.+....+.++..+.. ..|..+|+++.
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~ 246 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK 246 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHH
Confidence 346789999999999842 23336899999999999999999999999888888888887753 34567899999
Q ss_pred HHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 246 NLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
+||.+||++||++|||++|+++||||+..
T Consensus 247 ~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 247 DFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999999999999753
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.3e-62 Score=480.64 Aligned_cols=258 Identities=34% Similarity=0.677 Sum_probs=240.3
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
...+++|++++.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++||||+++++++.+....
T Consensus 37 ~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 116 (350)
T d1rdqe_ 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccc
Confidence 35579999999999999999999999999999999999876555555567899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus 117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~---- 192 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---- 192 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS----
T ss_pred ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecc----
Confidence 9999999999999999998999999999999999999999999999999999999999999999999999998543
Q ss_pred CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 249 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 249 (426)
....+.+||+.|+|||++.+.+| +.++|||||||++|+|++|+.||.+.+....+.++..+.+.+|..+++++.+||+
T Consensus 193 -~~~~~~~Gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 270 (350)
T d1rdqe_ 193 -GRTWTLCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270 (350)
T ss_dssp -SCBCCCEECGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHH
T ss_pred -cccccccCccccCCHHHHcCCCC-CccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHH
Confidence 23456789999999999988777 6899999999999999999999999999999999999999999999999999999
Q ss_pred HccccCccCCC-----CHHHHhcCccccc
Q 014347 250 KILEPNPVKRI-----TIAGIKADEWFEQ 273 (426)
Q Consensus 250 ~~L~~dP~~R~-----t~~eil~h~~f~~ 273 (426)
+||++||.+|+ |++++++||||+.
T Consensus 271 ~~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHhhhCHHhccccccccHHHHHcCccccC
Confidence 99999999995 9999999999975
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.5e-62 Score=471.81 Aligned_cols=255 Identities=25% Similarity=0.369 Sum_probs=230.0
Q ss_pred CeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEe
Q 014347 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 94 (426)
+|++++.||+|+||+||+|++..+|+.||||++.+.........+.+.+|+.+|+.++||||+++++++.+++..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 59999999999999999999999999999999988766666667889999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCccc
Q 014347 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH 174 (426)
Q Consensus 95 y~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 174 (426)
||.||+|..++...+++++.+++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|..... ..
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~~ 169 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------AN 169 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BC
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC------CC
Confidence 999999988888888999999999999999999999999999999999999999999999999999985432 34
Q ss_pred cccCCCcccchhhhccC--CCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCC--CCCCCHHHHHHHHH
Q 014347 175 TTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRK 250 (426)
Q Consensus 175 ~~~gt~~y~APE~l~~~--~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~Li~~ 250 (426)
..+||+.|+|||++.+. +.++.++|||||||++|+|++|..||.+.+......++..+..+. +..+|+++.+||.+
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~ 249 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHH
T ss_pred ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 57899999999998642 234689999999999999999999999988888777777765433 34589999999999
Q ss_pred ccccCccCCCCHHHHhcCccccccC
Q 014347 251 ILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 251 ~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
||++||.+|||++++++||||....
T Consensus 250 ~L~~dP~~Rpt~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 250 CLQKIPQDRPTSEVLLKHRFVLRER 274 (309)
T ss_dssp HTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HCcCChhHCcCHHHHHhCHHhcCCC
Confidence 9999999999999999999998654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-61 Score=464.48 Aligned_cols=257 Identities=35% Similarity=0.611 Sum_probs=233.4
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccch---hHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
-++|++++.||+|+||+||+|+++.+|+.||||++++...... ...+.+.+|+.+|++++||||+++++++.+++.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3679999999999999999999999999999999987554322 2357899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCC----CeEEeeccCccCCc
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG----NIKISDFGLSALPQ 165 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g----~vkL~DFGla~~~~ 165 (426)
|+|||||+||+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.+| .+||+|||+|....
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 99999999999999999888999999999999999999999999999999999999998877 49999999998543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCC----CCCC
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLS 241 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 241 (426)
......+.+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+....+.++......++ +.+|
T Consensus 169 ---~~~~~~~~~~t~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (293)
T d1jksa_ 169 ---FGNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244 (293)
T ss_dssp ---TSCBCSCCCCCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred ---CCccccccCCCCcccCHHHHcCCCC-CCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCC
Confidence 2334556789999999999987666 7999999999999999999999999999999999988877665 5689
Q ss_pred HHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 242 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
+++++||++||++||++|||++|+++||||+.
T Consensus 245 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 99999999999999999999999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.4e-61 Score=476.39 Aligned_cols=261 Identities=30% Similarity=0.586 Sum_probs=235.0
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
+..+++|++++.||+|+||.||+|++..+|+.||||++.+.. ....+.+.+|+.+|++++||||+++++++.+++.+
T Consensus 22 ~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 98 (350)
T d1koaa2 22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 98 (350)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEE
T ss_pred CCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 446789999999999999999999999999999999997654 23357789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecC--CCCeEEeeccCccCCcc
Q 014347 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS--KGNIKISDFGLSALPQH 166 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~--~g~vkL~DFGla~~~~~ 166 (426)
|+|||||+||+|.+++.+ .+++++.+++.++.||+.||.|||++||+||||||+|||++. +|.+||+|||+|+...
T Consensus 99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~- 177 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD- 177 (350)
T ss_dssp EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC-
T ss_pred EEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc-
Confidence 999999999999999954 567999999999999999999999999999999999999964 6789999999998543
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCC----CCCH
Q 014347 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSP 242 (426)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~ 242 (426)
......+.+||+.|+|||++.+.+| +.++|||||||++|+|++|+.||.+.+..+.+.++......++. .+|+
T Consensus 178 --~~~~~~~~~gT~~Y~aPEv~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 254 (350)
T d1koaa2 178 --PKQSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 254 (350)
T ss_dssp --TTSCEEEECSCTTTCCHHHHHTCCB-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCH
T ss_pred --cccccceecCcccccCHHHHcCCCC-ChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 2344567899999999999988777 68999999999999999999999999999999999888766653 4899
Q ss_pred HHHHHHHHccccCccCCCCHHHHhcCccccccCCC
Q 014347 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (426)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 277 (426)
++++||.+||++||++|||++|+++||||+....+
T Consensus 255 ~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 255 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 289 (350)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence 99999999999999999999999999999876543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.5e-61 Score=476.63 Aligned_cols=261 Identities=30% Similarity=0.571 Sum_probs=235.4
Q ss_pred CCccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 014347 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (426)
.+..+++|++++.||+|+||.||+|++..+|+.||||++++... .....+.+|+.+|++++||||+++++++.+++.
T Consensus 24 ~~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~ 100 (352)
T d1koba_ 24 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE 100 (352)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred CCCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 34567899999999999999999999999999999999976542 235678899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEec--CCCCeEEeeccCccCCc
Q 014347 89 IYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD--SKGNIKISDFGLSALPQ 165 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~--~~g~vkL~DFGla~~~~ 165 (426)
+|+|||||+||+|++.+... .++++.+++.++.||+.||.|||++||+||||||+|||++ .+|.+||+|||+|+...
T Consensus 101 ~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 101 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecC
Confidence 99999999999999987654 4799999999999999999999999999999999999998 57899999999998543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCC----CCCC
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLS 241 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 241 (426)
......+.+||+.|+|||++.+..| +.++|||||||++|+|++|+.||.+.+....+.++..+.+.+| ..+|
T Consensus 181 ---~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 256 (352)
T d1koba_ 181 ---PDEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS 256 (352)
T ss_dssp ---TTSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSC
T ss_pred ---CCCceeeccCcccccCHHHHcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCC
Confidence 3345667899999999999988777 6899999999999999999999999999999999988877655 4589
Q ss_pred HHHHHHHHHccccCccCCCCHHHHhcCccccccCC
Q 014347 242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (426)
Q Consensus 242 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 276 (426)
+++.+||.+||++||.+|||++|+++||||+....
T Consensus 257 ~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~ 291 (352)
T d1koba_ 257 PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 291 (352)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCcc
Confidence 99999999999999999999999999999987543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-61 Score=472.07 Aligned_cols=258 Identities=33% Similarity=0.600 Sum_probs=235.5
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHH-hCCCCCccceEEEEEeCCEEEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK-LLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~-~l~hpnIv~l~~~~~~~~~~~l 91 (426)
+++|++++.||+|+||+||+|+++.+|+.||||++++......+..+.+.+|..++. .++||||+++++++.+++.+|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 478999999999999999999999999999999998765433344566777777665 7899999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCC
Q 014347 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 171 (426)
||||++||+|.+++...+++++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... ...
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~--~~~ 158 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDA 158 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--TTC
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccc--ccc
Confidence 999999999999999989999999999999999999999999999999999999999999999999999985432 233
Q ss_pred ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Q 014347 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251 (426)
Q Consensus 172 ~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~ 251 (426)
.....+||+.|+|||++.+.+| +.++|||||||++|+|++|+.||.+.+...++.++..+.+.+|+.+|+++.+||++|
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~ 237 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL 237 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCCCcCCHHHHcCCCC-CchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHh
Confidence 4456789999999999998877 589999999999999999999999999999999999999999999999999999999
Q ss_pred cccCccCCCCHH-HHhcCccccc
Q 014347 252 LEPNPVKRITIA-GIKADEWFEQ 273 (426)
Q Consensus 252 L~~dP~~R~t~~-eil~h~~f~~ 273 (426)
|++||.+|||+. ++++||||++
T Consensus 238 L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 238 FVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp SCSSGGGSBTTBSCGGGSGGGTT
T ss_pred cccCCCCCcCHHHHHHhCchhcc
Confidence 999999999995 8999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-61 Score=457.15 Aligned_cols=252 Identities=26% Similarity=0.482 Sum_probs=220.9
Q ss_pred CCe-eeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe----CCE
Q 014347 14 GRY-ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----KSK 88 (426)
Q Consensus 14 ~~y-~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~ 88 (426)
||| ++.++||+|+||+||+|++..+++.||+|.+...... ....+.+.+|+++|++++||||+++++++.+ ...
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence 466 7888999999999999999999999999999765543 3446789999999999999999999999865 456
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC--ceeccCCCCcEEec-CCCCeEEeeccCccCCc
Q 014347 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLD-SKGNIKISDFGLSALPQ 165 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~g--IiHrDLKp~NILl~-~~g~vkL~DFGla~~~~ 165 (426)
+|+||||++||+|.+++.+.+.+++.+++.++.||++||+|||++| |+||||||+|||++ +++.+||+|||+|+..
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~- 165 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK- 165 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC-
T ss_pred EEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec-
Confidence 8999999999999999999899999999999999999999999998 99999999999996 5789999999999853
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCC-cHHHHHHHHHcCCC--CCCCCCCH
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-NLAVLYQKIFRGDF--KLPKWLSP 242 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~--~~p~~~s~ 242 (426)
......+.+||+.|+|||++.+ +| +.++|||||||++|+|++|+.||.+. +...+++.+..+.. .++...++
T Consensus 166 ---~~~~~~~~~GT~~Y~aPE~~~~-~~-~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (270)
T d1t4ha_ 166 ---RASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240 (270)
T ss_dssp ---CTTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred ---cCCccCCcccCccccCHHHhCC-CC-CCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCH
Confidence 2334567899999999999865 45 69999999999999999999999764 45566677666543 34456899
Q ss_pred HHHHHHHHccccCccCCCCHHHHhcCcccc
Q 014347 243 GAQNLLRKILEPNPVKRITIAGIKADEWFE 272 (426)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~eil~h~~f~ 272 (426)
++.+||.+||++||++|||++|+++||||+
T Consensus 241 ~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 999999999999999999999999999995
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.4e-60 Score=454.76 Aligned_cols=258 Identities=31% Similarity=0.548 Sum_probs=232.2
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccc------hhHHHHHHHHHHHHHhCC-CCCccceEEEEEe
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH------LKITDQIKREIATLKLLK-HPNVVRLHEVLAS 85 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~------~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~ 85 (426)
.++|++++.||+|+||+||+|++..+|+.||||++++..... ....+.+.+|+.+++.++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 579999999999999999999999999999999998765332 223457889999999997 9999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 86 ~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
++.+|+||||++||+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999999999998999999999999999999999999999999999999999999999999999998643
Q ss_pred cccCCCccccccCCCcccchhhhcc-----CCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCC--
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK-- 238 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~-- 238 (426)
. .......+||+.|+|||++.+ ...++.++||||+||+||+|++|+.||.+.+.......+..+....+.
T Consensus 162 ~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (277)
T d1phka_ 162 P---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238 (277)
T ss_dssp T---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred C---CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 2 233456789999999999863 233478999999999999999999999999999999999888765443
Q ss_pred --CCCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 239 --WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 239 --~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
.+|+++++||.+||++||.+|||++|+++||||++
T Consensus 239 ~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 58999999999999999999999999999999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8.8e-61 Score=474.85 Aligned_cols=259 Identities=27% Similarity=0.457 Sum_probs=227.3
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHH---HHHHHHHHhCCCCCccceEEEEEeCC
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI---KREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~---~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (426)
+.+++|++++.||+|+||.||+|++..+|+.||||++.+...........+ .+|+++++.++||||+++++++.+.+
T Consensus 1 lslddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~ 80 (364)
T d1omwa3 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 80 (364)
T ss_dssp CCSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CCHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC
Confidence 368899999999999999999999999999999999986554332222333 34577788888999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
.+|+||||++||+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~- 159 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK- 159 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS-
T ss_pred EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC-
Confidence 9999999999999999999989999999999999999999999999999999999999999999999999999985432
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCc---HHHHHHHHHcCCCCCCCCCCHHH
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGDFKLPKWLSPGA 244 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~ 244 (426)
......+||+.|+|||++.....++.++|||||||+||+|++|+.||.+.+ ...+...+......+|..+|+++
T Consensus 160 ---~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 236 (364)
T d1omwa3 160 ---KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 236 (364)
T ss_dssp ---SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHH
T ss_pred ---CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHH
Confidence 234567899999999999765555799999999999999999999998754 33455555666778888999999
Q ss_pred HHHHHHccccCccCCCC-----HHHHhcCccccc
Q 014347 245 QNLLRKILEPNPVKRIT-----IAGIKADEWFEQ 273 (426)
Q Consensus 245 ~~Li~~~L~~dP~~R~t-----~~eil~h~~f~~ 273 (426)
++||.+||++||.+||| ++++++||||+.
T Consensus 237 ~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 237 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp HHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred HHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 99999999999999999 799999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-61 Score=470.78 Aligned_cols=256 Identities=29% Similarity=0.446 Sum_probs=219.2
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
.-++|++++.||+|+||.||+|++..+|+.||+|++++.. ......++.+|+.+|+.++|||||++++++.+++.+|+
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4578999999999999999999999999999999997653 33446789999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-cCceeccCCCCcEEecCCCCeEEeeccCccCCccccCC
Q 014347 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~-~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 170 (426)
||||++||+|.+++.+.+++++..++.++.||+.||.|||+ +||+||||||+|||++.+|++||+|||+|+....
T Consensus 82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---- 157 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 157 (322)
T ss_dssp EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH----
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC----
Confidence 99999999999999988999999999999999999999997 5999999999999999999999999999985322
Q ss_pred CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHH------------------------
Q 014347 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY------------------------ 226 (426)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~------------------------ 226 (426)
....+.+||+.|+|||++.+..| +.++||||+||++|+|++|+.||.+.+.....
T Consensus 158 ~~~~~~~GT~~Y~APEvl~~~~y-~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 158 SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp HTC---CCSSCCCCHHHHHCSCC-CTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred CccccccCCccccCchHHcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 23456799999999999998777 68999999999999999999999765432110
Q ss_pred ------------------HHHHcC-CCCCCC-CCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 227 ------------------QKIFRG-DFKLPK-WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 227 ------------------~~i~~~-~~~~p~-~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
..+... ....|. .+|+++.+||.+||+.||.+|||++|+|+||||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 111111 111222 268899999999999999999999999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-60 Score=464.51 Aligned_cols=256 Identities=25% Similarity=0.484 Sum_probs=232.5
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 91 (426)
.++||++++.||+|+||+||+|+++.+|+.||||++++... ....+.+|+.+|+.++||||+++++++.+++.+|+
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc----cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 57899999999999999999999999999999999976532 23568899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCC--CCeEEeeccCccCCcccc
Q 014347 92 VLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHFR 168 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~~-~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~--g~vkL~DFGla~~~~~~~ 168 (426)
|||||+||+|+++|...+ ++++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~--- 155 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--- 155 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC---
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc---
Confidence 999999999999998654 79999999999999999999999999999999999999854 479999999998532
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCC----CCCHHH
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSPGA 244 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~ 244 (426)
......+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+....+.++.++.+.+|. .+|+++
T Consensus 156 ~~~~~~~~~~t~~y~ape~~~~~~~-~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 234 (321)
T d1tkia_ 156 PGDNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred cCCcccccccccccccchhccCCCC-CchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHH
Confidence 2344567789999999999887766 68999999999999999999999999999999999998887764 589999
Q ss_pred HHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 245 QNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
++||.+||++||++|||++|+++||||++..
T Consensus 235 ~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 265 (321)
T d1tkia_ 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHhhccCc
Confidence 9999999999999999999999999997643
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-60 Score=453.25 Aligned_cols=253 Identities=34% Similarity=0.595 Sum_probs=225.1
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchh---HHHHHHHHHHHHHhCC--CCCccceEEEEEeCC
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK--HPNVVRLHEVLASKS 87 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~---~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~ 87 (426)
-++|++++.||+|+||.||+|++..+|+.||||++++....... ...++.+|+.+|++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 47899999999999999999999999999999999875543221 1234678999999987 899999999999999
Q ss_pred EEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCC-CCeEEeeccCccCCc
Q 014347 88 KIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQ 165 (426)
Q Consensus 88 ~~~lV~Ey~~g-g~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~-g~vkL~DFGla~~~~ 165 (426)
..|+||||+.+ +++.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 99999999976 6888999888999999999999999999999999999999999999999854 789999999998532
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHH
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ 245 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 245 (426)
.....+.+||+.|+|||++.+..+++.++|||||||++|+|++|+.||.+.+ .+.++...+++.+|++++
T Consensus 163 ----~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~~~~s~~~~ 232 (273)
T d1xwsa_ 163 ----DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQ 232 (273)
T ss_dssp ----SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHHHH
T ss_pred ----cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCCCCCCHHHH
Confidence 2344567899999999999888887788999999999999999999998743 456778889999999999
Q ss_pred HHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 246 NLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
+||++||++||++|||++|+++||||++..
T Consensus 233 ~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 233 HLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 999999999999999999999999998643
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-59 Score=453.39 Aligned_cols=258 Identities=25% Similarity=0.330 Sum_probs=218.6
Q ss_pred eeceEeecCceEEEEEEECCCCCeEEEEEeecccccch--hHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEec
Q 014347 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL--KITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (426)
Q Consensus 18 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~--~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey 95 (426)
.++.||+|+||+||+|++..+|+.||||++++...... .....+.+|+.+|+.++||||+++++++.+++.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 56899999999999999999999999999976543221 2235788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCcccc
Q 014347 96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT 175 (426)
Q Consensus 96 ~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 175 (426)
+.|+++..+......+++.+++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+.... ......+
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~--~~~~~~~ 159 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYTH 159 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS--CCCCCCC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCC--Ccccccc
Confidence 99988877777677899999999999999999999999999999999999999999999999999985433 2334456
Q ss_pred ccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC--C------------------C
Q 014347 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--F------------------K 235 (426)
Q Consensus 176 ~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~------------------~ 235 (426)
.+||+.|+|||++.....++.++||||+||++|+|++|..||.+.+..+...++.+.. + .
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhcc
Confidence 7899999999998876666899999999999999999999999988887777665310 0 0
Q ss_pred C--------CCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccCCC
Q 014347 236 L--------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (426)
Q Consensus 236 ~--------p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 277 (426)
. .+.+++++.+||++||+.||++|||++|+|+||||++...|
T Consensus 240 ~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p 289 (299)
T d1ua2a_ 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 289 (299)
T ss_dssp CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence 0 12368899999999999999999999999999999865443
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-58 Score=444.82 Aligned_cols=261 Identities=29% Similarity=0.456 Sum_probs=220.1
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (426)
+++|++++.||+|+||+||+|++..+|+.||||+++.... .....+++.+|+.+|++++||||+++++++.+++.+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 5799999999999999999999999999999999975542 233457889999999999999999999999999999999
Q ss_pred EeccCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCC
Q 014347 93 LEYVTGGELFDKIA--SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~--~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 170 (426)
|||+.|+ +.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|+.... ..
T Consensus 80 ~e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~--~~ 156 (298)
T d1gz8a_ 80 FEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PV 156 (298)
T ss_dssp EECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC--CS
T ss_pred EeecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccC--Cc
Confidence 9999764 444443 245799999999999999999999999999999999999999999999999999975322 23
Q ss_pred CccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC-----------------
Q 014347 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD----------------- 233 (426)
Q Consensus 171 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~----------------- 233 (426)
......+||+.|+|||++....+.+.++||||+||++|+|++|+.||.+.+......++....
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence 344566899999999999888888899999999999999999999999988776655554210
Q ss_pred -CCCC-----------CCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccCCC
Q 014347 234 -FKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277 (426)
Q Consensus 234 -~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 277 (426)
...+ ..+|+++.+||++||++||++|||++|+++||||++-..|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 0111 1357899999999999999999999999999999875544
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-58 Score=453.60 Aligned_cols=256 Identities=30% Similarity=0.577 Sum_probs=217.5
Q ss_pred cCCccCCCeeeec-eEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHH-hCCCCCccceEEEEEe
Q 014347 8 QEGMRLGRYELGR-TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK-LLKHPNVVRLHEVLAS 85 (426)
Q Consensus 8 ~~~~~~~~y~i~~-~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~-~l~hpnIv~l~~~~~~ 85 (426)
+....+++|++++ .||+|+||.||+|++..+|+.||||++++. ..+.+|+.++. ..+||||+++++++.+
T Consensus 5 ~~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~ 76 (335)
T d2ozaa1 5 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYEN 76 (335)
T ss_dssp BCSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred CCCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 4456689999875 699999999999999999999999998643 45778999865 5689999999999876
Q ss_pred ----CCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecC---CCCeEEe
Q 014347 86 ----KSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KGNIKIS 156 (426)
Q Consensus 86 ----~~~~~lV~Ey~~gg~L~~~i~~~--~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~---~g~vkL~ 156 (426)
+..+|+|||||+||+|+++|.+. .++++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+
T Consensus 77 ~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred cccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccc
Confidence 46789999999999999999864 46999999999999999999999999999999999999985 4579999
Q ss_pred eccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHH----HHHHHHcC
Q 014347 157 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV----LYQKIFRG 232 (426)
Q Consensus 157 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~----~~~~i~~~ 232 (426)
|||+|+.... .....+.+||+.|+|||++.+..| +.++|||||||+||+|+||+.||.+.+... +..++..+
T Consensus 157 DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~y-~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~ 232 (335)
T d2ozaa1 157 DFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 232 (335)
T ss_dssp CCTTCEECCC---CCCCCCCSCCCSSCCCCCCCGGGG-SHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSC
T ss_pred ccceeeeccC---CCccccccCCcccCCcHHHcCCCC-CHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcC
Confidence 9999985432 334567799999999999988777 589999999999999999999998765433 33344445
Q ss_pred CCCCCC----CCCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 233 DFKLPK----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 233 ~~~~p~----~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
.+.+|. .+|+++.+||++||++||++|||+.|+++||||.+..
T Consensus 233 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 233 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 555553 3899999999999999999999999999999997643
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.9e-58 Score=437.06 Aligned_cols=261 Identities=27% Similarity=0.424 Sum_probs=221.4
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC---
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS--- 87 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 87 (426)
..-++|++++.||+|+||.||+|++..+|+.||||++++....+.....++.+|+.+|+.++||||+++++++...+
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence 34578999999999999999999999999999999998877666777788999999999999999999999987654
Q ss_pred -EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcc
Q 014347 88 -KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (426)
Q Consensus 88 -~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 166 (426)
.+|+||||++|++|.+++...+++++.+++.++.||+.||+|||++||+||||||+|||++.++..+|+|||.+.....
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred ceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 4899999999999999999989999999999999999999999999999999999999999999999999998875432
Q ss_pred cc-CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCC----CCCC
Q 014347 167 FR-DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLS 241 (426)
Q Consensus 167 ~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 241 (426)
.. ......+.+||+.|+|||++.+..| ++++||||+||++|+|+||+.||.+.+..+...++.......| +.+|
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s 242 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242 (277)
T ss_dssp ---------------TTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCC
T ss_pred ccccccccccccCcccccCHHHHcCCCC-CcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCC
Confidence 21 2224456789999999999987766 6899999999999999999999999998888888877665443 4589
Q ss_pred HHHHHHHHHccccCccCCCCHHHHhcCcccc
Q 014347 242 PGAQNLLRKILEPNPVKRITIAGIKADEWFE 272 (426)
Q Consensus 242 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~ 272 (426)
+++.+||.+||++||++||+..+.+.|+|.+
T Consensus 243 ~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 243 ADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 9999999999999999999555555677764
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.7e-58 Score=438.88 Aligned_cols=257 Identities=31% Similarity=0.465 Sum_probs=220.2
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (426)
++||++++.||+|+||.||+|+++ +|+.||||+++.... .....+++.+|+.+|++++||||+++++++.+++..|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 579999999999999999999985 789999999976543 233457899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
|||+.++.+..+....+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..... ....
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~--~~~~ 156 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRK 156 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceeccc--Cccc
Confidence 99999888877777788999999999999999999999999999999999999999999999999999875322 2223
Q ss_pred cccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC--CC----------------
Q 014347 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DF---------------- 234 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~---------------- 234 (426)
.....|++.|+|||++.+..+.+.++||||+||++|+|++|+.||.+.+......++... .+
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 445679999999999988777789999999999999999999999998877666655421 00
Q ss_pred -----------CCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 235 -----------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 235 -----------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
..+..+++.+.+||++||++||++|||++|+++||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 123346889999999999999999999999999999974
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-56 Score=436.12 Aligned_cols=266 Identities=25% Similarity=0.339 Sum_probs=219.3
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe----
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS---- 85 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~---- 85 (426)
...++||+++++||+|+||+||+|++..+|+.||||++.+.... .....++.+|+.+|+.++||||+++++++..
T Consensus 6 ~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~ 84 (318)
T d3blha1 6 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASP 84 (318)
T ss_dssp SCBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred CCccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeccccc
Confidence 34579999999999999999999999999999999998765432 2345678899999999999999999999854
Q ss_pred ----CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCc
Q 014347 86 ----KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS 161 (426)
Q Consensus 86 ----~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla 161 (426)
...+|+||||+.++.+.........+++..++.+++||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 85 ~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 85 YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp ------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeeccee
Confidence 3468999999988777666666778999999999999999999999999999999999999999999999999999
Q ss_pred cCCcccc--CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCCCCC-
Q 014347 162 ALPQHFR--DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK- 238 (426)
Q Consensus 162 ~~~~~~~--~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~- 238 (426)
+...... ......+.+||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+.......+.......++
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 7543221 2233455689999999999887665679999999999999999999999988877666555432111110
Q ss_pred -------------------------------CCCHHHHHHHHHccccCccCCCCHHHHhcCccccccCC
Q 014347 239 -------------------------------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (426)
Q Consensus 239 -------------------------------~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 276 (426)
..++++.+||.+||++||++|||++|+++||||+..+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~ 313 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 313 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSC
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCC
Confidence 02678899999999999999999999999999986543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-57 Score=429.51 Aligned_cols=253 Identities=25% Similarity=0.404 Sum_probs=208.1
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (426)
+..++|++++.||+|+||.||+|+. +..||||+++.... .....+.+.+|+.+|++++||||+++++++. .+.+|
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~ 79 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLA 79 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEE
Confidence 4568899999999999999999974 33599999976543 3345678999999999999999999999875 45689
Q ss_pred EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
+|||||+||+|.+++.. .+++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 99999999999999975 46799999999999999999999999999999999999999999999999999987654333
Q ss_pred CCccccccCCCcccchhhhccC--CCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHH-HHHHHHcCCC-----CCCCCCC
Q 014347 170 DGLLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYVILTGYLPFDDRNLAV-LYQKIFRGDF-----KLPKWLS 241 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~--~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~-----~~p~~~s 241 (426)
.....+.+||+.|+|||++... ..++.++|||||||+||||+||+.||.+.+... +...+.++.. ..+..++
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 239 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCC
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccch
Confidence 3455667899999999998643 223689999999999999999999998865443 3444444322 2356689
Q ss_pred HHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 242 PGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 242 ~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
+++.+||.+||+.||++|||+++|+++
T Consensus 240 ~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 240 KAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999999987
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-56 Score=424.69 Aligned_cols=259 Identities=28% Similarity=0.440 Sum_probs=225.3
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 92 (426)
++||++++.||+|+||+||+|++..+|+.||||+++.... ......++.+|+.+|+.++||||+++++++.+....+++
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 5799999999999999999999999999999999976653 445578899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
++++.|++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|..... ....
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~--~~~~ 157 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRC 157 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--CCSC
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccC--CCcc
Confidence 99999999999988888999999999999999999999999999999999999999999999999999986433 2223
Q ss_pred cccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCC-CCCcHHHHHHHHHcC-------------------
Q 014347 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFRG------------------- 232 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf-~~~~~~~~~~~i~~~------------------- 232 (426)
.....+++.|+|||++....+.+.++||||+||++|+|++|..|| .+.+......++...
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 344567889999999988777789999999999999999999885 555555555554321
Q ss_pred ----------CCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 233 ----------DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 233 ----------~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
....+..+++.+.+||++||++||.+|||++|+|+||||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 011223468899999999999999999999999999999764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-57 Score=440.42 Aligned_cols=254 Identities=24% Similarity=0.377 Sum_probs=215.9
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCC-----eEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEe
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGL-----PFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS 85 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~-----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 85 (426)
..++|++++.||+|+||+||+|++..+++ .||+|.+.... .......+.+|+.+|+++ +|||||++++++.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 34689999999999999999999876554 69999886543 223356788999999987 89999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCC
Q 014347 86 KSKIYMVLEYVTGGELFDKIASK-----------------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKL 142 (426)
Q Consensus 86 ~~~~~lV~Ey~~gg~L~~~i~~~-----------------------~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp 142 (426)
.+.+|+|||||+||+|.++|... +.+++..++.++.|++.||+|||++||+||||||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp 192 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 192 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCch
Confidence 99999999999999999999753 2489999999999999999999999999999999
Q ss_pred CcEEecCCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCc
Q 014347 143 ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRN 221 (426)
Q Consensus 143 ~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 221 (426)
+|||++.++++||+|||+|+............+.+||+.|+|||++.+..| +.++|||||||++|||+| |..||.+.+
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCC-CcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999986544333233446678999999999987777 689999999999999998 999999876
Q ss_pred HHHHHHHHHcC--CCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 222 LAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 222 ~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
......++... .++.|..+|+++.+||.+||+.||++|||++||++|
T Consensus 272 ~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 272 VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 65555555544 456778899999999999999999999999999876
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-56 Score=432.84 Aligned_cols=256 Identities=31% Similarity=0.410 Sum_probs=214.2
Q ss_pred CCCeeeeceEeecCceEEEEEEECCC-CCeEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCccceEEEEEe---
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLL---KHPNVVRLHEVLAS--- 85 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~--- 85 (426)
-++|++++.||+|+||+||+|++..+ ++.||||+++...... .....+.+|+.+|+.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 47999999999999999999999765 6679999997654322 1233466788777665 79999999999853
Q ss_pred --CCEEEEEEeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCcc
Q 014347 86 --KSKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (426)
Q Consensus 86 --~~~~~lV~Ey~~gg~L~~~i~-~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~ 162 (426)
...+|++|||+.++.+..... ....+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 357899999999877754443 34579999999999999999999999999999999999999999999999999988
Q ss_pred CCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC---------
Q 014347 163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--------- 233 (426)
Q Consensus 163 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--------- 233 (426)
.... .......+||+.|+|||++.+.+| +.++||||+||++|+|++|+.||.+.+......++....
T Consensus 165 ~~~~---~~~~~~~~gT~~Y~APE~~~~~~y-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 165 IYSF---QMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp CCCG---GGGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred hhcc---cccCCCcccChhhcCcchhcCCCC-ChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 5432 234557789999999999988877 689999999999999999999999988877776664310
Q ss_pred ------------------CCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 234 ------------------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 234 ------------------~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
..++..+++.+.+||.+||++||++|||++|+++||||++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence 0123457899999999999999999999999999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.1e-56 Score=429.90 Aligned_cols=255 Identities=22% Similarity=0.354 Sum_probs=210.9
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCC---eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (426)
...++|++.+.||+|+||+||+|++..+|+ .||||.+.... .....+.+.+|+.+|++++|||||++++++.+++
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 456789999999999999999999987765 58888876443 3445678999999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcc
Q 014347 88 KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 166 (426)
..|+|||||+||+|.+++.. .+.+++.++..++.||++||.|||++||+||||||+||||+.++.+||+|||+|+....
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence 99999999999999998876 45799999999999999999999999999999999999999999999999999986543
Q ss_pred ccCCC---ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCC
Q 014347 167 FRDDG---LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLS 241 (426)
Q Consensus 167 ~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s 241 (426)
..... ......||+.|+|||++.+..| +.++|||||||++|||+| |..||.+.+...+...+..+ .++.|..++
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 259 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCP 259 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCC-CcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccch
Confidence 22111 1122468999999999987776 689999999999999998 89999999888888888765 466777899
Q ss_pred HHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 242 PGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 242 ~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
+.+.+|+.+||+.||++|||+.+|+++
T Consensus 260 ~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 260 SALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999998765
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-56 Score=422.44 Aligned_cols=248 Identities=23% Similarity=0.415 Sum_probs=210.1
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
++|++++.||+|+||.||+|++. +++.||||++++.... .+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~ 79 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 79 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence 58999999999999999999975 5678999999764432 357899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 94 EYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
||+++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++++||+|||+|+...... ...
T Consensus 80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~-~~~ 158 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTS 158 (263)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCC-cee
Confidence 999999999998754 568999999999999999999999999999999999999999999999999998653321 122
Q ss_pred cccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHHHHHH
Q 014347 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRK 250 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~ 250 (426)
.....||+.|+|||++.+..| +.++|||||||++|||+| |.+||...+...+...+..+ ....|..+++++.+|+.+
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~-~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 237 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 237 (263)
T ss_dssp ------CTTSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred ecceecCcccCChHHhcCCCC-CchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 344679999999999988777 689999999999999999 68888888888888888776 456678899999999999
Q ss_pred ccccCccCCCCHHHHhcC
Q 014347 251 ILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 251 ~L~~dP~~R~t~~eil~h 268 (426)
||+.||++|||+++|++|
T Consensus 238 cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 238 CWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-56 Score=429.97 Aligned_cols=251 Identities=27% Similarity=0.392 Sum_probs=218.7
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (426)
+..++|++++.||+|+||.||+|++..+|+.||||+++++.. ..+++.+|+.+|++++||||+++++++.+++.+|
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 345689999999999999999999999999999999876542 2467899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 91 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~~--~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
+|||||++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+.....
T Consensus 90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~- 168 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD- 168 (287)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS-
T ss_pred EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCC-
Confidence 999999999999999753 57899999999999999999999999999999999999999999999999999865331
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCC-CCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHH
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY-LPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 246 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~-~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 246 (426)
.........||+.|+|||++.+..| +.++|||||||++|+|++|. +||.+.+...+++.+..+ .++.|..+++++.+
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 247 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 247 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred CceeeccccccccccChHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHH
Confidence 1112233468899999999988777 68999999999999999954 556666777777666554 46778889999999
Q ss_pred HHHHccccCccCCCCHHHHhc
Q 014347 247 LLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 247 Li~~~L~~dP~~R~t~~eil~ 267 (426)
||.+||+.||++|||++++++
T Consensus 248 li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 248 LMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHH
Confidence 999999999999999999965
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-56 Score=427.57 Aligned_cols=249 Identities=23% Similarity=0.350 Sum_probs=212.4
Q ss_pred ceEeecCceEEEEEEEC--CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEEeccC
Q 014347 20 RTLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (426)
Q Consensus 20 ~~LG~G~fg~Vy~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~Ey~~ 97 (426)
++||+|+||.||+|.+. .+++.||||+++.... +....+.+.+|+.+|++++||||+++++++.++ ..|+||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 47999999999999864 4567899999965432 344567899999999999999999999998654 5789999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCC-Cccccc
Q 014347 98 GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD-GLLHTT 176 (426)
Q Consensus 98 gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~-~~~~~~ 176 (426)
||+|.+++.+..++++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+........ ......
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 170 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence 9999999999889999999999999999999999999999999999999999999999999999854332111 122345
Q ss_pred cCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHcccc
Q 014347 177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEP 254 (426)
Q Consensus 177 ~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~ 254 (426)
.||+.|+|||++.+..+ +.++|||||||++|||+| |..||.+.+..++...+.++ .++.|..+|+++.+||.+||+.
T Consensus 171 ~gt~~y~APE~l~~~~~-~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~ 249 (277)
T d1xbba_ 171 KWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249 (277)
T ss_dssp CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCceecCchhhcCCCC-CchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCC
Confidence 79999999999987776 689999999999999998 99999998888888888776 4677888999999999999999
Q ss_pred CccCCCCHHHH---hcCccc
Q 014347 255 NPVKRITIAGI---KADEWF 271 (426)
Q Consensus 255 dP~~R~t~~ei---l~h~~f 271 (426)
||++|||+++| |+|+|+
T Consensus 250 dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 250 DVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp STTTSCCHHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHhhCHHh
Confidence 99999999998 456554
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-56 Score=425.76 Aligned_cols=257 Identities=25% Similarity=0.355 Sum_probs=221.0
Q ss_pred CCCeeeece-EeecCceEEEEEEECC--CCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 13 LGRYELGRT-LGEGNFGKVKFAQDLD--SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 13 ~~~y~i~~~-LG~G~fg~Vy~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
-++|.+.+. ||+|+||.||+|.+.. ++..||||++++.. .....+.+.+|+.+|++++||||+++++++.+ +.+
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~ 83 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 83 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence 356888885 9999999999998764 45579999997543 34456789999999999999999999999875 458
Q ss_pred EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
|+||||++||+|.+++.. ++.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 999999999999998765 4679999999999999999999999999999999999999999999999999998654321
Q ss_pred C-CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHH
Q 014347 169 D-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ 245 (426)
Q Consensus 169 ~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 245 (426)
. .......+||+.|+|||++....+ +.++|||||||++|||+| |..||.+.+..++...+..+ .++.|+.+|+++.
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~ 242 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY 242 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cccccccccccCccccChHHHhCCCC-CccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence 1 122334579999999999987776 689999999999999998 99999998888888888776 4678889999999
Q ss_pred HHHHHccccCccCCCCHHHH---hcCccccc
Q 014347 246 NLLRKILEPNPVKRITIAGI---KADEWFEQ 273 (426)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~ei---l~h~~f~~ 273 (426)
+||.+||+.||++|||+.+| |+|+|+.-
T Consensus 243 ~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 243 ALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 99999999999999999887 67787753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-56 Score=424.34 Aligned_cols=255 Identities=26% Similarity=0.419 Sum_probs=219.6
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 90 (426)
+..++|++++.||+|+||.||+|++. +++.||||+++..... .+.+.+|+.+|++++||||+++++++.+ +..|
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~ 83 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeE
Confidence 34578999999999999999999974 6788999999754422 4678999999999999999999998754 5679
Q ss_pred EEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 91 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~--~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
+||||+++|+|.+++.. ..++++..+..++.||+.||.|||++||+||||||+||||++++.+||+|||+|+.....
T Consensus 84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~- 162 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN- 162 (272)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS-
T ss_pred EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCC-
Confidence 99999999999997754 336999999999999999999999999999999999999999999999999999865321
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHH
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 246 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 246 (426)
.........||+.|+|||++....+ +.++|||||||++|||+| |.+||...+.....+.+..+ .+..|..+++++.+
T Consensus 163 ~~~~~~~~~gt~~y~APE~~~~~~~-~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 241 (272)
T d1qpca_ 163 EYTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 241 (272)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ccccccccCCcccccChHHHhCCCC-CchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHH
Confidence 1122335679999999999987766 689999999999999999 56777777887888887765 46678889999999
Q ss_pred HHHHccccCccCCCCHHHHhc--Cccccc
Q 014347 247 LLRKILEPNPVKRITIAGIKA--DEWFEQ 273 (426)
Q Consensus 247 Li~~~L~~dP~~R~t~~eil~--h~~f~~ 273 (426)
|+.+||+.||++|||++++++ |+||..
T Consensus 242 li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 242 LMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 999999999999999999988 788853
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-56 Score=435.59 Aligned_cols=254 Identities=29% Similarity=0.412 Sum_probs=213.5
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC-----
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----- 87 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----- 87 (426)
-++|++++.||+|+||+||+|++..+|+.||||++++... .....+++.+|+.+|+.++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 4799999999999999999999999999999999976433 4455788999999999999999999999997654
Q ss_pred -EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcc
Q 014347 88 -KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166 (426)
Q Consensus 88 -~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 166 (426)
.+|+||||+ |.+|...+. .+++++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+|+...
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~- 172 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD- 172 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC-
Confidence 579999999 667766654 5789999999999999999999999999999999999999999999999999998543
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCC-------------
Q 014347 167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD------------- 233 (426)
Q Consensus 167 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------- 233 (426)
......+||+.|+|||++.+..+.+.++||||+||++|+|++|+.||.+.+.......+....
T Consensus 173 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 173 ----SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp ----SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred ----CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence 234567899999999999887777899999999999999999999999887665544433210
Q ss_pred ------------------CCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCcccccc
Q 014347 234 ------------------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274 (426)
Q Consensus 234 ------------------~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 274 (426)
...+..+++++.+||++||+.||++|||++|+|+||||+.-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 01234578999999999999999999999999999999863
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-56 Score=432.50 Aligned_cols=263 Identities=31% Similarity=0.585 Sum_probs=228.3
Q ss_pred CccCCCeeeeceEeecCceEEEEEEEC---CCCCeEEEEEeeccccc-chhHHHHHHHHHHHHHhCCC-CCccceEEEEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLLKH-PNVVRLHEVLA 84 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~ 84 (426)
.+.+++|++++.||+|+||+||+|++. .+|+.||||++++.... +....+.+.+|+.+|++++| |||+++++++.
T Consensus 20 ~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~ 99 (322)
T d1vzoa_ 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 99 (322)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred ccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec
Confidence 356799999999999999999999974 47899999999765432 22335678899999999977 89999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCC
Q 014347 85 SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP 164 (426)
Q Consensus 85 ~~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~ 164 (426)
+....|++|||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 100 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 100 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred cCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999754
Q ss_pred ccccCCCccccccCCCcccchhhhccCC-CCCCcchhhhHHHHHHHHHhCCCCCCCCc----HHHHHHHHHcCCCCCCCC
Q 014347 165 QHFRDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRGDFKLPKW 239 (426)
Q Consensus 165 ~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~~~~~~p~~ 239 (426)
... ......+.+|++.|+|||.+.... +.+.++|||||||+||+|++|+.||.+.+ ...+........+++|..
T Consensus 180 ~~~-~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (322)
T d1vzoa_ 180 VAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 258 (322)
T ss_dssp CGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred ccc-ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCccc
Confidence 332 223445678999999999987644 45788999999999999999999997754 334555556677888889
Q ss_pred CCHHHHHHHHHccccCccCCC-----CHHHHhcCccccc
Q 014347 240 LSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 273 (426)
Q Consensus 240 ~s~~~~~Li~~~L~~dP~~R~-----t~~eil~h~~f~~ 273 (426)
+|+++.+||++||++||.+|| |++|+++||||+.
T Consensus 259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 999999999999999999999 5899999999974
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-55 Score=415.78 Aligned_cols=248 Identities=23% Similarity=0.409 Sum_probs=222.3
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 93 (426)
++|+++++||+|+||+||+|++ .+++.||||++++.... .+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 6899999999999999999998 47889999999875432 357899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccCCCc
Q 014347 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172 (426)
Q Consensus 94 Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 172 (426)
||+++|+|.+++.. ...+++..+++++.|+++||+|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~-~~~~ 157 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTS 157 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS-SCCC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC-Ccee
Confidence 99999999998764 567999999999999999999999999999999999999999999999999999865432 2223
Q ss_pred cccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHHHHHH
Q 014347 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRK 250 (426)
Q Consensus 173 ~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~ 250 (426)
....+||+.|+|||++.+..+ +.++|||||||++|||+| |+.||.+.+..++..++..+ ....|..+++.+.+||++
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~-~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 236 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 236 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred ecccCCCCCcCCcHHhcCCCC-CcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHH
Confidence 334679999999999988777 589999999999999998 89999999998888888876 456778899999999999
Q ss_pred ccccCccCCCCHHHHhcC
Q 014347 251 ILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 251 ~L~~dP~~R~t~~eil~h 268 (426)
||+.||++|||+++|++|
T Consensus 237 cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 237 CWHEKADERPTFKILLSN 254 (258)
T ss_dssp TTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-55 Score=431.12 Aligned_cols=260 Identities=28% Similarity=0.429 Sum_probs=215.3
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC----EE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----KI 89 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~~ 89 (426)
.||++++.||+|+||+||+|++..+|+.||||++++.. .....+++.+|+.+|+.++||||+++++++.... ..
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 57999999999999999999999999999999997543 3445678999999999999999999999987653 23
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 169 (426)
+++++|+.||+|++++.. +++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|........
T Consensus 86 ~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 444566779999999976 5799999999999999999999999999999999999999999999999999985433222
Q ss_pred -CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC--C-------------
Q 014347 170 -DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--D------------- 233 (426)
Q Consensus 170 -~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~------------- 233 (426)
.......+||+.|+|||++.....++.++||||+||++|+|++|+.||.+.+........... .
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence 223456789999999999877666689999999999999999999999987765544333210 0
Q ss_pred -----------C-----CCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccCC
Q 014347 234 -----------F-----KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (426)
Q Consensus 234 -----------~-----~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 276 (426)
. ...+.+++++.+||.+||+.||.+|||++|+|+||||++...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 0 012347889999999999999999999999999999986543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-55 Score=433.82 Aligned_cols=253 Identities=28% Similarity=0.364 Sum_probs=212.5
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe------CC
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------KS 87 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------~~ 87 (426)
-+|+.+++||+|+||+||+|++..+|+.||||++.+... ...+|+.+|++++||||+++++++.. ..
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence 379999999999999999999999999999999976542 23479999999999999999999854 34
Q ss_pred EEEEEEeccCCCChHH---HHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCC-CeEEeeccCccC
Q 014347 88 KIYMVLEYVTGGELFD---KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSAL 163 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~---~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g-~vkL~DFGla~~ 163 (426)
.+|+||||++++.+.. +......+++.+++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence 5899999998764333 233466899999999999999999999999999999999999999876 899999999985
Q ss_pred CccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC-----------
Q 014347 164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG----------- 232 (426)
Q Consensus 164 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~----------- 232 (426)
.. ......+.+||+.|+|||++.+...++.++||||+||++|+|++|+.||...+....+.++.+.
T Consensus 173 ~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 173 LV---RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CC---TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred cc---CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 43 2334556789999999999887666689999999999999999999999988777666555421
Q ss_pred ------CCCC------------CCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccCC
Q 014347 233 ------DFKL------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276 (426)
Q Consensus 233 ------~~~~------------p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 276 (426)
...+ ...+++++.+||.+||++||.+|||+.|+|+||||++...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 1111 2347899999999999999999999999999999986543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-55 Score=416.60 Aligned_cols=252 Identities=27% Similarity=0.432 Sum_probs=209.0
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCC---CeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (426)
..++|++++.||+|+||.||+|++..++ ..||||.++... .....+.+.+|+.+|++++||||+++++++. ++.
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 81 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 81 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCe
Confidence 3468999999999999999999987553 458888875432 4445678999999999999999999999985 567
Q ss_pred EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 89 IYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
+|+||||+++|+|.+++.. .+++++..++.++.||++||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 8999999999999998765 557999999999999999999999999999999999999999999999999999864332
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHH
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQ 245 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 245 (426)
........+||+.|+|||++.+..| +.++|||||||++|||++ |.+||.+.+...++.++..+. .+.|+.+|+.+.
T Consensus 162 -~~~~~~~~~gt~~y~apE~l~~~~~-~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 239 (273)
T d1mp8a_ 162 -TYYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 239 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred -cceeccceecCcccchhhHhccCCC-CCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 1223345678999999999987777 589999999999999998 999999998888888887764 678888999999
Q ss_pred HHHHHccccCccCCCCHHHHhcC
Q 014347 246 NLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~eil~h 268 (426)
+||.+||+.||++|||+.+|++|
T Consensus 240 ~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 240 SLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999876
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-55 Score=431.02 Aligned_cols=255 Identities=30% Similarity=0.394 Sum_probs=216.8
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC-----CE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----SK 88 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~ 88 (426)
+||++++.||+|+||+||+|++..+|+.||||++++... +....+++.+|+.+|+.++||||+++++++... ..
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 689999999999999999999999999999999976543 334467889999999999999999999998633 33
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
.+++|+|+.||+|.+++.. +++++.+++.+++||+.||+|||++||+||||||+|||++.+|.+|++|||++....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~--- 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--- 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT---
T ss_pred eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC---
Confidence 4666778889999998865 679999999999999999999999999999999999999999999999999997532
Q ss_pred CCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcCCCC-------------
Q 014347 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK------------- 235 (426)
Q Consensus 169 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~------------- 235 (426)
....+.+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 173 --~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (348)
T d2gfsa1 173 --DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250 (348)
T ss_dssp --GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred --cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence 23456789999999999888777789999999999999999999999998877666665432111
Q ss_pred ----------C--------CCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 236 ----------L--------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 236 ----------~--------p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
. ...+++++.+||++||+.||.+|||++|+|+||||++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 1 123689999999999999999999999999999998754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=415.21 Aligned_cols=257 Identities=25% Similarity=0.396 Sum_probs=215.8
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
.+..++|++++.||+|+||+||+|++..+ +.||||+++..... .+.+.+|+.+|++++||||+++++++.+ +.+
T Consensus 13 ~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~ 86 (285)
T d1fmka3 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 86 (285)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred EcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEec-CCe
Confidence 34568999999999999999999998655 56999999755432 3678999999999999999999999854 568
Q ss_pred EEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 90 YMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~--~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
|+||||+++|+|.+++.. .+.+++.+++.++.||+.||+|||++||+||||||+||||+.++++||+|||+|+.....
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 999999999999988854 457999999999999999999999999999999999999999999999999999864321
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHH
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ 245 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 245 (426)
........+||+.|+|||++.+..+ +.++|||||||++|+|++ |.+||.+.+...+...+..+ ..+.|..+++++.
T Consensus 167 -~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 244 (285)
T d1fmka3 167 -EYTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH 244 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHH
T ss_pred -CceeeccccccccccChHHHhCCCC-CcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHH
Confidence 1122334679999999999988777 689999999999999999 56667777777788777765 4678888999999
Q ss_pred HHHHHccccCccCCCCHHHHhc--Ccccccc
Q 014347 246 NLLRKILEPNPVKRITIAGIKA--DEWFEQD 274 (426)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~eil~--h~~f~~~ 274 (426)
+||.+||+.||++|||+++|++ ++||...
T Consensus 245 ~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 245 DLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 9999999999999999999987 7788653
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-54 Score=421.79 Aligned_cols=253 Identities=22% Similarity=0.336 Sum_probs=212.5
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCC----eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGL----PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 88 (426)
-.+|++++.||+|+||+||+|.+..+|+ .||+|.++... ..+..+.+.+|+.+|++++||||+++++++.++ .
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 84 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence 3679999999999999999999988877 47777775432 233467899999999999999999999999865 4
Q ss_pred EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 89 IYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
.++++||+.+|+|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 6788899999999998876 467999999999999999999999999999999999999999999999999999865433
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHH
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQ 245 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 245 (426)
..........||+.|+|||++.+..| +.++|||||||++|||+| |.+||.+.+...+...+..+. ++.|+.+++.+.
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~ 243 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY 243 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHH
T ss_pred cccccccccccCccccChHHHhcCCC-ChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHH
Confidence 22233344578999999999988776 689999999999999998 899999988777777777664 677888999999
Q ss_pred HHHHHccccCccCCCCHHHHhcCc
Q 014347 246 NLLRKILEPNPVKRITIAGIKADE 269 (426)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~eil~h~ 269 (426)
+|+.+||+.||.+|||+.+|+.|-
T Consensus 244 ~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 244 MIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHhCCCChhhCcCHHHHHHHH
Confidence 999999999999999999999884
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.1e-54 Score=420.75 Aligned_cols=250 Identities=24% Similarity=0.422 Sum_probs=209.8
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEEe--CCE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLAS--KSK 88 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~--~~~ 88 (426)
..++|+++++||+|+||+||+|+++.+|+.||||++++.. .+++.+|+.+|+.++ ||||+++++++.. ...
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 4478999999999999999999999999999999996543 467889999999986 9999999999974 456
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCC-CeEEeeccCccCCccc
Q 014347 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQHF 167 (426)
Q Consensus 89 ~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g-~vkL~DFGla~~~~~~ 167 (426)
+|+||||+.+++|.+.. +.+++.+++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~- 182 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP- 182 (328)
T ss_dssp EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT-
T ss_pred eeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC-
Confidence 99999999999997763 5699999999999999999999999999999999999998765 589999999985432
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHH-HHHHHHH-------------cCC
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIF-------------RGD 233 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~-~~~~~i~-------------~~~ 233 (426)
.......+||+.|+|||++.+...++.++||||+||++|+|++|..||...+.. .....+. ...
T Consensus 183 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 183 --GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp --TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred --CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 334566789999999999887766679999999999999999999999764321 1111111 000
Q ss_pred C------------------------CCCCCCCHHHHHHHHHccccCccCCCCHHHHhcCccccc
Q 014347 234 F------------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273 (426)
Q Consensus 234 ~------------------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 273 (426)
. .....+++++.+||++||++||.+|||++|+|+||||+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 0 011236889999999999999999999999999999975
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-54 Score=410.20 Aligned_cols=254 Identities=24% Similarity=0.366 Sum_probs=210.4
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCC----CeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeC
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 86 (426)
+.-+.|++.+.||+|+||.||+|.+..++ ..||||.+.... .......+.+|+.+|++++||||+++++++.+.
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 34467999999999999999999976554 469999986543 334456789999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 87 SKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
...++||||+.++++.+.+... +.+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+...
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999999999988654 679999999999999999999999999999999999999999999999999998654
Q ss_pred cccC-CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCH
Q 014347 166 HFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSP 242 (426)
Q Consensus 166 ~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 242 (426)
.... ........||+.|+|||++.+..+ +.++|||||||++|||++ |.+||.+.+...++..+..+ .++.|..+++
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 240 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS 240 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBH
T ss_pred CCCccceEeccCCCCccccCHHHHccCCC-CCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHH
Confidence 3211 112334578999999999987776 589999999999999999 56667777777777777665 4567788999
Q ss_pred HHHHHHHHccccCccCCCCHHHHhc
Q 014347 243 GAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 243 ~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
.+.+||.+||+.||++|||+.+|++
T Consensus 241 ~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 241 AIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 9999999999999999999999976
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8e-54 Score=414.10 Aligned_cols=252 Identities=26% Similarity=0.365 Sum_probs=219.9
Q ss_pred CCCeeeeceEeecCceEEEEEEEC-----CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 87 (426)
.++|++++.||+|+||+||+|+.. .+++.||||+++... ..+..+++.+|+.+|+.++||||+++++++....
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 468999999999999999999875 356789999987543 3445678999999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCC
Q 014347 88 KIYMVLEYVTGGELFDKIASKG------------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLE 143 (426)
Q Consensus 88 ~~~lV~Ey~~gg~L~~~i~~~~------------------------~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~ 143 (426)
..+++|||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~ 169 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence 9999999999999999996432 3889999999999999999999999999999999
Q ss_pred cEEecCCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhC-CCCCCCCcH
Q 014347 144 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNL 222 (426)
Q Consensus 144 NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG-~~Pf~~~~~ 222 (426)
|||++.++++||+|||+|+............+.+||+.|+|||++.+..| +.++|||||||++|||++| .+||.+.+.
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-t~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCC-ChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 99999999999999999985443333334456789999999999988777 5899999999999999998 478999999
Q ss_pred HHHHHHHHcCC-CCCCCCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 223 AVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 223 ~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
.++...+..+. ++.|..+++++.+||.+||+.||++|||+.||++
T Consensus 249 ~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 249 EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 88888888775 4567889999999999999999999999999964
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-54 Score=413.82 Aligned_cols=255 Identities=25% Similarity=0.371 Sum_probs=204.9
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECC-----CCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA 84 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 84 (426)
+..++|++++.||+|+||.||+|++.. +++.||||+++... .....+.+.+|..++.++ +|+||+.+++++.
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~ 87 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 87 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence 445789999999999999999999754 45689999987543 233356677788877766 6899999999876
Q ss_pred eC-CEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEe
Q 014347 85 SK-SKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL 147 (426)
Q Consensus 85 ~~-~~~~lV~Ey~~gg~L~~~i~~~----------------~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl 147 (426)
.. ..+|+|||||+||+|.+++... ..+++.+++.++.||++||.|||++||+||||||+|||+
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl 167 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 167 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE
Confidence 54 5689999999999999999753 248999999999999999999999999999999999999
Q ss_pred cCCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhC-CCCCCCCcHHHH-
Q 014347 148 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLAVL- 225 (426)
Q Consensus 148 ~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG-~~Pf~~~~~~~~- 225 (426)
+.++++||+|||+|+..............+||+.|+|||++.+..+ +.++|||||||++|+|++| ..||.+.+....
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~ 246 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999986544333334456789999999999988766 6899999999999999986 678887654433
Q ss_pred HHHHHcC-CCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 226 YQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 226 ~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
...+..+ .++.|..+++++.+||.+||+.||++|||++|+++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 247 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3444443 467788899999999999999999999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=422.72 Aligned_cols=256 Identities=29% Similarity=0.432 Sum_probs=206.5
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe------
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------ 85 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 85 (426)
.+++|+++++||+|+||+||+|+++.+|+.||||++.+... +.....++.+|+.+|+.++||||+++++++..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 35799999999999999999999999999999999986543 44556789999999999999999999999953
Q ss_pred CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCc
Q 014347 86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165 (426)
Q Consensus 86 ~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 165 (426)
...+|+||||+.|+ +.+.+. ..+++..++.+++||+.||.|||++||+||||||+|||++.++.+|++|||+++...
T Consensus 94 ~~~~~iv~Ey~~~~-l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 94 FQDVYLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp CCEEEEEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CceeEEEEeccchH-HHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc
Confidence 47899999999765 445443 569999999999999999999999999999999999999999999999999988543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHHHcC-------------
Q 014347 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------- 232 (426)
Q Consensus 166 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------- 232 (426)
. .......+||+.|+|||++.+..+ ++++||||+||++|+|++|+.||.+.+......++...
T Consensus 171 ~---~~~~~~~~~t~~y~aPE~l~~~~~-~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 171 T---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp -------------CCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred c---ccccccccccccccChhhhcCCCC-CCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 2 334456689999999999988766 68999999999999999999999988766655554321
Q ss_pred ---------CCCC--------------C------CCCCHHHHHHHHHccccCccCCCCHHHHhcCccccccC
Q 014347 233 ---------DFKL--------------P------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275 (426)
Q Consensus 233 ---------~~~~--------------p------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 275 (426)
.... + ...++++.+||++||++||++|||++|+|+||||+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 1000 0 01367889999999999999999999999999998754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=410.86 Aligned_cols=254 Identities=27% Similarity=0.451 Sum_probs=218.9
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCC-------CeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSG-------LPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEV 82 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-------~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~ 82 (426)
+..++|++++.||+|+||.||+|++..++ ..||||+++++. .......+.+|...+.++ +||||++++++
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 44589999999999999999999976554 479999997654 233456788898888877 79999999999
Q ss_pred EEeCCEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEE
Q 014347 83 LASKSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 146 (426)
Q Consensus 83 ~~~~~~~~lV~Ey~~gg~L~~~i~~~----------------~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NIL 146 (426)
+.+++..|+||||+++|+|.++|... ..+++.+++.++.||+.||.|||++||+||||||+|||
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 167 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccccee
Confidence 99999999999999999999999754 35899999999999999999999999999999999999
Q ss_pred ecCCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHH
Q 014347 147 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVL 225 (426)
Q Consensus 147 l~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~ 225 (426)
++.++.+||+|||+++..............+||+.|+|||.+.+..| +.++|||||||++|+|++ |.+||.+.+...+
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y-~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~ 246 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCC-CchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence 99999999999999997655444444556789999999999988777 699999999999999998 7999999998888
Q ss_pred HHHHHcC-CCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 226 YQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 226 ~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
+..+..+ .++.|.++++++.+||.+||++||++|||+.|+++
T Consensus 247 ~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 247 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 8887765 56778899999999999999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-53 Score=413.55 Aligned_cols=253 Identities=27% Similarity=0.401 Sum_probs=218.0
Q ss_pred CccCCCeeeeceEeecCceEEEEEEECCCCCe--EEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEEeC
Q 014347 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLP--FAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK 86 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~--vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 86 (426)
.+.+++|++.+.||+|+||.||+|++..+|.. ||||.++... ..+..+.+.+|+.+|+++ +||||+++++++.++
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 83 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 83 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC
Confidence 35678999999999999999999999888875 6667664332 233456799999999998 699999999999999
Q ss_pred CEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCC
Q 014347 87 SKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK 150 (426)
Q Consensus 87 ~~~~lV~Ey~~gg~L~~~i~~~----------------~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~ 150 (426)
+..|+||||++||+|.++|... ..+++..+.+++.||+.||.|||++||+||||||+|||++.+
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 163 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence 9999999999999999999653 579999999999999999999999999999999999999999
Q ss_pred CCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhC-CCCCCCCcHHHHHHHH
Q 014347 151 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLAVLYQKI 229 (426)
Q Consensus 151 g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG-~~Pf~~~~~~~~~~~i 229 (426)
+.+||+|||+|+..... ......+||+.|+|||.+.+..| +.++|||||||++|+|++| .+||.+.+..+++..+
T Consensus 164 ~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~-~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i 239 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 239 (309)
T ss_dssp GCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred CceEEcccccccccccc---ccccceecCCcccchHHhccCCC-CccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 99999999999864332 22345679999999999988777 6899999999999999996 5689999999998888
Q ss_pred HcC-CCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 230 FRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 230 ~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
..+ .++.|..+++++.+||.+||+.||++|||+.+|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 240 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 775 567788899999999999999999999999999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=404.93 Aligned_cols=245 Identities=25% Similarity=0.470 Sum_probs=209.6
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe-CCEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-KSKI 89 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~ 89 (426)
+.+++|++++.||+|+||.||+|++ +|+.||||+++++. ..+.+.+|+.++++++||||+++++++.+ .+.+
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 76 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred cCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence 4567899999999999999999997 47789999996543 24678999999999999999999998854 5668
Q ss_pred EEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccc
Q 014347 90 YMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~--~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 167 (426)
|+||||+++|+|.+++...+ .+++..++.++.||+.||.|||+++|+||||||+|||++.+|.+||+|||+++...
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~-- 154 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-- 154 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC--
Confidence 99999999999999997543 58999999999999999999999999999999999999999999999999998532
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHH
Q 014347 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ 245 (426)
Q Consensus 168 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 245 (426)
......++|+.|+|||++.+..+ ++++|||||||++|||+| |++||...+...+...+..+ .+++|..+++.+.
T Consensus 155 ---~~~~~~~~~~~y~aPE~l~~~~~-t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (262)
T d1byga_ 155 ---STQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY 230 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHH
T ss_pred ---CCCccccccccCCChHHHhCCCC-ChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHH
Confidence 23345678999999999988776 699999999999999998 89999998888888888764 5778888999999
Q ss_pred HHHHHccccCccCCCCHHHHhcC
Q 014347 246 NLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 246 ~Li~~~L~~dP~~R~t~~eil~h 268 (426)
+||.+||+.||.+|||+.+++++
T Consensus 231 ~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 231 EVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcccCHhHCcCHHHHHHH
Confidence 99999999999999999999864
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-54 Score=407.88 Aligned_cols=252 Identities=27% Similarity=0.411 Sum_probs=206.8
Q ss_pred CCCeeeeceEeecCceEEEEEEEC-CCC--CeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCCEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDL-DSG--LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~-~~~--~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 89 (426)
-++|++++.||+|+||.||+|+.. .++ ..||||++++......+..+.+.+|+.+|+.++||||+++++++.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 468999999999999999999864 333 3689999987766566667889999999999999999999999976 467
Q ss_pred EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCcccc
Q 014347 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~-~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 168 (426)
++||||+++|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 899999999999988765 4579999999999999999999999999999999999999999999999999998653322
Q ss_pred CCC-ccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHcCC--CCCCCCCCHHH
Q 014347 169 DDG-LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD--FKLPKWLSPGA 244 (426)
Q Consensus 169 ~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~ 244 (426)
... .....+||+.|+|||++.+..+ +.++|||||||++|||+| |..||.+.+..+...++.+.. ++.|+.+|+.+
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 244 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred CcceecCccccCcccCCHHHHhCCCC-CcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHH
Confidence 211 2234568889999999988666 688999999999999998 899999999999888887764 45567799999
Q ss_pred HHHHHHccccCccCCCCHHHHh
Q 014347 245 QNLLRKILEPNPVKRITIAGIK 266 (426)
Q Consensus 245 ~~Li~~~L~~dP~~R~t~~eil 266 (426)
.+||.+||+.||++|||+++|+
T Consensus 245 ~~li~~cl~~dp~~RPt~~ei~ 266 (273)
T d1u46a_ 245 YNVMVQCWAHKPEDRPTFVALR 266 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHH
Confidence 9999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=406.24 Aligned_cols=254 Identities=22% Similarity=0.304 Sum_probs=222.2
Q ss_pred ccCCCeeeeceEeecCceEEEEEEECC-----CCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 85 (426)
+..++|++++.||+|+||.||+|.+.. +++.||||++++.. .......+.+|+.++++++||||+++++++..
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 445899999999999999999998752 45789999997543 33445678999999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEE
Q 014347 86 KSKIYMVLEYVTGGELFDKIASK----------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKI 155 (426)
Q Consensus 86 ~~~~~lV~Ey~~gg~L~~~i~~~----------~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL 155 (426)
+...++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++++||
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEE
Confidence 99999999999999999988642 24788999999999999999999999999999999999999999999
Q ss_pred eeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhC-CCCCCCCcHHHHHHHHHcCC-
Q 014347 156 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLAVLYQKIFRGD- 233 (426)
Q Consensus 156 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~- 233 (426)
+|||+|+..............+||+.|+|||.+.+..+ +.++|||||||++|||+|| ..||.+.+....+..+.++.
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~-~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~ 253 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 253 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCC-CcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC
Confidence 99999986544333333445579999999999988777 5889999999999999997 68999999988888887764
Q ss_pred CCCCCCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 234 FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 234 ~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
++.|+.+++.+.+||.+||+.||++|||+.+|++
T Consensus 254 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 254 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 5667889999999999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-52 Score=405.20 Aligned_cols=254 Identities=27% Similarity=0.427 Sum_probs=217.2
Q ss_pred ccCCCeeeeceEeecCceEEEEEEEC-----CCCCeEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceEEEEE
Q 014347 11 MRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA 84 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 84 (426)
+.-++|++++.||+|+||.||+|+.. .+++.||||+++... .......+.+|+.+++.+ +||||+++++++.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 34479999999999999999999853 467789999997654 334466789999999998 6999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEE
Q 014347 85 SKSKIYMVLEYVTGGELFDKIASKG------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 146 (426)
Q Consensus 85 ~~~~~~lV~Ey~~gg~L~~~i~~~~------------------~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NIL 146 (426)
++...|+|||||+||+|.+++.+.. .+++..++.++.||+.||+|||++|++||||||+|||
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl 177 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccc
Confidence 9999999999999999999997543 5899999999999999999999999999999999999
Q ss_pred ecCCCCeEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcHHHH
Q 014347 147 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVL 225 (426)
Q Consensus 147 l~~~g~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~ 225 (426)
++.++.+|++|||+++..............+||+.|+|||++.+..+ +.++|||||||++|+|+| |.+||.+.+....
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC-CCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999987654333333345689999999999987665 689999999999999998 7777877666555
Q ss_pred HHHHHcC--CCCCCCCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 226 YQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 226 ~~~i~~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
+.++... .+..|..+++.+.+||.+||++||.+|||+++|++
T Consensus 257 ~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 5444433 35566779999999999999999999999999985
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-50 Score=390.10 Aligned_cols=249 Identities=24% Similarity=0.315 Sum_probs=206.0
Q ss_pred eeeceEeecCceEEEEEEECCCC---CeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEe-CCEEEEE
Q 014347 17 ELGRTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-KSKIYMV 92 (426)
Q Consensus 17 ~i~~~LG~G~fg~Vy~a~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~lV 92 (426)
.+.++||+|+||+||+|++..++ ..||||.+++. .+....+++.+|+.+|++++||||+++++++.. +...++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 34678999999999999986643 36899998643 245557889999999999999999999999765 5689999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccCccCCccccC--
Q 014347 93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-- 169 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-- 169 (426)
||||++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||+++++.+||+|||+++.......
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 9999999999988753 4578889999999999999999999999999999999999999999999999986533211
Q ss_pred CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCC-CcHHHHHHHHHcC-CCCCCCCCCHHHHHH
Q 014347 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRG-DFKLPKWLSPGAQNL 247 (426)
Q Consensus 170 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 247 (426)
........||+.|+|||.+....+ +.++||||||+++|||+||..||.. .+.......+..+ .+..|+.+++.+.+|
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~l 266 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV 266 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ceecccccccccccChHHHhcCCC-CChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHH
Confidence 112234578999999999887776 6899999999999999997666654 4444555666555 456778899999999
Q ss_pred HHHccccCccCCCCHHHHhcC
Q 014347 248 LRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 248 i~~~L~~dP~~R~t~~eil~h 268 (426)
|.+||+.||++|||+.||++|
T Consensus 267 i~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 267 MLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-50 Score=388.12 Aligned_cols=257 Identities=22% Similarity=0.253 Sum_probs=204.5
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-cceEEEEEeCCEEEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYMV 92 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV 92 (426)
++|++++.||+|+||.||+|++..+|+.||||++..... ..++.+|+++++.++|+|+ +.+.+++.+.+..++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 479999999999999999999999999999999876432 2357889999999987665 5556667888999999
Q ss_pred EeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecC---CCCeEEeeccCccCCcccc
Q 014347 93 LEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KGNIKISDFGLSALPQHFR 168 (426)
Q Consensus 93 ~Ey~~gg~L~~~i~-~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~---~g~vkL~DFGla~~~~~~~ 168 (426)
|||+ +++|.+.+. ..+.+++..+..++.|++.||+|||++||+||||||+|||++. +..+||+|||+|+......
T Consensus 82 me~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 9999 556666654 4568999999999999999999999999999999999999864 4579999999998654322
Q ss_pred C-----CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHHHHHHHH---HcCC-----CC
Q 014347 169 D-----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI---FRGD-----FK 235 (426)
Q Consensus 169 ~-----~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i---~~~~-----~~ 235 (426)
. .....+.+||+.|+|||++.+.++ +.++|||||||++|+|++|..||.+.........+ .... ..
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCC-CHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCC-CChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH
Confidence 1 122345689999999999988776 68999999999999999999999875543322221 1111 12
Q ss_pred CCCCCCHHHHHHHHHccccCccCCCCHH---HHhcCccccccCCC
Q 014347 236 LPKWLSPGAQNLLRKILEPNPVKRITIA---GIKADEWFEQDYTP 277 (426)
Q Consensus 236 ~p~~~s~~~~~Li~~~L~~dP~~R~t~~---eil~h~~f~~~~~~ 277 (426)
.++.+|+++.+||.+||+.||++||+++ ++++|+|.+..+..
T Consensus 240 ~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~ 284 (299)
T d1ckia_ 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 284 (299)
T ss_dssp HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCC
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCC
Confidence 3456899999999999999999999987 45788877665543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.9e-49 Score=378.40 Aligned_cols=248 Identities=19% Similarity=0.220 Sum_probs=206.9
Q ss_pred CCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCC-CCccceEEEEEeCCEEEE
Q 014347 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~l 91 (426)
-++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|++.++.+.| +|++.+++++......|+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 4699999999999999999999999999999999865432 2356789999999975 899999999999999999
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecC-----CCCeEEeeccCccCCc
Q 014347 92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-----KGNIKISDFGLSALPQ 165 (426)
Q Consensus 92 V~Ey~~gg~L~~~i~~~-~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~-----~g~vkL~DFGla~~~~ 165 (426)
||||+ |++|.+.+... ..+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99999 78999988764 47999999999999999999999999999999999999974 5789999999998654
Q ss_pred cccC-----CCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCc---HHHHHHHHHcCC----
Q 014347 166 HFRD-----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGD---- 233 (426)
Q Consensus 166 ~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~---- 233 (426)
.... .....+.+||+.|+|||++.+..+ ++++|||||||++|+|++|+.||.+.. ....+.++....
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~-~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCC-ChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 3211 123445689999999999988776 689999999999999999999997543 333333333221
Q ss_pred -CCCCCCCCHHHHHHHHHccccCccCCCCHHHHhc
Q 014347 234 -FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267 (426)
Q Consensus 234 -~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 267 (426)
..+++.+|+++.+++..|+..+|++||+.+.+.+
T Consensus 237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 1233568899999999999999999999877644
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=375.82 Aligned_cols=248 Identities=24% Similarity=0.318 Sum_probs=193.6
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceEEEEEeCC----EE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----KI 89 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~~ 89 (426)
.+|.+.+.||+|+||.||+|+. +|+.||||+++.... .....++|+..++.++||||+++++++.+.+ .+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 4789999999999999999985 688999999864421 1122334555666789999999999997654 68
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh--------cCceeccCCCCcEEecCCCCeEEeeccCc
Q 014347 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN--------KGVFHRDLKLENILLDSKGNIKISDFGLS 161 (426)
Q Consensus 90 ~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~--------~gIiHrDLKp~NILl~~~g~vkL~DFGla 161 (426)
|+||||+++|+|.+++.+ .++++.....++.|++.||.|||+ +||+||||||+||||+.+|++||+|||++
T Consensus 77 ~lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 999999999999999986 569999999999999999999996 59999999999999999999999999999
Q ss_pred cCCccccC--CCccccccCCCcccchhhhccCCC-----CCCcchhhhHHHHHHHHHhCCCCCCC---------------
Q 014347 162 ALPQHFRD--DGLLHTTCGSPNYVAPEVLANRGY-----DGATSDIWSCGVILYVILTGYLPFDD--------------- 219 (426)
Q Consensus 162 ~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~-----~~~~~DIwSlGvil~elltG~~Pf~~--------------- 219 (426)
+....... .......+||+.|+|||++.+... .+.++|||||||+||||+||..||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 85433211 123345789999999999875431 25689999999999999999887732
Q ss_pred CcHHHHHHHHHcCCC--CCCCC-----CCHHHHHHHHHccccCccCCCCHHHHhcC
Q 014347 220 RNLAVLYQKIFRGDF--KLPKW-----LSPGAQNLLRKILEPNPVKRITIAGIKAD 268 (426)
Q Consensus 220 ~~~~~~~~~i~~~~~--~~p~~-----~s~~~~~Li~~~L~~dP~~R~t~~eil~h 268 (426)
.+............. .+|.. ....+.+|+.+||+.||++|||+.||+++
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 123333333333332 33332 22358899999999999999999999763
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-47 Score=377.42 Aligned_cols=251 Identities=25% Similarity=0.437 Sum_probs=197.9
Q ss_pred CCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-----------CCCccceEEE
Q 014347 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-----------HPNVVRLHEV 82 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----------hpnIv~l~~~ 82 (426)
|||+++++||+|+||+||+|+++.+|+.||||+++++. ...+.+.+|+.+++.++ |+||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 57999999999999999999999999999999997643 23467788999988775 5789999988
Q ss_pred EEe--CCEEEEEEeccCCCChHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHhh-cCceeccCCCCcEEecCCCC----
Q 014347 83 LAS--KSKIYMVLEYVTGGELFDKIA---SKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGN---- 152 (426)
Q Consensus 83 ~~~--~~~~~lV~Ey~~gg~L~~~i~---~~~~l~~~~~~~i~~Ql~~aL~~LH~-~gIiHrDLKp~NILl~~~g~---- 152 (426)
+.. ....+++|+++..+....... ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence 754 466777887776655433332 34579999999999999999999998 89999999999999987664
Q ss_pred --eEEeeccCccCCccccCCCccccccCCCcccchhhhccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCcHH------H
Q 014347 153 --IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA------V 224 (426)
Q Consensus 153 --vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~------~ 224 (426)
+|++|||.|.... ......+||+.|+|||++....| +.++||||+||++++|++|+.||...+.. .
T Consensus 169 ~~~kl~dfg~s~~~~-----~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 169 IQIKIADLGNACWYD-----EHYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp EEEEECCCTTCEETT-----BCCCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred ceeeEeecccccccc-----cccccccccccccChhhccccCC-CccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 9999999987432 23356789999999999988777 58999999999999999999999754321 0
Q ss_pred HHHHH---Hc---------------------------------------CCCCCCCCCCHHHHHHHHHccccCccCCCCH
Q 014347 225 LYQKI---FR---------------------------------------GDFKLPKWLSPGAQNLLRKILEPNPVKRITI 262 (426)
Q Consensus 225 ~~~~i---~~---------------------------------------~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~ 262 (426)
..... .. .....+...++.+.+||.+||++||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 11100 00 0111122246789999999999999999999
Q ss_pred HHHhcCcccccc
Q 014347 263 AGIKADEWFEQD 274 (426)
Q Consensus 263 ~eil~h~~f~~~ 274 (426)
+|+|+||||++.
T Consensus 323 ~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 323 GGLVNHPWLKDT 334 (362)
T ss_dssp HHHHTCGGGTTC
T ss_pred HHHhcCcccCCC
Confidence 999999999854
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=1.2e-26 Score=207.74 Aligned_cols=136 Identities=20% Similarity=0.272 Sum_probs=109.1
Q ss_pred eeeeceEeecCceEEEEEEECCCCCeEEEEEeeccccc---------------chhHHHHHHHHHHHHHhCCCCCccceE
Q 014347 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---------------HLKITDQIKREIATLKLLKHPNVVRLH 80 (426)
Q Consensus 16 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---------------~~~~~~~~~~Ei~il~~l~hpnIv~l~ 80 (426)
|.++++||+|+||.||+|++ .+|+.||||+++..... .........+|...+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 56899999999999999998 47899999987532110 011123456789999999999999988
Q ss_pred EEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceeccCCCCcEEecCCCCeEEeeccC
Q 014347 81 EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL 160 (426)
Q Consensus 81 ~~~~~~~~~~lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~~gIiHrDLKp~NILl~~~g~vkL~DFGl 160 (426)
++.. .+++|||+++..+.+ ++...+..++.|++.+|.|||++||+||||||+|||+++++ ++|+|||+
T Consensus 81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~ 148 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQ 148 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTT
T ss_pred EecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCC
Confidence 7632 379999998866532 56667788999999999999999999999999999998655 89999999
Q ss_pred ccCC
Q 014347 161 SALP 164 (426)
Q Consensus 161 a~~~ 164 (426)
|...
T Consensus 149 a~~~ 152 (191)
T d1zara2 149 SVEV 152 (191)
T ss_dssp CEET
T ss_pred cccC
Confidence 8743
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.68 E-value=3.4e-08 Score=90.02 Aligned_cols=141 Identities=15% Similarity=0.111 Sum_probs=97.7
Q ss_pred cCCCeeeeceEeecCceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceEEEEEeCCEEE
Q 014347 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 90 (426)
.++.|+..+..+.++.+.||+.. ..++.+.+|......... ...+.+|...++.+. +--+.+++.+...++..|
T Consensus 12 ~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 12 LIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred hhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 45788888876666678999875 456678888875443222 235678888887764 434667888888899999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh--------------------------------------
Q 014347 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-------------------------------------- 132 (426)
Q Consensus 91 lV~Ey~~gg~L~~~i~~~~~l~~~~~~~i~~Ql~~aL~~LH~-------------------------------------- 132 (426)
+||++++|..+.+.... ......+..++...+..||+
T Consensus 87 lv~~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EEEECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred EEEEecccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccc
Confidence 99999999877554321 11123334445555555553
Q ss_pred ---------------------cCceeccCCCCcEEecCCCCeEEeeccCcc
Q 014347 133 ---------------------KGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (426)
Q Consensus 133 ---------------------~gIiHrDLKp~NILl~~~g~vkL~DFGla~ 162 (426)
..++|+|+.|.|||+++++..-|.||+.+.
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 137899999999999877666799999776
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.26 E-value=1.2e-06 Score=84.99 Aligned_cols=81 Identities=17% Similarity=0.144 Sum_probs=50.9
Q ss_pred eceEeecCceEEEEEEECCCCCeEEEEEeecccccc----hhHHHHHHHHHHHHHhCC-C--CCccceEEEEEeCCEEEE
Q 014347 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH----LKITDQIKREIATLKLLK-H--PNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~----~~~~~~~~~Ei~il~~l~-h--pnIv~l~~~~~~~~~~~l 91 (426)
.+.||.|....||++.+..+++.|++|.-....... ....++...|...|+.+. + ..+.+++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 557899999999999987788899999643211000 112345677888887663 2 335555544 4555678
Q ss_pred EEeccCCCCh
Q 014347 92 VLEYVTGGEL 101 (426)
Q Consensus 92 V~Ey~~gg~L 101 (426)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987554
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.22 E-value=1e-06 Score=79.46 Aligned_cols=80 Identities=18% Similarity=0.157 Sum_probs=54.6
Q ss_pred CCeeeeceEeecC-ceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCC--CCccceEEEEEeCCEEE
Q 014347 14 GRYELGRTLGEGN-FGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH--PNVVRLHEVLASKSKIY 90 (426)
Q Consensus 14 ~~y~i~~~LG~G~-fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~ 90 (426)
..++.. .+..|. -+.||+... ..+..+.+|.-.... ...+.+|...++.+.. -.+.+++.+..+++..+
T Consensus 11 ~g~~~~-~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~ 82 (255)
T d1nd4a_ 11 FGYDWA-QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW 82 (255)
T ss_dssp TTCEEE-ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred cCCceE-EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceE
Confidence 344443 334444 468998874 567778999765432 2346778888877653 23567788888888999
Q ss_pred EEEeccCCCCh
Q 014347 91 MVLEYVTGGEL 101 (426)
Q Consensus 91 lV~Ey~~gg~L 101 (426)
+||++++|.++
T Consensus 83 ~v~~~i~G~~~ 93 (255)
T d1nd4a_ 83 LLLGEVPGQDL 93 (255)
T ss_dssp EEEECCSSEET
T ss_pred EEEEeeecccc
Confidence 99999998665
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.15 E-value=3.4e-06 Score=65.27 Aligned_cols=73 Identities=7% Similarity=0.015 Sum_probs=64.9
Q ss_pred ccccccccCHHHHHHHHHHHHHHcCcEEEEe-CCeEEE----eecCCceEEEEEEEEee-cceeEEeeechhhhhhhhh
Q 014347 340 KIRFTSNHSAKDLLERIEDIVTEMGFRVQKK-NGKVNI----SSQLTHFNIKTSVISNI-NYVIYHKSINLTMCILMYL 412 (426)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 412 (426)
....||..+|++|+.+|+.+++.+|+.++++ ++.++. .++++.+.|.+|||++. +++.-++...++++.+.|.
T Consensus 12 sv~tTS~~~P~eIm~eI~rvL~~lgv~~~~~g~y~l~c~~~~~~~~~~v~fEieV~kv~~~~l~gv~~kR~~Gd~~~yk 90 (102)
T d1ul7a_ 12 SMKTTSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFK 90 (102)
T ss_dssp CCCCCBCSCHHHHHHHHHHHHHHTTCEEEECSTTCEEEEECSSCGGGCEEEEEEEEECSSSSSEEEEEEEEESCHHHHH
T ss_pred eeecCcCCCHHHHHHHHHHHHHHcCcEEEEcCCEEEEEEecCCCCCceEEEEEEEEEcCCCceEEEEEEEccCCHHHHH
Confidence 3557899999999999999999999999887 688888 45567899999999996 7999999999999999995
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.30 E-value=0.0005 Score=64.00 Aligned_cols=69 Identities=26% Similarity=0.279 Sum_probs=44.9
Q ss_pred ceEEEEEEECCCCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-----cce--EEEEEeCCEEEEEEeccCCC
Q 014347 27 FGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-----VRL--HEVLASKSKIYMVLEYVTGG 99 (426)
Q Consensus 27 fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-----v~l--~~~~~~~~~~~lV~Ey~~gg 99 (426)
--.||+++. .+|+.|++|+.+..... .+++..|...+..|...++ +.. -..+......+.+++++.|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 357999884 67889999997644321 3567778888877652221 111 11234577889999999874
Q ss_pred C
Q 014347 100 E 100 (426)
Q Consensus 100 ~ 100 (426)
.
T Consensus 110 ~ 110 (325)
T d1zyla1 110 Q 110 (325)
T ss_dssp E
T ss_pred C
Confidence 3
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.08 E-value=0.0011 Score=63.33 Aligned_cols=74 Identities=11% Similarity=0.131 Sum_probs=49.8
Q ss_pred eceEeecCceEEEEEEECC-------CCCeEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-cceEEEEEeCCEEE
Q 014347 19 GRTLGEGNFGKVKFAQDLD-------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIY 90 (426)
Q Consensus 19 ~~~LG~G~fg~Vy~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~ 90 (426)
++.|+.|-.-.+|++.... .++.|.+++.-... . .....+|..+++.+.-.++ .++++++.+ .
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--h---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 4678889999999998653 24567888764211 1 2345689999998863344 467776642 5
Q ss_pred EEEeccCCCCh
Q 014347 91 MVLEYVTGGEL 101 (426)
Q Consensus 91 lV~Ey~~gg~L 101 (426)
+|+||++|..|
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 78999988544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.67 E-value=0.0032 Score=57.63 Aligned_cols=30 Identities=27% Similarity=0.400 Sum_probs=27.0
Q ss_pred cCceeccCCCCcEEecCCCCeEEeeccCcc
Q 014347 133 KGVFHRDLKLENILLDSKGNIKISDFGLSA 162 (426)
Q Consensus 133 ~gIiHrDLKp~NILl~~~g~vkL~DFGla~ 162 (426)
.|+||+|+.++|++++.+...-|.||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 579999999999999988777899999876
|
| >d2v8qa1 d.129.6.2 (A:396-548) 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=91.88 E-value=0.29 Score=38.89 Aligned_cols=66 Identities=6% Similarity=0.057 Sum_probs=51.5
Q ss_pred cccccCHHHHHHHHHHHHHHcCcEEEEe-CCeEEEeec----CCceEEEEEEEEeecceeEEeeechhhhh
Q 014347 343 FTSNHSAKDLLERIEDIVTEMGFRVQKK-NGKVNISSQ----LTHFNIKTSVISNINYVIYHKSINLTMCI 408 (426)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (426)
+.|+..|.+|+..|..+.+.||+.|++. .+.|++... ...+.+..++|++-+.-+-+..-++..-.
T Consensus 5 IrS~s~P~dIM~eVyrALk~L~~eWk~~~~y~ir~R~~~~~~~~~~Km~lQLYqv~~~~YLLDfk~i~~~~ 75 (153)
T d2v8qa1 5 IRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEI 75 (153)
T ss_dssp EEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC-
T ss_pred cccCCCHHHHHHHHHHHHHHcCCeEEecCceEEEEEEECCCCCceeEEEEEEEEEcCCceEEEeeecCcch
Confidence 4577889999999999999999999988 788888322 34678888999998877666665555443
|
| >d2qrda1 d.129.6.2 (A:450-576) Snf1-like protein kinase ssp2 {Schizosaccharomyces pombe [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Snf1-like protein kinase ssp2 species: Schizosaccharomyces pombe [TaxId: 4896]
Probab=80.94 E-value=1.8 Score=33.22 Aligned_cols=61 Identities=8% Similarity=0.011 Sum_probs=45.4
Q ss_pred cccccccCHHHHHHHHHHHHHHcCcEEEEeC----------CeEEEee---------cCCceEEEEEEEEeecceeEEee
Q 014347 341 IRFTSNHSAKDLLERIEDIVTEMGFRVQKKN----------GKVNISS---------QLTHFNIKTSVISNINYVIYHKS 401 (426)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~ 401 (426)
.-+-|+..|-+|+-.|..+.+.+|+.|++.+ +.|++.- ....+.+..++|++-+.-+-+--
T Consensus 5 fGIRSrs~P~eiM~eVYrALk~Lg~eWk~~~~~~~~~~~d~y~Ir~R~~~~~~~~~~~~~~vkm~iQLYqve~~~YLlDF 84 (127)
T d2qrda1 5 FGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFMLDV 84 (127)
T ss_dssp ESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEEEEE
T ss_pred eccccCCChHHHHHHHHHHHHHcCCEEeecCcccccccCCceEEEEEeecCCccccCCCceEEEEEEEEEEcCCcEEEEE
Confidence 3455889999999999999999999998763 5677721 12346778888998776655543
|